sampleID AJCC_Stage_nature2012 Age_at_Initial_Pathologic_Diagnosis_nature2012 CN_Clusters_nature2012 Converted_Stage_nature2012 Days_to_Date_of_Last_Contact_nature2012 Days_to_date_of_Death_nature2012 ER_Status_nature2012 Gender_nature2012 HER2_Final_Status_nature2012 Integrated_Clusters_no_exp__nature2012 Integrated_Clusters_unsup_exp__nature2012 Integrated_Clusters_with_PAM50__nature2012 Metastasis_Coded_nature2012 Metastasis_nature2012 Node_Coded_nature2012 Node_nature2012 OS_Time_nature2012 OS_event_nature2012 PAM50Call_RNAseq PAM50_mRNA_nature2012 PR_Status_nature2012 RPPA_Clusters_nature2012 SigClust_Intrinsic_mRNA_nature2012 SigClust_Unsupervised_mRNA_nature2012 Survival_Data_Form_nature2012 Tumor_T1_Coded_nature2012 Tumor_nature2012 Vital_Status_nature2012 _INTEGRATION _PANCAN_CNA_PANCAN_K8 _PANCAN_Cluster_Cluster_PANCAN _PANCAN_DNAMethyl_BRCA _PANCAN_DNAMethyl_PANCAN _PANCAN_RPPA_PANCAN_K8 _PANCAN_UNC_RNAseq_PANCAN_K16 _PANCAN_miRNA_PANCAN _PANCAN_mirna_BRCA _PANCAN_mutation_PANCAN _PATIENT _cohort _primary_disease _primary_site additional_pharmaceutical_therapy additional_radiation_therapy additional_surgery_locoregional_procedure additional_surgery_metastatic_procedure age_at_initial_pathologic_diagnosis anatomic_neoplasm_subdivision axillary_lymph_node_stage_method_type axillary_lymph_node_stage_other_method_descriptive_text bcr_followup_barcode bcr_patient_barcode bcr_sample_barcode breast_cancer_surgery_margin_status breast_carcinoma_estrogen_receptor_status breast_carcinoma_immunohistochemistry_er_pos_finding_scale breast_carcinoma_immunohistochemistry_pos_cell_score breast_carcinoma_immunohistochemistry_prgstrn_rcptr_ps_fndng_scl breast_carcinoma_primary_surgical_procedure_name breast_carcinoma_progesterone_receptor_status breast_carcinoma_surgical_procedure_name breast_neoplasm_other_surgical_procedure_descriptive_text cytokeratin_immunohistochemistry_staining_method_mcrmtstss_ndctr days_to_additional_surgery_locoregional_procedure days_to_additional_surgery_metastatic_procedure days_to_birth days_to_collection days_to_death days_to_initial_pathologic_diagnosis days_to_last_followup days_to_last_known_alive days_to_new_tumor_event_additional_surgery_procedure days_to_new_tumor_event_after_initial_treatment disease_code distant_metastasis_present_ind2 er_detection_method_text er_level_cell_percentage_category fluorescence_in_st_hybrdztn_dgnstc_prcdr_chrmsm_17_sgnl_rslt_rng followup_case_report_form_submission_reason form_completion_date gender her2_and_centromere_17_positive_finding_other_measuremnt_scl_txt her2_erbb_method_calculation_method_text her2_erbb_pos_finding_cell_percent_category her2_erbb_pos_finding_fluorescence_n_st_hybrdztn_clcltn_mthd_txt her2_immunohistochemistry_level_result her2_neu_and_centromere_17_copy_number_analysis_npt_ttl_nmbr_cnt her2_neu_breast_carcinoma_copy_analysis_input_total_number her2_neu_chromosone_17_signal_ratio_value her2_neu_metastatic_breast_carcinoma_copy_analysis_inpt_ttl_nmbr histological_type histological_type_other history_of_neoadjuvant_treatment hr2_n_nd_cntrmr_17_cpy_nmbr_mtsttc_brst_crcnm_nlyss_npt_ttl_nmbr icd_10 icd_o_3_histology icd_o_3_site immunohistochemistry_positive_cell_score informed_consent_verified init_pathology_dx_method_other initial_pathologic_diagnosis_method initial_weight is_ffpe lab_proc_her2_neu_immunohistochemistry_receptor_status lab_procedure_her2_neu_in_situ_hybrid_outcome_type lost_follow_up lymph_node_examined_count margin_status menopause_status metastatic_breast_carcinm_ps_fndng_prgstrn_rcptr_thr_msr_scl_txt metastatic_breast_carcinom_lb_prc_hr2_n_mmnhstchmstry_rcptr_stts metastatic_breast_carcinoma_erbb2_immunohistochemistry_levl_rslt metastatic_breast_carcinoma_estrogen_receptor_detection_mthd_txt metastatic_breast_carcinoma_estrogen_receptor_status metastatic_breast_carcinoma_estrogen_receptr_lvl_cll_prcnt_ctgry metastatic_breast_carcinoma_her2_erbb_method_calculatin_mthd_txt metastatic_breast_carcinoma_her2_erbb_pos_findng_cll_prcnt_ctgry metastatic_breast_carcinoma_her2_neu_chromosone_17_signal_rat_vl metastatic_breast_carcinoma_immunhstchmstry_r_pstv_fndng_scl_typ metastatic_breast_carcinoma_immunohistochemistry_er_pos_cell_scr metastatic_breast_carcinoma_immunohistochemistry_pr_pos_cell_scr metastatic_breast_carcinoma_lab_proc_hr2_n_n_st_hybrdztn_tcm_typ metastatic_breast_carcinoma_pos_finding_hr2_rbb2_thr_msr_scl_txt metastatic_breast_carcinoma_progestern_rcptr_lvl_cll_prcnt_ctgry metastatic_breast_carcinoma_progesterone_receptor_dtctn_mthd_txt metastatic_breast_carcinoma_progesterone_receptor_status metastatic_site_at_diagnosis metastatic_site_at_diagnosis_other methylation_Clusters_nature2012 miRNA_Clusters_nature2012 mtsttc_brst_crcnm_flrscnc_n_st_hybrdztn_dgnstc_prc_cntrmr_17_sgn mtsttc_brst_crcnm_hr2_rbb_ps_fndng_flrscnc_n_st_hybrdztn_clcltn mtsttc_brst_crcnm_mmnhstchmstry_prgstrn_rcptr_pstv_fndng_scl_typ new_neoplasm_event_occurrence_anatomic_site new_neoplasm_event_type new_neoplasm_occurrence_anatomic_site_text new_tumor_event_additional_surgery_procedure new_tumor_event_after_initial_treatment number_of_lymphnodes_positive_by_he number_of_lymphnodes_positive_by_ihc oct_embedded other_dx pathologic_M pathologic_N pathologic_T pathologic_stage pathology_report_file_name patient_id person_neoplasm_cancer_status pgr_detection_method_text pos_finding_her2_erbb2_other_measurement_scale_text pos_finding_metastatic_brst_crcnm_strgn_rcptr_thr_msrmnt_scl_txt pos_finding_progesterone_receptor_other_measurement_scale_text positive_finding_estrogen_receptor_other_measurement_scale_text postoperative_rx_tx primary_lymph_node_presentation_assessment progesterone_receptor_level_cell_percent_category project_code radiation_therapy sample_type sample_type_id surgical_procedure_purpose_other_text system_version targeted_molecular_therapy tissue_prospective_collection_indicator tissue_retrospective_collection_indicator tissue_source_site tumor_tissue_site vial_number vital_status year_of_initial_pathologic_diagnosis _GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_exon _GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_PANCAN _GENOMIC_ID_TCGA_BRCA_RPPA_RBN _GENOMIC_ID_TCGA_BRCA_mutation _GENOMIC_ID_TCGA_BRCA_PDMRNAseq _GENOMIC_ID_TCGA_BRCA_hMethyl450 _GENOMIC_ID_TCGA_BRCA_RPPA _GENOMIC_ID_TCGA_BRCA_PDMRNAseqCNV _GENOMIC_ID_TCGA_BRCA_mutation_curated_wustl_gene _GENOMIC_ID_TCGA_BRCA_hMethyl27 _GENOMIC_ID_TCGA_BRCA_PDMarrayCNV _GENOMIC_ID_TCGA_BRCA_miRNA_HiSeq _GENOMIC_ID_TCGA_BRCA_mutation_wustl_gene _GENOMIC_ID_TCGA_BRCA_miRNA_GA _GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2_percentile _GENOMIC_ID_data/public/TCGA/BRCA/miRNA_GA_gene _GENOMIC_ID_TCGA_BRCA_gistic2thd _GENOMIC_ID_data/public/TCGA/BRCA/miRNA_HiSeq_gene _GENOMIC_ID_TCGA_BRCA_G4502A_07_3 _GENOMIC_ID_TCGA_BRCA_exp_HiSeqV2 _GENOMIC_ID_TCGA_BRCA_gistic2 _GENOMIC_ID_TCGA_BRCA_PDMarray TCGA-3C-AAAU-01 TCGA-3C-AAAU-01 TCGA-3C-AAAU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-3C-AAAU-F68069 TCGA-3C-AAAU TCGA-3C-AAAU-01A Positive Positive Modified Radical Mastectomy YES -20211 3599 0 4047 1808 50-59% 2015-3-24 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 60 NO Negative NO 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Lung Distant Metastasis NO 4 true No MX NX TX Stage X TCGA-3C-AAAU.0CD23E1B-3FA3-4A43-AE6E-C8E7B51252F8.pdf AAAU WITH TUMOR NO YES 50-59% NO Primary Tumor 01 6th NO YES 3C Breast A LIVING 2004 6ef883fc-81f3-4089-95e0-86904ffc0d38 6ef883fc-81f3-4089-95e0-86904ffc0d38 TCGA-3C-AAAU-01 TCGA-3C-AAAU-01A-11D-A41Q-05 TCGA-3C-AAAU-01 TCGA-3C-AAAU-01 6ef883fc-81f3-4089-95e0-86904ffc0d38 TCGA-3C-AAAU-01A-11D-A41E-01 TCGA-3C-AAAU-01 6ef883fc-81f3-4089-95e0-86904ffc0d38 TCGA-3C-AAAU-01A-11D-A41E-01 TCGA-3C-AALI-01 TCGA-3C-AALI-01 TCGA-3C-AALI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-3C-AALI-F68057 TCGA-3C-AALI TCGA-3C-AALI-01A Positive Positive Lumpectomy -18538 3772 0 4005 <10% 2014-11-13 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Positive NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No M0 N1a T2 Stage IIB TCGA-3C-AALI.84E6A935-1A49-4BC1-9669-3DEA161CF6FC.pdf AALI TUMOR FREE YES YES <10% YES Primary Tumor 01 6th NO YES 3C Breast A LIVING 2003 dd8d3665-ec9d-45be-b7b9-a85dac3585e2 dd8d3665-ec9d-45be-b7b9-a85dac3585e2 TCGA-3C-AALI-01 TCGA-3C-AALI-01A-11D-A41Q-05 1B37DE89-DEB6-4049-A2D4-450A4A1DE5D3 TCGA-3C-AALI-01 TCGA-3C-AALI-01 dd8d3665-ec9d-45be-b7b9-a85dac3585e2 TCGA-3C-AALI-01A-11D-A41E-01 TCGA-3C-AALI-01 dd8d3665-ec9d-45be-b7b9-a85dac3585e2 TCGA-3C-AALI-01A-11D-A41E-01 TCGA-3C-AALJ-01 TCGA-3C-AALJ-01 TCGA-3C-AALJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right TCGA-3C-AALJ-F71675 TCGA-3C-AALJ Positive Positive Modified Radical Mastectomy -22848 0 1474 90-99% 2015-3-27 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Indeterminate NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 No M0 N1a T2 Stage IIB AALJ TUMOR FREE NO YES 30-39% NO Primary Tumor 01 7th NO YES 3C Breast LIVING 2011 c924c2a8-ab41-4499-bb30-79705cc17d45 c924c2a8-ab41-4499-bb30-79705cc17d45 TCGA-3C-AALJ-01 TCGA-3C-AALJ-01A-31D-A41Q-05 TCGA-3C-AALJ-01 TCGA-3C-AALJ-01 c924c2a8-ab41-4499-bb30-79705cc17d45 TCGA-3C-AALJ-01A-31D-A41E-01 TCGA-3C-AALJ-01 c924c2a8-ab41-4499-bb30-79705cc17d45 TCGA-3C-AALJ-01A-31D-A41E-01 TCGA-3C-AALK-01 TCGA-3C-AALK-01 TCGA-3C-AALK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Sentinel node biopsy alone TCGA-3C-AALK-F71676 TCGA-3C-AALK TCGA-3C-AALK-01A Positive Positive Simple Mastectomy YES -19074 1022 0 1448 70-79% 2015-3-27 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 140 NO Positive NO 2 Close NO 0 1 true No M0 N0 (i+) T1c Stage IA TCGA-3C-AALK.F43B01E6-E1DB-44B1-8003-93870606346A.pdf AALK TUMOR FREE NO YES 80-89% NO Primary Tumor 01 7th NO YES 3C Breast A LIVING 2011 1a19e068-d213-41ef-aebb-104017a883cc 1a19e068-d213-41ef-aebb-104017a883cc TCGA-3C-AALK-01 TCGA-3C-AALK-01A-11D-A41Q-05 4B79D851-B233-49F8-95B1-B4AA057D7FD2 TCGA-3C-AALK-01 TCGA-3C-AALK-01 1a19e068-d213-41ef-aebb-104017a883cc TCGA-3C-AALK-01A-11D-A41E-01 TCGA-3C-AALK-01 1a19e068-d213-41ef-aebb-104017a883cc TCGA-3C-AALK-01A-11D-A41E-01 TCGA-4H-AAAK-01 TCGA-4H-AAAK-01 TCGA-4H-AAAK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left|Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-4H-AAAK-F67414 TCGA-4H-AAAK TCGA-4H-AAAK-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy NO -18371 35 0 348 60-69% 2014-11-13 FEMALE 10-19% 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Core needle biopsy 770 NO Equivocal NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 4 true No M0 N2a T2 Stage IIIA TCGA-4H-AAAK.8894688F-7167-48A1-BB1B-FC219B7675C2.pdf AAAK TUMOR FREE YES YES 70-79% NO Primary Tumor 01 7th YES NO 4H Breast A LIVING 2013 2ea9e472-a408-4ae0-975d-50a566f22b2a 2ea9e472-a408-4ae0-975d-50a566f22b2a TCGA-4H-AAAK-01 TCGA-4H-AAAK-01A-12D-A41Q-05 C1C10723-C328-4CAB-9959-E98025E4CD71 TCGA-4H-AAAK-01 TCGA-4H-AAAK-01 2ea9e472-a408-4ae0-975d-50a566f22b2a TCGA-4H-AAAK-01A-12D-A41E-01 TCGA-4H-AAAK-01 2ea9e472-a408-4ae0-975d-50a566f22b2a TCGA-4H-AAAK-01A-12D-A41E-01 TCGA-5L-AAT0-01 TCGA-5L-AAT0-01 TCGA-5L-AAT0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Right|Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-5L-AAT0 TCGA-5L-AAT0-01A Positive Positive Modified Radical Mastectomy NO -15393 1320 0 1477 70-79% 2014-8-15 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Incisional Biopsy 80 NO Negative 8 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false Yes M0 N0 T2 Stage IIA TCGA-5L-AAT0.F9B6971F-23C0-465F-BFEC-778BF228A1AE.pdf AAT0 TUMOR FREE YES YES 50-59% YES Primary Tumor 01 7th NO YES 5L Breast A LIVING 2010 32e61645-eb89-49f7-9876-85b1497c7e42 32e61645-eb89-49f7-9876-85b1497c7e42 TCGA-5L-AAT0-01 TCGA-5L-AAT0-01A-12D-A41Q-05 TCGA-5L-AAT0-01 TCGA-5L-AAT0-01 32e61645-eb89-49f7-9876-85b1497c7e42 TCGA-5L-AAT0-01A-12D-A41E-01 TCGA-5L-AAT0-01 32e61645-eb89-49f7-9876-85b1497c7e42 TCGA-5L-AAT0-01A-12D-A41E-01 TCGA-5L-AAT1-01 TCGA-5L-AAT1-01 TCGA-5L-AAT1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Other (specify) Level 1 clearance TCGA-5L-AAT1 TCGA-5L-AAT1-01A Positive Positive Simple Mastectomy NO -23225 1259 0 1471 80-89% 2014-8-15 FEMALE CISH 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 130 NO Equivocal 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone NO 0 false Yes M1 N0 T2 Stage IV TCGA-5L-AAT1.B5CA42BB-9514-42C6-9FB0-C8889C1DC51A.pdf AAT1 WITH TUMOR CISH YES YES 10-19% NO Primary Tumor 01 7th NO YES 5L Breast A LIVING 2010 34dfa8c6-6445-4ef8-bc3b-b2ba600b5808 34dfa8c6-6445-4ef8-bc3b-b2ba600b5808 TCGA-5L-AAT1-01 TCGA-5L-AAT1-01A-12D-A41Q-05 047431B7-6180-49AB-9DD0-D23D794F2953 TCGA-5L-AAT1-01 34dfa8c6-6445-4ef8-bc3b-b2ba600b5808 TCGA-5L-AAT1-01A-12D-A41E-01 34dfa8c6-6445-4ef8-bc3b-b2ba600b5808 TCGA-5L-AAT1-01A-12D-A41E-01 TCGA-5T-A9QA-01 TCGA-5T-A9QA-01 TCGA-5T-A9QA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left No axillary staging TCGA-5T-A9QA-F66889 TCGA-5T-A9QA TCGA-5T-A9QA-01A Positive 3 Point Scale Negative NO -19031 31 0 303 70-79% 2014-10-25 FEMALE 10-19% 2+ Other, specify No C50.9 8523/3 C50.9 2+ YES Excisional Biopsy 650 NO Equivocal Negative NO NO true No MX NX T2 Stage IIA TCGA-5T-A9QA.2DB5519B-B36D-4616-94F3-601A01185F22.pdf A9QA YES NO YES Primary Tumor 01 7th YES NO 5T Breast A LIVING 2013 41ab76d7-fae0-490c-9545-be576b64b827 41ab76d7-fae0-490c-9545-be576b64b827 TCGA-5T-A9QA-01 TCGA-5T-A9QA-01A-11D-A41Q-05 9E71A150-8FD7-466C-96AF-AAB29520BCDC TCGA-5T-A9QA-01 TCGA-5T-A9QA-01 41ab76d7-fae0-490c-9545-be576b64b827 TCGA-5T-A9QA-01A-11D-A41E-01 TCGA-5T-A9QA-01 41ab76d7-fae0-490c-9545-be576b64b827 TCGA-5T-A9QA-01A-11D-A41E-01 TCGA-A1-A0SB-01 Stage I 70 1 Stage I 259 Positive FEMALE Negative Negative M0 Negative N0 259 0 Normal Negative enrollment T1 T1 LIVING TCGA-A1-A0SB-01 Kirc+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-A1-A0SB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Left Sentinel node biopsy alone TCGA-A1-A0SB Positive Negative Lumpectomy -25833 0 259 NO 70-79% 2011-6-30 FEMALE Other, specify No C50.9 8200/3 C50.9 YES Fine needle aspiration biopsy Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 0 No M0 N0 T1c Stage I A0SB TUMOR FREE YES Primary Tumor 01 6th NO YES A1 Breast LIVING 2008 a2405d64-34eb-4915-abf7-8530151d5cb0 a2405d64-34eb-4915-abf7-8530151d5cb0 TCGA-A1-A0SB-01A-11D-A142-09 TCGA-A1-A0SB-01 TCGA-A1-A0SB-01A-11D-A145-05 TCGA-A1-A0SB-01 TCGA-A1-A0SB-01A-11D-A142-09 TCGA-A1-A0SB-01 TCGA-A1-A0SB-01A-11D-A142-09 a2405d64-34eb-4915-abf7-8530151d5cb0 TCGA-A1-A0SB-01A-11D-A141-01 TCGA-A1-A0SB-01 a2405d64-34eb-4915-abf7-8530151d5cb0 TCGA-A1-A0SB-01A-11D-A141-01 TCGA-A1-A0SD-01 Stage IIA 59 2 Stage IIA 437 Positive FEMALE Negative Negative M0 Negative N0 437 0 LumA Luminal A Positive -9 -3 enrollment T_Other T2 LIVING TCGA-A1-A0SD-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-A1-A0SD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SD TCGA-A1-A0SD-01A Negative Positive Lumpectomy Positive Lumpectomy -21793 1697 0 437 90-99% 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 50 NO Negative 3 Positive 1 6 0 0 true No M0 N0 T2 Stage IIA TCGA-A1-A0SD.DD89D265-9E20-49C2-93BD-666BE7D5E41B.pdf A0SD YES 90-99% Primary Tumor 01 6th NO YES A1 Breast A LIVING 2005 15bad71d-3031-413b-9e8d-6426ae5dfbea 15bad71d-3031-413b-9e8d-6426ae5dfbea TCGA-A1-A0SD-01A-11D-A10Y-09 TCGA-A1-A0SD-01 TCGA-A1-A0SD-01 TCGA-A1-A0SD-01A-11D-A10Y-09 TCGA-A1-A0SD-01A-11D-A112-05 TCGA-A1-A0SD-01 TCGA-A1-A0SD-01 TCGA-A1-A0SD-01A-11D-A10Y-09 15bad71d-3031-413b-9e8d-6426ae5dfbea TCGA-A1-A0SD-01A-11D-A111-01 TCGA-A1-A0SD-01 TCGA-A1-A0SD-01A-11R-A115-07 15bad71d-3031-413b-9e8d-6426ae5dfbea TCGA-A1-A0SD-01A-11D-A111-01 TCGA-A1-A0SD-01 TCGA-A1-A0SE-01 Stage I 56 2 Stage I 1320 Positive FEMALE Negative Negative M0 Negative N0 1320 0 LumA Luminal A Positive -5 -7 enrollment T1 T1 LIVING TCGA-A1-A0SE-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A1-A0SE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SE Positive 3+ Positive Modified Radical Mastectomy -20717 0 1321 80-89% 2 2010-12-6 FEMALE 1+ 2 1 Mixed Histology (please specify) invasive ductal and lobular carcinoma No C50.9 8522/3 C50.9 3+ YES Core needle biopsy Negative Negative 8 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 0 No M0 N0 (i-) T1c Stage I A0SE TUMOR FREE 90-99% Primary Tumor 01 6th NO YES A1 Breast LIVING 2005 a998e0ce-9248-460f-aabc-2dad452a1ff9 a998e0ce-9248-460f-aabc-2dad452a1ff9 TCGA-A1-A0SE-01A-11D-A099-09 TCGA-A1-A0SE-01 TCGA-A1-A0SE-01A-11D-A10P-05 TCGA-A1-A0SE-01 TCGA-A1-A0SE-01A-11D-A099-09 TCGA-A1-A0SE-01 TCGA-A1-A0SE-01A-11D-A099-09 TCGA-A1-A0SE-01 a998e0ce-9248-460f-aabc-2dad452a1ff9 TCGA-A1-A0SE-01 TCGA-A1-A0SE-01A-11D-A087-01 TCGA-A1-A0SE-01A-11R-A084-07 a998e0ce-9248-460f-aabc-2dad452a1ff9 TCGA-A1-A0SE-01A-11D-A087-01 TCGA-A1-A0SE-01 TCGA-A1-A0SF-01 Stage IIA 54 3 Stage IIA 1463 Positive FEMALE Negative Negative M0 Negative N0 1463 0 LumA Positive enrollment T_Other T2 LIVING TCGA-A1-A0SF-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-A1-A0SF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SF TCGA-A1-A0SF-01A Positive Positive Modified Radical Mastectomy -19731 1648 0 1463 NO 90-99% 2011-5-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 190 NO Negative 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 6 0 true No M0 N0 T2 Stage IIA TCGA-A1-A0SF.1617B36B-4EFB-445E-95BC-E63B129AAAE7.pdf A0SF TUMOR FREE YES 90-99% Primary Tumor 01 6th NO YES A1 Breast A LIVING 2006 28089e15-5e2c-4e83-ba6c-62b3cb40e431 28089e15-5e2c-4e83-ba6c-62b3cb40e431 TCGA-A1-A0SF-01A-21-A17I-20 TCGA-A1-A0SF-01A-11D-A142-09 TCGA-A1-A0SF-01 TCGA-A1-A0SF-01A-11D-A145-05 f0b3d871-c0aa-4ef8-ab74-c3e812393ed5 TCGA-A1-A0SF-01 TCGA-A1-A0SF-01A-11D-A142-09 TCGA-A1-A0SF-01 TCGA-A1-A0SF-01A-11D-A142-09 28089e15-5e2c-4e83-ba6c-62b3cb40e431 TCGA-A1-A0SF-01A-11D-A141-01 TCGA-A1-A0SF-01 28089e15-5e2c-4e83-ba6c-62b3cb40e431 TCGA-A1-A0SF-01A-11D-A141-01 TCGA-A1-A0SG-01 Stage IIB 61 4 Stage IIB 433 Positive FEMALE Negative Negative M0 Positive N1 433 0 LumA Positive enrollment T_Other T2 LIVING TCGA-A1-A0SG-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 5 mutation c1uster 9 TCGA-A1-A0SG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SG TCGA-A1-A0SG-01A Positive Positive Lumpectomy -22380 1581 0 434 90-99% 2011-5-31 FEMALE Other, specify No C50.9 8507/3 C50.9 YES Core needle biopsy 120 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 5 1 true No M0 N1a T2 Stage IIB TCGA-A1-A0SG.89A67051-898A-4E2A-A874-E0165F274E63.pdf A0SG YES 90-99% Primary Tumor 01 6th NO YES A1 Breast A LIVING 2006 0df6b948-367d-4951-9d98-d3bebabff63e 0df6b948-367d-4951-9d98-d3bebabff63e TCGA-A1-A0SG-01A-11D-A142-09 TCGA-A1-A0SG-01 TCGA-A1-A0SG-01A-11D-A145-05 TCGA-A1-A0SG-01 TCGA-A1-A0SG-01A-11D-A142-09 TCGA-A1-A0SG-01 TCGA-A1-A0SG-01A-11D-A142-09 0df6b948-367d-4951-9d98-d3bebabff63e TCGA-A1-A0SG-01A-11D-A141-01 TCGA-A1-A0SG-01 0df6b948-367d-4951-9d98-d3bebabff63e TCGA-A1-A0SG-01A-11D-A141-01 TCGA-A1-A0SH-01 Stage IIA 39 5 Stage IIA 1437 Negative FEMALE Negative 1 1 1 Negative M0 Negative N0 1437 0 LumA Luminal A Positive Her2 -5 -7 enrollment T_Other T2 LIVING TCGA-A1-A0SH-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 4 mutation c1uster 10 TCGA-A1-A0SH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-A1-A0SH TCGA-A1-A0SH-01A Negative Positive Lumpectomy -14595 1305 0 1437 1.8 2010-12-6 FEMALE 2+ 2.5 1.4 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 240 NO Equivocal Negative 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A1-A0SH.1FB1255E-D9EC-4FE9-BE96-F81271FCCFB6.pdf A0SH TUMOR FREE 90-99% Primary Tumor 01 6th NO YES A1 Breast A LIVING 2006 dce3de3e-f851-4859-a208-72e65d36ab3d dce3de3e-f851-4859-a208-72e65d36ab3d TCGA-A1-A0SH-01A-21-A13A-20 TCGA-A1-A0SH-01A-11D-A099-09 TCGA-A1-A0SH-01 TCGA-A1-A0SH-01A-11D-A10P-05 4760c029-9150-4384-b036-263684155c89 TCGA-A1-A0SH-01 TCGA-A1-A0SH-01A-11D-A099-09 TCGA-A1-A0SH-01 TCGA-A1-A0SH-01A-11D-A099-09 TCGA-A1-A0SH-01 dce3de3e-f851-4859-a208-72e65d36ab3d TCGA-A1-A0SH-01 TCGA-A1-A0SH-01A-11D-A087-01 TCGA-A1-A0SH-01A-11R-A084-07 dce3de3e-f851-4859-a208-72e65d36ab3d TCGA-A1-A0SH-01A-11D-A087-01 TCGA-A1-A0SH-01 TCGA-A1-A0SI-01 Stage IIB 52 3 Stage IIB 634 Positive FEMALE Negative Negative M0 Positive N1 634 0 LumB Positive enrollment T_Other T2 LIVING TCGA-A1-A0SI-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 3 TCGA-A1-A0SI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SI TCGA-A1-A0SI-01A Positive Positive Lumpectomy -19250 1267 0 635 NO 50-59% 2011-6-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 40 NO Negative 23 Negative 5 7 1 true No M0 N1a T2 Stage IIB TCGA-A1-A0SI.4CD6BDB7-9629-41C6-8514-7661E3D33A66.pdf A0SI TUMOR FREE YES 10-19% Primary Tumor 01 6th NO YES A1 Breast A LIVING 2007 44d93b9f-95d6-4382-9590-f6e7bdda65c5 44d93b9f-95d6-4382-9590-f6e7bdda65c5 TCGA-A1-A0SI-01A-11D-A142-09 TCGA-A1-A0SI-01 TCGA-A1-A0SI-01A-11D-A145-05 TCGA-A1-A0SI-01 TCGA-A1-A0SI-01A-11D-A142-09 TCGA-A1-A0SI-01 TCGA-A1-A0SI-01A-11D-A142-09 44d93b9f-95d6-4382-9590-f6e7bdda65c5 TCGA-A1-A0SI-01A-11D-A141-01 TCGA-A1-A0SI-01 44d93b9f-95d6-4382-9590-f6e7bdda65c5 TCGA-A1-A0SI-01A-11D-A141-01 TCGA-A1-A0SJ-01 Stage IIIA 39 3 Stage IIIA 426 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 426 0 LumA Luminal A Positive ReacI -3 -3 enrollment T_Other T3 LIVING TCGA-A1-A0SJ-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A1-A0SJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SJ TCGA-A1-A0SJ-01A Positive Positive Modified Radical Mastectomy -14383 1399 0 416 70-79% 4 2010-12-6 FEMALE 2+ 5 1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 140 NO Equivocal Negative 19 Negative 4 4 3 true No M0 N1a T3 Stage IIIA TCGA-A1-A0SJ.0C0EEC9F-A715-4769-B58C-99D06C3C91F3.pdf A0SJ TUMOR FREE 10-19% Primary Tumor 01 6th NO YES A1 Breast A LIVING 2006 61017170-a36a-4ce9-9b8e-324755b88dd7 61017170-a36a-4ce9-9b8e-324755b88dd7 TCGA-A1-A0SJ-01A-21-A13A-20 TCGA-A1-A0SJ-01A-11D-A099-09 TCGA-A1-A0SJ-01 TCGA-A1-A0SJ-01A-11D-A10P-05 33773418-77f8-4219-9b75-04d5ba09bb97 TCGA-A1-A0SJ-01 TCGA-A1-A0SJ-01A-11D-A099-09 TCGA-A1-A0SJ-01 TCGA-A1-A0SJ-01A-11D-A099-09 TCGA-A1-A0SJ-01 61017170-a36a-4ce9-9b8e-324755b88dd7 TCGA-A1-A0SJ-01 TCGA-A1-A0SJ-01A-11D-A087-01 TCGA-A1-A0SJ-01A-11R-A084-07 61017170-a36a-4ce9-9b8e-324755b88dd7 TCGA-A1-A0SJ-01A-11D-A087-01 TCGA-A1-A0SJ-01 TCGA-A1-A0SK-01 Stage IIA 54 1 Stage IIA 594 967 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 967 1 Basal Basal-like Negative Basal -13 -6 followup T_Other T2 DECEASED TCGA-A1-A0SK-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 GBM-like c6 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-A1-A0SK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SK-F15926 TCGA-A1-A0SK TCGA-A1-A0SK-01A Negative Negative Other Negative Lumpectomy surgical resection -20048 1164 967 0 Scheduled Follow-up Submission 2011-9-7 FEMALE 0 Other, specify No C50.9 8013/3 C50.9 YES Excisional Biopsy 160 NO Negative 4 Positive Indeterminate (neither Pre or Postmenopausal) 5 5 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A1-A0SK.13302EC6-6511-42FE-AA8B-C875B5384FFE.pdf A0SK WITH TUMOR Primary Tumor 01 6th NO YES A1 Breast A DECEASED 2007 a63583ca-0ef2-4417-b435-5f3a6951d0c2 a63583ca-0ef2-4417-b435-5f3a6951d0c2 TCGA-A1-A0SK-01A-21-A13A-20 TCGA-A1-A0SK-01A-12D-A099-09 TCGA-A1-A0SK-01 TCGA-A1-A0SK-01A-12D-A10P-05 8d8099ba-c207-473b-8ffc-e9610494386c TCGA-A1-A0SK-01 TCGA-A1-A0SK-01A-12D-A099-09 TCGA-A1-A0SK-01 TCGA-A1-A0SK-01A-12D-A099-09 TCGA-A1-A0SK-01 a63583ca-0ef2-4417-b435-5f3a6951d0c2 TCGA-A1-A0SK-01 TCGA-A1-A0SK-01A-12D-A087-01 TCGA-A1-A0SK-01A-12R-A084-07 a63583ca-0ef2-4417-b435-5f3a6951d0c2 TCGA-A1-A0SK-01A-12D-A087-01 TCGA-A1-A0SK-01 TCGA-A1-A0SM-01 Stage IIA 77 2 Stage IIA 242 Positive MALE Positive Negative M0 Negative N0 242 0 LumA Luminal B Negative -1 -3 enrollment T_Other T2 LIVING TCGA-A1-A0SM-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A1-A0SM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SM Positive Negative Modified Radical Mastectomy -28198 0 242 20-29% 2 2010-12-6 MALE 3+ 21 11 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive Positive 3 Negative 4 4 0 No M0 N0 (i-) T2 Stage IIA A0SM TUMOR FREE Primary Tumor 01 6th NO YES A1 Breast LIVING 2007 e637db43-508a-4a37-92e4-eea96b35b65b e637db43-508a-4a37-92e4-eea96b35b65b TCGA-A1-A0SM-01A-11D-A099-09 TCGA-A1-A0SM-01 TCGA-A1-A0SM-01A-11D-A10P-05 TCGA-A1-A0SM-01 TCGA-A1-A0SM-01A-11D-A099-09 TCGA-A1-A0SM-01 TCGA-A1-A0SM-01A-11D-A099-09 TCGA-A1-A0SM-01 e637db43-508a-4a37-92e4-eea96b35b65b TCGA-A1-A0SM-01 TCGA-A1-A0SM-01A-11D-A087-01 TCGA-A1-A0SM-01A-11R-A084-07 e637db43-508a-4a37-92e4-eea96b35b65b TCGA-A1-A0SM-01A-11D-A087-01 TCGA-A1-A0SM-01 TCGA-A1-A0SN-01 Stage IIIA 50 5 Stage IIA 1196 Positive FEMALE Positive Negative M0 Positive N1 1196 0 LumB Positive enrollment T1 T1 LIVING TCGA-A1-A0SN-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A1-A0SN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SN TCGA-A1-A0SN-01A Positive Positive Lumpectomy -18401 1091 0 1196 90-99% 2011-5-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Positive 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 4 true No MX N1 T1c Stage IIA TCGA-A1-A0SN.D0269758-EFAE-4EBA-8CCF-4A6CF4D4B35A.pdf A0SN TUMOR FREE YES 60-69% Primary Tumor 01 6th NO YES A1 Breast A LIVING 2007 7fdf1ebf-149a-43d5-bae7-6e01beb647dd 7fdf1ebf-149a-43d5-bae7-6e01beb647dd TCGA-A1-A0SN-01A-11D-A142-09 TCGA-A1-A0SN-01 TCGA-A1-A0SN-01A-11D-A145-05 TCGA-A1-A0SN-01 TCGA-A1-A0SN-01A-11D-A142-09 TCGA-A1-A0SN-01 TCGA-A1-A0SN-01A-11D-A142-09 7fdf1ebf-149a-43d5-bae7-6e01beb647dd TCGA-A1-A0SN-01A-11D-A141-01 TCGA-A1-A0SN-01 7fdf1ebf-149a-43d5-bae7-6e01beb647dd TCGA-A1-A0SN-01A-11D-A141-01 TCGA-A1-A0SO-01 Stage IIB 67 1 Stage IIB 852 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 852 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-A1-A0SO-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-A1-A0SO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SO TCGA-A1-A0SO-01A Negative Negative Modified Radical Mastectomy -24826 1057 0 852 3.2 2010-12-6 FEMALE 5 1.6 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO Equivocal Negative 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 1 true No M0 N1 T2 Stage IIB TCGA-A1-A0SO.6104F94F-BA8F-4435-A839-E1FEA6EFFDF3.pdf A0SO TUMOR FREE Primary Tumor 01 6th NO YES A1 Breast A LIVING 2007 e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0 e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0 TCGA-A1-A0SO-01A-11-A13A-20 TCGA-A1-A0SO-01A-22D-A099-09 TCGA-A1-A0SO-01 TCGA-A1-A0SO-01A-22D-A10P-05 3c86150e-49f3-4303-bd6e-3d4bcc4aad50 TCGA-A1-A0SO-01 TCGA-A1-A0SO-01 TCGA-A1-A0SO-01A-22D-A099-09 TCGA-A1-A0SO-01 e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0 TCGA-A1-A0SO-01 TCGA-A1-A0SO-01A-22D-A087-01 TCGA-A1-A0SO-01A-22R-A084-07 e3b4918d-43c1-4dde-9a92-f9c5cd6e63a0 TCGA-A1-A0SO-01A-22D-A087-01 TCGA-A1-A0SO-01 TCGA-A1-A0SP-01 Stage IIA 40 Stage IIA 583 Negative FEMALE Negative Negative M0 Negative N0 583 0 Basal Negative enrollment T_Other T2 LIVING TCGA-A1-A0SP-01 High C4-BRCA/Basal BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 12 mutation cluster 5 TCGA-A1-A0SP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Axillary lymph node dissection alone TCGA-A1-A0SP Negative Negative Lumpectomy -14954 0 584 2010-12-6 FEMALE 0 Infiltrating Ductal Carcinoma C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative 3 Negative 0 Yes M0 N0 (i-) T2 Stage IIA A0SP TUMOR FREE Primary Tumor 01 6th NO YES A1 Breast LIVING 2007 f091d050-4847-4d4d-b94c-1efacecdef6b f091d050-4847-4d4d-b94c-1efacecdef6b TCGA-A1-A0SP-01A-11D-A099-09 TCGA-A1-A0SP-01 TCGA-A1-A0SP-01A-11D-A10P-05 TCGA-A1-A0SP-01 TCGA-A1-A0SP-01A-11D-A099-09 TCGA-A1-A0SP-01 TCGA-A1-A0SP-01A-11D-A099-09 TCGA-A1-A0SP-01 f091d050-4847-4d4d-b94c-1efacecdef6b TCGA-A1-A0SP-01 TCGA-A1-A0SP-01A-11D-A087-01 TCGA-A1-A0SP-01A-11R-A084-07 f091d050-4847-4d4d-b94c-1efacecdef6b TCGA-A1-A0SP-01A-11D-A087-01 TCGA-A1-A0SP-01 TCGA-A1-A0SQ-01 Stage IIB 45 3 Stage IIB 553 Positive FEMALE Negative Negative M0 Positive N1 553 0 LumA Positive enrollment T_Other T2 LIVING TCGA-A1-A0SQ-01 Iq C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation c1uster 9 TCGA-A1-A0SQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A1-A0SQ TCGA-A1-A0SQ-01A Positive Positive Modified Radical Mastectomy -16458 967 0 554 NO 90-99% 2011-6-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative 15 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 2 1 true No MX N1 T2 Stage IIB TCGA-A1-A0SQ.92EE56BF-AAA0-438E-9244-780DBB2D9835.pdf A0SQ TUMOR FREE YES 90-99% Primary Tumor 01 6th NO YES A1 Breast A LIVING 2007 9efdba02-2752-4c89-bb53-e8018f5aa7bf 9efdba02-2752-4c89-bb53-e8018f5aa7bf TCGA-A1-A0SQ-01A-11-A17I-20 TCGA-A1-A0SQ-01A-21D-A142-09 TCGA-A1-A0SQ-01 TCGA-A1-A0SQ-01A-21D-A145-05 5f624f7e-a0d0-454e-ba7a-6ca212ec4fda TCGA-A1-A0SQ-01 TCGA-A1-A0SQ-01A-21D-A142-09 TCGA-A1-A0SQ-01 TCGA-A1-A0SQ-01A-21D-A142-09 9efdba02-2752-4c89-bb53-e8018f5aa7bf TCGA-A1-A0SQ-01A-21D-A141-01 TCGA-A1-A0SQ-01 9efdba02-2752-4c89-bb53-e8018f5aa7bf TCGA-A1-A0SQ-01A-21D-A141-01 TCGA-A2-A04N-01 Stage IA 66 4 Stage I 3188 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 3188 0 LumA Luminal A Positive LumA -5 -3 followup T1 T1 LIVING TCGA-A2-A04N-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-A2-A04N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Other (specify) Sentinel lymph node biopsy plus non-sentinel lymph node biopsy TCGA-A2-A04N-F59311 TCGA-A2-A04N TCGA-A2-A04N-01A Positive Positive Lumpectomy YES -24155 2850 0 4354 2014-5-8 FEMALE 1.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 130 NO Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A04N.45B4B99C-80E6-4AF4-8692-F7EE19D0467A.pdf A04N TUMOR FREE YES YES Primary Tumor 01 5th YES NO YES A2 Breast A LIVING 2002 71b60d53-513c-4da5-b095-39f913bd4f11 71b60d53-513c-4da5-b095-39f913bd4f11 TCGA-A2-A04N-01A-21-A13A-20 TCGA-A2-A04N-01A-11D-A10Y-09 TCGA-A2-A04N-01 2ef34d44-4aa3-4b06-8029-f92c4b3a49a7 TCGA-A2-A04N-01 TCGA-A2-A04N-01A-11D-A10Y-09 TCGA-A2-A04N-01A-11D-A112-05 TCGA-A2-A04N-01 TCGA-A2-A04N-01 TCGA-A2-A04N-01A-11D-A10Y-09 71b60d53-513c-4da5-b095-39f913bd4f11 TCGA-A2-A04N-01A-11D-A111-01 TCGA-A2-A04N-01 TCGA-A2-A04N-01A-11R-A115-07 71b60d53-513c-4da5-b095-39f913bd4f11 TCGA-A2-A04N-01A-11D-A111-01 TCGA-A2-A04N-01 TCGA-A2-A04P-01 Stage IIIC 36 1 No_Conversion 547 547 Negative FEMALE Negative 2 2 2 Negative M0 Positive N3 547 1 Basal Basal-like Negative Basal -13 0 followup T_Other T2 DECEASED TCGA-A2-A04P-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 3 TCGA-A2-A04P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO NO 36 Left Axillary lymph node dissection alone TCGA-A2-A04P-F71021 TCGA-A2-A04P TCGA-A2-A04P-01A Positive Negative Mastectomy NOS Negative Lumpectomy NO -13238 2623 548 0 179 179 <10% 2015-3-13 FEMALE 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 250 NO Negative NO 20 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 1.0 Negative Negative 5 5 Other, specify Locoregional Recurrence Axilla YES YES 18 0 true No M0 N3c T2 Stage IIIC TCGA-A2-A04P.0E4B0EA9-14D1-4A82-814D-51CC2B9BA2B5.pdf A04P WITH TUMOR YES <10% YES Primary Tumor 01 6th YES NO YES A2 Breast A DECEASED 2003 357ba9f6-716c-4ef0-8ac8-41977397dbf5 357ba9f6-716c-4ef0-8ac8-41977397dbf5 TCGA-A2-A04P-01A-41-A13A-20 TCGA-A2-A04P-01A-31D-A128-09 TCGA-A2-A04P-01 15a1aee0-d9cf-4122-9290-0d4bfaee159a TCGA-A2-A04P-01 TCGA-A2-A04P-01A-31D-A128-09 TCGA-A2-A04P-01A-31D-A032-05 TCGA-A2-A04P-01 TCGA-A2-A04P-01A-31D-A128-09 TCGA-A2-A04P-01 357ba9f6-716c-4ef0-8ac8-41977397dbf5 TCGA-A2-A04P-01 TCGA-A2-A04P-01A-31D-A036-01 TCGA-A2-A04P-01A-31R-A034-07 357ba9f6-716c-4ef0-8ac8-41977397dbf5 TCGA-A2-A04P-01A-31D-A036-01 TCGA-A2-A04P-01 TCGA-A2-A04Q-01 Stage IA 48 3 Stage I 1275 Negative FEMALE Negative 1 2 3 Negative M0 Negative N0 1275 0 Basal Basal-like Negative ReacII -13 -12 followup T1 T1 LIVING TCGA-A2-A04Q-01 High C4-BRCA/Basal cluster 1 BRCA CIMP c7 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A04Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Outer Quadrant|Right Other (specify) SLN AND NON-SLN BX TCGA-A2-A04Q-F59314 TCGA-A2-A04Q TCGA-A2-A04Q-01A Negative Negative Simple Mastectomy YES -17660 2260 0 2385 <10% 2014-5-8 FEMALE 2+ 1.4 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES SKIN BIOPSY Other method, specify: 230 NO Equivocal Negative YES 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A04Q.726B60CA-1B1C-440D-82FA-A4C978C4D484.pdf A04Q TUMOR FREE YES <10% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2004 d71e12c1-d92c-4cb6-8244-d100b2ef1c43 d71e12c1-d92c-4cb6-8244-d100b2ef1c43 TCGA-A2-A04Q-01A-11-A13A-20 TCGA-A2-A04Q-01A-21W-A050-09 TCGA-A2-A04Q-01 9e43165b-f93c-4a25-a1c8-7bdad54cee95 TCGA-A2-A04Q-01 TCGA-A2-A04Q-01A-21W-A050-09 TCGA-A2-A04Q-01A-21D-A032-05 TCGA-A2-A04Q-01 TCGA-A2-A04Q-01A-21W-A050-09 TCGA-A2-A04Q-01 d71e12c1-d92c-4cb6-8244-d100b2ef1c43 TCGA-A2-A04Q-01 TCGA-A2-A04Q-01A-21D-A036-01 TCGA-A2-A04Q-01A-21R-A034-07 d71e12c1-d92c-4cb6-8244-d100b2ef1c43 TCGA-A2-A04Q-01A-21D-A036-01 TCGA-A2-A04Q-01 TCGA-A2-A04R-01 Stage IA 36 5 Stage I 2499 Positive FEMALE Negative Negative M0 Negative N0 2499 0 LumB Luminal B Positive -10 -3 followup T1 T1 LIVING TCGA-A2-A04R-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 10 TCGA-A2-A04R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 36 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-A2-A04R-F59315 TCGA-A2-A04R TCGA-A2-A04R-01A Positive Positive Lumpectomy YES -13483 2233 0 3709 60-69% 2014-5-8 FEMALE 2+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 160 NO Equivocal Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A04R.6A97C809-91BB-4E35-9E12-F5F2A58C9D35.pdf A04R TUMOR FREE YES 80-89% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2004 8801f107-f5d5-4ad5-877d-a5acb12596b3 8801f107-f5d5-4ad5-877d-a5acb12596b3 TCGA-A2-A04R-01A-41D-A117-09 TCGA-A2-A04R-01 TCGA-A2-A04R-01A-41D-A10A-05 TCGA-A2-A04R-01 TCGA-A2-A04R-01A-41D-A117-09 TCGA-A2-A04R-01 TCGA-A2-A04R-01A-41D-A117-09 TCGA-A2-A04R-01 8801f107-f5d5-4ad5-877d-a5acb12596b3 TCGA-A2-A04R-01 TCGA-A2-A04R-01A-41D-A107-01 TCGA-A2-A04R-01A-41R-A109-07 8801f107-f5d5-4ad5-877d-a5acb12596b3 TCGA-A2-A04R-01A-41D-A107-01 TCGA-A2-A04R-01 TCGA-A2-A04T-01 Stage IIA 62 1 Stage IIA 2246 Negative FEMALE Negative Negative M0 Negative N0 2246 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-A2-A04T-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 5 TCGA-A2-A04T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-A2-A04T-F9343 TCGA-A2-A04T TCGA-A2-A04T-01A Negative Negative Lumpectomy YES -22707 1979 0 2246 <10% 2011-3-17 FEMALE 2+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Equivocal Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A04T.24D42292-B875-4FAF-8C3A-9834414C3A01.pdf A04T TUMOR FREE <10% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2004 79d7a589-60bd-4b4a-89c1-d557fe24c733 79d7a589-60bd-4b4a-89c1-d557fe24c733 TCGA-A2-A04T-01A-31-A13A-20 TCGA-A2-A04T-01 2724de89-78e5-4da5-b2d9-350a986a8abb TCGA-A2-A04T-01 TCGA-A2-A04T-01A-21W-A050-09 TCGA-A2-A04T-01A-21D-A032-05 TCGA-A2-A04T-01 TCGA-A2-A04T-01 79d7a589-60bd-4b4a-89c1-d557fe24c733 TCGA-A2-A04T-01 TCGA-A2-A04T-01A-21D-A036-01 TCGA-A2-A04T-01A-21R-A034-07 79d7a589-60bd-4b4a-89c1-d557fe24c733 TCGA-A2-A04T-01A-21D-A036-01 TCGA-A2-A04T-01 TCGA-A2-A04U-01 Stage IIA 47 Stage IIA 670 Negative FEMALE Negative Negative M0 Negative N0 670 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING TCGA-A2-A04U-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-A2-A04U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Sentinel node biopsy alone TCGA-A2-A04U-F59317 TCGA-A2-A04U TCGA-A2-A04U-01A Negative Negative Simple Mastectomy YES -17474 1924 0 2654 <10% 2014-5-8 FEMALE 1+ 2.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Negative Positive YES 3 Negative Peri (6-12 months since last menstrual period) 5 5 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A04U.B14456B1-4992-492D-AFB5-4F975F20A277.pdf A04U TUMOR FREE YES <10% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2004 4d12d021-3673-4e14-9fd9-033f811f87da 4d12d021-3673-4e14-9fd9-033f811f87da TCGA-A2-A04U-01A-21-A13A-20 TCGA-A2-A04U-01A-11D-A10Y-09 TCGA-A2-A04U-01 485e1504-dfe0-43a4-83a1-f4376e8e687b TCGA-A2-A04U-01 TCGA-A2-A04U-01A-11D-A10Y-09 TCGA-A2-A04U-01A-11D-A112-05 TCGA-A2-A04U-01 TCGA-A2-A04U-01 TCGA-A2-A04U-01A-11D-A10Y-09 4d12d021-3673-4e14-9fd9-033f811f87da TCGA-A2-A04U-01A-11D-A111-01 TCGA-A2-A04U-01 TCGA-A2-A04U-01A-11R-A115-07 4d12d021-3673-4e14-9fd9-033f811f87da TCGA-A2-A04U-01A-11D-A111-01 TCGA-A2-A04U-01 TCGA-A2-A04V-01 Stage IIA 39 2 Stage IIA 1920 1920 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 1920 1 LumA Luminal A Positive LumA/B 0 -3 enrollment T_Other T2 DECEASED TCGA-A2-A04V-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A04V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO NO 39 Right Lower Outer Quadrant|Right Sentinel node biopsy alone TCGA-A2-A04V-F10273 TCGA-A2-A04V TCGA-A2-A04V-01A Positive Positive Simple Mastectomy YES -14250 1812 1920 0 1470 90-99% 2011-3-18 FEMALE 2+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Equivocal Negative 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 2 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A04V.7D84A145-19AF-48D0-A5D9-F5724068CB26.pdf A04V WITH TUMOR MODERATE STRONG 10-19% NO Primary Tumor 01 6th YES NO YES A2 Breast A DECEASED 2005 72d79574-45e1-453a-bc95-a2dca1d3e251 72d79574-45e1-453a-bc95-a2dca1d3e251 TCGA-A2-A04V-01A-11-A13A-20 TCGA-A2-A04V-01A-21W-A050-09 TCGA-A2-A04V-01 676bd916-c1a1-4b1f-b406-0c3bae66640e TCGA-A2-A04V-01 TCGA-A2-A04V-01A-21W-A050-09 TCGA-A2-A04V-01A-21D-A032-05 TCGA-A2-A04V-01 TCGA-A2-A04V-01A-21W-A050-09,TCGA-A2-A04V-01A-21D-A045-09 TCGA-A2-A04V-01 72d79574-45e1-453a-bc95-a2dca1d3e251 TCGA-A2-A04V-01 TCGA-A2-A04V-01A-21D-A036-01 TCGA-A2-A04V-01A-21R-A034-07 72d79574-45e1-453a-bc95-a2dca1d3e251 TCGA-A2-A04V-01A-21D-A036-01 TCGA-A2-A04V-01 TCGA-A2-A04W-01 Stage IIB 50 3 No_Conversion 1948 Negative FEMALE Positive Negative M0 Positive N1 1948 0 Her2 HER2-enriched Negative Her2 -11 -5 followup T_Other T2 LIVING TCGA-A2-A04W-01 Squamous C3-BRCA/Luminal cluster 1 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 4 mutation cluster 3 TCGA-A2-A04W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A04W-F59320 TCGA-A2-A04W TCGA-A2-A04W-01A Negative Negative Modified Radical Mastectomy NO -18345 1630 0 3102 <10% 2014-5-8 FEMALE 3.2 Other, specify No C50.9 8401/3 C50.9 YES Core needle biopsy 420 NO Positive Positive NO 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 1 true No M0 N1mi T2 Stage IIB TCGA-A2-A04W.84CA9DDD-36CA-466E-A74C-C7FB03E7C9E4.pdf A04W TUMOR FREE YES <10% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2005 ddb62dc3-293b-4021-905a-83ae10aa0f8e ddb62dc3-293b-4021-905a-83ae10aa0f8e TCGA-A2-A04W-01A-21-A13A-20 TCGA-A2-A04W-01A-31D-A10Y-09 TCGA-A2-A04W-01 469913c6-08bb-4c19-8a68-2735f5c4f981 TCGA-A2-A04W-01 TCGA-A2-A04W-01A-31D-A10Y-09 TCGA-A2-A04W-01A-31D-A112-05 TCGA-A2-A04W-01 TCGA-A2-A04W-01 TCGA-A2-A04W-01A-31D-A10Y-09 ddb62dc3-293b-4021-905a-83ae10aa0f8e TCGA-A2-A04W-01A-31D-A111-01 TCGA-A2-A04W-01 TCGA-A2-A04W-01A-31R-A115-07 ddb62dc3-293b-4021-905a-83ae10aa0f8e TCGA-A2-A04W-01A-31D-A111-01 TCGA-A2-A04W-01 TCGA-A2-A04X-01 Stage IIA 34 3 Stage IIA 1686 Positive FEMALE Positive Negative M0 Negative N0 1686 0 Her2 HER2-enriched Positive -2 -5 followup T_Other T2 LIVING TCGA-A2-A04X-01 High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A04X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Left Sentinel node biopsy alone TCGA-A2-A04X-F9335 TCGA-A2-A04X TCGA-A2-A04X-01A Positive Positive Simple Mastectomy YES -12642 1390 0 1686 80-89% 2011-3-18 FEMALE 3+ 3.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 180 NO Positive Positive 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A04X.F114D078-5F03-47F8-82AE-B8A21C2F9D31.pdf A04X TUMOR FREE MODERATE STRONG 50-59% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2006 08c54c9c-195c-4754-83af-a97544d0eb12 08c54c9c-195c-4754-83af-a97544d0eb12 TCGA-A2-A04X-01A-21W-A050-09 TCGA-A2-A04X-01 TCGA-A2-A04X-01 TCGA-A2-A04X-01A-21W-A050-09 TCGA-A2-A04X-01A-21D-A032-05 TCGA-A2-A04X-01 TCGA-A2-A04X-01A-21W-A050-09 TCGA-A2-A04X-01 08c54c9c-195c-4754-83af-a97544d0eb12 TCGA-A2-A04X-01 TCGA-A2-A04X-01A-21D-A036-01 TCGA-A2-A04X-01A-21R-A034-07 08c54c9c-195c-4754-83af-a97544d0eb12 TCGA-A2-A04X-01A-21D-A036-01 TCGA-A2-A04X-01 TCGA-A2-A04Y-01 Stage IIB 53 5 No_Conversion 1099 Positive FEMALE Negative 2 3 3 Negative M0 Positive N1 1099 0 LumB Luminal A Positive LumA -2 -3 followup T_Other T2 LIVING TCGA-A2-A04Y-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-A2-A04Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A04Y-F9330 TCGA-A2-A04Y TCGA-A2-A04Y-01A Positive Positive Simple Mastectomy YES -19533 756 0 1099 90-99% 2011-3-18 FEMALE 1+ 1.13 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 220 NO Negative Negative 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 5 1 0 true No M0 N1mi T2 Stage IIB TCGA-A2-A04Y.E4F7064C-9D81-49B5-9992-898155B3F11E.pdf A04Y TUMOR FREE Strong 10-19% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2008 7002615e-435b-4631-bb5b-e4b7532a143a 7002615e-435b-4631-bb5b-e4b7532a143a TCGA-A2-A04Y-01A-11-A13A-20 TCGA-A2-A04Y-01A-21W-A050-09 TCGA-A2-A04Y-01 b850ebdc-d177-4c59-8c71-9cf8dd589307 TCGA-A2-A04Y-01 TCGA-A2-A04Y-01A-21W-A050-09 TCGA-A2-A04Y-01A-21D-A032-05 TCGA-A2-A04Y-01 TCGA-A2-A04Y-01A-21W-A050-09 TCGA-A2-A04Y-01 7002615e-435b-4631-bb5b-e4b7532a143a TCGA-A2-A04Y-01 TCGA-A2-A04Y-01A-21D-A036-01 TCGA-A2-A04Y-01A-21R-A034-07 7002615e-435b-4631-bb5b-e4b7532a143a TCGA-A2-A04Y-01A-21D-A036-01 TCGA-A2-A04Y-01 TCGA-A2-A0CK-01 TCGA-A2-A0CK-01 Iq BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 14 TCGA-A2-A0CK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 60 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0CK-F42396 TCGA-A2-A0CK TCGA-A2-A0CK-01A Negative Positive 3 Point Scale 3+ 3 Point Scale Modified radical mastectomy Positive Lumpectomy NO -22094 3080 0 4159 1409 1364 NO 40-49% 2013-4-18 FEMALE 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Excisional Biopsy 230 NO Negative Negative NO 20 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative Positive 50-59% 1.2 3 Point Scale 2+ 1+ Negative 10-19% Positive 3 Point Scale Other, specify New Primary Tumor LEFT BREAST YES YES 4 true No M0 N2a T3 Stage IIIA TCGA-A2-A0CK.B065FC65-CD33-4878-AE2C-7E8C04F5ECAB.pdf A0CK TUMOR FREE YES YES 80-89% YES Primary Tumor 01 5th NO YES A2 Breast A LIVING 2001 fe5e8cb8-45e2-4321-ad32-a776f79bfcac fe5e8cb8-45e2-4321-ad32-a776f79bfcac TCGA-A2-A0CK-01A-21-A24A-20 TCGA-A2-A0CK-01 TCGA-A2-A0CK-01A-11D-A22B-05 9c5f525e-a62e-4bfd-aed9-96603a95f72b TCGA-A2-A0CK-01 TCGA-A2-A0CK-01A-11D-A228-09 TCGA-A2-A0CK-01 fe5e8cb8-45e2-4321-ad32-a776f79bfcac TCGA-A2-A0CK-01A-11D-A227-01 TCGA-A2-A0CK-01 fe5e8cb8-45e2-4321-ad32-a776f79bfcac TCGA-A2-A0CK-01A-11D-A227-01 TCGA-A2-A0CL-01 Stage IIIA 37 3 No_Conversion 1963 Positive FEMALE Negative 1 1 1 Negative M0 Positive N2 1963 0 Normal HER2-enriched Positive Basal -2 -5 followup T_Other T3 LIVING TCGA-A2-A0CL-01 High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A0CL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0CL-F59313 TCGA-A2-A0CL Positive Positive Modified Radical Mastectomy NO -13556 0 3015 20-29% Scheduled Follow-up Submission 2014-5-8 FEMALE 1+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative Negative NO 14 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 9 0 No M0 N2a T3 Stage IIIA A0CL TUMOR FREE YES <10% YES Primary Tumor 01 6th YES NO YES A2 Breast LIVING 2006 ee92fcd7-4be2-47c2-9725-1ec425d212cf ee92fcd7-4be2-47c2-9725-1ec425d212cf TCGA-A2-A0CL-01A-21-A13C-20 TCGA-A2-A0CL-01A-11D-A10Y-09 TCGA-A2-A0CL-01 f660575f-37ae-427d-acf6-767799017d6d TCGA-A2-A0CL-01 TCGA-A2-A0CL-01A-11D-A10Y-09 TCGA-A2-A0CL-01A-11D-A112-05 TCGA-A2-A0CL-01 TCGA-A2-A0CL-01 TCGA-A2-A0CL-01A-11D-A10Y-09 ee92fcd7-4be2-47c2-9725-1ec425d212cf TCGA-A2-A0CL-01A-11D-A111-01 TCGA-A2-A0CL-01 TCGA-A2-A0CL-01A-11R-A115-07 ee92fcd7-4be2-47c2-9725-1ec425d212cf TCGA-A2-A0CL-01A-11D-A111-01 TCGA-A2-A0CL-01 TCGA-A2-A0CM-01 Stage IIA 40 4 Stage IIA 754 754 Negative FEMALE Negative 1 1 2 Negative M0 Negative N0 754 1 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 DECEASED TCGA-A2-A0CM-01 High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A2-A0CM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 40 Left Sentinel node biopsy alone TCGA-A2-A0CM-F2013 TCGA-A2-A0CM TCGA-A2-A0CM-01A Negative 0 Negative Simple Mastectomy YES -14969 2546 754 0 382 <10% 2010-9-6 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Excisional Biopsy 300 NO Negative 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0CM.2972AB07-2C29-43B8-96DA-1386C5E248EB.pdf A0CM WITH TUMOR <10% NO Primary Tumor 01 6th YES NO YES A2 Breast A DECEASED 2003 62dd11c2-2271-45e7-b753-d0f0d79fdf23 62dd11c2-2271-45e7-b753-d0f0d79fdf23 TCGA-A2-A0CM-01A-21-A13C-20 TCGA-A2-A0CM-01A-31W-A050-09 TCGA-A2-A0CM-01 bd38e599-aa6d-4349-b7de-630514cc1220 TCGA-A2-A0CM-01 TCGA-A2-A0CM-01A-31W-A050-09 TCGA-A2-A0CM-01A-31D-A032-05 TCGA-A2-A0CM-01 TCGA-A2-A0CM-01A-31W-A050-09 TCGA-A2-A0CM-01 62dd11c2-2271-45e7-b753-d0f0d79fdf23 TCGA-A2-A0CM-01 TCGA-A2-A0CM-01A-31D-A036-01 TCGA-A2-A0CM-01A-31R-A034-07 62dd11c2-2271-45e7-b753-d0f0d79fdf23 TCGA-A2-A0CM-01A-31D-A036-01 TCGA-A2-A0CM-01 TCGA-A2-A0CO-01 TCGA-A2-A0CO-01 Iq BRCA non-CIMP c9 miRNA cluster 3 TCGA-A2-A0CO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 85 Right Axillary lymph node dissection alone TCGA-A2-A0CO-F42395 TCGA-A2-A0CO Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy NO -31404 3492 0 3409 NO 40-49% 2013-4-18 FEMALE 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Core needle biopsy Negative Negative NO 11 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 No M0 N0 T3 Stage IIB A0CO TUMOR FREE YES YES 20-29% YES Primary Tumor 01 7th NO YES A2 Breast DECEASED 2002 cb2d5668-d44b-49dc-8941-79615d2fb6c2 cb2d5668-d44b-49dc-8941-79615d2fb6c2 TCGA-A2-A0CO-01 TCGA-A2-A0CO-01A-13D-A22B-05 TCGA-A2-A0CO-01 TCGA-A2-A0CO-01A-13D-A228-09 TCGA-A2-A0CO-01 cb2d5668-d44b-49dc-8941-79615d2fb6c2 TCGA-A2-A0CO-01A-13D-A227-01 TCGA-A2-A0CO-01 cb2d5668-d44b-49dc-8941-79615d2fb6c2 TCGA-A2-A0CO-01A-13D-A227-01 TCGA-A2-A0CP-01 Stage IA 60 4 Stage I 2813 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 2813 0 LumA Luminal A Positive X -5 -7 followup T1 T1 LIVING TCGA-A2-A0CP-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0CP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Sentinel node biopsy alone TCGA-A2-A0CP-F13741 TCGA-A2-A0CP TCGA-A2-A0CP-01A Positive Positive Lumpectomy YES -22133 2445 0 2813 90-99% Scheduled Follow-up Submission 2011-6-10 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 160 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0CP.DAB9A2B8-FCE7-4FF4-BAC4-4D2A04D7A43B.pdf A0CP TUMOR FREE 90-99% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2003 5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15 5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15 TCGA-A2-A0CP-01A-21-A13B-20 TCGA-A2-A0CP-01A-11W-A050-09 TCGA-A2-A0CP-01 901a41bd-d57b-46b6-afec-bfc93e5d2c93 TCGA-A2-A0CP-01 TCGA-A2-A0CP-01A-11W-A050-09 TCGA-A2-A0CP-01A-11D-A032-05 TCGA-A2-A0CP-01 TCGA-A2-A0CP-01A-11W-A050-09 TCGA-A2-A0CP-01 5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15 TCGA-A2-A0CP-01 TCGA-A2-A0CP-01A-11D-A036-01 TCGA-A2-A0CP-01A-11R-A034-07 5c4dae2a-4b4a-47d0-b6fb-456bdf58ca15 TCGA-A2-A0CP-01A-11D-A036-01 TCGA-A2-A0CP-01 TCGA-A2-A0CQ-01 Stage IA 62 2 Stage I 2694 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 2694 0 LumA Luminal A Positive LumA/B -12 -3 followup T1 T1 LIVING TCGA-A2-A0CQ-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A0CQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Sentinel node biopsy alone TCGA-A2-A0CQ-F13723 TCGA-A2-A0CQ TCGA-A2-A0CQ-01A Negative Positive Lumpectomy Positive Lumpectomy YES -22810 2310 0 2695 90-99% Scheduled Follow-up Submission 2011-6-10 FEMALE 2+ 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO Equivocal Negative 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A0CQ.964DFAC8-91EC-4C0E-B499-3ED5F2D70096.pdf A0CQ TUMOR FREE 90-99% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2003 31ff1045-fdc1-4b02-ae0e-880f652adb31 31ff1045-fdc1-4b02-ae0e-880f652adb31 TCGA-A2-A0CQ-01A-11-A13B-20 TCGA-A2-A0CQ-01A-21W-A050-09 TCGA-A2-A0CQ-01 deba1bb0-c1bf-4018-8c35-1376661c7d01 TCGA-A2-A0CQ-01 TCGA-A2-A0CQ-01A-21W-A050-09 TCGA-A2-A0CQ-01A-21D-A032-05 TCGA-A2-A0CQ-01 TCGA-A2-A0CQ-01A-21W-A050-09 TCGA-A2-A0CQ-01 31ff1045-fdc1-4b02-ae0e-880f652adb31 TCGA-A2-A0CQ-01 TCGA-A2-A0CQ-01A-21D-A036-01 TCGA-A2-A0CQ-01A-21R-A034-07 31ff1045-fdc1-4b02-ae0e-880f652adb31 TCGA-A2-A0CQ-01A-21D-A036-01 TCGA-A2-A0CQ-01 TCGA-A2-A0CR-01 TCGA-A2-A0CR-01 Quiet BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 13 TCGA-A2-A0CR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-A2-A0CR-F42400 TCGA-A2-A0CR TCGA-A2-A0CR-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -20075 2191 0 3283 NO 60-69% 2013-4-18 FEMALE 1.2 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 1+ YES Core needle biopsy 280 NO Negative Negative NO 16 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T3 Stage IIB TCGA-A2-A0CR.A3167E2D-3588-41D4-99AA-6DCB660D55A4.pdf A0CR TUMOR FREE YES YES 80-89% NO Primary Tumor 01 7th NO YES A2 Breast A LIVING 2004 00e597fa-72b4-4e92-9428-7ec686e4cc0b 00e597fa-72b4-4e92-9428-7ec686e4cc0b TCGA-A2-A0CR-01A-22-A24A-20 TCGA-A2-A0CR-01 TCGA-A2-A0CR-01A-11D-A22B-05 3ed7fa0f-b208-4493-aac0-71cb01860ac9 TCGA-A2-A0CR-01 TCGA-A2-A0CR-01A-11D-A228-09 TCGA-A2-A0CR-01 00e597fa-72b4-4e92-9428-7ec686e4cc0b TCGA-A2-A0CR-01A-11D-A227-01 TCGA-A2-A0CR-01 00e597fa-72b4-4e92-9428-7ec686e4cc0b TCGA-A2-A0CR-01A-11D-A227-01 TCGA-A2-A0CS-01 Stage IV 73 2 No_Conversion 2298 Positive FEMALE Negative 3 3 3 Positive M1 Positive N3 2298 0 LumA Luminal A Positive LumA -12 -3 followup T_Other T4 LIVING TCGA-A2-A0CS-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0CS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left Axillary lymph node dissection alone TCGA-A2-A0CS-F59316 TCGA-A2-A0CS TCGA-A2-A0CS-01A Positive Positive Modified Radical Mastectomy NO -26817 2030 2348 0 2298 80-89% Scheduled Follow-up Submission 2014-5-8 FEMALE 2+ 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Skin biopsy Other method, specify: 220 NO Equivocal Negative NO 15 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative Positive 1.09 Negative Positive Other, specify Ovary 2 4 NO 12 0 true No M1 N3a T4b Stage IV TCGA-A2-A0CS.A985FB5C-9E91-40E1-864E-CEA887B3866D.pdf A0CS TUMOR FREE YES 80-89% YES Primary Tumor 01 YES NO YES A2 Breast A DECEASED 2004 560ab6aa-cbfe-42ac-9446-9d3df720bc81 560ab6aa-cbfe-42ac-9446-9d3df720bc81 TCGA-A2-A0CS-01A-21-A13B-20 TCGA-A2-A0CS-01A-11D-A10Y-09 TCGA-A2-A0CS-01 b49a2c08-435f-4790-818a-267a2ce6499c TCGA-A2-A0CS-01 TCGA-A2-A0CS-01A-11D-A10Y-09 TCGA-A2-A0CS-01A-11D-A112-05 TCGA-A2-A0CS-01 TCGA-A2-A0CS-01 TCGA-A2-A0CS-01A-11D-A10Y-09 560ab6aa-cbfe-42ac-9446-9d3df720bc81 TCGA-A2-A0CS-01A-11D-A111-01 TCGA-A2-A0CS-01 TCGA-A2-A0CS-01A-11R-A115-07 560ab6aa-cbfe-42ac-9446-9d3df720bc81 TCGA-A2-A0CS-01A-11D-A111-01 TCGA-A2-A0CS-01 TCGA-A2-A0CT-01 Stage IIA 71 5 Stage IIA 2288 Positive FEMALE Negative 4 3 4 Negative M0 Negative N0 2288 0 LumA Luminal B Negative LumA/B -10 -3 followup T_Other T2 LIVING TCGA-A2-A0CT-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0CT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0CT-F13730 TCGA-A2-A0CT Positive 0 Negative Simple Mastectomy YES -25959 0 2289 90-99% Scheduled Follow-up Submission 2011-6-9 FEMALE 2+ 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 NO 0 0 No M0 N0 (i-) T2 Stage IIA A0CT TUMOR FREE <10% NO Primary Tumor 01 6th YES NO YES A2 Breast LIVING 2005 f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0 f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0 TCGA-A2-A0CT-01A-11-A13B-20 TCGA-A2-A0CT-01A-31W-A071-09 TCGA-A2-A0CT-01 TCGA-A2-A0CT-01A-31D-A10P-05 cfc7cb7e-3c46-41d6-9b19-ee2652b2c3e9 TCGA-A2-A0CT-01 TCGA-A2-A0CT-01A-31W-A071-09 TCGA-A2-A0CT-01 TCGA-A2-A0CT-01A-31W-A071-09 TCGA-A2-A0CT-01 f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0 TCGA-A2-A0CT-01 TCGA-A2-A0CT-01A-31D-A059-01 TCGA-A2-A0CT-01A-31R-A056-07 f33b0a48-706b-4fd8-b8b3-0a9f625bd0c0 TCGA-A2-A0CT-01A-31D-A059-01 TCGA-A2-A0CT-01 TCGA-A2-A0CU-01 Stage IIA 73 5 Stage IIA 139 157 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 157 1 LumA Luminal A Positive LumA/B 0 -3 followup T_Other T2 DECEASED TCGA-A2-A0CU-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0CU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0CU-F13735 TCGA-A2-A0CU TCGA-A2-A0CU-01A Positive Positive Simple Mastectomy YES -26823 1911 158 0 90-99% Scheduled Follow-up Submission 2011-6-10 FEMALE 2+ 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 190 NO Equivocal Negative 1 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0CU.D503E73D-8B94-46A0-A24F-93069A56DC7D.pdf A0CU TUMOR FREE <10% NO Primary Tumor 01 6th YES NO YES A2 Breast A DECEASED 2005 84ea9827-9ad4-4e2f-be02-c88a9d4c4051 84ea9827-9ad4-4e2f-be02-c88a9d4c4051 TCGA-A2-A0CU-01A-21-A13B-20 TCGA-A2-A0CU-01A-12W-A050-09 TCGA-A2-A0CU-01 74d7ee07-2eba-4552-a888-c29010bbc5ea TCGA-A2-A0CU-01 TCGA-A2-A0CU-01A-12W-A050-09 TCGA-A2-A0CU-01A-12D-A032-05 TCGA-A2-A0CU-01 TCGA-A2-A0CU-01A-12W-A050-09 TCGA-A2-A0CU-01 84ea9827-9ad4-4e2f-be02-c88a9d4c4051 TCGA-A2-A0CU-01 TCGA-A2-A0CU-01A-12D-A036-01 TCGA-A2-A0CU-01A-12R-A034-07 84ea9827-9ad4-4e2f-be02-c88a9d4c4051 TCGA-A2-A0CU-01A-12D-A036-01 TCGA-A2-A0CU-01 TCGA-A2-A0CV-01 Stage IIB 41 2 No_Conversion 1929 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1929 0 LumA Luminal A Positive LumA/B -5 -7 followup T_Other T2 LIVING TCGA-A2-A0CV-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 6 mutation c1uster 9 TCGA-A2-A0CV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0CV-F59321 TCGA-A2-A0CV Positive Positive Modified Radical Mastectomy NO -15289 0 3011 90-99% Scheduled Follow-up Submission 2014-5-8 FEMALE 1+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative Negative NO 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 4 0 No M0 N1a T2 Stage IIB A0CV TUMOR FREE YES 90-99% YES Primary Tumor 01 6th YES NO YES A2 Breast LIVING 2005 a8154f60-e391-44b5-b378-c944c5e8621d a8154f60-e391-44b5-b378-c944c5e8621d TCGA-A2-A0CV-01A-21-A13B-20 TCGA-A2-A0CV-01A-31D-A10Y-09 TCGA-A2-A0CV-01 b595e1e2-77fa-4ebd-b2d4-054e8b9ca3ae TCGA-A2-A0CV-01 TCGA-A2-A0CV-01A-31D-A10Y-09 TCGA-A2-A0CV-01A-31D-A112-05 TCGA-A2-A0CV-01 TCGA-A2-A0CV-01 TCGA-A2-A0CV-01A-31D-A10Y-09 a8154f60-e391-44b5-b378-c944c5e8621d TCGA-A2-A0CV-01A-31D-A111-01 TCGA-A2-A0CV-01 TCGA-A2-A0CV-01A-31R-A115-07 a8154f60-e391-44b5-b378-c944c5e8621d TCGA-A2-A0CV-01A-31D-A111-01 TCGA-A2-A0CV-01 TCGA-A2-A0CW-01 Stage IIB 67 1 No_Conversion 1947 Positive FEMALE Negative Negative M0 Positive N1 1947 0 LumB Luminal B Positive LumA/B -2 -5 followup T_Other T2 LIVING TCGA-A2-A0CW-01 Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation cluster 3 TCGA-A2-A0CW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0CW-F70690 TCGA-A2-A0CW TCGA-A2-A0CW-01A Positive Positive Lumpectomy YES -24541 1533 0 3283 90-99% Scheduled Follow-up Submission 2015-3-2 FEMALE 2+ 0.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 290 NO Equivocal Negative NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 2 0 true No M0 N1a T2 Stage IIB TCGA-A2-A0CW.7D1C2CD8-9842-48AC-BB16-897E2A45B88D.pdf A0CW TUMOR FREE YES 10-19% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2006 1c1560f6-62bf-4185-912f-25c234ebd71f 1c1560f6-62bf-4185-912f-25c234ebd71f TCGA-A2-A0CW-01A-11-A13B-20 TCGA-A2-A0CW-01A-21D-A10Y-09 TCGA-A2-A0CW-01 6d65d556-9be9-4491-bd22-85cee7a0ee7c TCGA-A2-A0CW-01 TCGA-A2-A0CW-01A-21D-A10Y-09 TCGA-A2-A0CW-01A-21D-A112-05 TCGA-A2-A0CW-01 TCGA-A2-A0CW-01 TCGA-A2-A0CW-01A-21D-A10Y-09 1c1560f6-62bf-4185-912f-25c234ebd71f TCGA-A2-A0CW-01A-21D-A111-01 TCGA-A2-A0CW-01 TCGA-A2-A0CW-01A-21R-A115-07 1c1560f6-62bf-4185-912f-25c234ebd71f TCGA-A2-A0CW-01A-21D-A111-01 TCGA-A2-A0CW-01 TCGA-A2-A0CX-01 Stage IIA 52 3 Stage IIA 1728 Positive FEMALE Positive Negative M0 Negative N0 1728 0 Her2 HER2-enriched Negative Her2 -11 -5 followup T_Other T2 LIVING TCGA-A2-A0CX-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 mutation cluster 5 TCGA-A2-A0CX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Sentinel node biopsy alone TCGA-A2-A0CX-F13721 TCGA-A2-A0CX TCGA-A2-A0CX-01A Positive Negative Lumpectomy YES -19152 1316 0 1728 Scheduled Follow-up Submission 2011-6-10 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 560 NO Positive 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0CX.28AFD5DD-B607-4837-819F-688C9218ED06.pdf A0CX TUMOR FREE <10% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2006 b1ecc303-eb55-436f-9629-cdac63bde297 b1ecc303-eb55-436f-9629-cdac63bde297 TCGA-A2-A0CX-01A-11-A13B-20 TCGA-A2-A0CX-01A-21W-A019-09 TCGA-A2-A0CX-01 1f7a4605-1972-4f36-b0e7-543ce95a3d0f TCGA-A2-A0CX-01 TCGA-A2-A0CX-01A-21W-A019-09 TCGA-A2-A0CX-01A-21D-A00Y-05 TCGA-A2-A0CX-01 TCGA-A2-A0CX-01A-21W-A019-09 b1ecc303-eb55-436f-9629-cdac63bde297 TCGA-A2-A0CX-01A-21D-A011-01 TCGA-A2-A0CX-01A-21R-A00Z-07 b1ecc303-eb55-436f-9629-cdac63bde297 TCGA-A2-A0CX-01A-21D-A011-01 TCGA-A2-A0CX-01 TCGA-A2-A0CY-01 Stage IIB 63 1 No_Conversion 1673 Positive FEMALE Negative Negative M0 Positive N1 1673 0 HER2-enriched Positive LumA/B 0 -3 followup T_Other T2 LIVING TCGA-A2-A0CY-01 Kirc+ cluster 5 Cluster 5 BRCA nonbasal-like c8 miRNA c1uster 10 cluster 7 TCGA-A2-A0CY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0CY-F13731 TCGA-A2-A0CY TCGA-A2-A0CY-01A Positive Positive Simple Mastectomy YES -23229 1274 0 1673 90-99% Scheduled Follow-up Submission 2011-6-9 FEMALE 1+ 0.89 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 220 NO Negative Negative 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 7 NO 1 0 true No M0 N1 T2 Stage IIB TCGA-A2-A0CY.CB780DE7-E98C-4F7E-9487-8F25FE80DC21.pdf A0CY TUMOR FREE 10-19% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2006 c7d2b685-5f11-4879-82d5-e983b5dbb07d c7d2b685-5f11-4879-82d5-e983b5dbb07d TCGA-A2-A0CY-01A-21-A13C-20 TCGA-A2-A0CY-01 3dc93dcc-2b14-4725-b40e-23be7cdbbb9d TCGA-A2-A0CY-01A-12D-A032-05 TCGA-A2-A0CY-01 c7d2b685-5f11-4879-82d5-e983b5dbb07d TCGA-A2-A0CY-01 TCGA-A2-A0CY-01A-12R-A034-07 c7d2b685-5f11-4879-82d5-e983b5dbb07d TCGA-A2-A0CY-01 TCGA-A2-A0CZ-01 Stage IIA 46 4 Stage IIA 1615 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 1615 0 Normal Luminal A Positive ReacII -5 -7 followup T_Other T2 LIVING TCGA-A2-A0CZ-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0CZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-A2-A0CZ-F13728 TCGA-A2-A0CZ TCGA-A2-A0CZ-01A Positive Positive Simple Mastectomy YES -17026 1204 0 1616 90-99% Scheduled Follow-up Submission 2011-6-10 FEMALE 1+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 240 NO Negative Negative 2 Positive Peri (6-12 months since last menstrual period) 1 2 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0CZ.57153075-9055-4D7E-9CD6-9167D165E860.pdf A0CZ TUMOR FREE 20-29% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2007 229ebbe9-4dc8-434f-998c-fc0660cd2b00 229ebbe9-4dc8-434f-998c-fc0660cd2b00 TCGA-A2-A0CZ-01A-21-A13C-20 TCGA-A2-A0CZ-01A-11W-A050-09 TCGA-A2-A0CZ-01 af5345d8-db03-4d37-b327-5a62c1fe1285 TCGA-A2-A0CZ-01A-11W-A050-09 TCGA-A2-A0CZ-01A-11D-A032-05 TCGA-A2-A0CZ-01A-11W-A050-09 TCGA-A2-A0CZ-01 229ebbe9-4dc8-434f-998c-fc0660cd2b00 TCGA-A2-A0CZ-01 TCGA-A2-A0CZ-01A-11R-A034-07 229ebbe9-4dc8-434f-998c-fc0660cd2b00 TCGA-A2-A0CZ-01 TCGA-A2-A0D0-01 Stage IIA 60 1 Stage IIA 643 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 643 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-A2-A0D0-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 5 mutation cluster 5 TCGA-A2-A0D0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0D0-F59399 TCGA-A2-A0D0 TCGA-A2-A0D0-01A Negative 0 Negative Simple Mastectomy NO -22115 720 0 2048 <10% Scheduled Follow-up Submission 2014-5-12 FEMALE 0 1.17 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 500 NO Negative Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0D0.D8B44020-EC34-4788-B7FB-790B9C12D886.pdf A0D0 TUMOR FREE YES <10% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2008 bd51f90a-ec67-4a7d-87bf-9d85acd65d51 bd51f90a-ec67-4a7d-87bf-9d85acd65d51 TCGA-A2-A0D0-01A-21-A13C-20 TCGA-A2-A0D0-01A-11W-A019-09 TCGA-A2-A0D0-01 980c774a-c662-489e-82a3-212d0a45f759 TCGA-A2-A0D0-01 TCGA-A2-A0D0-01A-11W-A019-09 TCGA-A2-A0D0-01A-11D-A00Y-05 TCGA-A2-A0D0-01 TCGA-A2-A0D0-01A-11W-A019-09 TCGA-A2-A0D0-01 bd51f90a-ec67-4a7d-87bf-9d85acd65d51 TCGA-A2-A0D0-01 TCGA-A2-A0D0-01A-11D-A011-01 TCGA-A2-A0D0-01A-11R-A00Z-07 bd51f90a-ec67-4a7d-87bf-9d85acd65d51 TCGA-A2-A0D0-01A-11D-A011-01 TCGA-A2-A0D0-01 TCGA-A2-A0D1-01 Stage IIA 76 1 Stage IIA 1051 Negative FEMALE Positive 2 2 1 Negative M0 Negative N0 1051 0 Her2 HER2-enriched Negative Basal -2 -6 followup T_Other T2 LIVING TCGA-A2-A0D1-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 8 TCGA-A2-A0D1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Lower Inner Quadrant Sentinel node biopsy alone TCGA-A2-A0D1-F13733 TCGA-A2-A0D1 TCGA-A2-A0D1-01A Negative Negative Lumpectomy YES -28084 637 0 1051 <10% Scheduled Follow-up Submission 2011-6-9 FEMALE 3+ 5.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 340 NO Positive Positive 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0D1.5DFA7970-3F68-4FC3-B2BA-5A42E866ECC3.pdf A0D1 TUMOR FREE Intensity=Weak Intensity=Weak <10% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2008 01370d42-f75c-4532-9b9c-24ff7302b033 01370d42-f75c-4532-9b9c-24ff7302b033 TCGA-A2-A0D1-01A-21-A13C-20 TCGA-A2-A0D1-01A-11W-A050-09 TCGA-A2-A0D1-01 aa90ba5a-1a36-46e9-a3f5-21ba48c5f29a TCGA-A2-A0D1-01 TCGA-A2-A0D1-01A-11W-A050-09 TCGA-A2-A0D1-01A-11D-A032-05 TCGA-A2-A0D1-01 TCGA-A2-A0D1-01A-11W-A050-09 TCGA-A2-A0D1-01 01370d42-f75c-4532-9b9c-24ff7302b033 TCGA-A2-A0D1-01 TCGA-A2-A0D1-01A-11D-A036-01 TCGA-A2-A0D1-01A-11R-A034-07 01370d42-f75c-4532-9b9c-24ff7302b033 TCGA-A2-A0D1-01A-11D-A036-01 TCGA-A2-A0D1-01 TCGA-A2-A0D2-01 Stage IIB 45 3 Stage IIA 1027 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1027 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-A2-A0D2-01 High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-A2-A0D2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0D2-F14458 TCGA-A2-A0D2 TCGA-A2-A0D2-01A Negative 0 Negative Simple Mastectomy YES -16623 614 0 1027 <10% Scheduled Follow-up Submission 2011-6-9 FEMALE 0 1.05 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 330 NO Negative Negative 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 NO 0 4 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0D2.B0DE3388-7826-40D3-ADEE-0B25FE201F4A.pdf A0D2 TUMOR FREE <10% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2008 2ad8d416-08a4-4e6f-947e-d74269d02ab1 2ad8d416-08a4-4e6f-947e-d74269d02ab1 TCGA-A2-A0D2-01A-11-A13C-20 TCGA-A2-A0D2-01A-21W-A050-09 TCGA-A2-A0D2-01 74c3c43d-b3f1-4846-be03-3b65098774c7 TCGA-A2-A0D2-01 TCGA-A2-A0D2-01A-21W-A050-09 TCGA-A2-A0D2-01A-21D-A032-05 TCGA-A2-A0D2-01 TCGA-A2-A0D2-01A-21W-A050-09 TCGA-A2-A0D2-01 2ad8d416-08a4-4e6f-947e-d74269d02ab1 TCGA-A2-A0D2-01 TCGA-A2-A0D2-01A-21D-A036-01 TCGA-A2-A0D2-01A-21R-A034-07 2ad8d416-08a4-4e6f-947e-d74269d02ab1 TCGA-A2-A0D2-01A-21D-A036-01 TCGA-A2-A0D2-01 TCGA-A2-A0D3-01 Stage IA 42 2 Stage I 875 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 875 0 LumA Luminal A Positive LumA -5 -3 followup T1 T1 LIVING TCGA-A2-A0D3-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-A2-A0D3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0D3-F59451 TCGA-A2-A0D3 TCGA-A2-A0D3-01A Positive Positive Simple Mastectomy YES -15524 545 0 1873 90-99% Scheduled Follow-up Submission 2014-5-13 FEMALE 1+ 1.41 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 420 NO Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0D3.5C563F73-3793-4902-ACBB-82F432AED592.pdf A0D3 TUMOR FREE YES 90-99% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2008 eefe67c9-48a1-4381-a3ef-81b51e46c6df eefe67c9-48a1-4381-a3ef-81b51e46c6df TCGA-A2-A0D3-01A-21-A13A-20 TCGA-A2-A0D3-01A-11D-A10Y-09 TCGA-A2-A0D3-01 068b3d7e-b3b4-4fd1-89c5-2019253806b2 TCGA-A2-A0D3-01 TCGA-A2-A0D3-01A-11D-A10Y-09 TCGA-A2-A0D3-01A-11D-A112-05 TCGA-A2-A0D3-01 TCGA-A2-A0D3-01 TCGA-A2-A0D3-01A-11D-A10Y-09 eefe67c9-48a1-4381-a3ef-81b51e46c6df TCGA-A2-A0D3-01A-11D-A111-01 TCGA-A2-A0D3-01 TCGA-A2-A0D3-01A-11R-A115-07 eefe67c9-48a1-4381-a3ef-81b51e46c6df TCGA-A2-A0D3-01A-11D-A111-01 TCGA-A2-A0D3-01 TCGA-A2-A0D4-01 Stage IIB 37 5 No_Conversion 767 Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 767 0 LumB Luminal B Positive LumA/B -10 -3 followup T_Other T2 LIVING TCGA-A2-A0D4-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-A2-A0D4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Left Axillary lymph node dissection alone TCGA-A2-A0D4-F13726 TCGA-A2-A0D4 TCGA-A2-A0D4-01A Positive Positive Lumpectomy NO -13805 384 0 767 90-99% Scheduled Follow-up Submission 2011-6-10 FEMALE 1+ 1.14 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 220 NO Negative Negative 23 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 5 NO 1 0 true No M0 N1a T2 Stage IIB TCGA-A2-A0D4.990F5885-8EDD-42A2-AEFE-9DEE3E95A0B1.pdf A0D4 TUMOR FREE Intensity=weak Intensity=moderate 10-19% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2009 2522bd3d-f6b3-45df-b68f-577ffbf3a819 2522bd3d-f6b3-45df-b68f-577ffbf3a819 TCGA-A2-A0D4-01A-21-A13C-20 TCGA-A2-A0D4-01A-11W-A019-09 TCGA-A2-A0D4-01 33556a57-3d4b-4d1d-ac6f-bf0974c4ca36 TCGA-A2-A0D4-01 TCGA-A2-A0D4-01A-11W-A019-09 TCGA-A2-A0D4-01A-11D-A00Y-05 TCGA-A2-A0D4-01 TCGA-A2-A0D4-01A-11W-A019-09 TCGA-A2-A0D4-01 2522bd3d-f6b3-45df-b68f-577ffbf3a819 TCGA-A2-A0D4-01 TCGA-A2-A0D4-01A-11D-A011-01 TCGA-A2-A0D4-01A-11R-A00Z-07 2522bd3d-f6b3-45df-b68f-577ffbf3a819 TCGA-A2-A0D4-01A-11D-A011-01 TCGA-A2-A0D4-01 TCGA-A2-A0EM-01 Stage IA 73 2 Stage I 3093 Positive FEMALE Negative Negative M0 Negative N0 3093 0 LumA Luminal A Positive -12 -3 followup T1 T1 LIVING TCGA-A2-A0EM-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A0EM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-A2-A0EM-F13714 TCGA-A2-A0EM TCGA-A2-A0EM-01A Positive Positive Lumpectomy YES -26845 2696 0 3094 Scheduled Follow-up Submission 2011-6-9 FEMALE 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 20 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A0EM.454CB5E9-3778-4666-9CED-913E08CB3615.pdf A0EM TUMOR FREE YES Primary Tumor 01 5th YES NO YES A2 Breast A LIVING 2002 8d30a0ab-a41f-40ef-bd59-f738f4b39941 8d30a0ab-a41f-40ef-bd59-f738f4b39941 TCGA-A2-A0EM-01A-11W-A050-09 TCGA-A2-A0EM-01 TCGA-A2-A0EM-01 TCGA-A2-A0EM-01A-11W-A050-09 TCGA-A2-A0EM-01A-11D-A032-05 TCGA-A2-A0EM-01 TCGA-A2-A0EM-01A-11W-A050-09 TCGA-A2-A0EM-01 8d30a0ab-a41f-40ef-bd59-f738f4b39941 TCGA-A2-A0EM-01 TCGA-A2-A0EM-01A-11D-A036-01 TCGA-A2-A0EM-01A-11R-A034-07 8d30a0ab-a41f-40ef-bd59-f738f4b39941 TCGA-A2-A0EM-01A-11D-A036-01 TCGA-A2-A0EM-01 TCGA-A2-A0EN-01 Stage IIA 70 2 Stage IIA 2717 Positive FEMALE Negative Negative M0 Negative N0 2717 0 LumA Luminal A Positive -5 -7 followup T_Other T2 LIVING TCGA-A2-A0EN-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A0EN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Sentinel node biopsy alone TCGA-A2-A0EN-F13725 TCGA-A2-A0EN TCGA-A2-A0EN-01A Positive Positive Lumpectomy YES -25771 2348 0 2718 Scheduled Follow-up Submission 2011-6-10 FEMALE 2+ 1.4 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Excisional Biopsy 110 NO Equivocal Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 2 NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0EN.8169AA00-E396-4A3E-A91C-F67B1F0B8E3E.pdf A0EN TUMOR FREE 50-59% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2003 3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed 3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed TCGA-A2-A0EN-01A-13D-A099-09 TCGA-A2-A0EN-01 TCGA-A2-A0EN-01A-13D-A10P-05 TCGA-A2-A0EN-01 TCGA-A2-A0EN-01A-13D-A099-09 TCGA-A2-A0EN-01 TCGA-A2-A0EN-01A-13D-A099-09 TCGA-A2-A0EN-01 3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed TCGA-A2-A0EN-01 TCGA-A2-A0EN-01A-13D-A087-01 TCGA-A2-A0EN-01A-13R-A084-07 3ac4a6fe-9d2b-4c95-a74a-525b0328c7ed TCGA-A2-A0EN-01A-13D-A087-01 TCGA-A2-A0EN-01 TCGA-A2-A0EO-01 Stage IA 54 2 Stage I 2441 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 2441 0 LumA Luminal A Positive LumA -5 -7 followup T1 T1 LIVING TCGA-A2-A0EO-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A2-A0EO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Sentinel node biopsy alone TCGA-A2-A0EO-F13732 TCGA-A2-A0EO TCGA-A2-A0EO-01A Positive Positive Lumpectomy YES -19880 2331 0 2442 Scheduled Follow-up Submission 2011-6-13 FEMALE 1+ 1.6 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative Negative 3 Close Peri (6-12 months since last menstrual period) 4 2 NO 0 0 true No M0 N0 (i-) T1 Stage IA TCGA-A2-A0EO.61BC91AE-CD06-432D-BCBA-6FAE2209C610.pdf A0EO TUMOR FREE YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2003 cdeceaf0-beb6-4374-8aea-83bd35318892 cdeceaf0-beb6-4374-8aea-83bd35318892 TCGA-A2-A0EO-01A-21-A13B-20 TCGA-A2-A0EO-01A-11W-A050-09 TCGA-A2-A0EO-01 368ae06c-f56e-4ba9-af38-0cc01e900f70 TCGA-A2-A0EO-01 TCGA-A2-A0EO-01A-11W-A050-09 TCGA-A2-A0EO-01A-11D-A032-05 TCGA-A2-A0EO-01 TCGA-A2-A0EO-01A-11W-A050-09 TCGA-A2-A0EO-01 cdeceaf0-beb6-4374-8aea-83bd35318892 TCGA-A2-A0EO-01 TCGA-A2-A0EO-01A-11D-A036-01 TCGA-A2-A0EO-01A-11R-A034-07 cdeceaf0-beb6-4374-8aea-83bd35318892 TCGA-A2-A0EO-01A-11D-A036-01 TCGA-A2-A0EO-01 TCGA-A2-A0EP-01 TCGA-A2-A0EP-01 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-A2-A0EP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Lower Inner Quadrant Sentinel node biopsy alone TCGA-A2-A0EP-F58499 TCGA-A2-A0EP Positive 3 Point Scale Negative Simple Mastectomy YES -20585 0 3603 80-89% 2014-4-11 FEMALE 1.3 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 1 No M0 N0 (i+) T1 Stage I A0EP TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES A2 Breast LIVING 2004 b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c TCGA-A2-A0EP-01A-61-A24A-20 TCGA-A2-A0EP-01 TCGA-A2-A0EP-01A-52D-A230-05 be62a150-20f9-449e-8992-796d4640879a TCGA-A2-A0EP-01 TCGA-A2-A0EP-01A-52D-A22X-09 TCGA-A2-A0EP-01 b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c TCGA-A2-A0EP-01A-52D-A22W-01 TCGA-A2-A0EP-01 b1dbf4a7-16f8-49bc-a89f-aeac729e3c3c TCGA-A2-A0EP-01A-52D-A22W-01 TCGA-A2-A0EQ-01 Stage IIA 64 4 Stage IIA 2426 Negative FEMALE Positive 1 1 4 Negative M0 Negative N0 2426 0 Her2 HER2-enriched Negative Basal -2 -5 followup T_Other T2 LIVING TCGA-A2-A0EQ-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 8 TCGA-A2-A0EQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left Other (specify) Sentinel lymph node and non-sentinel lymph node biopsy TCGA-A2-A0EQ-F13720 TCGA-A2-A0EQ Negative Negative 0 Lumpectomy Negative Lumpectomy YES -23543 0 2426 <10% Scheduled Follow-up Submission 2011-6-13 FEMALE 3+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy Positive Negative 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO 0 0 No M0 N0 (i-) T2 Stage IIA A0EQ TUMOR FREE <10% YES Primary Tumor 01 6th YES NO YES A2 Breast LIVING 2004 a083b072-7c1e-4ed6-90cf-1e49d21df4cb a083b072-7c1e-4ed6-90cf-1e49d21df4cb TCGA-A2-A0EQ-01A-21-A13C-20 TCGA-A2-A0EQ-01A-11W-A050-09 TCGA-A2-A0EQ-01 cd49aac8-9c6e-41d7-816c-1bdcb4aaca4a TCGA-A2-A0EQ-01 TCGA-A2-A0EQ-01A-11W-A050-09 TCGA-A2-A0EQ-01A-11D-A032-05 TCGA-A2-A0EQ-01 TCGA-A2-A0EQ-01A-11W-A050-09 TCGA-A2-A0EQ-01 a083b072-7c1e-4ed6-90cf-1e49d21df4cb TCGA-A2-A0EQ-01 TCGA-A2-A0EQ-01A-11D-A036-01 TCGA-A2-A0EQ-01A-11R-A034-07 a083b072-7c1e-4ed6-90cf-1e49d21df4cb TCGA-A2-A0EQ-01A-11D-A036-01 TCGA-A2-A0EQ-01 TCGA-A2-A0ER-01 Stage IB 63 5 No_Conversion 2262 Positive FEMALE Negative Negative M0 Positive N1 2262 0 LumA Luminal B Positive ReacII -10 -3 followup T1 T1 LIVING TCGA-A2-A0ER-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0ER TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0ER-F13719 TCGA-A2-A0ER TCGA-A2-A0ER-01A Negative Positive Lumpectomy Positive Lumpectomy YES -23021 1862 0 2263 90-99% Scheduled Follow-up Submission 2011-6-13 FEMALE 2+ 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 300 NO Equivocal Negative 14 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 1 0 true No M0 N1mi T1c Stage IB TCGA-A2-A0ER.A5D94D02-5423-4055-96E3-B5AA5799DC02.pdf A0ER TUMOR FREE 80-89% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2005 9c8e0865-894b-4a0b-83e4-c3e7a40e871b 9c8e0865-894b-4a0b-83e4-c3e7a40e871b TCGA-A2-A0ER-01A-11-A13C-20 TCGA-A2-A0ER-01A-21W-A050-09 TCGA-A2-A0ER-01 7b71576b-d077-4e99-ae77-0c061517a5f9 TCGA-A2-A0ER-01 TCGA-A2-A0ER-01A-21W-A050-09 TCGA-A2-A0ER-01A-21D-A032-05 TCGA-A2-A0ER-01 TCGA-A2-A0ER-01A-21W-A050-09 TCGA-A2-A0ER-01 9c8e0865-894b-4a0b-83e4-c3e7a40e871b TCGA-A2-A0ER-01 TCGA-A2-A0ER-01A-21D-A036-01 TCGA-A2-A0ER-01A-21R-A034-07 9c8e0865-894b-4a0b-83e4-c3e7a40e871b TCGA-A2-A0ER-01A-21D-A036-01 TCGA-A2-A0ER-01 TCGA-A2-A0ES-01 Stage IIA 52 4 Stage IIA 1127 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 1127 0 LumA Luminal A Positive ReacII -5 -7 followup T_Other T2 LIVING TCGA-A2-A0ES-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A2-A0ES TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0ES-F59395 TCGA-A2-A0ES TCGA-A2-A0ES-01A Positive Positive Simple Mastectomy YES -19160 756 0 2190 60-69% Scheduled Follow-up Submission 2014-5-12 FEMALE 1+ 1.32 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 460 NO Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0ES.6860A718-FAAB-44A1-A3C1-E4A9EC1ECB05.pdf A0ES TUMOR FREE YES 10-19% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2008 698c9928-1aa8-4b48-9048-5675e5943c22 698c9928-1aa8-4b48-9048-5675e5943c22 TCGA-A2-A0ES-01A-21-A13B-20 TCGA-A2-A0ES-01A-11D-A10Y-09 TCGA-A2-A0ES-01 8d841c4a-d6b2-4d89-8d26-b415bce6c25d TCGA-A2-A0ES-01 TCGA-A2-A0ES-01A-11D-A10Y-09 TCGA-A2-A0ES-01A-11D-A112-05 TCGA-A2-A0ES-01 TCGA-A2-A0ES-01 TCGA-A2-A0ES-01A-11D-A10Y-09 698c9928-1aa8-4b48-9048-5675e5943c22 TCGA-A2-A0ES-01A-11D-A111-01 TCGA-A2-A0ES-01 TCGA-A2-A0ES-01A-11R-A115-07 698c9928-1aa8-4b48-9048-5675e5943c22 TCGA-A2-A0ES-01A-11D-A111-01 TCGA-A2-A0ES-01 TCGA-A2-A0ET-01 Stage IIIA 58 3 No_Conversion 1066 Positive FEMALE Negative Negative M0 Positive N2 1066 0 LumA Luminal A Positive -10 -3 followup T_Other T2 LIVING TCGA-A2-A0ET-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-A2-A0ET TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0ET-F13713 TCGA-A2-A0ET TCGA-A2-A0ET-01A Positive Positive Lumpectomy NO -21464 674 0 1066 90-99% Scheduled Follow-up Submission 2011-6-10 FEMALE 2+ 1.09 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 890 NO Equivocal Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 NO 5 0 true No M0 N2a T2 Stage IIIA TCGA-A2-A0ET.E9D3FFF1-5FB2-4F17-9C1D-D9775E3CC5AC.pdf A0ET TUMOR FREE Intensity=Strong Intensity=Strong 70-79% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2008 4eb0c00d-595c-47ee-bcad-818c7723656d 4eb0c00d-595c-47ee-bcad-818c7723656d TCGA-A2-A0ET-01A-31D-A045-09 TCGA-A2-A0ET-01 TCGA-A2-A0ET-01 TCGA-A2-A0ET-01A-31D-A045-09 TCGA-A2-A0ET-01A-31D-A032-05 TCGA-A2-A0ET-01 TCGA-A2-A0ET-01A-31D-A045-09 TCGA-A2-A0ET-01 4eb0c00d-595c-47ee-bcad-818c7723656d TCGA-A2-A0ET-01 TCGA-A2-A0ET-01A-31D-A036-01 TCGA-A2-A0ET-01A-31R-A034-07 4eb0c00d-595c-47ee-bcad-818c7723656d TCGA-A2-A0ET-01A-31D-A036-01 TCGA-A2-A0ET-01 TCGA-A2-A0EU-01 Stage IA 79 4 Stage I 1043 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 1043 0 LumA Luminal A Positive ReacI -10 -3 followup T1 T1 LIVING TCGA-A2-A0EU-01 Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0EU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0EU-F13717 TCGA-A2-A0EU TCGA-A2-A0EU-01A Negative Positive Lumpectomy Positive Lumpectomy YES -29144 644 0 1043 90-99% Scheduled Follow-up Submission 2011-6-10 FEMALE 0 0.97 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 610 NO Negative Negative 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0EU.42649B9A-29D4-4D05-A78C-AC801792ADEB.pdf A0EU TUMOR FREE Intensity=Strong Intensity=Strong 90-99% YES Primary Tumor 01 6th NO NO YES A2 Breast A LIVING 2008 70633069-e9df-4fce-84df-6849f4b2693c 70633069-e9df-4fce-84df-6849f4b2693c TCGA-A2-A0EU-01A-11-A13B-20 TCGA-A2-A0EU-01A-22W-A071-09 TCGA-A2-A0EU-01 TCGA-A2-A0EU-01A-22D-A10P-05 616af0e6-b37f-48aa-aa61-2e5b5a72b749 TCGA-A2-A0EU-01 TCGA-A2-A0EU-01A-22W-A071-09 TCGA-A2-A0EU-01 TCGA-A2-A0EU-01A-22W-A071-09 TCGA-A2-A0EU-01 70633069-e9df-4fce-84df-6849f4b2693c TCGA-A2-A0EU-01 TCGA-A2-A0EU-01A-22D-A059-01 TCGA-A2-A0EU-01A-22R-A056-07 70633069-e9df-4fce-84df-6849f4b2693c TCGA-A2-A0EU-01A-22D-A059-01 TCGA-A2-A0EU-01 TCGA-A2-A0EV-01 Stage IA 80 3 Stage I 968 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 968 0 LumA Luminal A Positive ReacI 0 -4 followup T1 T1 LIVING TCGA-A2-A0EV-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0EV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left Sentinel node biopsy alone TCGA-A2-A0EV-F13712 TCGA-A2-A0EV TCGA-A2-A0EV-01A Positive Positive Lumpectomy YES -29285 590 0 968 90-99% Scheduled Follow-up Submission 2011-6-10 FEMALE <10% 0 1.40 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 960 NO Negative Negative 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0EV.2A62DD22-EFE6-48CD-8BE6-59B08168F78A.pdf A0EV TUMOR FREE 90-99% NO Primary Tumor 01 6th NO NO YES A2 Breast A LIVING 2008 75cd6423-52b8-4d29-97de-1fe2583dbac1 75cd6423-52b8-4d29-97de-1fe2583dbac1 TCGA-A2-A0EV-01A-21-A13C-20 TCGA-A2-A0EV-01A-11W-A050-09 TCGA-A2-A0EV-01 19683ba7-695c-484a-95ba-39a8dd02a6a3 TCGA-A2-A0EV-01 TCGA-A2-A0EV-01A-11W-A050-09 TCGA-A2-A0EV-01A-11D-A032-05 TCGA-A2-A0EV-01 TCGA-A2-A0EV-01A-11W-A050-09 TCGA-A2-A0EV-01 75cd6423-52b8-4d29-97de-1fe2583dbac1 TCGA-A2-A0EV-01 TCGA-A2-A0EV-01A-11D-A036-01 TCGA-A2-A0EV-01A-11R-A034-07 75cd6423-52b8-4d29-97de-1fe2583dbac1 TCGA-A2-A0EV-01A-11D-A036-01 TCGA-A2-A0EV-01 TCGA-A2-A0EW-01 Stage IIIC 53 2 No_Conversion 904 Positive FEMALE Negative 3 4 3 Negative M0 Positive N3 904 0 LumA Luminal A Positive ReacI -5 -7 followup T1 T1 LIVING TCGA-A2-A0EW-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-A2-A0EW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES 53 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0EW-F59511 TCGA-A2-A0EW TCGA-A2-A0EW-01A Positive Positive Simple Mastectomy YES -19413 542 1884 0 905 1353 90-99% Scheduled Follow-up Submission 2014-5-14 FEMALE 0 1.33 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 1710 NO Negative Negative NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 Bone Distant Metastasis NO YES 26 0 true No M0 N3a T1b Stage IIIC TCGA-A2-A0EW.2620E5E7-ED7D-4F04-A8AF-1499E9711E8A.pdf A0EW WITH TUMOR YES 10-19% YES Primary Tumor 01 6th YES NO YES A2 Breast A DECEASED 2008 5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9 5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9 TCGA-A2-A0EW-01A-31-A13B-20 TCGA-A2-A0EW-01A-21D-A10Y-09 TCGA-A2-A0EW-01 e365a292-15b3-4e28-bf58-3ecdde392c22 TCGA-A2-A0EW-01 TCGA-A2-A0EW-01A-21D-A10Y-09 TCGA-A2-A0EW-01A-21D-A112-05 TCGA-A2-A0EW-01 TCGA-A2-A0EW-01 TCGA-A2-A0EW-01A-21D-A10Y-09 5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9 TCGA-A2-A0EW-01A-21D-A111-01 TCGA-A2-A0EW-01 TCGA-A2-A0EW-01A-21R-A115-07 5bf6cf0d-8d00-4a50-b239-4b9d8f3e51b9 TCGA-A2-A0EW-01A-21D-A111-01 TCGA-A2-A0EW-01 TCGA-A2-A0EX-01 Stage IIB 46 4 Stage IIB 549 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 549 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T3 LIVING TCGA-A2-A0EX-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0EX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 46 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0EX-F13742 TCGA-A2-A0EX TCGA-A2-A0EX-01A Negative Positive Mastectomy NOS Positive Lumpectomy YES -16858 468 0 752 60-69% Scheduled Follow-up Submission 2011-6-10 FEMALE 1+ 1.22 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 650 NO Negative Negative 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 1 true No M0 N0 (i+) T3 Stage IIB TCGA-A2-A0EX.5B82545F-2636-4A8A-88DD-1B387DE678FF.pdf A0EX TUMOR FREE 90-99% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2009 6fc8b7da-3de6-4111-b685-bb03c032466a 6fc8b7da-3de6-4111-b685-bb03c032466a TCGA-A2-A0EX-01A-11-A13C-20 TCGA-A2-A0EX-01A-21W-A050-09 TCGA-A2-A0EX-01 83a37012-5a0c-4263-a361-3aaff03b0429 TCGA-A2-A0EX-01 TCGA-A2-A0EX-01A-21W-A050-09 TCGA-A2-A0EX-01A-21D-A032-05 TCGA-A2-A0EX-01 TCGA-A2-A0EX-01A-21W-A050-09 TCGA-A2-A0EX-01 6fc8b7da-3de6-4111-b685-bb03c032466a TCGA-A2-A0EX-01 TCGA-A2-A0EX-01A-21D-A036-01 TCGA-A2-A0EX-01A-21R-A034-07 6fc8b7da-3de6-4111-b685-bb03c032466a TCGA-A2-A0EX-01A-21D-A036-01 TCGA-A2-A0EX-01 TCGA-A2-A0EY-01 Stage IIB 62 3 No_Conversion 735 Positive FEMALE Positive 1 1 4 Negative M0 Positive N1 735 0 LumB Luminal B Negative Her2 -2 -5 followup T_Other T2 LIVING TCGA-A2-A0EY-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-A2-A0EY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0EY-F13716 TCGA-A2-A0EY TCGA-A2-A0EY-01A Positive Negative Lumpectomy YES -22872 358 0 1925 60-69% Scheduled Follow-up Submission 2011-6-10 FEMALE 3+ 7.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 580 NO Positive Positive 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 NO 1 0 true No M0 N1a T2 Stage IIB TCGA-A2-A0EY.61462D57-DF98-4F89-BAEF-E8156A47E2DD.pdf A0EY TUMOR FREE <10% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2009 4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6 4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6 TCGA-A2-A0EY-01A-21-A13C-20 TCGA-A2-A0EY-01A-11W-A050-09 TCGA-A2-A0EY-01 b4fefb35-16bd-4db4-aa7a-805703f36514 TCGA-A2-A0EY-01 TCGA-A2-A0EY-01A-11W-A050-09 TCGA-A2-A0EY-01A-11D-A032-05 TCGA-A2-A0EY-01 TCGA-A2-A0EY-01A-11W-A050-09 TCGA-A2-A0EY-01 4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6 TCGA-A2-A0EY-01 TCGA-A2-A0EY-01A-11D-A036-01 TCGA-A2-A0EY-01A-11R-A034-07 4f1ffb0e-b2f8-42ae-86cb-bbd3405014f6 TCGA-A2-A0EY-01A-11D-A036-01 TCGA-A2-A0EY-01 TCGA-A2-A0ST-01 Stage IIA 62 1 No_Conversion 1643 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1643 0 Basal Basal-like Negative Basal -13 -12 enrollment T1 T1 LIVING TCGA-A2-A0ST-01 Kirc+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-A2-A0ST TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0ST-F14035 TCGA-A2-A0ST TCGA-A2-A0ST-01A Negative Negative Lumpectomy YES -22922 2597 0 3017 Scheduled Follow-up Submission 2011-7-14 FEMALE 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 210 NO Negative 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 YES 3 0 true No M0 N1a T1c Stage IIA TCGA-A2-A0ST.1E8B978E-3D1B-46E8-80EE-3A11EE571CEC.pdf A0ST WITH TUMOR YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2003 920e47c0-1b19-46e6-b1db-b5fd95e44df0 920e47c0-1b19-46e6-b1db-b5fd95e44df0 TCGA-A2-A0ST-01A-21-A13A-20 TCGA-A2-A0ST-01A-12D-A099-09 TCGA-A2-A0ST-01 TCGA-A2-A0ST-01A-12D-A10P-05 d662c746-aeee-4b37-b811-a236222583b8 TCGA-A2-A0ST-01 TCGA-A2-A0ST-01A-12D-A099-09 TCGA-A2-A0ST-01 TCGA-A2-A0ST-01A-12D-A099-09 TCGA-A2-A0ST-01 920e47c0-1b19-46e6-b1db-b5fd95e44df0 TCGA-A2-A0ST-01 TCGA-A2-A0ST-01A-12D-A087-01 TCGA-A2-A0ST-01A-12R-A084-07 920e47c0-1b19-46e6-b1db-b5fd95e44df0 TCGA-A2-A0ST-01A-12D-A087-01 TCGA-A2-A0ST-01 TCGA-A2-A0SU-01 Stage IIA 66 2 Stage IIA 1661 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 1661 0 LumA Luminal A Positive LumA/B 0 0 followup T_Other T2 LIVING TCGA-A2-A0SU-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0SU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Sentinel node biopsy alone TCGA-A2-A0SU-F13954 TCGA-A2-A0SU TCGA-A2-A0SU-01A Positive Positive Simple Mastectomy YES -24219 1317 0 1662 90-99% Scheduled Follow-up Submission 2011-7-12 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 380 NO Negative 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0SU.BC75790C-FBC7-4897-B228-762245C48740.pdf A0SU TUMOR FREE <10% NO Primary Tumor 01 YES NO YES A2 Breast A LIVING 2006 05aa0960-505b-4b04-be9f-7b54940f5b27 05aa0960-505b-4b04-be9f-7b54940f5b27 TCGA-A2-A0SU-01A-21-A13C-20 TCGA-A2-A0SU-01A-11D-A099-09 TCGA-A2-A0SU-01 TCGA-A2-A0SU-01A-11D-A10P-05 4fbcc317-6f56-4227-a6ef-304afa8880eb TCGA-A2-A0SU-01 TCGA-A2-A0SU-01A-11D-A099-09 TCGA-A2-A0SU-01 TCGA-A2-A0SU-01A-11D-A099-09 TCGA-A2-A0SU-01 05aa0960-505b-4b04-be9f-7b54940f5b27 TCGA-A2-A0SU-01 TCGA-A2-A0SU-01A-11D-A087-01 TCGA-A2-A0SU-01A-11R-A084-07 05aa0960-505b-4b04-be9f-7b54940f5b27 TCGA-A2-A0SU-01A-11D-A087-01 TCGA-A2-A0SU-01 TCGA-A2-A0SV-01 Stage IV 63 5 No_Conversion 825 825 Positive FEMALE Negative 3 3 4 Positive M1 Positive N2 825 1 LumB Luminal B Positive Basal -2 -3 followup T_Other T2 DECEASED TCGA-A2-A0SV-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 5 TCGA-A2-A0SV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 63 Right Axillary lymph node dissection alone TCGA-A2-A0SV-F3755 TCGA-A2-A0SV TCGA-A2-A0SV-01A Positive Positive Simple Mastectomy NO -23126 1513 825 0 90-99% 2010-11-22 FEMALE 2+ 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 600 NO Equivocal Negative 9 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone 2 6 8 true No M1 N2a T2 Stage IV TCGA-A2-A0SV.161E2817-7DB2-46F8-BFEB-256DBBEFE633.pdf A0SV WITH TUMOR 10-19% YES Primary Tumor 01 6th YES NO YES A2 Breast A DECEASED 2006 783d861d-ba0c-4b0d-9922-06ac23d3fc85 783d861d-ba0c-4b0d-9922-06ac23d3fc85 TCGA-A2-A0SV-01A-21-A13A-20 TCGA-A2-A0SV-01A-11D-A099-09 TCGA-A2-A0SV-01 TCGA-A2-A0SV-01A-11D-A10P-05 fc3b7efa-17e1-4f22-82f6-46b9eb25ab83 TCGA-A2-A0SV-01 TCGA-A2-A0SV-01A-11D-A099-09 TCGA-A2-A0SV-01 TCGA-A2-A0SV-01A-11D-A099-09 TCGA-A2-A0SV-01 783d861d-ba0c-4b0d-9922-06ac23d3fc85 TCGA-A2-A0SV-01 TCGA-A2-A0SV-01A-11D-A087-01 TCGA-A2-A0SV-01A-11R-A084-07 783d861d-ba0c-4b0d-9922-06ac23d3fc85 TCGA-A2-A0SV-01A-11D-A087-01 TCGA-A2-A0SV-01 TCGA-A2-A0SW-01 Stage IV 82 4 No_Conversion 1364 1364 Positive FEMALE Negative 1 1 4 Positive M1 Positive N2 1364 1 LumB Luminal B Negative Basal -2 -5 followup T_Other T2 DECEASED TCGA-A2-A0SW-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 3 TCGA-A2-A0SW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO 82 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0SW-F3701 TCGA-A2-A0SW Positive Negative Lumpectomy NO -30085 1365 0 653 40-49% 2010-11-8 FEMALE Enumerate 60 tumor cells; ratio HER2/Centromer 17 >= 2.1 is amplified 60 1.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Liver 4 3 4 No M1 N2 T2 Stage IV A0SW WITH TUMOR <10% YES Primary Tumor 01 YES NO YES A2 Breast DECEASED 2006 d17676ea-d64e-49d0-9737-3b852879ce52 d17676ea-d64e-49d0-9737-3b852879ce52 TCGA-A2-A0SW-01A-21-A13A-20 TCGA-A2-A0SW-01A-11D-A099-09 TCGA-A2-A0SW-01 TCGA-A2-A0SW-01A-11D-A10P-05 dc3609ce-4a40-4456-b26f-f366770af706 TCGA-A2-A0SW-01 TCGA-A2-A0SW-01A-11D-A099-09 TCGA-A2-A0SW-01 TCGA-A2-A0SW-01A-11D-A099-09 TCGA-A2-A0SW-01 d17676ea-d64e-49d0-9737-3b852879ce52 TCGA-A2-A0SW-01 TCGA-A2-A0SW-01A-11D-A087-01 TCGA-A2-A0SW-01A-11R-A084-07 d17676ea-d64e-49d0-9737-3b852879ce52 TCGA-A2-A0SW-01A-11D-A087-01 TCGA-A2-A0SW-01 TCGA-A2-A0SX-01 Stage IA 48 1 Stage I 1288 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1288 0 Basal Basal-like Negative Basal -13 -12 followup T1 T1 LIVING TCGA-A2-A0SX-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A2-A0SX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES 48 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-A2-A0SX-F14037 TCGA-A2-A0SX TCGA-A2-A0SX-01A Negative Negative Lumpectomy Negative Lumpectomy YES 1239 -17774 1177 0 1534 1239 Scheduled Follow-up Submission 2011-7-14 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 910 NO Negative 1 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-A2-A0SX.63F76DB5-8433-4EFE-9054-6C04F065DF2D.pdf A0SX WITH TUMOR YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2007 28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825 28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825 TCGA-A2-A0SX-01A-21-A13A-20 TCGA-A2-A0SX-01A-12D-A099-09 TCGA-A2-A0SX-01 TCGA-A2-A0SX-01A-12D-A10P-05 13ef422e-b0f0-4c0a-bbe4-3d38bb2a2532 TCGA-A2-A0SX-01 TCGA-A2-A0SX-01A-12D-A099-09 TCGA-A2-A0SX-01 TCGA-A2-A0SX-01A-12D-A099-09 TCGA-A2-A0SX-01 28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825 TCGA-A2-A0SX-01 TCGA-A2-A0SX-01A-12D-A087-01 TCGA-A2-A0SX-01A-12R-A084-07 28f9b0d6-8b8f-4dd6-8a7d-73cdd374a825 TCGA-A2-A0SX-01A-12D-A087-01 TCGA-A2-A0SX-01 TCGA-A2-A0SY-01 Stage IIIA 62 2 No_Conversion 1347 Positive FEMALE Positive Negative M0 Positive N1 1347 0 LumA Luminal A Positive -5 -7 followup T_Other T3 LIVING TCGA-A2-A0SY-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-A2-A0SY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0SY-F13943 TCGA-A2-A0SY TCGA-A2-A0SY-01A Positive Positive Modified Radical Mastectomy YES -22928 1083 0 1347 80-89% Scheduled Follow-up Submission 2011-7-18 FEMALE Enumerate 60 tumor cells; ratio HER2/Centromere 17 >= 2.1 is amplified 60 4.8 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 510 NO Positive 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 1 0 true No M0 N1 T3 Stage IIIA TCGA-A2-A0SY.8E6902A6-A673-46CC-9AEB-3A71EF11099F.pdf A0SY TUMOR FREE 40-49% YES Primary Tumor 01 YES NO YES A2 Breast A LIVING 2007 30fad3cd-09a5-4867-9d18-a940041a2b60 30fad3cd-09a5-4867-9d18-a940041a2b60 TCGA-A2-A0SY-01A-31D-A099-09 TCGA-A2-A0SY-01 TCGA-A2-A0SY-01A-31D-A10P-05 TCGA-A2-A0SY-01 TCGA-A2-A0SY-01A-31D-A099-09 TCGA-A2-A0SY-01 TCGA-A2-A0SY-01A-31D-A099-09 TCGA-A2-A0SY-01 30fad3cd-09a5-4867-9d18-a940041a2b60 TCGA-A2-A0SY-01 TCGA-A2-A0SY-01A-31D-A087-01 TCGA-A2-A0SY-01A-31R-A084-07 30fad3cd-09a5-4867-9d18-a940041a2b60 TCGA-A2-A0SY-01A-31D-A087-01 TCGA-A2-A0SY-01 TCGA-A2-A0T0-01 Stage IIB 59 1 No_Conversion 533 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 533 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING TCGA-A2-A0T0-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 12 TCGA-A2-A0T0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0T0-F13944 TCGA-A2-A0T0 TCGA-A2-A0T0-01A Negative Negative Lumpectomy NO -21575 268 0 533 <10% Scheduled Follow-up Submission 2011-7-18 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 190 NO Negative 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 2 true No M0 N1 T2 Stage IIB TCGA-A2-A0T0.6F5EBE67-0A25-4B20-A1F6-9CE6C4FF4096.pdf A0T0 TUMOR FREE <10% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2009 7e073ecd-452a-4cba-9dfd-8601f3245721 7e073ecd-452a-4cba-9dfd-8601f3245721 TCGA-A2-A0T0-01A-11-A13D-20 TCGA-A2-A0T0-01A-22D-A099-09 TCGA-A2-A0T0-01 TCGA-A2-A0T0-01A-22D-A10P-05 87565b35-30bd-4e31-bb26-404baf053cdc TCGA-A2-A0T0-01 TCGA-A2-A0T0-01A-22D-A099-09 TCGA-A2-A0T0-01 TCGA-A2-A0T0-01A-22D-A099-09 TCGA-A2-A0T0-01 7e073ecd-452a-4cba-9dfd-8601f3245721 TCGA-A2-A0T0-01 TCGA-A2-A0T0-01A-22D-A087-01 TCGA-A2-A0T0-01A-22R-A084-07 7e073ecd-452a-4cba-9dfd-8601f3245721 TCGA-A2-A0T0-01A-22D-A087-01 TCGA-A2-A0T0-01 TCGA-A2-A0T1-01 Stage IIIC 55 4 No_Conversion 520 Negative FEMALE Positive 1 1 1 Negative M0 Positive N3 520 0 Her2 HER2-enriched Negative Her2 -11 -5 followup T_Other T3 LIVING TCGA-A2-A0T1-01 High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A2-A0T1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0T1-F13946 TCGA-A2-A0T1 TCGA-A2-A0T1-01A Negative Negative Lumpectomy NO -20227 233 0 521 <10% Scheduled Follow-up Submission 2011-7-18 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 230 NO Positive 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO 10 true No M0 N3 T3 Stage IIIC TCGA-A2-A0T1.7546B7FB-1976-4994-AFB7-6270382D44D7.pdf A0T1 TUMOR FREE <10% YES Primary Tumor 01 YES NO YES A2 Breast A LIVING 2009 8a19b992-4173-400d-8aec-d156525eedd6 8a19b992-4173-400d-8aec-d156525eedd6 TCGA-A2-A0T1-01A-11-A13D-20 TCGA-A2-A0T1-01A-21D-A099-09 TCGA-A2-A0T1-01 TCGA-A2-A0T1-01A-21D-A10P-05 84b6d9cc-201e-421d-b7af-77156e50c627 TCGA-A2-A0T1-01 TCGA-A2-A0T1-01A-21D-A099-09 TCGA-A2-A0T1-01 TCGA-A2-A0T1-01A-21D-A099-09 TCGA-A2-A0T1-01 8a19b992-4173-400d-8aec-d156525eedd6 TCGA-A2-A0T1-01 TCGA-A2-A0T1-01A-21D-A087-01 TCGA-A2-A0T1-01A-21R-A084-07 8a19b992-4173-400d-8aec-d156525eedd6 TCGA-A2-A0T1-01A-21D-A087-01 TCGA-A2-A0T1-01 TCGA-A2-A0T2-01 Stage IV 66 3 No_Conversion 240 240 Negative FEMALE Negative 2 2 2 Positive M1 Positive N3 240 1 Basal Basal-like Negative Basal -13 0 followup T_Other T3 DECEASED TCGA-A2-A0T2-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-A2-A0T2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO 66 Right Axillary lymph node dissection alone TCGA-A2-A0T2-F3706 TCGA-A2-A0T2 TCGA-A2-A0T2-01A Negative Negative Modified Radical Mastectomy NO -24235 261 255 0 <10% 2010-11-12 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 270 NO Negative 14 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Liver Abdomen 5 3 10 true No M1 N3 T3 Stage IV TCGA-A2-A0T2.0DCD80E1-173E-4A1B-BDD8-74C7D12C1313.pdf A0T2 WITH TUMOR <10% NO Primary Tumor 01 NO NO YES A2 Breast A DECEASED 2009 491c6c41-d1c5-4be7-bb7c-9df7275aa388 491c6c41-d1c5-4be7-bb7c-9df7275aa388 TCGA-A2-A0T2-01A-21-A13D-20 TCGA-A2-A0T2-01A-11W-A097-09 TCGA-A2-A0T2-01 TCGA-A2-A0T2-01A-11D-A10P-05 73634c23-d25e-4268-a1bb-f8270a5d1d00 TCGA-A2-A0T2-01 TCGA-A2-A0T2-01A-11W-A097-09 TCGA-A2-A0T2-01 TCGA-A2-A0T2-01A-11W-A097-09 TCGA-A2-A0T2-01 491c6c41-d1c5-4be7-bb7c-9df7275aa388 TCGA-A2-A0T2-01 TCGA-A2-A0T2-01A-11D-A087-01 TCGA-A2-A0T2-01A-11R-A084-07 491c6c41-d1c5-4be7-bb7c-9df7275aa388 TCGA-A2-A0T2-01A-11D-A087-01 TCGA-A2-A0T2-01 TCGA-A2-A0T3-01 Stage IA 37 3 Stage IIA 569 Positive FEMALE Negative 4 5 4 Negative M0 Positive N1 569 0 LumB Luminal B Positive ReacII 0 -3 followup T1 T1 LIVING TCGA-A2-A0T3-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 5 TCGA-A2-A0T3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0T3-F59384 TCGA-A2-A0T3 Negative Positive 3 Point Scale 3+ 3 Point Scale Other Positive Lumpectomy Margin resection YES -13680 0 1516 NO 90-99% 2.3 Scheduled Follow-up Submission 2014-5-12 FEMALE 2+ 556 3.2 1.4 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Equivocal Negative NO 13 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 7 NO 2 0 No M0 N1mi T1c Stage IB A0T3 TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO YES A2 Breast LIVING 2009 d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32 d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32 TCGA-A2-A0T3-01A-11-A13D-20 TCGA-A2-A0T3-01A-21D-A10Y-09 TCGA-A2-A0T3-01 c6a1647b-f6fb-4d3d-a67e-07719db0a308 TCGA-A2-A0T3-01 TCGA-A2-A0T3-01A-21D-A10Y-09 TCGA-A2-A0T3-01A-21D-A112-05 TCGA-A2-A0T3-01 TCGA-A2-A0T3-01 TCGA-A2-A0T3-01A-21D-A10Y-09 d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32 TCGA-A2-A0T3-01A-21D-A111-01 TCGA-A2-A0T3-01 TCGA-A2-A0T3-01A-21R-A115-07 d0f11931-ddcc-4cd5-8dfc-8ef984aa8a32 TCGA-A2-A0T3-01A-21D-A111-01 TCGA-A2-A0T3-01 TCGA-A2-A0T4-01 Stage IIA 62 2 Stage IIA 624 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 624 0 LumA Luminal B Positive ReacI -5 -7 followup T_Other T2 LIVING TCGA-A2-A0T4-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0T4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Inner Quadrant Other (specify) SLN and non-SLN biopsy TCGA-A2-A0T4-F13948 TCGA-A2-A0T4 TCGA-A2-A0T4-01A Positive 2+ Positive Simple Mastectomy YES -22849 303 0 624 90-99% Scheduled Follow-up Submission 2011-7-12 FEMALE 2+ 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 1500 NO Equivocal Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0T4.5B685F7F-917D-41BA-A7AB-D0E15D457BC5.pdf A0T4 TUMOR FREE 60-69% NO Primary Tumor 01 YES NO YES A2 Breast A LIVING 2009 09787ddc-336f-4a53-a687-339d90457085 09787ddc-336f-4a53-a687-339d90457085 TCGA-A2-A0T4-01A-21-A13D-20 TCGA-A2-A0T4-01A-31D-A099-09 TCGA-A2-A0T4-01 TCGA-A2-A0T4-01A-31D-A10P-05 a5869d20-d1ff-42f3-979d-797d1ed7a9e2 TCGA-A2-A0T4-01 TCGA-A2-A0T4-01A-31D-A099-09 TCGA-A2-A0T4-01 TCGA-A2-A0T4-01A-31D-A099-09 TCGA-A2-A0T4-01 09787ddc-336f-4a53-a687-339d90457085 TCGA-A2-A0T4-01 TCGA-A2-A0T4-01A-31D-A087-01 TCGA-A2-A0T4-01A-31R-A084-07 09787ddc-336f-4a53-a687-339d90457085 TCGA-A2-A0T4-01A-31D-A087-01 TCGA-A2-A0T4-01 TCGA-A2-A0T5-01 Stage IIB 39 2 Stage IIA 531 Positive FEMALE Negative Negative M0 Negative N0 531 0 LumA Luminal A Positive LumA -5 -3 followup T_Other T2 LIVING TCGA-A2-A0T5-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 TCGA-A2-A0T5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left Sentinel node biopsy alone TCGA-A2-A0T5-F13949 TCGA-A2-A0T5 TCGA-A2-A0T5-01A Positive Positive Simple Mastectomy YES -14503 263 0 531 90-99% Scheduled Follow-up Submission 2011-7-12 FEMALE 1+ 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 1740 NO Negative Negative 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0T5.7B1E6EEB-3B61-4CE8-B695-ED11C2EF169F.pdf A0T5 TUMOR FREE 90-99% NO Primary Tumor 01 YES NO YES A2 Breast A LIVING 2009 4c15b588-6017-4f0c-9b66-4f18122acc83 4c15b588-6017-4f0c-9b66-4f18122acc83 TCGA-A2-A0T5-01A-11-A13D-20 TCGA-A2-A0T5-01 TCGA-A2-A0T5-01A-21D-A10P-05 c7933393-6f03-4495-9e54-53e3e72d81e7 TCGA-A2-A0T5-01 TCGA-A2-A0T5-01A-21D-A099-09 TCGA-A2-A0T5-01 TCGA-A2-A0T5-01 4c15b588-6017-4f0c-9b66-4f18122acc83 TCGA-A2-A0T5-01 TCGA-A2-A0T5-01A-21D-A087-01 TCGA-A2-A0T5-01A-21R-A084-07 4c15b588-6017-4f0c-9b66-4f18122acc83 TCGA-A2-A0T5-01A-21D-A087-01 TCGA-A2-A0T5-01 TCGA-A2-A0T6-01 Stage IIB 50 2 Stage IIB 575 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 575 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T3 LIVING TCGA-A2-A0T6-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A2-A0T6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Sentinel node biopsy alone TCGA-A2-A0T6-F13950 TCGA-A2-A0T6 Positive 3+ Positive Simple Mastectomy YES -18334 0 575 90-99% Scheduled Follow-up Submission 2011-7-12 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy Negative 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 2 NO 0 0 No M0 N0 (i-) T3 Stage IIB A0T6 TUMOR FREE 90-99% YES Primary Tumor 01 YES NO YES A2 Breast LIVING 2009 e3639f71-cfe7-46c7-8390-73f8043ac6b0 e3639f71-cfe7-46c7-8390-73f8043ac6b0 TCGA-A2-A0T6-01A-21-A13C-20 TCGA-A2-A0T6-01A-11D-A099-09 TCGA-A2-A0T6-01 TCGA-A2-A0T6-01A-11D-A10P-05 dcf310c3-9f6b-492b-b733-ece45d60089a TCGA-A2-A0T6-01 TCGA-A2-A0T6-01A-11D-A099-09 TCGA-A2-A0T6-01 TCGA-A2-A0T6-01A-11D-A099-09 TCGA-A2-A0T6-01 e3639f71-cfe7-46c7-8390-73f8043ac6b0 TCGA-A2-A0T6-01 TCGA-A2-A0T6-01A-11D-A087-01 TCGA-A2-A0T6-01A-11R-A084-07 e3639f71-cfe7-46c7-8390-73f8043ac6b0 TCGA-A2-A0T6-01A-11D-A087-01 TCGA-A2-A0T6-01 TCGA-A2-A0T7-01 Stage IIA 51 2 Stage IIA 631 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 631 0 LumA Luminal A Positive ReacI -3 0 followup T_Other T2 LIVING TCGA-A2-A0T7-01 High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0T7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-A2-A0T7-F13953 TCGA-A2-A0T7 TCGA-A2-A0T7-01A Negative Positive 2+ Other Positive Modified Radical Mastectomy Skin excision YES -18756 280 0 631 90-99% Scheduled Follow-up Submission 2011-7-12 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 990 NO Negative 2 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-A2-A0T7.383EC600-FBF3-4F91-8FAC-41E3DDE6589E.pdf A0T7 TUMOR FREE 70-79% NO Primary Tumor 01 YES NO YES A2 Breast A LIVING 2009 b5de3654-8983-45ab-a83a-d15284740d39 b5de3654-8983-45ab-a83a-d15284740d39 TCGA-A2-A0T7-01A-11-A13A-20 TCGA-A2-A0T7-01A-21D-A099-09 TCGA-A2-A0T7-01 TCGA-A2-A0T7-01A-21D-A10P-05 7a10bda1-1af5-4641-91bd-9a5174a68ff9 TCGA-A2-A0T7-01 TCGA-A2-A0T7-01A-21D-A099-09 TCGA-A2-A0T7-01 TCGA-A2-A0T7-01A-21D-A099-09 TCGA-A2-A0T7-01 b5de3654-8983-45ab-a83a-d15284740d39 TCGA-A2-A0T7-01 TCGA-A2-A0T7-01A-21D-A087-01 TCGA-A2-A0T7-01A-21R-A084-07 b5de3654-8983-45ab-a83a-d15284740d39 TCGA-A2-A0T7-01A-21D-A087-01 TCGA-A2-A0T7-01 TCGA-A2-A0YC-01 Stage IIB 59 2 No_Conversion 989 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 989 0 LumA Luminal A Positive ReacII -12 -3 followup T_Other T2 LIVING TCGA-A2-A0YC-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0YC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES 59 Right Upper Inner Quadrant Other (specify) Sentinel lymph node biopsy x 2 and 1 non-sentinel lymph node biopsy TCGA-A2-A0YC-F15846 TCGA-A2-A0YC TCGA-A2-A0YC-01A Positive Positive Lumpectomy YES 798 -21685 673 0 990 798 90-99% Additional New Tumor Event 2011-8-30 FEMALE Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified 60 1.18 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 1170 NO Negative 3 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Equivocal Positive Positive 4 4 Bone Distant Metastasis YES 1 0 true No M0 N1mi T2 Stage IIB TCGA-A2-A0YC.9BAD4BD4-A54B-4115-A00E-6AA88F344FE1.pdf A0YC WITH TUMOR 90-99% YES Primary Tumor 01 YES NO YES A2 Breast A LIVING 2008 40c2be3f-f14a-4ab2-845a-2c1c174a4be7 40c2be3f-f14a-4ab2-845a-2c1c174a4be7 TCGA-A2-A0YC-01A-21-A13D-20 TCGA-A2-A0YC-01A-11D-A117-09 TCGA-A2-A0YC-01 TCGA-A2-A0YC-01A-11D-A10A-05 ca761204-8a14-4297-afa7-f200bc37d53a TCGA-A2-A0YC-01 TCGA-A2-A0YC-01A-11D-A117-09 TCGA-A2-A0YC-01 TCGA-A2-A0YC-01A-11D-A117-09 TCGA-A2-A0YC-01 40c2be3f-f14a-4ab2-845a-2c1c174a4be7 TCGA-A2-A0YC-01 TCGA-A2-A0YC-01A-11D-A107-01 TCGA-A2-A0YC-01A-11R-A109-07 40c2be3f-f14a-4ab2-845a-2c1c174a4be7 TCGA-A2-A0YC-01A-11D-A107-01 TCGA-A2-A0YC-01 TCGA-A2-A0YD-01 Stage IIB 63 2 Stage IIB 769 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 769 0 LumA Luminal A Positive LumA -5 -7 followup T_Other T3 LIVING TCGA-A2-A0YD-01 Iq C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A0YD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0YD-F15770 TCGA-A2-A0YD Positive Positive Simple Mastectomy YES -23021 0 769 90-99% Scheduled Follow-up Submission 2011-8-30 FEMALE Enumerate 60 tumor cells; ratio of HER2/Centromere 17 >= 2.1 is amplified 60 1.04 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 1 No M0 N0 (i+) T3 Stage IIB A0YD TUMOR FREE 80-89% NO Primary Tumor 01 YES NO YES A2 Breast LIVING 2009 c1190b96-b6cf-4cd5-8c4e-bc57d964a557 c1190b96-b6cf-4cd5-8c4e-bc57d964a557 TCGA-A2-A0YD-01A-21-A13D-20 TCGA-A2-A0YD-01A-11D-A10G-09 TCGA-A2-A0YD-01 TCGA-A2-A0YD-01A-11D-A10A-05 b3a0423a-0d47-45f2-aa7c-1ae650ab5dd0 TCGA-A2-A0YD-01 TCGA-A2-A0YD-01A-11D-A10G-09 TCGA-A2-A0YD-01 TCGA-A2-A0YD-01A-11D-A10G-09 TCGA-A2-A0YD-01 c1190b96-b6cf-4cd5-8c4e-bc57d964a557 TCGA-A2-A0YD-01 TCGA-A2-A0YD-01A-11D-A107-01 TCGA-A2-A0YD-01A-11R-A109-07 c1190b96-b6cf-4cd5-8c4e-bc57d964a557 TCGA-A2-A0YD-01A-11D-A107-01 TCGA-A2-A0YD-01 TCGA-A2-A0YE-01 Stage IIB 48 3 No_Conversion 553 Negative FEMALE Negative Negative M0 Positive N1 553 0 Basal Basal-like Negative X -13 -12 followup T_Other T2 LIVING TCGA-A2-A0YE-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 TCGA-A2-A0YE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0YE-F15771 TCGA-A2-A0YE TCGA-A2-A0YE-01A Negative Negative Lumpectomy NO -17727 238 0 554 <10% Scheduled Follow-up Submission 2011-8-30 FEMALE No membrane staining or incomplete membrane staining in <10% of tumor cells is negative <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 240 NO Negative 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 1 true No M0 N1a T2 Stage IIB TCGA-A2-A0YE.C58701EF-98C4-448E-978C-B39D125CC7E8.pdf A0YE TUMOR FREE <10% YES Primary Tumor 01 YES NO YES A2 Breast A LIVING 2010 7f57b9e7-1b1b-4e07-beb4-b877b7651f7b 7f57b9e7-1b1b-4e07-beb4-b877b7651f7b TCGA-A2-A0YE-01A-21-A13D-20 TCGA-A2-A0YE-01 TCGA-A2-A0YE-01A-11D-A10A-05 510563aa-4a19-4dd1-82c8-ac67f8a77a55 TCGA-A2-A0YE-01 TCGA-A2-A0YE-01A-11D-A10G-09 TCGA-A2-A0YE-01 7f57b9e7-1b1b-4e07-beb4-b877b7651f7b TCGA-A2-A0YE-01A-11D-A107-01 TCGA-A2-A0YE-01A-11R-A109-07 7f57b9e7-1b1b-4e07-beb4-b877b7651f7b TCGA-A2-A0YE-01A-11D-A107-01 TCGA-A2-A0YE-01 TCGA-A2-A0YF-01 Stage IA 67 2 Stage I 469 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 469 0 LumA Luminal A Negative ReacII -12 -3 followup T1 T1 LIVING TCGA-A2-A0YF-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-A2-A0YF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Sentinel node biopsy alone TCGA-A2-A0YF-F59385 TCGA-A2-A0YF TCGA-A2-A0YF-01A Positive 0 Negative Simple Mastectomy YES -24660 343 0 1535 90-99% Scheduled Follow-up Submission 2014-5-12 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 600 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 NO 0 1 true No M0 N0 (i+) T1b Stage I TCGA-A2-A0YF.C4C7D190-F0EC-4A70-8136-534EA3419217.pdf A0YF TUMOR FREE YES <10% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2009 b3ac6331-6c8f-4165-add7-482aadf7fa68 b3ac6331-6c8f-4165-add7-482aadf7fa68 TCGA-A2-A0YF-01A-11-A13D-20 TCGA-A2-A0YF-01A-21D-A10G-09 TCGA-A2-A0YF-01 TCGA-A2-A0YF-01A-21D-A10A-05 85fd3e18-e927-47b3-9e06-b73de5edd740 TCGA-A2-A0YF-01 TCGA-A2-A0YF-01A-21D-A10G-09 TCGA-A2-A0YF-01 TCGA-A2-A0YF-01A-21D-A10G-09 TCGA-A2-A0YF-01 b3ac6331-6c8f-4165-add7-482aadf7fa68 TCGA-A2-A0YF-01 TCGA-A2-A0YF-01A-21D-A107-01 TCGA-A2-A0YF-01A-21R-A109-07 b3ac6331-6c8f-4165-add7-482aadf7fa68 TCGA-A2-A0YF-01A-21D-A107-01 TCGA-A2-A0YF-01 TCGA-A2-A0YG-01 Stage IIIC 63 5 No_Conversion 665 Positive FEMALE Positive 1 1 4 Negative M0 Positive N3 665 0 LumB Luminal B Positive Her2 -2 -5 followup T_Other T2 LIVING TCGA-A2-A0YG-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-A2-A0YG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0YG-F16753 TCGA-A2-A0YG TCGA-A2-A0YG-01A Positive 2+ Positive Lumpectomy NO -23058 329 0 666 90-99% Scheduled Follow-up Submission 2011-9-16 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 1530 NO Positive 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 14 true No M0 N3a T2 Stage IIIC TCGA-A2-A0YG.B3D6A0F7-5E3C-4921-8399-6458E5222CC5.pdf A0YG TUMOR FREE <10% YES Primary Tumor 01 YES NO YES A2 Breast A LIVING 2009 c539f561-93db-41f3-8d9f-71cd77a096a7 c539f561-93db-41f3-8d9f-71cd77a096a7 TCGA-A2-A0YG-01A-31-A13D-20 TCGA-A2-A0YG-01A-21D-A10G-09 TCGA-A2-A0YG-01 TCGA-A2-A0YG-01A-21D-A10A-05 2d2789e0-0933-496a-a29b-63c0b05cfa19 TCGA-A2-A0YG-01 TCGA-A2-A0YG-01A-21D-A10G-09 TCGA-A2-A0YG-01 TCGA-A2-A0YG-01A-21D-A10G-09 TCGA-A2-A0YG-01 c539f561-93db-41f3-8d9f-71cd77a096a7 TCGA-A2-A0YG-01 TCGA-A2-A0YG-01A-21D-A107-01 TCGA-A2-A0YG-01A-21R-A109-07 c539f561-93db-41f3-8d9f-71cd77a096a7 TCGA-A2-A0YG-01A-21D-A107-01 TCGA-A2-A0YG-01 TCGA-A2-A0YH-01 Stage IIIA 53 4 No_Conversion 658 Positive FEMALE Negative 3 3 4 Negative M0 Positive N2 658 0 LumB Luminal B Positive LumA/B -2 -5 followup T_Other T2 LIVING TCGA-A2-A0YH-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-A2-A0YH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0YH-F16752 TCGA-A2-A0YH TCGA-A2-A0YH-01A Positive 3+ Positive Lumpectomy NO -19596 321 0 659 80-89% Scheduled Follow-up Submission 2011-9-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 480 NO Negative 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 5 true No M0 N2a T2 Stage IIIA TCGA-A2-A0YH.0C344CD7-6FAB-462B-9A8E-75B720F2D626.pdf A0YH TUMOR FREE 70-79% YES Primary Tumor 01 YES NO YES A2 Breast A LIVING 2009 5275bc42-18a3-43d1-9dee-dfb80c39ba20 5275bc42-18a3-43d1-9dee-dfb80c39ba20 TCGA-A2-A0YH-01A-21-A13D-20 TCGA-A2-A0YH-01A-11D-A10G-09 TCGA-A2-A0YH-01 TCGA-A2-A0YH-01A-11D-A10A-05 1682b578-8f05-4a4c-b98c-4ffe7ef3346e TCGA-A2-A0YH-01 TCGA-A2-A0YH-01A-11D-A10G-09 TCGA-A2-A0YH-01 TCGA-A2-A0YH-01A-11D-A10G-09 TCGA-A2-A0YH-01 5275bc42-18a3-43d1-9dee-dfb80c39ba20 TCGA-A2-A0YH-01 TCGA-A2-A0YH-01A-11D-A107-01 TCGA-A2-A0YH-01A-11R-A109-07 5275bc42-18a3-43d1-9dee-dfb80c39ba20 TCGA-A2-A0YH-01A-11D-A107-01 TCGA-A2-A0YH-01 TCGA-A2-A0YI-01 Stage IA 62 3 Stage I 441 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 441 0 LumA Luminal A Positive ReacI -12 -4 followup T1 T1 LIVING TCGA-A2-A0YI-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A2-A0YI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Other (specify) Sentinel Lymph node biopsy and one non-sentinel lymph node biopsy TCGA-A2-A0YI-F59386 TCGA-A2-A0YI TCGA-A2-A0YI-01A Positive 2+ Positive Lumpectomy YES -22961 303 0 1505 90-99% Scheduled Follow-up Submission 2014-5-12 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8522/3 C50.9 3+ YES Core needle biopsy 340 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 1 true No M0 N0 (i+) T1c Stage I TCGA-A2-A0YI.CEFD12BB-1AF7-400D-8A84-49650DFDD8A5.pdf A0YI TUMOR FREE YES 60-69% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2009 4de3ad78-68e4-4ab9-b1f6-eb0666140761 4de3ad78-68e4-4ab9-b1f6-eb0666140761 TCGA-A2-A0YI-01A-21-A13D-20 TCGA-A2-A0YI-01A-31D-A10M-09 TCGA-A2-A0YI-01 TCGA-A2-A0YI-01A-31D-A10N-05 0dca7119-3230-47a7-89e3-93c4bd405f4d TCGA-A2-A0YI-01 TCGA-A2-A0YI-01A-31D-A10M-09 TCGA-A2-A0YI-01 TCGA-A2-A0YI-01A-31D-A10M-09 TCGA-A2-A0YI-01 4de3ad78-68e4-4ab9-b1f6-eb0666140761 TCGA-A2-A0YI-01 TCGA-A2-A0YI-01A-31D-A10L-01 TCGA-A2-A0YI-01A-31R-A10J-07 4de3ad78-68e4-4ab9-b1f6-eb0666140761 TCGA-A2-A0YI-01A-31D-A10L-01 TCGA-A2-A0YI-01 TCGA-A2-A0YJ-01 Stage IIIA 39 3 No_Conversion 565 Positive FEMALE Negative Negative M0 Positive N2 565 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T3 LIVING TCGA-A2-A0YJ-01 COAD-READ C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 mutation cluster 5 TCGA-A2-A0YJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO YES 39 Left Axillary lymph node dissection alone TCGA-A2-A0YJ-F16756 TCGA-A2-A0YJ TCGA-A2-A0YJ-01A Positive 0 Negative Modified Radical Mastectomy NO 559 -14448 264 0 566 559 <10% Scheduled Follow-up Submission 2011-9-16 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Core needle biopsy 1080 NO Negative 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 1+ Negative <10% Negative 5 Other, specify Distant Metastasis Left Cervical Lymph Node YES 5 true No M0 N2a T3 Stage IIIA TCGA-A2-A0YJ.90F13DE2-7C8F-4FA2-B9BF-D68EEC37D514.pdf A0YJ WITH TUMOR <10% YES Primary Tumor 01 YES NO YES A2 Breast A LIVING 2010 330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19 330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19 TCGA-A2-A0YJ-01A-21-A13D-20 TCGA-A2-A0YJ-01A-11D-A10G-09 TCGA-A2-A0YJ-01 TCGA-A2-A0YJ-01A-11D-A10A-05 d6e27bfa-0efe-457b-8628-38958d21268b TCGA-A2-A0YJ-01 TCGA-A2-A0YJ-01A-11D-A10G-09 TCGA-A2-A0YJ-01 TCGA-A2-A0YJ-01A-11D-A10G-09 330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19 TCGA-A2-A0YJ-01A-11D-A107-01 TCGA-A2-A0YJ-01A-11R-A109-07 330bf4ac-9ed5-4bd1-93d0-f89b4f52bc19 TCGA-A2-A0YJ-01A-11D-A107-01 TCGA-A2-A0YJ-01 TCGA-A2-A0YK-01 Stage IIA 61 5 Stage IIA 587 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 587 0 Normal Normal-like Negative ReacII -5 -7 followup T_Other T2 LIVING TCGA-A2-A0YK-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-A2-A0YK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-A2-A0YK-F16750 TCGA-A2-A0YK TCGA-A2-A0YK-01A Positive Negative Simple Mastectomy YES -22625 280 0 588 90-99% Scheduled Follow-up Submission 2011-9-16 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 620 NO Negative 3 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0YK.C3B5F075-864A-4D8B-B0CB-1B1FA28ACF4F.pdf A0YK TUMOR FREE <10% NO Primary Tumor 01 YES NO YES A2 Breast A LIVING 2009 ae614f7b-b310-4c60-bd50-9e02be984943 ae614f7b-b310-4c60-bd50-9e02be984943 TCGA-A2-A0YK-01A-31-A13D-20 TCGA-A2-A0YK-01A-22D-A117-09 TCGA-A2-A0YK-01 TCGA-A2-A0YK-01A-22D-A10A-05 07e19b85-cee6-4ea4-8588-5df93bf33053 TCGA-A2-A0YK-01 TCGA-A2-A0YK-01A-22D-A117-09 TCGA-A2-A0YK-01 TCGA-A2-A0YK-01A-22D-A117-09 TCGA-A2-A0YK-01 ae614f7b-b310-4c60-bd50-9e02be984943 TCGA-A2-A0YK-01 TCGA-A2-A0YK-01A-22D-A107-01 TCGA-A2-A0YK-01A-22R-A109-07 ae614f7b-b310-4c60-bd50-9e02be984943 TCGA-A2-A0YK-01A-22D-A107-01 TCGA-A2-A0YK-01 TCGA-A2-A0YL-01 Stage IIIA 48 2 No_Conversion 445 Positive FEMALE Negative 3 4 3 Negative M0 Positive N2 445 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T3 LIVING TCGA-A2-A0YL-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-A2-A0YL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A0YL-F59387 TCGA-A2-A0YL TCGA-A2-A0YL-01A Positive 3+ Positive Simple Mastectomy YES -17702 205 0 1474 70-79% Scheduled Follow-up Submission 2014-5-12 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 730 NO Negative NO 29 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 NO 4 0 true No M0 N2a T3 Stage IIIA TCGA-A2-A0YL.AB083371-A2AB-4F57-8FBF-0DB2C91CEDDE.pdf A0YL TUMOR FREE YES 90-99% YES Primary Tumor 01 YES NO YES A2 Breast A LIVING 2010 32cfb4f4-1de9-4937-8cfa-dc6c37081583 32cfb4f4-1de9-4937-8cfa-dc6c37081583 TCGA-A2-A0YL-01A-11-A13D-20 TCGA-A2-A0YL-01A-21D-A10G-09 TCGA-A2-A0YL-01 TCGA-A2-A0YL-01A-21D-A10A-05 2f4ab3d7-e280-4c21-9b13-e1c240627337 TCGA-A2-A0YL-01 TCGA-A2-A0YL-01A-21D-A10G-09 TCGA-A2-A0YL-01 TCGA-A2-A0YL-01A-21D-A10G-09 TCGA-A2-A0YL-01 32cfb4f4-1de9-4937-8cfa-dc6c37081583 TCGA-A2-A0YL-01 TCGA-A2-A0YL-01A-21D-A107-01 TCGA-A2-A0YL-01A-21R-A109-07 32cfb4f4-1de9-4937-8cfa-dc6c37081583 TCGA-A2-A0YL-01A-21D-A107-01 TCGA-A2-A0YL-01 TCGA-A2-A0YM-01 Stage IIA 67 3 Stage IIA 964 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 964 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-A2-A0YM-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 OV-like c4 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 13 TCGA-A2-A0YM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Left Upper Outer Quadrant Other (specify) Sentinel lymph node biopsy and non-sentinel lymph node biopsy TCGA-A2-A0YM-F15767 TCGA-A2-A0YM TCGA-A2-A0YM-01A Negative Negative Lumpectomy YES -24831 691 0 965 <10% Scheduled Follow-up Submission 2011-8-30 FEMALE Enumerate 60 tumor cells; ratio of HER2/Centromere >=2.1 is amplified 60 1.08 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 360 NO Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A0YM.E1D8F2CB-25F1-49E0-92D3-132DCA8FD533.pdf A0YM TUMOR FREE <10% YES Primary Tumor 01 NO NO YES A2 Breast A LIVING 2008 1e59ea3f-36fa-4860-8c28-87b4b09075ec 1e59ea3f-36fa-4860-8c28-87b4b09075ec TCGA-A2-A0YM-01A-21-A13D-20 TCGA-A2-A0YM-01A-11D-A10G-09 TCGA-A2-A0YM-01 TCGA-A2-A0YM-01A-11D-A10A-05 a55195f2-8c4d-40ab-a452-8424a0403d03 TCGA-A2-A0YM-01 TCGA-A2-A0YM-01A-11D-A10G-09 TCGA-A2-A0YM-01 TCGA-A2-A0YM-01A-11D-A10G-09 TCGA-A2-A0YM-01 1e59ea3f-36fa-4860-8c28-87b4b09075ec TCGA-A2-A0YM-01 TCGA-A2-A0YM-01A-11D-A107-01 TCGA-A2-A0YM-01A-11R-A109-07 1e59ea3f-36fa-4860-8c28-87b4b09075ec TCGA-A2-A0YM-01A-11D-A107-01 TCGA-A2-A0YM-01 TCGA-A2-A0YT-01 Stage IIIB 56 No_Conversion 669 723 Positive FEMALE Negative Negative M0 Positive N2 723 1 LumB Negative followup T_Other T4 DECEASED TCGA-A2-A0YT-01 High C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 mutation cluster 3 TCGA-A2-A0YT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A0YT-F15768 TCGA-A2-A0YT TCGA-A2-A0YT-01A Positive Negative Modified Radical Mastectomy NO -20482 884 723 0 90-99% Scheduled Follow-up Submission 2011-8-30 FEMALE Enumerate 60 tumor cells; Ratio of HER2/Centromere 17 >=2.1 is amplified 60 1.3 Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES Core needle biopsy 950 NO Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 5 true No M0 N2a T4b Stage IIIB TCGA-A2-A0YT.1C420F6B-8720-4CB0-9FB3-86A0EC05FBBD.pdf A0YT TUMOR FREE <10% YES Primary Tumor 01 YES NO YES A2 Breast A DECEASED 2008 451099b0-f348-4aec-bf9f-2982601f013c 451099b0-f348-4aec-bf9f-2982601f013c TCGA-A2-A0YT-01A-21-A13D-20 TCGA-A2-A0YT-01A-11D-A10G-09 TCGA-A2-A0YT-01 TCGA-A2-A0YT-01A-11D-A10A-05 cea5a1de-f9e8-406b-a6ac-08e3d9869c5b TCGA-A2-A0YT-01 TCGA-A2-A0YT-01A-11D-A10G-09 TCGA-A2-A0YT-01 TCGA-A2-A0YT-01A-11D-A10G-09 TCGA-A2-A0YT-01 451099b0-f348-4aec-bf9f-2982601f013c TCGA-A2-A0YT-01 TCGA-A2-A0YT-01A-11D-A107-01 TCGA-A2-A0YT-01A-11R-A109-07 451099b0-f348-4aec-bf9f-2982601f013c TCGA-A2-A0YT-01A-11D-A107-01 TCGA-A2-A0YT-01 TCGA-A2-A1FV-01 Stage IIB 74 4 Stage IIB 460 Positive FEMALE Negative Negative M0 Negative N0 460 0 LumA Positive enrollment T_Other T3 LIVING TCGA-A2-A1FV-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-A2-A1FV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Sentinel node biopsy alone TCGA-A2-A1FV-F20238 TCGA-A2-A1FV TCGA-A2-A1FV-01A Positive Positive Simple Mastectomy YES -27287 372 0 714 NO 90-99% Scheduled Follow-up Submission 2012-1-9 FEMALE 1+ 0.92 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 150 NO Negative Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 6 NO 0 1 true No M0 N0 (i+) T3 Stage IIB TCGA-A2-A1FV.074223E9-5E1C-47E8-BE40-1C4442CAE9F0.pdf A1FV TUMOR FREE Strong Strong YES <10% YES Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2010 ee12f85b-64f8-4052-9477-392c4bd99257 ee12f85b-64f8-4052-9477-392c4bd99257 TCGA-A2-A1FV-01A-21-A17I-20 TCGA-A2-A1FV-01A-11D-A13L-09 TCGA-A2-A1FV-01 TCGA-A2-A1FV-01A-11D-A13K-05 5d85b493-8ea7-46e2-a2f1-f21b8ccc46c8 TCGA-A2-A1FV-01 TCGA-A2-A1FV-01A-11D-A13L-09 TCGA-A2-A1FV-01 TCGA-A2-A1FV-01A-11D-A13L-09 ee12f85b-64f8-4052-9477-392c4bd99257 TCGA-A2-A1FV-01A-11D-A13J-01 TCGA-A2-A1FV-01 ee12f85b-64f8-4052-9477-392c4bd99257 TCGA-A2-A1FV-01A-11D-A13J-01 TCGA-A2-A1FW-01 Stage IIIA 62 3 Stage IIIA 221 Positive FEMALE Negative Negative M0 Positive N2 221 0 LumB Negative enrollment T_Other T3 LIVING TCGA-A2-A1FW-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-A2-A1FW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A1FW-F20810 TCGA-A2-A1FW TCGA-A2-A1FW-01A Positive Negative Modified Radical Mastectomy NO -22779 198 0 528 NO 90-99% Scheduled Follow-up Submission 2012-1-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 640 NO Negative 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 5 true No M0 N2a T3 Stage IIIA TCGA-A2-A1FW.849E9FA7-3420-427B-A310-3346CFA9F0CC.pdf A1FW TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2010 2f1af8cf-ded3-45b6-88cd-2c154c66ab8c 2f1af8cf-ded3-45b6-88cd-2c154c66ab8c TCGA-A2-A1FW-01A-21-A17I-20 TCGA-A2-A1FW-01A-11D-A13L-09 TCGA-A2-A1FW-01 TCGA-A2-A1FW-01A-11D-A13K-05 fdc673b1-add6-4078-8f96-0ed4f6985240 TCGA-A2-A1FW-01 TCGA-A2-A1FW-01A-11D-A13L-09 TCGA-A2-A1FW-01 TCGA-A2-A1FW-01A-11D-A13L-09 2f1af8cf-ded3-45b6-88cd-2c154c66ab8c TCGA-A2-A1FW-01A-11D-A13J-01 TCGA-A2-A1FW-01 2f1af8cf-ded3-45b6-88cd-2c154c66ab8c TCGA-A2-A1FW-01A-11D-A13J-01 TCGA-A2-A1FX-01 Stage IIIA 61 4 Stage IIIA 935 Positive FEMALE Negative Negative M0 Positive N2 935 0 LumB Positive enrollment T_Other T3 LIVING TCGA-A2-A1FX-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A2-A1FX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A1FX-F59654 TCGA-A2-A1FX TCGA-A2-A1FX-01A Negative Positive Mastectomy NOS Positive Lumpectomy NO -22344 937 0 1847 NO 70-79% 160 Scheduled Follow-up Submission 2014-5-19 FEMALE 60 185 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 360 NO Negative NO 24 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 6 true No M0 N2a T3 Stage IIIA TCGA-A2-A1FX.EAFC71A1-D6FC-46EA-BC47-D054C497D705.pdf A1FX TUMOR FREE YES YES 60-69% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2008 60f078d7-d594-48a2-9011-f0f926243a42 60f078d7-d594-48a2-9011-f0f926243a42 TCGA-A2-A1FX-01A-21-A17I-20 TCGA-A2-A1FX-01A-11D-A13L-09 TCGA-A2-A1FX-01 TCGA-A2-A1FX-01A-11D-A13K-05 0b991416-2ca1-4582-b119-e95e4e8ca5e8 TCGA-A2-A1FX-01 TCGA-A2-A1FX-01A-11D-A13L-09 TCGA-A2-A1FX-01 TCGA-A2-A1FX-01A-11D-A13L-09 60f078d7-d594-48a2-9011-f0f926243a42 TCGA-A2-A1FX-01A-11D-A13J-01 TCGA-A2-A1FX-01 60f078d7-d594-48a2-9011-f0f926243a42 TCGA-A2-A1FX-01A-11D-A13J-01 TCGA-A2-A1FZ-01 Stage IIA 63 3 Stage IIA 409 Positive FEMALE Negative Negative M0 Negative N0 409 0 LumA Positive enrollment T_Other T2 LIVING TCGA-A2-A1FZ-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 4 TCGA-A2-A1FZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Sentinel node biopsy alone TCGA-A2-A1FZ-F20803 TCGA-A2-A1FZ TCGA-A2-A1FZ-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy YES -23055 335 0 683 NO 90-99% Scheduled Follow-up Submission 2012-1-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 740 NO Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A1FZ.F93E326D-F4E0-4000-8A67-AA19C4D3637A.pdf A1FZ TUMOR FREE YES 90-99% NO Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2010 27e70f84-80c5-4f6c-9d22-83c5a6e66eb5 27e70f84-80c5-4f6c-9d22-83c5a6e66eb5 TCGA-A2-A1FZ-01A-11-A17I-20 TCGA-A2-A1FZ-01A-51D-A17G-09 TCGA-A2-A1FZ-01 TCGA-A2-A1FZ-01A-51D-A14H-05 5157205e-da8c-4890-9df3-02f40831c268 TCGA-A2-A1FZ-01 TCGA-A2-A1FZ-01A-51D-A17G-09 TCGA-A2-A1FZ-01 TCGA-A2-A1FZ-01A-51D-A17G-09 27e70f84-80c5-4f6c-9d22-83c5a6e66eb5 TCGA-A2-A1FZ-01A-51D-A14F-01 TCGA-A2-A1FZ-01 27e70f84-80c5-4f6c-9d22-83c5a6e66eb5 TCGA-A2-A1FZ-01A-51D-A14F-01 TCGA-A2-A1G0-01 Stage IIB 49 3 Stage IIB 380 Positive FEMALE Negative Negative M0 Positive N1 380 0 LumA Positive enrollment T_Other T2 LIVING TCGA-A2-A1G0-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-A2-A1G0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A1G0-F20802 TCGA-A2-A1G0 TCGA-A2-A1G0-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy NO -18002 315 0 616 NO 90-99% Scheduled Follow-up Submission 2012-1-9 FEMALE 2+ 1.2 Other, specify No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 730 NO Equivocal Negative 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 2 true No M0 N1a T2 Stage IIB TCGA-A2-A1G0.DA82E751-09C3-466E-A63A-38368D8A2C7C.pdf A1G0 TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2010 753e77c2-6175-49d8-afd4-3a87d1dc2404 753e77c2-6175-49d8-afd4-3a87d1dc2404 TCGA-A2-A1G0-01A-21-A17I-20 TCGA-A2-A1G0-01A-11D-A13L-09 TCGA-A2-A1G0-01 TCGA-A2-A1G0-01A-11D-A13K-05 5875ba8b-aa27-4573-b1c7-30878613288e TCGA-A2-A1G0-01 TCGA-A2-A1G0-01A-11D-A13L-09 TCGA-A2-A1G0-01 TCGA-A2-A1G0-01A-11D-A13L-09 753e77c2-6175-49d8-afd4-3a87d1dc2404 TCGA-A2-A1G0-01A-11D-A13J-01 TCGA-A2-A1G0-01 753e77c2-6175-49d8-afd4-3a87d1dc2404 TCGA-A2-A1G0-01A-11D-A13J-01 TCGA-A2-A1G1-01 Stage IIB 85 4 Stage IIB 371 Negative FEMALE Positive Negative M0 Positive N1 371 0 Basal Negative enrollment T_Other T2 LIVING TCGA-A2-A1G1-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 14 cluster 6 mutation cluster 5 TCGA-A2-A1G1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 85 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A1G1-F20808 TCGA-A2-A1G1 TCGA-A2-A1G1-01A Negative Negative Lumpectomy NO -31223 338 0 584 NO 51 Scheduled Follow-up Submission 2012-1-12 FEMALE 2+ 30 816 16.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Equivocal Positive 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 NO 1 true No M0 N1 T2 Stage IIB TCGA-A2-A1G1.E2E6CA22-AFE4-4B8F-90AC-32639687A590.pdf A1G1 TUMOR FREE YES YES Primary Tumor 01 7th NO YES NO A2 Breast A LIVING 2010 122a1ed2-9757-4cac-9656-149da6d872f4 122a1ed2-9757-4cac-9656-149da6d872f4 TCGA-A2-A1G1-01A-11-A17I-20 TCGA-A2-A1G1-01A-21D-A13L-09 TCGA-A2-A1G1-01 TCGA-A2-A1G1-01A-21D-A13K-05 cd315ed6-e7af-4f4e-9990-348e464d5738 TCGA-A2-A1G1-01 TCGA-A2-A1G1-01A-21D-A13L-09 TCGA-A2-A1G1-01 TCGA-A2-A1G1-01A-21D-A13L-09 122a1ed2-9757-4cac-9656-149da6d872f4 TCGA-A2-A1G1-01A-21D-A13J-01 TCGA-A2-A1G1-01 122a1ed2-9757-4cac-9656-149da6d872f4 TCGA-A2-A1G1-01A-21D-A13J-01 TCGA-A2-A1G4-01 Stage IIIA 71 4 Stage IIIA 372 Positive FEMALE Negative Negative M0 Positive N1 372 0 LumB Positive enrollment T_Other T3 LIVING TCGA-A2-A1G4-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-A2-A1G4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A1G4-F20805 TCGA-A2-A1G4 TCGA-A2-A1G4-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -25966 310 0 595 NO 90-99% Scheduled Follow-up Submission 2012-1-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 710 NO Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO 2 true Yes M0 N1a T3 Stage IIIA TCGA-A2-A1G4.5AD3B697-F097-496C-978B-F73BDA5394A7.pdf A1G4 TUMOR FREE YES 90-99% NO Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2010 2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2 2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2 TCGA-A2-A1G4-01A-21-A17I-20 TCGA-A2-A1G4-01A-11D-A13L-09 TCGA-A2-A1G4-01 TCGA-A2-A1G4-01A-11D-A13K-05 d573b843-5656-47aa-958a-c295311876f0 TCGA-A2-A1G4-01 TCGA-A2-A1G4-01A-11D-A13L-09 TCGA-A2-A1G4-01 TCGA-A2-A1G4-01A-11D-A13L-09 2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2 TCGA-A2-A1G4-01A-11D-A13J-01 TCGA-A2-A1G4-01 2ce88ee9-0fc6-4d1d-82a7-be79eaee21d2 TCGA-A2-A1G4-01A-11D-A13J-01 TCGA-A2-A1G6-01 Stage IIIA 50 1 Stage IIIA 132 Negative FEMALE Negative Negative M0 Positive N2 132 0 Normal Negative enrollment T_Other T2 LIVING TCGA-A2-A1G6-01 Quiet C5-KIRC cluster 5 Low purity c2 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A2-A1G6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Axillary lymph node dissection alone TCGA-A2-A1G6-F20947 TCGA-A2-A1G6 TCGA-A2-A1G6-01A Negative Negative Modified Radical Mastectomy NO -18514 229 0 501 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 770 NO Negative 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 6 NO 4 true No M0 N2a T2 Stage IIIA TCGA-A2-A1G6.02B4C31E-38F0-4AF3-8DAD-527D5F27C11A.pdf A1G6 TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2010 8b216b0f-1881-45de-a4ae-78dfd87764fe 8b216b0f-1881-45de-a4ae-78dfd87764fe TCGA-A2-A1G6-01A-21-A17I-20 TCGA-A2-A1G6-01A-11D-A13L-09 TCGA-A2-A1G6-01 TCGA-A2-A1G6-01A-11D-A13K-05 02e55cff-87a6-4719-b988-4b8f46f079a5 TCGA-A2-A1G6-01 TCGA-A2-A1G6-01A-11D-A13L-09 TCGA-A2-A1G6-01 TCGA-A2-A1G6-01A-11D-A13L-09 8b216b0f-1881-45de-a4ae-78dfd87764fe TCGA-A2-A1G6-01A-11D-A13J-01 TCGA-A2-A1G6-01 8b216b0f-1881-45de-a4ae-78dfd87764fe TCGA-A2-A1G6-01A-11D-A13J-01 TCGA-A2-A259-01 Stage IA 70 4 Stage I 1285 Positive FEMALE Negative Negative M0 Negative N0 1285 0 LumA Positive enrollment T1 T1 LIVING TCGA-A2-A259-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 mutation c1uster 9 TCGA-A2-A259 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Left Sentinel node biopsy alone TCGA-A2-A259-F31034 TCGA-A2-A259 TCGA-A2-A259-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy YES -25666 1238 0 1596 NO 90-99% 125 Scheduled Follow-up Submission 2012-4-23 FEMALE 60 132 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Negative Negative 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 0 0 true No M0 N0 (i-) T1c Stage I TCGA-A2-A259.33569E07-D7BF-491B-A352-CEEA81556800.pdf A259 TUMOR FREE Strong using Weak, Moderate and Strong Strong using Weak, Moderate and Strong YES 80-89% NO Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2007 7157ccb4-b4f6-41ba-9f9c-da862b749a57 7157ccb4-b4f6-41ba-9f9c-da862b749a57 TCGA-A2-A259-01A-21-A17I-20 TCGA-A2-A259-01A-11D-A16D-09 TCGA-A2-A259-01 TCGA-A2-A259-01A-11D-A16G-05 f49215ab-aaf7-4a3a-bf77-196395a8cae7 TCGA-A2-A259-01 TCGA-A2-A259-01A-11D-A16D-09 TCGA-A2-A259-01 TCGA-A2-A259-01A-11D-A16D-09 7157ccb4-b4f6-41ba-9f9c-da862b749a57 TCGA-A2-A259-01A-11D-A16C-01 TCGA-A2-A259-01 7157ccb4-b4f6-41ba-9f9c-da862b749a57 TCGA-A2-A259-01A-11D-A16C-01 TCGA-A2-A25A-01 Stage IIA 44 2 Stage IIA 2968 Positive FEMALE Negative Negative M0 Negative N0 2968 0 Normal Positive enrollment T_Other T2 LIVING TCGA-A2-A25A-01 Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 mutation cluster 4 TCGA-A2-A25A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-A2-A25A-F30927 TCGA-A2-A25A TCGA-A2-A25A-01A Positive Positive Simple Mastectomy YES -16084 2927 0 3276 NO <10% Scheduled Follow-up Submission 2012-4-19 FEMALE 2+ 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 160 NO Equivocal Negative 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 0 0 true Yes M0 N0 (i-) T2 Stage IIA TCGA-A2-A25A.3971CA42-F1B0-4D85-9AD3-210B98E76A9C.pdf A25A TUMOR FREE YES <10% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2003 50c720f4-dbcb-4b8b-9808-d130f5197d27 50c720f4-dbcb-4b8b-9808-d130f5197d27 TCGA-A2-A25A-01A-21-A17I-20 TCGA-A2-A25A-01A-12D-A16D-09 TCGA-A2-A25A-01 TCGA-A2-A25A-01A-12D-A16G-05 bf3c63c7-643e-43b2-b5ea-3c2185ba9238 TCGA-A2-A25A-01 TCGA-A2-A25A-01A-12D-A16D-09 TCGA-A2-A25A-01 TCGA-A2-A25A-01A-12D-A16D-09 50c720f4-dbcb-4b8b-9808-d130f5197d27 TCGA-A2-A25A-01A-12D-A16C-01 TCGA-A2-A25A-01 50c720f4-dbcb-4b8b-9808-d130f5197d27 TCGA-A2-A25A-01A-12D-A16C-01 TCGA-A2-A25B-01 Stage IIB 39 5 Stage IIB 258 Positive FEMALE Negative Negative M0 Positive N1 258 0 LumB Positive enrollment T_Other T2 LIVING TCGA-A2-A25B-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation c1uster 9 TCGA-A2-A25B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A25B-F70679 TCGA-A2-A25B TCGA-A2-A25B-01A Positive Positive Simple Mastectomy NO -14454 183 0 1291 1290 NO 90-99% Scheduled Follow-up Submission 2015-3-2 FEMALE 2+ 0.93 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 840 NO Equivocal Negative NO 8 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Positive 4 5 Bone Distant Metastasis NO YES 2 true No M0 N1 T2 Stage IIB TCGA-A2-A25B.FCE29F34-5D13-4A21-A950-A8577C957C10.pdf A25B WITH TUMOR YES YES 10-19% YES Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2010 3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b 3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b TCGA-A2-A25B-01A-21-A17I-20 TCGA-A2-A25B-01A-11D-A167-09 TCGA-A2-A25B-01 TCGA-A2-A25B-01A-11D-A16A-05 b5b0794f-7149-4056-8687-98a9a1401d2c TCGA-A2-A25B-01 TCGA-A2-A25B-01A-11D-A167-09 TCGA-A2-A25B-01 TCGA-A2-A25B-01A-11D-A167-09 3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b TCGA-A2-A25B-01A-11D-A166-01 TCGA-A2-A25B-01 3fc1c7a8-e5ad-4a4e-89ab-ddf12aa11a3b TCGA-A2-A25B-01A-11D-A166-01 TCGA-A2-A25C-01 Stage IIB 50 3 Stage IIB 285 Positive FEMALE Negative Negative M0 Positive N1 285 0 LumB Positive enrollment T_Other T2 LIVING TCGA-A2-A25C-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation cluster 4 TCGA-A2-A25C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A25C-F31282 TCGA-A2-A25C Positive 3 Point Scale 2+ 3 Point Scale Positive Simple Mastectomy NO -18508 0 523 NO 90-99% Scheduled Follow-up Submission 2012-4-17 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Negative 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 5 NO 3 No M0 N1a T2 Stage IIB A25C TUMOR FREE YES 20-29% YES Primary Tumor 01 7th YES YES NO A2 Breast LIVING 2010 f5b16ba5-0fd1-4ca4-865f-fdff0af65901 f5b16ba5-0fd1-4ca4-865f-fdff0af65901 TCGA-A2-A25C-01A-21-A17I-20 TCGA-A2-A25C-01A-11D-A167-09 TCGA-A2-A25C-01 TCGA-A2-A25C-01A-11D-A16A-05 dbc23df1-b14d-4f24-81ef-fc12e2cdda21 TCGA-A2-A25C-01 TCGA-A2-A25C-01A-11D-A167-09 TCGA-A2-A25C-01 TCGA-A2-A25C-01A-11D-A167-09 f5b16ba5-0fd1-4ca4-865f-fdff0af65901 TCGA-A2-A25C-01A-11D-A166-01 TCGA-A2-A25C-01 f5b16ba5-0fd1-4ca4-865f-fdff0af65901 TCGA-A2-A25C-01A-11D-A166-01 TCGA-A2-A25D-01 Stage IIIC 90 4 Stage IIIC 243 Positive FEMALE Negative Negative M0 Positive N3 243 0 LumA Negative enrollment T_Other T2 LIVING TCGA-A2-A25D-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 mutation cluster 4 TCGA-A2-A25D TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A25D-F30931 TCGA-A2-A25D TCGA-A2-A25D-01A Positive Negative Lumpectomy NO -32872 224 0 552 NO 70-79% 118 Scheduled Follow-up Submission 2012-4-19 FEMALE 1+ 60 145 1.22 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 430 NO Negative Negative 24 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 22 true No M0 N3a T2 Stage IIIC TCGA-A2-A25D.BE63B06A-E3E0-4E00-9B9F-5E7DE8852E07.pdf A25D TUMOR FREE Moderate using the scale of Weak, Moderate, Strong YES YES Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2010 d6b5cec3-edeb-46c5-839b-e62a1e850e0e d6b5cec3-edeb-46c5-839b-e62a1e850e0e TCGA-A2-A25D-01A-21-A17I-20 TCGA-A2-A25D-01A-12D-A16D-09 TCGA-A2-A25D-01 TCGA-A2-A25D-01A-12D-A16G-05 6ff66f90-93c3-4c1e-84c6-9db89ca701c2 TCGA-A2-A25D-01 TCGA-A2-A25D-01A-12D-A16D-09 TCGA-A2-A25D-01 TCGA-A2-A25D-01A-12D-A16D-09 d6b5cec3-edeb-46c5-839b-e62a1e850e0e TCGA-A2-A25D-01A-12D-A16C-01 TCGA-A2-A25D-01 d6b5cec3-edeb-46c5-839b-e62a1e850e0e TCGA-A2-A25D-01A-12D-A16C-01 TCGA-A2-A25E-01 Stage IIIA 34 5 Stage IIIA 2511 Positive FEMALE Equivocal Negative M0 Positive N2 2511 0 LumB Positive enrollment T_Other T2 LIVING TCGA-A2-A25E-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation c1uster 9 TCGA-A2-A25E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 34 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A25E-F44982 TCGA-A2-A25E TCGA-A2-A25E-01A Positive Positive Modified Radical Mastectomy NO -12601 2441 0 3204 3024 2989 NO 80-89% Scheduled Follow-up Submission 2013-7-2 FEMALE 2+ 2.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 200 NO Equivocal Equivocal NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 1+ Positive 90-99% 3 Point Scale 3+ 2+ <10% Positive 4 5 3 Point Scale Other, specify Locoregional Recurrence Left Chest Wall YES YES 6 true No M0 N2a T2 Stage IIIA TCGA-A2-A25E.B81555D4-78D9-4235-AABE-F852CA6F15B5.pdf A25E TUMOR FREE Strong, using scale of Weak, Moderate and Strong Moderate using scale of Weak, Moderate, Strong YES YES 60-69% YES Primary Tumor 01 6th YES NO YES A2 Breast A LIVING 2004 7265c93b-7138-4bc8-bc9c-22ce1abf0ef2 7265c93b-7138-4bc8-bc9c-22ce1abf0ef2 TCGA-A2-A25E-01A-21-A17I-20 TCGA-A2-A25E-01A-11D-A167-09 TCGA-A2-A25E-01 TCGA-A2-A25E-01A-11D-A16A-05 6a6f4c33-d59e-462a-9fa7-aed32a35ff44 TCGA-A2-A25E-01 TCGA-A2-A25E-01A-11D-A167-09 TCGA-A2-A25E-01 TCGA-A2-A25E-01A-11D-A167-09 7265c93b-7138-4bc8-bc9c-22ce1abf0ef2 TCGA-A2-A25E-01A-11D-A166-01 TCGA-A2-A25E-01 7265c93b-7138-4bc8-bc9c-22ce1abf0ef2 TCGA-A2-A25E-01A-11D-A166-01 TCGA-A2-A25F-01 Stage IIA 66 1 Stage IIA 113 Negative FEMALE Negative Negative M0 Negative N0 113 0 Basal Positive enrollment T_Other T2 LIVING TCGA-A2-A25F-01 Kirc+ C4-BRCA/Basal cluster 1 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 mutation c1uster 9 TCGA-A2-A25F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-A2-A25F-F31197 TCGA-A2-A25F TCGA-A2-A25F-01A Negative Positive Lumpectomy YES -24319 86 0 322 NO Scheduled Follow-up Submission 2012-4-23 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 390 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-A2-A25F.AC60F5BB-9371-4F69-BAA0-099AD7FC2A0B.pdf A25F TUMOR FREE YES <10% YES Primary Tumor 01 7th YES YES NO A2 Breast A LIVING 2011 acd59617-770c-4653-891f-71ea87d67c41 acd59617-770c-4653-891f-71ea87d67c41 TCGA-A2-A25F-01A-21-A17I-20 TCGA-A2-A25F-01A-11D-A167-09 TCGA-A2-A25F-01 TCGA-A2-A25F-01A-11D-A16A-05 04f35825-e128-4a77-b58e-7b98019dad24 TCGA-A2-A25F-01 TCGA-A2-A25F-01A-11D-A167-09 TCGA-A2-A25F-01 TCGA-A2-A25F-01A-11D-A167-09 acd59617-770c-4653-891f-71ea87d67c41 TCGA-A2-A25F-01A-11D-A166-01 TCGA-A2-A25F-01 acd59617-770c-4653-891f-71ea87d67c41 TCGA-A2-A25F-01A-11D-A166-01 TCGA-A2-A3KC-01 LumA TCGA-A2-A3KC-01 Iq C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-A2-A3KC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A3KC-F59210 TCGA-A2-A3KC TCGA-A2-A3KC-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy NO -20401 299 0 1102 NO 90-99% 1.9 2014-5-5 FEMALE 2+ 20 1.8 1.0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 780 NO Equivocal Negative NO 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 2 0 true No M0 N1a T2 Stage IIB TCGA-A2-A3KC.593AF241-8F84-4BA0-8878-7C1CE72A460B.pdf A3KC TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO A2 Breast A LIVING 2011 7bbe4637-394e-42c0-af7d-6184c3f48916 7bbe4637-394e-42c0-af7d-6184c3f48916 TCGA-A2-A3KC-01A-21-A24A-20 TCGA-A2-A3KC-01 TCGA-A2-A3KC-01A-11D-A212-05 aa78b6ce-fccf-478e-b4b0-9cebaeeb99fb TCGA-A2-A3KC-01 TCGA-A2-A3KC-01A-11D-A20S-09 TCGA-A2-A3KC-01 7bbe4637-394e-42c0-af7d-6184c3f48916 TCGA-A2-A3KC-01A-11D-A20R-01 TCGA-A2-A3KC-01 7bbe4637-394e-42c0-af7d-6184c3f48916 TCGA-A2-A3KC-01A-11D-A20R-01 TCGA-A2-A3KD-01 LumA TCGA-A2-A3KD-01 Iq C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-A2-A3KD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A3KD-F37343 TCGA-A2-A3KD TCGA-A2-A3KD-01A Close Positive 3 Point Scale 3 Point Scale Mastectomy NOS Positive Lumpectomy YES -17372 700 0 1206 NO 90-99% 2012-12-3 FEMALE 1+ 1.2 Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Core needle biopsy 770 NO Negative Negative NO 19 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 1 true No M0 N1mi T3 Stage IIIA TCGA-A2-A3KD.3E4717BA-E9AE-45F9-9696-F8928D9FCECC.pdf A3KD TUMOR FREE Strong Strong YES YES 70-79% YES Primary Tumor 01 7th YES NO A2 Breast A LIVING 2010 8a224dc6-632b-418b-bd5e-bcefc8ad049e 8a224dc6-632b-418b-bd5e-bcefc8ad049e TCGA-A2-A3KD-01A-21-A24A-20 TCGA-A2-A3KD-01 TCGA-A2-A3KD-01A-12D-A212-05 981593f7-f9eb-44af-a697-624af03e6bbf TCGA-A2-A3KD-01 TCGA-A2-A3KD-01A-12D-A20S-09 TCGA-A2-A3KD-01 8a224dc6-632b-418b-bd5e-bcefc8ad049e TCGA-A2-A3KD-01A-12D-A20R-01 TCGA-A2-A3KD-01 8a224dc6-632b-418b-bd5e-bcefc8ad049e TCGA-A2-A3KD-01A-12D-A20R-01 TCGA-A2-A3XS-01 TCGA-A2-A3XS-01 miRNA cluster 4 TCGA-A2-A3XS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A3XS-F34446 TCGA-A2-A3XS TCGA-A2-A3XS-01A Negative Negative Mastectomy NOS Negative Lumpectomy YES -23000 3355 1032 0 682 YES Additional New Tumor Event 2012-8-15 FEMALE 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 40 NO Negative 19 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lung Distant Metastasis YES 9 0 true No M0 N2a T1 Stage IIIA TCGA-A2-A3XS.DD5295D4-3896-4AA5-AF75-30AEA45D1652.pdf A3XS WITH TUMOR YES NO Primary Tumor 01 6th YES NO YES A2 Breast A DECEASED 2003 799df122-75f1-46bf-8b5e-ca557cd38d53 799df122-75f1-46bf-8b5e-ca557cd38d53 TCGA-A2-A3XS-01 TCGA-A2-A3XS-01A-11D-A230-05 TCGA-A2-A3XS-01 TCGA-A2-A3XS-01A-11D-A22X-09 TCGA-A2-A3XS-01 799df122-75f1-46bf-8b5e-ca557cd38d53 TCGA-A2-A3XS-01A-11D-A22W-01 TCGA-A2-A3XS-01 799df122-75f1-46bf-8b5e-ca557cd38d53 TCGA-A2-A3XS-01A-11D-A22W-01 TCGA-A2-A3XT-01 TCGA-A2-A3XT-01 BRCA basal-like c6 miRNA cluster 4 TCGA-A2-A3XT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Other (specify) F plus axillary lymph node dissection TCGA-A2-A3XT-F55841 TCGA-A2-A3XT TCGA-A2-A3XT-01A Negative Negative Modified Radical Mastectomy NO -16649 2164 0 2770 2014-1-16 FEMALE 1.13 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 340 NO Negative Negative NO 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 true No M0 N1a T2 Stage IIB TCGA-A2-A3XT.A614B6B7-256F-4148-8941-6145B2D9B8B5.pdf A3XT TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES A2 Breast A LIVING 2006 e0a10445-6266-4f41-a747-fb19d7182652 e0a10445-6266-4f41-a747-fb19d7182652 TCGA-A2-A3XT-01A-21-A24A-20 TCGA-A2-A3XT-01 TCGA-A2-A3XT-01A-11D-A230-05 904a9035-e5e9-4a07-99dd-3a74f66c9145 TCGA-A2-A3XT-01 TCGA-A2-A3XT-01A-11D-A22X-09 TCGA-A2-A3XT-01 e0a10445-6266-4f41-a747-fb19d7182652 TCGA-A2-A3XT-01A-11D-A22W-01 TCGA-A2-A3XT-01 e0a10445-6266-4f41-a747-fb19d7182652 TCGA-A2-A3XT-01A-11D-A22W-01 TCGA-A2-A3XU-01 TCGA-A2-A3XU-01 BRCA basal-like c6 miRNA cluster 4 TCGA-A2-A3XU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 35 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A3XU-F34704 TCGA-A2-A3XU TCGA-A2-A3XU-01A Negative Negative Lumpectomy NO -13046 2089 912 0 596 1.5 2012-8-30 FEMALE 60 1.66 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 350 NO Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Positive Positive Other, specify Locoregional Recurrence Breast NO YES 3 0 true No M0 N1mi T2 Stage IIB TCGA-A2-A3XU.5018EC57-96C6-4D63-B708-45559B4D8527.pdf A3XU WITH TUMOR YES YES YES Primary Tumor 01 6th NO YES A2 Breast A DECEASED 2006 2ec1df5c-7272-44f4-922c-cdd6ba37f6b6 2ec1df5c-7272-44f4-922c-cdd6ba37f6b6 TCGA-A2-A3XU-01A-21-A24A-20 TCGA-A2-A3XU-01 TCGA-A2-A3XU-01A-12D-A230-05 2233e116-6f58-4bf5-bcb7-528fc4ff8d30 TCGA-A2-A3XU-01 TCGA-A2-A3XU-01A-12D-A22X-09 TCGA-A2-A3XU-01 2ec1df5c-7272-44f4-922c-cdd6ba37f6b6 TCGA-A2-A3XU-01A-12D-A22W-01 TCGA-A2-A3XU-01 2ec1df5c-7272-44f4-922c-cdd6ba37f6b6 TCGA-A2-A3XU-01A-12D-A22W-01 TCGA-A2-A3XV-01 TCGA-A2-A3XV-01 BRCA basal-like c6 TCGA-A2-A3XV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Sentinel node biopsy alone TCGA-A2-A3XV-F59117 TCGA-A2-A3XV Positive 3 Point Scale Negative Lumpectomy YES -16971 0 996 <10% 1.7 2014-5-1 FEMALE 2+ 60 4.5 2.6 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Core needle biopsy Equivocal Positive NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 0 No M0 N0 T2 Stage IIA A3XV TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO A2 Breast LIVING 2011 fc2aa9aa-3df5-4723-9892-95edcc92bb6f fc2aa9aa-3df5-4723-9892-95edcc92bb6f TCGA-A2-A3XV-01A-41-A24A-20 TCGA-A2-A3XV-01 TCGA-A2-A3XV-01A-21D-A23D-05 bcfc3c93-8457-45c3-bace-45fb134af40e TCGA-A2-A3XV-01 TCGA-A2-A3XV-01A-21D-A23C-09 TCGA-A2-A3XV-01 fc2aa9aa-3df5-4723-9892-95edcc92bb6f TCGA-A2-A3XV-01A-21D-A238-01 TCGA-A2-A3XV-01 fc2aa9aa-3df5-4723-9892-95edcc92bb6f TCGA-A2-A3XV-01A-21D-A238-01 TCGA-A2-A3XW-01 TCGA-A2-A3XW-01 BRCA nonbasal-like c8 TCGA-A2-A3XW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A2-A3XW-F55843 TCGA-A2-A3XW Positive 3 Point Scale Negative Simple Mastectomy YES -15670 0 1712 NO 90-99% 2014-1-16 FEMALE <10% 1.31 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy Negative Negative NO 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 3 0 No M0 N1a T2 Stage IIB A3XW TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO A2 Breast LIVING 2009 f6cbfa5a-7d10-4efb-ae74-195e1a1e9774 f6cbfa5a-7d10-4efb-ae74-195e1a1e9774 TCGA-A2-A3XW-01A-21-A24A-20 TCGA-A2-A3XW-01 TCGA-A2-A3XW-01A-11D-A23D-05 d9ca1e39-2191-444f-b17f-f5f57f73aa0c TCGA-A2-A3XW-01 TCGA-A2-A3XW-01A-11D-A23C-09 TCGA-A2-A3XW-01 f6cbfa5a-7d10-4efb-ae74-195e1a1e9774 TCGA-A2-A3XW-01A-11D-A238-01 TCGA-A2-A3XW-01 f6cbfa5a-7d10-4efb-ae74-195e1a1e9774 TCGA-A2-A3XW-01A-11D-A238-01 TCGA-A2-A3XX-01 TCGA-A2-A3XX-01 KIRC-like c1 TCGA-A2-A3XX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-A2-A3XX-F43310 TCGA-A2-A3XX TCGA-A2-A3XX-01A Negative Negative Simple Mastectomy YES -17981 1143 1439 0 1168 NO 2013-5-16 FEMALE 1+ 1.25 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 780 NO Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T2 Stage IIA TCGA-A2-A3XX.770EEADF-19CD-4AB9-A7FA-1A05EE17984C.pdf A3XX TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO A2 Breast A DECEASED 2009 043d5dcd-1524-402b-939c-984a1dc916a0 043d5dcd-1524-402b-939c-984a1dc916a0 TCGA-A2-A3XX-01A-41-A24A-20 TCGA-A2-A3XX-01 TCGA-A2-A3XX-01A-21D-A23D-05 c4757b28-bb38-49bb-bb06-70fa40ad8298 TCGA-A2-A3XX-01 TCGA-A2-A3XX-01A-21D-A23C-09 TCGA-A2-A3XX-01 043d5dcd-1524-402b-939c-984a1dc916a0 TCGA-A2-A3XX-01A-21D-A238-01 TCGA-A2-A3XX-01 043d5dcd-1524-402b-939c-984a1dc916a0 TCGA-A2-A3XX-01A-21D-A238-01 TCGA-A2-A3XY-01 TCGA-A2-A3XY-01 TCGA-A2-A3XY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES 49 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A3XY-F55836 TCGA-A2-A3XY TCGA-A2-A3XY-01A Negative Negative Modified Radical Mastectomy NO -18059 703 1093 0 786 1072 NO 2014-1-16 FEMALE 1.13 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 950 NO Negative Negative NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Brain Distant Metastasis NO YES 3 true No M0 N1a T2 Stage IIB TCGA-A2-A3XY.EC1BB6E8-6897-4E70-80A6-5A4E4B9C4E1F.pdf A3XY WITH TUMOR YES YES YES Primary Tumor 01 7th YES NO A2 Breast A DECEASED 2010 42c88ed3-de96-487d-8b03-e1d4269d0505 42c88ed3-de96-487d-8b03-e1d4269d0505 TCGA-A2-A3XY-01 TCGA-A2-A3XY-01A-11D-A23D-05 TCGA-A2-A3XY-01 TCGA-A2-A3XY-01A-11D-A23C-09 TCGA-A2-A3XY-01 42c88ed3-de96-487d-8b03-e1d4269d0505 TCGA-A2-A3XY-01A-11D-A238-01 TCGA-A2-A3XY-01 42c88ed3-de96-487d-8b03-e1d4269d0505 TCGA-A2-A3XY-01A-11D-A238-01 TCGA-A2-A3XZ-01 TCGA-A2-A3XZ-01 BRCA basal-like c6 TCGA-A2-A3XZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-A2-A3XZ-F58924 TCGA-A2-A3XZ TCGA-A2-A3XZ-01A Negative Negative Simple Mastectomy YES -16978 909 0 1532 2014-4-28 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 1100 NO Positive NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 0 true No M0 N0 T1c Stage I TCGA-A2-A3XZ.A7B6FCF6-1B81-40B5-AD92-54681CBC8FE0.pdf A3XZ TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES A2 Breast A LIVING 2009 176b2422-3599-41c5-be62-ae6e28d60b90 176b2422-3599-41c5-be62-ae6e28d60b90 TCGA-A2-A3XZ-01A-51-A24A-20 TCGA-A2-A3XZ-01 TCGA-A2-A3XZ-01A-42D-A23D-05 78747541-53ed-4037-af62-694fc6f00433 TCGA-A2-A3XZ-01 TCGA-A2-A3XZ-01A-42D-A23C-09 TCGA-A2-A3XZ-01 176b2422-3599-41c5-be62-ae6e28d60b90 TCGA-A2-A3XZ-01A-42D-A238-01 TCGA-A2-A3XZ-01 176b2422-3599-41c5-be62-ae6e28d60b90 TCGA-A2-A3XZ-01A-42D-A238-01 TCGA-A2-A3Y0-01 TCGA-A2-A3Y0-01 TCGA-A2-A3Y0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A3Y0-F59118 TCGA-A2-A3Y0 TCGA-A2-A3Y0-01A Positive 3 Point Scale Negative Modified Radical Mastectomy NO -21024 845 0 1546 90-99% 2014-5-1 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 850 NO Negative NO 39 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 0 true No M0 N1a T2 Stage IIB TCGA-A2-A3Y0.0FEAEEBA-A72C-4207-AC21-6AF5B5ED1AFC.pdf A3Y0 TUMOR FREE YES YES NO Primary Tumor 01 7th NO YES A2 Breast A LIVING 2010 9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5 9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5 TCGA-A2-A3Y0-01 TCGA-A2-A3Y0-01A-11D-A23D-05 TCGA-A2-A3Y0-01 TCGA-A2-A3Y0-01A-11D-A23C-09 TCGA-A2-A3Y0-01 9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5 TCGA-A2-A3Y0-01A-11D-A238-01 TCGA-A2-A3Y0-01 9a9d7ee5-e3fa-491f-ab5b-0ab69652b8a5 TCGA-A2-A3Y0-01A-11D-A238-01 TCGA-A2-A4RW-01 TCGA-A2-A4RW-01 TCGA-A2-A4RW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right|Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A4RW-F59123 TCGA-A2-A4RW Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -18060 0 222 80-89% 2014-5-1 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy Negative YES 27 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 27 0 No M0 N3a T2 Stage IIIC A4RW TUMOR FREE YES 90-99% Primary Tumor 01 7th YES NO A2 Breast LIVING 2011 f8bfd67a-1d78-44b0-9715-712dee01b008 f8bfd67a-1d78-44b0-9715-712dee01b008 TCGA-A2-A4RW-01 TCGA-A2-A4RW-01A-21D-A268-05 cee2c148-efa3-45e2-8b28-f65e56a5d2b9 TCGA-A2-A4RW-01 TCGA-A2-A4RW-01A-21D-A25Q-09 TCGA-A2-A4RW-01 f8bfd67a-1d78-44b0-9715-712dee01b008 TCGA-A2-A4RW-01A-21D-A25N-01 TCGA-A2-A4RW-01 f8bfd67a-1d78-44b0-9715-712dee01b008 TCGA-A2-A4RW-01A-21D-A25N-01 TCGA-A2-A4RX-01 TCGA-A2-A4RX-01 TCGA-A2-A4RX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-A2-A4RX-F58491 TCGA-A2-A4RX Positive 3 Point Scale 2+ 3 Point Scale Positive Simple Mastectomy YES -24779 0 742 <10% 2014-4-11 FEMALE 1+ Metaplastic Carcinoma No C50.9 8575/3 C50.9 1+ YES Core needle biopsy Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 No M0 N0 T2 Stage IIA A4RX TUMOR FREE YES <10% Primary Tumor 01 7th YES NO A2 Breast LIVING 2012 cbef9672-38ba-4873-b232-9a656b7428ce cbef9672-38ba-4873-b232-9a656b7428ce TCGA-A2-A4RX-01 TCGA-A2-A4RX-01A-11D-A268-05 d980ca91-4ae1-4fc2-a4d1-052051aa7d41 TCGA-A2-A4RX-01 TCGA-A2-A4RX-01A-11D-A25Q-09 TCGA-A2-A4RX-01 cbef9672-38ba-4873-b232-9a656b7428ce TCGA-A2-A4RX-01A-11D-A25N-01 TCGA-A2-A4RX-01 cbef9672-38ba-4873-b232-9a656b7428ce TCGA-A2-A4RX-01A-11D-A25N-01 TCGA-A2-A4RY-01 TCGA-A2-A4RY-01 TCGA-A2-A4RY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Axillary lymph node dissection alone TCGA-A2-A4RY-F59208 TCGA-A2-A4RY TCGA-A2-A4RY-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -17157 149 0 648 90-99% 2014-5-5 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Core needle biopsy 1180 NO Negative NO 30 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 18 0 true No M0 N3a T3 Stage IIIC TCGA-A2-A4RY.2D6815B5-7704-4D67-93D1-78EDD924F131.pdf A4RY TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO A2 Breast A LIVING 2012 51d9b960-276a-4c7b-b135-f2f8c05f3bd6 51d9b960-276a-4c7b-b135-f2f8c05f3bd6 TCGA-A2-A4RY-01 TCGA-A2-A4RY-01A-31D-A268-05 e40037c5-5570-43d6-ad24-cd4ceea41828 TCGA-A2-A4RY-01 TCGA-A2-A4RY-01A-31D-A25Q-09 TCGA-A2-A4RY-01 51d9b960-276a-4c7b-b135-f2f8c05f3bd6 TCGA-A2-A4RY-01A-31D-A25N-01 TCGA-A2-A4RY-01 51d9b960-276a-4c7b-b135-f2f8c05f3bd6 TCGA-A2-A4RY-01A-31D-A25N-01 TCGA-A2-A4S0-01 TCGA-A2-A4S0-01 TCGA-A2-A4S0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-A2-A4S0-F59120 TCGA-A2-A4S0 TCGA-A2-A4S0-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Simple Mastectomy YES -28416 159 0 706 90-99% 2014-5-1 FEMALE 1+ Mucinous Carcinoma No C50.9 8480/3 C50.9 3+ YES Core needle biopsy 960 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T2 Stage IIA TCGA-A2-A4S0.0118D9AE-B923-4EEF-BBBC-82D559763FF9.pdf A4S0 TUMOR FREE NO YES 90-99% NO Primary Tumor 01 7th YES NO A2 Breast A LIVING 2012 81e350d9-7e2f-4650-9871-54ed2d5a5ab3 81e350d9-7e2f-4650-9871-54ed2d5a5ab3 TCGA-A2-A4S0-01 TCGA-A2-A4S0-01A-21D-A268-05 b37a030f-c2f7-4690-8503-78a2af066cdf TCGA-A2-A4S0-01 TCGA-A2-A4S0-01A-21D-A25Q-09 TCGA-A2-A4S0-01 81e350d9-7e2f-4650-9871-54ed2d5a5ab3 TCGA-A2-A4S0-01A-21D-A25N-01 TCGA-A2-A4S0-01 81e350d9-7e2f-4650-9871-54ed2d5a5ab3 TCGA-A2-A4S0-01A-21D-A25N-01 TCGA-A2-A4S1-01 TCGA-A2-A4S1-01 TCGA-A2-A4S1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-A2-A4S1-F58925 TCGA-A2-A4S1 TCGA-A2-A4S1-01A Positive 3 Point Scale Negative Lumpectomy YES -24353 282 0 820 <10% 2014-4-28 FEMALE Metaplastic Carcinoma No C50.9 8575/3 C50.9 1+ YES Core needle biopsy 350 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T2 Stage IIA TCGA-A2-A4S1.041580F0-700A-4A47-83A6-207ED267E844.pdf A4S1 TUMOR FREE NO YES YES Primary Tumor 01 7th YES NO A2 Breast A LIVING 2012 3d9d61f1-ad25-45a5-b0be-8698dc4b8c68 3d9d61f1-ad25-45a5-b0be-8698dc4b8c68 TCGA-A2-A4S1-01 TCGA-A2-A4S1-01A-21D-A268-05 ae7e510a-5cda-4520-b879-ec7685609a2e TCGA-A2-A4S1-01 TCGA-A2-A4S1-01A-21D-A25Q-09 TCGA-A2-A4S1-01 3d9d61f1-ad25-45a5-b0be-8698dc4b8c68 TCGA-A2-A4S1-01A-21D-A25N-01 TCGA-A2-A4S1-01 3d9d61f1-ad25-45a5-b0be-8698dc4b8c68 TCGA-A2-A4S1-01A-21D-A25N-01 TCGA-A2-A4S2-01 TCGA-A2-A4S2-01 TCGA-A2-A4S2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Axillary lymph node dissection alone TCGA-A2-A4S2-F59085 TCGA-A2-A4S2 TCGA-A2-A4S2-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy NO -22936 112 0 643 90-99% 2014-4-30 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8524/3 C50.9 2+ YES Core needle biopsy 1390 NO Negative NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 5 0 true No M0 N2 T3 Stage IIIA TCGA-A2-A4S2.4A5630FF-0ADC-4E69-B22A-02F1F34F61F9.pdf A4S2 TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO A2 Breast A LIVING 2012 2c6af71f-b876-4475-a94a-61e99075123f 2c6af71f-b876-4475-a94a-61e99075123f TCGA-A2-A4S2-01 TCGA-A2-A4S2-01A-12D-A268-05 e2a6282d-a3b4-42be-b034-d1203d078044 TCGA-A2-A4S2-01 TCGA-A2-A4S2-01A-12D-A25Q-09 TCGA-A2-A4S2-01 2c6af71f-b876-4475-a94a-61e99075123f TCGA-A2-A4S2-01A-12D-A25N-01 TCGA-A2-A4S2-01 2c6af71f-b876-4475-a94a-61e99075123f TCGA-A2-A4S2-01A-12D-A25N-01 TCGA-A2-A4S3-01 TCGA-A2-A4S3-01 TCGA-A2-A4S3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-A2-A4S3-F59128 TCGA-A2-A4S3 TCGA-A2-A4S3-01A Positive Positive Modified Radical Mastectomy NO -21762 147 0 666 90-99% 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 1500 NO Negative NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 0 true No M0 N1a T2 Stage IIB TCGA-A2-A4S3.351D8E38-6E04-4F54-8CB1-975AEB7DB552.pdf A4S3 TUMOR FREE YES 90-99% Primary Tumor 01 7th YES NO A2 Breast A LIVING 2012 a26b4751-91a2-420c-9ff3-7df7361939fd a26b4751-91a2-420c-9ff3-7df7361939fd TCGA-A2-A4S3-01 TCGA-A2-A4S3-01A-21D-A268-05 18c0493c-af12-4d29-9e41-e4debdf3e0b1 TCGA-A2-A4S3-01 TCGA-A2-A4S3-01A-21D-A25Q-09 TCGA-A2-A4S3-01 a26b4751-91a2-420c-9ff3-7df7361939fd TCGA-A2-A4S3-01A-21D-A25N-01 TCGA-A2-A4S3-01 a26b4751-91a2-420c-9ff3-7df7361939fd TCGA-A2-A4S3-01A-21D-A25N-01 TCGA-A7-A0CD-01 Stage IA 66 3 Stage I 372 Positive FEMALE Negative 4 3 3 Negative M0 Negative N0 372 0 LumA Luminal A Positive LumA -10 -3 followup T1 T1 LIVING TCGA-A7-A0CD-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A7-A0CD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Sentinel node biopsy alone TCGA-A7-A0CD-F39827 TCGA-A7-A0CD TCGA-A7-A0CD-01A Positive Positive Lumpectomy NO -24242 157 0 1165 90-99% 4.0 2013-2-4 FEMALE PathVysion HER-2 D Probe Kit 2+ 279 4.6 1.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 420 NO Equivocal Negative NO 2 Negative Indeterminate (neither Pre or Postmenopausal) 3 2 NO 0 false Yes M0 N0 T1 Stage I TCGA-A7-A0CD.DEB67EB8-155C-4ACF-B3D4-595E4CBE2E5C.pdf A0CD TUMOR FREE YES 70-79% YES Primary Tumor 01 6th YES YES NO A7 Breast A LIVING 2009 1edf44b5-61ba-47cd-81ed-b586ae81cb32 1edf44b5-61ba-47cd-81ed-b586ae81cb32 TCGA-A7-A0CD-01A-21-A13A-20 TCGA-A7-A0CD-01A-11W-A019-09 TCGA-A7-A0CD-01 0466e496-e1c2-4cd0-ab1d-34babdbfc80f TCGA-A7-A0CD-01 TCGA-A7-A0CD-01A-11W-A019-09 TCGA-A7-A0CD-01A-11D-A00Y-05 TCGA-A7-A0CD-01 TCGA-A7-A0CD-01A-11W-A019-09 TCGA-A7-A0CD-01 1edf44b5-61ba-47cd-81ed-b586ae81cb32 TCGA-A7-A0CD-01 TCGA-A7-A0CD-01A-11D-A011-01 TCGA-A7-A0CD-01A-11R-A00Z-07 1edf44b5-61ba-47cd-81ed-b586ae81cb32 TCGA-A7-A0CD-01A-11D-A011-01 TCGA-A7-A0CD-01 TCGA-A7-A0CE-01 Stage IIA 57 1 Stage IIA 309 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 309 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING TCGA-A7-A0CE-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-A7-A0CE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0CE-F39153 TCGA-A7-A0CE TCGA-A7-A0CE-01A Negative Negative Lumpectomy YES -20863 129 0 1074 <10% 2.9 2013-1-14 FEMALE Vysis AutoVysion System PathVysion 2+ 389 3.2 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 330 NO Equivocal Negative NO 1 Negative Indeterminate (neither Pre or Postmenopausal) 5 5 NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0CE.8A853D7F-979F-4112-9659-1FDE84EF5102.pdf A0CE TUMOR FREE YES <10% YES Primary Tumor 01 YES YES NO A7 Breast A LIVING 2009 e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2 e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2 TCGA-A7-A0CE-01A-21-A13A-20 TCGA-A7-A0CE-01A-11W-A019-09 TCGA-A7-A0CE-01 7a0dcaa3-a8ab-4437-b642-11872fbf6456 TCGA-A7-A0CE-01 TCGA-A7-A0CE-01A-11W-A019-09 TCGA-A7-A0CE-01A-11D-A00Y-05 TCGA-A7-A0CE-01 TCGA-A7-A0CE-01A-11W-A019-09 TCGA-A7-A0CE-01 e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2 TCGA-A7-A0CE-01 TCGA-A7-A0CE-01A-11D-A011-01 TCGA-A7-A0CE-01A-11R-A00Z-07 e8ef8b75-7c0c-4a42-9a10-3789b6afa5d2 TCGA-A7-A0CE-01A-11D-A011-01 TCGA-A7-A0CE-01 TCGA-A7-A0CE-11 57 309 FEMALE 309 0 followup LIVING TCGA-A7-A0CE-11 C4-BRCA/Basal mutation cluster 5 TCGA-A7-A0CE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0CE-F39153 TCGA-A7-A0CE TCGA-A7-A0CE-11A Negative Negative Lumpectomy YES -20863 129 0 1074 <10% 2.9 2013-1-14 FEMALE Vysis AutoVysion System PathVysion 2+ 389 3.2 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 290 NO Equivocal Negative NO 1 Negative Indeterminate (neither Pre or Postmenopausal) NO 0 0 false No M0 N0 (i-) T2 Stage IIA A0CE TUMOR FREE YES <10% YES Solid Tissue Normal 11 YES YES NO A7 Breast A LIVING 2009 2d5351f1-e9d7-44a3-ae43-f595a0151516 2d5351f1-e9d7-44a3-ae43-f595a0151516 TCGA-A7-A0CE-11A-21D-A10Q-05 TCGA-A7-A0CE-11 2d5351f1-e9d7-44a3-ae43-f595a0151516 TCGA-A7-A0CE-11 TCGA-A7-A0CE-11A-21R-A089-07 2d5351f1-e9d7-44a3-ae43-f595a0151516 TCGA-A7-A0CG-01 Stage IIA 78 2 Stage IIA 230 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 230 0 LumA Luminal A Negative ReacI -5 -7 followup T_Other T2 LIVING TCGA-A7-A0CG-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation cluster 4 TCGA-A7-A0CG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0CG-F39202 TCGA-A7-A0CG TCGA-A7-A0CG-01A Positive Negative Lumpectomy YES -28596 93 0 1043 90-99% 2013-1-15 FEMALE 1+ Mixed Histology (please specify) Mixed infiltrating lobular and grade 1 ductal carcinoma No C50.9 8522/3 C50.9 YES Core needle biopsy 200 NO Negative NO 5 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 7 NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0CG.2BE28F5D-2DBB-476F-9AFF-6B2103ECF0CE.pdf A0CG TUMOR FREE NO <10% YES Primary Tumor 01 NO YES NO A7 Breast A LIVING 2010 2b0e2135-a1e4-4785-8b9f-b4cf7b36d938 2b0e2135-a1e4-4785-8b9f-b4cf7b36d938 TCGA-A7-A0CG-01A-21-A13A-20 TCGA-A7-A0CG-01A-11W-A019-09 TCGA-A7-A0CG-01 0b26254d-1199-487f-8cc1-e99d2dc58737 TCGA-A7-A0CG-01 TCGA-A7-A0CG-01A-11W-A019-09 TCGA-A7-A0CG-01A-11D-A00Y-05 TCGA-A7-A0CG-01 TCGA-A7-A0CG-01A-11W-A019-09 TCGA-A7-A0CG-01 2b0e2135-a1e4-4785-8b9f-b4cf7b36d938 TCGA-A7-A0CG-01 TCGA-A7-A0CG-01A-11D-A011-01 TCGA-A7-A0CG-01A-12R-A056-07 2b0e2135-a1e4-4785-8b9f-b4cf7b36d938 TCGA-A7-A0CG-01A-11D-A011-01 TCGA-A7-A0CG-01 TCGA-A7-A0CH-01 Stage IIA 79 2 Stage IIA 232 FEMALE Negative 3 3 3 Negative M0 Negative N0 232 0 LumA Luminal A LumA -12 -3 followup T_Other T2 LIVING TCGA-A7-A0CH-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A7-A0CH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-A7-A0CH-F39148 TCGA-A7-A0CH TCGA-A7-A0CH-01A Simple Mastectomy YES -29104 121 0 1079 2013-1-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 360 NO NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0CH.F70DA7E5-2AB3-487F-8B2C-72EEE91E58E0.pdf A0CH TUMOR FREE YES NO Primary Tumor 01 YES YES NO A7 Breast A LIVING 2009 0b225e38-d4c8-4cb5-a668-316894ab858f 0b225e38-d4c8-4cb5-a668-316894ab858f TCGA-A7-A0CH-01A-11-A13A-20 TCGA-A7-A0CH-01A-21W-A019-09 TCGA-A7-A0CH-01 d44c8f0f-090f-417f-b80e-ff5da42138d0 TCGA-A7-A0CH-01 TCGA-A7-A0CH-01A-21W-A019-09 TCGA-A7-A0CH-01A-21D-A00Y-05 TCGA-A7-A0CH-01 TCGA-A7-A0CH-01A-21W-A019-09 TCGA-A7-A0CH-01 0b225e38-d4c8-4cb5-a668-316894ab858f TCGA-A7-A0CH-01 TCGA-A7-A0CH-01A-21D-A011-01 TCGA-A7-A0CH-01A-21R-A00Z-07 0b225e38-d4c8-4cb5-a668-316894ab858f TCGA-A7-A0CH-01A-21D-A011-01 TCGA-A7-A0CH-01 TCGA-A7-A0CH-11 79 232 FEMALE 232 0 followup LIVING TCGA-A7-A0CH-11 C3-BRCA/Luminal mutation cluster 4 TCGA-A7-A0CH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-A7-A0CH-F39148 TCGA-A7-A0CH TCGA-A7-A0CH-11A Simple Mastectomy YES -29104 121 0 1079 2013-1-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 390 NO NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T2 Stage IIA A0CH TUMOR FREE YES NO Solid Tissue Normal 11 YES YES NO A7 Breast A LIVING 2009 a4b19504-8f04-48db-b88b-d76b8b3c3881 a4b19504-8f04-48db-b88b-d76b8b3c3881 TCGA-A7-A0CH-11A-32D-A10Q-05 a4b19504-8f04-48db-b88b-d76b8b3c3881 TCGA-A7-A0CH-11A-32R-A089-07 a4b19504-8f04-48db-b88b-d76b8b3c3881 TCGA-A7-A0CJ-01 Stage IIA 57 1 Stage IIA 409 Positive FEMALE Negative 4 3 4 Negative M0 Negative N0 409 0 LumB Luminal B Positive LumA/B -6 -3 followup T_Other T2 LIVING TCGA-A7-A0CJ-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 3 TCGA-A7-A0CJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0CJ-F39740 TCGA-A7-A0CJ TCGA-A7-A0CJ-01A Positive Other Positive Lumpectomy Re-excision of the inferior margin YES -21014 36 0 931 90-99% 2013-1-31 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 310 NO Negative NO 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0CJ.019F390D-7479-4CDC-8C82-45A27910E782.pdf A0CJ TUMOR FREE YES 70-79% YES Primary Tumor 01 YES YES NO A7 Breast A LIVING 2010 62de6863-5d60-473c-8e13-e300b0640ed7 62de6863-5d60-473c-8e13-e300b0640ed7 TCGA-A7-A0CJ-01A-11-A13A-20 TCGA-A7-A0CJ-01A-21W-A019-09 TCGA-A7-A0CJ-01 d9f09beb-2d34-4507-a3bf-039786bba9a9 TCGA-A7-A0CJ-01 TCGA-A7-A0CJ-01A-21W-A019-09 TCGA-A7-A0CJ-01A-21D-A00Y-05 TCGA-A7-A0CJ-01 TCGA-A7-A0CJ-01A-21W-A019-09 TCGA-A7-A0CJ-01 62de6863-5d60-473c-8e13-e300b0640ed7 TCGA-A7-A0CJ-01 TCGA-A7-A0CJ-01A-21D-A011-01 TCGA-A7-A0CJ-01A-21R-A00Z-07 62de6863-5d60-473c-8e13-e300b0640ed7 TCGA-A7-A0CJ-01A-21D-A011-01 TCGA-A7-A0CJ-01 TCGA-A7-A0D9-01 Stage IIA 37 4 Stage IIA 272 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 272 0 LumA Luminal A Negative ReacII -3 -3 followup T_Other T2 LIVING TCGA-A7-A0D9-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-A7-A0D9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-A7-A0D9-F39771 TCGA-A7-A0D9 TCGA-A7-A0D9-01A Positive Negative Simple Mastectomy YES -13836 173 0 1139 90-99% 2013-2-1 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 1760 NO Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 5 NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0D9.7D5763F7-7284-4AF5-BBFC-5D8B5CB7F495.pdf A0D9 TUMOR FREE YES <10% NO Primary Tumor 01 YES YES NO A7 Breast A LIVING 2009 755912f4-6725-4b7b-84b1-518c7529a176 755912f4-6725-4b7b-84b1-518c7529a176 TCGA-A7-A0D9-01A-21-A13C-20 TCGA-A7-A0D9-01A-31W-A071-09 TCGA-A7-A0D9-01 TCGA-A7-A0D9-01A-31D-A10P-05 8cbc03f3-4f0a-4a76-99cd-3a8479558cb1 TCGA-A7-A0D9-01 TCGA-A7-A0D9-01A-31W-A071-09 TCGA-A7-A0D9-01 TCGA-A7-A0D9-01A-31W-A071-09 TCGA-A7-A0D9-01 755912f4-6725-4b7b-84b1-518c7529a176 TCGA-A7-A0D9-01 TCGA-A7-A0D9-01A-31D-A059-01 TCGA-A7-A0D9-01A-31R-A056-07 755912f4-6725-4b7b-84b1-518c7529a176 TCGA-A7-A0D9-01A-31D-A059-01 TCGA-A7-A0D9-01 TCGA-A7-A0D9-11 37 272 FEMALE 272 0 Normal followup LIVING TCGA-A7-A0D9-11 C3-BRCA/Luminal mutation cluster 4 TCGA-A7-A0D9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-A7-A0D9-F39771 TCGA-A7-A0D9 TCGA-A7-A0D9-11A Positive Negative Simple Mastectomy YES -13836 173 0 1139 90-99% 2013-2-1 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 1830 NO Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 0 false No M0 N0 (i-) T2 Stage IIA A0D9 TUMOR FREE YES <10% NO Solid Tissue Normal 11 YES YES NO A7 Breast A LIVING 2009 fc5bb351-c5f7-4d8c-850c-13e69e13e04d fc5bb351-c5f7-4d8c-850c-13e69e13e04d TCGA-A7-A0D9-11A-53D-A10Q-05 fc5bb351-c5f7-4d8c-850c-13e69e13e04d TCGA-A7-A0D9-11A-53R-A089-07 fc5bb351-c5f7-4d8c-850c-13e69e13e04d TCGA-A7-A0DA-01 Stage IIA 62 1 Stage IIA 373 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 373 0 Basal Basal-like Negative X -13 0 followup T_Other T2 LIVING TCGA-A7-A0DA-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 cluster 4 mutation cluster 13 TCGA-A7-A0DA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0DA-F38487 TCGA-A7-A0DA TCGA-A7-A0DA-01A Negative Negative Lumpectomy -22708 177 0 1085 2012-12-14 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 350 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0DA.69AC5937-3FFD-40FB-9922-79DB3CED7510.pdf A0DA TUMOR FREE YES YES Primary Tumor 01 YES YES NO A7 Breast A LIVING 2009 9d04c180-7c23-490e-92cf-c018629b8b7f 9d04c180-7c23-490e-92cf-c018629b8b7f TCGA-A7-A0DA-01A-11-A13C-20 TCGA-A7-A0DA-01A-31D-A10Y-09 TCGA-A7-A0DA-01 190fcd17-0d7a-4d28-9958-492d56360678 TCGA-A7-A0DA-01 TCGA-A7-A0DA-01A-31D-A10Y-09 TCGA-A7-A0DA-01A-31D-A112-05 TCGA-A7-A0DA-01 TCGA-A7-A0DA-01 TCGA-A7-A0DA-01A-31D-A10Y-09 9d04c180-7c23-490e-92cf-c018629b8b7f TCGA-A7-A0DA-01A-31D-A111-01 TCGA-A7-A0DA-01 TCGA-A7-A0DA-01A-31R-A115-07 9d04c180-7c23-490e-92cf-c018629b8b7f TCGA-A7-A0DA-01A-31D-A111-01 TCGA-A7-A0DA-01 TCGA-A7-A0DB-01 Stage IIA 56 2 Stage IIA 266 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 266 0 LumA Luminal A Positive LumA -5 -7 followup T_Other T2 LIVING TCGA-A7-A0DB-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation cluster 4 TCGA-A7-A0DB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0DB-F38479 TCGA-A7-A0DB TCGA-A7-A0DB-01A Positive Positive Simple Mastectomy YES -20570 167 0 1007 FPPP 90-99% 2012-12-14 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 300 NO Negative NO 4 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A0DB.511CB4C5-FCEE-4EC4-98A4-4DD32ECA83C3.pdf A0DB TUMOR FREE YES 60-69% TCGA YES Primary Tumor 01 YES YES NO A7 Breast A LIVING 2009 0c74bde4-0411-4cfd-9c60-d8eaf8a09629 0c74bde4-0411-4cfd-9c60-d8eaf8a09629 TCGA-A7-A0DB-01A-21-A13C-20 TCGA-A7-A0DB-01A-11W-A019-09 TCGA-A7-A0DB-01 74072dd9-7503-4152-9734-65dcb4bca217 TCGA-A7-A0DB-01 TCGA-A7-A0DB-01A-11W-A019-09,TCGA-A7-A0DB-01A-11D-A272-09 TCGA-A7-A0DB-01A-11D-A00Y-05 TCGA-A7-A0DB-01 TCGA-A7-A0DB-01A-11W-A019-09 TCGA-A7-A0DB-01 0c74bde4-0411-4cfd-9c60-d8eaf8a09629 TCGA-A7-A0DB-01 TCGA-A7-A0DB-01A-11D-A011-01 TCGA-A7-A0DB-01A-11R-A00Z-07 0c74bde4-0411-4cfd-9c60-d8eaf8a09629 TCGA-A7-A0DB-01A-11D-A011-01 TCGA-A7-A0DB-01 TCGA-A7-A0DB-11 56 266 FEMALE 266 0 Normal followup LIVING TCGA-A7-A0DB-11 C3-BRCA/Luminal mutation cluster 4 TCGA-A7-A0DB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0DB-F38479 TCGA-A7-A0DB TCGA-A7-A0DB-11A Positive Positive Simple Mastectomy YES -20570 167 0 1007 FPPP 90-99% 2012-12-14 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 400 NO Negative NO 4 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T2 Stage IIA A0DB TUMOR FREE YES 60-69% TCGA YES Solid Tissue Normal 11 YES YES NO A7 Breast A LIVING 2009 3f3bdfbb-3490-42e4-9511-9df4b8a126a3 3f3bdfbb-3490-42e4-9511-9df4b8a126a3 TCGA-A7-A0DB-11A-33D-A093-05 3f3bdfbb-3490-42e4-9511-9df4b8a126a3 TCGA-A7-A0DB-11A-33R-A089-07 3f3bdfbb-3490-42e4-9511-9df4b8a126a3 TCGA-A7-A0DC-01 Stage IA 63 Stage I 386 Positive FEMALE Negative Negative M0 Negative N0 386 0 LumA Negative followup T1 T1 LIVING TCGA-A7-A0DC-01 BRCA nonbasal-like c8 TCGA-A7-A0DC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0DC-F40607 TCGA-A7-A0DC TCGA-A7-A0DC-01A Positive Negative Simple Mastectomy YES -23294 238 0 906 90-99% 2013-2-25 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 200 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T1c Stage IA TCGA-A7-A0DC.43D912CD-BD3C-4E69-B28B-AB2E173C0BC2.pdf A0DC TUMOR FREE YES <10% YES Primary Tumor 01 YES YES NO A7 Breast A LIVING 2009 43bbd0f7-87d7-472f-ad3e-e016df3d5d89 43bbd0f7-87d7-472f-ad3e-e016df3d5d89 TCGA-A7-A0DC-01A-21-A13C-20 TCGA-A7-A0DC-01B-04D-A22R-05 31b94bd4-e63e-4e52-b366-3bafe08524e7 TCGA-A7-A0DC-01B-04D-A22N-09 TCGA-A7-A0DC-01A-11D-A00Y-05 43bbd0f7-87d7-472f-ad3e-e016df3d5d89 TCGA-A7-A0DC-01A-11D-A011-01 TCGA-A7-A0DC-01A-11R-A00Z-07 43bbd0f7-87d7-472f-ad3e-e016df3d5d89 TCGA-A7-A0DC-01A-11D-A011-01 TCGA-A7-A0DC-11 63 386 FEMALE 386 0 Normal followup LIVING TCGA-A7-A0DC-11 TCGA-A7-A0DC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A0DC-F40607 TCGA-A7-A0DC TCGA-A7-A0DC-11A Positive Negative Simple Mastectomy YES -23294 238 0 906 90-99% 2013-2-25 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 470 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T1c Stage IA A0DC TUMOR FREE YES <10% YES Solid Tissue Normal 11 YES YES NO A7 Breast A LIVING 2009 cb3f974e-6bce-4757-a350-aef8e7925086 cb3f974e-6bce-4757-a350-aef8e7925086 TCGA-A7-A0DC-11A-41D-A10Q-05 cb3f974e-6bce-4757-a350-aef8e7925086 TCGA-A7-A0DC-11A-41R-A089-07 cb3f974e-6bce-4757-a350-aef8e7925086 TCGA-A7-A13D-01 Stage IIA 46 3 Stage IIA 267 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 267 0 Basal Basal-like Positive ReacII -13 0 followup T_Other T2 LIVING TCGA-A7-A13D-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 2 TCGA-A7-A13D TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-A7-A13D-F39794 TCGA-A7-A13D TCGA-A7-A13D-01A Negative Negative Lumpectomy Positive Lumpectomy NO -17070 240 0 965 FPPP <10% 1.8 2013-2-1 FEMALE PathVysion HER-2 D Probe Kit 2+ 197 1.9 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 240 NO Equivocal Negative NO 4 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 0 false No M0 N0 (i-) T2 Stage IIA TCGA-A7-A13D.6F3784B2-4A75-447C-9EAE-F146461C737E.pdf A13D TUMOR FREE YES <10% TCGA YES Primary Tumor 01 YES YES NO A7 Breast A LIVING 2010 3af60b03-66c3-48a1-a42b-1e05fdb529c4 3af60b03-66c3-48a1-a42b-1e05fdb529c4 TCGA-A7-A13D-01A-21-A13E-20 TCGA-A7-A13D-01A-13D-A12Q-09 TCGA-A7-A13D-01 TCGA-A7-A13D-01A-13D-A12R-05 bf4b9dc3-df06-4735-b9b6-4cc8240c93b7 TCGA-A7-A13D-01 TCGA-A7-A13D-01A-13D-A12Q-09,TCGA-A7-A13D-01A-13D-A272-09 TCGA-A7-A13D-01 TCGA-A7-A13D-01 TCGA-A7-A13D-01A-13D-A12Q-09 3af60b03-66c3-48a1-a42b-1e05fdb529c4 TCGA-A7-A13D-01A-13D-A12N-01 TCGA-A7-A13D-01 TCGA-A7-A13D-01A-13R-A12P-07 3af60b03-66c3-48a1-a42b-1e05fdb529c4 TCGA-A7-A13D-01A-13D-A12N-01 TCGA-A7-A13D-01 TCGA-A7-A13E-01 Stage IIB 62 1 No_Conversion 326 Positive FEMALE Negative Negative M0 Positive N1 326 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-A7-A13E-01 High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 TCGA-A7-A13E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A13E-F30405 TCGA-A7-A13E TCGA-A7-A13E-01A Positive Negative Lumpectomy NO -22690 220 614 0 326 556 FPPP 20-29% 3.0 Additional New Tumor Event 2012-4-9 FEMALE PathVysion HER-2 D Probe Kit 2+ 561 3.2 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 730 NO Equivocal Negative 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative 1+ Negative Negative 4 5 Other, specify Distant Metastasis Lung, Bone, Liver, Brain and Skin Nodules YES 2 false No MX N1 T2 Stage IIB TCGA-A7-A13E.2180850C-CC8D-4376-B2EE-1ADC3F5B3EC1.pdf A13E WITH TUMOR <10% TCGA NO Primary Tumor 01 YES YES NO A7 Breast A DECEASED 2010 b7f491a9-eddf-43b1-9baf-862db2d50383 b7f491a9-eddf-43b1-9baf-862db2d50383 TCGA-A7-A13E-01A-21-A13E-20 TCGA-A7-A13E-01 TCGA-A7-A13E-01A-11D-A12R-05 724b7cef-9bb6-4c6b-8c78-b632f910fe85 TCGA-A7-A13E-01 TCGA-A7-A13E-01A-11D-A12Q-09,TCGA-A7-A13E-01A-11D-A272-09 TCGA-A7-A13E-01 TCGA-A7-A13E-01 b7f491a9-eddf-43b1-9baf-862db2d50383 TCGA-A7-A13E-01A-11D-A12N-01 TCGA-A7-A13E-01 TCGA-A7-A13E-01A-11R-A12P-07 b7f491a9-eddf-43b1-9baf-862db2d50383 TCGA-A7-A13E-01A-11D-A12N-01 TCGA-A7-A13E-01 TCGA-A7-A13E-11 62 326 FEMALE 326 0 Normal followup LIVING TCGA-A7-A13E-11 C4-BRCA/Basal TCGA-A7-A13E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A13E-F30405 TCGA-A7-A13E TCGA-A7-A13E-11A Positive Negative Lumpectomy NO -22690 220 614 0 326 556 FPPP 20-29% 3.0 Additional New Tumor Event 2012-4-9 FEMALE PathVysion HER-2 D Probe Kit 2+ 561 3.2 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 770 NO Equivocal Negative 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative 1+ Negative Negative Other, specify Distant Metastasis Lung, Bone, Liver, Brain and Skin Nodules YES 2 false No MX N1 T2 Stage IIB A13E WITH TUMOR <10% TCGA NO Solid Tissue Normal 11 YES YES NO A7 Breast A DECEASED 2010 80efdbaa-067b-4018-89b2-b8869bfb9163 80efdbaa-067b-4018-89b2-b8869bfb9163 TCGA-A7-A13E-11A-61D-A12R-05 E408026E-6C07-4F2E-A609-29F21E997938 TCGA-A7-A13E-11 80efdbaa-067b-4018-89b2-b8869bfb9163 TCGA-A7-A13E-11 TCGA-A7-A13E-11A-61R-A12P-07 80efdbaa-067b-4018-89b2-b8869bfb9163 TCGA-A7-A13F-01 Stage IIIA 44 3 No_Conversion 387 Positive FEMALE Negative 1 3 4 Negative M0 Positive N1 387 0 LumB Luminal B Positive LumA/B 0 -3 followup T_Other T3 LIVING TCGA-A7-A13F-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A7-A13F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A13F-F39779 TCGA-A7-A13F Positive Positive Modified Radical Mastectomy NO -16363 0 765 2.8 Scheduled Follow-up Submission 2013-2-1 FEMALE PathVysion HER-2 D Probe Kit 2+ 403 3.0 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative NO 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 3 No M0 N1a T3 Stage IIIA A13F TUMOR FREE YES YES Primary Tumor 01 YES YES NO A7 Breast LIVING 2010 fc4f35dd-9924-4e5d-ba71-0d7a79752b6a fc4f35dd-9924-4e5d-ba71-0d7a79752b6a TCGA-A7-A13F-01A-21-A13E-20 TCGA-A7-A13F-01A-11D-A12Q-09 TCGA-A7-A13F-01 TCGA-A7-A13F-01A-11D-A12R-05 ad57bf3d-f283-4c26-95ad-86a116794296 TCGA-A7-A13F-01 TCGA-A7-A13F-01A-11D-A12Q-09 TCGA-A7-A13F-01 TCGA-A7-A13F-01 TCGA-A7-A13F-01A-11D-A12Q-09 fc4f35dd-9924-4e5d-ba71-0d7a79752b6a TCGA-A7-A13F-01A-11D-A12N-01 TCGA-A7-A13F-01 TCGA-A7-A13F-01A-11R-A12P-07 fc4f35dd-9924-4e5d-ba71-0d7a79752b6a TCGA-A7-A13F-01A-11D-A12N-01 TCGA-A7-A13F-01 TCGA-A7-A13F-11 44 387 FEMALE 387 0 Normal followup LIVING TCGA-A7-A13F-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-A7-A13F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A13F-F39779 TCGA-A7-A13F TCGA-A7-A13F-11A Positive Positive Modified Radical Mastectomy NO -16363 121 0 765 2.8 Scheduled Follow-up Submission 2013-2-1 FEMALE PathVysion HER-2 D Probe Kit 2+ 403 3.0 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 960 NO Equivocal Negative NO 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 3 false No M0 N1a T3 Stage IIIA A13F TUMOR FREE YES YES Solid Tissue Normal 11 YES YES NO A7 Breast A LIVING 2010 82f3157c-09cc-40d7-872e-59f82f5f31f4 82f3157c-09cc-40d7-872e-59f82f5f31f4 TCGA-A7-A13F-11A-42D-A12R-05 2F10F1D9-54A0-42EB-B9B7-C9733D431824 TCGA-A7-A13F-11 82f3157c-09cc-40d7-872e-59f82f5f31f4 TCGA-A7-A13F-11 TCGA-A7-A13F-11A-42R-A12P-07 82f3157c-09cc-40d7-872e-59f82f5f31f4 TCGA-A7-A13G-01 Stage IIA 79 2 Stage IIA 348 Positive FEMALE Negative Negative M0 Negative N0 348 0 LumA Positive followup T_Other T2 LIVING TCGA-A7-A13G-01 Iq cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 3 mutation cluster 4 TCGA-A7-A13G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 79 Left Sentinel node biopsy alone TCGA-A7-A13G-F35039 TCGA-A7-A13G Positive Positive Simple Mastectomy NO -28969 0 718 586 586 NO 90-99% Scheduled Follow-up Submission 2012-9-14 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 3 Other, specify New Primary Tumor Skin, right leg YES YES 0 Yes MX N0 T2 Stage IIA A13G TUMOR FREE YES YES 50-59% NO Primary Tumor 01 7th YES YES NO A7 Breast LIVING 2010 ac567288-88cc-4a65-937e-086655c038df ac567288-88cc-4a65-937e-086655c038df TCGA-A7-A13G-01A-11D-A13L-09 TCGA-A7-A13G-01 TCGA-A7-A13G-01B-04D-A22R-05,TCGA-A7-A13G-01A-11D-A13K-05 TCGA-A7-A13G-01 TCGA-A7-A13G-01A-11D-A13L-09 TCGA-A7-A13G-01 TCGA-A7-A13G-01A-11D-A13L-09 ac567288-88cc-4a65-937e-086655c038df TCGA-A7-A13G-01A-11D-A13J-01 TCGA-A7-A13G-01 ac567288-88cc-4a65-937e-086655c038df TCGA-A7-A13G-01A-11D-A13J-01 TCGA-A7-A13G-11 79 348 FEMALE 348 0 LumA followup LIVING TCGA-A7-A13G-11 mutation cluster 4 TCGA-A7-A13G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 79 Left Sentinel node biopsy alone TCGA-A7-A13G-F35039 TCGA-A7-A13G TCGA-A7-A13G-11A Positive Positive Simple Mastectomy NO -28969 69 0 718 586 586 NO 90-99% Scheduled Follow-up Submission 2012-9-14 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 880 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify New Primary Tumor Skin, right leg YES YES 0 false Yes MX N0 T2 Stage IIA A13G TUMOR FREE YES YES 50-59% NO Solid Tissue Normal 11 7th YES YES NO A7 Breast A LIVING 2010 76f30f56-7b80-4938-b514-1e1c2d24ff66 76f30f56-7b80-4938-b514-1e1c2d24ff66 TCGA-A7-A13G-11A-51D-A13T-05 76f30f56-7b80-4938-b514-1e1c2d24ff66 76f30f56-7b80-4938-b514-1e1c2d24ff66 TCGA-A7-A13H-01 TCGA-A7-A13H-01 Iq BRCA non-CIMP c9 miRNA cluster 4 TCGA-A7-A13H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 61 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A13H-F41651 TCGA-A7-A13H TCGA-A7-A13H-01A Positive Positive Simple Mastectomy YES -22643 62 0 899 840 795 NO 80-89% 2.7 2013-3-25 FEMALE Pathvysion HER2 D Probe Kit 2+ 371 3.2 2.2 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 140 NO Equivocal Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify New Primary Tumor Skin lesion-Basal Cell Left Lower Lateral Back YES YES 2 2 false No MX N1a T2 Stage IIB TCGA-A7-A13H.642B4B50-E227-4484-904E-E629F7F9DBC1.pdf A13H TUMOR FREE NO YES 30-39% NO Primary Tumor 01 7th YES NO A7 Breast A LIVING 2010 4f0fdfc6-6578-4d9a-92ae-6d82291a3785 4f0fdfc6-6578-4d9a-92ae-6d82291a3785 TCGA-A7-A13H-01 TCGA-A7-A13H-01A-11D-A22B-05 TCGA-A7-A13H-01 TCGA-A7-A13H-01A-11D-A228-09 TCGA-A7-A13H-01 4f0fdfc6-6578-4d9a-92ae-6d82291a3785 TCGA-A7-A13H-01A-11D-A227-01 TCGA-A7-A13H-01 4f0fdfc6-6578-4d9a-92ae-6d82291a3785 TCGA-A7-A13H-01A-11D-A227-01 TCGA-A7-A26E-01 Stage IIIA 71 2 Stage IIIA 421 Positive FEMALE Negative Negative M0 Positive N1 421 0 LumA Positive followup T_Other T3 LIVING TCGA-A7-A26E-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 1 TCGA-A7-A26E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A26E-F39792 TCGA-A7-A26E TCGA-A7-A26E-01A Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -26274 372 0 954 FPPP NO 90-99% Scheduled Follow-up Submission 2013-2-1 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 230 NO Negative NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 NO 0 false Yes MX N1a T3 Stage IIIA TCGA-A7-A26E.EA830A26-3DF5-4731-AD0A-F20A61D58817.pdf A26E TUMOR FREE YES YES 20-29% TCGA YES Primary Tumor 01 7th YES YES NO A7 Breast A LIVING 2010 6130b450-8b88-4a9a-b462-a34ec94183c9 6130b450-8b88-4a9a-b462-a34ec94183c9 TCGA-A7-A26E-01A-21-A17I-20 TCGA-A7-A26E-01A-11D-A167-09 TCGA-A7-A26E-01 TCGA-A7-A26E-01A-11D-A27B-05,TCGA-A7-A26E-01A-11D-A16A-05,TCGA-A7-A26E-01B-06D-A27B-05 1c700207-2bd3-421f-8c10-5365a680df72 TCGA-A7-A26E-01 TCGA-A7-A26E-01B-06D-A272-09,TCGA-A7-A26E-01A-11D-A167-09,TCGA-A7-A26E-01A-11D-A272-09 TCGA-A7-A26E-01 TCGA-A7-A26E-01A-11D-A167-09 6130b450-8b88-4a9a-b462-a34ec94183c9 TCGA-A7-A26E-01A-11D-A275-01 TCGA-A7-A26E-01 6130b450-8b88-4a9a-b462-a34ec94183c9 TCGA-A7-A26E-01A-11D-A275-01 TCGA-A7-A26F-01 Stage IA 55 3 Stage I 257 Negative FEMALE Negative Negative M0 Negative N0 257 0 Basal Negative enrollment T1 T1 LIVING TCGA-A7-A26F-01 BRCA-LUAD+ C4-BRCA/Basal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 3 TCGA-A7-A26F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left Sentinel node biopsy alone TCGA-A7-A26F-F38499 TCGA-A7-A26F TCGA-A7-A26F-01A Negative Negative Negative Lumpectomy NO -20210 173 0 738 NO 1.8 Scheduled Follow-up Submission 2012-12-14 FEMALE PathVysion HER-2 D probe kit. 2+ 330 1.9 1.1 Other, specify No C50.9 8575/3 C50.9 YES Fine needle aspiration biopsy 190 NO Equivocal Negative NO 1 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO 0 false Yes M0 N0 T1 Stage IA TCGA-A7-A26F.46A75AD3-BAD1-4A16-873E-0099BD10FA8C.pdf A26F TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO A7 Breast A LIVING 2010 2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b 2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b TCGA-A7-A26F-01A-11-A17I-20 TCGA-A7-A26F-01A-21D-A167-09 TCGA-A7-A26F-01 TCGA-A7-A26F-01A-21D-A16A-05,TCGA-A7-A26F-01B-04D-A22R-05 6bda0261-6c33-4c86-8cf9-c9dce2bcadec TCGA-A7-A26F-01 TCGA-A7-A26F-01A-21D-A167-09,TCGA-A7-A26F-01B-04D-A22N-09 TCGA-A7-A26F-01 TCGA-A7-A26F-01A-21D-A167-09 2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b TCGA-A7-A26F-01A-21D-A166-01 TCGA-A7-A26F-01 2a4747b5-1eeb-45b1-9e92-0e0e3d7a9c1b TCGA-A7-A26F-01A-21D-A166-01 TCGA-A7-A26G-01 Stage IIA 50 3 Stage IIA 209 Negative FEMALE Negative Negative M0 Negative N0 209 0 Basal Negative enrollment T_Other T2 LIVING TCGA-A7-A26G-01 COAD-READ C4-BRCA/Basal cluster 5 Low purity c2 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A7-A26G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A26G-F39047 TCGA-A7-A26G TCGA-A7-A26G-01A Negative Negative Other NO -18362 161 0 722 NO Scheduled Follow-up Submission 2013-1-9 FEMALE Other, specify No C50.9 8575/3 C50.9 YES Core needle biopsy 410 NO Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 NO 0 false No M0 N0 (i+) T2 Stage IIA TCGA-A7-A26G.6BE810A6-3D30-4F75-89B7-00C866553165.pdf A26G TUMOR FREE YES YES NO Primary Tumor 01 Total Mastectomy 7th YES YES NO A7 Breast A LIVING 2010 8cf1853a-55b2-4fb9-9a65-a46243304d54 8cf1853a-55b2-4fb9-9a65-a46243304d54 TCGA-A7-A26G-01A-11-A17I-20 TCGA-A7-A26G-01A-21D-A167-09 TCGA-A7-A26G-01 TCGA-A7-A26G-01A-21D-A16A-05 1c0d3d0a-579d-4cfc-bea5-cd7ecb74dd88 TCGA-A7-A26G-01 TCGA-A7-A26G-01A-21D-A167-09 TCGA-A7-A26G-01 TCGA-A7-A26G-01A-21D-A167-09 8cf1853a-55b2-4fb9-9a65-a46243304d54 TCGA-A7-A26G-01A-21D-A166-01 TCGA-A7-A26G-01 8cf1853a-55b2-4fb9-9a65-a46243304d54 TCGA-A7-A26G-01A-21D-A166-01 TCGA-A7-A26H-01 Stage IIA 72 3 Stage IIA 64 Positive FEMALE Positive Negative M0 Positive N1 64 0 LumA Negative enrollment T1 T1 LIVING TCGA-A7-A26H-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 4 TCGA-A7-A26H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 72 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A26H-F39890 TCGA-A7-A26H TCGA-A7-A26H-01A Positive Negative Other NO -26423 79 0 724 311 NO 90-99% 2.2 Scheduled Follow-up Submission 2013-2-5 FEMALE PathVysion Her-2 D 2+ 20 5.8 2.6 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Equivocal Positive NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative Positive 10-19% Negative 4 Liver Distant Metastasis YES 0 1 false Yes M0 N1a T1 Stage IIA TCGA-A7-A26H.1159E2EF-6407-4D90-8ED6-7AB04CF4FB32.pdf A26H WITH TUMOR YES YES NO Primary Tumor 01 Bilateral Mastectomy 7th YES YES NO A7 Breast A LIVING 2011 d1810175-47a5-4409-b1b8-f5ba78ed1c30 d1810175-47a5-4409-b1b8-f5ba78ed1c30 TCGA-A7-A26H-01A-21-A17I-20 TCGA-A7-A26H-01A-11D-A167-09 TCGA-A7-A26H-01 TCGA-A7-A26H-01A-11D-A16A-05 24bf1453-2154-4eb2-a417-274489d22753 TCGA-A7-A26H-01 TCGA-A7-A26H-01A-11D-A167-09 TCGA-A7-A26H-01 TCGA-A7-A26H-01A-11D-A167-09 d1810175-47a5-4409-b1b8-f5ba78ed1c30 TCGA-A7-A26H-01A-11D-A166-01 TCGA-A7-A26H-01 d1810175-47a5-4409-b1b8-f5ba78ed1c30 TCGA-A7-A26H-01A-11D-A166-01 TCGA-A7-A26I-01 Stage IIA 65 1 Stage IIA 122 Negative FEMALE Negative Negative M0 Negative N0 122 0 Basal Negative enrollment T_Other T2 LIVING TCGA-A7-A26I-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 mutation cluster 5 TCGA-A7-A26I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Axillary lymph node dissection alone TCGA-A7-A26I-F39791 TCGA-A7-A26I TCGA-A7-A26I-01A Negative Negative Other Negative Lumpectomy Re-Excision of Superior Margin NO -23948 40 0 661 NO 2.0 Scheduled Follow-up Submission 2013-2-1 FEMALE Path Vysion HER-2 D probe kit 2+ 229 2.2 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 120 NO Equivocal Negative NO 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 0 false Yes M0 N0 T2 Stage IIA TCGA-A7-A26I.CCE33A95-774E-4242-B2A1-05FF002ED1D9.pdf A26I TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO A7 Breast A LIVING 2011 5610fa97-eac4-4306-aead-983ee6570baf 5610fa97-eac4-4306-aead-983ee6570baf TCGA-A7-A26I-01A-21-A17I-20 TCGA-A7-A26I-01A-11D-A167-09 TCGA-A7-A26I-01 TCGA-A7-A26I-01A-11D-A16A-05 c74b933c-9dd5-42a6-a906-4951a21e8bc2 TCGA-A7-A26I-01 TCGA-A7-A26I-01A-11D-A167-09,TCGA-A7-A26I-01B-06D-A22N-09 TCGA-A7-A26I-01 TCGA-A7-A26I-01A-11D-A167-09 5610fa97-eac4-4306-aead-983ee6570baf TCGA-A7-A26I-01A-11D-A166-01 TCGA-A7-A26I-01 5610fa97-eac4-4306-aead-983ee6570baf TCGA-A7-A26I-01A-11D-A166-01 TCGA-A7-A26J-01 Stage IIA 49 3 Stage IIA 67 Positive FEMALE Negative Negative M0 Negative N0 67 0 LumA Positive enrollment T_Other T2 LIVING TCGA-A7-A26J-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-A7-A26J TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A26J-F39793 TCGA-A7-A26J Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -17930 0 627 FPPP NO 90-99% Scheduled Follow-up Submission 2013-2-1 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 6 NO 0 No M0 N0 T2 Stage IIA A26J TUMOR FREE YES YES 70-79% TCGA NO Primary Tumor 01 7th YES YES NO A7 Breast LIVING 2011 ed40061b-ad15-4f91-94ae-ae276394f42d ed40061b-ad15-4f91-94ae-ae276394f42d TCGA-A7-A26J-01A-11D-A167-09 TCGA-A7-A26J-01 TCGA-A7-A26J-01B-02D-A27B-05,TCGA-A7-A26J-01A-11D-A27B-05,TCGA-A7-A26J-01A-11D-A16A-05 TCGA-A7-A26J-01 TCGA-A7-A26J-01B-02D-A272-09,TCGA-A7-A26J-01A-11D-A272-09,TCGA-A7-A26J-01A-11D-A167-09 TCGA-A7-A26J-01 TCGA-A7-A26J-01A-11D-A167-09 ed40061b-ad15-4f91-94ae-ae276394f42d TCGA-A7-A26J-01A-11D-A275-01 TCGA-A7-A26J-01 ed40061b-ad15-4f91-94ae-ae276394f42d TCGA-A7-A26J-01A-11D-A275-01 TCGA-A7-A2KD-01 LumB TCGA-A7-A2KD-01 Squamous C3-BRCA/Luminal BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-A7-A2KD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right No axillary staging TCGA-A7-A2KD-F39783 TCGA-A7-A2KD TCGA-A7-A2KD-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -19563 141 0 679 90-99% Scheduled Follow-up Submission 2013-2-1 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 260 NO Positive NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 8 0 false Yes MX N2a T2 Stage IIIA TCGA-A7-A2KD.3C301346-4594-4071-A754-04F8B3BE894C.pdf A2KD TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES YES NO A7 Breast A LIVING 2011 5e04619f-0fa5-45fa-a30b-31b062600047 5e04619f-0fa5-45fa-a30b-31b062600047 TCGA-A7-A2KD-01A-41-A24A-20 TCGA-A7-A2KD-01 TCGA-A7-A2KD-01A-31D-A21R-05 58fcf58b-b94c-4605-a0fc-7ddc5e269879 TCGA-A7-A2KD-01 TCGA-A7-A2KD-01A-31D-A21Q-09 TCGA-A7-A2KD-01 5e04619f-0fa5-45fa-a30b-31b062600047 TCGA-A7-A2KD-01A-31D-A21P-01 TCGA-A7-A2KD-01 5e04619f-0fa5-45fa-a30b-31b062600047 TCGA-A7-A2KD-01A-31D-A21P-01 TCGA-A7-A3IY-01 LumA TCGA-A7-A3IY-01 Kirc+ BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-A7-A3IY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-A7-A3IY-F33856 TCGA-A7-A3IY Negative Positive Lumpectomy Positive Lumpectomy NO -26042 0 345 NO 90-99% Scheduled Follow-up Submission 2012-7-20 FEMALE Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Core needle biopsy Negative 1 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T1c Stage I A3IY TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES YES NO A7 Breast LIVING 2011 c4149cf6-980f-4da1-b749-c24aae86f351 c4149cf6-980f-4da1-b749-c24aae86f351 TCGA-A7-A3IY-01 TCGA-A7-A3IY-01A-21D-A21R-05 TCGA-A7-A3IY-01 TCGA-A7-A3IY-01A-21D-A21Q-09 TCGA-A7-A3IY-01 c4149cf6-980f-4da1-b749-c24aae86f351 TCGA-A7-A3IY-01A-21D-A21P-01 TCGA-A7-A3IY-01 c4149cf6-980f-4da1-b749-c24aae86f351 TCGA-A7-A3IY-01A-21D-A21P-01 TCGA-A7-A3IZ-01 LumA TCGA-A7-A3IZ-01 Kirc+ C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 TCGA-A7-A3IZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A3IZ-F34491 TCGA-A7-A3IZ TCGA-A7-A3IZ-01A Negative Positive Other Negative Lumpectomy Reexcision YES -22997 86 0 322 NO 90-99% 3.0 2012-8-16 FEMALE PathVysion HER-2 D probe kit. 2+ 569 3.0 1.0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 290 NO Equivocal Negative NO 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 false No M0 N0 (i+) T2 Stage IIA TCGA-A7-A3IZ.90F83655-038B-412C-91BD-84CC3A4201D4.pdf A3IZ TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2011 e4400dbf-b871-48ab-b571-4f883bb3c24e e4400dbf-b871-48ab-b571-4f883bb3c24e TCGA-A7-A3IZ-01A-21-A24A-20 TCGA-A7-A3IZ-01 TCGA-A7-A3IZ-01A-11D-A212-05 0d5491ae-73ff-44ad-9aba-cde4b61fbf78 TCGA-A7-A3IZ-01 TCGA-A7-A3IZ-01A-11D-A20S-09 TCGA-A7-A3IZ-01 e4400dbf-b871-48ab-b571-4f883bb3c24e TCGA-A7-A3IZ-01A-11D-A20R-01 TCGA-A7-A3IZ-01 e4400dbf-b871-48ab-b571-4f883bb3c24e TCGA-A7-A3IZ-01A-11D-A20R-01 TCGA-A7-A3J0-01 LumA TCGA-A7-A3J0-01 BRCA-LUAD+ C3-BRCA/Luminal Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 TCGA-A7-A3J0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Sentinel node biopsy alone TCGA-A7-A3J0-F35965 TCGA-A7-A3J0 TCGA-A7-A3J0-01A Positive Positive Lumpectomy NO -22672 78 0 313 NO 90-99% 2012-10-12 FEMALE 1+ Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Core needle biopsy 110 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T2 Stage IIA TCGA-A7-A3J0.A5AED5F0-A144-4615-AF78-539B8523D15F.pdf A3J0 TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2011 1fbf8004-0091-4eb0-9042-d2f1a5174abe 1fbf8004-0091-4eb0-9042-d2f1a5174abe TCGA-A7-A3J0-01A-21-A24A-20 TCGA-A7-A3J0-01 TCGA-A7-A3J0-01A-11D-A212-05 d601836e-e95a-41eb-ad27-e72deada49b6 TCGA-A7-A3J0-01 TCGA-A7-A3J0-01A-11D-A20S-09 TCGA-A7-A3J0-01 1fbf8004-0091-4eb0-9042-d2f1a5174abe TCGA-A7-A3J0-01A-11D-A20R-01 TCGA-A7-A3J0-01 1fbf8004-0091-4eb0-9042-d2f1a5174abe TCGA-A7-A3J0-01A-11D-A20R-01 TCGA-A7-A3J1-01 LumA TCGA-A7-A3J1-01 Iq C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-A7-A3J1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A3J1-F36693 TCGA-A7-A3J1 TCGA-A7-A3J1-01A Positive Positive Lumpectomy -23209 49 0 343 NO 90-99% 2012-11-12 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 100 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false Yes MX N0 T1c Stage IA TCGA-A7-A3J1.D8EFFB62-6A23-4033-8144-24B751DECB08.pdf A3J1 TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2011 3b042185-867f-492b-a448-7c51e05f9b42 3b042185-867f-492b-a448-7c51e05f9b42 TCGA-A7-A3J1-01A-21-A24A-20 TCGA-A7-A3J1-01 TCGA-A7-A3J1-01A-11D-A212-05 88ae23a8-e617-43a4-85be-d4b1f25847ec TCGA-A7-A3J1-01 TCGA-A7-A3J1-01A-11D-A20S-09 TCGA-A7-A3J1-01 3b042185-867f-492b-a448-7c51e05f9b42 TCGA-A7-A3J1-01A-11D-A20R-01 TCGA-A7-A3J1-01 3b042185-867f-492b-a448-7c51e05f9b42 TCGA-A7-A3J1-01A-11D-A20R-01 TCGA-A7-A3RF-01 TCGA-A7-A3RF-01 Quiet BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA c1uster 10 TCGA-A7-A3RF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 79 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-A7-A3RF-F40413 TCGA-A7-A3RF TCGA-A7-A3RF-01A Negative Positive Other Positive Lumpectomy Left breast reexcision NO -29184 61 0 408 174 90-99% 2013-2-19 FEMALE Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Core needle biopsy 190 NO Negative NO 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone Distant Metastasis NO YES 0 false No M0 N0 T2 Stage IIA TCGA-A7-A3RF.4AF67A51-97C1-4D58-9E60-03FDFFACD38A.pdf A3RF WITH TUMOR YES YES 30-39% YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 de0a584e-117e-4cf6-8c4a-6fb040270eda de0a584e-117e-4cf6-8c4a-6fb040270eda TCGA-A7-A3RF-01A-21-A24A-20 TCGA-A7-A3RF-01 TCGA-A7-A3RF-01A-11D-A22B-05 1ecde81b-56db-4c3f-981d-6f1c4baa4a32 TCGA-A7-A3RF-01 TCGA-A7-A3RF-01A-11D-A228-09 TCGA-A7-A3RF-01 de0a584e-117e-4cf6-8c4a-6fb040270eda TCGA-A7-A3RF-01A-11D-A227-01 TCGA-A7-A3RF-01 de0a584e-117e-4cf6-8c4a-6fb040270eda TCGA-A7-A3RF-01A-11D-A227-01 TCGA-A7-A425-01 TCGA-A7-A425-01 TCGA-A7-A425 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A425-F41648 TCGA-A7-A425 TCGA-A7-A425-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy YES -25678 198 0 447 419 419 90-99% 2.5 2013-3-25 FEMALE 30-39% Pathvysion HER-2 D Probe Kit 3+ 228 2.8 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 400 NO Indeterminate Negative NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative 1+ Positive 90-99% 3 Point Scale <10% Negative 3 Point Scale Other, specify Locoregional Recurrence Left Breast YES YES 12 false No MX N3a T3 Stage IIIC TCGA-A7-A425.F969E3E4-0053-44E9-85BC-BEFDBD62C512.pdf A425 WITH TUMOR YES YES 70-79% YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 0a423f86-ffa5-4c16-97ab-2d262c34fd41 0a423f86-ffa5-4c16-97ab-2d262c34fd41 TCGA-A7-A425-01 TCGA-A7-A425-01A-11D-A244-05 45d1596a-0b23-41ad-87c5-b1acc92619d2 TCGA-A7-A425-01 TCGA-A7-A425-01A-11D-A243-09 TCGA-A7-A425-01 0a423f86-ffa5-4c16-97ab-2d262c34fd41 TCGA-A7-A425-01A-11D-A242-01 TCGA-A7-A425-01 0a423f86-ffa5-4c16-97ab-2d262c34fd41 TCGA-A7-A425-01A-11D-A242-01 TCGA-A7-A426-01 TCGA-A7-A426-01 TCGA-A7-A426 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A426-F41743 TCGA-A7-A426 TCGA-A7-A426-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy YES -18296 132 0 364 70-79% 2013-3-26 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Core needle biopsy 180 NO Negative NO 20 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 13 false Yes MX N3a T3 Stage IIIC TCGA-A7-A426.B644AEB6-7D46-4D4D-BA00-D42BCDDCB164.pdf A426 TUMOR FREE YES YES 70-79% YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 185d3410-2daa-4d28-ab60-a7c13ae9d4fb 185d3410-2daa-4d28-ab60-a7c13ae9d4fb TCGA-A7-A426-01 TCGA-A7-A426-01A-22D-A244-05 TCGA-A7-A426-01 TCGA-A7-A426-01A-22D-A243-09 TCGA-A7-A426-01 185d3410-2daa-4d28-ab60-a7c13ae9d4fb TCGA-A7-A426-01A-22D-A242-01 TCGA-A7-A426-01 185d3410-2daa-4d28-ab60-a7c13ae9d4fb TCGA-A7-A426-01A-22D-A242-01 TCGA-A7-A4SA-01 TCGA-A7-A4SA-01 TCGA-A7-A4SA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A4SA-F49560 TCGA-A7-A4SA TCGA-A7-A4SA-01A Positive 3 Point Scale Negative Simple Mastectomy YES -14906 127 0 454 80-89% 2013-10-3 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 220 NO Negative NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 0 false No M0 N1a T2 Stage IIB TCGA-A7-A4SA.2649764C-9566-49DB-B8E9-B4B86DBB763C.pdf A4SA TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 781945fb-6d9e-4b45-8082-57675f21dc4a 781945fb-6d9e-4b45-8082-57675f21dc4a TCGA-A7-A4SA-01 TCGA-A7-A4SA-01A-11D-A268-05 95bdb84b-c36a-4c64-8059-445ebf7adbb4 TCGA-A7-A4SA-01 TCGA-A7-A4SA-01A-11D-A25Q-09 TCGA-A7-A4SA-01 781945fb-6d9e-4b45-8082-57675f21dc4a TCGA-A7-A4SA-01A-11D-A25N-01 TCGA-A7-A4SA-01 781945fb-6d9e-4b45-8082-57675f21dc4a TCGA-A7-A4SA-01A-11D-A25N-01 TCGA-A7-A4SA-11 TCGA-A7-A4SA-11 TCGA-A7-A4SA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A4SA-F49560 TCGA-A7-A4SA TCGA-A7-A4SA-11A Positive 3 Point Scale Negative Simple Mastectomy YES -14906 127 0 454 80-89% 2013-10-3 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 1430 NO Negative NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 0 false No M0 N1a T2 Stage IIB A4SA TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES NO A7 Breast A LIVING 2012 BF5A86FA-5213-494A-852B-C0782A9A0A56 TCGA-A7-A4SB-01 TCGA-A7-A4SB-01 TCGA-A7-A4SB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-A7-A4SB-F49625 TCGA-A7-A4SB TCGA-A7-A4SB-01A Negative Positive 3 Point Scale 3 Point Scale Other Positive Lumpectomy Right Breast reexcision YES -20539 75 0 418 70-79% 2013-10-4 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 120 NO Negative NO 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 1 false No M0 N1mi T3 Stage IIIA TCGA-A7-A4SB.03B39A59-0068-4276-8340-7B97A1395E68.pdf A4SB TUMOR FREE YES YES 50-59% YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 352dc94a-fc74-4292-890c-4ed9c22dcfbc 352dc94a-fc74-4292-890c-4ed9c22dcfbc TCGA-A7-A4SB-01 TCGA-A7-A4SB-01A-21D-A268-05 TCGA-A7-A4SB-01 TCGA-A7-A4SB-01A-21D-A25Q-09 TCGA-A7-A4SB-01 352dc94a-fc74-4292-890c-4ed9c22dcfbc TCGA-A7-A4SB-01A-21D-A25N-01 TCGA-A7-A4SB-01 352dc94a-fc74-4292-890c-4ed9c22dcfbc TCGA-A7-A4SB-01A-21D-A25N-01 TCGA-A7-A4SC-01 TCGA-A7-A4SC-01 TCGA-A7-A4SC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant TCGA-A7-A4SC-F49714 TCGA-A7-A4SC TCGA-A7-A4SC-01A Positive Negative Simple Mastectomy YES -23008 110 0 446 90-99% 2.2 2013-10-8 FEMALE PathVysion HER-2 D Probe kit 3+ 303 2.4 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 360 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 T3 Stage IIB TCGA-A7-A4SC.5E14E7CA-3417-4379-8EE3-7F00D6D4A02B.pdf A4SC TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 84633979-56dd-4244-90bc-fa4652718880 84633979-56dd-4244-90bc-fa4652718880 TCGA-A7-A4SC-01 TCGA-A7-A4SC-01A-12D-A268-05 3d087331-9673-4816-97ac-741f364cccae TCGA-A7-A4SC-01A-12D-A25Q-09 TCGA-A7-A4SC-01 84633979-56dd-4244-90bc-fa4652718880 TCGA-A7-A4SC-01 84633979-56dd-4244-90bc-fa4652718880 TCGA-A7-A4SC-11 TCGA-A7-A4SC-11 TCGA-A7-A4SC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant TCGA-A7-A4SC-F49714 TCGA-A7-A4SC TCGA-A7-A4SC-11A Positive Negative Simple Mastectomy YES -23008 110 0 446 90-99% 2.2 2013-10-8 FEMALE PathVysion HER-2 D Probe kit 3+ 303 2.4 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 610 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 T3 Stage IIB A4SC TUMOR FREE YES YES YES Solid Tissue Normal 11 7th YES NO A7 Breast A LIVING 2012 325798E1-709A-4A61-AF20-E1E85844CF20 TCGA-A7-A4SD-01 TCGA-A7-A4SD-01 TCGA-A7-A4SD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Sentinel node biopsy alone TCGA-A7-A4SD-F52732 TCGA-A7-A4SD TCGA-A7-A4SD-01A Negative Negative Simple Mastectomy YES -19131 63 0 441 5 2013-12-5 FEMALE PathVysion HER-2 D Probe Kit 2+ 20 6.4 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 230 NO Equivocal Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 T2 Stage IIA TCGA-A7-A4SD.563D1ED2-1A8B-4D90-BD42-AC3790D04913.pdf A4SD TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 cb0d669b-658a-4a41-9904-f838ddb12db2 cb0d669b-658a-4a41-9904-f838ddb12db2 TCGA-A7-A4SD-01 TCGA-A7-A4SD-01A-11D-A268-05 148f42bd-6aee-4dc7-bf8b-d5e8580c1b4d TCGA-A7-A4SD-01 TCGA-A7-A4SD-01A-11D-A25Q-09 TCGA-A7-A4SD-01 cb0d669b-658a-4a41-9904-f838ddb12db2 TCGA-A7-A4SD-01A-11D-A25N-01 TCGA-A7-A4SD-01 cb0d669b-658a-4a41-9904-f838ddb12db2 TCGA-A7-A4SD-01A-11D-A25N-01 TCGA-A7-A4SD-11 TCGA-A7-A4SD-11 TCGA-A7-A4SD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Sentinel node biopsy alone TCGA-A7-A4SD-F52732 TCGA-A7-A4SD TCGA-A7-A4SD-11A Negative Negative Simple Mastectomy YES -19131 63 0 441 5 2013-12-5 FEMALE PathVysion HER-2 D Probe Kit 2+ 20 6.4 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 980 NO Equivocal Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 T2 Stage IIA A4SD TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES NO A7 Breast A LIVING 2012 3EB15608-D3BE-4E35-89F9-BEF3DFEB60EC TCGA-A7-A4SE-01 TCGA-A7-A4SE-01 TCGA-A7-A4SE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Sentinel node biopsy alone TCGA-A7-A4SE-F50162 TCGA-A7-A4SE TCGA-A7-A4SE-01A Negative Negative Lumpectomy YES -20080 306 0 644 2013-10-16 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 160 NO Negative YES 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 T2 Stage IIA TCGA-A7-A4SE.C0C49D41-AA66-435B-9312-FAD8E2DC3305.pdf A4SE TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO A7 Breast A LIVING 2011 6bb217e7-3fd4-477f-87bf-b55e50a33e45 6bb217e7-3fd4-477f-87bf-b55e50a33e45 TCGA-A7-A4SE-01 TCGA-A7-A4SE-01A-11D-A268-05 7309fdea-a4df-4081-adac-88e2966c8642 TCGA-A7-A4SE-01 TCGA-A7-A4SE-01A-11D-A25Q-09 TCGA-A7-A4SE-01 6bb217e7-3fd4-477f-87bf-b55e50a33e45 TCGA-A7-A4SE-01A-11D-A25N-01 TCGA-A7-A4SE-01 6bb217e7-3fd4-477f-87bf-b55e50a33e45 TCGA-A7-A4SE-01A-11D-A25N-01 TCGA-A7-A4SE-11 TCGA-A7-A4SE-11 TCGA-A7-A4SE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Sentinel node biopsy alone TCGA-A7-A4SE-F50162 TCGA-A7-A4SE TCGA-A7-A4SE-11A Negative Negative Lumpectomy YES -20080 306 0 644 2013-10-16 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 650 NO Negative YES 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 T2 Stage IIA A4SE TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES NO A7 Breast A LIVING 2011 715C8450-EEA3-4C5C-8B9B-D30D994FB08D TCGA-A7-A4SF-01 TCGA-A7-A4SF-01 TCGA-A7-A4SF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Sentinel node biopsy alone TCGA-A7-A4SF-F49721 TCGA-A7-A4SF Positive Positive 3 Point Scale Other Negative Lumpectomy Right Breast Reexcision YES -19985 0 545 90-99% 2013-10-9 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive NO 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 No M0 N0 T2 Stage IIA A4SF TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO A7 Breast LIVING 2012 f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8 f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8 TCGA-A7-A4SF-01 TCGA-A7-A4SF-01A-11D-A268-05 e04e9fb6-be99-430f-8f5b-fd4aaba872dc TCGA-A7-A4SF-01 TCGA-A7-A4SF-01A-11D-A25Q-09 TCGA-A7-A4SF-01 f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8 TCGA-A7-A4SF-01A-11D-A25N-01 TCGA-A7-A4SF-01 f8b3fd9c-ba8c-49bf-aeb7-4e7dfedbb9a8 TCGA-A7-A4SF-01A-11D-A25N-01 TCGA-A7-A56D-01 TCGA-A7-A56D-01 TCGA-A7-A56D TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 84 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A56D-F50426 TCGA-A7-A56D TCGA-A7-A56D-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Lumpectomy YES -30783 140 0 448 90-99% 2013-10-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 80 NO Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 T2 Stage IIA TCGA-A7-A56D.D564A7FB-4F0A-4589-AB32-A6CD8B547219.pdf A56D TUMOR FREE YES YES <10% NO Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4 3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4 TCGA-A7-A56D-01 TCGA-A7-A56D-01A-11D-A27Y-05 TCGA-A7-A56D-01 TCGA-A7-A56D-01A-11D-A27P-09 TCGA-A7-A56D-01 3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4 TCGA-A7-A56D-01A-11D-A27O-01 TCGA-A7-A56D-01 3858b3ae-a4a9-4b91-8bd3-b7e20fb531e4 TCGA-A7-A56D-01A-11D-A27O-01 TCGA-A7-A5ZV-01 TCGA-A7-A5ZV-01 TCGA-A7-A5ZV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Sentinel node biopsy alone TCGA-A7-A5ZV-F51143 TCGA-A7-A5ZV Negative Negative Lumpectomy NO -22966 0 368 2.5 2013-11-8 FEMALE PathVysion HER-2 D Probe Kit 2+ 40 3.8 1.5 Infiltrating Carcinoma NOS No C50.9 8010/3 C50.9 YES Core needle biopsy Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T2 Stage IIA A5ZV TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO A7 Breast LIVING 2012 e121ae32-63c2-4b13-b135-d1837fc10999 e121ae32-63c2-4b13-b135-d1837fc10999 TCGA-A7-A5ZV-01 TCGA-A7-A5ZV-01A-11D-A28C-05 cc46932d-0799-42ae-8a92-5bf65e381969 TCGA-A7-A5ZV-01 TCGA-A7-A5ZV-01A-11D-A28B-09 TCGA-A7-A5ZV-01 e121ae32-63c2-4b13-b135-d1837fc10999 TCGA-A7-A5ZV-01A-11D-A28A-01 TCGA-A7-A5ZV-01 e121ae32-63c2-4b13-b135-d1837fc10999 TCGA-A7-A5ZV-01A-11D-A28A-01 TCGA-A7-A5ZW-01 TCGA-A7-A5ZW-01 TCGA-A7-A5ZW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-A7-A5ZW-F51509 TCGA-A7-A5ZW TCGA-A7-A5ZW-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy NO -17529 77 0 326 90-99% 2013-11-19 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 60 NO Negative NO 1 Negative Peri (6-12 months since last menstrual period) NO 1 false No M0 N1a T1c Stage IIA TCGA-A7-A5ZW.A56585F9-9651-472B-BF53-C708A686EB7D.pdf A5ZW TUMOR FREE YES YES 80-89% YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2012 8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f 8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f TCGA-A7-A5ZW-01 TCGA-A7-A5ZW-01A-12D-A29O-05 TCGA-A7-A5ZW-01 TCGA-A7-A5ZW-01A-12D-A29N-09 TCGA-A7-A5ZW-01 8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f TCGA-A7-A5ZW-01A-12D-A29M-01 TCGA-A7-A5ZW-01 8fc9ea4e-d3ce-40b1-81b7-fc3967503a8f TCGA-A7-A5ZW-01A-12D-A29M-01 TCGA-A7-A5ZX-01 TCGA-A7-A5ZX-01 TCGA-A7-A5ZX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A5ZX-F52721 TCGA-A7-A5ZX Positive 3 Point Scale 3 Point Scale Positive Other YES -17683 0 336 2013-12-6 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative NO 24 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 21 Yes M0 N3a T2 Stage IIIC A5ZX TUMOR FREE YES YES YES Primary Tumor 01 Bilateral skin sparing Mastectomy and Bilateral breast reconstruction with tissue expanders. 7th YES NO A7 Breast LIVING 2012 e3c70f4d-4a23-486b-b221-3058b13a1c69 e3c70f4d-4a23-486b-b221-3058b13a1c69 TCGA-A7-A5ZX-01 TCGA-A7-A5ZX-01A-12D-A29O-05 TCGA-A7-A5ZX-01 TCGA-A7-A5ZX-01A-12D-A29N-09 TCGA-A7-A5ZX-01 e3c70f4d-4a23-486b-b221-3058b13a1c69 TCGA-A7-A5ZX-01A-12D-A29M-01 TCGA-A7-A5ZX-01 e3c70f4d-4a23-486b-b221-3058b13a1c69 TCGA-A7-A5ZX-01A-12D-A29M-01 TCGA-A7-A6VV-01 TCGA-A7-A6VV-01 TCGA-A7-A6VV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A6VV-F57249 TCGA-A7-A6VV TCGA-A7-A6VV-01A Negative Negative Modified Radical Mastectomy NO -18695 85 0 313 2014-3-6 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 1100 NO Negative NO 5 Negative Peri (6-12 months since last menstrual period) NO 0 false No M0 N0 T2 Stage IIA TCGA-A7-A6VV.C26EAF0E-202B-4F3E-9E59-3395A1BFCAB8.pdf A6VV TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO A7 Breast A LIVING 2013 c02ec36d-9e79-4e2f-a46c-f898838766df c02ec36d-9e79-4e2f-a46c-f898838766df TCGA-A7-A6VV-01 TCGA-A7-A6VV-01A-22D-A33F-05 66E3766B-46AB-4A9B-8B6E-1EECA04D9B62 TCGA-A7-A6VV-01 TCGA-A7-A6VV-01 c02ec36d-9e79-4e2f-a46c-f898838766df TCGA-A7-A6VV-01A-22D-A33D-01 TCGA-A7-A6VV-01 c02ec36d-9e79-4e2f-a46c-f898838766df TCGA-A7-A6VV-01A-22D-A33D-01 TCGA-A7-A6VW-01 TCGA-A7-A6VW-01 TCGA-A7-A6VW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Sentinel node biopsy alone TCGA-A7-A6VW-F57227 TCGA-A7-A6VW Negative Negative Lumpectomy NO -17539 0 285 2014-3-6 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T2 Stage IIA A6VW TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO A7 Breast LIVING 2013 f572c953-e1aa-4dd2-a8f8-e292ab7bd139 f572c953-e1aa-4dd2-a8f8-e292ab7bd139 TCGA-A7-A6VW-01 TCGA-A7-A6VW-01A-21D-A33F-05 TCGA-A7-A6VW-01 TCGA-A7-A6VW-01 f572c953-e1aa-4dd2-a8f8-e292ab7bd139 TCGA-A7-A6VW-01A-21D-A33D-01 TCGA-A7-A6VW-01 f572c953-e1aa-4dd2-a8f8-e292ab7bd139 TCGA-A7-A6VW-01A-21D-A33D-01 TCGA-A7-A6VX-01 TCGA-A7-A6VX-01 TCGA-A7-A6VX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left|Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-A7-A6VX-F57518 TCGA-A7-A6VX TCGA-A7-A6VX-01A Positive Positive Lumpectomy NO -25066 73 0 317 Immune Stain by GenPath 90-99% 2014-3-13 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T2 Stage IIA TCGA-A7-A6VX.80EDDCAC-B87B-47E6-A48C-F166D227DA6C.pdf A6VX TUMOR FREE Immune stain by GenPath YES YES YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2013 aed86155-1d12-4447-bdf6-3aaba9938a71 aed86155-1d12-4447-bdf6-3aaba9938a71 TCGA-A7-A6VX-01 TCGA-A7-A6VX-01A-12D-A33F-05 8C0E2DD9-D3B3-4AF6-A450-4B7F1DBA5CE7 TCGA-A7-A6VX-01 TCGA-A7-A6VX-01 aed86155-1d12-4447-bdf6-3aaba9938a71 TCGA-A7-A6VX-01A-12D-A33D-01 TCGA-A7-A6VX-01 aed86155-1d12-4447-bdf6-3aaba9938a71 TCGA-A7-A6VX-01A-12D-A33D-01 TCGA-A7-A6VY-01 TCGA-A7-A6VY-01 TCGA-A7-A6VY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-A7-A6VY-F57257 TCGA-A7-A6VY TCGA-A7-A6VY-01A Negative Negative Lumpectomy NO -17640 29 0 266 2014-3-6 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 70 NO Negative NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 false No M0 N1 T2 Stage IIB TCGA-A7-A6VY.BB85F844-C710-41D5-8620-E246DC9D2C6A.pdf A6VY TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO A7 Breast A LIVING 2013 2fb506f2-4b76-4c20-ae45-8939f2e14753 2fb506f2-4b76-4c20-ae45-8939f2e14753 TCGA-A7-A6VY-01 TCGA-A7-A6VY-01A-12D-A33F-05 TCGA-A7-A6VY-01 TCGA-A7-A6VY-01 2fb506f2-4b76-4c20-ae45-8939f2e14753 TCGA-A7-A6VY-01A-12D-A33D-01 TCGA-A7-A6VY-01 2fb506f2-4b76-4c20-ae45-8939f2e14753 TCGA-A7-A6VY-01A-12D-A33D-01 TCGA-A8-A06N-01 Stage IIIB 66 3 Stage IIIB 0 Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 0 0 LumB Luminal B Negative LumA/B -10 -3 enrollment T_Other T4 LIVING TCGA-A8-A06N-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A06N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left TCGA-A8-A06N TCGA-A8-A06N-01A Positive Negative Other -24288 241 0 0 2011-5-27 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 510 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 false No M0 N0 T4b Stage IIIB TCGA-A8-A06N.2F0333BC-E9BB-4903-B3E2-8AE241DDDF84.pdf A06N TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 a14dc21a-6a46-4be8-9247-76cbc70dfe8b a14dc21a-6a46-4be8-9247-76cbc70dfe8b TCGA-A8-A06N-01A-21-A13B-20 TCGA-A8-A06N-01A-11W-A019-09 TCGA-A8-A06N-01 99692232-7d23-4ea5-847e-17064bac010d TCGA-A8-A06N-01 TCGA-A8-A06N-01A-11W-A019-09 TCGA-A8-A06N-01A-11D-A00Y-05 TCGA-A8-A06N-01 TCGA-A8-A06N-01A-11W-A019-09 TCGA-A8-A06N-01 a14dc21a-6a46-4be8-9247-76cbc70dfe8b TCGA-A8-A06N-01 TCGA-A8-A06N-01A-11D-A011-01 TCGA-A8-A06N-01A-12R-A056-07 a14dc21a-6a46-4be8-9247-76cbc70dfe8b TCGA-A8-A06N-01A-11D-A011-01 TCGA-A8-A06N-01 TCGA-A8-A06O-01 Stage I 60 5 Stage I 396 Positive FEMALE Negative Negative M0 Negative N0 396 0 LumB Luminal B Positive -2 -3 enrollment T1 T1 LIVING TCGA-A8-A06O-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A06O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left TCGA-A8-A06O-F40806 TCGA-A8-A06O TCGA-A8-A06O-01A Positive Positive Other -22157 272 0 396 2013-3-1 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 100 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO false No M0 N0 T1c Stage I TCGA-A8-A06O.EB9B8904-F6CC-451F-8628-50CC71F1F7C3.pdf A06O TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 7dbd8795-b264-4f68-bdea-4cfe39884864 7dbd8795-b264-4f68-bdea-4cfe39884864 TCGA-A8-A06O-01A-11W-A019-09 TCGA-A8-A06O-01 TCGA-A8-A06O-01 TCGA-A8-A06O-01A-11W-A019-09 TCGA-A8-A06O-01A-11D-A00Y-05 TCGA-A8-A06O-01 TCGA-A8-A06O-01A-11W-A019-09 TCGA-A8-A06O-01 7dbd8795-b264-4f68-bdea-4cfe39884864 TCGA-A8-A06O-01 TCGA-A8-A06O-01A-11D-A011-01 TCGA-A8-A06O-01A-11R-A00Z-07 7dbd8795-b264-4f68-bdea-4cfe39884864 TCGA-A8-A06O-01A-11D-A011-01 TCGA-A8-A06O-01 TCGA-A8-A06P-01 Stage IIIA 63 4 Stage IIIA 396 Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 396 0 LumA Luminal A Positive ReacI -5 -3 enrollment T1 T1 LIVING TCGA-A8-A06P-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A06P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right TCGA-A8-A06P-F40814 TCGA-A8-A06P TCGA-A8-A06P-01A Positive Positive Other -23011 241 0 396 2013-3-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 210 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 false No M0 N2a T1c Stage IIIA TCGA-A8-A06P.AADFAF8B-92B8-4292-96A3-912D55EB9C31.pdf A06P TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 9d8f2b85-f203-47ac-8217-987640f89b26 9d8f2b85-f203-47ac-8217-987640f89b26 TCGA-A8-A06P-01A-21-A13B-20 TCGA-A8-A06P-01A-11W-A019-09 TCGA-A8-A06P-01 9d804a48-aeb9-4785-af7c-2b8a4763c148 TCGA-A8-A06P-01 TCGA-A8-A06P-01A-11W-A019-09 TCGA-A8-A06P-01A-11D-A00Y-05 TCGA-A8-A06P-01 TCGA-A8-A06P-01A-11W-A019-09 TCGA-A8-A06P-01 9d8f2b85-f203-47ac-8217-987640f89b26 TCGA-A8-A06P-01 TCGA-A8-A06P-01A-11D-A011-01 TCGA-A8-A06P-01A-11R-A00Z-07 9d8f2b85-f203-47ac-8217-987640f89b26 TCGA-A8-A06P-01A-11D-A011-01 TCGA-A8-A06P-01 TCGA-A8-A06Q-01 Stage IIIA 63 3 No_Conversion 31 Positive FEMALE Negative Negative M0 Positive N2 31 0 LumB Luminal B Positive -2 -3 enrollment T_Other T3 LIVING TCGA-A8-A06Q-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation cluster 3 TCGA-A8-A06Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant TCGA-A8-A06Q TCGA-A8-A06Q-01A Positive Positive Other -23164 1184 0 31 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 50 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 false No M0 N2 T3 Stage IIIA TCGA-A8-A06Q.8FE77EF7-C83A-431F-B3BA-D93B5ECC70AF.pdf A06Q TUMOR FREE Primary Tumor 01 Surgical Resection 5th NO YES A8 Breast A LIVING 2007 0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae 0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae TCGA-A8-A06Q-01A-11W-A050-09 TCGA-A8-A06Q-01 TCGA-A8-A06Q-01 TCGA-A8-A06Q-01A-11W-A050-09 TCGA-A8-A06Q-01A-11D-A032-05 TCGA-A8-A06Q-01 TCGA-A8-A06Q-01A-11W-A050-09 TCGA-A8-A06Q-01 0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae TCGA-A8-A06Q-01 TCGA-A8-A06Q-01A-11D-A036-01 TCGA-A8-A06Q-01A-11R-A034-07 0e2a3a2c-173a-43b8-bd7d-0c09dfa8a2ae TCGA-A8-A06Q-01A-11D-A036-01 TCGA-A8-A06Q-01 TCGA-A8-A06R-01 Stage IIB 69 No_Conversion 546 Positive FEMALE Equivocal Negative M0 Positive N1 546 0 LumB Luminal B Negative ReacI -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A06R-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A06R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Outer Quadrant TCGA-A8-A06R-F40815 TCGA-A8-A06R TCGA-A8-A06R-01A Positive Negative Other -25477 1184 0 547 2013-3-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 220 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO false No M0 N1a T2 Stage IIB TCGA-A8-A06R.B6B7939C-63AF-4B52-B494-AA09A9C03871.pdf A06R TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 5th NO YES A8 Breast A LIVING 2007 e2d7656c-0d06-427c-998c-c26ba4a1def4 e2d7656c-0d06-427c-998c-c26ba4a1def4 TCGA-A8-A06R-01A-21-A13A-20 TCGA-A8-A06R-01A-11D-A015-09 TCGA-A8-A06R-01 7bcd06e7-a4de-4c5b-9337-4d7d3b8014b9 TCGA-A8-A06R-01 TCGA-A8-A06R-01A-11D-A015-09 TCGA-A8-A06R-01A-11D-A00Y-05 TCGA-A8-A06R-01 TCGA-A8-A06R-01A-11D-A015-09 TCGA-A8-A06R-01 e2d7656c-0d06-427c-998c-c26ba4a1def4 TCGA-A8-A06R-01 TCGA-A8-A06R-01A-11D-A011-01 TCGA-A8-A06R-01A-11R-A00Z-07 e2d7656c-0d06-427c-998c-c26ba4a1def4 TCGA-A8-A06R-01A-11D-A011-01 TCGA-A8-A06R-01 TCGA-A8-A06T-01 Stage IIIA 75 4 Stage IIIA 1249 Positive FEMALE Negative Negative M0 Positive N1 1249 0 LumA Luminal A Positive -10 -3 enrollment T_Other T3 LIVING TCGA-A8-A06T-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 14 TCGA-A8-A06T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Left Upper Outer Quadrant TCGA-A8-A06T-F40816 TCGA-A8-A06T Positive Positive Other -27393 0 1614 2013-3-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 Yes M0 N1a T3 Stage IIIA A06T TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2007 de1cdf25-62e6-41c0-b1c8-257175519041 de1cdf25-62e6-41c0-b1c8-257175519041 TCGA-A8-A06T-01A-11W-A019-09 TCGA-A8-A06T-01 TCGA-A8-A06T-01 TCGA-A8-A06T-01A-11W-A019-09 TCGA-A8-A06T-01A-11D-A00Y-05 TCGA-A8-A06T-01 TCGA-A8-A06T-01A-11W-A019-09 TCGA-A8-A06T-01 de1cdf25-62e6-41c0-b1c8-257175519041 TCGA-A8-A06T-01 TCGA-A8-A06T-01A-11D-A011-01 TCGA-A8-A06T-01A-11R-A00Z-07 de1cdf25-62e6-41c0-b1c8-257175519041 TCGA-A8-A06T-01A-11D-A011-01 TCGA-A8-A06T-01 TCGA-A8-A06U-01 Stage IIB 80 Stage IIB 882 882 Positive FEMALE Equivocal Negative M0 Positive N1 882 1 LumA Luminal A Positive LumA/B -2 -5 enrollment T_Other T2 DECEASED TCGA-A8-A06U-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A06U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Right Upper Outer Quadrant TCGA-A8-A06U-F40817 TCGA-A8-A06U TCGA-A8-A06U-01A Positive Positive Other -29525 759 883 0 2013-3-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 250 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 false Yes M0 N1a T2 Stage IIB TCGA-A8-A06U.A314FB55-F20A-4485-965D-D7894D070A16.pdf A06U TUMOR FREE NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A DECEASED 2008 89f9e509-5f4c-439b-b610-860f209332d2 89f9e509-5f4c-439b-b610-860f209332d2 TCGA-A8-A06U-01A-21-A13A-20 TCGA-A8-A06U-01A-11W-A019-09 TCGA-A8-A06U-01 f47ef5b8-45ae-4cd2-915a-ba5f790465bd TCGA-A8-A06U-01 TCGA-A8-A06U-01A-11W-A019-09 TCGA-A8-A06U-01A-11D-A00Y-05 TCGA-A8-A06U-01 TCGA-A8-A06U-01A-11W-A019-09 TCGA-A8-A06U-01 89f9e509-5f4c-439b-b610-860f209332d2 TCGA-A8-A06U-01 TCGA-A8-A06U-01A-11D-A011-01 TCGA-A8-A06U-01A-11R-A00Z-07 89f9e509-5f4c-439b-b610-860f209332d2 TCGA-A8-A06U-01A-11D-A011-01 TCGA-A8-A06U-01 TCGA-A8-A06X-01 Stage IIB 77 1 Stage IIB 943 943 Positive FEMALE Positive Negative M0 Negative N0 943 1 LumB Luminal B Negative LumA/B -2 -5 enrollment T_Other T3 DECEASED TCGA-A8-A06X-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation c1uster 10 TCGA-A8-A06X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Right Upper Outer Quadrant TCGA-A8-A06X-F40818 TCGA-A8-A06X TCGA-A8-A06X-01A Positive Negative Other -28338 1276 943 0 2013-3-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 760 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 false No M0 N0 T3 Stage IIB TCGA-A8-A06X.738B601A-24D8-4261-B000-198648213070.pdf A06X TUMOR FREE YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A DECEASED 2006 3ea9e7f1-39af-4089-b1c0-3c62db4e3102 3ea9e7f1-39af-4089-b1c0-3c62db4e3102 TCGA-A8-A06X-01A-11-A13A-20 TCGA-A8-A06X-01A-21W-A019-09 TCGA-A8-A06X-01 1896a8eb-415e-4b05-aad1-dec8b4a5c473 TCGA-A8-A06X-01 TCGA-A8-A06X-01A-21W-A019-09 TCGA-A8-A06X-01A-21D-A00Y-05 TCGA-A8-A06X-01 TCGA-A8-A06X-01A-21W-A019-09 3ea9e7f1-39af-4089-b1c0-3c62db4e3102 TCGA-A8-A06X-01A-21D-A011-01 TCGA-A8-A06X-01A-21R-A00Z-07 3ea9e7f1-39af-4089-b1c0-3c62db4e3102 TCGA-A8-A06X-01A-21D-A011-01 TCGA-A8-A06X-01 TCGA-A8-A06Y-01 Stage IIA 66 4 Stage IIA 791 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 791 0 LumA Luminal A Positive LumA 0 -3 enrollment T_Other T2 LIVING TCGA-A8-A06Y-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A06Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Upper Outer Quadrant TCGA-A8-A06Y-F40819 TCGA-A8-A06Y TCGA-A8-A06Y-01A Positive Positive Other -24442 667 0 791 791 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 130 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 YES false No M0 N0 T2 Stage IIA TCGA-A8-A06Y.5664F531-9D45-4302-A455-63E46B5EDD26.pdf A06Y TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 14f20743-35f3-4e68-a2e5-e03edfe31a97 14f20743-35f3-4e68-a2e5-e03edfe31a97 TCGA-A8-A06Y-01A-11-A13A-20 TCGA-A8-A06Y-01A-21W-A019-09 TCGA-A8-A06Y-01 71251016-7304-4492-8278-a1718ecdb97a TCGA-A8-A06Y-01 TCGA-A8-A06Y-01A-21W-A019-09 TCGA-A8-A06Y-01A-21D-A00Y-05 TCGA-A8-A06Y-01 TCGA-A8-A06Y-01A-21W-A019-09 TCGA-A8-A06Y-01 14f20743-35f3-4e68-a2e5-e03edfe31a97 TCGA-A8-A06Y-01 TCGA-A8-A06Y-01A-21D-A011-01 TCGA-A8-A06Y-01A-21R-A00Z-07 14f20743-35f3-4e68-a2e5-e03edfe31a97 TCGA-A8-A06Y-01A-21D-A011-01 TCGA-A8-A06Y-01 TCGA-A8-A06Z-01 Stage IIB 84 5 Stage IIB 31 Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 31 0 LumB Luminal B Positive Her2 -10 -3 enrollment T_Other T3 LIVING TCGA-A8-A06Z-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 5 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-A8-A06Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 84 Right Upper Outer Quadrant TCGA-A8-A06Z TCGA-A8-A06Z-01A Positive Positive Other -30984 1003 0 31 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 330 NO Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 1 false No M0 N0 T3 Stage IIB TCGA-A8-A06Z.956F45E5-A8C6-4A4A-9D1F-D31912180584.pdf A06Z Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2007 42b99ee7-a1ae-4383-b343-adf468cb8b51 42b99ee7-a1ae-4383-b343-adf468cb8b51 TCGA-A8-A06Z-01A-21-A13A-20 TCGA-A8-A06Z-01A-11W-A019-09 TCGA-A8-A06Z-01 afd9a962-46e2-4b42-bc6e-eb091d7f9b5b TCGA-A8-A06Z-01 TCGA-A8-A06Z-01A-11W-A019-09 TCGA-A8-A06Z-01A-11D-A00Y-05 TCGA-A8-A06Z-01 TCGA-A8-A06Z-01A-11W-A019-09 TCGA-A8-A06Z-01 42b99ee7-a1ae-4383-b343-adf468cb8b51 TCGA-A8-A06Z-01 TCGA-A8-A06Z-01A-11D-A011-01 TCGA-A8-A06Z-01A-11R-A00Z-07 42b99ee7-a1ae-4383-b343-adf468cb8b51 TCGA-A8-A06Z-01A-11D-A011-01 TCGA-A8-A06Z-01 TCGA-A8-A075-01 Stage IIB 42 2 Stage IIB 517 Positive FEMALE Negative 5 2 1 Negative M0 Positive N1 517 0 LumB HER2-enriched Positive X -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A075-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-A8-A075 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Left Upper Outer Quadrant TCGA-A8-A075-F40820 TCGA-A8-A075 TCGA-A8-A075-01A Positive Positive Other -15369 394 0 518 2013-3-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 120 NO Positive Positive NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 1 NO false No M0 N1a T2 Stage IIB TCGA-A8-A075.6643B290-5D7A-4649-B57D-47A5BA4E8D31.pdf A075 TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 1ccf908a-7620-4af8-b83f-0e287f3655c5 1ccf908a-7620-4af8-b83f-0e287f3655c5 TCGA-A8-A075-01A-21-A13A-20 TCGA-A8-A075-01A-11D-A099-09 TCGA-A8-A075-01 TCGA-A8-A075-01A-11D-A10P-05 a84864ab-5eba-4a64-aa65-883deca0c967 TCGA-A8-A075-01 TCGA-A8-A075-01A-11D-A099-09 TCGA-A8-A075-01 TCGA-A8-A075-01A-11D-A099-09 TCGA-A8-A075-01 1ccf908a-7620-4af8-b83f-0e287f3655c5 TCGA-A8-A075-01 TCGA-A8-A075-01A-11D-A087-01 TCGA-A8-A075-01A-11R-A084-07 1ccf908a-7620-4af8-b83f-0e287f3655c5 TCGA-A8-A075-01A-11D-A087-01 TCGA-A8-A075-01 TCGA-A8-A076-01 Stage IIA 66 4 Stage IIA 1641 Positive FEMALE Positive 1 1 1 Negative M0 Negative N0 1641 0 LumB HER2-enriched Positive Her2 -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A076-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation c1uster 9 TCGA-A8-A076 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Upper Outer Quadrant TCGA-A8-A076-F40821 TCGA-A8-A076 TCGA-A8-A076-01A Positive Positive Other -24230 1518 0 1642 2013-3-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 210 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO false No M0 N0 T2 Stage IIA TCGA-A8-A076.DD669244-34D8-4725-A52C-F3AAF59852F9.pdf A076 TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 5th NO YES A8 Breast A LIVING 2006 95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60 95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60 TCGA-A8-A076-01A-11-A13A-20 TCGA-A8-A076-01A-21W-A019-09 TCGA-A8-A076-01 9d5a9ed1-b633-4e0d-8006-826e20c62538 TCGA-A8-A076-01 TCGA-A8-A076-01A-21W-A019-09 TCGA-A8-A076-01A-21D-A00Y-05 TCGA-A8-A076-01 TCGA-A8-A076-01A-21W-A019-09 TCGA-A8-A076-01 95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60 TCGA-A8-A076-01 TCGA-A8-A076-01A-21D-A011-01 TCGA-A8-A076-01A-21R-A00Z-07 95b5d7ca-4078-4af9-ac6b-4ed1c3cd9c60 TCGA-A8-A076-01A-21D-A011-01 TCGA-A8-A076-01 TCGA-A8-A079-01 Stage IIIB 69 5 Stage IIIC 274 Positive FEMALE Negative 4 3 4 Negative M0 Positive N3 274 0 LumB Luminal B Positive LumA/B -6 -3 enrollment T_Other T4 LIVING TCGA-A8-A079-01 Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-A8-A079 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Left Upper Outer Quadrant TCGA-A8-A079-F40822 TCGA-A8-A079 TCGA-A8-A079-01A Positive Positive Other -25294 1033 0 274 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 380 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 5 false No M0 N3 T4b Stage IIIB TCGA-A8-A079.81ADDBAB-C02F-4DA8-9429-76293FB42E42.pdf A079 TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 5th NO YES A8 Breast A LIVING 2007 6fcf4a82-7687-4a9b-bae9-9dabff66aca8 6fcf4a82-7687-4a9b-bae9-9dabff66aca8 TCGA-A8-A079-01A-11-A13A-20 TCGA-A8-A079-01A-21W-A019-09 TCGA-A8-A079-01 b22ff43f-3646-49dd-ba2e-3cc1a82eb7bd TCGA-A8-A079-01 TCGA-A8-A079-01A-21W-A019-09 TCGA-A8-A079-01A-21D-A00Y-05 TCGA-A8-A079-01 TCGA-A8-A079-01A-21W-A019-09 TCGA-A8-A079-01 6fcf4a82-7687-4a9b-bae9-9dabff66aca8 TCGA-A8-A079-01 TCGA-A8-A079-01A-21D-A011-01 TCGA-A8-A079-01A-21R-A00Z-07 6fcf4a82-7687-4a9b-bae9-9dabff66aca8 TCGA-A8-A079-01A-21D-A011-01 TCGA-A8-A079-01 TCGA-A8-A07B-01 Stage IIA 69 5 Stage IIA 1004 Positive FEMALE Positive Negative M0 Negative N0 1004 0 LumA HER2-enriched Positive -1 -3 enrollment T_Other T2 LIVING TCGA-A8-A07B-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 2 TCGA-A8-A07B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Left Lower Outer Quadrant TCGA-A8-A07B-F40823 TCGA-A8-A07B TCGA-A8-A07B-01A Positive Positive Other -25475 880 0 1308 2013-3-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 90 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 false No M0 N0 T2 Stage IIA TCGA-A8-A07B.F24A752C-1AAE-4C70-B6D4-DD0E8C89D9AA.pdf A07B TUMOR FREE NO NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2007 0c9fe532-3920-4a59-b348-65b184c0eff4 0c9fe532-3920-4a59-b348-65b184c0eff4 TCGA-A8-A07B-01A-11W-A019-09 TCGA-A8-A07B-01 TCGA-A8-A07B-01 TCGA-A8-A07B-01A-11W-A019-09 TCGA-A8-A07B-01A-11D-A00Y-05 TCGA-A8-A07B-01 TCGA-A8-A07B-01A-11W-A019-09 TCGA-A8-A07B-01 0c9fe532-3920-4a59-b348-65b184c0eff4 TCGA-A8-A07B-01 TCGA-A8-A07B-01A-11D-A011-01 TCGA-A8-A07B-01A-11R-A00Z-07 0c9fe532-3920-4a59-b348-65b184c0eff4 TCGA-A8-A07B-01A-11D-A011-01 TCGA-A8-A07B-01 TCGA-A8-A07C-01 Stage IIA 57 2 Stage IIA 580 Negative FEMALE Negative Negative M0 Negative N0 580 0 Basal Basal-like Negative -13 -12 enrollment T_Other T2 LIVING TCGA-A8-A07C-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 14 TCGA-A8-A07C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Upper Outer Quadrant TCGA-A8-A07C-F40824 TCGA-A8-A07C TCGA-A8-A07C-01A Negative Negative Other -20820 637 0 1034 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 80 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO false No M0 N0 T2 Stage IIA TCGA-A8-A07C.DC5B662B-1ADD-4D6E-A6E3-3EF8B922BC71.pdf A07C TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 19d713e8-e754-44a4-9b23-0ef70f5d6b44 19d713e8-e754-44a4-9b23-0ef70f5d6b44 TCGA-A8-A07C-01A-11D-A045-09 TCGA-A8-A07C-01 TCGA-A8-A07C-01A-11D-A045-09 TCGA-A8-A07C-01A-11D-A032-05 TCGA-A8-A07C-01A-11D-A045-09 TCGA-A8-A07C-01 19d713e8-e754-44a4-9b23-0ef70f5d6b44 TCGA-A8-A07C-01 TCGA-A8-A07C-01A-11R-A034-07 19d713e8-e754-44a4-9b23-0ef70f5d6b44 TCGA-A8-A07C-01 TCGA-A8-A07E-01 Stage X 81 2 Stage IIIC 608 Positive FEMALE Negative 1 3 3 Negative M0 Positive N3 608 0 LumA Luminal A Positive ReacII -4 -3 enrollment T_Other T4 LIVING TCGA-A8-A07E-01 Squamous C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-A8-A07E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 81 Left Upper Outer Quadrant TCGA-A8-A07E-F40825 TCGA-A8-A07E TCGA-A8-A07E-01A Positive Positive Other -29800 545 0 608 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 260 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 NO false Yes MX N3a T4b Stage X TCGA-A8-A07E.E20AC0FF-43C4-49EA-9E33-764E553933B7.pdf A07E TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 3510559d-33b7-423a-88c9-d8c42270d546 3510559d-33b7-423a-88c9-d8c42270d546 TCGA-A8-A07E-01A-21-A13B-20 TCGA-A8-A07E-01A-11W-A050-09 TCGA-A8-A07E-01 857d3ad8-e3a8-4366-8f34-2b89be3dd24c TCGA-A8-A07E-01 TCGA-A8-A07E-01A-11W-A050-09 TCGA-A8-A07E-01A-11D-A032-05 TCGA-A8-A07E-01 TCGA-A8-A07E-01A-11W-A050-09 TCGA-A8-A07E-01 3510559d-33b7-423a-88c9-d8c42270d546 TCGA-A8-A07E-01 TCGA-A8-A07E-01A-11D-A036-01 TCGA-A8-A07E-01A-11R-A034-07 3510559d-33b7-423a-88c9-d8c42270d546 TCGA-A8-A07E-01A-11D-A036-01 TCGA-A8-A07E-01 TCGA-A8-A07F-01 Stage IIB 65 2 Stage IIB 576 Positive FEMALE Negative 1 4 3 Negative M0 Positive N1 576 0 LumA Luminal A Positive ReacI -1 -1 enrollment T_Other T2 LIVING TCGA-A8-A07F-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-A8-A07F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Outer Quadrant TCGA-A8-A07F-F40826 TCGA-A8-A07F TCGA-A8-A07F-01A Positive Positive Other -23742 453 0 577 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 150 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO false No M0 N1a T2 Stage IIB TCGA-A8-A07F.D1456192-83E7-4FC8-B783-90D615830156.pdf A07F TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 f6fd41e3-c597-4c5d-8f47-a315be0330f8 f6fd41e3-c597-4c5d-8f47-a315be0330f8 TCGA-A8-A07F-01A-21-A13B-20 TCGA-A8-A07F-01A-11W-A019-09 TCGA-A8-A07F-01 4d97ec15-8bf1-4bc7-9bc9-4ef5c58f1fbc TCGA-A8-A07F-01 TCGA-A8-A07F-01A-11W-A019-09 TCGA-A8-A07F-01A-11D-A00Y-05 TCGA-A8-A07F-01 TCGA-A8-A07F-01A-11W-A019-09 TCGA-A8-A07F-01 f6fd41e3-c597-4c5d-8f47-a315be0330f8 TCGA-A8-A07F-01 TCGA-A8-A07F-01A-11D-A011-01 TCGA-A8-A07F-01A-11R-A00Z-07 f6fd41e3-c597-4c5d-8f47-a315be0330f8 TCGA-A8-A07F-01A-11D-A011-01 TCGA-A8-A07F-01 TCGA-A8-A07G-01 Stage IIA 65 3 Stage IIA 576 Positive FEMALE Negative Negative M0 Positive N1 576 0 LumA Luminal A Positive -5 -7 enrollment T1 T1 LIVING TCGA-A8-A07G-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A07G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Upper Outer Quadrant TCGA-A8-A07G-F40827 TCGA-A8-A07G Positive Positive Other -23926 0 577 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO No M0 N1a T1c Stage IIA A07G TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2009 aad6a297-72fe-4483-8c81-b7bef2522437 aad6a297-72fe-4483-8c81-b7bef2522437 TCGA-A8-A07G-01A-11W-A050-09 TCGA-A8-A07G-01 TCGA-A8-A07G-01 TCGA-A8-A07G-01A-11W-A050-09 TCGA-A8-A07G-01A-11D-A032-05 TCGA-A8-A07G-01 TCGA-A8-A07G-01A-11W-A050-09 TCGA-A8-A07G-01 aad6a297-72fe-4483-8c81-b7bef2522437 TCGA-A8-A07G-01 TCGA-A8-A07G-01A-11D-A036-01 TCGA-A8-A07G-01A-11R-A034-07 aad6a297-72fe-4483-8c81-b7bef2522437 TCGA-A8-A07G-01A-11D-A036-01 TCGA-A8-A07G-01 TCGA-A8-A07I-01 Stage IIIA 69 3 Stage IIIA 426 Positive FEMALE Positive 1 1 1 Negative M0 Positive N2 426 0 Her2 HER2-enriched Negative Her2 -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A07I-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A07I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Left Upper Outer Quadrant TCGA-A8-A07I-F40828 TCGA-A8-A07I TCGA-A8-A07I-01A Positive Negative Other -25263 302 0 426 2013-3-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 130 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO false No M0 N2a T2 Stage IIIA TCGA-A8-A07I.5DA3A8E1-7EE6-45EC-89EC-69423E2B866B.pdf A07I TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 670eab31-e873-4404-bbff-1b427e7b80c1 670eab31-e873-4404-bbff-1b427e7b80c1 TCGA-A8-A07I-01A-21-A13B-20 TCGA-A8-A07I-01A-11W-A019-09 TCGA-A8-A07I-01 f8e3aadc-06b2-43d4-9cdb-a3c285bedaee TCGA-A8-A07I-01 TCGA-A8-A07I-01A-11W-A019-09 TCGA-A8-A07I-01A-11D-A00Y-05 TCGA-A8-A07I-01 TCGA-A8-A07I-01A-11W-A019-09 TCGA-A8-A07I-01 670eab31-e873-4404-bbff-1b427e7b80c1 TCGA-A8-A07I-01 TCGA-A8-A07I-01A-11D-A011-01 TCGA-A8-A07I-01A-11R-A00Z-07 670eab31-e873-4404-bbff-1b427e7b80c1 TCGA-A8-A07I-01A-11D-A011-01 TCGA-A8-A07I-01 TCGA-A8-A07J-01 Stage IIB 35 2 Stage IIB 365 Positive FEMALE Negative Negative M0 Positive N1 365 0 LumA Luminal A Positive -5 -7 enrollment T_Other T2 LIVING TCGA-A8-A07J-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A07J TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Upper Outer Quadrant TCGA-A8-A07J-F40829 TCGA-A8-A07J Positive Positive Other -12965 0 365 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Negative Negative NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO No M0 N1a T2 Stage IIB A07J TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2009 a5405b3a-e351-4e9e-b3fa-07c33e3318d3 a5405b3a-e351-4e9e-b3fa-07c33e3318d3 TCGA-A8-A07J-01A-11W-A019-09 TCGA-A8-A07J-01 TCGA-A8-A07J-01 TCGA-A8-A07J-01A-11W-A019-09 TCGA-A8-A07J-01A-11D-A00Y-05 TCGA-A8-A07J-01 TCGA-A8-A07J-01A-11W-A019-09 TCGA-A8-A07J-01 a5405b3a-e351-4e9e-b3fa-07c33e3318d3 TCGA-A8-A07J-01 TCGA-A8-A07J-01A-11D-A011-01 TCGA-A8-A07J-01A-11R-A00Z-07 a5405b3a-e351-4e9e-b3fa-07c33e3318d3 TCGA-A8-A07J-01A-11D-A011-01 TCGA-A8-A07J-01 TCGA-A8-A07L-01 Stage IIIA 58 4 Stage IIIA 517 Positive FEMALE Negative Negative M0 Positive N1 517 0 LumB Luminal B Positive -10 -3 enrollment T_Other T3 LIVING TCGA-A8-A07L-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 12 TCGA-A8-A07L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant TCGA-A8-A07L-F40830 TCGA-A8-A07L TCGA-A8-A07L-01A Positive Positive Other -21428 394 0 975 2013-3-2 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 80 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO false No M0 N1a T3 Stage IIIA TCGA-A8-A07L.5D93AE27-79A0-4809-AE7C-54814CED0851.pdf A07L TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 76cbecbe-22ef-479a-9306-2f09e1d87757 76cbecbe-22ef-479a-9306-2f09e1d87757 TCGA-A8-A07L-01A-11W-A019-09 TCGA-A8-A07L-01 TCGA-A8-A07L-01 TCGA-A8-A07L-01A-11W-A019-09 TCGA-A8-A07L-01A-11D-A00Y-05 TCGA-A8-A07L-01 TCGA-A8-A07L-01A-11W-A019-09 TCGA-A8-A07L-01 76cbecbe-22ef-479a-9306-2f09e1d87757 TCGA-A8-A07L-01 TCGA-A8-A07L-01A-11D-A011-01 TCGA-A8-A07L-01A-11R-A040-07 76cbecbe-22ef-479a-9306-2f09e1d87757 TCGA-A8-A07L-01A-11D-A011-01 TCGA-A8-A07L-01 TCGA-A8-A07O-01 Stage IIA 51 1 Stage IIA 304 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 304 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-A8-A07O-01 BRCA-LUAD+ C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A07O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Upper Outer Quadrant TCGA-A8-A07O-F40831 TCGA-A8-A07O TCGA-A8-A07O-01A Negative Negative Other -18870 180 0 304 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 220 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO false No M0 N0 T2 Stage IIA TCGA-A8-A07O.9ECA4450-A550-44DE-B2E5-FD1CFF02A9FE.pdf A07O TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 0b743ba9-a340-46a0-9276-a5ddd3ee69d6 0b743ba9-a340-46a0-9276-a5ddd3ee69d6 TCGA-A8-A07O-01A-21-A13B-20 TCGA-A8-A07O-01A-11W-A019-09 TCGA-A8-A07O-01 d7dd9819-8523-4dff-8ffb-689d37a73368 TCGA-A8-A07O-01 TCGA-A8-A07O-01A-11W-A019-09 TCGA-A8-A07O-01A-11D-A00Y-05 TCGA-A8-A07O-01 TCGA-A8-A07O-01A-11W-A019-09 TCGA-A8-A07O-01 0b743ba9-a340-46a0-9276-a5ddd3ee69d6 TCGA-A8-A07O-01 TCGA-A8-A07O-01A-11D-A011-01 TCGA-A8-A07O-01A-11R-A00Z-07 0b743ba9-a340-46a0-9276-a5ddd3ee69d6 TCGA-A8-A07O-01A-11D-A011-01 TCGA-A8-A07O-01 TCGA-A8-A07P-01 Stage IIB 68 4 Stage IIB 334 Positive FEMALE Positive 4 3 3 Negative M0 Positive N1 334 0 LumA Luminal A Positive LumA/B -10 -3 enrollment T_Other T2 LIVING TCGA-A8-A07P-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A07P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Upper Outer Quadrant TCGA-A8-A07P-F40832 TCGA-A8-A07P TCGA-A8-A07P-01A Positive Positive Other -24929 210 0 334 2013-3-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 120 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 false No M0 N1 T2 Stage IIB TCGA-A8-A07P.6C7D956E-1247-4663-9ED5-D406AE6E2959.pdf A07P TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 dad4f72e-cb2c-4015-af6a-53ad0ae45f12 dad4f72e-cb2c-4015-af6a-53ad0ae45f12 TCGA-A8-A07P-01A-21-A13B-20 TCGA-A8-A07P-01A-11W-A019-09 TCGA-A8-A07P-01 00703e0f-8964-4b44-a5f3-d1246e5358ff TCGA-A8-A07P-01 TCGA-A8-A07P-01A-11W-A019-09 TCGA-A8-A07P-01A-11D-A00Y-05 TCGA-A8-A07P-01 TCGA-A8-A07P-01A-11W-A019-09 TCGA-A8-A07P-01 dad4f72e-cb2c-4015-af6a-53ad0ae45f12 TCGA-A8-A07P-01 TCGA-A8-A07P-01A-11D-A011-01 TCGA-A8-A07P-01A-11R-A00Z-07 dad4f72e-cb2c-4015-af6a-53ad0ae45f12 TCGA-A8-A07P-01A-11D-A011-01 TCGA-A8-A07P-01 TCGA-A8-A07R-01 Stage IIIC 80 3 Stage IIIC 273 Negative FEMALE Equivocal 2 2 2 Negative M0 Positive N3 273 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-A8-A07R-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A07R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left Upper Outer Quadrant TCGA-A8-A07R Negative Negative Other -29251 0 273 2011-5-27 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Positive Positive 5 4 No M0 N3a T2 Stage IIIC A07R Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2009 ce045098-cbfb-4c73-9bbe-6a1d677ae0b0 ce045098-cbfb-4c73-9bbe-6a1d677ae0b0 TCGA-A8-A07R-01A-12-A13B-20 TCGA-A8-A07R-01A-21W-A050-09 TCGA-A8-A07R-01 f547b351-f375-4f31-970f-40e006020b01 TCGA-A8-A07R-01 TCGA-A8-A07R-01A-21W-A050-09 TCGA-A8-A07R-01A-21D-A032-05 TCGA-A8-A07R-01 TCGA-A8-A07R-01A-21W-A050-09 TCGA-A8-A07R-01 ce045098-cbfb-4c73-9bbe-6a1d677ae0b0 TCGA-A8-A07R-01 TCGA-A8-A07R-01A-21D-A036-01 TCGA-A8-A07R-01A-21R-A034-07 ce045098-cbfb-4c73-9bbe-6a1d677ae0b0 TCGA-A8-A07R-01A-21D-A036-01 TCGA-A8-A07R-01 TCGA-A8-A07S-01 Stage IIA 73 2 Stage IIA 242 Positive FEMALE Negative Negative M0 Negative N0 242 0 LumB Luminal B Negative LumA -12 -3 enrollment T_Other T2 LIVING TCGA-A8-A07S-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 TCGA-A8-A07S TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left Upper Outer Quadrant TCGA-A8-A07S-F40833 TCGA-A8-A07S TCGA-A8-A07S-01A Positive Negative Other -26998 119 0 243 2013-3-2 FEMALE Mixed Histology (please specify) lobular/ductal No C50.9 8522/3 C50.9 YES 220 NO Negative Negative NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 7 NO false No M0 N0 T2 Stage IIA TCGA-A8-A07S.AC2E3DDC-3AF6-45F0-8269-E9DA68F4367A.pdf A07S WITH TUMOR YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 15acd388-f958-4f43-bc38-39bab4cb830e 15acd388-f958-4f43-bc38-39bab4cb830e TCGA-A8-A07S-01A-22-A13B-20 TCGA-A8-A07S-01 a86ad293-8480-4f2f-b3d2-6f59fa709d03 TCGA-A8-A07S-01 TCGA-A8-A07S-01A-11D-A032-05 TCGA-A8-A07S-01 TCGA-A8-A07S-01 15acd388-f958-4f43-bc38-39bab4cb830e TCGA-A8-A07S-01 TCGA-A8-A07S-01A-11D-A036-01 TCGA-A8-A07S-01A-11R-A034-07 15acd388-f958-4f43-bc38-39bab4cb830e TCGA-A8-A07S-01A-11D-A036-01 TCGA-A8-A07S-01 TCGA-A8-A07U-01 Stage IIIA 66 3 Stage IIIA 303 Negative FEMALE Negative Negative M0 Positive N2 303 0 Basal Basal-like Positive -13 -12 enrollment T_Other T2 LIVING TCGA-A8-A07U-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 7 cluster 4 mutation cluster 5 TCGA-A8-A07U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Upper Outer Quadrant TCGA-A8-A07U-F40834 TCGA-A8-A07U TCGA-A8-A07U-01A Negative Positive Other -24411 210 0 760 2013-3-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 100 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO false No M0 N2a T2 Stage IIIA TCGA-A8-A07U.1E7788D8-B5FC-473A-8A10-79910443799A.pdf A07U TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 77daa4a6-93c2-4455-a173-ead372d92010 77daa4a6-93c2-4455-a173-ead372d92010 TCGA-A8-A07U-01A-11W-A050-09 TCGA-A8-A07U-01 TCGA-A8-A07U-01 TCGA-A8-A07U-01A-11W-A050-09 TCGA-A8-A07U-01A-11D-A032-05 TCGA-A8-A07U-01 TCGA-A8-A07U-01A-11W-A050-09 TCGA-A8-A07U-01 77daa4a6-93c2-4455-a173-ead372d92010 TCGA-A8-A07U-01 TCGA-A8-A07U-01A-11D-A036-01 TCGA-A8-A07U-01A-11R-A034-07 77daa4a6-93c2-4455-a173-ead372d92010 TCGA-A8-A07U-01A-11D-A036-01 TCGA-A8-A07U-01 TCGA-A8-A07W-01 Stage IV 76 3 Stage IV 304 Positive FEMALE Negative 1 1 4 Positive M1 Negative N0 304 0 LumB Luminal B Positive LumA/B -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A07W-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A07W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Upper Outer Quadrant TCGA-A8-A07W-F40835 TCGA-A8-A07W TCGA-A8-A07W-01A Positive Positive Other -27942 180 0 304 2013-3-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 180 NO Negative Negative NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 false No M1 NX T2 Stage IV TCGA-A8-A07W.C39563FD-CD7F-47C6-A257-5CB70A01C67C.pdf A07W WITH TUMOR YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 03403807-a06f-4d79-ac2d-2d494d4fabee 03403807-a06f-4d79-ac2d-2d494d4fabee TCGA-A8-A07W-01A-21-A13A-20 TCGA-A8-A07W-01A-11W-A019-09 TCGA-A8-A07W-01 e407dd09-754f-4167-b2cf-391893051541 TCGA-A8-A07W-01 TCGA-A8-A07W-01A-11W-A019-09 TCGA-A8-A07W-01A-11D-A00Y-05 TCGA-A8-A07W-01 TCGA-A8-A07W-01A-11W-A019-09 TCGA-A8-A07W-01 03403807-a06f-4d79-ac2d-2d494d4fabee TCGA-A8-A07W-01 TCGA-A8-A07W-01A-11D-A011-01 TCGA-A8-A07W-01A-11R-A00Z-07 03403807-a06f-4d79-ac2d-2d494d4fabee TCGA-A8-A07W-01A-11D-A011-01 TCGA-A8-A07W-01 TCGA-A8-A07Z-01 Stage IIA 85 3 Stage IIA 853 Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 853 0 Luminal B Positive LumA -12 -3 enrollment T_Other T2 LIVING TCGA-A8-A07Z-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A8-A07Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 85 Left TCGA-A8-A07Z-F40836 TCGA-A8-A07Z Positive Positive Other -31351 0 1371 2013-3-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO No M0 N0 T2 Stage IIA A07Z TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2008 a88a7f5b-09bc-43ec-ad0c-1a094d022f90 a88a7f5b-09bc-43ec-ad0c-1a094d022f90 TCGA-A8-A07Z-01A-21-A13A-20 TCGA-A8-A07Z-01A-11W-A019-09 TCGA-A8-A07Z-01 a0ca1a15-ed13-4ba7-9565-604073ec88a3 TCGA-A8-A07Z-01 TCGA-A8-A07Z-01A-11W-A019-09 TCGA-A8-A07Z-01A-11D-A00Y-05 TCGA-A8-A07Z-01 TCGA-A8-A07Z-01A-11W-A019-09 TCGA-A8-A07Z-01 a88a7f5b-09bc-43ec-ad0c-1a094d022f90 TCGA-A8-A07Z-01 TCGA-A8-A07Z-01A-11D-A011-01 TCGA-A8-A07Z-01A-11R-A00Z-07 a88a7f5b-09bc-43ec-ad0c-1a094d022f90 TCGA-A8-A07Z-01A-11D-A011-01 TCGA-A8-A07Z-01 TCGA-A8-A081-01 Stage IIA 80 5 Stage IIA 0 Positive FEMALE Negative 1 1 1 Negative M0 Negative N0 0 0 LumB HER2-enriched Positive Her2 -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A081-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 3 TCGA-A8-A081 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Right TCGA-A8-A081 TCGA-A8-A081-01A Positive Positive Other -29555 637 0 0 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 150 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 false No M0 N0 T2 Stage IIA TCGA-A8-A081.DE25BF82-5F7A-489B-BFC1-9386C44E7D62.pdf A081 TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 c88b614b-811e-42f9-86e3-10909ced98e7 c88b614b-811e-42f9-86e3-10909ced98e7 TCGA-A8-A081-01A-21-A13A-20 TCGA-A8-A081-01A-11W-A019-09 TCGA-A8-A081-01 8392c9cd-b36d-4cb2-887b-8fa3c219d843 TCGA-A8-A081-01 TCGA-A8-A081-01A-11W-A019-09 TCGA-A8-A081-01A-11D-A00Y-05 TCGA-A8-A081-01 TCGA-A8-A081-01A-11W-A019-09 TCGA-A8-A081-01 c88b614b-811e-42f9-86e3-10909ced98e7 TCGA-A8-A081-01 TCGA-A8-A081-01A-11D-A011-01 TCGA-A8-A081-01A-11R-A00Z-07 c88b614b-811e-42f9-86e3-10909ced98e7 TCGA-A8-A081-01A-11D-A011-01 TCGA-A8-A081-01 TCGA-A8-A082-01 Stage IIB 58 4 Stage IIB 549 Positive FEMALE Negative 1 3 4 Negative M0 Positive N1 549 0 LumB Luminal B Positive LumA -9 -3 enrollment T_Other T2 LIVING TCGA-A8-A082-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-A8-A082 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right TCGA-A8-A082-F40837 TCGA-A8-A082 TCGA-A8-A082-01A Positive Positive Other -21338 606 0 -31 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 130 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO false No M0 N1a T2 Stage IIB TCGA-A8-A082.3E967C4F-B916-4A80-A9A1-A5E94F02322C.pdf A082 TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 2fd81438-46a2-42f5-910e-728faea3872a 2fd81438-46a2-42f5-910e-728faea3872a TCGA-A8-A082-01A-21-A13A-20 TCGA-A8-A082-01A-11W-A019-09 TCGA-A8-A082-01 a9d13722-7419-4250-a943-ccb78a486228 TCGA-A8-A082-01 TCGA-A8-A082-01A-11W-A019-09 TCGA-A8-A082-01A-11D-A00Y-05 TCGA-A8-A082-01 TCGA-A8-A082-01A-11W-A019-09 TCGA-A8-A082-01 2fd81438-46a2-42f5-910e-728faea3872a TCGA-A8-A082-01 TCGA-A8-A082-01A-11D-A011-01 TCGA-A8-A082-01A-11R-A00Z-07 2fd81438-46a2-42f5-910e-728faea3872a TCGA-A8-A082-01A-11D-A011-01 TCGA-A8-A082-01 TCGA-A8-A083-01 Stage IIB 67 2 Stage IIB 0 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 0 0 LumA Luminal A Positive LumA -12 -3 enrollment T_Other T3 LIVING TCGA-A8-A083-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A083 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Left TCGA-A8-A083 TCGA-A8-A083-01A Positive Positive Other -24746 575 0 0 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 300 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 false No M0 N0 T3 Stage IIB TCGA-A8-A083.AF0A2220-DEEC-44C8-B15C-B6442D5B7517.pdf A083 TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 72b7ab0e-81e0-4385-8125-5146243e21ac 72b7ab0e-81e0-4385-8125-5146243e21ac TCGA-A8-A083-01A-11-A13A-20 TCGA-A8-A083-01A-21W-A019-09 TCGA-A8-A083-01 503f0e18-bc85-4950-bba1-b55d4c29760a TCGA-A8-A083-01 TCGA-A8-A083-01A-21W-A019-09 TCGA-A8-A083-01A-21D-A00Y-05 TCGA-A8-A083-01 TCGA-A8-A083-01A-21W-A019-09 TCGA-A8-A083-01 72b7ab0e-81e0-4385-8125-5146243e21ac TCGA-A8-A083-01 TCGA-A8-A083-01A-21D-A011-01 TCGA-A8-A083-01A-21R-A00Z-07 72b7ab0e-81e0-4385-8125-5146243e21ac TCGA-A8-A083-01A-21D-A011-01 TCGA-A8-A083-01 TCGA-A8-A084-01 Stage IIB 81 1 No_Conversion 458 Positive FEMALE Negative 2 2 2 Negative M0 Positive N1 458 0 LumB Luminal B Negative X -1 -5 enrollment T_Other T2 LIVING TCGA-A8-A084-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 3 TCGA-A8-A084 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 81 Left TCGA-A8-A084-F40838 TCGA-A8-A084 TCGA-A8-A084-01A Positive Negative Other -29858 1033 0 458 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES 270 NO Negative Negative NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 3 false Yes M0 N1a T2 Stage IIB TCGA-A8-A084.6A49B3F9-6B43-4D74-A28B-C83BFE61EC7B.pdf A084 WITH TUMOR NO YES Primary Tumor 01 Surgical resection 5th NO YES A8 Breast A LIVING 2007 2f2fe990-f8f6-4904-b3d5-083e17a7a29d 2f2fe990-f8f6-4904-b3d5-083e17a7a29d TCGA-A8-A084-01A-11-A13A-20 TCGA-A8-A084-01A-21W-A019-09 TCGA-A8-A084-01 adfcebcc-edf7-4351-ba59-e1fea8580893 TCGA-A8-A084-01 TCGA-A8-A084-01A-21W-A019-09 TCGA-A8-A084-01A-21D-A00Y-05 TCGA-A8-A084-01 TCGA-A8-A084-01A-21W-A019-09 2f2fe990-f8f6-4904-b3d5-083e17a7a29d TCGA-A8-A084-01A-21D-A011-01 TCGA-A8-A084-01A-21R-A00Z-07 2f2fe990-f8f6-4904-b3d5-083e17a7a29d TCGA-A8-A084-01A-21D-A011-01 TCGA-A8-A084-01 TCGA-A8-A085-01 Stage IIB 44 5 Stage IIB 1124 Positive MALE Negative 1 3 4 Negative M0 Positive N1 1124 0 LumB Luminal B Positive LumA/B -10 -3 enrollment T_Other T2 LIVING TCGA-A8-A085-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A085 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left TCGA-A8-A085-F40839 TCGA-A8-A085 TCGA-A8-A085-01A Positive Positive Other -16377 788 0 1124 2013-3-2 MALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 130 NO Negative Negative NO Negative 4 2 NO false No M0 N1a T2 Stage IIB TCGA-A8-A085.64F84FF4-A477-4E1E-B4BB-E5614517229E.pdf A085 TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 4be8001c-c6a2-420c-8761-93469a6a7904 4be8001c-c6a2-420c-8761-93469a6a7904 TCGA-A8-A085-01A-21-A13B-20 TCGA-A8-A085-01A-11W-A019-09 TCGA-A8-A085-01 96e8bae5-7cde-475e-b1ba-ec2ac2efeb6e TCGA-A8-A085-01 TCGA-A8-A085-01A-11W-A019-09 TCGA-A8-A085-01A-11D-A00Y-05 TCGA-A8-A085-01 TCGA-A8-A085-01A-11W-A019-09 TCGA-A8-A085-01 4be8001c-c6a2-420c-8761-93469a6a7904 TCGA-A8-A085-01 TCGA-A8-A085-01A-11D-A011-01 TCGA-A8-A085-01A-11R-A00Z-07 4be8001c-c6a2-420c-8761-93469a6a7904 TCGA-A8-A085-01A-11D-A011-01 TCGA-A8-A085-01 TCGA-A8-A086-01 Stage IIA 59 5 Stage IIA 396 Positive FEMALE Negative 2 3 3 Negative M0 Positive N1 396 0 LumA Luminal A Positive LumA -9 -3 enrollment T1 T1 LIVING TCGA-A8-A086-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation c1uster 9 TCGA-A8-A086 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right TCGA-A8-A086-F40840 TCGA-A8-A086 TCGA-A8-A086-01A Positive Positive Other -21731 272 0 396 2013-3-2 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 150 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 5 NO false No M0 N1a T1c Stage IIA TCGA-A8-A086.D4E86E20-B75E-4CDA-83F2-22C481D4B9E8.pdf A086 TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 7347a336-6248-47be-817b-88543164d564 7347a336-6248-47be-817b-88543164d564 TCGA-A8-A086-01A-21-A13B-20 TCGA-A8-A086-01A-11W-A019-09 TCGA-A8-A086-01 faed055f-e054-4c59-953f-c118dd531f04 TCGA-A8-A086-01 TCGA-A8-A086-01A-11W-A019-09 TCGA-A8-A086-01A-11D-A00Y-05 TCGA-A8-A086-01 TCGA-A8-A086-01A-11W-A019-09 TCGA-A8-A086-01 7347a336-6248-47be-817b-88543164d564 TCGA-A8-A086-01 TCGA-A8-A086-01A-11D-A011-01 TCGA-A8-A086-01A-11R-A00Z-07 7347a336-6248-47be-817b-88543164d564 TCGA-A8-A086-01A-11D-A011-01 TCGA-A8-A086-01 TCGA-A8-A08A-01 Stage I 89 2 Stage I 30 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 30 0 Luminal A Positive LumA -12 -3 enrollment T1 T1 LIVING TCGA-A8-A08A-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A08A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 89 Left Upper Inner Quadrant TCGA-A8-A08A TCGA-A8-A08A-01A Positive Positive Other -32750 1033 0 30 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 160 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 false No M0 N0 T1c Stage I TCGA-A8-A08A.6D2212CE-C80F-4545-A895-3F1B6E4C6DB6.pdf A08A TUMOR FREE Primary Tumor 01 Surgical Resection 5th NO YES A8 Breast A LIVING 2007 bf92b8cc-9a5c-4e96-917c-c264fe588f8d bf92b8cc-9a5c-4e96-917c-c264fe588f8d TCGA-A8-A08A-01A-21-A13A-20 TCGA-A8-A08A-01A-11W-A019-09 TCGA-A8-A08A-01 80af2202-8a16-4cb7-8556-5ff94a042038 TCGA-A8-A08A-01 TCGA-A8-A08A-01A-11W-A019-09 TCGA-A8-A08A-01A-11D-A00Y-05 TCGA-A8-A08A-01 TCGA-A8-A08A-01A-11W-A019-09 TCGA-A8-A08A-01 bf92b8cc-9a5c-4e96-917c-c264fe588f8d TCGA-A8-A08A-01 TCGA-A8-A08A-01A-11D-A011-01 TCGA-A8-A08A-01A-11R-A00Z-07 bf92b8cc-9a5c-4e96-917c-c264fe588f8d TCGA-A8-A08A-01A-11D-A011-01 TCGA-A8-A08A-01 TCGA-A8-A08B-01 Stage IIA 52 3 Stage IIA 702 Positive FEMALE Positive Negative M0 Negative N0 702 0 Her2 HER2-enriched Negative -1 -5 enrollment T_Other T2 LIVING TCGA-A8-A08B-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 7 mutation cluster 4 TCGA-A8-A08B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Upper Inner Quadrant TCGA-A8-A08B-F40841 TCGA-A8-A08B TCGA-A8-A08B-01A Positive Negative Other -19114 759 0 1156 2013-3-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 100 NO Positive Positive NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 7 NO false No M0 N0 T2 Stage IIA TCGA-A8-A08B.2261B407-340D-4BB3-94BC-F06096FBDA80.pdf A08B TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 0307bd0b-b59a-4996-b89d-612e72652890 0307bd0b-b59a-4996-b89d-612e72652890 TCGA-A8-A08B-01A-11W-A019-09 TCGA-A8-A08B-01 TCGA-A8-A08B-01 TCGA-A8-A08B-01A-11W-A019-09 TCGA-A8-A08B-01A-11D-A00Y-05 TCGA-A8-A08B-01 TCGA-A8-A08B-01A-11W-A019-09 TCGA-A8-A08B-01 0307bd0b-b59a-4996-b89d-612e72652890 TCGA-A8-A08B-01 TCGA-A8-A08B-01A-11D-A011-01 TCGA-A8-A08B-01A-11R-A00Z-07 0307bd0b-b59a-4996-b89d-612e72652890 TCGA-A8-A08B-01A-11D-A011-01 TCGA-A8-A08B-01 TCGA-A8-A08C-01 Stage IIA 65 2 Stage IIA 607 Positive FEMALE Negative Negative M0 Negative N0 607 0 LumA Luminal A Positive -12 -3 enrollment T_Other T2 LIVING TCGA-A8-A08C-01 BRCA-LUAD+ cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 TCGA-A8-A08C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Inner Quadrant TCGA-A8-A08C-F40842 TCGA-A8-A08C TCGA-A8-A08C-01A Positive Positive Other -24017 484 0 881 2013-3-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 110 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 NO false No M0 N0 T2 Stage IIA TCGA-A8-A08C.6E136F3D-A6E1-4541-AA4B-65BC5872DE06.pdf A08C TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 7c8b9d9a-653a-4dc7-8c53-b196fbd0482a 7c8b9d9a-653a-4dc7-8c53-b196fbd0482a TCGA-A8-A08C-01 TCGA-A8-A08C-01 TCGA-A8-A08C-01A-11W-A019-09 TCGA-A8-A08C-01A-11D-A00Y-05 TCGA-A8-A08C-01 TCGA-A8-A08C-01A-11W-A019-09 7c8b9d9a-653a-4dc7-8c53-b196fbd0482a TCGA-A8-A08C-01A-11D-A011-01 TCGA-A8-A08C-01A-11R-A00Z-07 7c8b9d9a-653a-4dc7-8c53-b196fbd0482a TCGA-A8-A08C-01A-11D-A011-01 TCGA-A8-A08C-01 TCGA-A8-A08F-01 Stage IIIC 59 4 Stage IIIC 549 Positive FEMALE Negative Negative M0 Positive N3 549 0 LumB Luminal B Positive -2 -3 enrollment T_Other T2 LIVING TCGA-A8-A08F-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 mutation c1uster 9 TCGA-A8-A08F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Upper Inner Quadrant TCGA-A8-A08F-F40843 TCGA-A8-A08F TCGA-A8-A08F-01A Positive Positive Other -21641 637 0 1004 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES 100 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 NO false Yes M0 N3a T2 Stage IIIC TCGA-A8-A08F.683AAF99-3B91-4501-B701-C3A4E8439647.pdf A08F TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 523e45c2-4f98-4010-b48e-bdbda62865cf 523e45c2-4f98-4010-b48e-bdbda62865cf TCGA-A8-A08F-01A-11W-A019-09 TCGA-A8-A08F-01 TCGA-A8-A08F-01 TCGA-A8-A08F-01A-11W-A019-09 TCGA-A8-A08F-01A-11D-A00Y-05 TCGA-A8-A08F-01 TCGA-A8-A08F-01A-11W-A019-09 523e45c2-4f98-4010-b48e-bdbda62865cf TCGA-A8-A08F-01A-11D-A011-01 TCGA-A8-A08F-01A-11R-A00Z-07 523e45c2-4f98-4010-b48e-bdbda62865cf TCGA-A8-A08F-01A-11D-A011-01 TCGA-A8-A08F-01 TCGA-A8-A08G-01 Stage IIA 41 3 Stage IIA 606 Positive FEMALE Positive 3 3 4 Negative M0 Negative N0 606 0 LumB Luminal B Positive LumA/B -10 -3 enrollment T_Other T2 LIVING TCGA-A8-A08G-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A08G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Inner Quadrant TCGA-A8-A08G-F40844 TCGA-A8-A08G TCGA-A8-A08G-01A Positive Positive Other -14976 422 0 607 2013-3-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 180 NO Positive Positive NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 NO false No M0 N0 T2 Stage IIA TCGA-A8-A08G.6DCA5C2C-F28A-409D-9623-24AB748FB4E7.pdf A08G TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 0584b467-a0f7-45fd-9948-9a01318d34bd 0584b467-a0f7-45fd-9948-9a01318d34bd TCGA-A8-A08G-01A-21-A13B-20 TCGA-A8-A08G-01A-11W-A019-09 TCGA-A8-A08G-01 df81dd47-6e43-495c-ad4a-e3347a9d233e TCGA-A8-A08G-01 TCGA-A8-A08G-01A-11W-A019-09 TCGA-A8-A08G-01A-11D-A00Y-05 TCGA-A8-A08G-01 TCGA-A8-A08G-01A-11W-A019-09 TCGA-A8-A08G-01 0584b467-a0f7-45fd-9948-9a01318d34bd TCGA-A8-A08G-01 TCGA-A8-A08G-01A-11D-A011-01 TCGA-A8-A08G-01A-11R-A00Z-07 0584b467-a0f7-45fd-9948-9a01318d34bd TCGA-A8-A08G-01A-11D-A011-01 TCGA-A8-A08G-01 TCGA-A8-A08H-01 Stage IIA 66 1 Stage IIA 0 Positive FEMALE Positive 1 4 3 Negative M0 Negative N0 0 0 Normal Basal-like Positive ReacI -5 -8 enrollment T_Other T2 LIVING TCGA-A8-A08H-01 Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A08H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Upper Inner Quadrant TCGA-A8-A08H TCGA-A8-A08H-01A Positive Positive Other -24137 1184 0 0 2011-5-27 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 250 NO Positive Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 false No M0 N0 T2 Stage IIA TCGA-A8-A08H.33188769-D86E-41AD-A74D-31A7C2DD08B7.pdf A08H TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2007 9c5eb452-caec-4a9a-9ced-215be92c91d2 9c5eb452-caec-4a9a-9ced-215be92c91d2 TCGA-A8-A08H-01A-11-A13B-20 TCGA-A8-A08H-01A-21W-A019-09 TCGA-A8-A08H-01 1ff81e2a-4af2-471e-805a-073a952b5b0e TCGA-A8-A08H-01 TCGA-A8-A08H-01A-21W-A019-09 TCGA-A8-A08H-01A-21D-A00Y-05 TCGA-A8-A08H-01 TCGA-A8-A08H-01A-21W-A019-09 TCGA-A8-A08H-01 9c5eb452-caec-4a9a-9ced-215be92c91d2 TCGA-A8-A08H-01 TCGA-A8-A08H-01A-21D-A011-01 TCGA-A8-A08H-01A-21R-A00Z-07 9c5eb452-caec-4a9a-9ced-215be92c91d2 TCGA-A8-A08H-01A-21D-A011-01 TCGA-A8-A08H-01 TCGA-A8-A08I-01 Stage IIA 53 4 Stage IIA 365 Positive FEMALE Negative Negative M0 Negative N0 365 0 LumB Luminal B Positive -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A08I-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-A8-A08I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Upper Inner Quadrant TCGA-A8-A08I-F40845 TCGA-A8-A08I TCGA-A8-A08I-01A Positive Positive Other -19389 241 0 365 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 80 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 3 NO false No M0 N0 T2 Stage IIA TCGA-A8-A08I.F2077079-D683-4D18-94B9-84C760674AF6.pdf A08I TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 3e853cb1-4747-4f98-be64-d5de7fba801e 3e853cb1-4747-4f98-be64-d5de7fba801e TCGA-A8-A08I-01A-11W-A019-09 TCGA-A8-A08I-01 TCGA-A8-A08I-01 TCGA-A8-A08I-01A-11W-A019-09 TCGA-A8-A08I-01A-11D-A00Y-05 TCGA-A8-A08I-01 TCGA-A8-A08I-01A-11W-A019-09 TCGA-A8-A08I-01 3e853cb1-4747-4f98-be64-d5de7fba801e TCGA-A8-A08I-01 TCGA-A8-A08I-01A-11D-A011-01 TCGA-A8-A08I-01A-11R-A00Z-07 3e853cb1-4747-4f98-be64-d5de7fba801e TCGA-A8-A08I-01A-11D-A011-01 TCGA-A8-A08I-01 TCGA-A8-A08J-01 Stage IV 52 5 Stage IV 1127 1127 Positive FEMALE Negative 1 1 1 Positive M1 Positive N3 1127 1 Her2 HER2-enriched Negative Her2 -2 -5 enrollment T_Other T4 DECEASED TCGA-A8-A08J-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 12 TCGA-A8-A08J TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right TCGA-A8-A08J-F40846 TCGA-A8-A08J TCGA-A8-A08J-01A Positive Negative Other -19266 1733 1127 0 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8541/3 C50.9 YES 630 NO Negative Negative NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 false No M1 N3 T4b Stage IV TCGA-A8-A08J.C1D59BA7-FC3E-46EA-B095-3B6DF42892B0.pdf A08J WITH TUMOR NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A DECEASED 2005 67e019fc-65c4-4274-a0f7-5a92f0f87bba 67e019fc-65c4-4274-a0f7-5a92f0f87bba TCGA-A8-A08J-01A-21-A13A-20 TCGA-A8-A08J-01A-11W-A019-09 TCGA-A8-A08J-01 c8144900-30dc-4081-882a-4dc863120a39 TCGA-A8-A08J-01 TCGA-A8-A08J-01A-11W-A019-09 TCGA-A8-A08J-01A-11D-A00Y-05 TCGA-A8-A08J-01 TCGA-A8-A08J-01A-11W-A019-09 TCGA-A8-A08J-01 67e019fc-65c4-4274-a0f7-5a92f0f87bba TCGA-A8-A08J-01 TCGA-A8-A08J-01A-11D-A011-01 TCGA-A8-A08J-01A-11R-A00Z-07 67e019fc-65c4-4274-a0f7-5a92f0f87bba TCGA-A8-A08J-01A-11D-A011-01 TCGA-A8-A08J-01 TCGA-A8-A08L-01 Stage IIIA 89 1 Stage IIIA 304 304 Positive FEMALE Negative 5 2 1 Negative M0 Positive N2 304 1 Her2 HER2-enriched Negative X -2 -6 enrollment T_Other T3 DECEASED TCGA-A8-A08L-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 1 TCGA-A8-A08L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 89 Left TCGA-A8-A08L-F40847 TCGA-A8-A08L TCGA-A8-A08L-01A Positive Negative Other -32842 698 304 0 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 200 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 false No M0 N2a T3 Stage IIIA TCGA-A8-A08L.BC0E0F93-B183-44E8-B551-EA463B2FBCE4.pdf A08L TUMOR FREE YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A DECEASED 2008 0b3c65ed-ff55-45c9-b6a3-dd3a596a0271 0b3c65ed-ff55-45c9-b6a3-dd3a596a0271 TCGA-A8-A08L-01A-21-A13A-20 TCGA-A8-A08L-01A-11W-A019-09 TCGA-A8-A08L-01 7a837782-6edf-48bb-83db-40548ddd2b69 TCGA-A8-A08L-01 TCGA-A8-A08L-01A-11W-A019-09 TCGA-A8-A08L-01A-11D-A00Y-05 TCGA-A8-A08L-01 TCGA-A8-A08L-01A-11W-A019-09 TCGA-A8-A08L-01 0b3c65ed-ff55-45c9-b6a3-dd3a596a0271 TCGA-A8-A08L-01 TCGA-A8-A08L-01A-11D-A011-01 TCGA-A8-A08L-01A-11R-A00Z-07 0b3c65ed-ff55-45c9-b6a3-dd3a596a0271 TCGA-A8-A08L-01A-11D-A011-01 TCGA-A8-A08L-01 TCGA-A8-A08O-01 Stage IV 45 2 Stage IV 942 Positive FEMALE Negative 3 4 3 Positive M1 Positive N3 942 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T2 LIVING TCGA-A8-A08O-01 COAD-READ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-A8-A08O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right TCGA-A8-A08O-F40848 TCGA-A8-A08O Positive Positive Other -16681 0 943 762 2013-3-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Negative Negative NO Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 YES No M1 N3a T2 Stage IV A08O WITH TUMOR YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2008 f71db767-ac59-49c8-b6a9-50bf20767ddc f71db767-ac59-49c8-b6a9-50bf20767ddc TCGA-A8-A08O-01A-11-A13A-20 TCGA-A8-A08O-01A-21W-A071-09 TCGA-A8-A08O-01 TCGA-A8-A08O-01A-21D-A10P-05 b661ea2e-2f24-44b9-b8ed-30f38223b85c TCGA-A8-A08O-01 TCGA-A8-A08O-01A-21W-A071-09 TCGA-A8-A08O-01 TCGA-A8-A08O-01A-21W-A071-09 TCGA-A8-A08O-01 f71db767-ac59-49c8-b6a9-50bf20767ddc TCGA-A8-A08O-01 TCGA-A8-A08O-01A-21D-A059-01 TCGA-A8-A08O-01A-21R-A056-07 f71db767-ac59-49c8-b6a9-50bf20767ddc TCGA-A8-A08O-01A-21D-A059-01 TCGA-A8-A08O-01 TCGA-A8-A08P-01 Stage IIIA 70 3 Stage IIIA 942 Positive FEMALE Positive Negative M0 Positive N2 942 0 LumB Luminal B Positive ReacII -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A08P-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation cluster 3 TCGA-A8-A08P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right TCGA-A8-A08P-F40561 TCGA-A8-A08P TCGA-A8-A08P-01A Positive Positive Other -25598 819 0 943 2013-2-24 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 210 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO false No M0 N2a T2 Stage IIIA TCGA-A8-A08P.7DB1F816-A55F-449A-8DF9-6724B5100CA1.pdf A08P TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 f8dbf3ce-7c30-4e62-a25f-d98843794672 f8dbf3ce-7c30-4e62-a25f-d98843794672 TCGA-A8-A08P-01A-21-A13A-20 TCGA-A8-A08P-01A-11W-A019-09 TCGA-A8-A08P-01 4e6516f3-1962-4f3e-99a4-e086891381c1 TCGA-A8-A08P-01 TCGA-A8-A08P-01A-11W-A019-09 TCGA-A8-A08P-01A-11D-A00Y-05 TCGA-A8-A08P-01 TCGA-A8-A08P-01A-11W-A019-09 f8dbf3ce-7c30-4e62-a25f-d98843794672 TCGA-A8-A08P-01A-11D-A011-01 TCGA-A8-A08P-01A-11R-A00Z-07 f8dbf3ce-7c30-4e62-a25f-d98843794672 TCGA-A8-A08P-01A-11D-A011-01 TCGA-A8-A08P-01 TCGA-A8-A08R-01 Stage IIB 52 4 Stage IIB 30 Negative FEMALE Negative Negative M0 Positive N1 30 0 Basal Basal-like Negative -13 -12 enrollment T_Other T2 LIVING TCGA-A8-A08R-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-A8-A08R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left TCGA-A8-A08R TCGA-A8-A08R-01A Negative Negative Other -19298 728 0 30 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 90 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 false No M0 N1a T2 Stage IIB TCGA-A8-A08R.FC0C1BF3-74C3-4DFC-B9B5-2FD1728E287A.pdf A08R TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 3a1d8959-f829-4b8a-a65f-70a51845f118 3a1d8959-f829-4b8a-a65f-70a51845f118 TCGA-A8-A08R-01A-11W-A050-09 TCGA-A8-A08R-01 TCGA-A8-A08R-01 TCGA-A8-A08R-01A-11W-A050-09 TCGA-A8-A08R-01A-11D-A032-05 TCGA-A8-A08R-01 TCGA-A8-A08R-01A-11W-A050-09 TCGA-A8-A08R-01 3a1d8959-f829-4b8a-a65f-70a51845f118 TCGA-A8-A08R-01 TCGA-A8-A08R-01A-11D-A036-01 TCGA-A8-A08R-01A-11R-A034-07 3a1d8959-f829-4b8a-a65f-70a51845f118 TCGA-A8-A08R-01A-11D-A036-01 TCGA-A8-A08R-01 TCGA-A8-A08S-01 Stage IIA 71 Stage IIA 580 Positive FEMALE Positive Negative M0 Positive N1 580 0 LumB Positive enrollment T1 T1 LIVING TCGA-A8-A08S-01 Squamous C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 4 TCGA-A8-A08S TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left TCGA-A8-A08S-F40560 TCGA-A8-A08S TCGA-A8-A08S-01A Positive Positive Other -25994 637 0 1004 2013-2-24 FEMALE 3+ Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES 80 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false Yes M0 N1 T1c Stage IIA TCGA-A8-A08S.0D293DF8-374D-4681-9B2A-ACC98601AA25.pdf A08S TUMOR FREE YES YES Primary Tumor 01 Surgical resection 6th NO YES A8 Breast A LIVING 2008 667c209e-9b4a-474d-8f69-102cfaffddf2 667c209e-9b4a-474d-8f69-102cfaffddf2 TCGA-A8-A08S-01A-11W-A050-09 TCGA-A8-A08S-01 TCGA-A8-A08S-01 TCGA-A8-A08S-01A-11W-A050-09 TCGA-A8-A08S-01A-11D-A032-05 TCGA-A8-A08S-01 TCGA-A8-A08S-01A-11W-A050-09 667c209e-9b4a-474d-8f69-102cfaffddf2 TCGA-A8-A08S-01A-11D-A036-01 TCGA-A8-A08S-01A-11R-A034-07 667c209e-9b4a-474d-8f69-102cfaffddf2 TCGA-A8-A08S-01A-11D-A036-01 TCGA-A8-A08S-01 TCGA-A8-A08T-01 Stage IV 64 4 Stage IV 2830 Positive FEMALE Negative 1 3 3 Positive M1 Positive N1 2830 0 LumA Luminal A Positive LumA -5 -3 enrollment T_Other T2 LIVING TCGA-A8-A08T-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A8-A08T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right TCGA-A8-A08T-F40559 TCGA-A8-A08T TCGA-A8-A08T-01A Positive Positive Other -23560 2767 3409 0 2830 2557 2013-2-24 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 190 NO Positive Positive NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 YES false No M1 N1a T2 Stage IV TCGA-A8-A08T.5780D50C-5BF0-4392-BC9B-894D1369866A.pdf A08T WITH TUMOR NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A DECEASED 2002 ed6ebb15-1401-49e0-be9a-e1391e84b374 ed6ebb15-1401-49e0-be9a-e1391e84b374 TCGA-A8-A08T-01A-11-A13A-20 TCGA-A8-A08T-01A-21W-A019-09 TCGA-A8-A08T-01 68cba786-7b1c-4e7c-863b-19a037b1d07e TCGA-A8-A08T-01 TCGA-A8-A08T-01A-21W-A019-09 TCGA-A8-A08T-01A-21D-A00Y-05 TCGA-A8-A08T-01 TCGA-A8-A08T-01A-21W-A019-09 TCGA-A8-A08T-01 ed6ebb15-1401-49e0-be9a-e1391e84b374 TCGA-A8-A08T-01 TCGA-A8-A08T-01A-21D-A011-01 TCGA-A8-A08T-01A-21R-A00Z-07 ed6ebb15-1401-49e0-be9a-e1391e84b374 TCGA-A8-A08T-01A-21D-A011-01 TCGA-A8-A08T-01 TCGA-A8-A08X-01 Stage IIIC 43 3 Stage IIIC 1034 Negative FEMALE Positive 2 2 1 Negative M0 Positive N3 1034 0 Her2 HER2-enriched Negative Her2 -13 -10 enrollment T_Other T4 LIVING TCGA-A8-A08X-01 High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-A8-A08X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left TCGA-A8-A08X-F40558 TCGA-A8-A08X TCGA-A8-A08X-01A Negative Negative Other -15705 941 0 1308 366 2013-2-24 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 170 NO Positive Positive NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 3 YES false No M0 N3a T4d Stage IIIC TCGA-A8-A08X.CA911D90-5DDA-49F1-993F-68FCA77A8558.pdf A08X TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2007 354adce5-6ca4-4d6d-a519-4eabc01c6b36 354adce5-6ca4-4d6d-a519-4eabc01c6b36 TCGA-A8-A08X-01A-11-A13B-20 TCGA-A8-A08X-01A-21W-A019-09 TCGA-A8-A08X-01 3fd8c428-08bb-4598-b3cb-0c4a33fc4eab TCGA-A8-A08X-01 TCGA-A8-A08X-01A-21W-A019-09 TCGA-A8-A08X-01A-21D-A00Y-05 TCGA-A8-A08X-01 TCGA-A8-A08X-01A-21W-A019-09 TCGA-A8-A08X-01 354adce5-6ca4-4d6d-a519-4eabc01c6b36 TCGA-A8-A08X-01 TCGA-A8-A08X-01A-21D-A011-01 TCGA-A8-A08X-01A-21R-A00Z-07 354adce5-6ca4-4d6d-a519-4eabc01c6b36 TCGA-A8-A08X-01A-21D-A011-01 TCGA-A8-A08X-01 TCGA-A8-A08Z-01 Stage IIIB 76 2 Stage IIIC 1217 Positive FEMALE Negative 3 3 3 Negative M0 Positive N3 1217 0 LumA Luminal A Positive LumA -5 -3 enrollment T_Other T4 LIVING TCGA-A8-A08Z-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A08Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left TCGA-A8-A08Z TCGA-A8-A08Z-01A Positive Positive Other -28003 2036 0 1217 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 350 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 false No M0 N3a T4b [Discrepancy] TCGA-A8-A08Z.DA7BD84B-C00E-40A0-9AE2-33FCE7995696.pdf A08Z TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2004 1462b0a9-6467-4977-aea7-006ea3f5109e 1462b0a9-6467-4977-aea7-006ea3f5109e TCGA-A8-A08Z-01A-11-A13B-20 TCGA-A8-A08Z-01A-21W-A019-09 TCGA-A8-A08Z-01 8f5042d5-cb01-4d32-a80e-f1e3c161ab78 TCGA-A8-A08Z-01 TCGA-A8-A08Z-01A-21W-A019-09 TCGA-A8-A08Z-01A-21D-A00Y-05 TCGA-A8-A08Z-01 TCGA-A8-A08Z-01A-21W-A019-09 TCGA-A8-A08Z-01 1462b0a9-6467-4977-aea7-006ea3f5109e TCGA-A8-A08Z-01 TCGA-A8-A08Z-01A-21D-A011-01 TCGA-A8-A08Z-01A-21R-A00Z-07 1462b0a9-6467-4977-aea7-006ea3f5109e TCGA-A8-A08Z-01A-21D-A011-01 TCGA-A8-A08Z-01 TCGA-A8-A090-01 Stage IIA 74 4 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumA Luminal A Positive 0 -3 enrollment T_Other T2 LIVING TCGA-A8-A090-01 COAD-READ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A090 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Right TCGA-A8-A090 TCGA-A8-A090-01A Positive Positive Other -27121 667 0 0 2011-5-27 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 110 NO Positive Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 false No M0 N0 T2 Stage IIA TCGA-A8-A090.549E825B-F206-4FF9-835B-2FBE51C7B831.pdf A090 TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 752efa27-8d87-4007-9dc5-baef53b37a87 752efa27-8d87-4007-9dc5-baef53b37a87 TCGA-A8-A090-01A-11W-A019-09 TCGA-A8-A090-01 TCGA-A8-A090-01 TCGA-A8-A090-01A-11W-A019-09 TCGA-A8-A090-01A-11D-A00Y-05 TCGA-A8-A090-01 TCGA-A8-A090-01A-11W-A019-09 TCGA-A8-A090-01 752efa27-8d87-4007-9dc5-baef53b37a87 TCGA-A8-A090-01 TCGA-A8-A090-01A-11D-A011-01 TCGA-A8-A090-01A-11R-A00Z-07 752efa27-8d87-4007-9dc5-baef53b37a87 TCGA-A8-A090-01A-11D-A011-01 TCGA-A8-A090-01 TCGA-A8-A091-01 Stage IIA 61 4 Stage IIA 580 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 580 0 LumA Luminal A Negative LumA/B -10 -3 enrollment T_Other T2 LIVING TCGA-A8-A091-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A091 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right TCGA-A8-A091-F40557 TCGA-A8-A091 TCGA-A8-A091-01A Positive Negative Other -22554 637 0 1004 243 2013-2-23 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 180 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 YES false Yes M0 N0 T2 Stage IIA TCGA-A8-A091.FECA34F6-CEF7-4A6D-AA7E-F88542EAF6F7.pdf A091 TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 e43cb8f2-6541-4d55-b11c-8288dcf3b78f e43cb8f2-6541-4d55-b11c-8288dcf3b78f TCGA-A8-A091-01A-21-A13B-20 TCGA-A8-A091-01A-11W-A019-09 TCGA-A8-A091-01 30426ea5-f884-4216-9435-4ba810f8687e TCGA-A8-A091-01 TCGA-A8-A091-01A-11W-A019-09 TCGA-A8-A091-01A-11D-A00Y-05 TCGA-A8-A091-01 TCGA-A8-A091-01A-11W-A019-09 TCGA-A8-A091-01 e43cb8f2-6541-4d55-b11c-8288dcf3b78f TCGA-A8-A091-01 TCGA-A8-A091-01A-11D-A011-01 TCGA-A8-A091-01A-11R-A00Z-07 e43cb8f2-6541-4d55-b11c-8288dcf3b78f TCGA-A8-A091-01A-11D-A011-01 TCGA-A8-A091-01 TCGA-A8-A092-01 Stage IIIA 48 2 Stage IIIA 518 Positive FEMALE Negative Negative M0 Positive N2 518 0 LumB HER2-enriched Positive -2 -3 enrollment T_Other T2 LIVING TCGA-A8-A092-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-A8-A092 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left TCGA-A8-A092-F40556 TCGA-A8-A092 TCGA-A8-A092-01A Positive Positive Other -17807 575 0 942 2013-2-23 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 100 NO Negative Negative NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 NO false No M0 N2a T2 Stage IIIA TCGA-A8-A092.93D66EAD-B7D3-4688-8EC9-75C4380619D9.pdf A092 TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 98b2b18a-004d-459c-8aba-499d06897910 98b2b18a-004d-459c-8aba-499d06897910 TCGA-A8-A092-01A-11W-A019-09 TCGA-A8-A092-01 TCGA-A8-A092-01 TCGA-A8-A092-01A-11W-A019-09 TCGA-A8-A092-01A-11D-A00Y-05 TCGA-A8-A092-01 TCGA-A8-A092-01A-11W-A019-09 TCGA-A8-A092-01 98b2b18a-004d-459c-8aba-499d06897910 TCGA-A8-A092-01 TCGA-A8-A092-01A-11D-A011-01 TCGA-A8-A092-01A-11R-A00Z-07 98b2b18a-004d-459c-8aba-499d06897910 TCGA-A8-A092-01A-11D-A011-01 TCGA-A8-A092-01 TCGA-A8-A093-01 Stage IIA 61 3 Stage IIA 545 Positive FEMALE Negative Negative M0 Negative N0 545 0 LumA Luminal A Positive -12 -3 enrollment T_Other T2 LIVING TCGA-A8-A093-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 2 mutation cluster 4 TCGA-A8-A093 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right TCGA-A8-A093-F40555 TCGA-A8-A093 TCGA-A8-A093-01A Positive Positive Other -22373 422 0 546 2013-2-23 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 100 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO false Yes M0 N0 T2 Stage IIA TCGA-A8-A093.9DCF000D-D996-49A6-950A-0CD1E90CC6C7.pdf A093 TUMOR FREE YES YES Primary Tumor 01 Surgical resection 6th NO YES A8 Breast A LIVING 2009 54d372bf-07c8-4525-a081-ff26c28aff39 54d372bf-07c8-4525-a081-ff26c28aff39 TCGA-A8-A093-01A-11W-A019-09 TCGA-A8-A093-01 TCGA-A8-A093-01 TCGA-A8-A093-01A-11W-A019-09 TCGA-A8-A093-01A-11D-A00Y-05 TCGA-A8-A093-01 TCGA-A8-A093-01A-11W-A019-09 TCGA-A8-A093-01 54d372bf-07c8-4525-a081-ff26c28aff39 TCGA-A8-A093-01 TCGA-A8-A093-01A-11D-A011-01 TCGA-A8-A093-01A-11R-A00Z-07 54d372bf-07c8-4525-a081-ff26c28aff39 TCGA-A8-A093-01A-11D-A011-01 TCGA-A8-A093-01 TCGA-A8-A094-01 Stage IIA 75 1 Stage IIA 0 Positive FEMALE Negative 2 2 1 Negative M0 Negative N0 0 0 Her2 HER2-enriched Negative Basal -11 -5 enrollment T_Other T2 LIVING TCGA-A8-A094-01 Squamous C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 6 TCGA-A8-A094 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Left TCGA-A8-A094 TCGA-A8-A094-01A Positive Negative Other -27729 363 0 0 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 400 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 3 false No M0 N0 T2 Stage IIA TCGA-A8-A094.85288EC6-0BDC-4955-8B88-1DEECBF0E235.pdf A094 TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 877adc79-0651-4140-bb6a-876162733bf3 877adc79-0651-4140-bb6a-876162733bf3 TCGA-A8-A094-01A-21-A13B-20 TCGA-A8-A094-01A-11W-A019-09 TCGA-A8-A094-01 c7af042d-07e1-40fd-878d-a91d31397bb6 TCGA-A8-A094-01 TCGA-A8-A094-01A-11W-A019-09 TCGA-A8-A094-01A-11D-A00Y-05 TCGA-A8-A094-01 TCGA-A8-A094-01A-11W-A019-09 TCGA-A8-A094-01 877adc79-0651-4140-bb6a-876162733bf3 TCGA-A8-A094-01 TCGA-A8-A094-01A-11D-A011-01 TCGA-A8-A094-01A-11R-A00Z-07 877adc79-0651-4140-bb6a-876162733bf3 TCGA-A8-A094-01A-11D-A011-01 TCGA-A8-A094-01 TCGA-A8-A095-01 Stage I 45 3 Stage I 1276 Positive FEMALE Negative Negative M0 Negative N0 1276 0 LumB Luminal B Positive ReacII -7 -3 enrollment T1 T1 LIVING TCGA-A8-A095-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A095 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left TCGA-A8-A095-F40554 TCGA-A8-A095 TCGA-A8-A095-01A Positive Positive Other -16742 1153 0 1277 2013-2-23 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 160 NO Negative Negative NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO false No M0 N0 T1c Stage I TCGA-A8-A095.41A41A7F-E4DD-4D3A-B97D-B4657CA211E1.pdf A095 TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2007 c943873c-e153-42bc-a8de-e1080b252e81 c943873c-e153-42bc-a8de-e1080b252e81 TCGA-A8-A095-01A-21-A13B-20 TCGA-A8-A095-01A-11W-A019-09 TCGA-A8-A095-01 61dbc912-9edf-4635-926c-e9ae57c40b67 TCGA-A8-A095-01 TCGA-A8-A095-01A-11W-A019-09 TCGA-A8-A095-01A-11D-A00Y-05 TCGA-A8-A095-01 TCGA-A8-A095-01A-11W-A019-09 TCGA-A8-A095-01 c943873c-e153-42bc-a8de-e1080b252e81 TCGA-A8-A095-01 TCGA-A8-A095-01A-11D-A011-01 TCGA-A8-A095-01A-11R-A00Z-07 c943873c-e153-42bc-a8de-e1080b252e81 TCGA-A8-A095-01A-11D-A011-01 TCGA-A8-A095-01 TCGA-A8-A096-01 Stage IIA 73 2 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumB Luminal B Positive -12 -4 enrollment T_Other T2 LIVING TCGA-A8-A096-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A096 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Right TCGA-A8-A096 TCGA-A8-A096-01A Positive Positive Other -26723 394 0 0 2011-5-27 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 110 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 false No M0 N0 T2 Stage IIA TCGA-A8-A096.91BFC77A-E56F-49F0-A294-A5EE9F266FB6.pdf A096 TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 7bf79330-52fa-4111-88fe-b3ea62bcc63a 7bf79330-52fa-4111-88fe-b3ea62bcc63a TCGA-A8-A096-01A-11W-A019-09 TCGA-A8-A096-01 TCGA-A8-A096-01 TCGA-A8-A096-01A-11W-A019-09 TCGA-A8-A096-01A-11D-A00Y-05 TCGA-A8-A096-01 TCGA-A8-A096-01A-11W-A019-09 TCGA-A8-A096-01 7bf79330-52fa-4111-88fe-b3ea62bcc63a TCGA-A8-A096-01 TCGA-A8-A096-01A-11D-A011-01 TCGA-A8-A096-01A-11R-A00Z-07 7bf79330-52fa-4111-88fe-b3ea62bcc63a TCGA-A8-A096-01A-11D-A011-01 TCGA-A8-A096-01 TCGA-A8-A097-01 Stage IIB 65 5 Stage IIB 365 Positive FEMALE Positive Negative M0 Positive N1 365 0 LumA Luminal B Positive 0 -2 enrollment T_Other T2 LIVING TCGA-A8-A097-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A097 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left TCGA-A8-A097-F40553 TCGA-A8-A097 TCGA-A8-A097-01A Positive Positive Other -23741 241 0 365 2013-2-23 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 100 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO false No M0 N1 T2 Stage IIB TCGA-A8-A097.5B867CB6-F94D-435D-83E3-0ADB814B8077.pdf A097 TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 1873a785-0f15-40ef-a7c9-1799ab482338 1873a785-0f15-40ef-a7c9-1799ab482338 TCGA-A8-A097-01A-11W-A050-09 TCGA-A8-A097-01 TCGA-A8-A097-01 TCGA-A8-A097-01A-11W-A050-09 TCGA-A8-A097-01A-11D-A032-05 TCGA-A8-A097-01 TCGA-A8-A097-01A-11W-A050-09 TCGA-A8-A097-01 1873a785-0f15-40ef-a7c9-1799ab482338 TCGA-A8-A097-01 TCGA-A8-A097-01A-11D-A036-01 TCGA-A8-A097-01A-11R-A034-07 1873a785-0f15-40ef-a7c9-1799ab482338 TCGA-A8-A097-01A-11D-A036-01 TCGA-A8-A097-01 TCGA-A8-A099-01 Stage X 76 2 Stage IIIC 304 Positive FEMALE Positive 4 3 3 Negative M0 Positive N3 304 0 LumA Luminal A Positive LumA/B -12 -3 enrollment T_Other T4 LIVING TCGA-A8-A099-01 Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-A8-A099 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Right TCGA-A8-A099-F40552 TCGA-A8-A099 TCGA-A8-A099-01A Positive Positive Other -28063 180 0 304 2013-2-23 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 210 NO Positive Positive NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 NO false No MX N3a T4b Stage X TCGA-A8-A099.34499A83-DFCE-4DB8-BAA0-A7590AF8BC07.pdf A099 YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 09d1b9e5-a828-4e12-8a66-2a90c18d2f3e 09d1b9e5-a828-4e12-8a66-2a90c18d2f3e TCGA-A8-A099-01A-21-A13B-20 TCGA-A8-A099-01A-11W-A019-09 TCGA-A8-A099-01 6e221e0d-416e-420d-a798-9afde72b03fb TCGA-A8-A099-01 TCGA-A8-A099-01A-11W-A019-09 TCGA-A8-A099-01A-11D-A00Y-05 TCGA-A8-A099-01 TCGA-A8-A099-01A-11W-A019-09 TCGA-A8-A099-01 09d1b9e5-a828-4e12-8a66-2a90c18d2f3e TCGA-A8-A099-01 TCGA-A8-A099-01A-11D-A011-01 TCGA-A8-A099-01A-11R-A00Z-07 09d1b9e5-a828-4e12-8a66-2a90c18d2f3e TCGA-A8-A099-01A-11D-A011-01 TCGA-A8-A099-01 TCGA-A8-A09A-01 Stage X 40 4 Stage IIA 304 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 304 0 LumA Luminal A Positive LumA -3 -3 enrollment T_Other T2 LIVING TCGA-A8-A09A-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation c1uster 10 TCGA-A8-A09A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left TCGA-A8-A09A-F40551 TCGA-A8-A09A TCGA-A8-A09A-01A Positive Positive Other -14883 180 0 304 2013-2-23 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 170 NO Negative Negative NO Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 false No M0 NX T2 Stage X TCGA-A8-A09A.5A6E0F10-758E-4DC1-A5C7-57D5DF9B25EF.pdf A09A WITH TUMOR YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 7b1992b8-781d-49cc-a600-4bee56bcf1b5 7b1992b8-781d-49cc-a600-4bee56bcf1b5 TCGA-A8-A09A-01A-21-A13B-20 TCGA-A8-A09A-01A-11W-A019-09 TCGA-A8-A09A-01 5e5a89f5-a778-4893-9d17-38c946016d53 TCGA-A8-A09A-01 TCGA-A8-A09A-01A-11W-A019-09 TCGA-A8-A09A-01A-11D-A00Y-05 TCGA-A8-A09A-01 TCGA-A8-A09A-01A-11W-A019-09 TCGA-A8-A09A-01 7b1992b8-781d-49cc-a600-4bee56bcf1b5 TCGA-A8-A09A-01 TCGA-A8-A09A-01A-11D-A011-01 TCGA-A8-A09A-01A-11R-A00Z-07 7b1992b8-781d-49cc-a600-4bee56bcf1b5 TCGA-A8-A09A-01A-11D-A011-01 TCGA-A8-A09A-01 TCGA-A8-A09B-01 Stage IIIB 58 4 Stage IIIB 365 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 365 0 LumA Luminal A Positive LumA 0 -3 enrollment T_Other T4 LIVING TCGA-A8-A09B-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A09B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left TCGA-A8-A09B-F40550 TCGA-A8-A09B Positive Positive Other -21520 0 365 2013-2-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 No M0 N1a T4b Stage IIIB A09B TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2009 df95b9f5-437f-438d-89b4-7c556e79b616 df95b9f5-437f-438d-89b4-7c556e79b616 TCGA-A8-A09B-01A-21-A13B-20 TCGA-A8-A09B-01A-11W-A019-09 TCGA-A8-A09B-01 cc046686-7a84-4a71-8b94-70b2ec82c616 TCGA-A8-A09B-01 TCGA-A8-A09B-01A-11W-A019-09 TCGA-A8-A09B-01A-11D-A00Y-05 TCGA-A8-A09B-01 TCGA-A8-A09B-01A-11W-A019-09 TCGA-A8-A09B-01 df95b9f5-437f-438d-89b4-7c556e79b616 TCGA-A8-A09B-01 TCGA-A8-A09B-01A-11D-A011-01 TCGA-A8-A09B-01A-11R-A00Z-07 df95b9f5-437f-438d-89b4-7c556e79b616 TCGA-A8-A09B-01A-11D-A011-01 TCGA-A8-A09B-01 TCGA-A8-A09C-01 Stage X 69 4 Stage IIA 31 Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 31 0 LumB Luminal B Positive LumA 0 -3 enrollment T_Other T2 LIVING TCGA-A8-A09C-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A8-A09C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right TCGA-A8-A09C TCGA-A8-A09C-01A Positive Positive Other -25355 180 0 31 2011-5-27 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 120 NO Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 false Yes MX N0 T2 Stage X TCGA-A8-A09C.1E002C47-CEC6-491C-9E67-B289687D5B66.pdf A09C Primary Tumor 01 Surgical resection 6th NO YES A8 Breast A LIVING 2009 95bcf18b-40bf-4a20-82bf-727c7bb2a8c2 95bcf18b-40bf-4a20-82bf-727c7bb2a8c2 TCGA-A8-A09C-01A-21-A13A-20 TCGA-A8-A09C-01A-11W-A019-09 TCGA-A8-A09C-01 9012f763-2482-415b-9d86-fdabde299719 TCGA-A8-A09C-01 TCGA-A8-A09C-01A-11W-A019-09 TCGA-A8-A09C-01A-11D-A00Y-05 TCGA-A8-A09C-01 TCGA-A8-A09C-01A-11W-A019-09 TCGA-A8-A09C-01 95bcf18b-40bf-4a20-82bf-727c7bb2a8c2 TCGA-A8-A09C-01 TCGA-A8-A09C-01A-11D-A011-01 TCGA-A8-A09C-01A-11R-A00Z-07 95bcf18b-40bf-4a20-82bf-727c7bb2a8c2 TCGA-A8-A09C-01A-11D-A011-01 TCGA-A8-A09C-01 TCGA-A8-A09D-01 Stage IIB 47 5 No_Conversion 396 Positive FEMALE Negative Negative M0 Positive N1 396 0 LumA Luminal B Positive -3 -3 enrollment T_Other T2 LIVING TCGA-A8-A09D-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-A8-A09D TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Lower Outer Quadrant TCGA-A8-A09D-F40549 TCGA-A8-A09D Positive Positive Other -17440 0 1522 2013-2-23 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 1 NO No M0 N1 T2 Stage IIB A09D TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 5th NO YES A8 Breast LIVING 2007 f2563687-e055-41a8-8436-614fbad762d4 f2563687-e055-41a8-8436-614fbad762d4 TCGA-A8-A09D-01A-11W-A019-09 TCGA-A8-A09D-01 TCGA-A8-A09D-01 TCGA-A8-A09D-01A-11W-A019-09 TCGA-A8-A09D-01A-11D-A00Y-05 TCGA-A8-A09D-01 TCGA-A8-A09D-01A-11W-A019-09 TCGA-A8-A09D-01 f2563687-e055-41a8-8436-614fbad762d4 TCGA-A8-A09D-01 TCGA-A8-A09D-01A-11D-A011-01 TCGA-A8-A09D-01A-11R-A00Z-07 f2563687-e055-41a8-8436-614fbad762d4 TCGA-A8-A09D-01A-11D-A011-01 TCGA-A8-A09D-01 TCGA-A8-A09E-01 Stage IIIB 73 Stage IIIB 942 Positive FEMALE Equivocal Negative M0 Positive N1 942 0 Positive enrollment T_Other T4 LIVING TCGA-A8-A09E-01 High C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 14 mutation c1uster 9 TCGA-A8-A09E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left Lower Outer Quadrant TCGA-A8-A09E-F40334 TCGA-A8-A09E TCGA-A8-A09E-01A Positive Positive Other -26724 819 0 1492 2013-2-17 FEMALE 2+ Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES 220 NO Positive Positive NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false Yes M0 N1a T4b Stage IIIB TCGA-A8-A09E.C55B6F4B-1248-4FBF-83C2-B0A1B33DEA03.pdf A09E WITH TUMOR YES YES Primary Tumor 01 Surgical resection 6th NO YES A8 Breast A LIVING 2008 1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd 1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd TCGA-A8-A09E-01A-21-A13A-20 TCGA-A8-A09E-01A-11W-A019-09 TCGA-A8-A09E-01 f0bc5acd-5e59-47c9-b2a6-8f47508a9ec6 TCGA-A8-A09E-01 TCGA-A8-A09E-01A-11W-A019-09 TCGA-A8-A09E-01A-11D-A00Y-05 TCGA-A8-A09E-01 TCGA-A8-A09E-01A-11W-A019-09 1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd TCGA-A8-A09E-01A-11D-A011-01 TCGA-A8-A09E-01A-11R-A00Z-07 1bbb85e8-8f55-44e3-8bd8-58c0a46c43bd TCGA-A8-A09E-01A-11D-A011-01 TCGA-A8-A09E-01 TCGA-A8-A09G-01 Stage IIIC 79 2 Stage IIIC 0 Positive FEMALE Positive 3 2 1 Negative M0 Positive N3 0 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T3 LIVING TCGA-A8-A09G-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-A8-A09G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Lower Outer Quadrant TCGA-A8-A09G TCGA-A8-A09G-01A Positive Negative Other -29006 759 0 0 2011-5-27 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 270 NO Positive Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 3 false No M0 N3a T3 Stage IIIC TCGA-A8-A09G.2728DB14-66D5-4E67-B9B6-63D93DBF509C.pdf A09G TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 31757dda-12d6-4f35-87f1-d00464f2815b 31757dda-12d6-4f35-87f1-d00464f2815b TCGA-A8-A09G-01A-11-A13A-20 TCGA-A8-A09G-01A-21W-A019-09 TCGA-A8-A09G-01 8390a7e5-0373-43e2-adc0-8f6fbdc665d1 TCGA-A8-A09G-01 TCGA-A8-A09G-01A-21W-A019-09 TCGA-A8-A09G-01A-21D-A00Y-05 TCGA-A8-A09G-01 TCGA-A8-A09G-01A-21W-A019-09 TCGA-A8-A09G-01 31757dda-12d6-4f35-87f1-d00464f2815b TCGA-A8-A09G-01 TCGA-A8-A09G-01A-21D-A011-01 TCGA-A8-A09G-01A-21R-A00Z-07 31757dda-12d6-4f35-87f1-d00464f2815b TCGA-A8-A09G-01A-21D-A011-01 TCGA-A8-A09G-01 TCGA-A8-A09I-01 Stage IIA 84 5 Stage IIA 1006 Positive FEMALE Positive 1 1 4 Negative M0 Negative N0 1006 0 LumB Luminal B Positive Her2 -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A09I-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A09I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 84 Right Lower Outer Quadrant TCGA-A8-A09I-F40333 TCGA-A8-A09I TCGA-A8-A09I-01A Positive Positive Other -30711 698 0 1371 2013-2-17 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 430 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO false Yes M0 N0 T2 Stage IIA TCGA-A8-A09I.AF12859A-D67A-488D-8BC2-ED28698F2ACA.pdf A09I TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 433b49ba-949b-4914-985a-be19b3b32502 433b49ba-949b-4914-985a-be19b3b32502 TCGA-A8-A09I-01A-11-A13A-20 TCGA-A8-A09I-01A-22W-A050-09 TCGA-A8-A09I-01 93a8128c-9314-44b7-8737-0c5b08c057f4 TCGA-A8-A09I-01 TCGA-A8-A09I-01A-22W-A050-09 TCGA-A8-A09I-01A-22D-A032-05 TCGA-A8-A09I-01 TCGA-A8-A09I-01A-22W-A050-09 TCGA-A8-A09I-01 433b49ba-949b-4914-985a-be19b3b32502 TCGA-A8-A09I-01 TCGA-A8-A09I-01A-22D-A036-01 TCGA-A8-A09I-01A-22R-A034-07 433b49ba-949b-4914-985a-be19b3b32502 TCGA-A8-A09I-01A-22D-A036-01 TCGA-A8-A09I-01 TCGA-A8-A09K-01 Stage IIA 68 Stage IIA 911 Positive FEMALE Negative Negative M0 Positive N1 911 0 LumA Positive enrollment T1 T1 LIVING TCGA-A8-A09K-01 High C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 mutation c1uster 9 TCGA-A8-A09K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Lower Outer Quadrant TCGA-A8-A09K-F40332 TCGA-A8-A09K TCGA-A8-A09K-01A Positive Positive Other -24960 788 0 912 2013-2-17 FEMALE 0 Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES 240 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false Yes M0 N1 T1c Stage IIA TCGA-A8-A09K.56C24ABB-CF1D-447F-A5A8-B762C4B01566.pdf A09K TUMOR FREE NO NO Primary Tumor 01 Surgical resection 6th NO YES A8 Breast A LIVING 2008 9b54f75f-80eb-441d-83ca-5ae1d00bdfa9 9b54f75f-80eb-441d-83ca-5ae1d00bdfa9 TCGA-A8-A09K-01A-21-A13A-20 TCGA-A8-A09K-01A-11W-A019-09 TCGA-A8-A09K-01 795da071-d853-421e-85e3-902a7e1af1eb TCGA-A8-A09K-01 TCGA-A8-A09K-01A-11W-A019-09 TCGA-A8-A09K-01A-11D-A00Y-05 TCGA-A8-A09K-01 TCGA-A8-A09K-01A-11W-A019-09 9b54f75f-80eb-441d-83ca-5ae1d00bdfa9 TCGA-A8-A09K-01A-11D-A011-01 TCGA-A8-A09K-01A-11R-A00Z-07 9b54f75f-80eb-441d-83ca-5ae1d00bdfa9 TCGA-A8-A09K-01A-11D-A011-01 TCGA-A8-A09K-01 TCGA-A8-A09M-01 Stage IIIC 75 5 Stage IIIC 457 Positive FEMALE Negative 1 1 4 Negative M0 Positive N3 457 0 LumB Luminal B Positive LumA/B -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A09M-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 5 mutation c1uster 10 TCGA-A8-A09M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Right Lower Outer Quadrant TCGA-A8-A09M-F40331 TCGA-A8-A09M TCGA-A8-A09M-01A Positive Positive Other -27455 333 0 1006 2013-2-17 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 170 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO false No M0 N3a T2 Stage IIIC TCGA-A8-A09M.EBBF2A70-2773-40FA-823A-E608ABFEF591.pdf A09M TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 3e08280c-f748-43c7-928b-007b322917b2 3e08280c-f748-43c7-928b-007b322917b2 TCGA-A8-A09M-01A-21-A13B-20 TCGA-A8-A09M-01A-11W-A019-09 TCGA-A8-A09M-01 fcc864a9-3f22-4717-a5e1-2c034b9ae7f5 TCGA-A8-A09M-01 TCGA-A8-A09M-01A-11W-A019-09 TCGA-A8-A09M-01A-11D-A00Y-05 TCGA-A8-A09M-01 TCGA-A8-A09M-01A-11W-A019-09 TCGA-A8-A09M-01 3e08280c-f748-43c7-928b-007b322917b2 TCGA-A8-A09M-01 TCGA-A8-A09M-01A-11D-A011-01 TCGA-A8-A09M-01A-11R-A00Z-07 3e08280c-f748-43c7-928b-007b322917b2 TCGA-A8-A09M-01A-11D-A011-01 TCGA-A8-A09M-01 TCGA-A8-A09N-01 Stage IIIC 57 1 Stage IIIC 31 Positive FEMALE Positive Negative M0 Positive N3 31 0 LumB Luminal B Positive 0 -3 enrollment T_Other T2 LIVING TCGA-A8-A09N-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 5 TCGA-A8-A09N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Lower Outer Quadrant TCGA-A8-A09N TCGA-A8-A09N-01A Positive Positive Other -21002 1276 0 31 2011-5-27 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 70 NO Positive Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 false No M0 N3a T2 Stage IIIC TCGA-A8-A09N.F5A97F05-4B5C-4B10-BF10-5DDE7D412BCF.pdf A09N TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2006 653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5 653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5 TCGA-A8-A09N-01A-11W-A019-09 TCGA-A8-A09N-01 TCGA-A8-A09N-01 TCGA-A8-A09N-01A-11W-A019-09 TCGA-A8-A09N-01A-11D-A00Y-05 TCGA-A8-A09N-01 TCGA-A8-A09N-01A-11W-A019-09 TCGA-A8-A09N-01 653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5 TCGA-A8-A09N-01 TCGA-A8-A09N-01A-11D-A011-01 TCGA-A8-A09N-01A-11R-A00Z-07 653e3eb4-ebdb-42d2-9479-a1ea8a43bdc5 TCGA-A8-A09N-01A-11D-A011-01 TCGA-A8-A09N-01 TCGA-A8-A09Q-01 Stage IIIB 83 2 Stage IIIB 761 Positive FEMALE Negative Negative M0 Positive N2 761 0 LumB Luminal B Positive -2 -5 enrollment T_Other T4 LIVING TCGA-A8-A09Q-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-A8-A09Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 83 Left Lower Inner Quadrant TCGA-A8-A09Q-F41022 TCGA-A8-A09Q TCGA-A8-A09Q-01A Positive Positive Other -30528 637 0 761 2013-3-10 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 100 NO Negative Negative NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 false No M0 N2a T4b Stage IIIB TCGA-A8-A09Q.46C0AB7B-82FC-4D06-9F26-22AEC8BEEDA7.pdf A09Q WITH TUMOR YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 9560e482-cb14-4456-b9a6-d2ac12f96a4f 9560e482-cb14-4456-b9a6-d2ac12f96a4f TCGA-A8-A09Q-01A-11W-A019-09 TCGA-A8-A09Q-01 TCGA-A8-A09Q-01 TCGA-A8-A09Q-01A-11W-A019-09 TCGA-A8-A09Q-01A-11D-A00Y-05 TCGA-A8-A09Q-01 TCGA-A8-A09Q-01A-11W-A019-09 TCGA-A8-A09Q-01 9560e482-cb14-4456-b9a6-d2ac12f96a4f TCGA-A8-A09Q-01 TCGA-A8-A09Q-01A-11D-A011-01 TCGA-A8-A09Q-01A-11R-A00Z-07 9560e482-cb14-4456-b9a6-d2ac12f96a4f TCGA-A8-A09Q-01A-11D-A011-01 TCGA-A8-A09Q-01 TCGA-A8-A09R-01 Stage IIB 82 5 Stage IIB 273 Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 273 0 LumB Luminal B Positive Her2 0 -3 enrollment T_Other T2 LIVING TCGA-A8-A09R-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-A8-A09R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 82 Left Lower Inner Quadrant TCGA-A8-A09R-F40330 TCGA-A8-A09R TCGA-A8-A09R-01A Positive Positive Other -30196 149 0 273 2013-2-17 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 180 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO false No M0 N1 T2 Stage IIB TCGA-A8-A09R.5E615F92-6FD0-48C7-AC37-78526974BCFC.pdf A09R TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 f4fcb7e1-20b8-4b66-86a2-1be81b06785e f4fcb7e1-20b8-4b66-86a2-1be81b06785e TCGA-A8-A09R-01A-21-A13B-20 TCGA-A8-A09R-01A-11W-A019-09 TCGA-A8-A09R-01 7c1073e9-1995-4dfa-a9aa-e260e8999d54 TCGA-A8-A09R-01 TCGA-A8-A09R-01A-11W-A019-09 TCGA-A8-A09R-01A-11D-A00Y-05 TCGA-A8-A09R-01 TCGA-A8-A09R-01A-11W-A019-09 TCGA-A8-A09R-01 f4fcb7e1-20b8-4b66-86a2-1be81b06785e TCGA-A8-A09R-01 TCGA-A8-A09R-01A-11D-A011-01 TCGA-A8-A09R-01A-11R-A00Z-07 f4fcb7e1-20b8-4b66-86a2-1be81b06785e TCGA-A8-A09R-01A-11D-A011-01 TCGA-A8-A09R-01 TCGA-A8-A09T-01 Stage X 68 4 Stage I 578 Positive FEMALE Negative Negative M0 Negative N0 578 0 LumA Luminal A Positive -12 -3 enrollment T1 T1 LIVING TCGA-A8-A09T-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A09T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left TCGA-A8-A09T-F40329 TCGA-A8-A09T Positive Positive Other -25110 0 579 2013-2-17 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO No MX N0 T1c Stage X A09T TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2009 c14f7362-25c3-4e1a-acd7-871bb22ea8a3 c14f7362-25c3-4e1a-acd7-871bb22ea8a3 TCGA-A8-A09T-01A-11W-A019-09 TCGA-A8-A09T-01 TCGA-A8-A09T-01 TCGA-A8-A09T-01A-11W-A019-09 TCGA-A8-A09T-01A-11D-A00Y-05 TCGA-A8-A09T-01 TCGA-A8-A09T-01A-11W-A019-09 TCGA-A8-A09T-01 c14f7362-25c3-4e1a-acd7-871bb22ea8a3 TCGA-A8-A09T-01 TCGA-A8-A09T-01A-11D-A011-01 TCGA-A8-A09T-01A-11R-A00Z-07 c14f7362-25c3-4e1a-acd7-871bb22ea8a3 TCGA-A8-A09T-01A-11D-A011-01 TCGA-A8-A09T-01 TCGA-A8-A09V-01 Stage IIA 51 2 Stage IIA 457 Positive FEMALE Negative Negative M0 Negative N0 457 0 LumA Luminal A Positive -12 -3 enrollment T_Other T2 LIVING TCGA-A8-A09V-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 mutation c1uster 9 TCGA-A8-A09V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Upper Inner Quadrant TCGA-A8-A09V-F40328 TCGA-A8-A09V TCGA-A8-A09V-01A Positive Positive Other -18628 333 0 457 2013-2-17 FEMALE 0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 60 NO Negative Negative NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 NO false No M0 N0 T2 Stage IIA TCGA-A8-A09V.E0B04FB6-9500-4786-B6D9-303165EF9090.pdf A09V TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 416041ff-f179-4c72-a281-f39d32c595c1 416041ff-f179-4c72-a281-f39d32c595c1 TCGA-A8-A09V-01A-11D-A045-09 TCGA-A8-A09V-01 TCGA-A8-A09V-01 TCGA-A8-A09V-01A-11D-A045-09 TCGA-A8-A09V-01A-11D-A032-05 TCGA-A8-A09V-01 TCGA-A8-A09V-01A-11D-A045-09 416041ff-f179-4c72-a281-f39d32c595c1 TCGA-A8-A09V-01A-11D-A036-01 TCGA-A8-A09V-01A-11R-A034-07 416041ff-f179-4c72-a281-f39d32c595c1 TCGA-A8-A09V-01A-11D-A036-01 TCGA-A8-A09V-01 TCGA-A8-A09W-01 Stage IIIB 70 2 Stage IIIC 30 Positive FEMALE Negative Negative M0 Positive N3 30 0 LumB Luminal B Positive Her2 -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A09W-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation c1uster 9 TCGA-A8-A09W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Upper Inner Quadrant TCGA-A8-A09W TCGA-A8-A09W-01A Positive Positive Other -25659 1033 0 30 2011-5-27 FEMALE 0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 180 NO Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 false No M0 N3 T2 Stage IIIB TCGA-A8-A09W.B73AF7B0-EED3-413C-B249-C97F27E4EA1C.pdf A09W Primary Tumor 01 Surgical Resection 5th NO YES A8 Breast A LIVING 2007 aaec0cbc-a493-48f4-9cc7-32629880ee24 aaec0cbc-a493-48f4-9cc7-32629880ee24 TCGA-A8-A09W-01A-21-A13A-20 TCGA-A8-A09W-01A-11W-A019-09 TCGA-A8-A09W-01 074231b9-2438-4e1e-9965-6ae7e02ae660 TCGA-A8-A09W-01 TCGA-A8-A09W-01A-11W-A019-09 TCGA-A8-A09W-01A-11D-A00Y-05 TCGA-A8-A09W-01 TCGA-A8-A09W-01A-11W-A019-09 aaec0cbc-a493-48f4-9cc7-32629880ee24 TCGA-A8-A09W-01A-11D-A011-01 TCGA-A8-A09W-01A-11R-A00Z-07 aaec0cbc-a493-48f4-9cc7-32629880ee24 TCGA-A8-A09W-01A-11D-A011-01 TCGA-A8-A09W-01 TCGA-A8-A09X-01 Stage IIIC 62 3 Stage IIIC 426 426 Negative FEMALE Negative 2 1 1 Negative M0 Positive N3 426 1 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 DECEASED TCGA-A8-A09X-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-A8-A09X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Inner Quadrant TCGA-A8-A09X TCGA-A8-A09X-01A Negative Negative Other -22858 302 426 0 2011-5-27 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 150 NO Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 false No M0 N3a T2 Stage IIIC TCGA-A8-A09X.F72703A2-2C57-459A-9015-94BD3D302491.pdf A09X Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A DECEASED 2009 f97f68be-6838-455c-91bf-7549543a82c3 f97f68be-6838-455c-91bf-7549543a82c3 TCGA-A8-A09X-01A-21-A13A-20 TCGA-A8-A09X-01A-11W-A019-09 TCGA-A8-A09X-01 62752717-e2ef-42c9-b0c2-282f66bc0096 TCGA-A8-A09X-01 TCGA-A8-A09X-01A-11W-A019-09 TCGA-A8-A09X-01A-11D-A00Y-05 TCGA-A8-A09X-01 TCGA-A8-A09X-01A-11W-A019-09 TCGA-A8-A09X-01 f97f68be-6838-455c-91bf-7549543a82c3 TCGA-A8-A09X-01 TCGA-A8-A09X-01A-11D-A011-01 TCGA-A8-A09X-01A-11R-A00Z-07 f97f68be-6838-455c-91bf-7549543a82c3 TCGA-A8-A09X-01A-11D-A011-01 TCGA-A8-A09X-01 TCGA-A8-A09Z-01 Stage IIB 83 2 Stage IIB 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 Luminal B Negative Basal 0 -5 enrollment T_Other T3 LIVING TCGA-A8-A09Z-01 Iq cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 14 cluster 2 TCGA-A8-A09Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 83 Right TCGA-A8-A09Z TCGA-A8-A09Z-01A Positive Negative Other -30590 728 0 0 2011-5-27 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 320 NO Negative Negative Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 false No M0 N0 T3 Stage IIB TCGA-A8-A09Z.DF890966-D14E-4EDF-B6E3-E10E40BA5B5D.pdf A09Z WITH TUMOR Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2008 2c3ad15f-0d26-441e-8139-85194b3389f2 2c3ad15f-0d26-441e-8139-85194b3389f2 TCGA-A8-A09Z-01A-21-A13A-20 TCGA-A8-A09Z-01 c8b43014-8e13-462a-90c5-c38032e02d7a TCGA-A8-A09Z-01 TCGA-A8-A09Z-01A-11W-A019-09 TCGA-A8-A09Z-01A-11D-A00Y-05 TCGA-A8-A09Z-01 TCGA-A8-A09Z-01 2c3ad15f-0d26-441e-8139-85194b3389f2 TCGA-A8-A09Z-01 TCGA-A8-A09Z-01A-11D-A011-01 TCGA-A8-A09Z-01A-11R-A00Z-07 2c3ad15f-0d26-441e-8139-85194b3389f2 TCGA-A8-A09Z-01A-11D-A011-01 TCGA-A8-A09Z-01 TCGA-A8-A0A1-01 Stage IIA 84 2 Stage IIA 365 Positive FEMALE Negative Negative M0 Negative N0 365 0 LumA Luminal A Positive -5 -7 enrollment T_Other T2 LIVING TCGA-A8-A0A1-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation cluster 4 TCGA-A8-A0A1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 84 Right TCGA-A8-A0A1 TCGA-A8-A0A1-01A Positive Positive Other -30742 241 0 365 2011-5-27 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 90 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 false No M0 N0 T2 Stage IIA TCGA-A8-A0A1.3BC6CE69-2641-4B6D-85DF-E8FE838015D0.pdf A0A1 TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 8522865b-457c-4199-a870-bf8353f2b0a5 8522865b-457c-4199-a870-bf8353f2b0a5 TCGA-A8-A0A1-01A-11W-A019-09 TCGA-A8-A0A1-01 TCGA-A8-A0A1-01 TCGA-A8-A0A1-01A-11W-A019-09 TCGA-A8-A0A1-01A-11D-A00Y-05 TCGA-A8-A0A1-01 TCGA-A8-A0A1-01A-11W-A019-09 TCGA-A8-A0A1-01 8522865b-457c-4199-a870-bf8353f2b0a5 TCGA-A8-A0A1-01 TCGA-A8-A0A1-01A-11D-A011-01 TCGA-A8-A0A1-01A-11R-A00Z-07 8522865b-457c-4199-a870-bf8353f2b0a5 TCGA-A8-A0A1-01A-11D-A011-01 TCGA-A8-A0A1-01 TCGA-A8-A0A2-01 Stage IIA 66 2 Stage IIA 578 Positive FEMALE Negative Negative M0 Negative N0 578 0 LumA Luminal A Positive 0 -3 enrollment T_Other T2 LIVING TCGA-A8-A0A2-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A0A2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Lower Outer Quadrant TCGA-A8-A0A2 TCGA-A8-A0A2-01A Positive Positive Other -24380 394 0 579 2011-5-27 FEMALE 0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 70 NO Negative Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 false No M0 N0 T2 Stage IIA TCGA-A8-A0A2.6443B16E-E6D9-4A1D-B950-BEEC7BAEDBBE.pdf A0A2 TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 6330ab59-db9d-4b22-a96b-1024c9b4908d 6330ab59-db9d-4b22-a96b-1024c9b4908d TCGA-A8-A0A2-01A-11W-A050-09 TCGA-A8-A0A2-01 TCGA-A8-A0A2-01 TCGA-A8-A0A2-01A-11W-A050-09 TCGA-A8-A0A2-01A-11D-A032-05 TCGA-A8-A0A2-01 TCGA-A8-A0A2-01A-11W-A050-09 TCGA-A8-A0A2-01 6330ab59-db9d-4b22-a96b-1024c9b4908d TCGA-A8-A0A2-01 TCGA-A8-A0A2-01A-11D-A036-01 TCGA-A8-A0A2-01A-11R-A034-07 6330ab59-db9d-4b22-a96b-1024c9b4908d TCGA-A8-A0A2-01A-11D-A036-01 TCGA-A8-A0A2-01 TCGA-A8-A0A4-01 Stage IIA 73 2 Stage IIA 396 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 396 0 LumA Luminal A Positive ReacII -5 -7 enrollment T_Other T2 LIVING TCGA-A8-A0A4-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-A8-A0A4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left TCGA-A8-A0A4-F40326 TCGA-A8-A0A4 TCGA-A8-A0A4-01A Positive Positive Other -26693 272 0 396 2013-2-16 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 160 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 NO false No M0 N0 T2 Stage IIA TCGA-A8-A0A4.25F8F043-2CD0-4344-9B4A-5BBB691B5BF9.pdf A0A4 TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 d9d0e575-bca2-45e6-9df3-fb6fee59ccd9 d9d0e575-bca2-45e6-9df3-fb6fee59ccd9 TCGA-A8-A0A4-01A-21-A13A-20 TCGA-A8-A0A4-01A-11W-A019-09 TCGA-A8-A0A4-01 9748e726-7d5e-4e3c-ad24-ab078118010c TCGA-A8-A0A4-01 TCGA-A8-A0A4-01A-11W-A019-09 TCGA-A8-A0A4-01A-11D-A00Y-05 TCGA-A8-A0A4-01 TCGA-A8-A0A4-01A-11W-A019-09 TCGA-A8-A0A4-01 d9d0e575-bca2-45e6-9df3-fb6fee59ccd9 TCGA-A8-A0A4-01 TCGA-A8-A0A4-01A-11D-A011-01 TCGA-A8-A0A4-01A-11R-A00Z-07 d9d0e575-bca2-45e6-9df3-fb6fee59ccd9 TCGA-A8-A0A4-01A-11D-A011-01 TCGA-A8-A0A4-01 TCGA-A8-A0A6-01 Stage IIIC 64 2 Stage IIIC 640 Positive FEMALE Negative Negative M0 Positive N3 640 0 LumA Luminal A Positive -5 -4 enrollment T_Other T2 LIVING TCGA-A8-A0A6-01 BRCA-LUAD+ cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 TCGA-A8-A0A6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left Upper Outer Quadrant TCGA-A8-A0A6-F40325 TCGA-A8-A0A6 TCGA-A8-A0A6-01A Positive Positive Other -23404 394 0 640 2013-2-16 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 90 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 NO false No M0 N3a T2 Stage IIIC TCGA-A8-A0A6.161A2735-C3CF-466D-AE21-C6A2C987BB1E.pdf A0A6 TUMOR FREE YES YES Primary Tumor 01 surgical resection 6th NO YES A8 Breast A LIVING 2009 6ba764ba-f6ae-4977-8b7f-4e9528009eb0 6ba764ba-f6ae-4977-8b7f-4e9528009eb0 TCGA-A8-A0A6-01 TCGA-A8-A0A6-01A-12D-A10P-05 TCGA-A8-A0A6-01 TCGA-A8-A0A6-01A-12W-A071-09 TCGA-A8-A0A6-01 TCGA-A8-A0A6-01 6ba764ba-f6ae-4977-8b7f-4e9528009eb0 TCGA-A8-A0A6-01 TCGA-A8-A0A6-01A-12D-A059-01 TCGA-A8-A0A6-01A-12R-A056-07 6ba764ba-f6ae-4977-8b7f-4e9528009eb0 TCGA-A8-A0A6-01A-12D-A059-01 TCGA-A8-A0A6-01 TCGA-A8-A0A7-01 Stage IIB 57 3 Stage IIB 30 Negative FEMALE Positive 1 1 1 Negative M0 Positive N1 30 0 Her2 HER2-enriched Negative Her2 -2 -5 enrollment T_Other T2 LIVING TCGA-A8-A0A7-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-A8-A0A7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Upper Outer Quadrant TCGA-A8-A0A7 Negative Negative Other -20940 0 30 2011-5-27 FEMALE 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Positive Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 No M0 N1a T2 Stage IIB A0A7 TUMOR FREE Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2009 bae23acf-5981-4071-a7e1-6363ab128561 bae23acf-5981-4071-a7e1-6363ab128561 TCGA-A8-A0A7-01A-21-A13A-20 TCGA-A8-A0A7-01A-11W-A019-09 TCGA-A8-A0A7-01 d459629a-8ef9-4556-adfb-a3105e460556 TCGA-A8-A0A7-01 TCGA-A8-A0A7-01A-11W-A019-09 TCGA-A8-A0A7-01A-11D-A00Y-05 TCGA-A8-A0A7-01 TCGA-A8-A0A7-01A-11W-A019-09 TCGA-A8-A0A7-01 bae23acf-5981-4071-a7e1-6363ab128561 TCGA-A8-A0A7-01 TCGA-A8-A0A7-01A-11D-A011-01 TCGA-A8-A0A7-01A-11R-A040-07 bae23acf-5981-4071-a7e1-6363ab128561 TCGA-A8-A0A7-01A-11D-A011-01 TCGA-A8-A0A7-01 TCGA-A8-A0A9-01 Stage IIA 80 3 Stage IIA 396 Positive FEMALE Negative Negative M0 Negative N0 396 0 LumA Luminal B Positive 0 -3 enrollment T_Other T2 LIVING TCGA-A8-A0A9-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-A8-A0A9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left Upper Outer Quadrant TCGA-A8-A0A9-F40323 TCGA-A8-A0A9 TCGA-A8-A0A9-01A Positive Positive Other -29370 272 0 822 2013-2-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 100 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 NO false No M0 N0 T2 Stage IIA TCGA-A8-A0A9.8612388B-3680-4BD8-986C-E7ABE9F92F91.pdf A0A9 TUMOR FREE YES YES Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 1766e42e-f8cf-447d-a694-3999a1fec43a 1766e42e-f8cf-447d-a694-3999a1fec43a TCGA-A8-A0A9-01A-11W-A019-09 TCGA-A8-A0A9-01 TCGA-A8-A0A9-01 TCGA-A8-A0A9-01A-11W-A019-09 TCGA-A8-A0A9-01A-11D-A00Y-05 TCGA-A8-A0A9-01 TCGA-A8-A0A9-01A-11W-A019-09 TCGA-A8-A0A9-01 1766e42e-f8cf-447d-a694-3999a1fec43a TCGA-A8-A0A9-01 TCGA-A8-A0A9-01A-11D-A011-01 TCGA-A8-A0A9-01A-11R-A00Z-07 1766e42e-f8cf-447d-a694-3999a1fec43a TCGA-A8-A0A9-01A-11D-A011-01 TCGA-A8-A0A9-01 TCGA-A8-A0AB-01 Stage IIA 54 2 Stage IIA 517 Positive FEMALE Negative Negative M0 Negative N0 517 0 LumA Luminal B Positive -1 -3 enrollment T_Other T2 LIVING TCGA-A8-A0AB-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-A8-A0AB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Outer Quadrant TCGA-A8-A0AB-F40322 TCGA-A8-A0AB TCGA-A8-A0AB-01A Positive Positive Other -19814 394 0 518 2013-2-16 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 70 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO false No M0 N0 T2 Stage IIA TCGA-A8-A0AB.E4D30B42-383A-40BF-BB91-511A90227655.pdf A0AB TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast A LIVING 2009 83fe3d7b-6905-49ea-bbc8-ea9c468004f6 83fe3d7b-6905-49ea-bbc8-ea9c468004f6 TCGA-A8-A0AB-01A-11W-A050-09 TCGA-A8-A0AB-01 TCGA-A8-A0AB-01 TCGA-A8-A0AB-01A-11W-A050-09 TCGA-A8-A0AB-01A-11D-A032-05 TCGA-A8-A0AB-01 TCGA-A8-A0AB-01A-11W-A050-09 TCGA-A8-A0AB-01 83fe3d7b-6905-49ea-bbc8-ea9c468004f6 TCGA-A8-A0AB-01 TCGA-A8-A0AB-01A-11D-A036-01 TCGA-A8-A0AB-01A-11R-A034-07 83fe3d7b-6905-49ea-bbc8-ea9c468004f6 TCGA-A8-A0AB-01A-11D-A036-01 TCGA-A8-A0AB-01 TCGA-A8-A0AD-01 Stage I 83 2 Stage I 1157 Positive FEMALE Negative Negative M0 Negative N0 1157 0 LumA Luminal A Positive -12 -3 enrollment T1 T1 LIVING TCGA-A8-A0AD-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation c1uster 9 TCGA-A8-A0AD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 83 Right Upper Outer Quadrant TCGA-A8-A0AD-F40321 TCGA-A8-A0AD Positive Positive Other -30407 0 1157 2013-2-16 FEMALE 1+ Mixed Histology (please specify) lobular/ductal No C50.9 8522/3 C50.9 YES Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO No M0 N0 T1c Stage I A0AD TUMOR FREE YES NO Primary Tumor 01 Surgical Resection 6th NO YES A8 Breast LIVING 2007 b62f3825-9634-4252-b841-4c455a007353 b62f3825-9634-4252-b841-4c455a007353 TCGA-A8-A0AD-01A-11W-A071-09 TCGA-A8-A0AD-01 TCGA-A8-A0AD-01A-11D-A10P-05 TCGA-A8-A0AD-01 TCGA-A8-A0AD-01A-11W-A071-09 TCGA-A8-A0AD-01 TCGA-A8-A0AD-01A-11W-A071-09 TCGA-A8-A0AD-01 b62f3825-9634-4252-b841-4c455a007353 TCGA-A8-A0AD-01 TCGA-A8-A0AD-01A-11D-A059-01 TCGA-A8-A0AD-01A-11R-A056-07 b62f3825-9634-4252-b841-4c455a007353 TCGA-A8-A0AD-01A-11D-A059-01 TCGA-A8-A0AD-01 TCGA-AC-A23C-01 62 3 Stage IIB 29 Positive FEMALE Positive Negative M0 Positive N1 29 0 LumA Positive enrollment T_Other T2 LIVING TCGA-AC-A23C-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation cluster 4 TCGA-AC-A23C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left TCGA-AC-A23C-F43235 TCGA-AC-A23C TCGA-AC-A23C-01A Positive Positive Modified Radical Mastectomy -22751 198 0 585 NO 90-99% 2013-5-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 100 NO Positive Positive NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 NO 1 false No MX N1 T2 Stage IIB TCGA-AC-A23C.926E93B6-EF7C-4F13-824D-13D08B7F7938.pdf A23C TUMOR FREE YES YES 50-59% NO Primary Tumor 01 7th NO YES AC Breast A LIVING 2010 052b565f-1955-4c4e-8b1f-dd48743ba944 052b565f-1955-4c4e-8b1f-dd48743ba944 TCGA-AC-A23C-01A-21-A17I-20 TCGA-AC-A23C-01A-12D-A167-09 TCGA-AC-A23C-01 TCGA-AC-A23C-01A-12D-A16A-05 53968cee-b8a9-43d6-b9cd-d4b9cd39baf0 TCGA-AC-A23C-01 TCGA-AC-A23C-01A-12D-A167-09 TCGA-AC-A23C-01 TCGA-AC-A23C-01A-12D-A167-09 052b565f-1955-4c4e-8b1f-dd48743ba944 TCGA-AC-A23C-01A-12D-A166-01 TCGA-AC-A23C-01 052b565f-1955-4c4e-8b1f-dd48743ba944 TCGA-AC-A23C-01A-12D-A166-01 TCGA-AC-A23E-01 50 2 Stage IIB 72 Positive FEMALE Negative Negative M0 Positive N1 72 0 LumA Positive enrollment T_Other T2 LIVING TCGA-AC-A23E-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 mutation cluster 4 TCGA-AC-A23E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Sentinel node biopsy alone TCGA-AC-A23E-F43240 TCGA-AC-A23E TCGA-AC-A23E-01A Positive Positive Modified Radical Mastectomy -18500 158 0 698 NO 30-39% 2013-5-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 130 NO NO 2 Negative 2 NO 1 false No MX N1 T2 Stage IIB TCGA-AC-A23E.C976ACED-7FF8-4287-9D68-C6FD17895FC0.pdf A23E TUMOR FREE YES YES 80-89% YES Primary Tumor 01 7th AC Breast A LIVING 2010 25be50e7-7705-492d-a44a-0e40180d10c8 25be50e7-7705-492d-a44a-0e40180d10c8 TCGA-AC-A23E-01A-21-A17I-20 TCGA-AC-A23E-01A-11D-A159-09 TCGA-AC-A23E-01 TCGA-AC-A23E-01A-11D-A161-05 f5ca4ea4-d35a-456e-aabb-0aec9f48a7be TCGA-AC-A23E-01 TCGA-AC-A23E-01A-11D-A159-09 TCGA-AC-A23E-01 TCGA-AC-A23E-01A-11D-A159-09 25be50e7-7705-492d-a44a-0e40180d10c8 TCGA-AC-A23E-01A-11D-A160-01 TCGA-AC-A23E-01 25be50e7-7705-492d-a44a-0e40180d10c8 TCGA-AC-A23E-01A-11D-A160-01 TCGA-AC-A23G-01 LumA TCGA-AC-A23G-01 Iq BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AC-A23G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Right Upper Inner Quadrant TCGA-AC-A23G-F43241 TCGA-AC-A23G TCGA-AC-A23G-01A Positive Positive Other -27934 1590 0 2248 NO 90-99% 2013-5-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 40 NO Positive Positive NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 false No MX N1 T1c Stage IIA TCGA-AC-A23G.810663DD-1718-4FD6-B9C2-77B4C091B3F1.pdf A23G TUMOR FREE YES YES 80-89% NO Primary Tumor 01 Right Total Mastectomy and Sentinel Node Biopsy 6th NO YES AC Breast A LIVING 2006 3cd0b704-99b5-401b-8f52-daead9359692 3cd0b704-99b5-401b-8f52-daead9359692 TCGA-AC-A23G-01 TCGA-AC-A23G-01A-11D-A212-05 TCGA-AC-A23G-01 TCGA-AC-A23G-01A-11D-A20S-09 TCGA-AC-A23G-01 3cd0b704-99b5-401b-8f52-daead9359692 TCGA-AC-A23G-01A-11D-A20R-01 TCGA-AC-A23G-01 3cd0b704-99b5-401b-8f52-daead9359692 TCGA-AC-A23G-01A-11D-A20R-01 TCGA-AC-A23H-01 90 3 Stage IIA 81 Positive FEMALE Positive Negative M0 Negative N0 81 0 Her2 Negative enrollment T_Other T2 LIVING TCGA-AC-A23H-01 High cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AC-A23H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Right Upper Inner Quadrant|Right Lower Inner Quadrant TCGA-AC-A23H-F45572 TCGA-AC-A23H TCGA-AC-A23H-01A Positive Negative Simple Mastectomy -32873 478 174 0 81 NO 10-19% 2013-7-17 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 70 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO false No M0 NX T2 Stage IIA TCGA-AC-A23H.A7C7D409-D086-4A9B-8C8F-E7E231D5891D.pdf A23H WITH TUMOR NO NO NO Primary Tumor 01 7th NO YES AC Breast A DECEASED 2009 28199d71-9111-4763-a07f-66734769bb98 28199d71-9111-4763-a07f-66734769bb98 TCGA-AC-A23H-01 TCGA-AC-A23H-01A-11D-A161-05 TCGA-AC-A23H-01 TCGA-AC-A23H-01A-11D-A159-09 TCGA-AC-A23H-01 28199d71-9111-4763-a07f-66734769bb98 TCGA-AC-A23H-01A-11D-A160-01 TCGA-AC-A23H-01 28199d71-9111-4763-a07f-66734769bb98 TCGA-AC-A23H-01A-11D-A160-01 TCGA-AC-A23H-11 90 81 FEMALE 81 0 Normal enrollment LIVING TCGA-AC-A23H-11 TCGA-AC-A23H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Right Upper Inner Quadrant|Right Lower Inner Quadrant TCGA-AC-A23H-F45572 TCGA-AC-A23H TCGA-AC-A23H-11A Positive Negative Simple Mastectomy -32873 478 174 0 81 NO 10-19% 2013-7-17 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 70 NO Positive Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false No M0 NX T2 Stage IIA A23H WITH TUMOR NO NO NO Solid Tissue Normal 11 7th NO YES AC Breast A DECEASED 2009 93108690-ccc2-4ae4-89e0-042a654a0228 93108690-ccc2-4ae4-89e0-042a654a0228 TCGA-AC-A23H-11A-12D-A161-05 TCGA-AC-A23H-11 93108690-ccc2-4ae4-89e0-042a654a0228 TCGA-AC-A23H-11 93108690-ccc2-4ae4-89e0-042a654a0228 TCGA-AC-A2B8-01 2 LumA TCGA-AC-A2B8-01 Iq C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AC-A2B8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES 84 Right Axillary lymph node dissection alone TCGA-AC-A2B8-F43210 TCGA-AC-A2B8 TCGA-AC-A2B8-01A Positive Positive Simple Mastectomy -31003 101 0 677 672 654 NO 90-99% 2013-5-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 150 NO Negative Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 Other, specify New Primary Tumor Rectum YES YES 0 0 false No M0 N0 (i-) T3 Stage IIB TCGA-AC-A2B8.3D878253-22B3-4A53-AE54-C0D95E085DB1.pdf A2B8 TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 ed74a7e1-90de-4943-9ca2-e7f94a5540e4 ed74a7e1-90de-4943-9ca2-e7f94a5540e4 TCGA-AC-A2B8-01A-21-A24A-20 TCGA-AC-A2B8-01 TCGA-AC-A2B8-01A-11D-A17F-05 7365ebda-a4f6-4d52-bed9-220059dc5e5e TCGA-AC-A2B8-01 TCGA-AC-A2B8-01A-11D-A17D-09 TCGA-AC-A2B8-01 ed74a7e1-90de-4943-9ca2-e7f94a5540e4 TCGA-AC-A2B8-01A-11D-A17C-01 TCGA-AC-A2B8-01 ed74a7e1-90de-4943-9ca2-e7f94a5540e4 TCGA-AC-A2B8-01A-11D-A17C-01 TCGA-AC-A2BK-01 Basal TCGA-AC-A2BK-01 High C4-BRCA/Basal BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 TCGA-AC-A2BK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AC-A2BK-F43987 TCGA-AC-A2BK TCGA-AC-A2BK-01A Negative Negative Modified Radical Mastectomy NO -28625 1717 0 2222 NO 2013-6-10 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 140 NO Negative NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 6 false No MX N2a T2 Stage IIIA TCGA-AC-A2BK.3E54B0CE-8863-4728-BC95-A47C1869F52A.pdf A2BK TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES AC Breast A LIVING 2006 08893743-829b-4594-ab67-d5eb5e80a4f3 08893743-829b-4594-ab67-d5eb5e80a4f3 TCGA-AC-A2BK-01A-21-A24A-20 TCGA-AC-A2BK-01 TCGA-AC-A2BK-01A-11D-A21R-05 1392fc51-37de-493d-a7e9-01269e73c9c5 TCGA-AC-A2BK-01 TCGA-AC-A2BK-01A-11D-A21Q-09 TCGA-AC-A2BK-01 08893743-829b-4594-ab67-d5eb5e80a4f3 TCGA-AC-A2BK-01A-11D-A21P-01 TCGA-AC-A2BK-01 08893743-829b-4594-ab67-d5eb5e80a4f3 TCGA-AC-A2BK-01A-11D-A21P-01 TCGA-AC-A2BM-01 LumB TCGA-AC-A2BM-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AC-A2BM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A2BM-F66202 TCGA-AC-A2BM TCGA-AC-A2BM-01A Positive Positive Modified Radical Mastectomy YES -15212 2164 0 3022 NO 60-69% 2014-10-3 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 120 NO Negative NO 13 Negative NO 1 1 false No MX N1a T2 Stage IIB TCGA-AC-A2BM.9F00B6F4-EE91-4A18-B533-127E39EF8554.pdf A2BM TUMOR FREE NO YES 10-19% NO Primary Tumor 01 6th NO YES AC Breast A LIVING 2005 54f1981b-9d8f-48cc-9586-d2e9a8d468f5 54f1981b-9d8f-48cc-9586-d2e9a8d468f5 TCGA-AC-A2BM-01A-21-A24A-20 TCGA-AC-A2BM-01 TCGA-AC-A2BM-01A-11D-A21R-05 2222f10b-39fd-4aa4-8021-7f320c835f88 TCGA-AC-A2BM-01 TCGA-AC-A2BM-01A-11D-A21Q-09 TCGA-AC-A2BM-01 54f1981b-9d8f-48cc-9586-d2e9a8d468f5 TCGA-AC-A2BM-01A-11D-A21P-01 TCGA-AC-A2BM-01 54f1981b-9d8f-48cc-9586-d2e9a8d468f5 TCGA-AC-A2BM-01A-11D-A21P-01 TCGA-AC-A2FB-01 3 LumA TCGA-AC-A2FB-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AC-A2FB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-AC-A2FB-F45574 TCGA-AC-A2FB TCGA-AC-A2FB-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy NO -23851 576 0 1234 NO 90-99% 2013-7-17 FEMALE 10-19% 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Core needle biopsy 140 NO Positive NO 1 Negative 1 NO 0 false No MX N0 T2 Stage IIA TCGA-AC-A2FB.F6CFE506-16BA-475A-A81F-1AC4B2EFE24A.pdf A2FB TUMOR FREE YES YES <10% NO Primary Tumor 01 6th NO YES AC Breast A LIVING 2009 fce0d59e-78a5-4d7b-8136-b8421f5116b0 fce0d59e-78a5-4d7b-8136-b8421f5116b0 TCGA-AC-A2FB-01A-21-A24A-20 TCGA-AC-A2FB-01 TCGA-AC-A2FB-01A-11D-A17F-05 6bde7ec5-1170-4bdf-afa6-bff4642ef9e3 TCGA-AC-A2FB-01 TCGA-AC-A2FB-01A-11D-A17D-09 TCGA-AC-A2FB-01 fce0d59e-78a5-4d7b-8136-b8421f5116b0 TCGA-AC-A2FB-01A-11D-A17C-01 TCGA-AC-A2FB-01 fce0d59e-78a5-4d7b-8136-b8421f5116b0 TCGA-AC-A2FB-01A-11D-A17C-01 TCGA-AC-A2FB-11 Normal TCGA-AC-A2FB-11 C3-BRCA/Luminal TCGA-AC-A2FB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-AC-A2FB-F45574 TCGA-AC-A2FB Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy NO -23851 0 1234 NO 90-99% 2013-7-17 FEMALE 10-19% 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Core needle biopsy Positive NO 1 Negative NO 0 No MX N0 T2 Stage IIA A2FB TUMOR FREE YES YES <10% NO Solid Tissue Normal 11 6th NO YES AC Breast LIVING 2009 f18b2ff7-eddb-40b5-9bbe-7ef09787ddef f18b2ff7-eddb-40b5-9bbe-7ef09787ddef TCGA-AC-A2FB-11A-13D-A17F-05 TCGA-AC-A2FB-11 f18b2ff7-eddb-40b5-9bbe-7ef09787ddef TCGA-AC-A2FB-11 f18b2ff7-eddb-40b5-9bbe-7ef09787ddef TCGA-AC-A2FE-01 TCGA-AC-A2FE-01 BRCA-LUAD+ BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 5 TCGA-AC-A2FE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A2FE-F47725 TCGA-AC-A2FE TCGA-AC-A2FE-01A Positive Positive Modified Radical Mastectomy NO -22746 2228 2636 0 791 2496 60-69% 2013-8-28 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 120 NO NO 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Liver Distant Metastasis NO YES 18 false No MX N3a T3 Stage IIIC TCGA-AC-A2FE.F694CBD6-880D-40C7-AB17-D0AD02B7F06B.pdf A2FE WITH TUMOR YES YES <10% YES Primary Tumor 01 6th NO YES AC Breast A DECEASED 2005 22e03b77-aa0f-4348-98c1-9b0914e8af8b 22e03b77-aa0f-4348-98c1-9b0914e8af8b TCGA-AC-A2FE-01A-21-A24A-20 TCGA-AC-A2FE-01 TCGA-AC-A2FE-01A-11D-A19Z-05 419206c6-a1d6-4541-b154-10aae75b04a2 TCGA-AC-A2FE-01 TCGA-AC-A2FE-01A-11D-A19Y-09 TCGA-AC-A2FE-01 22e03b77-aa0f-4348-98c1-9b0914e8af8b TCGA-AC-A2FE-01A-11D-A19X-01 TCGA-AC-A2FE-01 22e03b77-aa0f-4348-98c1-9b0914e8af8b TCGA-AC-A2FE-01A-11D-A19X-01 TCGA-AC-A2FF-01 1 LumA TCGA-AC-A2FF-01 Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AC-A2FF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A2FF-F58655 TCGA-AC-A2FF TCGA-AC-A2FF-01A Positive Positive Lumpectomy YES 1904 0 2759 NO 30-39% 2014-4-17 FEMALE 1.7 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 130 NO Negative NO 7 Negative 1 NO 3 0 false No MX N1 T2 Stage IIB TCGA-AC-A2FF.E6897E14-465A-486A-A6AD-FCFED21629F2.pdf A2FF TUMOR FREE YES YES 70-79% YES Primary Tumor 01 6th NO YES AC Breast A LIVING 2006 f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8 f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8 TCGA-AC-A2FF-01A-21-A24A-20 TCGA-AC-A2FF-01 TCGA-AC-A2FF-01A-11D-A17F-05 588f1cc2-09a3-4ffa-b934-a8b7c4c8524c TCGA-AC-A2FF-01 TCGA-AC-A2FF-01A-11D-A17D-09 TCGA-AC-A2FF-01 f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8 TCGA-AC-A2FF-01A-11D-A17C-01 TCGA-AC-A2FF-01 f99cbdbb-ae9c-4dc2-9b69-eeaa7798c2b8 TCGA-AC-A2FF-01A-11D-A17C-01 TCGA-AC-A2FF-11 Normal TCGA-AC-A2FF-11 C3-BRCA/Luminal TCGA-AC-A2FF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A2FF-F58655 TCGA-AC-A2FF TCGA-AC-A2FF-11A Positive Positive Lumpectomy YES 1904 0 2759 NO 30-39% 2014-4-17 FEMALE 1.7 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 80 NO Negative NO 7 Negative NO 3 0 false No MX N1 T2 Stage IIB A2FF TUMOR FREE YES YES 70-79% YES Solid Tissue Normal 11 6th NO YES AC Breast A LIVING 2006 3610639e-d947-446f-8483-86be65c80ed3 3610639e-d947-446f-8483-86be65c80ed3 TCGA-AC-A2FF-11A-13D-A17F-05 3610639e-d947-446f-8483-86be65c80ed3 3610639e-d947-446f-8483-86be65c80ed3 TCGA-AC-A2FG-01 2 LumA TCGA-AC-A2FG-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 TCGA-AC-A2FG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A2FG-F43221 TCGA-AC-A2FG TCGA-AC-A2FG-01A Positive Negative Modified Radical Mastectomy YES -29211 1517 0 1853 NO 90-99% 2013-5-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 120 NO Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 1 1 false No MX N1a T2 Stage IIB TCGA-AC-A2FG.C1ABCD83-40EA-4FF7-BEB6-69679589E8E7.pdf A2FG TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES AC Breast A LIVING 2007 c4cc228f-ab41-4779-b405-175618e5f77c c4cc228f-ab41-4779-b405-175618e5f77c TCGA-AC-A2FG-01A-21-A24A-20 TCGA-AC-A2FG-01 TCGA-AC-A2FG-01A-11D-A17F-05 4be4e39c-7061-4ef0-8347-75622194af98 TCGA-AC-A2FG-01 TCGA-AC-A2FG-01A-11D-A17D-09 TCGA-AC-A2FG-01 c4cc228f-ab41-4779-b405-175618e5f77c TCGA-AC-A2FG-01A-11D-A17C-01 TCGA-AC-A2FG-01 c4cc228f-ab41-4779-b405-175618e5f77c TCGA-AC-A2FG-01A-11D-A17C-01 TCGA-AC-A2FG-11 TCGA-AC-A2FG-11 C3-BRCA/Luminal TCGA-AC-A2FG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A2FG-F43221 TCGA-AC-A2FG TCGA-AC-A2FG-11A Positive Negative Modified Radical Mastectomy YES -29211 1517 0 1853 NO 90-99% 2013-5-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 120 NO Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 1 false No MX N1a T2 Stage IIB A2FG TUMOR FREE YES YES NO Solid Tissue Normal 11 6th NO YES AC Breast A LIVING 2007 TCGA-AC-A2FG-11A-22D-A17F-05 TCGA-AC-A2FK-01 Normal TCGA-AC-A2FK-01 Quiet Low purity c2 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-AC-A2FK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Outer Quadrant TCGA-AC-A2FK-F66196 TCGA-AC-A2FK TCGA-AC-A2FK-01A Positive Positive Modified Radical Mastectomy -16627 1833 0 2650 NO 90-99% 2014-10-3 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 80 NO Negative NO 3 Negative NO 3 false No M0 N3a T2 Stage IIIC TCGA-AC-A2FK.1CF3FA64-EAE6-4A18-9B51-F5980A885371.pdf A2FK TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES AC Breast A LIVING 2006 1fff796f-626b-4408-9fd1-4fea54e153a6 1fff796f-626b-4408-9fd1-4fea54e153a6 TCGA-AC-A2FK-01 TCGA-AC-A2FK-01A-12D-A17Z-05 TCGA-AC-A2FK-01 TCGA-AC-A2FK-01A-12D-A17W-09 TCGA-AC-A2FK-01 1fff796f-626b-4408-9fd1-4fea54e153a6 TCGA-AC-A2FK-01A-12D-A17U-01 TCGA-AC-A2FK-01 1fff796f-626b-4408-9fd1-4fea54e153a6 TCGA-AC-A2FK-01A-12D-A17U-01 TCGA-AC-A2FM-01 TCGA-AC-A2FM-01 High BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 5 TCGA-AC-A2FM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 87 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-AC-A2FM-F43237 TCGA-AC-A2FM TCGA-AC-A2FM-01A Modified Radical Mastectomy YES -31805 2606 792 0 780 YES 2013-5-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 170 NO NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify Distant Metastasis Bone Marrow NO YES 0 0 false No M0 N1mi T2 Stage IIB TCGA-AC-A2FM.83BA3E82-E8E4-4A70-ADEE-A1360940EECE.pdf A2FM WITH TUMOR NO YES NO Primary Tumor 01 6th NO YES AC Breast A DECEASED 2004 c1280be2-b926-4632-975a-fe52bb04c65d c1280be2-b926-4632-975a-fe52bb04c65d TCGA-AC-A2FM-01A-21-A24A-20 TCGA-AC-A2FM-01 TCGA-AC-A2FM-01A-11D-A19Z-05 26f52e65-dac7-4cd4-9d02-7d01c2c6f0b7 TCGA-AC-A2FM-01 TCGA-AC-A2FM-01A-11D-A19Y-09 TCGA-AC-A2FM-01 c1280be2-b926-4632-975a-fe52bb04c65d TCGA-AC-A2FM-01A-11D-A19X-01 TCGA-AC-A2FM-01 c1280be2-b926-4632-975a-fe52bb04c65d TCGA-AC-A2FM-01A-11D-A19X-01 TCGA-AC-A2FM-11 TCGA-AC-A2FM-11 TCGA-AC-A2FM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 87 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-AC-A2FM-F43237 TCGA-AC-A2FM TCGA-AC-A2FM-11B Modified Radical Mastectomy YES -31805 2733 792 0 780 YES 2013-5-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 220 NO NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify Distant Metastasis Bone Marrow NO YES 0 0 false No M0 N1mi T2 Stage IIB A2FM WITH TUMOR NO YES NO Solid Tissue Normal 11 6th NO YES AC Breast B DECEASED 2004 68ec8441-f60a-4c80-8a9f-7609a0f81430 68ec8441-f60a-4c80-8a9f-7609a0f81430 TCGA-AC-A2FM-11B-32D-A19Z-05 TCGA-AC-A2FM-11 68ec8441-f60a-4c80-8a9f-7609a0f81430 TCGA-AC-A2FM-11 68ec8441-f60a-4c80-8a9f-7609a0f81430 TCGA-AC-A2FO-01 LumA TCGA-AC-A2FO-01 Iq BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 TCGA-AC-A2FO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Outer Quadrant Other (specify) Sentinel lymph node plus Level I and Level II lymph nodes TCGA-AC-A2FO-F43223 TCGA-AC-A2FO Positive Negative Simple Mastectomy NO -23928 0 2255 NO 90-99% 2013-5-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative Indeterminate NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 No MX N1 T2 Stage IIB A2FO TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES AC Breast LIVING 2005 bd07aa68-708b-4bd3-88b9-78a8b9e298f5 bd07aa68-708b-4bd3-88b9-78a8b9e298f5 TCGA-AC-A2FO-01 TCGA-AC-A2FO-01A-11D-A17Z-05 TCGA-AC-A2FO-01 TCGA-AC-A2FO-01A-11D-A17W-09 TCGA-AC-A2FO-01 bd07aa68-708b-4bd3-88b9-78a8b9e298f5 TCGA-AC-A2FO-01A-11D-A17U-01 TCGA-AC-A2FO-01 bd07aa68-708b-4bd3-88b9-78a8b9e298f5 TCGA-AC-A2FO-01A-11D-A17U-01 TCGA-AC-A2QH-01 Basal TCGA-AC-A2QH-01 Squamous Cluster 5 GBM-like c6 miRNA cluster 13 TCGA-AC-A2QH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AC-A2QH-F64100 TCGA-AC-A2QH Negative Negative Modified Radical Mastectomy YES -21488 0 1005 NO 2014-8-26 FEMALE Metaplastic Carcinoma No C50.9 8575/3 C50.9 YES Core needle biopsy Negative NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 No MX N0 T3 Stage IIB A2QH TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO AC Breast LIVING 2011 d848ad65-9261-4854-a6bd-e76484c6a337 d848ad65-9261-4854-a6bd-e76484c6a337 TCGA-AC-A2QH-01 TCGA-AC-A2QH-01A-11D-A18O-05,TCGA-AC-A2QH-01B-04D-A22R-05 TCGA-AC-A2QH-01 TCGA-AC-A2QH-01B-04D-A22N-09,TCGA-AC-A2QH-01A-11D-A18P-09 TCGA-AC-A2QH-01 d848ad65-9261-4854-a6bd-e76484c6a337 TCGA-AC-A2QH-01A-11D-A18N-01 TCGA-AC-A2QH-01 d848ad65-9261-4854-a6bd-e76484c6a337 TCGA-AC-A2QH-01A-11D-A18N-01 TCGA-AC-A2QI-01 TCGA-AC-A2QI-01 BRCA-LUAD+ BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 3 TCGA-AC-A2QI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Right Sentinel node biopsy alone TCGA-AC-A2QI-F57047 TCGA-AC-A2QI TCGA-AC-A2QI-01A Positive Negative Other -27865 91 0 588 NO 90-99% 2014-2-28 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 140 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 false No MX N1a T3 Stage IIIA TCGA-AC-A2QI.5CF85AF1-D227-430C-99CD-C2A524CFFA29.pdf A2QI TUMOR FREE YES YES YES Primary Tumor 01 Total Mastectomy 7th YES NO AC Breast A LIVING 2011 d620baa1-c329-46c6-a56a-dc08dfa23470 d620baa1-c329-46c6-a56a-dc08dfa23470 TCGA-AC-A2QI-01A-21-A24A-20 TCGA-AC-A2QI-01 TCGA-AC-A2QI-01A-12D-A19Z-05 3d65de31-a929-4c60-af58-5c24b7e3d6a5 TCGA-AC-A2QI-01 TCGA-AC-A2QI-01A-12D-A19Y-09 TCGA-AC-A2QI-01 d620baa1-c329-46c6-a56a-dc08dfa23470 TCGA-AC-A2QI-01A-12D-A19X-01 TCGA-AC-A2QI-01 d620baa1-c329-46c6-a56a-dc08dfa23470 TCGA-AC-A2QI-01A-12D-A19X-01 TCGA-AC-A2QJ-01 TCGA-AC-A2QJ-01 BRCA-LUAD+ BRCA non-CIMP c9 KIRC-like c1 miRNA cluster 5 TCGA-AC-A2QJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES 48 Left Upper Outer Quadrant|Left Lower Outer Quadrant Other (specify) Sentinel lymph node and axillary lymph node biopsy TCGA-AC-A2QJ-F44021 TCGA-AC-A2QJ TCGA-AC-A2QJ-01A Negative Negative Other NO -17569 160 446 0 69 237 NO 2013-6-28 FEMALE Metaplastic Carcinoma No C50.9 8575/3 C50.9 YES Core needle biopsy 150 NO Negative NO 2 Negative Peri (6-12 months since last menstrual period) Bone Distant Metastasis NO YES 0 false No M0 N0 T4b Stage IIIB TCGA-AC-A2QJ.E422C6E8-084F-42B8-84E7-4EF387F098C7.pdf A2QJ WITH TUMOR YES YES YES Primary Tumor 01 Mastectomy 7th YES NO AC Breast A DECEASED 2011 49a0f1eb-6ece-48fc-970f-3922263fd20b 49a0f1eb-6ece-48fc-970f-3922263fd20b TCGA-AC-A2QJ-01A-21-A24A-20 TCGA-AC-A2QJ-01 TCGA-AC-A2QJ-01A-12D-A19Z-05 5755434d-e797-4963-b728-caefc7bd49d5 TCGA-AC-A2QJ-01 TCGA-AC-A2QJ-01A-12D-A19Y-09 TCGA-AC-A2QJ-01 49a0f1eb-6ece-48fc-970f-3922263fd20b TCGA-AC-A2QJ-01A-12D-A19X-01 TCGA-AC-A2QJ-01 49a0f1eb-6ece-48fc-970f-3922263fd20b TCGA-AC-A2QJ-01A-12D-A19X-01 TCGA-AC-A3BB-01 TCGA-AC-A3BB-01 BRCA-LUAD+ BRCA non-CIMP c9 miRNA cluster 5 TCGA-AC-A3BB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AC-A3BB-F58953 TCGA-AC-A3BB TCGA-AC-A3BB-01A Positive Positive Modified Radical Mastectomy -16983 106 0 987 NO 90-99% 2014-4-29 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 160 NO Negative NO 14 Negative NO 5 false No MX N2a T3 Stage IIIA TCGA-AC-A3BB.4D864947-076C-4A66-940D-682E75E525A2.pdf A3BB TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa 5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa TCGA-AC-A3BB-01 TCGA-AC-A3BB-01A-21D-A19Z-05 TCGA-AC-A3BB-01 TCGA-AC-A3BB-01A-21D-A19Y-09 TCGA-AC-A3BB-01 5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa TCGA-AC-A3BB-01A-21D-A19X-01 TCGA-AC-A3BB-01 5b9b0b0c-c751-4b7d-9951-a8f6a13e1afa TCGA-AC-A3BB-01A-21D-A19X-01 TCGA-AC-A3EH-01 TCGA-AC-A3EH-01 BRCA-LUAD+ BRCA CIMP c7 miRNA c1uster 9 TCGA-AC-A3EH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Axillary lymph node dissection alone TCGA-AC-A3EH-F65834 TCGA-AC-A3EH TCGA-AC-A3EH-01A Positive Negative Modified Radical Mastectomy NO -29014 67 197 0 17 2014-9-30 FEMALE Infiltrating Lobular Carcinoma No C50.9 8022/3 C50.9 YES Excisional Biopsy 150 NO Negative Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 12 false No M0 N3 T3 Stage IIIC TCGA-AC-A3EH.3094774B-B764-4D60-BFF3-48FEF39F4BEA.pdf A3EH TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO AC Breast A DECEASED 2011 616255fe-88b3-4567-ae8d-bd68dd8380a3 616255fe-88b3-4567-ae8d-bd68dd8380a3 TCGA-AC-A3EH-01 TCGA-AC-A3EH-01A-22D-A22B-05 TCGA-AC-A3EH-01 TCGA-AC-A3EH-01A-22D-A228-09 TCGA-AC-A3EH-01 616255fe-88b3-4567-ae8d-bd68dd8380a3 TCGA-AC-A3EH-01A-22D-A227-01 TCGA-AC-A3EH-01 616255fe-88b3-4567-ae8d-bd68dd8380a3 TCGA-AC-A3EH-01A-22D-A227-01 TCGA-AC-A3HN-01 LumA TCGA-AC-A3HN-01 Iq C3-BRCA/Luminal BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AC-A3HN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 87 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-AC-A3HN-F65835 TCGA-AC-A3HN TCGA-AC-A3HN-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Simple Mastectomy YES -32061 97 0 496 NO 90-99% 2014-9-30 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 160 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 0 false No MX N1a T2 Stage IIB TCGA-AC-A3HN.F0308FC8-D8B4-487F-A072-05E66D01842A.pdf A3HN TUMOR FREE YES YES <10% NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 79a14838-69d2-4c73-83a7-b57ff6ecdd79 79a14838-69d2-4c73-83a7-b57ff6ecdd79 TCGA-AC-A3HN-01A-21-A24A-20 TCGA-AC-A3HN-01 TCGA-AC-A3HN-01A-11D-A212-05 b7044729-14de-486e-932a-ed425ff476f0 TCGA-AC-A3HN-01 TCGA-AC-A3HN-01A-11D-A20S-09 TCGA-AC-A3HN-01 79a14838-69d2-4c73-83a7-b57ff6ecdd79 TCGA-AC-A3HN-01A-11D-A20R-01 TCGA-AC-A3HN-01 79a14838-69d2-4c73-83a7-b57ff6ecdd79 TCGA-AC-A3HN-01A-11D-A20R-01 TCGA-AC-A3OD-01 LumA TCGA-AC-A3OD-01 High BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 TCGA-AC-A3OD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A3OD-F45582 TCGA-AC-A3OD TCGA-AC-A3OD-01A Positive Positive Modified Radical Mastectomy YES -25186 63 0 451 NO 90-99% 2013-7-17 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 30 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 false No MX N1mi T2 Stage IIB TCGA-AC-A3OD.9F7E2B98-29E7-465F-AE12-33D78FDFD71A.pdf A3OD TUMOR FREE NO YES 90-99% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 7c521ef7-4adf-46ef-ade0-088cbe02223d 7c521ef7-4adf-46ef-ade0-088cbe02223d TCGA-AC-A3OD-01 TCGA-AC-A3OD-01B-06D-A22R-05,TCGA-AC-A3OD-01A-11D-A21R-05 TCGA-AC-A3OD-01 TCGA-AC-A3OD-01B-06D-A22N-09,TCGA-AC-A3OD-01A-11D-A21Q-09 TCGA-AC-A3OD-01 7c521ef7-4adf-46ef-ade0-088cbe02223d TCGA-AC-A3OD-01A-11D-A21P-01 TCGA-AC-A3OD-01 7c521ef7-4adf-46ef-ade0-088cbe02223d TCGA-AC-A3OD-01A-11D-A21P-01 TCGA-AC-A3QP-01 TCGA-AC-A3QP-01 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-AC-A3QP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Sentinel node biopsy alone TCGA-AC-A3QP-F56161 TCGA-AC-A3QP TCGA-AC-A3QP-01A Positive Positive Lumpectomy -29113 184 0 675 NO 70-79% 2.2 2014-1-29 FEMALE 2+ 30 2.6 1.2 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 150 NO Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 1 true No MX N1mi T2 Stage IIB TCGA-AC-A3QP.14E2FC4E-7205-4929-81B5-7FF3006F08AD.pdf A3QP TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 4545ed8f-a83b-4049-9504-ba673ecd6d1d 4545ed8f-a83b-4049-9504-ba673ecd6d1d TCGA-AC-A3QP-01A-21-A24A-20 TCGA-AC-A3QP-01 TCGA-AC-A3QP-01A-11D-A230-05 334363b1-b6e4-4135-a42d-4d49e62ce2c5 TCGA-AC-A3QP-01 TCGA-AC-A3QP-01A-11D-A22X-09 TCGA-AC-A3QP-01 4545ed8f-a83b-4049-9504-ba673ecd6d1d TCGA-AC-A3QP-01A-11D-A22W-01 TCGA-AC-A3QP-01 4545ed8f-a83b-4049-9504-ba673ecd6d1d TCGA-AC-A3QP-01A-11D-A22W-01 TCGA-AC-A3QQ-01 TCGA-AC-A3QQ-01 Iq BRCA non-CIMP c9 miRNA c1uster 10 TCGA-AC-A3QQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Sentinel node biopsy alone TCGA-AC-A3QQ-F66024 TCGA-AC-A3QQ Positive 3 Point Scale 3+ 3 Point Scale Positive Other YES -19723 0 734 90-99% 2014-10-1 FEMALE 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy Positive NO 5 Close Peri (6-12 months since last menstrual period) NO 0 0 No MX N0 (i-) T1c Stage IA A3QQ TUMOR FREE NO YES 70-79% NO Primary Tumor 01 Nipple Sparing Total Mastectomy 7th YES NO AC Breast LIVING 2011 bf9ca847-f30f-4dcf-bb91-a483be8db666 bf9ca847-f30f-4dcf-bb91-a483be8db666 TCGA-AC-A3QQ-01 TCGA-AC-A3QQ-01A-11D-A22B-05 TCGA-AC-A3QQ-01 TCGA-AC-A3QQ-01 bf9ca847-f30f-4dcf-bb91-a483be8db666 TCGA-AC-A3QQ-01A-11D-A227-01 TCGA-AC-A3QQ-01 bf9ca847-f30f-4dcf-bb91-a483be8db666 TCGA-AC-A3QQ-01A-11D-A227-01 TCGA-AC-A3TM-01 TCGA-AC-A3TM-01 Iq BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-AC-A3TM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Sentinel node biopsy alone TCGA-AC-A3TM-F60193 TCGA-AC-A3TM TCGA-AC-A3TM-01A Positive Positive Simple Mastectomy YES -18535 136 0 762 NO 90-99% 1.9 2014-5-31 FEMALE 2+ 60 3.3 1.9 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 160 NO Equivocal Equivocal NO 4 Negative Peri (6-12 months since last menstrual period) NO 0 2 false No M0 N1mi T3 Stage IIIA TCGA-AC-A3TM.87DB9AD3-7640-4A78-B401-D5562D03BA76.pdf A3TM TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 902592e6-c7c5-46b8-b70b-5520df79a8a3 902592e6-c7c5-46b8-b70b-5520df79a8a3 TCGA-AC-A3TM-01A-21-A24A-20 TCGA-AC-A3TM-01 TCGA-AC-A3TM-01A-11D-A22B-05 c53769a6-b6af-4346-9a88-ffa6ffc19bfe TCGA-AC-A3TM-01 TCGA-AC-A3TM-01A-11D-A228-09 TCGA-AC-A3TM-01 902592e6-c7c5-46b8-b70b-5520df79a8a3 TCGA-AC-A3TM-01A-11D-A227-01 TCGA-AC-A3TM-01 902592e6-c7c5-46b8-b70b-5520df79a8a3 TCGA-AC-A3TM-01A-11D-A227-01 TCGA-AC-A3TN-01 TCGA-AC-A3TN-01 Iq BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-AC-A3TN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A3TN-F60190 TCGA-AC-A3TN TCGA-AC-A3TN-01A Positive Positive Simple Mastectomy -27421 78 0 456 NO 90-99% 2014-5-31 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Other method, specify: 140 NO Positive Indeterminate NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No MX N0 T3 Stage IIB TCGA-AC-A3TN.1A0D203A-BC4B-441F-97F6-D1FF7E959262.pdf A3TN TUMOR FREE YES YES 80-89% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 032db552-7828-4ed4-a1d7-b01b7fa89e29 032db552-7828-4ed4-a1d7-b01b7fa89e29 TCGA-AC-A3TN-01A-21-A24A-20 TCGA-AC-A3TN-01 TCGA-AC-A3TN-01A-11D-A22B-05 c619a2c9-fbfd-4c44-b40c-3a12259b24c2 TCGA-AC-A3TN-01 TCGA-AC-A3TN-01A-11D-A228-09 TCGA-AC-A3TN-01 032db552-7828-4ed4-a1d7-b01b7fa89e29 TCGA-AC-A3TN-01A-11D-A227-01 TCGA-AC-A3TN-01 032db552-7828-4ed4-a1d7-b01b7fa89e29 TCGA-AC-A3TN-01A-11D-A227-01 TCGA-AC-A3W5-01 TCGA-AC-A3W5-01 High BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-AC-A3W5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Sentinel node biopsy alone TCGA-AC-A3W5-F56177 TCGA-AC-A3W5 TCGA-AC-A3W5-01A Positive Positive Lumpectomy YES -24029 120 0 504 50-59% 2014-1-29 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 130 NO Positive NO 3 Close NO 0 0 false Yes MX N0 T2 Stage IIA TCGA-AC-A3W5.CA0CD57E-DA92-463E-A004-D554825A22D6.pdf A3W5 TUMOR FREE YES YES 30-39% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 3e775d6c-3845-49a7-80e0-82c5c68a473c 3e775d6c-3845-49a7-80e0-82c5c68a473c TCGA-AC-A3W5-01A-21-A24A-20 TCGA-AC-A3W5-01 TCGA-AC-A3W5-01A-11D-A22B-05 795bf55f-c58c-45f4-9443-7f9fd1ef4c3e TCGA-AC-A3W5-01 TCGA-AC-A3W5-01A-11D-A228-09 TCGA-AC-A3W5-01 3e775d6c-3845-49a7-80e0-82c5c68a473c TCGA-AC-A3W5-01A-11D-A227-01 TCGA-AC-A3W5-01 3e775d6c-3845-49a7-80e0-82c5c68a473c TCGA-AC-A3W5-01A-11D-A227-01 TCGA-AC-A3W6-01 TCGA-AC-A3W6-01 Iq BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-AC-A3W6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Right Sentinel node biopsy alone TCGA-AC-A3W6-F57046 TCGA-AC-A3W6 TCGA-AC-A3W6-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Modified Radical Mastectomy YES -32872 101 0 602 90-99% 2014-2-28 FEMALE 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 1+ YES Core needle biopsy 140 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 3 3 false Yes MX N1 T3 Stage IIIA TCGA-AC-A3W6.B52E150F-5B34-482A-84E7-1739B9AC09B7.pdf A3W6 TUMOR FREE NO YES 20-29% NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 bfedc051-75dd-44f8-add4-40ec7eabf0b0 bfedc051-75dd-44f8-add4-40ec7eabf0b0 TCGA-AC-A3W6-01A-21-A24A-20 TCGA-AC-A3W6-01 TCGA-AC-A3W6-01A-12D-A22B-05 37b78d3f-d378-49c8-970c-8b83f7372aeb TCGA-AC-A3W6-01 TCGA-AC-A3W6-01A-12D-A228-09 TCGA-AC-A3W6-01 bfedc051-75dd-44f8-add4-40ec7eabf0b0 TCGA-AC-A3W6-01A-12D-A227-01 TCGA-AC-A3W6-01 bfedc051-75dd-44f8-add4-40ec7eabf0b0 TCGA-AC-A3W6-01A-12D-A227-01 TCGA-AC-A3W7-01 TCGA-AC-A3W7-01 Iq BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-AC-A3W7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-AC-A3W7-F57847 TCGA-AC-A3W7 TCGA-AC-A3W7-01A Positive Negative Simple Mastectomy NO -24327 65 0 471 90-99% 2014-3-27 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 210 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 false No MX N1a T2 Stage IIB TCGA-AC-A3W7.3B77A3E1-AB8F-47B2-A5CC-A3B593A055CE.pdf A3W7 TUMOR FREE YES YES <10% NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 e5636c48-9d0d-42d5-9ac2-31ad566bd168 e5636c48-9d0d-42d5-9ac2-31ad566bd168 TCGA-AC-A3W7-01A-21-A24A-20 TCGA-AC-A3W7-01 TCGA-AC-A3W7-01A-11D-A22B-05 1a6ceae8-c0e6-48fe-8ebc-1897613040c1 TCGA-AC-A3W7-01 TCGA-AC-A3W7-01A-11D-A228-09 TCGA-AC-A3W7-01 e5636c48-9d0d-42d5-9ac2-31ad566bd168 TCGA-AC-A3W7-01A-11D-A227-01 TCGA-AC-A3W7-01 e5636c48-9d0d-42d5-9ac2-31ad566bd168 TCGA-AC-A3W7-01A-11D-A227-01 TCGA-AC-A3YI-01 TCGA-AC-A3YI-01 TCGA-AC-A3YI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A3YI-F61513 TCGA-AC-A3YI TCGA-AC-A3YI-01A Positive Positive Lumpectomy NO -27143 87 0 707 90-99% 2014-6-30 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 120 NO Positive NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 12 false No MX N3a T1c Stage IIIC TCGA-AC-A3YI.52CEF542-0F5B-4660-8746-2CF4A27B214E.pdf A3YI TUMOR FREE YES YES 20-29% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26 20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26 TCGA-AC-A3YI-01 TCGA-AC-A3YI-01A-21D-A23D-05 TCGA-AC-A3YI-01 TCGA-AC-A3YI-01A-21D-A23C-09 TCGA-AC-A3YI-01 20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26 TCGA-AC-A3YI-01A-21D-A238-01 TCGA-AC-A3YI-01 20e8a6eb-4785-42f2-bb0c-bbdf5beb6c26 TCGA-AC-A3YI-01A-21D-A238-01 TCGA-AC-A3YJ-01 TCGA-AC-A3YJ-01 BRCA nonbasal-like c8 TCGA-AC-A3YJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Sentinel node biopsy alone TCGA-AC-A3YJ-F60187 TCGA-AC-A3YJ TCGA-AC-A3YJ-01A Positive Positive Modified Radical Mastectomy YES -24439 114 0 754 2014-5-31 FEMALE Other, specify No C50.9 8050/3 C50.9 YES Core needle biopsy 220 NO NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 (i-) T2 Stage IIA TCGA-AC-A3YJ.0F890724-8554-4B2B-B4EC-6B9B24C757D8.pdf A3YJ TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 5d5982c0-530f-4b2b-b1fb-d70c8168c793 5d5982c0-530f-4b2b-b1fb-d70c8168c793 TCGA-AC-A3YJ-01A-21-A24A-20 TCGA-AC-A3YJ-01 TCGA-AC-A3YJ-01A-11D-A230-05 7de47993-6f31-4dd7-8219-b5734464922f TCGA-AC-A3YJ-01 TCGA-AC-A3YJ-01A-11D-A22X-09 TCGA-AC-A3YJ-01 5d5982c0-530f-4b2b-b1fb-d70c8168c793 TCGA-AC-A3YJ-01A-11D-A22W-01 TCGA-AC-A3YJ-01 5d5982c0-530f-4b2b-b1fb-d70c8168c793 TCGA-AC-A3YJ-01A-11D-A22W-01 TCGA-AC-A4ZE-01 TCGA-AC-A4ZE-01 TCGA-AC-A4ZE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-AC-A4ZE-F72379 TCGA-AC-A4ZE TCGA-AC-A4ZE-01A Positive Positive Simple Mastectomy NO -23284 169 0 890 2015-6-9 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 180 NO Positive NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T3 Stage IIB TCGA-AC-A4ZE.6931CAAE-6DFE-4A61-84D5-4EC804C2F2C6.pdf A4ZE TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 089da1d2-bdac-4ef2-9d59-2d144f77d5da 089da1d2-bdac-4ef2-9d59-2d144f77d5da TCGA-AC-A4ZE-01 TCGA-AC-A4ZE-01A-11D-A41Q-05 77F57ED3-C635-4292-9D39-987F74C22793 TCGA-AC-A4ZE-01 TCGA-AC-A4ZE-01 089da1d2-bdac-4ef2-9d59-2d144f77d5da TCGA-AC-A4ZE-01A-11D-A41E-01 TCGA-AC-A4ZE-01 089da1d2-bdac-4ef2-9d59-2d144f77d5da TCGA-AC-A4ZE-01A-11D-A41E-01 TCGA-AC-A5EH-01 TCGA-AC-A5EH-01 TCGA-AC-A5EH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AC-A5EH-F60185 TCGA-AC-A5EH Positive Negative Modified Radical Mastectomy NO -27964 0 511 20-29% 2014-5-31 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 14 Negative NO 1 No MX N1mi T2 Stage IIB A5EH TUMOR FREE NO YES YES Primary Tumor 01 7th YES NO AC Breast LIVING 2012 eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7 eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7 TCGA-AC-A5EH-01 TCGA-AC-A5EH-01A-11D-A28C-05 TCGA-AC-A5EH-01 TCGA-AC-A5EH-01A-11D-A28B-09 TCGA-AC-A5EH-01 eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7 TCGA-AC-A5EH-01A-11D-A28A-01 TCGA-AC-A5EH-01 eb9b8bcb-aa3a-4e57-9479-543b53dc1cf7 TCGA-AC-A5EH-01A-11D-A28A-01 TCGA-AC-A5EI-01 TCGA-AC-A5EI-01 TCGA-AC-A5EI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 88 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-AC-A5EI-F60184 TCGA-AC-A5EI Positive Positive Simple Mastectomy NO -32375 0 442 90-99% 2014-5-31 FEMALE Other, specify No C50.9 9020/3 C50.9 YES Tumor resection Negative NO 2 Negative NO 1 Yes MX N1mi T1c Stage IB A5EI TUMOR FREE NO YES 60-69% NO Primary Tumor 01 7th YES NO AC Breast LIVING 2012 TCGA-AC-A5EI-01A-11D-A27Y-05 d26ea3b4-9e10-4e5e-8922-0d4070605764 TCGA-AC-A5EI-01A-11D-A27P-09 TCGA-AC-A5EI-01 TCGA-AC-A5EI-01A-11D-A27O-01 TCGA-AC-A5EI-01 TCGA-AC-A5EI-01A-11D-A27O-01 TCGA-AC-A5XS-01 TCGA-AC-A5XS-01 TCGA-AC-A5XS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-AC-A5XS-F64108 TCGA-AC-A5XS TCGA-AC-A5XS-01A Positive Positive Simple Mastectomy NO -27160 127 0 588 2014-8-26 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 110 NO Negative NO 8 Negative NO 0 false Yes MX N0 T2 Stage IIA TCGA-AC-A5XS.C4F259BA-7C00-4326-ACB2-924C4AE33E87.pdf A5XS TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 b713b36d-44c7-41ed-82a5-762322472a56 b713b36d-44c7-41ed-82a5-762322472a56 TCGA-AC-A5XS-01 TCGA-AC-A5XS-01A-11D-A29O-05 5bb0d7f3-6b33-4d61-95e4-1a9006c4b4c3 TCGA-AC-A5XS-01 TCGA-AC-A5XS-01A-11D-A29N-09 TCGA-AC-A5XS-01 b713b36d-44c7-41ed-82a5-762322472a56 TCGA-AC-A5XS-01A-11D-A29M-01 TCGA-AC-A5XS-01 b713b36d-44c7-41ed-82a5-762322472a56 TCGA-AC-A5XS-01A-11D-A29M-01 TCGA-AC-A5XU-01 TCGA-AC-A5XU-01 TCGA-AC-A5XU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-AC-A5XU-F60181 TCGA-AC-A5XU Positive Positive Lumpectomy -27191 0 455 90-99% 2014-5-31 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 2 Negative NO 0 No MX N0 (i-) T3 Stage IIB A5XU TUMOR FREE YES YES 60-69% YES Primary Tumor 01 7th YES NO AC Breast LIVING 2013 f48e8432-bcb7-4aa9-9c8f-6de4a96179b2 f48e8432-bcb7-4aa9-9c8f-6de4a96179b2 TCGA-AC-A5XU-01 TCGA-AC-A5XU-01A-11D-A28C-05 e6e4ace7-7888-4b68-9662-0b7caa3c68c5 TCGA-AC-A5XU-01 TCGA-AC-A5XU-01A-11D-A28B-09 TCGA-AC-A5XU-01 f48e8432-bcb7-4aa9-9c8f-6de4a96179b2 TCGA-AC-A5XU-01A-11D-A28A-01 TCGA-AC-A5XU-01 f48e8432-bcb7-4aa9-9c8f-6de4a96179b2 TCGA-AC-A5XU-01A-11D-A28A-01 TCGA-AC-A62V-01 TCGA-AC-A62V-01 TCGA-AC-A62V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-AC-A62V-F60177 TCGA-AC-A62V TCGA-AC-A62V-01A Positive Positive Modified Radical Mastectomy NO -21389 38 348 0 2 90-99% 2014-5-31 MALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO NO 17 Negative Bone NO 3 false No M1 N1a T2 Stage IV TCGA-AC-A62V.BBA96852-E70C-4D37-A185-611F568BE90C.pdf A62V WITH TUMOR YES YES <10% YES Primary Tumor 01 7th YES NO AC Breast A DECEASED 2013 7a356940-c460-4714-a949-42afe6ea5d86 7a356940-c460-4714-a949-42afe6ea5d86 TCGA-AC-A62V-01 TCGA-AC-A62V-01A-11D-A31V-05 TCGA-AC-A62V-01 TCGA-AC-A62V-01 7a356940-c460-4714-a949-42afe6ea5d86 TCGA-AC-A62V-01A-11D-A31T-01 TCGA-AC-A62V-01 7a356940-c460-4714-a949-42afe6ea5d86 TCGA-AC-A62V-01A-11D-A31T-01 TCGA-AC-A62X-01 TCGA-AC-A62X-01 TCGA-AC-A62X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-AC-A62X-F64105 TCGA-AC-A62X TCGA-AC-A62X-01A Positive Negative Modified Radical Mastectomy NO -26627 70 0 417 <10% 2014-8-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 130 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false Yes MX N0 T2 Stage IIA TCGA-AC-A62X.6BB72835-1002-4B35-9304-495E12A30905.pdf A62X TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2013 cdc523d2-da82-4a3d-a97e-9745c8a802d1 cdc523d2-da82-4a3d-a97e-9745c8a802d1 TCGA-AC-A62X-01 TCGA-AC-A62X-01A-11D-A29O-05 4956c5cb-1ab4-46c2-8df0-1d71a2a73f15 TCGA-AC-A62X-01 TCGA-AC-A62X-01A-11D-A29N-09 TCGA-AC-A62X-01 cdc523d2-da82-4a3d-a97e-9745c8a802d1 TCGA-AC-A62X-01A-11D-A29M-01 TCGA-AC-A62X-01 cdc523d2-da82-4a3d-a97e-9745c8a802d1 TCGA-AC-A62X-01A-11D-A29M-01 TCGA-AC-A62Y-01 TCGA-AC-A62Y-01 TCGA-AC-A62Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Sentinel node biopsy alone TCGA-AC-A62Y-F65833 TCGA-AC-A62Y TCGA-AC-A62Y-01A Positive 3 Point Scale 3 Point Scale Positive Modified Radical Mastectomy NO -28876 112 0 530 90-99% 2014-9-30 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 50 NO Negative NO 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 false No MX N1 T2 Stage IIB TCGA-AC-A62Y.83BCCC3C-0384-45CD-84B4-67E2EDE822EE.pdf A62Y TUMOR FREE YES YES 80-89% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 02d9d59b-de6f-41c7-b529-142116debfd9 02d9d59b-de6f-41c7-b529-142116debfd9 TCGA-AC-A62Y-01 TCGA-AC-A62Y-01A-11D-A29O-05 TCGA-AC-A62Y-01 TCGA-AC-A62Y-01A-11D-A29N-09 TCGA-AC-A62Y-01 02d9d59b-de6f-41c7-b529-142116debfd9 TCGA-AC-A62Y-01A-11D-A29M-01 TCGA-AC-A62Y-01 02d9d59b-de6f-41c7-b529-142116debfd9 TCGA-AC-A62Y-01A-11D-A29M-01 TCGA-AC-A6IV-01 TCGA-AC-A6IV-01 TCGA-AC-A6IV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Sentinel node biopsy alone TCGA-AC-A6IV-F66023 TCGA-AC-A6IV TCGA-AC-A6IV-01A Positive Positive Modified Radical Mastectomy YES -17521 289 0 568 90-99% 2014-10-1 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8524/3 C50.9 YES Core needle biopsy 110 NO Equivocal NO 1 Negative NO 1 1 false No MX N1 T2 Stage IIB TCGA-AC-A6IV.5B978086-7443-4721-854B-877CE0FC10C0.pdf A6IV TUMOR FREE YES YES 60-69% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2012 253e692f-71db-4a5a-b2f4-9e640ef831a2 253e692f-71db-4a5a-b2f4-9e640ef831a2 TCGA-AC-A6IV-01 TCGA-AC-A6IV-01A-12D-A33F-05 TCGA-AC-A6IV-01 TCGA-AC-A6IV-01 253e692f-71db-4a5a-b2f4-9e640ef831a2 TCGA-AC-A6IV-01A-12D-A33D-01 TCGA-AC-A6IV-01 253e692f-71db-4a5a-b2f4-9e640ef831a2 TCGA-AC-A6IV-01A-12D-A33D-01 TCGA-AC-A6IW-01 TCGA-AC-A6IW-01 TCGA-AC-A6IW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-AC-A6IW-F64106 TCGA-AC-A6IW TCGA-AC-A6IW-01A Negative Negative Simple Mastectomy YES -26896 74 0 413 <10% 2014-8-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 (i-) T2 Stage IIA TCGA-AC-A6IW.302E69E0-39F0-4CDB-97F9-A6CDDB3D7233.pdf A6IW TUMOR FREE NO YES <10% NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2013 fceb1551-4b16-45de-8ba0-7906aa3fe841 fceb1551-4b16-45de-8ba0-7906aa3fe841 TCGA-AC-A6IW-01 TCGA-AC-A6IW-01A-12D-A33F-05 7FE7ED52-C8B0-4C86-BE4E-BF31EFBEA9BB TCGA-AC-A6IW-01 TCGA-AC-A6IW-01 fceb1551-4b16-45de-8ba0-7906aa3fe841 TCGA-AC-A6IW-01A-12D-A33D-01 TCGA-AC-A6IW-01 fceb1551-4b16-45de-8ba0-7906aa3fe841 TCGA-AC-A6IW-01A-12D-A33D-01 TCGA-AC-A6IX-01 TCGA-AC-A6IX-01 TCGA-AC-A6IX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AC-A6IX-F66025 TCGA-AC-A6IX TCGA-AC-A6IX-01A Positive Positive Modified Radical Mastectomy NO -17969 107 0 373 90-99% 2014-10-1 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 110 NO NO 21 Negative Peri (6-12 months since last menstrual period) NO 19 false No MX N3a T2 Stage IIIC TCGA-AC-A6IX.3EE7548C-464D-4FC0-B1E2-2F6461C4A2A1.pdf A6IX TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2013 ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182 ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182 TCGA-AC-A6IX-01 TCGA-AC-A6IX-01A-12D-A32T-05 A01C3771-F0E8-4514-AE2A-927E852F47D8 TCGA-AC-A6IX-01 TCGA-AC-A6IX-01 ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182 TCGA-AC-A6IX-01A-12D-A32H-01 TCGA-AC-A6IX-01 ffd6c7c5-d4c4-4ead-9e55-de8f6aa62182 TCGA-AC-A6IX-01A-12D-A32H-01 TCGA-AC-A6IX-06 TCGA-AC-A6IX-06 TCGA-AC-A6IX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AC-A6IX-F66025 TCGA-AC-A6IX TCGA-AC-A6IX-06A Positive Positive Modified Radical Mastectomy NO -17969 107 0 373 90-99% 2014-10-1 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 40 NO NO 21 Negative Peri (6-12 months since last menstrual period) NO 19 false No MX N3a T2 Stage IIIC TCGA-AC-A6IX.A92859DA-41AD-4CF9-86AF-E4073E6276ED.pdf A6IX TUMOR FREE YES YES <10% YES Metastatic 06 7th YES NO AC Breast A LIVING 2013 9d5cd723-da40-47ce-a413-20057593905d 9d5cd723-da40-47ce-a413-20057593905d TCGA-AC-A6IX-06A-11D-A32T-05 TCGA-AC-A6IX-06 9d5cd723-da40-47ce-a413-20057593905d TCGA-AC-A6IX-06 9d5cd723-da40-47ce-a413-20057593905d TCGA-AC-A6NO-01 TCGA-AC-A6NO-01 TCGA-AC-A6NO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Right Axillary lymph node dissection alone TCGA-AC-A6NO TCGA-AC-A6NO-01A Positive Positive Modified Radical Mastectomy NO -15996 605 0 51 2014-4-10 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 150 NO Negative 16 Negative NO 2 false No MX N1a T2 Stage IIB TCGA-AC-A6NO.A81EB5E0-305E-4657-94AD-0922CD1D79C6.pdf A6NO TUMOR FREE YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 5055b564-b80d-4003-b1c1-3fe080c99fc1 5055b564-b80d-4003-b1c1-3fe080c99fc1 TCGA-AC-A6NO-01 TCGA-AC-A6NO-01A-12D-A33F-05 EE1327D4-4700-49EF-84B1-292DE21BB827 TCGA-AC-A6NO-01 TCGA-AC-A6NO-01 5055b564-b80d-4003-b1c1-3fe080c99fc1 TCGA-AC-A6NO-01A-12D-A33D-01 TCGA-AC-A6NO-01 5055b564-b80d-4003-b1c1-3fe080c99fc1 TCGA-AC-A6NO-01A-12D-A33D-01 TCGA-AC-A7VB-01 TCGA-AC-A7VB-01 TCGA-AC-A7VB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AC-A7VB-F66026 TCGA-AC-A7VB Positive Negative Modified Radical Mastectomy NO -18806 0 250 80-89% 2014-10-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy NO 15 Negative NO 3 No MX N1a T1c Stage IIA A7VB TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO AC Breast LIVING 2013 a0059fcb-6adc-47f4-8601-b7eed9e12576 a0059fcb-6adc-47f4-8601-b7eed9e12576 TCGA-AC-A7VB-01 TCGA-AC-A7VB-01A-11D-A357-05 TCGA-AC-A7VB-01 TCGA-AC-A7VB-01 a0059fcb-6adc-47f4-8601-b7eed9e12576 TCGA-AC-A7VB-01A-11D-A350-01 TCGA-AC-A7VB-01 a0059fcb-6adc-47f4-8601-b7eed9e12576 TCGA-AC-A7VB-01A-11D-A350-01 TCGA-AC-A7VC-01 TCGA-AC-A7VC-01 TCGA-AC-A7VC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Sentinel node biopsy alone TCGA-AC-A7VC Negative Negative Simple Mastectomy YES -20479 0 1 2014-3-29 FEMALE Metaplastic Carcinoma No C50.9 8575/3 C50.9 YES Tumor resection Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 No MX N0 T3 Stage IIB A7VC TUMOR FREE YES Primary Tumor 01 7th YES NO AC Breast LIVING 2013 f88a5259-4413-4d0c-9083-600d74caffbc f88a5259-4413-4d0c-9083-600d74caffbc TCGA-AC-A7VC-01 TCGA-AC-A7VC-01A-11D-A357-05 TCGA-AC-A7VC-01 TCGA-AC-A7VC-01 f88a5259-4413-4d0c-9083-600d74caffbc TCGA-AC-A7VC-01A-11D-A350-01 TCGA-AC-A7VC-01 f88a5259-4413-4d0c-9083-600d74caffbc TCGA-AC-A7VC-01A-11D-A350-01 TCGA-AC-A8OP-01 TCGA-AC-A8OP-01 TCGA-AC-A8OP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Right Lower Inner Quadrant Sentinel node biopsy alone TCGA-AC-A8OP-F66027 TCGA-AC-A8OP TCGA-AC-A8OP-01A Positive Positive Simple Mastectomy YES -26550 921 0 614 90-99% 2014-10-1 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 80 NO Indeterminate NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 (i-) T1c Stage IA TCGA-AC-A8OP.F4F5C477-30BB-41EE-B188-B20DE019F30A.pdf A8OP TUMOR FREE YES YES 10-19% NO Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 001773a6-9cf3-48a1-8ea1-1f0da4991bc5 001773a6-9cf3-48a1-8ea1-1f0da4991bc5 TCGA-AC-A8OP-01 TCGA-AC-A8OP-01A-11D-A36K-05 TCGA-AC-A8OP-01 TCGA-AC-A8OP-01 001773a6-9cf3-48a1-8ea1-1f0da4991bc5 TCGA-AC-A8OP-01A-11D-A36I-01 TCGA-AC-A8OP-01 001773a6-9cf3-48a1-8ea1-1f0da4991bc5 TCGA-AC-A8OP-01A-11D-A36I-01 TCGA-AC-A8OQ-01 TCGA-AC-A8OQ-01 TCGA-AC-A8OQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-AC-A8OQ TCGA-AC-A8OQ-01A Negative Negative Lumpectomy NO -26535 742 0 34 2014-2-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 100 NO Indeterminate 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 false No MX N1a T2 Stage IIB TCGA-AC-A8OQ.FFA6F9F3-71C1-4AF9-B9F7-0466550EBC90.pdf A8OQ TUMOR FREE YES Primary Tumor 01 7th YES NO AC Breast A LIVING 2011 cca6f765-44ff-4540-a961-0a2be4e41f93 cca6f765-44ff-4540-a961-0a2be4e41f93 TCGA-AC-A8OQ-01 TCGA-AC-A8OQ-01A-11D-A41Q-05 4B47C521-A9C2-4CF0-91BB-27DD99200EC7 TCGA-AC-A8OQ-01 TCGA-AC-A8OQ-01 cca6f765-44ff-4540-a961-0a2be4e41f93 TCGA-AC-A8OQ-01A-11D-A41E-01 TCGA-AC-A8OQ-01 cca6f765-44ff-4540-a961-0a2be4e41f93 TCGA-AC-A8OQ-01A-11D-A41E-01 TCGA-AC-A8OR-01 TCGA-AC-A8OR-01 TCGA-AC-A8OR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Left Sentinel node biopsy alone TCGA-AC-A8OR TCGA-AC-A8OR-01A Positive Positive Simple Mastectomy YES -27605 98 0 40 90-99% 2014-2-26 FEMALE <10% Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Core needle biopsy 120 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 (i-) T1c Stage IA TCGA-AC-A8OR.1E706FF8-F42C-4FC6-8976-BEB4213BD730.pdf A8OR TUMOR FREE YES 90-99% Primary Tumor 01 7th YES NO AC Breast A LIVING 2013 15c73666-b316-4108-97e9-9d0e40540a2c 15c73666-b316-4108-97e9-9d0e40540a2c TCGA-AC-A8OR-01 TCGA-AC-A8OR-01A-21D-A41Q-05 TCGA-AC-A8OR-01 TCGA-AC-A8OR-01 15c73666-b316-4108-97e9-9d0e40540a2c TCGA-AC-A8OR-01A-21D-A41E-01 TCGA-AC-A8OR-01 15c73666-b316-4108-97e9-9d0e40540a2c TCGA-AC-A8OR-01A-21D-A41E-01 TCGA-AC-A8OS-01 TCGA-AC-A8OS-01 TCGA-AC-A8OS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-AC-A8OS Positive Positive Simple Mastectomy YES -26248 0 70 90-99% 2014-2-26 FEMALE 10-19% 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Positive 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 No MX N0 (i-) T2 Stage IIA A8OS TUMOR FREE YES <10% Primary Tumor 01 7th YES NO AC Breast LIVING 2013 c119a170-e1ba-4965-a9c6-5c0b41ceefba c119a170-e1ba-4965-a9c6-5c0b41ceefba TCGA-AC-A8OS-01 TCGA-AC-A8OS-01A-12D-A41Q-05 TCGA-AC-A8OS-01 TCGA-AC-A8OS-01 c119a170-e1ba-4965-a9c6-5c0b41ceefba TCGA-AC-A8OS-01A-12D-A41E-01 TCGA-AC-A8OS-01 c119a170-e1ba-4965-a9c6-5c0b41ceefba TCGA-AC-A8OS-01A-12D-A41E-01 TCGA-AN-A03X-01 Stage IIA 74 4 No_Conversion 10 Positive FEMALE Negative Negative M0 Negative N0 10 0 LumA Luminal A Positive 0 -3 enrollment T_Other T2 LIVING TCGA-AN-A03X-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AN-A03X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Outer Quadrant No axillary staging TCGA-AN-A03X-F68976 TCGA-AN-A03X Positive Positive Modified Radical Mastectomy NO -27163 0 10 2014-12-24 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Positive YES 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 0 0 No M0 N0 T2 Stage IIA A03X TUMOR FREE 200 200 NO NO Primary Tumor 01 NO YES AN Breast LIVING 2010 ae97b841-ddef-4bed-81ac-0b91627c4ef3 ae97b841-ddef-4bed-81ac-0b91627c4ef3 TCGA-AN-A03X-01A-21W-A019-09 TCGA-AN-A03X-01 TCGA-AN-A03X-01 TCGA-AN-A03X-01A-21W-A019-09 TCGA-AN-A03X-01A-21D-A00Y-05 TCGA-AN-A03X-01 TCGA-AN-A03X-01A-21W-A019-09 TCGA-AN-A03X-01 ae97b841-ddef-4bed-81ac-0b91627c4ef3 TCGA-AN-A03X-01 TCGA-AN-A03X-01A-21D-A011-01 TCGA-AN-A03X-01A-21R-A00Z-07 ae97b841-ddef-4bed-81ac-0b91627c4ef3 TCGA-AN-A03X-01A-21D-A011-01 TCGA-AN-A03X-01 TCGA-AN-A03Y-01 Stage IIA 66 3 No_Conversion 10 Positive FEMALE Negative Negative M0 Negative N0 10 0 LumB Luminal B Positive -1 -3 enrollment T_Other T2 LIVING TCGA-AN-A03Y-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 5 mutation cluster 4 TCGA-AN-A03Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Upper Outer Quadrant No axillary staging TCGA-AN-A03Y-F68977 TCGA-AN-A03Y TCGA-AN-A03Y-01A Positive Positive Modified Radical Mastectomy NO -24232 36 0 10 2014-12-24 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 160 NO Negative YES 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 0 0 true No M0 N0 T2 Stage IIA TCGA-AN-A03Y.76734A82-9137-4DA4-871E-D4EC1BC33831.pdf A03Y TUMOR FREE 210 210 NO NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 7509b7dc-18cc-4430-ad93-fa598fc97330 7509b7dc-18cc-4430-ad93-fa598fc97330 TCGA-AN-A03Y-01A-21W-A019-09 TCGA-AN-A03Y-01 TCGA-AN-A03Y-01 TCGA-AN-A03Y-01A-21W-A019-09 TCGA-AN-A03Y-01A-21D-A00Y-05 TCGA-AN-A03Y-01 TCGA-AN-A03Y-01A-21W-A019-09 TCGA-AN-A03Y-01 7509b7dc-18cc-4430-ad93-fa598fc97330 TCGA-AN-A03Y-01 TCGA-AN-A03Y-01A-21D-A011-01 TCGA-AN-A03Y-01A-21R-A00Z-07 7509b7dc-18cc-4430-ad93-fa598fc97330 TCGA-AN-A03Y-01A-21D-A011-01 TCGA-AN-A03Y-01 TCGA-AN-A041-01 Stage IIB 29 5 Stage IIB 7 Positive FEMALE Equivocal 1 3 4 Negative M0 Positive N1 7 0 LumA Luminal B Negative LumA -2 -3 enrollment T_Other T2 LIVING TCGA-AN-A041-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A041 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 29 Left Upper Outer Quadrant TCGA-AN-A041-F68971 TCGA-AN-A041 Positive Negative -10812 0 7 NO 2014-12-24 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Positive YES 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 1 No M0 N1a T2 Stage IIB A041 TUMOR FREE 0 170 NO YES NO Primary Tumor 01 7th NO YES AN Breast LIVING 2010 dc131436-aa38-4601-a42e-e3ad746d5be3 dc131436-aa38-4601-a42e-e3ad746d5be3 TCGA-AN-A041-01A-31-A13A-20 TCGA-AN-A041-01A-11W-A050-09 TCGA-AN-A041-01 a64d4ca5-a6f8-4e09-9278-c8f7e2d88e86 TCGA-AN-A041-01 TCGA-AN-A041-01A-11W-A050-09 TCGA-AN-A041-01A-11D-A032-05 TCGA-AN-A041-01 TCGA-AN-A041-01A-11W-A050-09 TCGA-AN-A041-01 dc131436-aa38-4601-a42e-e3ad746d5be3 TCGA-AN-A041-01 TCGA-AN-A041-01A-11D-A036-01 TCGA-AN-A041-01A-11R-A034-07 dc131436-aa38-4601-a42e-e3ad746d5be3 TCGA-AN-A041-01A-11D-A036-01 TCGA-AN-A041-01 TCGA-AN-A046-01 Stage IIA 68 2 No_Conversion 10 Positive FEMALE Negative Negative M0 Negative N0 10 0 LumA Luminal A Positive 0 -3 enrollment T_Other T2 LIVING TCGA-AN-A046-01 Iq cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 TCGA-AN-A046 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right Lower Inner Quadrant No axillary staging TCGA-AN-A046-F68972 TCGA-AN-A046 TCGA-AN-A046-01A Positive Positive Modified Radical Mastectomy NO -25158 27 0 10 2014-12-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 150 NO Negative NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 0 0 true No M0 N0 T2 Stage IIA TCGA-AN-A046.1304FB17-A20A-4EBC-9CC8-1554808AC1F6.pdf A046 TUMOR FREE 0 108 205 NO NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 20eb1da4-ef70-49dd-956f-18d65725ba27 20eb1da4-ef70-49dd-956f-18d65725ba27 TCGA-AN-A046-01 TCGA-AN-A046-01 TCGA-AN-A046-01A-21W-A050-09 TCGA-AN-A046-01A-21D-A032-05 TCGA-AN-A046-01 TCGA-AN-A046-01 20eb1da4-ef70-49dd-956f-18d65725ba27 TCGA-AN-A046-01 TCGA-AN-A046-01A-21D-A036-01 TCGA-AN-A046-01A-21R-A034-07 20eb1da4-ef70-49dd-956f-18d65725ba27 TCGA-AN-A046-01A-21D-A036-01 TCGA-AN-A046-01 TCGA-AN-A049-01 Stage IIA 62 5 No_Conversion 19 Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 19 0 LumA Luminal B Positive ReacI 0 -3 enrollment T_Other T2 LIVING TCGA-AN-A049-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-AN-A049 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant No axillary staging TCGA-AN-A049-F68978 TCGA-AN-A049 TCGA-AN-A049-01A Positive 2+ Modified radical mastectomy Positive Simple Mastectomy NO -22710 769 0 19 Allred (Biocare) 2014-12-24 FEMALE Dako Hercept test 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 330 NO Negative YES 9 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 0 0 true No M0 N0 T2 Stage IIA TCGA-AN-A049.8C2B719A-D45A-4DF3-BA61-908A2E1F6D1D.pdf A049 TUMOR FREE Allred (Biocare) 100 80 Primary Tumor 01 NO YES AN Breast A LIVING 2008 53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0 53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0 TCGA-AN-A049-01A-31-A13A-20 TCGA-AN-A049-01A-21W-A019-09 TCGA-AN-A049-01 e292a5df-0dcf-4760-92cf-7bb2c8f69e1e TCGA-AN-A049-01 TCGA-AN-A049-01A-21W-A019-09 TCGA-AN-A049-01A-21D-A00Y-05 TCGA-AN-A049-01 TCGA-AN-A049-01A-21W-A019-09 TCGA-AN-A049-01 53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0 TCGA-AN-A049-01 TCGA-AN-A049-01A-21D-A011-01 TCGA-AN-A049-01A-21R-A00Z-07 53a89c04-16e5-4cc3-838c-6b6d1b8ea0c0 TCGA-AN-A049-01A-21D-A011-01 TCGA-AN-A049-01 TCGA-AN-A04A-01 Stage IIIA 36 5 No_Conversion 89 Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 89 0 LumA Luminal A Positive LumA/B -5 -3 enrollment T_Other T2 LIVING TCGA-AN-A04A-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A04A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 36 Left Lower Inner Quadrant|Left Lower Outer Quadrant No axillary staging TCGA-AN-A04A-F68973 TCGA-AN-A04A TCGA-AN-A04A-01A Positive 1+ Modified radical mastectomy Positive Simple Mastectomy NO -13445 743 0 90 Allred (Biocare) 2014-12-24 FEMALE Dako Hercept test 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Tumor resection 370 NO Negative YES 7 Positive Peri (6-12 months since last menstrual period) 2 4 4 0 true No M0 N2 T2 Stage IIIA TCGA-AN-A04A.6FB7A794-C3E7-4501-A844-CF65B9C3D32C.pdf A04A TUMOR FREE Allred (Biocare) 0 87 112 Primary Tumor 01 7th NO YES AN Breast A LIVING 2008 7e09faf6-137d-4d33-98dd-80c48af7ebab 7e09faf6-137d-4d33-98dd-80c48af7ebab TCGA-AN-A04A-01A-11-A13A-20 TCGA-AN-A04A-01A-21W-A050-09 TCGA-AN-A04A-01 08c6c9ec-04e4-4ce9-8b57-b35f8e562e32 TCGA-AN-A04A-01 TCGA-AN-A04A-01A-21W-A050-09 TCGA-AN-A04A-01A-21D-A032-05 TCGA-AN-A04A-01 TCGA-AN-A04A-01A-21W-A050-09 TCGA-AN-A04A-01 7e09faf6-137d-4d33-98dd-80c48af7ebab TCGA-AN-A04A-01 TCGA-AN-A04A-01A-21D-A036-01 TCGA-AN-A04A-01A-21R-A034-07 7e09faf6-137d-4d33-98dd-80c48af7ebab TCGA-AN-A04A-01A-21D-A036-01 TCGA-AN-A04A-01 TCGA-AN-A04C-01 Stage IIB 51 3 No_Conversion 54 Negative FEMALE Positive Negative M0 Positive N1 54 0 Her2 HER2-enriched Negative -11 -9 enrollment T_Other T2 LIVING TCGA-AN-A04C-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 6 cluster 5 mutation cluster 3 TCGA-AN-A04C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A04C-F68974 TCGA-AN-A04C Negative 0 Modified radical mastectomy Negative Simple Mastectomy NO -18851 0 54 Allred (Biocare) 2014-12-24 FEMALE Dako Hecept Test 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Tumor resection Positive YES 15 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 2 0 No M0 N1 T2 Stage IIB A04C TUMOR FREE Allred (Biocare) 0 0 Primary Tumor 01 NO YES AN Breast LIVING 2008 b713c549-0c1f-4c64-bffd-a3b5b693d5a6 b713c549-0c1f-4c64-bffd-a3b5b693d5a6 TCGA-AN-A04C-01A-21W-A050-09 TCGA-AN-A04C-01 TCGA-AN-A04C-01 TCGA-AN-A04C-01A-21W-A050-09 TCGA-AN-A04C-01A-21D-A032-05 TCGA-AN-A04C-01 TCGA-AN-A04C-01A-21W-A050-09 TCGA-AN-A04C-01 b713c549-0c1f-4c64-bffd-a3b5b693d5a6 TCGA-AN-A04C-01 TCGA-AN-A04C-01A-21D-A036-01 TCGA-AN-A04C-01A-21R-A034-07 b713c549-0c1f-4c64-bffd-a3b5b693d5a6 TCGA-AN-A04C-01A-21D-A036-01 TCGA-AN-A04C-01 TCGA-AN-A04D-01 Stage IIB 58 1 No_Conversion 52 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 52 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-AN-A04D-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AN-A04D TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Outer Quadrant No axillary staging TCGA-AN-A04D-F68975 TCGA-AN-A04D Negative 0 Modified radical mastectomy Negative Simple Mastectomy NO -21426 0 52 Allred (Biocare) 2014-12-24 FEMALE Dako Hercept Test 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Tumor resection Negative YES 15 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 2 0 No M0 N1 T2 Stage IIB A04D TUMOR FREE Allred (Biocare) 0 0 Primary Tumor 01 NO YES AN Breast LIVING 2008 a09baab9-3eac-4271-9c12-2684642f8869 a09baab9-3eac-4271-9c12-2684642f8869 TCGA-AN-A04D-01A-31-A13A-20 TCGA-AN-A04D-01A-21W-A050-09 TCGA-AN-A04D-01 e48b250c-b634-4bfb-90e4-c2e1c0069400 TCGA-AN-A04D-01 TCGA-AN-A04D-01A-21W-A050-09 TCGA-AN-A04D-01A-21D-A032-05 TCGA-AN-A04D-01 TCGA-AN-A04D-01A-21W-A050-09 TCGA-AN-A04D-01 a09baab9-3eac-4271-9c12-2684642f8869 TCGA-AN-A04D-01 TCGA-AN-A04D-01A-21D-A036-01 TCGA-AN-A04D-01A-21R-A034-07 a09baab9-3eac-4271-9c12-2684642f8869 TCGA-AN-A04D-01A-21D-A036-01 TCGA-AN-A04D-01 TCGA-AN-A0AJ-01 Stage IIB 79 5 No_Conversion 243 Positive FEMALE Positive 1 1 4 Negative M0 Negative N0 243 0 LumB Luminal B Positive LumA -2 -5 enrollment T_Other T3 LIVING TCGA-AN-A0AJ-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-AN-A0AJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0AJ-F68941 TCGA-AN-A0AJ TCGA-AN-A0AJ-01A Positive 2+ Positive Modified Radical Mastectomy NO -29131 63 0 303 dextran coated charcoal 80-89% 2014-12-23 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8522/3 C50.9 3+ YES Tumor resection 310 NO Positive NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO 0 0 false No M0 N0 T3 Stage IIB TCGA-AN-A0AJ.6E2365F3-0875-4949-8409-7E26BBCDE700.pdf A0AJ TUMOR FREE dextran coated charcoal 120 230 NO 40-49% NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 cc92e983-2367-4353-ac01-88851fd0f71e cc92e983-2367-4353-ac01-88851fd0f71e TCGA-AN-A0AJ-01A-21-A13B-20 TCGA-AN-A0AJ-01A-11W-A019-09 TCGA-AN-A0AJ-01 69d158b2-9c07-471c-a594-36551fb6f7f3 TCGA-AN-A0AJ-01 TCGA-AN-A0AJ-01A-11W-A019-09 TCGA-AN-A0AJ-01A-11D-A00Y-05 TCGA-AN-A0AJ-01 TCGA-AN-A0AJ-01A-11W-A019-09 TCGA-AN-A0AJ-01 cc92e983-2367-4353-ac01-88851fd0f71e TCGA-AN-A0AJ-01 TCGA-AN-A0AJ-01A-11D-A011-01 TCGA-AN-A0AJ-01A-11R-A00Z-07 cc92e983-2367-4353-ac01-88851fd0f71e TCGA-AN-A0AJ-01A-11D-A011-01 TCGA-AN-A0AJ-01 TCGA-AN-A0AK-01 Stage IIA 76 1 No_Conversion 223 Positive FEMALE Negative Negative M0 Negative N0 223 0 LumB Luminal B Negative Basal -10 -5 enrollment T_Other T2 LIVING TCGA-AN-A0AK-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 TCGA-AN-A0AK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0AK-F68942 TCGA-AN-A0AK TCGA-AN-A0AK-01A Positive 0 Negative Modified Radical Mastectomy NO -27977 58 0 224 dextran coated charcoal 80-89% 2014-12-23 FEMALE 70-79% 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 290 NO Positive NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 NO 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0AK.12683FCC-4828-4D9A-9B35-E4B7295CC417.pdf A0AK TUMOR FREE dextran coated charcoal 230 NO <10% NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 5cf8f64b-a9f4-4903-9e24-5d0be19e5d44 5cf8f64b-a9f4-4903-9e24-5d0be19e5d44 TCGA-AN-A0AK-01A-11-A13B-20 TCGA-AN-A0AK-01 d4158db7-366b-400e-af77-9a6db7eec59c TCGA-AN-A0AK-01 TCGA-AN-A0AK-01A-21W-A019-09 TCGA-AN-A0AK-01A-21D-A00Y-05 TCGA-AN-A0AK-01 TCGA-AN-A0AK-01 5cf8f64b-a9f4-4903-9e24-5d0be19e5d44 TCGA-AN-A0AK-01 TCGA-AN-A0AK-01A-21D-A011-01 TCGA-AN-A0AK-01A-21R-A00Z-07 5cf8f64b-a9f4-4903-9e24-5d0be19e5d44 TCGA-AN-A0AK-01A-21D-A011-01 TCGA-AN-A0AK-01 TCGA-AN-A0AL-01 Stage IIIB 41 1 No_Conversion 197 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 197 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T4 LIVING TCGA-AN-A0AL-01 Squamous C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AN-A0AL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0AL-F68944 TCGA-AN-A0AL TCGA-AN-A0AL-01A Negative 0 Negative Modified Radical Mastectomy NO -15286 49 0 227 dextran coated charcoal <10% 2014-12-23 FEMALE dextran coated charcoal <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Tumor resection 300 NO Negative NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO 0 0 false No M0 N0 T4 Stage IIIB TCGA-AN-A0AL.20F4DBD9-02FA-4FFD-AEF5-234910D31263.pdf A0AL TUMOR FREE dextran coated charcoal NO <10% NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 467314d6-f946-447f-920a-d33b60f66eb2 467314d6-f946-447f-920a-d33b60f66eb2 TCGA-AN-A0AL-01A-21-A13B-20 TCGA-AN-A0AL-01A-11W-A019-09 TCGA-AN-A0AL-01 b689bc66-7909-4edc-a0e1-701ffcd1a602 TCGA-AN-A0AL-01 TCGA-AN-A0AL-01A-11W-A019-09 TCGA-AN-A0AL-01A-11D-A00Y-05 TCGA-AN-A0AL-01 TCGA-AN-A0AL-01A-11W-A019-09 TCGA-AN-A0AL-01 467314d6-f946-447f-920a-d33b60f66eb2 TCGA-AN-A0AL-01 TCGA-AN-A0AL-01A-11D-A011-01 TCGA-AN-A0AL-01A-11R-A00Z-07 467314d6-f946-447f-920a-d33b60f66eb2 TCGA-AN-A0AL-01A-11D-A011-01 TCGA-AN-A0AL-01 TCGA-AN-A0AM-01 Stage IIA 56 3 No_Conversion 5 Positive FEMALE Negative 1 1 4 Negative M0 Negative N0 5 0 LumB Luminal B Negative LumA/B -2 -5 enrollment T_Other T2 LIVING TCGA-AN-A0AM-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0AM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant No axillary staging TCGA-AN-A0AM-F68945 TCGA-AN-A0AM TCGA-AN-A0AM-01A Positive Negative Modified Radical Mastectomy NO -20713 47 0 5 2014-12-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 350 NO Negative YES 20 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0AM.7189A8A8-EB8B-4795-B7FE-725CCC4B7FA7.pdf A0AM TUMOR FREE 0 0 205 NO NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 6050d8b9-2d10-4a03-ae57-979cba25bb70 6050d8b9-2d10-4a03-ae57-979cba25bb70 TCGA-AN-A0AM-01A-21-A13B-20 TCGA-AN-A0AM-01A-11W-A050-09 TCGA-AN-A0AM-01 a2edc1b2-9932-44f8-9135-cf6ec465f84d TCGA-AN-A0AM-01 TCGA-AN-A0AM-01A-11W-A050-09 TCGA-AN-A0AM-01A-11D-A032-05 TCGA-AN-A0AM-01 TCGA-AN-A0AM-01A-11W-A050-09 TCGA-AN-A0AM-01 6050d8b9-2d10-4a03-ae57-979cba25bb70 TCGA-AN-A0AM-01 TCGA-AN-A0AM-01A-11D-A036-01 TCGA-AN-A0AM-01A-11R-A034-07 6050d8b9-2d10-4a03-ae57-979cba25bb70 TCGA-AN-A0AM-01A-11D-A036-01 TCGA-AN-A0AM-01 TCGA-AN-A0AR-01 Stage IIA 55 1 No_Conversion 9 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 9 0 Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-AN-A0AR-01 Squamous C8-BLCA cluster 5 Cluster 5 BRCA basal-like c6 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AN-A0AR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Upper Inner Quadrant No axillary staging TCGA-AN-A0AR-F68946 TCGA-AN-A0AR TCGA-AN-A0AR-01A Negative 0 Negative Modified Radical Mastectomy NO -20152 34 0 10 2014-12-23 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Tumor resection 150 NO Negative YES 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 5 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0AR.0E27F140-3D60-4027-A370-68127564DE38.pdf A0AR TUMOR FREE NO NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 12c36b7c-f302-4cea-bb4f-5a01211e00e9 12c36b7c-f302-4cea-bb4f-5a01211e00e9 TCGA-AN-A0AR-01A-21-A13B-20 TCGA-AN-A0AR-01A-11W-A019-09 TCGA-AN-A0AR-01 a18bbbc7-9c94-4fe9-a927-5c07be69428c TCGA-AN-A0AR-01 TCGA-AN-A0AR-01A-11W-A019-09 TCGA-AN-A0AR-01A-11D-A00Y-05 TCGA-AN-A0AR-01 TCGA-AN-A0AR-01A-11W-A019-09 TCGA-AN-A0AR-01 12c36b7c-f302-4cea-bb4f-5a01211e00e9 TCGA-AN-A0AR-01 TCGA-AN-A0AR-01A-11D-A011-01 TCGA-AN-A0AR-01A-11R-A00Z-07 12c36b7c-f302-4cea-bb4f-5a01211e00e9 TCGA-AN-A0AR-01A-11D-A011-01 TCGA-AN-A0AR-01 TCGA-AN-A0AS-01 Stage IIIA 70 3 No_Conversion 9 Positive FEMALE Negative 3 3 4 Negative M0 Positive N2 9 0 LumA Luminal B Negative Basal -1 -3 enrollment T_Other T2 LIVING TCGA-AN-A0AS-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-AN-A0AS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Left Upper Outer Quadrant No axillary staging TCGA-AN-A0AS-F68947 TCGA-AN-A0AS TCGA-AN-A0AS-01A Positive 0 Negative Modified Radical Mastectomy NO -25658 33 0 10 2014-12-23 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 290 NO Negative YES 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 4 0 false No M0 N2 T2 Stage IIIA TCGA-AN-A0AS.0D1ACC76-910E-4243-A229-5F76B5A3299A.pdf A0AS TUMOR FREE 0 190 NO NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 e866475d-4919-4bf6-920e-5390720d15bf e866475d-4919-4bf6-920e-5390720d15bf TCGA-AN-A0AS-01A-21-A13B-20 TCGA-AN-A0AS-01A-11W-A019-09 TCGA-AN-A0AS-01 52341dad-b2bf-4985-bb60-4921675983de TCGA-AN-A0AS-01 TCGA-AN-A0AS-01A-11W-A019-09 TCGA-AN-A0AS-01A-11D-A00Y-05 TCGA-AN-A0AS-01 TCGA-AN-A0AS-01A-11W-A019-09 TCGA-AN-A0AS-01 e866475d-4919-4bf6-920e-5390720d15bf TCGA-AN-A0AS-01 TCGA-AN-A0AS-01A-11D-A011-01 TCGA-AN-A0AS-01A-11R-A00Z-07 e866475d-4919-4bf6-920e-5390720d15bf TCGA-AN-A0AS-01A-11D-A011-01 TCGA-AN-A0AS-01 TCGA-AN-A0AT-01 Stage IIA 62 1 No_Conversion 10 Negative FEMALE Negative Negative M0 Negative N0 10 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-AN-A0AT-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 mutation c1uster 9 TCGA-AN-A0AT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Inner Quadrant No axillary staging TCGA-AN-A0AT-F68948 TCGA-AN-A0AT Negative Negative Modified Radical Mastectomy NO -22798 0 10 2014-12-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 0 0 No M0 N0 T2 Stage IIA A0AT TUMOR FREE 0 0 0 NO NO Primary Tumor 01 NO YES AN Breast LIVING 2010 edda9023-a8d9-45dc-af21-5bba663967e4 edda9023-a8d9-45dc-af21-5bba663967e4 TCGA-AN-A0AT-01A-21-A13C-20 TCGA-AN-A0AT-01A-11D-A045-09 TCGA-AN-A0AT-01 d29e84ac-dc3b-4139-950c-fd197d9ca11f TCGA-AN-A0AT-01 TCGA-AN-A0AT-01A-11D-A045-09 TCGA-AN-A0AT-01A-11D-A032-05 TCGA-AN-A0AT-01 TCGA-AN-A0AT-01 TCGA-AN-A0AT-01A-11D-A045-09 edda9023-a8d9-45dc-af21-5bba663967e4 TCGA-AN-A0AT-01A-11D-A036-01 TCGA-AN-A0AT-01 TCGA-AN-A0AT-01A-11R-A034-07 edda9023-a8d9-45dc-af21-5bba663967e4 TCGA-AN-A0AT-01A-11D-A036-01 TCGA-AN-A0AT-01 TCGA-AN-A0FD-01 Stage IIA 71 1 No_Conversion 195 Positive FEMALE Positive 3 3 3 Negative M0 Negative N0 195 0 LumA Luminal A Positive LumA/B -8 -3 enrollment T_Other T2 LIVING TCGA-AN-A0FD-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0FD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0FD-F68949 TCGA-AN-A0FD TCGA-AN-A0FD-01A Positive 1+ Positive Modified Radical Mastectomy NO -26007 84 0 196 dextran coated charcoal 80-89% 2014-12-23 FEMALE dextran coated charcoal 60-69% 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 260 NO Positive Positive YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0FD.F124155D-6131-47F6-8320-46A41AB125D3.pdf A0FD TUMOR FREE dextran coated charcoal NO 10-19% NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 3264f809-4bbf-48e6-bbfd-77eaca9e602e 3264f809-4bbf-48e6-bbfd-77eaca9e602e TCGA-AN-A0FD-01A-21-A13C-20 TCGA-AN-A0FD-01A-11W-A050-09 TCGA-AN-A0FD-01 aecc7da7-67e1-41cb-b17f-5be1e6c55e34 TCGA-AN-A0FD-01 TCGA-AN-A0FD-01A-11W-A050-09 TCGA-AN-A0FD-01A-11D-A032-05 TCGA-AN-A0FD-01 TCGA-AN-A0FD-01A-11W-A050-09 TCGA-AN-A0FD-01 3264f809-4bbf-48e6-bbfd-77eaca9e602e TCGA-AN-A0FD-01 TCGA-AN-A0FD-01A-11D-A036-01 TCGA-AN-A0FD-01A-11R-A034-07 3264f809-4bbf-48e6-bbfd-77eaca9e602e TCGA-AN-A0FD-01A-11D-A036-01 TCGA-AN-A0FD-01 TCGA-AN-A0FE-01 TCGA-AN-A0FE-01 TCGA-AN-A0FE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast TCGA-AN-A0FE-01A 330 NO false Primary Tumor 01 A TCGA-AN-A0FE-01A-11D-A00Y-05 TCGA-AN-A0FE-01A-11R-A00Z-07 TCGA-AN-A0FF-01 Stage IA 32 3 No_Conversion 140 Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 140 0 LumB Luminal B Positive LumA 0 -3 enrollment T1 T1 LIVING TCGA-AN-A0FF-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-AN-A0FF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 32 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0FF-F68943 TCGA-AN-A0FF TCGA-AN-A0FF-01A Positive 3+ Positive Modified Radical Mastectomy NO -11929 75 0 172 dextran coated charcoal 90-99% 2014-12-23 FEMALE dextran coated charcoal <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 300 NO Negative NO 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 1 NO 0 0 false No M0 N0 T1b Stage IA TCGA-AN-A0FF.9B4BA15D-A071-4213-AD2C-075A04ED48CD.pdf A0FF TUMOR FREE dextran coated charcoal NO 90-99% NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 7a5bc56e-e787-4798-8c4d-ee792f9e3149 7a5bc56e-e787-4798-8c4d-ee792f9e3149 TCGA-AN-A0FF-01A-21-A13C-20 TCGA-AN-A0FF-01A-11W-A050-09 TCGA-AN-A0FF-01 87bf53e1-aab3-44d0-a641-3464095b9a51 TCGA-AN-A0FF-01 TCGA-AN-A0FF-01A-11W-A050-09 TCGA-AN-A0FF-01A-11D-A032-05 TCGA-AN-A0FF-01 TCGA-AN-A0FF-01A-11W-A050-09 TCGA-AN-A0FF-01 7a5bc56e-e787-4798-8c4d-ee792f9e3149 TCGA-AN-A0FF-01 TCGA-AN-A0FF-01A-11D-A036-01 TCGA-AN-A0FF-01A-11R-A034-07 7a5bc56e-e787-4798-8c4d-ee792f9e3149 TCGA-AN-A0FF-01A-11D-A036-01 TCGA-AN-A0FF-01 TCGA-AN-A0FG-01 TCGA-AN-A0FG-01 TCGA-AN-A0FG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast TCGA-AN-A0FG-01A 400 NO false Primary Tumor 01 A TCGA-AN-A0FG-01A-11D-A00Y-05 TCGA-AN-A0FG-01A-11R-A00Z-07 TCGA-AN-A0FJ-01 Stage IV 59 1 No_Conversion 241 Positive FEMALE Negative 2 2 2 Negative M0 Positive N2 241 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-AN-A0FJ-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AN-A0FJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0FJ-F68950 TCGA-AN-A0FJ Positive 0 Negative Modified Radical Mastectomy NO -21910 0 242 dextran coated charcoal 10-19% 2014-12-23 FEMALE dextran coated charcoal 40-49% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Tumor resection Positive YES 14 Negative Peri (6-12 months since last menstrual period) 5 5 8 0 No M1 N2 T2 Stage IV A0FJ TUMOR FREE dextran coated charcoal NO <10% NO Primary Tumor 01 NO YES AN Breast LIVING 2010 d6b8993f-e850-47a9-842d-ef6173866780 d6b8993f-e850-47a9-842d-ef6173866780 TCGA-AN-A0FJ-01A-21-A13A-20 TCGA-AN-A0FJ-01A-11W-A019-09 TCGA-AN-A0FJ-01 d2876882-dd7e-43af-b066-d578da1f8f3d TCGA-AN-A0FJ-01 TCGA-AN-A0FJ-01A-11W-A019-09 TCGA-AN-A0FJ-01A-11D-A00Y-05 TCGA-AN-A0FJ-01 TCGA-AN-A0FJ-01A-11W-A019-09 TCGA-AN-A0FJ-01 d6b8993f-e850-47a9-842d-ef6173866780 TCGA-AN-A0FJ-01 TCGA-AN-A0FJ-01A-11D-A011-01 TCGA-AN-A0FJ-01A-11R-A00Z-07 d6b8993f-e850-47a9-842d-ef6173866780 TCGA-AN-A0FJ-01A-11D-A011-01 TCGA-AN-A0FJ-01 TCGA-AN-A0FK-01 Stage IIIB 88 2 No_Conversion 212 Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 212 0 LumA Luminal B Positive LumA -12 -3 enrollment T_Other T4 LIVING TCGA-AN-A0FK-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0FK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 88 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0FK-F68951 TCGA-AN-A0FK TCGA-AN-A0FK-01A Positive 3+ Positive Modified Radical Mastectomy NO -32462 69 0 213 dextran coated charcoal 90-99% 2014-12-23 FEMALE dextran coated charcoal 20-29% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 340 NO Positive YES 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 0 0 false No M0 N0 T4 Stage IIIB TCGA-AN-A0FK.5F5FF3CA-2DBB-4DE1-9190-1FE36E2B5ACB.pdf A0FK TUMOR FREE dextran coated charcoal 230 230 NO 90-99% NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 570ee0fd-7003-45ce-9c42-8f6145604186 570ee0fd-7003-45ce-9c42-8f6145604186 TCGA-AN-A0FK-01A-21-A13A-20 TCGA-AN-A0FK-01A-11W-A050-09 TCGA-AN-A0FK-01 2030c965-6cfa-4164-b5c9-222e1d522f58 TCGA-AN-A0FK-01 TCGA-AN-A0FK-01A-11W-A050-09 TCGA-AN-A0FK-01A-11D-A032-05 TCGA-AN-A0FK-01 TCGA-AN-A0FK-01A-11W-A050-09 TCGA-AN-A0FK-01 570ee0fd-7003-45ce-9c42-8f6145604186 TCGA-AN-A0FK-01 TCGA-AN-A0FK-01A-11D-A036-01 TCGA-AN-A0FK-01A-11R-A034-07 570ee0fd-7003-45ce-9c42-8f6145604186 TCGA-AN-A0FK-01A-11D-A036-01 TCGA-AN-A0FK-01 TCGA-AN-A0FL-01 Stage IIA 62 1 No_Conversion 230 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 230 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-AN-A0FL-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AN-A0FL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-AN-A0FL-F68952 TCGA-AN-A0FL TCGA-AN-A0FL-01A Negative 1+ Negative Modified Radical Mastectomy NO -22805 69 0 231 dextran coated charcoal <10% 2014-12-23 FEMALE dextran coated charcoal 20-29% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Tumor resection 310 NO Positive YES 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0FL.049A2CA6-951A-452F-963A-F54FE87ECA31.pdf A0FL TUMOR FREE dextran coated charcoal NO <10% NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 299add94-3b97-41a6-9fd4-c572f88982d5 299add94-3b97-41a6-9fd4-c572f88982d5 TCGA-AN-A0FL-01A-21-A13A-20 TCGA-AN-A0FL-01A-11W-A050-09 TCGA-AN-A0FL-01 ef3ba9e1-e1ca-477a-8700-37e88c048655 TCGA-AN-A0FL-01 TCGA-AN-A0FL-01A-11W-A050-09 TCGA-AN-A0FL-01A-11D-A032-05 TCGA-AN-A0FL-01 TCGA-AN-A0FL-01A-11W-A050-09 TCGA-AN-A0FL-01 299add94-3b97-41a6-9fd4-c572f88982d5 TCGA-AN-A0FL-01 TCGA-AN-A0FL-01A-11D-A036-01 TCGA-AN-A0FL-01A-11R-A034-07 299add94-3b97-41a6-9fd4-c572f88982d5 TCGA-AN-A0FL-01A-11D-A036-01 TCGA-AN-A0FL-01 TCGA-AN-A0FN-01 Stage IB 61 1 No_Conversion 218 Positive FEMALE Negative Negative M0 Negative N0 218 0 LumA Luminal A Positive -5 -7 enrollment T1 T1 LIVING TCGA-AN-A0FN-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0FN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0FN-F68953 TCGA-AN-A0FN TCGA-AN-A0FN-01A Positive 1+ Positive Modified Radical Mastectomy NO -22629 57 0 218 dextran coated charcoal 90-99% 2014-12-23 FEMALE dextran coated charcoal 20-29% 1+ Infiltrating Lobular Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 110 NO Positive YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 0 0 false No M0 N0 T1c Stage IA TCGA-AN-A0FN.6B53F577-5EB6-4AF5-9773-3654D3432BE4.pdf A0FN TUMOR FREE dextran coated charcoal 250 NO 10-19% NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 4aac7c40-db6b-4648-a82a-7bf397de913a 4aac7c40-db6b-4648-a82a-7bf397de913a TCGA-AN-A0FN-01A-11W-A050-09 TCGA-AN-A0FN-01 TCGA-AN-A0FN-01 TCGA-AN-A0FN-01A-11W-A050-09 TCGA-AN-A0FN-01A-11D-A032-05 TCGA-AN-A0FN-01 TCGA-AN-A0FN-01A-11W-A050-09 TCGA-AN-A0FN-01 4aac7c40-db6b-4648-a82a-7bf397de913a TCGA-AN-A0FN-01 TCGA-AN-A0FN-01A-11D-A036-01 TCGA-AN-A0FN-01A-11R-A034-07 4aac7c40-db6b-4648-a82a-7bf397de913a TCGA-AN-A0FN-01A-11D-A036-01 TCGA-AN-A0FN-01 TCGA-AN-A0FS-01 Stage IB 55 2 No_Conversion 191 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 191 0 LumA Luminal A Negative ReacII -5 -7 enrollment T1 T1 LIVING TCGA-AN-A0FS-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AN-A0FS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0FS-F68954 TCGA-AN-A0FS TCGA-AN-A0FS-01A Positive 0 Negative Modified Radical Mastectomy NO -20352 44 0 210 dextran coated charcoal 90-99% 2014-12-23 FEMALE dextran coated charcoal 20-29% 1+ Infiltrating Lobular Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 170 NO Positive YES 14 Negative Peri (6-12 months since last menstrual period) 2 2 0 0 false No M0 N0 T1c Stage IA TCGA-AN-A0FS.3CD1D537-29E4-479B-99FA-26D27E192948.pdf A0FS TUMOR FREE dextran coated charcoal 230 NO <10% NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 29ac13ea-a350-42e9-a3eb-024c537ead94 29ac13ea-a350-42e9-a3eb-024c537ead94 TCGA-AN-A0FS-01A-21-A13C-20 TCGA-AN-A0FS-01A-11W-A050-09 TCGA-AN-A0FS-01 9cc29dc5-b324-4ee3-b94b-42a1f5927ae9 TCGA-AN-A0FS-01 TCGA-AN-A0FS-01A-11W-A050-09 TCGA-AN-A0FS-01A-11D-A032-05 TCGA-AN-A0FS-01 TCGA-AN-A0FS-01A-11W-A050-09 TCGA-AN-A0FS-01 29ac13ea-a350-42e9-a3eb-024c537ead94 TCGA-AN-A0FS-01 TCGA-AN-A0FS-01A-11D-A036-01 TCGA-AN-A0FS-01A-11R-A034-07 29ac13ea-a350-42e9-a3eb-024c537ead94 TCGA-AN-A0FS-01A-11D-A036-01 TCGA-AN-A0FS-01 TCGA-AN-A0FT-01 Stage IIB 63 3 No_Conversion 183 Positive FEMALE Positive 4 5 3 Negative M0 Positive N1 183 0 LumA Luminal A Positive Her2 -2 -3 enrollment T_Other T2 LIVING TCGA-AN-A0FT-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 5 mutation cluster 5 TCGA-AN-A0FT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0FT-F68964 TCGA-AN-A0FT TCGA-AN-A0FT-01A Positive 3+ Positive Modified Radical Mastectomy NO -23300 44 0 214 dextran coated charcoal 90-99% 2014-12-24 FEMALE dextran coated charcoal 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 130 NO Positive YES 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 5 1 0 false No M0 N1 T2 Stage IIB TCGA-AN-A0FT.338D5387-0CFB-4D91-944F-1F054C21C769.pdf A0FT TUMOR FREE dextran coated charcoal 230 NO 90-99% NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 ae592879-5689-4818-8ac3-23a00c5d3934 ae592879-5689-4818-8ac3-23a00c5d3934 TCGA-AN-A0FT-01A-21-A13C-20 TCGA-AN-A0FT-01A-11W-A050-09 TCGA-AN-A0FT-01 3953f300-15f9-4c43-a4a2-cc7d1c056d59 TCGA-AN-A0FT-01 TCGA-AN-A0FT-01A-11W-A050-09 TCGA-AN-A0FT-01A-11D-A032-05 TCGA-AN-A0FT-01 TCGA-AN-A0FT-01A-11W-A050-09 TCGA-AN-A0FT-01 ae592879-5689-4818-8ac3-23a00c5d3934 TCGA-AN-A0FT-01 TCGA-AN-A0FT-01A-11D-A036-01 TCGA-AN-A0FT-01A-11R-A034-07 ae592879-5689-4818-8ac3-23a00c5d3934 TCGA-AN-A0FT-01A-11D-A036-01 TCGA-AN-A0FT-01 TCGA-AN-A0FV-01 Stage IIA 58 1 No_Conversion 10 Negative FEMALE Positive 1 1 1 Negative M0 Negative N0 10 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING TCGA-AN-A0FV-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation cluster 5 TCGA-AN-A0FV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant No axillary staging TCGA-AN-A0FV-F68965 TCGA-AN-A0FV TCGA-AN-A0FV-01A Negative Negative Modified Radical Mastectomy NO -21479 42 0 10 2014-12-24 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 180 NO Positive YES 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0FV.5AEE90E0-A9A1-4944-AD6A-2675764D869D.pdf A0FV TUMOR FREE 0 0 NO NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 600db536-d7c5-4cfa-bb80-fcc269b96b8c 600db536-d7c5-4cfa-bb80-fcc269b96b8c TCGA-AN-A0FV-01A-21-A13A-20 TCGA-AN-A0FV-01A-11W-A019-09 TCGA-AN-A0FV-01 db678c4c-245c-4438-9e57-6daad3be0250 TCGA-AN-A0FV-01 TCGA-AN-A0FV-01A-11W-A019-09 TCGA-AN-A0FV-01A-11D-A00Y-05 TCGA-AN-A0FV-01 TCGA-AN-A0FV-01A-11W-A019-09 TCGA-AN-A0FV-01 600db536-d7c5-4cfa-bb80-fcc269b96b8c TCGA-AN-A0FV-01 TCGA-AN-A0FV-01A-11D-A011-01 TCGA-AN-A0FV-01A-11R-A00Z-07 600db536-d7c5-4cfa-bb80-fcc269b96b8c TCGA-AN-A0FV-01A-11D-A011-01 TCGA-AN-A0FV-01 TCGA-AN-A0FW-01 Stage IIIA 67 3 No_Conversion 11 Positive FEMALE Negative 4 3 3 Negative M0 Positive N2 11 0 LumA Luminal A Indeterminate LumA/B -4 -3 enrollment T_Other T2 LIVING TCGA-AN-A0FW-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-AN-A0FW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Left Upper Outer Quadrant No axillary staging TCGA-AN-A0FW-F68966 TCGA-AN-A0FW TCGA-AN-A0FW-01A Positive Indeterminate Modified Radical Mastectomy NO -24692 41 0 11 2014-12-24 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 180 NO Negative YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 NO 2 0 false No M0 N2 T2 Stage IIIA TCGA-AN-A0FW.03BD8920-CA01-4818-BBD7-925DDD3F6908.pdf A0FW TUMOR FREE 10 180 NO NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 34b7764e-748a-415c-84b5-c45d0932e642 34b7764e-748a-415c-84b5-c45d0932e642 TCGA-AN-A0FW-01A-21-A13C-20 TCGA-AN-A0FW-01A-11W-A050-09 TCGA-AN-A0FW-01 3eec78cf-bead-4279-b0b3-60b9dea9496f TCGA-AN-A0FW-01 TCGA-AN-A0FW-01A-11W-A050-09 TCGA-AN-A0FW-01A-11D-A032-05 TCGA-AN-A0FW-01 TCGA-AN-A0FW-01A-11W-A050-09 TCGA-AN-A0FW-01 34b7764e-748a-415c-84b5-c45d0932e642 TCGA-AN-A0FW-01 TCGA-AN-A0FW-01A-11D-A036-01 TCGA-AN-A0FW-01A-11R-A034-07 34b7764e-748a-415c-84b5-c45d0932e642 TCGA-AN-A0FW-01A-11D-A036-01 TCGA-AN-A0FW-01 TCGA-AN-A0FX-01 Stage IIA 52 1 No_Conversion 10 Negative FEMALE Negative 1 1 2 Negative M0 Negative N0 10 0 Basal Basal-like Negative ReacII -13 -11 enrollment T_Other T2 LIVING TCGA-AN-A0FX-01 High C4-BRCA/Basal cluster 4 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AN-A0FX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Outer Quadrant No axillary staging TCGA-AN-A0FX-F68967 TCGA-AN-A0FX TCGA-AN-A0FX-01A Negative Negative Modified Radical Mastectomy NO -19309 34 0 10 2014-12-24 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 230 NO Positive YES 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0FX.0CC079D3-EB90-47B5-B554-599A67C9E12A.pdf A0FX TUMOR FREE 0 0 NO NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 c1dc3f35-324b-4a69-b32c-24652ccf9e3a c1dc3f35-324b-4a69-b32c-24652ccf9e3a TCGA-AN-A0FX-01A-21-A13C-20 TCGA-AN-A0FX-01A-11W-A050-09 TCGA-AN-A0FX-01 14bd231c-c5f5-4e4a-a2e3-4ee4a17248af TCGA-AN-A0FX-01 TCGA-AN-A0FX-01A-11W-A050-09 TCGA-AN-A0FX-01A-11D-A032-05 TCGA-AN-A0FX-01 TCGA-AN-A0FX-01A-11W-A050-09 TCGA-AN-A0FX-01 c1dc3f35-324b-4a69-b32c-24652ccf9e3a TCGA-AN-A0FX-01 TCGA-AN-A0FX-01A-11D-A036-01 TCGA-AN-A0FX-01A-11R-A034-07 c1dc3f35-324b-4a69-b32c-24652ccf9e3a TCGA-AN-A0FX-01A-11D-A036-01 TCGA-AN-A0FX-01 TCGA-AN-A0FY-01 Stage IB 55 3 No_Conversion 10 Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 10 0 LumB Luminal B Positive LumA -2 -3 enrollment T1 T1 LIVING TCGA-AN-A0FY-01 High C3-BRCA/Luminal cluster 2 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-AN-A0FY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left Upper Outer Quadrant No axillary staging TCGA-AN-A0FY-F68968 TCGA-AN-A0FY TCGA-AN-A0FY-01A Positive Positive Modified Radical Mastectomy NO -20347 34 0 10 2014-12-24 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 170 NO Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 5 0 0 false No M0 N0 T1c Stage IA TCGA-AN-A0FY.6C520037-2A9B-41CB-8362-97FFCA2AA6E2.pdf A0FY TUMOR FREE 110 80 NO NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d 9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d TCGA-AN-A0FY-01A-21-A13C-20 TCGA-AN-A0FY-01A-11W-A050-09 TCGA-AN-A0FY-01 22b79545-b004-46b6-a9dc-02285b1e2988 TCGA-AN-A0FY-01 TCGA-AN-A0FY-01A-11W-A050-09 TCGA-AN-A0FY-01A-11D-A032-05 TCGA-AN-A0FY-01 TCGA-AN-A0FY-01A-11W-A050-09 TCGA-AN-A0FY-01 9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d TCGA-AN-A0FY-01 TCGA-AN-A0FY-01A-11D-A036-01 TCGA-AN-A0FY-01A-11R-A034-07 9f3ddcc1-a6a9-4f55-84b3-cbe06e58ff8d TCGA-AN-A0FY-01A-11D-A036-01 TCGA-AN-A0FY-01 TCGA-AN-A0FZ-01 Stage IIIA 45 3 No_Conversion 10 Positive FEMALE Equivocal 3 3 3 Negative M0 Positive N2 10 0 LumA Luminal A Negative LumA/B -3 -3 enrollment T_Other T2 LIVING TCGA-AN-A0FZ-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-AN-A0FZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Outer Quadrant No axillary staging TCGA-AN-A0FZ-F68969 TCGA-AN-A0FZ TCGA-AN-A0FZ-01A Positive Negative Modified Radical Mastectomy NO -16533 34 0 10 2014-12-24 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 230 NO Positive YES 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 1 0 false No M0 N2 T2 Stage IIIA TCGA-AN-A0FZ.8CC70CDC-01EC-4E2B-84C1-F1C946602CCE.pdf A0FZ TUMOR FREE 0 120 NO NO Primary Tumor 01 NO YES AN Breast A LIVING 2010 1fc2800f-3427-4134-8a02-fea3ecbd2656 1fc2800f-3427-4134-8a02-fea3ecbd2656 TCGA-AN-A0FZ-01A-21-A13C-20 TCGA-AN-A0FZ-01A-11W-A050-09 TCGA-AN-A0FZ-01 e91f0195-b30d-4641-b90c-5f5b2082c391 TCGA-AN-A0FZ-01 TCGA-AN-A0FZ-01A-11W-A050-09 TCGA-AN-A0FZ-01A-11D-A032-05 TCGA-AN-A0FZ-01 TCGA-AN-A0FZ-01A-11W-A050-09 TCGA-AN-A0FZ-01 1fc2800f-3427-4134-8a02-fea3ecbd2656 TCGA-AN-A0FZ-01 TCGA-AN-A0FZ-01A-11D-A036-01 TCGA-AN-A0FZ-01A-11R-A034-07 1fc2800f-3427-4134-8a02-fea3ecbd2656 TCGA-AN-A0FZ-01A-11D-A036-01 TCGA-AN-A0FZ-01 TCGA-AN-A0G0-01 Stage IIA 56 No_Conversion 16 Negative FEMALE Negative Negative M0 Negative N0 16 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-AN-A0G0-01 C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AN-A0G0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Inner Quadrant No axillary staging TCGA-AN-A0G0-F68970 TCGA-AN-A0G0 TCGA-AN-A0G0-01A Negative Negative Modified Radical Mastectomy NO -20504 34 0 16 2014-12-24 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 210 NO Negative YES 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 0 0 false No M0 N0 T2 Stage IIA TCGA-AN-A0G0.08519263-5ADD-4BA3-9BC6-C737ACA7DFE4.pdf A0G0 TUMOR FREE 0 0 YES YES Primary Tumor 01 NO YES AN Breast A LIVING 2010 c09e8a88-5a82-4fd6-8d03-ef3ecb988003 c09e8a88-5a82-4fd6-8d03-ef3ecb988003 TCGA-AN-A0G0-01A-21-A13C-20 TCGA-AN-A0G0-01A-11W-A050-09 TCGA-AN-A0G0-01 8675dc8b-b185-4aa8-9c1c-60505e502215 TCGA-AN-A0G0-01A-11W-A050-09 TCGA-AN-A0G0-01A-11D-A032-05 TCGA-AN-A0G0-01A-11W-A050-09 TCGA-AN-A0G0-01 c09e8a88-5a82-4fd6-8d03-ef3ecb988003 TCGA-AN-A0G0-01 TCGA-AN-A0G0-01A-11R-A034-07 c09e8a88-5a82-4fd6-8d03-ef3ecb988003 TCGA-AN-A0G0-01 TCGA-AN-A0XL-01 Stage IIA 61 5 Stage IIA 10 Positive FEMALE Negative Negative M0 Negative N0 10 0 LumA Luminal A Positive -5 -7 enrollment T_Other T2 LIVING TCGA-AN-A0XL-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 14 TCGA-AN-A0XL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Upper Outer Quadrant TCGA-AN-A0XL-F68955 TCGA-AN-A0XL TCGA-AN-A0XL-01A Positive Positive -22341 169 0 163 NO 2014-12-23 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 130 NO Negative YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 0 true No M0 N0 T2 Stage IIA TCGA-AN-A0XL.A85A959B-F18C-43D3-8BBF-770DA2189462.pdf A0XL TUMOR FREE 60 130 NO YES NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 0cde4246-2dcb-478b-ace9-df557f71e4cd 0cde4246-2dcb-478b-ace9-df557f71e4cd TCGA-AN-A0XL-01A-11D-A10M-09 TCGA-AN-A0XL-01 TCGA-AN-A0XL-01A-11D-A10N-05 TCGA-AN-A0XL-01 TCGA-AN-A0XL-01A-11D-A10M-09 TCGA-AN-A0XL-01 TCGA-AN-A0XL-01A-11D-A10M-09 TCGA-AN-A0XL-01 0cde4246-2dcb-478b-ace9-df557f71e4cd TCGA-AN-A0XL-01 TCGA-AN-A0XL-01A-11D-A10L-01 TCGA-AN-A0XL-01A-11R-A10J-07 0cde4246-2dcb-478b-ace9-df557f71e4cd TCGA-AN-A0XL-01A-11D-A10L-01 TCGA-AN-A0XL-01 TCGA-AN-A0XN-01 Stage IIIA 68 4 Stage IIIA 10 Negative FEMALE Negative 1 3 3 Negative M0 Positive N2 10 0 LumA Luminal A Positive ReacI -5 -3 enrollment T_Other T2 LIVING TCGA-AN-A0XN-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-AN-A0XN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right Upper Inner Quadrant TCGA-AN-A0XN-F68956 TCGA-AN-A0XN TCGA-AN-A0XN-01A Negative Positive -25029 163 0 10 NO 2014-12-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 180 NO Negative YES 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 1 true No M0 N2 T2 Stage IIIA TCGA-AN-A0XN.4C9C9D24-07E1-47BE-8D34-F94693576BD2.pdf A0XN TUMOR FREE 0 170 0 NO YES NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 5a269a43-59a4-4718-878e-1086a07b13ee 5a269a43-59a4-4718-878e-1086a07b13ee TCGA-AN-A0XN-01A-11-A13D-20 TCGA-AN-A0XN-01A-21D-A10G-09 TCGA-AN-A0XN-01 TCGA-AN-A0XN-01A-21D-A10A-05 20ec155a-e210-4e70-8de0-236318167eff TCGA-AN-A0XN-01 TCGA-AN-A0XN-01A-21D-A10G-09 TCGA-AN-A0XN-01 TCGA-AN-A0XN-01A-21D-A10G-09 TCGA-AN-A0XN-01 5a269a43-59a4-4718-878e-1086a07b13ee TCGA-AN-A0XN-01 TCGA-AN-A0XN-01A-21D-A107-01 TCGA-AN-A0XN-01A-21R-A109-07 5a269a43-59a4-4718-878e-1086a07b13ee TCGA-AN-A0XN-01A-21D-A107-01 TCGA-AN-A0XN-01 TCGA-AN-A0XO-01 Stage IIIA 59 2 Stage IIIA 375 Positive FEMALE Negative 1 3 3 Negative M0 Positive N2 375 0 LumA Luminal A Negative LumA/B -7 -3 enrollment T_Other T2 LIVING TCGA-AN-A0XO-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AN-A0XO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant TCGA-AN-A0XO-F68957 TCGA-AN-A0XO TCGA-AN-A0XO-01A Positive Negative -21640 163 0 375 NO 2014-12-23 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 190 NO Negative YES 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 2 true No M0 N2 T2 Stage IIIA TCGA-AN-A0XO.3423E8AE-CE73-4212-BB72-2AF92FD0BC2D.pdf A0XO TUMOR FREE 0 180 NO YES NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 508f0932-673f-48b4-ac71-845ed9eb7c52 508f0932-673f-48b4-ac71-845ed9eb7c52 TCGA-AN-A0XO-01A-21-A13D-20 TCGA-AN-A0XO-01A-11D-A10G-09 TCGA-AN-A0XO-01 TCGA-AN-A0XO-01A-11D-A10A-05 591208e6-48b0-4a0a-b925-255e07225396 TCGA-AN-A0XO-01 TCGA-AN-A0XO-01A-11D-A10G-09 TCGA-AN-A0XO-01 TCGA-AN-A0XO-01A-11D-A10G-09 TCGA-AN-A0XO-01 508f0932-673f-48b4-ac71-845ed9eb7c52 TCGA-AN-A0XO-01 TCGA-AN-A0XO-01A-11D-A107-01 TCGA-AN-A0XO-01A-11R-A109-07 508f0932-673f-48b4-ac71-845ed9eb7c52 TCGA-AN-A0XO-01A-11D-A107-01 TCGA-AN-A0XO-01 TCGA-AN-A0XP-01 Stage IIIA 69 2 Stage IIIA 9 Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 9 0 LumA Luminal A Positive LumA -12 -3 enrollment T_Other T2 LIVING TCGA-AN-A0XP-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AN-A0XP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Inner Quadrant TCGA-AN-A0XP-F68958 TCGA-AN-A0XP TCGA-AN-A0XP-01A Positive Positive -25305 162 0 9 NO 2014-12-23 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 160 NO Positive YES 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 1 true No M0 N2 T2 Stage IIIA TCGA-AN-A0XP.80E9B7CE-0D5D-4C01-A8E3-E6345BE145EC.pdf A0XP TUMOR FREE 140 260 NO YES NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 14fb9342-c11d-460d-af84-f31f7753beeb 14fb9342-c11d-460d-af84-f31f7753beeb TCGA-AN-A0XP-01A-21-A13D-20 TCGA-AN-A0XP-01A-11D-A117-09 TCGA-AN-A0XP-01 TCGA-AN-A0XP-01A-11D-A10A-05 a4ce1a58-da4d-4beb-9785-856f1d1a72e5 TCGA-AN-A0XP-01 TCGA-AN-A0XP-01A-11D-A117-09 TCGA-AN-A0XP-01 TCGA-AN-A0XP-01A-11D-A117-09 TCGA-AN-A0XP-01 14fb9342-c11d-460d-af84-f31f7753beeb TCGA-AN-A0XP-01 TCGA-AN-A0XP-01A-11D-A107-01 TCGA-AN-A0XP-01A-11R-A109-07 14fb9342-c11d-460d-af84-f31f7753beeb TCGA-AN-A0XP-01A-11D-A107-01 TCGA-AN-A0XP-01 TCGA-AN-A0XR-01 Stage IIIA 55 2 Stage IIIA 10 Positive FEMALE Negative Negative M0 Positive N2 10 0 LumB Luminal B Negative -12 -3 enrollment T_Other T2 LIVING TCGA-AN-A0XR-01 Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AN-A0XR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left Upper Outer Quadrant TCGA-AN-A0XR-F56951 TCGA-AN-A0XR TCGA-AN-A0XR-01A Positive Negative -20381 155 0 10 NO 2014-12-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 130 NO Negative YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 7 true No M0 N2 T2 Stage IIIA TCGA-AN-A0XR.1351520E-9B6A-4F06-B631-DF374396C7E6.pdf A0XR TUMOR FREE 0 160 NO YES NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 2738d02e-ac2a-4d26-beb6-794f3e11cf88 2738d02e-ac2a-4d26-beb6-794f3e11cf88 TCGA-AN-A0XR-01A-11D-A10G-09 TCGA-AN-A0XR-01 TCGA-AN-A0XR-01A-11D-A10A-05 TCGA-AN-A0XR-01 TCGA-AN-A0XR-01A-11D-A10G-09 TCGA-AN-A0XR-01 TCGA-AN-A0XR-01A-11D-A10G-09 TCGA-AN-A0XR-01 2738d02e-ac2a-4d26-beb6-794f3e11cf88 TCGA-AN-A0XR-01 TCGA-AN-A0XR-01A-11D-A107-01 TCGA-AN-A0XR-01A-11R-A109-07 2738d02e-ac2a-4d26-beb6-794f3e11cf88 TCGA-AN-A0XR-01A-11D-A107-01 TCGA-AN-A0XR-01 TCGA-AN-A0XS-01 Stage IIIA 63 4 Stage IIIA 10 Negative FEMALE Negative 3 3 3 Negative M0 Positive N2 10 0 LumA Luminal A Positive LumA -5 -4 enrollment T_Other T2 LIVING TCGA-AN-A0XS-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 14 TCGA-AN-A0XS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant TCGA-AN-A0XS-F68959 TCGA-AN-A0XS TCGA-AN-A0XS-01A Negative Positive -23358 120 0 10 NO 2014-12-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 210 NO Negative YES 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 1 true No M0 N2 T2 Stage IIIA TCGA-AN-A0XS.D5C9D3FF-3799-4773-8A86-B000DBE42BD8.pdf A0XS TUMOR FREE 160 0 NO YES NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 b77f4222-9000-4485-8728-8864780ebcb8 b77f4222-9000-4485-8728-8864780ebcb8 TCGA-AN-A0XS-01A-11-A13D-20 TCGA-AN-A0XS-01A-22D-A10G-09 TCGA-AN-A0XS-01 TCGA-AN-A0XS-01A-22D-A10A-05 7ca812ab-5eb8-4ae0-8da0-8a53020c32ef TCGA-AN-A0XS-01 TCGA-AN-A0XS-01A-22D-A10G-09 TCGA-AN-A0XS-01 TCGA-AN-A0XS-01A-22D-A10G-09 TCGA-AN-A0XS-01 b77f4222-9000-4485-8728-8864780ebcb8 TCGA-AN-A0XS-01 TCGA-AN-A0XS-01A-22D-A107-01 TCGA-AN-A0XS-01A-22R-A109-07 b77f4222-9000-4485-8728-8864780ebcb8 TCGA-AN-A0XS-01A-22D-A107-01 TCGA-AN-A0XS-01 TCGA-AN-A0XT-01 Stage IIIA 54 2 Stage IIIA 10 Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 10 0 LumA Luminal A Negative LumA/B 0 -3 enrollment T_Other T2 LIVING TCGA-AN-A0XT-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 7 mutation cluster 5 TCGA-AN-A0XT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Outer Quadrant TCGA-AN-A0XT-F68960 TCGA-AN-A0XT TCGA-AN-A0XT-01A Positive Negative -19794 114 0 10 NO 2014-12-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 160 NO Negative YES 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 7 1 true No M0 N2 T2 Stage IIIA TCGA-AN-A0XT.3C94BBAC-923E-43F0-B5DC-01207868AD05.pdf A0XT TUMOR FREE 0 120 NO YES NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 21f22460-fac7-4dbc-8ab2-75738331cb5c 21f22460-fac7-4dbc-8ab2-75738331cb5c TCGA-AN-A0XT-01A-21-A13D-20 TCGA-AN-A0XT-01A-11D-A10G-09 TCGA-AN-A0XT-01 TCGA-AN-A0XT-01A-11D-A10A-05 95d4260a-5886-44ff-824f-6c2c76c9c1bc TCGA-AN-A0XT-01 TCGA-AN-A0XT-01A-11D-A10G-09 TCGA-AN-A0XT-01 TCGA-AN-A0XT-01A-11D-A10G-09 TCGA-AN-A0XT-01 21f22460-fac7-4dbc-8ab2-75738331cb5c TCGA-AN-A0XT-01 TCGA-AN-A0XT-01A-11D-A107-01 TCGA-AN-A0XT-01A-11R-A109-07 21f22460-fac7-4dbc-8ab2-75738331cb5c TCGA-AN-A0XT-01A-11D-A107-01 TCGA-AN-A0XT-01 TCGA-AN-A0XU-01 Stage IIA 54 1 Stage IIA 10 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 10 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-AN-A0XU-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AN-A0XU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Outer Quadrant TCGA-AN-A0XU-F68961 TCGA-AN-A0XU TCGA-AN-A0XU-01A Negative Negative -20052 106 0 10 NO 2014-12-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 180 NO Negative YES 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 0 true No M0 N0 T2 Stage IIA TCGA-AN-A0XU.8216B837-DCF3-4E7F-A72A-212655F394F0.pdf A0XU TUMOR FREE 0 0 NO YES NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 74cba80b-7677-41d6-ab22-10f1a962ba2f 74cba80b-7677-41d6-ab22-10f1a962ba2f TCGA-AN-A0XU-01A-21-A13D-20 TCGA-AN-A0XU-01A-11D-A10G-09 TCGA-AN-A0XU-01 TCGA-AN-A0XU-01A-11D-A10A-05 fa8604b6-7128-4db4-bfaf-6f1000fb4017 TCGA-AN-A0XU-01 TCGA-AN-A0XU-01A-11D-A10G-09 TCGA-AN-A0XU-01 TCGA-AN-A0XU-01A-11D-A10G-09 TCGA-AN-A0XU-01 74cba80b-7677-41d6-ab22-10f1a962ba2f TCGA-AN-A0XU-01 TCGA-AN-A0XU-01A-11D-A107-01 TCGA-AN-A0XU-01A-11R-A109-07 74cba80b-7677-41d6-ab22-10f1a962ba2f TCGA-AN-A0XU-01A-11D-A107-01 TCGA-AN-A0XU-01 TCGA-AN-A0XV-01 Stage IIIA 67 4 Stage IIIA 162 Positive FEMALE Negative Negative M0 Positive N2 162 0 LumA Luminal A Positive 0 0 enrollment T_Other T2 LIVING TCGA-AN-A0XV-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AN-A0XV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AN-A0XV-F68962 TCGA-AN-A0XV TCGA-AN-A0XV-01A Positive 1+ 3 Point Scale Positive NO -24779 121 0 162 NO dextran coated charcoal 90-99% 2014-12-23 FEMALE 60-69% 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 100 NO Positive Negative YES 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 7 true No M0 N2 T2 Stage IIIA TCGA-AN-A0XV.5F626AB6-EEB5-4005-97C5-9E48D9FA7730.pdf A0XV TUMOR FREE dextran coated charcoal 90 H 270 H NO YES 30-39% NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 7b33b321-fe4b-4296-91bc-53bac35828e5 7b33b321-fe4b-4296-91bc-53bac35828e5 TCGA-AN-A0XV-01A-11D-A10G-09 TCGA-AN-A0XV-01 TCGA-AN-A0XV-01A-11D-A10A-05 TCGA-AN-A0XV-01 TCGA-AN-A0XV-01A-11D-A10G-09 TCGA-AN-A0XV-01 TCGA-AN-A0XV-01A-11D-A10G-09 TCGA-AN-A0XV-01 7b33b321-fe4b-4296-91bc-53bac35828e5 TCGA-AN-A0XV-01 TCGA-AN-A0XV-01A-11D-A107-01 TCGA-AN-A0XV-01A-11R-A109-07 7b33b321-fe4b-4296-91bc-53bac35828e5 TCGA-AN-A0XV-01A-11D-A107-01 TCGA-AN-A0XV-01 TCGA-AN-A0XW-01 Stage IIIA 36 5 Stage IIIA 170 Positive FEMALE Negative 1 1 4 Negative M0 Positive N2 170 0 LumA Luminal B Positive Her2 -2 -4 enrollment T_Other T2 LIVING TCGA-AN-A0XW-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AN-A0XW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 36 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-AN-A0XW-F68963 TCGA-AN-A0XW TCGA-AN-A0XW-01A Positive 3 Point Scale 3+ 3 Point Scale Positive NO -13208 121 0 170 NO dextran coated charcoal 90-99% 2014-12-23 FEMALE 60-69% 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 270 NO Positive Negative YES 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 NO 1 true No M0 N2 T2 Stage IIIA TCGA-AN-A0XW.5CBC6417-4E3D-4E9C-AE93-A56B777EF2F4.pdf A0XW TUMOR FREE dextran coated charcoal 240 H 240 H NO YES 90-99% NO Primary Tumor 01 7th NO YES AN Breast A LIVING 2010 52033f64-1e6f-4657-a4fb-7cfeffc61951 52033f64-1e6f-4657-a4fb-7cfeffc61951 TCGA-AN-A0XW-01A-21-A13D-20 TCGA-AN-A0XW-01A-11D-A10G-09 TCGA-AN-A0XW-01 TCGA-AN-A0XW-01A-11D-A10A-05 a8db4abd-7071-4135-96f6-dfcd0f003f02 TCGA-AN-A0XW-01 TCGA-AN-A0XW-01A-11D-A10G-09 TCGA-AN-A0XW-01 TCGA-AN-A0XW-01A-11D-A10G-09 TCGA-AN-A0XW-01 52033f64-1e6f-4657-a4fb-7cfeffc61951 TCGA-AN-A0XW-01 TCGA-AN-A0XW-01A-11D-A107-01 TCGA-AN-A0XW-01A-11R-A109-07 52033f64-1e6f-4657-a4fb-7cfeffc61951 TCGA-AN-A0XW-01A-11D-A107-01 TCGA-AN-A0XW-01 TCGA-AO-A03L-01 Stage IIIA 34 5 No_Conversion 2442 Positive FEMALE Negative 1 3 1 Negative M0 Positive N2 2442 0 LumA HER2-enriched Positive Basal -2 -4 followup T_Other T3 LIVING TCGA-AO-A03L-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-AO-A03L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A03L-F19390 TCGA-AO-A03L TCGA-AO-A03L-01A Positive 2+ Positive Modified Radical Mastectomy NO -12443 2456 0 2442 70-79% 63 Scheduled Follow-up Submission 2011-12-12 FEMALE 10-19% >= 2.0 Positive 2+ 30 47 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 680 NO Positive Negative 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 1 NO 4 true No M0 N2 T3 Stage IIIA TCGA-AO-A03L.FF7212E5-9A44-4659-B3B9-3EF2DB7A9E6D.pdf A03L TUMOR FREE 10-19% YES Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2003 34980e1d-956b-4d89-8bf2-dcc008dbaad7 34980e1d-956b-4d89-8bf2-dcc008dbaad7 TCGA-AO-A03L-01A-31-A13A-20 TCGA-AO-A03L-01A-41W-A071-09 TCGA-AO-A03L-01 TCGA-AO-A03L-01A-41D-A10P-05 f54048ea-ae8d-4786-b466-a9f4604507e0 TCGA-AO-A03L-01 TCGA-AO-A03L-01A-41W-A071-09 TCGA-AO-A03L-01 TCGA-AO-A03L-01A-41W-A071-09 TCGA-AO-A03L-01 34980e1d-956b-4d89-8bf2-dcc008dbaad7 TCGA-AO-A03L-01 TCGA-AO-A03L-01A-41D-A059-01 TCGA-AO-A03L-01A-41R-A056-07 34980e1d-956b-4d89-8bf2-dcc008dbaad7 TCGA-AO-A03L-01A-41D-A059-01 TCGA-AO-A03L-01 TCGA-AO-A03M-01 Stage IA 29 1 Stage I 1455 Positive FEMALE Negative Negative M0 Negative N0 1455 0 LumA Luminal A Positive ReacII -2 -5 followup T1 T1 LIVING TCGA-AO-A03M-01 High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 TCGA-AO-A03M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 29 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-AO-A03M-F30186 TCGA-AO-A03M Positive 3+ Positive Simple Mastectomy YES -10616 0 1866 70-79% Scheduled Follow-up Submission 2012-4-4 FEMALE 3+ Positive 30-39% >= 2.0 Positive 2+ 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy Negative Negative 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 7 NO 0 0 No M0 N0 (i-) T1c Stage I A03M TUMOR FREE 60-69% NO Primary Tumor 01 6th YES NO YES AO Breast LIVING 2006 f65936bc-02d6-4954-9068-0fb7c930d685 f65936bc-02d6-4954-9068-0fb7c930d685 TCGA-AO-A03M-01B-21-A13E-20 TCGA-AO-A03M-01 TCGA-AO-A03M-01B-11D-A10N-05 dbfbb734-f8c7-46df-b27b-0320a0372428 TCGA-AO-A03M-01 TCGA-AO-A03M-01B-11D-A10M-09 TCGA-AO-A03M-01 TCGA-AO-A03M-01 f65936bc-02d6-4954-9068-0fb7c930d685 TCGA-AO-A03M-01 TCGA-AO-A03M-01B-11D-A10L-01 TCGA-AO-A03M-01B-11R-A10J-07 f65936bc-02d6-4954-9068-0fb7c930d685 TCGA-AO-A03M-01B-11D-A10L-01 TCGA-AO-A03M-01 TCGA-AO-A03N-01 Stage IIB 59 3 No_Conversion 1645 Positive FEMALE Negative 3 3 4 Negative M0 Positive N1 1645 0 LumB HER2-enriched Positive Her2 -2 -3 followup T_Other T2 LIVING TCGA-AO-A03N-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation cluster 2 TCGA-AO-A03N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 59 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A03N-F20915 TCGA-AO-A03N TCGA-AO-A03N-01B Positive 1+ Positive Modified Radical Mastectomy NO -21816 1596 0 2031 1645 70-79% Scheduled Follow-up Submission 2012-1-24 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 360 NO Negative 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative Negative 4 Point Scale Negative 2 6 4 Point Scale Locoregional Disease YES 2 true No M0 N1a T2 Stage IIB TCGA-AO-A03N.44527CD3-6EC3-4861-8394-CEA005A17A9E.pdf A03N WITH TUMOR <10% NO Primary Tumor 01 6th YES NO YES AO Breast B LIVING 2006 ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6 ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6 TCGA-AO-A03N-01B-21-A13E-20 TCGA-AO-A03N-01B-11D-A10M-09 TCGA-AO-A03N-01 TCGA-AO-A03N-01B-11D-A10N-05 0a7af48e-5b73-42e8-acf6-a0bca1372cc4 TCGA-AO-A03N-01 TCGA-AO-A03N-01B-11D-A10M-09 TCGA-AO-A03N-01 TCGA-AO-A03N-01B-11D-A10M-09 TCGA-AO-A03N-01 ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6 TCGA-AO-A03N-01 TCGA-AO-A03N-01B-11D-A10L-01 TCGA-AO-A03N-01B-11R-A10J-07 ef37a73c-e0a0-4ff6-83a3-6befcdcb51c6 TCGA-AO-A03N-01B-11D-A10L-01 TCGA-AO-A03N-01 TCGA-AO-A03O-01 Stage IIA 69 3 Stage IIA 993 2483 Positive FEMALE Negative 1 1 4 Negative M0 Negative N0 2483 1 LumB Luminal B Positive LumA/B -2 -5 followup T_Other T2 DECEASED TCGA-AO-A03O-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 8 TCGA-AO-A03O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A03O-F3141 TCGA-AO-A03O TCGA-AO-A03O-01A Positive Positive Modified Radical Mastectomy YES -25362 2694 2483 0 >10% STAINING = POSITIVE 68 2010-9-19 FEMALE 3+ POSITIVE <10% > = 2.0 1+ 29 73 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 690 NO Negative Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A03O.FE9C56C4-B6D4-4054-A58C-13642370052E.pdf A03O TUMOR FREE >10% STAINING = POSITIVE NO Primary Tumor 01 YES NO YES AO Breast A DECEASED 2002 a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb TCGA-AO-A03O-01A-31-A13A-20 TCGA-AO-A03O-01A-11W-A019-09 TCGA-AO-A03O-01 191dae29-7228-4645-9efe-8c80596a5e50 TCGA-AO-A03O-01 TCGA-AO-A03O-01A-11W-A019-09 TCGA-AO-A03O-01A-11D-A00Y-05 TCGA-AO-A03O-01 TCGA-AO-A03O-01A-11W-A019-09 TCGA-AO-A03O-01 a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb TCGA-AO-A03O-01 TCGA-AO-A03O-01A-11D-A011-01 TCGA-AO-A03O-01A-11R-A00Z-07 a1460e9a-c4aa-4e07-abf4-fdb5f42f5eeb TCGA-AO-A03O-01A-11D-A011-01 TCGA-AO-A03O-01 TCGA-AO-A03P-01 Stage IIA 54 3 No_Conversion 2576 Positive FEMALE Negative Negative M0 Positive N1 2576 0 LumB Luminal B Positive LumA/B -10 -5 enrollment T_Other T2 LIVING TCGA-AO-A03P-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation c1uster 9 TCGA-AO-A03P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 54 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A03P-F15452 TCGA-AO-A03P TCGA-AO-A03P-01A Positive 2+ Positive Lumpectomy YES 1922 -19724 2414 2911 0 2576 2576 1922 90-99% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% 0 4.0 Infiltrating Ductal Carcinoma No 40 C50.9 8500/3 C50.9 4+ YES Core needle biopsy 370 NO Negative 26 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Equivocal 2+ Positive 90-99% 3 Point Scale 20-29% 1.7 4 Point Scale 4+ 2+ Negative 80-89% Positive 2 2.4 RATIO >2.2 4 Point Scale Liver Distant Metastasis YES 0 2 true No M0 N1 T2 Stage IIB TCGA-AO-A03P.0BFAB667-8B40-46AE-A224-535573E268C7.pdf A03P WITH TUMOR 40-49% YES Primary Tumor 01 6th NO NO YES AO Breast A DECEASED 2003 9543095d-b05b-43e0-8b8d-74bd916b510b 9543095d-b05b-43e0-8b8d-74bd916b510b TCGA-AO-A03P-01A-31-A13A-20 TCGA-AO-A03P-01A-11W-A019-09 TCGA-AO-A03P-01 dafdae39-54bf-4a1a-a15b-3538e36ed42c TCGA-AO-A03P-01 TCGA-AO-A03P-01A-11W-A019-09 TCGA-AO-A03P-01A-11D-A00Y-05 TCGA-AO-A03P-01 TCGA-AO-A03P-01A-11W-A019-09 9543095d-b05b-43e0-8b8d-74bd916b510b TCGA-AO-A03P-01A-11D-A011-01 TCGA-AO-A03P-01A-11R-A00Z-07 9543095d-b05b-43e0-8b8d-74bd916b510b TCGA-AO-A03P-01A-11D-A011-01 TCGA-AO-A03P-01 TCGA-AO-A03R-01 Stage IIB 57 4 No_Conversion 1707 Positive FEMALE Negative Negative M0 Positive N1 1707 0 Normal Normal-like Positive 0 0 followup T_Other T2 LIVING TCGA-AO-A03R-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation cluster 5 TCGA-AO-A03R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A03R-F15469 TCGA-AO-A03R TCGA-AO-A03R-01A Positive 2+ Positive Modified Radical Mastectomy NO -20930 1608 0 2091 90-99% 70 Scheduled Follow-up Submission 2011-8-22 FEMALE <10% Ratio >=2.0 0 28 105 1.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 140 NO Negative Negative 26 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 3 0 true No M0 N1a T2 Stage IIB TCGA-AO-A03R.D779EEF8-C83C-4CCA-A140-9BF15DCF14AE.pdf A03R TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2005 6722de75-5d6d-4b1d-a961-856ec5bd12f1 6722de75-5d6d-4b1d-a961-856ec5bd12f1 TCGA-AO-A03R-01A-21W-A050-09 TCGA-AO-A03R-01 TCGA-AO-A03R-01 TCGA-AO-A03R-01A-21W-A050-09 TCGA-AO-A03R-01A-21D-A032-05 TCGA-AO-A03R-01 TCGA-AO-A03R-01A-21W-A050-09 TCGA-AO-A03R-01 6722de75-5d6d-4b1d-a961-856ec5bd12f1 TCGA-AO-A03R-01 TCGA-AO-A03R-01A-21D-A036-01 TCGA-AO-A03R-01A-21R-A034-07 6722de75-5d6d-4b1d-a961-856ec5bd12f1 TCGA-AO-A03R-01A-21D-A036-01 TCGA-AO-A03R-01 TCGA-AO-A03T-01 Stage IIB 42 5 No_Conversion 1187 Positive FEMALE Negative Negative M0 Positive N1 1187 0 Normal Normal-like Positive -2 -3 enrollment T_Other T2 LIVING TCGA-AO-A03T-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 12 TCGA-AO-A03T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A03T-F43476 TCGA-AO-A03T TCGA-AO-A03T-01A Positive 2+ Positive Modified Radical Mastectomy NO -15540 1031 0 2124 90-99% Scheduled Follow-up Submission 2013-5-22 FEMALE 3+ POSITIVE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 140 NO Negative NO 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 NO 2 true No M0 N1a T2 Stage IIB TCGA-AO-A03T.D5EF8C37-811E-42B7-84E5-E6ED71217971.pdf A03T TUMOR FREE YES 60-69% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2007 0e6447b4-6e63-4420-bfa8-5b1d711d90fc 0e6447b4-6e63-4420-bfa8-5b1d711d90fc TCGA-AO-A03T-01A-21W-A050-09 TCGA-AO-A03T-01 TCGA-AO-A03T-01 TCGA-AO-A03T-01A-21W-A050-09 TCGA-AO-A03T-01A-21D-A032-05 TCGA-AO-A03T-01 TCGA-AO-A03T-01A-21W-A050-09 TCGA-AO-A03T-01 0e6447b4-6e63-4420-bfa8-5b1d711d90fc TCGA-AO-A03T-01 TCGA-AO-A03T-01A-21D-A036-01 TCGA-AO-A03T-01A-21R-A034-07 0e6447b4-6e63-4420-bfa8-5b1d711d90fc TCGA-AO-A03T-01A-21D-A036-01 TCGA-AO-A03T-01 TCGA-AO-A03U-01 Stage IA 31 1 Stage I 1727 1796 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1796 1 Normal Normal-like Negative Basal -5 0 followup T1 T1 DECEASED TCGA-AO-A03U-01 Kirc+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AO-A03U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO 31 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel node biopsy alone TCGA-AO-A03U-F20907 TCGA-AO-A03U TCGA-AO-A03U-01B Negative Negative Simple Mastectomy YES -11354 3254 1793 0 1614 <10% Scheduled Follow-up Submission 2012-1-24 FEMALE 3+ Positive <10% 0 Other, specify No C50.9 8502/3 C50.9 YES Core needle biopsy 170 NO Negative Negative 8 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative Negative Negative 5 4 Lung New Primary Tumor YES 0 0 true No M0 N0 (i-) T1c Stage I TCGA-AO-A03U.A8AF94A0-F3C2-4AB0-AB0C-22BDA51AF546.pdf A03U TUMOR FREE <10% NO Primary Tumor 01 6th YES NO YES AO Breast B DECEASED 2001 bbca4523-28a7-416c-98a8-02c3350705fc bbca4523-28a7-416c-98a8-02c3350705fc TCGA-AO-A03U-01B-11-A13E-20 TCGA-AO-A03U-01B-21D-A10M-09 TCGA-AO-A03U-01 TCGA-AO-A03U-01B-21D-A10N-05 93635795-8741-4a0d-b538-48fb08377942 TCGA-AO-A03U-01 TCGA-AO-A03U-01B-21D-A10M-09 TCGA-AO-A03U-01 TCGA-AO-A03U-01B-21D-A10M-09 TCGA-AO-A03U-01 bbca4523-28a7-416c-98a8-02c3350705fc TCGA-AO-A03U-01 TCGA-AO-A03U-01B-21D-A10L-01 TCGA-AO-A03U-01B-21R-A10J-07 bbca4523-28a7-416c-98a8-02c3350705fc TCGA-AO-A03U-01B-21D-A10L-01 TCGA-AO-A03U-01 TCGA-AO-A03V-01 Stage IA 41 1 Stage I 886 Positive FEMALE Negative Negative M0 Negative N0 886 0 LumA Luminal A Positive 0 -3 followup T1 T1 LIVING TCGA-AO-A03V-01 COAD-READ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 5 TCGA-AO-A03V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Inner Quadrant|Left Sentinel node biopsy alone TCGA-AO-A03V-F20912 TCGA-AO-A03V TCGA-AO-A03V-01A Positive 2+ Positive Simple Mastectomy YES -15284 670 0 1351 90-99% Scheduled Follow-up Submission 2012-1-24 FEMALE 3+ Positive <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 70 NO Negative 2 Negative Peri (6-12 months since last menstrual period) 2 7 NO 0 0 true No M0 N0 (i-) T1c Stage I TCGA-AO-A03V.63E34973-F630-4295-AC1B-94F81BBEBE41.pdf A03V TUMOR FREE 80-89% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2008 35a76121-7e58-4e28-a39c-6301a4cc0e2e 35a76121-7e58-4e28-a39c-6301a4cc0e2e TCGA-AO-A03V-01A-11D-A10Y-09 TCGA-AO-A03V-01 TCGA-AO-A03V-01 TCGA-AO-A03V-01A-11D-A10Y-09 TCGA-AO-A03V-01A-11D-A112-05 TCGA-AO-A03V-01 TCGA-AO-A03V-01 TCGA-AO-A03V-01A-11D-A10Y-09 35a76121-7e58-4e28-a39c-6301a4cc0e2e TCGA-AO-A03V-01A-11D-A111-01 TCGA-AO-A03V-01 TCGA-AO-A03V-01A-11R-A115-07 35a76121-7e58-4e28-a39c-6301a4cc0e2e TCGA-AO-A03V-01A-11D-A111-01 TCGA-AO-A03V-01 TCGA-AO-A0J2-01 Stage IA 41 3 Stage I 585 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 585 0 Her2 HER2-enriched Negative Basal -11 -9 followup T1 T1 LIVING TCGA-AO-A0J2-01 High C3-BRCA/Luminal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AO-A0J2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Lower Inner Quadrant|Left Sentinel node biopsy alone TCGA-AO-A0J2-F15481 TCGA-AO-A0J2 TCGA-AO-A0J2-01A Negative Negative Simple Mastectomy YES -15324 668 0 997 <10% 2.4 Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE 30-39% RATIO > 2.2 2+ 40 3.5 1.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 260 NO Equivocal Negative 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-AO-A0J2.DB0B1C9D-6B94-46EF-A84E-3D912E08B7FD.pdf A0J2 TUMOR FREE <10% NO Primary Tumor 01 YES NO YES AO Breast A LIVING 2008 81689324-2986-49f6-bef6-f5a525ca36c2 81689324-2986-49f6-bef6-f5a525ca36c2 TCGA-AO-A0J2-01A-21-A13A-20 TCGA-AO-A0J2-01A-11W-A050-09 TCGA-AO-A0J2-01 c8e29a9a-2a2c-49ad-8101-2f74df959c0c TCGA-AO-A0J2-01 TCGA-AO-A0J2-01A-11W-A050-09 TCGA-AO-A0J2-01A-11D-A032-05 TCGA-AO-A0J2-01 TCGA-AO-A0J2-01A-11W-A050-09 TCGA-AO-A0J2-01 81689324-2986-49f6-bef6-f5a525ca36c2 TCGA-AO-A0J2-01 TCGA-AO-A0J2-01A-11D-A036-01 TCGA-AO-A0J2-01A-11R-A034-07 81689324-2986-49f6-bef6-f5a525ca36c2 TCGA-AO-A0J2-01A-11D-A036-01 TCGA-AO-A0J2-01 TCGA-AO-A0J3-01 Stage IIB 67 5 No_Conversion 302 Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 302 0 LumB Luminal B Positive LumA/B -10 -3 followup T_Other T2 LIVING TCGA-AO-A0J3-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 1 mutation c1uster 9 TCGA-AO-A0J3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone TCGA-AO-A0J3-F15477 TCGA-AO-A0J3 TCGA-AO-A0J3-01A Positive 4+ Positive Modified Radical Mastectomy YES -24519 220 0 651 <10% 2.6 Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ Positive 10-19% Ratio >=2.2 2+ 40 2.4 0.9 Other, specify No C50.9 8523/3 C50.9 4+ YES Core needle biopsy 1180 NO Equivocal Negative 36 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 NO 1 0 true No M0 N1b T2 Stage IIB TCGA-AO-A0J3.29C262B5-D49D-4125-9661-19033A8EC6A8.pdf A0J3 TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2009 7455cc98-aceb-4adc-932b-4fddd979c522 7455cc98-aceb-4adc-932b-4fddd979c522 TCGA-AO-A0J3-01A-21-A13B-20 TCGA-AO-A0J3-01A-11W-A050-09 TCGA-AO-A0J3-01 67394de8-86f3-40e0-b897-52e23c163647 TCGA-AO-A0J3-01 TCGA-AO-A0J3-01A-11W-A050-09 TCGA-AO-A0J3-01A-11D-A032-05 TCGA-AO-A0J3-01 TCGA-AO-A0J3-01A-11W-A050-09 TCGA-AO-A0J3-01 7455cc98-aceb-4adc-932b-4fddd979c522 TCGA-AO-A0J3-01 TCGA-AO-A0J3-01A-11D-A036-01 TCGA-AO-A0J3-01A-11R-A034-07 7455cc98-aceb-4adc-932b-4fddd979c522 TCGA-AO-A0J3-01A-11D-A036-01 TCGA-AO-A0J3-01 TCGA-AO-A0J4-01 Stage IA 41 1 Stage I 294 Negative FEMALE Negative Negative M0 Negative N0 294 0 Basal Basal-like Negative -13 -12 followup T1 T1 LIVING TCGA-AO-A0J4-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AO-A0J4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-AO-A0J4-F15478 TCGA-AO-A0J4 TCGA-AO-A0J4-01A Negative Negative Lumpectomy YES -15052 224 0 1587 <10% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 130 NO Negative 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 NO 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-AO-A0J4.846851BE-3D24-46F0-A6BE-CEB22C7D0F62.pdf A0J4 TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2009 4808bc63-000a-4a49-a25b-4b817ca5ea54 4808bc63-000a-4a49-a25b-4b817ca5ea54 TCGA-AO-A0J4-01A-11W-A050-09 TCGA-AO-A0J4-01 TCGA-AO-A0J4-01 TCGA-AO-A0J4-01A-11W-A050-09 TCGA-AO-A0J4-01A-11D-A032-05 TCGA-AO-A0J4-01 TCGA-AO-A0J4-01A-11W-A050-09 TCGA-AO-A0J4-01 4808bc63-000a-4a49-a25b-4b817ca5ea54 TCGA-AO-A0J4-01 TCGA-AO-A0J4-01A-11D-A036-01 TCGA-AO-A0J4-01A-11R-A034-07 4808bc63-000a-4a49-a25b-4b817ca5ea54 TCGA-AO-A0J4-01A-11D-A036-01 TCGA-AO-A0J4-01 TCGA-AO-A0J5-01 Stage IV 48 No_Conversion 704 Positive FEMALE Negative Positive M1 Positive N1 704 0 LumA Negative followup T_Other T4 LIVING TCGA-AO-A0J5-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 4 TCGA-AO-A0J5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone TCGA-AO-A0J5-F19407 TCGA-AO-A0J5 TCGA-AO-A0J5-01A Positive Negative Modified Radical Mastectomy NO -17815 554 792 0 705 735 90-99% 64 Scheduled Follow-up Submission 2011-12-12 FEMALE >2.2 Positive 3+ Positive 10-19% 2+ 25 71 1.1 Other, specify Yes C50.9 8523/3 C50.9 4+ YES Core needle biopsy 500 NO Equivocal Negative 2 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Lung|Bone|Liver NO 2 true No M1 N1a T4 Stage IV TCGA-AO-A0J5.5EFC16F4-7FC7-479E-93F7-AEDC2D350A22.pdf A0J5 WITH TUMOR <10% YES Primary Tumor 01 YES NO YES AO Breast A DECEASED 2008 5d033f3f-b22f-4d10-b39b-0bae2b4db5be 5d033f3f-b22f-4d10-b39b-0bae2b4db5be TCGA-AO-A0J5-01A-21-A13A-20 TCGA-AO-A0J5-01A-11W-A050-09 TCGA-AO-A0J5-01 42dea565-bb3c-4c5f-badc-b1615a3482e4 TCGA-AO-A0J5-01 TCGA-AO-A0J5-01A-11W-A050-09 TCGA-AO-A0J5-01A-11D-A032-05 TCGA-AO-A0J5-01 TCGA-AO-A0J5-01A-11W-A050-09 TCGA-AO-A0J5-01 5d033f3f-b22f-4d10-b39b-0bae2b4db5be TCGA-AO-A0J5-01 TCGA-AO-A0J5-01A-11D-A036-01 TCGA-AO-A0J5-01A-11R-A034-07 5d033f3f-b22f-4d10-b39b-0bae2b4db5be TCGA-AO-A0J5-01A-11D-A036-01 TCGA-AO-A0J5-01 TCGA-AO-A0J6-01 Stage IIA 61 1 Stage IIA 775 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 775 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-AO-A0J6-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-AO-A0J6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-AO-A0J6-F15479 TCGA-AO-A0J6 TCGA-AO-A0J6-01A Negative Negative Lumpectomy YES -22462 748 0 1140 <10% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 390 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 2 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A0J6.CE2FF4D3-B82C-4435-AE1C-3E2E6F104271.pdf A0J6 TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2008 1fe98b05-6803-4803-83cd-a59e794b956e 1fe98b05-6803-4803-83cd-a59e794b956e TCGA-AO-A0J6-01A-21-A13A-20 TCGA-AO-A0J6-01A-11W-A050-09 TCGA-AO-A0J6-01 13c00c4c-d6c9-4d3f-b63d-780757d0e5e1 TCGA-AO-A0J6-01 TCGA-AO-A0J6-01A-11W-A050-09 TCGA-AO-A0J6-01A-11D-A032-05 TCGA-AO-A0J6-01 TCGA-AO-A0J6-01A-11W-A050-09 TCGA-AO-A0J6-01 1fe98b05-6803-4803-83cd-a59e794b956e TCGA-AO-A0J6-01 TCGA-AO-A0J6-01A-11D-A036-01 TCGA-AO-A0J6-01A-11R-A034-07 1fe98b05-6803-4803-83cd-a59e794b956e TCGA-AO-A0J6-01A-11D-A036-01 TCGA-AO-A0J6-01 TCGA-AO-A0J7-01 Stage IIB 71 2 No_Conversion 260 Positive FEMALE Negative 1 3 4 Negative M0 Positive N1 260 0 LumB Luminal B Positive LumA/B 0 -3 followup T_Other T2 LIVING TCGA-AO-A0J7-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AO-A0J7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0J7-F15480 TCGA-AO-A0J7 TCGA-AO-A0J7-01A Positive Positive Modified Radical Mastectomy NO -26281 177 0 618 90-99% 2011-8-22 FEMALE 3+ POSITIVE <10% 1+ Other, specify No C50.9 8523/3 C50.9 4+ YES Core needle biopsy 300 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 3 0 true No M0 N1 T2 Stage IIB TCGA-AO-A0J7.4022B2EB-04C3-43F6-9D2C-1A47D80EF6EE.pdf A0J7 TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2009 542bb107-1b0c-4ace-834d-9e32ed82429c 542bb107-1b0c-4ace-834d-9e32ed82429c TCGA-AO-A0J7-01A-21-A13B-20 TCGA-AO-A0J7-01A-11W-A050-09 TCGA-AO-A0J7-01 dd6cd205-238d-4ba8-88db-6f0028931ca7 TCGA-AO-A0J7-01 TCGA-AO-A0J7-01A-11W-A050-09 TCGA-AO-A0J7-01A-11D-A032-05 TCGA-AO-A0J7-01 TCGA-AO-A0J7-01A-11W-A050-09 TCGA-AO-A0J7-01 542bb107-1b0c-4ace-834d-9e32ed82429c TCGA-AO-A0J7-01 TCGA-AO-A0J7-01A-11D-A036-01 TCGA-AO-A0J7-01A-11R-A034-07 542bb107-1b0c-4ace-834d-9e32ed82429c TCGA-AO-A0J7-01A-11D-A036-01 TCGA-AO-A0J7-01 TCGA-AO-A0J8-01 Stage IIA 61 2 Stage IIA 277 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 277 0 LumA Luminal A Positive ReacI -12 -3 followup T_Other T2 LIVING TCGA-AO-A0J8-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AO-A0J8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-AO-A0J8-F15482 TCGA-AO-A0J8 TCGA-AO-A0J8-01A Positive 3+ Positive Lumpectomy YES -22284 241 0 680 90-99% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 4+ YES Core needle biopsy 670 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 2 NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-AO-A0J8.03C7A677-C223-47D6-869E-E6C3250B0C08.pdf A0J8 TUMOR FREE 70-79% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2009 70109263-1d2b-4abe-a582-2b28e87cde67 70109263-1d2b-4abe-a582-2b28e87cde67 TCGA-AO-A0J8-01A-11-A13A-20 TCGA-AO-A0J8-01A-21D-A045-09 TCGA-AO-A0J8-01 287094b7-2cf5-415d-81f7-5ef0196d181c TCGA-AO-A0J8-01 TCGA-AO-A0J8-01A-21D-A045-09 TCGA-AO-A0J8-01A-21D-A032-05 TCGA-AO-A0J8-01 TCGA-AO-A0J8-01A-21D-A045-09 TCGA-AO-A0J8-01 70109263-1d2b-4abe-a582-2b28e87cde67 TCGA-AO-A0J8-01 TCGA-AO-A0J8-01A-21D-A036-01 TCGA-AO-A0J8-01A-21R-A034-07 70109263-1d2b-4abe-a582-2b28e87cde67 TCGA-AO-A0J8-01A-21D-A036-01 TCGA-AO-A0J8-01 TCGA-AO-A0J9-01 Stage IIIC 61 2 No_Conversion 1255 Positive FEMALE Negative 1 4 3 Negative M0 Positive N3 1255 0 LumA Luminal A Positive ReacI -2 -3 followup T_Other T2 LIVING TCGA-AO-A0J9-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AO-A0J9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES 61 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0J9-F15483 TCGA-AO-A0J9 TCGA-AO-A0J9-01A Negative Positive 4+ Mastectomy NOS Positive Lumpectomy NO 1066 -22642 1207 0 1613 1066 90-99% 127 Scheduled Follow-up Submission 2011-8-22 FEMALE RATIO >EQUAL 2.0 33 149 1.2 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 4+ YES Core needle biopsy 430 NO Negative 32 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative 1+ Positive 90-99% 3+ POSITIVE <10% 4 Point Scale 4+ 1+ 3 Point Scale 10-19% Positive 4 2 4 Point Scale Bone Distant Metastasis YES 15 0 true No M0 N3 T2 Stage IIIC TCGA-AO-A0J9.1E3F3136-6D86-4470-85AA-55B11C9E24CD.pdf A0J9 WITH TUMOR 30-39% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2007 2d4b31ad-8790-426a-965b-25b74293156c 2d4b31ad-8790-426a-965b-25b74293156c TCGA-AO-A0J9-01A-21-A13B-20 TCGA-AO-A0J9-01A-11W-A050-09 TCGA-AO-A0J9-01 5141cf13-4997-4411-b0d5-9d2ecb048cdb TCGA-AO-A0J9-01 TCGA-AO-A0J9-01A-11W-A050-09 TCGA-AO-A0J9-01A-11D-A032-05 TCGA-AO-A0J9-01 TCGA-AO-A0J9-01A-11W-A050-09 TCGA-AO-A0J9-01 2d4b31ad-8790-426a-965b-25b74293156c TCGA-AO-A0J9-01 TCGA-AO-A0J9-01A-11D-A036-01 TCGA-AO-A0J9-01A-11R-A034-07 2d4b31ad-8790-426a-965b-25b74293156c TCGA-AO-A0J9-01A-11D-A036-01 TCGA-AO-A0J9-01 TCGA-AO-A0JA-01 Stage IIIC 36 2 No_Conversion 346 Positive FEMALE Negative Negative M0 Positive N3 346 0 LumA Luminal A Positive -4 -4 followup T_Other T2 LIVING TCGA-AO-A0JA-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-AO-A0JA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 36 Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0JA-F15484 TCGA-AO-A0JA Positive 1+ Positive Modified Radical Mastectomy NO 143 -13307 0 655 143 90-99% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy Negative 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 1+ Negative <10% 3+ POSITIVE <10% 4 Point Scale 2+ 3 Point Scale 70-79% Positive 4 1 4 Point Scale Bone Distant Metastasis YES 11 No M0 N3 T2 Stage IIIC A0JA WITH TUMOR <10% NO Primary Tumor 01 YES NO YES AO Breast LIVING 2009 d38a839f-06dc-40d2-81e9-3b7822e258c7 d38a839f-06dc-40d2-81e9-3b7822e258c7 TCGA-AO-A0JA-01A-11W-A071-09 TCGA-AO-A0JA-01 TCGA-AO-A0JA-01A-11D-A10P-05 TCGA-AO-A0JA-01 TCGA-AO-A0JA-01A-11W-A071-09 TCGA-AO-A0JA-01 TCGA-AO-A0JA-01A-11W-A071-09 TCGA-AO-A0JA-01 d38a839f-06dc-40d2-81e9-3b7822e258c7 TCGA-AO-A0JA-01 TCGA-AO-A0JA-01A-11D-A059-01 TCGA-AO-A0JA-01A-11R-A056-07 d38a839f-06dc-40d2-81e9-3b7822e258c7 TCGA-AO-A0JA-01A-11D-A059-01 TCGA-AO-A0JA-01 TCGA-AO-A0JB-01 Stage IIIA 50 1 No_Conversion 1150 Positive FEMALE Negative 2 2 2 Negative M0 Positive N1 1150 0 Normal-like Positive Basal -2 -3 followup T_Other T3 LIVING TCGA-AO-A0JB-01 High C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-AO-A0JB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone TCGA-AO-A0JB-F15485 TCGA-AO-A0JB Positive 2+ Positive Modified Radical Mastectomy NO -18561 0 1542 90-99% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy Negative 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 2 NO 1 0 No M0 N1a T3 Stage IIIA A0JB TUMOR FREE 60-69% YES Primary Tumor 01 YES NO YES AO Breast LIVING 2007 ad3c5cd7-6115-4e63-a282-f3f02907ebe5 ad3c5cd7-6115-4e63-a282-f3f02907ebe5 TCGA-AO-A0JB-01A-21-A13A-20 TCGA-AO-A0JB-01A-11W-A071-09 TCGA-AO-A0JB-01 TCGA-AO-A0JB-01A-11D-A10P-05 a9a1fd2e-401f-4469-87fd-a42b3680c32b TCGA-AO-A0JB-01 TCGA-AO-A0JB-01A-11W-A071-09 TCGA-AO-A0JB-01 TCGA-AO-A0JB-01A-11W-A071-09 TCGA-AO-A0JB-01 ad3c5cd7-6115-4e63-a282-f3f02907ebe5 TCGA-AO-A0JB-01 TCGA-AO-A0JB-01A-11D-A059-01 TCGA-AO-A0JB-01A-11R-A056-07 ad3c5cd7-6115-4e63-a282-f3f02907ebe5 TCGA-AO-A0JB-01A-11D-A059-01 TCGA-AO-A0JB-01 TCGA-AO-A0JC-01 Stage IIA 64 1 Stage IIA 1547 Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 1547 0 LumA Luminal B Positive LumA -2 -5 followup T_Other T2 LIVING TCGA-AO-A0JC-01 Quiet C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AO-A0JC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Outer Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0JC-F15486 TCGA-AO-A0JC TCGA-AO-A0JC-01A Positive 3+ Positive Modified Radical Mastectomy YES -23404 1522 0 1547 90-99% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy 550 NO Negative 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 2 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A0JC.A1F0FEB5-6FEF-4FF7-AA1E-8EAAE551138B.pdf A0JC TUMOR FREE 50-59% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2006 0f578102-ede7-46ad-ae1f-3c7351edb491 0f578102-ede7-46ad-ae1f-3c7351edb491 TCGA-AO-A0JC-01A-21-A13A-20 TCGA-AO-A0JC-01A-11W-A071-09 TCGA-AO-A0JC-01 TCGA-AO-A0JC-01A-11D-A10P-05 020a471c-8f4c-40c5-b4e2-6181b5499a0a TCGA-AO-A0JC-01 TCGA-AO-A0JC-01A-11W-A071-09 TCGA-AO-A0JC-01 TCGA-AO-A0JC-01A-11W-A071-09 TCGA-AO-A0JC-01 0f578102-ede7-46ad-ae1f-3c7351edb491 TCGA-AO-A0JC-01 TCGA-AO-A0JC-01A-11D-A059-01 TCGA-AO-A0JC-01A-11R-A056-07 0f578102-ede7-46ad-ae1f-3c7351edb491 TCGA-AO-A0JC-01A-11D-A059-01 TCGA-AO-A0JC-01 TCGA-AO-A0JD-01 Stage IIIA 59 2 No_Conversion 1813 Positive FEMALE Negative 3 3 4 Negative M0 Positive N1 1813 0 LumB Luminal B Positive Basal -2 -2 followup T_Other T3 LIVING TCGA-AO-A0JD-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 5 mutation cluster 8 TCGA-AO-A0JD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0JD-F15487 TCGA-AO-A0JD TCGA-AO-A0JD-01A Positive 2+ Positive Modified Radical Mastectomy NO -21831 1863 0 2190 90-99% 49 Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% RATIO > = 2.0 1+ 20 68 1.4 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 230 NO Negative Negative 27 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 5 NO 3 0 true No M0 N1a T3 Stage IIIA TCGA-AO-A0JD.E8A43FF3-3D98-45EE-9567-6EED4DA38274.pdf A0JD TUMOR FREE 40-49% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2005 0bef9bfc-43d3-4ac9-a60f-9b65623f7e37 0bef9bfc-43d3-4ac9-a60f-9b65623f7e37 TCGA-AO-A0JD-01A-21-A13B-20 TCGA-AO-A0JD-01A-11W-A071-09 TCGA-AO-A0JD-01 TCGA-AO-A0JD-01A-11D-A10P-05 ac0bdea2-ebe1-454a-8425-960820b9a1ad TCGA-AO-A0JD-01 TCGA-AO-A0JD-01A-11W-A071-09 TCGA-AO-A0JD-01 TCGA-AO-A0JD-01A-11W-A071-09 TCGA-AO-A0JD-01 0bef9bfc-43d3-4ac9-a60f-9b65623f7e37 TCGA-AO-A0JD-01 TCGA-AO-A0JD-01A-11D-A059-01 TCGA-AO-A0JD-01A-11R-A056-07 0bef9bfc-43d3-4ac9-a60f-9b65623f7e37 TCGA-AO-A0JD-01A-11D-A059-01 TCGA-AO-A0JD-01 TCGA-AO-A0JE-01 Stage IIIA 53 5 No_Conversion 1965 Negative FEMALE Positive 1 1 1 Negative M0 Positive N2 1965 0 Her2 HER2-enriched Negative Her2 -11 -5 followup T_Other T2 LIVING TCGA-AO-A0JE-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 4 mutation cluster 3 TCGA-AO-A0JE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0JE-F15488 TCGA-AO-A0JE Negative Negative Lumpectomy NO -19516 0 2335 <10% 71 Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE 50-59% RATIO > = 2.0 3+ 33 269 3.8 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive Positive 29 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 8 0 No M0 N2a T2 Stage IIIA A0JE TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast LIVING 2005 d73174ef-182c-48b9-af79-dfb457d5b7be d73174ef-182c-48b9-af79-dfb457d5b7be TCGA-AO-A0JE-01A-21-A13B-20 TCGA-AO-A0JE-01A-11W-A071-09 TCGA-AO-A0JE-01 TCGA-AO-A0JE-01A-11D-A10P-05 d9cdfaa4-a07d-4172-9ffd-67fb62cc8d9a TCGA-AO-A0JE-01 TCGA-AO-A0JE-01A-11W-A071-09 TCGA-AO-A0JE-01 TCGA-AO-A0JE-01A-11W-A071-09 TCGA-AO-A0JE-01 d73174ef-182c-48b9-af79-dfb457d5b7be TCGA-AO-A0JE-01 TCGA-AO-A0JE-01A-11D-A059-01 TCGA-AO-A0JE-01A-11R-A056-07 d73174ef-182c-48b9-af79-dfb457d5b7be TCGA-AO-A0JE-01A-11D-A059-01 TCGA-AO-A0JE-01 TCGA-AO-A0JF-01 Stage IIA 68 2 No_Conversion 354 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 354 0 LumA Luminal A Positive ReacI -5 -7 followup T1 T1 LIVING TCGA-AO-A0JF-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 4 TCGA-AO-A0JF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0JF-F72115 TCGA-AO-A0JF TCGA-AO-A0JF-01A Positive 2+ Positive Lumpectomy NO -24923 273 0 1980 90-99% Scheduled Follow-up Submission 2015-4-15 FEMALE 3+ POSITIVE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy 410 NO Negative NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 7 NO 2 0 true No M0 N1a T1c Stage IIA TCGA-AO-A0JF.D58E5D64-B5B9-4487-8E46-225AE3617C14.pdf A0JF TUMOR FREE YES 70-79% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2009 3389d4b9-0190-4a69-a647-a6d53e3c96be 3389d4b9-0190-4a69-a647-a6d53e3c96be TCGA-AO-A0JF-01A-21-A13B-20 TCGA-AO-A0JF-01A-11W-A071-09 TCGA-AO-A0JF-01 TCGA-AO-A0JF-01A-11D-A10P-05 c730759a-51df-45f0-94f3-c9054b9f40ff TCGA-AO-A0JF-01 TCGA-AO-A0JF-01A-11W-A071-09 TCGA-AO-A0JF-01 TCGA-AO-A0JF-01A-11W-A071-09 TCGA-AO-A0JF-01 3389d4b9-0190-4a69-a647-a6d53e3c96be TCGA-AO-A0JF-01 TCGA-AO-A0JF-01A-11D-A059-01 TCGA-AO-A0JF-01A-11R-A056-07 3389d4b9-0190-4a69-a647-a6d53e3c96be TCGA-AO-A0JF-01A-11D-A059-01 TCGA-AO-A0JF-01 TCGA-AO-A0JG-01 Stage IIIA 49 5 No_Conversion 449 Positive FEMALE Negative 1 3 3 Negative M0 Positive N2 449 0 LumA Luminal A Positive LumA/B -5 -7 followup T_Other T2 LIVING TCGA-AO-A0JG-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-AO-A0JG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Lower Outer Quadrant|Right Axillary lymph node dissection alone TCGA-AO-A0JG-F15492 TCGA-AO-A0JG TCGA-AO-A0JG-01A Positive 3+ Positive Modified Radical Mastectomy NO -18021 395 0 798 90-99% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% 1+ Other, specify No C50.9 8523/3 C50.9 4+ YES Core needle biopsy 410 NO Negative 19 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 NO 4 0 true No M0 N2a T2 Stage IIIA TCGA-AO-A0JG.3671D46F-6D69-42DA-9830-24F67EB8B0B6.pdf A0JG TUMOR FREE 10-19% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2009 97b5ef6f-d621-4093-ab77-d60dcf706173 97b5ef6f-d621-4093-ab77-d60dcf706173 TCGA-AO-A0JG-01A-21-A13C-20 TCGA-AO-A0JG-01A-31D-A099-09 TCGA-AO-A0JG-01 TCGA-AO-A0JG-01A-31D-A10P-05 a9d2c3f6-0a53-4e38-8a3c-93bf0748df8f TCGA-AO-A0JG-01 TCGA-AO-A0JG-01 TCGA-AO-A0JG-01A-31D-A099-09 TCGA-AO-A0JG-01 97b5ef6f-d621-4093-ab77-d60dcf706173 TCGA-AO-A0JG-01 TCGA-AO-A0JG-01A-31D-A087-01 TCGA-AO-A0JG-01A-31R-A084-07 97b5ef6f-d621-4093-ab77-d60dcf706173 TCGA-AO-A0JG-01A-31D-A087-01 TCGA-AO-A0JG-01 TCGA-AO-A0JI-01 Stage IIA 56 4 No_Conversion 1172 Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 1172 0 LumA Luminal B Negative LumA/B -10 -3 followup T1 T1 LIVING TCGA-AO-A0JI-01 Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-AO-A0JI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0JI-F19410 TCGA-AO-A0JI Positive Negative Modified Radical Mastectomy YES -20694 0 1528 90-99% Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy Negative 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 NO 0 1 No M0 N1 T1c Stage IIA A0JI TUMOR FREE <10% NO Primary Tumor 01 YES NO YES AO Breast LIVING 2007 fb0cd718-5300-4447-9740-a63308f65d92 fb0cd718-5300-4447-9740-a63308f65d92 TCGA-AO-A0JI-01A-11-A13A-20 TCGA-AO-A0JI-01A-21W-A100-09 TCGA-AO-A0JI-01 TCGA-AO-A0JI-01A-21D-A10P-05 ff238c04-e4ff-43e6-8ee6-38828939ed9f TCGA-AO-A0JI-01 TCGA-AO-A0JI-01A-21W-A100-09 TCGA-AO-A0JI-01 TCGA-AO-A0JI-01A-21W-A100-09 TCGA-AO-A0JI-01 fb0cd718-5300-4447-9740-a63308f65d92 TCGA-AO-A0JI-01 TCGA-AO-A0JI-01A-21D-A059-01 TCGA-AO-A0JI-01A-21R-A056-07 fb0cd718-5300-4447-9740-a63308f65d92 TCGA-AO-A0JI-01A-21D-A059-01 TCGA-AO-A0JI-01 TCGA-AO-A0JJ-01 Stage IIB 54 2 No_Conversion 1512 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1512 0 LumA Luminal A Positive LumA/B -5 -7 enrollment T_Other T2 LIVING TCGA-AO-A0JJ-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 7 mutation c1uster 9 TCGA-AO-A0JJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0JJ-F15493 TCGA-AO-A0JJ Positive 3+ Positive Modified Radical Mastectomy NO -19758 0 1887 90-99% Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% 0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 4+ YES Core needle biopsy Negative 44 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 7 NO 2 No M0 N1a T2 Stage IIB A0JJ TUMOR FREE 70-79% YES Primary Tumor 01 YES NO YES AO Breast LIVING 2006 b5eeba4f-8e46-4084-9054-961ea524cf72 b5eeba4f-8e46-4084-9054-961ea524cf72 TCGA-AO-A0JJ-01A-21-A13A-20 TCGA-AO-A0JJ-01A-11W-A071-09 TCGA-AO-A0JJ-01 TCGA-AO-A0JJ-01A-11D-A10P-05 c4fcf63c-a35e-451c-bf06-64b36bc30ba0 TCGA-AO-A0JJ-01 TCGA-AO-A0JJ-01A-11W-A071-09 TCGA-AO-A0JJ-01 TCGA-AO-A0JJ-01A-11W-A071-09 TCGA-AO-A0JJ-01 b5eeba4f-8e46-4084-9054-961ea524cf72 TCGA-AO-A0JJ-01 TCGA-AO-A0JJ-01A-11D-A059-01 TCGA-AO-A0JJ-01A-11R-A056-07 b5eeba4f-8e46-4084-9054-961ea524cf72 TCGA-AO-A0JJ-01A-11D-A059-01 TCGA-AO-A0JJ-01 TCGA-AO-A0JL-01 Stage IIIA 59 3 No_Conversion 1319 Negative FEMALE Negative 2 2 2 Negative M0 Positive N2 1319 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING TCGA-AO-A0JL-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AO-A0JL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone TCGA-AO-A0JL-F15495 TCGA-AO-A0JL TCGA-AO-A0JL-01A Negative Negative Modified Radical Mastectomy NO -21895 1332 0 1683 <10% 50 Scheduled Follow-up Submission 2011-8-22 FEMALE 3+ POSITIVE <10% RATIO > = 2.0 1+ 21 131 2.6 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 380 NO Negative Positive 26 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 7 true No M0 N2a T2 Stage IIIA TCGA-AO-A0JL.C2976F78-89AF-4461-8D22-BFEBC0504722.pdf A0JL TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2006 7953e62d-4871-4928-a2ba-a38c740134e1 7953e62d-4871-4928-a2ba-a38c740134e1 TCGA-AO-A0JL-01A-21-A13A-20 TCGA-AO-A0JL-01A-11W-A071-09 TCGA-AO-A0JL-01 TCGA-AO-A0JL-01A-11D-A10P-05 8299edee-f043-4cf2-8dc5-501df636be7d TCGA-AO-A0JL-01 TCGA-AO-A0JL-01A-11W-A071-09 TCGA-AO-A0JL-01 TCGA-AO-A0JL-01A-11W-A071-09 TCGA-AO-A0JL-01 7953e62d-4871-4928-a2ba-a38c740134e1 TCGA-AO-A0JL-01 TCGA-AO-A0JL-01A-11D-A059-01 TCGA-AO-A0JL-01A-11R-A056-07 7953e62d-4871-4928-a2ba-a38c740134e1 TCGA-AO-A0JL-01A-11D-A059-01 TCGA-AO-A0JL-01 TCGA-AO-A0JM-01 Stage IIB 40 3 No_Conversion 1826 Positive FEMALE Positive 4 5 4 Negative M0 Positive N1 1826 0 LumB Luminal B Positive ReacII -2 -5 followup T_Other T2 LIVING TCGA-AO-A0JM-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AO-A0JM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A0JM-F15496 TCGA-AO-A0JM TCGA-AO-A0JM-01A Positive 1+ Positive Modified Radical Mastectomy NO -14653 1828 0 2184 90-99% 74 2011-8-22 FEMALE 3+ POSITIVE 70-79% 3+ 30 366 5.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 710 NO Positive Positive 23 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 5 NO 2 true No M0 N1 T2 Stage IIB TCGA-AO-A0JM.3023C34B-CF59-43EA-9241-33B738D19B05.pdf A0JM TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2005 7b53ba9f-506e-4af7-9752-ae50e4445880 7b53ba9f-506e-4af7-9752-ae50e4445880 TCGA-AO-A0JM-01A-11-A13A-20 TCGA-AO-A0JM-01A-21W-A071-09 TCGA-AO-A0JM-01 TCGA-AO-A0JM-01A-21D-A10P-05 f53d3976-6b25-4a6d-9969-89f363a1b810 TCGA-AO-A0JM-01 TCGA-AO-A0JM-01A-21W-A071-09 TCGA-AO-A0JM-01 TCGA-AO-A0JM-01A-21W-A071-09 TCGA-AO-A0JM-01 7b53ba9f-506e-4af7-9752-ae50e4445880 TCGA-AO-A0JM-01 TCGA-AO-A0JM-01A-21D-A059-01 TCGA-AO-A0JM-01A-21R-A056-07 7b53ba9f-506e-4af7-9752-ae50e4445880 TCGA-AO-A0JM-01A-21D-A059-01 TCGA-AO-A0JM-01 TCGA-AO-A124-01 Stage IIA 38 3 Stage IIA 3119 Negative FEMALE Negative Negative M0 Negative N0 3119 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-AO-A124-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AO-A124 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A124-F19395 TCGA-AO-A124 TCGA-AO-A124-01A Negative Negative Modified Radical Mastectomy YES -14174 3213 0 3506 <10% Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% 0 Other, specify No C50.9 8523/3 C50.9 YES Core needle biopsy 730 NO Negative 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A124.9009B4A7-3570-4AD6-878E-90CE8DA7980A.pdf A124 TUMOR FREE <10% NO Primary Tumor 01 5th YES NO YES AO Breast A LIVING 2002 5cd42d4a-5971-4a01-8c10-99321105a864 5cd42d4a-5971-4a01-8c10-99321105a864 TCGA-AO-A124-01A-21-A13E-20 TCGA-AO-A124-01A-11D-A10M-09 TCGA-AO-A124-01 TCGA-AO-A124-01A-11D-A10N-05 184cfad8-a50d-4212-b808-dd5a0275cc32 TCGA-AO-A124-01 TCGA-AO-A124-01A-11D-A10M-09 TCGA-AO-A124-01 TCGA-AO-A124-01A-11D-A10M-09 TCGA-AO-A124-01 5cd42d4a-5971-4a01-8c10-99321105a864 TCGA-AO-A124-01 TCGA-AO-A124-01A-11D-A10L-01 TCGA-AO-A124-01A-11R-A10J-07 5cd42d4a-5971-4a01-8c10-99321105a864 TCGA-AO-A124-01A-11D-A10L-01 TCGA-AO-A124-01 TCGA-AO-A125-01 Stage IIA 72 2 Stage IIA 3018 Positive FEMALE Negative Negative M0 Negative N0 3018 0 LumA Luminal A Positive -12 -3 followup T_Other T2 LIVING TCGA-AO-A125-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-AO-A125 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-AO-A125-F19398 TCGA-AO-A125 TCGA-AO-A125-01A Positive 4+ Positive Simple Mastectomy YES -26466 3193 0 3456 50-59% Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% >=2.0 Positive 0 1.0 Other, specify No C50.9 8050/3 C50.9 3+ YES Core needle biopsy 90 NO Negative Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A125.AE348902-0573-4A57-BBD6-037FA2AF1872.pdf A125 TUMOR FREE 90-99% NO Primary Tumor 01 5th YES NO YES AO Breast A LIVING 2002 6c8cb6ae-99bb-4878-b6f5-9da28be98588 6c8cb6ae-99bb-4878-b6f5-9da28be98588 TCGA-AO-A125-01A-11D-A10M-09 TCGA-AO-A125-01 TCGA-AO-A125-01A-11D-A10N-05 TCGA-AO-A125-01 TCGA-AO-A125-01A-11D-A10M-09 TCGA-AO-A125-01 TCGA-AO-A125-01A-11D-A10M-09 TCGA-AO-A125-01 6c8cb6ae-99bb-4878-b6f5-9da28be98588 TCGA-AO-A125-01 TCGA-AO-A125-01A-11D-A10L-01 TCGA-AO-A125-01A-11R-A10J-07 6c8cb6ae-99bb-4878-b6f5-9da28be98588 TCGA-AO-A125-01A-11D-A10L-01 TCGA-AO-A125-01 TCGA-AO-A126-01 Stage IIA 39 5 Stage IIA 2850 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 2850 0 LumA Luminal A Positive Her2 0 -3 followup T_Other T2 LIVING TCGA-AO-A126-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 14 TCGA-AO-A126 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES YES NO 39 Right Upper Inner Quadrant|Right Sentinel node biopsy alone TCGA-AO-A126-F19402 TCGA-AO-A126 TCGA-AO-A126-01A Positive 2+ Positive Simple Mastectomy YES 295 295 -14264 3033 0 3307 267 20-29% 49 Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% >=2.0 Positive 0 31 62 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 450 NO Negative Negative 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 0 Positive 20-29% <10% 1.3 4 Point Scale Negative 60-69% Positive 4 6 4 Point Scale Locoregional Disease YES 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A126.A4BFA94D-166F-43D4-90B5-3C547F4026A0.pdf A126 TUMOR FREE 60-69% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2002 690cf196-9b2c-4886-a0e2-ce3a49cb4389 690cf196-9b2c-4886-a0e2-ce3a49cb4389 TCGA-AO-A126-01A-21-A13E-20 TCGA-AO-A126-01A-11D-A10M-09 TCGA-AO-A126-01 TCGA-AO-A126-01A-11D-A10N-05 da59b9c1-ff1d-4949-ac71-087257291201 TCGA-AO-A126-01 TCGA-AO-A126-01A-11D-A10M-09 TCGA-AO-A126-01 TCGA-AO-A126-01A-11D-A10M-09 TCGA-AO-A126-01 690cf196-9b2c-4886-a0e2-ce3a49cb4389 TCGA-AO-A126-01 TCGA-AO-A126-01A-11D-A10L-01 TCGA-AO-A126-01A-11R-A10J-07 690cf196-9b2c-4886-a0e2-ce3a49cb4389 TCGA-AO-A126-01A-11D-A10L-01 TCGA-AO-A126-01 TCGA-AO-A128-01 Stage IIA 61 3 Stage IIA 2877 Negative FEMALE Negative Negative M0 Negative N0 2877 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING TCGA-AO-A128-01 BRCA-LUAD+ C4-BRCA/Basal cluster 5 Cluster 5 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 6 TCGA-AO-A128 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Lower Outer Quadrant|Right Sentinel node biopsy alone TCGA-AO-A128-F19405 TCGA-AO-A128 TCGA-AO-A128-01A Negative Negative Lumpectomy YES -22340 2960 0 3248 <10% 49 Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% >=2.0 Positive 0 30 52 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 590 NO Negative Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A128.03526CFD-0C3E-4ACB-AB26-3E0B0ED0ADA2.pdf A128 TUMOR FREE <10% YES Primary Tumor 01 YES NO YES AO Breast A LIVING 2002 4a93eaee-d821-4640-a441-255008aaf3b4 4a93eaee-d821-4640-a441-255008aaf3b4 TCGA-AO-A128-01A-21-A13E-20 TCGA-AO-A128-01 TCGA-AO-A128-01A-11D-A10N-05 b629bd13-8d7f-4bff-aa80-08dec4b64d8e TCGA-AO-A128-01 TCGA-AO-A128-01A-11D-A10M-09 TCGA-AO-A128-01 TCGA-AO-A128-01 4a93eaee-d821-4640-a441-255008aaf3b4 TCGA-AO-A128-01 TCGA-AO-A128-01A-11D-A10L-01 TCGA-AO-A128-01A-11R-A10J-07 4a93eaee-d821-4640-a441-255008aaf3b4 TCGA-AO-A128-01A-11D-A10L-01 TCGA-AO-A128-01 TCGA-AO-A129-01 Stage IIB 29 1 No_Conversion 2923 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 2923 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-AO-A129-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 3 mutation cluster 5 TCGA-AO-A129 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 29 Left Lower Outer Quadrant|Left Axillary lymph node dissection alone TCGA-AO-A129-F19415 TCGA-AO-A129 TCGA-AO-A129-01A Negative Negative Modified Radical Mastectomy NO -10898 2915 0 3286 <10% 49 Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% >=2.0 Positive 0 31 52 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 320 NO Negative Negative 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO 2 true No M0 N1a T2 Stage IIB TCGA-AO-A129.DD973A0E-3CC3-4ED7-BE2C-7E5E3C55032B.pdf A129 TUMOR FREE <10% YES Primary Tumor 01 5th YES NO YES AO Breast A LIVING 2002 15b9736e-eafc-465e-9ddd-b1b498e8b701 15b9736e-eafc-465e-9ddd-b1b498e8b701 TCGA-AO-A129-01A-11-A13E-20 TCGA-AO-A129-01A-21D-A10M-09 TCGA-AO-A129-01 TCGA-AO-A129-01A-21D-A10N-05 480c68cf-c569-476a-86eb-cd14d5ba6b54 TCGA-AO-A129-01 TCGA-AO-A129-01A-21D-A10M-09 TCGA-AO-A129-01 TCGA-AO-A129-01A-21D-A10M-09 TCGA-AO-A129-01 15b9736e-eafc-465e-9ddd-b1b498e8b701 TCGA-AO-A129-01 TCGA-AO-A129-01A-21D-A10L-01 TCGA-AO-A129-01A-21R-A10J-07 15b9736e-eafc-465e-9ddd-b1b498e8b701 TCGA-AO-A129-01A-21D-A10L-01 TCGA-AO-A129-01 TCGA-AO-A12A-01 Stage IIA 47 2 Stage IIA 2754 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 2754 0 LumA Luminal A Positive LumA -5 -7 followup T_Other T2 LIVING TCGA-AO-A12A-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-AO-A12A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A12A-F19418 TCGA-AO-A12A TCGA-AO-A12A-01A Positive 4+ Positive Modified Radical Mastectomy YES -17420 2793 0 3112 90-99% 58 Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% >=2.0 Positive 1+ 30 61 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 220 NO Negative Negative 27 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-AO-A12A.A54E82A4-D7C2-4A5C-A69C-C66976F0282F.pdf A12A TUMOR FREE 90-99% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2003 3f4c6d17-a971-4ba0-83ad-3addc24f1298 3f4c6d17-a971-4ba0-83ad-3addc24f1298 TCGA-AO-A12A-01A-11-A13E-20 TCGA-AO-A12A-01A-21D-A10Y-09 TCGA-AO-A12A-01 e6f501dd-64cd-404e-92f3-56c0de08d987 TCGA-AO-A12A-01 TCGA-AO-A12A-01A-21D-A10Y-09 TCGA-AO-A12A-01A-21D-A112-05 TCGA-AO-A12A-01 TCGA-AO-A12A-01 TCGA-AO-A12A-01A-21D-A10Y-09 3f4c6d17-a971-4ba0-83ad-3addc24f1298 TCGA-AO-A12A-01A-21D-A111-01 TCGA-AO-A12A-01 TCGA-AO-A12A-01A-21R-A115-07 3f4c6d17-a971-4ba0-83ad-3addc24f1298 TCGA-AO-A12A-01A-21D-A111-01 TCGA-AO-A12A-01 TCGA-AO-A12B-01 Stage IIA 63 3 Stage IIA 2359 Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 2359 0 LumA Luminal B Positive LumA/B -12 -3 followup T_Other T2 LIVING TCGA-AO-A12B-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-AO-A12B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right Sentinel node biopsy alone TCGA-AO-A12B-F43473 TCGA-AO-A12B TCGA-AO-A12B-01A Positive 4+ Positive Simple Mastectomy YES -23150 2365 0 2989 90-99% Scheduled Follow-up Submission 2013-5-22 FEMALE 3+ Positive <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy 570 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 3 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A12B.CF071D24-7BA2-43BE-B3E7-A981DBDFCA0F.pdf A12B TUMOR FREE YES 90-99% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2004 44225bb7-92c6-4a6d-b136-bc51666ba84a 44225bb7-92c6-4a6d-b136-bc51666ba84a TCGA-AO-A12B-01A-21-A13E-20 TCGA-AO-A12B-01A-11D-A10M-09 TCGA-AO-A12B-01 TCGA-AO-A12B-01A-11D-A10N-05 1ecefd90-2eeb-48bb-9f53-3c5ccdfa465c TCGA-AO-A12B-01 TCGA-AO-A12B-01A-11D-A10M-09 TCGA-AO-A12B-01 TCGA-AO-A12B-01 TCGA-AO-A12B-01A-11D-A10M-09 44225bb7-92c6-4a6d-b136-bc51666ba84a TCGA-AO-A12B-01A-11D-A10L-01 TCGA-AO-A12B-01 TCGA-AO-A12B-01A-11R-A10J-07 44225bb7-92c6-4a6d-b136-bc51666ba84a TCGA-AO-A12B-01A-11D-A10L-01 TCGA-AO-A12B-01 TCGA-AO-A12C-01 Stage IIB 42 2 No_Conversion 1993 Positive FEMALE Positive Negative M0 Positive N1 1993 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T2 LIVING TCGA-AO-A12C-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 TCGA-AO-A12C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A12C-F19425 TCGA-AO-A12C TCGA-AO-A12C-01A Negative Positive 2+ Modified radical mastectomy Positive Lumpectomy NO -15469 2086 0 2372 90-99% 78 Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive 90-99% >=2.0 Positive 3+ 30 125 1.6 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 350 NO Positive Negative 31 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 6 NO 2 true No M0 N1a T2 Stage IIB TCGA-AO-A12C.7E9202F6-F2DB-4CC0-A10F-3D9A82E84242.pdf A12C TUMOR FREE 40-49% YES Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2005 3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3 3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3 TCGA-AO-A12C-01A-21-A13E-20 TCGA-AO-A12C-01 TCGA-AO-A12C-01A-11D-A10N-05 6b20b15d-4ebc-4169-a36c-e9abab1dd6f0 TCGA-AO-A12C-01 3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3 TCGA-AO-A12C-01 TCGA-AO-A12C-01A-11R-A10J-07 3b1da7ee-4470-4ab5-b1a7-53ac92b4e4d3 TCGA-AO-A12C-01 TCGA-AO-A12D-01 Stage IIA 43 3 No_Conversion 1948 Negative FEMALE Positive 2 2 1 Negative M0 Positive N1 1948 0 Her2 HER2-enriched Negative Her2 -11 -10 followup T1 T1 LIVING TCGA-AO-A12D-01 High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AO-A12D TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A12D-F43438 TCGA-AO-A12D TCGA-AO-A12D-01A Negative Negative Modified Radical Mastectomy YES -15774 1948 0 2515 <10% 66 Scheduled Follow-up Submission 2013-5-21 FEMALE 3+ Positive 90-99% >=2.0 Positive 3+ 32 441 6.7 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 750 NO Positive Positive NO 16 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO 1 0 true No M0 N1a T1c Stage IIA TCGA-AO-A12D.9363D53D-BC3B-4AC0-8185-536C6DB3A6AE.pdf A12D TUMOR FREE YES <10% YES Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2005 4adf4439-3d60-44ac-a6f0-9f42cc081a93 4adf4439-3d60-44ac-a6f0-9f42cc081a93 TCGA-AO-A12D-01A-21-A13E-20 TCGA-AO-A12D-01A-11D-A10Y-09 TCGA-AO-A12D-01 1dd0fa5e-8122-4008-a89b-025ed17a3dd9 TCGA-AO-A12D-01 TCGA-AO-A12D-01A-11D-A10Y-09 TCGA-AO-A12D-01A-11D-A112-05 TCGA-AO-A12D-01 TCGA-AO-A12D-01 TCGA-AO-A12D-01A-11D-A10Y-09 4adf4439-3d60-44ac-a6f0-9f42cc081a93 TCGA-AO-A12D-01A-11D-A111-01 TCGA-AO-A12D-01 TCGA-AO-A12D-01A-11R-A115-07 4adf4439-3d60-44ac-a6f0-9f42cc081a93 TCGA-AO-A12D-01A-11D-A111-01 TCGA-AO-A12D-01 TCGA-AO-A12E-01 Stage IIB 51 3 Stage IIB 1742 Positive FEMALE Negative 4 3 3 Negative M0 Negative N0 1742 0 LumA Luminal A Positive LumA/B -5 -7 followup T_Other T3 LIVING TCGA-AO-A12E-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-AO-A12E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone TCGA-AO-A12E-F19431 TCGA-AO-A12E TCGA-AO-A12E-01A Positive 2+ Positive Modified Radical Mastectomy YES -18721 1822 0 2142 80-89% Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% 0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Core needle biopsy 630 NO Negative 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 1 NO 0 1 true No M0 N0 (i+) T3 Stage IIB TCGA-AO-A12E.332675C9-53CB-4244-8480-82E1546DA7F2.pdf A12E TUMOR FREE 40-49% YES Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2005 222c7e4d-f6ed-4db0-ba36-1670159cee1b 222c7e4d-f6ed-4db0-ba36-1670159cee1b TCGA-AO-A12E-01A-21-A13E-20 TCGA-AO-A12E-01A-11D-A10M-09 TCGA-AO-A12E-01 TCGA-AO-A12E-01A-11D-A10N-05 b6ec964a-db35-4120-aaaf-f3018a330490 TCGA-AO-A12E-01 TCGA-AO-A12E-01A-11D-A10M-09 TCGA-AO-A12E-01 TCGA-AO-A12E-01A-11D-A10M-09 TCGA-AO-A12E-01 222c7e4d-f6ed-4db0-ba36-1670159cee1b TCGA-AO-A12E-01 TCGA-AO-A12E-01A-11D-A10L-01 TCGA-AO-A12E-01A-11R-A10J-07 222c7e4d-f6ed-4db0-ba36-1670159cee1b TCGA-AO-A12E-01A-11D-A10L-01 TCGA-AO-A12E-01 TCGA-AO-A12F-01 Stage IIA 36 1 Stage IIA 1471 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1471 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING TCGA-AO-A12F-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AO-A12F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 36 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-AO-A12F-F19434 TCGA-AO-A12F TCGA-AO-A12F-01A Negative Negative Simple Mastectomy YES -13409 1578 0 1842 <10% Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 600 NO Negative 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 5 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A12F.96B43BA2-7099-436C-8AFD-FD53E55E7F51.pdf A12F TUMOR FREE <10% YES Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2006 05610046-ec77-4592-892a-464a81d55c45 05610046-ec77-4592-892a-464a81d55c45 TCGA-AO-A12F-01A-21-A13D-20 TCGA-AO-A12F-01A-11D-A10Y-09 TCGA-AO-A12F-01 8f64c41b-17ee-40d2-98d6-4c483e5d5384 TCGA-AO-A12F-01 TCGA-AO-A12F-01A-11D-A10Y-09 TCGA-AO-A12F-01A-11D-A112-05 TCGA-AO-A12F-01 TCGA-AO-A12F-01 TCGA-AO-A12F-01A-11D-A10Y-09 05610046-ec77-4592-892a-464a81d55c45 TCGA-AO-A12F-01A-11D-A111-01 TCGA-AO-A12F-01 TCGA-AO-A12F-01A-11R-A115-07 05610046-ec77-4592-892a-464a81d55c45 TCGA-AO-A12F-01A-11D-A111-01 TCGA-AO-A12F-01 TCGA-AO-A12G-01 Stage IIA 75 2 Stage IIA 1265 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 1265 0 LumA Luminal A Positive LumA/B -1 0 followup T_Other T2 LIVING TCGA-AO-A12G-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 8 TCGA-AO-A12G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-AO-A12G-F19448 TCGA-AO-A12G TCGA-AO-A12G-01A Positive 2+ Positive Simple Mastectomy YES -27705 1415 0 1639 90-99% 67 Scheduled Follow-up Submission 2011-6-16 FEMALE >=2.0 Positive 2+ 23 66 1.0 Other, specify No C50.9 8022/3 C50.9 4+ YES Core needle biopsy 280 NO Positive Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 1 true No M0 N0 (i+) T2 Stage IIA TCGA-AO-A12G.6CE21603-4200-40BA-94AA-15F24EE4AC7F.pdf A12G TUMOR FREE 30-39% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2006 348a0fd6-eb6b-4550-a26a-3896c4963b3a 348a0fd6-eb6b-4550-a26a-3896c4963b3a TCGA-AO-A12G-01A-21-A13D-20 TCGA-AO-A12G-01A-11D-A10M-09 TCGA-AO-A12G-01 TCGA-AO-A12G-01A-11D-A10N-05 e5214399-e1f0-42f1-be38-366c47e438fa TCGA-AO-A12G-01 TCGA-AO-A12G-01A-11D-A10M-09 TCGA-AO-A12G-01 TCGA-AO-A12G-01A-11D-A10M-09 TCGA-AO-A12G-01 348a0fd6-eb6b-4550-a26a-3896c4963b3a TCGA-AO-A12G-01 TCGA-AO-A12G-01A-11D-A10L-01 TCGA-AO-A12G-01A-11R-A10J-07 348a0fd6-eb6b-4550-a26a-3896c4963b3a TCGA-AO-A12G-01A-11D-A10L-01 TCGA-AO-A12G-01 TCGA-AO-A12H-01 Stage IIA 69 1 Stage IIA 862 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 862 0 LumA Luminal A Positive LumA/B -12 -3 followup T_Other T2 LIVING TCGA-AO-A12H-01 Quiet C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 2 mutation cluster 4 TCGA-AO-A12H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-AO-A12H-F19451 TCGA-AO-A12H TCGA-AO-A12H-01A Positive 2+ Positive Simple Mastectomy YES -25515 1017 0 1234 90-99% Scheduled Follow-up Submission 2011-12-12 FEMALE 3+ Positive <10% 0 Other, specify No C50.9 8523/3 C50.9 4+ YES Core needle biopsy 290 NO Negative 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 2 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A12H.2FDFCEB5-74F7-417E-9FD1-ECC81B27803B.pdf A12H TUMOR FREE <10% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2008 71b58051-3bf8-4dfb-a431-c8aceab7c799 71b58051-3bf8-4dfb-a431-c8aceab7c799 TCGA-AO-A12H-01A-21-A13D-20 TCGA-AO-A12H-01A-11D-A10Y-09 TCGA-AO-A12H-01 6988badd-172f-4880-9ad6-75f7896112bb TCGA-AO-A12H-01 TCGA-AO-A12H-01A-11D-A10Y-09 TCGA-AO-A12H-01A-11D-A112-05 TCGA-AO-A12H-01 TCGA-AO-A12H-01 TCGA-AO-A12H-01A-11D-A10Y-09 71b58051-3bf8-4dfb-a431-c8aceab7c799 TCGA-AO-A12H-01A-11D-A111-01 TCGA-AO-A12H-01 TCGA-AO-A12H-01A-11R-A115-07 71b58051-3bf8-4dfb-a431-c8aceab7c799 TCGA-AO-A12H-01A-11D-A111-01 TCGA-AO-A12H-01 TCGA-AO-A1KO-01 Stage IIB 46 1 Stage IIB 448 Positive FEMALE Negative Negative M0 Negative N0 448 0 Normal Positive followup T_Other T3 LIVING TCGA-AO-A1KO-01 Quiet C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 6 mutation c1uster 9 TCGA-AO-A1KO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A1KO-F20630 TCGA-AO-A1KO TCGA-AO-A1KO-01A Positive 4 Point Scale 4+ 4 Point Scale Positive Simple Mastectomy YES -16817 832 0 622 NO 90-99% Scheduled Follow-up Submission 2012-2-20 FEMALE <10% 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 4+ YES Excisional Biopsy 580 NO Negative 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 6 NO 0 1 true No M0 N0 (i+) T3 Stage IIB TCGA-AO-A1KO.15FB8CBD-85EF-45BE-8065-9F4E922D457E.pdf A1KO TUMOR FREE YES 90-99% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2008 62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34 62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34 TCGA-AO-A1KO-01A-41-A17I-20 TCGA-AO-A1KO-01A-31D-A188-09 TCGA-AO-A1KO-01 TCGA-AO-A1KO-01A-31D-A13K-05 a17c27f3-818b-4fbb-aa5d-ab86494f4456 TCGA-AO-A1KO-01 TCGA-AO-A1KO-01A-31D-A188-09 TCGA-AO-A1KO-01 TCGA-AO-A1KO-01A-31D-A188-09 62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34 TCGA-AO-A1KO-01A-31D-A13J-01 TCGA-AO-A1KO-01 62a37d05-a1f5-48e1-b4cd-7b24b5ca0b34 TCGA-AO-A1KO-01A-31D-A13J-01 TCGA-AO-A1KP-01 Stage IIA 77 2 Stage IIA 2513 Positive FEMALE Negative Negative M0 Positive N1 2513 0 LumB Positive followup T1 T1 LIVING TCGA-AO-A1KP-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-AO-A1KP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A1KP-F21774 TCGA-AO-A1KP TCGA-AO-A1KP-01A Positive 4 Point Scale 4+ 4 Point Scale Positive Simple Mastectomy YES -28247 2604 0 2953 NO 80-89% Scheduled Follow-up Submission 2012-2-20 FEMALE <10% >=2.0 Positive 1+ 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy 360 NO Negative Negative 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 0 1 true No M0 N1 T1 Stage IIA TCGA-AO-A1KP.467172CC-6EA1-435D-BDC1-D65FBF8EA0E8.pdf A1KP TUMOR FREE YES 40-49% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2003 773a2357-99b8-40df-b657-f237d9735db9 773a2357-99b8-40df-b657-f237d9735db9 TCGA-AO-A1KP-01A-21-A17I-20 TCGA-AO-A1KP-01A-11D-A13L-09 TCGA-AO-A1KP-01 TCGA-AO-A1KP-01A-11D-A13K-05 a69b3e33-9fa5-47f1-931d-d100136d9d80 TCGA-AO-A1KP-01 TCGA-AO-A1KP-01A-11D-A13L-09 TCGA-AO-A1KP-01 TCGA-AO-A1KP-01A-11D-A13L-09 773a2357-99b8-40df-b657-f237d9735db9 TCGA-AO-A1KP-01A-11D-A13J-01 TCGA-AO-A1KP-01 773a2357-99b8-40df-b657-f237d9735db9 TCGA-AO-A1KP-01A-11D-A13J-01 TCGA-AO-A1KQ-01 Stage IIIB 84 4 Stage IIIB 1519 Positive MALE Negative Negative M0 Positive N1 1519 0 LumB Positive followup T_Other T4 LIVING TCGA-AO-A1KQ-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 TCGA-AO-A1KQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 84 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-AO-A1KQ-F21775 TCGA-AO-A1KQ TCGA-AO-A1KQ-01A Positive 4 Point Scale 3+ 4 Point Scale Positive Modified Radical Mastectomy NO -30859 1553 0 1882 NO 90-99% Scheduled Follow-up Submission 2012-2-20 MALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy 540 NO Negative 9 Negative 2 4 NO 2 0 true No M0 N1 T4 Stage IIIB TCGA-AO-A1KQ.EB5199BA-6164-4CFB-AFAA-B41544B83103.pdf A1KQ TUMOR FREE YES 80-89% NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2006 204a78d9-67aa-4e49-b285-bbb25c6ed142 204a78d9-67aa-4e49-b285-bbb25c6ed142 TCGA-AO-A1KQ-01A-21-A17I-20 TCGA-AO-A1KQ-01 TCGA-AO-A1KQ-01A-11D-A13K-05 ccdaef5f-d816-426d-8e4f-b1bc561a11c5 TCGA-AO-A1KQ-01 TCGA-AO-A1KQ-01 204a78d9-67aa-4e49-b285-bbb25c6ed142 TCGA-AO-A1KQ-01A-11D-A13J-01 TCGA-AO-A1KQ-01 204a78d9-67aa-4e49-b285-bbb25c6ed142 TCGA-AO-A1KQ-01A-11D-A13J-01 TCGA-AO-A1KR-01 51 1 2140 Negative FEMALE 2140 0 Basal Negative enrollment LIVING TCGA-AO-A1KR-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-AO-A1KR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-AO-A1KR-F21768 TCGA-AO-A1KR TCGA-AO-A1KR-01A Negative 4 Point Scale 3 Point Scale Negative Simple Mastectomy YES -18900 1932 0 2513 NO Scheduled Follow-up Submission 2013-5-21 FEMALE 1+ 1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 190 NO Negative Negative 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-AO-A1KR.FF188295-E139-4AEE-8EE8-364536F2BBE8.pdf A1KR TUMOR FREE YES NO Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2005 6d22f538-114f-48b6-94ba-fb60151ed567 6d22f538-114f-48b6-94ba-fb60151ed567 TCGA-AO-A1KR-01A-21-A17I-20 TCGA-AO-A1KR-01A-12D-A142-09 TCGA-AO-A1KR-01 TCGA-AO-A1KR-01A-12D-A145-05 209b9ca9-04fe-441d-915a-b8f4ef9e4b74 TCGA-AO-A1KR-01 TCGA-AO-A1KR-01A-12D-A142-09 TCGA-AO-A1KR-01 TCGA-AO-A1KR-01A-12D-A142-09 6d22f538-114f-48b6-94ba-fb60151ed567 TCGA-AO-A1KR-01A-12D-A141-01 TCGA-AO-A1KR-01 6d22f538-114f-48b6-94ba-fb60151ed567 TCGA-AO-A1KR-01A-12D-A141-01 TCGA-AO-A1KS-01 Stage IIA 69 5 Stage IIA 16 Positive FEMALE Negative Negative M0 Negative N0 16 0 LumB Positive followup T_Other T2 LIVING TCGA-AO-A1KS-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AO-A1KS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel node biopsy alone TCGA-AO-A1KS-F21777 TCGA-AO-A1KS TCGA-AO-A1KS-01A Positive 4 Point Scale 2+ 4 Point Scale Positive Lumpectomy YES -25230 147 0 350 NO 90-99% 3.2 Scheduled Follow-up Submission 2012-2-20 FEMALE 10-19% Positive >2.2 2+ 40 3.2 1.0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 4+ YES Core needle biopsy 420 NO Equivocal Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-AO-A1KS.0FB93D92-81F6-4241-9094-4AABF70E6A0F.pdf A1KS TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO YES AO Breast A LIVING 2010 9eab0553-20cc-41bb-bcdb-9ade0578da82 9eab0553-20cc-41bb-bcdb-9ade0578da82 TCGA-AO-A1KS-01A-21-A17I-20 TCGA-AO-A1KS-01A-11D-A13L-09 TCGA-AO-A1KS-01 TCGA-AO-A1KS-01A-11D-A13K-05 6022e4a0-4bd2-4d51-ac93-56f6b54dfa39 TCGA-AO-A1KS-01 TCGA-AO-A1KS-01A-11D-A13L-09 TCGA-AO-A1KS-01 TCGA-AO-A1KS-01A-11D-A13L-09 9eab0553-20cc-41bb-bcdb-9ade0578da82 TCGA-AO-A1KS-01A-11D-A13J-01 TCGA-AO-A1KS-01 9eab0553-20cc-41bb-bcdb-9ade0578da82 TCGA-AO-A1KS-01A-11D-A13J-01 TCGA-AO-A1KT-01 Stage IIA 78 2 Stage IIA 541 Positive FEMALE Negative Negative M0 Positive N1 541 0 LumB Positive followup T1 T1 LIVING TCGA-AO-A1KT-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AO-A1KT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-AO-A1KT-F9905 TCGA-AO-A1KT TCGA-AO-A1KT-01A Positive 4 Point Scale 4+ 4 Point Scale Positive Lumpectomy YES -28660 617 0 541 NO 90-99% 1.7 2011-4-1 FEMALE 10-19% >2.2 Positive 2+ 40 2.4 1.4 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy 200 NO Equivocal Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 1 1 true [Discrepancy] M0 N1 T1 Stage IIA TCGA-AO-A1KT.D9432167-0F2E-4377-9DB4-EA4E59A6C9B9.pdf A1KT TUMOR FREE YES 40-49% YES Primary Tumor 01 6th YES NO YES AO Breast A LIVING 2009 82140d3a-0787-4e1e-993d-1b222c073cf8 82140d3a-0787-4e1e-993d-1b222c073cf8 TCGA-AO-A1KT-01A-21-A17I-20 TCGA-AO-A1KT-01A-11D-A13L-09 TCGA-AO-A1KT-01 TCGA-AO-A1KT-01A-11D-A13K-05 c440c6d0-6b35-4764-be41-cd4ca2d3c713 TCGA-AO-A1KT-01 TCGA-AO-A1KT-01A-11D-A13L-09 TCGA-AO-A1KT-01 TCGA-AO-A1KT-01A-11D-A13L-09 82140d3a-0787-4e1e-993d-1b222c073cf8 TCGA-AO-A1KT-01A-11D-A13J-01 TCGA-AO-A1KT-01 82140d3a-0787-4e1e-993d-1b222c073cf8 TCGA-AO-A1KT-01A-11D-A13J-01 TCGA-AQ-A04H-01 Stage IIIA 61 5 No_Conversion 439 Positive FEMALE Positive Positive N2 439 0 LumB Luminal B Positive -10 -3 followup T_Other T2 LIVING TCGA-AQ-A04H-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 5 TCGA-AQ-A04H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-AQ-A04H-F35322 TCGA-AQ-A04H Positive Positive Modified Radical Mastectomy NO -22539 0 754 90-99% 2012-9-24 FEMALE 2+ 30 3.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Indeterminate Positive NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 7 NO 4 No MX N2a T2 Stage IIIA A04H TUMOR FREE >10% >10% YES 20-29% YES Primary Tumor 01 6th YES NO YES AQ Breast LIVING 2009 bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d TCGA-AQ-A04H-01B-11D-A10M-09 TCGA-AQ-A04H-01 TCGA-AQ-A04H-01B-11D-A10N-05 TCGA-AQ-A04H-01 TCGA-AQ-A04H-01B-11D-A10M-09 TCGA-AQ-A04H-01 TCGA-AQ-A04H-01B-11D-A10M-09 TCGA-AQ-A04H-01 bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d TCGA-AQ-A04H-01 TCGA-AQ-A04H-01B-11D-A10L-01 TCGA-AQ-A04H-01B-11R-A10J-07 bcd8ae7a-cd43-4781-9ce3-8c87b92dd69d TCGA-AQ-A04H-01B-11D-A10L-01 TCGA-AQ-A04H-01 TCGA-AQ-A04J-01 Stage IIA 45 1 Stage IIA 499 Negative FEMALE Negative Negative M0 Negative N0 499 0 Basal Basal-like Negative -13 -12 followup T_Other T2 LIVING TCGA-AQ-A04J-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AQ-A04J TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AQ-A04J-F21740 TCGA-AQ-A04J TCGA-AQ-A04J-01A Negative 0 Negative Simple Mastectomy NO -16615 118 0 819 <10% Scheduled Follow-up Submission 2012-2-20 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 160 NO Negative 20 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 NO 0 0 false No M0 N0 (i+) T2 Stage IIA TCGA-AQ-A04J.71CEC5F6-16E5-46E1-A91B-B5E0F699B231.pdf A04J TUMOR FREE <10% NO Primary Tumor 01 YES NO YES AQ Breast A LIVING 2009 97168a1f-abf8-414b-af10-b63f5daa7023 97168a1f-abf8-414b-af10-b63f5daa7023 TCGA-AQ-A04J-01A-02W-A050-09 TCGA-AQ-A04J-01 TCGA-AQ-A04J-01 TCGA-AQ-A04J-01A-02W-A050-09 TCGA-AQ-A04J-01A-02D-A032-05 TCGA-AQ-A04J-01 TCGA-AQ-A04J-01A-02W-A050-09 TCGA-AQ-A04J-01 97168a1f-abf8-414b-af10-b63f5daa7023 TCGA-AQ-A04J-01 TCGA-AQ-A04J-01A-02D-A036-01 TCGA-AQ-A04J-01A-02R-A034-07 97168a1f-abf8-414b-af10-b63f5daa7023 TCGA-AQ-A04J-01A-02D-A036-01 TCGA-AQ-A04J-01 TCGA-AQ-A04L-01 Stage IIA 48 1 Stage IIA 3344 Positive FEMALE Positive 2 2 2 Negative M0 Negative N0 3344 0 LumA Luminal A Negative ReacI -1 -5 followup T_Other T2 LIVING TCGA-AQ-A04L-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 13 TCGA-AQ-A04L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Sentinel node biopsy alone TCGA-AQ-A04L-F35324 TCGA-AQ-A04L TCGA-AQ-A04L-01B Positive Negative Modified Radical Mastectomy NO -17759 3403 0 3957 60-69% 2012-9-24 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Fine needle aspiration biopsy 160 NO Positive NO 2 Negative Peri (6-12 months since last menstrual period) 3 3 NO 0 false No MX N0 (i-) T2 Stage IIA TCGA-AQ-A04L.40B58A7A-2A05-4AAF-B1D4-B418E4A56115.pdf A04L TUMOR FREE YES NO Primary Tumor 01 5th YES NO YES AQ Breast B LIVING 2001 1fa9c013-4d2c-4f3e-8e77-6437dad440c9 1fa9c013-4d2c-4f3e-8e77-6437dad440c9 TCGA-AQ-A04L-01B-11-A13D-20 TCGA-AQ-A04L-01B-21D-A10M-09 TCGA-AQ-A04L-01 TCGA-AQ-A04L-01B-21D-A10N-05 16b9cd57-86e9-4409-8ad3-02d5a4540f0f TCGA-AQ-A04L-01 TCGA-AQ-A04L-01B-21D-A10M-09 TCGA-AQ-A04L-01 TCGA-AQ-A04L-01B-21D-A10M-09 TCGA-AQ-A04L-01 1fa9c013-4d2c-4f3e-8e77-6437dad440c9 TCGA-AQ-A04L-01 TCGA-AQ-A04L-01B-21D-A10L-01 TCGA-AQ-A04L-01B-21R-A10J-07 1fa9c013-4d2c-4f3e-8e77-6437dad440c9 TCGA-AQ-A04L-01B-21D-A10L-01 TCGA-AQ-A04L-01 TCGA-AQ-A0Y5-01 Stage IIIA 70 3 Stage IIIA 161 Positive FEMALE Positive Negative M0 Positive N2 161 1 LumA Positive followup T_Other T2 DECEASED TCGA-AQ-A0Y5-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AQ-A0Y5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AQ-A0Y5-F10119 TCGA-AQ-A0Y5 TCGA-AQ-A0Y5-01A Positive Positive Modified Radical Mastectomy NO -25793 212 172 0 NO 70-79% 2011-4-7 FEMALE 2+ 3.8 Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES Core needle biopsy 160 NO Positive Positive 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 5 false Yes MX N2a T2 Stage IIIA TCGA-AQ-A0Y5.5BC01981-366E-44EC-A986-087DB7904E5C.pdf A0Y5 TUMOR FREE YES 40-49% NO Primary Tumor 01 7th YES YES NO AQ Breast A DECEASED 2010 9bb258a4-dd26-4c43-bd29-04b68ea3c7ca 9bb258a4-dd26-4c43-bd29-04b68ea3c7ca TCGA-AQ-A0Y5-01A-11D-A14K-09 TCGA-AQ-A0Y5-01 TCGA-AQ-A0Y5-01A-11D-A14N-05 TCGA-AQ-A0Y5-01 TCGA-AQ-A0Y5-01A-11D-A14K-09 TCGA-AQ-A0Y5-01 TCGA-AQ-A0Y5-01A-11D-A14K-09 9bb258a4-dd26-4c43-bd29-04b68ea3c7ca TCGA-AQ-A0Y5-01A-11D-A14J-01 TCGA-AQ-A0Y5-01 9bb258a4-dd26-4c43-bd29-04b68ea3c7ca TCGA-AQ-A0Y5-01A-11D-A14J-01 TCGA-AQ-A1H2-01 Stage IIIA 84 5 Stage IIIA 197 Positive FEMALE Positive Negative M0 Positive N2 197 0 LumA Positive enrollment T_Other T2 LIVING TCGA-AQ-A1H2-01 Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-AQ-A1H2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 84 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AQ-A1H2-F19896 TCGA-AQ-A1H2 TCGA-AQ-A1H2-01A Positive Positive Modified Radical Mastectomy NO -30958 156 0 475 NO 90-99% Scheduled Follow-up Submission 2012-1-3 FEMALE 2+ 2.7 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO Indeterminate Positive 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 NO 13 false No MX N2a T2 Stage IIIA TCGA-AQ-A1H2.1B5FA34B-E3B4-4D4B-AF0A-1C90016CC532.pdf A1H2 TUMOR FREE YES 10-19% YES Primary Tumor 01 7th YES YES NO AQ Breast A LIVING 2010 8b954cec-cf3e-4b0d-a4e8-cfbc9575a732 8b954cec-cf3e-4b0d-a4e8-cfbc9575a732 TCGA-AQ-A1H2-01A-21-A17I-20 TCGA-AQ-A1H2-01A-11D-A13L-09 TCGA-AQ-A1H2-01 TCGA-AQ-A1H2-01A-11D-A13K-05 8191dc7a-6508-44aa-beb6-397c035c8052 TCGA-AQ-A1H2-01 TCGA-AQ-A1H2-01A-11D-A13L-09 TCGA-AQ-A1H2-01 TCGA-AQ-A1H2-01A-11D-A13L-09 8b954cec-cf3e-4b0d-a4e8-cfbc9575a732 TCGA-AQ-A1H2-01A-11D-A13J-01 TCGA-AQ-A1H2-01 8b954cec-cf3e-4b0d-a4e8-cfbc9575a732 TCGA-AQ-A1H2-01A-11D-A13J-01 TCGA-AQ-A1H3-01 Stage IIIC 49 2 Stage IIIC 138 Positive FEMALE Negative Negative M0 Positive N3 138 0 LumA Positive enrollment T_Other T2 LIVING TCGA-AQ-A1H3-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 cluster 6 mutation c1uster 9 TCGA-AQ-A1H3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AQ-A1H3-F50661 TCGA-AQ-A1H3 TCGA-AQ-A1H3-01A Positive Positive Modified Radical Mastectomy NO -18177 94 0 989 NO 90-99% Scheduled Follow-up Submission 2013-10-28 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 300 NO Negative NO 23 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 6 NO 14 false No MX N3a T2 Stage IIIC TCGA-AQ-A1H3.6EB1A616-E99C-4AF6-9C0A-0FDC521A79CD.pdf A1H3 TUMOR FREE YES YES 80-89% YES Primary Tumor 01 7th YES YES NO AQ Breast A LIVING 2010 554df3b0-e305-4dab-a268-47ad7c1dcffc 554df3b0-e305-4dab-a268-47ad7c1dcffc TCGA-AQ-A1H3-01A-41-A17I-20 TCGA-AQ-A1H3-01A-31D-A13L-09 TCGA-AQ-A1H3-01 TCGA-AQ-A1H3-01A-31D-A13K-05 ba38e345-7c27-4ab0-a8e9-57b727fec06c TCGA-AQ-A1H3-01 TCGA-AQ-A1H3-01A-31D-A13L-09 TCGA-AQ-A1H3-01 TCGA-AQ-A1H3-01A-31D-A13L-09 554df3b0-e305-4dab-a268-47ad7c1dcffc TCGA-AQ-A1H3-01A-31D-A13J-01 TCGA-AQ-A1H3-01 554df3b0-e305-4dab-a268-47ad7c1dcffc TCGA-AQ-A1H3-01A-31D-A13J-01 TCGA-AQ-A54N-01 TCGA-AQ-A54N-01 TCGA-AQ-A54N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Lower Inner Quadrant Sentinel node biopsy alone TCGA-AQ-A54N-F55736 TCGA-AQ-A54N TCGA-AQ-A54N-01A Negative Negative Lumpectomy YES -18741 639 0 78 2014-1-14 FEMALE 2+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 360 NO Equivocal Negative YES 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false Yes M0 N0 T2 Stage IIA TCGA-AQ-A54N.9BF0E34A-F78C-4BFD-AC4C-926FA1D60342.pdf A54N TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO AQ Breast A LIVING 2011 ed3e6c57-a0ec-4441-a1a1-794f3f15e112 ed3e6c57-a0ec-4441-a1a1-794f3f15e112 TCGA-AQ-A54N-01 TCGA-AQ-A54N-01A-11D-A268-05 3b93ce2c-bc79-48ef-910d-9d1e7c070008 TCGA-AQ-A54N-01 TCGA-AQ-A54N-01A-11D-A25Q-09 TCGA-AQ-A54N-01 ed3e6c57-a0ec-4441-a1a1-794f3f15e112 TCGA-AQ-A54N-01A-11D-A25N-01 TCGA-AQ-A54N-01 ed3e6c57-a0ec-4441-a1a1-794f3f15e112 TCGA-AQ-A54N-01A-11D-A25N-01 TCGA-AQ-A54O-01 TCGA-AQ-A54O-01 TCGA-AQ-A54O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AQ-A54O-F55731 TCGA-AQ-A54O TCGA-AQ-A54O-01A Positive Positive Simple Mastectomy YES -18694 617 0 1001 90-99% 2014-1-14 MALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 360 NO Negative NO 14 Negative NO 0 0 false Yes M0 N0 T2 Stage IIA TCGA-AQ-A54O.B3884493-D0D2-445C-B9BB-BC475021EBA4.pdf A54O TUMOR FREE YES YES 70-79% NO Primary Tumor 01 7th YES NO AQ Breast A LIVING 2011 3c1b6647-26bb-4110-aaea-f542024e8bf3 3c1b6647-26bb-4110-aaea-f542024e8bf3 TCGA-AQ-A54O-01 TCGA-AQ-A54O-01A-11D-A268-05 e546ea71-dcab-49bf-b972-d6b6dbe57b8f TCGA-AQ-A54O-01 TCGA-AQ-A54O-01A-11D-A25Q-09 TCGA-AQ-A54O-01 3c1b6647-26bb-4110-aaea-f542024e8bf3 TCGA-AQ-A54O-01A-11D-A25N-01 TCGA-AQ-A54O-01 3c1b6647-26bb-4110-aaea-f542024e8bf3 TCGA-AQ-A54O-01A-11D-A25N-01 TCGA-AQ-A7U7-01 TCGA-AQ-A7U7-01 TCGA-AQ-A7U7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left Sentinel lymph node biopsy plus axillary dissection TCGA-AQ-A7U7-F68763 TCGA-AQ-A7U7 TCGA-AQ-A7U7-01A Positive Positive Other YES -20239 223 584 0 304 80-89% 2014-12-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy NO Negative NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 4 0 false Yes M0 N2a T2 Stage IIIA TCGA-AQ-A7U7.2B30A85F-7A5F-46E4-BE22-28C902D5DFA3.pdf A7U7 TUMOR FREE YES YES 80-89% YES Primary Tumor 01 L Total Mastectomy 7th YES NO AQ Breast A DECEASED 2013 0f3672e4-ab71-4cb6-9d46-3ae57b58e249 0f3672e4-ab71-4cb6-9d46-3ae57b58e249 TCGA-AQ-A7U7-01 TCGA-AQ-A7U7-01A-22D-A357-05 3956ACBB-F98A-4510-95FF-E9A7FFF1AEF7 TCGA-AQ-A7U7-01 TCGA-AQ-A7U7-01 0f3672e4-ab71-4cb6-9d46-3ae57b58e249 TCGA-AQ-A7U7-01A-22D-A350-01 TCGA-AQ-A7U7-01 0f3672e4-ab71-4cb6-9d46-3ae57b58e249 TCGA-AQ-A7U7-01A-22D-A350-01 TCGA-AR-A0TP-01 Stage II 43 1 No_Conversion 2392 Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 2392 0 Basal Basal-like Negative Basal -13 -11 enrollment T_Other T2 LIVING TCGA-AR-A0TP-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AR-A0TP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0TP-F71715 TCGA-AR-A0TP Positive Negative Other YES -15812 0 4275 <10% Scheduled Follow-up Submission 2015-3-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO 0 0 No M0 N0 T2 Stage IIA A0TP TUMOR FREE YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast LIVING 2003 f9739b94-ac64-40d5-bfdd-041a412976c4 f9739b94-ac64-40d5-bfdd-041a412976c4 TCGA-AR-A0TP-01A-21-A13C-20 TCGA-AR-A0TP-01A-11D-A099-09 TCGA-AR-A0TP-01 TCGA-AR-A0TP-01A-11D-A10P-05 c8173431-25a0-4853-a0ca-7df5c5cf40e8 TCGA-AR-A0TP-01 TCGA-AR-A0TP-01 TCGA-AR-A0TP-01A-11D-A099-09 TCGA-AR-A0TP-01 f9739b94-ac64-40d5-bfdd-041a412976c4 TCGA-AR-A0TP-01 TCGA-AR-A0TP-01A-11D-A087-01 TCGA-AR-A0TP-01A-11R-A084-07 f9739b94-ac64-40d5-bfdd-041a412976c4 TCGA-AR-A0TP-01A-11D-A087-01 TCGA-AR-A0TP-01 TCGA-AR-A0TQ-01 Stage III 27 3 No_Conversion 1500 Positive FEMALE Positive 1 1 4 Negative M0 Positive N1 1500 0 LumB Luminal B Negative Her2 -2 -5 enrollment T_Other T3 LIVING TCGA-AR-A0TQ-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-AR-A0TQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 27 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AR-A0TQ-F71717 TCGA-AR-A0TQ TCGA-AR-A0TQ-01A Positive Negative Simple Mastectomy NO -9873 1512 0 2991 10-19% Scheduled Follow-up Submission 2015-3-30 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 750 NO Equivocal Positive NO 15 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 2 true No M0 N1 T3 Stage IIIA TCGA-AR-A0TQ.6061FCA5-A113-4985-905D-E17020F6933E.pdf A0TQ TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2006 7c7b9232-aadf-476f-b9c7-2fdd67efe1e7 7c7b9232-aadf-476f-b9c7-2fdd67efe1e7 TCGA-AR-A0TQ-01A-21-A13C-20 TCGA-AR-A0TQ-01A-11D-A099-09 TCGA-AR-A0TQ-01 TCGA-AR-A0TQ-01A-11D-A10P-05 e214f5bd-2ee3-4f27-b1e4-2895df122c9f TCGA-AR-A0TQ-01 TCGA-AR-A0TQ-01 TCGA-AR-A0TQ-01A-11D-A099-09 TCGA-AR-A0TQ-01 7c7b9232-aadf-476f-b9c7-2fdd67efe1e7 TCGA-AR-A0TQ-01 TCGA-AR-A0TQ-01A-11D-A087-01 TCGA-AR-A0TQ-01A-11R-A084-07 7c7b9232-aadf-476f-b9c7-2fdd67efe1e7 TCGA-AR-A0TQ-01A-11D-A087-01 TCGA-AR-A0TQ-01 TCGA-AR-A0TR-01 Stage II 68 1 No_Conversion 21 160 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 160 1 LumA Luminal A Positive LumA/B -12 -3 enrollment T_Other T2 DECEASED TCGA-AR-A0TR-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 7 mutation cluster 4 TCGA-AR-A0TR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0TR-F18771 TCGA-AR-A0TR TCGA-AR-A0TR-01A Positive Positive Modified Radical Mastectomy NO -25190 1535 160 0 Scheduled Follow-up Submission 2011-12-12 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy not specified Other method, specify: 520 NO Equivocal Negative 27 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 7 NO 1 true No M0 N1 T2 Stage IIB TCGA-AR-A0TR.6535D911-D718-4794-9D5E-6E06553464FF.pdf A0TR NO Primary Tumor 01 YES NO YES AR Breast A DECEASED 2006 b31bf328-6ead-4ee4-b8c7-4407372dc683 b31bf328-6ead-4ee4-b8c7-4407372dc683 TCGA-AR-A0TR-01A-21-A13C-20 TCGA-AR-A0TR-01A-11D-A099-09 TCGA-AR-A0TR-01 TCGA-AR-A0TR-01A-11D-A10P-05 64d25a8c-e5fc-42f2-8d71-7cf2afb1d9ff TCGA-AR-A0TR-01 TCGA-AR-A0TR-01 TCGA-AR-A0TR-01A-11D-A099-09 TCGA-AR-A0TR-01 b31bf328-6ead-4ee4-b8c7-4407372dc683 TCGA-AR-A0TR-01 TCGA-AR-A0TR-01A-11D-A087-01 TCGA-AR-A0TR-01A-11R-A084-07 b31bf328-6ead-4ee4-b8c7-4407372dc683 TCGA-AR-A0TR-01A-11D-A087-01 TCGA-AR-A0TR-01 TCGA-AR-A0TS-01 Stage II 46 4 No_Conversion 1138 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1138 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-AR-A0TS-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 cluster 5 mutation cluster 5 TCGA-AR-A0TS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0TS-F71730 TCGA-AR-A0TS TCGA-AR-A0TS-01A Negative 0 Negative Lumpectomy YES -17141 1549 0 2558 Scheduled Follow-up Submission 2015-3-30 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 250 NO Negative NO 16 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 5 NO 2 true No M0 N1 T2 Stage IIB TCGA-AR-A0TS.39A0AD32-D372-422F-94F2-173F963C7AAB.pdf A0TS TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2006 3e57b40c-7079-4f05-bf37-f560304966c1 3e57b40c-7079-4f05-bf37-f560304966c1 TCGA-AR-A0TS-01A-21-A13C-20 TCGA-AR-A0TS-01A-11D-A10Y-09 TCGA-AR-A0TS-01 3dd4ebe5-1445-46c9-8815-f9a3dc659585 TCGA-AR-A0TS-01 TCGA-AR-A0TS-01A-11D-A10Y-09 TCGA-AR-A0TS-01A-11D-A112-05 TCGA-AR-A0TS-01 TCGA-AR-A0TS-01 TCGA-AR-A0TS-01A-11D-A10Y-09 3e57b40c-7079-4f05-bf37-f560304966c1 TCGA-AR-A0TS-01A-11D-A111-01 TCGA-AR-A0TS-01 TCGA-AR-A0TS-01A-11R-A115-07 3e57b40c-7079-4f05-bf37-f560304966c1 TCGA-AR-A0TS-01A-11D-A111-01 TCGA-AR-A0TS-01 TCGA-AR-A0TT-01 Stage III 53 3 No_Conversion 1679 Positive FEMALE Negative 1 1 4 Negative M0 Positive N2 1679 0 LumB Luminal B Negative LumA/B -2 -5 enrollment T_Other T2 LIVING TCGA-AR-A0TT-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A0TT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0TT-F71737 TCGA-AR-A0TT TCGA-AR-A0TT-01A Positive 0 Negative Other -19679 1567 0 3316 10-19% Scheduled Follow-up Submission 2015-3-30 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 310 NO Negative NO 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 5 true No M0 N2 T2 Stage IIIA TCGA-AR-A0TT.E9231B33-E1CE-4396-9F9E-03DBF049919A.pdf A0TT TUMOR FREE YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 dc2ddb88-79d7-44b2-a770-a5f7dde21e3c dc2ddb88-79d7-44b2-a770-a5f7dde21e3c TCGA-AR-A0TT-01A-21-A13C-20 TCGA-AR-A0TT-01A-31D-A099-09 TCGA-AR-A0TT-01 TCGA-AR-A0TT-01A-31D-A10P-05 5f13706f-5c4d-421f-9b16-eaeec34f283b TCGA-AR-A0TT-01 TCGA-AR-A0TT-01 TCGA-AR-A0TT-01A-31D-A099-09 TCGA-AR-A0TT-01 dc2ddb88-79d7-44b2-a770-a5f7dde21e3c TCGA-AR-A0TT-01 TCGA-AR-A0TT-01A-31D-A087-01 TCGA-AR-A0TT-01A-31R-A084-07 dc2ddb88-79d7-44b2-a770-a5f7dde21e3c TCGA-AR-A0TT-01A-31D-A087-01 TCGA-AR-A0TT-01 TCGA-AR-A0TU-01 Stage II 35 4 No_Conversion 360 Negative FEMALE Negative Negative M0 Negative N0 360 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-AR-A0TU-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 mutation c1uster 9 TCGA-AR-A0TU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0TU-F71735 TCGA-AR-A0TU TCGA-AR-A0TU-01A Negative 0 Negative Simple Mastectomy YES -13039 1633 0 709 Scheduled Follow-up Submission 2015-3-30 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 830 NO Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A0TU.81A39E94-059E-4307-A75A-E8C051E9D0C3.pdf A0TU TUMOR FREE YES NO Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2006 2877059f-b560-413b-b8be-40d9fde8fbcf 2877059f-b560-413b-b8be-40d9fde8fbcf TCGA-AR-A0TU-01A-21-A13C-20 TCGA-AR-A0TU-01A-31D-A10G-09 TCGA-AR-A0TU-01 TCGA-AR-A0TU-01A-31D-A10A-05 3c72159d-4ac6-4f06-89f5-4e7bc6a4e134 TCGA-AR-A0TU-01A-31D-A10G-09 TCGA-AR-A0TU-01A-31D-A10G-09 2877059f-b560-413b-b8be-40d9fde8fbcf TCGA-AR-A0TU-01A-31R-A109-07 2877059f-b560-413b-b8be-40d9fde8fbcf TCGA-AR-A0TU-01 TCGA-AR-A0TV-01 Stage II 66 1 No_Conversion 904 Positive FEMALE Negative 1 1 4 Negative M0 Negative N0 904 0 LumB Luminal B Positive LumA/B -10 -5 enrollment T_Other T2 LIVING TCGA-AR-A0TV-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 8 TCGA-AR-A0TV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0TV-F71734 TCGA-AR-A0TV TCGA-AR-A0TV-01A Positive Positive Simple Mastectomy YES -24279 1716 0 2288 90-99% Scheduled Follow-up Submission 2015-3-30 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 550 NO Equivocal Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A0TV.7594A7F8-1806-4B74-99EF-4E4C889E7BEA.pdf A0TV TUMOR FREE NO NO Primary Tumor 01 6th NO NO YES AR Breast A LIVING 2005 3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c 3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c TCGA-AR-A0TV-01A-11-A13D-20 TCGA-AR-A0TV-01A-21D-A099-09 TCGA-AR-A0TV-01 TCGA-AR-A0TV-01A-21D-A10P-05 457d54a9-a2c9-4747-928c-4c428e187548 TCGA-AR-A0TV-01 TCGA-AR-A0TV-01 TCGA-AR-A0TV-01A-21D-A099-09 TCGA-AR-A0TV-01 3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c TCGA-AR-A0TV-01 TCGA-AR-A0TV-01A-21D-A087-01 TCGA-AR-A0TV-01A-21R-A084-07 3d0d24de-c3b4-4396-bfb1-2c8c2788cf0c TCGA-AR-A0TV-01A-21D-A087-01 TCGA-AR-A0TV-01 TCGA-AR-A0TW-01 Stage III 50 4 No_Conversion 739 Positive FEMALE Negative Negative M0 Positive N1 739 0 LumA Luminal A Positive Basal -2 -5 enrollment T_Other T3 LIVING TCGA-AR-A0TW-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation c1uster 9 TCGA-AR-A0TW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Upper Outer Quadrant|Right Lower Outer Quadrant TCGA-AR-A0TW-F49464 TCGA-AR-A0TW Positive Positive Modified Radical Mastectomy -18263 0 3009 739 Scheduled Follow-up Submission 2013-10-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative 27 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 3 No M0 N1 T3 Stage IIIA A0TW TUMOR FREE YES NO Primary Tumor 01 YES NO YES AR Breast LIVING 2005 f8fd0762-44b8-41ff-9c1a-ff688497e312 f8fd0762-44b8-41ff-9c1a-ff688497e312 TCGA-AR-A0TW-01A-21-A13D-20 TCGA-AR-A0TW-01A-11D-A099-09 TCGA-AR-A0TW-01 TCGA-AR-A0TW-01A-11D-A10P-05 d09f498e-9952-4926-b6e2-56e774b0bdcf TCGA-AR-A0TW-01 TCGA-AR-A0TW-01 TCGA-AR-A0TW-01A-11D-A099-09 f8fd0762-44b8-41ff-9c1a-ff688497e312 TCGA-AR-A0TW-01A-11D-A087-01 TCGA-AR-A0TW-01A-11R-A084-07 f8fd0762-44b8-41ff-9c1a-ff688497e312 TCGA-AR-A0TW-01A-11D-A087-01 TCGA-AR-A0TW-01 TCGA-AR-A0TX-01 Stage II 64 1 No_Conversion 15 Positive FEMALE Positive 2 2 1 Negative M0 Positive N1 15 0 Her2 HER2-enriched Positive ReacII -11 -5 enrollment T1 T1 LIVING TCGA-AR-A0TX-01 High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 8 TCGA-AR-A0TX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-AR-A0TX-F63939 TCGA-AR-A0TX TCGA-AR-A0TX-01A Positive Positive Other NO -23653 1976 0 1972 <10% Scheduled Follow-up Submission 2014-8-21 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 470 NO Positive NO 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 1 NO 3 true No M0 N1 T1 Stage IIA TCGA-AR-A0TX.4FC34715-9004-4F53-B914-F0004AEA88C8.pdf A0TX TUMOR FREE YES Primary Tumor 01 Wide local excision NO YES AR Breast A LIVING 2005 08d85849-cda7-4709-a934-fdc586418d7f 08d85849-cda7-4709-a934-fdc586418d7f TCGA-AR-A0TX-01A-21-A13D-20 TCGA-AR-A0TX-01A-11D-A099-09 TCGA-AR-A0TX-01 TCGA-AR-A0TX-01A-11D-A10P-05 82828084-520c-4384-aa18-0d668bfa5ed6 TCGA-AR-A0TX-01 TCGA-AR-A0TX-01A-11D-A099-09 TCGA-AR-A0TX-01 TCGA-AR-A0TX-01A-11D-A099-09 TCGA-AR-A0TX-01 08d85849-cda7-4709-a934-fdc586418d7f TCGA-AR-A0TX-01 TCGA-AR-A0TX-01A-11D-A087-01 TCGA-AR-A0TX-01A-11R-A084-07 08d85849-cda7-4709-a934-fdc586418d7f TCGA-AR-A0TX-01A-11D-A087-01 TCGA-AR-A0TX-01 TCGA-AR-A0TY-01 Stage II 54 1 No_Conversion 544 1699 Positive FEMALE Negative 1 1 4 Negative M0 Negative N0 1699 1 LumB Luminal B Negative LumA/B -2 -5 enrollment T_Other T2 DECEASED TCGA-AR-A0TY-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 12 TCGA-AR-A0TY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0TY-F18561 TCGA-AR-A0TY TCGA-AR-A0TY-01A Positive 0 Negative Simple Mastectomy YES -19836 2141 1699 0 544 10-19% Scheduled Follow-up Submission 2011-12-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 410 NO Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1+ Positive Negative 4 4 Bone Distant Metastasis YES 0 true No M0 N0 T2 Stage IIA TCGA-AR-A0TY.12A4A731-1ADF-4D36-88F3-16C9642484F3.pdf A0TY WITH TUMOR NO Primary Tumor 01 YES NO YES AR Breast A DECEASED 2004 7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920 7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920 TCGA-AR-A0TY-01A-21-A13D-20 TCGA-AR-A0TY-01A-12W-A12T-09 TCGA-AR-A0TY-01 8a76d3b0-5e1c-48d9-a325-71be8a93a093 TCGA-AR-A0TY-01 TCGA-AR-A0TY-01A-12W-A12T-09 TCGA-AR-A0TY-01A-12D-A112-05 TCGA-AR-A0TY-01 TCGA-AR-A0TY-01 TCGA-AR-A0TY-01A-12W-A12T-09 7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920 TCGA-AR-A0TY-01A-12D-A111-01 TCGA-AR-A0TY-01 TCGA-AR-A0TY-01A-12R-A115-07 7fe47d2c-6b7d-4fa3-8e22-14fdb2b44920 TCGA-AR-A0TY-01A-12D-A111-01 TCGA-AR-A0TY-01 TCGA-AR-A0TZ-01 Stage III 43 5 No_Conversion 1313 Positive FEMALE Negative 4 3 4 Negative M0 Positive N2 1313 0 LumA Luminal B Positive ReacII -10 -3 enrollment T_Other T2 LIVING TCGA-AR-A0TZ-01 Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AR-A0TZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Outer Quadrant TCGA-AR-A0TZ-F49471 TCGA-AR-A0TZ TCGA-AR-A0TZ-01A Positive Positive Modified Radical Mastectomy -15720 2239 3262 0 2316 1313 Scheduled Follow-up Submission 2013-10-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 290 NO Equivocal Negative NO 30 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 1+ Positive 70-79% <10% Positive Bone 3 2 Bone Distant Metastasis YES 6 true No M1 N2 T2 Stage IIIA TCGA-AR-A0TZ.48F86416-8304-479E-B477-7C37A2F951A2.pdf A0TZ YES YES Primary Tumor 01 YES NO YES AR Breast A DECEASED 2004 1d6480da-a470-4726-8bc4-57fa30799a15 1d6480da-a470-4726-8bc4-57fa30799a15 TCGA-AR-A0TZ-01A-21-A13D-20 TCGA-AR-A0TZ-01A-12D-A099-09 TCGA-AR-A0TZ-01 TCGA-AR-A0TZ-01A-12D-A10P-05 5afd9456-59f9-44d4-ac7c-b086ef899105 TCGA-AR-A0TZ-01 TCGA-AR-A0TZ-01 TCGA-AR-A0TZ-01A-12D-A099-09 TCGA-AR-A0TZ-01 1d6480da-a470-4726-8bc4-57fa30799a15 TCGA-AR-A0TZ-01 TCGA-AR-A0TZ-01A-12D-A087-01 TCGA-AR-A0TZ-01A-12R-A084-07 1d6480da-a470-4726-8bc4-57fa30799a15 TCGA-AR-A0TZ-01A-12D-A087-01 TCGA-AR-A0TZ-01 TCGA-AR-A0U0-01 Stage II 73 1 No_Conversion 8 Negative FEMALE Negative Negative M0 Positive N1 8 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-AR-A0U0-01 Squamous C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA basal-like c8 mutation cluster 3 TCGA-AR-A0U0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0U0-F65068 TCGA-AR-A0U0 TCGA-AR-A0U0-01A Negative 0 Negative Simple Mastectomy YES -26993 2289 0 1988 Scheduled Follow-up Submission 2014-9-18 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 370 NO NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 0 2 true No M0 N1 T2 Stage IIB TCGA-AR-A0U0.322BB8BB-100F-4838-9771-EAEE5A3B817A.pdf A0U0 TUMOR FREE YES Primary Tumor 01 NO YES AR Breast A LIVING 2004 dea20128-b180-4da1-9da5-0f00bea3b1ab dea20128-b180-4da1-9da5-0f00bea3b1ab TCGA-AR-A0U0-01A-21-A13D-20 TCGA-AR-A0U0-01A-11D-A10G-09 TCGA-AR-A0U0-01 TCGA-AR-A0U0-01A-11D-A10A-05 4c67c3c8-cc93-4bb4-a8c6-76232335c00f TCGA-AR-A0U0-01 TCGA-AR-A0U0-01A-11D-A10G-09 TCGA-AR-A0U0-01 TCGA-AR-A0U0-01A-11D-A10G-09 dea20128-b180-4da1-9da5-0f00bea3b1ab TCGA-AR-A0U0-01A-11D-A107-01 TCGA-AR-A0U0-01A-11R-A109-07 dea20128-b180-4da1-9da5-0f00bea3b1ab TCGA-AR-A0U0-01A-11D-A107-01 TCGA-AR-A0U0-01 TCGA-AR-A0U1-01 Stage II 36 1 No_Conversion 185 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 185 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-AR-A0U1-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-AR-A0U1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 36 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0U1-F71729 TCGA-AR-A0U1 TCGA-AR-A0U1-01A Negative 0 Negative Other NO -13467 2301 0 4052 Scheduled Follow-up Submission 2015-3-30 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 300 NO Negative NO 31 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 6 NO 1 true No M0 N1 T2 Stage IIB TCGA-AR-A0U1.007C609A-7874-4E39-BC4D-1EA81F4722EA.pdf A0U1 TUMOR FREE YES YES Primary Tumor 01 wide local excision 6th YES NO YES AR Breast A LIVING 2004 3450eaab-777a-46ab-9d13-8e0783c4a686 3450eaab-777a-46ab-9d13-8e0783c4a686 TCGA-AR-A0U1-01A-21-A13C-20 TCGA-AR-A0U1-01A-11D-A10Y-09 9b542860-aebc-49d8-a1a3-3f693c8b119a TCGA-AR-A0U1-01A-11D-A10Y-09 TCGA-AR-A0U1-01A-11D-A112-05 TCGA-AR-A0U1-01A-11D-A10Y-09 3450eaab-777a-46ab-9d13-8e0783c4a686 TCGA-AR-A0U1-01A-11D-A111-01 TCGA-AR-A0U1-01A-11R-A115-07 3450eaab-777a-46ab-9d13-8e0783c4a686 TCGA-AR-A0U1-01A-11D-A111-01 TCGA-AR-A0U2-01 Stage III 47 5 No_Conversion 1608 2551 Positive FEMALE Negative Negative M0 Positive N2 2551 1 LumB Luminal B Positive ReacII -10 -5 enrollment T_Other T2 DECEASED TCGA-AR-A0U2-01 High C3-BRCA/Luminal cluster 2 BRCA CIMP c7 squamous c3 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AR-A0U2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-AR-A0U2-F18483 TCGA-AR-A0U2 TCGA-AR-A0U2-01A Negative Positive Positive Modified Radical Mastectomy NO -17390 2395 2551 0 1609 10-19% Scheduled Follow-up Submission 2011-12-15 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 150 NO Negative 16 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 2+ Positive 70-79% 2.47 Negative Negative Bone|Liver 2 5 Bone Distant Metastasis Liver YES 4 0 true No M0 N2 T2 Stage IIIA TCGA-AR-A0U2.51F69645-9564-4257-A86E-3A574C27034F.pdf A0U2 WITH TUMOR YES Primary Tumor 01 YES NO YES AR Breast A DECEASED 2004 45f011a1-cc58-47f8-9545-66c313441650 45f011a1-cc58-47f8-9545-66c313441650 TCGA-AR-A0U2-01A-21-A13D-20 TCGA-AR-A0U2-01A-11D-A10G-09 TCGA-AR-A0U2-01 TCGA-AR-A0U2-01A-11D-A10A-05 bb541d0b-a4ba-482a-b4ff-427185e70239 TCGA-AR-A0U2-01 TCGA-AR-A0U2-01A-11D-A10G-09 TCGA-AR-A0U2-01 TCGA-AR-A0U2-01A-11D-A10G-09 TCGA-AR-A0U2-01 45f011a1-cc58-47f8-9545-66c313441650 TCGA-AR-A0U2-01 TCGA-AR-A0U2-01A-11D-A107-01 TCGA-AR-A0U2-01A-11R-A109-07 45f011a1-cc58-47f8-9545-66c313441650 TCGA-AR-A0U2-01A-11D-A107-01 TCGA-AR-A0U2-01 TCGA-AR-A0U3-01 Stage II 59 4 No_Conversion 2263 Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 2263 0 LumA Luminal B Positive LumA/B 0 -3 enrollment T_Other T2 LIVING TCGA-AR-A0U3-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 5 TCGA-AR-A0U3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0U3-F71712 TCGA-AR-A0U3 Positive Positive Other NO -21755 0 4080 10-19% Scheduled Follow-up Submission 2015-3-30 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 7 NO 1 No M0 N1 T2 Stage IIB A0U3 TUMOR FREE YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast LIVING 2004 b36b5a17-972f-442a-84a0-469099a619ec b36b5a17-972f-442a-84a0-469099a619ec TCGA-AR-A0U3-01A-21-A13C-20 TCGA-AR-A0U3-01A-11D-A10G-09 TCGA-AR-A0U3-01 TCGA-AR-A0U3-01A-11D-A10A-05 c5be7166-dd6f-422d-b420-ee73dc2675f4 TCGA-AR-A0U3-01 TCGA-AR-A0U3-01A-11D-A10G-09 TCGA-AR-A0U3-01 TCGA-AR-A0U3-01A-11D-A10G-09 TCGA-AR-A0U3-01 b36b5a17-972f-442a-84a0-469099a619ec TCGA-AR-A0U3-01 TCGA-AR-A0U3-01A-11D-A107-01 TCGA-AR-A0U3-01A-11R-A109-07 b36b5a17-972f-442a-84a0-469099a619ec TCGA-AR-A0U3-01A-11D-A107-01 TCGA-AR-A0U3-01 TCGA-AR-A0U4-01 Stage II 54 1 No_Conversion 1627 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1627 0 Basal Basal-like Negative ReacII -13 -12 enrollment T_Other T2 LIVING TCGA-AR-A0U4-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 11 TCGA-AR-A0U4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A0U4-F71739 TCGA-AR-A0U4 Negative 0 Negative Simple Mastectomy NO -19729 0 3261 Scheduled Follow-up Submission 2015-3-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 5 NO 0 No M0 N0 T2 Stage IIA A0U4 TUMOR FREE YES NO Primary Tumor 01 6th YES NO YES AR Breast LIVING 2006 ee7156b6-f469-402c-8f63-f4c2f6913db1 ee7156b6-f469-402c-8f63-f4c2f6913db1 TCGA-AR-A0U4-01A-21-A13D-20 TCGA-AR-A0U4-01A-11D-A117-09 TCGA-AR-A0U4-01 TCGA-AR-A0U4-01A-11D-A10A-05 e4120a7f-41ff-4928-a173-0cb5f7fb8674 TCGA-AR-A0U4-01 TCGA-AR-A0U4-01 TCGA-AR-A0U4-01A-11D-A117-09 TCGA-AR-A0U4-01 ee7156b6-f469-402c-8f63-f4c2f6913db1 TCGA-AR-A0U4-01 TCGA-AR-A0U4-01A-11D-A107-01 TCGA-AR-A0U4-01A-11R-A109-07 ee7156b6-f469-402c-8f63-f4c2f6913db1 TCGA-AR-A0U4-01A-11D-A107-01 TCGA-AR-A0U4-01 TCGA-AR-A1AH-01 Stage II 51 1 Stage IIB 2298 Positive FEMALE Negative 2 2 2 Negative M0 Positive N1 2298 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-AR-A1AH-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AR-A1AH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-AR-A1AH-F69267 TCGA-AR-A1AH TCGA-AR-A1AH-01A Positive Negative Other -18991 2368 0 3807 1136 10-19% Scheduled Follow-up Submission 2014-12-31 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 140 NO Negative NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 Other, specify New Primary Tumor Renal NO 1 true No M0 N1 T2 Stage IIB TCGA-AR-A1AH.75F29A17-B6AF-43B9-BE12-3ABF850F23BA.pdf A1AH TUMOR FREE YES YES NO Primary Tumor 01 Total Mastectomy 6th YES NO YES AR Breast A LIVING 2004 ff0d7627-cec2-42e7-891b-cba5f42e3272 ff0d7627-cec2-42e7-891b-cba5f42e3272 TCGA-AR-A1AH-01A-21-A13E-20 TCGA-AR-A1AH-01A-11D-A12B-09 TCGA-AR-A1AH-01 180cde2e-13d3-462d-bba2-ae37bdee0f3f TCGA-AR-A1AH-01 TCGA-AR-A1AH-01A-11D-A12B-09 TCGA-AR-A1AH-01A-11D-A12E-05 TCGA-AR-A1AH-01 TCGA-AR-A1AH-01 TCGA-AR-A1AH-01A-11D-A12B-09 ff0d7627-cec2-42e7-891b-cba5f42e3272 TCGA-AR-A1AH-01A-11D-A12A-01 TCGA-AR-A1AH-01 TCGA-AR-A1AH-01A-11R-A12D-07 ff0d7627-cec2-42e7-891b-cba5f42e3272 TCGA-AR-A1AH-01A-11D-A12A-01 TCGA-AR-A1AH-01 TCGA-AR-A1AI-01 Stage II 47 1 Stage IIA 1881 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1881 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-AR-A1AI-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AR-A1AI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AI-F69268 TCGA-AR-A1AI TCGA-AR-A1AI-01A Negative Negative Simple Mastectomy YES -17229 1939 0 3296 588 Scheduled Follow-up Submission 2014-12-31 FEMALE 2+ Medullary Carcinoma No C50.9 8510/3 C50.9 YES Fine needle aspiration biopsy 1050 NO Equivocal Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 Other, specify New Primary Tumor Contralateral Breast NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A1AI.F5CAE962-5347-46FA-86EE-169121BED547.pdf A1AI TUMOR FREE YES YES NO Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2005 52ff562f-6a13-435a-acab-16a064633b1d 52ff562f-6a13-435a-acab-16a064633b1d TCGA-AR-A1AI-01A-21-A13E-20 TCGA-AR-A1AI-01A-11D-A12Q-09 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01A-11D-A12R-05 d872badb-8c24-48fe-b482-6b3c262a4259 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01A-11D-A12Q-09 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01A-11D-A12Q-09 52ff562f-6a13-435a-acab-16a064633b1d TCGA-AR-A1AI-01A-11D-A12N-01 TCGA-AR-A1AI-01 TCGA-AR-A1AI-01A-11R-A12P-07 52ff562f-6a13-435a-acab-16a064633b1d TCGA-AR-A1AI-01A-11D-A12N-01 TCGA-AR-A1AI-01 TCGA-AR-A1AJ-01 Stage I 83 3 Stage I 1604 Positive FEMALE Negative 1 2 2 Negative M0 Negative N0 1604 0 Basal Basal-like Negative ReacI -13 -12 enrollment T1 T1 LIVING TCGA-AR-A1AJ-01 High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AR-A1AJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 83 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AJ-F69269 TCGA-AR-A1AJ TCGA-AR-A1AJ-01A Positive Negative Other YES -30489 1828 0 3072 10-19% Scheduled Follow-up Submission 2014-12-31 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A1AJ.0DEAC35F-8B73-4A9F-B7FA-2F501B736B0E.pdf A1AJ TUMOR FREE NO YES YES Primary Tumor 01 Wide local excision 6th NO NO YES AR Breast A LIVING 2005 98703904-572d-4220-b959-a1293a2e1c33 98703904-572d-4220-b959-a1293a2e1c33 TCGA-AR-A1AJ-01A-31-A13E-20 TCGA-AR-A1AJ-01A-21D-A12Q-09 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01A-21D-A12R-05 26cb824a-251d-4b4c-a00c-19de6d7e2562 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01A-21D-A12Q-09 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01A-21D-A12Q-09 98703904-572d-4220-b959-a1293a2e1c33 TCGA-AR-A1AJ-01A-21D-A12N-01 TCGA-AR-A1AJ-01 TCGA-AR-A1AJ-01A-21R-A12P-07 98703904-572d-4220-b959-a1293a2e1c33 TCGA-AR-A1AJ-01A-21D-A12N-01 TCGA-AR-A1AJ-01 TCGA-AR-A1AK-01 Stage I 70 3 Stage I 1558 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 1558 0 LumA Luminal A Positive ReacI -5 0 enrollment T1 T1 LIVING TCGA-AR-A1AK-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A1AK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AK-F69271 TCGA-AR-A1AK Positive Positive Simple Mastectomy YES -25825 0 3159 10-19% Scheduled Follow-up Submission 2014-12-31 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 No M0 N0 T1 Stage I A1AK TUMOR FREE YES YES 10-19% NO Primary Tumor 01 6th YES NO YES AR Breast LIVING 2006 a3568fd6-4b6d-4507-9c59-1788834d3a75 a3568fd6-4b6d-4507-9c59-1788834d3a75 TCGA-AR-A1AK-01A-31-A13E-20 TCGA-AR-A1AK-01A-21D-A12Q-09 TCGA-AR-A1AK-01 TCGA-AR-A1AK-01A-21D-A12R-05 f0e4daf7-c2e8-40e8-826e-1cb9df14327e TCGA-AR-A1AK-01 TCGA-AR-A1AK-01A-21D-A12Q-09 TCGA-AR-A1AK-01 TCGA-AR-A1AK-01 TCGA-AR-A1AK-01A-21D-A12Q-09 a3568fd6-4b6d-4507-9c59-1788834d3a75 TCGA-AR-A1AK-01A-21D-A12N-01 TCGA-AR-A1AK-01 TCGA-AR-A1AK-01A-21R-A12P-07 a3568fd6-4b6d-4507-9c59-1788834d3a75 TCGA-AR-A1AK-01A-21D-A12N-01 TCGA-AR-A1AK-01 TCGA-AR-A1AL-01 Stage III 60 2 Stage IIIA 1485 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1485 0 LumA Luminal A Positive ReacI -4 0 enrollment T_Other T3 LIVING TCGA-AR-A1AL-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 1 TCGA-AR-A1AL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AL-F69272 TCGA-AR-A1AL TCGA-AR-A1AL-01A Positive Positive Simple Mastectomy YES -22023 1528 0 2971 70-79% Scheduled Follow-up Submission 2014-12-31 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 630 NO Negative NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 3 true No M0 N1 T3 Stage IIIA TCGA-AR-A1AL.E3D44C6B-4497-4212-8CA1-AC9444B4CC54.pdf A1AL TUMOR FREE YES YES 70-79% YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2006 ad602633-fdd7-4bf1-b3ac-e1c8e0a02934 ad602633-fdd7-4bf1-b3ac-e1c8e0a02934 TCGA-AR-A1AL-01A-31-A13E-20 TCGA-AR-A1AL-01A-21D-A12Q-09 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01A-21D-A12R-05 12c1530b-8aaf-4eb5-bda4-5d3225242d79 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01A-21D-A12Q-09 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01A-21D-A12Q-09 ad602633-fdd7-4bf1-b3ac-e1c8e0a02934 TCGA-AR-A1AL-01A-21D-A12N-01 TCGA-AR-A1AL-01 TCGA-AR-A1AL-01A-21R-A12P-07 ad602633-fdd7-4bf1-b3ac-e1c8e0a02934 TCGA-AR-A1AL-01A-21D-A12N-01 TCGA-AR-A1AL-01 TCGA-AR-A1AM-01 TCGA-AR-A1AM-01 Iq BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-AR-A1AM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Upper Outer Quadrant TCGA-AR-A1AM-F71733 TCGA-AR-A1AM Positive Positive Simple Mastectomy -19123 0 2991 2015-3-30 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Equivocal Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 No M0 N1 T3 Stage IIIA A1AM TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES AR Breast LIVING 2006 a58de230-f177-4c58-95ec-55b6edb08452 a58de230-f177-4c58-95ec-55b6edb08452 TCGA-AR-A1AM-01A-31-A24A-20 TCGA-AR-A1AM-01 TCGA-AR-A1AM-01A-41D-A22B-05 d30acc0b-b6b7-4134-96f5-4b76004ca893 TCGA-AR-A1AM-01 TCGA-AR-A1AM-01A-41D-A228-09 TCGA-AR-A1AM-01 a58de230-f177-4c58-95ec-55b6edb08452 TCGA-AR-A1AM-01A-41D-A227-01 TCGA-AR-A1AM-01 a58de230-f177-4c58-95ec-55b6edb08452 TCGA-AR-A1AM-01A-41D-A227-01 TCGA-AR-A1AN-01 Stage II 46 1 Stage IIA 1329 Positive FEMALE Negative Negative M0 Negative N0 1329 0 LumA Luminal A Positive -5 -7 enrollment T_Other T2 LIVING TCGA-AR-A1AN-01 High C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 7 cluster 6 mutation cluster 5 TCGA-AR-A1AN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AN-F69273 TCGA-AR-A1AN TCGA-AR-A1AN-01A Positive Positive Other YES -16974 1463 0 2920 70-79% Scheduled Follow-up Submission 2014-12-31 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 70 NO Negative NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 6 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A1AN.DA251274-7966-4F48-A02F-393ABBDAB4E9.pdf A1AN TUMOR FREE YES YES 70-79% YES Primary Tumor 01 Wide Local Excision 6th YES NO YES AR Breast A LIVING 2006 9046caf3-bbfe-4554-b9d2-11b333ad7704 9046caf3-bbfe-4554-b9d2-11b333ad7704 TCGA-AR-A1AN-01A-11D-A12Q-09 TCGA-AR-A1AN-01 TCGA-AR-A1AN-01A-11D-A12R-05 TCGA-AR-A1AN-01 TCGA-AR-A1AN-01A-11D-A12Q-09 TCGA-AR-A1AN-01 TCGA-AR-A1AN-01 TCGA-AR-A1AN-01A-11D-A12Q-09 9046caf3-bbfe-4554-b9d2-11b333ad7704 TCGA-AR-A1AN-01A-11D-A12N-01 TCGA-AR-A1AN-01 TCGA-AR-A1AN-01A-11R-A12P-07 9046caf3-bbfe-4554-b9d2-11b333ad7704 TCGA-AR-A1AN-01A-11D-A12N-01 TCGA-AR-A1AN-01 TCGA-AR-A1AO-01 Stage II 47 1 Stage IIA 1324 Positive FEMALE Negative 2 2 2 Negative M0 Positive N1 1324 0 Normal Normal-like Negative Basal -5 -8 enrollment T1 T1 LIVING TCGA-AR-A1AO-01 Quiet C3-BRCA/Luminal cluster 5 Low purity c2 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A1AO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AO-F69274 TCGA-AR-A1AO TCGA-AR-A1AO-01A Positive Negative Other YES -17332 1471 0 2618 Scheduled Follow-up Submission 2014-12-31 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative NO 39 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 NO 2 true No M0 N1 T1 Stage IIA TCGA-AR-A1AO.37EF1828-0A53-4358-97C7-A7849EC653AF.pdf A1AO TUMOR FREE YES YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 56183330-0700-46d7-b45f-6d915ae587fa 56183330-0700-46d7-b45f-6d915ae587fa TCGA-AR-A1AO-01A-21-A13E-20 TCGA-AR-A1AO-01A-11D-A12Q-09 TCGA-AR-A1AO-01 TCGA-AR-A1AO-01A-11D-A12R-05 310b6320-7ad9-4977-9c23-e80e0500e94c TCGA-AR-A1AO-01 TCGA-AR-A1AO-01A-11D-A12Q-09 TCGA-AR-A1AO-01 TCGA-AR-A1AO-01 TCGA-AR-A1AO-01A-11D-A12Q-09 56183330-0700-46d7-b45f-6d915ae587fa TCGA-AR-A1AO-01A-11D-A12N-01 TCGA-AR-A1AO-01 TCGA-AR-A1AO-01A-11R-A12P-07 56183330-0700-46d7-b45f-6d915ae587fa TCGA-AR-A1AO-01A-11D-A12N-01 TCGA-AR-A1AO-01 TCGA-AR-A1AP-01 Stage I 80 2 Stage I 1215 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 1215 0 LumA Luminal A Positive LumA/B 0 0 enrollment T1 T1 LIVING TCGA-AR-A1AP-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-AR-A1AP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AP-F69275 TCGA-AR-A1AP TCGA-AR-A1AP-01A Negative Positive Mastectomy NOS Positive Other YES -29406 1450 0 2856 70-79% Scheduled Follow-up Submission 2014-12-31 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 310 NO Equivocal Negative NO 1 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A1AP.0BFF09DE-6F36-4F68-AC13-8BC16AA0DCBE.pdf A1AP TUMOR FREE YES YES <10% NO Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 8b0f1897-20d8-492d-9ea9-22f771bbae9d 8b0f1897-20d8-492d-9ea9-22f771bbae9d TCGA-AR-A1AP-01A-21-A13E-20 TCGA-AR-A1AP-01A-11D-A12Q-09 TCGA-AR-A1AP-01 TCGA-AR-A1AP-01A-11D-A12R-05 07e57b56-5370-4a69-86e4-cdd0955d371b TCGA-AR-A1AP-01 TCGA-AR-A1AP-01A-11D-A12Q-09 TCGA-AR-A1AP-01 TCGA-AR-A1AP-01 TCGA-AR-A1AP-01A-11D-A12Q-09 8b0f1897-20d8-492d-9ea9-22f771bbae9d TCGA-AR-A1AP-01A-11D-A12N-01 TCGA-AR-A1AP-01 TCGA-AR-A1AP-01A-11R-A12P-07 8b0f1897-20d8-492d-9ea9-22f771bbae9d TCGA-AR-A1AP-01A-11D-A12N-01 TCGA-AR-A1AP-01 TCGA-AR-A1AQ-01 Stage II 49 1 Stage IIA 1309 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1309 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-AR-A1AQ-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-AR-A1AQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Upper Inner Quadrant|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AQ-F69276 TCGA-AR-A1AQ TCGA-AR-A1AQ-01A Negative Negative Other YES -18109 1424 0 3021 Scheduled Follow-up Submission 2014-12-31 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 180 NO Equivocal Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A1AQ.FC236604-AAE5-4394-9D39-270FFEFB635A.pdf A1AQ TUMOR FREE YES YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 747f56be-2fdd-4eb8-99a7-34afd923d8e1 747f56be-2fdd-4eb8-99a7-34afd923d8e1 TCGA-AR-A1AQ-01A-21-A13E-20 TCGA-AR-A1AQ-01A-11D-A12Q-09 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01A-11D-A12R-05 23358473-9909-47ff-b683-d046e292d504 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01A-11D-A12Q-09 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01A-11D-A12Q-09 747f56be-2fdd-4eb8-99a7-34afd923d8e1 TCGA-AR-A1AQ-01A-11D-A12N-01 TCGA-AR-A1AQ-01 TCGA-AR-A1AQ-01A-11R-A12P-07 747f56be-2fdd-4eb8-99a7-34afd923d8e1 TCGA-AR-A1AQ-01A-11D-A12N-01 TCGA-AR-A1AQ-01 TCGA-AR-A1AR-01 Stage III 50 1 Stage IIIA 523 Negative FEMALE Negative Negative M0 Positive N2 523 1 Basal Basal-like Negative -13 0 enrollment T1 T1 DECEASED TCGA-AR-A1AR-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AR-A1AR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-AR-A1AR-F21825 TCGA-AR-A1AR TCGA-AR-A1AR-01A Negative Negative Lumpectomy -18482 1416 524 0 387 Additional New Tumor Event 2012-2-27 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 250 NO Negative 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 Other, specify New Primary Tumor Breast YES 5 true Yes M0 N2 T1 Stage IIIA TCGA-AR-A1AR.747FB91B-F523-4FA0-91DD-6014EF55643D.pdf A1AR WITH TUMOR YES Primary Tumor 01 6th YES NO YES AR Breast A DECEASED 2007 6d066a72-f59f-45a8-ab90-216000b36da4 6d066a72-f59f-45a8-ab90-216000b36da4 TCGA-AR-A1AR-01A-31D-A135-09 TCGA-AR-A1AR-01 TCGA-AR-A1AR-01A-31D-A138-05 TCGA-AR-A1AR-01 TCGA-AR-A1AR-01A-31D-A135-09 TCGA-AR-A1AR-01 TCGA-AR-A1AR-01 TCGA-AR-A1AR-01A-31D-A135-09 6d066a72-f59f-45a8-ab90-216000b36da4 TCGA-AR-A1AR-01A-31D-A134-01 TCGA-AR-A1AR-01 TCGA-AR-A1AR-01A-31R-A137-07 6d066a72-f59f-45a8-ab90-216000b36da4 TCGA-AR-A1AR-01A-31D-A134-01 TCGA-AR-A1AR-01 TCGA-AR-A1AS-01 Stage II 54 3 Stage IIB 1242 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1242 0 LumA Luminal A Positive LumA -7 -3 enrollment T_Other T2 LIVING TCGA-AR-A1AS-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-AR-A1AS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-AR-A1AS-F49470 TCGA-AR-A1AS TCGA-AR-A1AS-01A Positive Positive Other -20028 1331 0 1150 70-79% Scheduled Follow-up Submission 2013-10-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 300 NO Negative NO 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 1 true No M0 N1 T2 Stage IIB TCGA-AR-A1AS.180AA688-0B63-4DD9-BA29-708E80FBC4C9.pdf A1AS TUMOR FREE NO YES 70-79% YES Primary Tumor 01 Wide local excision 6th NO NO YES AR Breast A LIVING 2007 e7b64cc3-9b2b-4938-9896-84b640d1586f e7b64cc3-9b2b-4938-9896-84b640d1586f TCGA-AR-A1AS-01A-21-A13E-20 TCGA-AR-A1AS-01A-11D-A12Q-09 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01A-11D-A12R-05 0db7dee4-ca2e-4f47-a9bc-5e55ca0df269 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01A-11D-A12Q-09 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01A-11D-A12Q-09 e7b64cc3-9b2b-4938-9896-84b640d1586f TCGA-AR-A1AS-01A-11D-A12N-01 TCGA-AR-A1AS-01 TCGA-AR-A1AS-01A-11R-A12P-07 e7b64cc3-9b2b-4938-9896-84b640d1586f TCGA-AR-A1AS-01A-11D-A12N-01 TCGA-AR-A1AS-01 TCGA-AR-A1AT-01 Stage II 62 Stage IIA 1272 Positive FEMALE Positive Negative M0 Negative N0 1272 1 HER2-enriched Positive Her2 -11 -5 enrollment T_Other T2 DECEASED TCGA-AR-A1AT-01 cluster 1 BRCA CIMP c7 BRCA basal-like c6 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A1AT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AT-F22148 TCGA-AR-A1AT TCGA-AR-A1AT-01A Positive Positive Other YES -22942 1339 1272 0 <10% Scheduled Follow-up Submission 2012-3-1 FEMALE 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 250 NO Positive 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 1 true No M0 N0 T2 Stage IIA TCGA-AR-A1AT.D52A6E4B-C80A-4947-96FE-3295E418EC67.pdf A1AT YES <10% YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A DECEASED 2007 e70e1882-b4be-4ed6-9c2d-4e8c84fde633 e70e1882-b4be-4ed6-9c2d-4e8c84fde633 TCGA-AR-A1AT-01A-21-A13E-20 TCGA-AR-A1AT-01A-11D-A12Q-09 TCGA-AR-A1AT-01 TCGA-AR-A1AT-01A-11D-A12R-05 6605222f-3dc9-4a93-987e-a8720dc38b32 TCGA-AR-A1AT-01A-11D-A12Q-09 TCGA-AR-A1AT-01 TCGA-AR-A1AT-01A-11D-A12Q-09 e70e1882-b4be-4ed6-9c2d-4e8c84fde633 TCGA-AR-A1AT-01 TCGA-AR-A1AT-01A-11R-A12P-07 e70e1882-b4be-4ed6-9c2d-4e8c84fde633 TCGA-AR-A1AT-01 TCGA-AR-A1AU-01 Stage III 39 4 Stage IIIA 1409 Positive FEMALE Negative 3 4 3 Negative M0 Positive N2 1409 0 LumA Luminal A Positive ReacI -3 -7 enrollment T_Other T2 LIVING TCGA-AR-A1AU-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-AR-A1AU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Right Upper Inner Quadrant|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AU-F71744 TCGA-AR-A1AU TCGA-AR-A1AU-01A Positive Positive Other -14564 1317 0 2868 70-79% Scheduled Follow-up Submission 2015-3-30 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 260 NO Equivocal Negative NO 37 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 4 true No M0 N2 T2 Stage IIIA TCGA-AR-A1AU.5654FC27-47D3-4C7F-A0E7-A5B6140991C2.pdf A1AU TUMOR FREE YES YES 70-79% YES Primary Tumor 01 Total Mastectomy 6th YES NO YES AR Breast A LIVING 2007 bb07b646-1dcc-4cf5-9aae-1df150e84a84 bb07b646-1dcc-4cf5-9aae-1df150e84a84 TCGA-AR-A1AU-01A-21-A13E-20 TCGA-AR-A1AU-01A-11D-A12Q-09 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01A-11D-A12R-05 48cc7955-160a-4e19-aafc-4fad203a9082 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01A-11D-A12Q-09 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01A-11D-A12Q-09 bb07b646-1dcc-4cf5-9aae-1df150e84a84 TCGA-AR-A1AU-01A-11D-A12N-01 TCGA-AR-A1AU-01 TCGA-AR-A1AU-01A-11R-A12P-07 bb07b646-1dcc-4cf5-9aae-1df150e84a84 TCGA-AR-A1AU-01A-11D-A12N-01 TCGA-AR-A1AU-01 TCGA-AR-A1AV-01 Stage II 68 3 Stage IIB 1295 Positive MALE Negative 4 5 4 Negative M0 Positive N1 1295 0 LumA Luminal B Positive LumA/B -2 -5 enrollment T_Other T2 LIVING TCGA-AR-A1AV-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-AR-A1AV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Axillary lymph node dissection alone TCGA-AR-A1AV-F49475 TCGA-AR-A1AV TCGA-AR-A1AV-01A Positive Positive Modified Radical Mastectomy -24875 1233 0 1864 70-79% Scheduled Follow-up Submission 2013-10-2 MALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 420 NO Negative NO 25 Negative 3 7 NO 1 true No M0 N1 T2 Stage IIB TCGA-AR-A1AV.5AD5B38F-5CC1-4A2F-96E6-F344D8FE0149.pdf A1AV TUMOR FREE YES YES 70-79% YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2007 dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a TCGA-AR-A1AV-01A-31-A13E-20 TCGA-AR-A1AV-01A-21D-A12Q-09 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01A-21D-A12R-05 9432773f-696b-4104-9232-c6e6a6a379c2 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01A-21D-A12Q-09 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01A-21D-A12Q-09 dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a TCGA-AR-A1AV-01A-21D-A12N-01 TCGA-AR-A1AV-01 TCGA-AR-A1AV-01A-21R-A12P-07 dddfaed8-0d0e-42ba-9add-fae3cc1e5a9a TCGA-AR-A1AV-01A-21D-A12N-01 TCGA-AR-A1AV-01 TCGA-AR-A1AW-01 Stage II 65 3 Stage IIA 1072 Positive FEMALE Negative 2 2 3 Negative M0 Negative N0 1072 0 LumB Luminal A Positive ReacII -12 -3 enrollment T_Other T2 LIVING TCGA-AR-A1AW-01 High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 3 TCGA-AR-A1AW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AW-F71714 TCGA-AR-A1AW TCGA-AR-A1AW-01A Positive Positive Lumpectomy YES -23855 1157 0 2632 70-79% Scheduled Follow-up Submission 2015-3-30 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 800 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 3 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A1AW.BB485405-199C-48C7-96D7-8C315DEA66B4.pdf A1AW TUMOR FREE YES YES 70-79% YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2007 cff4a5bc-ba2b-47d6-8d36-6277ae991606 cff4a5bc-ba2b-47d6-8d36-6277ae991606 TCGA-AR-A1AW-01A-11-A13E-20 TCGA-AR-A1AW-01A-21D-A12Q-09 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01A-21D-A12R-05 15e9c25c-1736-4fed-9c7f-5a2f86ee7248 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01A-21D-A12Q-09 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01A-21D-A12Q-09 cff4a5bc-ba2b-47d6-8d36-6277ae991606 TCGA-AR-A1AW-01A-21D-A12N-01 TCGA-AR-A1AW-01 TCGA-AR-A1AW-01A-21R-A12P-07 cff4a5bc-ba2b-47d6-8d36-6277ae991606 TCGA-AR-A1AW-01A-21D-A12N-01 TCGA-AR-A1AW-01 TCGA-AR-A1AX-01 Stage I 64 4 Stage I 1103 Positive FEMALE Positive 3 1 3 Negative M0 Negative N0 1103 0 LumA Luminal A Positive ReacII 0 -5 enrollment T1 T1 LIVING TCGA-AR-A1AX-01 Squamous C5-KIRC cluster 5 Low purity c2 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-AR-A1AX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AX-F71720 TCGA-AR-A1AX TCGA-AR-A1AX-01A Positive Positive Other YES -23507 1140 0 2629 Scheduled Follow-up Submission 2015-3-30 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 340 NO Positive NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A1AX.4FDBA110-6E14-428C-BF82-168AE28A14E4.pdf A1AX TUMOR FREE YES YES 70-79% YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 66626142-7c5c-4ed0-8ef0-f4133423f275 66626142-7c5c-4ed0-8ef0-f4133423f275 TCGA-AR-A1AX-01A-21-A13E-20 TCGA-AR-A1AX-01A-11D-A12Q-09 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01A-11D-A12R-05 f30b231a-6dd9-4ae5-a0d4-34056bcbd5f8 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01A-11D-A12Q-09 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01A-11D-A12Q-09 66626142-7c5c-4ed0-8ef0-f4133423f275 TCGA-AR-A1AX-01A-11D-A12N-01 TCGA-AR-A1AX-01 TCGA-AR-A1AX-01A-11R-A12P-07 66626142-7c5c-4ed0-8ef0-f4133423f275 TCGA-AR-A1AX-01A-11D-A12N-01 TCGA-AR-A1AX-01 TCGA-AR-A1AY-01 Stage I 65 1 Stage I 614 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 614 0 Basal Basal-like Negative Basal -13 -12 enrollment T1 T1 LIVING TCGA-AR-A1AY-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-AR-A1AY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A1AY-F49482 TCGA-AR-A1AY TCGA-AR-A1AY-01A Negative Negative Other YES -23927 1085 0 1026 Scheduled Follow-up Submission 2013-10-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 110 NO Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A1AY.01D97550-C616-4001-85A5-5502D35FA38E.pdf A1AY TUMOR FREE YES YES YES Primary Tumor 01 Wide Local Excision 6th YES NO YES AR Breast A LIVING 2008 49c4166c-701a-4f53-8968-99aec3347214 49c4166c-701a-4f53-8968-99aec3347214 TCGA-AR-A1AY-01A-11-A13E-20 TCGA-AR-A1AY-01A-21D-A12Q-09 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01A-21D-A12R-05 1815b916-4da0-4ada-9774-7231a10c6862 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01A-21D-A12Q-09 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01A-21D-A12Q-09 49c4166c-701a-4f53-8968-99aec3347214 TCGA-AR-A1AY-01A-21D-A12N-01 TCGA-AR-A1AY-01 TCGA-AR-A1AY-01A-21R-A12P-07 49c4166c-701a-4f53-8968-99aec3347214 TCGA-AR-A1AY-01A-21D-A12N-01 TCGA-AR-A1AY-01 TCGA-AR-A24H-01 Stage II 65 2 Stage IIA 3333 Positive FEMALE Negative Negative M0 Negative N0 3333 0 LumB Positive enrollment T_Other T2 LIVING TCGA-AR-A24H-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 13 mutation c1uster 9 TCGA-AR-A24H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Lower Inner Quadrant|Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24H-F65797 TCGA-AR-A24H Positive Positive Other -24046 0 4894 Scheduled Follow-up Submission 2014-9-30 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 0 No M0 N0 T2 Stage IIA A24H TUMOR FREE YES YES YES Primary Tumor 01 Excision 5th YES NO YES AR Breast LIVING 2001 a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c TCGA-AR-A24H-01A-11D-A167-09 TCGA-AR-A24H-01 TCGA-AR-A24H-01A-11D-A16A-05 TCGA-AR-A24H-01 TCGA-AR-A24H-01A-11D-A167-09 TCGA-AR-A24H-01 TCGA-AR-A24H-01A-11D-A167-09 a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c TCGA-AR-A24H-01A-11D-A166-01 TCGA-AR-A24H-01 a4ae2bc2-bc93-4f5c-aef7-730eb0e2ba0c TCGA-AR-A24H-01A-11D-A166-01 TCGA-AR-A24K-01 Stage II 46 3 Stage IIA 1548 Positive FEMALE Negative Negative M0 Negative N0 1548 0 LumB Positive enrollment T_Other T2 LIVING TCGA-AR-A24K-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 mutation cluster 3 TCGA-AR-A24K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24K-F49485 TCGA-AR-A24K TCGA-AR-A24K-01A Positive Positive Other YES -16961 2325 0 1548 No value Given 10-19% Scheduled Follow-up Submission 2013-10-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Equivocal Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A24K.BC7B3577-CA6C-41AD-98E2-89D357D29D37.pdf A24K TUMOR FREE YES YES 10-19% YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2004 e3008c10-aa31-40ef-ad50-77fd8ec7a1a9 e3008c10-aa31-40ef-ad50-77fd8ec7a1a9 TCGA-AR-A24K-01A-21-A17I-20 TCGA-AR-A24K-01A-11D-A167-09 TCGA-AR-A24K-01 TCGA-AR-A24K-01A-11D-A16A-05 6308773f-3789-47c1-8254-eaf5f9801868 TCGA-AR-A24K-01 TCGA-AR-A24K-01A-11D-A167-09 TCGA-AR-A24K-01 TCGA-AR-A24K-01A-11D-A167-09 e3008c10-aa31-40ef-ad50-77fd8ec7a1a9 TCGA-AR-A24K-01A-11D-A166-01 TCGA-AR-A24K-01 e3008c10-aa31-40ef-ad50-77fd8ec7a1a9 TCGA-AR-A24K-01A-11D-A166-01 TCGA-AR-A24L-01 Stage II 26 5 Stage IIB 2221 Positive FEMALE Negative Negative M0 Positive N1 2221 0 LumA Positive enrollment T_Other T2 LIVING TCGA-AR-A24L-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A24L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 26 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24L-F49488 TCGA-AR-A24L Positive Positive Other -9706 2866 0 2221 1414 10-19% Scheduled Follow-up Submission 2013-10-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative NO 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 Locoregional Disease YES 2 No M0 N1 T2 Stage IIB A24L WITH TUMOR YES YES 10-19% YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast DECEASED 2005 bfa78a45-16bf-410a-816d-bd369ded91e5 bfa78a45-16bf-410a-816d-bd369ded91e5 TCGA-AR-A24L-01A-21-A17I-20 TCGA-AR-A24L-01A-11D-A167-09 TCGA-AR-A24L-01 TCGA-AR-A24L-01A-11D-A16A-05 e1bd54aa-7e28-47ce-98fb-95593ee07f96 TCGA-AR-A24L-01 TCGA-AR-A24L-01A-11D-A167-09 TCGA-AR-A24L-01 TCGA-AR-A24L-01A-11D-A167-09 bfa78a45-16bf-410a-816d-bd369ded91e5 TCGA-AR-A24L-01A-11D-A166-01 TCGA-AR-A24L-01 bfa78a45-16bf-410a-816d-bd369ded91e5 TCGA-AR-A24L-01A-11D-A166-01 TCGA-AR-A24M-01 Stage III 38 3 Stage IIIA 1990 Positive FEMALE Negative Negative M0 Positive N2 1990 0 LumA Positive enrollment T_Other T2 LIVING TCGA-AR-A24M-01 Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-AR-A24M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24M-F71732 TCGA-AR-A24M TCGA-AR-A24M-01A Positive Positive Other -14119 2245 0 3660 10-19% Scheduled Follow-up Submission 2015-3-30 FEMALE 1+ Mixed Histology (please specify) Mixed invasive ductal and invasive lobular No C50.9 8522/3 C50.9 YES Core needle biopsy 400 NO Negative NO 28 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 7 NO 4 true No M0 N2 T2 Stage IIIA TCGA-AR-A24M.56DFBCCE-A9D9-4F08-AC7E-33998F3439B2.pdf A24M TUMOR FREE YES YES 10-19% YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2005 4977200c-765d-475f-8df4-bf8d9a3b0aa9 4977200c-765d-475f-8df4-bf8d9a3b0aa9 TCGA-AR-A24M-01A-21-A17I-20 TCGA-AR-A24M-01A-11D-A167-09 TCGA-AR-A24M-01 TCGA-AR-A24M-01A-11D-A16A-05 8728cab4-4860-4753-aa84-05f91f245005 TCGA-AR-A24M-01 TCGA-AR-A24M-01A-11D-A167-09 TCGA-AR-A24M-01 TCGA-AR-A24M-01A-11D-A167-09 4977200c-765d-475f-8df4-bf8d9a3b0aa9 TCGA-AR-A24M-01A-11D-A166-01 TCGA-AR-A24M-01 4977200c-765d-475f-8df4-bf8d9a3b0aa9 TCGA-AR-A24M-01A-11D-A166-01 TCGA-AR-A24N-01 Stage I 54 2 Stage I 2074 Positive FEMALE Negative Negative M0 Negative N0 2074 0 LumB Positive enrollment T1 T1 LIVING TCGA-AR-A24N-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 3 mutation c1uster 9 TCGA-AR-A24N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24N-F71723 TCGA-AR-A24N TCGA-AR-A24N-01A Positive Positive Simple Mastectomy YES -19989 2219 0 3035 10-19% Scheduled Follow-up Submission 2015-3-30 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 310 NO Equivocal Negative NO 4 Negative Peri (6-12 months since last menstrual period) 3 3 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A24N.AAF32BB7-716A-4C0E-AE7E-04F6A5BF5628.pdf A24N TUMOR FREE NO YES 10-19% NO Primary Tumor 01 6th NO NO YES AR Breast A LIVING 2005 48bf0fa5-66c2-495d-93ef-943bc7ff31ac 48bf0fa5-66c2-495d-93ef-943bc7ff31ac TCGA-AR-A24N-01A-21-A17I-20 TCGA-AR-A24N-01A-11D-A167-09 TCGA-AR-A24N-01 TCGA-AR-A24N-01A-11D-A16A-05 90813751-60f8-4e79-bfd3-1f363203a029 TCGA-AR-A24N-01 TCGA-AR-A24N-01A-11D-A167-09 TCGA-AR-A24N-01 TCGA-AR-A24N-01A-11D-A167-09 48bf0fa5-66c2-495d-93ef-943bc7ff31ac TCGA-AR-A24N-01A-11D-A166-01 TCGA-AR-A24N-01 48bf0fa5-66c2-495d-93ef-943bc7ff31ac TCGA-AR-A24N-01A-11D-A166-01 TCGA-AR-A24O-01 Stage III 43 2 Stage IIIA 1997 Positive FEMALE Negative Negative M0 Positive N2 1997 0 LumA Positive enrollment T_Other T3 LIVING TCGA-AR-A24O-01 Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-AR-A24O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left TCGA-AR-A24O-F71713 TCGA-AR-A24O TCGA-AR-A24O-01A Negative Positive Mastectomy NOS Positive Modified Radical Mastectomy -15977 2213 0 3607 2561 Scheduled Follow-up Submission 2015-3-30 FEMALE Mixed Histology (please specify) Lobular carcinoma with ductal features No C50.9 8522/3 C50.9 YES Incisional Biopsy 700 NO Negative NO 19 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 7 YES 7 true No M0 N2 T3 Stage IIIA TCGA-AR-A24O.887F0E3A-DC70-4CD4-AAAF-3C613195D895.pdf A24O WITH TUMOR YES YES YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2005 2cd8167d-d35f-43e8-927f-cd7decebd9cf 2cd8167d-d35f-43e8-927f-cd7decebd9cf TCGA-AR-A24O-01A-21-A17I-20 TCGA-AR-A24O-01A-11D-A167-09 TCGA-AR-A24O-01 TCGA-AR-A24O-01A-11D-A16A-05 c364acc4-6658-4deb-97ff-a367022c6958 TCGA-AR-A24O-01 TCGA-AR-A24O-01A-11D-A167-09 TCGA-AR-A24O-01 TCGA-AR-A24O-01A-11D-A167-09 2cd8167d-d35f-43e8-927f-cd7decebd9cf TCGA-AR-A24O-01A-11D-A166-01 TCGA-AR-A24O-01 2cd8167d-d35f-43e8-927f-cd7decebd9cf TCGA-AR-A24O-01A-11D-A166-01 TCGA-AR-A24P-01 Stage I 47 2 Stage I 26 Positive FEMALE Negative Negative M0 Negative N0 26 0 LumA Positive enrollment T1 T1 LIVING TCGA-AR-A24P-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-AR-A24P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24P-F31403 TCGA-AR-A24P TCGA-AR-A24P-01A Positive Positive Other YES -17490 2161 0 84 10-19% Scheduled Follow-up Submission 2012-5-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 130 NO Equivocal Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A24P.0BF7CB67-49F1-42EA-8B41-988BD7E0DE61.pdf A24P YES 10-19% Primary Tumor 01 Wide local excision 6th NO YES AR Breast A LIVING 2005 49bdbb64-75a8-4a30-bde6-57f3c2a38f9b 49bdbb64-75a8-4a30-bde6-57f3c2a38f9b TCGA-AR-A24P-01A-21-A17I-20 TCGA-AR-A24P-01A-11D-A167-09 TCGA-AR-A24P-01 TCGA-AR-A24P-01A-11D-A16A-05 085b7387-61df-4f55-a320-72c165bf8647 TCGA-AR-A24P-01 TCGA-AR-A24P-01A-11D-A167-09 TCGA-AR-A24P-01 TCGA-AR-A24P-01A-11D-A167-09 49bdbb64-75a8-4a30-bde6-57f3c2a38f9b TCGA-AR-A24P-01A-11D-A166-01 TCGA-AR-A24P-01 49bdbb64-75a8-4a30-bde6-57f3c2a38f9b TCGA-AR-A24P-01A-11D-A166-01 TCGA-AR-A24Q-01 Stage II 49 1 Stage IIB 2008 Positive FEMALE Negative Negative M0 Negative N0 2008 0 Basal Negative enrollment T_Other T3 LIVING TCGA-AR-A24Q-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA c1uster 9 cluster 6 mutation cluster 2 TCGA-AR-A24Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24Q-F65802 TCGA-AR-A24Q TCGA-AR-A24Q-01A Positive Negative Simple Mastectomy -18084 1932 0 3172 <10% Scheduled Follow-up Submission 2014-9-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 590 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 NO 0 true No M0 N0 T3 Stage IIB TCGA-AR-A24Q.CCE8E855-2582-4214-B9B1-25F0431065CB.pdf A24Q TUMOR FREE YES YES YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2006 72c34d2c-f255-492b-9249-e9e9c506ece2 72c34d2c-f255-492b-9249-e9e9c506ece2 TCGA-AR-A24Q-01A-21-A17I-20 TCGA-AR-A24Q-01A-12D-A167-09 TCGA-AR-A24Q-01 TCGA-AR-A24Q-01A-12D-A16A-05 f39fe8fb-2c5e-403b-aceb-bd9604f1a25e TCGA-AR-A24Q-01 TCGA-AR-A24Q-01A-12D-A167-09 TCGA-AR-A24Q-01 TCGA-AR-A24Q-01A-12D-A167-09 72c34d2c-f255-492b-9249-e9e9c506ece2 TCGA-AR-A24Q-01A-12D-A166-01 TCGA-AR-A24Q-01 72c34d2c-f255-492b-9249-e9e9c506ece2 TCGA-AR-A24Q-01A-12D-A166-01 TCGA-AR-A24R-01 Stage III 45 5 Stage IIIA 1745 Positive FEMALE Negative Negative M0 Positive N2 1745 0 LumB Positive enrollment T1 T1 LIVING TCGA-AR-A24R-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-AR-A24R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Upper Inner Quadrant|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24R-F71731 TCGA-AR-A24R TCGA-AR-A24R-01A Positive Positive Other -16642 1913 0 3430 10-19% Scheduled Follow-up Submission 2015-3-30 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 300 NO Negative Negative NO 28 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 5 NO 6 true No M0 N2 T1 Stage IIIA TCGA-AR-A24R.C3259BD1-1A2A-40C4-A106-FA2EF0201811.pdf A24R TUMOR FREE YES YES 10-19% YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 401721b2-a1d1-46d3-b73c-ec06df30d61e 401721b2-a1d1-46d3-b73c-ec06df30d61e TCGA-AR-A24R-01A-21-A17I-20 TCGA-AR-A24R-01A-11D-A167-09 TCGA-AR-A24R-01 TCGA-AR-A24R-01A-11D-A16A-05 1734096f-0942-4abe-acb4-cd6e183080c0 TCGA-AR-A24R-01 TCGA-AR-A24R-01A-11D-A167-09 TCGA-AR-A24R-01 TCGA-AR-A24R-01A-11D-A167-09 401721b2-a1d1-46d3-b73c-ec06df30d61e TCGA-AR-A24R-01A-11D-A166-01 TCGA-AR-A24R-01 401721b2-a1d1-46d3-b73c-ec06df30d61e TCGA-AR-A24R-01A-11D-A166-01 TCGA-AR-A24S-01 Stage I 61 1 Stage I 1888 Positive FEMALE Negative Negative M0 Negative N0 1888 0 LumB Positive enrollment T1 T1 LIVING TCGA-AR-A24S-01 Squamous C3-BRCA/Luminal cluster 2 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-AR-A24S TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24S-F31496 TCGA-AR-A24S TCGA-AR-A24S-01A Positive Positive Other YES -22587 1812 0 2976 70-79% Scheduled Follow-up Submission 2012-5-4 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 520 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A24S.C0A8A457-8790-4745-BD5D-AFBE55254A1C.pdf A24S YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 3795f6d6-3a1d-4b41-8a4b-e832078e9d48 3795f6d6-3a1d-4b41-8a4b-e832078e9d48 TCGA-AR-A24S-01A-21-A17I-20 TCGA-AR-A24S-01A-11D-A167-09 TCGA-AR-A24S-01 TCGA-AR-A24S-01A-11D-A16A-05 9e00e8b9-5977-4a9c-aef4-c9f3e8007475 TCGA-AR-A24S-01 TCGA-AR-A24S-01A-11D-A167-09 TCGA-AR-A24S-01 TCGA-AR-A24S-01A-11D-A167-09 3795f6d6-3a1d-4b41-8a4b-e832078e9d48 TCGA-AR-A24S-01A-11D-A166-01 TCGA-AR-A24S-01 3795f6d6-3a1d-4b41-8a4b-e832078e9d48 TCGA-AR-A24S-01A-11D-A166-01 TCGA-AR-A24T-01 Stage III 46 2 Stage IIIC 1620 Positive FEMALE Negative Negative M0 Positive N3 1620 0 LumA Positive enrollment T_Other T3 LIVING TCGA-AR-A24T-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AR-A24T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24T-F71728 TCGA-AR-A24T TCGA-AR-A24T-01A Positive Positive Simple Mastectomy -17135 1786 0 3202 10-19% Scheduled Follow-up Submission 2015-3-30 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 490 NO Equivocal Negative NO 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 2 NO 15 true No M0 N3 T3 Stage IIIC TCGA-AR-A24T.226031B3-D9C2-4343-B3F7-4E0C36B901E7.pdf A24T TUMOR FREE YES YES 10-19% YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2006 d2e1fdf7-1ac9-49e9-a611-b15c90772bf6 d2e1fdf7-1ac9-49e9-a611-b15c90772bf6 TCGA-AR-A24T-01A-21-A17I-20 TCGA-AR-A24T-01A-11D-A167-09 TCGA-AR-A24T-01 TCGA-AR-A24T-01A-11D-A16A-05 7c08cdc2-f620-4ba3-9a66-37bd23d75d3e TCGA-AR-A24T-01 TCGA-AR-A24T-01A-11D-A167-09 TCGA-AR-A24T-01 TCGA-AR-A24T-01A-11D-A167-09 d2e1fdf7-1ac9-49e9-a611-b15c90772bf6 TCGA-AR-A24T-01A-11D-A166-01 TCGA-AR-A24T-01 d2e1fdf7-1ac9-49e9-a611-b15c90772bf6 TCGA-AR-A24T-01A-11D-A166-01 TCGA-AR-A24U-01 Stage II 47 4 Stage IIA 1623 Negative FEMALE Positive Negative M0 Positive N1 1623 0 Her2 Negative enrollment T1 T1 LIVING TCGA-AR-A24U-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation c1uster 9 TCGA-AR-A24U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24U-F71738 TCGA-AR-A24U TCGA-AR-A24U-01A Negative Negative Mastectomy NOS Negative Simple Mastectomy -17523 1763 0 3128 Scheduled Follow-up Submission 2015-3-30 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 320 NO Positive NO 25 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 7 NO 2 true No M0 N1 T1 Stage IIA TCGA-AR-A24U.B481795F-C52C-4FCE-827A-07991C7A7C2E.pdf A24U TUMOR FREE YES YES YES Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2006 296c69de-2b77-4b3a-a228-9552a8a9836e 296c69de-2b77-4b3a-a228-9552a8a9836e TCGA-AR-A24U-01A-21-A17I-20 TCGA-AR-A24U-01A-11D-A167-09 TCGA-AR-A24U-01 TCGA-AR-A24U-01A-11D-A16A-05 c0592373-1465-46d8-984a-2c02e0c53cfc TCGA-AR-A24U-01 TCGA-AR-A24U-01A-11D-A167-09 TCGA-AR-A24U-01 TCGA-AR-A24U-01A-11D-A167-09 296c69de-2b77-4b3a-a228-9552a8a9836e TCGA-AR-A24U-01A-11D-A166-01 TCGA-AR-A24U-01 296c69de-2b77-4b3a-a228-9552a8a9836e TCGA-AR-A24U-01A-11D-A166-01 TCGA-AR-A24V-01 Stage II 52 5 Stage IIB 1648 Positive FEMALE Negative Negative M0 Positive N1 1648 0 LumA Positive enrollment T_Other T2 LIVING TCGA-AR-A24V-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A24V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24V-F71740 TCGA-AR-A24V TCGA-AR-A24V-01A Positive Positive Other YES -19027 1720 0 3203 80-89% Scheduled Follow-up Submission 2015-3-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 400 NO Negative NO 2 Negative Peri (6-12 months since last menstrual period) 4 4 NO 1 true No M0 N1 T2 Stage IIB TCGA-AR-A24V.468CD293-C9F7-43C6-A40A-18FCDD22F6AA.pdf A24V TUMOR FREE YES YES <10% YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 29b04717-c5f2-4d4c-b006-e5c5f0aade7a 29b04717-c5f2-4d4c-b006-e5c5f0aade7a TCGA-AR-A24V-01A-11-A17I-20 TCGA-AR-A24V-01A-21D-A167-09 TCGA-AR-A24V-01 TCGA-AR-A24V-01A-21D-A16A-05 38c6af12-c50f-4dbe-8130-0b737b29390a TCGA-AR-A24V-01 TCGA-AR-A24V-01A-21D-A167-09 TCGA-AR-A24V-01 TCGA-AR-A24V-01A-21D-A167-09 29b04717-c5f2-4d4c-b006-e5c5f0aade7a TCGA-AR-A24V-01A-21D-A166-01 TCGA-AR-A24V-01 29b04717-c5f2-4d4c-b006-e5c5f0aade7a TCGA-AR-A24V-01A-21D-A166-01 TCGA-AR-A24W-01 3 LumA TCGA-AR-A24W-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-AR-A24W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24W-F49476 TCGA-AR-A24W Positive Positive Other -20123 0 991 Scheduled Follow-up Submission 2013-10-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 3 No M0 N1 T2 Stage IIB A24W TUMOR FREE YES YES NO Primary Tumor 01 Total Mastectomy 6th YES NO YES AR Breast LIVING 2006 a2f3fd7f-9a5d-44aa-8810-4978abad6e12 a2f3fd7f-9a5d-44aa-8810-4978abad6e12 TCGA-AR-A24W-01A-21-A17I-20 TCGA-AR-A24W-01A-11D-A17G-09 TCGA-AR-A24W-01 TCGA-AR-A24W-01A-11D-A16A-05 bb6402d2-2bc7-461a-8143-4e6939bb6813 TCGA-AR-A24W-01 TCGA-AR-A24W-01A-11D-A17G-09 TCGA-AR-A24W-01 TCGA-AR-A24W-01A-11D-A17G-09 a2f3fd7f-9a5d-44aa-8810-4978abad6e12 TCGA-AR-A24W-01A-11D-A166-01 TCGA-AR-A24W-01 a2f3fd7f-9a5d-44aa-8810-4978abad6e12 TCGA-AR-A24W-01A-11D-A166-01 TCGA-AR-A24X-01 Stage II 52 2 Stage IIA 1465 Positive FEMALE Negative Negative M0 Negative N0 1465 0 LumA Positive enrollment T_Other T2 LIVING TCGA-AR-A24X-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-AR-A24X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24X-F71741 TCGA-AR-A24X TCGA-AR-A24X-01A Positive Positive Simple Mastectomy YES -19030 1717 0 3004 80-89% Scheduled Follow-up Submission 2015-3-30 FEMALE 2+ Mixed Histology (please specify) Mixed invasive ductal and invasive lobular No C50.9 8522/3 C50.9 YES Core needle biopsy 210 NO Equivocal Negative NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 2 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A24X.B537A19C-C7E8-42EB-BA3F-673417F3A9BA.pdf A24X TUMOR FREE YES YES 90-99% NO Primary Tumor 01 6th YES NO YES AR Breast A LIVING 2006 42a7e579-365d-4393-8b98-e4516863299e 42a7e579-365d-4393-8b98-e4516863299e TCGA-AR-A24X-01A-21-A17I-20 TCGA-AR-A24X-01A-11D-A167-09 TCGA-AR-A24X-01 TCGA-AR-A24X-01A-11D-A16A-05 44e1a92c-dabb-4fdb-936c-bd1dfb2719ac TCGA-AR-A24X-01 TCGA-AR-A24X-01A-11D-A167-09 TCGA-AR-A24X-01 TCGA-AR-A24X-01A-11D-A167-09 42a7e579-365d-4393-8b98-e4516863299e TCGA-AR-A24X-01A-11D-A166-01 TCGA-AR-A24X-01 42a7e579-365d-4393-8b98-e4516863299e TCGA-AR-A24X-01A-11D-A166-01 TCGA-AR-A24Z-01 Stage II 57 3 Stage IIA 1574 Positive FEMALE Negative Negative M0 Negative N0 1574 0 LumB Positive enrollment T_Other T2 LIVING TCGA-AR-A24Z-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 mutation c1uster 9 TCGA-AR-A24Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A24Z-F71743 TCGA-AR-A24Z TCGA-AR-A24Z-01A Positive Positive Other YES -20900 1673 0 3001 Scheduled Follow-up Submission 2015-3-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A24Z.AD07F611-0EEA-4890-A02C-6DA3F5F57C45.pdf A24Z TUMOR FREE YES YES NO Primary Tumor 01 Total mastectomy 6th YES NO YES AR Breast A LIVING 2006 8d0d1eea-9e60-4507-8cfa-1fac66edc8a4 8d0d1eea-9e60-4507-8cfa-1fac66edc8a4 TCGA-AR-A24Z-01A-21-A17I-20 TCGA-AR-A24Z-01A-11D-A167-09 TCGA-AR-A24Z-01 TCGA-AR-A24Z-01A-11D-A16A-05 93fa3c81-01ce-4073-811d-146d1ef739ac TCGA-AR-A24Z-01 TCGA-AR-A24Z-01A-11D-A167-09 TCGA-AR-A24Z-01 TCGA-AR-A24Z-01A-11D-A167-09 8d0d1eea-9e60-4507-8cfa-1fac66edc8a4 TCGA-AR-A24Z-01A-11D-A166-01 TCGA-AR-A24Z-01 8d0d1eea-9e60-4507-8cfa-1fac66edc8a4 TCGA-AR-A24Z-01A-11D-A166-01 TCGA-AR-A250-01 Stage II 58 3 Stage IIA 1707 Positive FEMALE Positive Negative M0 Negative N0 1707 0 LumB Negative enrollment T_Other T2 LIVING TCGA-AR-A250-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-AR-A250 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A250-F65794 TCGA-AR-A250 TCGA-AR-A250-01A Negative Positive Mastectomy NOS Negative Other -21309 1629 0 2707 70-79% 2014-9-30 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 300 NO Equivocal Positive NO 4 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A250.16BE833B-E17B-4B8A-9D71-B0D83D73D9DE.pdf A250 TUMOR FREE YES YES NO Primary Tumor 01 Wide local excision and simple mastectomy 6th YES NO YES AR Breast A LIVING 2006 86373f83-264a-4875-8672-749ea434422f 86373f83-264a-4875-8672-749ea434422f TCGA-AR-A250-01A-41-A17I-20 TCGA-AR-A250-01A-31D-A167-09 TCGA-AR-A250-01 TCGA-AR-A250-01A-31D-A16A-05 1c3c4e67-cd5b-42b6-9cd8-5f18356a8e80 TCGA-AR-A250-01 TCGA-AR-A250-01A-31D-A167-09 TCGA-AR-A250-01 TCGA-AR-A250-01A-31D-A167-09 86373f83-264a-4875-8672-749ea434422f TCGA-AR-A250-01A-31D-A166-01 TCGA-AR-A250-01 86373f83-264a-4875-8672-749ea434422f TCGA-AR-A250-01A-31D-A166-01 TCGA-AR-A251-01 Stage III 51 1 Stage IIIA 1373 Positive FEMALE Negative Negative M0 Positive N2 1373 0 Basal Negative enrollment T_Other T2 LIVING TCGA-AR-A251-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 7 mutation c1uster 9 TCGA-AR-A251 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A251-F71716 TCGA-AR-A251 TCGA-AR-A251-01A Negative Positive Mastectomy NOS Negative Other -18771 1611 0 3030 Scheduled Follow-up Submission 2015-3-30 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 450 NO Equivocal Negative NO 7 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 NO 4 true No M0 N2 T2 Stage IIIA TCGA-AR-A251.F5B17108-8904-48E7-9B3D-182F0EA388B7.pdf A251 TUMOR FREE YES YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2006 06760907-c6ec-4b72-bfd4-87811823b8ba 06760907-c6ec-4b72-bfd4-87811823b8ba TCGA-AR-A251-01A-21-A17I-20 TCGA-AR-A251-01A-12D-A167-09 TCGA-AR-A251-01 TCGA-AR-A251-01A-12D-A16A-05 4378eaf7-993d-40b3-ab7f-1a909c768a47 TCGA-AR-A251-01 TCGA-AR-A251-01A-12D-A167-09 TCGA-AR-A251-01 TCGA-AR-A251-01A-12D-A167-09 06760907-c6ec-4b72-bfd4-87811823b8ba TCGA-AR-A251-01A-12D-A166-01 TCGA-AR-A251-01 06760907-c6ec-4b72-bfd4-87811823b8ba TCGA-AR-A251-01A-12D-A166-01 TCGA-AR-A252-01 Stage I 50 3 Stage I 1236 Positive FEMALE Negative Negative M0 Negative N0 1236 0 LumA Positive enrollment T1 T1 LIVING TCGA-AR-A252-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-AR-A252 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Outer Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A252-F71727 TCGA-AR-A252 TCGA-AR-A252-01A Positive Positive Other YES -18611 1405 0 2838 70-79% Scheduled Follow-up Submission 2015-3-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 480 NO Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 1 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A252.8C52C92F-26CA-4E72-BE47-CA2ED1746785.pdf A252 TUMOR FREE YES YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 f325c7a8-46b0-4d75-9228-db391c270c71 f325c7a8-46b0-4d75-9228-db391c270c71 TCGA-AR-A252-01A-21-A17I-20 TCGA-AR-A252-01A-11D-A167-09 TCGA-AR-A252-01 TCGA-AR-A252-01A-11D-A16A-05 8fd7447f-07c3-4bd3-a877-7bf96db17d03 TCGA-AR-A252-01 TCGA-AR-A252-01A-11D-A167-09 TCGA-AR-A252-01 TCGA-AR-A252-01A-11D-A167-09 f325c7a8-46b0-4d75-9228-db391c270c71 TCGA-AR-A252-01A-11D-A166-01 TCGA-AR-A252-01 f325c7a8-46b0-4d75-9228-db391c270c71 TCGA-AR-A252-01A-11D-A166-01 TCGA-AR-A254-01 Stage III 50 3 Stage IIIA 1212 Positive FEMALE Positive Negative M0 Positive N2 1212 0 Her2 Positive enrollment T_Other T2 LIVING TCGA-AR-A254-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 5 TCGA-AR-A254 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Inner Quadrant|Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A254-F71726 TCGA-AR-A254 TCGA-AR-A254-01A Positive Positive Other -18270 1381 0 2605 Scheduled Follow-up Submission 2015-3-30 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Wide local incision Other method, specify: 990 NO Positive NO 30 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 9 true No M0 N2 T2 Stage IIIA TCGA-AR-A254.C026CFCE-1A82-446D-AC78-8CF4788FD9EB.pdf A254 TUMOR FREE YES YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 5741e1ce-5d4c-40dc-aa01-e71a45341884 5741e1ce-5d4c-40dc-aa01-e71a45341884 TCGA-AR-A254-01A-11-A17I-20 TCGA-AR-A254-01A-21D-A167-09 TCGA-AR-A254-01 TCGA-AR-A254-01A-21D-A16A-05 a7ba4821-8817-4411-a013-904b5c771b9e TCGA-AR-A254-01 TCGA-AR-A254-01A-21D-A167-09 TCGA-AR-A254-01 TCGA-AR-A254-01A-21D-A167-09 5741e1ce-5d4c-40dc-aa01-e71a45341884 TCGA-AR-A254-01A-21D-A166-01 TCGA-AR-A254-01 5741e1ce-5d4c-40dc-aa01-e71a45341884 TCGA-AR-A254-01A-21D-A166-01 TCGA-AR-A255-01 Stage I 62 5 Stage I 1058 Positive FEMALE Positive Negative M0 Negative N0 1058 0 LumA Positive enrollment T1 T1 LIVING TCGA-AR-A255-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 13 mutation cluster 4 TCGA-AR-A255 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A255-F71745 TCGA-AR-A255 TCGA-AR-A255-01A Positive Positive Other YES -22809 1225 0 2161 Scheduled Follow-up Submission 2015-3-30 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 250 NO Positive NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 0 true No M0 N0 T1 Stage I TCGA-AR-A255.492DDF00-858B-4420-A43F-4FED2DF61C15.pdf A255 TUMOR FREE YES YES YES Primary Tumor 01 Wide local excision 6th YES NO YES AR Breast A LIVING 2007 5f714b76-1ed1-4828-8b66-3627c5d78189 5f714b76-1ed1-4828-8b66-3627c5d78189 TCGA-AR-A255-01A-21-A17I-20 TCGA-AR-A255-01A-11D-A167-09 TCGA-AR-A255-01 TCGA-AR-A255-01A-11D-A16A-05 1f885532-b89a-406c-af84-bcfc9441ae2a TCGA-AR-A255-01 TCGA-AR-A255-01A-11D-A167-09 TCGA-AR-A255-01 TCGA-AR-A255-01A-11D-A167-09 5f714b76-1ed1-4828-8b66-3627c5d78189 TCGA-AR-A255-01A-11D-A166-01 TCGA-AR-A255-01 5f714b76-1ed1-4828-8b66-3627c5d78189 TCGA-AR-A255-01A-11D-A166-01 TCGA-AR-A256-01 Stage II 45 1 Stage IIA 2854 2854 Negative FEMALE Negative Negative M0 Negative N0 2854 1 Basal Negative enrollment T_Other T2 DECEASED TCGA-AR-A256-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 mutation cluster 5 TCGA-AR-A256 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A256-F31923 TCGA-AR-A256 TCGA-AR-A256-01A Negative Negative Other YES -16642 3740 2854 0 1640 Scheduled Follow-up Submission 2012-5-11 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 210 NO Negative 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 Locoregional Disease YES 0 true No M0 N0 T2 Stage IIA TCGA-AR-A256.0FDC2801-71F8-4D45-BFF1-89445E621A41.pdf A256 YES NO Primary Tumor 01 Mastectomy 5th YES NO YES AR Breast A DECEASED 2001 60534f8f-970a-4308-9844-a3a41dd6c187 60534f8f-970a-4308-9844-a3a41dd6c187 TCGA-AR-A256-01A-21-A17I-20 TCGA-AR-A256-01A-11D-A167-09 TCGA-AR-A256-01 TCGA-AR-A256-01A-11D-A16A-05 c98c88ee-f8ed-444b-a51c-67e6d942a8b5 TCGA-AR-A256-01 TCGA-AR-A256-01A-11D-A167-09 TCGA-AR-A256-01 TCGA-AR-A256-01A-11D-A167-09 60534f8f-970a-4308-9844-a3a41dd6c187 TCGA-AR-A256-01A-11D-A166-01 TCGA-AR-A256-01 60534f8f-970a-4308-9844-a3a41dd6c187 TCGA-AR-A256-01A-11D-A166-01 TCGA-AR-A2LE-01 LumA TCGA-AR-A2LE-01 Iq C3-BRCA/Luminal BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA c1uster 10 TCGA-AR-A2LE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Sentinel node biopsy alone TCGA-AR-A2LE-F35164 TCGA-AR-A2LE TCGA-AR-A2LE-01A Positive Negative Other YES -25499 3755 0 5062 4203 NO 2015-3-30 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 320 NO NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify New Primary Tumor Endometrium NO 0 true No M0 N0 T1 Stage I TCGA-AR-A2LE.95DC80AB-C070-4613-8C11-A124AEDF9754.pdf A2LE TUMOR FREE YES YES YES Primary Tumor 01 Excision 5th NO YES AR Breast A LIVING 2001 5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74 5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74 TCGA-AR-A2LE-01A-21-A24A-20 TCGA-AR-A2LE-01 TCGA-AR-A2LE-01A-11D-A17Z-05 642d23a8-3c0c-4004-9d50-3787178cb070 TCGA-AR-A2LE-01 TCGA-AR-A2LE-01A-11D-A17W-09 TCGA-AR-A2LE-01 5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74 TCGA-AR-A2LE-01A-11D-A17U-01 TCGA-AR-A2LE-01 5c052fcb-a9f9-4d6a-86cd-6fa490fe9d74 TCGA-AR-A2LE-01A-11D-A17U-01 TCGA-AR-A2LH-01 Normal TCGA-AR-A2LH-01 Quiet C3-BRCA/Luminal BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-AR-A2LH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LH-F35165 TCGA-AR-A2LH TCGA-AR-A2LH-01A Negative Negative Modified Radical Mastectomy -20288 1661 616 0 434 YES 2012-12-6 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 1100 NO Equivocal Negative NO 39 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone|Liver Bone Distant Metastasis YES 29 true No M0 N3 T3 Stage III TCGA-AR-A2LH.4E3FDA72-93E1-4961-B1DE-5BFDAC7E947D.pdf A2LH YES YES YES Primary Tumor 01 6th NO YES AR Breast A DECEASED 2007 6aa1a643-013f-43d4-a3e6-a4a946ac3678 6aa1a643-013f-43d4-a3e6-a4a946ac3678 TCGA-AR-A2LH-01A-41-A24A-20 TCGA-AR-A2LH-01 TCGA-AR-A2LH-01A-31D-A18O-05 eca21066-45f1-49c3-b6ac-d594ed529c0e TCGA-AR-A2LH-01 TCGA-AR-A2LH-01A-31D-A18P-09 TCGA-AR-A2LH-01 6aa1a643-013f-43d4-a3e6-a4a946ac3678 TCGA-AR-A2LH-01A-31D-A18N-01 TCGA-AR-A2LH-01 6aa1a643-013f-43d4-a3e6-a4a946ac3678 TCGA-AR-A2LH-01A-31D-A18N-01 TCGA-AR-A2LJ-01 TCGA-AR-A2LJ-01 Iq BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-AR-A2LJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LJ-F71721 TCGA-AR-A2LJ TCGA-AR-A2LJ-01A Positive Positive Other YES -14723 1382 0 2632 NO 70-79% 2015-3-30 FEMALE 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 540 NO Positive Positive NO 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 true No MX N1 T3 Stage IIIA TCGA-AR-A2LJ.5411AC07-09E4-40C3-844F-2DFAA216D947.pdf A2LJ TUMOR FREE YES YES 70-79% YES Primary Tumor 01 Total Mastectomy 6th NO YES AR Breast A LIVING 2007 52cca577-c5d1-4dff-9e3a-4007beb120db 52cca577-c5d1-4dff-9e3a-4007beb120db TCGA-AR-A2LJ-01A-21-A24B-20 TCGA-AR-A2LJ-01 TCGA-AR-A2LJ-01A-12D-A19Z-05 c7155c5f-8110-4eb1-9c42-a959435f5f88 TCGA-AR-A2LJ-01 TCGA-AR-A2LJ-01A-12D-A19Y-09 TCGA-AR-A2LJ-01 52cca577-c5d1-4dff-9e3a-4007beb120db TCGA-AR-A2LJ-01A-12D-A19X-01 TCGA-AR-A2LJ-01 52cca577-c5d1-4dff-9e3a-4007beb120db TCGA-AR-A2LJ-01A-12D-A19X-01 TCGA-AR-A2LK-01 LumB TCGA-AR-A2LK-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AR-A2LK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant|Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LK-F35203 TCGA-AR-A2LK TCGA-AR-A2LK-01A Negative Positive Mastectomy NOS Positive Other -22800 1340 1649 0 1304 1304 NO 70-79% 2012-12-6 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 650 NO Equivocal Negative NO 18 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative Positive Positive Bone Distant Metastasis YES 5 true No M0 N2 T3 Stage III TCGA-AR-A2LK.73FFBADB-37C0-4F17-8C95-F8DC94EF1AD3.pdf A2LK YES YES YES Primary Tumor 01 Wide local excision 6th NO YES AR Breast A DECEASED 2007 047160f7-3727-4915-b02d-61557350d88b 047160f7-3727-4915-b02d-61557350d88b TCGA-AR-A2LK-01A-21-A24A-20 TCGA-AR-A2LK-01 TCGA-AR-A2LK-01A-11D-A17Z-05 bcdf5107-7ac1-4f83-8b7e-30173b7d4760 TCGA-AR-A2LK-01 TCGA-AR-A2LK-01A-11D-A17W-09 TCGA-AR-A2LK-01 047160f7-3727-4915-b02d-61557350d88b TCGA-AR-A2LK-01A-11D-A17U-01 TCGA-AR-A2LK-01 047160f7-3727-4915-b02d-61557350d88b TCGA-AR-A2LK-01A-11D-A17U-01 TCGA-AR-A2LL-01 LumB TCGA-AR-A2LL-01 High C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 TCGA-AR-A2LL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Left Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LL-F49493 TCGA-AR-A2LL TCGA-AR-A2LL-01A Positive Positive Simple Mastectomy YES -25747 1315 0 2012 NO 70-79% 2013-10-2 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 1300 NO Equivocal Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true Yes M0 N0 T3 Stage IIB TCGA-AR-A2LL.B2314041-3E85-4E3F-8924-39FC285B08B2.pdf A2LL TUMOR FREE YES YES 70-79% NO Primary Tumor 01 6th NO YES AR Breast A LIVING 2007 2c08d3bc-c5f6-4077-86b5-633ed85818ec 2c08d3bc-c5f6-4077-86b5-633ed85818ec TCGA-AR-A2LL-01A-21-A24A-20 TCGA-AR-A2LL-01 TCGA-AR-A2LL-01A-11D-A17Z-05 6aee5a1d-a53e-4c02-90f5-fdb8e7765573 TCGA-AR-A2LL-01 TCGA-AR-A2LL-01A-11D-A17W-09 2c08d3bc-c5f6-4077-86b5-633ed85818ec TCGA-AR-A2LL-01A-11D-A17U-01 2c08d3bc-c5f6-4077-86b5-633ed85818ec TCGA-AR-A2LL-01A-11D-A17U-01 TCGA-AR-A2LM-01 LumA TCGA-AR-A2LM-01 Iq C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 TCGA-AR-A2LM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LM-F71746 TCGA-AR-A2LM TCGA-AR-A2LM-01A Positive Positive Simple Mastectomy YES -18053 1339 0 1935 NO 70-79% 2015-3-30 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 490 NO Negative NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 true No M0 N1 T1 Stage II TCGA-AR-A2LM.F868DC95-23CA-4DFC-BAA3-FBF5BF6F45A9.pdf A2LM TUMOR FREE YES YES 70-79% NO Primary Tumor 01 6th NO YES AR Breast A LIVING 2007 461cbf67-a11d-4411-95b5-cf83ecf05d02 461cbf67-a11d-4411-95b5-cf83ecf05d02 TCGA-AR-A2LM-01A-21-A24A-20 TCGA-AR-A2LM-01 TCGA-AR-A2LM-01A-11D-A17Z-05 02ae8e2a-6a69-4de2-b23c-f4e6a3b8ef7d TCGA-AR-A2LM-01 TCGA-AR-A2LM-01A-11D-A17W-09 TCGA-AR-A2LM-01 461cbf67-a11d-4411-95b5-cf83ecf05d02 TCGA-AR-A2LM-01A-11D-A17U-01 TCGA-AR-A2LM-01 461cbf67-a11d-4411-95b5-cf83ecf05d02 TCGA-AR-A2LM-01A-11D-A17U-01 TCGA-AR-A2LN-01 LumA TCGA-AR-A2LN-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-AR-A2LN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LN-F49496 TCGA-AR-A2LN TCGA-AR-A2LN-01A Positive Positive Other -23992 513 0 1161 NO 70-79% 2013-10-2 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 1460 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T2 Stage IIA TCGA-AR-A2LN.128D4F7D-017D-459F-9664-AF509AE4555E.pdf A2LN TUMOR FREE YES YES 70-79% NO Primary Tumor 01 Mastectomy 7th NO YES AR Breast A LIVING 2010 8a23348d-3371-431e-a6c8-b031cde82279 8a23348d-3371-431e-a6c8-b031cde82279 TCGA-AR-A2LN-01A-31-A24A-20 TCGA-AR-A2LN-01 TCGA-AR-A2LN-01A-21D-A18O-05 bbf9a555-e910-4604-bffd-d7e76c024c46 TCGA-AR-A2LN-01 TCGA-AR-A2LN-01A-21D-A18P-09 TCGA-AR-A2LN-01 8a23348d-3371-431e-a6c8-b031cde82279 TCGA-AR-A2LN-01A-21D-A18N-01 TCGA-AR-A2LN-01 8a23348d-3371-431e-a6c8-b031cde82279 TCGA-AR-A2LN-01A-21D-A18N-01 TCGA-AR-A2LO-01 LumA TCGA-AR-A2LO-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-AR-A2LO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LO-F49498 TCGA-AR-A2LO TCGA-AR-A2LO-01A Positive Positive Simple Mastectomy -17080 486 0 1198 NO 70-79% 2013-10-2 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 1650 NO Equivocal Negative 16 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 true No M0 N1 T2 Stage IIB TCGA-AR-A2LO.E5B6771D-450A-49AD-AEBC-7FC056BFCDBE.pdf A2LO TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES AR Breast A LIVING 2010 3e71718b-3ab9-4b0d-a92b-52c46e6f1670 3e71718b-3ab9-4b0d-a92b-52c46e6f1670 TCGA-AR-A2LO-01A-41-A24A-20 TCGA-AR-A2LO-01 TCGA-AR-A2LO-01A-31D-A18O-05 d9a30b5c-ba93-4cee-8ad7-937a95df1679 TCGA-AR-A2LO-01 TCGA-AR-A2LO-01A-31D-A18P-09 TCGA-AR-A2LO-01 3e71718b-3ab9-4b0d-a92b-52c46e6f1670 TCGA-AR-A2LO-01A-31D-A19G-01 TCGA-AR-A2LO-01 3e71718b-3ab9-4b0d-a92b-52c46e6f1670 TCGA-AR-A2LO-01A-31D-A19G-01 TCGA-AR-A2LQ-01 Normal TCGA-AR-A2LQ-01 Quiet C3-BRCA/Luminal BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-AR-A2LQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Upper Inner Quadrant|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LQ-F49500 TCGA-AR-A2LQ TCGA-AR-A2LQ-01A Positive Positive Simple Mastectomy -21865 449 0 1233 NO 70-79% 2013-10-2 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 1270 NO Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T3 Stage IIB TCGA-AR-A2LQ.C3537961-4636-4BD1-BC89-892580B36E43.pdf A2LQ TUMOR FREE YES YES <10% YES Primary Tumor 01 7th NO YES AR Breast A LIVING 2010 7a72bd47-7504-4a59-ae95-096c32f70965 7a72bd47-7504-4a59-ae95-096c32f70965 TCGA-AR-A2LQ-01A-11-A24A-20 TCGA-AR-A2LQ-01 TCGA-AR-A2LQ-01A-22D-A18O-05 a4b9430f-9ede-4e82-8d92-b7483d029609 TCGA-AR-A2LQ-01 TCGA-AR-A2LQ-01A-22D-A18P-09 TCGA-AR-A2LQ-01 7a72bd47-7504-4a59-ae95-096c32f70965 TCGA-AR-A2LQ-01A-22D-A18N-01 TCGA-AR-A2LQ-01 7a72bd47-7504-4a59-ae95-096c32f70965 TCGA-AR-A2LQ-01A-22D-A18N-01 TCGA-AR-A2LR-01 Basal TCGA-AR-A2LR-01 High C4-BRCA/Basal BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 5 TCGA-AR-A2LR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A2LR-F71747 TCGA-AR-A2LR TCGA-AR-A2LR-01A Negative Negative Simple Mastectomy -18214 447 0 1742 NO 2015-3-30 FEMALE Metaplastic Carcinoma No C50.9 8575/3 C50.9 YES Core needle biopsy 800 NO Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true Yes M0 N0 T1 Stage I TCGA-AR-A2LR.C310F4EC-D8B1-45C4-8D55-705A9EE35902.pdf A2LR TUMOR FREE NO YES NO Primary Tumor 01 7th NO YES AR Breast A LIVING 2010 9f693816-6957-413c-a100-54f7bc0eddf9 9f693816-6957-413c-a100-54f7bc0eddf9 TCGA-AR-A2LR-01A-21-A24A-20 TCGA-AR-A2LR-01 TCGA-AR-A2LR-01A-12D-A18O-05 1504ffd3-5ca4-4858-a554-120455f8d456 TCGA-AR-A2LR-01 TCGA-AR-A2LR-01A-12D-A18P-09 9f693816-6957-413c-a100-54f7bc0eddf9 TCGA-AR-A2LR-01A-12D-A18N-01 9f693816-6957-413c-a100-54f7bc0eddf9 TCGA-AR-A2LR-01A-12D-A18N-01 TCGA-AR-A5QM-01 TCGA-AR-A5QM-01 TCGA-AR-A5QM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A5QM-F43848 TCGA-AR-A5QM TCGA-AR-A5QM-01A Positive Positive Other -22780 1541 0 2231 968 2014-12-31 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 350 NO Equivocal NO 9 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify New Primary Tumor Malignant melanoma NO 0 true Yes M0 N0 T2 Stage IIA TCGA-AR-A5QM.4C3E3E5B-E24E-447B-A688-68D6EBE15A9F.pdf A5QM TUMOR FREE YES YES YES Primary Tumor 01 Wide Excision 6th NO YES AR Breast A LIVING 2008 6bbb74ed-93be-4cbe-a854-4ea6aaec0615 6bbb74ed-93be-4cbe-a854-4ea6aaec0615 TCGA-AR-A5QM-01 TCGA-AR-A5QM-01A-11D-A27Y-05 049c6f4f-37ba-4507-b37b-0686a3b7bf19 TCGA-AR-A5QM-01 TCGA-AR-A5QM-01A-11D-A27P-09 TCGA-AR-A5QM-01 6bbb74ed-93be-4cbe-a854-4ea6aaec0615 TCGA-AR-A5QM-01A-11D-A27O-01 TCGA-AR-A5QM-01 6bbb74ed-93be-4cbe-a854-4ea6aaec0615 TCGA-AR-A5QM-01A-11D-A27O-01 TCGA-AR-A5QN-01 TCGA-AR-A5QN-01 TCGA-AR-A5QN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Axillary lymph node dissection alone TCGA-AR-A5QN-F69265 TCGA-AR-A5QN TCGA-AR-A5QN-01A Positive Positive Modified Radical Mastectomy -25089 328 0 1013 2014-12-31 FEMALE 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 510 NO Positive NO 19 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 10 true No M0 N3 T2 Stage IIIC TCGA-AR-A5QN.A9015F6A-F6BB-4AC8-B681-099232A6DFAC.pdf A5QN TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES AR Breast A LIVING 2012 76353751-a05c-432e-a35b-12f2bf62a494 76353751-a05c-432e-a35b-12f2bf62a494 TCGA-AR-A5QN-01 TCGA-AR-A5QN-01A-12D-A28C-05 29dda56e-2d14-4864-97a2-03bc1a97e7fd TCGA-AR-A5QN-01 TCGA-AR-A5QN-01A-12D-A28B-09 TCGA-AR-A5QN-01 76353751-a05c-432e-a35b-12f2bf62a494 TCGA-AR-A5QN-01A-12D-A28A-01 TCGA-AR-A5QN-01 76353751-a05c-432e-a35b-12f2bf62a494 TCGA-AR-A5QN-01A-12D-A28A-01 TCGA-AR-A5QP-01 TCGA-AR-A5QP-01 TCGA-AR-A5QP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Sentinel lymph node biopsy plus axillary dissection TCGA-AR-A5QP-F69266 TCGA-AR-A5QP TCGA-AR-A5QP-01A Positive Positive Lumpectomy -19805 498 0 1185 2014-12-31 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 230 NO Equivocal NO 40 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No M0 N1 T2 Stage IIB TCGA-AR-A5QP.F2409024-D848-4B02-A371-92BEA1105EC4.pdf A5QP TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES AR Breast A LIVING 2011 b2d0c724-40ae-44ca-90eb-ce86a9546c05 b2d0c724-40ae-44ca-90eb-ce86a9546c05 TCGA-AR-A5QP-01 TCGA-AR-A5QP-01A-11D-A28C-05 160070ff-2113-459e-b1ab-ffe2167da75d TCGA-AR-A5QP-01 TCGA-AR-A5QP-01A-11D-A28B-09 TCGA-AR-A5QP-01 b2d0c724-40ae-44ca-90eb-ce86a9546c05 TCGA-AR-A5QP-01A-11D-A28A-01 TCGA-AR-A5QP-01 b2d0c724-40ae-44ca-90eb-ce86a9546c05 TCGA-AR-A5QP-01A-11D-A28A-01 TCGA-AR-A5QQ-01 TCGA-AR-A5QQ-01 TCGA-AR-A5QQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right Axillary lymph node dissection alone TCGA-AR-A5QQ-F42734 TCGA-AR-A5QQ TCGA-AR-A5QQ-01A Negative Negative Modified Radical Mastectomy -24841 576 322 0 301 2013-6-10 FEMALE 1+ Other, specify No C50.9 8575/3 C50.9 YES Core needle biopsy 800 NO Negative NO 24 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lung Distant Metastasis Liver, bone, chest wall, adrenal glands YES 1 true No M0 N1 T3 Stage IIIA TCGA-AR-A5QQ.511282C5-02AC-4105-8B52-5BBEC8B45D22.pdf A5QQ WITH TUMOR YES YES YES Primary Tumor 01 7th NO YES AR Breast A DECEASED 2011 16f90247-c9a5-40d5-a3a1-08bba2d1d266 16f90247-c9a5-40d5-a3a1-08bba2d1d266 TCGA-AR-A5QQ-01 TCGA-AR-A5QQ-01A-11D-A28C-05 23195a90-ef03-4655-9b11-4668986a94c3 TCGA-AR-A5QQ-01 TCGA-AR-A5QQ-01A-11D-A28B-09 TCGA-AR-A5QQ-01 16f90247-c9a5-40d5-a3a1-08bba2d1d266 TCGA-AR-A5QQ-01A-11D-A28A-01 TCGA-AR-A5QQ-01 16f90247-c9a5-40d5-a3a1-08bba2d1d266 TCGA-AR-A5QQ-01A-11D-A28A-01 TCGA-B6-A0I1-01 Basal TCGA-B6-A0I1-01 High BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 4 TCGA-B6-A0I1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 73 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-B6-A0I1-F38909 TCGA-B6-A0I1 TCGA-B6-A0I1-01A Negative Negative Modified Radical Mastectomy NO -26902 4248 2361 0 1120 1120 image cytometry 2013-1-3 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 100 NO NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative Negative Lung Distant Metastasis YES YES 0 true No M0 N0 T2 Stage IIA TCGA-B6-A0I1.1E498731-FE74-493E-A330-477643800305.pdf A0I1 TUMOR FREE image cytometry NO YES NO Primary Tumor 01 5th NO YES B6 Breast A DECEASED 1998 785856fc-d042-4b7f-a137-95b17c59b876 785856fc-d042-4b7f-a137-95b17c59b876 TCGA-B6-A0I1-01 TCGA-B6-A0I1-01A-11D-A21R-05 TCGA-B6-A0I1-01 TCGA-B6-A0I1-01A-11D-A21Q-09 TCGA-B6-A0I1-01 785856fc-d042-4b7f-a137-95b17c59b876 TCGA-B6-A0I1-01A-11D-A21P-01 TCGA-B6-A0I1-01 785856fc-d042-4b7f-a137-95b17c59b876 TCGA-B6-A0I1-01A-11D-A21P-01 TCGA-B6-A0I2-01 Stage IA 45 3 Stage I 4360 FEMALE Negative 2 2 2 Negative M0 Negative N0 4360 0 Basal Basal-like ReacII -13 -12 followup T1 T1 LIVING TCGA-B6-A0I2-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-B6-A0I2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0I2-F12630 TCGA-B6-A0I2 TCGA-B6-A0I2-01A NO -16702 5305 0 4361 Scheduled Follow-up Submission 2011-6-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 200 NO 8 Indeterminate (neither Pre or Postmenopausal) 5 3 NO 0 true No M0 N0 (i-) T1c Stage IA TCGA-B6-A0I2.CA834E5F-30DC-46CF-AF33-AD11226FC09E.pdf A0I2 TUMOR FREE YES Primary Tumor 01 4th YES NO YES B6 Breast A LIVING 1995 7175b3eb-5198-4d7f-b205-91ae8df344b4 7175b3eb-5198-4d7f-b205-91ae8df344b4 TCGA-B6-A0I2-01A-21-A13C-20 TCGA-B6-A0I2-01A-11W-A050-09 TCGA-B6-A0I2-01 3c520911-0d5d-4a69-bef5-f2666b99544c TCGA-B6-A0I2-01 TCGA-B6-A0I2-01A-11W-A050-09 TCGA-B6-A0I2-01A-11D-A032-05 TCGA-B6-A0I2-01 TCGA-B6-A0I2-01A-11W-A050-09 TCGA-B6-A0I2-01 7175b3eb-5198-4d7f-b205-91ae8df344b4 TCGA-B6-A0I2-01 TCGA-B6-A0I2-01A-11D-A036-01 TCGA-B6-A0I2-01A-11R-A034-07 7175b3eb-5198-4d7f-b205-91ae8df344b4 TCGA-B6-A0I2-01A-11D-A036-01 TCGA-B6-A0I2-01 TCGA-B6-A0I5-01 Stage IIB 49 2 No_Conversion 4549 Positive FEMALE Negative Negative M0 Positive N1 4549 0 LumA Luminal A Positive -5 -3 followup T_Other T2 LIVING TCGA-B6-A0I5-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation cluster 4 TCGA-B6-A0I5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Lower Inner Quadrant Axillary lymph node dissection alone TCGA-B6-A0I5-F71505 TCGA-B6-A0I5 TCGA-B6-A0I5-01A Positive Positive Other NO -18038 7820 0 8556 Scheduled Follow-up Submission 2015-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES biopsy, NOS Other method, specify: 50 NO NO 13 Negative Indeterminate (neither Pre or Postmenopausal) 1 6 NO 5 true No M0 N1b T2 Stage IIB TCGA-B6-A0I5.FA43414D-3757-43CC-8949-77F82DF4FA4D.pdf A0I5 TUMOR FREE YES NO Primary Tumor 01 biopsy 3rd YES NO YES B6 Breast A LIVING 1988 2448118f-9664-4b9e-b67f-c019cf5b8d35 2448118f-9664-4b9e-b67f-c019cf5b8d35 TCGA-B6-A0I5-01A-11W-A100-09 TCGA-B6-A0I5-01 TCGA-B6-A0I5-01 TCGA-B6-A0I5-01A-11W-A100-09 TCGA-B6-A0I5-01A-11D-A032-05 TCGA-B6-A0I5-01 TCGA-B6-A0I5-01A-11W-A100-09 TCGA-B6-A0I5-01 2448118f-9664-4b9e-b67f-c019cf5b8d35 TCGA-B6-A0I5-01 TCGA-B6-A0I5-01A-11D-A036-01 TCGA-B6-A0I5-01A-11R-A034-07 2448118f-9664-4b9e-b67f-c019cf5b8d35 TCGA-B6-A0I5-01A-11D-A036-01 TCGA-B6-A0I5-01 TCGA-B6-A0I6-01 Stage IIA 49 No_Conversion 991 997 Negative FEMALE Negative M0 Positive N1 997 1 Basal Basal-like Negative Basal -13 0 followup T1 T1 DECEASED TCGA-B6-A0I6-01 C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0I6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO 49 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0I6-F12605 TCGA-B6-A0I6 TCGA-B6-A0I6-01A Negative Negative Modified Radical Mastectomy NO -18014 7362 991 0 859 Scheduled Follow-up Submission 2011-6-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 200 NO 32 Negative Indeterminate (neither Pre or Postmenopausal) 5 4 Other, specify Distant Metastasis Skin and bone YES 6 true No M0 N1 T1c Stage IIA TCGA-B6-A0I6.2D3D759B-D06A-4FC6-855A-5E9F83ADBED9.pdf A0I6 WITH TUMOR NO Primary Tumor 01 3rd YES NO YES B6 Breast A DECEASED 1990 09c248f8-cdd7-4c13-9085-26c56544bcf7 09c248f8-cdd7-4c13-9085-26c56544bcf7 TCGA-B6-A0I6-01A-21-A13B-20 TCGA-B6-A0I6-01A-11D-A128-09 TCGA-B6-A0I6-01 4b55651d-88f5-411e-9986-702e8173a3d9 TCGA-B6-A0I6-01A-11D-A128-09 TCGA-B6-A0I6-01A-11D-A032-05 TCGA-B6-A0I6-01A-11D-A128-09 TCGA-B6-A0I6-01 09c248f8-cdd7-4c13-9085-26c56544bcf7 TCGA-B6-A0I6-01 TCGA-B6-A0I6-01A-11R-A034-07 09c248f8-cdd7-4c13-9085-26c56544bcf7 TCGA-B6-A0I6-01 TCGA-B6-A0I8-01 46 No_Conversion 749 749 FEMALE Negative M0 Negative N0 749 1 LumA Luminal A Her2 0 -3 followup T1 T1 DECEASED TCGA-B6-A0I8-01 C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0I8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES 46 Right Upper Inner Quadrant|Right No axillary staging TCGA-B6-A0I8-F12607 TCGA-B6-A0I8 NO 746 -17073 749 0 746 Scheduled Follow-up Submission 2011-6-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 0 Indeterminate (neither Pre or Postmenopausal) 2 4 Other, specify Locoregional Disease Pectoral muscle YES Yes M0 NX T1 Stage X A0I8 WITH TUMOR NO Primary Tumor 01 4th YES NO YES B6 Breast DECEASED 1992 c71ca9f7-248f-460c-b5d3-afb2c648fef2 c71ca9f7-248f-460c-b5d3-afb2c648fef2 TCGA-B6-A0I8-01A-21-A13B-20 TCGA-B6-A0I8-01A-11W-A050-09 TCGA-B6-A0I8-01 b8370b84-548e-42c1-8cf5-435502ae0050 TCGA-B6-A0I8-01A-11W-A050-09 TCGA-B6-A0I8-01A-11D-A032-05 TCGA-B6-A0I8-01A-11W-A050-09 TCGA-B6-A0I8-01 c71ca9f7-248f-460c-b5d3-afb2c648fef2 TCGA-B6-A0I8-01 TCGA-B6-A0I8-01A-11R-A034-07 c71ca9f7-248f-460c-b5d3-afb2c648fef2 TCGA-B6-A0I8-01 TCGA-B6-A0I9-01 Stage IV 62 5 No_Conversion 369 369 Indeterminate FEMALE Positive 1 1 1 Positive M1 Negative N0 369 1 Her2 HER2-enriched Positive Her2 -2 -5 followup T_Other T3 DECEASED TCGA-B6-A0I9-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-B6-A0I9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Lower Outer Quadrant|Left No axillary staging TCGA-B6-A0I9-F12609 TCGA-B6-A0I9 TCGA-B6-A0I9-01A Indeterminate Positive NO -22798 6687 362 0 IHC Scheduled Follow-up Submission 2011-6-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 180 NO Indeterminate (neither Pre or Postmenopausal) Bone 4 4 NO true No M1 NX T3 Stage IV TCGA-B6-A0I9.291884D2-FDFD-4C98-BA19-1A0824ABB68F.pdf A0I9 WITH TUMOR IHC YES Primary Tumor 01 3rd YES NO YES B6 Breast A DECEASED 1992 1a99c4ba-6948-4054-96cd-62164ff4a6f0 1a99c4ba-6948-4054-96cd-62164ff4a6f0 TCGA-B6-A0I9-01A-21-A13B-20 TCGA-B6-A0I9-01A-11W-A050-09 TCGA-B6-A0I9-01 be91388f-7261-4e1a-94a0-29215be9bb4d TCGA-B6-A0I9-01 TCGA-B6-A0I9-01A-11W-A050-09 TCGA-B6-A0I9-01A-11D-A032-05 TCGA-B6-A0I9-01 TCGA-B6-A0I9-01A-11W-A050-09 TCGA-B6-A0I9-01 1a99c4ba-6948-4054-96cd-62164ff4a6f0 TCGA-B6-A0I9-01 TCGA-B6-A0I9-01A-11D-A036-01 TCGA-B6-A0I9-01A-11R-A034-07 1a99c4ba-6948-4054-96cd-62164ff4a6f0 TCGA-B6-A0I9-01A-11D-A036-01 TCGA-B6-A0I9-01 TCGA-B6-A0IA-01 Stage IIA 51 4 Stage IIA 6718 Positive FEMALE Negative Negative M0 Negative N0 6718 0 LumA Luminal A Positive -12 -3 followup T_Other T2 LIVING TCGA-B6-A0IA-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-B6-A0IA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Axillary lymph node dissection alone TCGA-B6-A0IA-F71513 TCGA-B6-A0IA TCGA-B6-A0IA-01A Positive Positive Other NO -18748 6664 0 8391 IHC Scheduled Follow-up Submission 2015-3-26 FEMALE Other, specify No C50.9 8523/3 C50.9 YES Biopsy, NOS Other method, specify: 70 NO NO 15 Negative Indeterminate (neither Pre or Postmenopausal) 2 4 NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-B6-A0IA.55F3F917-E441-4C10-A3E3-0645A4E8374E.pdf A0IA TUMOR FREE IHC YES NO Primary Tumor 01 Excisional biopsy YES NO YES B6 Breast A LIVING 1992 80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a 80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a TCGA-B6-A0IA-01A-11W-A050-09 TCGA-B6-A0IA-01 TCGA-B6-A0IA-01 TCGA-B6-A0IA-01A-11W-A050-09 TCGA-B6-A0IA-01A-11D-A032-05 TCGA-B6-A0IA-01 TCGA-B6-A0IA-01A-11W-A050-09 TCGA-B6-A0IA-01 80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a TCGA-B6-A0IA-01 TCGA-B6-A0IA-01A-11D-A036-01 TCGA-B6-A0IA-01A-11R-A034-07 80cfaf9d-f0aa-4a35-918a-2eaad05b3a5a TCGA-B6-A0IA-01A-11D-A036-01 TCGA-B6-A0IA-01 TCGA-B6-A0IB-01 Stage IV 64 4 No_Conversion 3941 3941 Positive FEMALE Negative 1 3 4 Positive M1 Positive N3 3941 1 LumB Luminal B Positive LumA/B 0 -3 followup T_Other T3 DECEASED TCGA-B6-A0IB-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-B6-A0IB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO 64 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0IB-F12612 TCGA-B6-A0IB TCGA-B6-A0IB-01A Positive Positive Modified Radical Mastectomy NO -23646 6660 3941 0 2717 IHC Scheduled Follow-up Submission 2011-6-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 150 NO 15 Negative Indeterminate (neither Pre or Postmenopausal) fmol/mg image cytometry Positive image cytometry Positive Other, specify Skin 4 1 Other, specify Distant Metastasis lung, bone, liver YES 8 true No M1 N3 T3 Stage IV TCGA-B6-A0IB.CFC4801B-04BD-4FFC-911A-7B88E2FA4B49.pdf A0IB WITH TUMOR IHC fmol/mg NO Primary Tumor 01 3rd YES NO YES B6 Breast A DECEASED 1992 9857acef-08eb-43d6-b086-4b513e23753a 9857acef-08eb-43d6-b086-4b513e23753a TCGA-B6-A0IB-01A-21-A13B-20 TCGA-B6-A0IB-01A-11W-A050-09 TCGA-B6-A0IB-01 5e4f32df-eccb-4283-b97e-41addb397f4b TCGA-B6-A0IB-01 TCGA-B6-A0IB-01A-11W-A050-09 TCGA-B6-A0IB-01A-11D-A032-05 TCGA-B6-A0IB-01 TCGA-B6-A0IB-01A-11W-A050-09 TCGA-B6-A0IB-01 9857acef-08eb-43d6-b086-4b513e23753a TCGA-B6-A0IB-01 TCGA-B6-A0IB-01A-11D-A036-01 TCGA-B6-A0IB-01A-11R-A034-07 9857acef-08eb-43d6-b086-4b513e23753a TCGA-B6-A0IB-01A-11D-A036-01 TCGA-B6-A0IB-01 TCGA-B6-A0IC-01 90 2 No_Conversion 1542 1542 Positive FEMALE Negative Negative N0 1542 1 LumA Luminal B Positive -12 -3 followup T_Other T2 DECEASED TCGA-B6-A0IC-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A0IC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Right No axillary staging TCGA-B6-A0IC-F12613 TCGA-B6-A0IC TCGA-B6-A0IC-01A Positive Positive Other NO -32872 6475 1542 0 IHC Scheduled Follow-up Submission 2011-6-1 FEMALE Other, specify No C50.9 8503/3 C50.9 YES Fine needle aspiration biopsy 100 NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO true No MX NX T2 Stage X TCGA-B6-A0IC.8AABC46F-03C7-4FBF-AC20-2C862E303A8B.pdf A0IC TUMOR FREE IHC NO Primary Tumor 01 Excisional biopsy 3rd NO NO YES B6 Breast A DECEASED 1992 718599d7-723a-4121-ac07-51120cde9af1 718599d7-723a-4121-ac07-51120cde9af1 TCGA-B6-A0IC-01A-11W-A050-09 TCGA-B6-A0IC-01 TCGA-B6-A0IC-01 TCGA-B6-A0IC-01A-11W-A050-09 TCGA-B6-A0IC-01A-11D-A032-05 TCGA-B6-A0IC-01 TCGA-B6-A0IC-01A-11W-A050-09 TCGA-B6-A0IC-01 718599d7-723a-4121-ac07-51120cde9af1 TCGA-B6-A0IC-01 TCGA-B6-A0IC-01A-11D-A036-01 TCGA-B6-A0IC-01A-11R-A034-07 718599d7-723a-4121-ac07-51120cde9af1 TCGA-B6-A0IC-01A-11D-A036-01 TCGA-B6-A0IC-01 TCGA-B6-A0IE-01 38 3 No_Conversion 1998 1998 Negative FEMALE Negative Negative M0 Positive N1 1998 1 LumA Normal-like Negative -2 -3 followup TX DECEASED TCGA-B6-A0IE-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-B6-A0IE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO 38 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0IE-F12614 TCGA-B6-A0IE Negative Negative Negative Other NO -13982 1993 0 834 Image Analysis Scheduled Follow-up Submission 2011-6-1 FEMALE Mixed Histology (please specify) Lobular/Ductal No C50.9 8520/3 C50.9 YES Incisional Biopsy 24 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 Bone Distant Metastasis YES 6 No M0 N1b T3 Stage IIIA A0IE WITH TUMOR Image Analysis YES Primary Tumor 01 Wide re-excisional biopsy 4th YES NO YES B6 Breast DECEASED 1995 f40b4aa3-b474-4c2e-a197-0347e46d3309 f40b4aa3-b474-4c2e-a197-0347e46d3309 TCGA-B6-A0IE-01A-11W-A050-09 TCGA-B6-A0IE-01 TCGA-B6-A0IE-01 TCGA-B6-A0IE-01A-11W-A050-09 TCGA-B6-A0IE-01A-11D-A032-05 TCGA-B6-A0IE-01 TCGA-B6-A0IE-01A-11W-A050-09 TCGA-B6-A0IE-01 f40b4aa3-b474-4c2e-a197-0347e46d3309 TCGA-B6-A0IE-01 TCGA-B6-A0IE-01A-11D-A036-01 TCGA-B6-A0IE-01A-11R-A034-07 f40b4aa3-b474-4c2e-a197-0347e46d3309 TCGA-B6-A0IE-01A-11D-A036-01 TCGA-B6-A0IE-01 TCGA-B6-A0IG-01 Stage IIB 50 No_Conversion 4456 4456 Positive FEMALE Negative M0 Positive N1 4456 1 LumA Luminal A Positive Her2 -2 0 followup T_Other T2 DECEASED TCGA-B6-A0IG-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 12 TCGA-B6-A0IG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Axillary lymph node dissection alone TCGA-B6-A0IG-F12616 TCGA-B6-A0IG TCGA-B6-A0IG-01A Positive Positive Modified Radical Mastectomy NO -18433 5836 4456 0 Image Analysis Scheduled Follow-up Submission 2011-6-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 200 NO 16 Negative Indeterminate (neither Pre or Postmenopausal) 4 7 4 true No M0 N1b T2 Stage IIB TCGA-B6-A0IG.4379DEE0-F7CB-4A73-8828-21EA0AA830F5.pdf A0IG WITH TUMOR Image Analysis YES Primary Tumor 01 4th YES NO YES B6 Breast A DECEASED 1994 463d3f12-16bb-456a-8fb1-f200c7996406 463d3f12-16bb-456a-8fb1-f200c7996406 TCGA-B6-A0IG-01A-21-A13B-20 TCGA-B6-A0IG-01A-11W-A050-09 TCGA-B6-A0IG-01 439c88c2-8efe-4981-96b8-015a9360ec6a TCGA-B6-A0IG-01 TCGA-B6-A0IG-01A-11W-A050-09 TCGA-B6-A0IG-01A-11D-A032-05 TCGA-B6-A0IG-01 TCGA-B6-A0IG-01A-11W-A050-09 TCGA-B6-A0IG-01 463d3f12-16bb-456a-8fb1-f200c7996406 TCGA-B6-A0IG-01 TCGA-B6-A0IG-01A-11D-A036-01 TCGA-B6-A0IG-01A-11R-A034-07 463d3f12-16bb-456a-8fb1-f200c7996406 TCGA-B6-A0IG-01A-11D-A036-01 TCGA-B6-A0IG-01 TCGA-B6-A0IH-01 Stage IIIA 81 2 Stage IIIA 3418 Positive FEMALE Negative Negative M0 Positive N1 3418 1 LumA Luminal A Positive -5 -7 followup T_Other T3 DECEASED TCGA-B6-A0IH-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-B6-A0IH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 81 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0IH-F12617 TCGA-B6-A0IH TCGA-B6-A0IH-01A Negative Positive Modified radical mastectomy Positive Other NO -29907 5388 3418 0 Image Analysis Scheduled Follow-up Submission 2011-6-2 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 110 NO 27 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 25 true No M0 N1b T3 Stage IIIA TCGA-B6-A0IH.12C64846-1CB3-42E4-B307-54C7AD12F530.pdf A0IH Image Analysis YES YES Primary Tumor 01 Excisional biopsy 4th YES NO YES B6 Breast A DECEASED 1995 76fabc98-ad85-4315-8653-4028e24cd2ff 76fabc98-ad85-4315-8653-4028e24cd2ff TCGA-B6-A0IH-01A-11D-A10Y-09 TCGA-B6-A0IH-01 TCGA-B6-A0IH-01 TCGA-B6-A0IH-01A-11D-A10Y-09 TCGA-B6-A0IH-01A-11D-A112-05 TCGA-B6-A0IH-01 TCGA-B6-A0IH-01 TCGA-B6-A0IH-01A-11D-A10Y-09 76fabc98-ad85-4315-8653-4028e24cd2ff TCGA-B6-A0IH-01A-11D-A111-01 TCGA-B6-A0IH-01 TCGA-B6-A0IH-01A-11R-A115-07 76fabc98-ad85-4315-8653-4028e24cd2ff TCGA-B6-A0IH-01A-11D-A111-01 TCGA-B6-A0IH-01 TCGA-B6-A0IJ-01 Stage IIB 42 3 Stage IIB 5383 Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 5383 0 Basal Basal-like Positive Basal -13 -12 followup T_Other T3 LIVING TCGA-B6-A0IJ-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-B6-A0IJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0IJ-F71500 TCGA-B6-A0IJ TCGA-B6-A0IJ-01A Positive Positive Modified Radical Mastectomy NO -15625 5350 0 7106 Image Analysis Scheduled Follow-up Submission 2015-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 170 NO NO 27 Negative Indeterminate (neither Pre or Postmenopausal) 5 5 NO 0 true No M0 N0 (i-) T3 Stage IIB TCGA-B6-A0IJ.F3BAF04C-35EE-450F-BFA8-E9DFE9F984FD.pdf A0IJ TUMOR FREE Image Analysis YES NO Primary Tumor 01 YES NO YES B6 Breast A LIVING 1995 f77e9ef0-0a62-426b-98d9-6813edeb63a5 f77e9ef0-0a62-426b-98d9-6813edeb63a5 TCGA-B6-A0IJ-01A-21-A13B-20 TCGA-B6-A0IJ-01A-11W-A050-09 TCGA-B6-A0IJ-01 25933fc4-60a0-4223-af5f-c8eed92f0f02 TCGA-B6-A0IJ-01 TCGA-B6-A0IJ-01A-11W-A050-09 TCGA-B6-A0IJ-01A-11D-A032-05 TCGA-B6-A0IJ-01 TCGA-B6-A0IJ-01A-11W-A050-09 TCGA-B6-A0IJ-01 f77e9ef0-0a62-426b-98d9-6813edeb63a5 TCGA-B6-A0IJ-01 TCGA-B6-A0IJ-01A-11D-A036-01 TCGA-B6-A0IJ-01A-11R-A034-07 f77e9ef0-0a62-426b-98d9-6813edeb63a5 TCGA-B6-A0IJ-01A-11D-A036-01 TCGA-B6-A0IJ-01 TCGA-B6-A0IK-01 Stage IIIB 63 5 No_Conversion 571 571 Negative FEMALE Negative 1 1 1 Negative M0 Positive N1 571 1 Her2 HER2-enriched Negative ReacII -11 -5 followup T_Other T4 DECEASED TCGA-B6-A0IK-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-B6-A0IK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES 63 Left TCGA-B6-A0IK-F12621 TCGA-B6-A0IK TCGA-B6-A0IK-01A Negative Negative Modified radical mastectomy Negative Lumpectomy NO 489 -23150 5724 571 0 489 Image Analysis Scheduled Follow-up Submission 2011-6-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 140 NO 14 Positive Indeterminate (neither Pre or Postmenopausal) 4 4 Brain Distant Metastasis YES 1 true No M0 N1 T4 Stage IIIB TCGA-B6-A0IK.3A38A97C-2CBB-4802-9528-A4BBD62AEA4A.pdf A0IK WITH TUMOR Image Analysis NO Primary Tumor 01 4th YES NO YES B6 Breast A DECEASED 1994 8fb338fe-ffa8-45c2-857b-f713d1935330 8fb338fe-ffa8-45c2-857b-f713d1935330 TCGA-B6-A0IK-01A-21-A13B-20 TCGA-B6-A0IK-01A-12W-A071-09 TCGA-B6-A0IK-01 TCGA-B6-A0IK-01A-12D-A10P-05 3d6a2ce9-3d70-4bec-80f1-bd5035ae2b3d TCGA-B6-A0IK-01 TCGA-B6-A0IK-01A-12W-A071-09 TCGA-B6-A0IK-01 TCGA-B6-A0IK-01A-12W-A071-09 TCGA-B6-A0IK-01 8fb338fe-ffa8-45c2-857b-f713d1935330 TCGA-B6-A0IK-01 TCGA-B6-A0IK-01A-12D-A059-01 TCGA-B6-A0IK-01A-12R-A056-07 8fb338fe-ffa8-45c2-857b-f713d1935330 TCGA-B6-A0IK-01A-12D-A059-01 TCGA-B6-A0IK-01 TCGA-B6-A0IM-01 Stage IIB 75 4 Stage IIB 3836 Positive FEMALE Negative Negative M0 Negative N0 3836 0 LumA Luminal B Positive -10 -3 followup T_Other T3 LIVING TCGA-B6-A0IM-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0IM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0IM-F12623 TCGA-B6-A0IM TCGA-B6-A0IM-01A Negative Positive Modified radical mastectomy Positive Lumpectomy NO -27557 4754 3873 0 3836 Image Analysis Scheduled Follow-up Submission 2011-6-2 FEMALE Other, specify No C50.9 8523/3 C50.9 YES Fine needle aspiration biopsy 110 NO 9 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 true No M0 N0 (i-) T3 Stage IIB TCGA-B6-A0IM.4A86A028-C56D-455E-A5CD-47D8A34B5734.pdf A0IM TUMOR FREE Image Analysis NO Primary Tumor 01 4th YES NO YES B6 Breast A DECEASED 1997 53f4d557-cad7-4367-9546-c10752cc6189 53f4d557-cad7-4367-9546-c10752cc6189 TCGA-B6-A0IM-01A-11W-A050-09 TCGA-B6-A0IM-01 TCGA-B6-A0IM-01 TCGA-B6-A0IM-01A-11W-A050-09 TCGA-B6-A0IM-01A-11D-A032-05 TCGA-B6-A0IM-01 TCGA-B6-A0IM-01A-11W-A050-09 TCGA-B6-A0IM-01 53f4d557-cad7-4367-9546-c10752cc6189 TCGA-B6-A0IM-01 TCGA-B6-A0IM-01A-11D-A036-01 TCGA-B6-A0IM-01A-11R-A034-07 53f4d557-cad7-4367-9546-c10752cc6189 TCGA-B6-A0IM-01A-11D-A036-01 TCGA-B6-A0IM-01 TCGA-B6-A0IN-01 45 3 No_Conversion 2573 2573 Positive FEMALE Negative N0 2573 1 LumB Luminal A Negative -2 -3 followup T1 T1 DECEASED TCGA-B6-A0IN-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-B6-A0IN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 45 Right Upper Outer Quadrant|Right No axillary staging TCGA-B6-A0IN-F12625 TCGA-B6-A0IN TCGA-B6-A0IN-01A Negative Positive Modified radical mastectomy Negative Other NO -16705 5073 2573 0 1412 Image Analysis Scheduled Follow-up Submission 2011-6-2 FEMALE Other, specify No C50.9 8523/3 C50.9 YES Fine needle aspiration biopsy 20 NO Positive Indeterminate (neither Pre or Postmenopausal) 4 1 Other, specify Distant Metastasis bone, brain YES true No MX NX T1c Stage X TCGA-B6-A0IN.267F1EFD-AB89-4124-B803-00CC0E8E9CD2.pdf A0IN WITH TUMOR Image Analysis NO Primary Tumor 01 Excisional biopsy 4th YES NO YES B6 Breast A DECEASED 1996 4eaae575-d631-4e2e-8e70-4b4e0a429d74 4eaae575-d631-4e2e-8e70-4b4e0a429d74 TCGA-B6-A0IN-01A-11W-A050-09 TCGA-B6-A0IN-01 TCGA-B6-A0IN-01 TCGA-B6-A0IN-01A-11W-A050-09 TCGA-B6-A0IN-01A-11D-A032-05 TCGA-B6-A0IN-01 TCGA-B6-A0IN-01A-11W-A050-09 TCGA-B6-A0IN-01 4eaae575-d631-4e2e-8e70-4b4e0a429d74 TCGA-B6-A0IN-01 TCGA-B6-A0IN-01A-11D-A036-01 TCGA-B6-A0IN-01A-11R-A034-07 4eaae575-d631-4e2e-8e70-4b4e0a429d74 TCGA-B6-A0IN-01A-11D-A036-01 TCGA-B6-A0IN-01 TCGA-B6-A0IO-01 Stage IIA 66 3 Stage IIA 3350 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 3350 0 LumA Luminal A Indeterminate X 0 -3 followup T_Other T2 LIVING TCGA-B6-A0IO-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-B6-A0IO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Axillary lymph node dissection alone TCGA-B6-A0IO-F71503 TCGA-B6-A0IO Positive Indeterminate Modified Radical Mastectomy NO -24322 0 5042 Image Analysis Scheduled Follow-up Submission 2015-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy NO 17 Negative Indeterminate (neither Pre or Postmenopausal) 2 1 NO 0 No M0 N0 (i-) T2 Stage IIA A0IO TUMOR FREE Image Analysis YES NO Primary Tumor 01 YES NO YES B6 Breast LIVING 2001 e7a1527b-dbaf-48ae-a322-e54efd36985d e7a1527b-dbaf-48ae-a322-e54efd36985d TCGA-B6-A0IO-01A-21-A13B-20 TCGA-B6-A0IO-01A-11W-A050-09 TCGA-B6-A0IO-01 f7075f2f-6892-4338-b042-1c48529275bd TCGA-B6-A0IO-01 TCGA-B6-A0IO-01A-11W-A050-09 TCGA-B6-A0IO-01A-11D-A032-05 TCGA-B6-A0IO-01 TCGA-B6-A0IO-01A-11W-A050-09 TCGA-B6-A0IO-01 e7a1527b-dbaf-48ae-a322-e54efd36985d TCGA-B6-A0IO-01 TCGA-B6-A0IO-01A-11D-A036-01 TCGA-B6-A0IO-01A-11R-A034-07 e7a1527b-dbaf-48ae-a322-e54efd36985d TCGA-B6-A0IO-01A-11D-A036-01 TCGA-B6-A0IO-01 TCGA-B6-A0IP-01 Stage IA 74 2 Stage I 3374 Positive FEMALE Negative Negative M0 Negative N0 3374 0 LumA Luminal A Positive -5 0 followup T1 T1 LIVING TCGA-B6-A0IP-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A0IP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-B6-A0IP-F71501 TCGA-B6-A0IP TCGA-B6-A0IP-01A Positive Positive Modified Radical Mastectomy NO -27047 4565 3926 0 3374 IMAGE ALYSIS Scheduled Follow-up Submission 2015-3-26 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 80 NO NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 true No M0 N0 (i-) T1c Stage IA TCGA-B6-A0IP.6C91D49C-9738-4A4F-A480-E71CD8EE5268.pdf A0IP TUMOR FREE IMAGE ALYSIS YES NO Primary Tumor 01 NO NO YES B6 Breast A DECEASED 1997 9384eb09-5787-49e8-b07e-bd9f71997771 9384eb09-5787-49e8-b07e-bd9f71997771 TCGA-B6-A0IP-01A-11D-A045-09 TCGA-B6-A0IP-01 TCGA-B6-A0IP-01 TCGA-B6-A0IP-01A-11D-A045-09 TCGA-B6-A0IP-01A-11D-A032-05 TCGA-B6-A0IP-01 TCGA-B6-A0IP-01A-11D-A045-09 TCGA-B6-A0IP-01 9384eb09-5787-49e8-b07e-bd9f71997771 TCGA-B6-A0IP-01 TCGA-B6-A0IP-01A-11D-A036-01 TCGA-B6-A0IP-01A-11R-A034-07 9384eb09-5787-49e8-b07e-bd9f71997771 TCGA-B6-A0IP-01A-11D-A036-01 TCGA-B6-A0IP-01 TCGA-B6-A0IQ-01 Stage IIIA 40 1 No_Conversion 4284 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 4284 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T3 LIVING TCGA-B6-A0IQ-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 5 mutation cluster 5 TCGA-B6-A0IQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0IQ-F12629 TCGA-B6-A0IQ TCGA-B6-A0IQ-01A Negative Negative Modified Radical Mastectomy NO -14669 5238 0 4285 Image Analysis Scheduled Follow-up Submission 2011-6-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 210 NO 26 Negative Indeterminate (neither Pre or Postmenopausal) 5 5 NO 1 true No M0 N1b T3 Stage IIIA TCGA-B6-A0IQ.0ED7357E-662C-4D65-82ED-29739919068F.pdf A0IQ TUMOR FREE Image Analysis YES Primary Tumor 01 4th YES NO YES B6 Breast A LIVING 1996 2e9c893c-1d72-49a7-8755-1ede20b26fcf 2e9c893c-1d72-49a7-8755-1ede20b26fcf TCGA-B6-A0IQ-01A-21-A13B-20 TCGA-B6-A0IQ-01A-11W-A050-09 TCGA-B6-A0IQ-01 940d8074-3223-49f6-8d86-d50e9ae69c9b TCGA-B6-A0IQ-01 TCGA-B6-A0IQ-01A-11W-A050-09 TCGA-B6-A0IQ-01A-11D-A032-05 TCGA-B6-A0IQ-01 TCGA-B6-A0IQ-01A-11W-A050-09 TCGA-B6-A0IQ-01 2e9c893c-1d72-49a7-8755-1ede20b26fcf TCGA-B6-A0IQ-01 TCGA-B6-A0IQ-01A-11D-A036-01 TCGA-B6-A0IQ-01A-11R-A034-07 2e9c893c-1d72-49a7-8755-1ede20b26fcf TCGA-B6-A0IQ-01A-11D-A036-01 TCGA-B6-A0IQ-01 TCGA-B6-A0RE-01 61 1 No_Conversion 6434 Negative FEMALE Negative Negative M0 Negative N0 6434 0 Basal Basal-like Negative -13 -12 followup TX LIVING TCGA-B6-A0RE-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-B6-A0RE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0RE-F71507 TCGA-B6-A0RE Negative Negative Modified Radical Mastectomy NO -22449 0 7777 Scheduled Follow-up Submission 2015-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Other method, specify: NO 14 Negative Indeterminate (neither Pre or Postmenopausal) 5 4 NO 0 No M0 N0 (i-) TX Stage X A0RE TUMOR FREE NO YES Primary Tumor 01 NO NO YES B6 Breast LIVING 1989 ad46ed65-3cc2-4956-9d90-3e1edca24417 ad46ed65-3cc2-4956-9d90-3e1edca24417 TCGA-B6-A0RE-01A-11W-A071-09 TCGA-B6-A0RE-01 TCGA-B6-A0RE-01A-11D-A10P-05 TCGA-B6-A0RE-01 TCGA-B6-A0RE-01A-11W-A071-09 TCGA-B6-A0RE-01 TCGA-B6-A0RE-01A-11W-A071-09 TCGA-B6-A0RE-01 ad46ed65-3cc2-4956-9d90-3e1edca24417 TCGA-B6-A0RE-01 TCGA-B6-A0RE-01A-11D-A059-01 TCGA-B6-A0RE-01A-11R-A056-07 ad46ed65-3cc2-4956-9d90-3e1edca24417 TCGA-B6-A0RE-01A-11D-A059-01 TCGA-B6-A0RE-01 TCGA-B6-A0RG-01 Stage IIB 26 2 Stage IIB 2082 Negative FEMALE Negative 3 3 3 Negative M0 Negative N0 2082 0 LumA Luminal A Negative ReacII 0 -3 followup T_Other T3 LIVING TCGA-B6-A0RG-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 4 mutation cluster 4 TCGA-B6-A0RG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 26 Left Axillary lymph node dissection alone TCGA-B6-A0RG-F13793 TCGA-B6-A0RG TCGA-B6-A0RG-01A Negative Negative Lumpectomy NO -9840 6869 0 2082 IHC Scheduled Follow-up Submission 2011-7-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 160 NO 19 Negative Indeterminate (neither Pre or Postmenopausal) 2 4 NO 0 true No M0 N0 (i-) T3 Stage IIB TCGA-B6-A0RG.0429FA9A-AD19-424C-94ED-1A902119E559.pdf A0RG TUMOR FREE IHC NO Primary Tumor 01 4th YES NO YES B6 Breast A LIVING 1991 006e88ce-ad31-45bf-8da5-802f0e387b3a 006e88ce-ad31-45bf-8da5-802f0e387b3a TCGA-B6-A0RG-01A-21-A13C-20 TCGA-B6-A0RG-01A-11W-A071-09 TCGA-B6-A0RG-01 TCGA-B6-A0RG-01A-11D-A10P-05 5da7a020-3d19-499b-9941-2028de5c5a3e TCGA-B6-A0RG-01 TCGA-B6-A0RG-01A-11W-A071-09 TCGA-B6-A0RG-01 TCGA-B6-A0RG-01A-11W-A071-09 TCGA-B6-A0RG-01 006e88ce-ad31-45bf-8da5-802f0e387b3a TCGA-B6-A0RG-01 TCGA-B6-A0RG-01A-11D-A059-01 TCGA-B6-A0RG-01A-11R-A056-07 006e88ce-ad31-45bf-8da5-802f0e387b3a TCGA-B6-A0RG-01A-11D-A059-01 TCGA-B6-A0RG-01 TCGA-B6-A0RH-01 Stage IIA 51 2 Stage IIA 5748 Positive FEMALE Positive 3 3 3 Negative M0 Negative N0 5748 0 Her2 HER2-enriched Positive ReacII -1 -5 followup T_Other T2 LIVING TCGA-B6-A0RH-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 3 TCGA-B6-A0RH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES 51 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-B6-A0RH-F71512 TCGA-B6-A0RH TCGA-B6-A0RH-01A Negative Positive Positive Modified Radical Mastectomy NO 2268 -18759 6821 6456 0 5749 2165 Immunohistochemistry Scheduled Follow-up Submission 2015-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 130 NO NO 23 Positive Indeterminate (neither Pre or Postmenopausal) 2 6 Other, specify Locoregional Disease Chest Wall NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-B6-A0RH.3801F39A-6F4B-40C0-9625-9E0818266819.pdf A0RH TUMOR FREE Immunohistochemistry YES YES NO Primary Tumor 01 6th YES NO YES B6 Breast A DECEASED 1991 d40f62c9-c134-4477-98d7-11d343b5e867 d40f62c9-c134-4477-98d7-11d343b5e867 TCGA-B6-A0RH-01A-11-A13C-20 TCGA-B6-A0RH-01A-21D-A10Y-09 TCGA-B6-A0RH-01 90975b3f-f130-4032-804a-88f06b0d3147 TCGA-B6-A0RH-01 TCGA-B6-A0RH-01A-21D-A10Y-09 TCGA-B6-A0RH-01A-21D-A112-05 TCGA-B6-A0RH-01 TCGA-B6-A0RH-01 TCGA-B6-A0RH-01A-21D-A10Y-09 d40f62c9-c134-4477-98d7-11d343b5e867 TCGA-B6-A0RH-01A-21D-A111-01 TCGA-B6-A0RH-01 TCGA-B6-A0RH-01A-21R-A115-07 d40f62c9-c134-4477-98d7-11d343b5e867 TCGA-B6-A0RH-01A-21D-A111-01 TCGA-B6-A0RH-01 TCGA-B6-A0RI-01 Stage IIIB 44 2 No_Conversion 7125 Positive FEMALE Negative Negative M0 Positive N1 7125 0 LumA Luminal A Positive -7 -3 followup T_Other T4 LIVING TCGA-B6-A0RI-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0RI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES 44 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0RI-F13795 TCGA-B6-A0RI TCGA-B6-A0RI-01A Positive Positive Modified Radical Mastectomy NO 1100 -16138 6755 0 7126 1100 IHC Scheduled Follow-up Submission 2011-7-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 50 NO 15 Negative Indeterminate (neither Pre or Postmenopausal) 105 fmol/mg image cytometry Positive Other Reporting Scale image cytometry Positive 2 4 Other Reporting Scale Other, specify Locoregional Disease Chest Wall YES 6 true No M0 N1b T4b Stage IIIB TCGA-B6-A0RI.F2B21F52-74F4-44C5-9991-60EBCC4E43A6.pdf A0RI WITH TUMOR IHC 133 fmol/mg YES Primary Tumor 01 3rd YES NO YES B6 Breast A LIVING 1992 6f5986b6-28b9-4213-97a9-899190ea36dd 6f5986b6-28b9-4213-97a9-899190ea36dd TCGA-B6-A0RI-01A-11W-A071-09 TCGA-B6-A0RI-01 TCGA-B6-A0RI-01A-11D-A10P-05 TCGA-B6-A0RI-01 TCGA-B6-A0RI-01A-11W-A071-09 TCGA-B6-A0RI-01 TCGA-B6-A0RI-01A-11W-A071-09 TCGA-B6-A0RI-01 6f5986b6-28b9-4213-97a9-899190ea36dd TCGA-B6-A0RI-01 TCGA-B6-A0RI-01A-11D-A059-01 TCGA-B6-A0RI-01A-11R-A056-07 6f5986b6-28b9-4213-97a9-899190ea36dd TCGA-B6-A0RI-01A-11D-A059-01 TCGA-B6-A0RI-01 TCGA-B6-A0RL-01 Stage IIA 60 2 Stage IIA 2469 2469 Positive FEMALE Negative 4 3 4 Negative M0 Negative N0 2469 1 LumB Luminal B Positive LumA/B -10 -3 followup T_Other T2 DECEASED TCGA-B6-A0RL-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 10 TCGA-B6-A0RL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left Axillary lymph node dissection alone TCGA-B6-A0RL-F13796 TCGA-B6-A0RL TCGA-B6-A0RL-01A Positive Positive Modified Radical Mastectomy NO -22238 6336 2469 0 Image Analysis Scheduled Follow-up Submission 2011-7-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 170 NO 16 Negative 3 5 NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-B6-A0RL.6C50D456-A828-4514-92D2-01A5900B74F1.pdf A0RL TUMOR FREE Image Analysis NO Primary Tumor 01 4th YES NO YES B6 Breast A DECEASED 1993 0e704d8f-c0c0-4165-83c4-a1fa93014894 0e704d8f-c0c0-4165-83c4-a1fa93014894 TCGA-B6-A0RL-01A-21-A13C-20 TCGA-B6-A0RL-01A-11D-A099-09 TCGA-B6-A0RL-01 TCGA-B6-A0RL-01A-11D-A10P-05 0ca6a866-1fd5-4144-80a9-01cc7f7caa9c TCGA-B6-A0RL-01 TCGA-B6-A0RL-01 TCGA-B6-A0RL-01A-11D-A099-09 TCGA-B6-A0RL-01 0e704d8f-c0c0-4165-83c4-a1fa93014894 TCGA-B6-A0RL-01 TCGA-B6-A0RL-01A-11D-A087-01 TCGA-B6-A0RL-01A-11R-A084-07 0e704d8f-c0c0-4165-83c4-a1fa93014894 TCGA-B6-A0RL-01A-11D-A087-01 TCGA-B6-A0RL-01 TCGA-B6-A0RM-01 57 4 No_Conversion 2373 2373 Positive FEMALE Negative 3 3 3 Negative N0 2373 1 LumA Luminal A Positive LumA -10 -3 followup TX DECEASED TCGA-B6-A0RM-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-B6-A0RM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left No axillary staging TCGA-B6-A0RM-F13797 TCGA-B6-A0RM TCGA-B6-A0RM-01A Positive Positive NO -21047 6279 2373 0 Image Analysis Scheduled Follow-up Submission 2011-7-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 160 NO 0 Indeterminate (neither Pre or Postmenopausal) 2 2 NO true No MX NX TX Stage X TCGA-B6-A0RM.EC8093CD-66E7-4466-99AD-B2A6B93526FD.pdf A0RM TUMOR FREE Image Analysis NO Primary Tumor 01 4th NO NO YES B6 Breast A DECEASED 1993 17fdb26d-d808-4b0d-a794-6b664dae8b2b 17fdb26d-d808-4b0d-a794-6b664dae8b2b TCGA-B6-A0RM-01A-21-A13C-20 TCGA-B6-A0RM-01A-11D-A099-09 TCGA-B6-A0RM-01 TCGA-B6-A0RM-01A-11D-A10P-05 10cf7b61-7523-4c17-a786-618537217cff TCGA-B6-A0RM-01 TCGA-B6-A0RM-01 TCGA-B6-A0RM-01A-11D-A099-09 TCGA-B6-A0RM-01 17fdb26d-d808-4b0d-a794-6b664dae8b2b TCGA-B6-A0RM-01 TCGA-B6-A0RM-01A-11D-A087-01 TCGA-B6-A0RM-01A-11R-A084-07 17fdb26d-d808-4b0d-a794-6b664dae8b2b TCGA-B6-A0RM-01A-11D-A087-01 TCGA-B6-A0RM-01 TCGA-B6-A0RN-01 Stage IA 60 2 Stage I 5261 Negative FEMALE Negative 1 4 3 Negative M0 Negative N0 5261 0 LumA Luminal A Negative ReacI -5 -3 followup T1 T1 LIVING TCGA-B6-A0RN-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A0RN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0RN-F71514 TCGA-B6-A0RN TCGA-B6-A0RN-01A Negative Negative Modified Radical Mastectomy NO -22077 6286 0 8008 Image Analysis Scheduled Follow-up Submission 2015-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 130 NO NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 true No M0 N0 (i-) T1c Stage IA TCGA-B6-A0RN.5F08632D-BC1D-4414-80C1-75F67F3A07AF.pdf A0RN TUMOR FREE Image Analysis YES YES Primary Tumor 01 YES NO YES B6 Breast A LIVING 1993 c417152a-d278-4aeb-951e-a7b6ae5654c1 c417152a-d278-4aeb-951e-a7b6ae5654c1 TCGA-B6-A0RN-01A-21-A13C-20 TCGA-B6-A0RN-01A-12D-A099-09 TCGA-B6-A0RN-01 TCGA-B6-A0RN-01A-12D-A10P-05 734fdc04-4666-4ae2-898f-d375c47eb33b TCGA-B6-A0RN-01 TCGA-B6-A0RN-01A-12D-A099-09 TCGA-B6-A0RN-01 TCGA-B6-A0RN-01A-12D-A099-09 TCGA-B6-A0RN-01 c417152a-d278-4aeb-951e-a7b6ae5654c1 TCGA-B6-A0RN-01 TCGA-B6-A0RN-01A-12D-A087-01 TCGA-B6-A0RN-01A-12R-A084-07 c417152a-d278-4aeb-951e-a7b6ae5654c1 TCGA-B6-A0RN-01A-12D-A087-01 TCGA-B6-A0RN-01 TCGA-B6-A0RO-01 Stage IIIB 71 3 No_Conversion 4928 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 4928 0 LumA Luminal A Positive ReacI 0 -3 followup T_Other T4 LIVING TCGA-B6-A0RO-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-B6-A0RO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Axillary lymph node dissection alone TCGA-B6-A0RO-F13799 TCGA-B6-A0RO TCGA-B6-A0RO-01A Positive Positive Modified Radical Mastectomy NO -26269 6035 0 4929 Image Analysis Scheduled Follow-up Submission 2011-7-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 140 NO 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 NO 2 true No M0 N1a T4 Stage IIIB TCGA-B6-A0RO.EFA0354A-641D-4EC2-A1BE-4ACC7CE421DF.pdf A0RO TUMOR FREE Image Analysis NO Primary Tumor 01 4th YES NO YES B6 Breast A LIVING 1993 d99fef01-1eb5-4300-8031-d5a157fd5b28 d99fef01-1eb5-4300-8031-d5a157fd5b28 TCGA-B6-A0RO-01A-11-A13C-20 TCGA-B6-A0RO-01A-22D-A099-09 TCGA-B6-A0RO-01 TCGA-B6-A0RO-01A-22D-A10P-05 02857059-5b3e-4a7a-a0e0-93ee7f90cfff TCGA-B6-A0RO-01 TCGA-B6-A0RO-01A-22D-A099-09 TCGA-B6-A0RO-01 TCGA-B6-A0RO-01A-22D-A099-09 TCGA-B6-A0RO-01 d99fef01-1eb5-4300-8031-d5a157fd5b28 TCGA-B6-A0RO-01 TCGA-B6-A0RO-01A-22D-A087-01 TCGA-B6-A0RO-01A-22R-A084-07 d99fef01-1eb5-4300-8031-d5a157fd5b28 TCGA-B6-A0RO-01A-22D-A087-01 TCGA-B6-A0RO-01 TCGA-B6-A0RP-01 Stage IIIB 73 4 No_Conversion 3126 3126 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 3126 1 LumA Luminal A Positive LumA -12 -4 followup T_Other T2 DECEASED TCGA-B6-A0RP-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-B6-A0RP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 73 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0RP-F13786 TCGA-B6-A0RP Negative Positive Modified radical mastectomy Positive Lumpectomy NO -26941 3126 0 2787 Image Analysis Scheduled Follow-up Submission 2011-7-12 FEMALE Mixed Histology (please specify) ductal/lobular No C50.9 8522/3 C50.9 YES Biopsy, NOS Other method, specify: 15 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 Bone Distant Metastasis YES 2 No M0 N1b T2 [Discrepancy] A0RP WITH TUMOR Image Analysis NO Primary Tumor 01 4th YES NO YES B6 Breast DECEASED 1994 a77173cb-3e81-4957-a76f-18824d5e06dd a77173cb-3e81-4957-a76f-18824d5e06dd TCGA-B6-A0RP-01A-11-A13C-20 TCGA-B6-A0RP-01A-21D-A099-09 TCGA-B6-A0RP-01 TCGA-B6-A0RP-01A-21D-A10P-05 ac2921f3-13fa-457b-b436-1da8977a163c TCGA-B6-A0RP-01 TCGA-B6-A0RP-01A-21D-A099-09 TCGA-B6-A0RP-01 TCGA-B6-A0RP-01A-21D-A099-09 TCGA-B6-A0RP-01 a77173cb-3e81-4957-a76f-18824d5e06dd TCGA-B6-A0RP-01 TCGA-B6-A0RP-01A-21D-A087-01 TCGA-B6-A0RP-01A-21R-A084-07 a77173cb-3e81-4957-a76f-18824d5e06dd TCGA-B6-A0RP-01A-21D-A087-01 TCGA-B6-A0RP-01 TCGA-B6-A0RQ-01 Stage IIB 68 1 Stage IIB 4273 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 4273 1 Normal Luminal A Positive ReacI -5 -7 followup T_Other T3 DECEASED TCGA-B6-A0RQ-01 Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-B6-A0RQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0RQ-F13787 TCGA-B6-A0RQ TCGA-B6-A0RQ-01A Negative Positive Positive Other NO -25010 5890 4267 0 Image Analysis Scheduled Follow-up Submission 2011-7-12 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 160 NO 14 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 0 true No M0 N0 (i-) T3 Stage IIB TCGA-B6-A0RQ.46B892B9-82C8-4305-BCB9-805F6F5FC90A.pdf A0RQ TUMOR FREE Image Analysis YES NO Primary Tumor 01 excisional biopsy 4th YES NO YES B6 Breast A DECEASED 1994 184fe3c4-58bb-45c5-a9a5-9a8a56985f9f 184fe3c4-58bb-45c5-a9a5-9a8a56985f9f TCGA-B6-A0RQ-01A-21-A13C-20 TCGA-B6-A0RQ-01A-11D-A10Y-09 TCGA-B6-A0RQ-01 23aabbc3-fe66-44d8-8640-5c153f409754 TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01A-11D-A10Y-09 TCGA-B6-A0RQ-01A-11D-A112-05 TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01A-11D-A10Y-09 184fe3c4-58bb-45c5-a9a5-9a8a56985f9f TCGA-B6-A0RQ-01A-11D-A111-01 TCGA-B6-A0RQ-01 TCGA-B6-A0RQ-01A-11R-A115-07 184fe3c4-58bb-45c5-a9a5-9a8a56985f9f TCGA-B6-A0RQ-01A-11D-A111-01 TCGA-B6-A0RQ-01 TCGA-B6-A0RS-01 Stage IIA 38 1 Stage IIA 3062 3062 Negative FEMALE Negative Negative M0 Negative N0 3062 1 Her2 HER2-enriched Negative 0 0 followup T_Other T2 DECEASED TCGA-B6-A0RS-01 High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-B6-A0RS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES 38 Left Lower Inner Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0RS-F13788 TCGA-B6-A0RS Negative Negative Modified Radical Mastectomy NO 2041 -14134 3063 0 2041 Scheduled Follow-up Submission 2011-7-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Biopsy, NOS Other method, specify: 15 Negative Indeterminate (neither Pre or Postmenopausal) Negative Negative 5 4 Other, specify New Primary Tumor Breast YES 0 No M0 N0 (i-) T2 Stage IIA A0RS WITH TUMOR NO Primary Tumor 01 3rd YES NO YES B6 Breast DECEASED 1988 be1f09ae-deec-45d7-8504-fea3f6e7feb4 be1f09ae-deec-45d7-8504-fea3f6e7feb4 TCGA-B6-A0RS-01A-11D-A099-09 TCGA-B6-A0RS-01 TCGA-B6-A0RS-01A-11D-A10P-05 TCGA-B6-A0RS-01 TCGA-B6-A0RS-01 TCGA-B6-A0RS-01A-11D-A099-09 TCGA-B6-A0RS-01 be1f09ae-deec-45d7-8504-fea3f6e7feb4 TCGA-B6-A0RS-01 TCGA-B6-A0RS-01A-11D-A087-01 TCGA-B6-A0RS-01A-11R-A084-07 be1f09ae-deec-45d7-8504-fea3f6e7feb4 TCGA-B6-A0RS-01A-11D-A087-01 TCGA-B6-A0RS-01 TCGA-B6-A0RT-01 Stage IIIA 39 1 No_Conversion 2721 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 2721 0 Basal Basal-like Negative ReacII -13 -12 followup T_Other T3 LIVING TCGA-B6-A0RT-01 BRCA-LUAD+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-B6-A0RT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0RT-F13789 TCGA-B6-A0RT TCGA-B6-A0RT-01A Negative Negative Modified Radical Mastectomy NO -14374 5047 0 2721 Image Analysis Scheduled Follow-up Submission 2011-7-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 230 NO 23 Close Indeterminate (neither Pre or Postmenopausal) 5 3 NO 1 true No M0 N1 T3 Stage IIIA TCGA-B6-A0RT.64D53A4B-4735-4AD2-A413-520797F5F9CB.pdf A0RT TUMOR FREE Image Analysis YES Primary Tumor 01 4th YES NO YES B6 Breast A LIVING 1996 2b721e04-5452-4b34-b3df-c6cdd04e87b1 2b721e04-5452-4b34-b3df-c6cdd04e87b1 TCGA-B6-A0RT-01A-11-A13C-20 TCGA-B6-A0RT-01A-21D-A099-09 TCGA-B6-A0RT-01 TCGA-B6-A0RT-01A-21D-A10P-05 f4b94eba-e9e8-4f06-812e-7f68eefa407b TCGA-B6-A0RT-01 TCGA-B6-A0RT-01A-21D-A099-09 TCGA-B6-A0RT-01 TCGA-B6-A0RT-01A-21D-A099-09 TCGA-B6-A0RT-01 2b721e04-5452-4b34-b3df-c6cdd04e87b1 TCGA-B6-A0RT-01 TCGA-B6-A0RT-01A-21D-A087-01 TCGA-B6-A0RT-01A-21R-A084-07 2b721e04-5452-4b34-b3df-c6cdd04e87b1 TCGA-B6-A0RT-01A-21D-A087-01 TCGA-B6-A0RT-01 TCGA-B6-A0RU-01 Stage IA 49 1 Stage I 3991 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 3991 0 Basal Basal-like Negative Basal -13 -11 followup T1 T1 LIVING TCGA-B6-A0RU-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-B6-A0RU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES 40 Right Axillary lymph node dissection alone TCGA-B6-A0RU-F71565 TCGA-B6-A0RU TCGA-B6-A0RU-01A Negative Negative Other NO 3076 -14920 7290 0 8605 3076 Image Analysis Scheduled Follow-up Submission 2015-3-26 FEMALE Other, specify No C50.9 8523/3 C50.9 YES Tumor resection 170 NO NO 15 Negative Indeterminate (neither Pre or Postmenopausal) 5 6 Other, specify New Primary Tumor Right Breast NO 0 true No M0 N0 (i-) T1c Stage IA TCGA-B6-A0RU.39C689CA-F7BA-4554-BEC8-11F9C8142D9C.pdf A0RU TUMOR FREE Image Analysis YES YES Primary Tumor 01 Excisional biopsy 3rd YES NO YES B6 Breast A LIVING 1990 7abad802-817a-4d95-b022-f21cc4b1d9bc 7abad802-817a-4d95-b022-f21cc4b1d9bc TCGA-B6-A0RU-01A-21-A13C-20 TCGA-B6-A0RU-01A-11D-A099-09 TCGA-B6-A0RU-01 TCGA-B6-A0RU-01A-11D-A10P-05 608bb166-ceaa-49d5-ae7d-d4060e8c6dc2 TCGA-B6-A0RU-01 TCGA-B6-A0RU-01A-11D-A099-09 TCGA-B6-A0RU-01 TCGA-B6-A0RU-01A-11D-A099-09 TCGA-B6-A0RU-01 7abad802-817a-4d95-b022-f21cc4b1d9bc TCGA-B6-A0RU-01 TCGA-B6-A0RU-01A-11D-A087-01 TCGA-B6-A0RU-01A-11R-A084-07 7abad802-817a-4d95-b022-f21cc4b1d9bc TCGA-B6-A0RU-01A-11D-A087-01 TCGA-B6-A0RU-01 TCGA-B6-A0RV-01 Stage IIIA 42 4 No_Conversion 4788 Positive FEMALE Negative 3 4 3 Negative M0 Positive N2 4788 0 LumA Luminal A Positive ReacII -5 0 followup T_Other T3 LIVING TCGA-B6-A0RV-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-B6-A0RV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Right Axillary lymph node dissection alone TCGA-B6-A0RV-F13791 TCGA-B6-A0RV TCGA-B6-A0RV-01A Positive Positive Modified Radical Mastectomy NO -15507 5165 0 5156 Image Analysis Scheduled Follow-up Submission 2011-7-12 FEMALE Mixed Histology (please specify) Lobular/Ductal No C50.9 8522/3 C50.9 YES Incisional Biopsy 480 NO 10 Negative Indeterminate (neither Pre or Postmenopausal) 1 6 NO 5 true No M0 N2 T3 Stage IIIA TCGA-B6-A0RV.FF5D000A-4600-4C42-8802-4BCD29F61CA6.pdf A0RV TUMOR FREE Image Analysis YES Primary Tumor 01 4th YES NO YES B6 Breast A LIVING 1996 25068ef3-d87f-45e2-a15f-152b87e9dedb 25068ef3-d87f-45e2-a15f-152b87e9dedb TCGA-B6-A0RV-01A-21-A13C-20 TCGA-B6-A0RV-01A-11D-A099-09 TCGA-B6-A0RV-01 TCGA-B6-A0RV-01A-11D-A10P-05 f132d6af-68eb-4b00-8a2d-84322ac5758b TCGA-B6-A0RV-01 TCGA-B6-A0RV-01A-11D-A099-09 TCGA-B6-A0RV-01 TCGA-B6-A0RV-01A-11D-A099-09 TCGA-B6-A0RV-01 25068ef3-d87f-45e2-a15f-152b87e9dedb TCGA-B6-A0RV-01 TCGA-B6-A0RV-01A-11D-A087-01 TCGA-B6-A0RV-01A-11R-A084-07 25068ef3-d87f-45e2-a15f-152b87e9dedb TCGA-B6-A0RV-01A-11D-A087-01 TCGA-B6-A0RV-01 TCGA-B6-A0WS-01 58 4 Stage I 2965 Positive FEMALE Negative Negative M0 Negative N0 2965 1 LumA Luminal A Positive 0 -4 followup T1 T1 DECEASED TCGA-B6-A0WS-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-B6-A0WS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Outer Quadrant|Left No axillary staging TCGA-B6-A0WS-F15707 TCGA-B6-A0WS TCGA-B6-A0WS-01A Positive Positive Lumpectomy NO -21230 5113 2965 0 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 110 NO Positive Indeterminate (neither Pre or Postmenopausal) 1 7 NO true No MX NX T1c Stage X TCGA-B6-A0WS.36AE47A6-B881-4C1D-8436-EB65783243CF.pdf A0WS TUMOR FREE Image Analysis NO NO Primary Tumor 01 4th NO NO YES B6 Breast A DECEASED 1996 44bd10a8-c4c0-466c-8cd8-31a5da70ba0b 44bd10a8-c4c0-466c-8cd8-31a5da70ba0b TCGA-B6-A0WS-01A-11D-A10Y-09 TCGA-B6-A0WS-01 TCGA-B6-A0WS-01 TCGA-B6-A0WS-01A-11D-A10Y-09 TCGA-B6-A0WS-01A-11D-A112-05 TCGA-B6-A0WS-01 TCGA-B6-A0WS-01 TCGA-B6-A0WS-01A-11D-A10Y-09 44bd10a8-c4c0-466c-8cd8-31a5da70ba0b TCGA-B6-A0WS-01A-11D-A111-01 TCGA-B6-A0WS-01 TCGA-B6-A0WS-01A-11R-A115-07 44bd10a8-c4c0-466c-8cd8-31a5da70ba0b TCGA-B6-A0WS-01A-11D-A111-01 TCGA-B6-A0WS-01 TCGA-B6-A0WT-01 Stage IIB 61 3 No_Conversion 5739 Positive FEMALE Negative Negative M0 Positive N1 5739 0 LumA Luminal A Positive -2 -4 followup T_Other T2 LIVING TCGA-B6-A0WT-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0WT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES 61 Left Lower Inner Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0WT-F15728 TCGA-B6-A0WT TCGA-B6-A0WT-01A Positive Positive Modified Radical Mastectomy NO 3862 -22362 5606 0 5739 3862 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 90 NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) fmol/mg Equivocal 2+ image cytometry Positive Other Reporting Scale Negative image cytometry Positive 2 4 Other Reporting Scale Other, specify New Primary Tumor right breast cancer contralateral YES 1 true No M0 N1 T2 Stage IIB TCGA-B6-A0WT.BACD800B-F320-472C-ACFF-175E9F525E9F.pdf A0WT TUMOR FREE Image Analysis fmol/mg NO Primary Tumor 01 4th YES NO YES B6 Breast A LIVING 1995 0507f62d-e776-4efb-bd51-dba9d74090bd 0507f62d-e776-4efb-bd51-dba9d74090bd TCGA-B6-A0WT-01A-11D-A10G-09 TCGA-B6-A0WT-01 TCGA-B6-A0WT-01A-11D-A10A-05 TCGA-B6-A0WT-01 TCGA-B6-A0WT-01A-11D-A10G-09 TCGA-B6-A0WT-01 TCGA-B6-A0WT-01A-11D-A10G-09 TCGA-B6-A0WT-01 0507f62d-e776-4efb-bd51-dba9d74090bd TCGA-B6-A0WT-01 TCGA-B6-A0WT-01A-11D-A107-01 TCGA-B6-A0WT-01A-11R-A109-07 0507f62d-e776-4efb-bd51-dba9d74090bd TCGA-B6-A0WT-01A-11D-A107-01 TCGA-B6-A0WT-01 TCGA-B6-A0WV-01 Stage IIB 67 5 No_Conversion 2422 2422 Positive FEMALE Negative Negative M0 Positive N1 2422 1 LumB Luminal B Positive 0 -3 followup T_Other T2 DECEASED TCGA-B6-A0WV-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-B6-A0WV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Axillary lymph node dissection alone TCGA-B6-A0WV-F15732 TCGA-B6-A0WV TCGA-B6-A0WV-01A Positive Positive Modified Radical Mastectomy NO -24803 5531 2417 0 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 30 NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 4 true No M0 N1b T2 Stage IIB TCGA-B6-A0WV.506BFD3B-240B-440E-B7A0-E596FC0B7F72.pdf A0WV TUMOR FREE Image Analysis NO Primary Tumor 01 4th YES NO YES B6 Breast A DECEASED 1995 87bdfb78-8690-4569-ba85-592cd2390c24 87bdfb78-8690-4569-ba85-592cd2390c24 TCGA-B6-A0WV-01A-11D-A10G-09 TCGA-B6-A0WV-01 TCGA-B6-A0WV-01A-11D-A10A-05 TCGA-B6-A0WV-01 TCGA-B6-A0WV-01A-11D-A10G-09 TCGA-B6-A0WV-01 TCGA-B6-A0WV-01A-11D-A10G-09 TCGA-B6-A0WV-01 87bdfb78-8690-4569-ba85-592cd2390c24 TCGA-B6-A0WV-01 TCGA-B6-A0WV-01A-11D-A107-01 TCGA-B6-A0WV-01A-11R-A109-07 87bdfb78-8690-4569-ba85-592cd2390c24 TCGA-B6-A0WV-01A-11D-A107-01 TCGA-B6-A0WV-01 TCGA-B6-A0WW-01 58 4 No_Conversion 546 557 Positive FEMALE Negative Positive N1 557 1 LumB Luminal B Positive 0 -3 followup T_Other T2 DECEASED TCGA-B6-A0WW-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A0WW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 58 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0WW-F15734 TCGA-B6-A0WW TCGA-B6-A0WW-01A Positive Positive Modified Radical Mastectomy NO -21479 4664 558 0 447 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 30 NO 18 Negative Indeterminate (neither Pre or Postmenopausal) 4 2 Liver Distant Metastasis YES 5 true No MX N1b T2 Stage X TCGA-B6-A0WW.F05F5886-DC5D-4685-B2BF-57A68A0BB7B9.pdf A0WW WITH TUMOR Image Analysis YES Primary Tumor 01 4th NO NO YES B6 Breast A DECEASED 1997 3bdcdadf-67da-4a50-b311-81196c0c8362 3bdcdadf-67da-4a50-b311-81196c0c8362 TCGA-B6-A0WW-01A-11D-A10G-09 TCGA-B6-A0WW-01 TCGA-B6-A0WW-01A-11D-A10A-05 TCGA-B6-A0WW-01 TCGA-B6-A0WW-01A-11D-A10G-09 TCGA-B6-A0WW-01 TCGA-B6-A0WW-01A-11D-A10G-09 TCGA-B6-A0WW-01 3bdcdadf-67da-4a50-b311-81196c0c8362 TCGA-B6-A0WW-01 TCGA-B6-A0WW-01A-11D-A107-01 TCGA-B6-A0WW-01A-11R-A109-07 3bdcdadf-67da-4a50-b311-81196c0c8362 TCGA-B6-A0WW-01A-11D-A107-01 TCGA-B6-A0WW-01 TCGA-B6-A0WX-01 Stage IIIA 40 1 No_Conversion 653 653 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 653 1 Basal Basal-like Negative X -13 0 followup T_Other T3 DECEASED TCGA-B6-A0WX-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-B6-A0WX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO 40 Left Axillary lymph node dissection alone TCGA-B6-A0WX-F15729 TCGA-B6-A0WX TCGA-B6-A0WX-01A Negative Negative Modified Radical Mastectomy NO -14784 4476 639 0 563 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Other, specify No C50.9 8520/3 C50.9 YES Excisional Biopsy 300 NO 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 Bone Distant Metastasis YES 9 true No M0 N1b T3 Stage IIIA TCGA-B6-A0WX.EE5BB205-D59B-4FEF-8D8F-D5720EDEB075.pdf A0WX WITH TUMOR Image Analysis NO Primary Tumor 01 5th YES NO YES B6 Breast A DECEASED 1998 8dc04505-fae5-4185-b3f8-53882fbbb4fd 8dc04505-fae5-4185-b3f8-53882fbbb4fd TCGA-B6-A0WX-01A-21-A13D-20 TCGA-B6-A0WX-01A-11D-A10G-09 TCGA-B6-A0WX-01 TCGA-B6-A0WX-01A-11D-A10A-05 f484ca3b-7c40-42fe-b5aa-a73453b45b0b TCGA-B6-A0WX-01 TCGA-B6-A0WX-01A-11D-A10G-09 TCGA-B6-A0WX-01 TCGA-B6-A0WX-01A-11D-A10G-09 TCGA-B6-A0WX-01 8dc04505-fae5-4185-b3f8-53882fbbb4fd TCGA-B6-A0WX-01 TCGA-B6-A0WX-01A-11D-A107-01 TCGA-B6-A0WX-01A-11R-A109-07 8dc04505-fae5-4185-b3f8-53882fbbb4fd TCGA-B6-A0WX-01A-11D-A107-01 TCGA-B6-A0WX-01 TCGA-B6-A0WY-01 Stage IIIA 40 4 No_Conversion 3410 3460 Positive FEMALE Negative Negative M0 Positive N1 3460 1 LumA Luminal A Negative -5 -3 followup T_Other T3 DECEASED TCGA-B6-A0WY-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-B6-A0WY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO 40 Left Lower Inner Quadrant|Left Axillary lymph node dissection alone TCGA-B6-A0WY-F15730 TCGA-B6-A0WY TCGA-B6-A0WY-01A Positive Negative Lumpectomy NO -14778 5294 3461 0 2011 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 30 NO 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 1 4 Bone Distant Metastasis YES 3 true No M0 N1b T3 Stage IIIA TCGA-B6-A0WY.C0E92852-4146-468C-9713-2DE9C3316B9F.pdf A0WY WITH TUMOR Image Analysis YES Primary Tumor 01 4th YES NO YES B6 Breast A DECEASED 1996 90a60ebe-ce7e-4b64-af2a-1676f46e6601 90a60ebe-ce7e-4b64-af2a-1676f46e6601 TCGA-B6-A0WY-01A-11D-A10G-09 TCGA-B6-A0WY-01 TCGA-B6-A0WY-01A-11D-A10A-05 TCGA-B6-A0WY-01 TCGA-B6-A0WY-01A-11D-A10G-09 TCGA-B6-A0WY-01 TCGA-B6-A0WY-01A-11D-A10G-09 TCGA-B6-A0WY-01 90a60ebe-ce7e-4b64-af2a-1676f46e6601 TCGA-B6-A0WY-01 TCGA-B6-A0WY-01A-11D-A107-01 TCGA-B6-A0WY-01A-11R-A109-07 90a60ebe-ce7e-4b64-af2a-1676f46e6601 TCGA-B6-A0WY-01A-11D-A107-01 TCGA-B6-A0WY-01 TCGA-B6-A0WZ-01 Stage IIB 50 2 No_Conversion 3941 Positive FEMALE Negative Negative M0 Positive N1 3941 0 LumA Luminal A Positive -12 -3 followup T_Other T2 LIVING TCGA-B6-A0WZ-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation cluster 4 TCGA-B6-A0WZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0WZ-F71575 TCGA-B6-A0WZ Positive Positive Other NO -18584 0 6292 5117 5117 Image Analysis Scheduled Follow-up Submission 2015-3-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy NO 21 Negative Indeterminate (neither Pre or Postmenopausal) 4 4 Bone New Primary Tumor YES YES 11 No M0 N1b T2 Stage II A0WZ TUMOR FREE Image Analysis YES YES Primary Tumor 01 Fine Needle aspiration biopsy 4th YES NO YES B6 Breast LIVING 1996 dc4a013a-c52a-40ef-8aeb-e1163519cdb8 dc4a013a-c52a-40ef-8aeb-e1163519cdb8 TCGA-B6-A0WZ-01A-11D-A10G-09 TCGA-B6-A0WZ-01 TCGA-B6-A0WZ-01A-11D-A10A-05 TCGA-B6-A0WZ-01 TCGA-B6-A0WZ-01A-11D-A10G-09 TCGA-B6-A0WZ-01 TCGA-B6-A0WZ-01A-11D-A10G-09 TCGA-B6-A0WZ-01 dc4a013a-c52a-40ef-8aeb-e1163519cdb8 TCGA-B6-A0WZ-01 TCGA-B6-A0WZ-01A-11D-A107-01 TCGA-B6-A0WZ-01A-11R-A109-07 dc4a013a-c52a-40ef-8aeb-e1163519cdb8 TCGA-B6-A0WZ-01A-11D-A107-01 TCGA-B6-A0WZ-01 TCGA-B6-A0X0-01 Stage IA 54 2 Stage I 3945 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 3945 1 LumA Luminal A Positive LumA -5 -3 followup T1 T1 DECEASED TCGA-B6-A0X0-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 12 TCGA-B6-A0X0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone TCGA-B6-A0X0-F15710 TCGA-B6-A0X0 TCGA-B6-A0X0-01A Positive Positive Modified Radical Mastectomy NO -19802 5243 3945 0 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Other, specify No C50.919 8201/3 C50.9 YES Fine needle aspiration biopsy 150 NO 31 Negative Indeterminate (neither Pre or Postmenopausal) 2 7 NO 0 true No M0 N0 (i-) T1c Stage I TCGA-B6-A0X0.84A8BA4A-35F0-46C4-BDB0-64C033AFD1A8.pdf A0X0 Image Analysis YES NO Primary Tumor 01 4th YES NO YES B6 Breast A DECEASED 1996 222a566c-2bad-4b47-97dc-ca1f60a9a981 222a566c-2bad-4b47-97dc-ca1f60a9a981 TCGA-B6-A0X0-01A-11-A13D-20 TCGA-B6-A0X0-01A-21D-A10Y-09 TCGA-B6-A0X0-01 1831ec43-6958-4950-8b0f-dd822fc81f17 TCGA-B6-A0X0-01 TCGA-B6-A0X0-01A-21D-A10Y-09 TCGA-B6-A0X0-01A-21D-A112-05 TCGA-B6-A0X0-01 TCGA-B6-A0X0-01 TCGA-B6-A0X0-01A-21D-A10Y-09 222a566c-2bad-4b47-97dc-ca1f60a9a981 TCGA-B6-A0X0-01A-21D-A111-01 TCGA-B6-A0X0-01 TCGA-B6-A0X0-01A-21R-A115-07 222a566c-2bad-4b47-97dc-ca1f60a9a981 TCGA-B6-A0X0-01A-21D-A111-01 TCGA-B6-A0X0-01 TCGA-B6-A0X1-01 Stage IV 48 3 No_Conversion 5671 Negative FEMALE Positive M1 Positive N2 5671 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-B6-A0X1-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 mutation cluster 5 TCGA-B6-A0X1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO 48 Left Axillary lymph node dissection alone TCGA-B6-A0X1-F71498 TCGA-B6-A0X1 TCGA-B6-A0X1-01A Negative Negative Other NO -17624 6035 7455 0 5677 490 Image Analysis Scheduled Follow-up Submission 2015-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 240 NO NO 21 Negative Indeterminate (neither Pre or Postmenopausal) 5 Brain Distant Metastasis NO 16 true No M1 N1 T2 Stage IIB TCGA-B6-A0X1.D792031E-2CCE-4341-B3B3-C7D1D84F8F6B.pdf A0X1 TUMOR FREE Image Analysis NO NO Primary Tumor 01 Fine needle aspiration biopsy 4th YES NO YES B6 Breast A DECEASED 1994 897b769d-f66a-4baf-b5fa-fe92ed49a8b4 897b769d-f66a-4baf-b5fa-fe92ed49a8b4 TCGA-B6-A0X1-01A-21-A13D-20 TCGA-B6-A0X1-01A-11D-A10G-09 TCGA-B6-A0X1-01 TCGA-B6-A0X1-01A-11D-A10A-05 03c36239-f261-44e4-829b-01e679a414ad TCGA-B6-A0X1-01 TCGA-B6-A0X1-01A-11D-A10G-09 TCGA-B6-A0X1-01 TCGA-B6-A0X1-01A-11D-A10G-09 897b769d-f66a-4baf-b5fa-fe92ed49a8b4 TCGA-B6-A0X1-01A-11D-A107-01 TCGA-B6-A0X1-01A-11R-A109-07 897b769d-f66a-4baf-b5fa-fe92ed49a8b4 TCGA-B6-A0X1-01A-11D-A107-01 TCGA-B6-A0X1-01 TCGA-B6-A0X4-01 Stage IIB 62 3 No_Conversion 776 859 Positive FEMALE Negative Negative M0 Positive N1 859 1 LumA Luminal A Positive -12 -3 followup T_Other T2 DECEASED TCGA-B6-A0X4-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-B6-A0X4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO 62 Left Axillary lymph node dissection alone TCGA-B6-A0X4-F15723 TCGA-B6-A0X4 TCGA-B6-A0X4-01A Positive Positive Modified Radical Mastectomy NO -22688 5323 860 0 716 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 110 NO 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 Bone Distant Metastasis YES 2 true No M0 N1b T2 Stage IIB TCGA-B6-A0X4.CA935E8D-ED8A-4485-BDC6-02C07CCE2EA5.pdf A0X4 WITH TUMOR Image Analysis NO Primary Tumor 01 4th YES NO YES B6 Breast A DECEASED 1996 3d3d2beb-8c6f-45d0-bde3-12a68dbd5317 3d3d2beb-8c6f-45d0-bde3-12a68dbd5317 TCGA-B6-A0X4-01A-11D-A10G-09 TCGA-B6-A0X4-01 TCGA-B6-A0X4-01A-11D-A10A-05 TCGA-B6-A0X4-01 TCGA-B6-A0X4-01A-11D-A10G-09 TCGA-B6-A0X4-01 TCGA-B6-A0X4-01A-11D-A10G-09 TCGA-B6-A0X4-01 3d3d2beb-8c6f-45d0-bde3-12a68dbd5317 TCGA-B6-A0X4-01 TCGA-B6-A0X4-01A-11D-A107-01 TCGA-B6-A0X4-01A-11R-A109-07 3d3d2beb-8c6f-45d0-bde3-12a68dbd5317 TCGA-B6-A0X4-01A-11D-A107-01 TCGA-B6-A0X4-01 TCGA-B6-A0X5-01 Stage IIB 61 4 No_Conversion 2097 2097 Positive FEMALE Negative Negative M0 Positive N1 2097 1 LumB Luminal B Positive 0 -3 followup T_Other T2 DECEASED TCGA-B6-A0X5-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-B6-A0X5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO 61 Left Axillary lymph node dissection alone TCGA-B6-A0X5-F15726 TCGA-B6-A0X5 Positive Positive Modified Radical Mastectomy NO -22380 2097 0 1343 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 Other, specify Distant Metastasis Liver and Pleura and Bone YES 3 No M0 N1b T2 Stage IIB A0X5 WITH TUMOR Image Analysis NO Primary Tumor 01 4th YES NO YES B6 Breast DECEASED 1995 d4d04af8-9c60-4d14-90a2-c2b211e20092 d4d04af8-9c60-4d14-90a2-c2b211e20092 TCGA-B6-A0X5-01A-21D-A10G-09 TCGA-B6-A0X5-01 TCGA-B6-A0X5-01A-21D-A10A-05 TCGA-B6-A0X5-01 TCGA-B6-A0X5-01A-21D-A10G-09 TCGA-B6-A0X5-01 TCGA-B6-A0X5-01A-21D-A10G-09 TCGA-B6-A0X5-01 d4d04af8-9c60-4d14-90a2-c2b211e20092 TCGA-B6-A0X5-01 TCGA-B6-A0X5-01A-21D-A107-01 TCGA-B6-A0X5-01A-21R-A109-07 d4d04af8-9c60-4d14-90a2-c2b211e20092 TCGA-B6-A0X5-01A-21D-A107-01 TCGA-B6-A0X5-01 TCGA-B6-A0X7-01 62 2 No_Conversion 1791 1791 Positive FEMALE Negative Negative N0 1791 1 LumA Luminal A Positive -5 -3 enrollment T1 T1 DECEASED TCGA-B6-A0X7-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-B6-A0X7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO YES 62 Right No axillary staging TCGA-B6-A0X7-F15714 TCGA-B6-A0X7 Positive Positive NO 1104 -22723 1781 0 1104 Image Analysis Scheduled Follow-up Submission 2011-8-29 FEMALE Mixed Histology (please specify) Ductal/Lobular No C50.9 8500/3 C50.9 YES Excisional Biopsy 0 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 3 Other, specify New Primary Tumor colon YES No MX NX T1c Stage X A0X7 TUMOR FREE Image Analysis YES Primary Tumor 01 4th YES NO YES B6 Breast DECEASED 1994 b5ec5184-90d6-4b74-b08c-e39af59bc807 b5ec5184-90d6-4b74-b08c-e39af59bc807 TCGA-B6-A0X7-01A-11D-A10M-09 TCGA-B6-A0X7-01 TCGA-B6-A0X7-01A-11D-A10N-05 TCGA-B6-A0X7-01 TCGA-B6-A0X7-01A-11D-A10M-09 TCGA-B6-A0X7-01 TCGA-B6-A0X7-01A-11D-A10M-09 TCGA-B6-A0X7-01 b5ec5184-90d6-4b74-b08c-e39af59bc807 TCGA-B6-A0X7-01 TCGA-B6-A0X7-01A-11D-A10L-01 TCGA-B6-A0X7-01A-11R-A10J-07 b5ec5184-90d6-4b74-b08c-e39af59bc807 TCGA-B6-A0X7-01A-11D-A10L-01 TCGA-B6-A0X7-01 TCGA-B6-A1KC-01 Stage IIA 67 4 Stage IIB 1326 Positive FEMALE Negative M0 Positive N1 1326 0 LumB Negative followup T_Other T2 LIVING TCGA-B6-A1KC-01 BRCA-LUAD+ cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 5 mutation c1uster 9 TCGA-B6-A1KC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-B6-A1KC-F15740 TCGA-B6-A1KC Positive Negative Lumpectomy NO -24791 0 1326 NO image cytometry Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 5 NO 1 No M0 N1 T2 Stage IIB A1KC TUMOR FREE image cytometry 49 fmol/mg protein YES YES Primary Tumor 01 6th YES NO YES B6 Breast LIVING 2003 fe5e5b08-d5c0-4165-ae92-bec6a1d98e60 fe5e5b08-d5c0-4165-ae92-bec6a1d98e60 TCGA-B6-A1KC-01B-11D-A159-09 TCGA-B6-A1KC-01 TCGA-B6-A1KC-01B-11D-A161-05,TCGA-B6-A1KC-01A-11D-A13K-05 TCGA-B6-A1KC-01 TCGA-B6-A1KC-01B-11D-A159-09 TCGA-B6-A1KC-01 TCGA-B6-A1KC-01B-11D-A159-09 fe5e5b08-d5c0-4165-ae92-bec6a1d98e60 TCGA-B6-A1KC-01B-11D-A160-01 TCGA-B6-A1KC-01 fe5e5b08-d5c0-4165-ae92-bec6a1d98e60 TCGA-B6-A1KC-01B-11D-A160-01 TCGA-B6-A1KF-01 Stage IIB 68 1 Stage IIB 3088 Negative FEMALE Positive Negative M0 Positive N1 3088 0 Basal Negative followup T_Other T2 LIVING TCGA-B6-A1KF-01 High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-B6-A1KF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-B6-A1KF-F15739 TCGA-B6-A1KF Negative Negative Other NO -24891 0 3088 NO Scheduled Follow-up Submission 2011-8-29 FEMALE 60-69% 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Equivocal 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO 2 No M0 N1 T2 Stage IIB A1KF TUMOR FREE YES YES Primary Tumor 01 Excisional biopsy 5th YES NO YES B6 Breast LIVING 1998 e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66 e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66 TCGA-B6-A1KF-01A-11D-A13L-09 TCGA-B6-A1KF-01 TCGA-B6-A1KF-01A-11D-A13K-05 TCGA-B6-A1KF-01 TCGA-B6-A1KF-01A-11D-A13L-09 TCGA-B6-A1KF-01 TCGA-B6-A1KF-01A-11D-A13L-09 e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66 TCGA-B6-A1KF-01A-11D-A13J-01 TCGA-B6-A1KF-01 e7d1fcd1-eb2a-4b6d-b5bd-6a0a6e4bec66 TCGA-B6-A1KF-01A-11D-A13J-01 TCGA-B6-A1KI-01 Stage I 63 2 Stage I 2236 Positive FEMALE Negative Negative M0 Negative N0 2236 0 LumA Positive followup T1 T1 LIVING TCGA-B6-A1KI-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-B6-A1KI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-B6-A1KI-F15737 TCGA-B6-A1KI TCGA-B6-A1KI-01A Positive Positive Other NO -23031 2634 0 2236 NO image cytometry 3.1 Scheduled Follow-up Submission 2011-8-29 FEMALE 90-99% 2+ 60 3.8 1.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 40 NO Equivocal Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 2 NO 0 true No M0 N0 T1c Stage I TCGA-B6-A1KI.C2711492-0BDD-487E-9C9B-CEF20BBE57C3.pdf A1KI TUMOR FREE image cytometry 70 fmol/mg 288 fmol/mg YES YES Primary Tumor 01 Excisional biospy 6th YES NO YES B6 Breast A LIVING 2003 7d34b1bc-ac5a-4365-8dae-75b3f2ea5055 7d34b1bc-ac5a-4365-8dae-75b3f2ea5055 TCGA-B6-A1KI-01A-11D-A14K-09 TCGA-B6-A1KI-01 TCGA-B6-A1KI-01A-11D-A14N-05 TCGA-B6-A1KI-01 TCGA-B6-A1KI-01A-11D-A14K-09 TCGA-B6-A1KI-01 TCGA-B6-A1KI-01A-11D-A14K-09 7d34b1bc-ac5a-4365-8dae-75b3f2ea5055 TCGA-B6-A1KI-01A-11D-A14J-01 TCGA-B6-A1KI-01 7d34b1bc-ac5a-4365-8dae-75b3f2ea5055 TCGA-B6-A1KI-01A-11D-A14J-01 TCGA-B6-A1KN-01 Stage IIIB 57 5 Stage IIIC 4233 Negative FEMALE Positive Negative M0 Positive N1 4233 0 LumB Negative followup T_Other T4 LIVING TCGA-B6-A1KN-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 5 TCGA-B6-A1KN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-B6-A1KN-F15738 TCGA-B6-A1KN TCGA-B6-A1KN-01A Negative Negative Modified Radical Mastectomy NO -21183 4537 0 4233 NO Scheduled Follow-up Submission 2011-8-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 80 NO 30 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 6 NO 24 true No M0 N1 T4b Stage IIIB TCGA-B6-A1KN.72996825-1FFA-4C51-8DB0-DA74BCB595EB.pdf A1KN TUMOR FREE YES YES Primary Tumor 01 5th YES NO YES B6 Breast A LIVING 1998 71b773fb-1efb-4d0f-9499-110ba937ade6 71b773fb-1efb-4d0f-9499-110ba937ade6 TCGA-B6-A1KN-01A-11D-A13L-09 TCGA-B6-A1KN-01 TCGA-B6-A1KN-01A-11D-A13K-05 TCGA-B6-A1KN-01 TCGA-B6-A1KN-01A-11D-A13L-09 TCGA-B6-A1KN-01 TCGA-B6-A1KN-01A-11D-A13L-09 71b773fb-1efb-4d0f-9499-110ba937ade6 TCGA-B6-A1KN-01A-11D-A13J-01 TCGA-B6-A1KN-01 71b773fb-1efb-4d0f-9499-110ba937ade6 TCGA-B6-A1KN-01A-11D-A13J-01 TCGA-B6-A2IU-01 LumA TCGA-B6-A2IU-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-B6-A2IU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES 62 Right Axillary lymph node dissection alone TCGA-B6-A2IU-F38907 TCGA-B6-A2IU TCGA-B6-A2IU-01A Positive Positive Modified Radical Mastectomy NO -22905 4665 0 5176 4224 image cytometry 2013-1-3 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 140 NO NO 28 Negative Indeterminate (neither Pre or Postmenopausal) Other, specify New Primary Tumor Lung NO YES 0 true No M0 N0 T2 Stage IIA TCGA-B6-A2IU.EE769039-220E-4158-8999-09F17AFB4C46.pdf A2IU WITH TUMOR image cytometry YES YES YES Primary Tumor 01 5th NO YES B6 Breast A LIVING 1998 71a6367e-a876-4f1e-b80c-0e2d7d02e7cd 71a6367e-a876-4f1e-b80c-0e2d7d02e7cd TCGA-B6-A2IU-01A-21-A24A-20 TCGA-B6-A2IU-01 TCGA-B6-A2IU-01A-32D-A18O-05 fe9fb778-16b4-47ef-84a1-e5f74c25ae59 TCGA-B6-A2IU-01 TCGA-B6-A2IU-01A-32D-A19T-09 TCGA-B6-A2IU-01 71a6367e-a876-4f1e-b80c-0e2d7d02e7cd TCGA-B6-A2IU-01A-32D-A18N-01 TCGA-B6-A2IU-01 71a6367e-a876-4f1e-b80c-0e2d7d02e7cd TCGA-B6-A2IU-01A-32D-A18N-01 TCGA-B6-A3ZX-01 TCGA-B6-A3ZX-01 TCGA-B6-A3ZX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES 50 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-B6-A3ZX-F59573 TCGA-B6-A3ZX Negative Negative 4 Point Scale 1+ 4 Point Scale Lumpectomy Negative Lumpectomy NO -18434 1152 0 1132 1096 994 <10% 2014-6-3 FEMALE <10% 1+ Mixed Histology (please specify) ductal and lobular No C50.9 8522/3 C50.9 1+ YES Core needle biopsy Negative NO 7 Close Bone Bone Distant Metastasis YES YES 1 No M1 N1 T3 Stage IV A3ZX WITH TUMOR YES YES <10% YES Primary Tumor 01 6th NO YES B6 Breast DECEASED 2007 e89806d3-1cd5-4bc0-8e8a-edf823d8f110 e89806d3-1cd5-4bc0-8e8a-edf823d8f110 TCGA-B6-A3ZX-01 TCGA-B6-A3ZX-01A-11D-A23D-05 TCGA-B6-A3ZX-01 TCGA-B6-A3ZX-01A-11D-A23C-09 TCGA-B6-A3ZX-01 e89806d3-1cd5-4bc0-8e8a-edf823d8f110 TCGA-B6-A3ZX-01A-11D-A238-01 TCGA-B6-A3ZX-01 e89806d3-1cd5-4bc0-8e8a-edf823d8f110 TCGA-B6-A3ZX-01A-11D-A238-01 TCGA-B6-A400-01 TCGA-B6-A400-01 TCGA-B6-A400 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-B6-A400-F59655 TCGA-B6-A400 TCGA-B6-A400-01A Negative 4 Point Scale 1+ 4 Point Scale Negative Lumpectomy NO -16022 1610 0 215 <10% 2014-6-3 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Tumor resection 20 NO Negative YES 5 Negative NO 4 true No M0 N2a T2 Stage IIIA TCGA-B6-A400.AF83CCA2-3AA4-4933-B6AD-9C11DF501DDD.pdf A400 TUMOR FREE YES YES <10% YES Primary Tumor 01 6th NO YES B6 Breast A LIVING 2008 6b70d210-9cbd-44bc-a770-a075fd0d4672 6b70d210-9cbd-44bc-a770-a075fd0d4672 TCGA-B6-A400-01 TCGA-B6-A400-01A-11D-A23D-05 TCGA-B6-A400-01 TCGA-B6-A400-01A-11D-A23C-09 TCGA-B6-A400-01 6b70d210-9cbd-44bc-a770-a075fd0d4672 TCGA-B6-A400-01A-11D-A238-01 TCGA-B6-A400-01 6b70d210-9cbd-44bc-a770-a075fd0d4672 TCGA-B6-A400-01A-11D-A238-01 TCGA-B6-A401-01 TCGA-B6-A401-01 TCGA-B6-A401 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-B6-A401-F59658 TCGA-B6-A401 TCGA-B6-A401-01A Positive 4 Point Scale 3+ 4 Point Scale Positive Lumpectomy NO -17438 1935 0 2596 80-89% 2014-6-3 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 30 NO Negative NO 4 Negative NO 1 true No M0 N1a T1c Stage IIA TCGA-B6-A401.D76CF03A-54CD-4769-87AA-466473F41FC7.pdf A401 TUMOR FREE NO YES 90-99% NO Primary Tumor 01 6th NO YES B6 Breast A LIVING 2007 2a591fdd-c9e5-4c6e-90f8-8f993450a8d7 2a591fdd-c9e5-4c6e-90f8-8f993450a8d7 TCGA-B6-A401-01 TCGA-B6-A401-01A-11D-A23D-05 TCGA-B6-A401-01 TCGA-B6-A401-01A-11D-A23C-09 TCGA-B6-A401-01 2a591fdd-c9e5-4c6e-90f8-8f993450a8d7 TCGA-B6-A401-01A-11D-A238-01 TCGA-B6-A401-01 2a591fdd-c9e5-4c6e-90f8-8f993450a8d7 TCGA-B6-A401-01A-11D-A238-01 TCGA-B6-A402-01 TCGA-B6-A402-01 TCGA-B6-A402 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 47 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-B6-A402-F60751 TCGA-B6-A402 TCGA-B6-A402-01A Negative 4 Point Scale 1+ 4 Point Scale Negative Lumpectomy YES -17314 1563 0 2134 2330 <10% 2014-7-8 FEMALE <10% 1+ 4.4 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Core needle biopsy 10 NO Negative NO 3 Negative Positive 2+ Positive <10% <10% 4.1 3 Point Scale 2+ 2+ Negative 70-79% Negative 3.1 3 Point Scale Other, specify Locoregional Recurrence Lymph Node NO YES 0 0 true No M0 N0 (i-) T1c Stage I TCGA-B6-A402.9BC704DE-0914-49F1-80F9-36CFE52B8484.pdf A402 WITH TUMOR YES YES <10% YES Primary Tumor 01 6th NO YES B6 Breast A LIVING 2008 976a1b88-ed7a-493a-8ac9-3d504edfbc76 976a1b88-ed7a-493a-8ac9-3d504edfbc76 TCGA-B6-A402-01 TCGA-B6-A402-01A-11D-A23D-05 TCGA-B6-A402-01 TCGA-B6-A402-01A-11D-A23C-09 TCGA-B6-A402-01 976a1b88-ed7a-493a-8ac9-3d504edfbc76 TCGA-B6-A402-01A-11D-A238-01 TCGA-B6-A402-01 976a1b88-ed7a-493a-8ac9-3d504edfbc76 TCGA-B6-A402-01A-11D-A238-01 TCGA-B6-A408-01 TCGA-B6-A408-01 TCGA-B6-A408 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left Axillary lymph node dissection alone TCGA-B6-A408-F59666 TCGA-B6-A408 Positive 4 Point Scale 3+ 4 Point Scale Positive Simple Mastectomy NO -20102 0 2072 90-99% 2.6 2014-6-3 FEMALE 20-29% 2+ 60 2.9 1.2 Mixed Histology (please specify) ductal and lobular No C50.9 8522/3 C50.9 3+ YES Tumor resection Equivocal Negative NO 23 Negative NO 10 No M0 N3a T2 Stage IIIC A408 TUMOR FREE YES YES 60-69% YES Primary Tumor 01 6th NO YES B6 Breast LIVING 2008 bbb7f769-ac55-4e7f-b0bf-acc36294bb05 bbb7f769-ac55-4e7f-b0bf-acc36294bb05 TCGA-B6-A408-01 TCGA-B6-A408-01A-12D-A244-05 TCGA-B6-A408-01 TCGA-B6-A408-01A-12D-A243-09 TCGA-B6-A408-01 bbb7f769-ac55-4e7f-b0bf-acc36294bb05 TCGA-B6-A408-01A-12D-A242-01 TCGA-B6-A408-01 bbb7f769-ac55-4e7f-b0bf-acc36294bb05 TCGA-B6-A408-01A-12D-A242-01 TCGA-B6-A409-01 TCGA-B6-A409-01 TCGA-B6-A409 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-B6-A409 TCGA-B6-A409-01A Negative 4 Point Scale 1+ 4 Point Scale Negative Simple Mastectomy NO -16178 1480 573 0 <10% 1.8 2012-9-20 FEMALE 10-19% 1+ 60 2 1.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Fine needle aspiration biopsy 20 NO Equivocal Negative 22 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) YES 6 true No M0 N2a T1c Stage IIIA TCGA-B6-A409.CC77BA51-CE5A-4839-A27A-DD8F389A2733.pdf A409 WITH TUMOR YES YES <10% NO Primary Tumor 01 6th NO YES B6 Breast A DECEASED 2008 4d9bb08c-d954-4e14-aff2-3bec55cdf1c1 4d9bb08c-d954-4e14-aff2-3bec55cdf1c1 TCGA-B6-A409-01 TCGA-B6-A409-01A-11D-A244-05 TCGA-B6-A409-01 TCGA-B6-A409-01A-11D-A243-09 TCGA-B6-A409-01 4d9bb08c-d954-4e14-aff2-3bec55cdf1c1 TCGA-B6-A409-01A-11D-A242-01 TCGA-B6-A409-01 4d9bb08c-d954-4e14-aff2-3bec55cdf1c1 TCGA-B6-A409-01A-11D-A242-01 TCGA-B6-A40B-01 TCGA-B6-A40B-01 TCGA-B6-A40B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-B6-A40B-F59661 TCGA-B6-A40B TCGA-B6-A40B-01A Positive 4 Point Scale 3+ 4 Point Scale Positive Lumpectomy YES -27811 2467 0 3152 90-99% 2014-6-3 FEMALE <10% 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 10 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 (i-) T1b Stage I TCGA-B6-A40B.CB2E56BC-16AC-4BFE-AB6C-2FC7E48943BB.pdf A40B TUMOR FREE NO YES 90-99% NO Primary Tumor 01 6th NO YES B6 Breast A LIVING 2005 40c7e862-e1f6-4425-af9d-c9d07161a2ed 40c7e862-e1f6-4425-af9d-c9d07161a2ed TCGA-B6-A40B-01 TCGA-B6-A40B-01A-11D-A23D-05 TCGA-B6-A40B-01 TCGA-B6-A40B-01A-11D-A23C-09 TCGA-B6-A40B-01 40c7e862-e1f6-4425-af9d-c9d07161a2ed TCGA-B6-A40B-01A-11D-A238-01 TCGA-B6-A40B-01 40c7e862-e1f6-4425-af9d-c9d07161a2ed TCGA-B6-A40B-01A-11D-A238-01 TCGA-B6-A40C-01 TCGA-B6-A40C-01 TCGA-B6-A40C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-B6-A40C-F59660 TCGA-B6-A40C Positive 4 Point Scale 3+ 4 Point Scale Positive Simple Mastectomy YES -18852 0 2164 50-59% 2014-6-3 FEMALE <10% 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy Negative NO 3 Negative NO 0 0 No M0 N0 (i-) T3 Stage IIB A40C TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES B6 Breast LIVING 2005 e04bddbb-224b-4c6c-a8c8-88fd42a52ac5 e04bddbb-224b-4c6c-a8c8-88fd42a52ac5 TCGA-B6-A40C-01 TCGA-B6-A40C-01A-11D-A23D-05 TCGA-B6-A40C-01 TCGA-B6-A40C-01A-11D-A23C-09 TCGA-B6-A40C-01 e04bddbb-224b-4c6c-a8c8-88fd42a52ac5 TCGA-B6-A40C-01A-11D-A238-01 TCGA-B6-A40C-01 e04bddbb-224b-4c6c-a8c8-88fd42a52ac5 TCGA-B6-A40C-01A-11D-A238-01 TCGA-BH-A0AU-01 Stage IIA 45 1 Stage IIA 746 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 746 0 LumB Luminal B Positive ReacI -3 -3 enrollment T_Other T2 LIVING TCGA-BH-A0AU-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0AU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Inner Quadrant TCGA-BH-A0AU-F60769 TCGA-BH-A0AU TCGA-BH-A0AU-01A Positive Positive Other -16688 583 0 1914 NO 2014-6-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Positive Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 0 true No M0 N0 T2 Stage IIA TCGA-BH-A0AU.4C942A1D-53B2-43A6-9B96-5155CCDEEC34.pdf A0AU TUMOR FREE NO YES YES Primary Tumor 01 left segmental mastectomy with sentinel node dissection 6th NO YES BH Breast A LIVING 2008 d448433c-3c4b-4371-b749-f96af8da2237 d448433c-3c4b-4371-b749-f96af8da2237 TCGA-BH-A0AU-01A-21-A13C-20 TCGA-BH-A0AU-01A-11D-A12Q-09 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01A-11D-A12R-05 6b8a5434-3207-46f0-836b-542e427d22d5 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01A-11D-A12Q-09 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01A-11D-A12Q-09 d448433c-3c4b-4371-b749-f96af8da2237 TCGA-BH-A0AU-01A-11D-A12N-01 TCGA-BH-A0AU-01 TCGA-BH-A0AU-01A-11R-A12P-07 d448433c-3c4b-4371-b749-f96af8da2237 TCGA-BH-A0AU-01A-11D-A12N-01 TCGA-BH-A0AU-01 TCGA-BH-A0AU-11 45 746 FEMALE 746 0 Normal enrollment LIVING TCGA-BH-A0AU-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0AU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Inner Quadrant TCGA-BH-A0AU-F60769 TCGA-BH-A0AU Positive Positive Other -16688 0 1914 NO 2014-6-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 No M0 N0 T2 Stage IIA A0AU TUMOR FREE NO YES YES Solid Tissue Normal 11 left segmental mastectomy with sentinel node dissection 6th NO YES BH Breast LIVING 2008 eb7e6bfc-79ad-4674-9d58-2cbad8c65658 eb7e6bfc-79ad-4674-9d58-2cbad8c65658 TCGA-BH-A0AU-11A-11D-A12R-05 TCGA-BH-A0AU-11 eb7e6bfc-79ad-4674-9d58-2cbad8c65658 TCGA-BH-A0AU-11 TCGA-BH-A0AU-11A-11R-A12P-07 eb7e6bfc-79ad-4674-9d58-2cbad8c65658 TCGA-BH-A0AV-01 Stage I 52 1 Stage I 1180 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1180 0 Basal Basal-like Negative ReacII -13 0 enrollment T1 T1 LIVING TCGA-BH-A0AV-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0AV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Inner Quadrant TCGA-BH-A0AV-F59174 TCGA-BH-A0AV TCGA-BH-A0AV-01A Negative Negative Other -19314 761 0 1820 NO 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 250 NO Negative NO 2 Negative 5 4 NO 0 true No M0 N0 T1c Stage I TCGA-BH-A0AV.6DFA6F0F-09BC-4246-87B9-247207B74A39.pdf A0AV TUMOR FREE YES YES YES Primary Tumor 01 Segmental mastectomy with left axillary lymph node dissection 6th NO YES BH Breast A LIVING 2008 afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93 afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93 TCGA-BH-A0AV-01A-21-A13C-20 TCGA-BH-A0AV-01A-31D-A10Y-09 TCGA-BH-A0AV-01 9a298279-0097-4dfc-bfb0-b119b92d1fd7 TCGA-BH-A0AV-01 TCGA-BH-A0AV-01A-31D-A10Y-09 TCGA-BH-A0AV-01A-31D-A112-05 TCGA-BH-A0AV-01 TCGA-BH-A0AV-01 TCGA-BH-A0AV-01A-31D-A10Y-09 afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93 TCGA-BH-A0AV-01A-31D-A111-01 TCGA-BH-A0AV-01 TCGA-BH-A0AV-01A-31R-A115-07 afe0fbfe-18e0-4b80-a44c-7abe3c7e5c93 TCGA-BH-A0AV-01A-31D-A111-01 TCGA-BH-A0AV-01 TCGA-BH-A0AW-01 Stage IIA 56 3 No_Conversion 622 Positive FEMALE Positive Negative M0 Positive N1 622 0 Her2 HER2-enriched Negative -11 -5 followup T1 T1 LIVING TCGA-BH-A0AW-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-BH-A0AW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0AW-F15445 TCGA-BH-A0AW TCGA-BH-A0AW-01A Positive Negative Lumpectomy NO -20468 545 0 622 ER Positive H-Score 95 Scheduled Follow-up Submission 2010-11-3 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 50 NO Positive 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 5 NO 2 0 true No M0 N1a T1c Stage IIA TCGA-BH-A0AW.D1B30DA1-FF63-4FC7-AB8B-818331EE6D72.pdf A0AW TUMOR FREE PR Negative H-Score 0 H-Score H-Score YES Primary Tumor 01 YES NO YES BH Breast A LIVING 2008 8b615995-6210-4dd5-bf58-cf8a109d7648 8b615995-6210-4dd5-bf58-cf8a109d7648 TCGA-BH-A0AW-01A-11W-A071-09 TCGA-BH-A0AW-01 TCGA-BH-A0AW-01A-11D-A10P-05 TCGA-BH-A0AW-01 TCGA-BH-A0AW-01A-11W-A071-09 TCGA-BH-A0AW-01 TCGA-BH-A0AW-01A-11W-A071-09 TCGA-BH-A0AW-01 8b615995-6210-4dd5-bf58-cf8a109d7648 TCGA-BH-A0AW-01 TCGA-BH-A0AW-01A-11D-A059-01 TCGA-BH-A0AW-01A-11R-A056-07 8b615995-6210-4dd5-bf58-cf8a109d7648 TCGA-BH-A0AW-01A-11D-A059-01 TCGA-BH-A0AW-01 TCGA-BH-A0AY-01 Stage IIA 62 3 Stage IIA 777 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 777 0 LumA Luminal B Positive ReacI -1 -3 followup T_Other T2 LIVING TCGA-BH-A0AY-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0AY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Lower Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0AY-F15456 TCGA-BH-A0AY TCGA-BH-A0AY-01A Positive Positive Simple Mastectomy NO -22703 587 0 777 Scheduled Follow-up Submission 2010-11-3 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0AY.06905BD3-4D17-4625-8631-46CA81D1B47B.pdf A0AY TUMOR FREE NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2008 80817359-b0f0-4bea-ada4-b48bea37f5d2 80817359-b0f0-4bea-ada4-b48bea37f5d2 TCGA-BH-A0AY-01A-11-A13B-20 TCGA-BH-A0AY-01A-21W-A019-09 TCGA-BH-A0AY-01 71b12add-c266-433f-b842-86be8893fb06 TCGA-BH-A0AY-01 TCGA-BH-A0AY-01A-21W-A019-09 TCGA-BH-A0AY-01A-21D-A00Y-05 TCGA-BH-A0AY-01 TCGA-BH-A0AY-01A-21W-A019-09 TCGA-BH-A0AY-01 80817359-b0f0-4bea-ada4-b48bea37f5d2 TCGA-BH-A0AY-01 TCGA-BH-A0AY-01A-21D-A011-01 TCGA-BH-A0AY-01A-21R-A00Z-07 80817359-b0f0-4bea-ada4-b48bea37f5d2 TCGA-BH-A0AY-01A-21D-A011-01 TCGA-BH-A0AY-01 TCGA-BH-A0AY-11 62 777 FEMALE 777 0 Normal followup LIVING TCGA-BH-A0AY-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0AY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Lower Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0AY-F15456 TCGA-BH-A0AY TCGA-BH-A0AY-11A Positive Positive Simple Mastectomy NO -22703 587 0 777 Scheduled Follow-up Submission 2010-11-3 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 360 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 (i-) T2 Stage IIA A0AY TUMOR FREE NO Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2008 d9c8ecc3-0e92-49e9-99e4-9976785c73a6 d9c8ecc3-0e92-49e9-99e4-9976785c73a6 TCGA-BH-A0AY-11A-23D-A10Q-05 80042D05-76C1-40BE-90E4-5391A86314E9 TCGA-BH-A0AY-11 d9c8ecc3-0e92-49e9-99e4-9976785c73a6 TCGA-BH-A0AY-11 TCGA-BH-A0AY-11A-23R-A089-07 d9c8ecc3-0e92-49e9-99e4-9976785c73a6 TCGA-BH-A0AZ-01 Stage IIIA 47 2 Stage IIIA 867 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 867 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T3 LIVING TCGA-BH-A0AZ-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0AZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right TCGA-BH-A0AZ-F58602 TCGA-BH-A0AZ Positive Positive Other -17465 0 1919 NO 2014-4-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 NO 1 No cM0 (i+) N1a T3 Stage IIIA A0AZ TUMOR FREE YES YES NO Primary Tumor 01 total mastectomy with sentinel lymph node biopsy with tissue reconstruction 6th NO YES BH Breast LIVING 2008 cb9d4717-15a8-4499-ae3b-e047e5c2926a cb9d4717-15a8-4499-ae3b-e047e5c2926a TCGA-BH-A0AZ-01A-11-A13A-20 TCGA-BH-A0AZ-01A-21D-A12Q-09 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01A-21D-A12R-05 e7b4dae9-ba72-4281-a84c-9207120cfd65 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01A-21D-A12Q-09 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01A-21D-A12Q-09 cb9d4717-15a8-4499-ae3b-e047e5c2926a TCGA-BH-A0AZ-01A-21D-A12N-01 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-01A-21R-A12P-07 cb9d4717-15a8-4499-ae3b-e047e5c2926a TCGA-BH-A0AZ-01A-21D-A12N-01 TCGA-BH-A0AZ-01 TCGA-BH-A0AZ-11 47 867 FEMALE 867 0 Normal enrollment LIVING TCGA-BH-A0AZ-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0AZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right TCGA-BH-A0AZ-F58602 TCGA-BH-A0AZ Positive Positive Other -17465 0 1919 NO 2014-4-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 No cM0 (i+) N1a T3 Stage IIIA A0AZ TUMOR FREE YES YES NO Solid Tissue Normal 11 total mastectomy with sentinel lymph node biopsy with tissue reconstruction 6th NO YES BH Breast LIVING 2008 ec31d946-74b0-4984-b3d8-cb1bf58e4d20 ec31d946-74b0-4984-b3d8-cb1bf58e4d20 TCGA-BH-A0AZ-11A-22D-A12R-05 TCGA-BH-A0AZ-11 ec31d946-74b0-4984-b3d8-cb1bf58e4d20 TCGA-BH-A0AZ-11 ec31d946-74b0-4984-b3d8-cb1bf58e4d20 TCGA-BH-A0B0-01 Stage I 56 2 Stage I 1427 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 1427 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING TCGA-BH-A0B0-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 3 TCGA-BH-A0B0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant TCGA-BH-A0B0-F59204 TCGA-BH-A0B0 TCGA-BH-A0B0-01A Positive Positive Other -20776 1223 0 2477 NO 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 320 NO Negative NO 2 Negative Peri (6-12 months since last menstrual period) 1 6 NO 0 true No M0 N0 T1c Stage I TCGA-BH-A0B0.EB09D890-879C-4874-AE3F-47E41C2C66FE.pdf A0B0 TUMOR FREE YES YES YES Primary Tumor 01 left segmental mastectomy with axillary sentinel lymph node biopsy 6th NO YES BH Breast A LIVING 2006 059c8834-efd5-447c-97c6-49fd68c09c0d 059c8834-efd5-447c-97c6-49fd68c09c0d TCGA-BH-A0B0-01A-11-A13C-20 TCGA-BH-A0B0-01A-21D-A10Y-09 TCGA-BH-A0B0-01 3e408dd6-0e42-4310-909b-95a91fe6cd3c TCGA-BH-A0B0-01 TCGA-BH-A0B0-01A-21D-A10Y-09 TCGA-BH-A0B0-01A-21D-A112-05 TCGA-BH-A0B0-01 TCGA-BH-A0B0-01 TCGA-BH-A0B0-01A-21D-A10Y-09 059c8834-efd5-447c-97c6-49fd68c09c0d TCGA-BH-A0B0-01A-21D-A111-01 TCGA-BH-A0B0-01 TCGA-BH-A0B0-01A-21R-A115-07 059c8834-efd5-447c-97c6-49fd68c09c0d TCGA-BH-A0B0-01A-21D-A111-01 TCGA-BH-A0B0-01 TCGA-BH-A0B1-01 Stage IIB 66 No_Conversion 1148 Positive FEMALE Negative Negative M0 Positive N1 1148 0 LumA Luminal A Positive LumA/B -3 -3 followup T_Other T2 LIVING TCGA-BH-A0B1-01 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0B1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0B1-F15429 TCGA-BH-A0B1 TCGA-BH-A0B1-01A Positive 3+ Positive Modified Radical Mastectomy NO -24315 1071 0 1148 90-99% Scheduled Follow-up Submission 2010-11-3 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 740 NO Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 6 NO 1 0 true No M0 N1a T2 Stage IIB TCGA-BH-A0B1.BAEB6705-FCDC-4B40-B1CB-D926B8287F92.pdf A0B1 TUMOR FREE 40-49% YES Primary Tumor 01 YES NO YES BH Breast A LIVING 2007 0042b857-502f-4d8e-baac-845c1a9bb64b 0042b857-502f-4d8e-baac-845c1a9bb64b TCGA-BH-A0B1-01A-21-A13C-20 TCGA-BH-A0B1-01A-12W-A071-09 TCGA-BH-A0B1-01 cb0ffa62-bbfe-481a-9eda-099f9381319e TCGA-BH-A0B1-01A-12W-A071-09 TCGA-BH-A0B1-01A-12W-A071-09 TCGA-BH-A0B1-01 0042b857-502f-4d8e-baac-845c1a9bb64b TCGA-BH-A0B1-01 TCGA-BH-A0B1-01A-12R-A056-07 0042b857-502f-4d8e-baac-845c1a9bb64b TCGA-BH-A0B1-01 TCGA-BH-A0B2-01 Stage I 43 Stage I 1242 Positive FEMALE Negative Negative M0 Negative N0 1242 0 LumA Positive enrollment T1 T1 LIVING TCGA-BH-A0B2-01 BRCA nonbasal-like c8 TCGA-BH-A0B2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast TCGA-BH-A0B2-01A 1031 220 NO true TCGA-BH-A0B2.81FABA8A-1F6A-43DD-80F2-2466A7E8664E.pdf Primary Tumor 01 A a27c5907-1ad2-4414-a9c9-448f1b484946 a27c5907-1ad2-4414-a9c9-448f1b484946 TCGA-BH-A0B2-01A-21-A13C-20 TCGA-BH-A0B2-01A-11D-A10N-05 2cdcaddf-2dd3-492b-a08f-71adc1065fec TCGA-BH-A0B2-01 a27c5907-1ad2-4414-a9c9-448f1b484946 TCGA-BH-A0B2-01 TCGA-BH-A0B2-01A-11D-A10L-01 TCGA-BH-A0B2-01A-11R-A10J-07 a27c5907-1ad2-4414-a9c9-448f1b484946 TCGA-BH-A0B2-01A-11D-A10L-01 TCGA-BH-A0B2-11 43 1242 FEMALE 1242 0 Normal enrollment LIVING TCGA-BH-A0B2-11 TCGA-BH-A0B2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast TCGA-BH-A0B2-11A 1031 130 NO true Solid Tissue Normal 11 A 83b0bb89-66a7-4c70-87e1-78a0cc7de9e6 83b0bb89-66a7-4c70-87e1-78a0cc7de9e6 TCGA-BH-A0B2-11A-11D-A10N-05 83b0bb89-66a7-4c70-87e1-78a0cc7de9e6 TCGA-BH-A0B2-11A-11R-A10J-07 83b0bb89-66a7-4c70-87e1-78a0cc7de9e6 TCGA-BH-A0B3-01 Stage IIB 53 1 No_Conversion 1203 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1203 0 Basal Basal-like Negative Basal -13 -12 followup T_Other T2 LIVING TCGA-BH-A0B3-01 High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0B3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0B3-F15418 TCGA-BH-A0B3 TCGA-BH-A0B3-01A Negative 0 Negative Other NO -19479 1030 0 1203 Scheduled Follow-up Submission 2010-11-3 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 280 NO Negative 29 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO 2 true No M0 N1a T2 Stage IIB TCGA-BH-A0B3.A6E2735B-AAD3-48D7-8289-306257CB5B6F.pdf A0B3 TUMOR FREE YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2007 6d2744ba-4817-482b-ad46-2e4e0897ad88 6d2744ba-4817-482b-ad46-2e4e0897ad88 TCGA-BH-A0B3-01A-21-A13A-20 TCGA-BH-A0B3-01A-11W-A071-09 TCGA-BH-A0B3-01 TCGA-BH-A0B3-01A-11D-A10P-05 971d0c2f-844b-45a2-a541-05189e0278d4 TCGA-BH-A0B3-01 TCGA-BH-A0B3-01A-11W-A071-09 TCGA-BH-A0B3-01 TCGA-BH-A0B3-01A-11W-A071-09 TCGA-BH-A0B3-01 6d2744ba-4817-482b-ad46-2e4e0897ad88 TCGA-BH-A0B3-01 TCGA-BH-A0B3-01A-11D-A059-01 TCGA-BH-A0B3-01A-11R-A056-07 6d2744ba-4817-482b-ad46-2e4e0897ad88 TCGA-BH-A0B3-01A-11D-A059-01 TCGA-BH-A0B3-01 TCGA-BH-A0B3-11 53 1203 FEMALE 1203 0 Normal followup LIVING TCGA-BH-A0B3-11 C4-BRCA/Basal mutation cluster 5 TCGA-BH-A0B3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0B3-F15418 TCGA-BH-A0B3 Negative 0 Negative Other NO -19479 0 1203 Scheduled Follow-up Submission 2010-11-3 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy Negative 29 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 No M0 N1a T2 Stage IIB A0B3 TUMOR FREE YES Solid Tissue Normal 11 Segmental mastectomy YES NO YES BH Breast LIVING 2007 bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437 bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437 TCGA-BH-A0B3-11B-21D-A10Q-05 TCGA-BH-A0B3-11 bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437 TCGA-BH-A0B3-11 TCGA-BH-A0B3-11B-21R-A089-07 bc387ac9-46c2-49b5-9dbb-2d2b5ea2d437 TCGA-BH-A0B4-01 Stage IIIA 65 5 No_Conversion 1191 Positive MALE Positive 1 3 3 Negative M0 Positive N2 1191 0 LumA Luminal A Positive ReacII -3 -3 followup T_Other T2 LIVING TCGA-BH-A0B4-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0B4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Axillary lymph node dissection alone TCGA-BH-A0B4-F15435 TCGA-BH-A0B4 TCGA-BH-A0B4-01A Positive 3+ Positive Modified Radical Mastectomy NO -23980 995 0 1191 80-89% 2.0 Scheduled Follow-up Submission 2010-11-4 MALE 2+ 40 5.65 2.83 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 340 NO Equivocal Positive 10 Negative 4 6 NO 6 true No M0 N2 T2 Stage IIIA TCGA-BH-A0B4.00C75246-4343-490D-9782-E6C0068C77B2.pdf A0B4 TUMOR FREE 50-59% YES Primary Tumor 01 YES NO YES BH Breast A LIVING 2007 8af4a557-aebf-44ac-8ed5-b8b7b10ed24e 8af4a557-aebf-44ac-8ed5-b8b7b10ed24e TCGA-BH-A0B4-01A-21-A13C-20 TCGA-BH-A0B4-01A-11W-A019-09 TCGA-BH-A0B4-01 8406b2cf-e6f8-40ac-b0e9-f63535cc3574 TCGA-BH-A0B4-01 TCGA-BH-A0B4-01A-11W-A019-09 TCGA-BH-A0B4-01A-11D-A00Y-05 TCGA-BH-A0B4-01 TCGA-BH-A0B4-01A-11W-A019-09 TCGA-BH-A0B4-01 8af4a557-aebf-44ac-8ed5-b8b7b10ed24e TCGA-BH-A0B4-01 TCGA-BH-A0B4-01A-11D-A011-01 TCGA-BH-A0B4-01A-11R-A00Z-07 8af4a557-aebf-44ac-8ed5-b8b7b10ed24e TCGA-BH-A0B4-01A-11D-A011-01 TCGA-BH-A0B4-01 TCGA-BH-A0B5-01 Stage IIIA 40 2 Stage IIIA 1471 Positive FEMALE Negative 1 3 4 Negative M0 Positive N2 1471 0 LumA Luminal B Positive ReacII -7 -3 enrollment T_Other T2 LIVING TCGA-BH-A0B5-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 1 TCGA-BH-A0B5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left TCGA-BH-A0B5-F59182 TCGA-BH-A0B5 TCGA-BH-A0B5-01A Positive Positive Modified Radical Mastectomy -14920 1008 0 2136 NO 2014-5-2 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 700 NO Negative NO 24 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 7 NO 5 true No M0 N2a T2 Stage IIIA TCGA-BH-A0B5.F44C515D-5A58-4382-A147-4429A78D434F.pdf A0B5 TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES BH Breast A LIVING 2007 4b964043-f6dd-4f19-ab4c-439ee68ce2b0 4b964043-f6dd-4f19-ab4c-439ee68ce2b0 TCGA-BH-A0B5-01A-21-A13C-20 TCGA-BH-A0B5-01A-11D-A12Q-09 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01A-11D-A12R-05 e6f7c6af-6c88-4305-a8f4-d8ea46f8b302 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01A-11D-A12Q-09 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01A-11D-A12Q-09 4b964043-f6dd-4f19-ab4c-439ee68ce2b0 TCGA-BH-A0B5-01A-11D-A12N-01 TCGA-BH-A0B5-01 TCGA-BH-A0B5-01A-11R-A12P-07 4b964043-f6dd-4f19-ab4c-439ee68ce2b0 TCGA-BH-A0B5-01A-11D-A12N-01 TCGA-BH-A0B5-01 TCGA-BH-A0B5-11 40 1471 FEMALE 1471 0 LumA enrollment LIVING TCGA-BH-A0B5-11 C3-BRCA/Luminal mutation cluster 1 TCGA-BH-A0B5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left TCGA-BH-A0B5-F59182 TCGA-BH-A0B5 TCGA-BH-A0B5-11A Positive Positive Modified Radical Mastectomy -14920 1008 0 2136 NO 2014-5-2 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 600 NO Negative NO 24 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 5 true No M0 N2a T2 Stage IIIA A0B5 TUMOR FREE YES YES YES Solid Tissue Normal 11 6th NO YES BH Breast A LIVING 2007 35429f42-252a-4a9d-8e99-125f26019418 35429f42-252a-4a9d-8e99-125f26019418 35429f42-252a-4a9d-8e99-125f26019418 TCGA-BH-A0B5-11A-23R-A12P-07 35429f42-252a-4a9d-8e99-125f26019418 TCGA-BH-A0B6-01 TCGA-BH-A0B6-01 Squamous BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 3 TCGA-BH-A0B6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant TCGA-BH-A0B6-F61943 TCGA-BH-A0B6 Positive Positive Other -17346 0 2483 NO 2014-7-10 FEMALE Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Positive NO 4 Negative NO 0 Yes M0 N0 T1c Stage I A0B6 TUMOR FREE NO YES YES Primary Tumor 01 segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast LIVING 2006 b455387f-a8b4-43b8-b898-89628723d7da b455387f-a8b4-43b8-b898-89628723d7da TCGA-BH-A0B6-01A-21-A24A-20 TCGA-BH-A0B6-01 TCGA-BH-A0B6-01A-11D-A19Z-05 e7cb5207-9749-4bfb-9982-58a8efca7a8f TCGA-BH-A0B6-01 TCGA-BH-A0B6-01A-11D-A19Y-09 b455387f-a8b4-43b8-b898-89628723d7da TCGA-BH-A0B6-01A-11D-A19X-01 b455387f-a8b4-43b8-b898-89628723d7da TCGA-BH-A0B6-01A-11D-A19X-01 TCGA-BH-A0B7-01 Stage IIB 42 3 Stage IIB 1733 Positive FEMALE Positive 2 2 1 Negative M0 Positive N1 1733 0 Her2 HER2-enriched Positive Her2 -11 -8 enrollment T_Other T2 LIVING TCGA-BH-A0B7-01 High C3-BRCA/Luminal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-BH-A0B7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Right TCGA-BH-A0B7-F58717 TCGA-BH-A0B7 TCGA-BH-A0B7-01A Positive Positive Other -15593 1391 0 2559 NO 2014-4-22 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 320 NO Positive NO 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO 1 true No M0 N1a T2 Stage IIB TCGA-BH-A0B7.B5E5A3B8-108E-47D3-99DA-EC7A64B5FA9C.pdf A0B7 TUMOR FREE YES YES YES Primary Tumor 01 right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP 6th NO YES BH Breast A LIVING 2006 2af2adfe-bd7b-4eb1-9971-182b11075159 2af2adfe-bd7b-4eb1-9971-182b11075159 TCGA-BH-A0B7-01A-21-A13B-20 TCGA-BH-A0B7-01A-12D-A10Y-09 TCGA-BH-A0B7-01 c759e411-0873-4535-8b6d-ed41dd2e6fba TCGA-BH-A0B7-01 TCGA-BH-A0B7-01A-12D-A10Y-09 TCGA-BH-A0B7-01A-12D-A112-05 TCGA-BH-A0B7-01 TCGA-BH-A0B7-01 TCGA-BH-A0B7-01A-12D-A10Y-09 2af2adfe-bd7b-4eb1-9971-182b11075159 TCGA-BH-A0B7-01A-12D-A111-01 TCGA-BH-A0B7-01 TCGA-BH-A0B7-01A-12R-A115-07 2af2adfe-bd7b-4eb1-9971-182b11075159 TCGA-BH-A0B7-01A-12D-A111-01 TCGA-BH-A0B7-01 TCGA-BH-A0B7-11 42 1733 FEMALE 1733 0 Normal enrollment LIVING TCGA-BH-A0B7-11 C3-BRCA/Luminal mutation cluster 5 TCGA-BH-A0B7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Right TCGA-BH-A0B7-F58717 TCGA-BH-A0B7 TCGA-BH-A0B7-11A Positive Positive Other -15593 1391 0 2559 NO 2014-4-22 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 930 NO Positive NO 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 true No M0 N1a T2 Stage IIB A0B7 TUMOR FREE YES YES YES Solid Tissue Normal 11 right total mastectomy with sentinel lymph node dissection right reconstruction with TRAMP 6th NO YES BH Breast A LIVING 2006 30cee921-7fb5-4543-aeb6-ab3eaf669f84 30cee921-7fb5-4543-aeb6-ab3eaf669f84 A353AE14-6488-43F1-A9D1-BBD0C66D0814 TCGA-BH-A0B7-11A-34D-A112-05 TCGA-BH-A0B7-11 30cee921-7fb5-4543-aeb6-ab3eaf669f84 TCGA-BH-A0B7-11 TCGA-BH-A0B7-11A-34R-A115-07 30cee921-7fb5-4543-aeb6-ab3eaf669f84 TCGA-BH-A0B8-01 Stage IB 64 Stage I 1569 Positive FEMALE Negative Negative M0 Negative N0 1569 0 LumA Luminal A Positive -10 -3 followup T1 T1 LIVING TCGA-BH-A0B8-01 cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation c1uster 9 TCGA-BH-A0B8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Inner Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0B8-F15442 TCGA-BH-A0B8 Positive 3+ Positive Lumpectomy NO -23380 0 1569 90-99% Scheduled Follow-up Submission 2010-11-3 FEMALE 2+ 1.29 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Equivocal Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 7 NO 0 No M0 N0 (i-) T1b Stage I A0B8 TUMOR FREE 30-39% YES Primary Tumor 01 YES NO YES BH Breast LIVING 2006 de7eef02-1a8d-4a6a-9d87-e2b1430066e3 de7eef02-1a8d-4a6a-9d87-e2b1430066e3 TCGA-BH-A0B8-01A-21W-A071-09 TCGA-BH-A0B8-01 TCGA-BH-A0B8-01A-21D-A10P-05 TCGA-BH-A0B8-01A-21W-A071-09 TCGA-BH-A0B8-01A-21W-A071-09 TCGA-BH-A0B8-01 de7eef02-1a8d-4a6a-9d87-e2b1430066e3 TCGA-BH-A0B8-01 TCGA-BH-A0B8-01A-21R-A056-07 de7eef02-1a8d-4a6a-9d87-e2b1430066e3 TCGA-BH-A0B8-01 TCGA-BH-A0B8-11 64 1569 FEMALE 1569 0 Normal followup LIVING TCGA-BH-A0B8-11 mutation c1uster 9 TCGA-BH-A0B8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Inner Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0B8-F15442 TCGA-BH-A0B8 TCGA-BH-A0B8-11A Positive 3+ Positive Lumpectomy NO -23380 1401 0 1569 90-99% Scheduled Follow-up Submission 2010-11-3 FEMALE 2+ 1.29 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 400 NO Equivocal Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 (i-) T1b Stage I A0B8 TUMOR FREE 30-39% YES Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2006 61e357f3-e4e1-49b8-9e37-7e0ef5a29e23 61e357f3-e4e1-49b8-9e37-7e0ef5a29e23 TCGA-BH-A0B8-11A-41D-A093-05 61e357f3-e4e1-49b8-9e37-7e0ef5a29e23 TCGA-BH-A0B8-11A-41R-A089-07 61e357f3-e4e1-49b8-9e37-7e0ef5a29e23 TCGA-BH-A0B9-01 Stage IA 44 1 Stage I 1572 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 1572 0 Basal-like Negative Basal -13 -12 followup T1 T1 LIVING TCGA-BH-A0B9-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 miRNA cluster 14 cluster 5 mutation cluster 5 TCGA-BH-A0B9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0B9-F15438 TCGA-BH-A0B9 TCGA-BH-A0B9-01A Negative 0 Negative Other NO -16310 1391 0 1572 Scheduled Follow-up Submission 2010-11-4 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 190 NO Negative 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 5 NO 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0B9.EB00527B-1E37-420E-85E4-10063DB4BC1C.pdf A0B9 TUMOR FREE YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2006 d5c39754-79c3-432c-b496-34a394662e17 d5c39754-79c3-432c-b496-34a394662e17 TCGA-BH-A0B9-01A-21-A13C-20 TCGA-BH-A0B9-01A-11W-A071-09 TCGA-BH-A0B9-01 TCGA-BH-A0B9-01A-11D-A10P-05 99bf951a-a4c0-424e-bdf5-4308ec20f38d TCGA-BH-A0B9-01 TCGA-BH-A0B9-01A-11W-A071-09 TCGA-BH-A0B9-01 TCGA-BH-A0B9-01A-11W-A071-09 TCGA-BH-A0B9-01 d5c39754-79c3-432c-b496-34a394662e17 TCGA-BH-A0B9-01 TCGA-BH-A0B9-01A-11D-A059-01 TCGA-BH-A0B9-01A-11R-A056-07 d5c39754-79c3-432c-b496-34a394662e17 TCGA-BH-A0B9-01A-11D-A059-01 TCGA-BH-A0B9-01 TCGA-BH-A0BA-01 Stage IIIC 51 3 No_Conversion 1132 Positive FEMALE Negative 1 4 3 Negative M0 Positive N3 1132 0 LumA Luminal A Positive ReacI -5 0 followup T_Other T3 LIVING TCGA-BH-A0BA-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-BH-A0BA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BA-F15461 TCGA-BH-A0BA TCGA-BH-A0BA-01A Positive 1+ Positive Modified Radical Mastectomy NO -18839 1266 0 1132 80-89% Scheduled Follow-up Submission 2010-11-4 FEMALE 1+ Mixed Histology (please specify) Infiltrating ductal & lobular No C50.9 8522/3 C50.9 3+ YES Core needle biopsy 360 NO Negative 27 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 6 NO 27 true No M0 N3a T3 Stage IIIC TCGA-BH-A0BA.142F03FE-5B60-416D-8DCD-EC34DB5495DB.pdf A0BA TUMOR FREE 40-49% YES Primary Tumor 01 YES NO YES BH Breast A LIVING 2006 651d6ca6-8e1c-4c5a-b7f4-1af98b415561 651d6ca6-8e1c-4c5a-b7f4-1af98b415561 TCGA-BH-A0BA-01A-21-A13C-20 TCGA-BH-A0BA-01A-11W-A071-09 TCGA-BH-A0BA-01 TCGA-BH-A0BA-01A-11D-A10P-05 348679c1-9edf-44d0-96e2-83602db6c2e7 TCGA-BH-A0BA-01 TCGA-BH-A0BA-01A-11W-A071-09 TCGA-BH-A0BA-01 TCGA-BH-A0BA-01A-11W-A071-09 TCGA-BH-A0BA-01 651d6ca6-8e1c-4c5a-b7f4-1af98b415561 TCGA-BH-A0BA-01 TCGA-BH-A0BA-01A-11D-A059-01 TCGA-BH-A0BA-01A-11R-A056-07 651d6ca6-8e1c-4c5a-b7f4-1af98b415561 TCGA-BH-A0BA-01A-11D-A059-01 TCGA-BH-A0BA-01 TCGA-BH-A0BA-11 51 1132 FEMALE 1132 0 Normal followup LIVING TCGA-BH-A0BA-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0BA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BA-F15461 TCGA-BH-A0BA TCGA-BH-A0BA-11A Positive 1+ Positive Modified Radical Mastectomy NO -18839 1266 0 1132 80-89% Scheduled Follow-up Submission 2010-11-4 FEMALE 1+ Mixed Histology (please specify) Infiltrating ductal & lobular No C50.9 8522/3 C50.9 3+ YES Core needle biopsy 220 NO Negative 27 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 27 true No M0 N3a T3 Stage IIIC A0BA TUMOR FREE 40-49% YES Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2006 3bfd1811-bd2a-439d-8dde-237abcf855af 3bfd1811-bd2a-439d-8dde-237abcf855af TCGA-BH-A0BA-11A-22D-A10Q-05 3bfd1811-bd2a-439d-8dde-237abcf855af TCGA-BH-A0BA-11A-22R-A089-07 3bfd1811-bd2a-439d-8dde-237abcf855af TCGA-BH-A0BC-01 Stage IIIC 60 2 No_Conversion 974 Positive FEMALE Negative 3 4 3 Negative M0 Positive N3 974 0 LumA Luminal A Positive ReacI -4 -4 followup T_Other T2 LIVING TCGA-BH-A0BC-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-BH-A0BC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BC-F4487 TCGA-BH-A0BC TCGA-BH-A0BC-01A Positive 1+ Positive Other NO -21949 1098 0 974 90-99% 2010-11-4 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 160 NO Negative 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 12 true No M0 N3 T2 Stage IIIC TCGA-BH-A0BC.9714A9F8-B507-43E6-9D56-1852F5D1F675.pdf A0BC TUMOR FREE 30-39% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2007 9fc55d1c-ecb6-4406-bf25-34f59a0dcfec 9fc55d1c-ecb6-4406-bf25-34f59a0dcfec TCGA-BH-A0BC-01A-11-A13B-20 TCGA-BH-A0BC-01A-22D-A099-09 TCGA-BH-A0BC-01 TCGA-BH-A0BC-01A-22D-A10P-05 6b66ea4c-8556-4fc6-8014-f99e59727021 TCGA-BH-A0BC-01 TCGA-BH-A0BC-01A-22D-A099-09 TCGA-BH-A0BC-01 TCGA-BH-A0BC-01A-22D-A099-09 TCGA-BH-A0BC-01 9fc55d1c-ecb6-4406-bf25-34f59a0dcfec TCGA-BH-A0BC-01 TCGA-BH-A0BC-01A-22D-A087-01 TCGA-BH-A0BC-01A-22R-A084-07 9fc55d1c-ecb6-4406-bf25-34f59a0dcfec TCGA-BH-A0BC-01A-22D-A087-01 TCGA-BH-A0BC-01 TCGA-BH-A0BC-11 60 974 FEMALE 974 0 Normal followup LIVING TCGA-BH-A0BC-11 C3-BRCA/Luminal mutation cluster 3 TCGA-BH-A0BC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BC-F4487 TCGA-BH-A0BC TCGA-BH-A0BC-11A Positive 1+ Positive Other NO -21949 1098 0 974 90-99% 2010-11-4 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 200 NO Negative 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 12 true No M0 N3 T2 Stage IIIC A0BC TUMOR FREE 30-39% YES Solid Tissue Normal 11 Segmental mastectomy YES NO YES BH Breast A LIVING 2007 32336250-dc07-4e96-9a6c-3c7094fd5342 32336250-dc07-4e96-9a6c-3c7094fd5342 TCGA-BH-A0BC-11A-22D-A093-05 TCGA-BH-A0BC-11 32336250-dc07-4e96-9a6c-3c7094fd5342 TCGA-BH-A0BC-11 TCGA-BH-A0BC-11A-22R-A089-07 32336250-dc07-4e96-9a6c-3c7094fd5342 TCGA-BH-A0BD-01 Stage IIA 47 4 No_Conversion 554 Positive FEMALE Negative Negative M0 Positive N1 554 0 LumB Luminal B Positive 0 0 followup T1 T1 LIVING TCGA-BH-A0BD-01 Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A0BD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BD-F15423 TCGA-BH-A0BD Positive Positive Other NO -17275 0 554 H-Score-190 Scheduled Follow-up Submission 2010-11-4 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 2 No M0 N1a T1c Stage IIA A0BD TUMOR FREE H-Score-230 H-Score H-Score YES Primary Tumor 01 segmental mastectomy 6th YES NO YES BH Breast LIVING 2009 bf23a402-18ab-47b7-8bca-a9b01eeaf605 bf23a402-18ab-47b7-8bca-a9b01eeaf605 TCGA-BH-A0BD-01A-11W-A050-09 TCGA-BH-A0BD-01 TCGA-BH-A0BD-01 TCGA-BH-A0BD-01A-11W-A050-09 TCGA-BH-A0BD-01A-11D-A032-05 TCGA-BH-A0BD-01 TCGA-BH-A0BD-01A-11W-A050-09 TCGA-BH-A0BD-01 bf23a402-18ab-47b7-8bca-a9b01eeaf605 TCGA-BH-A0BD-01 TCGA-BH-A0BD-01A-11D-A036-01 TCGA-BH-A0BD-01A-11R-A034-07 bf23a402-18ab-47b7-8bca-a9b01eeaf605 TCGA-BH-A0BD-01A-11D-A036-01 TCGA-BH-A0BD-01 TCGA-BH-A0BF-01 Stage IIB 56 2 Stage IIB 781 Positive FEMALE Negative 3 1 4 Negative M0 Positive N1 781 0 LumB Luminal B Positive Basal -2 -5 enrollment T_Other T2 LIVING TCGA-BH-A0BF-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-BH-A0BF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Outer Quadrant TCGA-BH-A0BF-F59142 TCGA-BH-A0BF TCGA-BH-A0BF-01A Positive Positive Other -20691 413 1324 0 782 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 260 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 1 true No M0 N1mi T2 Stage IIB TCGA-BH-A0BF.0D76394C-40B4-4E74-8A80-FAE00E21FD10.pdf A0BF TUMOR FREE NO YES NO Primary Tumor 01 Total mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A DECEASED 2009 3491d44a-675b-4510-8699-2ee83f960d02 3491d44a-675b-4510-8699-2ee83f960d02 TCGA-BH-A0BF-01A-11-A13C-20 TCGA-BH-A0BF-01A-21D-A12Q-09 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01A-21D-A12R-05 3d84a5c4-09f1-44f6-9ae6-dcb6a3c19b81 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01A-21D-A12Q-09 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01A-21D-A12Q-09 3491d44a-675b-4510-8699-2ee83f960d02 TCGA-BH-A0BF-01A-21D-A12N-01 TCGA-BH-A0BF-01 TCGA-BH-A0BF-01A-21R-A12P-07 3491d44a-675b-4510-8699-2ee83f960d02 TCGA-BH-A0BF-01A-21D-A12N-01 TCGA-BH-A0BF-01 TCGA-BH-A0BF-11 56 781 FEMALE 781 0 enrollment LIVING TCGA-BH-A0BF-11 C3-BRCA/Luminal mutation cluster 3 TCGA-BH-A0BF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Outer Quadrant TCGA-BH-A0BF-F59142 TCGA-BH-A0BF TCGA-BH-A0BF-11A Positive Positive Other -20691 413 1324 0 782 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No M0 N1mi T2 Stage IIB A0BF TUMOR FREE NO YES NO Solid Tissue Normal 11 Total mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A DECEASED 2009 TCGA-BH-A0BF-11A-31D-A12R-05 TCGA-BH-A0BG-01 Stage I 73 1 Stage I 756 Negative FEMALE Negative Negative M0 Negative N0 756 0 Basal Basal-like Negative -13 -12 enrollment T1 T1 LIVING TCGA-BH-A0BG-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA c1uster 9 cluster 4 mutation cluster 5 TCGA-BH-A0BG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left Lower Outer Quadrant TCGA-BH-A0BG-F58615 TCGA-BH-A0BG TCGA-BH-A0BG-01A Negative Negative Other -26988 798 0 1871 NO 2014-4-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 50 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO 0 true No M0 N0 T1 Stage I TCGA-BH-A0BG.CB0C2E8E-2D5D-492C-9C7E-0ECD0458425A.pdf A0BG TUMOR FREE NO YES YES Primary Tumor 01 Segmental mastectomy with sentinel axillary lymph node biopsy 6th NO YES BH Breast A LIVING 2008 70b29dd6-1688-4510-94dd-5fcb26a1a908 70b29dd6-1688-4510-94dd-5fcb26a1a908 TCGA-BH-A0BG-01A-11D-A10Y-09 TCGA-BH-A0BG-01 TCGA-BH-A0BG-01 TCGA-BH-A0BG-01A-11D-A10Y-09 TCGA-BH-A0BG-01A-11D-A112-05 TCGA-BH-A0BG-01 TCGA-BH-A0BG-01 TCGA-BH-A0BG-01A-11D-A10Y-09 70b29dd6-1688-4510-94dd-5fcb26a1a908 TCGA-BH-A0BG-01A-11D-A111-01 TCGA-BH-A0BG-01 TCGA-BH-A0BG-01A-11R-A115-07 70b29dd6-1688-4510-94dd-5fcb26a1a908 TCGA-BH-A0BG-01A-11D-A111-01 TCGA-BH-A0BG-01 TCGA-BH-A0BJ-01 Stage IIB 41 3 No_Conversion 660 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 660 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T2 LIVING TCGA-BH-A0BJ-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation c1uster 9 TCGA-BH-A0BJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BJ-F4480 TCGA-BH-A0BJ TCGA-BH-A0BJ-01A Positive 3+ Positive Other NO -15027 595 0 660 H-Score 300 90-99% 2010-11-15 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 110 NO Negative 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 7 2 true No M0 N1a T2 Stage IIB TCGA-BH-A0BJ.A3CDF051-4162-47EC-BE8A-1519A5564518.pdf A0BJ TUMOR FREE H-Score 260 H-Score H Score 70-79% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2008 224cbe13-ebf8-41eb-ab1c-1d6792a66774 224cbe13-ebf8-41eb-ab1c-1d6792a66774 TCGA-BH-A0BJ-01A-21-A13A-20 TCGA-BH-A0BJ-01A-11W-A071-09 TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-01A-11D-A10P-05 188575e2-83fd-4463-8bd3-aed928b5acf0 TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-01A-11W-A071-09 TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-01A-11W-A071-09 TCGA-BH-A0BJ-01 224cbe13-ebf8-41eb-ab1c-1d6792a66774 TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-01A-11D-A059-01 TCGA-BH-A0BJ-01A-11R-A056-07 224cbe13-ebf8-41eb-ab1c-1d6792a66774 TCGA-BH-A0BJ-01A-11D-A059-01 TCGA-BH-A0BJ-01 TCGA-BH-A0BJ-11 41 660 FEMALE 660 0 Normal followup LIVING TCGA-BH-A0BJ-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0BJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BJ-F4480 TCGA-BH-A0BJ TCGA-BH-A0BJ-11A Positive 3+ Positive Other NO -15027 595 0 660 H-Score 300 90-99% 2010-11-15 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 200 NO Negative 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 true No M0 N1a T2 Stage IIB A0BJ TUMOR FREE H-Score 260 H-Score H Score 70-79% YES Solid Tissue Normal 11 Segmental mastectomy YES NO YES BH Breast A LIVING 2008 4317b197-dc43-44f2-8854-557832570098 4317b197-dc43-44f2-8854-557832570098 TCGA-BH-A0BJ-11A-23D-A10Q-05 TCGA-BH-A0BJ-11 4317b197-dc43-44f2-8854-557832570098 TCGA-BH-A0BJ-11 TCGA-BH-A0BJ-11A-23R-A089-07 4317b197-dc43-44f2-8854-557832570098 TCGA-BH-A0BL-01 Stage I 35 3 Stage I 1339 Negative FEMALE Negative Negative M0 Negative N0 1339 0 Basal Basal-like Negative -13 -12 enrollment T1 T1 LIVING TCGA-BH-A0BL-01 BRCA-LUAD+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c8 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0BL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Upper Outer Quadrant TCGA-BH-A0BL-F59189 TCGA-BH-A0BL TCGA-BH-A0BL-01A Negative Negative Other -12841 1135 0 2278 NO 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 60 NO Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 4 NO 0 true No M0 N0 T1c Stage I TCGA-BH-A0BL.DD647293-3CEA-4845-A0B3-D7000CBAB4C0.pdf A0BL TUMOR FREE YES YES NO Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A LIVING 2007 39ca8590-3733-4b61-9a46-4ec5e6e0501e 39ca8590-3733-4b61-9a46-4ec5e6e0501e TCGA-BH-A0BL-01A-11D-A10Y-09 TCGA-BH-A0BL-01 TCGA-BH-A0BL-01 TCGA-BH-A0BL-01A-11D-A10Y-09 TCGA-BH-A0BL-01A-11D-A112-05 TCGA-BH-A0BL-01 TCGA-BH-A0BL-01 TCGA-BH-A0BL-01A-11D-A10Y-09 39ca8590-3733-4b61-9a46-4ec5e6e0501e TCGA-BH-A0BL-01A-11D-A111-01 TCGA-BH-A0BL-01 TCGA-BH-A0BL-01A-11R-A115-07 39ca8590-3733-4b61-9a46-4ec5e6e0501e TCGA-BH-A0BL-01A-11D-A111-01 TCGA-BH-A0BL-01 TCGA-BH-A0BL-11 35 1339 FEMALE 1339 0 enrollment LIVING TCGA-BH-A0BL-11 C4-BRCA/Basal mutation cluster 5 TCGA-BH-A0BL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Upper Outer Quadrant TCGA-BH-A0BL-F59189 TCGA-BH-A0BL TCGA-BH-A0BL-11A Negative Negative Other -12841 1135 0 2278 NO 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 50 NO Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 T1c Stage I A0BL TUMOR FREE YES YES NO Solid Tissue Normal 11 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A LIVING 2007 TCGA-BH-A0BL-11A-12D-A112-05 TCGA-BH-A0BM-01 Stage IIB 54 2 No_Conversion 1117 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1117 0 LumA Luminal A Negative ReacI -5 -7 enrollment T_Other T2 LIVING TCGA-BH-A0BM-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-BH-A0BM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BM-F34064 TCGA-BH-A0BM TCGA-BH-A0BM-01A Positive 0 Negative Lumpectomy NO -20049 1080 0 1876 Scheduled Follow-up Submission 2012-7-29 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 100 NO Negative 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 3 true No M0 N1a T2 Stage IIB TCGA-BH-A0BM.7F75F15A-2476-4FFD-97B3-313F06568E21.pdf A0BM TUMOR FREE NO Primary Tumor 01 6th YES NO YES BH Breast A LIVING 2007 986550fb-92db-4e9f-b79a-6c3023dd63a3 986550fb-92db-4e9f-b79a-6c3023dd63a3 TCGA-BH-A0BM-01A-21-A13B-20 TCGA-BH-A0BM-01A-11W-A071-09 TCGA-BH-A0BM-01 TCGA-BH-A0BM-01A-11D-A10P-05 f8cccdf6-fdf0-43a1-86f9-4897d845db8c TCGA-BH-A0BM-01 TCGA-BH-A0BM-01A-11W-A071-09 TCGA-BH-A0BM-01 TCGA-BH-A0BM-01A-11W-A071-09 TCGA-BH-A0BM-01 986550fb-92db-4e9f-b79a-6c3023dd63a3 TCGA-BH-A0BM-01 TCGA-BH-A0BM-01A-11D-A059-01 TCGA-BH-A0BM-01A-11R-A056-07 986550fb-92db-4e9f-b79a-6c3023dd63a3 TCGA-BH-A0BM-01A-11D-A059-01 TCGA-BH-A0BM-01 TCGA-BH-A0BM-11 54 1117 FEMALE 1117 0 Normal enrollment LIVING TCGA-BH-A0BM-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0BM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BM-F34064 TCGA-BH-A0BM TCGA-BH-A0BM-11A Positive 0 Negative Lumpectomy NO -20049 1080 0 1876 Scheduled Follow-up Submission 2012-7-29 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 100 NO Negative 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 3 true No M0 N1a T2 Stage IIB A0BM TUMOR FREE NO Solid Tissue Normal 11 6th YES NO YES BH Breast A LIVING 2007 fe538d53-c7ce-455f-afe6-cb4fc3a63dbd fe538d53-c7ce-455f-afe6-cb4fc3a63dbd TCGA-BH-A0BM-11A-12D-A093-05 fe538d53-c7ce-455f-afe6-cb4fc3a63dbd TCGA-BH-A0BM-11A-12R-A089-07 fe538d53-c7ce-455f-afe6-cb4fc3a63dbd TCGA-BH-A0BO-01 Stage I 54 1 Stage I 1085 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 1085 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING TCGA-BH-A0BO-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-BH-A0BO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Inner Quadrant TCGA-BH-A0BO-F61949 TCGA-BH-A0BO TCGA-BH-A0BO-01A Positive Positive Other -19767 1162 0 2197 NO 2014-7-10 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 290 NO Negative NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 NO 0 true No M0 N0 T1b Stage I TCGA-BH-A0BO.DDAB2FC2-D9F0-4D8F-A7FE-6C0B823E6823.pdf A0BO TUMOR FREE NO YES YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A LIVING 2007 682a9c8d-8174-4435-9ec8-cb2d58bbe6d5 682a9c8d-8174-4435-9ec8-cb2d58bbe6d5 TCGA-BH-A0BO-01A-11-A13B-20 TCGA-BH-A0BO-01A-23D-A12B-09 TCGA-BH-A0BO-01 6f30f209-57e0-4430-8132-4c36bcc0862c TCGA-BH-A0BO-01 TCGA-BH-A0BO-01A-23D-A12B-09 TCGA-BH-A0BO-01A-23D-A12E-05 TCGA-BH-A0BO-01 TCGA-BH-A0BO-01 TCGA-BH-A0BO-01A-23D-A12B-09 682a9c8d-8174-4435-9ec8-cb2d58bbe6d5 TCGA-BH-A0BO-01A-23D-A12A-01 TCGA-BH-A0BO-01 TCGA-BH-A0BO-01A-23R-A12D-07 682a9c8d-8174-4435-9ec8-cb2d58bbe6d5 TCGA-BH-A0BO-01A-23D-A12A-01 TCGA-BH-A0BO-01 TCGA-BH-A0BO-11 54 1085 FEMALE 1085 0 enrollment LIVING TCGA-BH-A0BO-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0BO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Inner Quadrant TCGA-BH-A0BO-F61949 TCGA-BH-A0BO TCGA-BH-A0BO-11A Positive Positive Other -19767 1162 0 2197 NO 2014-7-10 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 60 NO Negative NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 T1b Stage I A0BO TUMOR FREE NO YES YES Solid Tissue Normal 11 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A LIVING 2007 TCGA-BH-A0BO-11A-11D-A12E-05 TCGA-BH-A0BP-01 Stage I 76 2 Stage I 1481 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 1481 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING TCGA-BH-A0BP-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0BP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Upper Outer Quadrant TCGA-BH-A0BP-F59122 TCGA-BH-A0BP TCGA-BH-A0BP-01A Positive Positive Other -27917 1217 2296 0 1481 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 150 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 true No M0 N0 T1c Stage I TCGA-BH-A0BP.2444E1FE-E0AB-4AA0-9081-967426B90EE6.pdf A0BP TUMOR FREE NO YES YES Primary Tumor 01 Segmental mastectomy 6th NO YES BH Breast A DECEASED 2006 acbae442-ba6c-4d28-b3bc-58bb4dd93ece acbae442-ba6c-4d28-b3bc-58bb4dd93ece TCGA-BH-A0BP-01A-21-A13C-20 TCGA-BH-A0BP-01A-11D-A10Y-09 TCGA-BH-A0BP-01 4ab91e5f-6fff-4de9-a249-9013a79f6a10 TCGA-BH-A0BP-01 TCGA-BH-A0BP-01A-11D-A10Y-09 TCGA-BH-A0BP-01A-11D-A112-05 TCGA-BH-A0BP-01 TCGA-BH-A0BP-01 TCGA-BH-A0BP-01A-11D-A10Y-09 acbae442-ba6c-4d28-b3bc-58bb4dd93ece TCGA-BH-A0BP-01A-11D-A111-01 TCGA-BH-A0BP-01 TCGA-BH-A0BP-01A-11R-A115-07 acbae442-ba6c-4d28-b3bc-58bb4dd93ece TCGA-BH-A0BP-01A-11D-A111-01 TCGA-BH-A0BP-01 TCGA-BH-A0BQ-01 Stage I 39 2 Stage I 826 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 826 0 LumA Luminal A Positive Her2 -5 -7 enrollment T1 T1 LIVING TCGA-BH-A0BQ-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0BQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left TCGA-BH-A0BQ-F58695 TCGA-BH-A0BQ TCGA-BH-A0BQ-01A Positive Positive Other -14494 1197 0 2255 1750 1709 NO 2014-4-22 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Positive NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 Other, specify Locoregional Recurrence Dermis and epidermis YES YES 0 true No M0 N0 T1c Stage I TCGA-BH-A0BQ.24245506-25BA-411D-8A43-52DB8F6B6037.pdf A0BQ TUMOR FREE NO YES NO Primary Tumor 01 Total mastectomy with retromammary lymph node excision 6th NO YES BH Breast A LIVING 2007 2ada4fe0-57f2-4a54-9580-4e0ae45a2f65 2ada4fe0-57f2-4a54-9580-4e0ae45a2f65 TCGA-BH-A0BQ-01A-11-A13C-20 TCGA-BH-A0BQ-01A-21D-A10Y-09 TCGA-BH-A0BQ-01 f74f1027-b835-4e74-976c-8a884db74123 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01A-21D-A10Y-09 TCGA-BH-A0BQ-01A-21D-A112-05 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01A-21D-A10Y-09 2ada4fe0-57f2-4a54-9580-4e0ae45a2f65 TCGA-BH-A0BQ-01A-21D-A111-01 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-01A-21R-A115-07 2ada4fe0-57f2-4a54-9580-4e0ae45a2f65 TCGA-BH-A0BQ-01A-21D-A111-01 TCGA-BH-A0BQ-01 TCGA-BH-A0BQ-11 39 826 FEMALE 826 0 Normal enrollment LIVING TCGA-BH-A0BQ-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0BQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left TCGA-BH-A0BQ-F58695 TCGA-BH-A0BQ TCGA-BH-A0BQ-11A Positive Positive Other -14494 1197 0 2255 1750 1709 NO 2014-4-22 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 340 NO Positive NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Other, specify Locoregional Recurrence Dermis and epidermis YES YES 0 true No M0 N0 T1c Stage I A0BQ TUMOR FREE NO YES NO Solid Tissue Normal 11 Total mastectomy with retromammary lymph node excision 6th NO YES BH Breast A LIVING 2007 4096c8a6-5ead-4410-8da1-a20b0f37cce8 4096c8a6-5ead-4410-8da1-a20b0f37cce8 TCGA-BH-A0BQ-11A-33D-A112-05 TCGA-BH-A0BQ-11 4096c8a6-5ead-4410-8da1-a20b0f37cce8 TCGA-BH-A0BQ-11 TCGA-BH-A0BQ-11A-33R-A115-07 4096c8a6-5ead-4410-8da1-a20b0f37cce8 TCGA-BH-A0BR-01 Stage I 59 1 Stage I 1632 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 1632 0 LumA Luminal A Positive ReacI -4 -3 enrollment T1 T1 LIVING TCGA-BH-A0BR-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation cluster 3 TCGA-BH-A0BR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Lower Inner Quadrant TCGA-BH-A0BR-F61951 TCGA-BH-A0BR TCGA-BH-A0BR-01A Positive Positive Other -21622 1170 0 2330 NO 2014-7-10 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 160 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 true No M0 N0 T1c Stage I TCGA-BH-A0BR.6122CE59-23C0-4205-91B5-B71E39C6EAB8.pdf A0BR TUMOR FREE NO YES YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A LIVING 2007 0ef20000-2c8e-47bb-86e5-ffa2814099a7 0ef20000-2c8e-47bb-86e5-ffa2814099a7 TCGA-BH-A0BR-01A-11-A13C-20 TCGA-BH-A0BR-01A-21W-A12T-09 TCGA-BH-A0BR-01 94b57709-97e9-4421-a146-e82570a42258 TCGA-BH-A0BR-01 TCGA-BH-A0BR-01A-21W-A12T-09 TCGA-BH-A0BR-01A-21D-A112-05 TCGA-BH-A0BR-01 TCGA-BH-A0BR-01 TCGA-BH-A0BR-01A-21W-A12T-09 0ef20000-2c8e-47bb-86e5-ffa2814099a7 TCGA-BH-A0BR-01A-21D-A111-01 TCGA-BH-A0BR-01 TCGA-BH-A0BR-01A-21R-A115-07 0ef20000-2c8e-47bb-86e5-ffa2814099a7 TCGA-BH-A0BR-01A-21D-A111-01 TCGA-BH-A0BR-01 TCGA-BH-A0BS-01 Stage IIIA 55 2 Stage IIIA 1640 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1640 0 LumA Luminal A Positive LumA/B 0 -2 enrollment T_Other T3 LIVING TCGA-BH-A0BS-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-BH-A0BS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left TCGA-BH-A0BS-F61955 TCGA-BH-A0BS TCGA-BH-A0BS-01A Positive Positive Simple Mastectomy -20374 1164 0 2612 NO 2014-8-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 180 NO Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 7 NO 0 true No M0 N1c T3 Stage IIIA TCGA-BH-A0BS.A231BC51-EFA3-4FEB-A83F-C793FFF8E607.pdf A0BS TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES BH Breast A LIVING 2007 354c08e2-61d3-4cfa-9d26-76d74dcfe44f 354c08e2-61d3-4cfa-9d26-76d74dcfe44f TCGA-BH-A0BS-01A-21-A13A-20 TCGA-BH-A0BS-01A-11D-A12Q-09 TCGA-BH-A0BS-01 TCGA-BH-A0BS-01A-11D-A12R-05 bc9af2fb-d022-40cc-9fca-685bd206e71b TCGA-BH-A0BS-01 TCGA-BH-A0BS-01A-11D-A12Q-09 TCGA-BH-A0BS-01 TCGA-BH-A0BS-01 TCGA-BH-A0BS-01A-11D-A12Q-09 354c08e2-61d3-4cfa-9d26-76d74dcfe44f TCGA-BH-A0BS-01A-11D-A12N-01 TCGA-BH-A0BS-01 TCGA-BH-A0BS-01A-11R-A12P-07 354c08e2-61d3-4cfa-9d26-76d74dcfe44f TCGA-BH-A0BS-01A-11D-A12N-01 TCGA-BH-A0BS-01 TCGA-BH-A0BS-11 55 1640 FEMALE 1640 0 Normal enrollment LIVING TCGA-BH-A0BS-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0BS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left TCGA-BH-A0BS-F61955 TCGA-BH-A0BS TCGA-BH-A0BS-11A Positive Positive Simple Mastectomy -20374 1164 0 2612 NO 2014-8-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N1c T3 Stage IIIA A0BS TUMOR FREE YES YES YES Solid Tissue Normal 11 6th NO YES BH Breast A LIVING 2007 10d54893-647f-40a9-8aa7-602e04d55faf 10d54893-647f-40a9-8aa7-602e04d55faf TCGA-BH-A0BS-11A-11D-A12R-05 TCGA-BH-A0BS-11 10d54893-647f-40a9-8aa7-602e04d55faf TCGA-BH-A0BS-11 TCGA-BH-A0BS-11A-11R-A12P-07 10d54893-647f-40a9-8aa7-602e04d55faf TCGA-BH-A0BT-01 Stage IIA 56 4 Stage IIA 1386 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1386 0 LumA Luminal A Positive ReacII -12 -3 enrollment T1 T1 LIVING TCGA-BH-A0BT-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 6 mutation cluster 3 TCGA-BH-A0BT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Inner Quadrant TCGA-BH-A0BT-F59143 TCGA-BH-A0BT TCGA-BH-A0BT-01A Positive Positive Other -20625 1167 0 2365 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 140 NO Negative NO Negative 2 6 NO true No M0 N1mi T1c Stage IIA TCGA-BH-A0BT.18E4043D-34BF-4CD1-9E2D-F906C7C7B019.pdf A0BT TUMOR FREE YES YES Primary Tumor 01 segmental mastectomy with sentinel lymph node excision and biopsy 6th NO YES BH Breast A LIVING 2007 fe8764cf-04ee-480d-96ce-09d0d388f4f6 fe8764cf-04ee-480d-96ce-09d0d388f4f6 TCGA-BH-A0BT-01A-21-A13C-20 TCGA-BH-A0BT-01A-11D-A12Q-09 TCGA-BH-A0BT-01 TCGA-BH-A0BT-01A-11D-A12R-05 99e5ad3c-e46a-4d06-9feb-33f1b3819e6f TCGA-BH-A0BT-01 TCGA-BH-A0BT-01A-11D-A12Q-09 TCGA-BH-A0BT-01 TCGA-BH-A0BT-01 TCGA-BH-A0BT-01A-11D-A12Q-09 fe8764cf-04ee-480d-96ce-09d0d388f4f6 TCGA-BH-A0BT-01A-11D-A12N-01 TCGA-BH-A0BT-01 TCGA-BH-A0BT-01A-11R-A12P-07 fe8764cf-04ee-480d-96ce-09d0d388f4f6 TCGA-BH-A0BT-01A-11D-A12N-01 TCGA-BH-A0BT-01 TCGA-BH-A0BT-11 56 1386 FEMALE 1386 0 Normal enrollment LIVING TCGA-BH-A0BT-11 C3-BRCA/Luminal mutation cluster 3 TCGA-BH-A0BT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Inner Quadrant TCGA-BH-A0BT-F59143 TCGA-BH-A0BT TCGA-BH-A0BT-11A Positive Positive Other -20625 1167 0 2365 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 130 NO Negative NO Negative NO true No M0 N1mi T1c Stage IIA A0BT TUMOR FREE YES YES Solid Tissue Normal 11 segmental mastectomy with sentinel lymph node excision and biopsy 6th NO YES BH Breast A LIVING 2007 8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef 8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef TCGA-BH-A0BT-11A-21D-A12R-05 TCGA-BH-A0BT-11 8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef TCGA-BH-A0BT-11 8e31c471-6f4b-4d2d-8594-5c2c91f6e5ef TCGA-BH-A0BV-01 Stage IIB 78 5 No_Conversion 1519 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 1519 0 LumA Luminal A Positive LumA/B 0 -4 followup T_Other T2 LIVING TCGA-BH-A0BV-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 4 TCGA-BH-A0BV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BV-F4513 TCGA-BH-A0BV TCGA-BH-A0BV-01A Positive 2+ Positive Modified Radical Mastectomy NO -28699 1328 0 1519 90-99% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 450 NO Negative 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 2 true No M0 N1a T2 Stage IIB TCGA-BH-A0BV.7C877EE0-B4BC-4B17-94AB-81B67C7B6DB3.pdf A0BV TUMOR FREE 50-59% NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2006 6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc 6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc TCGA-BH-A0BV-01A-21-A13B-20 TCGA-BH-A0BV-01A-11W-A019-09 TCGA-BH-A0BV-01 7815a57a-e2d9-42ae-93f3-6ddcf1f33ab2 TCGA-BH-A0BV-01 TCGA-BH-A0BV-01A-11W-A019-09 TCGA-BH-A0BV-01A-11D-A00Y-05 TCGA-BH-A0BV-01 TCGA-BH-A0BV-01A-11W-A019-09 TCGA-BH-A0BV-01 6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc TCGA-BH-A0BV-01 TCGA-BH-A0BV-01A-11D-A011-01 TCGA-BH-A0BV-01A-11R-A00Z-07 6dc89d5b-7613-4a0f-bbdc-ba13f51d12cc TCGA-BH-A0BV-01A-11D-A011-01 TCGA-BH-A0BV-01 TCGA-BH-A0BV-11 78 1519 FEMALE 1519 0 Normal followup LIVING TCGA-BH-A0BV-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0BV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0BV-F4513 TCGA-BH-A0BV TCGA-BH-A0BV-11A Positive 2+ Positive Modified Radical Mastectomy NO -28699 1328 0 1519 90-99% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 200 NO Negative 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 true No M0 N1a T2 Stage IIB A0BV TUMOR FREE 50-59% NO Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2006 452bf9da-c065-4d95-8272-adce3684a9e9 452bf9da-c065-4d95-8272-adce3684a9e9 TCGA-BH-A0BV-11A-31D-A10Q-05 TCGA-BH-A0BV-11 452bf9da-c065-4d95-8272-adce3684a9e9 TCGA-BH-A0BV-11 TCGA-BH-A0BV-11A-31R-A089-07 452bf9da-c065-4d95-8272-adce3684a9e9 TCGA-BH-A0BW-01 Stage I 71 1 Stage I 355 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 355 0 Basal Basal-like Negative Basal -13 -12 enrollment T1 T1 LIVING TCGA-BH-A0BW-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-BH-A0BW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Lower Outer Quadrant TCGA-BH-A0BW-F59127 TCGA-BH-A0BW TCGA-BH-A0BW-01A Negative Negative Other -25974 1344 0 2371 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 NO 0 true No M0 N0 T1c Stage I TCGA-BH-A0BW.14CE78F3-8FB4-476D-A09C-AE87F7919D77.pdf A0BW TUMOR FREE YES YES YES Primary Tumor 01 Segmental mastectomy 6th NO YES BH Breast A LIVING 2006 7e84df9f-1da5-4add-a5e8-a9d9d8af409c 7e84df9f-1da5-4add-a5e8-a9d9d8af409c TCGA-BH-A0BW-01A-21-A13B-20 TCGA-BH-A0BW-01A-11D-A10Y-09 TCGA-BH-A0BW-01 a5fc2a17-0d67-4a6f-ae45-373d3cc91129 TCGA-BH-A0BW-01 TCGA-BH-A0BW-01A-11D-A10Y-09 TCGA-BH-A0BW-01A-11D-A112-05 TCGA-BH-A0BW-01 TCGA-BH-A0BW-01 TCGA-BH-A0BW-01A-11D-A10Y-09 7e84df9f-1da5-4add-a5e8-a9d9d8af409c TCGA-BH-A0BW-01A-11D-A111-01 TCGA-BH-A0BW-01 TCGA-BH-A0BW-01A-11R-A115-07 7e84df9f-1da5-4add-a5e8-a9d9d8af409c TCGA-BH-A0BW-01A-11D-A111-01 TCGA-BH-A0BW-01 TCGA-BH-A0BW-11 71 355 FEMALE 355 0 Normal enrollment LIVING TCGA-BH-A0BW-11 C4-BRCA/Basal mutation c1uster 9 TCGA-BH-A0BW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Lower Outer Quadrant TCGA-BH-A0BW-F59127 TCGA-BH-A0BW Negative Negative Other -25974 0 2371 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T1c Stage I A0BW TUMOR FREE YES YES YES Solid Tissue Normal 11 Segmental mastectomy 6th NO YES BH Breast LIVING 2006 ca5076dc-0fb2-444f-b34f-305c8479cba3 ca5076dc-0fb2-444f-b34f-305c8479cba3 TCGA-BH-A0BW-11A-12D-A112-05 TCGA-BH-A0BW-11 ca5076dc-0fb2-444f-b34f-305c8479cba3 TCGA-BH-A0BW-11 TCGA-BH-A0BW-11A-12R-A115-07 ca5076dc-0fb2-444f-b34f-305c8479cba3 TCGA-BH-A0BZ-01 Stage IIIA 59 4 Stage IIIA 1492 Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 1492 0 LumB Luminal B Positive X -2 -5 enrollment T_Other T3 LIVING TCGA-BH-A0BZ-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 10 TCGA-BH-A0BZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left TCGA-BH-A0BZ-F58683 TCGA-BH-A0BZ TCGA-BH-A0BZ-01A Positive Positive Modified Radical Mastectomy -21856 1084 0 2255 NO 2014-4-21 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 830 NO Negative NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 1 true No M0 N1a T3 Stage IIIA TCGA-BH-A0BZ.1B56E5A6-35B8-4C60-8BC5-68716C946799.pdf A0BZ TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES BH Breast A LIVING 2007 317ffb84-f4a8-435b-907b-b05587d6515e 317ffb84-f4a8-435b-907b-b05587d6515e TCGA-BH-A0BZ-01A-21-A13B-20 TCGA-BH-A0BZ-01A-31D-A12Q-09 TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01A-31D-A12R-05 d2de5993-e58f-4d41-812b-2a355dd855ea TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01A-31D-A12Q-09 TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01A-31D-A12Q-09 317ffb84-f4a8-435b-907b-b05587d6515e TCGA-BH-A0BZ-01A-31D-A12N-01 TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-01A-31R-A12P-07 317ffb84-f4a8-435b-907b-b05587d6515e TCGA-BH-A0BZ-01A-31D-A12N-01 TCGA-BH-A0BZ-01 TCGA-BH-A0BZ-11 59 1492 FEMALE 1492 0 Normal enrollment LIVING TCGA-BH-A0BZ-11 C3-BRCA/Luminal mutation c1uster 10 TCGA-BH-A0BZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left TCGA-BH-A0BZ-F58683 TCGA-BH-A0BZ TCGA-BH-A0BZ-11A Positive Positive Modified Radical Mastectomy -21856 1084 0 2255 NO 2014-4-21 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 620 NO Negative NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No M0 N1a T3 Stage IIIA A0BZ TUMOR FREE YES YES YES Solid Tissue Normal 11 6th NO YES BH Breast A LIVING 2007 561e0da7-0e2c-430c-8a54-c9a3535a1679 561e0da7-0e2c-430c-8a54-c9a3535a1679 TCGA-BH-A0BZ-11A-61D-A12R-05 C3371B54-7D2D-4868-B8EF-E5C0466B0172 TCGA-BH-A0BZ-11 561e0da7-0e2c-430c-8a54-c9a3535a1679 TCGA-BH-A0BZ-11 TCGA-BH-A0BZ-11A-61R-A12P-07 561e0da7-0e2c-430c-8a54-c9a3535a1679 TCGA-BH-A0C0-01 Stage IIA 62 3 No_Conversion 1270 Positive FEMALE Positive 1 1 4 Negative M0 Positive N1 1270 0 LumB Luminal B Positive Basal -2 -5 followup T1 T1 LIVING TCGA-BH-A0C0-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0C0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0C0-F4518 TCGA-BH-A0C0 Positive Positive Other NO -23006 0 1270 90-99% 2.65 2010-11-16 FEMALE 2+ 40 12.45 4.7 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Equivocal Positive 35 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 1 No M0 N1a T1c Stage IIA A0C0 TUMOR FREE 60-69% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast LIVING 2007 f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c TCGA-BH-A0C0-01A-11-A13B-20 TCGA-BH-A0C0-01A-21W-A071-09 TCGA-BH-A0C0-01 TCGA-BH-A0C0-01A-21D-A10P-05 a4009327-f700-4c89-88fa-a560641ab193 TCGA-BH-A0C0-01 TCGA-BH-A0C0-01A-21W-A071-09 TCGA-BH-A0C0-01 TCGA-BH-A0C0-01A-21W-A071-09 TCGA-BH-A0C0-01 f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c TCGA-BH-A0C0-01 TCGA-BH-A0C0-01A-21D-A059-01 TCGA-BH-A0C0-01A-21R-A056-07 f8ac9655-03ed-4e14-a4d3-88f63ef6bf7c TCGA-BH-A0C0-01A-21D-A059-01 TCGA-BH-A0C0-01 TCGA-BH-A0C0-11 62 1270 FEMALE 1270 0 Normal followup LIVING TCGA-BH-A0C0-11 C3-BRCA/Luminal mutation cluster 5 TCGA-BH-A0C0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0C0-F4518 TCGA-BH-A0C0 TCGA-BH-A0C0-11A Positive Positive Other NO -23006 1094 0 1270 90-99% 2.65 2010-11-16 FEMALE 2+ 40 12.45 4.7 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 330 NO Equivocal Positive 35 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 true No M0 N1a T1c Stage IIA A0C0 TUMOR FREE 60-69% YES Solid Tissue Normal 11 Segmental mastectomy YES NO YES BH Breast A LIVING 2007 86c4b2fd-d034-469d-adfa-712055f30dc3 86c4b2fd-d034-469d-adfa-712055f30dc3 TCGA-BH-A0C0-11A-21D-A10Q-05 TCGA-BH-A0C0-11 86c4b2fd-d034-469d-adfa-712055f30dc3 TCGA-BH-A0C0-11 TCGA-BH-A0C0-11A-21R-A089-07 86c4b2fd-d034-469d-adfa-712055f30dc3 TCGA-BH-A0C1-01 Stage IIIA 61 2 Stage IIIA 1338 Positive FEMALE Negative 1 3 3 Negative M0 Positive N2 1338 0 LumA Luminal A Positive ReacII -1 -1 enrollment T_Other T3 LIVING TCGA-BH-A0C1-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-BH-A0C1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right TCGA-BH-A0C1-F63399 TCGA-BH-A0C1 TCGA-BH-A0C1-01B Positive Positive Modified Radical Mastectomy -22377 1073 1411 0 1339 1123 YES 2014-8-7 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 250 NO Negative NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 Bone Distant Metastasis YES 8 true No M0 N2a T3 Stage IIIA TCGA-BH-A0C1.1EC74EB3-9ECC-49B6-AE25-048A5F6A1D02.pdf A0C1 WITH TUMOR YES YES YES Primary Tumor 01 6th NO YES BH Breast B DECEASED 2007 73b732bb-f387-4618-a2a3-8c7db1c75fd8 73b732bb-f387-4618-a2a3-8c7db1c75fd8 TCGA-BH-A0C1-01B-21-A13D-20 TCGA-BH-A0C1-01B-11D-A12B-09 TCGA-BH-A0C1-01 dc364a19-d15e-4c8e-8d9b-cbd70b27d532 TCGA-BH-A0C1-01 TCGA-BH-A0C1-01B-11D-A12B-09 TCGA-BH-A0C1-01B-11D-A12E-05 TCGA-BH-A0C1-01 TCGA-BH-A0C1-01 TCGA-BH-A0C1-01B-11D-A12B-09 73b732bb-f387-4618-a2a3-8c7db1c75fd8 TCGA-BH-A0C1-01B-11D-A12A-01 TCGA-BH-A0C1-01 TCGA-BH-A0C1-01B-11R-A12D-07 73b732bb-f387-4618-a2a3-8c7db1c75fd8 TCGA-BH-A0C1-01B-11D-A12A-01 TCGA-BH-A0C1-01 TCGA-BH-A0C3-01 Stage I 47 3 Stage I 1464 Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 1464 0 LumB Luminal B Negative Her2 -4 0 enrollment T1 T1 LIVING TCGA-BH-A0C3-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-BH-A0C3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left TCGA-BH-A0C3-F63533 TCGA-BH-A0C3 TCGA-BH-A0C3-01A Positive Negative Other -17221 1335 0 2709 2674 NO 2014-8-12 FEMALE Mixed Histology (please specify) with ductal and lobular phenotypes No C50.9 8522/3 C50.9 YES Core needle biopsy 160 NO Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 Bone Distant Metastasis YES 0 true No M0 N0 T1c Stage I TCGA-BH-A0C3.3A54CF6E-AFDB-4609-A827-77D75BB376A7.pdf A0C3 WITH TUMOR YES YES YES Primary Tumor 01 Segmental mastectomy with sentinel node biopsy 6th NO YES BH Breast A LIVING 2006 52a863fe-b210-456b-9c2d-545277362b65 52a863fe-b210-456b-9c2d-545277362b65 TCGA-BH-A0C3-01A-11-A13C-20 TCGA-BH-A0C3-01A-21D-A12Q-09 TCGA-BH-A0C3-01 TCGA-BH-A0C3-01A-21D-A12R-05 42fa3207-2c4f-4499-99b8-fe5275232eed TCGA-BH-A0C3-01 TCGA-BH-A0C3-01A-21D-A12Q-09 TCGA-BH-A0C3-01 TCGA-BH-A0C3-01 TCGA-BH-A0C3-01A-21D-A12Q-09 52a863fe-b210-456b-9c2d-545277362b65 TCGA-BH-A0C3-01A-21D-A12N-01 TCGA-BH-A0C3-01 TCGA-BH-A0C3-01A-21R-A12P-07 52a863fe-b210-456b-9c2d-545277362b65 TCGA-BH-A0C3-01A-21D-A12N-01 TCGA-BH-A0C3-01 TCGA-BH-A0C3-11 47 1464 FEMALE 1464 0 Normal enrollment LIVING TCGA-BH-A0C3-11 C3-BRCA/Luminal mutation cluster 5 TCGA-BH-A0C3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left TCGA-BH-A0C3-F63533 TCGA-BH-A0C3 TCGA-BH-A0C3-11A Positive Negative Other -17221 1335 0 2709 2674 NO 2014-8-12 FEMALE Mixed Histology (please specify) with ductal and lobular phenotypes No C50.9 8522/3 C50.9 YES Core needle biopsy 200 NO Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Bone Distant Metastasis YES 0 true No M0 N0 T1c Stage I A0C3 WITH TUMOR YES YES YES Solid Tissue Normal 11 Segmental mastectomy with sentinel node biopsy 6th NO YES BH Breast A LIVING 2006 65923c68-2c86-4b4d-abe2-5320c08bb68f 65923c68-2c86-4b4d-abe2-5320c08bb68f TCGA-BH-A0C3-11A-23D-A12R-05 TCGA-BH-A0C3-11 65923c68-2c86-4b4d-abe2-5320c08bb68f TCGA-BH-A0C3-11 TCGA-BH-A0C3-11A-23R-A12P-07 65923c68-2c86-4b4d-abe2-5320c08bb68f TCGA-BH-A0C7-01 Stage IIB 48 5 Stage IIB 1305 Positive FEMALE Positive 1 3 4 Negative M0 Positive N1 1305 0 LumB Luminal B Negative LumA/B 0 -3 enrollment T_Other T2 LIVING TCGA-BH-A0C7-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0C7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left TCGA-BH-A0C7-F59178 TCGA-BH-A0C7 TCGA-BH-A0C7-01B Positive Negative Simple Mastectomy -17871 1520 0 2767 NO 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 140 NO Positive NO 18 Negative Peri (6-12 months since last menstrual period) 4 4 NO 1 true No M0 N1mi T2 Stage IIB TCGA-BH-A0C7.880F3DC6-4342-4232-A04E-A128F1A8201D.pdf A0C7 TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES BH Breast B LIVING 2006 e58a6cf4-a4ff-4179-9671-a5661f380a8d e58a6cf4-a4ff-4179-9671-a5661f380a8d TCGA-BH-A0C7-01B-21-A13D-20 TCGA-BH-A0C7-01B-11D-A10Y-09 TCGA-BH-A0C7-01 0846b423-a60b-4c54-9224-b9d129fb3278 TCGA-BH-A0C7-01 TCGA-BH-A0C7-01B-11D-A10Y-09 TCGA-BH-A0C7-01B-11D-A112-05 TCGA-BH-A0C7-01 TCGA-BH-A0C7-01 TCGA-BH-A0C7-01B-11D-A10Y-09 e58a6cf4-a4ff-4179-9671-a5661f380a8d TCGA-BH-A0C7-01B-11D-A111-01 TCGA-BH-A0C7-01 TCGA-BH-A0C7-01B-11R-A115-07 e58a6cf4-a4ff-4179-9671-a5661f380a8d TCGA-BH-A0C7-01B-11D-A111-01 TCGA-BH-A0C7-01 TCGA-BH-A0DD-01 Stage IIB 58 3 Stage IIB 1393 Positive MALE Positive 1 3 4 Negative M0 Positive N1 1393 0 LumB Luminal B Positive LumA/B -6 -3 enrollment T_Other T2 LIVING TCGA-BH-A0DD-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A0DD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right TCGA-BH-A0DD-F60386 TCGA-BH-A0DD TCGA-BH-A0DD-01A Positive Positive Modified Radical Mastectomy -21386 1248 0 2486 NO 2014-6-9 MALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 430 NO Positive Positive NO 22 Negative 4 4 NO 0 true No M0 N1a T2 Stage IIB TCGA-BH-A0DD.35FFF2A4-7956-47AC-B6B8-1AA6775E332B.pdf A0DD TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES BH Breast A LIVING 2006 e15ff180-38d3-4614-88ee-3645afaab54b e15ff180-38d3-4614-88ee-3645afaab54b TCGA-BH-A0DD-01A-21-A13B-20 TCGA-BH-A0DD-01A-31D-A12Q-09 TCGA-BH-A0DD-01 TCGA-BH-A0DD-01A-31D-A12R-05 7ac181c9-6dba-4e27-a5fc-09cf02f735cf TCGA-BH-A0DD-01 TCGA-BH-A0DD-01A-31D-A12Q-09 TCGA-BH-A0DD-01 TCGA-BH-A0DD-01 TCGA-BH-A0DD-01A-31D-A12Q-09 e15ff180-38d3-4614-88ee-3645afaab54b TCGA-BH-A0DD-01A-31D-A12N-01 TCGA-BH-A0DD-01 TCGA-BH-A0DD-01A-31R-A12P-07 e15ff180-38d3-4614-88ee-3645afaab54b TCGA-BH-A0DD-01A-31D-A12N-01 TCGA-BH-A0DD-01 TCGA-BH-A0DD-11 58 1393 MALE 1393 0 LumA enrollment LIVING TCGA-BH-A0DD-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0DD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right TCGA-BH-A0DD-F60386 TCGA-BH-A0DD TCGA-BH-A0DD-11A Positive Positive Modified Radical Mastectomy -21386 1248 0 2486 NO 2014-6-9 MALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 460 NO Positive Positive NO 22 Negative NO 0 true No M0 N1a T2 Stage IIB A0DD TUMOR FREE YES YES NO Solid Tissue Normal 11 6th NO YES BH Breast A LIVING 2006 c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5 c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5 c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5 TCGA-BH-A0DD-11A-23R-A12P-07 c38c7c6d-7c7c-45ea-9fae-a889e6ce0df5 TCGA-BH-A0DE-01 Stage IIA 62 5 Stage IIA 948 Positive FEMALE Negative Negative M0 Negative N0 948 0 LumA Luminal A Positive -5 -7 enrollment T_Other T2 LIVING TCGA-BH-A0DE-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-BH-A0DE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant TCGA-BH-A0DE-F63543 TCGA-BH-A0DE Positive Positive Other -22656 0 2372 NO 2014-8-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 0 No M0 N0 T2 Stage IIA A0DE TUMOR FREE NO YES YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast LIVING 2007 b9a1f505-713e-4044-b76e-57134a4802f1 b9a1f505-713e-4044-b76e-57134a4802f1 TCGA-BH-A0DE-01A-11D-A10Y-09 TCGA-BH-A0DE-01 TCGA-BH-A0DE-01 TCGA-BH-A0DE-01A-11D-A10Y-09 TCGA-BH-A0DE-01A-11D-A112-05 TCGA-BH-A0DE-01 TCGA-BH-A0DE-01 TCGA-BH-A0DE-01A-11D-A10Y-09 b9a1f505-713e-4044-b76e-57134a4802f1 TCGA-BH-A0DE-01A-11D-A111-01 TCGA-BH-A0DE-01 TCGA-BH-A0DE-01A-11R-A115-07 b9a1f505-713e-4044-b76e-57134a4802f1 TCGA-BH-A0DE-01A-11D-A111-01 TCGA-BH-A0DE-01 TCGA-BH-A0DE-11 62 948 FEMALE 948 0 enrollment LIVING TCGA-BH-A0DE-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0DE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant TCGA-BH-A0DE-F63543 TCGA-BH-A0DE TCGA-BH-A0DE-11A Positive Positive Other -22656 1130 0 2372 NO 2014-8-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 150 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T2 Stage IIA A0DE TUMOR FREE NO YES YES Solid Tissue Normal 11 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A LIVING 2007 TCGA-BH-A0DE-11A-23D-A112-05 TCGA-BH-A0DG-01 Stage IIA 30 3 Stage IIA 713 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 713 0 LumA Luminal A Negative ReacI -4 -4 enrollment T_Other T2 LIVING TCGA-BH-A0DG-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0DG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 30 Right Upper Outer Quadrant TCGA-BH-A0DG-F63658 TCGA-BH-A0DG Positive Negative Other -11204 0 2041 NO 2014-8-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 0 No M0 N0 T2 Stage IIA A0DG TUMOR FREE YES YES YES Primary Tumor 01 Total mastectomy 6th NO YES BH Breast LIVING 2007 a6b72c40-c921-4159-abad-b64e20619241 a6b72c40-c921-4159-abad-b64e20619241 TCGA-BH-A0DG-01A-11-A13B-20 TCGA-BH-A0DG-01A-21D-A12Q-09 TCGA-BH-A0DG-01 TCGA-BH-A0DG-01A-21D-A12R-05 c74c7143-1584-4072-872f-405fd8e3bf0c TCGA-BH-A0DG-01 TCGA-BH-A0DG-01A-21D-A12Q-09 TCGA-BH-A0DG-01 TCGA-BH-A0DG-01 TCGA-BH-A0DG-01A-21D-A12Q-09 a6b72c40-c921-4159-abad-b64e20619241 TCGA-BH-A0DG-01A-21D-A12N-01 TCGA-BH-A0DG-01 TCGA-BH-A0DG-01A-21R-A12P-07 a6b72c40-c921-4159-abad-b64e20619241 TCGA-BH-A0DG-01A-21D-A12N-01 TCGA-BH-A0DG-01 TCGA-BH-A0DG-11 30 713 FEMALE 713 0 Normal enrollment LIVING TCGA-BH-A0DG-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0DG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 30 Right Upper Outer Quadrant TCGA-BH-A0DG-F63658 TCGA-BH-A0DG TCGA-BH-A0DG-11A Positive Negative Other -11204 972 0 2041 NO 2014-8-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 470 NO Negative NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 T2 Stage IIA A0DG TUMOR FREE YES YES YES Solid Tissue Normal 11 Total mastectomy 6th NO YES BH Breast A LIVING 2007 61c8278b-4c06-4563-b1ac-97cceec76ca4 61c8278b-4c06-4563-b1ac-97cceec76ca4 TCGA-BH-A0DG-11A-43D-A12R-05 TCGA-BH-A0DG-11 61c8278b-4c06-4563-b1ac-97cceec76ca4 TCGA-BH-A0DG-11 61c8278b-4c06-4563-b1ac-97cceec76ca4 TCGA-BH-A0DH-01 Stage IIB 63 2 No_Conversion 1156 Positive FEMALE Negative 5 3 3 Negative M0 Positive N1 1156 0 LumA Luminal A Positive X 0 -3 followup T_Other T2 LIVING TCGA-BH-A0DH-01 Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-BH-A0DH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0DH-F4529 TCGA-BH-A0DH Negative Positive 3+ Mastectomy NOS Positive Other NO -23366 0 1156 90-99% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Negative 28 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 3 No M0 N1a T2 Stage IIB A0DH TUMOR FREE 40-49% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast LIVING 2007 c643222a-e138-4b3c-a96d-02be24ccb0d0 c643222a-e138-4b3c-a96d-02be24ccb0d0 TCGA-BH-A0DH-01A-21-A13B-20 TCGA-BH-A0DH-01A-11D-A099-09 TCGA-BH-A0DH-01 TCGA-BH-A0DH-01A-11D-A10P-05 ce59142d-05cc-4392-92d4-806c8136465b TCGA-BH-A0DH-01 TCGA-BH-A0DH-01A-11D-A099-09 TCGA-BH-A0DH-01 TCGA-BH-A0DH-01A-11D-A099-09 TCGA-BH-A0DH-01 c643222a-e138-4b3c-a96d-02be24ccb0d0 TCGA-BH-A0DH-01 TCGA-BH-A0DH-01A-11D-A087-01 TCGA-BH-A0DH-01A-11R-A084-07 c643222a-e138-4b3c-a96d-02be24ccb0d0 TCGA-BH-A0DH-01A-11D-A087-01 TCGA-BH-A0DH-01 TCGA-BH-A0DH-11 63 1156 FEMALE 1156 0 Normal followup LIVING TCGA-BH-A0DH-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0DH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0DH-F4529 TCGA-BH-A0DH TCGA-BH-A0DH-11A Negative Positive 3+ Mastectomy NOS Positive Other NO -23366 968 0 1156 90-99% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 280 NO Negative 28 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 true No M0 N1a T2 Stage IIB A0DH TUMOR FREE 40-49% YES Solid Tissue Normal 11 Segmental mastectomy YES NO YES BH Breast A LIVING 2007 4a8c96d9-b08d-4812-93ec-c8c9db8139aa 4a8c96d9-b08d-4812-93ec-c8c9db8139aa TCGA-BH-A0DH-11A-31D-A10Q-05 4a8c96d9-b08d-4812-93ec-c8c9db8139aa TCGA-BH-A0DH-11A-31R-A089-07 4a8c96d9-b08d-4812-93ec-c8c9db8139aa TCGA-BH-A0DI-01 Stage IIB 63 5 Stage IIB 673 Positive FEMALE Negative 1 4 3 Negative M0 Positive N1 673 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T2 LIVING TCGA-BH-A0DI-01 Squamous C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-BH-A0DI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right TCGA-BH-A0DI-F58698 TCGA-BH-A0DI TCGA-BH-A0DI-01A Positive Positive Modified Radical Mastectomy -23327 267 0 912 NO 2014-4-22 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative NO 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 3 true No M0 N1a T2 Stage IIB TCGA-BH-A0DI.5B7CE4A4-E1D5-4D0B-B9B4-71B94E32D782.pdf A0DI TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES BH Breast A LIVING 2009 91285ac6-c627-4101-b551-28f37b947276 91285ac6-c627-4101-b551-28f37b947276 TCGA-BH-A0DI-01A-11-A13B-20 TCGA-BH-A0DI-01A-21D-A12Q-09 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01A-21D-A12R-05 12b20a6c-5b0f-4014-85f5-b411c0ad5651 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01A-21D-A12Q-09 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01A-21D-A12Q-09 91285ac6-c627-4101-b551-28f37b947276 TCGA-BH-A0DI-01A-21D-A12N-01 TCGA-BH-A0DI-01 TCGA-BH-A0DI-01A-21R-A12P-07 91285ac6-c627-4101-b551-28f37b947276 TCGA-BH-A0DI-01A-21D-A12N-01 TCGA-BH-A0DI-01 TCGA-BH-A0DI-11 63 673 FEMALE 673 0 enrollment LIVING TCGA-BH-A0DI-11 C3-BRCA/Luminal mutation cluster 3 TCGA-BH-A0DI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right TCGA-BH-A0DI-F58698 TCGA-BH-A0DI TCGA-BH-A0DI-11A Positive Positive Modified Radical Mastectomy -23327 267 0 912 NO 2014-4-22 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 640 NO Negative NO 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 3 true No M0 N1a T2 Stage IIB A0DI TUMOR FREE YES YES YES Solid Tissue Normal 11 6th NO YES BH Breast A LIVING 2009 TCGA-BH-A0DI-11A-32D-A12R-05 TCGA-BH-A0DK-01 Stage IIA 49 2 Stage IIA 423 Positive FEMALE Negative 4 3 3 Negative M0 Negative N0 423 0 LumA Luminal A Positive LumA/B -4 -4 followup T_Other T2 LIVING TCGA-BH-A0DK-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-BH-A0DK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0DK-F4532 TCGA-BH-A0DK TCGA-BH-A0DK-01A Positive Positive Simple Mastectomy NO -18237 254 0 423 H-SCORE 260 2010-11-16 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 240 NO Negative 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 2 0 true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0DK.1E3F22FC-3D82-4911-9C97-8CB87A3D131C.pdf A0DK TUMOR FREE H-SCORE 120 H-SCORE H-SCORE NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2009 fef221ff-634b-4188-92cf-5723b9a3c04d fef221ff-634b-4188-92cf-5723b9a3c04d TCGA-BH-A0DK-01A-11-A13B-20 TCGA-BH-A0DK-01A-21W-A071-09 TCGA-BH-A0DK-01 TCGA-BH-A0DK-01A-21D-A10P-05 1ae8085b-99e9-4a9c-94a7-bcf4f903b95a TCGA-BH-A0DK-01 TCGA-BH-A0DK-01A-21W-A071-09 TCGA-BH-A0DK-01 TCGA-BH-A0DK-01A-21W-A071-09 TCGA-BH-A0DK-01 fef221ff-634b-4188-92cf-5723b9a3c04d TCGA-BH-A0DK-01 TCGA-BH-A0DK-01A-21D-A059-01 TCGA-BH-A0DK-01A-21R-A056-07 fef221ff-634b-4188-92cf-5723b9a3c04d TCGA-BH-A0DK-01A-21D-A059-01 TCGA-BH-A0DK-01 TCGA-BH-A0DK-11 49 423 FEMALE 423 0 LumA followup LIVING TCGA-BH-A0DK-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0DK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0DK-F4532 TCGA-BH-A0DK TCGA-BH-A0DK-11A Positive Positive Simple Mastectomy NO -18237 254 0 423 H-SCORE 260 2010-11-16 FEMALE 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 550 NO Negative 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 0 true No M0 N0 (i-) T2 Stage IIA A0DK TUMOR FREE H-SCORE 120 H-SCORE H-SCORE NO Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2009 4c1d73ba-31f8-4652-a83d-cc367dde9f43 4c1d73ba-31f8-4652-a83d-cc367dde9f43 TCGA-BH-A0DK-11A-13D-A10Q-05 F17E1810-1E54-4920-A1EA-A5B693205A55 TCGA-BH-A0DK-11 4c1d73ba-31f8-4652-a83d-cc367dde9f43 TCGA-BH-A0DK-11 TCGA-BH-A0DK-11A-13R-A089-07 4c1d73ba-31f8-4652-a83d-cc367dde9f43 TCGA-BH-A0DL-01 Stage IIA 64 3 Stage IIA 1467 Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 1467 0 Basal Basal-like Negative Basal -13 0 enrollment T_Other T2 LIVING TCGA-BH-A0DL-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 11 cluster 4 mutation cluster 3 TCGA-BH-A0DL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left TCGA-BH-A0DL-F60389 TCGA-BH-A0DL TCGA-BH-A0DL-01A Positive Negative Other -23628 1074 0 2381 NO 2014-6-9 FEMALE Other, specify No C50.9 8575/3 C50.9 YES Core needle biopsy 350 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO 0 true No M0 N0 T2 Stage IIA TCGA-BH-A0DL.C96287D0-A60B-4BAA-ABA0-8AD4F48662DB.pdf A0DL TUMOR FREE YES YES YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A LIVING 2007 1013446f-5beb-485d-809a-efe81a2138dd 1013446f-5beb-485d-809a-efe81a2138dd TCGA-BH-A0DL-01A-21-A13B-20 TCGA-BH-A0DL-01A-11D-A10Y-09 TCGA-BH-A0DL-01 301ec456-dd25-42ff-9779-a4f7f86ff509 TCGA-BH-A0DL-01 TCGA-BH-A0DL-01A-11D-A10Y-09 TCGA-BH-A0DL-01A-11D-A112-05 TCGA-BH-A0DL-01 TCGA-BH-A0DL-01 TCGA-BH-A0DL-01A-11D-A10Y-09 1013446f-5beb-485d-809a-efe81a2138dd TCGA-BH-A0DL-01A-11D-A111-01 TCGA-BH-A0DL-01 TCGA-BH-A0DL-01A-11R-A115-07 1013446f-5beb-485d-809a-efe81a2138dd TCGA-BH-A0DL-01A-11D-A111-01 TCGA-BH-A0DL-01 TCGA-BH-A0DL-11 64 1467 FEMALE 1467 0 Normal enrollment LIVING TCGA-BH-A0DL-11 C4-BRCA/Basal mutation cluster 3 TCGA-BH-A0DL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left TCGA-BH-A0DL-F60389 TCGA-BH-A0DL Positive Negative Other -23628 0 2381 NO 2014-6-9 FEMALE Other, specify No C50.9 8575/3 C50.9 YES Core needle biopsy Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T2 Stage IIA A0DL TUMOR FREE YES YES YES Solid Tissue Normal 11 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast LIVING 2007 f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d TCGA-BH-A0DL-11A-13D-A112-05 TCGA-BH-A0DL-11 f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d TCGA-BH-A0DL-11 TCGA-BH-A0DL-11A-13R-A115-07 f6745ef4-b601-4d5f-bb7a-0bf7e1f1671d TCGA-BH-A0DO-01 Stage I 78 2 Stage I 525 Positive FEMALE Negative Negative M0 Negative N0 525 0 LumA Luminal A Positive -5 -7 enrollment T1 T1 LIVING TCGA-BH-A0DO-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-BH-A0DO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Left Upper Inner Quadrant TCGA-BH-A0DO-F63671 TCGA-BH-A0DO TCGA-BH-A0DO-01B Positive Positive Simple Mastectomy -28529 454 0 1644 NO 2014-8-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 80 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 0 true Yes M0 N0 T1c Stage I TCGA-BH-A0DO.C75872B6-2260-41C3-9E21-91E4F52AD7EA.pdf A0DO TUMOR FREE NO YES NO Primary Tumor 01 6th NO YES BH Breast B LIVING 2009 46892fa4-f179-4991-99da-629d8cf936f6 46892fa4-f179-4991-99da-629d8cf936f6 TCGA-BH-A0DO-01B-11D-A12B-09 TCGA-BH-A0DO-01 TCGA-BH-A0DO-01 TCGA-BH-A0DO-01B-11D-A12B-09 TCGA-BH-A0DO-01B-11D-A12E-05 TCGA-BH-A0DO-01 TCGA-BH-A0DO-01 TCGA-BH-A0DO-01B-11D-A12B-09 46892fa4-f179-4991-99da-629d8cf936f6 TCGA-BH-A0DO-01B-11D-A12A-01 TCGA-BH-A0DO-01 TCGA-BH-A0DO-01B-11R-A12D-07 46892fa4-f179-4991-99da-629d8cf936f6 TCGA-BH-A0DO-01B-11D-A12A-01 TCGA-BH-A0DO-01 TCGA-BH-A0DO-11 78 525 FEMALE 525 0 Normal enrollment LIVING TCGA-BH-A0DO-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0DO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Left Upper Inner Quadrant TCGA-BH-A0DO-F63671 TCGA-BH-A0DO Positive Positive Simple Mastectomy -28529 0 1644 NO 2014-8-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 Yes M0 N0 T1c Stage I A0DO TUMOR FREE NO YES NO Solid Tissue Normal 11 6th NO YES BH Breast LIVING 2009 eb9e415f-0545-4e97-ad35-b56b0f3db79b eb9e415f-0545-4e97-ad35-b56b0f3db79b TCGA-BH-A0DO-11A-22D-A12E-05 TCGA-BH-A0DO-11 eb9e415f-0545-4e97-ad35-b56b0f3db79b TCGA-BH-A0DO-11 TCGA-BH-A0DO-11A-22R-A12D-07 eb9e415f-0545-4e97-ad35-b56b0f3db79b TCGA-BH-A0DP-01 Stage IIB 60 2 Stage IIB 476 Positive FEMALE Negative 1 4 3 Negative M0 Negative N0 476 0 LumA Luminal A Positive ReacI -5 -7 followup T_Other T3 LIVING TCGA-BH-A0DP-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation cluster 4 TCGA-BH-A0DP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Sentinel node biopsy alone TCGA-BH-A0DP-F4538 TCGA-BH-A0DP TCGA-BH-A0DP-01A Positive 3+ Positive Simple Mastectomy NO -22199 293 0 476 H-SCORE 280 80-89% 2010-11-16 FEMALE <10% 0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 510 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 0 true No M0 N0 (i-) T3 Stage IIB TCGA-BH-A0DP.F04188AB-51CE-4AA1-B72C-399BE7863235.pdf A0DP TUMOR FREE H-SCORE 280 H-SCORE H-SCORE 80-89% YES Primary Tumor 01 YES NO YES BH Breast A LIVING 2009 72967b75-a711-425a-819d-dd673c5edc44 72967b75-a711-425a-819d-dd673c5edc44 TCGA-BH-A0DP-01A-11-A13B-20 TCGA-BH-A0DP-01A-21W-A071-09 TCGA-BH-A0DP-01 TCGA-BH-A0DP-01A-21D-A10P-05 2816036d-ed53-4c0d-b7fa-5a72f37da510 TCGA-BH-A0DP-01 TCGA-BH-A0DP-01A-21W-A071-09 TCGA-BH-A0DP-01 TCGA-BH-A0DP-01A-21W-A071-09 TCGA-BH-A0DP-01 72967b75-a711-425a-819d-dd673c5edc44 TCGA-BH-A0DP-01 TCGA-BH-A0DP-01A-21D-A059-01 TCGA-BH-A0DP-01A-21R-A056-07 72967b75-a711-425a-819d-dd673c5edc44 TCGA-BH-A0DP-01A-21D-A059-01 TCGA-BH-A0DP-01 TCGA-BH-A0DP-11 60 476 FEMALE 476 0 Normal followup LIVING TCGA-BH-A0DP-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0DP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Sentinel node biopsy alone TCGA-BH-A0DP-F4538 TCGA-BH-A0DP TCGA-BH-A0DP-11A Positive 3+ Positive Simple Mastectomy NO -22199 293 0 476 H-SCORE 280 80-89% 2010-11-16 FEMALE <10% 0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 290 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 0 true No M0 N0 (i-) T3 Stage IIB A0DP TUMOR FREE H-SCORE 280 H-SCORE H-SCORE 80-89% YES Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2009 6ff2976a-2570-409b-afde-b7d2e7f2e4ea 6ff2976a-2570-409b-afde-b7d2e7f2e4ea TCGA-BH-A0DP-11A-12D-A10Q-05 6B935910-61A6-4AC5-87EB-D3557C0777E4 TCGA-BH-A0DP-11 6ff2976a-2570-409b-afde-b7d2e7f2e4ea TCGA-BH-A0DP-11 TCGA-BH-A0DP-11A-12R-A089-07 6ff2976a-2570-409b-afde-b7d2e7f2e4ea TCGA-BH-A0DQ-01 Stage IIB 42 5 No_Conversion 98 Positive FEMALE Negative Negative M0 Positive N1 98 0 LumA Luminal A Positive -5 0 followup T_Other T2 LIVING TCGA-BH-A0DQ-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A0DQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0DQ-F4560 TCGA-BH-A0DQ TCGA-BH-A0DQ-01A Positive 1+ Positive Other NO -15533 190 0 98 H-SCORE 136 60-69% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Core needle biopsy 110 NO Negative 25 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 1 true No M0 N1 T2 Stage IIB TCGA-BH-A0DQ.D644B589-A6ED-4DCC-97D4-751E22AE3A7D.pdf A0DQ TUMOR FREE H-SCORE 140 H-SCORE H-SCORE 70-79% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2009 6022db68-1e06-4974-b657-cd65aed560c4 6022db68-1e06-4974-b657-cd65aed560c4 TCGA-BH-A0DQ-01A-11D-A099-09 TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-01A-11D-A10P-05 TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-01A-11D-A099-09 TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-01A-11D-A099-09 TCGA-BH-A0DQ-01 6022db68-1e06-4974-b657-cd65aed560c4 TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-01A-11D-A087-01 TCGA-BH-A0DQ-01A-11R-A084-07 6022db68-1e06-4974-b657-cd65aed560c4 TCGA-BH-A0DQ-01A-11D-A087-01 TCGA-BH-A0DQ-01 TCGA-BH-A0DQ-11 42 98 FEMALE 98 0 LumA followup LIVING TCGA-BH-A0DQ-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0DQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0DQ-F4560 TCGA-BH-A0DQ TCGA-BH-A0DQ-11A Positive 1+ Positive Other NO -15533 190 0 98 H-SCORE 136 60-69% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Core needle biopsy 100 NO Negative 25 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 true No M0 N1 T2 Stage IIB A0DQ TUMOR FREE H-SCORE 140 H-SCORE H-SCORE 70-79% YES Solid Tissue Normal 11 Segmental mastectomy YES NO YES BH Breast A LIVING 2009 2b11e565-01a8-4054-a200-03e06765bd5e 2b11e565-01a8-4054-a200-03e06765bd5e TCGA-BH-A0DQ-11A-12D-A10Q-05 TCGA-BH-A0DQ-11 2b11e565-01a8-4054-a200-03e06765bd5e TCGA-BH-A0DQ-11 TCGA-BH-A0DQ-11A-12R-A089-07 2b11e565-01a8-4054-a200-03e06765bd5e TCGA-BH-A0DS-01 Stage IIIA 71 3 No_Conversion 77 Positive FEMALE Negative 4 5 3 Negative M0 Positive N2 77 0 LumA Luminal A Positive LumA -5 -7 followup T_Other T2 LIVING TCGA-BH-A0DS-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-BH-A0DS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0DS-F4573 TCGA-BH-A0DS TCGA-BH-A0DS-01A Positive 2+ Positive Other NO -25944 79 0 78 H-SCORE 190 70-79% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 200 NO Negative 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 6 8 true No M0 N2a T2 Stage IIIA TCGA-BH-A0DS.E4CBDC29-63E2-4CF0-B02F-16CA9C69F26E.pdf A0DS TUMOR FREE H-SCORE 162 H-SCORE H-SCORE 70-79% YES Primary Tumor 01 Segmental mastectomy 7th YES NO YES BH Breast A LIVING 2010 00ee8acd-0841-4c85-a99a-8966a6828dd7 00ee8acd-0841-4c85-a99a-8966a6828dd7 TCGA-BH-A0DS-01A-21-A13B-20 TCGA-BH-A0DS-01A-11W-A071-09 TCGA-BH-A0DS-01 TCGA-BH-A0DS-01A-11D-A10P-05 ad643947-edbf-4a15-a959-76ffd5589907 TCGA-BH-A0DS-01 TCGA-BH-A0DS-01A-11W-A071-09 TCGA-BH-A0DS-01 TCGA-BH-A0DS-01A-11W-A071-09 TCGA-BH-A0DS-01 00ee8acd-0841-4c85-a99a-8966a6828dd7 TCGA-BH-A0DS-01 TCGA-BH-A0DS-01A-11D-A059-01 TCGA-BH-A0DS-01A-11R-A056-07 00ee8acd-0841-4c85-a99a-8966a6828dd7 TCGA-BH-A0DS-01A-11D-A059-01 TCGA-BH-A0DS-01 TCGA-BH-A0DT-01 Stage IIA 41 2 Stage IIA 1170 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1170 0 LumA Luminal A Positive LumA -5 -7 enrollment T1 T1 LIVING TCGA-BH-A0DT-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-BH-A0DT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Right TCGA-BH-A0DT-F59149 TCGA-BH-A0DT Positive Positive Other -15078 0 2403 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 NO 1 No M0 N1a T1c Stage IIA A0DT TUMOR FREE YES YES YES Primary Tumor 01 Total mastectomy with sentinel lymoh node biopsy 6th NO YES BH Breast LIVING 2007 e88bcf68-e904-4511-92f6-01cbd0da62de e88bcf68-e904-4511-92f6-01cbd0da62de TCGA-BH-A0DT-01A-11-A13B-20 TCGA-BH-A0DT-01A-21D-A12B-09 TCGA-BH-A0DT-01 b170d872-08a7-4c4a-9e3f-e6525d8d5a88 TCGA-BH-A0DT-01 TCGA-BH-A0DT-01A-21D-A12B-09 TCGA-BH-A0DT-01A-21D-A12E-05 TCGA-BH-A0DT-01 TCGA-BH-A0DT-01 TCGA-BH-A0DT-01A-21D-A12B-09 e88bcf68-e904-4511-92f6-01cbd0da62de TCGA-BH-A0DT-01A-21D-A12A-01 TCGA-BH-A0DT-01 TCGA-BH-A0DT-01A-21R-A12D-07 e88bcf68-e904-4511-92f6-01cbd0da62de TCGA-BH-A0DT-01A-21D-A12A-01 TCGA-BH-A0DT-01 TCGA-BH-A0DT-11 41 1170 FEMALE 1170 0 Normal enrollment LIVING TCGA-BH-A0DT-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0DT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Right TCGA-BH-A0DT-F59149 TCGA-BH-A0DT TCGA-BH-A0DT-11A Positive Positive Other -15078 1044 0 2403 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 250 NO Negative NO 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 true No M0 N1a T1c Stage IIA A0DT TUMOR FREE YES YES YES Solid Tissue Normal 11 Total mastectomy with sentinel lymoh node biopsy 6th NO YES BH Breast A LIVING 2007 75ba5803-449e-4770-8105-b675af8e6907 75ba5803-449e-4770-8105-b675af8e6907 TCGA-BH-A0DT-11A-12D-A12E-05 TCGA-BH-A0DT-11 75ba5803-449e-4770-8105-b675af8e6907 TCGA-BH-A0DT-11 TCGA-BH-A0DT-11A-12R-A12D-07 75ba5803-449e-4770-8105-b675af8e6907 TCGA-BH-A0DV-01 Stage IIIA 54 3 Stage IIIA 1374 Positive FEMALE Negative Negative M0 Positive N2 1374 0 LumA Positive ReacII enrollment T_Other T2 LIVING TCGA-BH-A0DV-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-BH-A0DV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left TCGA-BH-A0DV-F63672 TCGA-BH-A0DV TCGA-BH-A0DV-01A Positive Positive Modified Radical Mastectomy -19781 975 0 2064 NO 2014-8-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 370 NO Negative NO 9 Negative Peri (6-12 months since last menstrual period) 1 6 NO 9 true No M0 N2a T2 Stage IIIA TCGA-BH-A0DV.3A0E1EF6-B234-46EC-BD15-95B5FAB06D45.pdf A0DV TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES BH Breast A LIVING 2007 0d029d04-13cd-4870-a9e3-9d2e65c9b0b7 0d029d04-13cd-4870-a9e3-9d2e65c9b0b7 TCGA-BH-A0DV-01A-11-A13B-20 TCGA-BH-A0DV-01A-21D-A12Q-09 TCGA-BH-A0DV-01 TCGA-BH-A0DV-01A-21D-A12R-05 2ddc51b1-8ac4-4b9e-85d3-23c698917d5f TCGA-BH-A0DV-01 TCGA-BH-A0DV-01A-21D-A12Q-09 TCGA-BH-A0DV-01 TCGA-BH-A0DV-01A-21D-A12Q-09 0d029d04-13cd-4870-a9e3-9d2e65c9b0b7 TCGA-BH-A0DV-01A-21D-A12N-01 TCGA-BH-A0DV-01 0d029d04-13cd-4870-a9e3-9d2e65c9b0b7 TCGA-BH-A0DV-01A-21D-A12N-01 TCGA-BH-A0DV-11 54 1374 FEMALE 1374 0 Normal enrollment LIVING TCGA-BH-A0DV-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0DV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Inner Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left TCGA-BH-A0DV-F63672 TCGA-BH-A0DV TCGA-BH-A0DV-11A Positive Positive Modified Radical Mastectomy -19781 975 0 2064 NO 2014-8-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative NO 9 Negative Peri (6-12 months since last menstrual period) NO 9 true No M0 N2a T2 Stage IIIA A0DV TUMOR FREE YES YES YES Solid Tissue Normal 11 6th NO YES BH Breast A LIVING 2007 09f570eb-a751-41db-9511-300be228f24e 09f570eb-a751-41db-9511-300be228f24e TCGA-BH-A0DV-11A-22D-A12R-05 TCGA-BH-A0DV-11 09f570eb-a751-41db-9511-300be228f24e TCGA-BH-A0DV-11 TCGA-BH-A0DV-11A-22R-A12P-07 09f570eb-a751-41db-9511-300be228f24e TCGA-BH-A0DX-01 Stage I 62 1 Stage I 1442 Positive FEMALE Negative Negative M0 Negative N0 1442 0 LumA Luminal A Positive -4 -7 enrollment T1 T1 LIVING TCGA-BH-A0DX-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 4 TCGA-BH-A0DX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Inner Quadrant TCGA-BH-A0DX-F59135 TCGA-BH-A0DX Positive Positive Other -22833 0 2156 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 0 No M0 N0 T1b Stage I A0DX TUMOR FREE YES YES YES Primary Tumor 01 Segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast LIVING 2007 c791026a-9fda-47b4-86fd-9b5933325326 c791026a-9fda-47b4-86fd-9b5933325326 TCGA-BH-A0DX-01A-11D-A10Y-09 TCGA-BH-A0DX-01 TCGA-BH-A0DX-01 TCGA-BH-A0DX-01A-11D-A10Y-09 TCGA-BH-A0DX-01A-11D-A112-05 TCGA-BH-A0DX-01 TCGA-BH-A0DX-01 TCGA-BH-A0DX-01A-11D-A10Y-09 c791026a-9fda-47b4-86fd-9b5933325326 TCGA-BH-A0DX-01A-11D-A111-01 TCGA-BH-A0DX-01 TCGA-BH-A0DX-01A-11R-A115-07 c791026a-9fda-47b4-86fd-9b5933325326 TCGA-BH-A0DX-01A-11D-A111-01 TCGA-BH-A0DX-01 TCGA-BH-A0DZ-01 Stage IIB 43 5 No_Conversion 495 Positive FEMALE Positive Negative M0 Positive N1 495 0 LumA HER2-enriched Positive -2 -3 followup T_Other T2 LIVING TCGA-BH-A0DZ-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 2 TCGA-BH-A0DZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0DZ-F4588 TCGA-BH-A0DZ TCGA-BH-A0DZ-01A Positive 2+ Positive Simple Mastectomy NO -15980 308 0 495 H-SCORE 140 50-59% 2010-11-16 FEMALE 30-39% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 170 NO Positive 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 1 true No M0 N1a T2 Stage IIB TCGA-BH-A0DZ.16DE55CE-076E-43D3-84BD-332A79B95EFD.pdf A0DZ TUMOR FREE H-SCORE 15 H-SCORE H-SCORE <10% NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2009 4543cecd-6333-473b-b5ce-96d33ab47706 4543cecd-6333-473b-b5ce-96d33ab47706 TCGA-BH-A0DZ-01A-11W-A019-09 TCGA-BH-A0DZ-01 TCGA-BH-A0DZ-01 TCGA-BH-A0DZ-01A-11W-A019-09 TCGA-BH-A0DZ-01A-11D-A00Y-05 TCGA-BH-A0DZ-01 TCGA-BH-A0DZ-01A-11W-A019-09 TCGA-BH-A0DZ-01 4543cecd-6333-473b-b5ce-96d33ab47706 TCGA-BH-A0DZ-01 TCGA-BH-A0DZ-01A-11D-A011-01 TCGA-BH-A0DZ-01A-11R-A00Z-07 4543cecd-6333-473b-b5ce-96d33ab47706 TCGA-BH-A0DZ-01A-11D-A011-01 TCGA-BH-A0DZ-01 TCGA-BH-A0DZ-11 43 495 FEMALE 495 0 followup LIVING TCGA-BH-A0DZ-11 C3-BRCA/Luminal mutation cluster 2 TCGA-BH-A0DZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0DZ-F4588 TCGA-BH-A0DZ Positive 2+ Positive Simple Mastectomy NO -15980 0 495 H-SCORE 140 50-59% 2010-11-16 FEMALE 30-39% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy Positive 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 No M0 N1a T2 Stage IIB A0DZ TUMOR FREE H-SCORE 15 H-SCORE H-SCORE <10% NO Solid Tissue Normal 11 YES NO YES BH Breast LIVING 2009 f59f9272-412f-4884-9874-a6ff59ab1740 f59f9272-412f-4884-9874-a6ff59ab1740 TCGA-BH-A0DZ-11A-22D-A10Q-05 TCGA-BH-A0DZ-11 f59f9272-412f-4884-9874-a6ff59ab1740 TCGA-BH-A0DZ-11 TCGA-BH-A0DZ-11A-22R-A089-07 f59f9272-412f-4884-9874-a6ff59ab1740 TCGA-BH-A0E0-01 Stage IIIC 38 1 No_Conversion 133 Negative FEMALE Negative 2 2 2 Negative M0 Positive N3 133 0 Basal Basal-like Negative Basal -13 0 followup T_Other T3 LIVING TCGA-BH-A0E0-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 5 TCGA-BH-A0E0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0E0-F4603 TCGA-BH-A0E0 TCGA-BH-A0E0-01A Negative 0 Negative Modified Radical Mastectomy NO -14175 136 0 134 H-SCORE 0 2010-10-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 620 NO Negative 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 5 10 true No M0 N3a T3 Stage IIIC TCGA-BH-A0E0.975989FE-8785-42C1-8551-53661B7B16A1.pdf A0E0 TUMOR FREE H-SCORE 0 H-SCORE H-SCORE YES Primary Tumor 01 YES NO YES BH Breast A LIVING 2009 fac9101c-a974-4415-9eac-d2d433d02b13 fac9101c-a974-4415-9eac-d2d433d02b13 TCGA-BH-A0E0-01A-21-A13B-20 TCGA-BH-A0E0-01A-11W-A071-09 TCGA-BH-A0E0-01 TCGA-BH-A0E0-01A-11D-A10P-05 9ccd25d1-e45d-469d-942d-0b514d4cb5a0 TCGA-BH-A0E0-01 TCGA-BH-A0E0-01A-11W-A071-09 TCGA-BH-A0E0-01 TCGA-BH-A0E0-01A-11W-A071-09 TCGA-BH-A0E0-01 fac9101c-a974-4415-9eac-d2d433d02b13 TCGA-BH-A0E0-01 TCGA-BH-A0E0-01A-11D-A059-01 TCGA-BH-A0E0-01A-11R-A056-07 fac9101c-a974-4415-9eac-d2d433d02b13 TCGA-BH-A0E0-01A-11D-A059-01 TCGA-BH-A0E0-01 TCGA-BH-A0E0-11 38 133 FEMALE 133 0 Normal followup LIVING TCGA-BH-A0E0-11 C4-BRCA/Basal mutation cluster 5 TCGA-BH-A0E0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0E0-F4603 TCGA-BH-A0E0 TCGA-BH-A0E0-11A Negative 0 Negative Modified Radical Mastectomy NO -14175 136 0 134 H-SCORE 0 2010-10-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 140 NO Negative 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 10 true No M0 N3a T3 Stage IIIC A0E0 TUMOR FREE H-SCORE 0 H-SCORE H-SCORE YES Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2009 5cc82d2c-f960-40c3-9b37-59e087563dc1 5cc82d2c-f960-40c3-9b37-59e087563dc1 TCGA-BH-A0E0-11A-13D-A10Q-05 5cc82d2c-f960-40c3-9b37-59e087563dc1 TCGA-BH-A0E0-11A-13R-A089-07 5cc82d2c-f960-40c3-9b37-59e087563dc1 TCGA-BH-A0E1-01 Stage IIB 52 2 No_Conversion 477 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 477 0 LumA Luminal A Positive ReacII -12 -3 followup T_Other T2 LIVING TCGA-BH-A0E1-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation c1uster 10 TCGA-BH-A0E1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0E1-F4631 TCGA-BH-A0E1 TCGA-BH-A0E1-01A Positive 3+ Positive Simple Mastectomy NO -19192 301 0 477 H-SCORE 180 70-79% 1.67 2010-11-16 FEMALE 2+ 40 2.81 1.69 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 990 NO Equivocal Negative 17 Negative Peri (6-12 months since last menstrual period) 2 6 2 true No M0 N1 T2 Stage IIB TCGA-BH-A0E1.891F4C63-8207-4CB8-AB59-A970CC6F1A1A.pdf A0E1 TUMOR FREE H-SCORE 245 H-SCORE H-SCORE 50-59% NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2009 9bf836ee-036e-40f2-88fb-cf903a40d9f5 9bf836ee-036e-40f2-88fb-cf903a40d9f5 TCGA-BH-A0E1-01A-21-A13B-20 TCGA-BH-A0E1-01A-11W-A071-09 TCGA-BH-A0E1-01 TCGA-BH-A0E1-01A-11D-A10P-05 e4fbf61f-e3f8-4722-b3fc-b5479c75ddae TCGA-BH-A0E1-01 TCGA-BH-A0E1-01A-11W-A071-09 TCGA-BH-A0E1-01 TCGA-BH-A0E1-01A-11W-A071-09 TCGA-BH-A0E1-01 9bf836ee-036e-40f2-88fb-cf903a40d9f5 TCGA-BH-A0E1-01 TCGA-BH-A0E1-01A-11D-A059-01 TCGA-BH-A0E1-01A-11R-A056-07 9bf836ee-036e-40f2-88fb-cf903a40d9f5 TCGA-BH-A0E1-01A-11D-A059-01 TCGA-BH-A0E1-01 TCGA-BH-A0E1-11 52 477 FEMALE 477 0 Normal followup LIVING TCGA-BH-A0E1-11 C3-BRCA/Luminal mutation c1uster 10 TCGA-BH-A0E1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0E1-F4631 TCGA-BH-A0E1 TCGA-BH-A0E1-11A Positive 3+ Positive Simple Mastectomy NO -19192 301 0 477 H-SCORE 180 70-79% 1.67 2010-11-16 FEMALE 2+ 40 2.81 1.69 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 500 NO Equivocal Negative 17 Negative Peri (6-12 months since last menstrual period) 2 true No M0 N1 T2 Stage IIB A0E1 TUMOR FREE H-SCORE 245 H-SCORE H-SCORE 50-59% NO Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2009 b6302c6b-2bab-40b1-b835-7f285719fff5 b6302c6b-2bab-40b1-b835-7f285719fff5 TCGA-BH-A0E1-11A-13D-A10Q-05 B5FC6749-9A17-4739-9144-FE17660801C3 TCGA-BH-A0E1-11 b6302c6b-2bab-40b1-b835-7f285719fff5 TCGA-BH-A0E1-11 TCGA-BH-A0E1-11A-13R-A089-07 b6302c6b-2bab-40b1-b835-7f285719fff5 TCGA-BH-A0E2-01 Stage IIIA 49 2 No_Conversion 435 Positive FEMALE Negative Negative M0 Positive N2 435 0 LumA Luminal A Positive LumA/B -8 -3 followup T_Other T2 LIVING TCGA-BH-A0E2-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation c1uster 9 TCGA-BH-A0E2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone TCGA-BH-A0E2-F4639 TCGA-BH-A0E2 TCGA-BH-A0E2-01A Positive 1+ Positive Modified Radical Mastectomy NO -18152 210 0 435 H-SCORE 300 90-99% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 160 NO Negative 26 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 true No M0 N2a T2 Stage IIIA TCGA-BH-A0E2.29EDE507-90BA-4ABE-B3EF-559EBA4CCD56.pdf A0E2 TUMOR FREE H-SCORE 1 H-SCORE H-SCORE <10% NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2009 b605d803-523b-46e6-b656-7d9888d306cc b605d803-523b-46e6-b656-7d9888d306cc TCGA-BH-A0E2-01A-21-A13A-20 TCGA-BH-A0E2-01A-11W-A071-09 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01A-11D-A10P-05 98a8d468-efe1-41ff-a02a-615e09da0330 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01A-11W-A071-09 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01A-11W-A071-09 b605d803-523b-46e6-b656-7d9888d306cc TCGA-BH-A0E2-01A-11D-A059-01 TCGA-BH-A0E2-01 TCGA-BH-A0E2-01A-11R-A056-07 b605d803-523b-46e6-b656-7d9888d306cc TCGA-BH-A0E2-01A-11D-A059-01 TCGA-BH-A0E2-01 TCGA-BH-A0E6-01 Stage IA 69 1 Stage I 292 Negative FEMALE Negative 1 4 3 Negative M0 Negative N0 292 0 Basal Basal-like Negative ReacI -13 0 followup T1 T1 LIVING TCGA-BH-A0E6-01 High C4-BRCA/Basal cluster 1 BRCA basal-like c8 OV-like c4 BRCA basal-like c8 miRNA cluster 12 cluster 4 mutation cluster 2 TCGA-BH-A0E6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0E6-F4650 TCGA-BH-A0E6 TCGA-BH-A0E6-01A Negative 0 Negative Other NO -25408 134 0 293 H-SCORE 0 2.38 2010-11-16 FEMALE 2+ 40 2.83 1.19 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 80 NO Equivocal Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0E6.739E1733-3540-4E82-AC91-F511105DABD5.pdf A0E6 TUMOR FREE H-SCORE 0 H-SCORE H-SCORE YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2009 6bf094a5-1f62-406c-9b3a-e686bb4a074e 6bf094a5-1f62-406c-9b3a-e686bb4a074e TCGA-BH-A0E6-01A-21-A13C-20 TCGA-BH-A0E6-01A-11W-A050-09 TCGA-BH-A0E6-01 1b1bb0d9-e8c0-4efa-bab4-73225525bd9c TCGA-BH-A0E6-01 TCGA-BH-A0E6-01A-11W-A050-09 TCGA-BH-A0E6-01A-11D-A032-05 TCGA-BH-A0E6-01 TCGA-BH-A0E6-01A-11W-A050-09 TCGA-BH-A0E6-01 6bf094a5-1f62-406c-9b3a-e686bb4a074e TCGA-BH-A0E6-01 TCGA-BH-A0E6-01A-11D-A036-01 TCGA-BH-A0E6-01A-11R-A034-07 6bf094a5-1f62-406c-9b3a-e686bb4a074e TCGA-BH-A0E6-01A-11D-A036-01 TCGA-BH-A0E6-01 TCGA-BH-A0E7-01 Stage IIB 79 4 No_Conversion 1362 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1362 0 LumA Luminal A Positive LumA -12 -3 followup T_Other T2 LIVING TCGA-BH-A0E7-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0E7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 79 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0E7-F4656 TCGA-BH-A0E7 TCGA-BH-A0E7-01A Positive 3+ Positive Other NO -29115 1259 0 1363 50-59% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Excisional Biopsy 140 NO Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 1 true No M0 N1a T2 Stage IIB TCGA-BH-A0E7.CE32A294-10FC-4DBA-A779-FAEEBE677D38.pdf A0E7 TUMOR FREE 60-69% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2006 3850a348-8e53-497d-8e06-680672b19557 3850a348-8e53-497d-8e06-680672b19557 TCGA-BH-A0E7-01A-21-A13C-20 TCGA-BH-A0E7-01A-11W-A050-09 TCGA-BH-A0E7-01 7c513473-0b7a-4cc6-9748-d0eaa83b6744 TCGA-BH-A0E7-01 TCGA-BH-A0E7-01A-11W-A050-09 TCGA-BH-A0E7-01A-11D-A032-05 TCGA-BH-A0E7-01 TCGA-BH-A0E7-01A-11W-A050-09 TCGA-BH-A0E7-01 3850a348-8e53-497d-8e06-680672b19557 TCGA-BH-A0E7-01 TCGA-BH-A0E7-01A-11D-A036-01 TCGA-BH-A0E7-01A-11R-A034-07 3850a348-8e53-497d-8e06-680672b19557 TCGA-BH-A0E7-01A-11D-A036-01 TCGA-BH-A0E7-01 TCGA-BH-A0E9-01 Stage IIB 53 3 Stage IIB 1405 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 1405 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T2 LIVING TCGA-BH-A0E9-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation c1uster 9 TCGA-BH-A0E9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right TCGA-BH-A0E9-F59107 TCGA-BH-A0E9 TCGA-BH-A0E9-01B Positive Positive Modified Radical Mastectomy -19415 1357 0 2489 NO 2014-5-1 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 480 NO Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 3 true No M0 N1a T2 Stage IIB TCGA-BH-A0E9.8FDACA3D-C172-4198-9BBB-8F9E5A5FF0D6.pdf A0E9 TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES BH Breast B LIVING 2006 bfc39e77-7a26-4699-a4a3-217d4ea9425b bfc39e77-7a26-4699-a4a3-217d4ea9425b TCGA-BH-A0E9-01B-21-A13A-20 TCGA-BH-A0E9-01B-11D-A10Y-09 TCGA-BH-A0E9-01 8eb64683-4ff3-4cc6-84ff-902fbb7a2bb1 TCGA-BH-A0E9-01 TCGA-BH-A0E9-01B-11D-A10Y-09 TCGA-BH-A0E9-01B-11D-A112-05 TCGA-BH-A0E9-01 TCGA-BH-A0E9-01 TCGA-BH-A0E9-01B-11D-A10Y-09 bfc39e77-7a26-4699-a4a3-217d4ea9425b TCGA-BH-A0E9-01B-11D-A111-01 TCGA-BH-A0E9-01 TCGA-BH-A0E9-01B-11R-A115-07 bfc39e77-7a26-4699-a4a3-217d4ea9425b TCGA-BH-A0E9-01B-11D-A111-01 TCGA-BH-A0E9-01 TCGA-BH-A0EA-01 Stage IIA 72 2 Stage IIA 831 993 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 993 1 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 DECEASED TCGA-BH-A0EA-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 4 TCGA-BH-A0EA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Left TCGA-BH-A0EA-F58566 TCGA-BH-A0EA TCGA-BH-A0EA-01A Positive Positive Other -26548 567 991 0 NO 2014-4-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 220 NO Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 2 true Yes M0 N1a T1c Stage IIA TCGA-BH-A0EA.28231C7B-64EE-49AC-B7AB-9BADDDDCC17C.pdf A0EA TUMOR FREE YES YES NO Primary Tumor 01 Total mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast A DECEASED 2008 ca71ca96-cbb7-4eab-9487-251dda34e107 ca71ca96-cbb7-4eab-9487-251dda34e107 TCGA-BH-A0EA-01A-21-A13C-20 TCGA-BH-A0EA-01A-11D-A10Y-09 TCGA-BH-A0EA-01 8629bf5a-cdaf-4f6a-90bb-27dd4a7565c5 TCGA-BH-A0EA-01 TCGA-BH-A0EA-01A-11D-A10Y-09 TCGA-BH-A0EA-01A-11D-A112-05 TCGA-BH-A0EA-01 TCGA-BH-A0EA-01 TCGA-BH-A0EA-01A-11D-A10Y-09 ca71ca96-cbb7-4eab-9487-251dda34e107 TCGA-BH-A0EA-01A-11D-A111-01 TCGA-BH-A0EA-01 TCGA-BH-A0EA-01A-11R-A115-07 ca71ca96-cbb7-4eab-9487-251dda34e107 TCGA-BH-A0EA-01A-11D-A111-01 TCGA-BH-A0EA-01 TCGA-BH-A0EB-01 Stage IA 69 2 Stage I 745 Positive FEMALE Negative Negative M0 Negative N0 745 0 LumA Luminal A Positive LumA -12 -4 followup T1 T1 LIVING TCGA-BH-A0EB-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation cluster 4 TCGA-BH-A0EB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 69 Right Lower Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0EB-F4662 TCGA-BH-A0EB Positive 3+ Positive Other NO -25259 0 745 H-SCORE 300 90-99% 2.13 2010-11-16 FEMALE 2+ 40 2.65 1.25 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Equivocal Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 0 No M0 N0 (i-) T1c Stage IA A0EB TUMOR FREE H-SCORE 210 H-SCORE H-SCORE 40-49% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast LIVING 2008 efb01993-cfe4-4f01-b628-ee34fceb4a5e efb01993-cfe4-4f01-b628-ee34fceb4a5e TCGA-BH-A0EB-01A-21-A13C-20 TCGA-BH-A0EB-01A-11W-A050-09 TCGA-BH-A0EB-01 ac9f49b6-6bc1-42c6-9722-0cee04e91fdd TCGA-BH-A0EB-01 TCGA-BH-A0EB-01A-11W-A050-09 TCGA-BH-A0EB-01A-11D-A032-05 TCGA-BH-A0EB-01 TCGA-BH-A0EB-01A-11W-A050-09 efb01993-cfe4-4f01-b628-ee34fceb4a5e TCGA-BH-A0EB-01A-11D-A036-01 TCGA-BH-A0EB-01A-11R-A034-07 efb01993-cfe4-4f01-b628-ee34fceb4a5e TCGA-BH-A0EB-01A-11D-A036-01 TCGA-BH-A0EB-01 TCGA-BH-A0EE-01 Stage IIB 68 5 Stage IIB 943 Negative FEMALE Positive 2 3 1 Negative M0 Negative N0 943 0 Her2 HER2-enriched Negative Basal -11 -9 followup T_Other T3 LIVING TCGA-BH-A0EE-01 High C3-BRCA/Luminal cluster 1 Cluster 6 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-BH-A0EE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 68 Right Upper Inner Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0EE-F4674 TCGA-BH-A0EE TCGA-BH-A0EE-01A Negative 0 Negative Simple Mastectomy NO -24850 946 0 943 2010-11-16 FEMALE 30-39% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 890 NO Positive 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 7 0 true No M0 N0 (i-) T3 Stage IIB TCGA-BH-A0EE.B8664381-386A-44A2-AC3B-D69A4980A8EA.pdf A0EE TUMOR FREE NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2007 24c0ef45-670d-4595-b623-87f81aeb92a7 24c0ef45-670d-4595-b623-87f81aeb92a7 TCGA-BH-A0EE-01A-21-A13C-20 TCGA-BH-A0EE-01A-11W-A050-09 TCGA-BH-A0EE-01 b92e55c0-b921-4817-9984-3f58c13f93b5 TCGA-BH-A0EE-01 TCGA-BH-A0EE-01A-11W-A050-09 TCGA-BH-A0EE-01A-11D-A032-05 TCGA-BH-A0EE-01 TCGA-BH-A0EE-01A-11W-A050-09 TCGA-BH-A0EE-01 24c0ef45-670d-4595-b623-87f81aeb92a7 TCGA-BH-A0EE-01 TCGA-BH-A0EE-01A-11D-A036-01 TCGA-BH-A0EE-01A-11R-A034-07 24c0ef45-670d-4595-b623-87f81aeb92a7 TCGA-BH-A0EE-01A-11D-A036-01 TCGA-BH-A0EE-01 TCGA-BH-A0EI-01 Stage IIA 51 5 Stage IIA 743 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 743 0 LumA Luminal A Positive LumA -5 -7 enrollment T1 T1 LIVING TCGA-BH-A0EI-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A0EI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right TCGA-BH-A0EI-F59115 TCGA-BH-A0EI Positive Positive Other -18741 0 1926 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 2 Negative Peri (6-12 months since last menstrual period) 4 4 NO 2 No M0 N1a T1c Stage IIA A0EI TUMOR FREE NO YES YES Primary Tumor 01 segmental mastectomy with right sentinel lymph node biopsy 6th NO YES BH Breast LIVING 2008 c6929312-e22d-4d4e-830d-6f735184d9b2 c6929312-e22d-4d4e-830d-6f735184d9b2 TCGA-BH-A0EI-01A-21-A13B-20 TCGA-BH-A0EI-01A-11D-A10Y-09 TCGA-BH-A0EI-01 d2fe1d76-437a-4eec-b376-d17426760c2a TCGA-BH-A0EI-01 TCGA-BH-A0EI-01A-11D-A10Y-09 TCGA-BH-A0EI-01A-11D-A112-05 TCGA-BH-A0EI-01 TCGA-BH-A0EI-01 TCGA-BH-A0EI-01A-11D-A10Y-09 c6929312-e22d-4d4e-830d-6f735184d9b2 TCGA-BH-A0EI-01A-11D-A111-01 TCGA-BH-A0EI-01 TCGA-BH-A0EI-01A-11R-A115-07 c6929312-e22d-4d4e-830d-6f735184d9b2 TCGA-BH-A0EI-01A-11D-A111-01 TCGA-BH-A0EI-01 TCGA-BH-A0GY-01 Stage IIA 67 3 No_Conversion 923 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 923 0 LumA Luminal A Positive ReacI -3 -3 followup T_Other T2 LIVING TCGA-BH-A0GY-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 3 TCGA-BH-A0GY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 67 Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0GY-F4695 TCGA-BH-A0GY TCGA-BH-A0GY-01A Positive 3+ Positive Other NO -24493 745 0 923 H-Score 150 40-49% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 200 NO Negative 26 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 5 3 true No M0 N1 T2 Stage IIA TCGA-BH-A0GY.A997FF30-F112-48BE-8FF1-15F8266A5E62.pdf A0GY TUMOR FREE H-Score 290 H-Score H-Score 90-99% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2008 91d63f86-9c62-47cb-8b4a-e3bd981ab8b2 91d63f86-9c62-47cb-8b4a-e3bd981ab8b2 TCGA-BH-A0GY-01A-21-A13C-20 TCGA-BH-A0GY-01A-11W-A071-09 TCGA-BH-A0GY-01 TCGA-BH-A0GY-01A-11D-A10P-05 9a0ff086-5678-4a7d-953e-cd6be5d03183 TCGA-BH-A0GY-01 TCGA-BH-A0GY-01A-11W-A071-09 TCGA-BH-A0GY-01 TCGA-BH-A0GY-01A-11W-A071-09 TCGA-BH-A0GY-01 91d63f86-9c62-47cb-8b4a-e3bd981ab8b2 TCGA-BH-A0GY-01 TCGA-BH-A0GY-01A-11D-A059-01 TCGA-BH-A0GY-01A-11R-A056-07 91d63f86-9c62-47cb-8b4a-e3bd981ab8b2 TCGA-BH-A0GY-01A-11D-A059-01 TCGA-BH-A0GY-01 TCGA-BH-A0GZ-01 Stage IIA 62 3 No_Conversion 328 Positive FEMALE Negative Negative M0 Positive N1 328 0 LumA Luminal A Positive 0 -3 followup T1 T1 LIVING TCGA-BH-A0GZ-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0GZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO NO 62 Left Upper Inner Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0GZ-F4697 TCGA-BH-A0GZ TCGA-BH-A0GZ-01A Negative Positive 3+ Positive Other NO -22714 206 0 328 H-SCORE 300 90-99% 2.08 2010-11-16 FEMALE 2+ 40 2.2 1.05 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 60 NO Equivocal Negative 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 1 true No M0 N1a T1c Stage IIA TCGA-BH-A0GZ.C956B4B1-99E6-4823-886A-FA8FCD1E3E4D.pdf A0GZ TUMOR FREE H-SCORE 280 H-SCORE H-SCORE 80-89% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2009 8ffcb765-094c-4623-b172-ea8400965f00 8ffcb765-094c-4623-b172-ea8400965f00 TCGA-BH-A0GZ-01A-11W-A071-09 TCGA-BH-A0GZ-01 TCGA-BH-A0GZ-01A-11D-A10P-05 TCGA-BH-A0GZ-01 TCGA-BH-A0GZ-01A-11W-A071-09 TCGA-BH-A0GZ-01 TCGA-BH-A0GZ-01A-11W-A071-09 TCGA-BH-A0GZ-01 8ffcb765-094c-4623-b172-ea8400965f00 TCGA-BH-A0GZ-01 TCGA-BH-A0GZ-01A-11D-A059-01 TCGA-BH-A0GZ-01A-11R-A056-07 8ffcb765-094c-4623-b172-ea8400965f00 TCGA-BH-A0GZ-01A-11D-A059-01 TCGA-BH-A0GZ-01 TCGA-BH-A0H0-01 Stage IA 69 2 Stage I 461 Positive FEMALE Negative Negative M0 Negative N0 461 0 LumB Luminal B Positive -10 -3 followup T1 T1 LIVING TCGA-BH-A0H0-01 Squamous C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 3 cluster 2 mutation c1uster 9 TCGA-BH-A0H0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0H0-F4704 TCGA-BH-A0H0 TCGA-BH-A0H0-01A Positive 2+ Positive Other NO -25223 344 0 461 H-SCORE 190 50-59% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 70 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0H0.94CF5704-1BE7-4CCC-870E-FB8527AC47E8.pdf A0H0 TUMOR FREE H-SCORE 7 H-SCORE H-SCORE <10% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2009 38e26122-c473-41c1-afb0-cd3b9096e9f4 38e26122-c473-41c1-afb0-cd3b9096e9f4 TCGA-BH-A0H0-01A-11W-A071-09 TCGA-BH-A0H0-01 TCGA-BH-A0H0-01A-11D-A10P-05 TCGA-BH-A0H0-01 TCGA-BH-A0H0-01A-11W-A071-09 TCGA-BH-A0H0-01 TCGA-BH-A0H0-01A-11W-A071-09 TCGA-BH-A0H0-01 38e26122-c473-41c1-afb0-cd3b9096e9f4 TCGA-BH-A0H0-01 TCGA-BH-A0H0-01A-11D-A059-01 TCGA-BH-A0H0-01A-11R-A056-07 38e26122-c473-41c1-afb0-cd3b9096e9f4 TCGA-BH-A0H0-01A-11D-A059-01 TCGA-BH-A0H0-01 TCGA-BH-A0H3-01 Stage I 46 2 Stage I 1149 Positive FEMALE Negative Negative M0 Negative N0 1149 0 LumA Luminal A Positive -2 -4 enrollment T1 T1 LIVING TCGA-BH-A0H3-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-BH-A0H3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Upper Outer Quadrant TCGA-BH-A0H3-F58599 TCGA-BH-A0H3 TCGA-BH-A0H3-01A Positive Positive Other -17152 773 0 1928 NO 2014-4-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 80 NO Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 0 true No M0 N0 T1c Stage I TCGA-BH-A0H3.6D3F79A6-C55C-497F-9CCD-1C6D3ACE7492.pdf A0H3 TUMOR FREE NO YES YES Primary Tumor 01 Left segmental mastectomy with axillary lymph node dissection 6th NO YES BH Breast A LIVING 2008 4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d 4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d TCGA-BH-A0H3-01A-11D-A12Q-09 TCGA-BH-A0H3-01 TCGA-BH-A0H3-01A-11D-A12R-05 TCGA-BH-A0H3-01 TCGA-BH-A0H3-01A-11D-A12Q-09 TCGA-BH-A0H3-01 TCGA-BH-A0H3-01 TCGA-BH-A0H3-01A-11D-A12Q-09 4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d TCGA-BH-A0H3-01A-11D-A12N-01 TCGA-BH-A0H3-01 TCGA-BH-A0H3-01A-11R-A12P-07 4baa8edc-9ab0-4cd6-b316-dfe1ff7c1f4d TCGA-BH-A0H3-01A-11D-A12N-01 TCGA-BH-A0H3-01 TCGA-BH-A0H5-01 Stage I 45 1 Stage I 1080 Positive FEMALE Negative 2 2 1 Negative M0 Negative N0 1080 0 LumA Luminal A Positive Basal -2 -5 enrollment T1 T1 LIVING TCGA-BH-A0H5-01 Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-BH-A0H5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Upper Outer Quadrant TCGA-BH-A0H5-F58727 TCGA-BH-A0H5 TCGA-BH-A0H5-01A Positive Positive Other -16719 815 0 1620 NO 2014-4-22 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 410 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 3 NO 0 true No M0 N0 (i-) T1c Stage I TCGA-BH-A0H5.C350A3BE-1709-427D-8E1D-E0BBA480A56D.pdf A0H5 TUMOR FREE YES YES NO Primary Tumor 01 Right total mastectomy with lymph node left axillary lymph node excision 6th NO YES BH Breast A LIVING 2008 e5378cd0-4045-4afe-8157-7187b3d294ef e5378cd0-4045-4afe-8157-7187b3d294ef TCGA-BH-A0H5-01A-11-A13C-20 TCGA-BH-A0H5-01A-21D-A10Y-09 TCGA-BH-A0H5-01 3fd5b19e-218a-400d-85e7-23fb60737f41 TCGA-BH-A0H5-01 TCGA-BH-A0H5-01A-21D-A10Y-09 TCGA-BH-A0H5-01A-21D-A112-05 TCGA-BH-A0H5-01 TCGA-BH-A0H5-01 TCGA-BH-A0H5-01A-21D-A10Y-09 e5378cd0-4045-4afe-8157-7187b3d294ef TCGA-BH-A0H5-01A-21D-A111-01 TCGA-BH-A0H5-01 TCGA-BH-A0H5-01A-21R-A115-07 e5378cd0-4045-4afe-8157-7187b3d294ef TCGA-BH-A0H5-01A-21D-A111-01 TCGA-BH-A0H5-01 TCGA-BH-A0H5-11 45 1080 FEMALE 1080 0 Normal enrollment LIVING TCGA-BH-A0H5-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0H5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Upper Outer Quadrant TCGA-BH-A0H5-F58727 TCGA-BH-A0H5 Positive Positive Other -16719 0 1620 NO 2014-4-22 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 (i-) T1c Stage I A0H5 TUMOR FREE YES YES NO Solid Tissue Normal 11 Right total mastectomy with lymph node left axillary lymph node excision 6th NO YES BH Breast LIVING 2008 fe1a74fd-c9b4-405b-86a7-61bcb75f825d fe1a74fd-c9b4-405b-86a7-61bcb75f825d TCGA-BH-A0H5-11A-62D-A112-05 TCGA-BH-A0H5-11 fe1a74fd-c9b4-405b-86a7-61bcb75f825d TCGA-BH-A0H5-11 TCGA-BH-A0H5-11A-62R-A115-07 fe1a74fd-c9b4-405b-86a7-61bcb75f825d TCGA-BH-A0H6-01 Stage IA 82 4 No_Conversion 747 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 747 0 LumA Luminal A Positive ReacI -5 -3 followup T1 T1 LIVING TCGA-BH-A0H6-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0H6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 82 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right No axillary staging TCGA-BH-A0H6-F4711 TCGA-BH-A0H6 Positive 3+ Positive Other NO -30125 0 747 H-SCORE 230 50-59% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy Negative 0 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 0 0 No M0 NX T1b Stage I A0H6 TUMOR FREE H-SCORE 250 H-SCORE H-SCORE 60-69% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast LIVING 2008 f7e26041-2b2f-45ea-8da9-5a0d5bf25781 f7e26041-2b2f-45ea-8da9-5a0d5bf25781 TCGA-BH-A0H6-01A-31-A13C-20 TCGA-BH-A0H6-01A-21W-A071-09 TCGA-BH-A0H6-01 TCGA-BH-A0H6-01A-21D-A10P-05 cc4de94d-e4e4-4e21-823c-005b9a846f19 TCGA-BH-A0H6-01 TCGA-BH-A0H6-01A-21W-A071-09 TCGA-BH-A0H6-01 TCGA-BH-A0H6-01A-21W-A071-09 TCGA-BH-A0H6-01 f7e26041-2b2f-45ea-8da9-5a0d5bf25781 TCGA-BH-A0H6-01 TCGA-BH-A0H6-01A-21D-A059-01 TCGA-BH-A0H6-01A-21R-A056-07 f7e26041-2b2f-45ea-8da9-5a0d5bf25781 TCGA-BH-A0H6-01A-21D-A059-01 TCGA-BH-A0H6-01 TCGA-BH-A0H7-01 Stage IIIA 65 3 No_Conversion 701 Positive FEMALE Negative 1 3 3 Negative M0 Positive N2 701 0 LumA Luminal A Positive ReacII -3 -3 followup T1 T1 LIVING TCGA-BH-A0H7-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation cluster 5 TCGA-BH-A0H7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone TCGA-BH-A0H7-F4737 TCGA-BH-A0H7 TCGA-BH-A0H7-01A Positive 2+ Positive Modified Radical Mastectomy NO -23972 542 0 702 H-SCORE 255 70-79% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 440 NO Negative 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 6 true No M0 N2a T1c Stage IIIA TCGA-BH-A0H7.CC7D1177-1638-4A80-A3AA-266ADC260EC9.pdf A0H7 TUMOR FREE H-SCORE 150 H-SCORE H-SCORE 30-39% YES Primary Tumor 01 YES NO YES BH Breast A LIVING 2008 5969d3bb-19fb-4bda-9483-db4791257b95 5969d3bb-19fb-4bda-9483-db4791257b95 TCGA-BH-A0H7-01A-21-A13C-20 TCGA-BH-A0H7-01A-13W-A071-09 TCGA-BH-A0H7-01 TCGA-BH-A0H7-01A-13D-A10P-05 571ca6b7-118d-4261-a194-c0856e62b1d9 TCGA-BH-A0H7-01 TCGA-BH-A0H7-01A-13W-A071-09 TCGA-BH-A0H7-01 TCGA-BH-A0H7-01A-13W-A071-09 TCGA-BH-A0H7-01 5969d3bb-19fb-4bda-9483-db4791257b95 TCGA-BH-A0H7-01 TCGA-BH-A0H7-01A-13D-A059-01 TCGA-BH-A0H7-01A-13R-A056-07 5969d3bb-19fb-4bda-9483-db4791257b95 TCGA-BH-A0H7-01A-13D-A059-01 TCGA-BH-A0H7-01 TCGA-BH-A0H7-11 65 701 FEMALE 701 0 Normal followup LIVING TCGA-BH-A0H7-11 C3-BRCA/Luminal mutation cluster 5 TCGA-BH-A0H7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Axillary lymph node dissection alone TCGA-BH-A0H7-F4737 TCGA-BH-A0H7 TCGA-BH-A0H7-11A Positive 2+ Positive Modified Radical Mastectomy NO -23972 542 0 702 H-SCORE 255 70-79% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 380 NO Negative 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 6 true No M0 N2a T1c Stage IIIA A0H7 TUMOR FREE H-SCORE 150 H-SCORE H-SCORE 30-39% YES Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2008 6136a15e-6c8f-44bc-85c2-c7cbf675cab0 6136a15e-6c8f-44bc-85c2-c7cbf675cab0 TCGA-BH-A0H7-11A-13D-A10Q-05 TCGA-BH-A0H7-11 6136a15e-6c8f-44bc-85c2-c7cbf675cab0 TCGA-BH-A0H7-11 TCGA-BH-A0H7-11A-13R-A089-07 6136a15e-6c8f-44bc-85c2-c7cbf675cab0 TCGA-BH-A0H9-01 Stage IIA 69 1 Stage IIA 1247 Positive FEMALE Negative 2 2 2 Negative M0 Negative N0 1247 0 LumA Luminal A Positive LumA/B -3 -3 followup T_Other T2 LIVING TCGA-BH-A0H9-01 Iq C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 14 TCGA-BH-A0H9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0H9-F4703 TCGA-BH-A0H9 TCGA-BH-A0H9-01A Positive 1+ Positive Other NO -25289 1088 0 1247 90-99% 2.98 2010-11-16 FEMALE 2+ 40 3.43 1.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 120 NO Equivocal Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 0 true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0H9.584E15EE-1C80-4507-8AD3-558DF06DBDF3.pdf A0H9 TUMOR FREE 30-39% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2007 827431d3-e25a-45b6-9b0f-5732501e2a5b 827431d3-e25a-45b6-9b0f-5732501e2a5b TCGA-BH-A0H9-01A-21-A13C-20 TCGA-BH-A0H9-01A-11W-A071-09 TCGA-BH-A0H9-01 TCGA-BH-A0H9-01A-11D-A10P-05 84ff2baf-9961-4324-91b6-e2e9a86128aa TCGA-BH-A0H9-01 TCGA-BH-A0H9-01A-11W-A071-09 TCGA-BH-A0H9-01 TCGA-BH-A0H9-01A-11W-A071-09 TCGA-BH-A0H9-01 827431d3-e25a-45b6-9b0f-5732501e2a5b TCGA-BH-A0H9-01 TCGA-BH-A0H9-01A-11D-A059-01 TCGA-BH-A0H9-01A-11R-A056-07 827431d3-e25a-45b6-9b0f-5732501e2a5b TCGA-BH-A0H9-01A-11D-A059-01 TCGA-BH-A0H9-01 TCGA-BH-A0H9-11 69 1247 FEMALE 1247 0 followup LIVING TCGA-BH-A0H9-11 C3-BRCA/Luminal mutation cluster 14 TCGA-BH-A0H9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0H9-F4703 TCGA-BH-A0H9 TCGA-BH-A0H9-11A Positive 1+ Positive Other NO -25289 1088 0 1247 90-99% 2.98 2010-11-16 FEMALE 2+ 40 3.43 1.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 220 NO Equivocal Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 0 true No M0 N0 (i-) T2 Stage IIA A0H9 TUMOR FREE 30-39% YES Solid Tissue Normal 11 Segmental mastectomy YES NO YES BH Breast A LIVING 2007 27d4c881-e906-437f-921d-467eb107798a 27d4c881-e906-437f-921d-467eb107798a TCGA-BH-A0H9-11A-22D-A093-05 27d4c881-e906-437f-921d-467eb107798a TCGA-BH-A0H9-11A-22R-A089-07 27d4c881-e906-437f-921d-467eb107798a TCGA-BH-A0HA-01 Stage I 31 1 Stage I 856 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 856 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING TCGA-BH-A0HA-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-BH-A0HA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 31 Right TCGA-BH-A0HA-F43320 TCGA-BH-A0HA Positive Positive Other -11379 0 1611 NO Scheduled Follow-up Submission 2013-5-17 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 0 No M0 N0 (i-) T1c Stage I A0HA TUMOR FREE NO YES NO Primary Tumor 01 bilateral total mastectomies with right sentinel node biopsy 6th NO NO YES BH Breast LIVING 2008 cffc0fe5-533f-46f8-a54a-2e09c392767d cffc0fe5-533f-46f8-a54a-2e09c392767d TCGA-BH-A0HA-01A-21-A13C-20 TCGA-BH-A0HA-01A-11D-A12Q-09 TCGA-BH-A0HA-01 TCGA-BH-A0HA-01A-11D-A12R-05 f1a9fcd6-b351-4300-ab8c-e488c8d76cee TCGA-BH-A0HA-01 TCGA-BH-A0HA-01A-11D-A12Q-09 TCGA-BH-A0HA-01 TCGA-BH-A0HA-01 TCGA-BH-A0HA-01A-11D-A12Q-09 cffc0fe5-533f-46f8-a54a-2e09c392767d TCGA-BH-A0HA-01A-11D-A12N-01 TCGA-BH-A0HA-01 TCGA-BH-A0HA-01A-11R-A12P-07 cffc0fe5-533f-46f8-a54a-2e09c392767d TCGA-BH-A0HA-01A-11D-A12N-01 TCGA-BH-A0HA-01 TCGA-BH-A0HA-11 31 856 FEMALE 856 0 Normal enrollment LIVING TCGA-BH-A0HA-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A0HA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 31 Right TCGA-BH-A0HA-F43320 TCGA-BH-A0HA TCGA-BH-A0HA-11A Positive Positive Other -11379 675 0 1611 NO Scheduled Follow-up Submission 2013-5-17 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 340 NO Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 (i-) T1c Stage I A0HA TUMOR FREE NO YES NO Solid Tissue Normal 11 bilateral total mastectomies with right sentinel node biopsy 6th NO NO YES BH Breast A LIVING 2008 a521a6fa-da2b-48ef-94e8-3307030427b6 a521a6fa-da2b-48ef-94e8-3307030427b6 TCGA-BH-A0HA-11A-31D-A12R-05 4DD09312-C6DE-4532-811D-242BAAE47F9D TCGA-BH-A0HA-11 a521a6fa-da2b-48ef-94e8-3307030427b6 TCGA-BH-A0HA-11 TCGA-BH-A0HA-11A-31R-A12P-07 a521a6fa-da2b-48ef-94e8-3307030427b6 TCGA-BH-A0HB-01 Stage IA 55 5 Stage I 806 Positive FEMALE Negative Negative M0 Negative N0 806 0 LumA Luminal A Positive -8 -3 followup T1 T1 LIVING TCGA-BH-A0HB-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 14 TCGA-BH-A0HB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0HB-F4718 TCGA-BH-A0HB TCGA-BH-A0HB-01A Positive 1+ Positive Other NO -20448 739 0 806 H-Score 300 90-99% 2.13 2010-11-16 FEMALE 2+ 40 2.58 1.21 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 70 NO Equivocal Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HB.C7476B2B-0040-4013-8D30-06935E3FB897.pdf A0HB TUMOR FREE H-Score 70 H-Score H-Score 30-39% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2008 67b214bc-ac5f-4993-9907-fe0e0398d4ed 67b214bc-ac5f-4993-9907-fe0e0398d4ed TCGA-BH-A0HB-01A-11W-A071-09 TCGA-BH-A0HB-01 TCGA-BH-A0HB-01A-11D-A10P-05 TCGA-BH-A0HB-01 TCGA-BH-A0HB-01A-11W-A071-09 TCGA-BH-A0HB-01 TCGA-BH-A0HB-01A-11W-A071-09 TCGA-BH-A0HB-01 67b214bc-ac5f-4993-9907-fe0e0398d4ed TCGA-BH-A0HB-01 TCGA-BH-A0HB-01A-11D-A059-01 TCGA-BH-A0HB-01A-11R-A056-07 67b214bc-ac5f-4993-9907-fe0e0398d4ed TCGA-BH-A0HB-01A-11D-A059-01 TCGA-BH-A0HB-01 TCGA-BH-A0HF-01 Stage IA 77 Stage I 727 Positive FEMALE Negative Negative M0 Negative N0 727 0 LumA Luminal A Positive -5 -7 followup T1 T1 LIVING TCGA-BH-A0HF-01 cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 TCGA-BH-A0HF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0HF-F4734 TCGA-BH-A0HF TCGA-BH-A0HF-01A Positive 1+ Positive Other NO -28233 549 0 727 H-Score 295 90-99% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 40 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HF.71291A56-C2DB-4EB9-8223-DD7563CBBDC9.pdf A0HF TUMOR FREE H-Score 15 H-Score H-Score <10% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2008 5b92fd62-9fec-4b18-b7c3-50c88fa0d464 5b92fd62-9fec-4b18-b7c3-50c88fa0d464 TCGA-BH-A0HF-01 TCGA-BH-A0HF-01A-11D-A10P-05 TCGA-BH-A0HF-01A-11W-A071-09 TCGA-BH-A0HF-01 5b92fd62-9fec-4b18-b7c3-50c88fa0d464 TCGA-BH-A0HF-01 TCGA-BH-A0HF-01A-11R-A056-07 5b92fd62-9fec-4b18-b7c3-50c88fa0d464 TCGA-BH-A0HF-01 TCGA-BH-A0HI-01 Stage IA 78 2 Stage I 619 Positive FEMALE Negative Negative M0 Negative N0 619 0 LumA Luminal A Positive -12 -3 followup T1 T1 LIVING TCGA-BH-A0HI-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-BH-A0HI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right Upper Inner Quadrant|Right Lower Inner Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0HI-F4756 TCGA-BH-A0HI TCGA-BH-A0HI-01A Positive 1+ Positive Other YES -28644 554 0 620 H-Score 240 50-59% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 20 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 7 0 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HI.EE9E0908-05D2-4F26-B3C2-2B40A48FEA6D.pdf A0HI TUMOR FREE H-Score 160 H-Score H-Score 40-49% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2008 682942cb-589f-4348-abc2-3c7cc76fb34d 682942cb-589f-4348-abc2-3c7cc76fb34d TCGA-BH-A0HI-01A-11D-A099-09 TCGA-BH-A0HI-01 TCGA-BH-A0HI-01A-11D-A10P-05 TCGA-BH-A0HI-01 TCGA-BH-A0HI-01A-11D-A099-09 TCGA-BH-A0HI-01 TCGA-BH-A0HI-01A-11D-A099-09 TCGA-BH-A0HI-01 682942cb-589f-4348-abc2-3c7cc76fb34d TCGA-BH-A0HI-01 TCGA-BH-A0HI-01A-11D-A087-01 TCGA-BH-A0HI-01A-11R-A084-07 682942cb-589f-4348-abc2-3c7cc76fb34d TCGA-BH-A0HI-01A-11D-A087-01 TCGA-BH-A0HI-01 TCGA-BH-A0HK-01 Stage IIB 81 2 No_Conversion 178 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 178 0 LumA Luminal A Negative LumA/B 0 0 followup T_Other T2 LIVING TCGA-BH-A0HK-01 Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-BH-A0HK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 81 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone TCGA-BH-A0HK-F4758 TCGA-BH-A0HK TCGA-BH-A0HK-01A Positive 0 Negative Modified Radical Mastectomy NO -29751 35 0 178 H-SCORE 260 70-79% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 700 NO Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 7 2 true No M0 N1 T2 Stage IIB TCGA-BH-A0HK.575F2EFD-2D8B-4140-9FCB-D8CB9EC14D09.pdf A0HK TUMOR FREE H-SCORE 0 H-SCORE H-SCORE <10% NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2010 85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5 85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5 TCGA-BH-A0HK-01A-21-A13C-20 TCGA-BH-A0HK-01A-11W-A071-09 TCGA-BH-A0HK-01 TCGA-BH-A0HK-01A-11D-A10P-05 c6d75d78-0a3e-4221-840e-b2c6099b8e72 TCGA-BH-A0HK-01 TCGA-BH-A0HK-01A-11W-A071-09 TCGA-BH-A0HK-01 TCGA-BH-A0HK-01A-11W-A071-09 TCGA-BH-A0HK-01 85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5 TCGA-BH-A0HK-01 TCGA-BH-A0HK-01A-11D-A059-01 TCGA-BH-A0HK-01A-11R-A056-07 85845e8c-e9d7-43c4-8dfc-d7fb0cf85ac5 TCGA-BH-A0HK-01A-11D-A059-01 TCGA-BH-A0HK-01 TCGA-BH-A0HK-11 81 178 FEMALE 178 0 Normal followup LIVING TCGA-BH-A0HK-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A0HK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 81 Right Upper Inner Quadrant|Right Axillary lymph node dissection alone TCGA-BH-A0HK-F4758 TCGA-BH-A0HK TCGA-BH-A0HK-11A Positive 0 Negative Modified Radical Mastectomy NO -29751 35 0 178 H-SCORE 260 70-79% 2010-11-16 FEMALE <10% 0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 240 NO Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 true No M0 N1 T2 Stage IIB A0HK TUMOR FREE H-SCORE 0 H-SCORE H-SCORE <10% NO Solid Tissue Normal 11 YES NO YES BH Breast A LIVING 2010 01163f75-8956-40a6-97a5-3c0478d904f8 01163f75-8956-40a6-97a5-3c0478d904f8 TCGA-BH-A0HK-11A-11D-A10Q-05 9959CAD8-B950-41C0-A0C7-3EF86F4DA9EC TCGA-BH-A0HK-11 01163f75-8956-40a6-97a5-3c0478d904f8 TCGA-BH-A0HK-11 TCGA-BH-A0HK-11A-11R-A089-07 01163f75-8956-40a6-97a5-3c0478d904f8 TCGA-BH-A0HL-01 Stage IIB 56 No_Conversion 72 Positive FEMALE Negative Negative M0 Positive N1 72 0 Basal-like Positive LumA/B -13 0 followup T_Other T2 LIVING TCGA-BH-A0HL-01 cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 11 cluster 4 mutation c1uster 9 TCGA-BH-A0HL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Lower Inner Quadrant|Right Lower Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0HL-F4792 TCGA-BH-A0HL TCGA-BH-A0HL-01A Positive 3+ Positive Modified Radical Mastectomy NO -20804 352 0 72 H-SCORE 295 90-99% 2.25 2010-11-16 FEMALE 2+ 40 2.23 0.99 Infiltrating Ductal Carcinoma No C50.9 8503/3 C50.9 3+ YES Core needle biopsy 250 NO Equivocal Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 2 true No M0 N1a T2 Stage IIB TCGA-BH-A0HL.79DAEAE5-A177-40E0-9BFC-54DC9F544764.pdf A0HL TUMOR FREE H-SCORE 200 H-SCORE H-SCORE 40-49% NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2009 1ee60bda-48df-4288-90cb-480fbfbc5d50 1ee60bda-48df-4288-90cb-480fbfbc5d50 TCGA-BH-A0HL-01A-21-A13C-20 TCGA-BH-A0HL-01A-11W-A050-09 TCGA-BH-A0HL-01 2167df75-1057-4cb6-acea-3e737541d1ee TCGA-BH-A0HL-01A-11W-A050-09 TCGA-BH-A0HL-01A-11D-A032-05 TCGA-BH-A0HL-01 TCGA-BH-A0HL-01A-11W-A050-09 1ee60bda-48df-4288-90cb-480fbfbc5d50 TCGA-BH-A0HL-01 1ee60bda-48df-4288-90cb-480fbfbc5d50 TCGA-BH-A0HN-01 Stage IA 67 Stage I 516 Positive FEMALE Negative Negative M0 Negative N0 516 0 Basal-like Positive ReacI -13 0 followup T1 T1 LIVING TCGA-BH-A0HN-01 cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 11 cluster 6 mutation cluster 14 TCGA-BH-A0HN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0HN-F4811 TCGA-BH-A0HN TCGA-BH-A0HN-01A Negative Positive 3+ Mastectomy NOS Positive Other NO -24731 359 0 516 H-SCORE 300 90-99% 1.78 2010-11-16 FEMALE 2+ 40 2.0 1.13 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 130 NO Equivocal Negative 2 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HN.CA7E5555-5898-411A-8A5B-9BA2239A2B30.pdf A0HN TUMOR FREE H-SCORE 290 H-SCORE H-SCORE 90-99% NO Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2009 6f0cf450-76f1-489d-9890-5093816c0680 6f0cf450-76f1-489d-9890-5093816c0680 TCGA-BH-A0HN-01A-21-A13C-20 TCGA-BH-A0HN-01A-11D-A099-09 TCGA-BH-A0HN-01 TCGA-BH-A0HN-01A-11D-A10P-05 b81e2777-d661-4576-b8dc-e95b03351e27 TCGA-BH-A0HN-01A-11D-A099-09 TCGA-BH-A0HN-01 TCGA-BH-A0HN-01A-11D-A099-09 6f0cf450-76f1-489d-9890-5093816c0680 TCGA-BH-A0HN-01 6f0cf450-76f1-489d-9890-5093816c0680 TCGA-BH-A0HO-01 Stage IIA 48 2 No_Conversion 76 Positive FEMALE Negative Negative M0 Positive N1 76 0 LumA Luminal A Positive -12 -3 followup T1 T1 LIVING TCGA-BH-A0HO-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 6 cluster 2 mutation c1uster 9 TCGA-BH-A0HO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Outer Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0HO-F4771 TCGA-BH-A0HO TCGA-BH-A0HO-01A Positive 3+ Positive Other YES -17710 224 0 76 H-Score 200 90-99% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 110 NO Negative 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 2 1 1 true No M0 N1a T1c Stage IIA TCGA-BH-A0HO.C9AD69EB-506A-4442-B1C2-C8F09B519CB2.pdf A0HO TUMOR FREE H-Score 290 H-Score H-Score 90-99% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2009 92f53e8e-abd5-4597-a6be-678be549315d 92f53e8e-abd5-4597-a6be-678be549315d TCGA-BH-A0HO-01A-11W-A050-09 TCGA-BH-A0HO-01 TCGA-BH-A0HO-01 TCGA-BH-A0HO-01A-11W-A050-09 TCGA-BH-A0HO-01A-11D-A032-05 TCGA-BH-A0HO-01 TCGA-BH-A0HO-01A-11W-A050-09 TCGA-BH-A0HO-01 92f53e8e-abd5-4597-a6be-678be549315d TCGA-BH-A0HO-01 TCGA-BH-A0HO-01A-11D-A036-01 TCGA-BH-A0HO-01A-11R-A034-07 92f53e8e-abd5-4597-a6be-678be549315d TCGA-BH-A0HO-01A-11D-A036-01 TCGA-BH-A0HO-01 TCGA-BH-A0HP-01 Stage IIIA 65 2 No_Conversion 414 Positive FEMALE Negative 3 4 3 Negative M0 Positive N2 414 0 LumA Luminal A Negative ReacI -5 -7 followup T_Other T3 LIVING TCGA-BH-A0HP-01 Iq C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-BH-A0HP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Axillary lymph node dissection alone TCGA-BH-A0HP-F4784 TCGA-BH-A0HP TCGA-BH-A0HP-01A Positive 0 Negative Modified Radical Mastectomy NO -23883 346 0 414 H-Score 280 80-89% 2010-11-16 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 720 NO Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Positive Negative 1 6 8 true No M0 N2a T3 Stage IIIA TCGA-BH-A0HP.F13CE7B3-F275-4EEE-90A3-11B8B92FA431.pdf A0HP TUMOR FREE H-Score 0 H-Score H-Score YES Primary Tumor 01 YES NO YES BH Breast A LIVING 2009 f0c59856-0421-46e3-a2f9-e17f0f267930 f0c59856-0421-46e3-a2f9-e17f0f267930 TCGA-BH-A0HP-01A-21-A13C-20 TCGA-BH-A0HP-01A-12D-A099-09 TCGA-BH-A0HP-01 TCGA-BH-A0HP-01A-12D-A10P-05 189540a2-042e-4bac-99f0-b7b0feda0a23 TCGA-BH-A0HP-01 TCGA-BH-A0HP-01A-12D-A099-09 TCGA-BH-A0HP-01 TCGA-BH-A0HP-01A-12D-A099-09 TCGA-BH-A0HP-01 f0c59856-0421-46e3-a2f9-e17f0f267930 TCGA-BH-A0HP-01 TCGA-BH-A0HP-01A-12D-A087-01 TCGA-BH-A0HP-01A-12R-A084-07 f0c59856-0421-46e3-a2f9-e17f0f267930 TCGA-BH-A0HP-01A-12D-A087-01 TCGA-BH-A0HP-01 TCGA-BH-A0HQ-01 Stage IIA 56 Stage IIA 1121 Positive FEMALE Negative Negative M0 Negative N0 1121 0 LumA Luminal A Positive -5 -3 followup T_Other T2 LIVING TCGA-BH-A0HQ-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0HQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0HQ-F4795 TCGA-BH-A0HQ TCGA-BH-A0HQ-01A Positive 3+ Positive Other YES -20719 962 0 1121 90-99% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 110 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 0 true No M0 N0 (i+) T2 Stage IIA TCGA-BH-A0HQ.A76A272F-675E-4E56-8761-96B71419A012.pdf A0HQ TUMOR FREE 90-99% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2007 856452d1-5480-4921-bf5b-4c6f625a99c0 856452d1-5480-4921-bf5b-4c6f625a99c0 TCGA-BH-A0HQ-01A-11W-A050-09 TCGA-BH-A0HQ-01 TCGA-BH-A0HQ-01 TCGA-BH-A0HQ-01A-11W-A050-09 TCGA-BH-A0HQ-01A-11D-A032-05 TCGA-BH-A0HQ-01 TCGA-BH-A0HQ-01A-11W-A050-09 TCGA-BH-A0HQ-01 856452d1-5480-4921-bf5b-4c6f625a99c0 TCGA-BH-A0HQ-01 TCGA-BH-A0HQ-01A-11D-A036-01 TCGA-BH-A0HQ-01A-11R-A034-07 856452d1-5480-4921-bf5b-4c6f625a99c0 TCGA-BH-A0HQ-01A-11D-A036-01 TCGA-BH-A0HQ-01 TCGA-BH-A0HU-01 Stage IA 52 2 Stage I 392 Positive FEMALE Negative 3 1 4 Negative M0 Negative N0 392 0 LumB Luminal B Positive Her2 -2 -3 followup T1 T1 LIVING TCGA-BH-A0HU-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation cluster 4 TCGA-BH-A0HU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Upper Outer Quadrant|Right Sentinel node biopsy alone TCGA-BH-A0HU-F4813 TCGA-BH-A0HU TCGA-BH-A0HU-01A Positive 2+ Positive Other NO -19216 394 0 392 H-Score 140 40-49% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 140 NO Negative 1 Negative Peri (6-12 months since last menstrual period) 2 4 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HU.1F35A542-2795-4B1F-A846-7097B442C2D9.pdf A0HU TUMOR FREE H-Score 140 H-Score H-Score 40-49% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2009 c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f TCGA-BH-A0HU-01A-21-A13A-20 TCGA-BH-A0HU-01A-11W-A050-09 TCGA-BH-A0HU-01 1b5d1cb8-6b38-485a-aff3-24213e459637 TCGA-BH-A0HU-01 TCGA-BH-A0HU-01A-11W-A050-09 TCGA-BH-A0HU-01A-11D-A032-05 TCGA-BH-A0HU-01 TCGA-BH-A0HU-01A-11W-A050-09 TCGA-BH-A0HU-01 c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f TCGA-BH-A0HU-01 TCGA-BH-A0HU-01A-11D-A036-01 TCGA-BH-A0HU-01A-11R-A034-07 c3c6bd09-e8ea-45f3-bdd6-e592bfc2b94f TCGA-BH-A0HU-01A-11D-A036-01 TCGA-BH-A0HU-01 TCGA-BH-A0HW-01 Stage IA 62 4 Stage I 1560 Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 1560 0 LumB Luminal B Negative LumA/B -10 -3 followup T1 T1 LIVING TCGA-BH-A0HW-01 Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A0HW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0HW-F4827 TCGA-BH-A0HW TCGA-BH-A0HW-01A Positive 0 Negative Other NO -22962 1591 0 1561 90-99% 2010-11-16 FEMALE 2+ 1.6 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 200 NO Equivocal Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 0 true No M0 N0 (i-) T1c Stage IA TCGA-BH-A0HW.8AC7EF1D-53EB-466B-9C45-A6A7E9DB9CCD.pdf A0HW TUMOR FREE <10% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2006 0172d30c-287c-4f3e-b70c-5760c6dccb7c 0172d30c-287c-4f3e-b70c-5760c6dccb7c TCGA-BH-A0HW-01A-21-A13B-20 TCGA-BH-A0HW-01A-11W-A050-09 TCGA-BH-A0HW-01 fe1d6a4b-4950-48e6-92fd-7ddc10953a83 TCGA-BH-A0HW-01 TCGA-BH-A0HW-01A-11W-A050-09 TCGA-BH-A0HW-01A-11D-A032-05 TCGA-BH-A0HW-01 TCGA-BH-A0HW-01A-11W-A050-09 TCGA-BH-A0HW-01 0172d30c-287c-4f3e-b70c-5760c6dccb7c TCGA-BH-A0HW-01 TCGA-BH-A0HW-01A-11D-A036-01 TCGA-BH-A0HW-01A-11R-A034-07 0172d30c-287c-4f3e-b70c-5760c6dccb7c TCGA-BH-A0HW-01A-11D-A036-01 TCGA-BH-A0HW-01 TCGA-BH-A0HX-01 Stage IIB 54 4 No_Conversion 829 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 829 0 LumA Luminal A Positive LumA/B -10 -3 followup T_Other T2 LIVING TCGA-BH-A0HX-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0HX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant|Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0HX-F4838 TCGA-BH-A0HX TCGA-BH-A0HX-01A Positive 3+ Positive Simple Mastectomy YES -19900 672 0 829 H-Score 270 80-89% 2010-11-16 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 190 NO Negative 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 2 2 true No M0 N1a T2 Stage IIB TCGA-BH-A0HX.8C4FEB77-99B6-4C73-9751-508953A874DC.pdf A0HX TUMOR FREE H-Score 190 H-Score H-Score 50-59% NO Primary Tumor 01 YES NO YES BH Breast A LIVING 2008 8bbaef6c-31c4-47a4-8e7b-7e6242d02666 8bbaef6c-31c4-47a4-8e7b-7e6242d02666 TCGA-BH-A0HX-01A-11-A13B-20 TCGA-BH-A0HX-01A-21W-A071-09 TCGA-BH-A0HX-01 TCGA-BH-A0HX-01A-21D-A10P-05 a58fd02f-a169-42ee-ab9b-761d00d11179 TCGA-BH-A0HX-01 TCGA-BH-A0HX-01A-21W-A071-09 TCGA-BH-A0HX-01 TCGA-BH-A0HX-01A-21W-A071-09 TCGA-BH-A0HX-01 8bbaef6c-31c4-47a4-8e7b-7e6242d02666 TCGA-BH-A0HX-01 TCGA-BH-A0HX-01A-21D-A059-01 TCGA-BH-A0HX-01A-21R-A056-07 8bbaef6c-31c4-47a4-8e7b-7e6242d02666 TCGA-BH-A0HX-01A-21D-A059-01 TCGA-BH-A0HX-01 TCGA-BH-A0HY-01 Stage I 60 Stage I 867 Positive FEMALE Negative M0 Negative N0 867 0 LumB HER2-enriched Negative ReacII -1 -5 enrollment T1 T1 LIVING TCGA-BH-A0HY-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A0HY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left TCGA-BH-A0HY-F43316 TCGA-BH-A0HY Positive Negative Other -22179 0 1545 NO Scheduled Follow-up Submission 2013-5-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO 0 No M0 N0 T1c Stage I A0HY TUMOR FREE YES YES NO Primary Tumor 01 Total mastectomy with left sentinel lymph node biospy 6th YES NO YES BH Breast LIVING 2009 e074391d-348f-4f95-aad0-7f51c56b9696 e074391d-348f-4f95-aad0-7f51c56b9696 TCGA-BH-A0HY-01A-21-A13B-20 TCGA-BH-A0HY-01A-11W-A071-09 TCGA-BH-A0HY-01 TCGA-BH-A0HY-01A-11D-A10P-05 b5cba62d-f66e-40c7-88c8-0040d3d38607 TCGA-BH-A0HY-01 TCGA-BH-A0HY-01A-11W-A071-09 TCGA-BH-A0HY-01 TCGA-BH-A0HY-01A-11W-A071-09 TCGA-BH-A0HY-01 e074391d-348f-4f95-aad0-7f51c56b9696 TCGA-BH-A0HY-01 TCGA-BH-A0HY-01A-11D-A059-01 TCGA-BH-A0HY-01A-11R-A056-07 e074391d-348f-4f95-aad0-7f51c56b9696 TCGA-BH-A0HY-01A-11D-A059-01 TCGA-BH-A0HY-01 TCGA-BH-A0RX-01 Stage IIA 59 4 Stage IIA 170 Negative FEMALE Negative 3 2 2 Negative M0 Negative N0 170 0 Basal Basal-like Negative ReacII -13 -12 followup T_Other T2 LIVING TCGA-BH-A0RX-01 High C4-BRCA/Basal cluster 5 Low purity c2 KIRC-like c1 BRCA basal-like c8 miRNA cluster 7 cluster 4 mutation cluster 5 TCGA-BH-A0RX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES 59 Left Upper Outer Quadrant|Left Sentinel node biopsy alone TCGA-BH-A0RX-F4875 TCGA-BH-A0RX TCGA-BH-A0RX-01A Negative 0 Negative Other NO -21857 63 0 170 H-Score 0 <10% 2010-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 0 YES Core needle biopsy 170 NO Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 0 true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0RX.57359A9F-7E5A-4599-918C-A95DCF0D9479.pdf A0RX TUMOR FREE H-Score 0 H-Score H-Score <10% YES Primary Tumor 01 Segmental mastectomy YES NO YES BH Breast A LIVING 2010 5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88 5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88 TCGA-BH-A0RX-01A-11-A13C-20 TCGA-BH-A0RX-01A-21D-A099-09 TCGA-BH-A0RX-01 TCGA-BH-A0RX-01A-21D-A10P-05 c8d587b3-a3d1-4375-bb94-7208c050421a TCGA-BH-A0RX-01 TCGA-BH-A0RX-01A-21D-A099-09 TCGA-BH-A0RX-01 TCGA-BH-A0RX-01A-21D-A099-09 TCGA-BH-A0RX-01 5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88 TCGA-BH-A0RX-01 TCGA-BH-A0RX-01A-21D-A087-01 TCGA-BH-A0RX-01A-21R-A084-07 5c911cb7-4e7b-4ffd-bd2b-4498ee7b0e88 TCGA-BH-A0RX-01A-21D-A087-01 TCGA-BH-A0RX-01 TCGA-BH-A0W3-01 Stage IIA 58 2 No_Conversion 180 Positive FEMALE Negative Negative M0 Positive N1 180 0 LumB Luminal B Positive -12 -3 enrollment T1 T1 LIVING TCGA-BH-A0W3-01 Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-BH-A0W3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Inner Quadrant TCGA-BH-A0W3-F34065 TCGA-BH-A0W3 TCGA-BH-A0W3-01A Positive Positive Other -21369 85 0 728 Scheduled Follow-up Submission 2012-7-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Equivocal Negative 4 Indeterminate (neither Pre or Postmenopausal) 2 5 NO 1 1 true No M0 N1a T1c Stage IIA TCGA-BH-A0W3.801A4E2F-E26E-424F-BF42-CD0D9CD62BCE.pdf A0W3 TUMOR FREE YES Primary Tumor 01 Segmental mastectomy 7th NO NO YES BH Breast A LIVING 2010 0def3ef8-7608-483c-b899-4d459f6d2e2d 0def3ef8-7608-483c-b899-4d459f6d2e2d TCGA-BH-A0W3-01A-11D-A10G-09 TCGA-BH-A0W3-01 TCGA-BH-A0W3-01A-11D-A10A-05 TCGA-BH-A0W3-01 TCGA-BH-A0W3-01A-11D-A10G-09 TCGA-BH-A0W3-01 TCGA-BH-A0W3-01A-11D-A10G-09 TCGA-BH-A0W3-01 0def3ef8-7608-483c-b899-4d459f6d2e2d TCGA-BH-A0W3-01 TCGA-BH-A0W3-01A-11D-A107-01 TCGA-BH-A0W3-01A-11R-A109-07 0def3ef8-7608-483c-b899-4d459f6d2e2d TCGA-BH-A0W3-01A-11D-A107-01 TCGA-BH-A0W3-01 TCGA-BH-A0W4-01 Stage IIA 46 2 Stage IIA 175 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 175 0 LumA Luminal A Positive LumA -5 -7 enrollment T_Other T2 LIVING TCGA-BH-A0W4-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A0W4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Upper Outer Quadrant TCGA-BH-A0W4-F34069 TCGA-BH-A0W4 TCGA-BH-A0W4-01A Positive Positive Other -16911 119 0 759 Scheduled Follow-up Submission 2012-7-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Negative 3 2 4 NO true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A0W4.0C158269-A420-4E71-9E59-8775FB26084B.pdf A0W4 TUMOR FREE NO Primary Tumor 01 Total mastectomy 7th NO NO YES BH Breast A LIVING 2010 750469b2-05c7-4647-b101-cdd94246d254 750469b2-05c7-4647-b101-cdd94246d254 TCGA-BH-A0W4-01A-21-A13D-20 TCGA-BH-A0W4-01A-11D-A10G-09 TCGA-BH-A0W4-01 TCGA-BH-A0W4-01A-11D-A10A-05 6a26c8ad-e0f9-44a9-9039-983f6771a989 TCGA-BH-A0W4-01 TCGA-BH-A0W4-01A-11D-A10G-09 TCGA-BH-A0W4-01 TCGA-BH-A0W4-01A-11D-A10G-09 TCGA-BH-A0W4-01 750469b2-05c7-4647-b101-cdd94246d254 TCGA-BH-A0W4-01 TCGA-BH-A0W4-01A-11D-A107-01 TCGA-BH-A0W4-01A-11R-A109-07 750469b2-05c7-4647-b101-cdd94246d254 TCGA-BH-A0W4-01A-11D-A107-01 TCGA-BH-A0W4-01 TCGA-BH-A0W5-01 Stage IIA 77 4 No_Conversion 543 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 543 0 LumA Luminal A Positive LumA -5 -4 enrollment T1 T1 LIVING TCGA-BH-A0W5-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation cluster 4 TCGA-BH-A0W5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A0W5-F34070 TCGA-BH-A0W5 TCGA-BH-A0W5-01A Positive Positive Other -28304 906 0 1288 Scheduled Follow-up Submission 2012-7-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 80 NO Equivocal Equivocal 11 Negative 1 4 NO 1 1 true No M0 N1a T1c Stage IIA TCGA-BH-A0W5.60F59595-928B-43BB-978F-9E5B48539EFA.pdf A0W5 TUMOR FREE YES Primary Tumor 01 segmental mastectomy 6th YES NO YES BH Breast A LIVING 2008 91e55e6f-b884-4112-8d3f-a9f8974dd63b 91e55e6f-b884-4112-8d3f-a9f8974dd63b TCGA-BH-A0W5-01A-21-A13D-20 TCGA-BH-A0W5-01A-11D-A10G-09 TCGA-BH-A0W5-01 TCGA-BH-A0W5-01A-11D-A10A-05 ef0f5ff2-5b71-45fa-9036-b5dfc63510aa TCGA-BH-A0W5-01 TCGA-BH-A0W5-01A-11D-A10G-09 TCGA-BH-A0W5-01 TCGA-BH-A0W5-01A-11D-A10G-09 TCGA-BH-A0W5-01 91e55e6f-b884-4112-8d3f-a9f8974dd63b TCGA-BH-A0W5-01 TCGA-BH-A0W5-01A-11D-A107-01 TCGA-BH-A0W5-01A-11R-A109-07 91e55e6f-b884-4112-8d3f-a9f8974dd63b TCGA-BH-A0W5-01A-11D-A107-01 TCGA-BH-A0W5-01 TCGA-BH-A0W7-01 Stage IA 49 4 Stage I 558 Positive FEMALE Negative Negative M0 Negative N0 558 0 LumA Luminal A Positive -4 -4 enrollment T1 T1 LIVING TCGA-BH-A0W7-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A0W7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-BH-A0W7-F34073 TCGA-BH-A0W7 Positive Positive Other -17996 0 1363 Scheduled Follow-up Submission 2012-7-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative 2 Negative 1 4 NO 0 0 No M0 N0 (i-) T1c Stage I A0W7 TUMOR FREE YES Primary Tumor 01 segmental mastectomy 6th YES NO YES BH Breast LIVING 2008 afaeb45f-d795-4fe0-b4ee-5b90816e6427 afaeb45f-d795-4fe0-b4ee-5b90816e6427 TCGA-BH-A0W7-01A-11D-A10Y-09 TCGA-BH-A0W7-01 TCGA-BH-A0W7-01 TCGA-BH-A0W7-01A-11D-A10Y-09 TCGA-BH-A0W7-01A-11D-A112-05 TCGA-BH-A0W7-01 TCGA-BH-A0W7-01 TCGA-BH-A0W7-01A-11D-A10Y-09 afaeb45f-d795-4fe0-b4ee-5b90816e6427 TCGA-BH-A0W7-01A-11D-A111-01 TCGA-BH-A0W7-01 TCGA-BH-A0W7-01A-11R-A115-07 afaeb45f-d795-4fe0-b4ee-5b90816e6427 TCGA-BH-A0W7-01A-11D-A111-01 TCGA-BH-A0W7-01 TCGA-BH-A0WA-01 Stage IA 82 1 Stage I 372 Negative FEMALE Negative Negative M0 Negative N0 372 0 Basal Basal-like Negative -13 -12 enrollment T1 T1 LIVING TCGA-BH-A0WA-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-BH-A0WA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 82 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-BH-A0WA-F34068 TCGA-BH-A0WA TCGA-BH-A0WA-01A Negative Negative Other -30025 724 0 701 Scheduled Follow-up Submission 2012-7-29 FEMALE No C50.9 8575/3 C50.9 YES Fine needle aspiration biopsy 80 NO Negative 3 Negative 5 5 NO 0 true No M0 N0 (i-) T1c Stage I TCGA-BH-A0WA.87E28DAE-5012-4A16-BE27-A9F0F3F30F5B.pdf A0WA TUMOR FREE NO Primary Tumor 01 segmental mastectomy 6th NO NO YES BH Breast A LIVING 2008 519e1ea1-6658-4978-9f3d-313d7cc1e0c1 519e1ea1-6658-4978-9f3d-313d7cc1e0c1 TCGA-BH-A0WA-01A-11D-A10G-09 TCGA-BH-A0WA-01 TCGA-BH-A0WA-01A-11D-A10A-05 TCGA-BH-A0WA-01 TCGA-BH-A0WA-01A-11D-A10G-09 TCGA-BH-A0WA-01 TCGA-BH-A0WA-01A-11D-A10G-09,TCGA-BH-A0WA-01A-11D-A128-09 TCGA-BH-A0WA-01 519e1ea1-6658-4978-9f3d-313d7cc1e0c1 TCGA-BH-A0WA-01 TCGA-BH-A0WA-01A-11D-A107-01 TCGA-BH-A0WA-01A-11R-A109-07 519e1ea1-6658-4978-9f3d-313d7cc1e0c1 TCGA-BH-A0WA-01A-11D-A107-01 TCGA-BH-A0WA-01 TCGA-BH-A18F-01 Stage IIA 50 2 Stage IIA 268 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 268 0 LumA Luminal B Positive ReacI -4 -7 enrollment T_Other T2 LIVING TCGA-BH-A18F-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation cluster 4 TCGA-BH-A18F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-BH-A18F-F59193 TCGA-BH-A18F TCGA-BH-A18F-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Other -18594 114 0 1001 70-79% 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 200 NO Negative NO 1 Negative Peri (6-12 months since last menstrual period) 1 6 NO 0 true No M0 N0 T2 Stage IIA TCGA-BH-A18F.771497E1-473E-421A-A149-CFA58E95B728.pdf A18F TUMOR FREE YES YES 40-49% YES Primary Tumor 01 needle localized segmental mastectomy 7th NO YES BH Breast A LIVING 2010 eed6d177-6cec-493a-b811-1779bebae72a eed6d177-6cec-493a-b811-1779bebae72a TCGA-BH-A18F-01A-21-A13F-20 TCGA-BH-A18F-01A-11D-A12B-09 TCGA-BH-A18F-01 90367af6-b44b-46f1-9482-c1ddc1bc42e6 TCGA-BH-A18F-01 TCGA-BH-A18F-01A-11D-A12B-09 TCGA-BH-A18F-01A-11D-A12E-05 TCGA-BH-A18F-01 TCGA-BH-A18F-01 TCGA-BH-A18F-01A-11D-A12B-09 eed6d177-6cec-493a-b811-1779bebae72a TCGA-BH-A18F-01A-11D-A12A-01 TCGA-BH-A18F-01 TCGA-BH-A18F-01A-11R-A12D-07 eed6d177-6cec-493a-b811-1779bebae72a TCGA-BH-A18F-01A-11D-A12A-01 TCGA-BH-A18F-01 TCGA-BH-A18F-11 50 268 FEMALE 268 0 enrollment LIVING TCGA-BH-A18F-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A18F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-BH-A18F-F59193 TCGA-BH-A18F TCGA-BH-A18F-11A Positive 3 Point Scale 3+ 3 Point Scale Positive Other -18594 114 0 1001 70-79% 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 190 NO Negative NO 1 Negative Peri (6-12 months since last menstrual period) NO 0 true No M0 N0 T2 Stage IIA A18F TUMOR FREE YES YES 40-49% YES Solid Tissue Normal 11 needle localized segmental mastectomy 7th NO YES BH Breast A LIVING 2010 TCGA-BH-A18F-11A-22D-A12E-05 TCGA-BH-A18G-01 Stage X 81 3 No_Conversion 61 Negative FEMALE Negative Negative M0 Negative N0 61 0 Basal Basal-like Negative Basal -13 0 enrollment T1 T1 LIVING TCGA-BH-A18G-01 Iq C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 4 TCGA-BH-A18G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 81 Right Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A18G-F64216 TCGA-BH-A18G TCGA-BH-A18G-01A Negative Negative Other -29820 78 0 149 2014-8-27 FEMALE Infiltrating Ductal Carcinoma No C50.5 8500/3 C50.5 YES Core needle biopsy 100 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 true No M0 N0 T1c Stage IA TCGA-BH-A18G.7C92F144-4A84-4D9E-8A35-C059FD082150.pdf A18G TUMOR FREE NO YES YES Primary Tumor 01 right segmental mastectomy NO YES BH Breast A LIVING 2010 a8a7a335-8e21-4f24-b48b-8764caa21329 a8a7a335-8e21-4f24-b48b-8764caa21329 TCGA-BH-A18G-01A-21-A13F-20 TCGA-BH-A18G-01 7deb8368-b91a-4e0e-bd5c-5b6c93f12d8a TCGA-BH-A18G-01 TCGA-BH-A18G-01A-11D-A12B-09 TCGA-BH-A18G-01A-11D-A12E-05 TCGA-BH-A18G-01 TCGA-BH-A18G-01 a8a7a335-8e21-4f24-b48b-8764caa21329 TCGA-BH-A18G-01A-11D-A12A-01 TCGA-BH-A18G-01 TCGA-BH-A18G-01A-11R-A12D-07 a8a7a335-8e21-4f24-b48b-8764caa21329 TCGA-BH-A18G-01A-11D-A12A-01 TCGA-BH-A18G-01 TCGA-BH-A18H-01 Stage IB 63 3 Stage I 0 Positive FEMALE Negative 3 1 3 Negative M0 Negative N0 0 0 LumA Luminal A Positive LumA/B -2 -5 enrollment T1 T1 LIVING TCGA-BH-A18H-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-BH-A18H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A18H-F59198 TCGA-BH-A18H TCGA-BH-A18H-01A Positive Positive Other YES -23065 16 0 652 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 80 NO Positive Equivocal NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 0 true Yes M0 N0 T1b Stage IA TCGA-BH-A18H.DF536409-601F-489B-9F8A-A2B372BF9999.pdf A18H TUMOR FREE YES YES YES Primary Tumor 01 segmental mastectomy 7th NO YES BH Breast A LIVING 2010 7bc7f99c-28d4-4b54-b9bd-53d5de00cab7 7bc7f99c-28d4-4b54-b9bd-53d5de00cab7 TCGA-BH-A18H-01A-21-A13F-20 TCGA-BH-A18H-01A-11D-A12B-09 TCGA-BH-A18H-01 d378a15a-1276-482a-b924-87df01d062f2 TCGA-BH-A18H-01 TCGA-BH-A18H-01A-11D-A12B-09 TCGA-BH-A18H-01A-11D-A12E-05 TCGA-BH-A18H-01 TCGA-BH-A18H-01 TCGA-BH-A18H-01A-11D-A12B-09 7bc7f99c-28d4-4b54-b9bd-53d5de00cab7 TCGA-BH-A18H-01A-11D-A12A-01 TCGA-BH-A18H-01 TCGA-BH-A18H-01A-11R-A12D-07 7bc7f99c-28d4-4b54-b9bd-53d5de00cab7 TCGA-BH-A18H-01A-11D-A12A-01 TCGA-BH-A18H-01 TCGA-BH-A18I-01 Stage IIA 53 4 Stage IIA 220 Positive FEMALE Negative Negative M0 Positive N1 220 0 LumA Luminal A Positive -5 -4 enrollment T1 T1 LIVING TCGA-BH-A18I-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A18I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-BH-A18I-F58710 TCGA-BH-A18I TCGA-BH-A18I-01A Negative Positive Modified radical mastectomy Positive Other -19489 80 0 1093 2014-4-22 FEMALE Infiltrating Ductal Carcinoma No C50.2 8500/3 C50.2 YES Core needle biopsy 100 NO Positive NO 3 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 1 1 true No cM0 (i+) N1a T1c Stage IIA TCGA-BH-A18I.01E8D241-C303-47FA-B484-B800D580B34C.pdf A18I TUMOR FREE H score H score YES YES NO Primary Tumor 01 segmental mastectomy 7th NO YES BH Breast A LIVING 2010 844b3442-a740-4cb4-a1fb-b481c552cc88 844b3442-a740-4cb4-a1fb-b481c552cc88 TCGA-BH-A18I-01A-11D-A12B-09 TCGA-BH-A18I-01 TCGA-BH-A18I-01 TCGA-BH-A18I-01A-11D-A12B-09 TCGA-BH-A18I-01A-11D-A12E-05 TCGA-BH-A18I-01 TCGA-BH-A18I-01 TCGA-BH-A18I-01A-11D-A12B-09 844b3442-a740-4cb4-a1fb-b481c552cc88 TCGA-BH-A18I-01A-11D-A12A-01 TCGA-BH-A18I-01 TCGA-BH-A18I-01A-11R-A12D-07 844b3442-a740-4cb4-a1fb-b481c552cc88 TCGA-BH-A18I-01A-11D-A12A-01 TCGA-BH-A18I-01 TCGA-BH-A18J-01 Stage IV 56 2 No_Conversion 611 611 Positive FEMALE Negative 3 3 4 Positive M1 Positive N2 611 1 LumA Luminal B Positive ReacII -1 -3 enrollment T_Other T4 DECEASED TCGA-BH-A18J-01 Squamous C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-BH-A18J TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right TCGA-BH-A18J TCGA-BH-A18J-01A Positive Positive Modified Radical Mastectomy -20678 3948 612 0 YES 40-49% 2011-6-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 640 NO Negative Negative Negative Positive Negative Positive Bone 1 4 true No M1 N2 T4b Stage IV TCGA-BH-A18J.589BC4DD-0079-4106-A2E6-9A48E9BD7DE2.pdf A18J WITH TUMOR 30-39% Primary Tumor 01 5th NO YES BH Breast A DECEASED 2000 56d889ba-6484-4940-ae85-1373ce4255b9 56d889ba-6484-4940-ae85-1373ce4255b9 TCGA-BH-A18J-01A-21-A13E-20 TCGA-BH-A18J-01A-11D-A12B-09 TCGA-BH-A18J-01 dd4097f7-8330-42c3-aa6f-dd289837f65e TCGA-BH-A18J-01 TCGA-BH-A18J-01A-11D-A12B-09 TCGA-BH-A18J-01A-11D-A12E-05 TCGA-BH-A18J-01 TCGA-BH-A18J-01 TCGA-BH-A18J-01A-11D-A12B-09 56d889ba-6484-4940-ae85-1373ce4255b9 TCGA-BH-A18J-01A-11D-A12A-01 TCGA-BH-A18J-01 TCGA-BH-A18J-01A-11R-A12D-07 56d889ba-6484-4940-ae85-1373ce4255b9 TCGA-BH-A18J-01A-11D-A12A-01 TCGA-BH-A18J-01 TCGA-BH-A18J-11 56 611 611 FEMALE 611 1 Normal enrollment DECEASED TCGA-BH-A18J-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A18J TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right TCGA-BH-A18J TCGA-BH-A18J-11A Positive Positive Modified Radical Mastectomy -20678 3948 612 0 YES 40-49% 2011-6-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 230 NO Negative Negative Negative Positive Negative Positive Bone true No M1 N2 T4b Stage IV A18J WITH TUMOR 30-39% Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 2000 9fa440b0-6e8d-4c48-a425-50abc2682f6e 9fa440b0-6e8d-4c48-a425-50abc2682f6e TCGA-BH-A18J-11A-31D-A12E-05 TCGA-BH-A18J-11 9fa440b0-6e8d-4c48-a425-50abc2682f6e TCGA-BH-A18J-11 TCGA-BH-A18J-11A-31R-A12D-07 9fa440b0-6e8d-4c48-a425-50abc2682f6e TCGA-BH-A18K-01 Stage I 46 2 Stage I 2547 2762 Positive FEMALE Negative Negative M0 Negative N0 2762 1 LumA Basal-like Positive -13 -12 enrollment T1 T1 DECEASED TCGA-BH-A18K-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation cluster 4 TCGA-BH-A18K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A18K TCGA-BH-A18K-01A Positive Positive Other -16824 4011 2763 0 NO 2011-6-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 100 NO Negative 11 Negative 2 5 0 true No M0 N0 T1 Stage I TCGA-BH-A18K.EEB515A4-4AF3-475B-B6C0-A6134C96480A.pdf A18K WITH TUMOR YES Primary Tumor 01 segmental mastectomy with axillary dissection 5th NO YES BH Breast A DECEASED 1999 78e00469-0dd6-490e-93f1-068b9a386839 78e00469-0dd6-490e-93f1-068b9a386839 TCGA-BH-A18K-01A-11D-A12B-09 TCGA-BH-A18K-01 TCGA-BH-A18K-01 TCGA-BH-A18K-01A-11D-A12B-09 TCGA-BH-A18K-01A-11D-A12E-05 TCGA-BH-A18K-01 TCGA-BH-A18K-01 TCGA-BH-A18K-01A-11D-A12B-09 78e00469-0dd6-490e-93f1-068b9a386839 TCGA-BH-A18K-01A-11D-A12A-01 TCGA-BH-A18K-01 TCGA-BH-A18K-01A-11R-A12D-07 78e00469-0dd6-490e-93f1-068b9a386839 TCGA-BH-A18K-01A-11D-A12A-01 TCGA-BH-A18K-01 TCGA-BH-A18K-11 46 2547 2762 FEMALE 2762 1 Normal enrollment DECEASED TCGA-BH-A18K-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A18K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A18K Positive Positive Other -16824 2763 0 NO 2011-6-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative 11 Negative 0 No M0 N0 T1 Stage I A18K WITH TUMOR YES Solid Tissue Normal 11 segmental mastectomy with axillary dissection 5th NO YES BH Breast DECEASED 1999 dc55c016-0e33-46b0-ac5e-f854c667a378 dc55c016-0e33-46b0-ac5e-f854c667a378 TCGA-BH-A18K-11A-13D-A12E-05 TCGA-BH-A18K-11 dc55c016-0e33-46b0-ac5e-f854c667a378 TCGA-BH-A18K-11 TCGA-BH-A18K-11A-13R-A12D-07 dc55c016-0e33-46b0-ac5e-f854c667a378 TCGA-BH-A18L-01 Stage IIB 50 5 Stage IIIA 372 811 Positive FEMALE 1 1 4 Negative M0 Positive N1 811 1 LumB Luminal B Positive ReacII -10 -5 enrollment T_Other T3 DECEASED TCGA-BH-A18L-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-BH-A18L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-BH-A18L Positive Positive Other -18519 811 0 NO 2011-6-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative 3 Negative 4 1 1 1 No M0 N1mi T3 Stage IIIA A18L YES Primary Tumor 01 total mastectomy and sentinel node biopsy 6th NO YES BH Breast DECEASED 2003 c3604281-d909-4819-a90e-a1081b1e9d7f c3604281-d909-4819-a90e-a1081b1e9d7f TCGA-BH-A18L-01A-21-A13F-20 TCGA-BH-A18L-01A-32D-A12B-09 TCGA-BH-A18L-01 ede8d4b2-4cfd-4f4f-a11f-3269c0ba7661 TCGA-BH-A18L-01 TCGA-BH-A18L-01A-32D-A12B-09 TCGA-BH-A18L-01A-32D-A12E-05 TCGA-BH-A18L-01 TCGA-BH-A18L-01 TCGA-BH-A18L-01A-32D-A12B-09 c3604281-d909-4819-a90e-a1081b1e9d7f TCGA-BH-A18L-01A-32D-A12A-01 TCGA-BH-A18L-01 TCGA-BH-A18L-01A-32R-A12D-07 c3604281-d909-4819-a90e-a1081b1e9d7f TCGA-BH-A18L-01A-32D-A12A-01 TCGA-BH-A18L-01 TCGA-BH-A18L-11 50 372 811 FEMALE 811 1 Normal enrollment DECEASED TCGA-BH-A18L-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A18L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-BH-A18L TCGA-BH-A18L-11A Positive Positive Other -18519 2669 811 0 NO 2011-6-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 530 NO Negative 3 Negative 1 1 true No M0 N1mi T3 Stage IIIA A18L YES Solid Tissue Normal 11 total mastectomy and sentinel node biopsy 6th NO YES BH Breast A DECEASED 2003 0b937a20-66d4-4d05-bf50-4828cead9c92 0b937a20-66d4-4d05-bf50-4828cead9c92 AE6873BA-EA4A-4FE3-9D4F-B32FFC5BBF98 TCGA-BH-A18L-11A-42D-A12E-05 TCGA-BH-A18L-11 0b937a20-66d4-4d05-bf50-4828cead9c92 TCGA-BH-A18L-11 TCGA-BH-A18L-11A-42R-A12D-07 0b937a20-66d4-4d05-bf50-4828cead9c92 TCGA-BH-A18M-01 Stage IIB 39 2 Stage IIIA 2207 2207 Positive FEMALE Positive 3 4 3 Negative M0 Positive N1 2207 1 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T3 DECEASED TCGA-BH-A18M-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-BH-A18M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left Upper Inner Quadrant TCGA-BH-A18M TCGA-BH-A18M-01A Positive Positive Modified Radical Mastectomy -14532 3629 2207 0 NO 2011-6-15 FEMALE Infiltrating Ductal Carcinoma No C50.3 8500/3 C50.3 YES Core needle biopsy 360 NO Positive Positive 6 Negative 1 6 4 4 true No M0 N1 T3 Stage IIIA TCGA-BH-A18M.4F67B7BE-68C1-40E1-8276-2D26B46C744D.pdf A18M YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 2001 4dfbdec6-1911-412c-9873-f6782ab8ff66 4dfbdec6-1911-412c-9873-f6782ab8ff66 TCGA-BH-A18M-01A-21-A13E-20 TCGA-BH-A18M-01A-11D-A12B-09 TCGA-BH-A18M-01 1d42bf05-8579-448e-bb82-e07aa1c93c97 TCGA-BH-A18M-01 TCGA-BH-A18M-01A-11D-A12B-09 TCGA-BH-A18M-01A-11D-A12E-05 TCGA-BH-A18M-01 TCGA-BH-A18M-01 TCGA-BH-A18M-01A-11D-A12B-09 4dfbdec6-1911-412c-9873-f6782ab8ff66 TCGA-BH-A18M-01A-11D-A12A-01 TCGA-BH-A18M-01 TCGA-BH-A18M-01A-11R-A12D-07 4dfbdec6-1911-412c-9873-f6782ab8ff66 TCGA-BH-A18M-01A-11D-A12A-01 TCGA-BH-A18M-01 TCGA-BH-A18M-11 39 2207 2207 FEMALE 2207 1 Normal enrollment DECEASED TCGA-BH-A18M-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A18M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left Upper Inner Quadrant TCGA-BH-A18M TCGA-BH-A18M-11A Positive Positive Modified Radical Mastectomy -14532 3629 2207 0 NO 2011-6-15 FEMALE Infiltrating Ductal Carcinoma No C50.3 8500/3 C50.3 YES Core needle biopsy 310 NO Positive Positive 6 Negative 4 4 true No M0 N1 T3 Stage IIIA A18M YES Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 2001 2147e537-16f0-4bc3-a87f-572f8dcb9191 2147e537-16f0-4bc3-a87f-572f8dcb9191 TCGA-BH-A18M-11A-33D-A12E-05 TCGA-BH-A18M-11 2147e537-16f0-4bc3-a87f-572f8dcb9191 TCGA-BH-A18M-11 TCGA-BH-A18M-11A-33R-A12D-07 2147e537-16f0-4bc3-a87f-572f8dcb9191 TCGA-BH-A18N-01 Stage IIA 88 3 No_Conversion 1148 1148 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 1148 1 LumA Luminal A Positive LumA -12 -3 enrollment T_Other T2 DECEASED TCGA-BH-A18N-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-BH-A18N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 88 Left Axillary lymph node dissection alone TCGA-BH-A18N-F59153 TCGA-BH-A18N Positive Positive Modified Radical Mastectomy -32404 1148 0 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative NO 26 Negative 2 6 2 2 No M0 N1b T2 Stage IIA A18N NO YES NO Primary Tumor 01 NO YES BH Breast DECEASED 2001 a8884443-832f-45bb-96a0-dead699cc7e3 a8884443-832f-45bb-96a0-dead699cc7e3 TCGA-BH-A18N-01A-21-A13E-20 TCGA-BH-A18N-01A-11D-A12B-09 TCGA-BH-A18N-01 f3320803-e927-4d94-aafa-5bc8cef352f9 TCGA-BH-A18N-01 TCGA-BH-A18N-01A-11D-A12B-09 TCGA-BH-A18N-01A-11D-A12E-05 TCGA-BH-A18N-01 TCGA-BH-A18N-01 TCGA-BH-A18N-01A-11D-A12B-09 a8884443-832f-45bb-96a0-dead699cc7e3 TCGA-BH-A18N-01A-11D-A12A-01 TCGA-BH-A18N-01 TCGA-BH-A18N-01A-11R-A12D-07 a8884443-832f-45bb-96a0-dead699cc7e3 TCGA-BH-A18N-01A-11D-A12A-01 TCGA-BH-A18N-01 TCGA-BH-A18N-11 88 1148 1148 FEMALE 1148 1 Normal enrollment DECEASED TCGA-BH-A18N-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A18N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 88 Left Axillary lymph node dissection alone TCGA-BH-A18N-F59153 TCGA-BH-A18N TCGA-BH-A18N-11A Positive Positive Modified Radical Mastectomy -32404 3374 1148 0 NO 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 590 NO Negative NO 26 Negative 2 2 true No M0 N1b T2 Stage IIA A18N NO YES NO Solid Tissue Normal 11 NO YES BH Breast A DECEASED 2001 d40f0f2c-4acf-4ea6-b344-1eca23f50fa6 d40f0f2c-4acf-4ea6-b344-1eca23f50fa6 3A6CFBA6-849B-416F-A652-F3540DEBEB02 TCGA-BH-A18N-11A-43D-A12E-05 TCGA-BH-A18N-11 d40f0f2c-4acf-4ea6-b344-1eca23f50fa6 TCGA-BH-A18N-11 TCGA-BH-A18N-11A-43R-A12D-07 d40f0f2c-4acf-4ea6-b344-1eca23f50fa6 TCGA-BH-A18P-01 Stage I 60 2 Stage I 921 921 Positive FEMALE Negative 1 3 1 Negative M0 Negative N0 921 1 Her2 HER2-enriched Negative X -1 -1 enrollment T1 T1 DECEASED TCGA-BH-A18P-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-BH-A18P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left Lower Inner Quadrant Sentinel node biopsy alone TCGA-BH-A18P TCGA-BH-A18P-01A Positive Negative Simple Mastectomy -22222 2639 921 0 <10% 2011-6-22 FEMALE 10-19% 2+ Infiltrating Ductal Carcinoma No C50.3 8500/3 C50.3 1+ YES Fine needle aspiration biopsy 230 NO Positive Positive 2 Negative 4 5 0 true No M0 N0 T1 Stage I TCGA-BH-A18P.D24BB508-6E9A-4CF7-93C6-975E79F6E86D.pdf A18P WITH TUMOR YES Primary Tumor 01 6th NO YES BH Breast A DECEASED 2003 3b48796b-8591-4d7a-a502-5c4293647156 3b48796b-8591-4d7a-a502-5c4293647156 TCGA-BH-A18P-01A-21-A13F-20 TCGA-BH-A18P-01A-11D-A12B-09 TCGA-BH-A18P-01 dc104da8-075e-46cb-b43b-d1c5bda730d3 TCGA-BH-A18P-01 TCGA-BH-A18P-01A-11D-A12B-09 TCGA-BH-A18P-01A-11D-A12E-05 TCGA-BH-A18P-01 TCGA-BH-A18P-01 TCGA-BH-A18P-01A-11D-A12B-09 3b48796b-8591-4d7a-a502-5c4293647156 TCGA-BH-A18P-01A-11D-A12A-01 TCGA-BH-A18P-01 TCGA-BH-A18P-01A-11R-A12D-07 3b48796b-8591-4d7a-a502-5c4293647156 TCGA-BH-A18P-01A-11D-A12A-01 TCGA-BH-A18P-01 TCGA-BH-A18P-11 60 921 921 FEMALE 921 1 Normal enrollment DECEASED TCGA-BH-A18P-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A18P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left Lower Inner Quadrant Sentinel node biopsy alone TCGA-BH-A18P TCGA-BH-A18P-11A Positive Negative Simple Mastectomy -22222 2639 921 0 <10% 2011-6-22 FEMALE 10-19% 2+ Infiltrating Ductal Carcinoma No C50.3 8500/3 C50.3 1+ YES Fine needle aspiration biopsy 520 NO Positive Positive 2 Negative 0 true No M0 N0 T1 Stage I A18P WITH TUMOR YES Solid Tissue Normal 11 6th NO YES BH Breast A DECEASED 2003 08236177-a046-4cfe-a11c-a24292a1f777 08236177-a046-4cfe-a11c-a24292a1f777 5C2F7AFD-3F6E-46BB-A17B-F10BE5E243FC TCGA-BH-A18P-11A-43D-A12E-05 TCGA-BH-A18P-11 08236177-a046-4cfe-a11c-a24292a1f777 TCGA-BH-A18P-11 TCGA-BH-A18P-11A-43R-A12D-07 08236177-a046-4cfe-a11c-a24292a1f777 TCGA-BH-A18Q-01 Stage IIB 56 1 No_Conversion 1692 1692 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1692 1 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 DECEASED TCGA-BH-A18Q-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 5 mutation cluster 13 TCGA-BH-A18Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Axillary lymph node dissection alone TCGA-BH-A18Q TCGA-BH-A18Q-01A Negative Negative Modified Radical Mastectomy -20675 3417 1692 0 2011-6-24 FEMALE Infiltrating Ductal Carcinoma No C50.8 8500/3 C50.8 YES Core needle biopsy 130 NO Positive Negative 25 Negative 5 5 2 2 true No M0 N1b T2 Stage IIB TCGA-BH-A18Q.BB4C7377-F10C-48D2-A8AA-6D5B43FEB108.pdf A18Q YES Primary Tumor 01 NO YES BH Breast A DECEASED 2001 2c75afc3-11b5-444d-b6e0-61d76b299f40 2c75afc3-11b5-444d-b6e0-61d76b299f40 TCGA-BH-A18Q-01A-21-A13E-20 TCGA-BH-A18Q-01A-12D-A12B-09 TCGA-BH-A18Q-01 44798c24-89d7-4d25-a4bc-3d2fab66b4e8 TCGA-BH-A18Q-01 TCGA-BH-A18Q-01A-12D-A12B-09 TCGA-BH-A18Q-01A-12D-A12E-05 TCGA-BH-A18Q-01 TCGA-BH-A18Q-01 TCGA-BH-A18Q-01A-12D-A12B-09 2c75afc3-11b5-444d-b6e0-61d76b299f40 TCGA-BH-A18Q-01A-12D-A12A-01 TCGA-BH-A18Q-01 TCGA-BH-A18Q-01A-12R-A12D-07 2c75afc3-11b5-444d-b6e0-61d76b299f40 TCGA-BH-A18Q-01A-12D-A12A-01 TCGA-BH-A18Q-01 TCGA-BH-A18Q-11 56 1692 1692 FEMALE 1692 1 Normal enrollment DECEASED TCGA-BH-A18Q-11 C4-BRCA/Basal mutation cluster 13 TCGA-BH-A18Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Axillary lymph node dissection alone TCGA-BH-A18Q TCGA-BH-A18Q-11A Negative Negative Modified Radical Mastectomy -20675 3417 1692 0 2011-6-24 FEMALE Infiltrating Ductal Carcinoma No C50.8 8500/3 C50.8 YES Core needle biopsy 510 NO Positive Negative 25 Negative 2 2 true No M0 N1b T2 Stage IIB A18Q YES Solid Tissue Normal 11 NO YES BH Breast A DECEASED 2001 120bc298-f016-4c80-aa5f-a9006444942c 120bc298-f016-4c80-aa5f-a9006444942c E36930F3-2442-4C58-B426-DC2C0CDCB79D TCGA-BH-A18Q-11A-34D-A12E-05 TCGA-BH-A18Q-11 120bc298-f016-4c80-aa5f-a9006444942c TCGA-BH-A18Q-11 TCGA-BH-A18Q-11A-34R-A12D-07 120bc298-f016-4c80-aa5f-a9006444942c TCGA-BH-A18R-01 Stage IB 50 3 No_Conversion 1099 1141 Indeterminate FEMALE Positive 1 1 1 Negative M0 Positive N1 1141 1 Her2 HER2-enriched Negative Her2 -2 0 enrollment T_Other T2 DECEASED TCGA-BH-A18R-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A18R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Upper Outer Quadrant TCGA-BH-A18R Indeterminate Negative Modified Radical Mastectomy -18524 1142 0 NO 20-29% 2011-7-3 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy Positive Positive 15 Negative 4 4 10 No M0 N1 T2b Stage IIA A18R TUMOR FREE YES Primary Tumor 01 NO YES BH Breast DECEASED 2001 b05828bc-eb75-4220-9972-6c6d62fa5303 b05828bc-eb75-4220-9972-6c6d62fa5303 TCGA-BH-A18R-01A-21-A13E-20 TCGA-BH-A18R-01A-11D-A12B-09 TCGA-BH-A18R-01 ae2a3335-136b-4a32-b247-5b160862fb22 TCGA-BH-A18R-01 TCGA-BH-A18R-01A-11D-A12B-09 TCGA-BH-A18R-01A-11D-A12E-05 TCGA-BH-A18R-01 TCGA-BH-A18R-01 TCGA-BH-A18R-01A-11D-A12B-09 b05828bc-eb75-4220-9972-6c6d62fa5303 TCGA-BH-A18R-01A-11D-A12A-01 TCGA-BH-A18R-01 TCGA-BH-A18R-01A-11R-A12D-07 b05828bc-eb75-4220-9972-6c6d62fa5303 TCGA-BH-A18R-01A-11D-A12A-01 TCGA-BH-A18R-01 TCGA-BH-A18R-11 50 1099 1141 FEMALE 1141 1 Normal enrollment DECEASED TCGA-BH-A18R-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A18R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Upper Outer Quadrant TCGA-BH-A18R TCGA-BH-A18R-11A Indeterminate Negative Modified Radical Mastectomy -18524 3571 1142 0 NO 20-29% 2011-7-3 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 350 NO Positive Positive 15 Negative 10 true No M0 N1 T2b Stage IIA A18R TUMOR FREE YES Solid Tissue Normal 11 NO YES BH Breast A DECEASED 2001 5462aaff-d060-4ba7-9ab5-0e6977accb91 5462aaff-d060-4ba7-9ab5-0e6977accb91 0F909B7E-B7B3-4B79-B3E6-31BAAFFFA9C6 TCGA-BH-A18R-11A-42D-A12E-05 TCGA-BH-A18R-11 5462aaff-d060-4ba7-9ab5-0e6977accb91 TCGA-BH-A18R-11 TCGA-BH-A18R-11A-42R-A12D-07 5462aaff-d060-4ba7-9ab5-0e6977accb91 TCGA-BH-A18S-01 Stage I 79 5 Stage I 2009 2009 Positive FEMALE 3 3 3 Negative M0 Negative N0 2009 1 LumA Luminal A Positive LumA/B -12 -3 enrollment T1 T1 DECEASED TCGA-BH-A18S-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 12 TCGA-BH-A18S TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Lower Inner Quadrant Sentinel node biopsy alone TCGA-BH-A18S Positive Positive Other -28974 2009 0 2011-7-2 FEMALE Mucinous Carcinoma No C50.3 8523/3 C50.3 YES Core needle biopsy Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 7 0 No M0 N0 T1c Stage I A18S TUMOR FREE YES Primary Tumor 01 total mastectomy 6th NO YES BH Breast DECEASED 2003 cf00b389-d06b-4dd5-9b18-737b06ab9bed cf00b389-d06b-4dd5-9b18-737b06ab9bed TCGA-BH-A18S-01A-21-A13E-20 TCGA-BH-A18S-01A-11D-A12B-09 TCGA-BH-A18S-01 cd625353-3b48-44c0-9695-074db13850d9 TCGA-BH-A18S-01 TCGA-BH-A18S-01A-11D-A12B-09 TCGA-BH-A18S-01A-11D-A12E-05 TCGA-BH-A18S-01 TCGA-BH-A18S-01 TCGA-BH-A18S-01A-11D-A12B-09 cf00b389-d06b-4dd5-9b18-737b06ab9bed TCGA-BH-A18S-01A-11D-A12A-01 TCGA-BH-A18S-01 TCGA-BH-A18S-01A-11R-A12D-07 cf00b389-d06b-4dd5-9b18-737b06ab9bed TCGA-BH-A18S-01A-11D-A12A-01 TCGA-BH-A18S-01 TCGA-BH-A18S-11 79 2009 2009 FEMALE 2009 1 Normal enrollment DECEASED TCGA-BH-A18S-11 C3-BRCA/Luminal mutation cluster 12 TCGA-BH-A18S TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Lower Inner Quadrant Sentinel node biopsy alone TCGA-BH-A18S Positive Positive Other -28974 2009 0 2011-7-2 FEMALE Mucinous Carcinoma No C50.3 8523/3 C50.3 YES Core needle biopsy Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 0 No M0 N0 T1c Stage I A18S TUMOR FREE YES Solid Tissue Normal 11 total mastectomy 6th NO YES BH Breast DECEASED 2003 fa7bcdff-10e1-44f1-86ed-90fab26bc61f fa7bcdff-10e1-44f1-86ed-90fab26bc61f TCGA-BH-A18S-11A-43D-A12E-05 TCGA-BH-A18S-11 fa7bcdff-10e1-44f1-86ed-90fab26bc61f TCGA-BH-A18S-11 TCGA-BH-A18S-11A-43R-A12D-07 fa7bcdff-10e1-44f1-86ed-90fab26bc61f TCGA-BH-A18T-01 Stage IIA 70 1 Stage IIA 224 224 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 224 1 Basal Luminal A Negative ReacII 0 -3 enrollment T_Other T2 DECEASED TCGA-BH-A18T-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-BH-A18T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-BH-A18T TCGA-BH-A18T-01A Negative Negative Other -25674 2737 224 0 2011-7-2 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 210 NO Positive Negative Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 2 true No M0 N0 T2 Stage IIA TCGA-BH-A18T.B8FF655E-47AB-4BB0-B119-1402A335126A.pdf A18T WITH TUMOR Primary Tumor 01 segmental mastectomy 6th NO YES BH Breast A DECEASED 2003 733890d7-6557-454e-8697-fe9c619874e3 733890d7-6557-454e-8697-fe9c619874e3 TCGA-BH-A18T-01A-21-A13E-20 TCGA-BH-A18T-01A-11D-A12B-09 TCGA-BH-A18T-01 169f872a-65f6-40ae-8cd9-948822cc3a20 TCGA-BH-A18T-01 TCGA-BH-A18T-01A-11D-A12B-09 TCGA-BH-A18T-01A-11D-A12E-05 TCGA-BH-A18T-01 TCGA-BH-A18T-01 TCGA-BH-A18T-01A-11D-A12B-09 733890d7-6557-454e-8697-fe9c619874e3 TCGA-BH-A18T-01A-11D-A12A-01 TCGA-BH-A18T-01 TCGA-BH-A18T-01A-11R-A12D-07 733890d7-6557-454e-8697-fe9c619874e3 TCGA-BH-A18T-01A-11D-A12A-01 TCGA-BH-A18T-01 TCGA-BH-A18U-01 Stage IIIA 72 3 Stage IIIA 1317 1563 Positive FEMALE Positive 4 5 4 Negative M0 Positive N2 1563 1 LumB Luminal B Positive ReacI -2 -5 enrollment T_Other T2 DECEASED TCGA-BH-A18U-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 13 TCGA-BH-A18U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A18U TCGA-BH-A18U-01A Positive Positive Other -26426 2697 1563 0 2011-7-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.4 8500/3 C50.4 YES Core needle biopsy 530 NO Positive 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 5 9 true No M0 N2a T2 Stage IIIA TCGA-BH-A18U.2616F70D-3E15-45BA-8907-65694595F726.pdf A18U TUMOR FREE YES Primary Tumor 01 total mastectomy 6th NO YES BH Breast A DECEASED 2003 f6e76192-c4ed-485f-bb51-1b752bd7f544 f6e76192-c4ed-485f-bb51-1b752bd7f544 TCGA-BH-A18U-01A-31-A13E-20 TCGA-BH-A18U-01A-21D-A12B-09 TCGA-BH-A18U-01 12e8835a-7f82-4402-929a-bdce63fee8ed TCGA-BH-A18U-01 TCGA-BH-A18U-01A-21D-A12B-09 TCGA-BH-A18U-01A-21D-A12E-05 TCGA-BH-A18U-01 TCGA-BH-A18U-01 TCGA-BH-A18U-01A-21D-A12B-09 f6e76192-c4ed-485f-bb51-1b752bd7f544 TCGA-BH-A18U-01A-21D-A12A-01 TCGA-BH-A18U-01 TCGA-BH-A18U-01A-21R-A12D-07 f6e76192-c4ed-485f-bb51-1b752bd7f544 TCGA-BH-A18U-01A-21D-A12A-01 TCGA-BH-A18U-01 TCGA-BH-A18U-11 72 1317 1563 FEMALE 1563 1 Normal enrollment DECEASED TCGA-BH-A18U-11 C3-BRCA/Luminal mutation cluster 13 TCGA-BH-A18U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Left Sentinel lymph node biopsy plus axillary dissection TCGA-BH-A18U TCGA-BH-A18U-11A Positive Positive Other -26426 2697 1563 0 2011-7-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.4 8500/3 C50.4 YES Core needle biopsy 230 NO Positive 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 9 true No M0 N2a T2 Stage IIIA A18U TUMOR FREE YES Solid Tissue Normal 11 total mastectomy 6th NO YES BH Breast A DECEASED 2003 02222fea-f3da-4328-8188-8ef24d1f55e4 02222fea-f3da-4328-8188-8ef24d1f55e4 TCGA-BH-A18U-11A-23D-A12E-05 TCGA-BH-A18U-11 02222fea-f3da-4328-8188-8ef24d1f55e4 TCGA-BH-A18U-11 TCGA-BH-A18U-11A-23R-A12D-07 02222fea-f3da-4328-8188-8ef24d1f55e4 TCGA-BH-A18V-01 Stage IIB 48 1 No_Conversion 1555 1555 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 1555 1 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 DECEASED TCGA-BH-A18V-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 2 TCGA-BH-A18V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Axillary lymph node dissection alone TCGA-BH-A18V TCGA-BH-A18V-01A Negative Negative Other -17682 3621 1556 0 YES 2011-7-2 FEMALE Infiltrating Ductal Carcinoma No C50.4 8500/3 C50.4 YES Core needle biopsy 300 NO Negative 25 Negative Negative Negative Negative Other, specify axilaary node negative but intrammary node positive 5 5 0 true No M0 N1b T2 Stage IIB TCGA-BH-A18V.3C1C2CED-A1CF-48FC-BCB2-658D74E1982B.pdf A18V YES Primary Tumor 01 Modified radical mastectomy with left breast biopsy 5th NO YES BH Breast A DECEASED 2001 429b50eb-316f-459c-bc3a-0aca6e6dba46 429b50eb-316f-459c-bc3a-0aca6e6dba46 TCGA-BH-A18V-01A-11D-A12B-09 TCGA-BH-A18V-01 7bf9da92-5872-4f29-ba4d-f247ec7984f0 TCGA-BH-A18V-01 TCGA-BH-A18V-01A-11D-A12B-09 TCGA-BH-A18V-01A-11D-A12E-05 TCGA-BH-A18V-01 TCGA-BH-A18V-01 TCGA-BH-A18V-01A-11D-A12B-09 429b50eb-316f-459c-bc3a-0aca6e6dba46 TCGA-BH-A18V-01A-11D-A12A-01 TCGA-BH-A18V-01 TCGA-BH-A18V-01A-11R-A12D-07 429b50eb-316f-459c-bc3a-0aca6e6dba46 TCGA-BH-A18V-01A-11D-A12A-01 TCGA-BH-A18V-01 TCGA-BH-A18V-06 48 1555 1555 FEMALE 1555 1 Basal enrollment DECEASED TCGA-BH-A18V-06 C4-BRCA/Basal BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 11 mutation cluster 2 TCGA-BH-A18V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Axillary lymph node dissection alone TCGA-BH-A18V Negative Negative Other -17682 1556 0 YES 2011-7-2 FEMALE Infiltrating Ductal Carcinoma No C50.4 8500/3 C50.4 YES Core needle biopsy Negative 25 Negative Negative Negative Negative Other, specify axilaary node negative but intrammary node positive 0 No M0 N1b T2 Stage IIB A18V YES Metastatic 06 Modified radical mastectomy with left breast biopsy 5th NO YES BH Breast DECEASED 2001 ded1efed-b3b9-4d1a-b4c9-b595543fc461 ded1efed-b3b9-4d1a-b4c9-b595543fc461 TCGA-BH-A18V-06A-21-A24B-20 TCGA-BH-A18V-06A-11D-A212-05 f03d8a09-8fcf-4f2b-a5b3-ac6ffb2c0681 TCGA-BH-A18V-06A-11D-A20S-09 TCGA-BH-A18V-06 ded1efed-b3b9-4d1a-b4c9-b595543fc461 TCGA-BH-A18V-06 ded1efed-b3b9-4d1a-b4c9-b595543fc461 TCGA-BH-A18V-11 48 1555 1555 FEMALE 1555 1 Normal enrollment DECEASED TCGA-BH-A18V-11 C4-BRCA/Basal mutation cluster 2 TCGA-BH-A18V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Axillary lymph node dissection alone TCGA-BH-A18V TCGA-BH-A18V-11A Negative Negative Other -17682 3621 1556 0 YES 2011-7-2 FEMALE Infiltrating Ductal Carcinoma No C50.4 8500/3 C50.4 YES Core needle biopsy 450 NO Negative 25 Negative Negative Negative Negative Other, specify axilaary node negative but intrammary node positive 0 true No M0 N1b T2 Stage IIB A18V YES Solid Tissue Normal 11 Modified radical mastectomy with left breast biopsy 5th NO YES BH Breast A DECEASED 2001 288c81eb-4c43-406b-a5e5-fee452a95afb 288c81eb-4c43-406b-a5e5-fee452a95afb 1D76CB85-A291-45F8-88B0-29D72E04FA07 TCGA-BH-A18V-11A-52D-A12E-05 288c81eb-4c43-406b-a5e5-fee452a95afb TCGA-BH-A18V-11A-52R-A12D-07 288c81eb-4c43-406b-a5e5-fee452a95afb TCGA-BH-A1EN-01 Stage IIA 78 3 Stage IIA 2052 Negative FEMALE Positive Negative M0 Negative N0 2052 1 Her2 Negative enrollment T_Other T2 DECEASED TCGA-BH-A1EN-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-BH-A1EN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right TCGA-BH-A1EN TCGA-BH-A1EN-01A Negative Negative Other -28724 4343 2127 0 NO 2011-9-3 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 140 NO Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 3 true No M0 NX T2 Stage IIA TCGA-BH-A1EN.809F294F-8C48-4719-866B-7169FB1CE24D.pdf A1EN TUMOR FREE Primary Tumor 01 right segmental mastectomy 5th NO YES BH Breast A DECEASED 1999 a6db80e4-b161-412d-932a-fe2898a1722f a6db80e4-b161-412d-932a-fe2898a1722f TCGA-BH-A1EN-01A-21-A17I-20 TCGA-BH-A1EN-01A-11D-A17G-09 TCGA-BH-A1EN-01 TCGA-BH-A1EN-01A-11D-A13K-05 8de8ac77-d6ea-437d-9ca8-ef6f5480eb1b TCGA-BH-A1EN-01 TCGA-BH-A1EN-01A-11D-A17G-09 TCGA-BH-A1EN-01 TCGA-BH-A1EN-01A-11D-A17G-09 a6db80e4-b161-412d-932a-fe2898a1722f TCGA-BH-A1EN-01A-11D-A13J-01 TCGA-BH-A1EN-01 a6db80e4-b161-412d-932a-fe2898a1722f TCGA-BH-A1EN-01A-11D-A13J-01 TCGA-BH-A1EN-11 78 2052 FEMALE 2052 1 Normal enrollment DECEASED TCGA-BH-A1EN-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1EN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right TCGA-BH-A1EN Negative Negative Other -28724 2127 0 NO 2011-9-3 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) No M0 NX T2 Stage IIA A1EN TUMOR FREE Solid Tissue Normal 11 right segmental mastectomy 5th NO YES BH Breast DECEASED 1999 c03683bd-2fe1-4ab2-9a16-796553be5467 c03683bd-2fe1-4ab2-9a16-796553be5467 TCGA-BH-A1EN-11A-23D-A13T-05 TCGA-BH-A1EN-11 c03683bd-2fe1-4ab2-9a16-796553be5467 TCGA-BH-A1EN-11 c03683bd-2fe1-4ab2-9a16-796553be5467 TCGA-BH-A1EO-01 Stage IIA 68 3 Stage IIA 2798 Positive FEMALE Negative Negative M0 Positive N1 2798 1 LumA Luminal A Positive -5 -3 enrollment T1 T1 DECEASED TCGA-BH-A1EO-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-BH-A1EO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right TCGA-BH-A1EO TCGA-BH-A1EO-01A Positive Positive Other -25136 4330 2798 0 NO 2011-9-6 FEMALE Mixed Histology (please specify) ductal and lobular features No C50.9 8522/3 C50.9 YES Excisional Biopsy 100 NO Negative 15 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 1 true No M0 N1 T1c Stage IIA TCGA-BH-A1EO.A2B755DD-00C4-4349-8E11-C1196EBC91D3.pdf A1EO TUMOR FREE YES Primary Tumor 01 right segmental mastectomy witrh axillary node dissection 5th NO YES BH Breast A DECEASED 1999 e6f1450a-6731-4593-82c3-28f839ebf148 e6f1450a-6731-4593-82c3-28f839ebf148 TCGA-BH-A1EO-01A-21-A17I-20 TCGA-BH-A1EO-01A-11D-A135-09 TCGA-BH-A1EO-01 TCGA-BH-A1EO-01A-11D-A138-05 819bff28-56b5-455b-b86d-c803b081d75e TCGA-BH-A1EO-01 TCGA-BH-A1EO-01A-11D-A135-09 TCGA-BH-A1EO-01 TCGA-BH-A1EO-01 TCGA-BH-A1EO-01A-11D-A135-09 e6f1450a-6731-4593-82c3-28f839ebf148 TCGA-BH-A1EO-01A-11D-A134-01 TCGA-BH-A1EO-01 TCGA-BH-A1EO-01A-11R-A137-07 e6f1450a-6731-4593-82c3-28f839ebf148 TCGA-BH-A1EO-01A-11D-A134-01 TCGA-BH-A1EO-01 TCGA-BH-A1EO-11 68 2798 FEMALE 2798 1 LumA enrollment DECEASED TCGA-BH-A1EO-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1EO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right TCGA-BH-A1EO TCGA-BH-A1EO-11A Positive Positive Other -25136 4330 2798 0 NO 2011-9-6 FEMALE Mixed Histology (please specify) ductal and lobular features No C50.9 8522/3 C50.9 YES Excisional Biopsy 250 NO Negative 15 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 true No M0 N1 T1c Stage IIA A1EO TUMOR FREE YES Solid Tissue Normal 11 right segmental mastectomy witrh axillary node dissection 5th NO YES BH Breast A DECEASED 1999 71cc9cf0-2992-4ac6-8642-6fdb66958fca 71cc9cf0-2992-4ac6-8642-6fdb66958fca TCGA-BH-A1EO-11A-31D-A138-05 71cc9cf0-2992-4ac6-8642-6fdb66958fca TCGA-BH-A1EO-11A-31R-A137-07 71cc9cf0-2992-4ac6-8642-6fdb66958fca TCGA-BH-A1ES-01 Stage IIB 35 5 Stage IIB 3462 Positive FEMALE Negative Negative M0 Positive N1 3462 1 LumA Luminal A Positive -9 -3 enrollment T_Other T2 DECEASED TCGA-BH-A1ES-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-BH-A1ES TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Upper Inner Quadrant TCGA-BH-A1ES Positive Positive Other -13138 3462 0 NO 2011-9-6 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative 4 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 5 1 No M0 N1a T2 Stage IIB A1ES WITH TUMOR YES Primary Tumor 01 total mastectomy with rigth axillary lymph node and sentinel lymph node dissection 5th NO YES BH Breast DECEASED 1999 cbb45082-6d4e-4457-b023-52f9372ae053 cbb45082-6d4e-4457-b023-52f9372ae053 TCGA-BH-A1ES-01A-11D-A135-09 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01A-11D-A138-05 e6c70136-ae35-4294-a16d-5673f0edbea5 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01A-11D-A135-09 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01A-11D-A135-09 cbb45082-6d4e-4457-b023-52f9372ae053 TCGA-BH-A1ES-01A-11D-A134-01 TCGA-BH-A1ES-01 TCGA-BH-A1ES-01A-11R-A137-07 cbb45082-6d4e-4457-b023-52f9372ae053 TCGA-BH-A1ES-01A-11D-A134-01 TCGA-BH-A1ES-01 TCGA-BH-A1ES-06 35 3462 FEMALE 3462 1 enrollment DECEASED TCGA-BH-A1ES-06 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1ES TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Upper Inner Quadrant TCGA-BH-A1ES TCGA-BH-A1ES-06A Positive Positive Other -13138 4787 3462 0 NO 2011-9-6 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 400 NO Negative 4 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 true No M0 N1a T2 Stage IIB TCGA-BH-A1ES.7222C51A-3A1E-454B-A0E4-B8A0BBA042E4.pdf A1ES WITH TUMOR YES Metastatic 06 total mastectomy with rigth axillary lymph node and sentinel lymph node dissection 5th NO YES BH Breast A DECEASED 1999 fc895598-73b9-4269-a250-52e4475c6be7 fc895598-73b9-4269-a250-52e4475c6be7 TCGA-BH-A1ES-06A-21-A24B-20 TCGA-BH-A1ES-06A-12D-A244-05 21ae0b23-d3aa-4b22-a3c7-3eb6d8e98a26 TCGA-BH-A1ES-06A-12D-A243-09 TCGA-BH-A1ES-06 fc895598-73b9-4269-a250-52e4475c6be7 TCGA-BH-A1ES-06 fc895598-73b9-4269-a250-52e4475c6be7 TCGA-BH-A1ES-11 35 3462 FEMALE 3462 1 enrollment DECEASED TCGA-BH-A1ES-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1ES TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Upper Inner Quadrant TCGA-BH-A1ES TCGA-BH-A1ES-11A Positive Positive Other -13138 4242 3462 0 NO 2011-9-6 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 340 NO Negative 4 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 true No M0 N1a T2 Stage IIB A1ES WITH TUMOR YES Solid Tissue Normal 11 total mastectomy with rigth axillary lymph node and sentinel lymph node dissection 5th NO YES BH Breast A DECEASED 1999 TCGA-BH-A1ES-11A-33D-A138-05 TCGA-BH-A1ET-01 Stage IIA 55 2 Stage I 2520 Positive FEMALE Negative Negative M0 Negative N0 2520 1 LumA Luminal A Positive -12 -7 enrollment T1 T1 DECEASED TCGA-BH-A1ET-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-BH-A1ET TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left TCGA-BH-A1ET Positive Positive Other -20425 2520 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative 19 2 6 1 No M0 N0 T1 Stage I A1ET TUMOR FREE YES Primary Tumor 01 Left segmental mastectomy with left axillary lymph node dissection 5th NO YES BH Breast DECEASED 1999 b0388c2e-0793-4084-bcc3-454c2ec88931 b0388c2e-0793-4084-bcc3-454c2ec88931 TCGA-BH-A1ET-01A-21-A17I-20 TCGA-BH-A1ET-01A-11D-A135-09 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01A-11D-A138-05 a8e7241b-076a-4fa3-83da-755694823091 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01A-11D-A135-09 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01A-11D-A135-09 b0388c2e-0793-4084-bcc3-454c2ec88931 TCGA-BH-A1ET-01A-11D-A134-01 TCGA-BH-A1ET-01 TCGA-BH-A1ET-01A-11R-A137-07 b0388c2e-0793-4084-bcc3-454c2ec88931 TCGA-BH-A1ET-01A-11D-A134-01 TCGA-BH-A1ET-01 TCGA-BH-A1ET-11 55 2520 FEMALE 2520 1 Normal enrollment DECEASED TCGA-BH-A1ET-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A1ET TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left TCGA-BH-A1ET TCGA-BH-A1ET-11B Positive Positive Other -20425 4137 2520 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 380 NO Negative 19 1 false No M0 N0 T1 Stage I A1ET TUMOR FREE YES Solid Tissue Normal 11 Left segmental mastectomy with left axillary lymph node dissection 5th NO YES BH Breast B DECEASED 1999 ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be TCGA-BH-A1ET-11B-23D-A138-05 48D344A0-2C10-412C-A51E-BB830474D9D5 TCGA-BH-A1ET-11 ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be TCGA-BH-A1ET-11 TCGA-BH-A1ET-11B-23R-A137-07 ef7f2a68-bbfc-4458-9c3e-18c5d81ef7be TCGA-BH-A1EU-01 Stage I 83 1 Stage I 1286 Positive FEMALE Negative Negative M0 Negative N0 1286 1 LumA Luminal A Positive -5 -7 enrollment T1 T1 DECEASED TCGA-BH-A1EU-01 Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-BH-A1EU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 83 Right TCGA-BH-A1EU TCGA-BH-A1EU-01A Positive Positive -30339 4106 1286 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 410 NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 true No M0 N0 T1 Stage I TCGA-BH-A1EU.FF6BC87F-029E-4565-A35A-6FB968F8EABA.pdf A1EU TUMOR FREE NO Primary Tumor 01 Right segmental mastectomy 5th NO YES BH Breast A DECEASED 1999 bfeed1cc-e0f8-493f-a950-829ecb3acccc bfeed1cc-e0f8-493f-a950-829ecb3acccc TCGA-BH-A1EU-01A-21-A17I-20 TCGA-BH-A1EU-01A-11D-A135-09 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01A-11D-A138-05 73eb0467-0d24-4ef1-b0e6-ca457ad24f09 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01A-11D-A135-09 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01A-11D-A135-09 bfeed1cc-e0f8-493f-a950-829ecb3acccc TCGA-BH-A1EU-01A-11D-A134-01 TCGA-BH-A1EU-01 TCGA-BH-A1EU-01A-11R-A137-07 bfeed1cc-e0f8-493f-a950-829ecb3acccc TCGA-BH-A1EU-01A-11D-A134-01 TCGA-BH-A1EU-01 TCGA-BH-A1EU-11 83 1286 FEMALE 1286 1 Normal enrollment DECEASED TCGA-BH-A1EU-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A1EU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 83 Right TCGA-BH-A1EU TCGA-BH-A1EU-11A Positive Positive -30339 4106 1286 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 240 NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) true No M0 N0 T1 Stage I A1EU TUMOR FREE NO Solid Tissue Normal 11 Right segmental mastectomy 5th NO YES BH Breast A DECEASED 1999 9e12314d-d1f0-44be-93f7-e50a56f86b46 9e12314d-d1f0-44be-93f7-e50a56f86b46 TCGA-BH-A1EU-11A-23D-A138-05 TCGA-BH-A1EU-11 9e12314d-d1f0-44be-93f7-e50a56f86b46 TCGA-BH-A1EU-11 TCGA-BH-A1EU-11A-23R-A137-07 9e12314d-d1f0-44be-93f7-e50a56f86b46 TCGA-BH-A1EV-01 45 2 365 Positive FEMALE 365 1 Her2 HER2-enriched Positive -1 -5 enrollment DECEASED TCGA-BH-A1EV-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 7 mutation cluster 5 TCGA-BH-A1EV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left TCGA-BH-A1EV-F59154 TCGA-BH-A1EV TCGA-BH-A1EV-01A Positive Positive Modified Radical Mastectomy -16504 4103 365 0 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 600 NO Positive NO 10 2 7 NO 3 true No M0 N1b T3 Stage IIIA TCGA-BH-A1EV.16DEA43F-4A61-44E3-854F-6B6575B45628.pdf A1EV WITH TUMOR NO YES YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1999 4dac7a33-db46-4815-8c6c-fb326959c741 4dac7a33-db46-4815-8c6c-fb326959c741 TCGA-BH-A1EV-01A-21-A17I-20 TCGA-BH-A1EV-01A-11D-A135-09 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01A-11D-A138-05 59c3ce2b-d84e-4d4a-b6dc-ffdb9e3a34f5 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01A-11D-A135-09 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01A-11D-A135-09 4dac7a33-db46-4815-8c6c-fb326959c741 TCGA-BH-A1EV-01A-11D-A134-01 TCGA-BH-A1EV-01 TCGA-BH-A1EV-01A-11R-A137-07 4dac7a33-db46-4815-8c6c-fb326959c741 TCGA-BH-A1EV-01A-11D-A134-01 TCGA-BH-A1EV-01 TCGA-BH-A1EV-11 45 365 FEMALE 365 1 Normal enrollment DECEASED TCGA-BH-A1EV-11 C3-BRCA/Luminal mutation cluster 5 TCGA-BH-A1EV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left TCGA-BH-A1EV-F59154 TCGA-BH-A1EV TCGA-BH-A1EV-11A Positive Positive Modified Radical Mastectomy -16504 4103 365 0 2014-5-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 580 NO Positive NO 10 NO 3 true No M0 N1b T3 Stage IIIA A1EV WITH TUMOR NO YES YES Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 1999 7b234c36-729b-422d-8e2a-ebd42af74bce 7b234c36-729b-422d-8e2a-ebd42af74bce TCGA-BH-A1EV-11A-24D-A138-05 TCGA-BH-A1EV-11 7b234c36-729b-422d-8e2a-ebd42af74bce TCGA-BH-A1EV-11 7b234c36-729b-422d-8e2a-ebd42af74bce TCGA-BH-A1EW-01 Stage IIA 38 3 No_Conversion 1694 Negative FEMALE Negative Negative M0 Positive N1 1694 1 LumA Luminal B Negative -3 -3 enrollment T_Other T2 DECEASED TCGA-BH-A1EW-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-BH-A1EW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Left Upper Outer Quadrant TCGA-BH-A1EW TCGA-BH-A1EW-01A Negative Negative Other -14090 4230 1694 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 550 NO Negative 16 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 1 true No M0 N1b T2 Stage IIA TCGA-BH-A1EW.56EFCA58-2328-4C5C-9618-981447E76B12.pdf A1EW WITH TUMOR YES Primary Tumor 01 Left segmental mastectomy with level 1 and level 2 axillary dissection 5th NO YES BH Breast A DECEASED 1999 59783c67-6446-44c1-b9b3-505470f54c82 59783c67-6446-44c1-b9b3-505470f54c82 TCGA-BH-A1EW-01A-21-A17I-20 TCGA-BH-A1EW-01A-11D-A135-09 TCGA-BH-A1EW-01 TCGA-BH-A1EW-01A-11D-A138-05 fd676c7e-c137-4699-a8ea-57b72b10ff5b TCGA-BH-A1EW-01 TCGA-BH-A1EW-01A-11D-A135-09 TCGA-BH-A1EW-01 TCGA-BH-A1EW-01 TCGA-BH-A1EW-01A-11D-A135-09 59783c67-6446-44c1-b9b3-505470f54c82 TCGA-BH-A1EW-01A-11D-A134-01 TCGA-BH-A1EW-01 TCGA-BH-A1EW-01A-11R-A137-07 59783c67-6446-44c1-b9b3-505470f54c82 TCGA-BH-A1EW-01A-11D-A134-01 TCGA-BH-A1EW-01 TCGA-BH-A1EW-11 38 1694 FEMALE 1694 1 LumA enrollment DECEASED TCGA-BH-A1EW-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1EW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Left Upper Outer Quadrant TCGA-BH-A1EW TCGA-BH-A1EW-11B Negative Negative Other -14090 4230 1694 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 1030 NO Negative 16 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 false No M0 N1b T2 Stage IIA A1EW WITH TUMOR YES Solid Tissue Normal 11 Left segmental mastectomy with level 1 and level 2 axillary dissection 5th NO YES BH Breast B DECEASED 1999 cf1027dc-9ba9-4e3c-80d9-4bb13021cc31 cf1027dc-9ba9-4e3c-80d9-4bb13021cc31 TCGA-BH-A1EW-11B-33D-A138-05 6AC30F47-7622-4DBF-94E9-4E6D93D8442F TCGA-BH-A1EW-11 cf1027dc-9ba9-4e3c-80d9-4bb13021cc31 TCGA-BH-A1EW-11 TCGA-BH-A1EW-11B-33R-A137-07 cf1027dc-9ba9-4e3c-80d9-4bb13021cc31 TCGA-BH-A1EX-01 Stage IIB 67 3 Stage IIB 1508 Positive FEMALE Negative Negative M0 Positive N1 1508 1 LumA Positive enrollment T_Other T2 DECEASED TCGA-BH-A1EX-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-BH-A1EX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Lower Inner Quadrant TCGA-BH-A1EX Positive Positive Other -24544 1508 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive Negative 24 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 2 No M0 N1b T2 Stage IIB A1EX WITH TUMOR YES Primary Tumor 01 Right segmental mastectomy with sentinel lymph node and axillary lymph node biopsy 5th NO YES BH Breast DECEASED 2000 b5c8962b-15d5-45ba-9a5a-a75dfacbaad9 b5c8962b-15d5-45ba-9a5a-a75dfacbaad9 TCGA-BH-A1EX-01A-21-A17I-20 TCGA-BH-A1EX-01A-11D-A13L-09 TCGA-BH-A1EX-01 TCGA-BH-A1EX-01A-11D-A13K-05 e4809caf-a1a9-4d9f-807f-530ae7c2e434 TCGA-BH-A1EX-01 TCGA-BH-A1EX-01A-11D-A13L-09 TCGA-BH-A1EX-01 TCGA-BH-A1EX-01A-11D-A13L-09 b5c8962b-15d5-45ba-9a5a-a75dfacbaad9 TCGA-BH-A1EX-01A-11D-A13J-01 TCGA-BH-A1EX-01 b5c8962b-15d5-45ba-9a5a-a75dfacbaad9 TCGA-BH-A1EX-01A-11D-A13J-01 TCGA-BH-A1EY-01 Stage IIA 79 2 Stage IIA 538 Positive FEMALE Negative Negative M0 Negative N0 538 1 LumA Positive enrollment T_Other T2 DECEASED TCGA-BH-A1EY-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 3 TCGA-BH-A1EY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Outer Quadrant TCGA-BH-A1EY-F59173 TCGA-BH-A1EY TCGA-BH-A1EY-01A Positive Positive Modified Radical Mastectomy -28940 3840 538 0 396 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 290 NO Negative NO 12 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 Lung Distant Metastasis Liver YES 0 true No M0 N0 T2 Stage IIA TCGA-BH-A1EY.2ED10396-96FF-4705-93AE-82FB9A80EC28.pdf A1EY WITH TUMOR NO YES NO Primary Tumor 01 5th NO YES BH Breast A DECEASED 2000 4a6f7935-86f8-4c08-9d0e-9fe77878f2ce 4a6f7935-86f8-4c08-9d0e-9fe77878f2ce TCGA-BH-A1EY-01A-21-A17I-20 TCGA-BH-A1EY-01A-11D-A13L-09 TCGA-BH-A1EY-01 TCGA-BH-A1EY-01A-11D-A13K-05 7de680e0-63d0-41b4-ace3-82a8e80aaae3 TCGA-BH-A1EY-01 TCGA-BH-A1EY-01A-11D-A13L-09 TCGA-BH-A1EY-01 TCGA-BH-A1EY-01A-11D-A13L-09 4a6f7935-86f8-4c08-9d0e-9fe77878f2ce TCGA-BH-A1EY-01A-11D-A13J-01 TCGA-BH-A1EY-01 4a6f7935-86f8-4c08-9d0e-9fe77878f2ce TCGA-BH-A1EY-01A-11D-A13J-01 TCGA-BH-A1EY-11 79 538 FEMALE 538 1 enrollment DECEASED TCGA-BH-A1EY-11 C3-BRCA/Luminal mutation cluster 3 TCGA-BH-A1EY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Outer Quadrant TCGA-BH-A1EY-F59173 TCGA-BH-A1EY TCGA-BH-A1EY-11B Positive Positive Modified Radical Mastectomy -28940 3840 538 0 396 2014-5-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 450 NO Negative NO 12 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lung Distant Metastasis Liver YES 0 false No M0 N0 T2 Stage IIA A1EY WITH TUMOR NO YES NO Solid Tissue Normal 11 5th NO YES BH Breast B DECEASED 2000 TCGA-BH-A1EY-11B-21D-A13T-05 A5047A5B-665D-4C47-ADC8-1DFDF0180130 TCGA-BH-A1F0-01 Stage IIA 80 1 Stage IIA 785 Negative FEMALE Negative Negative M0 Positive N1 785 1 Basal Basal-like Indeterminate -13 -12 enrollment T1 T1 DECEASED TCGA-BH-A1F0-01 High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 cluster 6 mutation cluster 5 TCGA-BH-A1F0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left TCGA-BH-A1F0 Negative Indeterminate Modified Radical Mastectomy -29335 785 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative 9 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 1 No M0 N1c T1a Stage IIA A1F0 WITH TUMOR YES Primary Tumor 01 5th NO YES BH Breast DECEASED 2000 d31b476c-c047-4e5f-a0cb-eff1065f0121 d31b476c-c047-4e5f-a0cb-eff1065f0121 TCGA-BH-A1F0-01A-21-A17I-20 TCGA-BH-A1F0-01A-11D-A135-09 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01A-11D-A138-05 a4bd17eb-0741-4d81-b457-158367d20ae9 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01A-11D-A135-09 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01A-11D-A135-09 d31b476c-c047-4e5f-a0cb-eff1065f0121 TCGA-BH-A1F0-01A-11D-A134-01 TCGA-BH-A1F0-01 TCGA-BH-A1F0-01A-11R-A137-07 d31b476c-c047-4e5f-a0cb-eff1065f0121 TCGA-BH-A1F0-01A-11D-A134-01 TCGA-BH-A1F0-01 TCGA-BH-A1F0-11 80 785 FEMALE 785 1 Normal enrollment DECEASED TCGA-BH-A1F0-11 C4-BRCA/Basal mutation cluster 5 TCGA-BH-A1F0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left TCGA-BH-A1F0 TCGA-BH-A1F0-11B Negative Indeterminate Modified Radical Mastectomy -29335 3879 785 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 180 NO Negative 9 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 false No M0 N1c T1a Stage IIA A1F0 WITH TUMOR YES Solid Tissue Normal 11 5th NO YES BH Breast B DECEASED 2000 889f6f61-9b3a-406c-9af8-ddee74a8a19e 889f6f61-9b3a-406c-9af8-ddee74a8a19e TCGA-BH-A1F0-11B-23D-A138-05 TCGA-BH-A1F0-11 889f6f61-9b3a-406c-9af8-ddee74a8a19e TCGA-BH-A1F0-11 TCGA-BH-A1F0-11B-23R-A137-07 889f6f61-9b3a-406c-9af8-ddee74a8a19e TCGA-BH-A1F2-01 Stage IIIB 53 5 Stage 959 Positive FEMALE Positive Negative M0 Positive N1 959 1 LumB Positive enrollment T_Other T4 DECEASED TCGA-BH-A1F2-01 High C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 14 TCGA-BH-A1F2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left TCGA-BH-A1F2 TCGA-BH-A1F2-01A Positive Positive Modified Radical Mastectomy -19701 4147 959 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8541/3 C50.9 YES Core needle biopsy 230 NO Positive 19 2 6 6 true No M0 N1b T4b Stage IIIB TCGA-BH-A1F2.FA781D93-C180-4453-BF95-B2D01B6CDB5C.pdf A1F2 TUMOR FREE YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1999 dbba4276-4b85-4309-8f98-951313c3a3dc dbba4276-4b85-4309-8f98-951313c3a3dc TCGA-BH-A1F2-01A-21-A17I-20 TCGA-BH-A1F2-01A-31D-A13L-09 TCGA-BH-A1F2-01 TCGA-BH-A1F2-01A-31D-A13K-05 9c29c7e9-78b0-434d-a795-343fa6d8d937 TCGA-BH-A1F2-01 TCGA-BH-A1F2-01A-31D-A13L-09 TCGA-BH-A1F2-01 TCGA-BH-A1F2-01A-31D-A13L-09 dbba4276-4b85-4309-8f98-951313c3a3dc TCGA-BH-A1F2-01A-31D-A13J-01 TCGA-BH-A1F2-01 dbba4276-4b85-4309-8f98-951313c3a3dc TCGA-BH-A1F2-01A-31D-A13J-01 TCGA-BH-A1F2-11 53 959 FEMALE 959 1 Normal enrollment DECEASED TCGA-BH-A1F2-11 C3-BRCA/Luminal mutation cluster 14 TCGA-BH-A1F2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left TCGA-BH-A1F2 TCGA-BH-A1F2-11A Positive Positive Modified Radical Mastectomy -19701 4147 959 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8541/3 C50.9 YES Core needle biopsy 270 NO Positive 19 6 true No M0 N1b T4b Stage IIIB A1F2 TUMOR FREE YES Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 1999 85e9922a-0ede-4fea-8338-ead05addef79 85e9922a-0ede-4fea-8338-ead05addef79 TCGA-BH-A1F2-11A-32D-A13T-05 TCGA-BH-A1F2-11 85e9922a-0ede-4fea-8338-ead05addef79 TCGA-BH-A1F2-11 85e9922a-0ede-4fea-8338-ead05addef79 TCGA-BH-A1F5-01 62 2712 Positive FEMALE 2712 1 LumA Positive enrollment DECEASED TCGA-BH-A1F5-01 Kirc+ C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 mutation c1uster 9 TCGA-BH-A1F5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right TCGA-BH-A1F5 TCGA-BH-A1F5-01A Positive Positive -22842 3091 2712 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative 4 1 true Yes M0 N1a T1c Stage IIA TCGA-BH-A1F5.F70DE761-F081-4F4C-AD22-9A166CF78CA8.pdf A1F5 TUMOR FREE YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 2002 07c52f68-8ece-4702-8573-9b21f32df787 07c52f68-8ece-4702-8573-9b21f32df787 TCGA-BH-A1F5-01A-21-A17I-20 TCGA-BH-A1F5-01A-12D-A13L-09 TCGA-BH-A1F5-01 TCGA-BH-A1F5-01A-12D-A13K-05 07dd3a1f-05f8-488d-9b80-4fe5b94923c4 TCGA-BH-A1F5-01 TCGA-BH-A1F5-01A-12D-A13L-09 TCGA-BH-A1F5-01 TCGA-BH-A1F5-01A-12D-A13L-09 07c52f68-8ece-4702-8573-9b21f32df787 TCGA-BH-A1F5-01A-12D-A13J-01 TCGA-BH-A1F5-01 07c52f68-8ece-4702-8573-9b21f32df787 TCGA-BH-A1F5-01A-12D-A13J-01 TCGA-BH-A1F5-11 62 2712 FEMALE 2712 1 enrollment DECEASED TCGA-BH-A1F5-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1F5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right TCGA-BH-A1F5 TCGA-BH-A1F5-11A Positive Positive -22842 3091 2712 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 420 NO Negative 4 1 true Yes M0 N1a T1c Stage IIA A1F5 TUMOR FREE YES Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 2002 TCGA-BH-A1F5-11A-43D-A13T-05 TCGA-BH-A1F6-01 51 2965 Negative FEMALE 2965 1 Basal Negative enrollment DECEASED TCGA-BH-A1F6-01 High C4-BRCA/Basal BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 mutation cluster 5 TCGA-BH-A1F6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left TCGA-BH-A1F6 TCGA-BH-A1F6-01A Negative Negative Modified Radical Mastectomy -18691 5230 2965 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 360 NO Negative 6 6 true No MX N2a T4d TCGA-BH-A1F6.7E9B0BE7-121E-423F-AA37-445BA922FC13.pdf A1F6 YES Primary Tumor 01 NO YES BH Breast A DECEASED 1996 5f5a884c-ffbd-401a-8689-baded1bdbe50 5f5a884c-ffbd-401a-8689-baded1bdbe50 TCGA-BH-A1F6-01A-21-A17I-20 TCGA-BH-A1F6-01A-11D-A13L-09 TCGA-BH-A1F6-01 TCGA-BH-A1F6-01A-11D-A13K-05 9e1df13d-422b-46a6-8dd0-0f3d943c301b TCGA-BH-A1F6-01 TCGA-BH-A1F6-01A-11D-A13L-09 TCGA-BH-A1F6-01 TCGA-BH-A1F6-01A-11D-A13L-09 5f5a884c-ffbd-401a-8689-baded1bdbe50 TCGA-BH-A1F6-01A-11D-A13J-01 TCGA-BH-A1F6-01 5f5a884c-ffbd-401a-8689-baded1bdbe50 TCGA-BH-A1F6-01A-11D-A13J-01 TCGA-BH-A1F6-11 51 2965 FEMALE 2965 1 Normal enrollment DECEASED TCGA-BH-A1F6-11 C4-BRCA/Basal mutation cluster 5 TCGA-BH-A1F6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left TCGA-BH-A1F6 Negative Negative Modified Radical Mastectomy -18691 2965 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative 6 6 No MX N2a T4d A1F6 YES Solid Tissue Normal 11 NO YES BH Breast DECEASED 1996 a248476b-7c40-42c6-905b-b9c3ba6b2aed a248476b-7c40-42c6-905b-b9c3ba6b2aed TCGA-BH-A1F6-11B-94D-A13T-05 TCGA-BH-A1F6-11 a248476b-7c40-42c6-905b-b9c3ba6b2aed TCGA-BH-A1F6-11 a248476b-7c40-42c6-905b-b9c3ba6b2aed TCGA-BH-A1F8-01 Stage IIIB 90 1 Stage IIIC 749 Positive FEMALE Negative Negative M0 Positive N2 749 1 LumB Positive enrollment T_Other T4 DECEASED TCGA-BH-A1F8-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 4 mutation cluster 4 TCGA-BH-A1F8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Left TCGA-BH-A1F8 Positive Positive Modified Radical Mastectomy -32871 763 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive 13 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 12 No M0 N2 T4b Stage IIIB A1F8 WITH TUMOR YES Primary Tumor 01 5th NO YES BH Breast DECEASED 1999 ca39657a-073d-4b89-a3da-900f7c9f1012 ca39657a-073d-4b89-a3da-900f7c9f1012 TCGA-BH-A1F8-01A-21-A17I-20 TCGA-BH-A1F8-01A-11D-A13L-09 TCGA-BH-A1F8-01 TCGA-BH-A1F8-01A-11D-A13K-05 bcc978dd-e7cd-4cff-be13-d6f0926dfc9d TCGA-BH-A1F8-01 TCGA-BH-A1F8-01A-11D-A13L-09 TCGA-BH-A1F8-01 TCGA-BH-A1F8-01A-11D-A13L-09 ca39657a-073d-4b89-a3da-900f7c9f1012 TCGA-BH-A1F8-01A-11D-A13J-01 TCGA-BH-A1F8-01 ca39657a-073d-4b89-a3da-900f7c9f1012 TCGA-BH-A1F8-01A-11D-A13J-01 TCGA-BH-A1F8-11 90 749 FEMALE 749 1 Normal enrollment DECEASED TCGA-BH-A1F8-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A1F8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Left TCGA-BH-A1F8 TCGA-BH-A1F8-11B Positive Positive Modified Radical Mastectomy -32871 4301 763 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 750 NO Positive 13 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 12 false No M0 N2 T4b Stage IIIB A1F8 WITH TUMOR YES Solid Tissue Normal 11 5th NO YES BH Breast B DECEASED 1999 c6cc7496-98d2-4181-8517-fbd875fd5623 c6cc7496-98d2-4181-8517-fbd875fd5623 TCGA-BH-A1F8-11B-21D-A13T-05 80FD1099-D66E-4A9A-AA9E-CB7D0178D612 TCGA-BH-A1F8-11 c6cc7496-98d2-4181-8517-fbd875fd5623 TCGA-BH-A1F8-11 c6cc7496-98d2-4181-8517-fbd875fd5623 TCGA-BH-A1FB-01 Stage IIB 60 4 Stage IIB 3669 Positive FEMALE Negative Negative M0 Positive N1 3669 1 LumA Positive enrollment T_Other T2 DECEASED TCGA-BH-A1FB-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 TCGA-BH-A1FB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right TCGA-BH-A1FB TCGA-BH-A1FB-01A Positive Positive -21933 3871 3669 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Negative 15 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 0 true No M0 N1b T2 Stage IIB TCGA-BH-A1FB.C5D116FF-3193-48A0-B69C-D98831D9976A.pdf A1FB WITH TUMOR YES Primary Tumor 01 segmental mastectomy with sentinel lymph node dissection 5th NO YES BH Breast A DECEASED 2000 5b262ec0-72f2-4c54-820e-a39afad67212 5b262ec0-72f2-4c54-820e-a39afad67212 TCGA-BH-A1FB-01A-21-A17I-20 TCGA-BH-A1FB-01 TCGA-BH-A1FB-01A-11D-A13K-05 ee88f81e-c7f3-41b4-a115-751d02d07fd0 TCGA-BH-A1FB-01 TCGA-BH-A1FB-01 5b262ec0-72f2-4c54-820e-a39afad67212 TCGA-BH-A1FB-01A-11D-A13J-01 TCGA-BH-A1FB-01 5b262ec0-72f2-4c54-820e-a39afad67212 TCGA-BH-A1FB-01A-11D-A13J-01 TCGA-BH-A1FB-11 60 3669 FEMALE 3669 1 Normal enrollment DECEASED TCGA-BH-A1FB-11 C3-BRCA/Luminal TCGA-BH-A1FB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right TCGA-BH-A1FB TCGA-BH-A1FB-11A Positive Positive -21933 3871 3669 0 2011-9-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 320 NO Negative 15 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 0 true No M0 N1b T2 Stage IIB A1FB WITH TUMOR YES Solid Tissue Normal 11 segmental mastectomy with sentinel lymph node dissection 5th NO YES BH Breast A DECEASED 2000 71899388-d223-4774-a1ce-3be260240b2c 71899388-d223-4774-a1ce-3be260240b2c TCGA-BH-A1FB-11A-33D-A13T-05 TCGA-BH-A1FB-11 71899388-d223-4774-a1ce-3be260240b2c TCGA-BH-A1FB-11 71899388-d223-4774-a1ce-3be260240b2c TCGA-BH-A1FC-01 Stage IIA 78 4 Stage IIA 3471 Negative FEMALE Negative Negative M0 Positive N1 3471 1 Basal Negative enrollment T1 T1 DECEASED TCGA-BH-A1FC-01 High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-BH-A1FC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right Upper Outer Quadrant TCGA-BH-A1FC TCGA-BH-A1FC-01A Negative Negative Other -28706 4456 3472 0 2011-9-8 FEMALE Medullary Carcinoma No C50.9 8510/3 C50.9 YES Fine needle aspiration biopsy 90 NO Negative 23 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 1 true No M0 N1b T1c Stage IIA TCGA-BH-A1FC.7B1B31D2-0CC5-4EE6-8AF3-16DF726BE13F.pdf A1FC TUMOR FREE YES Primary Tumor 01 localized segmental mastectomy with axillary node dissection 5th NO YES BH Breast A DECEASED 1998 42e2160c-07b5-4be6-a989-1e3474926d2a 42e2160c-07b5-4be6-a989-1e3474926d2a TCGA-BH-A1FC-01A-21-A17I-20 TCGA-BH-A1FC-01A-11D-A13L-09 TCGA-BH-A1FC-01 TCGA-BH-A1FC-01A-11D-A13K-05 9ce04c0d-97f2-4acd-a985-c9b162221210 TCGA-BH-A1FC-01 TCGA-BH-A1FC-01A-11D-A13L-09 TCGA-BH-A1FC-01 TCGA-BH-A1FC-01A-11D-A13L-09 42e2160c-07b5-4be6-a989-1e3474926d2a TCGA-BH-A1FC-01A-11D-A13J-01 TCGA-BH-A1FC-01 42e2160c-07b5-4be6-a989-1e3474926d2a TCGA-BH-A1FC-01A-11D-A13J-01 TCGA-BH-A1FC-11 78 3471 FEMALE 3471 1 Normal enrollment DECEASED TCGA-BH-A1FC-11 C4-BRCA/Basal mutation cluster 5 TCGA-BH-A1FC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right Upper Outer Quadrant TCGA-BH-A1FC TCGA-BH-A1FC-11A Negative Negative Other -28706 4456 3472 0 2011-9-8 FEMALE Medullary Carcinoma No C50.9 8510/3 C50.9 YES Fine needle aspiration biopsy 260 NO Negative 23 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 true No M0 N1b T1c Stage IIA A1FC TUMOR FREE YES Solid Tissue Normal 11 localized segmental mastectomy with axillary node dissection 5th NO YES BH Breast A DECEASED 1998 58e94be5-2da2-4a96-944a-060f20216572 58e94be5-2da2-4a96-944a-060f20216572 TCGA-BH-A1FC-11A-32D-A13T-05 TCGA-BH-A1FC-11 58e94be5-2da2-4a96-944a-060f20216572 TCGA-BH-A1FC-11 58e94be5-2da2-4a96-944a-060f20216572 TCGA-BH-A1FD-01 Stage I 68 4 Stage I 1008 Positive FEMALE Negative Negative M0 Negative N0 1008 1 LumB Positive enrollment T1 T1 DECEASED TCGA-BH-A1FD-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation cluster 3 TCGA-BH-A1FD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left TCGA-BH-A1FD TCGA-BH-A1FD-01A Positive Positive -24940 4420 1009 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative 19 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 0 true No M0 N0 T1c Stage I TCGA-BH-A1FD.9F838476-4DF1-44D6-989F-33A1D490424B.pdf A1FD WITH TUMOR YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1998 744ed141-8809-4bc9-90e6-74098383914e 744ed141-8809-4bc9-90e6-74098383914e TCGA-BH-A1FD-01A-21-A17I-20 TCGA-BH-A1FD-01A-11W-A14Q-09 TCGA-BH-A1FD-01 TCGA-BH-A1FD-01A-11D-A13K-05 7c4d6492-831a-4535-b46f-7fdcafd3dcdf TCGA-BH-A1FD-01 TCGA-BH-A1FD-01A-11W-A14Q-09 TCGA-BH-A1FD-01A-11W-A14Q-09 744ed141-8809-4bc9-90e6-74098383914e TCGA-BH-A1FD-01A-11D-A13J-01 744ed141-8809-4bc9-90e6-74098383914e TCGA-BH-A1FD-01A-11D-A13J-01 TCGA-BH-A1FD-11 68 1008 FEMALE 1008 1 Normal enrollment DECEASED TCGA-BH-A1FD-11 C3-BRCA/Luminal mutation cluster 3 TCGA-BH-A1FD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left TCGA-BH-A1FD TCGA-BH-A1FD-11B Positive Positive -24940 4420 1009 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 440 NO Negative 19 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 0 false No M0 N0 T1c Stage I A1FD WITH TUMOR YES Solid Tissue Normal 11 5th NO YES BH Breast B DECEASED 1998 e0ed3e93-0ead-4fc0-a82d-79807c7d5162 e0ed3e93-0ead-4fc0-a82d-79807c7d5162 TCGA-BH-A1FD-11B-21D-A13T-05 81425ECA-DA4A-428C-BAAE-E3B55821C356 TCGA-BH-A1FD-11 e0ed3e93-0ead-4fc0-a82d-79807c7d5162 TCGA-BH-A1FD-11 e0ed3e93-0ead-4fc0-a82d-79807c7d5162 TCGA-BH-A1FE-01 Stage IIB 31 2 Stage IIB 2273 Positive FEMALE Negative Negative M0 Positive N1 2273 1 LumA Positive enrollment T_Other T2 DECEASED TCGA-BH-A1FE-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 3 TCGA-BH-A1FE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 31 Left TCGA-BH-A1FE TCGA-BH-A1FE-01A Positive Positive Modified Radical Mastectomy -11650 4456 2273 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 130 NO 12 4 6 1 true No M0 N1 T2 Stage IIB TCGA-BH-A1FE.098BAFB4-94D0-4FC8-B938-D8A410BD8FC1.pdf A1FE WITH TUMOR YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1998 2cb3a793-6e37-42fd-a544-65aa2d939d50 2cb3a793-6e37-42fd-a544-65aa2d939d50 TCGA-BH-A1FE-01A-11D-A13L-09 TCGA-BH-A1FE-01 TCGA-BH-A1FE-01A-11D-A13K-05 8e3a6a91-27f1-497a-84dc-76ab2ee74185 TCGA-BH-A1FE-01 TCGA-BH-A1FE-01A-11D-A13L-09 TCGA-BH-A1FE-01 TCGA-BH-A1FE-01A-11D-A13L-09 2cb3a793-6e37-42fd-a544-65aa2d939d50 TCGA-BH-A1FE-01A-11D-A13J-01 TCGA-BH-A1FE-01 2cb3a793-6e37-42fd-a544-65aa2d939d50 TCGA-BH-A1FE-01A-11D-A13J-01 TCGA-BH-A1FE-06 31 2273 FEMALE 2273 1 Normal enrollment DECEASED TCGA-BH-A1FE-06 C3-BRCA/Luminal Low purity c2 GBM-like c6 miRNA cluster 5 mutation cluster 3 TCGA-BH-A1FE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 31 Left TCGA-BH-A1FE Positive Positive Modified Radical Mastectomy -11650 2273 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 12 1 No M0 N1 T2 Stage IIB A1FE WITH TUMOR YES Metastatic 06 5th NO YES BH Breast DECEASED 1998 aad871a8-1a52-4e96-8b13-444d08289236 aad871a8-1a52-4e96-8b13-444d08289236 TCGA-BH-A1FE-06A-21-A24B-20 TCGA-BH-A1FE-06A-11D-A212-05 ee4151b6-cf2c-43e9-b3ed-9407e9e83282 TCGA-BH-A1FE-06 TCGA-BH-A1FE-06A-11D-A20S-09 aad871a8-1a52-4e96-8b13-444d08289236 TCGA-BH-A1FE-06 aad871a8-1a52-4e96-8b13-444d08289236 TCGA-BH-A1FE-11 31 2273 FEMALE 2273 1 Normal enrollment DECEASED TCGA-BH-A1FE-11 C3-BRCA/Luminal mutation cluster 3 TCGA-BH-A1FE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 31 Left TCGA-BH-A1FE TCGA-BH-A1FE-11B Positive Positive Modified Radical Mastectomy -11650 4456 2273 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 520 NO 12 1 true No M0 N1 T2 Stage IIB A1FE WITH TUMOR YES Solid Tissue Normal 11 5th NO YES BH Breast B DECEASED 1998 64f3f52d-a484-49c6-9048-6eadedd2c2c5 64f3f52d-a484-49c6-9048-6eadedd2c2c5 TCGA-BH-A1FE-11B-14D-A13T-05 160198A9-3024-40DF-9887-E20F9371AC0A TCGA-BH-A1FE-11 64f3f52d-a484-49c6-9048-6eadedd2c2c5 TCGA-BH-A1FE-11 64f3f52d-a484-49c6-9048-6eadedd2c2c5 TCGA-BH-A1FG-01 Stage I 88 4 Stage I 3738 Positive FEMALE Negative M0 Negative N0 3738 1 LumA Positive enrollment T1 T1 DECEASED TCGA-BH-A1FG-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-BH-A1FG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 88 Left TCGA-BH-A1FG TCGA-BH-A1FG-01A Positive Positive Other -32295 4460 3736 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 120 NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 true No M0 NX T1c Stage I TCGA-BH-A1FG.49927626-EB84-4A79-8073-67818722123A.pdf A1FG Primary Tumor 01 segmental mastectomy 5th NO YES BH Breast A DECEASED 1998 39fe5d50-f454-4f7b-b07b-1a59b5c828f9 39fe5d50-f454-4f7b-b07b-1a59b5c828f9 TCGA-BH-A1FG-01A-21-A17I-20 TCGA-BH-A1FG-01A-11D-A13L-09 TCGA-BH-A1FG-01 TCGA-BH-A1FG-01A-11D-A13K-05 590744af-fc53-40ec-957f-ca5ca31d76c5 TCGA-BH-A1FG-01 TCGA-BH-A1FG-01A-11D-A13L-09 TCGA-BH-A1FG-01 TCGA-BH-A1FG-01A-11D-A13L-09 39fe5d50-f454-4f7b-b07b-1a59b5c828f9 TCGA-BH-A1FG-01A-11D-A13J-01 TCGA-BH-A1FG-01 39fe5d50-f454-4f7b-b07b-1a59b5c828f9 TCGA-BH-A1FG-01A-11D-A13J-01 TCGA-BH-A1FG-11 88 3738 FEMALE 3738 1 Normal enrollment DECEASED TCGA-BH-A1FG-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1FG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 88 Left TCGA-BH-A1FG Positive Positive Other -32295 3736 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) No M0 NX T1c Stage I A1FG Solid Tissue Normal 11 segmental mastectomy 5th NO YES BH Breast DECEASED 1998 ea037776-3759-425c-a7f4-35e8a5571025 ea037776-3759-425c-a7f4-35e8a5571025 TCGA-BH-A1FG-11B-12D-A13T-05 TCGA-BH-A1FG-11 ea037776-3759-425c-a7f4-35e8a5571025 TCGA-BH-A1FG-11 ea037776-3759-425c-a7f4-35e8a5571025 TCGA-BH-A1FH-01 Stage IV 47 4 No_Conversion 1123 Positive FEMALE Negative Positive M1 Positive N1 1123 1 LumA Negative enrollment T_Other T2 DECEASED TCGA-BH-A1FH-01 Kirc+ C3-BRCA/Luminal cluster 1 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-BH-A1FH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant TCGA-BH-A1FH TCGA-BH-A1FH-01A Positive Negative Modified Radical Mastectomy -17172 4670 1034 0 YES 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 430 NO 13 Bone 1 6 8 true No M1 N1b T2 Stage IV TCGA-BH-A1FH.501C3E1B-573B-4A5A-A0ED-3CD15432E6FF.pdf A1FH WITH TUMOR YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1998 693a3c69-75bd-435d-874e-f3b90b7ed180 693a3c69-75bd-435d-874e-f3b90b7ed180 TCGA-BH-A1FH-01A-21-A17I-20 TCGA-BH-A1FH-01A-12D-A13L-09 TCGA-BH-A1FH-01 TCGA-BH-A1FH-01A-12D-A13K-05 c2f9d1f7-4fea-4868-a3ec-58f863b4e449 TCGA-BH-A1FH-01 TCGA-BH-A1FH-01A-12D-A13L-09 TCGA-BH-A1FH-01 TCGA-BH-A1FH-01A-12D-A13L-09 693a3c69-75bd-435d-874e-f3b90b7ed180 TCGA-BH-A1FH-01A-12D-A13J-01 TCGA-BH-A1FH-01 693a3c69-75bd-435d-874e-f3b90b7ed180 TCGA-BH-A1FH-01A-12D-A13J-01 TCGA-BH-A1FH-11 47 1123 FEMALE 1123 1 Normal enrollment DECEASED TCGA-BH-A1FH-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1FH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant TCGA-BH-A1FH TCGA-BH-A1FH-11B Positive Negative Modified Radical Mastectomy -17172 4670 1034 0 YES 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO 13 Bone 8 false No M1 N1b T2 Stage IV A1FH WITH TUMOR YES Solid Tissue Normal 11 5th NO YES BH Breast B DECEASED 1998 1b831e2d-c265-4eac-aee0-248493a14218 1b831e2d-c265-4eac-aee0-248493a14218 TCGA-BH-A1FH-11B-42D-A13T-05 TCGA-BH-A1FH-11 1b831e2d-c265-4eac-aee0-248493a14218 TCGA-BH-A1FH-11 1b831e2d-c265-4eac-aee0-248493a14218 TCGA-BH-A1FJ-01 Stage IIIA 66 3 Stage IIIA 1927 Negative FEMALE Negative Negative M0 Positive N1 1927 1 LumB Positive enrollment T_Other T3 DECEASED TCGA-BH-A1FJ-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 2 mutation c1uster 9 TCGA-BH-A1FJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Upper Outer Quadrant TCGA-BH-A1FJ TCGA-BH-A1FJ-01A Negative Positive Modified Radical Mastectomy -24262 4574 1927 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 190 NO 35 4 2 6 true No M0 N1b T3 Stage IIIA TCGA-BH-A1FJ.8169BE67-03C8-4F4D-9A60-200705B795AE.pdf A1FJ YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1998 28bc840d-296e-436e-93b8-9c28c0eaf47a 28bc840d-296e-436e-93b8-9c28c0eaf47a TCGA-BH-A1FJ-01A-21-A17I-20 TCGA-BH-A1FJ-01A-11D-A13L-09 TCGA-BH-A1FJ-01 TCGA-BH-A1FJ-01A-11D-A13K-05 1efab28c-3820-4638-b688-f34d0daa58d3 TCGA-BH-A1FJ-01 TCGA-BH-A1FJ-01A-11D-A13L-09 TCGA-BH-A1FJ-01 TCGA-BH-A1FJ-01A-11D-A13L-09 28bc840d-296e-436e-93b8-9c28c0eaf47a TCGA-BH-A1FJ-01A-11D-A13J-01 TCGA-BH-A1FJ-01 28bc840d-296e-436e-93b8-9c28c0eaf47a TCGA-BH-A1FJ-01A-11D-A13J-01 TCGA-BH-A1FJ-11 66 1927 FEMALE 1927 1 Normal enrollment DECEASED TCGA-BH-A1FJ-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1FJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Upper Outer Quadrant TCGA-BH-A1FJ TCGA-BH-A1FJ-11B Negative Positive Modified Radical Mastectomy -24262 4574 1927 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 380 NO 35 6 false No M0 N1b T3 Stage IIIA A1FJ YES Solid Tissue Normal 11 5th NO YES BH Breast B DECEASED 1998 3078c384-b624-4f5a-ae36-fc896212e616 3078c384-b624-4f5a-ae36-fc896212e616 TCGA-BH-A1FJ-11B-42D-A13T-05 TCGA-BH-A1FJ-11 3078c384-b624-4f5a-ae36-fc896212e616 TCGA-BH-A1FJ-11 3078c384-b624-4f5a-ae36-fc896212e616 TCGA-BH-A1FL-01 Stage IIB 69 2 Stage IIIA 1673 Positive FEMALE Negative Negative M0 Positive N1 1673 1 LumA Positive enrollment T_Other T2 DECEASED TCGA-BH-A1FL-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-BH-A1FL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Left Upper Outer Quadrant TCGA-BH-A1FL TCGA-BH-A1FL-01A Positive Positive Other -25558 4572 1673 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 100 NO 22 4 6 4 true No M0 N1b T2 Stage IIB TCGA-BH-A1FL.032B81C5-F936-448E-A352-C186DF160B7C.pdf A1FL WITH TUMOR YES Primary Tumor 01 needle directed right breast biopsy with left segmental mastectomy with axillary lymph node dissection 5th NO YES BH Breast A DECEASED 1998 0858a026-142c-4428-b05d-fdc22080afd3 0858a026-142c-4428-b05d-fdc22080afd3 TCGA-BH-A1FL-01A-21-A17I-20 TCGA-BH-A1FL-01A-11D-A13L-09 TCGA-BH-A1FL-01 TCGA-BH-A1FL-01A-11D-A13K-05 dcfae1dd-7e5f-49d7-b3b8-171c97913d1a TCGA-BH-A1FL-01 TCGA-BH-A1FL-01A-11D-A13L-09 TCGA-BH-A1FL-01 TCGA-BH-A1FL-01A-11D-A13L-09 0858a026-142c-4428-b05d-fdc22080afd3 TCGA-BH-A1FL-01A-11D-A13J-01 TCGA-BH-A1FL-01 0858a026-142c-4428-b05d-fdc22080afd3 TCGA-BH-A1FL-01A-11D-A13J-01 TCGA-BH-A1FM-01 Stage IIIA 44 1 Stage IIIA 1388 Positive FEMALE Negative Negative M0 Positive N2 1388 1 LumB Negative enrollment T_Other T2 DECEASED TCGA-BH-A1FM-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-BH-A1FM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Upper Outer Quadrant TCGA-BH-A1FM TCGA-BH-A1FM-01A Positive Negative Modified Radical Mastectomy -16289 4753 1388 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 260 NO 10 3 4 8 true No M0 N2 T2 Stage IIIA TCGA-BH-A1FM.DA6A0EC9-6E20-4E4A-9B7F-A32EFF7627AD.pdf A1FM YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1998 99157b66-ae2a-4ba2-8b28-5653803063a9 99157b66-ae2a-4ba2-8b28-5653803063a9 TCGA-BH-A1FM-01A-21-A17I-20 TCGA-BH-A1FM-01A-11D-A13L-09 TCGA-BH-A1FM-01 TCGA-BH-A1FM-01A-11D-A13K-05 25b0f619-ad2b-437a-bf44-e03cce5ff63f TCGA-BH-A1FM-01 TCGA-BH-A1FM-01A-11D-A13L-09 TCGA-BH-A1FM-01 TCGA-BH-A1FM-01A-11D-A13L-09 99157b66-ae2a-4ba2-8b28-5653803063a9 TCGA-BH-A1FM-01A-11D-A13J-01 TCGA-BH-A1FM-01 99157b66-ae2a-4ba2-8b28-5653803063a9 TCGA-BH-A1FM-01A-11D-A13J-01 TCGA-BH-A1FM-11 44 1388 FEMALE 1388 1 Normal enrollment DECEASED TCGA-BH-A1FM-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1FM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Upper Outer Quadrant TCGA-BH-A1FM TCGA-BH-A1FM-11B Positive Negative Modified Radical Mastectomy -16289 4753 1388 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO 10 8 false No M0 N2 T2 Stage IIIA A1FM YES Solid Tissue Normal 11 5th NO YES BH Breast B DECEASED 1998 39ec3623-c15f-4af6-b2df-5413eec21bec 39ec3623-c15f-4af6-b2df-5413eec21bec TCGA-BH-A1FM-11B-23D-A13T-05 TCGA-BH-A1FM-11 39ec3623-c15f-4af6-b2df-5413eec21bec TCGA-BH-A1FM-11 39ec3623-c15f-4af6-b2df-5413eec21bec TCGA-BH-A1FN-01 Stage IIA 34 1 Stage IIA 2192 Positive FEMALE Negative Negative M0 Negative N0 2192 1 LumB Positive enrollment T_Other T2 DECEASED TCGA-BH-A1FN-01 High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-BH-A1FN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Right Upper Outer Quadrant TCGA-BH-A1FN TCGA-BH-A1FN-01A Positive Positive Other -12525 4838 2192 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 80 NO 29 5 4 0 true No M0 N0 T2 Stage IIA TCGA-BH-A1FN.26F47A4F-B501-4C33-9D49-2039E98DBF26.pdf A1FN WITH TUMOR YES Primary Tumor 01 segmental mastectomy with axillary lymph node dissection 5th NO YES BH Breast A DECEASED 1997 c870e04b-c3b7-495c-8465-7ef2a00fadc7 c870e04b-c3b7-495c-8465-7ef2a00fadc7 TCGA-BH-A1FN-01A-21-A17I-20 TCGA-BH-A1FN-01A-11D-A13L-09 TCGA-BH-A1FN-01 TCGA-BH-A1FN-01A-11D-A13K-05 3d0671e6-de93-4023-b91c-66a2e311fed6 TCGA-BH-A1FN-01 TCGA-BH-A1FN-01A-11D-A13L-09 TCGA-BH-A1FN-01 TCGA-BH-A1FN-01A-11D-A13L-09 c870e04b-c3b7-495c-8465-7ef2a00fadc7 TCGA-BH-A1FN-01A-11D-A13J-01 TCGA-BH-A1FN-01 c870e04b-c3b7-495c-8465-7ef2a00fadc7 TCGA-BH-A1FN-01A-11D-A13J-01 TCGA-BH-A1FN-11 34 2192 FEMALE 2192 1 Normal enrollment DECEASED TCGA-BH-A1FN-11 C3-BRCA/Luminal mutation cluster 5 TCGA-BH-A1FN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Right Upper Outer Quadrant TCGA-BH-A1FN TCGA-BH-A1FN-11A Positive Positive Other -12525 4838 2192 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy NO 29 0 true No M0 N0 T2 Stage IIA A1FN WITH TUMOR YES Solid Tissue Normal 11 segmental mastectomy with axillary lymph node dissection 5th NO YES BH Breast A DECEASED 1997 48353101-484c-4d47-ae60-239d710ec00a 48353101-484c-4d47-ae60-239d710ec00a TCGA-BH-A1FN-11A-34D-A13T-05 BAC42747-AC16-4A8B-A673-236A4F3F0568 TCGA-BH-A1FN-11 48353101-484c-4d47-ae60-239d710ec00a TCGA-BH-A1FN-11 48353101-484c-4d47-ae60-239d710ec00a TCGA-BH-A1FR-01 Stage IIIB 73 1 No_Conversion 4398 Positive FEMALE Negative Negative M0 Positive N1 4398 1 LumA Positive enrollment T_Other T4 DECEASED TCGA-BH-A1FR-01 Quiet C3-BRCA/Luminal cluster 2 KIRC-like c17 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-BH-A1FR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Right Upper Inner Quadrant TCGA-BH-A1FR TCGA-BH-A1FR-01A Positive Positive Other -26684 4876 1642 0 2011-9-8 FEMALE Other, specify No C50.9 8523/3 C50.9 YES Core needle biopsy 110 NO 10 2 1 4 true No M0 N1a T4b Stage IIIB TCGA-BH-A1FR.B6E6765F-14BC-4D3D-9266-EF8065354070.pdf A1FR WITH TUMOR YES Primary Tumor 01 segmental mastectomy with excision of mass on chest wall and axillary node dissection 5th NO YES BH Breast A DECEASED 1997 56d5aac4-62b4-43e4-b0e4-f40b19a5893f 56d5aac4-62b4-43e4-b0e4-f40b19a5893f TCGA-BH-A1FR-01A-21-A17I-20 TCGA-BH-A1FR-01A-11D-A13L-09 TCGA-BH-A1FR-01 TCGA-BH-A1FR-01A-11D-A13K-05 a20031de-1d1e-4019-8d09-d8810bea4462 TCGA-BH-A1FR-01 TCGA-BH-A1FR-01A-11D-A13L-09 TCGA-BH-A1FR-01 TCGA-BH-A1FR-01A-11D-A13L-09 56d5aac4-62b4-43e4-b0e4-f40b19a5893f TCGA-BH-A1FR-01A-11D-A13J-01 TCGA-BH-A1FR-01 56d5aac4-62b4-43e4-b0e4-f40b19a5893f TCGA-BH-A1FR-01A-11D-A13J-01 TCGA-BH-A1FR-11 73 4398 FEMALE 4398 1 Normal enrollment DECEASED TCGA-BH-A1FR-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-BH-A1FR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Right Upper Inner Quadrant TCGA-BH-A1FR Positive Positive Other -26684 1642 0 2011-9-8 FEMALE Other, specify No C50.9 8523/3 C50.9 YES Core needle biopsy 10 4 No M0 N1a T4b Stage IIIB A1FR WITH TUMOR YES Solid Tissue Normal 11 segmental mastectomy with excision of mass on chest wall and axillary node dissection 5th NO YES BH Breast DECEASED 1997 c2db17b1-c288-4f73-8e22-22929d846678 c2db17b1-c288-4f73-8e22-22929d846678 TCGA-BH-A1FR-11B-42D-A13T-05 TCGA-BH-A1FR-11 c2db17b1-c288-4f73-8e22-22929d846678 TCGA-BH-A1FR-11 c2db17b1-c288-4f73-8e22-22929d846678 TCGA-BH-A1FU-01 Stage IA 44 4 Stage I 2192 Negative FEMALE Positive Negative M0 Negative N0 2192 1 Normal Negative enrollment T1 T1 DECEASED TCGA-BH-A1FU-01 Kirc+ C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 5 TCGA-BH-A1FU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Upper Outer Quadrant TCGA-BH-A1FU TCGA-BH-A1FU-01A Negative Negative Modified Radical Mastectomy -16174 5041 1688 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 110 NO 5 1 6 0 true No M0 N0 T1c Stage IA TCGA-BH-A1FU.58B02C83-2AF7-4978-A3F7-A8B9E0D914A1.pdf A1FU WITH TUMOR YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1997 05a4f4ff-cdfd-4332-8146-066657a4c3cc 05a4f4ff-cdfd-4332-8146-066657a4c3cc TCGA-BH-A1FU-01A-11D-A14G-09 TCGA-BH-A1FU-01 TCGA-BH-A1FU-01A-11D-A14H-05 TCGA-BH-A1FU-01 TCGA-BH-A1FU-01A-11D-A14G-09 TCGA-BH-A1FU-01 TCGA-BH-A1FU-01A-11D-A14G-09 05a4f4ff-cdfd-4332-8146-066657a4c3cc TCGA-BH-A1FU-01A-11D-A14F-01 TCGA-BH-A1FU-01 05a4f4ff-cdfd-4332-8146-066657a4c3cc TCGA-BH-A1FU-01A-11D-A14F-01 TCGA-BH-A1FU-11 44 2192 FEMALE 2192 1 Normal enrollment DECEASED TCGA-BH-A1FU-11 C3-BRCA/Luminal mutation cluster 5 TCGA-BH-A1FU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Upper Outer Quadrant TCGA-BH-A1FU Negative Negative Modified Radical Mastectomy -16174 1688 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 5 0 No M0 N0 T1c Stage IA A1FU WITH TUMOR YES Solid Tissue Normal 11 5th NO YES BH Breast DECEASED 1997 df661ba2-098b-49e0-884c-27cf2ecd87f2 df661ba2-098b-49e0-884c-27cf2ecd87f2 TCGA-BH-A1FU-11 df661ba2-098b-49e0-884c-27cf2ecd87f2 TCGA-BH-A1FU-11 df661ba2-098b-49e0-884c-27cf2ecd87f2 TCGA-BH-A201-01 64 5 209 Positive FEMALE 209 0 LumA Positive enrollment LIVING TCGA-BH-A201-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation c1uster 9 TCGA-BH-A201 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left TCGA-BH-A201-F64222 TCGA-BH-A201 TCGA-BH-A201-01A Positive Positive Other -23423 86 0 856 2014-8-27 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative NO 2 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 0 true No M0 N0 T1 Stage IA TCGA-BH-A201.6AE92F6F-E29D-43B6-AF1E-F15720C1AAE8.pdf A201 TUMOR FREE NO YES YES Primary Tumor 01 segmental mastectomy with sentinel lymph node biopsy and wire localization 7th NO YES BH Breast A LIVING 2011 a7050752-eefd-4576-a304-c79dc6fa30e7 a7050752-eefd-4576-a304-c79dc6fa30e7 TCGA-BH-A201-01A-21-A17I-20 TCGA-BH-A201-01A-11D-A14K-09 TCGA-BH-A201-01 TCGA-BH-A201-01A-11D-A14N-05 27773791-0c8a-421a-9469-3e9b93ce80d2 TCGA-BH-A201-01 TCGA-BH-A201-01A-11D-A14K-09 TCGA-BH-A201-01 TCGA-BH-A201-01A-11D-A14K-09 a7050752-eefd-4576-a304-c79dc6fa30e7 TCGA-BH-A201-01A-11D-A14J-01 TCGA-BH-A201-01 a7050752-eefd-4576-a304-c79dc6fa30e7 TCGA-BH-A201-01A-11D-A14J-01 TCGA-BH-A202-01 60 2 22 Positive FEMALE 22 0 LumB Positive enrollment LIVING TCGA-BH-A202-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 3 TCGA-BH-A202 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left TCGA-BH-A202-F64226 TCGA-BH-A202 Positive Positive Other -22052 0 795 2014-8-27 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive NO 4 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 0 No M0 N0 T2 Stage II A202 TUMOR FREE YES YES YES Primary Tumor 01 segmental mastectomy with sentinel lymph node biopsy 6th NO YES BH Breast LIVING 2011 d3169d74-dd69-4c6b-8232-6e15ac2920b9 d3169d74-dd69-4c6b-8232-6e15ac2920b9 TCGA-BH-A202-01A-21-A17K-20 TCGA-BH-A202-01A-11D-A14K-09 TCGA-BH-A202-01 TCGA-BH-A202-01A-11D-A14N-05 c393111f-c4f6-473b-a396-05dd90d531e1 TCGA-BH-A202-01 TCGA-BH-A202-01A-11D-A14K-09 TCGA-BH-A202-01 TCGA-BH-A202-01A-11D-A14K-09 d3169d74-dd69-4c6b-8232-6e15ac2920b9 TCGA-BH-A202-01A-11D-A14J-01 TCGA-BH-A202-01 d3169d74-dd69-4c6b-8232-6e15ac2920b9 TCGA-BH-A202-01A-11D-A14J-01 TCGA-BH-A203-01 78 3 1174 FEMALE 1174 1 Her2 enrollment DECEASED TCGA-BH-A203-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 4 TCGA-BH-A203 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right TCGA-BH-A203 TCGA-BH-A203-01A Lumpectomy -28609 5418 1174 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 340 NO 39 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 35 true No M0 N1b T2 Stage IIB TCGA-BH-A203.3EBBE51B-6D17-4A77-AAE1-E0424CEA56DB.pdf A203 WITH TUMOR YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1996 ff6fb75e-aefc-44e3-accd-c4f690a51cca ff6fb75e-aefc-44e3-accd-c4f690a51cca TCGA-BH-A203-01A-21-A17K-20 TCGA-BH-A203-01A-12D-A167-09 TCGA-BH-A203-01 TCGA-BH-A203-01A-12D-A16A-05 570d0406-4cbb-471f-bf26-b07dd4f927cf TCGA-BH-A203-01 TCGA-BH-A203-01A-12D-A167-09 TCGA-BH-A203-01 TCGA-BH-A203-01A-12D-A167-09 ff6fb75e-aefc-44e3-accd-c4f690a51cca TCGA-BH-A203-01A-12D-A166-01 TCGA-BH-A203-01 ff6fb75e-aefc-44e3-accd-c4f690a51cca TCGA-BH-A203-01A-12D-A166-01 TCGA-BH-A203-11 78 1174 FEMALE 1174 1 Normal enrollment DECEASED TCGA-BH-A203-11 C3-BRCA/Luminal mutation cluster 4 TCGA-BH-A203 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right TCGA-BH-A203 TCGA-BH-A203-11A Lumpectomy -28609 5418 1174 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES 480 NO 39 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 35 false No M0 N1b T2 Stage IIB A203 WITH TUMOR YES Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 1996 6e5015d8-55e8-448a-9663-7b8625f170ae 6e5015d8-55e8-448a-9663-7b8625f170ae TCGA-BH-A203-11A-42D-A16A-05 87EB8632-D2C0-4E37-A707-66410942D9A1 TCGA-BH-A203-11 6e5015d8-55e8-448a-9663-7b8625f170ae TCGA-BH-A203-11 6e5015d8-55e8-448a-9663-7b8625f170ae TCGA-BH-A204-01 80 4 2534 FEMALE 2534 1 LumB enrollment DECEASED TCGA-BH-A204-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 mutation cluster 14 TCGA-BH-A204 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left TCGA-BH-A204 TCGA-BH-A204-01A Modified Radical Mastectomy -29529 5538 2534 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 420 NO 16 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 true No M0 N1b T2 Stage IIB TCGA-BH-A204.531B1E8E-9936-42E0-B49B-39C61DD4E943.pdf A204 YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1996 19c3c4c7-d34c-47d5-b09f-c5671f49b858 19c3c4c7-d34c-47d5-b09f-c5671f49b858 TCGA-BH-A204-01A-21-A17K-20 TCGA-BH-A204-01A-11D-A159-09 TCGA-BH-A204-01 TCGA-BH-A204-01A-11D-A161-05 6bf2c85b-1783-4017-9305-e1f18c0e7645 TCGA-BH-A204-01 TCGA-BH-A204-01A-11D-A159-09 TCGA-BH-A204-01 TCGA-BH-A204-01A-11D-A159-09 19c3c4c7-d34c-47d5-b09f-c5671f49b858 TCGA-BH-A204-01A-11D-A160-01 TCGA-BH-A204-01 19c3c4c7-d34c-47d5-b09f-c5671f49b858 TCGA-BH-A204-01A-11D-A160-01 TCGA-BH-A204-11 80 2534 FEMALE 2534 1 Normal enrollment DECEASED TCGA-BH-A204-11 C3-BRCA/Luminal mutation cluster 14 TCGA-BH-A204 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left TCGA-BH-A204 TCGA-BH-A204-11A Modified Radical Mastectomy -29529 5538 2534 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 450 NO 16 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 false No M0 N1b T2 Stage IIB A204 YES Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 1996 6b52803e-274b-4a1b-910f-2d307932bbb2 6b52803e-274b-4a1b-910f-2d307932bbb2 TCGA-BH-A204-11A-53D-A161-05 TCGA-BH-A204-11 6b52803e-274b-4a1b-910f-2d307932bbb2 TCGA-BH-A204-11 6b52803e-274b-4a1b-910f-2d307932bbb2 TCGA-BH-A208-01 48 3 1759 FEMALE 1759 1 Normal enrollment DECEASED TCGA-BH-A208-01 High C3-BRCA/Luminal cluster 5 OV-like c1 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 11 mutation cluster 8 TCGA-BH-A208 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left TCGA-BH-A208 TCGA-BH-A208-01A Lumpectomy -17715 5893 1759 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 620 NO 15 5 3 true No M0 N1b T2 Stage IIB TCGA-BH-A208.4F943D12-E769-45F3-86BE-75193786DD4E.pdf A208 TUMOR FREE YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1995 7a276d04-8f45-4c07-9c24-8b1f50a1202d 7a276d04-8f45-4c07-9c24-8b1f50a1202d TCGA-BH-A208-01A-21-A17K-20 TCGA-BH-A208-01A-11D-A159-09 TCGA-BH-A208-01 TCGA-BH-A208-01A-11D-A161-05 20175b85-f502-4712-aa9d-f3a96c5921f8 TCGA-BH-A208-01 TCGA-BH-A208-01A-11D-A159-09 TCGA-BH-A208-01 TCGA-BH-A208-01A-11D-A159-09 7a276d04-8f45-4c07-9c24-8b1f50a1202d TCGA-BH-A208-01A-11D-A160-01 TCGA-BH-A208-01 7a276d04-8f45-4c07-9c24-8b1f50a1202d TCGA-BH-A208-01A-11D-A160-01 TCGA-BH-A208-11 48 1759 FEMALE 1759 1 Normal enrollment DECEASED TCGA-BH-A208-11 C3-BRCA/Luminal mutation cluster 8 TCGA-BH-A208 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left TCGA-BH-A208 TCGA-BH-A208-11A Lumpectomy -17715 5893 1759 0 2011-9-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 920 NO 15 3 false No M0 N1b T2 Stage IIB A208 TUMOR FREE YES Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 1995 a0ac3d9f-7700-4319-929a-fb51d85c9d49 a0ac3d9f-7700-4319-929a-fb51d85c9d49 TCGA-BH-A208-11A-51D-A161-05 CE2C9C0F-7CD7-4C05-AF2F-85D4552F8183 TCGA-BH-A208-11 a0ac3d9f-7700-4319-929a-fb51d85c9d49 TCGA-BH-A208-11 a0ac3d9f-7700-4319-929a-fb51d85c9d49 TCGA-BH-A209-01 77 4 3959 Positive FEMALE 3959 1 LumB Positive enrollment DECEASED TCGA-BH-A209-01 High C3-BRCA/Luminal cluster 3 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 mutation cluster 14 TCGA-BH-A209 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Left Upper Outer Quadrant TCGA-BH-A209 TCGA-BH-A209-01A Positive Positive Lumpectomy -28403 5392 3959 0 2011-9-8 FEMALE Medullary Carcinoma No C50.9 8510/3 C50.9 YES Fine needle aspiration biopsy 390 NO 12 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 0 true No M0 N0 T1c Stage I TCGA-BH-A209.E28150CE-E9B6-4C3F-B867-F9A75E2648DC.pdf A209 TUMOR FREE YES Primary Tumor 01 5th NO YES BH Breast A DECEASED 1996 9073fc5c-a281-4ed2-a66e-5235a5a55098 9073fc5c-a281-4ed2-a66e-5235a5a55098 TCGA-BH-A209-01A-21-A17K-20 TCGA-BH-A209-01A-11D-A17G-09 TCGA-BH-A209-01 TCGA-BH-A209-01A-11D-A161-05 f89486f5-6292-40bd-a4af-ff27eae691aa TCGA-BH-A209-01 TCGA-BH-A209-01A-11D-A17G-09 TCGA-BH-A209-01 TCGA-BH-A209-01A-11D-A17G-09 9073fc5c-a281-4ed2-a66e-5235a5a55098 TCGA-BH-A209-01A-11D-A160-01 TCGA-BH-A209-01 9073fc5c-a281-4ed2-a66e-5235a5a55098 TCGA-BH-A209-01A-11D-A160-01 TCGA-BH-A209-11 77 3959 FEMALE 3959 1 Normal enrollment DECEASED TCGA-BH-A209-11 C3-BRCA/Luminal mutation cluster 14 TCGA-BH-A209 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Left Upper Outer Quadrant TCGA-BH-A209 TCGA-BH-A209-11A Positive Positive Lumpectomy -28403 5392 3959 0 2011-9-8 FEMALE Medullary Carcinoma No C50.9 8510/3 C50.9 YES Fine needle aspiration biopsy 400 NO 12 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 0 false No M0 N0 T1c Stage I A209 TUMOR FREE YES Solid Tissue Normal 11 5th NO YES BH Breast A DECEASED 1996 7a4e994d-ed10-45e7-9107-51dc02068963 7a4e994d-ed10-45e7-9107-51dc02068963 TCGA-BH-A209-11A-42D-A161-05 TCGA-BH-A209-11 7a4e994d-ed10-45e7-9107-51dc02068963 TCGA-BH-A209-11 7a4e994d-ed10-45e7-9107-51dc02068963 TCGA-BH-A28O-01 TCGA-BH-A28O-01 Quiet Low purity c2 miRNA cluster 4 TCGA-BH-A28O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-BH-A28O-F64237 TCGA-BH-A28O TCGA-BH-A28O-01A Positive Positive Other NO -18501 163 0 1120 NO 2014-8-27 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 80 NO Negative NO 14 Negative NO 14 true No M0 N3 T3a Stage IIIC TCGA-BH-A28O.12A869FC-7578-4506-BB23-7C25597834EA.pdf A28O TUMOR FREE YES YES YES Primary Tumor 01 Segmental mastectomy 7th YES NO BH Breast A LIVING 2010 7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b 7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b TCGA-BH-A28O-01 TCGA-BH-A28O-01A-11D-A22B-05 TCGA-BH-A28O-01 TCGA-BH-A28O-01A-11D-A228-09 TCGA-BH-A28O-01 7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b TCGA-BH-A28O-01A-11D-A227-01 TCGA-BH-A28O-01 7fdcbf9d-e485-4b2b-8b9e-dba41ceed97b TCGA-BH-A28O-01A-11D-A227-01 TCGA-BH-A28Q-01 46 2 196 Positive FEMALE 196 0 LumA Positive enrollment LIVING TCGA-BH-A28Q-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 mutation c1uster 9 TCGA-BH-A28Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right TCGA-BH-A28Q-F64272 TCGA-BH-A28Q TCGA-BH-A28Q-01A Positive Positive Modified Radical Mastectomy -16882 223 0 1119 2014-8-28 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 400 NO Negative Indeterminate NO 18 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 2 true No M0 N1a T2 Stage IIB TCGA-BH-A28Q.9D040C65-C225-4D41-BA4C-6BB21EC1CD32.pdf A28Q TUMOR FREE NO YES NO Primary Tumor 01 7th NO YES BH Breast A LIVING 2010 5427eb83-38f3-4258-b241-25efae8fa70a 5427eb83-38f3-4258-b241-25efae8fa70a TCGA-BH-A28Q-01A-21-A17K-20 TCGA-BH-A28Q-01A-11D-A16D-09 TCGA-BH-A28Q-01 TCGA-BH-A28Q-01A-11D-A16G-05 45d40b9a-e057-4d32-b7f5-46d9d4e89d89 TCGA-BH-A28Q-01 TCGA-BH-A28Q-01A-11D-A16D-09 TCGA-BH-A28Q-01 TCGA-BH-A28Q-01A-11D-A16D-09 5427eb83-38f3-4258-b241-25efae8fa70a TCGA-BH-A28Q-01A-11D-A16C-01 TCGA-BH-A28Q-01 5427eb83-38f3-4258-b241-25efae8fa70a TCGA-BH-A28Q-01A-11D-A16C-01 TCGA-BH-A2L8-01 LumA TCGA-BH-A2L8-01 Kirc+ C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-BH-A2L8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-BH-A2L8-F39616 TCGA-BH-A2L8 TCGA-BH-A2L8-01A Positive Positive Other NO -16658 86 0 612 NO 70-79% 2013-1-28 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 210 NO Negative Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-BH-A2L8.B232BEE4-8579-4E26-B45C-8A5BFC0CEDBD.pdf A2L8 TUMOR FREE Oncotype Dx test Oncotype Dx test YES YES 80-89% NO Primary Tumor 01 TOTAL MASTECTOMY 7th YES NO BH Breast A LIVING 2011 c55bb0b8-3417-4142-97f8-c43f1ec56496 c55bb0b8-3417-4142-97f8-c43f1ec56496 TCGA-BH-A2L8-01A-21-A24A-20 TCGA-BH-A2L8-01 TCGA-BH-A2L8-01A-11D-A18O-05 0c505acf-0d07-4d38-a4cb-ad0311c255b3 TCGA-BH-A2L8-01 TCGA-BH-A2L8-01A-11D-A18P-09 TCGA-BH-A2L8-01 c55bb0b8-3417-4142-97f8-c43f1ec56496 TCGA-BH-A2L8-01A-11D-A18N-01 TCGA-BH-A2L8-01 c55bb0b8-3417-4142-97f8-c43f1ec56496 TCGA-BH-A2L8-01A-11D-A18N-01 TCGA-BH-A42T-01 TCGA-BH-A42T-01 TCGA-BH-A42T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Left Sentinel node biopsy alone TCGA-BH-A42T-F61922 TCGA-BH-A42T TCGA-BH-A42T-01A Positive Positive Simple Mastectomy -27731 80 320 0 30 2014-7-10 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 130 NO Positive Equivocal NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No M0 N0 (i+) T2 Stage IIA TCGA-BH-A42T.3FFD87C3-1E75-4A8E-AA26-BF7995E42245.pdf A42T TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO BH Breast A DECEASED 2012 59b2f0cb-4789-4642-9aa6-605a1ebb0e32 59b2f0cb-4789-4642-9aa6-605a1ebb0e32 TCGA-BH-A42T-01 TCGA-BH-A42T-01A-11D-A244-05 be2031ff-59ba-4ee0-aa0e-9831692a949f TCGA-BH-A42T-01 TCGA-BH-A42T-01A-11D-A243-09 TCGA-BH-A42T-01 59b2f0cb-4789-4642-9aa6-605a1ebb0e32 TCGA-BH-A42T-01A-11D-A242-01 TCGA-BH-A42T-01 59b2f0cb-4789-4642-9aa6-605a1ebb0e32 TCGA-BH-A42T-01A-11D-A242-01 TCGA-BH-A42U-01 TCGA-BH-A42U-01 TCGA-BH-A42U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Right TCGA-BH-A42U-F61923 TCGA-BH-A42U TCGA-BH-A42U-01A Negative Negative Simple Mastectomy -29330 3080 0 3364 2014-7-10 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 290 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No M0 N0 T2 Stage IIA TCGA-BH-A42U.25F791D8-27D6-4DC6-8D96-5D5CF68A5F13.pdf A42U TUMOR FREE NO YES NO Primary Tumor 01 6th YES NO BH Breast A LIVING 2004 b3ce7ee4-fc5e-445c-b1ca-5f324b33678a b3ce7ee4-fc5e-445c-b1ca-5f324b33678a TCGA-BH-A42U-01 TCGA-BH-A42U-01A-12D-A244-05 6bab8423-84c9-41ec-88f7-5efcfcc1ab30 TCGA-BH-A42U-01 TCGA-BH-A42U-01A-12D-A243-09 TCGA-BH-A42U-01 b3ce7ee4-fc5e-445c-b1ca-5f324b33678a TCGA-BH-A42U-01A-12D-A242-01 TCGA-BH-A42U-01 b3ce7ee4-fc5e-445c-b1ca-5f324b33678a TCGA-BH-A42U-01A-12D-A242-01 TCGA-BH-A42V-01 TCGA-BH-A42V-01 TCGA-BH-A42V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-BH-A42V-F61941 TCGA-BH-A42V TCGA-BH-A42V-01A Negative Positive Other Positive Modified Radical Mastectomy Reexcision of segmental mastectomy -15158 197 0 635 2014-7-10 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 60 NO Negative NO 3 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 true No M0 N1mi T1c Stage IB TCGA-BH-A42V.5BB5CEFD-CC07-4451-A774-25FB146067C7.pdf A42V TUMOR FREE NO YES YES Primary Tumor 01 7th YES NO BH Breast A LIVING 2012 2fa59be9-ecde-49b2-b109-7000d5180847 2fa59be9-ecde-49b2-b109-7000d5180847 TCGA-BH-A42V-01 TCGA-BH-A42V-01A-11D-A244-05 719aaf42-d96b-466f-b6ac-40439aec2138 TCGA-BH-A42V-01 TCGA-BH-A42V-01A-11D-A243-09 TCGA-BH-A42V-01 2fa59be9-ecde-49b2-b109-7000d5180847 TCGA-BH-A42V-01A-11D-A242-01 TCGA-BH-A42V-01 2fa59be9-ecde-49b2-b109-7000d5180847 TCGA-BH-A42V-01A-11D-A242-01 TCGA-BH-A5IZ-01 TCGA-BH-A5IZ-01 TCGA-BH-A5IZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left TCGA-BH-A5IZ-F63663 TCGA-BH-A5IZ TCGA-BH-A5IZ-01A Positive Negative Lumpectomy -18927 140 0 567 2014-8-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 70 NO Negative Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No cM0 (i+) N1a T2 Stage IIB TCGA-BH-A5IZ.52B5D974-2653-44CA-937D-5467EE39938B.pdf A5IZ TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO BH Breast A LIVING 2012 39033a17-79c9-4723-9fa7-fa82f67f5344 39033a17-79c9-4723-9fa7-fa82f67f5344 TCGA-BH-A5IZ-01 TCGA-BH-A5IZ-01A-11D-A27Y-05 TCGA-BH-A5IZ-01 TCGA-BH-A5IZ-01A-11D-A27P-09 TCGA-BH-A5IZ-01 39033a17-79c9-4723-9fa7-fa82f67f5344 TCGA-BH-A5IZ-01A-11D-A27O-01 TCGA-BH-A5IZ-01 39033a17-79c9-4723-9fa7-fa82f67f5344 TCGA-BH-A5IZ-01A-11D-A27O-01 TCGA-BH-A5J0-01 TCGA-BH-A5J0-01 TCGA-BH-A5J0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left TCGA-BH-A5J0-F63664 TCGA-BH-A5J0 Positive Positive Simple Mastectomy -23072 0 715 2014-8-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T1c Stage IA A5J0 TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO BH Breast LIVING 2012 a5f14d53-fe35-494e-b6b1-bc5c8484e4a9 a5f14d53-fe35-494e-b6b1-bc5c8484e4a9 TCGA-BH-A5J0-01 TCGA-BH-A5J0-01A-11D-A27Y-05 TCGA-BH-A5J0-01 TCGA-BH-A5J0-01A-11D-A27P-09 TCGA-BH-A5J0-01 a5f14d53-fe35-494e-b6b1-bc5c8484e4a9 TCGA-BH-A5J0-01A-11D-A27O-01 TCGA-BH-A5J0-01 a5f14d53-fe35-494e-b6b1-bc5c8484e4a9 TCGA-BH-A5J0-01A-11D-A27O-01 TCGA-BH-A6R8-01 TCGA-BH-A6R8-01 TCGA-BH-A6R8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left TCGA-BH-A6R8-F63677 TCGA-BH-A6R8 TCGA-BH-A6R8-01A Positive Positive Lumpectomy -16829 260 0 293 2014-8-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Negative NO 4 Negative NO 0 true No M0 N0 T2 Stage IIA TCGA-BH-A6R8.BF07FF13-D7EE-40E1-9729-8F9CCBD1534F.pdf A6R8 TUMOR FREE NO YES YES Primary Tumor 01 7th YES NO BH Breast A LIVING 2012 2bea5d05-bcad-4a2e-8954-462b589a8aa4 2bea5d05-bcad-4a2e-8954-462b589a8aa4 TCGA-BH-A6R8-01 TCGA-BH-A6R8-01A-21D-A33F-05 C23EA212-403F-44F3-B3BC-8F07229D7006 TCGA-BH-A6R8-01 TCGA-BH-A6R8-01 2bea5d05-bcad-4a2e-8954-462b589a8aa4 TCGA-BH-A6R8-01A-21D-A33D-01 TCGA-BH-A6R8-01 2bea5d05-bcad-4a2e-8954-462b589a8aa4 TCGA-BH-A6R8-01A-21D-A33D-01 TCGA-BH-A6R9-01 TCGA-BH-A6R9-01 TCGA-BH-A6R9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left TCGA-BH-A6R9-F63678 TCGA-BH-A6R9 TCGA-BH-A6R9-01A Negative Positive Modified Radical Mastectomy -22325 237 0 160 2014-8-15 FEMALE Metaplastic Carcinoma No C50.9 8575/3 C50.9 YES Core needle biopsy 220 NO Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No M0 N0 T2 Stage IIA TCGA-BH-A6R9.1DB8FAFB-FC4A-4401-8316-30FB5352335D.pdf A6R9 TUMOR FREE NO NO Primary Tumor 01 7th YES NO BH Breast A LIVING 2012 7c73dae6-4478-4cbc-aee1-0b18e730f7a2 7c73dae6-4478-4cbc-aee1-0b18e730f7a2 TCGA-BH-A6R9-01 TCGA-BH-A6R9-01A-21D-A32T-05 8C499FE0-D3D8-41FD-9E45-679C3403942C TCGA-BH-A6R9-01 TCGA-BH-A6R9-01 7c73dae6-4478-4cbc-aee1-0b18e730f7a2 TCGA-BH-A6R9-01A-21D-A32H-01 TCGA-BH-A6R9-01 7c73dae6-4478-4cbc-aee1-0b18e730f7a2 TCGA-BH-A6R9-01A-21D-A32H-01 TCGA-BH-A8FY-01 TCGA-BH-A8FY-01 TCGA-BH-A8FY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 87 Left|Left Upper Outer Quadrant|Left Lower Outer Quadrant TCGA-BH-A8FY TCGA-BH-A8FY-01A Positive Positive Simple Mastectomy -31932 477 295 0 2014-3-25 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 200 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true Yes M0 N0 (i+) T1c Stage IA TCGA-BH-A8FY.BC78EC6E-73C6-4234-9369-9A5586CD1A69.pdf A8FY TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO BH Breast A DECEASED 2012 f037b9d3-819b-429d-8e2d-fa8b27008e70 f037b9d3-819b-429d-8e2d-fa8b27008e70 TCGA-BH-A8FY-01 TCGA-BH-A8FY-01A-11D-A36K-05 12726541-C142-46CD-8AE1-763DAC0943B7 TCGA-BH-A8FY-01 TCGA-BH-A8FY-01 f037b9d3-819b-429d-8e2d-fa8b27008e70 TCGA-BH-A8FY-01A-11D-A36I-01 TCGA-BH-A8FY-01 f037b9d3-819b-429d-8e2d-fa8b27008e70 TCGA-BH-A8FY-01A-11D-A36I-01 TCGA-BH-A8FZ-01 TCGA-BH-A8FZ-01 TCGA-BH-A8FZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left TCGA-BH-A8FZ-F63679 TCGA-BH-A8FZ TCGA-BH-A8FZ-01A Positive Positive Simple Mastectomy -21343 468 0 574 2014-8-27 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 190 NO Equivocal NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T1b Stage IA TCGA-BH-A8FZ.A2B05D26-AC8E-4439-B32C-B48537D20836.pdf A8FZ TUMOR FREE NO YES YES Primary Tumor 01 7th YES NO BH Breast A LIVING 2012 2281c64c-9394-44f6-a4e7-87c7cce08c13 2281c64c-9394-44f6-a4e7-87c7cce08c13 TCGA-BH-A8FZ-01 TCGA-BH-A8FZ-01A-11D-A357-05 2B0ED842-B3E6-42E2-9A1E-7D4F96EF2E9D TCGA-BH-A8FZ-01 TCGA-BH-A8FZ-01 2281c64c-9394-44f6-a4e7-87c7cce08c13 TCGA-BH-A8FZ-01A-11D-A350-01 TCGA-BH-A8FZ-01 2281c64c-9394-44f6-a4e7-87c7cce08c13 TCGA-BH-A8FZ-01A-11D-A350-01 TCGA-BH-A8G0-01 TCGA-BH-A8G0-01 TCGA-BH-A8G0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left TCGA-BH-A8G0-F64200 TCGA-BH-A8G0 TCGA-BH-A8G0-01A Positive Positive Simple Mastectomy -19975 436 0 662 2014-8-27 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 110 NO Negative NO 3 Negative Peri (6-12 months since last menstrual period) NO 3 true No M0 N1a T2 Stage IIB TCGA-BH-A8G0.22134EA5-5ED5-47B8-9A33-01E59E58B54C.pdf A8G0 TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO BH Breast A LIVING 2012 8e9f7a7a-3115-4687-9fce-a97e4c3c9cde 8e9f7a7a-3115-4687-9fce-a97e4c3c9cde TCGA-BH-A8G0-01 TCGA-BH-A8G0-01A-11D-A357-05 A05330AE-C933-4E90-941C-2063295F9A7A TCGA-BH-A8G0-01 TCGA-BH-A8G0-01 8e9f7a7a-3115-4687-9fce-a97e4c3c9cde TCGA-BH-A8G0-01A-11D-A350-01 TCGA-BH-A8G0-01 8e9f7a7a-3115-4687-9fce-a97e4c3c9cde TCGA-BH-A8G0-01A-11D-A350-01 TCGA-BH-AB28-01 TCGA-BH-AB28-01 TCGA-BH-AB28 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left TCGA-BH-AB28-F64209 TCGA-BH-AB28 TCGA-BH-AB28-01A Positive Positive Modified Radical Mastectomy -19570 105 0 287 2015-2-25 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 440 NO Negative Indeterminate NO 20 Negative NO 3 true No M0 N1a T3 Stage IIIA TCGA-BH-AB28.3A87B5EE-D1AE-4D28-8F7A-3898AD4E0796.pdf AB28 TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO BH Breast A LIVING 2013 3cf4fddd-7fb5-4bb6-bca8-412019df4e2d 3cf4fddd-7fb5-4bb6-bca8-412019df4e2d TCGA-BH-AB28-01 TCGA-BH-AB28-01A-31D-A41Q-05 TCGA-BH-AB28-01 TCGA-BH-AB28-01 3cf4fddd-7fb5-4bb6-bca8-412019df4e2d TCGA-BH-AB28-01A-31D-A41E-01 TCGA-BH-AB28-01 3cf4fddd-7fb5-4bb6-bca8-412019df4e2d TCGA-BH-AB28-01A-31D-A41E-01 TCGA-C8-A12K-01 Stage IIB 80 1 No_Conversion 0 FEMALE Negative 2 2 2 Negative M0 Positive N1 0 0 Basal Basal-like Basal -13 -12 enrollment T_Other T2 LIVING TCGA-C8-A12K-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 3 mutation cluster 8 TCGA-C8-A12K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Right Upper Inner Quadrant Other (specify) Pateys surgery TCGA-C8-A12K TCGA-C8-A12K-01A Other NO -29463 57 0 0 2011-4-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 970 NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 1 true No M0 N1 T2 Stage IIB TCGA-C8-A12K.149E102C-FE01-4FC0-8410-CD9743CAFA15.pdf A12K TUMOR FREE Primary Tumor 01 Pateys surgery 6th YES NO C8 Breast A LIVING 2010 0ef00203-8a0a-4d04-aa1e-c1164958d8ec 0ef00203-8a0a-4d04-aa1e-c1164958d8ec TCGA-C8-A12K-01A-11-A13D-20 TCGA-C8-A12K-01A-21D-A10Y-09 TCGA-C8-A12K-01 5daae9b4-734a-479f-a414-50e0629a8598 TCGA-C8-A12K-01 TCGA-C8-A12K-01A-21D-A10Y-09 TCGA-C8-A12K-01A-21D-A112-05 TCGA-C8-A12K-01 TCGA-C8-A12K-01 TCGA-C8-A12K-01A-21D-A10Y-09 0ef00203-8a0a-4d04-aa1e-c1164958d8ec TCGA-C8-A12K-01A-21D-A111-01 TCGA-C8-A12K-01 TCGA-C8-A12K-01A-21R-A115-07 0ef00203-8a0a-4d04-aa1e-c1164958d8ec TCGA-C8-A12K-01A-21D-A111-01 TCGA-C8-A12K-01 TCGA-C8-A12L-01 Stage IIA 67 1 Stage IIA 0 Negative FEMALE Positive 1 1 1 Negative M0 Negative N0 0 0 Her2 HER2-enriched Negative Her2 -11 -9 enrollment T_Other T2 LIVING TCGA-C8-A12L-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-C8-A12L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Axillary lymph node dissection alone TCGA-C8-A12L-F20258 TCGA-C8-A12L TCGA-C8-A12L-01A Negative Negative Other -24710 62 0 363 Scheduled Follow-up Submission 2012-1-9 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Suregery Other method, specify: 460 NO Equivocal 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO true No M0 N0 (i-) T2 Stage IIA TCGA-C8-A12L.150DD5CB-1CA0-4110-95A7-6476B5B6FC24.pdf A12L TUMOR FREE NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 0a5a7511-4e7b-4fe4-b323-c354acffab57 0a5a7511-4e7b-4fe4-b323-c354acffab57 TCGA-C8-A12L-01A-21-A13D-20 TCGA-C8-A12L-01A-11D-A10Y-09 TCGA-C8-A12L-01 f9312b49-d0bf-45d8-b6b1-96b3752475e7 TCGA-C8-A12L-01 TCGA-C8-A12L-01A-11D-A10Y-09 TCGA-C8-A12L-01A-11D-A112-05 TCGA-C8-A12L-01 TCGA-C8-A12L-01 TCGA-C8-A12L-01A-11D-A10Y-09 0a5a7511-4e7b-4fe4-b323-c354acffab57 TCGA-C8-A12L-01A-11D-A111-01 TCGA-C8-A12L-01 TCGA-C8-A12L-01A-11R-A115-07 0a5a7511-4e7b-4fe4-b323-c354acffab57 TCGA-C8-A12L-01A-11D-A111-01 TCGA-C8-A12L-01 TCGA-C8-A12M-01 Stage IIA 70 5 Stage IIA 0 Positive FEMALE 4 1 4 Negative M0 Negative N0 0 0 LumB Luminal B Negative LumA/B -10 -5 enrollment T_Other T2 LIVING TCGA-C8-A12M-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-C8-A12M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Left Axillary lymph node dissection alone TCGA-C8-A12M-F19093 TCGA-C8-A12M TCGA-C8-A12M-01A Positive Negative Other -25811 57 0 358 Scheduled Follow-up Submission 2011-12-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 510 NO Negative 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO true No M0 N0 (i-) T2 Stage IIA TCGA-C8-A12M.76F67AA2-4E17-48F5-810B-E4F4338902DC.pdf A12M TUMOR FREE Allred Score 8 NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 8f007e7a-6260-4ecc-baff-f68665b760cb 8f007e7a-6260-4ecc-baff-f68665b760cb TCGA-C8-A12M-01A-21-A13D-20 TCGA-C8-A12M-01A-11D-A135-09 TCGA-C8-A12M-01 abdef80c-32bb-4620-95d2-16d985cd20f0 TCGA-C8-A12M-01 TCGA-C8-A12M-01A-11D-A135-09 TCGA-C8-A12M-01A-11D-A112-05 TCGA-C8-A12M-01 TCGA-C8-A12M-01 TCGA-C8-A12M-01A-11D-A135-09 8f007e7a-6260-4ecc-baff-f68665b760cb TCGA-C8-A12M-01A-11D-A111-01 TCGA-C8-A12M-01 TCGA-C8-A12M-01A-11R-A115-07 8f007e7a-6260-4ecc-baff-f68665b760cb TCGA-C8-A12M-01A-11D-A111-01 TCGA-C8-A12M-01 TCGA-C8-A12N-01 Stage IIA 58 4 Stage IIA 0 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 0 0 LumA Luminal A Positive ReacI -12 -3 enrollment T_Other T2 LIVING TCGA-C8-A12N-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-C8-A12N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Axillary lymph node dissection alone TCGA-C8-A12N-F20264 TCGA-C8-A12N TCGA-C8-A12N-01A Positive Positive Other -21428 57 0 358 Scheduled Follow-up Submission 2012-1-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 290 NO Negative 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO true No M0 N0 (i-) T2 Stage IIA TCGA-C8-A12N.A845013D-BF15-42FB-8BFE-FCE206E943FE.pdf A12N TUMOR FREE Allread Score 8 Allred Score 8 NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 9eb3306d-6c84-4bc1-be42-4bd00ef46cbb 9eb3306d-6c84-4bc1-be42-4bd00ef46cbb TCGA-C8-A12N-01A-21-A13D-20 TCGA-C8-A12N-01A-11D-A10Y-09 TCGA-C8-A12N-01 8e2ac007-601d-45c4-a94c-3cefb96b8f99 TCGA-C8-A12N-01 TCGA-C8-A12N-01A-11D-A10Y-09 TCGA-C8-A12N-01A-11D-A112-05 TCGA-C8-A12N-01 TCGA-C8-A12N-01 TCGA-C8-A12N-01A-11D-A10Y-09 9eb3306d-6c84-4bc1-be42-4bd00ef46cbb TCGA-C8-A12N-01A-11D-A111-01 TCGA-C8-A12N-01 TCGA-C8-A12N-01A-11R-A115-07 9eb3306d-6c84-4bc1-be42-4bd00ef46cbb TCGA-C8-A12N-01A-11D-A111-01 TCGA-C8-A12N-01 TCGA-C8-A12O-01 Stage IIA 50 Stage IIA 0 Positive FEMALE Negative M0 Negative N0 0 0 LumA Luminal A Positive Her2 -2 0 enrollment T_Other T2 LIVING TCGA-C8-A12O-01 C3-BRCA/Luminal cluster 1 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 13 TCGA-C8-A12O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Axillary lymph node dissection alone TCGA-C8-A12O-F20261 TCGA-C8-A12O TCGA-C8-A12O-01A Positive Positive Other -18506 57 0 385 Scheduled Follow-up Submission 2012-1-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 650 NO Negative 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO true No M0 N0 (i-) T2 Stage IIA TCGA-C8-A12O.273152AA-7B4C-4AE5-9231-1A3160058C74.pdf A12O TUMOR FREE Allred Score 7 Allred Score 7 NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 5efabaa8-f296-4c9c-9632-559ef7f6dd44 5efabaa8-f296-4c9c-9632-559ef7f6dd44 TCGA-C8-A12O-01A-21-A13D-20 TCGA-C8-A12O-01A-11D-A10Y-09 TCGA-C8-A12O-01 834cc759-8dcd-4d51-9570-aef1622b90e1 TCGA-C8-A12O-01 TCGA-C8-A12O-01A-11D-A10Y-09 TCGA-C8-A12O-01A-11D-A112-05 TCGA-C8-A12O-01 TCGA-C8-A12O-01 TCGA-C8-A12O-01A-11D-A10Y-09 5efabaa8-f296-4c9c-9632-559ef7f6dd44 TCGA-C8-A12O-01A-11D-A111-01 TCGA-C8-A12O-01 TCGA-C8-A12O-01A-11R-A115-07 5efabaa8-f296-4c9c-9632-559ef7f6dd44 TCGA-C8-A12O-01A-11D-A111-01 TCGA-C8-A12O-01 TCGA-C8-A12P-01 Stage IIB 55 3 No_Conversion 0 Negative FEMALE Positive 1 1 1 Negative M0 Positive N1 0 0 Her2 HER2-enriched Negative Her2 -11 -10 enrollment T_Other T2 LIVING TCGA-C8-A12P-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-C8-A12P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left TCGA-C8-A12P-F20267 TCGA-C8-A12P TCGA-C8-A12P-01A Negative Negative Other -20332 57 0 358 Scheduled Follow-up Submission 2012-1-9 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 380 NO Positive 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO true No M0 N1 T2 Stage IIB TCGA-C8-A12P.F04324BB-F0B1-4948-9189-7833646029F1.pdf A12P TUMOR FREE NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 9e30b9ee-391d-40d9-8eba-de47656f3629 9e30b9ee-391d-40d9-8eba-de47656f3629 TCGA-C8-A12P-01A-21-A13D-20 TCGA-C8-A12P-01A-11D-A10Y-09 TCGA-C8-A12P-01 a3b71b2e-5bb6-4585-95e7-6a2ddbf99659 TCGA-C8-A12P-01 TCGA-C8-A12P-01A-11D-A10Y-09 TCGA-C8-A12P-01A-11D-A112-05 TCGA-C8-A12P-01 TCGA-C8-A12P-01 TCGA-C8-A12P-01A-11D-A10Y-09 9e30b9ee-391d-40d9-8eba-de47656f3629 TCGA-C8-A12P-01A-11D-A111-01 TCGA-C8-A12P-01 TCGA-C8-A12P-01A-11R-A115-07 9e30b9ee-391d-40d9-8eba-de47656f3629 TCGA-C8-A12P-01A-11D-A111-01 TCGA-C8-A12P-01 TCGA-C8-A12Q-01 Stage IIIA 78 5 No_Conversion 0 Negative FEMALE Positive 1 1 1 Negative M0 Positive N2 0 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T1 T1 LIVING TCGA-C8-A12Q-01 High C3-BRCA/Luminal cluster 2 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-C8-A12Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO 78 Left Axillary lymph node dissection alone TCGA-C8-A12Q-F20253 TCGA-C8-A12Q TCGA-C8-A12Q-01A Negative Negative Other -28733 57 385 0 2 Scheduled Follow-up Submission 2012-1-9 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 810 NO Positive 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 Liver Distant Metastasis YES true No M0 N2 T1 Stage IIIA TCGA-C8-A12Q.90AF32F0-5684-4D5B-B619-2B12DA3823C6.pdf A12Q WITH TUMOR NO Primary Tumor 01 Pateys Surgery NO YES NO C8 Breast A DECEASED 2010 e042ea6d-3204-41a7-9811-25f4ac0c3558 e042ea6d-3204-41a7-9811-25f4ac0c3558 TCGA-C8-A12Q-01A-21-A13D-20 TCGA-C8-A12Q-01A-11D-A10Y-09 TCGA-C8-A12Q-01 588f723a-3e25-4cdc-91f6-36d00bb179e5 TCGA-C8-A12Q-01 TCGA-C8-A12Q-01A-11D-A10Y-09 TCGA-C8-A12Q-01A-11D-A112-05 TCGA-C8-A12Q-01 TCGA-C8-A12Q-01 TCGA-C8-A12Q-01A-11D-A10Y-09 e042ea6d-3204-41a7-9811-25f4ac0c3558 TCGA-C8-A12Q-01A-11D-A111-01 TCGA-C8-A12Q-01 TCGA-C8-A12Q-01A-11R-A115-07 e042ea6d-3204-41a7-9811-25f4ac0c3558 TCGA-C8-A12Q-01A-11D-A111-01 TCGA-C8-A12Q-01 TCGA-C8-A12T-01 Stage IIA 43 4 Stage IIA 0 Positive FEMALE Positive 1 1 1 Negative M0 Negative N0 0 0 Her2 HER2-enriched Positive ReacII -2 -1 enrollment T_Other T2 LIVING TCGA-C8-A12T-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-C8-A12T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Axillary lymph node dissection alone TCGA-C8-A12T TCGA-C8-A12T-01A Positive Positive Other NO 51 0 0 NO 2011-4-11 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 540 NO Positive 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 0 true No M0 N0 T2 Stage IIA TCGA-C8-A12T.4D751232-CD64-468E-AEBF-46F94FB6281F.pdf A12T TUMOR FREE Allred Score 8 Allred Score 6 YES Primary Tumor 01 Pateys Surgery 6th YES NO C8 Breast A LIVING 2010 c13962b2-674a-4edc-a7c8-c077ab86d198 c13962b2-674a-4edc-a7c8-c077ab86d198 TCGA-C8-A12T-01A-21-A13D-20 TCGA-C8-A12T-01A-11D-A10Y-09 TCGA-C8-A12T-01 08bd259e-9a37-4dd1-b97c-c67f288f833e TCGA-C8-A12T-01 TCGA-C8-A12T-01A-11D-A10Y-09 TCGA-C8-A12T-01A-11D-A112-05 TCGA-C8-A12T-01 TCGA-C8-A12T-01 TCGA-C8-A12T-01A-11D-A10Y-09 c13962b2-674a-4edc-a7c8-c077ab86d198 TCGA-C8-A12T-01A-11D-A111-01 TCGA-C8-A12T-01 TCGA-C8-A12T-01A-11R-A115-07 c13962b2-674a-4edc-a7c8-c077ab86d198 TCGA-C8-A12T-01A-11D-A111-01 TCGA-C8-A12T-01 TCGA-C8-A12U-01 Stage IB 46 5 Stage IIB 0 Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 0 0 LumB Luminal B Positive Basal -2 -5 enrollment T_Other T2 LIVING TCGA-C8-A12U-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 4 TCGA-C8-A12U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Axillary lymph node dissection alone TCGA-C8-A12U-F20249 TCGA-C8-A12U TCGA-C8-A12U-01A Positive Positive Other -17045 57 0 385 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 580 NO Negative 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 5 NO true No M0 N1 T2 Stage IIB TCGA-C8-A12U.B6428344-2D68-404B-AD9F-CA6E0B0552B2.pdf A12U TUMOR FREE Allred Score 3 Allred Score 5 YES NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 803bb42f-e0f2-44b6-aebb-8f956646ecc7 803bb42f-e0f2-44b6-aebb-8f956646ecc7 TCGA-C8-A12U-01A-21-A13D-20 TCGA-C8-A12U-01A-11D-A10Y-09 TCGA-C8-A12U-01 671835d4-23bb-4945-a62a-26d5f9094325 TCGA-C8-A12U-01 TCGA-C8-A12U-01A-11D-A10Y-09 TCGA-C8-A12U-01A-11D-A112-05 TCGA-C8-A12U-01 TCGA-C8-A12U-01 TCGA-C8-A12U-01A-11D-A10Y-09 803bb42f-e0f2-44b6-aebb-8f956646ecc7 TCGA-C8-A12U-01A-11D-A111-01 TCGA-C8-A12U-01 TCGA-C8-A12U-01A-11R-A115-07 803bb42f-e0f2-44b6-aebb-8f956646ecc7 TCGA-C8-A12U-01A-11D-A111-01 TCGA-C8-A12U-01 TCGA-C8-A12V-01 Stage IIA 55 1 Stage IIA 0 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 0 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-C8-A12V-01 BRCA-LUAD+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-C8-A12V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Axillary lymph node dissection alone TCGA-C8-A12V-F19095 TCGA-C8-A12V TCGA-C8-A12V-01A Negative Negative Other -20346 57 0 385 NO Scheduled Follow-up Submission 2011-12-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 540 NO Negative 5 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 NO 0 true No M0 N0 T2 Stage IIA TCGA-C8-A12V.8ED8A37B-C885-4333-AC5D-EA73A5A81173.pdf A12V TUMOR FREE YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 b12c9095-55c7-4add-9e22-3d65eeef2040 b12c9095-55c7-4add-9e22-3d65eeef2040 TCGA-C8-A12V-01A-21-A13D-20 TCGA-C8-A12V-01A-11D-A10Y-09 TCGA-C8-A12V-01 46c61ec3-e651-474c-8ce2-0cbced7cbca5 TCGA-C8-A12V-01 TCGA-C8-A12V-01A-11D-A10Y-09 TCGA-C8-A12V-01A-11D-A112-05 TCGA-C8-A12V-01 TCGA-C8-A12V-01 TCGA-C8-A12V-01A-11D-A10Y-09 b12c9095-55c7-4add-9e22-3d65eeef2040 TCGA-C8-A12V-01A-11D-A111-01 TCGA-C8-A12V-01 TCGA-C8-A12V-01A-11R-A115-07 b12c9095-55c7-4add-9e22-3d65eeef2040 TCGA-C8-A12V-01A-11D-A111-01 TCGA-C8-A12V-01 TCGA-C8-A12W-01 Stage IIIB 49 3 Stage IIIB 0 Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 0 0 LumB Luminal B Positive ReacII -2 -5 enrollment T_Other T4 LIVING TCGA-C8-A12W-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-C8-A12W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Axillary lymph node dissection alone TCGA-C8-A12W-F20244 TCGA-C8-A12W TCGA-C8-A12W-01A Positive Positive Other -18140 57 0 385 Scheduled Follow-up Submission 2012-1-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 890 NO Negative 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO true No M0 N1 T4 Stage IIIB TCGA-C8-A12W.8A64D890-ABEF-4AF2-8915-D17DA89B8FC5.pdf A12W TUMOR FREE Allred Score 6 Allred Score 7 YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 24e6e8f5-3caa-46f0-8915-7bd09f0736f9 24e6e8f5-3caa-46f0-8915-7bd09f0736f9 TCGA-C8-A12W-01A-21-A13D-20 TCGA-C8-A12W-01A-11D-A10Y-09 TCGA-C8-A12W-01 ee4be56e-b6c6-421f-ae10-fd129c8028df TCGA-C8-A12W-01 TCGA-C8-A12W-01A-11D-A10Y-09 TCGA-C8-A12W-01A-11D-A112-05 TCGA-C8-A12W-01 TCGA-C8-A12W-01 TCGA-C8-A12W-01A-11D-A10Y-09 24e6e8f5-3caa-46f0-8915-7bd09f0736f9 TCGA-C8-A12W-01A-11D-A111-01 TCGA-C8-A12W-01 TCGA-C8-A12W-01A-11R-A115-07 24e6e8f5-3caa-46f0-8915-7bd09f0736f9 TCGA-C8-A12W-01A-11D-A111-01 TCGA-C8-A12W-01 TCGA-C8-A12X-01 Stage IIB 62 4 Stage IIB 0 Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 0 0 LumA Luminal B Positive LumA/B -10 -3 enrollment T_Other T2 LIVING TCGA-C8-A12X-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-C8-A12X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Axillary lymph node dissection alone TCGA-C8-A12X-F19102 TCGA-C8-A12X TCGA-C8-A12X-01A Positive Positive Other -22889 57 0 385 NO Scheduled Follow-up Submission 2011-12-2 FEMALE 1+ Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Pateys Surgery Other method, specify: 410 NO Negative 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 NO true No M0 N1 T2 Stage IIB TCGA-C8-A12X.B3FCE052-931C-4798-A188-F04A2178A5F6.pdf A12X TUMOR FREE Allred Score 7 Allred Score 8 YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 2efa4fd0-1c0b-49c8-a11f-606d8618ec97 2efa4fd0-1c0b-49c8-a11f-606d8618ec97 TCGA-C8-A12X-01A-21-A13D-20 TCGA-C8-A12X-01A-11D-A10Y-09 TCGA-C8-A12X-01 b91a61e2-4b2e-4a9c-b79d-07570ae50cc3 TCGA-C8-A12X-01 TCGA-C8-A12X-01A-11D-A10Y-09 TCGA-C8-A12X-01A-11D-A112-05 TCGA-C8-A12X-01 TCGA-C8-A12X-01 TCGA-C8-A12X-01A-11D-A10Y-09 2efa4fd0-1c0b-49c8-a11f-606d8618ec97 TCGA-C8-A12X-01A-11D-A111-01 TCGA-C8-A12X-01 TCGA-C8-A12X-01A-11R-A115-07 2efa4fd0-1c0b-49c8-a11f-606d8618ec97 TCGA-C8-A12X-01A-11D-A111-01 TCGA-C8-A12X-01 TCGA-C8-A12Y-01 Stage IIB 44 2 Stage IIB 0 FEMALE Negative 3 3 3 Negative M0 Positive N1 0 0 LumA Luminal A LumA 0 -3 enrollment T_Other T2 LIVING TCGA-C8-A12Y-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-C8-A12Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left Axillary lymph node dissection alone TCGA-C8-A12Y-F70839 TCGA-C8-A12Y TCGA-C8-A12Y-01A Other 57 0 1476 NO 2015-3-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 380 NO NO 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO true No M0 N1 T2 Stage IIB TCGA-C8-A12Y.28E368DA-56B9-4BB1-99C3-7FF2CEC964CF.pdf A12Y TUMOR FREE YES YES YES Primary Tumor 01 Pateys Surgery 6th YES NO C8 Breast A LIVING 2010 ef42155a-112e-48fe-b52a-a99ebcd5f7f5 ef42155a-112e-48fe-b52a-a99ebcd5f7f5 TCGA-C8-A12Y-01A-21-A13D-20 TCGA-C8-A12Y-01A-11D-A12B-09 TCGA-C8-A12Y-01 1e9b9f3a-3fb5-4404-94e5-d22d4702391e TCGA-C8-A12Y-01 TCGA-C8-A12Y-01A-11D-A12B-09 TCGA-C8-A12Y-01A-11D-A12E-05 TCGA-C8-A12Y-01 TCGA-C8-A12Y-01 TCGA-C8-A12Y-01A-11D-A12B-09 ef42155a-112e-48fe-b52a-a99ebcd5f7f5 TCGA-C8-A12Y-01A-11D-A12A-01 TCGA-C8-A12Y-01 TCGA-C8-A12Y-01A-11R-A12D-07 ef42155a-112e-48fe-b52a-a99ebcd5f7f5 TCGA-C8-A12Y-01A-11D-A12A-01 TCGA-C8-A12Y-01 TCGA-C8-A12Z-01 Stage II 45 2 Stage IIB 0 Negative FEMALE Positive 1 1 1 Negative M0 Positive N1 0 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING TCGA-C8-A12Z-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-C8-A12Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Axillary lymph node dissection alone TCGA-C8-A12Z-F70810 TCGA-C8-A12Z TCGA-C8-A12Z-01A Negative Negative Negative Other -16508 69 0 382 NO 2015-3-9 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 490 NO Positive NO 2 Negative Peri (6-12 months since last menstrual period) 4 4 NO 2 true No M0 N1 T2 Stage IIB TCGA-C8-A12Z.89B312D1-9FDD-4756-9C15-5442B428F75A.pdf A12Z TUMOR FREE YES YES NO Primary Tumor 01 Pateys Surgery 6th YES NO C8 Breast A LIVING 2010 4018d26c-0ce0-4c5a-9ce4-200bb4273349 4018d26c-0ce0-4c5a-9ce4-200bb4273349 TCGA-C8-A12Z-01A-21-A13D-20 TCGA-C8-A12Z-01A-11D-A10Y-09 TCGA-C8-A12Z-01 76306f2d-c820-4442-966f-b79872d69025 TCGA-C8-A12Z-01 TCGA-C8-A12Z-01A-11D-A10Y-09 TCGA-C8-A12Z-01A-11D-A112-05 TCGA-C8-A12Z-01 TCGA-C8-A12Z-01 TCGA-C8-A12Z-01A-11D-A10Y-09 4018d26c-0ce0-4c5a-9ce4-200bb4273349 TCGA-C8-A12Z-01A-11D-A111-01 TCGA-C8-A12Z-01 TCGA-C8-A12Z-01A-11R-A115-07 4018d26c-0ce0-4c5a-9ce4-200bb4273349 TCGA-C8-A12Z-01A-11D-A111-01 TCGA-C8-A12Z-01 TCGA-C8-A130-01 Stage IIIA 52 1 Stage IIIA 0 Positive FEMALE Equivocal 1 1 1 Negative M0 Positive N2 0 0 LumB HER2-enriched Positive Her2 -2 0 enrollment T_Other T3 LIVING TCGA-C8-A130-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-C8-A130 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Axillary lymph node dissection alone TCGA-C8-A130-F70814 TCGA-C8-A130 TCGA-C8-A130-01A Positive Positive Other -19117 89 0 370 NO Scheduled Follow-up Submission 2015-3-9 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 550 NO Equivocal NO 8 Negative Peri (6-12 months since last menstrual period) 2 4 NO true No M0 N2 T3 Stage IIIA TCGA-C8-A130.3E24D3A0-9741-4635-89DB-EED4BA3F6AAA.pdf A130 TUMOR FREE Allred Score 7 Allred Score 7 [Discrepancy] YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 697dfcbf-0c6b-4cae-b851-d46dd6be42c9 697dfcbf-0c6b-4cae-b851-d46dd6be42c9 TCGA-C8-A130-01A-21-A13D-20 TCGA-C8-A130-01A-31D-A10Y-09 TCGA-C8-A130-01 62caa696-e8a5-46f6-b4c1-1baf5ae62bd4 TCGA-C8-A130-01 TCGA-C8-A130-01A-31D-A10Y-09 TCGA-C8-A130-01A-31D-A112-05 TCGA-C8-A130-01 TCGA-C8-A130-01 TCGA-C8-A130-01A-31D-A10Y-09 697dfcbf-0c6b-4cae-b851-d46dd6be42c9 TCGA-C8-A130-01A-31D-A111-01 TCGA-C8-A130-01 TCGA-C8-A130-01A-31R-A115-07 697dfcbf-0c6b-4cae-b851-d46dd6be42c9 TCGA-C8-A130-01A-31D-A111-01 TCGA-C8-A130-01 TCGA-C8-A131-01 Stage III 82 1 Stage IIIA 0 Negative FEMALE Negative 2 2 2 Negative M0 Positive N2 0 0 Basal Basal-like Negative ReacII -13 0 enrollment T_Other T2 LIVING TCGA-C8-A131-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 OV-like c4 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 2 TCGA-C8-A131 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 82 Left Axillary lymph node dissection alone TCGA-C8-A131-F70827 TCGA-C8-A131 TCGA-C8-A131-01A Negative Negative Other -29966 163 0 411 NO Scheduled Follow-up Submission 2015-3-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 460 NO Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 5 NO 4 true No M0 N2 T2 Stage IIIA TCGA-C8-A131.65C73797-1A8F-474D-94F6-45A2878B2C45.pdf A131 TUMOR FREE YES YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 5162ef6d-6978-4ff7-b385-a59325cefe17 5162ef6d-6978-4ff7-b385-a59325cefe17 TCGA-C8-A131-01A-21-A13D-20 TCGA-C8-A131-01A-11D-A10Y-09 TCGA-C8-A131-01 4a1fa1ef-67ab-4ea7-a650-5276030b04ee TCGA-C8-A131-01 TCGA-C8-A131-01A-11D-A10Y-09 TCGA-C8-A131-01A-11D-A112-05 TCGA-C8-A131-01 TCGA-C8-A131-01 TCGA-C8-A131-01A-11D-A10Y-09 5162ef6d-6978-4ff7-b385-a59325cefe17 TCGA-C8-A131-01A-11D-A111-01 TCGA-C8-A131-01 TCGA-C8-A131-01A-11R-A115-07 5162ef6d-6978-4ff7-b385-a59325cefe17 TCGA-C8-A131-01A-11D-A111-01 TCGA-C8-A131-01 TCGA-C8-A132-01 Stage II 56 5 Stage IIB 0 Positive FEMALE Positive 2 3 3 Negative M0 Positive N1 0 0 LumA Luminal A Positive Her2 -2 -4 enrollment T_Other T2 LIVING TCGA-C8-A132-01 Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 5 mutation c1uster 9 TCGA-C8-A132 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Axillary lymph node dissection alone TCGA-C8-A132-F70826 TCGA-C8-A132 TCGA-C8-A132-01A Positive Positive Other -20471 162 0 383 NO Scheduled Follow-up Submission 2015-3-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 420 NO NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 5 NO 1 true No M0 N1 T2 Stage IIB TCGA-C8-A132.175224E6-3A06-4799-B695-704C254A847C.pdf A132 TUMOR FREE Allred Score 7 Allred Score 8 [Discrepancy] YES NO Primary Tumor 01 Modified Radical Masectomy 6th YES YES NO C8 Breast A LIVING 2010 143e8620-56cc-4b65-a2aa-d793543f6854 143e8620-56cc-4b65-a2aa-d793543f6854 TCGA-C8-A132-01A-41-A13D-20 TCGA-C8-A132-01A-31D-A10Y-09 TCGA-C8-A132-01 4b907222-06fc-47d4-b425-b116df8162aa TCGA-C8-A132-01 TCGA-C8-A132-01A-31D-A10Y-09 TCGA-C8-A132-01A-31D-A112-05 TCGA-C8-A132-01 TCGA-C8-A132-01 TCGA-C8-A132-01A-31D-A10Y-09 143e8620-56cc-4b65-a2aa-d793543f6854 TCGA-C8-A132-01A-31D-A111-01 TCGA-C8-A132-01 TCGA-C8-A132-01A-31R-A115-07 143e8620-56cc-4b65-a2aa-d793543f6854 TCGA-C8-A132-01A-31D-A111-01 TCGA-C8-A132-01 TCGA-C8-A133-01 Stage IIIA 65 1 Stage IIIA 0 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 0 0 LumA Luminal A Positive LumA/B -12 -3 enrollment T_Other T3 LIVING TCGA-C8-A133-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-C8-A133 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Axillary lymph node dissection alone TCGA-C8-A133 TCGA-C8-A133-01A Positive Positive Modified Radical Mastectomy -23922 119 0 0 2011-4-15 FEMALE Other, specify No C50.9 8523/3 C50.9 YES Modified Radical Masectomy Other method, specify: 480 NO 26 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 true No M0 N1 T3 Stage IIIA TCGA-C8-A133.C47488B4-0E7E-46FB-91C6-0BEA58695974.pdf A133 TUMOR FREE Allred Score 8 Allred Score 8 YES Primary Tumor 01 6th YES NO C8 Breast A LIVING 2010 3028d15d-698a-4a23-8a09-a79221e28a62 3028d15d-698a-4a23-8a09-a79221e28a62 TCGA-C8-A133-01A-21-A13D-20 TCGA-C8-A133-01A-32D-A12B-09 TCGA-C8-A133-01 a4236581-7665-4520-84c9-16fb6fa8fd22 TCGA-C8-A133-01 TCGA-C8-A133-01A-32D-A12B-09 TCGA-C8-A133-01A-32D-A12E-05 TCGA-C8-A133-01 TCGA-C8-A133-01 TCGA-C8-A133-01A-32D-A12B-09 3028d15d-698a-4a23-8a09-a79221e28a62 TCGA-C8-A133-01A-32D-A12A-01 TCGA-C8-A133-01 TCGA-C8-A133-01A-32R-A12D-07 3028d15d-698a-4a23-8a09-a79221e28a62 TCGA-C8-A133-01A-32D-A12A-01 TCGA-C8-A133-01 TCGA-C8-A134-01 Stage IIA 52 1 No_Conversion 0 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 0 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-C8-A134-01 BRCA-LUAD+ C8-BLCA cluster 4 Cluster 6 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 5 cluster 6 mutation cluster 5 TCGA-C8-A134 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Axillary lymph node dissection alone TCGA-C8-A134-F70822 TCGA-C8-A134 Negative Negative Other -19010 0 383 Scheduled Follow-up Submission 2015-3-9 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal NO 7 Negative Peri (6-12 months since last menstrual period) 4 6 NO No M0 N0 T2 Stage IIA A134 TUMOR FREE YES NO Primary Tumor 01 Modified Radical Masectomy 6th YES YES NO C8 Breast LIVING 2010 d96863aa-33a8-43bf-a9b5-589de1e9cf44 d96863aa-33a8-43bf-a9b5-589de1e9cf44 TCGA-C8-A134-01A-21-A13D-20 TCGA-C8-A134-01A-11D-A10Y-09 TCGA-C8-A134-01 ec21c134-e0b1-44e4-be21-ff70c20ee979 TCGA-C8-A134-01 TCGA-C8-A134-01A-11D-A10Y-09 TCGA-C8-A134-01A-11D-A112-05 TCGA-C8-A134-01 TCGA-C8-A134-01 TCGA-C8-A134-01A-11D-A10Y-09 d96863aa-33a8-43bf-a9b5-589de1e9cf44 TCGA-C8-A134-01A-11D-A111-01 TCGA-C8-A134-01 TCGA-C8-A134-01A-11R-A115-07 d96863aa-33a8-43bf-a9b5-589de1e9cf44 TCGA-C8-A134-01A-11D-A111-01 TCGA-C8-A134-01 TCGA-C8-A135-01 Stage II 64 1 Stage IIB 0 Negative FEMALE Positive 2 2 1 Negative M0 Positive N1 0 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING TCGA-C8-A135-01 High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 7 mutation cluster 3 TCGA-C8-A135 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left Axillary lymph node dissection alone TCGA-C8-A135-F70817 TCGA-C8-A135 TCGA-C8-A135-01A Negative Negative Modified Radical Mastectomy -23667 162 0 393 NO Scheduled Follow-up Submission 2015-3-9 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 760 NO Positive NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 7 NO 1 true No M0 N1 T2 Stage IIB TCGA-C8-A135.7045ECC9-72B3-4AD3-A6C6-4F8C6914EAA1.pdf A135 TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES NO C8 Breast A LIVING 2010 306818e8-2e51-4dee-b27c-53ee9cea8d03 306818e8-2e51-4dee-b27c-53ee9cea8d03 TCGA-C8-A135-01A-21-A13D-20 TCGA-C8-A135-01A-11D-A10Y-09 TCGA-C8-A135-01 bded0f4f-068a-4577-a130-66b59f0bce47 TCGA-C8-A135-01 TCGA-C8-A135-01A-11D-A10Y-09 TCGA-C8-A135-01A-11D-A112-05 TCGA-C8-A135-01 TCGA-C8-A135-01 TCGA-C8-A135-01A-11D-A10Y-09 306818e8-2e51-4dee-b27c-53ee9cea8d03 TCGA-C8-A135-01A-11D-A111-01 TCGA-C8-A135-01 TCGA-C8-A135-01A-11R-A115-07 306818e8-2e51-4dee-b27c-53ee9cea8d03 TCGA-C8-A135-01A-11D-A111-01 TCGA-C8-A135-01 TCGA-C8-A137-01 Stage II 34 5 Stage IIB 3 Negative FEMALE Positive Negative M0 Positive N1 3 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING TCGA-C8-A137-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 mutation c1uster 9 TCGA-C8-A137 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES 34 Left Axillary lymph node dissection alone TCGA-C8-A137-F70815 TCGA-C8-A137 TCGA-C8-A137-01A Negative Negative Modified Radical Mastectomy -12729 102 0 379 136 NO Scheduled Follow-up Submission 2015-3-9 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 610 NO Positive NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 Locoregional Recurrence NO YES true No M0 N1 T2 Stage IIB TCGA-C8-A137.140F8918-739F-498A-9A17-B307E40E6060.pdf A137 WITH TUMOR [Discrepancy] YES NO Primary Tumor 01 6th YES YES NO C8 Breast A LIVING 2010 2c829af4-a6a7-48b1-9e48-a88be0564752 2c829af4-a6a7-48b1-9e48-a88be0564752 TCGA-C8-A137-01A-21-A13D-20 TCGA-C8-A137-01A-11D-A10Y-09 TCGA-C8-A137-01 b7d481d8-71b8-473b-802b-0457592d7054 TCGA-C8-A137-01 TCGA-C8-A137-01A-11D-A10Y-09 TCGA-C8-A137-01A-11D-A112-05 TCGA-C8-A137-01 TCGA-C8-A137-01 TCGA-C8-A137-01A-11D-A10Y-09 2c829af4-a6a7-48b1-9e48-a88be0564752 TCGA-C8-A137-01A-11D-A111-01 TCGA-C8-A137-01 TCGA-C8-A137-01A-11R-A115-07 2c829af4-a6a7-48b1-9e48-a88be0564752 TCGA-C8-A137-01A-11D-A111-01 TCGA-C8-A137-01 TCGA-C8-A138-01 Stage III 54 2 Stage IIIA 7 Positive FEMALE Positive 3 2 1 Negative M0 Positive N2 7 0 Her2 HER2-enriched Negative Basal -2 -5 enrollment T_Other T2 LIVING TCGA-C8-A138-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 5 TCGA-C8-A138 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Axillary lymph node dissection alone TCGA-C8-A138-F71893 TCGA-C8-A138 TCGA-C8-A138-01A Positive Negative Modified Radical Mastectomy -20053 93 0 380 NO Scheduled Follow-up Submission 2015-3-31 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 230 NO Equivocal NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 NO true No M0 N2 T2 Stage IIIA TCGA-C8-A138.3584F6CE-F9ED-441C-8714-BDF67C141CD6.pdf A138 TUMOR FREE Allred Score 5 YES YES NO Primary Tumor 01 6th NO YES NO C8 Breast A LIVING 2010 f543c792-d997-420a-8bf1-c45456b62a8b f543c792-d997-420a-8bf1-c45456b62a8b TCGA-C8-A138-01A-21-A13D-20 TCGA-C8-A138-01A-11D-A10Y-09 TCGA-C8-A138-01 5fa600b0-7ba1-45bf-be7d-8d60925dce68 TCGA-C8-A138-01 TCGA-C8-A138-01A-11D-A10Y-09 TCGA-C8-A138-01A-11D-A112-05 TCGA-C8-A138-01 TCGA-C8-A138-01 TCGA-C8-A138-01A-11D-A10Y-09 f543c792-d997-420a-8bf1-c45456b62a8b TCGA-C8-A138-01A-11D-A111-01 TCGA-C8-A138-01 TCGA-C8-A138-01A-11R-A115-07 f543c792-d997-420a-8bf1-c45456b62a8b TCGA-C8-A138-01A-11D-A111-01 TCGA-C8-A138-01 TCGA-C8-A1HE-01 Stage IIA 59 2 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumA Positive enrollment T_Other T2 LIVING TCGA-C8-A1HE-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-C8-A1HE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Axillary lymph node dissection alone TCGA-C8-A1HE-F20269 TCGA-C8-A1HE Positive Positive Other NO 0 375 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: Equivocal 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO No M0 N0 T2 Stage IIA A1HE TUMOR FREE Allred Score 4 Allred Score 7 YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast LIVING 2010 b5f56bfb-6fc1-448f-8c2b-4753084aaa00 b5f56bfb-6fc1-448f-8c2b-4753084aaa00 TCGA-C8-A1HE-01A-21-A17J-20 TCGA-C8-A1HE-01A-11D-A188-09 TCGA-C8-A1HE-01 TCGA-C8-A1HE-01A-11D-A13K-05 f1bdea64-1ae0-442f-83cd-00ae1531f9fb TCGA-C8-A1HE-01 TCGA-C8-A1HE-01A-11D-A188-09 TCGA-C8-A1HE-01 TCGA-C8-A1HE-01A-11D-A188-09 b5f56bfb-6fc1-448f-8c2b-4753084aaa00 TCGA-C8-A1HE-01A-11D-A13J-01 TCGA-C8-A1HE-01 b5f56bfb-6fc1-448f-8c2b-4753084aaa00 TCGA-C8-A1HE-01A-11D-A13J-01 TCGA-C8-A1HF-01 Stage IIA 48 2 Stage IIA 0 Negative FEMALE Positive Negative M0 Negative N0 0 0 Her2 HER2-enriched Positive -11 -5 enrollment T_Other T2 LIVING TCGA-C8-A1HF-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 3 TCGA-C8-A1HF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Axillary lymph node dissection alone TCGA-C8-A1HF-F19092 TCGA-C8-A1HF TCGA-C8-A1HF-01A Negative Positive Other NO 109 0 332 NO Scheduled Follow-up Submission 2011-12-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 460 NO Positive 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO true No M0 N0 T2 Stage IIA TCGA-C8-A1HF.40B07BB9-2CDB-463A-8773-771017E73DBC.pdf A1HF TUMOR FREE Allred Score 3 YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 62b06301-531d-4fc1-bb00-ede8e507e8f4 62b06301-531d-4fc1-bb00-ede8e507e8f4 TCGA-C8-A1HF-01A-21-A17J-20 TCGA-C8-A1HF-01A-11D-A135-09 TCGA-C8-A1HF-01 TCGA-C8-A1HF-01A-11D-A138-05 c95c9a7c-4192-4100-9452-5def84184e9c TCGA-C8-A1HF-01 TCGA-C8-A1HF-01A-11D-A135-09 TCGA-C8-A1HF-01 TCGA-C8-A1HF-01 TCGA-C8-A1HF-01A-11D-A135-09 62b06301-531d-4fc1-bb00-ede8e507e8f4 TCGA-C8-A1HF-01A-11D-A134-01 TCGA-C8-A1HF-01 TCGA-C8-A1HF-01A-11R-A137-07 62b06301-531d-4fc1-bb00-ede8e507e8f4 TCGA-C8-A1HF-01A-11D-A134-01 TCGA-C8-A1HF-01 TCGA-C8-A1HG-01 Stage IIA 50 4 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumB Luminal B Positive -2 -5 enrollment T_Other T2 LIVING TCGA-C8-A1HG-01 High C3-BRCA/Luminal cluster 5 Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 8 TCGA-C8-A1HG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Axillary lymph node dissection alone TCGA-C8-A1HG-F19096 TCGA-C8-A1HG TCGA-C8-A1HG-01A Positive Positive Other NO 122 0 345 NO Scheduled Follow-up Submission 2011-12-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 300 NO Negative Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO true No M0 N0 T2 Stage IIA TCGA-C8-A1HG.0813A175-83ED-4F6E-AD7D-FB4135CFF34C.pdf A1HG TUMOR FREE Allred Score 7 Allred Score 8 NO NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 094076d0-97e4-460d-b48c-7ee2371db99d 094076d0-97e4-460d-b48c-7ee2371db99d TCGA-C8-A1HG-01A-21-A17J-20 TCGA-C8-A1HG-01A-11D-A135-09 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01A-11D-A138-05 3ba46266-c84a-482f-abc7-8756831856e6 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01A-11D-A135-09 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01A-11D-A135-09 094076d0-97e4-460d-b48c-7ee2371db99d TCGA-C8-A1HG-01A-11D-A134-01 TCGA-C8-A1HG-01 TCGA-C8-A1HG-01A-11R-A137-07 094076d0-97e4-460d-b48c-7ee2371db99d TCGA-C8-A1HG-01A-11D-A134-01 TCGA-C8-A1HG-01 TCGA-C8-A1HI-01 Stage IIIA 40 2 Stage IIIA 2 Positive FEMALE Negative Negative M0 Positive N2 2 0 LumA Luminal A Positive -5 0 enrollment T_Other T2 LIVING TCGA-C8-A1HI-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-C8-A1HI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Axillary lymph node dissection alone TCGA-C8-A1HI-F19099 TCGA-C8-A1HI TCGA-C8-A1HI-01A Positive Positive Other 120 0 343 NO Scheduled Follow-up Submission 2011-12-2 FEMALE 1+ Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 490 NO Negative 6 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO true No M0 N2 T2 Stage IIIA TCGA-C8-A1HI.04EF4A48-80E1-4567-BB61-2B542F715266.pdf A1HI TUMOR FREE Allred Score 6 Allred Score 8 YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 994c96ec-ea0a-4741-8fef-53cdbfe28cfa 994c96ec-ea0a-4741-8fef-53cdbfe28cfa TCGA-C8-A1HI-01A-21-A17J-20 TCGA-C8-A1HI-01A-11D-A135-09 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01A-11D-A138-05 8e8a6562-23a5-48a7-a06e-efc30fab8f15 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01A-11D-A135-09 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01A-11D-A135-09 994c96ec-ea0a-4741-8fef-53cdbfe28cfa TCGA-C8-A1HI-01A-11D-A134-01 TCGA-C8-A1HI-01 TCGA-C8-A1HI-01A-11R-A137-07 994c96ec-ea0a-4741-8fef-53cdbfe28cfa TCGA-C8-A1HI-01A-11D-A134-01 TCGA-C8-A1HI-01 TCGA-C8-A1HJ-01 Stage II 53 1 Stage IIA 5 Negative FEMALE Negative Negative M0 Negative N0 5 0 Basal Negative enrollment T_Other T2 LIVING TCGA-C8-A1HJ-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 13 TCGA-C8-A1HJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Axillary lymph node dissection alone TCGA-C8-A1HJ TCGA-C8-A1HJ-01A Negative Negative Other -19629 121 0 5 NO 2011-6-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 1070 NO Negative 10 Negative Peri (6-12 months since last menstrual period) 5 5 true No M0 N0 T2 Stage IIA TCGA-C8-A1HJ.11F98715-1482-4D7D-9102-E362634806A7.pdf A1HJ TUMOR FREE YES Primary Tumor 01 Pateys Surgery 6th YES NO C8 Breast A LIVING 2010 c0dd6c33-008d-44e8-b20c-8089bc3e29a3 c0dd6c33-008d-44e8-b20c-8089bc3e29a3 TCGA-C8-A1HJ-01A-21-A17J-20 TCGA-C8-A1HJ-01A-11D-A13L-09 TCGA-C8-A1HJ-01 TCGA-C8-A1HJ-01A-11D-A13K-05 6528f6b1-d0f5-413c-a304-0fa218a132ac TCGA-C8-A1HJ-01 TCGA-C8-A1HJ-01A-11D-A13L-09 TCGA-C8-A1HJ-01 TCGA-C8-A1HJ-01A-11D-A13L-09 c0dd6c33-008d-44e8-b20c-8089bc3e29a3 TCGA-C8-A1HJ-01A-11D-A13J-01 TCGA-C8-A1HJ-01 c0dd6c33-008d-44e8-b20c-8089bc3e29a3 TCGA-C8-A1HJ-01A-11D-A13J-01 TCGA-C8-A1HK-01 Stage IIB 53 5 Stage IIB 7 Negative FEMALE Positive Negative M0 Positive N1 7 0 Her2 Negative enrollment T_Other T2 LIVING TCGA-C8-A1HK-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 5 TCGA-C8-A1HK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Axillary lymph node dissection alone TCGA-C8-A1HK-F19100 TCGA-C8-A1HK TCGA-C8-A1HK-01A Negative Negative Other 116 0 366 NO Scheduled Follow-up Submission 2011-12-2 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 460 NO Positive 8 Negative Peri (6-12 months since last menstrual period) 4 1 NO true No M0 N1 T2 Stage IIB TCGA-C8-A1HK.4D1B4A09-FB4E-45EC-895B-2941D18AED18.pdf A1HK TUMOR FREE YES NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c 83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c TCGA-C8-A1HK-01A-11-A17J-20 TCGA-C8-A1HK-01A-21D-A13L-09 TCGA-C8-A1HK-01 TCGA-C8-A1HK-01A-21D-A13K-05 5f7c521f-28b4-46ba-9d1e-a6bf55885d28 TCGA-C8-A1HK-01 TCGA-C8-A1HK-01A-21D-A13L-09 TCGA-C8-A1HK-01 TCGA-C8-A1HK-01A-21D-A13L-09 83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c TCGA-C8-A1HK-01A-21D-A13J-01 TCGA-C8-A1HK-01 83d9c730-9a1e-42b6-a1dd-6a57d0e24f2c TCGA-C8-A1HK-01A-21D-A13J-01 TCGA-C8-A1HL-01 Stage IIIA 38 5 Stage IIIA 2 Positive FEMALE Positive Negative M0 Positive N1 2 0 LumB Luminal B Negative -2 -3 enrollment T_Other T3 LIVING TCGA-C8-A1HL-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-C8-A1HL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Left Axillary lymph node dissection alone TCGA-C8-A1HL-F20266 TCGA-C8-A1HL TCGA-C8-A1HL-01A Positive Negative Other 94 0 317 NO Scheduled Follow-up Submission 2012-1-9 FEMALE 2+ Other, specify No C50.9 8480/3 C50.9 YES Pateys Surgery Other method, specify: 980 NO Equivocal 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 NO true Yes M0 N1 T3 Stage IIIA TCGA-C8-A1HL.ACA6B606-681C-427F-8923-77BAA7390795.pdf A1HL TUMOR FREE Allred Score 8 YES NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 9d80ba46-b65f-4338-99bc-370f8eaefe4e 9d80ba46-b65f-4338-99bc-370f8eaefe4e TCGA-C8-A1HL-01A-21-A17J-20 TCGA-C8-A1HL-01A-11D-A135-09 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01A-11D-A138-05 d026ab37-87a8-4486-a09d-0aabeba2dd89 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01A-11D-A135-09 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01A-11D-A135-09 9d80ba46-b65f-4338-99bc-370f8eaefe4e TCGA-C8-A1HL-01A-11D-A134-01 TCGA-C8-A1HL-01 TCGA-C8-A1HL-01A-11R-A137-07 9d80ba46-b65f-4338-99bc-370f8eaefe4e TCGA-C8-A1HL-01A-11D-A134-01 TCGA-C8-A1HL-01 TCGA-C8-A1HM-01 Stage II 74 3 Stage IIA 6 Positive FEMALE Negative Negative M0 Negative N0 6 0 LumB Luminal B Positive -2 -5 enrollment T_Other T2 LIVING TCGA-C8-A1HM-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 13 TCGA-C8-A1HM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Axillary lymph node dissection alone TCGA-C8-A1HM-F70806 TCGA-C8-A1HM Positive Positive Modified Radical Mastectomy -27063 0 375 NO Scheduled Follow-up Submission 2015-3-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO No M0 N0 T2 Stage IIA A1HM TUMOR FREE Allred Score 5 Allred Score 8 YES NO NO Primary Tumor 01 6th YES YES NO C8 Breast LIVING 2010 eb908a6f-d6f2-40ef-90da-97438cd2281e eb908a6f-d6f2-40ef-90da-97438cd2281e TCGA-C8-A1HM-01A-21-A17J-20 TCGA-C8-A1HM-01A-12D-A135-09 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01A-12D-A138-05 e15bb106-69e3-4af4-bd2f-9c9098aa34e3 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01A-12D-A135-09 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01A-12D-A135-09 eb908a6f-d6f2-40ef-90da-97438cd2281e TCGA-C8-A1HM-01A-12D-A134-01 TCGA-C8-A1HM-01 TCGA-C8-A1HM-01A-12R-A137-07 eb908a6f-d6f2-40ef-90da-97438cd2281e TCGA-C8-A1HM-01A-12D-A134-01 TCGA-C8-A1HM-01 TCGA-C8-A1HN-01 Stage II 56 Stage IIA 2 Positive FEMALE Equivocal Negative M0 Negative N0 2 0 LumB Luminal B Positive -10 -5 enrollment T_Other T2 LIVING TCGA-C8-A1HN-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-C8-A1HN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Axillary lymph node dissection alone TCGA-C8-A1HN-F71885 TCGA-C8-A1HN TCGA-C8-A1HN-01A Positive Positive Modified Radical Mastectomy -20712 88 0 394 NO Scheduled Follow-up Submission 2015-3-31 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Equivocal NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 7 NO true No M0 N0 T2 Stage IIA TCGA-C8-A1HN.4C7445ED-B346-4DD7-8AFA-2E95E65364BF.pdf A1HN TUMOR FREE Allred Score 3 Allred Score 8 YES NO NO Primary Tumor 01 6th YES YES NO C8 Breast A LIVING 2010 4795628e-50d8-41e0-b3c6-00fe4600dc5d 4795628e-50d8-41e0-b3c6-00fe4600dc5d TCGA-C8-A1HN-01A-21-A17J-20 TCGA-C8-A1HN-01A-11D-A135-09 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01A-11D-A138-05 4090fc73-565b-4fa8-96c9-958fcb8eda09 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01A-11D-A135-09 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01A-11D-A135-09 4795628e-50d8-41e0-b3c6-00fe4600dc5d TCGA-C8-A1HN-01A-11D-A134-01 TCGA-C8-A1HN-01 TCGA-C8-A1HN-01A-11R-A137-07 4795628e-50d8-41e0-b3c6-00fe4600dc5d TCGA-C8-A1HN-01A-11D-A134-01 TCGA-C8-A1HN-01 TCGA-C8-A1HO-01 Stage III 34 5 Stage IIIC 0 Positive FEMALE Negative Negative M0 Positive N3 0 0 LumA Positive enrollment T_Other T3 LIVING TCGA-C8-A1HO-01 Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-C8-A1HO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Left Upper Inner Quadrant TCGA-C8-A1HO-F70802 TCGA-C8-A1HO TCGA-C8-A1HO-01A Positive Positive [Discrepancy] -12715 52 0 375 2015-3-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 380 NO Negative NO Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 5 NO true No M0 N3 T3 Stage IIIC TCGA-C8-A1HO.24B1FA5C-7D84-4CE5-B094-2358ECE73C10.pdf A1HO TUMOR FREE Allred Score 5 Allred Score 7 YES NO NO Primary Tumor 01 6th YES NO C8 Breast A LIVING 2010 1d8ecbae-6996-4d9d-bff8-ac761a8309ea 1d8ecbae-6996-4d9d-bff8-ac761a8309ea TCGA-C8-A1HO-01A-21-A17J-20 TCGA-C8-A1HO-01A-11D-A13L-09 TCGA-C8-A1HO-01 TCGA-C8-A1HO-01A-11D-A13K-05 654028c2-038a-4cfb-95c6-13ad5000346d TCGA-C8-A1HO-01 TCGA-C8-A1HO-01A-11D-A13L-09 TCGA-C8-A1HO-01 TCGA-C8-A1HO-01A-11D-A13L-09 1d8ecbae-6996-4d9d-bff8-ac761a8309ea TCGA-C8-A1HO-01A-11D-A13J-01 TCGA-C8-A1HO-01 1d8ecbae-6996-4d9d-bff8-ac761a8309ea TCGA-C8-A1HO-01A-11D-A13J-01 TCGA-C8-A26V-01 Stage III 47 1 Stage IIIA 9 Positive FEMALE Negative Negative M0 Positive N2 9 0 LumB Positive enrollment T_Other T3 LIVING TCGA-C8-A26V-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 mutation cluster 8 TCGA-C8-A26V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right TCGA-C8-A26V-F70799 TCGA-C8-A26V TCGA-C8-A26V-01A Positive Positive Modified Radical Mastectomy -17468 143 0 616 2015-3-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Modified Radical Masectomy Other method, specify: 310 NO Negative NO Negative Peri (6-12 months since last menstrual period) 4 NO true No M0 N2 T3 Stage IIIA TCGA-C8-A26V.929AB6C9-58B0-4E37-A2B4-9FC1F9099437.pdf A26V TUMOR FREE Allred Score 8 Allred Score 8 YES NO YES Primary Tumor 01 6th YES NO C8 Breast A LIVING 2010 67a58c72-fa64-4c63-b568-bec834626edf 67a58c72-fa64-4c63-b568-bec834626edf TCGA-C8-A26V-01A-21-A17K-20 TCGA-C8-A26V-01A-11D-A16D-09 TCGA-C8-A26V-01 TCGA-C8-A26V-01A-11D-A16G-05 a8d7929f-263f-4277-be5e-f01eadc08bc3 TCGA-C8-A26V-01 TCGA-C8-A26V-01A-11D-A16D-09 TCGA-C8-A26V-01 TCGA-C8-A26V-01A-11D-A16D-09 67a58c72-fa64-4c63-b568-bec834626edf TCGA-C8-A26V-01A-11D-A16C-01 TCGA-C8-A26V-01 67a58c72-fa64-4c63-b568-bec834626edf TCGA-C8-A26V-01A-11D-A16C-01 TCGA-C8-A26W-01 Stage II 58 1 Stage IIB 7 Positive FEMALE Positive Negative M0 Positive N1 7 0 LumB Positive enrollment T_Other T2 LIVING TCGA-C8-A26W-01 Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 mutation cluster 8 TCGA-C8-A26W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Outer Quadrant TCGA-C8-A26W-F70796 TCGA-C8-A26W TCGA-C8-A26W-01A Positive Positive Modified Radical Mastectomy -21391 142 0 381 2015-3-9 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 300 NO Equivocal NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO true No M0 N1 T2 Stage IIB TCGA-C8-A26W.0F1DC8BC-5987-4C50-9A34-79FFC1D2BA30.pdf A26W TUMOR FREE Allred Score 8 Allred Score 8 YES NO NO Primary Tumor 01 6th YES NO C8 Breast A LIVING 2010 bd304a35-2d0c-4b11-bd62-3db480c1e730 bd304a35-2d0c-4b11-bd62-3db480c1e730 TCGA-C8-A26W-01A-21-A17K-20 TCGA-C8-A26W-01A-11D-A16D-09 TCGA-C8-A26W-01 TCGA-C8-A26W-01A-11D-A16G-05 4c5440c5-3eb7-4bfc-a5e7-51e1a55aa219 TCGA-C8-A26W-01 TCGA-C8-A26W-01A-11D-A16D-09 TCGA-C8-A26W-01 TCGA-C8-A26W-01A-11D-A16D-09 bd304a35-2d0c-4b11-bd62-3db480c1e730 TCGA-C8-A26W-01A-11D-A16C-01 TCGA-C8-A26W-01 bd304a35-2d0c-4b11-bd62-3db480c1e730 TCGA-C8-A26W-01A-11D-A16C-01 TCGA-C8-A26X-01 Stage II 58 4 Stage IIA 11 Negative FEMALE Negative Negative M0 Positive N1 11 0 Her2 Negative enrollment T1 T1 LIVING TCGA-C8-A26X-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 mutation cluster 3 TCGA-C8-A26X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant TCGA-C8-A26X-F70792 TCGA-C8-A26X TCGA-C8-A26X-01A Negative Negative Modified Radical Mastectomy -21463 136 0 376 2015-3-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 190 NO Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO true No M0 N1 T1 Stage IIA TCGA-C8-A26X.8C845114-BBC6-45F2-9135-7E8298E24422.pdf A26X TUMOR FREE YES NO NO Primary Tumor 01 6th YES NO C8 Breast A LIVING 2010 5213da80-35ac-4172-b2e8-de686e73a498 5213da80-35ac-4172-b2e8-de686e73a498 TCGA-C8-A26X-01A-41-A17K-20 TCGA-C8-A26X-01A-31D-A16D-09 TCGA-C8-A26X-01 TCGA-C8-A26X-01A-31D-A16G-05 6a344715-e7bd-49b5-9ca7-0e1060a19710 TCGA-C8-A26X-01 TCGA-C8-A26X-01A-31D-A16D-09 TCGA-C8-A26X-01 TCGA-C8-A26X-01A-31D-A16D-09 5213da80-35ac-4172-b2e8-de686e73a498 TCGA-C8-A26X-01A-31D-A16C-01 TCGA-C8-A26X-01 5213da80-35ac-4172-b2e8-de686e73a498 TCGA-C8-A26X-01A-31D-A16C-01 TCGA-C8-A26Y-01 Stage II 90 2 Stage IIA 13 Negative FEMALE Negative Negative M0 Negative N0 13 0 Her2 Negative enrollment T_Other T2 LIVING TCGA-C8-A26Y-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-C8-A26Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Left Upper Outer Quadrant TCGA-C8-A26Y-F70791 TCGA-C8-A26Y TCGA-C8-A26Y-01A Negative Negative Modified Radical Mastectomy -32872 134 0 394 2015-3-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 140 NO Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO true No M0 N0 T2 Stage IIA TCGA-C8-A26Y.B660432A-A67B-40CC-89F8-80648DB8AE98.pdf A26Y TUMOR FREE NO NO NO Primary Tumor 01 6th YES NO C8 Breast A LIVING 2010 afad9647-befe-4493-8386-475d0097c716 afad9647-befe-4493-8386-475d0097c716 TCGA-C8-A26Y-01A-21-A17K-20 TCGA-C8-A26Y-01 TCGA-C8-A26Y-01A-11D-A16G-05 4cf610ef-12f6-4149-ab0b-d0211e9642a6 TCGA-C8-A26Y-01 TCGA-C8-A26Y-01A-11D-A16D-09 TCGA-C8-A26Y-01 afad9647-befe-4493-8386-475d0097c716 TCGA-C8-A26Y-01A-11D-A16C-01 TCGA-C8-A26Y-01 afad9647-befe-4493-8386-475d0097c716 TCGA-C8-A26Y-01A-11D-A16C-01 TCGA-C8-A26Z-01 Stage IIA 59 3 Stage IIA 4 Positive FEMALE Negative Negative M0 Negative N0 4 0 LumA Positive enrollment T_Other T2 LIVING TCGA-C8-A26Z-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 mutation c1uster 9 TCGA-C8-A26Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Upper Inner Quadrant TCGA-C8-A26Z-F70835 TCGA-C8-A26Z TCGA-C8-A26Z-01A Positive Positive Other 125 0 470 NO Scheduled Follow-up Submission 2015-3-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 470 NO Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO true No M0 N0 T2 Stage IIA TCGA-C8-A26Z.5E21E07E-BD5F-4AC7-985A-178416D756E2.pdf A26Z TUMOR FREE Allred Score 4 Allred Score 8 YES NO NO Primary Tumor 01 Pateys Surgery 6th NO YES NO C8 Breast A LIVING 2010 8213eb8c-db23-4f92-b3d3-07b45eeec76a 8213eb8c-db23-4f92-b3d3-07b45eeec76a TCGA-C8-A26Z-01A-21-A17K-20 TCGA-C8-A26Z-01A-11D-A16D-09 TCGA-C8-A26Z-01 TCGA-C8-A26Z-01A-11D-A16G-05 fb0eeacf-e38d-42f7-85b5-215ceed54e69 TCGA-C8-A26Z-01 TCGA-C8-A26Z-01A-11D-A16D-09 TCGA-C8-A26Z-01 TCGA-C8-A26Z-01A-11D-A16D-09 8213eb8c-db23-4f92-b3d3-07b45eeec76a TCGA-C8-A26Z-01A-11D-A16C-01 TCGA-C8-A26Z-01 8213eb8c-db23-4f92-b3d3-07b45eeec76a TCGA-C8-A26Z-01A-11D-A16C-01 TCGA-C8-A273-01 Stage IIB 29 3 Stage IIB 6 Positive FEMALE Negative Negative M0 Positive N1 6 0 LumA Positive enrollment T_Other T2 LIVING TCGA-C8-A273-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation c1uster 9 TCGA-C8-A273 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 29 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-C8-A273-F70833 TCGA-C8-A273 TCGA-C8-A273-01A Positive Positive Other 168 0 513 Scheduled Follow-up Submission 2015-3-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 590 NO Negative NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 2 true No M0 N1 T2 Stage IIB TCGA-C8-A273.EAB9E75C-2795-4D83-9806-5019DC14256E.pdf A273 TUMOR FREE Allred Score 5 Allred Score 8 YES YES NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa TCGA-C8-A273-01A-21-A17K-20 TCGA-C8-A273-01A-11D-A16D-09 TCGA-C8-A273-01 TCGA-C8-A273-01A-11D-A16G-05 67662a35-222b-4c66-a105-86e9332fc019 TCGA-C8-A273-01 TCGA-C8-A273-01A-11D-A16D-09 TCGA-C8-A273-01 TCGA-C8-A273-01A-11D-A16D-09 c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa TCGA-C8-A273-01A-11D-A16C-01 TCGA-C8-A273-01 c2e4eb91-bc79-4c8a-beef-4c5abc61d2fa TCGA-C8-A273-01A-11D-A16C-01 TCGA-C8-A274-01 Stage IIA 63 2 Stage IIA 1 Positive FEMALE Negative Negative M0 Negative N0 1 0 LumB Positive enrollment T_Other T2 LIVING TCGA-C8-A274-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 mutation cluster 1 TCGA-C8-A274 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right TCGA-C8-A274-F70831 TCGA-C8-A274 TCGA-C8-A274-01A Positive Positive Other -23337 163 0 508 Scheduled Follow-up Submission 2015-3-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 470 NO Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO true No M0 N0 T2 Stage IIA TCGA-C8-A274.A7FAA4F2-1846-48CF-9FB5-15E98430F6CE.pdf A274 TUMOR FREE Allred Score 7 Allred Score 8 YES NO NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 f9521be2-aaaf-414c-a906-3ba53a060614 f9521be2-aaaf-414c-a906-3ba53a060614 TCGA-C8-A274-01A-21-A17K-20 TCGA-C8-A274-01A-11D-A16D-09 TCGA-C8-A274-01 TCGA-C8-A274-01A-11D-A16G-05 99762a09-75aa-4d91-8911-2f259e4f4f40 TCGA-C8-A274-01 TCGA-C8-A274-01A-11D-A16D-09 TCGA-C8-A274-01 TCGA-C8-A274-01A-11D-A16D-09 f9521be2-aaaf-414c-a906-3ba53a060614 TCGA-C8-A274-01A-11D-A16C-01 TCGA-C8-A274-01 f9521be2-aaaf-414c-a906-3ba53a060614 TCGA-C8-A274-01A-11D-A16C-01 TCGA-C8-A275-01 Stage IIA 56 3 Stage IIA 1 FEMALE Positive Negative M0 Positive N1 1 0 Her2 enrollment T1 T1 LIVING TCGA-C8-A275-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 5 TCGA-C8-A275 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant TCGA-C8-A275 TCGA-C8-A275-01A Other -20774 169 0 1 2011-7-21 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 300 NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 true No M0 N1 T1 Stage IIA TCGA-C8-A275.BDE9E2A9-09E9-49BC-AFBE-BD32916972DC.pdf A275 TUMOR FREE NO Primary Tumor 01 Pateys Surgery 6th YES NO C8 Breast A LIVING 2010 59c6ed76-762c-4caa-98c1-0886b6d9651c 59c6ed76-762c-4caa-98c1-0886b6d9651c TCGA-C8-A275-01A-11-A17K-20 TCGA-C8-A275-01A-21D-A16D-09 TCGA-C8-A275-01 TCGA-C8-A275-01A-21D-A16G-05 46fbe024-54ed-49b2-9492-98b4f59c8f51 TCGA-C8-A275-01 TCGA-C8-A275-01A-21D-A16D-09 TCGA-C8-A275-01 TCGA-C8-A275-01A-21D-A16D-09 59c6ed76-762c-4caa-98c1-0886b6d9651c TCGA-C8-A275-01A-21D-A16C-01 TCGA-C8-A275-01 59c6ed76-762c-4caa-98c1-0886b6d9651c TCGA-C8-A275-01A-21D-A16C-01 TCGA-C8-A278-01 Stage IIIA 61 4 Stage IIIA 1 Negative FEMALE Positive Negative M0 Positive N2 1 0 Her2 Negative enrollment T_Other T2 LIVING TCGA-C8-A278-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 mutation cluster 3 TCGA-C8-A278 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left TCGA-C8-A278-F20278 TCGA-C8-A278 TCGA-C8-A278-01A Negative Negative Other -22598 163 0 297 Scheduled Follow-up Submission 2012-1-9 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Pateys Surgery Other method, specify: 630 NO Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO true No M0 N2 T2 Stage IIIA TCGA-C8-A278.4F3E197A-9731-427C-A2AB-2D506A1C717B.pdf A278 TUMOR FREE NO NO Primary Tumor 01 Pateys Surgery 6th YES YES NO C8 Breast A LIVING 2010 8cdae811-9f3f-4c8b-9fe5-e542d30d40f2 8cdae811-9f3f-4c8b-9fe5-e542d30d40f2 TCGA-C8-A278-01A-21-A17K-20 TCGA-C8-A278-01A-11D-A167-09 TCGA-C8-A278-01 TCGA-C8-A278-01A-11D-A16A-05 0b7b4dce-2a48-489f-aa4d-68af0d749a17 TCGA-C8-A278-01 TCGA-C8-A278-01A-11D-A167-09 TCGA-C8-A278-01 TCGA-C8-A278-01A-11D-A167-09 8cdae811-9f3f-4c8b-9fe5-e542d30d40f2 TCGA-C8-A278-01A-11D-A166-01 TCGA-C8-A278-01 8cdae811-9f3f-4c8b-9fe5-e542d30d40f2 TCGA-C8-A278-01A-11D-A166-01 TCGA-C8-A27A-01 Stage IIB 48 4 Stage IIB 371 Positive FEMALE Negative Negative M0 Positive N1 371 0 LumB Positive enrollment T_Other T2 LIVING TCGA-C8-A27A-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-C8-A27A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Outer Quadrant TCGA-C8-A27A-F70786 TCGA-C8-A27A TCGA-C8-A27A-01A Positive Positive Modified Radical Mastectomy -17779 435 0 747 2015-3-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 230 NO Negative NO Negative Peri (6-12 months since last menstrual period) 3 5 NO true No M0 N1 T2 Stage IIB TCGA-C8-A27A.4CC1413A-5D03-4BE4-91E5-80B578CE7DFA.pdf A27A TUMOR FREE Allred Score 7 YES NO NO Primary Tumor 01 6th YES NO C8 Breast A LIVING 2010 520a6569-bf3a-495f-9460-7f65e4f59687 520a6569-bf3a-495f-9460-7f65e4f59687 TCGA-C8-A27A-01A-21-A17K-20 TCGA-C8-A27A-01A-11D-A167-09 TCGA-C8-A27A-01 TCGA-C8-A27A-01A-11D-A16A-05 6e6b5e9d-fbb0-480b-9300-d9ecdbbde2b7 TCGA-C8-A27A-01 TCGA-C8-A27A-01A-11D-A167-09 TCGA-C8-A27A-01 TCGA-C8-A27A-01A-11D-A167-09 520a6569-bf3a-495f-9460-7f65e4f59687 TCGA-C8-A27A-01A-11D-A166-01 TCGA-C8-A27A-01 520a6569-bf3a-495f-9460-7f65e4f59687 TCGA-C8-A27A-01A-11D-A166-01 TCGA-C8-A27B-01 Stage IIB 48 1 Stage IIB 30 Negative FEMALE Negative Negative M0 Negative N0 30 0 Basal Negative enrollment T_Other T3 LIVING TCGA-C8-A27B-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 13 TCGA-C8-A27B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left TCGA-C8-A27B-F70781 TCGA-C8-A27B TCGA-C8-A27B-01A Negative Negative Modified Radical Mastectomy -17763 93 0 439 2015-3-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 240 NO Negative NO Negative Peri (6-12 months since last menstrual period) 5 5 NO true No M0 N0 T3 Stage IIB TCGA-C8-A27B.CD43BA31-A5C6-4C0C-AA07-3171332776CC.pdf A27B TUMOR FREE YES NO NO Primary Tumor 01 6th YES NO C8 Breast A LIVING 2011 fb03a31f-6611-4343-816d-37a332147eac fb03a31f-6611-4343-816d-37a332147eac TCGA-C8-A27B-01A-21-A17K-20 TCGA-C8-A27B-01A-11D-A167-09 TCGA-C8-A27B-01 TCGA-C8-A27B-01A-11D-A16A-05 14732205-f21b-44fc-9e31-7d8f9dde67df TCGA-C8-A27B-01 TCGA-C8-A27B-01A-11D-A167-09 TCGA-C8-A27B-01 TCGA-C8-A27B-01A-11D-A167-09 fb03a31f-6611-4343-816d-37a332147eac TCGA-C8-A27B-01A-11D-A166-01 TCGA-C8-A27B-01 fb03a31f-6611-4343-816d-37a332147eac TCGA-C8-A27B-01A-11D-A166-01 TCGA-C8-A3M7-01 LumA TCGA-C8-A3M7-01 Iq C3-BRCA/Luminal BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-C8-A3M7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 60 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-C8-A3M7-F70838 TCGA-C8-A3M7 Negative Negative Modified Radical Mastectomy NO -22096 1034 0 1 1034 NO 2015-3-9 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Locoregional Recurrence NO YES 0 No M0 N0 T4b Stage IIIB A3M7 WITH TUMOR YES YES YES Primary Tumor 01 7th YES NO C8 Breast DECEASED 2010 b55b6630-7cf5-4bca-b76f-e135271018e4 b55b6630-7cf5-4bca-b76f-e135271018e4 TCGA-C8-A3M7-01A-21-A24A-20 TCGA-C8-A3M7-01 TCGA-C8-A3M7-01A-12D-A21R-05 c07c21cd-c286-4fd3-b98a-886e161a6ead TCGA-C8-A3M7-01 TCGA-C8-A3M7-01A-12D-A21Q-09 TCGA-C8-A3M7-01 b55b6630-7cf5-4bca-b76f-e135271018e4 TCGA-C8-A3M7-01A-12D-A21P-01 TCGA-C8-A3M7-01 b55b6630-7cf5-4bca-b76f-e135271018e4 TCGA-C8-A3M7-01A-12D-A21P-01 TCGA-C8-A3M8-01 LumB TCGA-C8-A3M8-01 High C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-C8-A3M8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-C8-A3M8-F70779 TCGA-C8-A3M8 TCGA-C8-A3M8-01A Positive Positive Modified Radical Mastectomy NO -24877 264 0 394 NO 2015-3-9 FEMALE 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 280 NO Positive NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No M0 N0 T1c Stage IA TCGA-C8-A3M8.25CD89AC-052F-4B9F-AE1C-B0824A7A5145.pdf A3M8 TUMOR FREE Dako Allred Allred YES YES NO Primary Tumor 01 7th YES NO C8 Breast A LIVING 2011 a04ad65d-6d83-4e84-8bd8-3cab2a195642 a04ad65d-6d83-4e84-8bd8-3cab2a195642 TCGA-C8-A3M8-01A-21-A24A-20 TCGA-C8-A3M8-01 TCGA-C8-A3M8-01A-11D-A212-05 45db31fd-5919-4580-8641-31aec5565486 TCGA-C8-A3M8-01 TCGA-C8-A3M8-01A-11D-A20S-09 TCGA-C8-A3M8-01 a04ad65d-6d83-4e84-8bd8-3cab2a195642 TCGA-C8-A3M8-01A-11D-A20R-01 TCGA-C8-A3M8-01 a04ad65d-6d83-4e84-8bd8-3cab2a195642 TCGA-C8-A3M8-01A-11D-A20R-01 TCGA-C8-A8HP-01 TCGA-C8-A8HP-01 TCGA-C8-A8HP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-C8-A8HP-F69610 TCGA-C8-A8HP TCGA-C8-A8HP-01A Negative Negative Modified Radical Mastectomy -21613 231 0 396 2015-1-15 FEMALE Metaplastic Carcinoma No C50.9 8575/3 C50.9 YES Core needle biopsy 240 NO Positive NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 6 true No M0 N2 T2 Stage IIIA TCGA-C8-A8HP.581088D6-9F9C-4572-B61D-BAF0F6C79B2F.pdf A8HP TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO C8 Breast A LIVING 2013 02cf1db9-55c0-4ece-b230-966b30cd0b94 02cf1db9-55c0-4ece-b230-966b30cd0b94 TCGA-C8-A8HP-01 TCGA-C8-A8HP-01A-11D-A36K-05 0D8764CE-08F0-4612-886E-07065119924F TCGA-C8-A8HP-01 TCGA-C8-A8HP-01 02cf1db9-55c0-4ece-b230-966b30cd0b94 TCGA-C8-A8HP-01A-11D-A36I-01 TCGA-C8-A8HP-01 02cf1db9-55c0-4ece-b230-966b30cd0b94 TCGA-C8-A8HP-01A-11D-A36I-01 TCGA-C8-A8HQ-01 TCGA-C8-A8HQ-01 TCGA-C8-A8HQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Axillary lymph node dissection alone TCGA-C8-A8HQ-F69879 TCGA-C8-A8HQ TCGA-C8-A8HQ-01A Positive Positive Modified Radical Mastectomy NO -19432 185 0 380 2015-1-22 FEMALE Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Core needle biopsy 300 NO Negative NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 3 4 true No M0 N1 T2 Stage IIB TCGA-C8-A8HQ.37FA6CD0-E789-44EA-AD78-C195CBB1EDE3.pdf A8HQ TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO C8 Breast A LIVING 2013 7f8c9d62-0803-44d6-9375-b4e71612a0b1 7f8c9d62-0803-44d6-9375-b4e71612a0b1 TCGA-C8-A8HQ-01 TCGA-C8-A8HQ-01A-11D-A36K-05 39E9AC4D-F0C1-4629-9C69-09C72747A2E8 TCGA-C8-A8HQ-01 TCGA-C8-A8HQ-01 7f8c9d62-0803-44d6-9375-b4e71612a0b1 TCGA-C8-A8HQ-01A-11D-A36I-01 TCGA-C8-A8HQ-01 7f8c9d62-0803-44d6-9375-b4e71612a0b1 TCGA-C8-A8HQ-01A-11D-A36I-01 TCGA-C8-A8HR-01 TCGA-C8-A8HR-01 TCGA-C8-A8HR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Axillary lymph node dissection alone TCGA-C8-A8HR-F69796 TCGA-C8-A8HR TCGA-C8-A8HR-01A Modified Radical Mastectomy NO -17921 162 0 408 2015-1-20 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 420 NO NO 8 Negative Peri (6-12 months since last menstrual period) NO 5 true No M0 N2 T3 Stage IIIA TCGA-C8-A8HR.CA1E5192-ABB0-45E6-8547-2BA2B035238C.pdf A8HR TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO C8 Breast A LIVING 2013 d817dcee-1322-4949-a6e9-138447e6fc56 d817dcee-1322-4949-a6e9-138447e6fc56 TCGA-C8-A8HR-01 TCGA-C8-A8HR-01A-11D-A36K-05 D888CD95-8F1F-48DE-8DDC-70C9AD64579F TCGA-C8-A8HR-01 TCGA-C8-A8HR-01 d817dcee-1322-4949-a6e9-138447e6fc56 TCGA-C8-A8HR-01A-11D-A36I-01 TCGA-C8-A8HR-01 d817dcee-1322-4949-a6e9-138447e6fc56 TCGA-C8-A8HR-01A-11D-A36I-01 TCGA-C8-A9FZ-01 TCGA-C8-A9FZ-01 TCGA-C8-A9FZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Axillary lymph node dissection alone TCGA-C8-A9FZ-F69966 TCGA-C8-A9FZ TCGA-C8-A9FZ-01A Modified Radical Mastectomy NO -18038 191 0 592 2015-1-23 FEMALE Mixed Histology (please specify) Infiltrating Tubulo-Lobular Carcinoma No C50.9 8524/3 C50.9 YES Core needle biopsy 280 NO Negative NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 3 true No M0 N1 T2 Stage IIB TCGA-C8-A9FZ.23B3BAED-E281-4A1D-AB78-51D8D62466FF.pdf A9FZ TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO C8 Breast A LIVING 2013 TCGA-C8-A9FZ-01A-11D-A41Q-05 7E0EFE5A-8C0A-4B7F-950D-9F0CFFB57F01 TCGA-C8-A9FZ-01 TCGA-C8-A9FZ-01A-11D-A41E-01 TCGA-C8-A9FZ-01 TCGA-C8-A9FZ-01A-11D-A41E-01 TCGA-D8-A13Y-01 Stage IA 52 5 No_Conversion 362 Positive FEMALE Negative 3 2 4 Negative M0 Negative N0 362 0 LumB Luminal B Positive Basal -2 -6 followup T1 T1 LIVING TCGA-D8-A13Y-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 GBM-like c6 miRNA cluster 6 cluster 1 mutation cluster 2 TCGA-D8-A13Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A13Y-F72210 TCGA-D8-A13Y TCGA-D8-A13Y-01A Positive Positive Modified Radical Mastectomy NO -19028 184 0 1728 manual counting 70-79% Scheduled Follow-up Submission 2015-4-29 FEMALE Hecep Test TM DAKO 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 430 NO Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 NO 0 false No M0 N0 T1c Stage IA TCGA-D8-A13Y.0CF5DE3C-272C-4127-8047-4359D1278181.pdf A13Y TUMOR FREE manual counting 10-75% 10-75% YES 70-79% NO Primary Tumor 01 YES YES NO D8 Breast A LIVING 2010 9a92e20a-2a43-4917-981d-c93179770050 9a92e20a-2a43-4917-981d-c93179770050 TCGA-D8-A13Y-01A-21-A13D-20 TCGA-D8-A13Y-01A-11D-A10Y-09 TCGA-D8-A13Y-01 664694fa-7bea-4f87-b6ff-4df52540d15b TCGA-D8-A13Y-01 TCGA-D8-A13Y-01A-11D-A10Y-09 TCGA-D8-A13Y-01A-11D-A112-05 TCGA-D8-A13Y-01 TCGA-D8-A13Y-01 TCGA-D8-A13Y-01A-11D-A10Y-09 9a92e20a-2a43-4917-981d-c93179770050 TCGA-D8-A13Y-01A-11D-A111-01 TCGA-D8-A13Y-01 TCGA-D8-A13Y-01A-11R-A115-07 9a92e20a-2a43-4917-981d-c93179770050 TCGA-D8-A13Y-01A-11D-A111-01 TCGA-D8-A13Y-01 TCGA-D8-A13Z-01 Stage X 51 1 Stage IIIA 210 Negative FEMALE Negative 2 2 1 Negative M0 Positive N2 210 0 Her2 HER2-enriched Negative Basal -13 -10 enrollment T_Other T2 LIVING TCGA-D8-A13Z-01 High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-D8-A13Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A13Z-F20731 TCGA-D8-A13Z TCGA-D8-A13Z-01A Negative Negative Modified Radical Mastectomy -18942 214 0 635 Scheduled Follow-up Submission 2012-1-14 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 470 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 9 false No M0 N2a T2 TCGA-D8-A13Z.8EFA6C19-2FA1-4F23-AF7B-15681E8E930A.pdf A13Z TUMOR FREE Hercep Test TM Dako YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 624ac458-8ff1-441c-a8c5-aaf4a08a4b84 624ac458-8ff1-441c-a8c5-aaf4a08a4b84 TCGA-D8-A13Z-01A-21-A13D-20 TCGA-D8-A13Z-01A-11D-A10Y-09 TCGA-D8-A13Z-01 ecffe473-31aa-41e3-a964-ca96147a8023 TCGA-D8-A13Z-01 TCGA-D8-A13Z-01A-11D-A10Y-09 TCGA-D8-A13Z-01A-11D-A112-05 TCGA-D8-A13Z-01 TCGA-D8-A13Z-01 TCGA-D8-A13Z-01A-11D-A10Y-09 624ac458-8ff1-441c-a8c5-aaf4a08a4b84 TCGA-D8-A13Z-01A-11D-A111-01 TCGA-D8-A13Z-01 TCGA-D8-A13Z-01A-11R-A115-07 624ac458-8ff1-441c-a8c5-aaf4a08a4b84 TCGA-D8-A13Z-01A-11D-A111-01 TCGA-D8-A13Z-01 TCGA-D8-A140-01 Stage IIB 62 Stage IIB 403 Positive FEMALE Positive Negative M0 Positive N1 403 0 LumA Luminal B Positive LumA/B -10 -5 followup T_Other T2 LIVING TCGA-D8-A140-01 C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-D8-A140 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant|Left Axillary lymph node dissection alone TCGA-D8-A140-F13808 TCGA-D8-A140 TCGA-D8-A140-01A Positive Positive Modified Radical Mastectomy NO -22900 204 0 403 manual counting Scheduled Follow-up Submission 2011-6-20 FEMALE Hercep Test TM DAKO 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 400 NO Positive 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 6 NO 1 false No M0 N1a T2 Stage IIB TCGA-D8-A140.D78476E6-799F-4DED-A219-CBFE2DE3C77B.pdf A140 TUMOR FREE manual counting <10% >75% YES <10% NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 116f1b9d-8c0c-4b29-b9b2-06ea186f4480 116f1b9d-8c0c-4b29-b9b2-06ea186f4480 TCGA-D8-A140-01A-21-A13D-20 TCGA-D8-A140-01A-11D-A10Y-09 TCGA-D8-A140-01 ce3b8c9f-acd7-4ba7-8042-3a3de6225cde TCGA-D8-A140-01 TCGA-D8-A140-01A-11D-A10Y-09 TCGA-D8-A140-01A-11D-A112-05 TCGA-D8-A140-01 TCGA-D8-A140-01 TCGA-D8-A140-01A-11D-A10Y-09 116f1b9d-8c0c-4b29-b9b2-06ea186f4480 TCGA-D8-A140-01A-11D-A111-01 TCGA-D8-A140-01 TCGA-D8-A140-01A-11R-A115-07 116f1b9d-8c0c-4b29-b9b2-06ea186f4480 TCGA-D8-A140-01A-11D-A111-01 TCGA-D8-A140-01 TCGA-D8-A141-01 Stage X 40 2 Stage IIA 113 Positive FEMALE Negative Negative M0 Positive N1 113 0 LumA Luminal A Positive -5 -4 enrollment T1 T1 LIVING TCGA-D8-A141-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A141 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Axillary lymph node dissection alone TCGA-D8-A141-F20734 TCGA-D8-A141 Positive Positive Modified Radical Mastectomy -14626 0 626 manual counting Scheduled Follow-up Submission 2012-1-14 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative 15 Negative Indeterminate (neither Pre or Postmenopausal) 1 4 NO 1 No M0 N1 T1c A141 TUMOR FREE manual counting Hercep Test TM Dako >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2010 cb6c668a-ff24-4ebe-99f7-0c24fcf17c32 cb6c668a-ff24-4ebe-99f7-0c24fcf17c32 TCGA-D8-A141-01A-11D-A10Y-09 TCGA-D8-A141-01 TCGA-D8-A141-01 TCGA-D8-A141-01A-11D-A10Y-09 TCGA-D8-A141-01A-11D-A112-05 TCGA-D8-A141-01 TCGA-D8-A141-01 TCGA-D8-A141-01A-11D-A10Y-09 cb6c668a-ff24-4ebe-99f7-0c24fcf17c32 TCGA-D8-A141-01A-11D-A111-01 TCGA-D8-A141-01 TCGA-D8-A141-01A-11R-A115-07 cb6c668a-ff24-4ebe-99f7-0c24fcf17c32 TCGA-D8-A141-01A-11D-A111-01 TCGA-D8-A141-01 TCGA-D8-A142-01 Stage IIB 74 1 Stage IIB 425 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 425 0 Basal Basal-like Negative X -13 0 followup T_Other T3 LIVING TCGA-D8-A142-01 High C4-BRCA/Basal cluster 5 Cluster 5 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 cluster 3 mutation cluster 5 TCGA-D8-A142 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Lower Outer Quadrant|Left Axillary lymph node dissection alone TCGA-D8-A142-F13813 TCGA-D8-A142 TCGA-D8-A142-01A Negative Negative Modified Radical Mastectomy NO -27313 212 0 425 Scheduled Follow-up Submission 2011-6-20 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 490 NO Equivocal Negative 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 NO 0 false No M0 N0 T3 Stage IIB TCGA-D8-A142.7D2C880F-6897-44A0-9470-5A5B5429A9C0.pdf A142 TUMOR FREE FISH YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 9f440cd6-d55f-4cb6-a433-637ef1f9d38f 9f440cd6-d55f-4cb6-a433-637ef1f9d38f TCGA-D8-A142-01A-21-A13D-20 TCGA-D8-A142-01A-11D-A10Y-09 TCGA-D8-A142-01 d434b104-6d07-417e-9a84-c729c071cf14 TCGA-D8-A142-01 TCGA-D8-A142-01A-11D-A10Y-09 TCGA-D8-A142-01A-11D-A112-05 TCGA-D8-A142-01 TCGA-D8-A142-01 TCGA-D8-A142-01A-11D-A10Y-09 9f440cd6-d55f-4cb6-a433-637ef1f9d38f TCGA-D8-A142-01A-11D-A111-01 TCGA-D8-A142-01 TCGA-D8-A142-01A-11R-A115-07 9f440cd6-d55f-4cb6-a433-637ef1f9d38f TCGA-D8-A142-01A-11D-A111-01 TCGA-D8-A142-01 TCGA-D8-A143-01 Stage IIA 51 3 Stage IIA 431 Negative FEMALE Negative Negative M0 Negative N0 431 0 Basal Basal-like Negative Basal -13 0 followup T_Other T2 LIVING TCGA-D8-A143-01 High C3-BRCA/Luminal cluster 5 BRCA CIMP c7 squamous c3 BRCA nonbasal-like c7 mutation cluster 3 TCGA-D8-A143 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-D8-A143-F13817 TCGA-D8-A143 TCGA-D8-A143-01A Negative Negative Modified Radical Mastectomy NO -18984 211 0 431 Scheduled Follow-up Submission 2011-7-4 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 0 false No M0 N0 T2 Stage IIA TCGA-D8-A143.F8C2F3EF-FA73-4FF8-9A4E-7F557E68D560.pdf A143 TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 4bf5f56d-448a-426a-8edc-f1bdbf6a8d55 4bf5f56d-448a-426a-8edc-f1bdbf6a8d55 TCGA-D8-A143-01A-21-A13D-20 TCGA-D8-A143-01A-11D-A10Y-09 TCGA-D8-A143-01 e9cd47fb-4a8f-44c9-af6a-f931387d14a7 TCGA-D8-A143-01 TCGA-D8-A143-01A-11D-A10Y-09 TCGA-D8-A143-01A-11D-A112-05 TCGA-D8-A143-01 TCGA-D8-A143-01 TCGA-D8-A143-01A-11D-A10Y-09 4bf5f56d-448a-426a-8edc-f1bdbf6a8d55 TCGA-D8-A143-01A-11D-A111-01 TCGA-D8-A143-01 TCGA-D8-A143-01A-11R-A115-07 4bf5f56d-448a-426a-8edc-f1bdbf6a8d55 TCGA-D8-A143-01A-11D-A111-01 TCGA-D8-A143-01 TCGA-D8-A145-01 Stage IIA 80 1 Stage IIA 410 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 410 0 LumA Luminal A Positive ReacI -5 -7 followup T1 T1 LIVING TCGA-D8-A145-01 COAD-READ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-D8-A145 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Right Upper Inner Quadrant|Right Sentinel lymph node biopsy plus axillary dissection TCGA-D8-A145-F13811 TCGA-D8-A145 TCGA-D8-A145-01A Positive Positive Simple Mastectomy NO -29280 191 0 410 manual counting Scheduled Follow-up Submission 2011-7-4 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 190 NO Equivocal Negative 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 1 false No M0 N1a T1c Stage IIA TCGA-D8-A145.1D26CB97-536A-4D10-A593-73C3A846BB13.pdf A145 TUMOR FREE manual counting >75% YES <10% NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 6223244a-ed38-46b5-8e65-cc8e4926c809 6223244a-ed38-46b5-8e65-cc8e4926c809 TCGA-D8-A145-01A-21-A13D-20 TCGA-D8-A145-01A-11D-A10Y-09 TCGA-D8-A145-01 c734c71e-bd11-4c7c-862a-1d578d1951b1 TCGA-D8-A145-01 TCGA-D8-A145-01A-11D-A10Y-09 TCGA-D8-A145-01A-11D-A112-05 TCGA-D8-A145-01 TCGA-D8-A145-01 TCGA-D8-A145-01A-11D-A10Y-09 6223244a-ed38-46b5-8e65-cc8e4926c809 TCGA-D8-A145-01A-11D-A111-01 TCGA-D8-A145-01 TCGA-D8-A145-01A-11R-A115-07 6223244a-ed38-46b5-8e65-cc8e4926c809 TCGA-D8-A145-01A-11D-A111-01 TCGA-D8-A145-01 TCGA-D8-A146-01 Stage IIA 57 Stage IIA 344 Positive FEMALE Negative Negative M0 Negative N0 344 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A146-01 Iq C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 4 TCGA-D8-A146 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Upper Outer Quadrant|Right Axillary lymph node dissection alone TCGA-D8-A146-F20750 TCGA-D8-A146 TCGA-D8-A146-01A Positive Positive Modified Radical Mastectomy NO -20861 221 0 643 NO manual counting Scheduled Follow-up Submission 2012-1-15 FEMALE DAKO Hercep Test TM 1+ Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 230 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false Yes MX N0 T2 Stage IIA TCGA-D8-A146.79749F5D-329A-400D-8511-C4CF479C1FCC.pdf A146 TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 69f535c7-8f70-4efc-98bc-7f99924d7db1 69f535c7-8f70-4efc-98bc-7f99924d7db1 TCGA-D8-A146-01A-21-A13D-20 TCGA-D8-A146-01A-31D-A10Y-09 TCGA-D8-A146-01 9953ddb6-cba3-4fd0-9917-42071efaabdb TCGA-D8-A146-01 TCGA-D8-A146-01A-31D-A10Y-09 TCGA-D8-A146-01A-31D-A112-05 TCGA-D8-A146-01 TCGA-D8-A146-01A-31D-A10Y-09 69f535c7-8f70-4efc-98bc-7f99924d7db1 TCGA-D8-A146-01A-31D-A111-01 TCGA-D8-A146-01A-31R-A115-07 69f535c7-8f70-4efc-98bc-7f99924d7db1 TCGA-D8-A146-01A-31D-A111-01 TCGA-D8-A146-01 TCGA-D8-A147-01 Stage X 45 1 Stage IIA 2 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 2 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-D8-A147-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 13 TCGA-D8-A147 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-D8-A147-F20737 TCGA-D8-A147 TCGA-D8-A147-01A Negative Negative Lumpectomy -16736 163 0 584 Scheduled Follow-up Submission 2012-1-14 FEMALE Hercep Test TM Dako Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 130 NO Negative 1 Negative Indeterminate (neither Pre or Postmenopausal) 5 5 NO 0 false No M0 N0 T2 TCGA-D8-A147.380639A2-E89C-4495-8168-82120617129F.pdf A147 TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 4d28bcbc-dbdd-46f8-9329-49f359480a97 4d28bcbc-dbdd-46f8-9329-49f359480a97 TCGA-D8-A147-01A-21-A13D-20 TCGA-D8-A147-01A-11D-A10Y-09 TCGA-D8-A147-01 a8d9009e-ecf1-420f-a3b7-faab805210de TCGA-D8-A147-01 TCGA-D8-A147-01A-11D-A10Y-09 TCGA-D8-A147-01A-11D-A112-05 TCGA-D8-A147-01 TCGA-D8-A147-01 TCGA-D8-A147-01A-11D-A10Y-09 4d28bcbc-dbdd-46f8-9329-49f359480a97 TCGA-D8-A147-01A-11D-A111-01 TCGA-D8-A147-01 TCGA-D8-A147-01A-11R-A115-07 4d28bcbc-dbdd-46f8-9329-49f359480a97 TCGA-D8-A147-01A-11D-A111-01 TCGA-D8-A147-01 TCGA-D8-A1J8-01 Stage IIB 77 2 Stage IIB 256 Positive FEMALE Negative Negative M0 Positive N1 256 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1J8-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 TCGA-D8-A1J8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1J8-F14040 TCGA-D8-A1J8 Positive Positive Modified Radical Mastectomy -28444 0 431 70-79% Scheduled Follow-up Submission 2011-7-18 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO 3 No M0 N1a T2 Stage IIB A1J8 TUMOR FREE 70-79% NO Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2010 ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef TCGA-D8-A1J8-01A-21-A17J-20 TCGA-D8-A1J8-01 TCGA-D8-A1J8-01A-11D-A13K-05 f1a4f40a-6d0d-49a8-ab70-d275856a8996 TCGA-D8-A1J8-01 TCGA-D8-A1J8-01A-11D-A13L-09 TCGA-D8-A1J8-01 ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef TCGA-D8-A1J8-01A-11D-A13J-01 TCGA-D8-A1J8-01 ddb6efb2-2ef7-42a0-b00d-42c5b0fc6aef TCGA-D8-A1J8-01A-11D-A13J-01 TCGA-D8-A1J9-01 Stage IA 48 2 Stage I 248 Positive FEMALE Positive Negative M0 Negative N0 248 0 LumB Negative enrollment T1 T1 LIVING TCGA-D8-A1J9-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 8 TCGA-D8-A1J9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1J9-F20944 TCGA-D8-A1J9 TCGA-D8-A1J9-01A Positive Negative Modified Radical Mastectomy -17879 211 0 532 manual counting Scheduled Follow-up Submission 2012-1-19 FEMALE Hecep Test TM DAKO 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 230 NO Positive 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 NO 0 false No M0 N0 T1c Stage IA TCGA-D8-A1J9.D80E9389-AAD8-4EEB-9DE0-5DE57B5E5F6B.pdf A1J9 TUMOR FREE manual counting 0% 10-75% NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 ff7159e7-e9f2-4cc8-ab89-f4167d19672c ff7159e7-e9f2-4cc8-ab89-f4167d19672c TCGA-D8-A1J9-01A-21-A17J-20 TCGA-D8-A1J9-01A-11D-A13L-09 TCGA-D8-A1J9-01 TCGA-D8-A1J9-01A-11D-A13K-05 07d51184-85a3-4ba7-9cc2-badcb3ccfa23 TCGA-D8-A1J9-01 TCGA-D8-A1J9-01A-11D-A13L-09 TCGA-D8-A1J9-01 TCGA-D8-A1J9-01A-11D-A13L-09 ff7159e7-e9f2-4cc8-ab89-f4167d19672c TCGA-D8-A1J9-01A-11D-A13J-01 TCGA-D8-A1J9-01 ff7159e7-e9f2-4cc8-ab89-f4167d19672c TCGA-D8-A1J9-01A-11D-A13J-01 TCGA-D8-A1JA-01 Stage X 60 1 Stage IIIB 18 Negative FEMALE Positive Negative M0 Negative N0 18 0 Her2 Negative enrollment T_Other T4 LIVING TCGA-D8-A1JA-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 TCGA-D8-A1JA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES NO 60 Left Upper Outer Quadrant No axillary staging TCGA-D8-A1JA-F20941 TCGA-D8-A1JA TCGA-D8-A1JA-01A Negative Negative Modified Radical Mastectomy NO -21918 194 0 502 431 manual counting <10% Scheduled Follow-up Submission 2012-1-19 FEMALE Hecep Test TM DAKO 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: 310 NO Positive Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 Locoregional Disease YES false No M0 NX T4b TCGA-D8-A1JA.51A2B7B5-0CDD-427D-BC82-5498810B2641.pdf A1JA WITH TUMOR manual counting 0% NO YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 ae81378c-ada3-43cb-9855-941467fd856c ae81378c-ada3-43cb-9855-941467fd856c TCGA-D8-A1JA-01A-21-A17J-20 TCGA-D8-A1JA-01 TCGA-D8-A1JA-01A-11D-A13K-05 62f05450-0574-4a36-aaae-6a2d2078950e TCGA-D8-A1JA-01 TCGA-D8-A1JA-01A-11D-A13L-09 TCGA-D8-A1JA-01 ae81378c-ada3-43cb-9855-941467fd856c TCGA-D8-A1JA-01A-11D-A13J-01 TCGA-D8-A1JA-01 ae81378c-ada3-43cb-9855-941467fd856c TCGA-D8-A1JA-01A-11D-A13J-01 TCGA-D8-A1JB-01 Stage IIB 54 3 Stage IIB 0 Positive FEMALE Positive Negative M0 Positive N1 0 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A1JB-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-D8-A1JB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JB-F72209 TCGA-D8-A1JB TCGA-D8-A1JB-01A Positive Positive Modified Radical Mastectomy NO -19822 232 0 1688 manual counting Scheduled Follow-up Submission 2015-4-29 FEMALE Hecep Test TM DAKO Path Vysion HER2 D Probe Kit 2+ not amplified Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 350 NO Equivocal Positive NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 1 false No M0 N1a T2 Stage IIB TCGA-D8-A1JB.27376503-A55C-4905-A885-632440EFCED2.pdf A1JB TUMOR FREE manual counting 10-75% >75% YES YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 45fe02d2-5d68-43c4-9cea-7da6e16a55a2 45fe02d2-5d68-43c4-9cea-7da6e16a55a2 TCGA-D8-A1JB-01A-21-A17J-20 TCGA-D8-A1JB-01A-11D-A13L-09 TCGA-D8-A1JB-01 TCGA-D8-A1JB-01A-11D-A13K-05 6c49abf3-08bb-47a4-be2c-6957bf1de2eb TCGA-D8-A1JB-01 TCGA-D8-A1JB-01A-11D-A13L-09 TCGA-D8-A1JB-01 TCGA-D8-A1JB-01A-11D-A13L-09 45fe02d2-5d68-43c4-9cea-7da6e16a55a2 TCGA-D8-A1JB-01A-11D-A13J-01 TCGA-D8-A1JB-01 45fe02d2-5d68-43c4-9cea-7da6e16a55a2 TCGA-D8-A1JB-01A-11D-A13J-01 TCGA-D8-A1JC-01 Stage IIIA 59 5 Stage IIIA 178 Positive FEMALE Negative Negative M0 Positive N2 178 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1JC-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-D8-A1JC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JC-F20847 TCGA-D8-A1JC TCGA-D8-A1JC-01A Positive Positive Modified Radical Mastectomy NO -21898 201 0 480 Scheduled Follow-up Submission 2012-1-19 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: 180 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 4 false No M0 N2a T2 Stage IIIA TCGA-D8-A1JC.B4DB830F-BFA4-47F5-94C7-D95984315866.pdf A1JC TUMOR FREE >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 d69c60ae-d21b-4e6e-89c5-ef0750a31c71 d69c60ae-d21b-4e6e-89c5-ef0750a31c71 TCGA-D8-A1JC-01A-21-A17J-20 TCGA-D8-A1JC-01A-11D-A13L-09 TCGA-D8-A1JC-01 TCGA-D8-A1JC-01A-11D-A13K-05 57323434-3660-45b6-90fd-6183e75a5b54 TCGA-D8-A1JC-01 TCGA-D8-A1JC-01A-11D-A13L-09 TCGA-D8-A1JC-01 TCGA-D8-A1JC-01A-11D-A13L-09 d69c60ae-d21b-4e6e-89c5-ef0750a31c71 TCGA-D8-A1JC-01A-11D-A13J-01 TCGA-D8-A1JC-01 d69c60ae-d21b-4e6e-89c5-ef0750a31c71 TCGA-D8-A1JC-01A-11D-A13J-01 TCGA-D8-A1JD-01 Stage IIB 41 5 Stage IIB 273 Positive FEMALE Negative Negative M0 Positive N1 273 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1JD-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1JD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JD-F20844 TCGA-D8-A1JD TCGA-D8-A1JD-01A Positive Positive Modified Radical Mastectomy -15166 230 0 552 manual counting Scheduled Follow-up Submission 2012-1-19 FEMALE Hecep Test TM DAKO 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 400 NO Negative 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 NO 3 0 false No M0 N1a T2 Stage IIB TCGA-D8-A1JD.332880ED-FE4E-4EE4-9E96-0A61BFCCA27E.pdf A1JD TUMOR FREE manual counting 10-75% >75% YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 f2ee7101-b51e-4f75-95fa-555b5b79af74 f2ee7101-b51e-4f75-95fa-555b5b79af74 TCGA-D8-A1JD-01A-21-A17J-20 TCGA-D8-A1JD-01A-11D-A13L-09 TCGA-D8-A1JD-01 TCGA-D8-A1JD-01A-11D-A13K-05 7788922c-5c28-46e3-9ee9-6fb8aab752d4 TCGA-D8-A1JD-01 TCGA-D8-A1JD-01A-11D-A13L-09 TCGA-D8-A1JD-01 TCGA-D8-A1JD-01A-11D-A13L-09 f2ee7101-b51e-4f75-95fa-555b5b79af74 TCGA-D8-A1JD-01A-11D-A13J-01 TCGA-D8-A1JD-01 f2ee7101-b51e-4f75-95fa-555b5b79af74 TCGA-D8-A1JD-01A-11D-A13J-01 TCGA-D8-A1JE-01 Stage IIA 62 2 Stage IIA 57 Positive FEMALE Negative Negative M0 Positive N1 57 0 LumB Positive enrollment T1 T1 LIVING TCGA-D8-A1JE-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1JE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JE-F20759 TCGA-D8-A1JE Positive Positive Modified Radical Mastectomy NO -22683 0 575 manual counting Scheduled Follow-up Submission 2012-1-8 FEMALE Hecep Test TM DAKO 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 3 No M0 N1a T1c Stage IIA A1JE TUMOR FREE manual counting 10-75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2010 c7139402-146f-4c49-bcd0-f2a6a378911e c7139402-146f-4c49-bcd0-f2a6a378911e TCGA-D8-A1JE-01A-21-A17J-20 TCGA-D8-A1JE-01A-11D-A13L-09 TCGA-D8-A1JE-01 TCGA-D8-A1JE-01A-11D-A13K-05 ad15f06b-4988-4132-9b8c-1c04e14fa98e TCGA-D8-A1JE-01 TCGA-D8-A1JE-01A-11D-A13L-09 TCGA-D8-A1JE-01 TCGA-D8-A1JE-01A-11D-A13L-09 c7139402-146f-4c49-bcd0-f2a6a378911e TCGA-D8-A1JE-01A-11D-A13J-01 TCGA-D8-A1JE-01 c7139402-146f-4c49-bcd0-f2a6a378911e TCGA-D8-A1JE-01A-11D-A13J-01 TCGA-D8-A1JF-01 Stage IIIA 79 3 Stage IIIA 96 Negative FEMALE Negative Negative M0 Positive N2 96 0 Her2 Negative enrollment T1 T1 LIVING TCGA-D8-A1JF-01 COAD-READ C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 8 TCGA-D8-A1JF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JF-F14058 TCGA-D8-A1JF Negative Negative Modified Radical Mastectomy NO -29199 0 366 Scheduled Follow-up Submission 2011-7-18 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: Negative 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 3 NO 8 No M0 N2a T1c Stage IIIA A1JF TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2010 a74b20ca-06f9-47ec-8888-cb01e0ba3257 a74b20ca-06f9-47ec-8888-cb01e0ba3257 TCGA-D8-A1JF-01A-21-A17J-20 TCGA-D8-A1JF-01A-11D-A13L-09 TCGA-D8-A1JF-01 TCGA-D8-A1JF-01A-11D-A13K-05 c9bf8bae-3cf7-4b3f-8fb4-51e9bd4e83a8 TCGA-D8-A1JF-01 TCGA-D8-A1JF-01A-11D-A13L-09 TCGA-D8-A1JF-01 TCGA-D8-A1JF-01A-11D-A13L-09 a74b20ca-06f9-47ec-8888-cb01e0ba3257 TCGA-D8-A1JF-01A-11D-A13J-01 TCGA-D8-A1JF-01 a74b20ca-06f9-47ec-8888-cb01e0ba3257 TCGA-D8-A1JF-01A-11D-A13J-01 TCGA-D8-A1JG-01 Stage IIA 62 1 Stage IIA 187 Negative FEMALE Negative Negative M0 Negative N0 187 0 Her2 Negative enrollment T_Other T2 LIVING TCGA-D8-A1JG-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-D8-A1JG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-D8-A1JG-F72208 TCGA-D8-A1JG Negative Negative Lumpectomy NO -22878 0 1612 Scheduled Follow-up Submission 2015-4-29 FEMALE 2+ not amplified Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 NO 0 No M0 N0 T2 Stage IIA A1JG TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2010 ee8b563d-11bb-4d84-ac53-e2acc8d0275d ee8b563d-11bb-4d84-ac53-e2acc8d0275d TCGA-D8-A1JG-01B-21-A17J-20 TCGA-D8-A1JG-01B-11D-A13L-09 TCGA-D8-A1JG-01 TCGA-D8-A1JG-01B-11D-A13K-05 dc251841-a624-484b-b4ce-b149651d3b57 TCGA-D8-A1JG-01 TCGA-D8-A1JG-01B-11D-A13L-09 TCGA-D8-A1JG-01 TCGA-D8-A1JG-01B-11D-A13L-09 ee8b563d-11bb-4d84-ac53-e2acc8d0275d TCGA-D8-A1JG-01B-11D-A13J-01 TCGA-D8-A1JG-01 ee8b563d-11bb-4d84-ac53-e2acc8d0275d TCGA-D8-A1JG-01B-11D-A13J-01 TCGA-D8-A1JH-01 Stage IA 56 1 Stage I 426 Positive FEMALE Negative Negative M0 Negative N0 426 0 LumA Positive followup T1 T1 LIVING TCGA-D8-A1JH-01 Quiet C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation cluster 4 TCGA-D8-A1JH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JH-F14055 TCGA-D8-A1JH TCGA-D8-A1JH-01A Positive Positive Modified Radical Mastectomy -20497 263 0 426 manual counting Scheduled Follow-up Submission 2011-7-18 FEMALE Hecep Test TM DAKO 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 140 NO Negative 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO false No M0 N0 T1c Stage IA TCGA-D8-A1JH.49C79E09-2F69-4089-BFB1-53197DA09A46.pdf A1JH TUMOR FREE manual counting >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8 00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8 TCGA-D8-A1JH-01A-21-A17J-20 TCGA-D8-A1JH-01A-11D-A188-09 TCGA-D8-A1JH-01 TCGA-D8-A1JH-01A-11D-A13K-05 16c99b80-d0de-4a1e-b8f8-d119431fc8db TCGA-D8-A1JH-01 TCGA-D8-A1JH-01A-11D-A188-09 TCGA-D8-A1JH-01 TCGA-D8-A1JH-01A-11D-A188-09 00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8 TCGA-D8-A1JH-01A-11D-A13J-01 TCGA-D8-A1JH-01 00a3c8f4-bd75-4aa8-abb7-21005b1a5ad8 TCGA-D8-A1JH-01A-11D-A13J-01 TCGA-D8-A1JI-01 Stage IIA 54 2 Stage IIA 21 Positive FEMALE Negative Negative M0 Positive N1 21 0 LumB Positive enrollment T1 T1 LIVING TCGA-D8-A1JI-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-D8-A1JI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JI-F20757 TCGA-D8-A1JI TCGA-D8-A1JI-01A Positive Positive Modified Radical Mastectomy NO -20072 226 0 577 manual counting Scheduled Follow-up Submission 2012-1-19 FEMALE DAKOHercepTest TM Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 190 NO Negative 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 NO 2 false No MX N1a T1c Stage IIA TCGA-D8-A1JI.EF2DC6FB-F026-4025-B148-DF07194914AB.pdf A1JI TUMOR FREE manual counting >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 27706c21-96cb-48e9-88ec-1c52769bfe45 27706c21-96cb-48e9-88ec-1c52769bfe45 TCGA-D8-A1JI-01A-21-A17J-20 TCGA-D8-A1JI-01A-11D-A13L-09 TCGA-D8-A1JI-01 TCGA-D8-A1JI-01A-11D-A13K-05 621f10de-1603-49a6-ab27-8cfc9c4fd621 TCGA-D8-A1JI-01 TCGA-D8-A1JI-01A-11D-A13L-09 TCGA-D8-A1JI-01 TCGA-D8-A1JI-01A-11D-A13L-09 27706c21-96cb-48e9-88ec-1c52769bfe45 TCGA-D8-A1JI-01A-11D-A13J-01 TCGA-D8-A1JI-01 27706c21-96cb-48e9-88ec-1c52769bfe45 TCGA-D8-A1JI-01A-11D-A13J-01 TCGA-D8-A1JJ-01 Stage IIA 54 1 Stage IIA 274 Positive FEMALE Negative Negative M0 Negative N0 274 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1JJ-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation cluster 3 TCGA-D8-A1JJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-D8-A1JJ-F20754 TCGA-D8-A1JJ TCGA-D8-A1JJ-01A Positive Positive Other -19966 260 0 611 manual counting Scheduled Follow-up Submission 2012-1-19 FEMALE DAKOHercepTest TM 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 240 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1JJ.3F1DA529-4967-462D-8966-E634D66EB3E1.pdf A1JJ TUMOR FREE manual counting 10-75% 10-75% >75% YES YES Primary Tumor 01 breast conserving therapy 7th YES YES NO D8 Breast A LIVING 2010 091cb252-dd08-4e9c-939c-749f595713f6 091cb252-dd08-4e9c-939c-749f595713f6 TCGA-D8-A1JJ-01A-11-A17J-20 TCGA-D8-A1JJ-01A-31D-A14K-09 TCGA-D8-A1JJ-01 TCGA-D8-A1JJ-01A-31D-A14N-05 f1275b85-f44d-447b-8def-00e4f4c9b2c0 TCGA-D8-A1JJ-01 TCGA-D8-A1JJ-01A-31D-A14K-09 TCGA-D8-A1JJ-01 TCGA-D8-A1JJ-01A-31D-A14K-09 091cb252-dd08-4e9c-939c-749f595713f6 TCGA-D8-A1JJ-01A-31D-A14J-01 TCGA-D8-A1JJ-01 091cb252-dd08-4e9c-939c-749f595713f6 TCGA-D8-A1JJ-01A-31D-A14J-01 TCGA-D8-A1JK-01 Stage IIA 90 1 Stage IIA 109 Negative FEMALE Negative Negative M0 Negative N0 109 0 Basal Positive enrollment T_Other T2 LIVING TCGA-D8-A1JK-01 High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 4 mutation cluster 3 TCGA-D8-A1JK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Left Upper Inner Quadrant|Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JK-F20751 TCGA-D8-A1JK TCGA-D8-A1JK-01A Negative Positive Modified Radical Mastectomy -32872 261 0 612 manual counting Scheduled Follow-up Submission 2012-1-19 FEMALE DAKOHercepTest TM 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 270 NO Negative 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1JK.1841FEE0-EC36-4EC4-8B5E-6D340C80735B.pdf A1JK TUMOR FREE manual counting 0% YES <10% NO Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 f7dd2e6b-a87e-467b-890a-3c422ae3dea7 f7dd2e6b-a87e-467b-890a-3c422ae3dea7 TCGA-D8-A1JK-01A-21-A17J-20 TCGA-D8-A1JK-01A-11D-A13L-09 TCGA-D8-A1JK-01 TCGA-D8-A1JK-01A-11D-A13K-05 0f3becf1-2a76-4401-950b-6809dfd90276 TCGA-D8-A1JK-01 TCGA-D8-A1JK-01A-11D-A13L-09 TCGA-D8-A1JK-01 TCGA-D8-A1JK-01A-11D-A13L-09 f7dd2e6b-a87e-467b-890a-3c422ae3dea7 TCGA-D8-A1JK-01A-11D-A13J-01 TCGA-D8-A1JK-01 f7dd2e6b-a87e-467b-890a-3c422ae3dea7 TCGA-D8-A1JK-01A-11D-A13J-01 TCGA-D8-A1JL-01 Stage IIA 72 3 Stage IIA 265 Negative FEMALE Negative Negative M0 Negative N0 265 0 Basal Negative enrollment T_Other T2 LIVING TCGA-D8-A1JL-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-D8-A1JL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-D8-A1JL-F20747 TCGA-D8-A1JL Negative Negative Modified Radical Mastectomy -26484 0 611 manual counting Scheduled Follow-up Submission 2012-1-15 FEMALE DAKOHercepTest TM 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 2 NO 0 No M0 N0 T2 Stage IIA A1JL TUMOR FREE manual counting 0% 0% YES NO Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2010 b4673313-fa18-43e8-a01b-5cdb3cf5425e b4673313-fa18-43e8-a01b-5cdb3cf5425e TCGA-D8-A1JL-01A-21-A17J-20 TCGA-D8-A1JL-01A-11D-A13L-09 TCGA-D8-A1JL-01 TCGA-D8-A1JL-01A-11D-A13K-05 c5c33030-617d-46a1-89a5-fa6ddd7d06fc TCGA-D8-A1JL-01 TCGA-D8-A1JL-01A-11D-A13L-09 TCGA-D8-A1JL-01 TCGA-D8-A1JL-01A-11D-A13L-09 b4673313-fa18-43e8-a01b-5cdb3cf5425e TCGA-D8-A1JL-01A-11D-A13J-01 TCGA-D8-A1JL-01 b4673313-fa18-43e8-a01b-5cdb3cf5425e TCGA-D8-A1JL-01A-11D-A13J-01 TCGA-D8-A1JM-01 Stage IIB 59 1 Stage IIB 238 Positive FEMALE Negative Negative M0 Positive N1 238 0 Basal Negative enrollment T_Other T2 LIVING TCGA-D8-A1JM-01 High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 mutation c1uster 9 TCGA-D8-A1JM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JM-F20742 TCGA-D8-A1JM TCGA-D8-A1JM-01A Positive Negative Modified Radical Mastectomy -21602 243 0 590 manual counting <10% Scheduled Follow-up Submission 2012-1-15 FEMALE DAKOHercepTest TM 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 350 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 3 false No M0 N1a T2 Stage IIB TCGA-D8-A1JM.947954F1-4CBA-42D3-99B2-6BE6E44E5239.pdf A1JM TUMOR FREE manual counting 0% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525 ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525 TCGA-D8-A1JM-01A-21-A17J-20 TCGA-D8-A1JM-01A-11D-A13L-09 TCGA-D8-A1JM-01 TCGA-D8-A1JM-01A-11D-A13K-05 8d31dc1e-928f-4d15-9ebc-cdab6a5e3527 TCGA-D8-A1JM-01 TCGA-D8-A1JM-01A-11D-A13L-09 TCGA-D8-A1JM-01A-11D-A13L-09 ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525 TCGA-D8-A1JM-01A-11D-A13J-01 ab3e7f05-9fb2-4c19-a6a9-3ffe1e4c1525 TCGA-D8-A1JM-01A-11D-A13J-01 TCGA-D8-A1JN-01 Stage IIIC 80 2 Stage IIIC 217 Positive FEMALE Negative Negative M0 Positive N3 217 0 LumA Positive enrollment T_Other T3 LIVING TCGA-D8-A1JN-01 Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-D8-A1JN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left Axillary lymph node dissection alone TCGA-D8-A1JN-F20745 TCGA-D8-A1JN TCGA-D8-A1JN-01A Positive Positive Modified Radical Mastectomy -29331 273 0 620 manual counting Scheduled Follow-up Submission 2012-1-15 FEMALE HER2 amplification - negative DAKOHercepTest TM PathVision HER2 D Probe Kit Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Incisional Biopsy 180 NO Indeterminate Negative 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 3 NO 11 false No MX N3a T3 Stage IIIC TCGA-D8-A1JN.021DF0B3-A535-4AD4-9545-1B9A7BC3E1E6.pdf A1JN TUMOR FREE manual counting >75% YES <10% NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 874de789-c1c4-4fd3-b45c-e885f62aaeab 874de789-c1c4-4fd3-b45c-e885f62aaeab TCGA-D8-A1JN-01A-21-A17J-20 TCGA-D8-A1JN-01A-11D-A13L-09 TCGA-D8-A1JN-01 TCGA-D8-A1JN-01A-11D-A13K-05 42e89a13-3aee-4749-861a-947fc66091bc TCGA-D8-A1JN-01 TCGA-D8-A1JN-01A-11D-A13L-09 TCGA-D8-A1JN-01 TCGA-D8-A1JN-01A-11D-A13L-09 874de789-c1c4-4fd3-b45c-e885f62aaeab TCGA-D8-A1JN-01A-11D-A13J-01 TCGA-D8-A1JN-01 874de789-c1c4-4fd3-b45c-e885f62aaeab TCGA-D8-A1JN-01A-11D-A13J-01 TCGA-D8-A1JP-01 Stage IA 73 1 Stage I 167 Positive FEMALE Negative Negative M0 Negative N0 167 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A1JP-01 High C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-D8-A1JP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-D8-A1JP-F20740 TCGA-D8-A1JP Negative Positive Mastectomy NOS Positive Lumpectomy -26862 0 639 manual counting Scheduled Follow-up Submission 2012-1-15 FEMALE DAKOHercepTest TM 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 NO No M0 N0 T1c Stage IA A1JP TUMOR FREE manual counting >75% YES <10% NO Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2010 f7461164-08b5-4a5c-ae74-cb4332f5ff7a f7461164-08b5-4a5c-ae74-cb4332f5ff7a TCGA-D8-A1JP-01A-21-A17J-20 TCGA-D8-A1JP-01A-11D-A13L-09 TCGA-D8-A1JP-01 TCGA-D8-A1JP-01A-11D-A13K-05 f51d8572-21b5-4b6f-99dd-00ca06c53b6f TCGA-D8-A1JP-01 TCGA-D8-A1JP-01A-11D-A13L-09 TCGA-D8-A1JP-01 TCGA-D8-A1JP-01A-11D-A13L-09 f7461164-08b5-4a5c-ae74-cb4332f5ff7a TCGA-D8-A1JP-01A-11D-A13J-01 TCGA-D8-A1JP-01 f7461164-08b5-4a5c-ae74-cb4332f5ff7a TCGA-D8-A1JP-01A-11D-A13J-01 TCGA-D8-A1JS-01 Stage IA 77 2 Stage I 371 Positive FEMALE Negative Negative M0 Negative N0 371 0 LumA Positive followup T1 T1 LIVING TCGA-D8-A1JS-01 Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-D8-A1JS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JS-F14051 TCGA-D8-A1JS TCGA-D8-A1JS-01A Positive Positive Lumpectomy NO -28178 212 0 371 manual counting Scheduled Follow-up Submission 2011-7-18 FEMALE Hecep Test TM DAKO 1+ Other, specify No C50.9 8503/3 C50.9 YES intraoperative examination Other method, specify: 190 NO Negative 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 NO 0 false No M0 N0 T1c Stage IA TCGA-D8-A1JS.0EA57ABF-E3DA-4862-BAB8-A6E36408AC42.pdf A1JS TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 b347056d-3ae3-43c7-9e3b-f48cee1bfbb2 b347056d-3ae3-43c7-9e3b-f48cee1bfbb2 TCGA-D8-A1JS-01A-21-A17J-20 TCGA-D8-A1JS-01A-11D-A13L-09 TCGA-D8-A1JS-01 TCGA-D8-A1JS-01A-11D-A13K-05 7ec4164a-68b4-4bbd-a560-b754876e5d33 TCGA-D8-A1JS-01 TCGA-D8-A1JS-01A-11D-A13L-09 TCGA-D8-A1JS-01 TCGA-D8-A1JS-01A-11D-A13L-09 b347056d-3ae3-43c7-9e3b-f48cee1bfbb2 TCGA-D8-A1JS-01A-11D-A13J-01 TCGA-D8-A1JS-01 b347056d-3ae3-43c7-9e3b-f48cee1bfbb2 TCGA-D8-A1JS-01A-11D-A13J-01 TCGA-D8-A1JT-01 Stage IIA 70 4 Stage IIA 405 Positive FEMALE Negative Negative M0 Negative N0 405 0 LumB Positive followup T_Other T2 LIVING TCGA-D8-A1JT-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-D8-A1JT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1JT-F14048 TCGA-D8-A1JT TCGA-D8-A1JT-01A Positive Positive Modified Radical Mastectomy NO -25677 250 0 405 70-79% Scheduled Follow-up Submission 2011-7-18 FEMALE 2+ not amplified Other, specify No C50.9 8523/3 C50.9 YES Fine needle aspiration biopsy 250 NO Equivocal Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1JT.72AF26A2-FAD0-42FD-A63C-6E8E2597B84E.pdf A1JT TUMOR FREE YES 70-79% NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 33600bf2-ec43-49d2-93dd-4985feb500aa 33600bf2-ec43-49d2-93dd-4985feb500aa TCGA-D8-A1JT-01A-41-A17J-20 TCGA-D8-A1JT-01A-31D-A13L-09 TCGA-D8-A1JT-01 TCGA-D8-A1JT-01A-31D-A13K-05 fd766efd-b1bc-4000-97bf-a8f88aea66a7 TCGA-D8-A1JT-01 TCGA-D8-A1JT-01A-31D-A13L-09 TCGA-D8-A1JT-01 TCGA-D8-A1JT-01A-31D-A13L-09 33600bf2-ec43-49d2-93dd-4985feb500aa TCGA-D8-A1JT-01A-31D-A13J-01 TCGA-D8-A1JT-01 33600bf2-ec43-49d2-93dd-4985feb500aa TCGA-D8-A1JT-01A-31D-A13J-01 TCGA-D8-A1JU-01 Stage IA 51 2 Stage I 447 Positive FEMALE Negative Negative M0 Negative N0 447 0 LumA Positive followup T1 T1 LIVING TCGA-D8-A1JU-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-D8-A1JU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-D8-A1JU-F14045 TCGA-D8-A1JU TCGA-D8-A1JU-01A Positive Positive Simple Mastectomy -18733 295 0 447 manual counting Scheduled Follow-up Submission 2011-7-18 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 450 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 NO 0 false No M0 N0 T1c Stage IA TCGA-D8-A1JU.B5074D1A-C617-414F-B349-6096F59E122D.pdf A1JU TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 8e10b30e-5789-4ad4-a70b-c7a86927ac6b 8e10b30e-5789-4ad4-a70b-c7a86927ac6b TCGA-D8-A1JU-01A-21-A17J-20 TCGA-D8-A1JU-01A-11D-A13L-09 TCGA-D8-A1JU-01 TCGA-D8-A1JU-01A-11D-A13K-05 226a87df-e0cb-4c94-80ab-9d1bed969e0f TCGA-D8-A1JU-01 TCGA-D8-A1JU-01A-11D-A13L-09 TCGA-D8-A1JU-01 TCGA-D8-A1JU-01A-11D-A13L-09 8e10b30e-5789-4ad4-a70b-c7a86927ac6b TCGA-D8-A1JU-01A-11D-A13J-01 TCGA-D8-A1JU-01 8e10b30e-5789-4ad4-a70b-c7a86927ac6b TCGA-D8-A1JU-01A-11D-A13J-01 TCGA-D8-A1X5-01 Stage IIIC 81 5 Stage IIIC 171 Positive FEMALE Positive Negative M0 Positive N3 171 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1X5-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 squamous c3 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-D8-A1X5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 81 Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1X5-F29934 TCGA-D8-A1X5 TCGA-D8-A1X5-01A Positive Positive Modified Radical Mastectomy -29734 197 0 565 NO manual counting Scheduled Follow-up Submission 2012-3-30 FEMALE Hercep Test TM Dako 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 240 NO Positive 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 5 NO 14 false No MX N3a T2 Stage IIIC TCGA-D8-A1X5.449F70F0-DFE1-40F9-879D-43283CFAF525.pdf A1X5 TUMOR FREE manual counting 10-75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 95a12af8-5704-4745-b0a0-960f67af8cec 95a12af8-5704-4745-b0a0-960f67af8cec TCGA-D8-A1X5-01A-21-A17K-20 TCGA-D8-A1X5-01A-11D-A14G-09 TCGA-D8-A1X5-01 TCGA-D8-A1X5-01A-11D-A14H-05 8e7e66c1-ecb2-47e7-a590-56fd4b0cb3b5 TCGA-D8-A1X5-01 TCGA-D8-A1X5-01A-11D-A14G-09 TCGA-D8-A1X5-01 TCGA-D8-A1X5-01A-11D-A14G-09 95a12af8-5704-4745-b0a0-960f67af8cec TCGA-D8-A1X5-01A-11D-A14F-01 TCGA-D8-A1X5-01 95a12af8-5704-4745-b0a0-960f67af8cec TCGA-D8-A1X5-01A-11D-A14F-01 TCGA-D8-A1X6-01 Stage IIIA 80 4 Stage IIIA 236 Positive FEMALE Negative Negative M0 Positive N2 236 0 LumB Positive enrollment T_Other T3 LIVING TCGA-D8-A1X6-01 Squamous C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation c1uster 9 TCGA-D8-A1X6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left Upper Inner Quadrant|Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1X6-F29980 TCGA-D8-A1X6 TCGA-D8-A1X6-01A Positive Positive Modified Radical Mastectomy -29256 173 0 541 NO manual counting Scheduled Follow-up Submission 2012-3-31 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 550 NO Negative 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO 5 false No MX N2a T3 Stage IIIA TCGA-D8-A1X6.880A4D38-40C5-46C3-8EE7-36539DD64773.pdf A1X6 TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 ac361cbe-2302-4115-8c0f-40845c0ccec9 ac361cbe-2302-4115-8c0f-40845c0ccec9 TCGA-D8-A1X6-01A-21-A17K-20 TCGA-D8-A1X6-01A-11D-A14K-09 TCGA-D8-A1X6-01 TCGA-D8-A1X6-01A-11D-A14N-05 45aa8d7f-2fd6-4413-8191-52872f8d31d7 TCGA-D8-A1X6-01 TCGA-D8-A1X6-01A-11D-A14K-09 TCGA-D8-A1X6-01 TCGA-D8-A1X6-01A-11D-A14K-09 ac361cbe-2302-4115-8c0f-40845c0ccec9 TCGA-D8-A1X6-01A-11D-A14J-01 TCGA-D8-A1X6-01 ac361cbe-2302-4115-8c0f-40845c0ccec9 TCGA-D8-A1X6-01A-11D-A14J-01 TCGA-D8-A1X7-01 Stage IIA 40 3 Stage IIA 85 Positive FEMALE Negative Negative M0 Negative N0 85 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1X7-01 Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 9 TCGA-D8-A1X7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1X7-F29985 TCGA-D8-A1X7 TCGA-D8-A1X7-01A Positive Positive Simple Mastectomy -14858 141 0 509 NO manual counting Scheduled Follow-up Submission 2012-3-31 FEMALE Other, specify No C50.9 8503/3 C50.9 YES Fine needle aspiration biopsy 170 NO Negative 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 6 NO 0 false No MX N0 T2 Stage IIA TCGA-D8-A1X7.D3EA3547-7E53-442E-A957-B2DD7EBAFBB9.pdf A1X7 TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 6b2497ef-abe8-4f6f-9225-1d700f55ad1c 6b2497ef-abe8-4f6f-9225-1d700f55ad1c TCGA-D8-A1X7-01A-21-A17K-20 TCGA-D8-A1X7-01A-11D-A14K-09 TCGA-D8-A1X7-01 TCGA-D8-A1X7-01A-11D-A14N-05 436728e0-24a5-4033-86d5-2d24f669ea72 TCGA-D8-A1X7-01 TCGA-D8-A1X7-01A-11D-A14K-09 TCGA-D8-A1X7-01 TCGA-D8-A1X7-01A-11D-A14K-09 6b2497ef-abe8-4f6f-9225-1d700f55ad1c TCGA-D8-A1X7-01A-11D-A14J-01 TCGA-D8-A1X7-01 6b2497ef-abe8-4f6f-9225-1d700f55ad1c TCGA-D8-A1X7-01A-11D-A14J-01 TCGA-D8-A1X8-01 Stage IIA 62 2 Stage IIIA 272 Positive FEMALE Negative Negative M0 Positive N2 272 0 LumA Indeterminate enrollment T1 T1 LIVING TCGA-D8-A1X8-01 Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-D8-A1X8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1X8-F29428 TCGA-D8-A1X8 TCGA-D8-A1X8-01A Positive 2+ 4 Point Scale Indeterminate Modified Radical Mastectomy NO -22995 225 0 783 NO % IHC Scheduled Follow-up Submission 2012-10-19 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 360 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 1 NO 9 0 false No M0 N2a T1c Stage IIIA TCGA-D8-A1X8.5F1C3B85-5E5C-428B-8779-3A5878DCE1F2.pdf A1X8 TUMOR FREE %IHC >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 cbc8608e-ffe1-41d5-93c5-66dd665c9bf0 cbc8608e-ffe1-41d5-93c5-66dd665c9bf0 TCGA-D8-A1X8-01A-21-A17K-20 TCGA-D8-A1X8-01A-11D-A14K-09 TCGA-D8-A1X8-01 TCGA-D8-A1X8-01A-11D-A14N-05 9bd7faf1-8b85-4e46-b968-35a1a5cc2cb5 TCGA-D8-A1X8-01 TCGA-D8-A1X8-01A-11D-A14K-09 TCGA-D8-A1X8-01 TCGA-D8-A1X8-01A-11D-A14K-09 cbc8608e-ffe1-41d5-93c5-66dd665c9bf0 TCGA-D8-A1X8-01A-11D-A14J-01 TCGA-D8-A1X8-01 cbc8608e-ffe1-41d5-93c5-66dd665c9bf0 TCGA-D8-A1X8-01A-11D-A14J-01 TCGA-D8-A1X9-01 Stage IIA 66 5 Stage IIB 380 Positive FEMALE Negative Negative M0 Positive N1 380 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A1X9-01 Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 14 TCGA-D8-A1X9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1X9-F29431 TCGA-D8-A1X9 TCGA-D8-A1X9-01A Positive Positive Modified Radical Mastectomy NO -24417 399 0 727 NO % IHC Scheduled Follow-up Submission 2012-3-19 FEMALE not amplified Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Indeterminate Negative 23 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 3 0 false No M0 N1a T2 Stage IIB TCGA-D8-A1X9.E69CF3E3-4799-4892-87E9-4291B14A1B9C.pdf A1X9 TUMOR FREE %IHC >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 2b3d596a-68ca-4c60-bb16-8c0cbd8fb190 2b3d596a-68ca-4c60-bb16-8c0cbd8fb190 TCGA-D8-A1X9-01A-21-A17K-20 TCGA-D8-A1X9-01A-12D-A159-09 TCGA-D8-A1X9-01 TCGA-D8-A1X9-01A-12D-A161-05 4672d6c4-b826-4143-887c-464ab4020a6d TCGA-D8-A1X9-01 TCGA-D8-A1X9-01A-12D-A159-09 TCGA-D8-A1X9-01 TCGA-D8-A1X9-01A-12D-A159-09 2b3d596a-68ca-4c60-bb16-8c0cbd8fb190 TCGA-D8-A1X9-01A-12D-A160-01 TCGA-D8-A1X9-01 2b3d596a-68ca-4c60-bb16-8c0cbd8fb190 TCGA-D8-A1X9-01A-12D-A160-01 TCGA-D8-A1XA-01 Stage IA 64 1 Stage I 274 Positive FEMALE Negative Negative M0 Negative N0 274 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A1XA-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-D8-A1XA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-D8-A1XA-F29434 TCGA-D8-A1XA TCGA-D8-A1XA-01A Positive Positive Lumpectomy NO -23387 218 0 839 NO % IHC Scheduled Follow-up Submission 2012-12-3 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: 140 NO Equivocal 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 0 false No M0 N0 T1c Stage IA TCGA-D8-A1XA.9320030D-5E19-4BEE-99DA-366B6762DED1.pdf A1XA TUMOR FREE %IHC >75% >75% YES YES Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 79d0e02e-b518-4dce-8c20-00073d04e399 79d0e02e-b518-4dce-8c20-00073d04e399 TCGA-D8-A1XA-01A-21-A17K-20 TCGA-D8-A1XA-01A-11D-A14G-09 TCGA-D8-A1XA-01 TCGA-D8-A1XA-01A-11D-A14H-05 b480ba7d-ad4f-41f6-87a4-ad062ced62ae TCGA-D8-A1XA-01 TCGA-D8-A1XA-01A-11D-A14G-09 TCGA-D8-A1XA-01 TCGA-D8-A1XA-01A-11D-A14G-09 79d0e02e-b518-4dce-8c20-00073d04e399 TCGA-D8-A1XA-01A-11D-A14F-01 TCGA-D8-A1XA-01 79d0e02e-b518-4dce-8c20-00073d04e399 TCGA-D8-A1XA-01A-11D-A14F-01 TCGA-D8-A1XB-01 Stage IIB 62 4 Stage IIB 201 Positive FEMALE Negative Negative M0 Positive N1 201 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A1XB-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1XB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XB-F29436 TCGA-D8-A1XB TCGA-D8-A1XB-01A Positive Positive Modified Radical Mastectomy NO -22976 251 0 552 NO % IHC Scheduled Follow-up Submission 2012-3-19 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO Negative 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 1 0 false No M0 N1a T2 Stage IIB TCGA-D8-A1XB.B7367E27-2A40-4E8F-8975-D5665E6506D9.pdf A1XB TUMOR FREE %IHC >75% >75% YES YES Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 8a2adff0-2527-43fa-ad17-a3081e22f846 8a2adff0-2527-43fa-ad17-a3081e22f846 TCGA-D8-A1XB-01A-21-A17K-20 TCGA-D8-A1XB-01A-11D-A14G-09 TCGA-D8-A1XB-01 TCGA-D8-A1XB-01A-11D-A14H-05 7badd356-a8c5-4c61-a520-27a25695f71e TCGA-D8-A1XB-01 TCGA-D8-A1XB-01A-11D-A14G-09 TCGA-D8-A1XB-01 TCGA-D8-A1XB-01A-11D-A14G-09 8a2adff0-2527-43fa-ad17-a3081e22f846 TCGA-D8-A1XB-01A-11D-A14F-01 TCGA-D8-A1XB-01 8a2adff0-2527-43fa-ad17-a3081e22f846 TCGA-D8-A1XB-01A-11D-A14F-01 TCGA-D8-A1XC-01 Stage IIIB 85 3 Stage IIIB 81 Positive FEMALE Negative Negative M0 Positive N1 81 0 LumA Positive enrollment T_Other T4 LIVING TCGA-D8-A1XC-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-D8-A1XC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO 85 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-D8-A1XC-F29439 TCGA-D8-A1XC TCGA-D8-A1XC-01A Positive Positive Modified Radical Mastectomy NO -31220 215 377 0 81 [Discrepancy] NO % IHC Scheduled Follow-up Submission 2012-3-26 FEMALE 1+ Mucinous Carcinoma No C50.9 8480/3 C50.9 YES intraoperative examination Other method, specify: 260 NO Negative 20 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 7 Bone Distant Metastasis YES 1 0 false No M0 N1a T4b Stage IIIB TCGA-D8-A1XC.E5D2E429-C41C-47E2-96CB-F3B6F412499B.pdf A1XC WITH TUMOR %IHC >75% >75% YES NO Primary Tumor 01 7th NO YES NO D8 Breast A DECEASED 2010 4328ae51-6063-4296-b266-a70bc5dda94f 4328ae51-6063-4296-b266-a70bc5dda94f TCGA-D8-A1XC-01A-21-A17K-20 TCGA-D8-A1XC-01A-11D-A14G-09 TCGA-D8-A1XC-01 TCGA-D8-A1XC-01A-11D-A14H-05 d91c5cb0-55c9-4cf9-814c-d26df5d0a971 TCGA-D8-A1XC-01 TCGA-D8-A1XC-01A-11D-A14G-09 TCGA-D8-A1XC-01 TCGA-D8-A1XC-01A-11D-A14G-09 4328ae51-6063-4296-b266-a70bc5dda94f TCGA-D8-A1XC-01A-11D-A14F-01 TCGA-D8-A1XC-01 4328ae51-6063-4296-b266-a70bc5dda94f TCGA-D8-A1XC-01A-11D-A14F-01 TCGA-D8-A1XD-01 Stage IIIA 36 4 Stage IIIA 155 Positive FEMALE Negative Negative M0 Positive N2 155 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A1XD-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 TCGA-D8-A1XD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 36 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XD-F29440 TCGA-D8-A1XD TCGA-D8-A1XD-01A Positive Positive Modified Radical Mastectomy NO -13510 188 0 522 NO % IHC Scheduled Follow-up Submission 2012-3-19 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES [Discrepancy] 210 NO Negative 18 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 5 NO 6 false No M0 N2a T1c Stage IIIA TCGA-D8-A1XD.D5614445-4EBF-4050-8FC6-D34D5CAADD82.pdf A1XD TUMOR FREE %IHC >75% >75% YES YES Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 af520d74-dc8a-4d36-bd2c-80bc23e6d029 af520d74-dc8a-4d36-bd2c-80bc23e6d029 TCGA-D8-A1XD-01A-21-A17K-20 TCGA-D8-A1XD-01 TCGA-D8-A1XD-01A-11D-A14H-05 71a3ddcc-c443-445f-b3c6-e0d36183ac53 TCGA-D8-A1XD-01 TCGA-D8-A1XD-01 af520d74-dc8a-4d36-bd2c-80bc23e6d029 TCGA-D8-A1XD-01A-11D-A14F-01 TCGA-D8-A1XD-01 af520d74-dc8a-4d36-bd2c-80bc23e6d029 TCGA-D8-A1XD-01A-11D-A14F-01 TCGA-D8-A1XF-01 Stage IIA 45 3 Stage IIA 197 Positive FEMALE Negative Negative M0 Negative N0 197 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1XF-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-D8-A1XF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XF-F29442 TCGA-D8-A1XF TCGA-D8-A1XF-01A Positive Positive Modified Radical Mastectomy NO -16787 170 0 463 NO % IHC Scheduled Follow-up Submission 2012-3-19 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: 180 NO Negative 8 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 5 NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1XF.FCBB54EB-6FBF-4DC4-B4D5-DB533687FA58.pdf A1XF TUMOR FREE %IHC >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 80562b20-3e3e-4f77-8ca2-958f8636d720 80562b20-3e3e-4f77-8ca2-958f8636d720 TCGA-D8-A1XF-01A-21-A17K-20 TCGA-D8-A1XF-01A-11D-A14G-09 TCGA-D8-A1XF-01 TCGA-D8-A1XF-01A-11D-A14H-05 83d58431-912e-4861-90cb-1dffc7d4a8b0 TCGA-D8-A1XF-01 TCGA-D8-A1XF-01A-11D-A14G-09 TCGA-D8-A1XF-01 TCGA-D8-A1XF-01A-11D-A14G-09 80562b20-3e3e-4f77-8ca2-958f8636d720 TCGA-D8-A1XF-01A-11D-A14F-01 TCGA-D8-A1XF-01 80562b20-3e3e-4f77-8ca2-958f8636d720 TCGA-D8-A1XF-01A-11D-A14F-01 TCGA-D8-A1XG-01 Stage IIIB 86 3 Stage IIIB 196 Positive FEMALE Negative Negative M0 Positive N1 196 0 LumA Negative enrollment T_Other T4 LIVING TCGA-D8-A1XG-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-D8-A1XG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 86 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-D8-A1XG-F29444 TCGA-D8-A1XG TCGA-D8-A1XG-01A Positive Negative Modified Radical Mastectomy YES -31748 169 0 448 NO % IHC Scheduled Follow-up Submission 2012-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: 590 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 NO 2 0 false No M0 N1a T4b Stage IIIB TCGA-D8-A1XG.AA869507-1B46-4812-8EC5-A4E01C588E6E.pdf A1XG TUMOR FREE 10-75% YES NO Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 56bc2076-bafe-47aa-8255-9f03d438cb00 56bc2076-bafe-47aa-8255-9f03d438cb00 TCGA-D8-A1XG-01A-21-A17K-20 TCGA-D8-A1XG-01A-11D-A14G-09 TCGA-D8-A1XG-01 TCGA-D8-A1XG-01A-11D-A14H-05 c51c59e6-0a2c-4597-88df-59166bf2c096 TCGA-D8-A1XG-01 TCGA-D8-A1XG-01A-11D-A14G-09 TCGA-D8-A1XG-01 TCGA-D8-A1XG-01A-11D-A14G-09 56bc2076-bafe-47aa-8255-9f03d438cb00 TCGA-D8-A1XG-01A-11D-A14F-01 TCGA-D8-A1XG-01 56bc2076-bafe-47aa-8255-9f03d438cb00 TCGA-D8-A1XG-01A-11D-A14F-01 TCGA-D8-A1XJ-01 Stage IIIA 76 1 Stage IIIA 352 Positive FEMALE Positive Negative M0 Positive N1 352 0 Her2 Positive enrollment T_Other T3 LIVING TCGA-D8-A1XJ-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 5 TCGA-D8-A1XJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Upper Outer Quadrant|Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XJ-F30111 TCGA-D8-A1XJ TCGA-D8-A1XJ-01A Positive Positive Modified Radical Mastectomy -27967 295 0 663 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE Hercep Test TM Dako 3+ Other, specify No C50.9 8523/3 C50.9 YES Fine needle aspiration biopsy 440 NO Positive 43 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 7 NO 2 false No MX N1a T3 Stage IIIA TCGA-D8-A1XJ.EEA126DE-A667-4373-9DC5-96B55E4ABF07.pdf A1XJ TUMOR FREE manual counting 10-75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 ef91ee42-e50f-44f7-967a-48698e920d12 ef91ee42-e50f-44f7-967a-48698e920d12 TCGA-D8-A1XJ-01A-21-A17K-20 TCGA-D8-A1XJ-01A-11D-A14K-09 TCGA-D8-A1XJ-01 TCGA-D8-A1XJ-01A-11D-A14N-05 9dcb0e51-ac2f-4954-ac24-a1c9e20e7c8a TCGA-D8-A1XJ-01 TCGA-D8-A1XJ-01A-11D-A14K-09 TCGA-D8-A1XJ-01 TCGA-D8-A1XJ-01A-11D-A14K-09 ef91ee42-e50f-44f7-967a-48698e920d12 TCGA-D8-A1XJ-01A-11D-A14J-01 TCGA-D8-A1XJ-01 ef91ee42-e50f-44f7-967a-48698e920d12 TCGA-D8-A1XJ-01A-11D-A14J-01 TCGA-D8-A1XK-01 Stage IB 55 1 Stage IIB 326 Negative FEMALE Negative Negative M0 Positive N1 326 0 Basal Negative enrollment T_Other T2 LIVING TCGA-D8-A1XK-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 14 cluster 5 TCGA-D8-A1XK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-D8-A1XK-F30074 TCGA-D8-A1XK TCGA-D8-A1XK-01A Negative Negative Modified Radical Mastectomy -20092 275 0 441 NO Scheduled Follow-up Submission 2012-2-4 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 260 NO Negative 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 3 false No MX N1a T2 Stage IIB TCGA-D8-A1XK.B3DB4F9E-C91B-4913-93E8-F18FF22CBA7C.pdf A1XK TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 e4edbc10-8939-4bbf-befa-ee44229e4394 e4edbc10-8939-4bbf-befa-ee44229e4394 TCGA-D8-A1XK-01A-11-A17K-20 TCGA-D8-A1XK-01 TCGA-D8-A1XK-01A-21D-A14N-05 567f0c52-eb40-43cc-a34c-a7e1714b420a TCGA-D8-A1XK-01 TCGA-D8-A1XK-01A-21D-A14K-09 TCGA-D8-A1XK-01 e4edbc10-8939-4bbf-befa-ee44229e4394 TCGA-D8-A1XK-01A-21D-A14J-01 TCGA-D8-A1XK-01 e4edbc10-8939-4bbf-befa-ee44229e4394 TCGA-D8-A1XK-01A-21D-A14J-01 TCGA-D8-A1XL-01 Stage IIB 34 1 Stage IIB 319 Positive FEMALE Negative Negative M0 Positive N1 319 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1XL-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 3 TCGA-D8-A1XL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XL-F29990 TCGA-D8-A1XL TCGA-D8-A1XL-01A Positive Positive Lumpectomy -12668 282 0 606 NO manual counting Scheduled Follow-up Submission 2012-3-31 FEMALE HercepTest TM Dako 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 260 NO Equivocal Negative 13 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 7 NO 2 false No MX N1a T2 Stage IIB TCGA-D8-A1XL.762963FB-3D8C-4616-8C8C-0CD3E45FD243.pdf A1XL TUMOR FREE manual counting >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 26f5aec2-a2d8-4151-b975-33d7518e36d0 26f5aec2-a2d8-4151-b975-33d7518e36d0 TCGA-D8-A1XL-01A-21-A17K-20 TCGA-D8-A1XL-01A-11D-A14K-09 TCGA-D8-A1XL-01 TCGA-D8-A1XL-01A-11D-A14N-05 2505f3cc-34a7-448a-9935-97126fec7c57 TCGA-D8-A1XL-01 TCGA-D8-A1XL-01A-11D-A14K-09 TCGA-D8-A1XL-01 TCGA-D8-A1XL-01A-11D-A14K-09 26f5aec2-a2d8-4151-b975-33d7518e36d0 TCGA-D8-A1XL-01A-11D-A14J-01 TCGA-D8-A1XL-01 26f5aec2-a2d8-4151-b975-33d7518e36d0 TCGA-D8-A1XL-01A-11D-A14J-01 TCGA-D8-A1XM-01 Stage IA 57 3 Stage I 218 Positive FEMALE Negative Negative M0 Negative N0 218 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A1XM-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1XM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-D8-A1XM-F29445 TCGA-D8-A1XM TCGA-D8-A1XM-01A Positive Positive Lumpectomy NO -21056 189 0 538 NO % IHC Scheduled Follow-up Submission 2012-3-19 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 200 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 0 false No M0 N0 T1c Stage IA TCGA-D8-A1XM.7E48315C-3717-40DB-8773-71D070AFC47B.pdf A1XM TUMOR FREE %IHC >75% >75% YES YES Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 3049e9ab-8e65-4264-865a-b7a14e27aae1 3049e9ab-8e65-4264-865a-b7a14e27aae1 TCGA-D8-A1XM-01A-11-A17K-20 TCGA-D8-A1XM-01A-21D-A14K-09 TCGA-D8-A1XM-01 TCGA-D8-A1XM-01A-21D-A14N-05 6885966b-8453-46b3-8f90-6dfc1117e87b TCGA-D8-A1XM-01 TCGA-D8-A1XM-01A-21D-A14K-09 TCGA-D8-A1XM-01 TCGA-D8-A1XM-01A-21D-A14K-09 3049e9ab-8e65-4264-865a-b7a14e27aae1 TCGA-D8-A1XM-01A-21D-A14J-01 TCGA-D8-A1XM-01 3049e9ab-8e65-4264-865a-b7a14e27aae1 TCGA-D8-A1XM-01A-21D-A14J-01 TCGA-D8-A1XO-01 Stage IIB 56 2 Stage IIB 242 Positive FEMALE Negative Negative M0 Positive N1 242 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A1XO-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 7 mutation cluster 4 TCGA-D8-A1XO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XO-F72206 TCGA-D8-A1XO Positive Positive Modified Radical Mastectomy NO -20606 0 1682 NO % IHC Scheduled Follow-up Submission 2015-4-29 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 7 NO 1 0 No M0 N1a T2 Stage IIB A1XO TUMOR FREE %IHC >75% >75% YES YES YES Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2010 eddd285e-a946-4e4e-a21d-6e84ed397594 eddd285e-a946-4e4e-a21d-6e84ed397594 TCGA-D8-A1XO-01A-21-A17K-20 TCGA-D8-A1XO-01A-11D-A14K-09 TCGA-D8-A1XO-01 TCGA-D8-A1XO-01A-11D-A14N-05 f75c4694-aa3e-4855-8b51-bfb5de5373fc TCGA-D8-A1XO-01 TCGA-D8-A1XO-01A-11D-A14K-09 TCGA-D8-A1XO-01 TCGA-D8-A1XO-01A-11D-A14K-09 eddd285e-a946-4e4e-a21d-6e84ed397594 TCGA-D8-A1XO-01A-11D-A14J-01 TCGA-D8-A1XO-01 eddd285e-a946-4e4e-a21d-6e84ed397594 TCGA-D8-A1XO-01A-11D-A14J-01 TCGA-D8-A1XQ-01 Stage IIA 69 1 Stage IIA 177 Negative FEMALE Negative Negative M0 Negative N0 177 0 Basal Negative enrollment T_Other T2 LIVING TCGA-D8-A1XQ-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 TCGA-D8-A1XQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XQ-F29449 TCGA-D8-A1XQ TCGA-D8-A1XQ-01A Negative Negative Modified Radical Mastectomy NO -25345 158 0 499 NO % IHC Scheduled Follow-up Submission 2012-3-26 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 100 NO Negative 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1XQ.33B6269D-1D59-4184-A786-2BEB73F6D3A8.pdf A1XQ TUMOR FREE 0% YES <10% NO Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 0c7fc003-950b-4138-8390-036c072b640e 0c7fc003-950b-4138-8390-036c072b640e TCGA-D8-A1XQ-01A-21-A17K-20 TCGA-D8-A1XQ-01 TCGA-D8-A1XQ-01A-11D-A14N-05 43fa736b-5235-4357-8ae7-2b0029efecfc TCGA-D8-A1XQ-01 TCGA-D8-A1XQ-01A-11D-A14K-09 TCGA-D8-A1XQ-01 0c7fc003-950b-4138-8390-036c072b640e TCGA-D8-A1XQ-01A-11D-A14J-01 TCGA-D8-A1XQ-01 0c7fc003-950b-4138-8390-036c072b640e TCGA-D8-A1XQ-01A-11D-A14J-01 TCGA-D8-A1XR-01 Stage IIB 56 2 Stage IIB 168 Positive FEMALE Negative Negative M0 Positive N1 168 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1XR-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-D8-A1XR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XR-F29451 TCGA-D8-A1XR TCGA-D8-A1XR-01A Positive Positive Modified Radical Mastectomy NO -20488 162 0 482 NO % IHC Scheduled Follow-up Submission 2012-3-6 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Negative 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 3 NO 2 0 false No M0 N1a T2 Stage IIB TCGA-D8-A1XR.D9A0E659-99BC-4704-AC85-E63098BA731D.pdf A1XR TUMOR FREE %IHC >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 9c55164e-fb87-46b5-87ce-cc277ba378f5 9c55164e-fb87-46b5-87ce-cc277ba378f5 TCGA-D8-A1XR-01A-21-A17K-20 TCGA-D8-A1XR-01A-11D-A14K-09 TCGA-D8-A1XR-01 TCGA-D8-A1XR-01A-11D-A14N-05 f97f91f5-8d8b-494d-847c-848251489758 TCGA-D8-A1XR-01 TCGA-D8-A1XR-01A-11D-A14K-09 TCGA-D8-A1XR-01 TCGA-D8-A1XR-01A-11D-A14K-09 9c55164e-fb87-46b5-87ce-cc277ba378f5 TCGA-D8-A1XR-01A-11D-A14J-01 TCGA-D8-A1XR-01 9c55164e-fb87-46b5-87ce-cc277ba378f5 TCGA-D8-A1XR-01A-11D-A14J-01 TCGA-D8-A1XS-01 Stage IIIC 48 3 Stage IIIC 18 Positive MALE Positive Negative M0 Positive N3 18 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1XS-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1XS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XS-F12133 TCGA-D8-A1XS TCGA-D8-A1XS-01A Positive Positive Modified Radical Mastectomy NO -17708 164 0 496 NO % IHC Scheduled Follow-up Submission 2012-3-19 MALE 3+ Other, specify No C50.9 8507/3 C50.9 YES Core needle biopsy 340 NO Positive 28 Negative 2 4 NO 25 0 false No M0 N3a T2 Stage IIIC TCGA-D8-A1XS.6C97C157-05A0-45CE-91E9-3DC8946EFEDE.pdf A1XS TUMOR FREE %IHC >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 11b43261-66e4-4c28-8d24-6e38b4295f34 11b43261-66e4-4c28-8d24-6e38b4295f34 TCGA-D8-A1XS-01A-21-A17K-20 TCGA-D8-A1XS-01A-11D-A14K-09 TCGA-D8-A1XS-01 TCGA-D8-A1XS-01A-11D-A14N-05 22edabb4-30a0-4d5d-95f2-3ee9c3883fd1 TCGA-D8-A1XS-01 TCGA-D8-A1XS-01A-11D-A14K-09 TCGA-D8-A1XS-01 TCGA-D8-A1XS-01A-11D-A14K-09 11b43261-66e4-4c28-8d24-6e38b4295f34 TCGA-D8-A1XS-01A-11D-A14J-01 TCGA-D8-A1XS-01 11b43261-66e4-4c28-8d24-6e38b4295f34 TCGA-D8-A1XS-01A-11D-A14J-01 TCGA-D8-A1XT-01 Stage IIA 61 1 Stage IIA 193 Negative FEMALE Positive Negative M0 Positive N1 193 0 Her2 Negative enrollment T1 T1 LIVING TCGA-D8-A1XT-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-D8-A1XT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XT-F29454 TCGA-D8-A1XT TCGA-D8-A1XT-01A Negative Negative Modified Radical Mastectomy NO -22448 144 0 506 NO % IHC Scheduled Follow-up Submission 2012-3-26 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 230 NO Positive 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 3 0 false No M0 N1a T1c Stage IIA TCGA-D8-A1XT.99050E48-8DFE-4405-B8D8-7649CE2C9CFF.pdf A1XT TUMOR FREE %IHC 0% 0% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 47901dff-8acf-4afa-9e42-851d98777085 47901dff-8acf-4afa-9e42-851d98777085 TCGA-D8-A1XT-01A-21-A17K-20 TCGA-D8-A1XT-01A-11D-A14K-09 TCGA-D8-A1XT-01 TCGA-D8-A1XT-01A-11D-A14N-05 0321074c-bcf8-42f7-9212-b2673201860d TCGA-D8-A1XT-01 TCGA-D8-A1XT-01A-11D-A14K-09 TCGA-D8-A1XT-01 TCGA-D8-A1XT-01A-11D-A14K-09 47901dff-8acf-4afa-9e42-851d98777085 TCGA-D8-A1XT-01A-11D-A14J-01 TCGA-D8-A1XT-01 47901dff-8acf-4afa-9e42-851d98777085 TCGA-D8-A1XT-01A-11D-A14J-01 TCGA-D8-A1XU-01 Stage IA 56 Stage I 149 Positive FEMALE Negative Negative M0 Negative N0 149 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A1XU-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-D8-A1XU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-D8-A1XU-F29456 TCGA-D8-A1XU TCGA-D8-A1XU-01A Negative Positive Positive Modified Radical Mastectomy NO -20715 102 0 395 NO % IHC Scheduled Follow-up Submission 2012-3-26 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 6 NO 0 0 false No M0 N0 T1c Stage IA TCGA-D8-A1XU.845F8FCF-CF3C-4CEF-B673-A57DE626939C.pdf A1XU TUMOR FREE %IHC 10-75% >75% YES NO Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 0718af55-25eb-45b7-9e76-5d663a00dca5 0718af55-25eb-45b7-9e76-5d663a00dca5 TCGA-D8-A1XU-01A-21-A17K-20 TCGA-D8-A1XU-01A-11D-A14K-09 TCGA-D8-A1XU-01 TCGA-D8-A1XU-01A-11D-A14N-05 d4978f30-9304-47e3-a4a7-1c5b32f6ddde TCGA-D8-A1XU-01 TCGA-D8-A1XU-01A-11D-A14K-09 TCGA-D8-A1XU-01 TCGA-D8-A1XU-01A-11D-A14K-09 0718af55-25eb-45b7-9e76-5d663a00dca5 TCGA-D8-A1XU-01A-11D-A14J-01 TCGA-D8-A1XU-01 0718af55-25eb-45b7-9e76-5d663a00dca5 TCGA-D8-A1XU-01A-11D-A14J-01 TCGA-D8-A1XV-01 Stage IIA 84 3 Stage IIA 146 Positive FEMALE Negative Negative M0 Negative N0 146 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A1XV-01 Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 7 mutation c1uster 9 TCGA-D8-A1XV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 84 Right Lower Inner Quadrant Sentinel node biopsy alone TCGA-D8-A1XV-F29457 TCGA-D8-A1XV TCGA-D8-A1XV-01A Positive Positive Modified Radical Mastectomy NO -30830 103 0 461 NO % IHC Scheduled Follow-up Submission 2012-3-19 FEMALE 2+ not amplified Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Fine needle aspiration biopsy 420 NO Equivocal Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 7 NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1XV.D3AC6B8A-CC8F-475C-BD2E-A869BD07D94C.pdf A1XV TUMOR FREE %IHC >75% >75% YES NO Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6 5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6 TCGA-D8-A1XV-01A-21-A17K-20 TCGA-D8-A1XV-01A-11D-A14K-09 TCGA-D8-A1XV-01 TCGA-D8-A1XV-01A-11D-A14N-05 fc4169c4-863c-42b2-9b67-2682355d343d TCGA-D8-A1XV-01 TCGA-D8-A1XV-01A-11D-A14K-09 TCGA-D8-A1XV-01 TCGA-D8-A1XV-01A-11D-A14K-09 5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6 TCGA-D8-A1XV-01A-11D-A14J-01 TCGA-D8-A1XV-01 5a0e92d3-7eb2-4ab2-8ee7-f2f180c6a6e6 TCGA-D8-A1XV-01A-11D-A14J-01 TCGA-D8-A1XW-01 Stage IIA 53 3 Stage IIA 117 Negative FEMALE Negative Negative M0 Negative N0 117 0 Normal Positive enrollment T_Other T2 LIVING TCGA-D8-A1XW-01 High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-D8-A1XW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-D8-A1XW-F72205 TCGA-D8-A1XW TCGA-D8-A1XW-01A Negative Positive Modified Radical Mastectomy NO -19478 76 0 1309 NO % IHC Scheduled Follow-up Submission 2015-4-29 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 310 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A1XW.BD71F606-58BC-46B9-8A03-CB25D5BECA96.pdf A1XW TUMOR FREE 0% YES YES <10% NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 8e24b2f8-459c-4861-9d31-d171e8d1a08b 8e24b2f8-459c-4861-9d31-d171e8d1a08b TCGA-D8-A1XW-01A-21-A17K-20 TCGA-D8-A1XW-01A-11D-A14K-09 TCGA-D8-A1XW-01 TCGA-D8-A1XW-01A-11D-A14N-05 645dc9bf-f601-46eb-84e0-cb5df8d9981b TCGA-D8-A1XW-01 TCGA-D8-A1XW-01A-11D-A14K-09 TCGA-D8-A1XW-01 TCGA-D8-A1XW-01A-11D-A14K-09 8e24b2f8-459c-4861-9d31-d171e8d1a08b TCGA-D8-A1XW-01A-11D-A14J-01 TCGA-D8-A1XW-01 8e24b2f8-459c-4861-9d31-d171e8d1a08b TCGA-D8-A1XW-01A-11D-A14J-01 TCGA-D8-A1XY-01 Stage IIA 74 Stage IIA 81 Positive FEMALE Positive Negative M0 Negative N0 81 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A1XY-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-D8-A1XY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1XY-F29994 TCGA-D8-A1XY TCGA-D8-A1XY-01A Positive Positive Simple Mastectomy -27106 135 0 503 NO manual counting Scheduled Follow-up Submission 2012-3-31 FEMALE HerceptTest TM Dako 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 190 NO Positive 3 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 0 false No MX N0 T2 Stage IIA TCGA-D8-A1XY.9D1EDFE8-FA4E-4F6C-99E9-1FEB12175D6C.pdf A1XY TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 5b233291-8984-4925-8be4-3911f541a15f 5b233291-8984-4925-8be4-3911f541a15f TCGA-D8-A1XY-01A-21-A17K-20 TCGA-D8-A1XY-01A-11D-A14K-09 TCGA-D8-A1XY-01 TCGA-D8-A1XY-01A-11D-A14N-05 68b05ccb-ae51-4690-9b4d-e18bc9b4e9ea TCGA-D8-A1XY-01 TCGA-D8-A1XY-01A-11D-A14K-09 TCGA-D8-A1XY-01 TCGA-D8-A1XY-01A-11D-A14K-09 5b233291-8984-4925-8be4-3911f541a15f TCGA-D8-A1XY-01A-11D-A14J-01 TCGA-D8-A1XY-01 5b233291-8984-4925-8be4-3911f541a15f TCGA-D8-A1XY-01A-11D-A14J-01 TCGA-D8-A1XZ-01 Stage IIIA 81 1 Stage IIIA 120 Positive FEMALE Negative Negative M0 Positive N2 120 0 LumB Negative enrollment T1 T1 LIVING TCGA-D8-A1XZ-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 5 mutation cluster 13 TCGA-D8-A1XZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 81 Right Lower Inner Quadrant Axillary lymph node dissection alone TCGA-D8-A1XZ-F30077 TCGA-D8-A1XZ TCGA-D8-A1XZ-01A Positive Negative Modified Radical Mastectomy -29916 98 0 466 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 130 NO Negative 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO 6 false No MX N2a T1c Stage IIIA TCGA-D8-A1XZ.1D6EE39C-DE75-4595-943A-CF53873F96BF.pdf A1XZ TUMOR FREE >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 8b592b3b-47b5-45fa-98eb-01bf75096605 8b592b3b-47b5-45fa-98eb-01bf75096605 TCGA-D8-A1XZ-01A-21-A17K-20 TCGA-D8-A1XZ-01A-11D-A14K-09 TCGA-D8-A1XZ-01 TCGA-D8-A1XZ-01A-11D-A14N-05 6de7dbf5-0fdb-4871-a5ba-5909cd85f6e1 TCGA-D8-A1XZ-01 TCGA-D8-A1XZ-01A-11D-A14K-09 TCGA-D8-A1XZ-01 TCGA-D8-A1XZ-01A-11D-A14K-09 8b592b3b-47b5-45fa-98eb-01bf75096605 TCGA-D8-A1XZ-01A-11D-A14J-01 TCGA-D8-A1XZ-01 8b592b3b-47b5-45fa-98eb-01bf75096605 TCGA-D8-A1XZ-01A-11D-A14J-01 TCGA-D8-A1Y0-01 Stage IIIA 65 5 Stage IIIA 166 Positive FEMALE Negative Negative M0 Positive N2 166 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A1Y0-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-D8-A1Y0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Axillary lymph node dissection alone TCGA-D8-A1Y0-F30080 TCGA-D8-A1Y0 TCGA-D8-A1Y0-01A Positive Positive Modified Radical Mastectomy -24083 104 0 472 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Incisional Biopsy 190 NO Negative 15 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 NO 9 false No MX N2a T1c Stage IIIA TCGA-D8-A1Y0.53ED4388-8CD2-4925-81A9-9C4792C83566.pdf A1Y0 TUMOR FREE manual counting >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 8dd30d68-86d0-456f-814c-ae59a5c0a071 8dd30d68-86d0-456f-814c-ae59a5c0a071 TCGA-D8-A1Y0-01A-21-A17K-20 TCGA-D8-A1Y0-01A-11D-A14K-09 TCGA-D8-A1Y0-01 TCGA-D8-A1Y0-01A-11D-A14N-05 afa6d295-e75a-41fa-a678-2b0d4d82cbc2 TCGA-D8-A1Y0-01 TCGA-D8-A1Y0-01A-11D-A14K-09 TCGA-D8-A1Y0-01 TCGA-D8-A1Y0-01A-11D-A14K-09 8dd30d68-86d0-456f-814c-ae59a5c0a071 TCGA-D8-A1Y0-01A-11D-A14J-01 TCGA-D8-A1Y0-01 8dd30d68-86d0-456f-814c-ae59a5c0a071 TCGA-D8-A1Y0-01A-11D-A14J-01 TCGA-D8-A1Y1-01 Stage IIIA 80 2 Stage IIIA 115 Positive FEMALE Negative Negative M0 Positive N1 115 0 LumB Positive enrollment T_Other T3 LIVING TCGA-D8-A1Y1-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 1 TCGA-D8-A1Y1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Left Upper Inner Quadrant|Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1Y1-F30084 TCGA-D8-A1Y1 TCGA-D8-A1Y1-01A Positive Positive Modified Radical Mastectomy -29474 93 302 0 116 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 200 NO Negative 22 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 NO 1 false No MX N1a T3 Stage IIIA TCGA-D8-A1Y1.1B198706-8844-452A-8F5B-8880A239717C.pdf A1Y1 WITH TUMOR manual counting >75% 10-75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A DECEASED 2010 2d49cea0-0d08-4203-afa0-a1252cbf739a 2d49cea0-0d08-4203-afa0-a1252cbf739a TCGA-D8-A1Y1-01A-11-A17K-20 TCGA-D8-A1Y1-01A-21D-A14K-09 TCGA-D8-A1Y1-01 TCGA-D8-A1Y1-01A-21D-A14N-05 2a4e381f-db2d-4b2e-828c-9264d218439c TCGA-D8-A1Y1-01 TCGA-D8-A1Y1-01A-21D-A14K-09 TCGA-D8-A1Y1-01 TCGA-D8-A1Y1-01A-21D-A14K-09 2d49cea0-0d08-4203-afa0-a1252cbf739a TCGA-D8-A1Y1-01A-21D-A14J-01 TCGA-D8-A1Y1-01 2d49cea0-0d08-4203-afa0-a1252cbf739a TCGA-D8-A1Y1-01A-21D-A14J-01 TCGA-D8-A1Y2-01 Stage IIA 71 4 Stage IIA 72 Positive FEMALE Negative Negative M0 Negative N0 72 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1Y2-01 Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 mutation cluster 4 TCGA-D8-A1Y2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1Y2-F30086 TCGA-D8-A1Y2 TCGA-D8-A1Y2-01A Positive Positive Modified Radical Mastectomy -26021 65 0 433 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE Venten 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 470 NO Indeterminate Negative 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 0 false No MX N0 T2 Stage IIA TCGA-D8-A1Y2.4ACD42D6-9520-4DC6-BB40-9187A4D49981.pdf A1Y2 TUMOR FREE manual counting >75% YES <10% NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 4d184421-3a3d-499a-bdb5-230f45e6d16f 4d184421-3a3d-499a-bdb5-230f45e6d16f TCGA-D8-A1Y2-01A-21-A17K-20 TCGA-D8-A1Y2-01A-11D-A159-09 TCGA-D8-A1Y2-01 TCGA-D8-A1Y2-01A-11D-A161-05 4a0da6ed-16e6-4f14-8f18-0df68e63d002 TCGA-D8-A1Y2-01 TCGA-D8-A1Y2-01A-11D-A159-09 TCGA-D8-A1Y2-01 TCGA-D8-A1Y2-01A-11D-A159-09 4d184421-3a3d-499a-bdb5-230f45e6d16f TCGA-D8-A1Y2-01A-11D-A160-01 TCGA-D8-A1Y2-01 4d184421-3a3d-499a-bdb5-230f45e6d16f TCGA-D8-A1Y2-01A-11D-A160-01 TCGA-D8-A1Y3-01 Stage IIIA 61 4 Stage IIIA 124 Positive FEMALE Negative Negative M0 Positive N2 124 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A1Y3-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 mutation cluster 5 TCGA-D8-A1Y3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A1Y3-F30088 TCGA-D8-A1Y3 TCGA-D8-A1Y3-01A Positive Positive Modified Radical Mastectomy -22317 62 0 430 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE Venten 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 300 NO Indeterminate Negative 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 5 false No MX N2a T2 Stage IIIA TCGA-D8-A1Y3.E8D4229D-5049-4991-BDE0-AFC2CBC1827E.pdf A1Y3 TUMOR FREE manual counting >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9 e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9 TCGA-D8-A1Y3-01A-21-A17K-20 TCGA-D8-A1Y3-01A-11D-A159-09 TCGA-D8-A1Y3-01 TCGA-D8-A1Y3-01A-11D-A161-05 98a25723-ede5-43a7-988d-5a753c500649 TCGA-D8-A1Y3-01 TCGA-D8-A1Y3-01A-11D-A159-09 TCGA-D8-A1Y3-01 TCGA-D8-A1Y3-01A-11D-A159-09 e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9 TCGA-D8-A1Y3-01A-11D-A160-01 TCGA-D8-A1Y3-01 e65be669-85f6-4a00-8c0f-3ee7d0fb8bf9 TCGA-D8-A1Y3-01A-11D-A160-01 TCGA-D8-A27E-01 Stage IA 66 Stage I 182 Positive FEMALE Negative Negative M0 Negative N0 182 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A27E-01 Quiet C3-BRCA/Luminal cluster 5 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 mutation c1uster 9 TCGA-D8-A27E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-D8-A27E-F30112 TCGA-D8-A27E TCGA-D8-A27E-01A Positive Positive [Discrepancy] NO -24315 204 0 530 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE Hercep Test TM Dako 1+ Other, specify No C50.9 8523/3 C50.9 YES Fine needle aspiration biopsy 110 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 0 false No M0 N0 T1c Stage IA TCGA-D8-A27E.36F6CB19-17FE-47FA-BFCA-3846578C028B.pdf A27E TUMOR FREE >75% YES <10% YES Primary Tumor 01 quadrantectomy 7th YES YES NO D8 Breast A LIVING 2010 5e32f7e7-6022-4ce2-aa79-4c6671493406 5e32f7e7-6022-4ce2-aa79-4c6671493406 TCGA-D8-A27E-01A-21-A17K-20 TCGA-D8-A27E-01A-11D-A16D-09 TCGA-D8-A27E-01 TCGA-D8-A27E-01A-11D-A16G-05 bac504b5-18a0-4fdb-aea0-4b6e76e8eeb9 TCGA-D8-A27E-01 TCGA-D8-A27E-01A-11D-A16D-09 TCGA-D8-A27E-01 TCGA-D8-A27E-01A-11D-A16D-09 5e32f7e7-6022-4ce2-aa79-4c6671493406 TCGA-D8-A27E-01A-11D-A16C-01 TCGA-D8-A27E-01 5e32f7e7-6022-4ce2-aa79-4c6671493406 TCGA-D8-A27E-01A-11D-A16C-01 TCGA-D8-A27F-01 Stage IIA 40 1 Stage IIA 227 Negative FEMALE Negative Negative M0 Negative N0 227 0 Basal Negative enrollment T_Other T2 LIVING TCGA-D8-A27F-01 BRCA-LUAD+ C1-LUAD-enriched cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 12 mutation cluster 12 TCGA-D8-A27F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A27F-F29515 TCGA-D8-A27F TCGA-D8-A27F-01A Negative Negative Modified Radical Mastectomy NO -14731 166 0 488 NO Scheduled Follow-up Submission 2012-3-21 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: 320 NO Negative 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A27F.976C6F9E-DDCB-42F4-BD2C-A4D715396B47.pdf A27F TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 0a69935d-9552-4792-9b2e-1a630114691e 0a69935d-9552-4792-9b2e-1a630114691e TCGA-D8-A27F-01A-21-A17K-20 TCGA-D8-A27F-01A-11D-A16D-09 TCGA-D8-A27F-01 TCGA-D8-A27F-01A-11D-A16G-05 7ce10802-b13b-47af-abe3-b8deaf2c64f4 TCGA-D8-A27F-01 TCGA-D8-A27F-01A-11D-A16D-09 TCGA-D8-A27F-01 TCGA-D8-A27F-01A-11D-A16D-09 0a69935d-9552-4792-9b2e-1a630114691e TCGA-D8-A27F-01A-11D-A16C-01 TCGA-D8-A27F-01 0a69935d-9552-4792-9b2e-1a630114691e TCGA-D8-A27F-01A-11D-A16C-01 TCGA-D8-A27G-01 Stage IIA 75 2 Stage IIA 209 Positive FEMALE Negative Negative M0 Negative N0 209 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A27G-01 Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-D8-A27G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A27G-F29519 TCGA-D8-A27G TCGA-D8-A27G-01A Positive Positive Modified Radical Mastectomy NO -27521 156 0 409 NO manual counting Scheduled Follow-up Submission 2012-3-21 FEMALE 2+ not amplified Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 170 NO Equivocal Negative 31 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 0 0 false No M0 N0 T2 Stage IIA TCGA-D8-A27G.F8B8EEB1-0603-4181-9BD3-209143024EF8.pdf A27G TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2010 2ba9072c-39b9-438d-9a2c-0726dc3dc659 2ba9072c-39b9-438d-9a2c-0726dc3dc659 TCGA-D8-A27G-01A-21-A17K-20 TCGA-D8-A27G-01 TCGA-D8-A27G-01A-11D-A16G-05 10a00b30-4059-4d67-90a5-6fc691cb676e TCGA-D8-A27G-01 TCGA-D8-A27G-01A-11D-A16D-09 TCGA-D8-A27G-01 2ba9072c-39b9-438d-9a2c-0726dc3dc659 TCGA-D8-A27G-01A-11D-A16C-01 TCGA-D8-A27G-01 2ba9072c-39b9-438d-9a2c-0726dc3dc659 TCGA-D8-A27G-01A-11D-A16C-01 TCGA-D8-A27H-01 Stage IIA 72 1 Stage IIA 140 Negative FEMALE Negative Negative M0 Negative N0 140 0 Basal Negative enrollment T_Other T2 LIVING TCGA-D8-A27H-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 3 mutation cluster 2 TCGA-D8-A27H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Right Upper Outer Quadrant No axillary staging TCGA-D8-A27H-F29536 TCGA-D8-A27H TCGA-D8-A27H-01A Negative Negative Modified Radical Mastectomy NO -26588 84 0 397 NO Scheduled Follow-up Submission 2012-3-22 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: 170 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO false No M0 N0 T2 Stage IIA TCGA-D8-A27H.52D7E980-806C-499D-9DB9-40E1D651D9EB.pdf A27H TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 123725b8-4f66-4b97-9726-e0c70300d38e 123725b8-4f66-4b97-9726-e0c70300d38e TCGA-D8-A27H-01A-21-A17K-20 TCGA-D8-A27H-01A-11D-A16D-09 TCGA-D8-A27H-01 TCGA-D8-A27H-01A-11D-A16G-05 54304e23-2f82-43d6-9ace-f054d7a0f410 TCGA-D8-A27H-01 TCGA-D8-A27H-01A-11D-A16D-09 TCGA-D8-A27H-01 TCGA-D8-A27H-01A-11D-A16D-09 123725b8-4f66-4b97-9726-e0c70300d38e TCGA-D8-A27H-01A-11D-A16C-01 TCGA-D8-A27H-01 123725b8-4f66-4b97-9726-e0c70300d38e TCGA-D8-A27H-01A-11D-A16C-01 TCGA-D8-A27I-01 Stage IIIA 58 3 Stage IIIA 185 Positive FEMALE Negative Negative M0 Positive N2 185 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A27I-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 mutation c1uster 9 TCGA-D8-A27I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A27I-F29521 TCGA-D8-A27I TCGA-D8-A27I-01A Positive Positive Modified Radical Mastectomy NO -21327 132 0 439 NO manual counting Scheduled Follow-up Submission 2012-3-21 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 900 NO Negative 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 4 0 false No M0 N2a T1c Stage IIIA TCGA-D8-A27I.FAB622C2-3E45-4E72-AA36-9530BB830993.pdf A27I TUMOR FREE manual counting >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2010 6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1 6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1 TCGA-D8-A27I-01A-21-A17L-20 TCGA-D8-A27I-01A-11D-A16D-09 TCGA-D8-A27I-01 TCGA-D8-A27I-01A-11D-A16G-05 19440cd1-daa0-4103-9be8-b878a9c59988 TCGA-D8-A27I-01 TCGA-D8-A27I-01A-11D-A16D-09 TCGA-D8-A27I-01 TCGA-D8-A27I-01A-11D-A16D-09 6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1 TCGA-D8-A27I-01A-11D-A16C-01 TCGA-D8-A27I-01 6e144eb1-f9c3-4cb1-9e69-28c63ca7e4d1 TCGA-D8-A27I-01A-11D-A16C-01 TCGA-D8-A27K-01 Stage IIB 47 2 Stage IIB 118 Positive FEMALE Negative Negative M0 Positive N1 118 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A27K-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 mutation cluster 4 TCGA-D8-A27K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-D8-A27K-F72201 TCGA-D8-A27K Positive Positive Modified Radical Mastectomy NO -17426 0 1461 NO manual counting Scheduled Follow-up Submission 2015-4-29 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Negative NO 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 2 No M0 N1a T2 Stage IIB A27K TUMOR FREE manual counting >75% >75% YES YES NO Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2011 c0ecd31a-9cce-45d2-9d04-89c465f9b55d c0ecd31a-9cce-45d2-9d04-89c465f9b55d TCGA-D8-A27K-01A-21-A17L-20 TCGA-D8-A27K-01A-11D-A16D-09 TCGA-D8-A27K-01 TCGA-D8-A27K-01A-11D-A16G-05 d8b985f8-cbad-42bb-995c-42d7f8221ea4 TCGA-D8-A27K-01 TCGA-D8-A27K-01A-11D-A16D-09 TCGA-D8-A27K-01 TCGA-D8-A27K-01A-11D-A16D-09 c0ecd31a-9cce-45d2-9d04-89c465f9b55d TCGA-D8-A27K-01A-11D-A16C-01 TCGA-D8-A27K-01 c0ecd31a-9cce-45d2-9d04-89c465f9b55d TCGA-D8-A27K-01A-11D-A16C-01 TCGA-D8-A27L-01 Stage IIB 49 4 Stage IIIA 125 Positive FEMALE Negative Negative M0 Positive N2 125 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A27L-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 mutation cluster 14 TCGA-D8-A27L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-D8-A27L-F29590 TCGA-D8-A27L TCGA-D8-A27L-01A Positive Positive Modified Radical Mastectomy NO -18025 84 0 499 NO manual counting Scheduled Follow-up Submission 2012-6-26 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 220 NO Negative 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 2 false No M0 N2a T1c Stage IIIA TCGA-D8-A27L.1281F503-C256-4DFF-A3BD-BD5E51CE4249.pdf A27L TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 de27ab29-90b0-4d13-8102-1c2bebc4c29a de27ab29-90b0-4d13-8102-1c2bebc4c29a TCGA-D8-A27L-01A-21-A17L-20 TCGA-D8-A27L-01A-11D-A16D-09 TCGA-D8-A27L-01 TCGA-D8-A27L-01A-11D-A16G-05 5f8e2312-38bd-45f9-b2e3-4b51674613c6 TCGA-D8-A27L-01 TCGA-D8-A27L-01A-11D-A16D-09 TCGA-D8-A27L-01 TCGA-D8-A27L-01A-11D-A16D-09 de27ab29-90b0-4d13-8102-1c2bebc4c29a TCGA-D8-A27L-01A-11D-A16C-01 TCGA-D8-A27L-01 de27ab29-90b0-4d13-8102-1c2bebc4c29a TCGA-D8-A27L-01A-11D-A16C-01 TCGA-D8-A27M-01 Stage IIA 59 1 Stage I 144 Negative FEMALE Negative Negative M0 Negative N0 144 0 Basal Negative enrollment T1 T1 LIVING TCGA-D8-A27M-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 5 mutation cluster 5 TCGA-D8-A27M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-D8-A27M-F29592 TCGA-D8-A27M TCGA-D8-A27M-01A Negative Negative Modified Radical Mastectomy NO -21910 83 0 410 NO Scheduled Follow-up Submission 2012-3-26 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 140 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO false No M0 N0 T1c Stage IA TCGA-D8-A27M.85045216-10EC-473C-96A9-268E71D2B566.pdf A27M TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 20486352-7d5f-4065-ab10-7a3f792ec1e1 20486352-7d5f-4065-ab10-7a3f792ec1e1 TCGA-D8-A27M-01A-21-A17L-20 TCGA-D8-A27M-01A-11D-A16D-09 TCGA-D8-A27M-01 TCGA-D8-A27M-01A-11D-A16G-05 1d3de8e5-df7a-4e6c-a929-e03f23ddf78b TCGA-D8-A27M-01 TCGA-D8-A27M-01A-11D-A16D-09 TCGA-D8-A27M-01 TCGA-D8-A27M-01A-11D-A16D-09 20486352-7d5f-4065-ab10-7a3f792ec1e1 TCGA-D8-A27M-01A-11D-A16C-01 TCGA-D8-A27M-01 20486352-7d5f-4065-ab10-7a3f792ec1e1 TCGA-D8-A27M-01A-11D-A16C-01 TCGA-D8-A27N-01 Stage IIIA 36 5 Stage IIIA 145 Positive FEMALE Positive Negative M0 Positive N2 145 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A27N-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 5 TCGA-D8-A27N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 36 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A27N-F29594 TCGA-D8-A27N TCGA-D8-A27N-01A Positive Positive Modified Radical Mastectomy NO -13243 75 0 519 NO manual counting Scheduled Follow-up Submission 2012-3-26 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Positive 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 4 0 false No M0 N2a T2 Stage IIIA TCGA-D8-A27N.69007BC0-E1DF-4E68-BA6A-352F6A12F233.pdf A27N TUMOR FREE manual counting 10-75% >75% YES NO Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 50808f98-d10b-4190-aff7-428f56abb0f9 50808f98-d10b-4190-aff7-428f56abb0f9 TCGA-D8-A27N-01A-21-A17L-20 TCGA-D8-A27N-01A-11D-A16D-09 TCGA-D8-A27N-01 TCGA-D8-A27N-01A-11D-A16G-05 40a0ee09-0c09-4320-8895-74c68841c341 TCGA-D8-A27N-01 TCGA-D8-A27N-01A-11D-A16D-09 TCGA-D8-A27N-01 TCGA-D8-A27N-01A-11D-A16D-09 50808f98-d10b-4190-aff7-428f56abb0f9 TCGA-D8-A27N-01A-11D-A16C-01 TCGA-D8-A27N-01 50808f98-d10b-4190-aff7-428f56abb0f9 TCGA-D8-A27N-01A-11D-A16C-01 TCGA-D8-A27P-01 Stage IIA 64 2 Stage I 22 Positive FEMALE Negative Negative M0 Negative N0 22 0 LumA Positive enrollment T1 T1 LIVING TCGA-D8-A27P-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 mutation cluster 4 TCGA-D8-A27P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-D8-A27P-F29596 TCGA-D8-A27P TCGA-D8-A27P-01A Positive Positive Modified Radical Mastectomy NO -23576 37 0 49 NO manual counting Scheduled Follow-up Submission 2012-10-26 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES intraoperative examination Other method, specify: 100 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 NO 0 false No M0 N0 T1c Stage IA TCGA-D8-A27P.ACC0A0E7-218F-4112-AC74-9F5D5A512DD3.pdf A27P TUMOR FREE manual counting >75% >75% YES NO Primary Tumor 01 7th NO YES NO D8 Breast A LIVING 2011 189c7b41-4d4e-422e-85a2-1f575b5c8b5c 189c7b41-4d4e-422e-85a2-1f575b5c8b5c TCGA-D8-A27P-01A-21-A17L-20 TCGA-D8-A27P-01A-11D-A16D-09 TCGA-D8-A27P-01 TCGA-D8-A27P-01A-11D-A16G-05 ead322fe-b46f-4cc6-a367-5e7681a6f494 TCGA-D8-A27P-01 TCGA-D8-A27P-01A-11D-A16D-09 TCGA-D8-A27P-01 TCGA-D8-A27P-01A-11D-A16D-09 189c7b41-4d4e-422e-85a2-1f575b5c8b5c TCGA-D8-A27P-01A-11D-A16C-01 TCGA-D8-A27P-01 189c7b41-4d4e-422e-85a2-1f575b5c8b5c TCGA-D8-A27P-01A-11D-A16C-01 TCGA-D8-A27R-01 Stage IIIC 41 5 Stage IIIC 90 Positive FEMALE Negative Negative M0 Positive N3 90 0 LumB Positive enrollment T_Other T2 LIVING TCGA-D8-A27R-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 mutation c1uster 9 TCGA-D8-A27R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A27R-F29701 TCGA-D8-A27R TCGA-D8-A27R-01A Positive Positive Modified Radical Mastectomy NO -15122 50 0 29 NO manual counting polisomy Scheduled Follow-up Submission 2012-4-28 FEMALE 2+ not amplified Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 440 NO Equivocal Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 11 false No M0 N3a T2 Stage IIIC TCGA-D8-A27R.5E997487-9A03-4723-B1E6-FA0B557D8FDF.pdf A27R TUMOR FREE manual counting >75% >75% YES Primary Tumor 01 7th YES NO D8 Breast A LIVING 2011 70546486-80a3-452c-8722-1bd7b14d5ac4 70546486-80a3-452c-8722-1bd7b14d5ac4 TCGA-D8-A27R-01A-21-A17L-20 TCGA-D8-A27R-01A-11D-A16D-09 TCGA-D8-A27R-01 TCGA-D8-A27R-01A-11D-A16G-05 a5eef620-ca1e-4125-9143-286bada198cf TCGA-D8-A27R-01 TCGA-D8-A27R-01A-11D-A16D-09 TCGA-D8-A27R-01 TCGA-D8-A27R-01A-11D-A16D-09 70546486-80a3-452c-8722-1bd7b14d5ac4 TCGA-D8-A27R-01A-11D-A16C-01 TCGA-D8-A27R-01 70546486-80a3-452c-8722-1bd7b14d5ac4 TCGA-D8-A27R-01A-11D-A16C-01 TCGA-D8-A27T-01 Stage IIIC 53 2 Stage IIIC 135 Positive FEMALE Negative Negative M0 Positive N3 135 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A27T-01 Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 mutation cluster 4 TCGA-D8-A27T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Upper Outer Quadrant|Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-D8-A27T-F30096 TCGA-D8-A27T TCGA-D8-A27T-01A Positive Positive Simple Mastectomy NO -19591 68 0 398 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE Venten 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 170 NO Negative 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 12 false No M0 N3a T2 Stage IIIC TCGA-D8-A27T.15237FF6-A56E-4E05-B81D-B87E91B59917.pdf A27T TUMOR FREE manual counting >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 090d6483-72df-4a55-84ef-5e196d1982cf 090d6483-72df-4a55-84ef-5e196d1982cf TCGA-D8-A27T-01A-21-A17L-20 TCGA-D8-A27T-01A-11D-A16D-09 TCGA-D8-A27T-01 TCGA-D8-A27T-01A-11D-A16G-05 bc97c384-d3a4-400b-b9f7-cbca9e5356d8 TCGA-D8-A27T-01 TCGA-D8-A27T-01A-11D-A16D-09 TCGA-D8-A27T-01 TCGA-D8-A27T-01A-11D-A16D-09 090d6483-72df-4a55-84ef-5e196d1982cf TCGA-D8-A27T-01A-11D-A16C-01 TCGA-D8-A27T-01 090d6483-72df-4a55-84ef-5e196d1982cf TCGA-D8-A27T-01A-11D-A16C-01 TCGA-D8-A27V-01 Stage IIA 62 2 Stage IIA 73 Positive FEMALE Negative Negative M0 Negative N0 73 0 LumA Positive enrollment T_Other T2 LIVING TCGA-D8-A27V-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 TCGA-D8-A27V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant|Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-D8-A27V-F30105 TCGA-D8-A27V Positive Positive Simple Mastectomy NO -22958 0 381 NO manual counting Scheduled Follow-up Submission 2012-3-29 FEMALE Venten 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 0 No M0 N0 T2 Stage IIA A27V TUMOR FREE >75% YES <10% NO Primary Tumor 01 7th YES YES NO D8 Breast LIVING 2011 a4c963fd-c8a6-4dcb-8b6e-159591e61d49 a4c963fd-c8a6-4dcb-8b6e-159591e61d49 TCGA-D8-A27V-01A-21-A24A-20 TCGA-D8-A27V-01 TCGA-D8-A27V-01A-12D-A17F-05 afa1063a-d82c-4277-a7af-552dd7df54b5 TCGA-D8-A27V-01 TCGA-D8-A27V-01A-12D-A17D-09 TCGA-D8-A27V-01 a4c963fd-c8a6-4dcb-8b6e-159591e61d49 TCGA-D8-A27V-01A-12D-A17C-01 TCGA-D8-A27V-01 a4c963fd-c8a6-4dcb-8b6e-159591e61d49 TCGA-D8-A27V-01A-12D-A17C-01 TCGA-D8-A27W-01 Stage IIIB 55 3 Stage IIIB 15 Positive FEMALE Positive Negative M0 Negative N0 15 0 LumB Positive enrollment T_Other T4 LIVING TCGA-D8-A27W-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 mutation c1uster 9 TCGA-D8-A27W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Axillary lymph node dissection alone TCGA-D8-A27W-F30107 TCGA-D8-A27W TCGA-D8-A27W-01A Positive Positive Modified Radical Mastectomy NO -20173 43 0 373 NO manual counting Scheduled Follow-up Submission 2012-4-2 FEMALE Venten Path Vysion HER2 D Probe Kit 2+ Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Fine needle aspiration biopsy 390 NO Equivocal Positive 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 0 false No M0 N0 T4b Stage IIIB TCGA-D8-A27W.292571E3-D500-4337-B435-834B504F3109.pdf A27W TUMOR FREE manual counting >75% >75% YES YES Primary Tumor 01 7th YES YES NO D8 Breast A LIVING 2011 65843fe1-4da2-4165-8926-a0d6f878a7f8 65843fe1-4da2-4165-8926-a0d6f878a7f8 TCGA-D8-A27W-01A-21-A17L-20 TCGA-D8-A27W-01A-11D-A16D-09 TCGA-D8-A27W-01 TCGA-D8-A27W-01A-11D-A16G-05 14737f59-b01c-4ed7-a08b-3a05926f8d87 TCGA-D8-A27W-01 TCGA-D8-A27W-01A-11D-A16D-09 TCGA-D8-A27W-01 TCGA-D8-A27W-01A-11D-A16D-09 65843fe1-4da2-4165-8926-a0d6f878a7f8 TCGA-D8-A27W-01A-11D-A16C-01 TCGA-D8-A27W-01 65843fe1-4da2-4165-8926-a0d6f878a7f8 TCGA-D8-A27W-01A-11D-A16C-01 TCGA-D8-A3Z5-01 TCGA-D8-A3Z5-01 TCGA-D8-A3Z5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Other (specify) mastectomy with TLND TCGA-D8-A3Z5-F57869 TCGA-D8-A3Z5 TCGA-D8-A3Z5-01A Positive Positive Simple Mastectomy NO -19846 418 0 1015 NO 2014-3-28 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 320 NO Negative NO 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 19 false No M0 N3a T2 Stage IIIC TCGA-D8-A3Z5.B16B3335-492B-471B-AEFE-2350EA558BFC.pdf A3Z5 TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO D8 Breast A LIVING 2011 f47007db-f16a-4721-aac4-c7fb6e9ca868 f47007db-f16a-4721-aac4-c7fb6e9ca868 TCGA-D8-A3Z5-01 TCGA-D8-A3Z5-01A-41D-A244-05 4d39d2a1-a65b-4845-8938-cf37bb0ac0ea TCGA-D8-A3Z5-01 TCGA-D8-A3Z5-01A-41D-A243-09 TCGA-D8-A3Z5-01 f47007db-f16a-4721-aac4-c7fb6e9ca868 TCGA-D8-A3Z5-01A-41D-A242-01 TCGA-D8-A3Z5-01 f47007db-f16a-4721-aac4-c7fb6e9ca868 TCGA-D8-A3Z5-01A-41D-A242-01 TCGA-D8-A3Z6-01 TCGA-D8-A3Z6-01 TCGA-D8-A3Z6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Other (specify) mastectomy with TLND TCGA-D8-A3Z6-F51367 TCGA-D8-A3Z6 TCGA-D8-A3Z6-01A Positive Positive Modified Radical Mastectomy NO -20629 160 0 563 NO 2013-11-18 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 60 NO Negative NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 19 false No M0 N3a T3 Stage IIIC TCGA-D8-A3Z6.A8F63D86-37DF-472E-AF29-FB734EAB7E5C.pdf A3Z6 TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO D8 Breast A LIVING 2011 0593faf5-8fcc-4aba-a926-c06c70cef7a8 0593faf5-8fcc-4aba-a926-c06c70cef7a8 TCGA-D8-A3Z6-01 TCGA-D8-A3Z6-01A-11D-A23D-05 TCGA-D8-A3Z6-01 TCGA-D8-A3Z6-01A-11D-A23C-09 TCGA-D8-A3Z6-01 0593faf5-8fcc-4aba-a926-c06c70cef7a8 TCGA-D8-A3Z6-01A-11D-A238-01 TCGA-D8-A3Z6-01 0593faf5-8fcc-4aba-a926-c06c70cef7a8 TCGA-D8-A3Z6-01A-11D-A238-01 TCGA-D8-A4Z1-01 TCGA-D8-A4Z1-01 TCGA-D8-A4Z1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Right|Right Upper Inner Quadrant No axillary staging TCGA-D8-A4Z1-F58485 TCGA-D8-A4Z1 Positive Positive Simple Mastectomy NO -25097 0 659 70-79% 2014-4-11 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T1c Stage IA A4Z1 TUMOR FREE YES YES 10-19% NO Primary Tumor 01 7th YES NO D8 Breast LIVING 2012 e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72 e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72 TCGA-D8-A4Z1-01 TCGA-D8-A4Z1-01A-21D-A268-05 TCGA-D8-A4Z1-01 TCGA-D8-A4Z1-01A-21D-A25Q-09 TCGA-D8-A4Z1-01 e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72 TCGA-D8-A4Z1-01A-21D-A25N-01 TCGA-D8-A4Z1-01 e6dbaf07-3551-4c73-a2f2-f1bea4fa8e72 TCGA-D8-A4Z1-01A-21D-A25N-01 TCGA-D8-A73U-01 TCGA-D8-A73U-01 TCGA-D8-A73U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 88 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-D8-A73U-F57871 TCGA-D8-A73U TCGA-D8-A73U-01A Positive Positive Simple Mastectomy NO -32208 285 0 492 70-79% 2014-3-28 FEMALE <10% 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 90 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false No M0 N0 T2 Stage IIA TCGA-D8-A73U.7BA4658F-3343-4176-BDCD-620A1001A032.pdf A73U WITH TUMOR YES NO 70-79% NO Primary Tumor 01 7th YES NO D8 Breast A LIVING 2012 57728a07-cb68-45d9-ac86-eba57e674e1d 57728a07-cb68-45d9-ac86-eba57e674e1d TCGA-D8-A73U-01 TCGA-D8-A73U-01A-11D-A33F-05 B493DB95-AFD7-42BC-A00E-B703F9FB9D1F TCGA-D8-A73U-01 TCGA-D8-A73U-01 57728a07-cb68-45d9-ac86-eba57e674e1d TCGA-D8-A73U-01A-11D-A33D-01 TCGA-D8-A73U-01 57728a07-cb68-45d9-ac86-eba57e674e1d TCGA-D8-A73U-01A-11D-A33D-01 TCGA-D8-A73W-01 TCGA-D8-A73W-01 TCGA-D8-A73W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES 79 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-D8-A73W-F72197 TCGA-D8-A73W TCGA-D8-A73W-01A Positive Negative Simple Mastectomy NO -29125 191 385 0 244 21 70-79% 2015-4-29 FEMALE 1+ Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Tumor resection 230 NO Negative NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lung|Bone Lung Distant Metastasis NO YES 1 false No MX N1a T3 Stage IIIA TCGA-D8-A73W.359DB5F2-BD23-42E1-B316-9D908DBACD78.pdf A73W WITH TUMOR YES YES YES Primary Tumor 01 7th YES NO D8 Breast A DECEASED 2013 ae442e30-9756-46a8-825b-3e5b7ad394d5 ae442e30-9756-46a8-825b-3e5b7ad394d5 TCGA-D8-A73W-01 TCGA-D8-A73W-01A-22D-A357-05 411140F2-9383-4269-B52B-D48CC374DBDE TCGA-D8-A73W-01 TCGA-D8-A73W-01 ae442e30-9756-46a8-825b-3e5b7ad394d5 TCGA-D8-A73W-01A-22D-A350-01 TCGA-D8-A73W-01 ae442e30-9756-46a8-825b-3e5b7ad394d5 TCGA-D8-A73W-01A-22D-A350-01 TCGA-D8-A73X-01 TCGA-D8-A73X-01 TCGA-D8-A73X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-D8-A73X-F72193 TCGA-D8-A73X TCGA-D8-A73X-01A Positive Positive Simple Mastectomy NO -19607 140 0 767 70-79% 2015-4-29 FEMALE 1+ Other, specify No C50.9 8211/3 C50.9 YES Core needle biopsy 140 NO Negative Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO false No M0 N0 T2 Stage IIA TCGA-D8-A73X.9B227A4E-6237-4C95-B640-E64AFF0CC5F4.pdf A73X TUMOR FREE YES NO 70-79% YES Primary Tumor 01 7th YES NO D8 Breast A LIVING 2013 a982e795-5256-439a-ae7b-9c250eefea53 a982e795-5256-439a-ae7b-9c250eefea53 TCGA-D8-A73X-01 TCGA-D8-A73X-01A-11D-A32T-05 062D46A5-FB34-4EF7-86A8-C56A88FC5119 TCGA-D8-A73X-01 TCGA-D8-A73X-01 a982e795-5256-439a-ae7b-9c250eefea53 TCGA-D8-A73X-01A-11D-A32H-01 TCGA-D8-A73X-01 a982e795-5256-439a-ae7b-9c250eefea53 TCGA-D8-A73X-01A-11D-A32H-01 TCGA-E2-A105-01 Stage IIA 79 5 Stage IIA 1163 Positive FEMALE Equivocal Negative M0 Negative N0 1163 0 LumA Luminal A Positive -10 -3 enrollment T_Other T2 LIVING TCGA-E2-A105-01 Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation cluster 4 TCGA-E2-A105 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-E2-A105-F17431 TCGA-E2-A105 Positive Positive Lumpectomy NO -28855 0 1308 Allred score 3 + 2 = 5 Scheduled Follow-up Submission 2011-9-9 FEMALE 70-79% 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 NO 0 No M0 N0 (i-) T2 Stage IIA A105 TUMOR FREE Allred score 3 + 2 = 5 Allred score 5 Allred score 5 YES Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2007 b9bb3fb2-5692-4e7b-9353-45db1d58843f b9bb3fb2-5692-4e7b-9353-45db1d58843f TCGA-E2-A105-01A-11D-A10M-09 TCGA-E2-A105-01 TCGA-E2-A105-01A-11D-A10N-05 TCGA-E2-A105-01 TCGA-E2-A105-01A-11D-A10M-09 TCGA-E2-A105-01 TCGA-E2-A105-01A-11D-A10M-09 TCGA-E2-A105-01 b9bb3fb2-5692-4e7b-9353-45db1d58843f TCGA-E2-A105-01 TCGA-E2-A105-01A-11D-A10L-01 TCGA-E2-A105-01A-11R-A10J-07 b9bb3fb2-5692-4e7b-9353-45db1d58843f TCGA-E2-A105-01A-11D-A10L-01 TCGA-E2-A105-01 TCGA-E2-A106-01 Stage IB 34 4 No_Conversion 1807 Positive FEMALE Negative Negative M0 Positive N1 1807 0 LumA Luminal A Positive 0 -3 followup T1 T1 LIVING TCGA-E2-A106-01 Kirc+ cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 TCGA-E2-A106 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A106-F70397 TCGA-E2-A106 Negative Positive Other Positive Simple Mastectomy inner-upper margin re-excision NO -12528 0 2541 90-99% Scheduled Follow-up Submission 2015-3-17 FEMALE 10-19% 2+ 1.05 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative NO 16 Close Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 1 No M0 N1mi T1c Stage IB A106 TUMOR FREE YES 80-89% NO Primary Tumor 01 YES NO YES E2 Breast LIVING 2006 cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2 cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2 TCGA-E2-A106-01 TCGA-E2-A106-01A-11D-A10N-05 TCGA-E2-A106-01 cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2 TCGA-E2-A106-01 TCGA-E2-A106-01A-11R-A10J-07 cbd64838-97a7-47a9-a4dc-aa9e0d0ab3d2 TCGA-E2-A106-01 TCGA-E2-A107-01 Stage IIIA 54 2 No_Conversion 1046 Positive FEMALE Negative 1 3 4 Negative M0 Positive N2 1046 0 Luminal B Negative LumA/B 0 -3 followup T_Other T3 LIVING TCGA-E2-A107-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A107 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A107-F17173 TCGA-E2-A107 TCGA-E2-A107-01A Positive Negative Simple Mastectomy NO -20065 715 0 1047 Allred score 5+3=8 Scheduled Follow-up Submission 2011-9-28 FEMALE 2+ 1.2 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 170 NO Equivocal Negative 27 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 4 false No M0 N2a T3 Stage IIIA TCGA-E2-A107.BA87D188-A3B3-4A6F-B3AF-1FEB25B9E357.pdf A107 TUMOR FREE Allred score 0+0=0 Allred score 0 Allred score 8 YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 254c611f-7808-4745-9155-f2d578b29df2 254c611f-7808-4745-9155-f2d578b29df2 TCGA-E2-A107-01A-21-A13D-20 TCGA-E2-A107-01A-11D-A10M-09 TCGA-E2-A107-01 TCGA-E2-A107-01A-11D-A10N-05 ea9612ed-23f6-44e6-92f4-7cc7d3cef266 TCGA-E2-A107-01 TCGA-E2-A107-01A-11D-A10M-09 TCGA-E2-A107-01 TCGA-E2-A107-01A-11D-A10M-09 TCGA-E2-A107-01 254c611f-7808-4745-9155-f2d578b29df2 TCGA-E2-A107-01 TCGA-E2-A107-01A-11D-A10L-01 TCGA-E2-A107-01A-11R-A10J-07 254c611f-7808-4745-9155-f2d578b29df2 TCGA-E2-A107-01A-11D-A10L-01 TCGA-E2-A107-01 TCGA-E2-A108-01 Stage IIIA 64 4 No_Conversion 837 Positive FEMALE Negative 1 4 3 Negative M0 Positive N2 837 0 Normal Normal-like Positive ReacI -5 -8 followup T_Other T2 LIVING TCGA-E2-A108-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-E2-A108 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Outer Quadrant TCGA-E2-A108-F17423 TCGA-E2-A108 TCGA-E2-A108-01A Positive Positive Lumpectomy -23530 596 0 837 Allred score 7 (outside facility) Scheduled Follow-up Submission 2011-9-28 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Negative 27 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 4 false No M0 N2a T2 Stage IIIA TCGA-E2-A108.DDBEE56C-F8E8-4A7D-8CF6-E0D63EE53FC4.pdf A108 WITH TUMOR Allred score 7 per outside facility report Allred score 7 per outside facility report Allred score 7 (per outside facility) YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 48188b57-1f05-43dc-b8d4-a422c4f443a9 48188b57-1f05-43dc-b8d4-a422c4f443a9 TCGA-E2-A108-01A-21-A13D-20 TCGA-E2-A108-01A-13D-A10M-09 TCGA-E2-A108-01 TCGA-E2-A108-01A-13D-A10N-05 0e4168e1-0fd3-4a3b-b878-d4c88ced0311 TCGA-E2-A108-01 TCGA-E2-A108-01A-13D-A10M-09 TCGA-E2-A108-01 TCGA-E2-A108-01A-13D-A10M-09 TCGA-E2-A108-01 48188b57-1f05-43dc-b8d4-a422c4f443a9 TCGA-E2-A108-01 TCGA-E2-A108-01A-13D-A10L-01 TCGA-E2-A108-01A-13R-A10J-07 48188b57-1f05-43dc-b8d4-a422c4f443a9 TCGA-E2-A108-01A-13D-A10L-01 TCGA-E2-A108-01 TCGA-E2-A109-01 Stage IIA 64 5 Stage IIA 1417 Positive FEMALE Negative 4 1 4 Negative M0 Negative N0 1417 0 LumB Luminal B Negative LumA/B -10 -5 followup T_Other T2 LIVING TCGA-E2-A109-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 6 mutation cluster 5 TCGA-E2-A109 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A109-F17418 TCGA-E2-A109 Positive Negative Simple Mastectomy NO -23521 0 1417 Allred score 5+3=8 Scheduled Follow-up Submission 2011-9-9 FEMALE 50-59% 2+ 1.46 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 6 NO 0 No M0 N0 (i-) T2 Stage IIA A109 TUMOR FREE Allred score 0+0=0 Allred score 0 Allred score 8 NO Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2007 d6aae541-9dec-4055-bfd6-51ebbdcbf7a2 d6aae541-9dec-4055-bfd6-51ebbdcbf7a2 TCGA-E2-A109-01A-21-A13D-20 TCGA-E2-A109-01A-11D-A10M-09 TCGA-E2-A109-01 TCGA-E2-A109-01A-11D-A10N-05 a2cbc0c2-b14e-460f-bc12-5aa350950e00 TCGA-E2-A109-01 TCGA-E2-A109-01A-11D-A10M-09 TCGA-E2-A109-01 TCGA-E2-A109-01A-11D-A10M-09 TCGA-E2-A109-01 d6aae541-9dec-4055-bfd6-51ebbdcbf7a2 TCGA-E2-A109-01 TCGA-E2-A109-01A-11D-A10L-01 TCGA-E2-A109-01A-11R-A10J-07 d6aae541-9dec-4055-bfd6-51ebbdcbf7a2 TCGA-E2-A109-01A-11D-A10L-01 TCGA-E2-A109-01 TCGA-E2-A10A-01 Stage IIB 41 2 Stage IIB 1229 Positive FEMALE Negative 3 3 4 Negative M0 Negative N0 1229 0 LumA Luminal B Positive LumA/B 0 -3 followup T_Other T3 LIVING TCGA-E2-A10A-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-E2-A10A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES NO 41 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A10A-F17522 TCGA-E2-A10A TCGA-E2-A10A-01A Positive Positive Simple Mastectomy NO -15085 1096 0 1229 92 Allred score 4+3=7 Scheduled Follow-up Submission 2011-10-12 FEMALE 40-49% 2+ 1.21 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 370 NO Positive Negative 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 1 Brain Distant Metastasis YES 0 0 false No M0 N0 (i-) T3 Stage IIB TCGA-E2-A10A.AA1BACC4-0B3D-4E2E-865E-24B570DA4E74.pdf A10A WITH TUMOR Allred score 5+3=8 Allred score 8 Allred score 7 YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2007 104213ad-3ec6-4a24-9760-72333b6c2c22 104213ad-3ec6-4a24-9760-72333b6c2c22 TCGA-E2-A10A-01A-11-A13D-20 TCGA-E2-A10A-01A-21D-A10Y-09 TCGA-E2-A10A-01 18a5dc5d-47d6-495a-a3d5-e19cd79678f4 TCGA-E2-A10A-01 TCGA-E2-A10A-01A-21D-A10Y-09 TCGA-E2-A10A-01A-21D-A112-05 TCGA-E2-A10A-01 TCGA-E2-A10A-01 TCGA-E2-A10A-01A-21D-A10Y-09 104213ad-3ec6-4a24-9760-72333b6c2c22 TCGA-E2-A10A-01A-21D-A111-01 TCGA-E2-A10A-01 TCGA-E2-A10A-01A-21R-A115-07 104213ad-3ec6-4a24-9760-72333b6c2c22 TCGA-E2-A10A-01A-21D-A111-01 TCGA-E2-A10A-01 TCGA-E2-A10B-01 Stage IIB 67 3 No_Conversion 1141 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 1141 0 LumA Luminal A Positive LumA -12 -3 followup T_Other T2 LIVING TCGA-E2-A10B-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A10B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES YES 67 Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A10B-F17370 TCGA-E2-A10B TCGA-E2-A10B-01A Positive Positive Lumpectomy NO 195 -24577 1065 0 1141 195 Allred score 5+3= 8 Scheduled Follow-up Submission 2011-9-19 FEMALE 10-19% 2+ 1.11 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO Equivocal Negative 28 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative Negative 4 4 Lung New Primary Tumor YES 2 0 false No M0 N1a T2 Stage IIB TCGA-E2-A10B.5DAC95DD-5DA6-475B-AC14-5C79FC2F30A6.pdf A10B TUMOR FREE Allred score 5+3= 8 Allred score 8 Allred score 8 YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2007 3b72a173-8ce4-444e-aeeb-39be3f3eb558 3b72a173-8ce4-444e-aeeb-39be3f3eb558 TCGA-E2-A10B-01A-21-A13D-20 TCGA-E2-A10B-01A-11D-A10M-09 TCGA-E2-A10B-01 TCGA-E2-A10B-01A-11D-A10N-05 f0d6030f-5893-4ff7-8072-b4ecafb7a860 TCGA-E2-A10B-01 TCGA-E2-A10B-01A-11D-A10M-09 TCGA-E2-A10B-01 TCGA-E2-A10B-01A-11D-A10M-09 TCGA-E2-A10B-01 3b72a173-8ce4-444e-aeeb-39be3f3eb558 TCGA-E2-A10B-01 TCGA-E2-A10B-01A-11D-A10L-01 TCGA-E2-A10B-01A-11R-A10J-07 3b72a173-8ce4-444e-aeeb-39be3f3eb558 TCGA-E2-A10B-01A-11D-A10L-01 TCGA-E2-A10B-01 TCGA-E2-A10C-01 Stage IIB 54 3 No_Conversion 1219 Positive FEMALE Negative 1 1 4 Negative M0 Positive N1 1219 0 LumB Luminal B Positive ReacI -2 -5 followup T_Other T2 LIVING TCGA-E2-A10C-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 3 TCGA-E2-A10C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A10C-F17357 TCGA-E2-A10C TCGA-E2-A10C-01A Positive Positive Lumpectomy NO -19849 995 0 1220 Allred score 5+3=8 Scheduled Follow-up Submission 2011-9-26 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 150 NO Negative 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 NO 1 false No M0 N1a T2 Stage IIB TCGA-E2-A10C.E8A61AAC-BFF5-4341-B051-EDD87515ECDC.pdf A10C TUMOR FREE Allred score 3+3=6 Allred score 6 Allred score 8 YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99 1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99 TCGA-E2-A10C-01A-11-A13D-20 TCGA-E2-A10C-01A-21D-A10M-09 TCGA-E2-A10C-01 TCGA-E2-A10C-01A-21D-A10N-05 a000b0bf-7241-4898-8bc9-1d130065cc5d TCGA-E2-A10C-01 TCGA-E2-A10C-01A-21D-A10M-09 TCGA-E2-A10C-01 TCGA-E2-A10C-01A-21D-A10M-09 TCGA-E2-A10C-01 1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99 TCGA-E2-A10C-01 TCGA-E2-A10C-01A-21D-A10L-01 TCGA-E2-A10C-01A-21R-A10J-07 1f7762ae-94bf-4ab4-a6d6-7fe57b1e1e99 TCGA-E2-A10C-01A-21D-A10L-01 TCGA-E2-A10C-01 TCGA-E2-A10E-01 Stage IIA 64 2 No_Conversion 865 Positive FEMALE Negative 1 3 3 Negative M0 Positive N1 865 0 LumA Luminal A Positive LumA/B -12 -3 followup T1 T1 LIVING TCGA-E2-A10E-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A10E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A10E-F17248 TCGA-E2-A10E TCGA-E2-A10E-01A Positive Positive Simple Mastectomy NO -23684 869 0 865 Allred score 5+3=8 Scheduled Follow-up Submission 2011-9-26 FEMALE 40-49% 2+ 1.07 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 240 NO Equivocal Negative 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 2 false No M0 N1a T1c Stage IIA TCGA-E2-A10E.CFB8EE09-41D3-4A39-A4AE-4CDEC84BB9BC.pdf A10E TUMOR FREE Allred score 3+2=5 Allred score 5 Allred score 8 YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 0e932148-a592-42e2-b1df-4fd599db21e9 0e932148-a592-42e2-b1df-4fd599db21e9 TCGA-E2-A10E-01A-11-A13D-20 TCGA-E2-A10E-01A-21D-A10M-09 TCGA-E2-A10E-01 TCGA-E2-A10E-01A-21D-A10N-05 3511ab99-23f6-45bb-b2f9-28e547200841 TCGA-E2-A10E-01 TCGA-E2-A10E-01A-21D-A10M-09 TCGA-E2-A10E-01 TCGA-E2-A10E-01A-21D-A10M-09 TCGA-E2-A10E-01 0e932148-a592-42e2-b1df-4fd599db21e9 TCGA-E2-A10E-01 TCGA-E2-A10E-01A-21D-A10L-01 TCGA-E2-A10E-01A-21R-A10J-07 0e932148-a592-42e2-b1df-4fd599db21e9 TCGA-E2-A10E-01A-21D-A10L-01 TCGA-E2-A10E-01 TCGA-E2-A10F-01 Stage IIA 47 2 Stage IIA 878 Positive FEMALE Negative Negative M0 Negative N0 878 0 LumA Luminal A Positive -5 -4 followup T_Other T2 LIVING TCGA-E2-A10F-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A10F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A10F-F17187 TCGA-E2-A10F TCGA-E2-A10F-01A Positive Positive Lumpectomy NO -17257 801 0 878 Allred score 5+3=8 Scheduled Follow-up Submission 2011-9-27 FEMALE 20-29% 2+ 1.05 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 110 NO Equivocal Negative 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 0 false No M0 N0 (i-) T2 Stage IIA TCGA-E2-A10F.71C82089-E070-4C7B-B15B-0492DECCB3BF.pdf A10F TUMOR FREE Allred score 5+3=8 Allred score 8 Allred score 8 YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 05918561-a713-464b-9b5c-4f7c9258a827 05918561-a713-464b-9b5c-4f7c9258a827 TCGA-E2-A10F-01A-11D-A10M-09 TCGA-E2-A10F-01 TCGA-E2-A10F-01A-11D-A10N-05 TCGA-E2-A10F-01 TCGA-E2-A10F-01A-11D-A10M-09 TCGA-E2-A10F-01 TCGA-E2-A10F-01A-11D-A10M-09 TCGA-E2-A10F-01 05918561-a713-464b-9b5c-4f7c9258a827 TCGA-E2-A10F-01 TCGA-E2-A10F-01A-11D-A10L-01 TCGA-E2-A10F-01A-11R-A10J-07 05918561-a713-464b-9b5c-4f7c9258a827 TCGA-E2-A10F-01A-11D-A10L-01 TCGA-E2-A10F-01 TCGA-E2-A14N-01 Stage IIB 37 4 Stage IIB 1350 Negative FEMALE Negative Negative M0 Positive N1 1350 0 Basal Basal-like Negative -13 -12 enrollment T_Other T2 LIVING TCGA-E2-A14N-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 5 cluster 6 mutation cluster 5 TCGA-E2-A14N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A14N-F19154 TCGA-E2-A14N TCGA-E2-A14N-01A Negative Negative Simple Mastectomy NO -13743 1240 0 1434 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-11-17 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 440 NO Negative 38 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 6 NO 1 false No M0 N1 T2 Stage IIB TCGA-E2-A14N.C972EC08-E1AE-4FCB-B8A1-15000306CDE7.pdf A14N TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2007 6e45dd01-225d-4871-9a3a-f591808ad234 6e45dd01-225d-4871-9a3a-f591808ad234 TCGA-E2-A14N-01A-21-A17I-20 TCGA-E2-A14N-01A-31D-A135-09 TCGA-E2-A14N-01 TCGA-E2-A14N-01A-31D-A138-05 df24b18e-26f0-494d-a7bc-4672b1a0314b TCGA-E2-A14N-01 TCGA-E2-A14N-01A-31D-A135-09 TCGA-E2-A14N-01 TCGA-E2-A14N-01 TCGA-E2-A14N-01A-31D-A135-09 6e45dd01-225d-4871-9a3a-f591808ad234 TCGA-E2-A14N-01A-31D-A134-01 TCGA-E2-A14N-01 TCGA-E2-A14N-01A-31R-A137-07 6e45dd01-225d-4871-9a3a-f591808ad234 TCGA-E2-A14N-01A-31D-A134-01 TCGA-E2-A14N-01 TCGA-E2-A14O-01 Stage IIIA 76 2 Stage IIIA 1172 Positive FEMALE Negative 1 3 4 Negative M0 Positive N1 1172 0 LumB Luminal B Positive LumA/B 0 -3 enrollment T_Other T3 LIVING TCGA-E2-A14O-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A14O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A14O-F18521 TCGA-E2-A14O TCGA-E2-A14O-01A Positive Positive Modified Radical Mastectomy NO -27837 1064 0 1359 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-10-19 FEMALE 50-59% 2+ 1.65 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 210 NO Equivocal Negative 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 2 false No M0 N1a T3 Stage IIIA TCGA-E2-A14O.42E9A561-B052-412E-B0FD-563DC097C3C5.pdf A14O TUMOR FREE Allred score 5+2 = 7 Allred score = 7 Allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 2791089c-f659-41e8-8e18-57fc6a079e6b 2791089c-f659-41e8-8e18-57fc6a079e6b TCGA-E2-A14O-01A-21-A13E-20 TCGA-E2-A14O-01A-31D-A10Y-09 TCGA-E2-A14O-01 1b57149c-21de-43c8-8f92-f6adbd5623c3 TCGA-E2-A14O-01 TCGA-E2-A14O-01A-31D-A10Y-09 TCGA-E2-A14O-01A-31D-A112-05 TCGA-E2-A14O-01 TCGA-E2-A14O-01 TCGA-E2-A14O-01A-31D-A10Y-09 2791089c-f659-41e8-8e18-57fc6a079e6b TCGA-E2-A14O-01A-31D-A111-01 TCGA-E2-A14O-01 TCGA-E2-A14O-01A-31R-A115-07 2791089c-f659-41e8-8e18-57fc6a079e6b TCGA-E2-A14O-01A-31D-A111-01 TCGA-E2-A14O-01 TCGA-E2-A14P-01 Stage IIIC 79 3 Stage IIIC 487 Negative FEMALE Positive 1 1 1 Negative M0 Positive N3 487 0 Her2 HER2-enriched Negative Her2 -11 -5 enrollment T_Other T2 LIVING TCGA-E2-A14P-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-E2-A14P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A14P-F18846 TCGA-E2-A14P TCGA-E2-A14P-01A Negative Negative Lumpectomy NO -28923 965 0 1246 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-10-20 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 290 NO Positive 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 10 false No M0 N3 T2 Stage IIIC TCGA-E2-A14P.FD8CDFD9-6DCF-4CE1-9BB1-A7FF568EE53C.pdf A14P TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES Primary Tumor 01 6th NO NO YES E2 Breast A LIVING 2008 a4cb04f5-91b3-40ba-8005-b1df46d6b555 a4cb04f5-91b3-40ba-8005-b1df46d6b555 TCGA-E2-A14P-01A-21-A13E-20 TCGA-E2-A14P-01A-31D-A12B-09 TCGA-E2-A14P-01 3a9dace0-ee3c-42bc-8c9a-30998aae35f0 TCGA-E2-A14P-01 TCGA-E2-A14P-01A-31D-A12B-09 TCGA-E2-A14P-01A-31D-A12E-05 TCGA-E2-A14P-01 TCGA-E2-A14P-01 TCGA-E2-A14P-01A-31D-A12B-09 a4cb04f5-91b3-40ba-8005-b1df46d6b555 TCGA-E2-A14P-01A-31D-A12A-01 TCGA-E2-A14P-01 TCGA-E2-A14P-01A-31R-A12D-07 a4cb04f5-91b3-40ba-8005-b1df46d6b555 TCGA-E2-A14P-01A-31D-A12A-01 TCGA-E2-A14P-01 TCGA-E2-A14Q-01 Stage IIA 50 2 Stage IIB 974 Positive FEMALE Negative 3 4 3 Negative M0 Positive N1 974 0 LumA Luminal A Positive LumA 0 -7 enrollment T_Other T2 LIVING TCGA-E2-A14Q-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A14Q TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A14Q-F18800 TCGA-E2-A14Q TCGA-E2-A14Q-01A Positive Positive Lumpectomy NO -18507 960 0 1163 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-10-20 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 110 NO Negative 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 2 NO 1 false No M0 N1mi T2 Stage IIB TCGA-E2-A14Q.42A1A073-69B4-4A66-A998-BE4366E0C89C.pdf A14Q TUMOR FREE Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 48d70a9a-b6ae-4ed6-80da-999a919f8da9 48d70a9a-b6ae-4ed6-80da-999a919f8da9 TCGA-E2-A14Q-01A-21-A13E-20 TCGA-E2-A14Q-01A-11D-A12B-09 TCGA-E2-A14Q-01 9ebd7a3c-5f75-479b-a6a3-b4f00221955f TCGA-E2-A14Q-01 TCGA-E2-A14Q-01A-11D-A12B-09 TCGA-E2-A14Q-01A-11D-A12E-05 TCGA-E2-A14Q-01 TCGA-E2-A14Q-01 TCGA-E2-A14Q-01A-11D-A12B-09 48d70a9a-b6ae-4ed6-80da-999a919f8da9 TCGA-E2-A14Q-01A-11D-A12A-01 TCGA-E2-A14Q-01 TCGA-E2-A14Q-01A-11R-A12D-07 48d70a9a-b6ae-4ed6-80da-999a919f8da9 TCGA-E2-A14Q-01A-11D-A12A-01 TCGA-E2-A14Q-01 TCGA-E2-A14R-01 Stage IIA 62 1 Stage IIA 845 Negative FEMALE Negative Negative M0 Negative N0 845 0 Basal Basal-like Negative -13 -12 enrollment T_Other T2 LIVING TCGA-E2-A14R-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E2-A14R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES YES 62 Left Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A14R-F18838 TCGA-E2-A14R TCGA-E2-A14R-01A Negative Negative Lumpectomy NO 971 -22686 910 0 1174 971 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-10-24 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 190 NO Negative 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 Other, specify New Primary Tumor Endometrial YES 0 false No M0 N0 T2 Stage IIA TCGA-E2-A14R.0B6DCA80-3108-4D25-B095-3EC704598B23.pdf A14R TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 76a625e9-22b3-42b8-8813-27c133d0b248 76a625e9-22b3-42b8-8813-27c133d0b248 TCGA-E2-A14R-01A-11D-A10Y-09 TCGA-E2-A14R-01 TCGA-E2-A14R-01 TCGA-E2-A14R-01A-11D-A10Y-09 TCGA-E2-A14R-01A-11D-A112-05 TCGA-E2-A14R-01 TCGA-E2-A14R-01 TCGA-E2-A14R-01A-11D-A10Y-09 76a625e9-22b3-42b8-8813-27c133d0b248 TCGA-E2-A14R-01A-11D-A111-01 TCGA-E2-A14R-01 TCGA-E2-A14R-01A-11R-A115-07 76a625e9-22b3-42b8-8813-27c133d0b248 TCGA-E2-A14R-01A-11D-A111-01 TCGA-E2-A14R-01 TCGA-E2-A14S-01 Stage I 65 4 Stage I 834 Positive FEMALE Negative 1 3 4 Negative M0 Negative N0 834 0 LumB Luminal B Positive LumA/B -10 -3 enrollment T1 T1 LIVING TCGA-E2-A14S-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A14S TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A14S-F18831 TCGA-E2-A14S TCGA-E2-A14S-01A Positive Positive Lumpectomy NO -23878 827 0 1009 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-3 FEMALE 2+ 1.04 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 120 NO Equivocal Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A14S.810B3936-DFF0-420C-BD6C-8D4990B8F536.pdf A14S TUMOR FREE Allred score 4+3 = 7 Allred score = 7 Allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 5aaf8edc-5d66-4099-824b-f4e06827ad12 5aaf8edc-5d66-4099-824b-f4e06827ad12 TCGA-E2-A14S-01A-21-A13E-20 TCGA-E2-A14S-01A-11D-A12B-09 TCGA-E2-A14S-01 010a31fc-4218-4110-b2d0-4791ca77d417 TCGA-E2-A14S-01 TCGA-E2-A14S-01A-11D-A12B-09 TCGA-E2-A14S-01A-11D-A12E-05 TCGA-E2-A14S-01 TCGA-E2-A14S-01 TCGA-E2-A14S-01A-11D-A12B-09 5aaf8edc-5d66-4099-824b-f4e06827ad12 TCGA-E2-A14S-01A-11D-A12A-01 TCGA-E2-A14S-01 TCGA-E2-A14S-01A-11R-A12D-07 5aaf8edc-5d66-4099-824b-f4e06827ad12 TCGA-E2-A14S-01A-11D-A12A-01 TCGA-E2-A14S-01 TCGA-E2-A14T-01 Stage IIA 52 Stage IIA 890 Positive FEMALE Negative Negative M0 Negative N0 890 0 LumA Luminal A Positive LumA/B 0 -3 enrollment T_Other T2 LIVING TCGA-E2-A14T-01 C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-E2-A14T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-E2-A14T-F70396 TCGA-E2-A14T TCGA-E2-A14T-01A Positive Positive Simple Mastectomy NO -19237 792 0 2311 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2015-3-17 FEMALE 1+ 1.29 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 210 NO Negative Negative NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 1 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A14T.6C8B56C1-330B-4116-8B60-7A81A1983277.pdf A14T TUMOR FREE Allred score 2+2 = 4 Allred score = 4 Allred score = 8 YES YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 7aa46530-2311-41ed-a452-9ca06f38c0c1 7aa46530-2311-41ed-a452-9ca06f38c0c1 TCGA-E2-A14T-01A-21-A13E-20 TCGA-E2-A14T-01A-11D-A10Y-09 TCGA-E2-A14T-01 356382a7-c34b-4e96-aaf2-9901ccc6d72c TCGA-E2-A14T-01 TCGA-E2-A14T-01A-11D-A10Y-09 TCGA-E2-A14T-01A-11D-A112-05 TCGA-E2-A14T-01 TCGA-E2-A14T-01 TCGA-E2-A14T-01A-11D-A10Y-09 7aa46530-2311-41ed-a452-9ca06f38c0c1 TCGA-E2-A14T-01A-11D-A111-01 TCGA-E2-A14T-01 TCGA-E2-A14T-01A-11R-A115-07 7aa46530-2311-41ed-a452-9ca06f38c0c1 TCGA-E2-A14T-01A-11D-A111-01 TCGA-E2-A14T-01 TCGA-E2-A14U-01 TCGA-E2-A14U-01 Quiet BRCA non-CIMP c9 miRNA cluster 5 TCGA-E2-A14U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Right Upper Outer Quadrant Other (specify) Sentinel lymph node dissection TCGA-E2-A14U-F33622 TCGA-E2-A14U TCGA-E2-A14U-01A Positive Positive Lumpectomy NO -27389 796 0 1318 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2012-7-11 FEMALE 40-49% 2+ 1.04 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 70 NO Equivocal Negative 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T1c Stage I TCGA-E2-A14U.7E0F430B-B96B-49B1-B4C1-88C1F3A855A7.pdf A14U TUMOR FREE Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 20d25e27-b509-45eb-a734-9b8d6a40c632 20d25e27-b509-45eb-a734-9b8d6a40c632 TCGA-E2-A14U-01 TCGA-E2-A14U-01A-11D-A22B-05 TCGA-E2-A14U-01 TCGA-E2-A14U-01A-11D-A228-09 TCGA-E2-A14U-01 20d25e27-b509-45eb-a734-9b8d6a40c632 TCGA-E2-A14U-01A-11D-A227-01 TCGA-E2-A14U-01 20d25e27-b509-45eb-a734-9b8d6a40c632 TCGA-E2-A14U-01A-11D-A227-01 TCGA-E2-A14V-01 Stage IIB 53 5 Stage IIB 748 Positive FEMALE Positive 1 1 1 Negative M0 Positive N1 748 0 Her2 HER2-enriched Positive Her2 -1 -5 enrollment T_Other T2 LIVING TCGA-E2-A14V-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A14V TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A14V-F18870 TCGA-E2-A14V TCGA-E2-A14V-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy NO -19643 722 0 1042 NO Scheduled Follow-up Submission 2011-11-4 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 160 NO Positive 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 3 false No M0 N1 T2 Stage IIB TCGA-E2-A14V.DC8FD7C7-A908-4B90-860F-04984244167C.pdf A14V TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf TCGA-E2-A14V-01A-21-A13E-20 TCGA-E2-A14V-01A-11D-A12B-09 TCGA-E2-A14V-01 40a19899-83c4-44c1-8e91-c4b4339d7ea8 TCGA-E2-A14V-01 TCGA-E2-A14V-01A-11D-A12B-09 TCGA-E2-A14V-01A-11D-A12E-05 TCGA-E2-A14V-01 TCGA-E2-A14V-01 TCGA-E2-A14V-01A-11D-A12B-09 d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf TCGA-E2-A14V-01A-11D-A12A-01 TCGA-E2-A14V-01 TCGA-E2-A14V-01A-11R-A12D-07 d6f0abd0-ff39-4c30-a8ee-e74e6f3621bf TCGA-E2-A14V-01A-11D-A12A-01 TCGA-E2-A14V-01 TCGA-E2-A14W-01 Stage IIA 78 5 Stage IIA 833 Positive FEMALE Positive 3 3 4 Negative M0 Negative N0 833 0 LumB Luminal B Positive Her2 0 -3 enrollment T_Other T2 LIVING TCGA-E2-A14W-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation cluster 12 TCGA-E2-A14W TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A14W-F18803 TCGA-E2-A14W Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -28664 0 974 NO Scheduled Follow-up Submission 2011-11-4 MALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Positive 5 Negative 2 7 NO 0 No M0 N0 T2 Stage IIA A14W TUMOR FREE YES NO Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2008 f898f44d-a728-41cf-b1ac-20b1995a86b9 f898f44d-a728-41cf-b1ac-20b1995a86b9 TCGA-E2-A14W-01A-21-A13E-20 TCGA-E2-A14W-01A-11D-A12B-09 TCGA-E2-A14W-01 de3f269f-cfa8-4ff2-bd60-14ffe2a45d83 TCGA-E2-A14W-01 TCGA-E2-A14W-01A-11D-A12B-09 TCGA-E2-A14W-01A-11D-A12E-05 TCGA-E2-A14W-01 TCGA-E2-A14W-01 TCGA-E2-A14W-01A-11D-A12B-09 f898f44d-a728-41cf-b1ac-20b1995a86b9 TCGA-E2-A14W-01A-11D-A12A-01 TCGA-E2-A14W-01 TCGA-E2-A14W-01A-11R-A12D-07 f898f44d-a728-41cf-b1ac-20b1995a86b9 TCGA-E2-A14W-01A-11D-A12A-01 TCGA-E2-A14W-01 TCGA-E2-A14X-01 Stage IIIA 55 4 Stage IIIA 692 Negative FEMALE Negative 3 2 2 Negative M0 Positive N2 692 0 Basal Basal-like Negative ReacII -13 -12 enrollment T_Other T2 LIVING TCGA-E2-A14X-01 BRCA-LUAD+ C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-E2-A14X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A14X-F18857 TCGA-E2-A14X TCGA-E2-A14X-01A Negative Negative Lumpectomy NO -20105 652 0 972 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-11-4 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 130 NO Negative 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 NO 5 false No M0 N2 T2 Stage IIIA TCGA-E2-A14X.734305A3-5EC4-4DE4-B263-91A49082F146.pdf A14X TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 d9f827bb-2498-49b0-aa85-71cb554eb926 d9f827bb-2498-49b0-aa85-71cb554eb926 TCGA-E2-A14X-01A-21-A13E-20 TCGA-E2-A14X-01A-11D-A10Y-09 TCGA-E2-A14X-01 29a42295-97db-4c28-885f-801d655b5b0f TCGA-E2-A14X-01 TCGA-E2-A14X-01A-11D-A10Y-09 TCGA-E2-A14X-01A-11D-A112-05 TCGA-E2-A14X-01 TCGA-E2-A14X-01 TCGA-E2-A14X-01A-11D-A10Y-09 d9f827bb-2498-49b0-aa85-71cb554eb926 TCGA-E2-A14X-01A-11D-A111-01 TCGA-E2-A14X-01 TCGA-E2-A14X-01A-11R-A115-07 d9f827bb-2498-49b0-aa85-71cb554eb926 TCGA-E2-A14X-01A-11D-A111-01 TCGA-E2-A14X-01 TCGA-E2-A14Y-01 Stage IIA 35 2 Stage IIA 688 Positive FEMALE Positive 3 3 3 Negative M0 Negative N0 688 0 Basal Basal-like Positive ReacII -13 0 enrollment T_Other T2 LIVING TCGA-E2-A14Y-01 Iq C4-BRCA/Basal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 3 TCGA-E2-A14Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Sentinel node biopsy alone TCGA-E2-A14Y-F70401 TCGA-E2-A14Y TCGA-E2-A14Y-01A Positive Positive Simple Mastectomy NO -13004 597 0 2109 NO Scheduled Follow-up Submission 2015-3-17 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 190 NO Equivocal Positive NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 5 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A14Y.957AC7B0-D613-4F97-BBBC-930EB95EE2E4.pdf A14Y TUMOR FREE YES YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 3ea70053-af2a-4fec-9416-d18b6156f516 3ea70053-af2a-4fec-9416-d18b6156f516 TCGA-E2-A14Y-01A-11-A13E-20 TCGA-E2-A14Y-01A-21D-A12B-09 TCGA-E2-A14Y-01 173f9cd2-092c-479a-b9f2-f58ebd0ffa69 TCGA-E2-A14Y-01 TCGA-E2-A14Y-01A-21D-A12B-09 TCGA-E2-A14Y-01A-21D-A12E-05 TCGA-E2-A14Y-01 TCGA-E2-A14Y-01 TCGA-E2-A14Y-01A-21D-A12B-09 3ea70053-af2a-4fec-9416-d18b6156f516 TCGA-E2-A14Y-01A-21D-A12A-01 TCGA-E2-A14Y-01 TCGA-E2-A14Y-01A-21R-A12D-07 3ea70053-af2a-4fec-9416-d18b6156f516 TCGA-E2-A14Y-01A-21D-A12A-01 TCGA-E2-A14Y-01 TCGA-E2-A14Y-11 35 688 FEMALE 688 0 enrollment LIVING TCGA-E2-A14Y-11 C4-BRCA/Basal mutation cluster 3 TCGA-E2-A14Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Right Sentinel node biopsy alone TCGA-E2-A14Y-F70401 TCGA-E2-A14Y TCGA-E2-A14Y-11A Positive Positive Simple Mastectomy NO -13004 597 0 2109 NO Scheduled Follow-up Submission 2015-3-17 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 290 NO Equivocal Positive NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 false No M0 N0 T2 Stage IIA A14Y TUMOR FREE YES YES NO Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2009 TCGA-E2-A14Y-11A-33D-A12E-05 TCGA-E2-A14Z-01 Stage I 64 1 Stage I 518 Positive FEMALE Negative 3 2 3 Negative M0 Negative N0 518 0 LumA Luminal A Positive LumA 0 -2 enrollment T1 T1 LIVING TCGA-E2-A14Z-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-E2-A14Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO 64 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A14Z-F18792 TCGA-E2-A14Z TCGA-E2-A14Z-01A Positive Positive Lumpectomy NO -23682 519 563 0 518 188 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-28 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 120 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 Liver Distant Metastasis YES 0 false No M0 N0 T1c Stage I TCGA-E2-A14Z.750D4149-BD70-4D7C-B915-9694BD1EC760.pdf A14Z WITH TUMOR Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A DECEASED 2009 bcf768ee-138c-42a4-a3bf-b8d509c644d9 bcf768ee-138c-42a4-a3bf-b8d509c644d9 TCGA-E2-A14Z-01A-21-A13E-20 TCGA-E2-A14Z-01A-11D-A10Y-09 TCGA-E2-A14Z-01 5a68a63e-17ae-4bd8-ab5d-0451e8ae8cc1 TCGA-E2-A14Z-01 TCGA-E2-A14Z-01A-11D-A10Y-09 TCGA-E2-A14Z-01A-11D-A112-05 TCGA-E2-A14Z-01 TCGA-E2-A14Z-01 TCGA-E2-A14Z-01A-11D-A10Y-09 bcf768ee-138c-42a4-a3bf-b8d509c644d9 TCGA-E2-A14Z-01A-11D-A111-01 TCGA-E2-A14Z-01 TCGA-E2-A14Z-01A-11R-A115-07 bcf768ee-138c-42a4-a3bf-b8d509c644d9 TCGA-E2-A14Z-01A-11D-A111-01 TCGA-E2-A14Z-01 TCGA-E2-A150-01 Stage IIA 48 1 Stage IIA 591 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 591 0 Basal Basal-like Negative X -13 -12 enrollment T_Other T2 LIVING TCGA-E2-A150-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 squamous c3 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-E2-A150 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A150-F71066 TCGA-E2-A150 TCGA-E2-A150-01A Negative Negative Lumpectomy NO -17580 506 0 1935 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2015-3-18 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 180 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A150.5173DB84-EE23-4973-A244-4BB1D79325C9.pdf A150 TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 46262a6c-8a11-4bb9-8851-8b6e44c95288 46262a6c-8a11-4bb9-8851-8b6e44c95288 TCGA-E2-A150-01A-21-A13E-20 TCGA-E2-A150-01A-11D-A12B-09 TCGA-E2-A150-01 c44ec1a9-cea5-46a0-b2c5-1686127fd1eb TCGA-E2-A150-01 TCGA-E2-A150-01A-11D-A12B-09 TCGA-E2-A150-01A-11D-A12E-05 TCGA-E2-A150-01 TCGA-E2-A150-01 TCGA-E2-A150-01A-11D-A12B-09 46262a6c-8a11-4bb9-8851-8b6e44c95288 TCGA-E2-A150-01A-11D-A12A-01 TCGA-E2-A150-01 TCGA-E2-A150-01A-11R-A12D-07 46262a6c-8a11-4bb9-8851-8b6e44c95288 TCGA-E2-A150-01A-11D-A12A-01 TCGA-E2-A150-01 TCGA-E2-A152-01 Stage I 56 1 Stage I 588 Positive FEMALE Positive 2 2 1 Negative M0 Negative N0 588 0 Her2 HER2-enriched Negative Her2 -1 -5 enrollment T1 T1 LIVING TCGA-E2-A152-01 High C3-BRCA/Luminal cluster 1 Cluster 5 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 8 TCGA-E2-A152 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO 56 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-E2-A152-F72471 TCGA-E2-A152 Positive Negative Lumpectomy NO -20705 0 2128 1044 966 NO Scheduled Follow-up Submission 2015-6-23 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Positive NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Positive 3+ Negative Negative 1 5 Other, specify Locoregional Recurrence Breast YES YES 0 No M0 N0 T1c Stage I A152 TUMOR FREE YES YES NO Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2009 be8c1926-064b-4a2f-9345-e34f0dc78bff be8c1926-064b-4a2f-9345-e34f0dc78bff TCGA-E2-A152-01A-21-A13E-20 TCGA-E2-A152-01A-11D-A12B-09 TCGA-E2-A152-01 f726d427-03ec-4234-b1e1-fec426bb46ac TCGA-E2-A152-01 TCGA-E2-A152-01A-11D-A12B-09 TCGA-E2-A152-01A-11D-A12E-05 TCGA-E2-A152-01 TCGA-E2-A152-01 TCGA-E2-A152-01A-11D-A12B-09 be8c1926-064b-4a2f-9345-e34f0dc78bff TCGA-E2-A152-01A-11D-A12A-01 TCGA-E2-A152-01 TCGA-E2-A152-01A-11R-A12D-07 be8c1926-064b-4a2f-9345-e34f0dc78bff TCGA-E2-A152-01A-11D-A12A-01 TCGA-E2-A152-01 TCGA-E2-A153-01 Stage IIB 51 2 Stage IIA 586 Positive FEMALE Negative 3 3 3 Negative M0 Positive N1 586 0 LumA Luminal A Positive LumA -12 -3 enrollment T1 T1 LIVING TCGA-E2-A153-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A153 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A153-F18945 TCGA-E2-A153 Positive Positive Modified Radical Mastectomy NO -18875 0 707 NO Scheduled Follow-up Submission 2011-11-8 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative 15 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 3 No M0 N1a T2 Stage IIB A153 TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2009 be4b0243-555a-4e4b-94fb-af6ba60058d0 be4b0243-555a-4e4b-94fb-af6ba60058d0 TCGA-E2-A153-01A-21-A13E-20 TCGA-E2-A153-01A-12D-A12B-09 TCGA-E2-A153-01 e93fc765-47be-401c-bbbb-8b3e16ae7c65 TCGA-E2-A153-01 TCGA-E2-A153-01A-12D-A12B-09 TCGA-E2-A153-01A-12D-A12E-05 TCGA-E2-A153-01 TCGA-E2-A153-01 TCGA-E2-A153-01A-12D-A12B-09 be4b0243-555a-4e4b-94fb-af6ba60058d0 TCGA-E2-A153-01A-12D-A12A-01 TCGA-E2-A153-01 TCGA-E2-A153-01A-12R-A12D-07 be4b0243-555a-4e4b-94fb-af6ba60058d0 TCGA-E2-A153-01A-12D-A12A-01 TCGA-E2-A153-01 TCGA-E2-A153-11 51 586 FEMALE 586 0 Normal enrollment LIVING TCGA-E2-A153-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E2-A153 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A153-F18945 TCGA-E2-A153 Positive Positive Modified Radical Mastectomy NO -18875 0 707 NO Scheduled Follow-up Submission 2011-11-8 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative 15 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 3 No M0 N1a T2 Stage IIB A153 TUMOR FREE YES YES Solid Tissue Normal 11 6th YES NO YES E2 Breast LIVING 2009 b5ab3b76-36f6-45a7-acad-77288da0d13c b5ab3b76-36f6-45a7-acad-77288da0d13c TCGA-E2-A153-11A-31D-A12E-05 TCGA-E2-A153-11 b5ab3b76-36f6-45a7-acad-77288da0d13c TCGA-E2-A153-11 TCGA-E2-A153-11A-31R-A12D-07 b5ab3b76-36f6-45a7-acad-77288da0d13c TCGA-E2-A154-01 Stage I 68 2 Stage I 325 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 325 0 LumA Luminal A Positive LumA -12 -3 enrollment T1 T1 LIVING TCGA-E2-A154-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-E2-A154 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A154-F18940 TCGA-E2-A154 TCGA-E2-A154-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy NO -24999 461 0 591 NO 90-99% Scheduled Follow-up Submission 2011-11-8 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 400 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A154.8F8DCA87-B27A-429C-952A-186F8D4502AE.pdf A154 TUMOR FREE YES 90-99% YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 81589acc-5dae-4cad-9f97-88b81fa53f92 81589acc-5dae-4cad-9f97-88b81fa53f92 TCGA-E2-A154-01A-21-A13E-20 TCGA-E2-A154-01A-11D-A10Y-09 TCGA-E2-A154-01 9f67c05d-d95e-4932-bace-78ee0cfbf304 TCGA-E2-A154-01 TCGA-E2-A154-01A-11D-A10Y-09 TCGA-E2-A154-01A-11D-A112-05 TCGA-E2-A154-01 TCGA-E2-A154-01 TCGA-E2-A154-01A-11D-A10Y-09 81589acc-5dae-4cad-9f97-88b81fa53f92 TCGA-E2-A154-01A-11D-A111-01 TCGA-E2-A154-01 TCGA-E2-A154-01A-11R-A115-07 81589acc-5dae-4cad-9f97-88b81fa53f92 TCGA-E2-A154-01A-11D-A111-01 TCGA-E2-A154-01 TCGA-E2-A155-01 Stage IIB 58 1 Stage IIB 553 Positive FEMALE Negative 4 3 4 Negative M0 Positive N1 553 0 LumB Luminal B Negative LumA/B -10 -3 enrollment T_Other T2 LIVING TCGA-E2-A155-01 Kirc+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-E2-A155 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Inner Quadrant|Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E2-A155-F18942 TCGA-E2-A155 TCGA-E2-A155-01A Positive Negative Modified Radical Mastectomy NO -21348 457 0 640 NO Scheduled Follow-up Submission 2011-11-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 280 NO Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 5 NO 2 false No M0 N1a T2 Stage IIB TCGA-E2-A155.C3E398CE-1918-4107-948C-6579B1DA1F77.pdf A155 TUMOR FREE YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 6a345a9e-8173-4c9e-972d-df0b154c97b0 6a345a9e-8173-4c9e-972d-df0b154c97b0 TCGA-E2-A155-01A-21-A13E-20 TCGA-E2-A155-01A-11D-A12B-09 TCGA-E2-A155-01 89f9e8d3-6526-4680-a393-c6b3b997599d TCGA-E2-A155-01 TCGA-E2-A155-01A-11D-A12B-09 TCGA-E2-A155-01A-11D-A12E-05 TCGA-E2-A155-01 TCGA-E2-A155-01 TCGA-E2-A155-01A-11D-A12B-09 6a345a9e-8173-4c9e-972d-df0b154c97b0 TCGA-E2-A155-01A-11D-A12A-01 TCGA-E2-A155-01 TCGA-E2-A155-01A-11R-A12D-07 6a345a9e-8173-4c9e-972d-df0b154c97b0 TCGA-E2-A155-01A-11D-A12A-01 TCGA-E2-A155-01 TCGA-E2-A156-01 Stage I 61 2 Stage I 481 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 481 0 LumA Luminal A Positive LumA -12 -3 enrollment T1 T1 LIVING TCGA-E2-A156-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A156 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Sentinel node biopsy alone TCGA-E2-A156-F18786 TCGA-E2-A156 Positive Positive Lumpectomy NO -22422 0 726 NO Scheduled Follow-up Submission 2011-11-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 No M0 N0 T1c Stage I A156 TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2009 b6ed3dfa-4d81-4e5c-9c1a-166894f92752 b6ed3dfa-4d81-4e5c-9c1a-166894f92752 TCGA-E2-A156-01A-21-A13E-20 TCGA-E2-A156-01A-11D-A12B-09 TCGA-E2-A156-01 eafe692c-6651-466b-a92c-1ed965eba047 TCGA-E2-A156-01 TCGA-E2-A156-01A-11D-A12B-09 TCGA-E2-A156-01A-11D-A12E-05 TCGA-E2-A156-01 TCGA-E2-A156-01 TCGA-E2-A156-01A-11D-A12B-09 b6ed3dfa-4d81-4e5c-9c1a-166894f92752 TCGA-E2-A156-01A-11D-A12A-01 TCGA-E2-A156-01 TCGA-E2-A156-01A-11R-A12D-07 b6ed3dfa-4d81-4e5c-9c1a-166894f92752 TCGA-E2-A156-01A-11D-A12A-01 TCGA-E2-A156-01 TCGA-E2-A158-01 Stage IIA 43 1 Stage IIA 450 Negative FEMALE Negative 2 2 2 Negative M0 Positive N1 450 0 Basal Basal-like Negative Basal -13 0 enrollment T1 T1 LIVING TCGA-E2-A158-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E2-A158 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A158-F18956 TCGA-E2-A158 TCGA-E2-A158-01A Negative Negative Simple Mastectomy NO -15903 436 0 450 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-11-8 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 200 NO Negative 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 5 NO 1 false Yes M0 N1mi T1c Stage IIA TCGA-E2-A158.1CEBF20D-767A-4A19-AA41-B9EAFCF05176.pdf A158 TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 43326f71-c61c-410b-af4b-c71a054e27c9 43326f71-c61c-410b-af4b-c71a054e27c9 TCGA-E2-A158-01A-21-A13E-20 TCGA-E2-A158-01A-11D-A12B-09 TCGA-E2-A158-01 cc34e050-b748-413b-a5ec-064c216e98c3 TCGA-E2-A158-01 TCGA-E2-A158-01A-11D-A12B-09 TCGA-E2-A158-01A-11D-A12E-05 TCGA-E2-A158-01 TCGA-E2-A158-01 TCGA-E2-A158-01A-11D-A12B-09 43326f71-c61c-410b-af4b-c71a054e27c9 TCGA-E2-A158-01A-11D-A12A-01 TCGA-E2-A158-01 TCGA-E2-A158-01A-11R-A12D-07 43326f71-c61c-410b-af4b-c71a054e27c9 TCGA-E2-A158-01A-11D-A12A-01 TCGA-E2-A158-01 TCGA-E2-A158-11 43 450 FEMALE 450 0 Normal enrollment LIVING TCGA-E2-A158-11 C4-BRCA/Basal mutation cluster 5 TCGA-E2-A158 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A158-F18956 TCGA-E2-A158 TCGA-E2-A158-11A Negative Negative Simple Mastectomy NO -15903 436 0 450 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-11-8 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 170 NO Negative 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 false Yes M0 N1mi T1c Stage IIA A158 TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES NO Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2009 5ba99650-56d2-4951-aa24-3d2fea3d1921 5ba99650-56d2-4951-aa24-3d2fea3d1921 TCGA-E2-A158-11A-22D-A12E-05 5ba99650-56d2-4951-aa24-3d2fea3d1921 TCGA-E2-A158-11A-22R-A12D-07 5ba99650-56d2-4951-aa24-3d2fea3d1921 TCGA-E2-A159-01 Stage IIA 50 1 Stage IIA 515 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 515 0 Basal Basal-like Negative Basal -13 -10 enrollment T_Other T2 LIVING TCGA-E2-A159-01 High C4-BRCA/Basal cluster 5 Cluster 5 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-E2-A159 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A159-F19115 TCGA-E2-A159 TCGA-E2-A159-01A Negative Negative Lumpectomy NO -18621 434 0 762 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-11-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 240 NO Negative 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 3 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A159.7CA117DA-5D1C-4F8B-8330-5C58FE05DE36.pdf A159 TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 95c7abfa-a417-4d81-96c2-a952a081d997 95c7abfa-a417-4d81-96c2-a952a081d997 TCGA-E2-A159-01A-21-A13E-20 TCGA-E2-A159-01A-11D-A10Y-09 TCGA-E2-A159-01 c9662a04-c4e9-42c3-989f-cade253340dc TCGA-E2-A159-01 TCGA-E2-A159-01A-11D-A10Y-09 TCGA-E2-A159-01A-11D-A112-05 TCGA-E2-A159-01 TCGA-E2-A159-01 TCGA-E2-A159-01A-11D-A10Y-09 95c7abfa-a417-4d81-96c2-a952a081d997 TCGA-E2-A159-01A-11D-A111-01 TCGA-E2-A159-01 TCGA-E2-A159-01A-11R-A115-07 95c7abfa-a417-4d81-96c2-a952a081d997 TCGA-E2-A159-01A-11D-A111-01 TCGA-E2-A159-01 TCGA-E2-A15A-01 Stage IIIC 45 4 Stage IIIC 502 Positive FEMALE Negative 1 1 4 Negative M0 Positive N3 502 0 LumB Luminal B Positive Her2 -2 -5 enrollment T_Other T2 LIVING TCGA-E2-A15A-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A15A-F18926 TCGA-E2-A15A Positive Positive Simple Mastectomy NO -16750 0 710 NO Scheduled Follow-up Submission 2011-11-10 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 13 No M0 N3a T2 Stage IIIC A15A TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2009 a4754430-f713-4aeb-998c-0f470a5549d1 a4754430-f713-4aeb-998c-0f470a5549d1 TCGA-E2-A15A-01A-11D-A12B-09 TCGA-E2-A15A-01 eee0fe49-2254-4347-b328-49a69bea7619 TCGA-E2-A15A-01 TCGA-E2-A15A-01A-11D-A12B-09 TCGA-E2-A15A-01A-11D-A12E-05 TCGA-E2-A15A-01 TCGA-E2-A15A-01 TCGA-E2-A15A-01A-11D-A12B-09 a4754430-f713-4aeb-998c-0f470a5549d1 TCGA-E2-A15A-01A-11D-A12A-01 TCGA-E2-A15A-01 TCGA-E2-A15A-01A-11R-A12D-07 a4754430-f713-4aeb-998c-0f470a5549d1 TCGA-E2-A15A-01A-11D-A12A-01 TCGA-E2-A15A-01 TCGA-E2-A15A-06 45 502 FEMALE 502 0 LumB enrollment LIVING TCGA-E2-A15A-06 C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A15A-F18926 TCGA-E2-A15A TCGA-E2-A15A-06A Positive Positive Simple Mastectomy NO -16750 426 0 710 NO Scheduled Follow-up Submission 2011-11-10 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 120 NO Negative 19 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 13 false No M0 N3a T2 Stage IIIC TCGA-E2-A15A.3687AF42-4BB3-46E2-8091-E0C5C84F15E6.pdf A15A TUMOR FREE YES YES Metastatic 06 6th YES NO YES E2 Breast A LIVING 2009 e55bc0c9-ee0f-4efb-8024-3baed3c24080 e55bc0c9-ee0f-4efb-8024-3baed3c24080 TCGA-E2-A15A-06A-21-A24B-20 234a8293-3dd6-4625-9f76-fa9e144aee3e TCGA-E2-A15A-06A-11D-A12B-09 TCGA-E2-A15A-06A-11D-A12E-05 TCGA-E2-A15A-06 TCGA-E2-A15A-06A-11D-A12B-09 e55bc0c9-ee0f-4efb-8024-3baed3c24080 TCGA-E2-A15A-06 TCGA-E2-A15A-06A-11R-A12D-07 e55bc0c9-ee0f-4efb-8024-3baed3c24080 TCGA-E2-A15C-01 Stage I 61 4 Stage I 496 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 496 0 LumA Luminal A Positive ReacI -5 -4 enrollment T1 T1 LIVING TCGA-E2-A15C-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A15C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15C-F18935 TCGA-E2-A15C TCGA-E2-A15C-01A Positive Positive Lumpectomy NO -22583 393 0 694 NO Scheduled Follow-up Submission 2011-11-9 FEMALE 20-29% 2+ 1.02 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 200 NO Equivocal Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A15C.04FF2CF1-737B-4FD2-8A1D-F9B5488DE510.pdf A15C TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 1a77082d-f130-436b-9028-23c8dd9dc565 1a77082d-f130-436b-9028-23c8dd9dc565 TCGA-E2-A15C-01A-21-A13E-20 TCGA-E2-A15C-01A-31D-A12B-09 TCGA-E2-A15C-01 b003e078-2c0b-42bc-ad2e-adb171765c57 TCGA-E2-A15C-01 TCGA-E2-A15C-01A-31D-A12B-09 TCGA-E2-A15C-01A-31D-A12E-05 TCGA-E2-A15C-01 TCGA-E2-A15C-01 TCGA-E2-A15C-01A-31D-A12B-09 1a77082d-f130-436b-9028-23c8dd9dc565 TCGA-E2-A15C-01A-31D-A12A-01 TCGA-E2-A15C-01 TCGA-E2-A15C-01A-31R-A12D-07 1a77082d-f130-436b-9028-23c8dd9dc565 TCGA-E2-A15C-01A-31D-A12A-01 TCGA-E2-A15C-01 TCGA-E2-A15D-01 Stage IIA 47 Stage IIA 315 Positive FEMALE Negative Negative M0 Negative N0 315 0 LumA Luminal A Positive LumA -5 -3 enrollment T_Other T2 LIVING TCGA-E2-A15D-01 C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15D TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Sentinel node biopsy alone TCGA-E2-A15D-F18783 TCGA-E2-A15D TCGA-E2-A15D-01A Positive Positive Lumpectomy NO -17224 393 0 526 NO Scheduled Follow-up Submission 2011-11-9 FEMALE 2+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 330 NO Equivocal Negative 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A15D.1FE4EB4C-FEF8-486A-B39D-6F9F023FDAC4.pdf A15D TUMOR FREE Allred score = 8 Allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 b58514d7-7785-497d-ba94-165ee0a1b941 b58514d7-7785-497d-ba94-165ee0a1b941 TCGA-E2-A15D-01A-21-A13E-20 TCGA-E2-A15D-01A-11D-A10Y-09 TCGA-E2-A15D-01 0a257700-c228-4e46-9b2d-af39db001515 TCGA-E2-A15D-01 TCGA-E2-A15D-01A-11D-A10Y-09 TCGA-E2-A15D-01A-11D-A112-05 TCGA-E2-A15D-01 TCGA-E2-A15D-01 TCGA-E2-A15D-01A-11D-A10Y-09 b58514d7-7785-497d-ba94-165ee0a1b941 TCGA-E2-A15D-01A-11D-A111-01 TCGA-E2-A15D-01 TCGA-E2-A15D-01A-11R-A115-07 b58514d7-7785-497d-ba94-165ee0a1b941 TCGA-E2-A15D-01A-11D-A111-01 TCGA-E2-A15D-01 TCGA-E2-A15E-01 Stage IIA 40 4 Stage IIA 517 Positive FEMALE Positive 3 4 3 Negative M0 Positive N1 517 0 LumA Luminal A Positive Her2 -5 -7 enrollment T1 T1 LIVING TCGA-E2-A15E-01 Squamous C3-BRCA/Luminal cluster 2 Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-E2-A15E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A15E-F18919 TCGA-E2-A15E TCGA-E2-A15E-01A Positive Positive Lumpectomy NO -14894 387 0 630 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 520 NO Positive 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 1 false No M0 N1a T1c Stage IIA TCGA-E2-A15E.514D4C2E-8215-4770-9FC1-25F988232A85.pdf A15E TUMOR FREE Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3 42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3 TCGA-E2-A15E-01A-21-A13E-20 TCGA-E2-A15E-01A-11D-A12B-09 TCGA-E2-A15E-01 d0c1fe33-e7c4-4705-9a97-1520151d4ffb TCGA-E2-A15E-01 TCGA-E2-A15E-01A-11D-A12B-09 TCGA-E2-A15E-01A-11D-A12E-05 TCGA-E2-A15E-01 TCGA-E2-A15E-01 TCGA-E2-A15E-01A-11D-A12B-09 42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3 TCGA-E2-A15E-01A-11D-A12A-01 TCGA-E2-A15E-01 TCGA-E2-A15E-01A-11R-A12D-07 42ba8e87-8d37-4cbd-82f0-bca0cbe5dcd3 TCGA-E2-A15E-01A-11D-A12A-01 TCGA-E2-A15E-01 TCGA-E2-A15E-06 40 517 FEMALE 517 0 LumA enrollment LIVING TCGA-E2-A15E-06 C3-BRCA/Luminal cluster 2 Low purity c2 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 3 TCGA-E2-A15E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A15E-F18919 TCGA-E2-A15E TCGA-E2-A15E-06A Positive Positive Lumpectomy NO -14894 387 0 630 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 60 NO Positive 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 false No M0 N1a T1c Stage IIA TCGA-E2-A15E.57341F00-74F5-4015-B6D4-7BDED33F35A7.pdf A15E TUMOR FREE Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES YES Metastatic 06 6th YES NO YES E2 Breast A LIVING 2009 8131b824-c3db-4c83-99b9-aa0c60747c5d 8131b824-c3db-4c83-99b9-aa0c60747c5d TCGA-E2-A15E-06A-11D-A12B-09 TCGA-E2-A15E-06A-11D-A12E-05 TCGA-E2-A15E-06 TCGA-E2-A15E-06A-11D-A12B-09 8131b824-c3db-4c83-99b9-aa0c60747c5d TCGA-E2-A15E-06 TCGA-E2-A15E-06A-11R-A12D-07 8131b824-c3db-4c83-99b9-aa0c60747c5d TCGA-E2-A15F-01 Stage I 64 Stage IIA 468 Positive FEMALE Negative Negative M0 Negative N0 468 0 Luminal A Positive ReacI -3 -3 enrollment T_Other T2 LIVING TCGA-E2-A15F-01 cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15F TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15F-F18906 TCGA-E2-A15F TCGA-E2-A15F-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy NO -23660 360 0 658 NO 90-99% Scheduled Follow-up Submission 2011-11-10 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 190 NO Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A15F.19360B66-C514-4EE1-ACD7-08873828133E.pdf A15F TUMOR FREE YES 90-99% YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 2e41bc6a-bece-4b6d-a646-be9b98707bba 2e41bc6a-bece-4b6d-a646-be9b98707bba TCGA-E2-A15F-01A-21-A13E-20 TCGA-E2-A15F-01A-11D-A10Y-09 TCGA-E2-A15F-01 3d2f1976-cf0a-4cab-817a-92301b6d9275 TCGA-E2-A15F-01 TCGA-E2-A15F-01A-11D-A10Y-09 TCGA-E2-A15F-01A-11D-A112-05 TCGA-E2-A15F-01 TCGA-E2-A15F-01 TCGA-E2-A15F-01A-11D-A10Y-09 2e41bc6a-bece-4b6d-a646-be9b98707bba TCGA-E2-A15F-01A-11D-A111-01 TCGA-E2-A15F-01 TCGA-E2-A15F-01A-11R-A115-07 2e41bc6a-bece-4b6d-a646-be9b98707bba TCGA-E2-A15F-01A-11D-A111-01 TCGA-E2-A15F-01 TCGA-E2-A15G-01 Stage IIA 76 2 Stage IIA 315 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 315 0 LumA Luminal A Positive LumA -12 -3 enrollment T_Other T2 LIVING TCGA-E2-A15G-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 1 mutation cluster 4 TCGA-E2-A15G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 76 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15G-F18901 TCGA-E2-A15G TCGA-E2-A15G-01A Positive Positive Lumpectomy NO -28013 358 0 554 NO Scheduled Follow-up Submission 2011-11-14 FEMALE 1+ Mixed Histology (please specify) Invasive ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 110 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 1 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A15G.DD9FDF3B-29CA-4D11-8615-E2EEB5D601D1.pdf A15G TUMOR FREE Allred score = 8 Allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 a88e6892-93fe-451f-9b7e-f6fe260ba9af a88e6892-93fe-451f-9b7e-f6fe260ba9af TCGA-E2-A15G-01A-21-A13E-20 TCGA-E2-A15G-01A-11D-A12B-09 TCGA-E2-A15G-01 1af0a946-026d-4dbb-b52d-db12449e4c31 TCGA-E2-A15G-01 TCGA-E2-A15G-01A-11D-A12B-09 TCGA-E2-A15G-01A-11D-A12E-05 TCGA-E2-A15G-01 TCGA-E2-A15G-01 TCGA-E2-A15G-01A-11D-A12B-09 a88e6892-93fe-451f-9b7e-f6fe260ba9af TCGA-E2-A15G-01A-11D-A12A-01 TCGA-E2-A15G-01 TCGA-E2-A15G-01A-11R-A12D-07 a88e6892-93fe-451f-9b7e-f6fe260ba9af TCGA-E2-A15G-01A-11D-A12A-01 TCGA-E2-A15G-01 TCGA-E2-A15H-01 Stage IIA 38 2 Stage IIA 42 Positive FEMALE Positive 3 1 3 Negative M0 Positive N1 42 0 LumA Luminal A Positive Her2 0 0 enrollment T1 T1 LIVING TCGA-E2-A15H-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15H-F18916 TCGA-E2-A15H TCGA-E2-A15H-01A Positive Positive Lumpectomy NO -13985 357 0 393 NO Scheduled Follow-up Submission 2011-11-14 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 90 NO Equivocal Positive 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 4 NO 1 false No M0 N1mi T1c Stage IIA TCGA-E2-A15H.E4D1A7DC-62B1-44D8-A747-5A19842C6F69.pdf A15H TUMOR FREE Allred score = 8 Allred Score = 7 YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 75b2227e-0279-4dfb-a1a1-e64c53b48d7a 75b2227e-0279-4dfb-a1a1-e64c53b48d7a TCGA-E2-A15H-01A-21-A13E-20 TCGA-E2-A15H-01A-11D-A12B-09 TCGA-E2-A15H-01 f381f799-7861-47be-b54f-26a1e5236887 TCGA-E2-A15H-01 TCGA-E2-A15H-01A-11D-A12B-09 TCGA-E2-A15H-01A-11D-A12E-05 TCGA-E2-A15H-01 TCGA-E2-A15H-01 TCGA-E2-A15H-01A-11D-A12B-09 75b2227e-0279-4dfb-a1a1-e64c53b48d7a TCGA-E2-A15H-01A-11D-A12A-01 TCGA-E2-A15H-01 TCGA-E2-A15H-01A-11R-A12D-07 75b2227e-0279-4dfb-a1a1-e64c53b48d7a TCGA-E2-A15H-01A-11D-A12A-01 TCGA-E2-A15H-01 TCGA-E2-A15I-01 Stage IIA 44 2 Stage IIA 411 Positive FEMALE Negative Negative M0 Negative N0 411 0 LumA Luminal A Positive -5 -7 enrollment T_Other T2 LIVING TCGA-E2-A15I-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-E2-A15I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left Upper Outer Quadrant|Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15I-F70023 TCGA-E2-A15I TCGA-E2-A15I-01A Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -16163 344 0 1692 NO 90-99% Scheduled Follow-up Submission 2015-2-9 FEMALE 2+ 1.04 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 100 NO Equivocal Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 7 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A15I.FE41053B-16F4-46B0-B243-571F4D5A1665.pdf A15I TUMOR FREE YES YES 90-99% NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c 4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c TCGA-E2-A15I-01A-11-A17I-20 TCGA-E2-A15I-01A-21D-A135-09 TCGA-E2-A15I-01 TCGA-E2-A15I-01A-21D-A138-05 6be5e02d-4e5b-4b24-b603-4512dff0f17c TCGA-E2-A15I-01 TCGA-E2-A15I-01A-21D-A135-09 TCGA-E2-A15I-01 TCGA-E2-A15I-01 TCGA-E2-A15I-01A-21D-A135-09 4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c TCGA-E2-A15I-01A-21D-A134-01 TCGA-E2-A15I-01 TCGA-E2-A15I-01A-21R-A137-07 4f3a68ee-00c8-44bd-b9d6-f3fa6dc4084c TCGA-E2-A15I-01A-21D-A134-01 TCGA-E2-A15I-01 TCGA-E2-A15I-11 44 411 FEMALE 411 0 Normal enrollment LIVING TCGA-E2-A15I-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E2-A15I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left Upper Outer Quadrant|Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15I-F70023 TCGA-E2-A15I Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -16163 0 1692 NO 90-99% Scheduled Follow-up Submission 2015-2-9 FEMALE 2+ 1.04 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Equivocal Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 No M0 N0 T2 Stage IIA A15I TUMOR FREE YES YES 90-99% NO Solid Tissue Normal 11 6th YES NO YES E2 Breast LIVING 2009 f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9 f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9 TCGA-E2-A15I-11A-32D-A138-05 TCGA-E2-A15I-11 f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9 TCGA-E2-A15I-11 TCGA-E2-A15I-11A-32R-A137-07 f9df2254-ab08-4ab2-9b86-ed40e6c8a4b9 TCGA-E2-A15J-01 Stage I 51 2 Stage I 463 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 463 0 LumA Luminal A Positive LumA/B -12 -3 enrollment T1 T1 LIVING TCGA-E2-A15J-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A15J TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15J-F70020 TCGA-E2-A15J TCGA-E2-A15J-01A Positive Positive Simple Mastectomy NO -18771 344 0 1640 NO Scheduled Follow-up Submission 2015-2-9 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 210 NO Equivocal Negative NO 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A15J.352BF6A2-974B-440E-BB0B-DCD79874DAC3.pdf A15J TUMOR FREE Allred score = 8 Allred score = 7 YES YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 376c13fa-ba3e-4f2e-a8bc-87fb70541239 376c13fa-ba3e-4f2e-a8bc-87fb70541239 TCGA-E2-A15J-01A-21-A13E-20 TCGA-E2-A15J-01A-11D-A12Q-09 TCGA-E2-A15J-01 TCGA-E2-A15J-01A-11D-A12R-05 ffe06b3a-f290-463c-bb0e-994c0679f8be TCGA-E2-A15J-01 TCGA-E2-A15J-01A-11D-A12Q-09 TCGA-E2-A15J-01 TCGA-E2-A15J-01 TCGA-E2-A15J-01A-11D-A12Q-09 376c13fa-ba3e-4f2e-a8bc-87fb70541239 TCGA-E2-A15J-01A-11D-A12N-01 TCGA-E2-A15J-01 TCGA-E2-A15J-01A-11R-A12P-07 376c13fa-ba3e-4f2e-a8bc-87fb70541239 TCGA-E2-A15J-01A-11D-A12N-01 TCGA-E2-A15J-01 TCGA-E2-A15K-01 Stage IIA 58 2 Stage IIB 34 Positive FEMALE Negative 3 3 4 Negative M0 Positive N1 34 0 LumB Luminal B Positive LumA -12 -3 enrollment T_Other T2 LIVING TCGA-E2-A15K-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A15K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A15K-F18869 TCGA-E2-A15K TCGA-E2-A15K-01A Positive Positive Lumpectomy NO -21514 309 0 275 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-15 FEMALE 10-19% 2+ 0.9 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 170 NO Equivocal Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 2 false No M0 N1a T2 Stage IIB TCGA-E2-A15K.2BAC50DA-016F-4B5C-B8D1-DE75377EF0C7.pdf A15K TUMOR FREE Allred score 2+2 = 4 Allred score = 4 Allred score = 8 YES YES Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 141e15ac-1537-4182-9db5-ba2115cd93d6 141e15ac-1537-4182-9db5-ba2115cd93d6 TCGA-E2-A15K-01A-11D-A12Q-09 TCGA-E2-A15K-01 TCGA-E2-A15K-01A-11D-A12R-05 1afef343-eb28-46d1-ba40-2475188b33c5 TCGA-E2-A15K-01 TCGA-E2-A15K-01A-11D-A12Q-09 TCGA-E2-A15K-01 TCGA-E2-A15K-01 TCGA-E2-A15K-01A-11D-A12Q-09 141e15ac-1537-4182-9db5-ba2115cd93d6 TCGA-E2-A15K-01A-11D-A12N-01 TCGA-E2-A15K-01 TCGA-E2-A15K-01A-11R-A12P-07 141e15ac-1537-4182-9db5-ba2115cd93d6 TCGA-E2-A15K-01A-11D-A12N-01 TCGA-E2-A15K-01 TCGA-E2-A15K-06 58 34 FEMALE 34 0 LumB enrollment LIVING TCGA-E2-A15K-06 C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-E2-A15K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A15K-F18869 TCGA-E2-A15K TCGA-E2-A15K-06A Positive Positive Lumpectomy NO -21514 309 0 275 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-15 FEMALE 10-19% 2+ 0.9 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 280 NO Equivocal Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 false No M0 N1a T2 Stage IIB TCGA-E2-A15K.72FE0659-6B7E-4129-B61D-C376C59C428F.pdf A15K TUMOR FREE Allred score 2+2 = 4 Allred score = 4 Allred score = 8 YES YES Metastatic 06 7th YES NO YES E2 Breast A LIVING 2010 69f0bc59-c026-40e2-a3b6-88fcde091a82 69f0bc59-c026-40e2-a3b6-88fcde091a82 TCGA-E2-A15K-06A-21-A24B-20 TCGA-E2-A15K-06A-11D-A12R-05 7e1db33b-2235-49f6-8f01-5d8ab274ce14 TCGA-E2-A15K-06A-11D-A12Q-09 TCGA-E2-A15K-06 TCGA-E2-A15K-06A-11D-A12Q-09 69f0bc59-c026-40e2-a3b6-88fcde091a82 TCGA-E2-A15K-06 TCGA-E2-A15K-06A-11R-A12P-07 69f0bc59-c026-40e2-a3b6-88fcde091a82 TCGA-E2-A15K-11 58 34 FEMALE 34 0 enrollment LIVING TCGA-E2-A15K-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E2-A15K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A15K-F18869 TCGA-E2-A15K TCGA-E2-A15K-11A Positive Positive Lumpectomy NO -21514 309 0 275 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-15 FEMALE 10-19% 2+ 0.9 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 120 NO Equivocal Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 false No M0 N1a T2 Stage IIB A15K TUMOR FREE Allred score 2+2 = 4 Allred score = 4 Allred score = 8 YES YES Solid Tissue Normal 11 7th YES NO YES E2 Breast A LIVING 2010 49a33b4d-4b1e-4b30-b0ba-a7c7d594db41 49a33b4d-4b1e-4b30-b0ba-a7c7d594db41 TCGA-E2-A15K-11A-13D-A12R-05 TCGA-E2-A15K-11 49a33b4d-4b1e-4b30-b0ba-a7c7d594db41 TCGA-E2-A15K-11 49a33b4d-4b1e-4b30-b0ba-a7c7d594db41 TCGA-E2-A15L-01 Stage IIA 65 2 Stage IIA 331 Positive FEMALE Negative Negative M0 Negative N0 331 0 LumA Luminal B Positive ReacI -12 -3 enrollment T_Other T2 LIVING TCGA-E2-A15L-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation cluster 4 TCGA-E2-A15L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Sentinel node biopsy alone TCGA-E2-A15L-F18885 TCGA-E2-A15L TCGA-E2-A15L-01A Positive Positive Simple Mastectomy NO -23845 289 0 626 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-15 FEMALE 30-39% 2+ 0.9 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 240 NO Equivocal Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A15L.C04B3267-9833-44D6-8C3D-45D7F829C38C.pdf A15L TUMOR FREE Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES NO Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 68a4bd03-2b97-4387-926f-c9d25fac8d29 68a4bd03-2b97-4387-926f-c9d25fac8d29 TCGA-E2-A15L-01A-21-A13E-20 TCGA-E2-A15L-01A-11D-A12B-09 TCGA-E2-A15L-01 bf925eb7-7a5b-44b2-9ace-627782f168c3 TCGA-E2-A15L-01 TCGA-E2-A15L-01A-11D-A12B-09 TCGA-E2-A15L-01A-11D-A12E-05 TCGA-E2-A15L-01 TCGA-E2-A15L-01 TCGA-E2-A15L-01A-11D-A12B-09 68a4bd03-2b97-4387-926f-c9d25fac8d29 TCGA-E2-A15L-01A-11D-A12A-01 TCGA-E2-A15L-01 TCGA-E2-A15L-01A-11R-A12D-07 68a4bd03-2b97-4387-926f-c9d25fac8d29 TCGA-E2-A15L-01A-11D-A12A-01 TCGA-E2-A15L-01 TCGA-E2-A15L-11 65 331 FEMALE 331 0 enrollment LIVING TCGA-E2-A15L-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E2-A15L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Sentinel node biopsy alone TCGA-E2-A15L-F18885 TCGA-E2-A15L TCGA-E2-A15L-11A Positive Positive Simple Mastectomy NO -23845 289 0 626 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-15 FEMALE 30-39% 2+ 0.9 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 210 NO Equivocal Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T2 Stage IIA A15L TUMOR FREE Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES NO Solid Tissue Normal 11 7th YES NO YES E2 Breast A LIVING 2010 TCGA-E2-A15L-11A-31D-A12E-05 TCGA-E2-A15M-01 Stage IIA 66 3 Stage IIA 234 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 234 0 LumA Luminal B Positive ReacI -4 -4 enrollment T_Other T2 LIVING TCGA-E2-A15M-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 5 TCGA-E2-A15M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15M-F18852 TCGA-E2-A15M TCGA-E2-A15M-01A Positive Positive Lumpectomy NO -24266 287 336 0 235 NO Scheduled Follow-up Submission 2011-11-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 270 NO Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A15M.51601F8B-BA50-42C4-B0C9-B3581F80CD2C.pdf A15M TUMOR FREE Allred score = 8 Allred score = 8 YES YES Primary Tumor 01 7th YES NO YES E2 Breast A DECEASED 2010 e596b149-e807-4d29-b0fa-685f07efb9d6 e596b149-e807-4d29-b0fa-685f07efb9d6 TCGA-E2-A15M-01A-21-A13E-20 TCGA-E2-A15M-01A-11D-A12B-09 TCGA-E2-A15M-01 52e4ab39-3d51-4623-a65a-09a99017e96b TCGA-E2-A15M-01 TCGA-E2-A15M-01A-11D-A12B-09 TCGA-E2-A15M-01A-11D-A12E-05 TCGA-E2-A15M-01 TCGA-E2-A15M-01 TCGA-E2-A15M-01A-11D-A12B-09 e596b149-e807-4d29-b0fa-685f07efb9d6 TCGA-E2-A15M-01A-11D-A12A-01 TCGA-E2-A15M-01 TCGA-E2-A15M-01A-11R-A12D-07 e596b149-e807-4d29-b0fa-685f07efb9d6 TCGA-E2-A15M-01A-11D-A12A-01 TCGA-E2-A15M-01 TCGA-E2-A15M-11 66 234 FEMALE 234 0 Normal enrollment LIVING TCGA-E2-A15M-11 C3-BRCA/Luminal mutation cluster 5 TCGA-E2-A15M TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15M-F18852 TCGA-E2-A15M Positive Positive Lumpectomy NO -24266 336 0 235 NO Scheduled Follow-up Submission 2011-11-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T2 Stage IIA A15M TUMOR FREE Allred score = 8 Allred score = 8 YES YES Solid Tissue Normal 11 7th YES NO YES E2 Breast DECEASED 2010 f75e5efb-056f-40bf-afed-33d971478ca4 f75e5efb-056f-40bf-afed-33d971478ca4 TCGA-E2-A15M-11A-22D-A12E-05 TCGA-E2-A15M-11 f75e5efb-056f-40bf-afed-33d971478ca4 TCGA-E2-A15M-11 TCGA-E2-A15M-11A-22R-A12D-07 f75e5efb-056f-40bf-afed-33d971478ca4 TCGA-E2-A15O-01 Stage I 89 4 Stage IIA 395 Positive FEMALE Negative 1 3 3 Negative M0 Negative N0 395 0 LumA Luminal A Positive LumA 0 -3 enrollment T_Other T2 LIVING TCGA-E2-A15O-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-E2-A15O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 89 Left Upper Inner Quadrant No axillary staging TCGA-E2-A15O-F70024 TCGA-E2-A15O TCGA-E2-A15O-01A Positive Positive Lumpectomy NO -32583 273 0 1545 1230 1210 NO Allred score 5+2 = 7 Scheduled Follow-up Submission 2015-3-16 FEMALE 10-19% 2+ 0.9 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 110 NO Equivocal Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative 1+ Positive 3 Point Scale 3+ 3+ Positive 4 2 3 Point Scale Locoregional Recurrence YES YES false Yes M0 NX T1c Stage I TCGA-E2-A15O.AA4B6E2D-7503-4E51-BEA4-632CC994770A.pdf A15O TUMOR FREE Allred score 4+3 = 7 Allred score = 7 Allred score = 7 YES NO NO Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 4a28ecf3-c70e-42d0-918b-866d11804c13 4a28ecf3-c70e-42d0-918b-866d11804c13 TCGA-E2-A15O-01A-21-A13E-20 TCGA-E2-A15O-01A-11D-A10Y-09 TCGA-E2-A15O-01 538d33c5-6bc8-4cda-950b-93c16e500d48 TCGA-E2-A15O-01 TCGA-E2-A15O-01A-11D-A10Y-09 TCGA-E2-A15O-01A-11D-A112-05 TCGA-E2-A15O-01 TCGA-E2-A15O-01 TCGA-E2-A15O-01A-11D-A10Y-09 4a28ecf3-c70e-42d0-918b-866d11804c13 TCGA-E2-A15O-01A-11D-A111-01 TCGA-E2-A15O-01 TCGA-E2-A15O-01A-11R-A115-07 4a28ecf3-c70e-42d0-918b-866d11804c13 TCGA-E2-A15O-01A-11D-A111-01 TCGA-E2-A15O-01 TCGA-E2-A15P-01 Stage IA 61 2 Stage I 315 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 315 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING TCGA-E2-A15P-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 4 TCGA-E2-A15P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15P-F19144 TCGA-E2-A15P TCGA-E2-A15P-01A Positive Positive Lumpectomy NO -22524 269 0 595 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-11-16 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 110 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 false No M0 N0 T1c Stage IA TCGA-E2-A15P.8C7442C0-540C-4023-BBFA-8482935259A7.pdf A15P TUMOR FREE Allred score 2+2 = 4 Allred score = 4 Allred score = 8 YES YES Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 61c279ee-777a-4c05-bc38-e1a9183faaff 61c279ee-777a-4c05-bc38-e1a9183faaff TCGA-E2-A15P-01A-21-A13E-20 TCGA-E2-A15P-01A-11D-A10Y-09 TCGA-E2-A15P-01 776d3800-9f60-4eb4-930c-8bb036607730 TCGA-E2-A15P-01 TCGA-E2-A15P-01A-11D-A10Y-09 TCGA-E2-A15P-01A-11D-A112-05 TCGA-E2-A15P-01 TCGA-E2-A15P-01 TCGA-E2-A15P-01A-11D-A10Y-09 61c279ee-777a-4c05-bc38-e1a9183faaff TCGA-E2-A15P-01A-11D-A111-01 TCGA-E2-A15P-01 TCGA-E2-A15P-01A-11R-A115-07 61c279ee-777a-4c05-bc38-e1a9183faaff TCGA-E2-A15P-01A-11D-A111-01 TCGA-E2-A15P-01 TCGA-E2-A15R-01 Stage IIIA 64 4 Stage IIA 330 Positive FEMALE Negative 4 3 3 Negative M0 Positive N1 330 0 LumA Luminal A Positive LumA/B -10 -3 enrollment T1 T1 LIVING TCGA-E2-A15R-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation c1uster 9 TCGA-E2-A15R TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15R-F70011 TCGA-E2-A15R TCGA-E2-A15R-01A Positive Positive Lumpectomy NO -23570 247 0 1732 NO Allred score 5+3 = 8 1.9 Scheduled Follow-up Submission 2015-2-9 FEMALE 2+ 2.4 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 140 NO Equivocal Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 5 NO 3 false No M0 N1a T1c Stage IIA TCGA-E2-A15R.0F708C6E-0262-46EE-8ED2-67E791D5C379.pdf A15R TUMOR FREE Allred score 2+2 = 4 Allred score = 4 Allred score = 8 YES YES YES Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 8f90121d-5f9a-4702-a2ae-2a9b34a99171 8f90121d-5f9a-4702-a2ae-2a9b34a99171 TCGA-E2-A15R-01A-21-A13E-20 TCGA-E2-A15R-01A-11D-A10Y-09 TCGA-E2-A15R-01 7bec7525-d926-443f-a521-09334b963a89 TCGA-E2-A15R-01 TCGA-E2-A15R-01A-11D-A10Y-09 TCGA-E2-A15R-01A-11D-A112-05 TCGA-E2-A15R-01 TCGA-E2-A15R-01 TCGA-E2-A15R-01A-11D-A10Y-09 8f90121d-5f9a-4702-a2ae-2a9b34a99171 TCGA-E2-A15R-01A-11D-A111-01 TCGA-E2-A15R-01 TCGA-E2-A15R-01A-11R-A115-07 8f90121d-5f9a-4702-a2ae-2a9b34a99171 TCGA-E2-A15R-01A-11D-A111-01 TCGA-E2-A15R-01 TCGA-E2-A15S-01 Stage IIB 34 Stage IIB 274 Positive FEMALE Negative Negative M0 Positive N1 274 0 LumB Luminal B Negative LumA/B -10 -3 enrollment T_Other T2 LIVING TCGA-E2-A15S-01 C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 6 mutation c1uster 9 TCGA-E2-A15S TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Left Upper Inner Quadrant|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A15S-F19135 TCGA-E2-A15S TCGA-E2-A15S-01A Positive Negative Simple Mastectomy NO -12671 247 0 428 NO Scheduled Follow-up Submission 2011-11-16 FEMALE 2+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 560 NO Equivocal Negative 17 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 1 false No M0 N1 T2 Stage IIB TCGA-E2-A15S.AF740239-D3E2-4C74-844E-0F5AD1A905ED.pdf A15S TUMOR FREE Allred score = 2 Allred score = 7 YES YES Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 754fd66b-f39a-4308-a57c-05de251f9014 754fd66b-f39a-4308-a57c-05de251f9014 TCGA-E2-A15S-01A-21-A13E-20 TCGA-E2-A15S-01A-11D-A10Y-09 TCGA-E2-A15S-01 19e14655-2099-4ebc-91eb-d95db082bbc7 TCGA-E2-A15S-01 TCGA-E2-A15S-01A-11D-A10Y-09 TCGA-E2-A15S-01A-11D-A112-05 TCGA-E2-A15S-01 TCGA-E2-A15S-01 TCGA-E2-A15S-01A-11D-A10Y-09 754fd66b-f39a-4308-a57c-05de251f9014 TCGA-E2-A15S-01A-11D-A111-01 TCGA-E2-A15S-01 TCGA-E2-A15S-01A-11R-A115-07 754fd66b-f39a-4308-a57c-05de251f9014 TCGA-E2-A15S-01A-11D-A111-01 TCGA-E2-A15S-01 TCGA-E2-A15T-01 Stage IIA 65 Stage IIA 267 Positive FEMALE Negative Negative M0 Negative N0 267 0 Luminal B Positive LumA/B -10 -3 enrollment T_Other T2 LIVING TCGA-E2-A15T-01 cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-E2-A15T TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A15T-F70019 TCGA-E2-A15T TCGA-E2-A15T-01A Positive Positive Simple Mastectomy NO -24054 162 0 1563 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2015-2-9 FEMALE 2+ 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 360 NO Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 false No M0 N0 T2 Stage IIA TCGA-E2-A15T.8FEBDA40-59FF-4E76-A9B1-F46BAB7C3E4A.pdf A15T TUMOR FREE Allred score 2+3 = 5 Allred score = 5 Allred score = 8 YES YES NO Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 5db1c37a-2329-4bd3-baf2-89d26a8959fa 5db1c37a-2329-4bd3-baf2-89d26a8959fa TCGA-E2-A15T-01A-21-A13E-20 TCGA-E2-A15T-01A-11D-A10Y-09 TCGA-E2-A15T-01 e8fe1a3f-ec8a-49a8-a932-01341de67004 TCGA-E2-A15T-01 TCGA-E2-A15T-01A-11D-A10Y-09 TCGA-E2-A15T-01A-11D-A112-05 TCGA-E2-A15T-01 TCGA-E2-A15T-01 TCGA-E2-A15T-01A-11D-A10Y-09 5db1c37a-2329-4bd3-baf2-89d26a8959fa TCGA-E2-A15T-01A-11D-A111-01 TCGA-E2-A15T-01 TCGA-E2-A15T-01A-11R-A115-07 5db1c37a-2329-4bd3-baf2-89d26a8959fa TCGA-E2-A15T-01A-11D-A111-01 TCGA-E2-A15T-01 TCGA-E2-A1AZ-01 Stage IIB 63 4 Stage IIB 1964 Negative FEMALE Negative Negative M0 Positive N1 1964 0 Basal Basal-like Negative Basal -13 -12 enrollment T_Other T2 LIVING TCGA-E2-A1AZ-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 mutation c1uster 9 TCGA-E2-A1AZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-E2-A1AZ-F19462 TCGA-E2-A1AZ TCGA-E2-A1AZ-01A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy NO -23230 2527 0 2329 NO Scheduled Follow-up Submission 2011-12-6 FEMALE 0.42 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 250 NO Indeterminate Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 1 true No M0 N1a T2 Stage IIB TCGA-E2-A1AZ.4E233F7D-035A-44A0-A5B6-6248357EB7B2.pdf A1AZ TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2004 fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c TCGA-E2-A1AZ-01A-21-A13E-20 TCGA-E2-A1AZ-01A-11D-A12Q-09 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01A-11D-A12R-05 187a4af6-1941-419e-a58d-d3fb18510b65 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01A-11D-A12Q-09 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01A-11D-A12Q-09 fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c TCGA-E2-A1AZ-01A-11D-A12N-01 TCGA-E2-A1AZ-01 TCGA-E2-A1AZ-01A-11R-A12P-07 fa462e79-c5a4-4ddc-b3e6-32e8adcdd80c TCGA-E2-A1AZ-01A-11D-A12N-01 TCGA-E2-A1AZ-01 TCGA-E2-A1B0-01 Stage IIIA 50 3 Stage IIIA 1271 Negative FEMALE Positive 1 2 2 Negative M0 Positive N2 1271 0 Her2 HER2-enriched Negative ReacI -13 -10 enrollment T_Other T2 LIVING TCGA-E2-A1B0-01 High C3-BRCA/Luminal cluster 5 Cluster 5 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-E2-A1B0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A1B0-F19460 TCGA-E2-A1B0 TCGA-E2-A1B0-01A Negative Negative Modified Radical Mastectomy NO -18346 1315 0 1631 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-12-7 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 110 NO Positive 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO 6 true No M0 N2 T2 Stage IIIA TCGA-E2-A1B0.9C3987A7-D474-4717-8DCE-4AF1AE03ED84.pdf A1B0 TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2007 8bb3543b-5c83-41c6-b81c-b20935c38d72 8bb3543b-5c83-41c6-b81c-b20935c38d72 TCGA-E2-A1B0-01A-21-A13E-20 TCGA-E2-A1B0-01A-11D-A12Q-09 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01A-11D-A12R-05 2eae7190-37af-4257-9a9e-29a8c937a513 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01A-11D-A12Q-09 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01A-11D-A12Q-09 8bb3543b-5c83-41c6-b81c-b20935c38d72 TCGA-E2-A1B0-01A-11D-A12N-01 TCGA-E2-A1B0-01 TCGA-E2-A1B0-01A-11R-A12P-07 8bb3543b-5c83-41c6-b81c-b20935c38d72 TCGA-E2-A1B0-01A-11D-A12N-01 TCGA-E2-A1B0-01 TCGA-E2-A1B1-01 Stage IIB 45 3 Stage IIB 1361 Positive FEMALE Positive 1 2 3 Negative M0 Positive N1 1361 0 LumA Luminal A Positive ReacI -5 -7 enrollment T_Other T2 LIVING TCGA-E2-A1B1-01 Kirc+ C5-KIRC cluster 5 Low purity c2 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A1B1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1B1-F70009 TCGA-E2-A1B1 TCGA-E2-A1B1-01A Positive Positive Lumpectomy NO -16603 1268 0 2653 NO Allred score 3+2 = 5 Scheduled Follow-up Submission 2015-2-9 FEMALE 70-79% 2+ 15.12 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 300 NO Equivocal Positive NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 4 NO 1 true No M0 N1 T2 Stage IIB TCGA-E2-A1B1.431AE1CB-9605-45E3-B6C3-5253B24655D6.pdf A1B1 TUMOR FREE Allred score 2+2 = 4 Allred score = 4 Allred score = 5 YES YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2007 2aa34033-a6f5-45a8-833b-b433352e58ba 2aa34033-a6f5-45a8-833b-b433352e58ba TCGA-E2-A1B1-01A-11-A13E-20 TCGA-E2-A1B1-01A-21D-A12Q-09 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01A-21D-A12R-05 c476545a-0d56-4d49-9180-bb707d02a1c9 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01A-21D-A12Q-09 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01A-21D-A12Q-09 2aa34033-a6f5-45a8-833b-b433352e58ba TCGA-E2-A1B1-01A-21D-A12N-01 TCGA-E2-A1B1-01 TCGA-E2-A1B1-01A-21R-A12P-07 2aa34033-a6f5-45a8-833b-b433352e58ba TCGA-E2-A1B1-01A-21D-A12N-01 TCGA-E2-A1B1-01 TCGA-E2-A1B4-01 Stage IIIA 74 2 Stage IIIA 911 Positive FEMALE Negative 3 3 3 Negative M0 Positive N2 911 0 LumA Luminal A Positive LumA/B -12 -3 enrollment T1 T1 LIVING TCGA-E2-A1B4-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 cluster 6 mutation cluster 4 TCGA-E2-A1B4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-E2-A1B4-F19443 TCGA-E2-A1B4 TCGA-E2-A1B4-01A Positive Positive Lumpectomy NO -27241 798 1004 0 911 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-12-8 FEMALE 10-19% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 110 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 3 true No M0 N2a T1c Stage IIIA TCGA-E2-A1B4.2F35A09A-7EB3-484C-9738-664C8914C116.pdf A1B4 TUMOR FREE Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A DECEASED 2008 2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6 2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6 TCGA-E2-A1B4-01A-21-A13E-20 TCGA-E2-A1B4-01A-11D-A12Q-09 TCGA-E2-A1B4-01 TCGA-E2-A1B4-01A-11D-A12R-05 4b198843-12fe-41e0-af18-0638dd948c6a TCGA-E2-A1B4-01 TCGA-E2-A1B4-01A-11D-A12Q-09 TCGA-E2-A1B4-01 TCGA-E2-A1B4-01 TCGA-E2-A1B4-01A-11D-A12Q-09 2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6 TCGA-E2-A1B4-01A-11D-A12N-01 TCGA-E2-A1B4-01 TCGA-E2-A1B4-01A-11R-A12P-07 2d51ae30-4c8a-4c99-b216-fc4fbda0fbb6 TCGA-E2-A1B4-01A-11D-A12N-01 TCGA-E2-A1B4-01 TCGA-E2-A1B5-01 Stage IIA 46 3 Stage IIA 774 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 774 0 LumA Basal-like Positive ReacI -13 -12 enrollment T_Other T2 LIVING TCGA-E2-A1B5-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-E2-A1B5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Sentinel node biopsy alone TCGA-E2-A1B5-F19393 TCGA-E2-A1B5 TCGA-E2-A1B5-01A Positive Positive Lumpectomy NO -17039 783 0 984 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-12-8 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 260 NO Negative 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 NO 0 true No M0 N0 T2 Stage IIA TCGA-E2-A1B5.EDD254CA-0EC6-42F8-B213-C2D386AB11F4.pdf A1B5 TUMOR FREE Allred score 2+3 = 5 Allred score = 5 Allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 a2c80f8e-f08d-4574-90a0-f0651c0a9b1b a2c80f8e-f08d-4574-90a0-f0651c0a9b1b TCGA-E2-A1B5-01A-31-A13E-20 TCGA-E2-A1B5-01A-21D-A12Q-09 TCGA-E2-A1B5-01 TCGA-E2-A1B5-01A-21D-A12R-05 96c90192-0896-42a2-bc87-ae6bf8bb5c9f TCGA-E2-A1B5-01 TCGA-E2-A1B5-01A-21D-A12Q-09 TCGA-E2-A1B5-01 TCGA-E2-A1B5-01 TCGA-E2-A1B5-01A-21D-A12Q-09 a2c80f8e-f08d-4574-90a0-f0651c0a9b1b TCGA-E2-A1B5-01A-21D-A12N-01 TCGA-E2-A1B5-01 TCGA-E2-A1B5-01A-21R-A12P-07 a2c80f8e-f08d-4574-90a0-f0651c0a9b1b TCGA-E2-A1B5-01A-21D-A12N-01 TCGA-E2-A1B5-01 TCGA-E2-A1B5-11 46 774 FEMALE 774 0 enrollment LIVING TCGA-E2-A1B5-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-E2-A1B5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Sentinel node biopsy alone TCGA-E2-A1B5-F19393 TCGA-E2-A1B5 TCGA-E2-A1B5-11A Positive Positive Lumpectomy NO -17039 783 0 984 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2011-12-8 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 260 NO Negative 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 T2 Stage IIA A1B5 TUMOR FREE Allred score 2+3 = 5 Allred score = 5 Allred score = 8 YES YES Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2008 TCGA-E2-A1B5-11A-23D-A12R-05 TCGA-E2-A1B6-01 Stage IIA 44 1 Stage IIA 338 Negative FEMALE Negative 2 2 2 Negative M0 Negative N0 338 0 Luminal A Negative Basal -5 -7 enrollment T_Other T2 LIVING TCGA-E2-A1B6-01 Quiet C13-AML cluster 5 Low purity c2 BRCA basal-like c6 miRNA cluster 15 cluster 6 mutation cluster 5 TCGA-E2-A1B6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left Sentinel node biopsy alone TCGA-E2-A1B6-F19389 TCGA-E2-A1B6 Negative Negative Simple Mastectomy NO -16370 0 867 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2011-12-8 FEMALE 10-19% 2+ 1.03 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Equivocal Negative 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 6 NO 0 No M0 N0 T2 Stage IIA A1B6 TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES NO Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2008 eb398b00-8669-4c22-8285-03cdf76436f3 eb398b00-8669-4c22-8285-03cdf76436f3 TCGA-E2-A1B6-01A-21-A13E-20 TCGA-E2-A1B6-01A-31D-A12Q-09 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01A-31D-A12R-05 dc503863-7967-469b-b966-69dcea2dfb86 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01A-31D-A12Q-09 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01A-31D-A12Q-09 eb398b00-8669-4c22-8285-03cdf76436f3 TCGA-E2-A1B6-01A-31D-A12N-01 TCGA-E2-A1B6-01 TCGA-E2-A1B6-01A-31R-A12P-07 eb398b00-8669-4c22-8285-03cdf76436f3 TCGA-E2-A1B6-01A-31D-A12N-01 TCGA-E2-A1B6-01 TCGA-E2-A1BC-01 Stage IA 63 2 Stage I 297 Positive FEMALE Negative 3 4 3 Negative M0 Negative N0 297 0 LumA Luminal A Positive ReacI -5 -7 enrollment T1 T1 LIVING TCGA-E2-A1BC-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-E2-A1BC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Sentinel node biopsy alone TCGA-E2-A1BC-F19427 TCGA-E2-A1BC TCGA-E2-A1BC-01A Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -23168 275 0 501 NO Scheduled Follow-up Submission 2011-12-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8524/3 C50.9 YES Tumor resection 100 NO Negative 4 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 0 true Yes M0 N0 T1c Stage IA TCGA-E2-A1BC.817D4725-01FE-4148-A8FC-3431F28D5CD8.pdf A1BC TUMOR FREE YES NO Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 a2cf164c-5b26-43eb-9de9-d1d457a5de06 a2cf164c-5b26-43eb-9de9-d1d457a5de06 TCGA-E2-A1BC-01A-21-A13E-20 TCGA-E2-A1BC-01A-11D-A14G-09 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01A-11D-A12R-05 8d3961ff-444a-4808-a697-c21898446648 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01A-11D-A14G-09 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01A-11D-A14G-09 a2cf164c-5b26-43eb-9de9-d1d457a5de06 TCGA-E2-A1BC-01A-11D-A12N-01 TCGA-E2-A1BC-01 TCGA-E2-A1BC-01A-11R-A12P-07 a2cf164c-5b26-43eb-9de9-d1d457a5de06 TCGA-E2-A1BC-01A-11D-A12N-01 TCGA-E2-A1BC-01 TCGA-E2-A1BC-11 63 297 FEMALE 297 0 enrollment LIVING TCGA-E2-A1BC-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E2-A1BC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Sentinel node biopsy alone TCGA-E2-A1BC-F19427 TCGA-E2-A1BC Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -23168 0 501 NO Scheduled Follow-up Submission 2011-12-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8524/3 C50.9 YES Tumor resection Negative 4 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 Yes M0 N0 T1c Stage IA A1BC TUMOR FREE YES NO Solid Tissue Normal 11 7th YES NO YES E2 Breast LIVING 2010 afe373b9-f1c1-412d-9506-091749d47534 afe373b9-f1c1-412d-9506-091749d47534 TCGA-E2-A1BC-11A-32D-A12R-05 TCGA-E2-A1BC-11 afe373b9-f1c1-412d-9506-091749d47534 TCGA-E2-A1BC-11 TCGA-E2-A1BC-11A-32R-A12P-07 afe373b9-f1c1-412d-9506-091749d47534 TCGA-E2-A1BD-01 Stage IIA 53 2 Stage IIA 317 Positive FEMALE Negative 3 3 3 Negative M0 Negative N0 317 0 LumA Luminal A Positive LumA -7 -3 enrollment T_Other T2 LIVING TCGA-E2-A1BD-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-E2-A1BD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1BD-F70021 TCGA-E2-A1BD TCGA-E2-A1BD-01A Positive Positive Lumpectomy NO -19627 260 0 1133 NO Allred score 5+3 = 8 Scheduled Follow-up Submission 2015-2-9 FEMALE 10-19% 2+ 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 100 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 0 true No M0 N0 T2 Stage IIA TCGA-E2-A1BD.DF746E32-AD2F-49CB-9AA6-4F8494C16B20.pdf A1BD TUMOR FREE Allred score 5+3 = 8 Allred score = 8 Allred score = 8 YES YES YES Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 fa1917b0-c3e1-412d-b063-e74b5cafb8dc fa1917b0-c3e1-412d-b063-e74b5cafb8dc TCGA-E2-A1BD-01A-21-A13E-20 TCGA-E2-A1BD-01A-11D-A12Q-09 TCGA-E2-A1BD-01 TCGA-E2-A1BD-01A-11D-A12R-05 139a9795-35ff-4c82-9530-fb103ea5ca8c TCGA-E2-A1BD-01 TCGA-E2-A1BD-01A-11D-A12Q-09 TCGA-E2-A1BD-01 TCGA-E2-A1BD-01 TCGA-E2-A1BD-01A-11D-A12Q-09 fa1917b0-c3e1-412d-b063-e74b5cafb8dc TCGA-E2-A1BD-01A-11D-A12N-01 TCGA-E2-A1BD-01 TCGA-E2-A1BD-01A-11R-A12P-07 fa1917b0-c3e1-412d-b063-e74b5cafb8dc TCGA-E2-A1BD-01A-11D-A12N-01 TCGA-E2-A1BD-01 TCGA-E2-A1IE-01 Stage IIB 61 5 Stage IIB 983 Positive FEMALE Negative Negative M0 Positive N1 983 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E2-A1IE-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 12 cluster 6 mutation c1uster 9 TCGA-E2-A1IE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 61 Right Sentinel node biopsy alone TCGA-E2-A1IE-F70297 TCGA-E2-A1IE Positive Positive Lumpectomy NO -22510 0 2362 1810 NO allred score 5 + 3 = 8 Scheduled Follow-up Submission 2015-3-16 FEMALE 20-29% 2+ 1.05 2.1 Infiltrating Ductal Carcinoma No 200 C50.9 8500/3 C50.9 YES Tumor resection Equivocal Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Positive 1.0 3 Point Scale 3+ 3+ Negative Positive 3 6 2.2 3 Point Scale Liver Distant Metastasis NO YES 1 No M0 N1 T2 Stage IIB A1IE WITH TUMOR allred score 3 + 3 = 6 allred score = 6 allred score = 8 YES YES YES Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2008 ec6f69db-ff0b-491c-8b70-d53d0e7ad65f ec6f69db-ff0b-491c-8b70-d53d0e7ad65f TCGA-E2-A1IE-01A-11D-A188-09 TCGA-E2-A1IE-01 TCGA-E2-A1IE-01A-11D-A13K-05 TCGA-E2-A1IE-01 TCGA-E2-A1IE-01A-11D-A188-09 TCGA-E2-A1IE-01 TCGA-E2-A1IE-01A-11D-A188-09 ec6f69db-ff0b-491c-8b70-d53d0e7ad65f TCGA-E2-A1IE-01A-11D-A13J-01 TCGA-E2-A1IE-01 ec6f69db-ff0b-491c-8b70-d53d0e7ad65f TCGA-E2-A1IE-01A-11D-A13J-01 TCGA-E2-A1IF-01 Stage I 74 2 Stage I 956 Positive FEMALE Negative Negative M0 Negative N0 956 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1IF-01 Iq C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 1 TCGA-E2-A1IF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1IF-F19962 TCGA-E2-A1IF TCGA-E2-A1IF-01A Positive Positive Lumpectomy NO -27341 932 0 1138 NO allred score 5+3=8 Scheduled Follow-up Submission 2011-12-21 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 70 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 6 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A1IF.9E2EF2C8-A60D-443D-99B6-205B7053175A.pdf A1IF TUMOR FREE allred score 4+2=6 allred score = 6 allred scrore = 8 YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 34a8b02b-01a2-4f2d-8e8e-c3358d43665a 34a8b02b-01a2-4f2d-8e8e-c3358d43665a TCGA-E2-A1IF-01A-11D-A142-09 TCGA-E2-A1IF-01 TCGA-E2-A1IF-01A-11D-A145-05 TCGA-E2-A1IF-01 TCGA-E2-A1IF-01A-11D-A142-09 TCGA-E2-A1IF-01 TCGA-E2-A1IF-01A-11D-A142-09 34a8b02b-01a2-4f2d-8e8e-c3358d43665a TCGA-E2-A1IF-01A-11D-A141-01 TCGA-E2-A1IF-01 34a8b02b-01a2-4f2d-8e8e-c3358d43665a TCGA-E2-A1IF-01A-11D-A141-01 TCGA-E2-A1IF-11 74 956 FEMALE 956 0 enrollment LIVING TCGA-E2-A1IF-11 C3-BRCA/Luminal mutation cluster 1 TCGA-E2-A1IF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1IF-F19962 TCGA-E2-A1IF TCGA-E2-A1IF-11A Positive Positive Lumpectomy NO -27341 932 0 1138 NO allred score 5+3=8 Scheduled Follow-up Submission 2011-12-21 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 140 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T1c Stage I A1IF TUMOR FREE allred score 4+2=6 allred score = 6 allred scrore = 8 YES NO Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2008 TCGA-E2-A1IF-11A-22D-A145-05 TCGA-E2-A1IG-01 Stage IIB 45 5 Stage IIB 755 Positive FEMALE Negative M0 Positive N1 755 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E2-A1IG-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation c1uster 9 TCGA-E2-A1IG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-E2-A1IG-F70394 TCGA-E2-A1IG Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -16757 0 2140 NO Scheduled Follow-up Submission 2015-3-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 4 NO 1 No M0 N1mi T2 Stage IIB A1IG TUMOR FREE YES YES YES Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2009 d0705a73-e6d0-4282-82b1-76d44bda242f d0705a73-e6d0-4282-82b1-76d44bda242f TCGA-E2-A1IG-01A-21-A17J-20 TCGA-E2-A1IG-01A-11D-A142-09 TCGA-E2-A1IG-01 TCGA-E2-A1IG-01A-11D-A145-05 e1a96343-ccc9-4e16-a96d-749528da4dfb TCGA-E2-A1IG-01 TCGA-E2-A1IG-01A-11D-A142-09 TCGA-E2-A1IG-01 TCGA-E2-A1IG-01A-11D-A142-09 d0705a73-e6d0-4282-82b1-76d44bda242f TCGA-E2-A1IG-01A-11D-A141-01 TCGA-E2-A1IG-01 d0705a73-e6d0-4282-82b1-76d44bda242f TCGA-E2-A1IG-01A-11D-A141-01 TCGA-E2-A1IG-11 45 755 FEMALE 755 0 Normal enrollment LIVING TCGA-E2-A1IG-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-E2-A1IG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-E2-A1IG-F70394 TCGA-E2-A1IG TCGA-E2-A1IG-11A Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -16757 679 0 2140 NO Scheduled Follow-up Submission 2015-3-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 210 NO Negative NO 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 false No M0 N1mi T2 Stage IIB A1IG TUMOR FREE YES YES YES Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2009 1e55cf08-da43-471d-813c-9d37c7abc730 1e55cf08-da43-471d-813c-9d37c7abc730 TCGA-E2-A1IG-11 1e55cf08-da43-471d-813c-9d37c7abc730 TCGA-E2-A1IG-11 1e55cf08-da43-471d-813c-9d37c7abc730 TCGA-E2-A1IH-01 Stage I 80 2 Stage I 658 Positive FEMALE Negative Negative M0 Negative N0 658 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1IH-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation c1uster 10 TCGA-E2-A1IH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-E2-A1IH-F19960 TCGA-E2-A1IH TCGA-E2-A1IH-01A Positive Positive Lumpectomy NO -29444 883 0 1026 NO allred score 5+3=8 Scheduled Follow-up Submission 2011-12-21 FEMALE 20-29% 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 80 NO Equivocal 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A1IH.12DAEBF2-CDBF-4D90-9C74-2A2AEF1E8433.pdf A1IH TUMOR FREE allred score 5+3+8 allred score = 8 allred score = 8 YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 2d06908f-3332-4b77-b88c-145dc5c4828f 2d06908f-3332-4b77-b88c-145dc5c4828f TCGA-E2-A1IH-01A-11D-A188-09 TCGA-E2-A1IH-01 TCGA-E2-A1IH-01A-11D-A13K-05 TCGA-E2-A1IH-01 TCGA-E2-A1IH-01A-11D-A188-09 TCGA-E2-A1IH-01 TCGA-E2-A1IH-01A-11D-A188-09 2d06908f-3332-4b77-b88c-145dc5c4828f TCGA-E2-A1IH-01A-11D-A13J-01 TCGA-E2-A1IH-01 2d06908f-3332-4b77-b88c-145dc5c4828f TCGA-E2-A1IH-01A-11D-A13J-01 TCGA-E2-A1II-01 Stage I 51 2 Stage I 850 Negative FEMALE Negative Negative M0 Negative N0 850 0 Basal Positive enrollment T1 T1 LIVING TCGA-E2-A1II-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E2-A1II TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Sentinel node biopsy alone TCGA-E2-A1II-F19954 TCGA-E2-A1II Negative Positive Lumpectomy NO -18788 0 1025 NO allred score 0 + 0 = 0 Scheduled Follow-up Submission 2011-12-21 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 0 No M0 N0 T1c Stage I A1II TUMOR FREE allred score 2+2 = 4 allred score = 4 allred score = 0 YES YES Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2008 f7a5cfcb-623c-4858-ba32-e6ca63c75d2a f7a5cfcb-623c-4858-ba32-e6ca63c75d2a TCGA-E2-A1II-01A-11D-A142-09 TCGA-E2-A1II-01 TCGA-E2-A1II-01A-11D-A145-05 TCGA-E2-A1II-01 TCGA-E2-A1II-01A-11D-A142-09 TCGA-E2-A1II-01 TCGA-E2-A1II-01A-11D-A142-09 f7a5cfcb-623c-4858-ba32-e6ca63c75d2a TCGA-E2-A1II-01A-11D-A141-01 TCGA-E2-A1II-01 f7a5cfcb-623c-4858-ba32-e6ca63c75d2a TCGA-E2-A1II-01A-11D-A141-01 TCGA-E2-A1II-11 51 850 FEMALE 850 0 enrollment LIVING TCGA-E2-A1II-11 C4-BRCA/Basal mutation cluster 5 TCGA-E2-A1II TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Sentinel node biopsy alone TCGA-E2-A1II-F19954 TCGA-E2-A1II TCGA-E2-A1II-11A Negative Positive Lumpectomy NO -18788 854 0 1025 NO allred score 0 + 0 = 0 Scheduled Follow-up Submission 2011-12-21 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 170 NO Negative 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T1c Stage I A1II TUMOR FREE allred score 2+2 = 4 allred score = 4 allred score = 0 YES YES Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2008 TCGA-E2-A1II-11A-21D-A145-05 TCGA-E2-A1IJ-01 Stage I 57 3 Stage I 725 Positive FEMALE Negative Negative M0 Negative N0 725 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1IJ-01 Iq C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E2-A1IJ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1IJ-F19950 TCGA-E2-A1IJ TCGA-E2-A1IJ-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy NO -20956 707 0 865 NO 90-99% Scheduled Follow-up Submission 2011-12-21 FEMALE 2+ 1.2 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 70 NO Equivocal Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A1IJ.35F7D0D1-BA21-4135-B444-6B10EAF66F25.pdf A1IJ TUMOR FREE YES 90-99% YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2 14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2 TCGA-E2-A1IJ-01A-11D-A142-09 TCGA-E2-A1IJ-01 TCGA-E2-A1IJ-01A-11D-A145-05 TCGA-E2-A1IJ-01 TCGA-E2-A1IJ-01A-11D-A142-09 TCGA-E2-A1IJ-01 TCGA-E2-A1IJ-01A-11D-A142-09 14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2 TCGA-E2-A1IJ-01A-11D-A141-01 TCGA-E2-A1IJ-01 14404fa2-adc4-4ecd-b4ee-5f4a75b54ff2 TCGA-E2-A1IJ-01A-11D-A141-01 TCGA-E2-A1IK-01 Stage IIA 71 1 Stage IIA 518 Positive FEMALE Negative Negative M0 Positive N1 518 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1IK-01 Quiet C5-KIRC cluster 1 Low purity c2 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation c1uster 9 TCGA-E2-A1IK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Sentinel node biopsy alone TCGA-E2-A1IK-F70395 TCGA-E2-A1IK TCGA-E2-A1IK-01A Positive Positive Lumpectomy NO -26052 423 0 1800 NO Scheduled Follow-up Submission 2015-3-17 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 70 NO Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 7 NO 1 false No M0 N1mi T1c Stage IIA TCGA-E2-A1IK.FE54D4DC-C35E-44D2-B8B5-0B631AE0F89D.pdf A1IK TUMOR FREE YES YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 96a11934-f6cd-4892-a808-672433f84429 96a11934-f6cd-4892-a808-672433f84429 TCGA-E2-A1IK-01A-11D-A17G-09 TCGA-E2-A1IK-01 TCGA-E2-A1IK-01A-11D-A145-05 TCGA-E2-A1IK-01 TCGA-E2-A1IK-01A-11D-A17G-09 TCGA-E2-A1IK-01 TCGA-E2-A1IK-01A-11D-A17G-09 96a11934-f6cd-4892-a808-672433f84429 TCGA-E2-A1IK-01A-11D-A141-01 TCGA-E2-A1IK-01 96a11934-f6cd-4892-a808-672433f84429 TCGA-E2-A1IK-01A-11D-A141-01 TCGA-E2-A1IL-01 Stage IIA 78 2 Stage IIA 14 Positive FEMALE Negative Negative M0 Positive N1 14 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1IL-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-E2-A1IL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1IL-F20276 TCGA-E2-A1IL TCGA-E2-A1IL-01A Positive Positive Lumpectomy NO -28495 417 0 118 NO allred score 5+3=8 Scheduled Follow-up Submission 2012-1-3 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 120 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 6 NO 1 false No M0 N1a T1c Stage IIA TCGA-E2-A1IL.E0CCE6AD-38A6-446C-ACF7-358C1DFC59F8.pdf A1IL TUMOR FREE allred score 4 + 3 = 7 allred score = 7 allred score = 8 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d 5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d TCGA-E2-A1IL-01A-21-A17J-20 TCGA-E2-A1IL-01A-11D-A14G-09 TCGA-E2-A1IL-01 TCGA-E2-A1IL-01A-11D-A14H-05 dbdb0a12-88ea-4a7b-a215-e7e83adc666f TCGA-E2-A1IL-01 TCGA-E2-A1IL-01A-11D-A14G-09 TCGA-E2-A1IL-01 TCGA-E2-A1IL-01A-11D-A14G-09 5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d TCGA-E2-A1IL-01A-11D-A14F-01 TCGA-E2-A1IL-01 5610cbc9-1031-4b6a-9bba-a6b3ed7ced4d TCGA-E2-A1IL-01A-11D-A14F-01 TCGA-E2-A1IN-01 Stage I 60 4 Stage I 392 Positive FEMALE Negative Negative M0 Negative N0 392 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1IN-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 3 TCGA-E2-A1IN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Sentinel node biopsy alone TCGA-E2-A1IN-F20323 TCGA-E2-A1IN Positive Positive Lumpectomy NO -22199 0 675 NO allred score 5+3=8 Scheduled Follow-up Submission 2012-1-4 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 0 No M0 N0 T1c Stage I A1IN TUMOR FREE allred score 5+3+8 allred score = 8 allred score = 8 YES YES Primary Tumor 01 7th YES NO YES E2 Breast LIVING 2010 dde1d3ab-ad71-4526-bc98-058b6049edcf dde1d3ab-ad71-4526-bc98-058b6049edcf TCGA-E2-A1IN-01A-11D-A13L-09 TCGA-E2-A1IN-01 TCGA-E2-A1IN-01A-11D-A13K-05 TCGA-E2-A1IN-01 TCGA-E2-A1IN-01A-11D-A13L-09 TCGA-E2-A1IN-01 TCGA-E2-A1IN-01A-11D-A13L-09 dde1d3ab-ad71-4526-bc98-058b6049edcf TCGA-E2-A1IN-01A-11D-A13J-01 TCGA-E2-A1IN-01 dde1d3ab-ad71-4526-bc98-058b6049edcf TCGA-E2-A1IN-01A-11D-A13J-01 TCGA-E2-A1IO-01 Stage I 37 1 Stage I 448 Positive FEMALE Negative Negative M0 Negative N0 448 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1IO-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 3 TCGA-E2-A1IO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Right Sentinel node biopsy alone TCGA-E2-A1IO-F70391 TCGA-E2-A1IO TCGA-E2-A1IO-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy NO -13671 416 0 1855 NO Scheduled Follow-up Submission 2015-3-16 FEMALE 30-39% 2+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 70 NO Equivocal Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A1IO.A9D36308-DAEF-48B9-A4EC-6B9B24EE3DC2.pdf A1IO TUMOR FREE YES YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 72611671-51cc-4662-b992-6701eb1df987 72611671-51cc-4662-b992-6701eb1df987 TCGA-E2-A1IO-01A-11D-A142-09 TCGA-E2-A1IO-01 TCGA-E2-A1IO-01A-11D-A145-05 TCGA-E2-A1IO-01 TCGA-E2-A1IO-01A-11D-A142-09 TCGA-E2-A1IO-01 TCGA-E2-A1IO-01A-11D-A142-09 72611671-51cc-4662-b992-6701eb1df987 TCGA-E2-A1IO-01A-11D-A141-01 TCGA-E2-A1IO-01 72611671-51cc-4662-b992-6701eb1df987 TCGA-E2-A1IO-01A-11D-A141-01 TCGA-E2-A1IO-11 37 448 FEMALE 448 0 enrollment LIVING TCGA-E2-A1IO-11 C3-BRCA/Luminal mutation cluster 3 TCGA-E2-A1IO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Right Sentinel node biopsy alone TCGA-E2-A1IO-F70391 TCGA-E2-A1IO TCGA-E2-A1IO-11A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy NO -13671 416 0 1855 NO Scheduled Follow-up Submission 2015-3-16 FEMALE 30-39% 2+ 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 140 NO Equivocal Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 false No M0 N0 T1c Stage I A1IO TUMOR FREE YES YES YES Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2009 TCGA-E2-A1IO-11A-21D-A145-05 TCGA-E2-A1IP-01 Stage IIB 42 Stage IIB 427 Positive FEMALE Negative Negative M0 Positive N1 427 0 Basal Negative enrollment T_Other T2 LIVING TCGA-E2-A1IP-01 TCGA-E2-A1IP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast TCGA-E2-A1IP-01A 359 80 NO false TCGA-E2-A1IP.021D6868-16EA-4D55-9784-46A0F85C50C8.pdf Primary Tumor 01 A dfd81aa5-5be4-4cf3-877f-0f52e01beb60 dfd81aa5-5be4-4cf3-877f-0f52e01beb60 TCGA-E2-A1IP-01A-11D-A14H-05 dfd81aa5-5be4-4cf3-877f-0f52e01beb60 dfd81aa5-5be4-4cf3-877f-0f52e01beb60 TCGA-E2-A1IU-01 Stage IA 60 2 Stage I 127 Positive FEMALE Negative Negative M0 Negative N0 127 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1IU-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 2 mutation cluster 4 TCGA-E2-A1IU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1IU-F19974 TCGA-E2-A1IU TCGA-E2-A1IU-01A Positive Positive Simple Mastectomy NO -22279 136 0 337 NO Scheduled Follow-up Submission 2012-1-4 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 270 NO Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 2 NO 0 false No M0 N0 (mol+) T1c Stage IA TCGA-E2-A1IU.ACE20EC5-2822-4F50-949E-E194C59F0FCD.pdf A1IU TUMOR FREE YES NO Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 53c8bbbd-16cd-4790-a99b-f45b0f958157 53c8bbbd-16cd-4790-a99b-f45b0f958157 TCGA-E2-A1IU-01A-21-A17J-20 TCGA-E2-A1IU-01A-11D-A14G-09 TCGA-E2-A1IU-01 TCGA-E2-A1IU-01A-11D-A14H-05 19429156-19ad-44f5-a671-1fef7a6e693c TCGA-E2-A1IU-01 TCGA-E2-A1IU-01A-11D-A14G-09 TCGA-E2-A1IU-01 TCGA-E2-A1IU-01A-11D-A14G-09 53c8bbbd-16cd-4790-a99b-f45b0f958157 TCGA-E2-A1IU-01A-11D-A14F-01 TCGA-E2-A1IU-01 53c8bbbd-16cd-4790-a99b-f45b0f958157 TCGA-E2-A1IU-01A-11D-A14F-01 TCGA-E2-A1L6-01 Stage IIA 44 2 Stage IIA 1312 Positive FEMALE Negative Negative M0 Positive N1 1312 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1L6-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 7 mutation cluster 4 TCGA-E2-A1L6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A1L6-F20570 TCGA-E2-A1L6 TCGA-E2-A1L6-01A Positive Positive Simple Mastectomy NO -16403 1325 0 1648 NO allred score 5 + 3 = 8 Scheduled Follow-up Submission 2012-1-10 FEMALE 40-49% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 110 NO Negative 6 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 7 NO 1 false No M0 N1mi T1c Stage IIA TCGA-E2-A1L6.F23523C7-B6E9-4205-BD36-D76E9EE9C453.pdf A1L6 TUMOR FREE allred score 5 + 3 = 8 allred score = 8 allred score = 8 YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2007 4142c779-86ab-44f5-9371-539bbaa363d2 4142c779-86ab-44f5-9371-539bbaa363d2 TCGA-E2-A1L6-01A-21-A17J-20 TCGA-E2-A1L6-01A-11D-A13L-09 TCGA-E2-A1L6-01 TCGA-E2-A1L6-01A-11D-A13K-05 bca87047-7257-4983-9e8c-e6811b33a10e TCGA-E2-A1L6-01 TCGA-E2-A1L6-01A-11D-A13L-09 TCGA-E2-A1L6-01 TCGA-E2-A1L6-01A-11D-A13L-09 4142c779-86ab-44f5-9371-539bbaa363d2 TCGA-E2-A1L6-01A-11D-A13J-01 TCGA-E2-A1L6-01 4142c779-86ab-44f5-9371-539bbaa363d2 TCGA-E2-A1L6-01A-11D-A13J-01 TCGA-E2-A1L7-01 Stage IIIA 40 1 Stage IIIA 633 Negative FEMALE Negative Negative M0 Positive N2 633 0 LumB Negative enrollment T_Other T2 LIVING TCGA-E2-A1L7-01 Squamous C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 2 cluster 5 mutation cluster 5 TCGA-E2-A1L7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES 40 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A1L7-F70298 TCGA-E2-A1L7 TCGA-E2-A1L7-01A Negative Negative Modified Radical Mastectomy NO -14854 548 0 1836 1662 1619 NO Allred score 1+1 = 2 Scheduled Follow-up Submission 2015-3-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 150 NO Negative NO 20 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative Negative 2 5 Other, specify New Primary Tumor left breast YES YES 7 false No M0 N2 T2 Stage IIIA TCGA-E2-A1L7.E78526AB-D72D-4407-B7E1-2255BB5B2F68.pdf A1L7 TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 2 YES YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 ec38c31b-def8-41cc-8656-57ce98f3faa7 ec38c31b-def8-41cc-8656-57ce98f3faa7 TCGA-E2-A1L7-01A-21-A17J-20 TCGA-E2-A1L7-01A-11D-A142-09 TCGA-E2-A1L7-01 TCGA-E2-A1L7-01A-11D-A145-05 9a9baaf4-427c-48cd-ae41-25fd84ae612f TCGA-E2-A1L7-01 TCGA-E2-A1L7-01A-11D-A142-09 TCGA-E2-A1L7-01 TCGA-E2-A1L7-01A-11D-A142-09 ec38c31b-def8-41cc-8656-57ce98f3faa7 TCGA-E2-A1L7-01A-11D-A141-01 TCGA-E2-A1L7-01 ec38c31b-def8-41cc-8656-57ce98f3faa7 TCGA-E2-A1L7-01A-11D-A141-01 TCGA-E2-A1L7-11 40 633 FEMALE 633 0 Normal enrollment LIVING TCGA-E2-A1L7-11 C3-BRCA/Luminal mutation cluster 5 TCGA-E2-A1L7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO YES 40 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A1L7-F70298 TCGA-E2-A1L7 TCGA-E2-A1L7-11A Negative Negative Modified Radical Mastectomy NO -14854 548 0 1836 1662 1619 NO Allred score 1+1 = 2 Scheduled Follow-up Submission 2015-3-16 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 280 NO Negative NO 20 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative Negative Other, specify New Primary Tumor left breast YES YES 7 false No M0 N2 T2 Stage IIIA A1L7 TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 2 YES YES YES Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2009 53e9749e-5554-443b-b41e-5efade6fce7a 53e9749e-5554-443b-b41e-5efade6fce7a TCGA-E2-A1L7-11A-33D-A145-05 TCGA-E2-A1L7-11 53e9749e-5554-443b-b41e-5efade6fce7a TCGA-E2-A1L7-11 53e9749e-5554-443b-b41e-5efade6fce7a TCGA-E2-A1L8-01 Stage IIA 52 2 Stage IIB 1015 Positive FEMALE Negative Negative M0 Positive N1 1015 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E2-A1L8-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 6 mutation cluster 4 TCGA-E2-A1L8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A1L8-F70018 TCGA-E2-A1L8 TCGA-E2-A1L8-01A Positive Positive Simple Mastectomy NO -19187 912 0 2240 NO allred score 5 + 3 = 8 Scheduled Follow-up Submission 2015-2-9 FEMALE 40-49% 2+ 1.10 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 180 NO Equivocal Negative NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 6 NO 2 false Yes M0 N1a T2 Stage IIB TCGA-E2-A1L8.9AA68C63-2C14-430A-85C0-5A92F7FCCD36.pdf A1L8 TUMOR FREE allred score 4 + 3 = 7 allred score = 7 allred score = 8 YES YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 68c8e567-1ac0-40f1-a3a7-a79d77a4ae12 68c8e567-1ac0-40f1-a3a7-a79d77a4ae12 TCGA-E2-A1L8-01A-21-A17J-20 TCGA-E2-A1L8-01A-11D-A13L-09 TCGA-E2-A1L8-01 TCGA-E2-A1L8-01A-11D-A13K-05 da720181-484f-4eff-8f96-b7e4298c751b TCGA-E2-A1L8-01 TCGA-E2-A1L8-01A-11D-A13L-09 TCGA-E2-A1L8-01 TCGA-E2-A1L8-01A-11D-A13L-09 68c8e567-1ac0-40f1-a3a7-a79d77a4ae12 TCGA-E2-A1L8-01A-11D-A13J-01 TCGA-E2-A1L8-01 68c8e567-1ac0-40f1-a3a7-a79d77a4ae12 TCGA-E2-A1L8-01A-11D-A13J-01 TCGA-E2-A1L9-01 Stage IIB 40 3 Stage IIA 388 Positive FEMALE Negative Negative M0 Positive N1 388 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1L9-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-E2-A1L9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Sentinel node biopsy alone TCGA-E2-A1L9-F20597 TCGA-E2-A1L9 TCGA-E2-A1L9-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy NO -14868 465 0 598 NO 80-89% Scheduled Follow-up Submission 2012-1-11 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 40 NO Negative 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 NO 1 false No M0 N1mi T1c Stage IIA TCGA-E2-A1L9.97B6C43B-4C7D-49FC-BA49-00D2DF41827D.pdf A1L9 TUMOR FREE allred score = 7 allred score = 7 YES 80-89% YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 05329e4e-6623-4044-9abf-46f3ed4ccfd8 05329e4e-6623-4044-9abf-46f3ed4ccfd8 TCGA-E2-A1L9-01A-11D-A13L-09 TCGA-E2-A1L9-01 TCGA-E2-A1L9-01A-11D-A13K-05 TCGA-E2-A1L9-01 TCGA-E2-A1L9-01A-11D-A13L-09 TCGA-E2-A1L9-01 TCGA-E2-A1L9-01A-11D-A13L-09 05329e4e-6623-4044-9abf-46f3ed4ccfd8 TCGA-E2-A1L9-01A-11D-A13J-01 TCGA-E2-A1L9-01 05329e4e-6623-4044-9abf-46f3ed4ccfd8 TCGA-E2-A1L9-01A-11D-A13J-01 TCGA-E2-A1LA-01 Stage IIA 59 5 Stage IIA 463 Positive FEMALE Negative Negative M0 Positive N1 463 0 LumA Positive enrollment T1 T1 LIVING TCGA-E2-A1LA-01 High C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 12 TCGA-E2-A1LA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A1LA-F20586 TCGA-E2-A1LA TCGA-E2-A1LA-01A Positive Positive Simple Mastectomy NO -21773 581 0 748 NO allred score 5 + 3 = 8 Scheduled Follow-up Submission 2012-1-12 FEMALE 2+ 1.15 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 40 NO Equivocal Negative 35 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 1 false No M0 N1a T1c Stage IIA TCGA-E2-A1LA.8F401B38-8D91-4F75-ADE5-52521EAA7DFE.pdf A1LA TUMOR FREE allred score 5 +3 = 8 allred score = 8 allred score = 8 YES NO Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2009 9a56eb8b-99fa-4671-99dc-29776dca4cd6 9a56eb8b-99fa-4671-99dc-29776dca4cd6 TCGA-E2-A1LA-01A-11D-A142-09 TCGA-E2-A1LA-01 TCGA-E2-A1LA-01A-11D-A145-05 TCGA-E2-A1LA-01 TCGA-E2-A1LA-01A-11D-A142-09 TCGA-E2-A1LA-01 TCGA-E2-A1LA-01A-11D-A142-09 9a56eb8b-99fa-4671-99dc-29776dca4cd6 TCGA-E2-A1LA-01A-11D-A141-01 TCGA-E2-A1LA-01 9a56eb8b-99fa-4671-99dc-29776dca4cd6 TCGA-E2-A1LA-01A-11D-A141-01 TCGA-E2-A1LB-01 Stage IIB 41 1 Stage IIB 972 Negative FEMALE Positive Negative M0 Positive N1 972 0 Her2 Negative enrollment T_Other T2 LIVING TCGA-E2-A1LB-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-E2-A1LB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A1LB-F70015 TCGA-E2-A1LB TCGA-E2-A1LB-01A Negative Negative Lumpectomy NO -15283 909 0 2306 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2015-2-9 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 190 NO Positive NO 25 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 3 NO 2 false No M0 N1 T2 Stage IIB TCGA-E2-A1LB.A868EC86-9CB6-445E-B961-5D4C57263548.pdf A1LB TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 acf1ec71-46a5-4e7b-84b1-55203bca29d8 acf1ec71-46a5-4e7b-84b1-55203bca29d8 TCGA-E2-A1LB-01A-21-A17J-20 TCGA-E2-A1LB-01A-11D-A142-09 TCGA-E2-A1LB-01 TCGA-E2-A1LB-01A-11D-A145-05 82c21aa1-4547-4da6-aaf4-ca207c327ea1 TCGA-E2-A1LB-01 TCGA-E2-A1LB-01A-11D-A142-09 TCGA-E2-A1LB-01 TCGA-E2-A1LB-01A-11D-A142-09 acf1ec71-46a5-4e7b-84b1-55203bca29d8 TCGA-E2-A1LB-01A-11D-A141-01 TCGA-E2-A1LB-01 acf1ec71-46a5-4e7b-84b1-55203bca29d8 TCGA-E2-A1LB-01A-11D-A141-01 TCGA-E2-A1LB-11 41 972 FEMALE 972 0 Normal enrollment LIVING TCGA-E2-A1LB-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-E2-A1LB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A1LB-F70015 TCGA-E2-A1LB Negative Negative Lumpectomy NO -15283 0 2306 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2015-2-9 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Positive NO 25 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 2 No M0 N1 T2 Stage IIB A1LB TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES YES Solid Tissue Normal 11 6th YES NO YES E2 Breast LIVING 2008 b34ad5ac-c581-4747-88db-e2d52fa7e463 b34ad5ac-c581-4747-88db-e2d52fa7e463 TCGA-E2-A1LB-11A-22D-A145-05 TCGA-E2-A1LB-11 b34ad5ac-c581-4747-88db-e2d52fa7e463 TCGA-E2-A1LB-11 b34ad5ac-c581-4747-88db-e2d52fa7e463 TCGA-E2-A1LE-01 TCGA-E2-A1LE-01 Squamous BRCA CIMP c7 BRCA basal-like c6 miRNA cluster 7 TCGA-E2-A1LE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 71 Right Upper Inner Quadrant|Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A1LE-F20657 TCGA-E2-A1LE TCGA-E2-A1LE-01A Negative Negative Simple Mastectomy NO -26239 986 879 0 361 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2012-1-18 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 600 NO Positive 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lung Distant Metastasis YES 27 false No M0 N3a T2 Stage IIIC TCGA-E2-A1LE.42E3E8C1-D18A-4457-B2F0-FE49F4C027D7.pdf A1LE WITH TUMOR Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A DECEASED 2008 776c18b3-4e53-41d6-8838-70a6029c07dd 776c18b3-4e53-41d6-8838-70a6029c07dd TCGA-E2-A1LE-01A-21-A24A-20 TCGA-E2-A1LE-01 TCGA-E2-A1LE-01A-12D-A19Z-05 fc80abcf-e8e0-4354-8646-d9ea84d87f7d TCGA-E2-A1LE-01 TCGA-E2-A1LE-01A-12D-A19Y-09 TCGA-E2-A1LE-01 776c18b3-4e53-41d6-8838-70a6029c07dd TCGA-E2-A1LE-01A-12D-A19X-01 TCGA-E2-A1LE-01 776c18b3-4e53-41d6-8838-70a6029c07dd TCGA-E2-A1LE-01A-12D-A19X-01 TCGA-E2-A1LG-01 Stage IIA 50 2 Stage IIA 350 Negative FEMALE Negative Negative M0 Negative N0 350 0 Basal Negative enrollment T_Other T2 LIVING TCGA-E2-A1LG-01 Squamous C4-BRCA/Basal cluster 5 Low purity c2 KIRC-like c1 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 5 TCGA-E2-A1LG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A1LG-F70390 TCGA-E2-A1LG TCGA-E2-A1LG-01A Negative Negative Modified Radical Mastectomy NO -18492 252 0 1523 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2015-3-16 FEMALE 60-69% 2+ 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 310 NO Equivocal Negative NO 19 Negative Peri (6-12 months since last menstrual period) 5 5 NO 0 false Yes M0 N0 T2 Stage IIA TCGA-E2-A1LG.08A790DE-B01D-4140-BB1C-B4844291D71E.pdf A1LG TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES NO Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 94d92cd8-21cf-495d-b4fe-8f8c6067fe9e 94d92cd8-21cf-495d-b4fe-8f8c6067fe9e TCGA-E2-A1LG-01A-41-A17J-20 TCGA-E2-A1LG-01A-21D-A14K-09 TCGA-E2-A1LG-01 TCGA-E2-A1LG-01A-21D-A14N-05 ed36c1d5-f0b6-4ff7-bb8b-34a94cf24075 TCGA-E2-A1LG-01 TCGA-E2-A1LG-01A-21D-A14K-09 TCGA-E2-A1LG-01 TCGA-E2-A1LG-01A-21D-A14K-09 94d92cd8-21cf-495d-b4fe-8f8c6067fe9e TCGA-E2-A1LG-01A-21D-A14J-01 TCGA-E2-A1LG-01 94d92cd8-21cf-495d-b4fe-8f8c6067fe9e TCGA-E2-A1LG-01A-21D-A14J-01 TCGA-E2-A1LH-01 Stage I 59 3 Stage I 2875 Negative FEMALE Negative Negative M0 Negative N0 2875 0 Basal Negative enrollment T1 T1 LIVING TCGA-E2-A1LH-01 High C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c8 mutation cluster 2 TCGA-E2-A1LH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Sentinel node biopsy alone TCGA-E2-A1LH-F20649 TCGA-E2-A1LH TCGA-E2-A1LH-01A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy NO -21628 2998 0 3247 NO Scheduled Follow-up Submission 2012-1-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 130 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 0 false No M0 N0 T1c Stage I TCGA-E2-A1LH.DAB174BB-862D-49BE-9BA4-9C11C4489305.pdf A1LH TUMOR FREE ACIS YES YES Primary Tumor 01 5th YES NO YES E2 Breast A LIVING 2002 66f3892f-f4ec-412c-9c56-a9e9b56a15ee 66f3892f-f4ec-412c-9c56-a9e9b56a15ee TCGA-E2-A1LH-01A-11D-A14G-09 TCGA-E2-A1LH-01 TCGA-E2-A1LH-01A-11D-A14H-05 TCGA-E2-A1LH-01 TCGA-E2-A1LH-01A-11D-A14G-09 TCGA-E2-A1LH-01 TCGA-E2-A1LH-01A-11D-A14G-09 66f3892f-f4ec-412c-9c56-a9e9b56a15ee TCGA-E2-A1LH-01A-11D-A14F-01 TCGA-E2-A1LH-01 66f3892f-f4ec-412c-9c56-a9e9b56a15ee TCGA-E2-A1LH-01A-11D-A14F-01 TCGA-E2-A1LH-11 59 2875 FEMALE 2875 0 Normal enrollment LIVING TCGA-E2-A1LH-11 C4-BRCA/Basal mutation cluster 2 TCGA-E2-A1LH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Sentinel node biopsy alone TCGA-E2-A1LH-F20649 TCGA-E2-A1LH Negative 3 Point Scale 3 Point Scale Negative Lumpectomy NO -21628 0 3247 NO Scheduled Follow-up Submission 2012-1-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No M0 N0 T1c Stage I A1LH TUMOR FREE ACIS YES YES Solid Tissue Normal 11 5th YES NO YES E2 Breast LIVING 2002 c0c2059a-2931-4834-84a7-bfacf137c182 c0c2059a-2931-4834-84a7-bfacf137c182 TCGA-E2-A1LH-11 c0c2059a-2931-4834-84a7-bfacf137c182 TCGA-E2-A1LH-11 c0c2059a-2931-4834-84a7-bfacf137c182 TCGA-E2-A1LI-01 Stage IIB 57 3 Stage IIB 2750 Negative FEMALE Negative Negative M0 Positive N1 2750 0 Basal Negative enrollment T_Other T2 LIVING TCGA-E2-A1LI-01 High C4-BRCA/Basal cluster 4 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 7 mutation c1uster 9 TCGA-E2-A1LI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1LI-F20623 TCGA-E2-A1LI Negative 3 Point Scale 3 Point Scale Negative Lumpectomy NO -21064 0 3121 NO Scheduled Follow-up Submission 2012-1-12 FEMALE 1.21 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Equivocal Negative 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 0 No M0 N1 T2 Stage IIB A1LI TUMOR FREE ACIS YES YES Primary Tumor 01 6th YES NO YES E2 Breast LIVING 2003 fa643dcc-4f4c-44d0-9f4d-199de04f8d2b fa643dcc-4f4c-44d0-9f4d-199de04f8d2b TCGA-E2-A1LI-01A-12D-A159-09 TCGA-E2-A1LI-01 TCGA-E2-A1LI-01A-12D-A161-05 TCGA-E2-A1LI-01 TCGA-E2-A1LI-01A-12D-A159-09 TCGA-E2-A1LI-01 TCGA-E2-A1LI-01A-12D-A159-09 fa643dcc-4f4c-44d0-9f4d-199de04f8d2b TCGA-E2-A1LI-01A-12D-A160-01 TCGA-E2-A1LI-01 fa643dcc-4f4c-44d0-9f4d-199de04f8d2b TCGA-E2-A1LI-01A-12D-A160-01 TCGA-E2-A1LI-11 57 2750 FEMALE 2750 0 enrollment LIVING TCGA-E2-A1LI-11 C4-BRCA/Basal mutation c1uster 9 TCGA-E2-A1LI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1LI-F20623 TCGA-E2-A1LI TCGA-E2-A1LI-11A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy NO -21064 2815 0 3121 NO Scheduled Follow-up Submission 2012-1-12 FEMALE 1.21 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 190 NO Equivocal Negative 2 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N1 T2 Stage IIB A1LI TUMOR FREE ACIS YES YES Solid Tissue Normal 11 6th YES NO YES E2 Breast A LIVING 2003 TCGA-E2-A1LI-11A-23D-A161-05 TCGA-E2-A1LK-01 Stage IIIC 84 4 Stage IIIA 266 Negative FEMALE Negative Negative M0 Positive N1 266 1 Basal Negative enrollment T_Other T3 DECEASED TCGA-E2-A1LK-01 Squamous C4-BRCA/Basal cluster 3 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 5 TCGA-E2-A1LK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO YES 84 Left Upper Outer Quadrant|Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A1LK-F20620 TCGA-E2-A1LK Negative Negative Modified Radical Mastectomy NO 200 -30757 266 0 155 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2012-1-12 FEMALE 80-89% 2+ 1.41 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Equivocal Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Allred Score = 0 Equivocal 2+ Allred score 0+0 = 0 Negative 30-39% 0.95 Negative Allred score 0+0 = 0 Negative 3 5 Other, specify Locoregional Disease Left axilla YES 11 No M0 N3a T4b Stage IIIC A1LK WITH TUMOR Allred score 0+0 = 0 Allred score = 0 Allred score = 0 Allred score = 0 YES NO Primary Tumor 01 6th NO NO YES E2 Breast DECEASED 2008 d6301614-9ba7-4632-bdca-ac1b11e8e811 d6301614-9ba7-4632-bdca-ac1b11e8e811 TCGA-E2-A1LK-01A-11-A17K-20 TCGA-E2-A1LK-01A-21D-A14G-09 TCGA-E2-A1LK-01 TCGA-E2-A1LK-01A-21D-A14H-05 f5fd203d-214a-42f1-aaf9-c9ee9b12c4fc TCGA-E2-A1LK-01 TCGA-E2-A1LK-01A-21D-A14G-09 TCGA-E2-A1LK-01 TCGA-E2-A1LK-01A-21D-A14G-09 d6301614-9ba7-4632-bdca-ac1b11e8e811 TCGA-E2-A1LK-01A-21D-A14F-01 TCGA-E2-A1LK-01 d6301614-9ba7-4632-bdca-ac1b11e8e811 TCGA-E2-A1LK-01A-21D-A14F-01 TCGA-E2-A1LL-01 Stage IIIA 73 1 Stage IIIA 1014 Negative FEMALE Negative Negative M0 Positive N2 1014 0 Basal Negative enrollment T_Other T3 LIVING TCGA-E2-A1LL-01 Squamous C2-Squamous-like cluster 1 BRCA CIMP c7 KIRC-like c1 squamous-like c4 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E2-A1LL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO NO 73 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A1LL-F20616 TCGA-E2-A1LL TCGA-E2-A1LL-01A Negative Negative Simple Mastectomy NO -27028 988 0 1309 1303 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2012-1-17 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 290 NO Negative 44 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 Liver Distant Metastasis YES 5 false No MX N2a T3 Stage IIIA TCGA-E2-A1LL.3327975F-94BE-460E-9900-E063340927BE.pdf A1LL WITH TUMOR Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES Primary Tumor 01 6th YES NO YES E2 Breast A LIVING 2008 526c9170-0f25-4374-9287-1fc40acb6555 526c9170-0f25-4374-9287-1fc40acb6555 TCGA-E2-A1LL-01A-21-A17J-20 TCGA-E2-A1LL-01A-11D-A142-09 TCGA-E2-A1LL-01 TCGA-E2-A1LL-01A-11D-A145-05 fdf3231f-d485-4a5e-b10b-43d9ab536a66 TCGA-E2-A1LL-01 TCGA-E2-A1LL-01A-11D-A142-09 TCGA-E2-A1LL-01 TCGA-E2-A1LL-01A-11D-A142-09 526c9170-0f25-4374-9287-1fc40acb6555 TCGA-E2-A1LL-01A-11D-A141-01 TCGA-E2-A1LL-01 526c9170-0f25-4374-9287-1fc40acb6555 TCGA-E2-A1LL-01A-11D-A141-01 TCGA-E2-A1LS-01 Stage IA 46 Stage I 239 Negative FEMALE Negative Negative M0 Negative N0 239 0 Basal Negative enrollment T1 T1 LIVING TCGA-E2-A1LS-01 C4-BRCA/Basal cluster 3 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 mutation cluster 5 TCGA-E2-A1LS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1LS-F70016 TCGA-E2-A1LS TCGA-E2-A1LS-01A Negative Negative Simple Mastectomy NO -16887 176 0 1604 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2015-2-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 100 NO Negative NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 NO 0 false No M0 N0 T1c Stage IA TCGA-E2-A1LS.A514658A-FB29-4AA0-9451-2A960B3720C1.pdf A1LS TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES NO Primary Tumor 01 7th YES NO YES E2 Breast A LIVING 2010 81239059-614b-46b7-a21e-224ec62e2939 81239059-614b-46b7-a21e-224ec62e2939 TCGA-E2-A1LS-01A-21-A17J-20 TCGA-E2-A1LS-01A-12D-A159-09 TCGA-E2-A1LS-01 TCGA-E2-A1LS-01A-12D-A161-05 9e7e3f34-faa6-4a3d-a0cb-d733c45b9b65 TCGA-E2-A1LS-01A-12D-A159-09 TCGA-E2-A1LS-01 TCGA-E2-A1LS-01A-12D-A159-09 81239059-614b-46b7-a21e-224ec62e2939 TCGA-E2-A1LS-01 81239059-614b-46b7-a21e-224ec62e2939 TCGA-E2-A1LS-11 46 239 FEMALE 239 0 Normal enrollment LIVING TCGA-E2-A1LS-11 C4-BRCA/Basal mutation cluster 5 TCGA-E2-A1LS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-E2-A1LS-F70016 TCGA-E2-A1LS TCGA-E2-A1LS-11A Negative Negative Simple Mastectomy NO -16887 176 0 1604 NO Allred score 0+0 = 0 Scheduled Follow-up Submission 2015-2-9 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 280 NO Negative NO 5 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 false No M0 N0 T1c Stage IA A1LS TUMOR FREE Allred score 0+0 = 0 Allred score = 0 Allred score = 0 YES YES NO Solid Tissue Normal 11 7th YES NO YES E2 Breast A LIVING 2010 a2c2973d-0af5-4065-a5b0-1dd73abdc581 a2c2973d-0af5-4065-a5b0-1dd73abdc581 TCGA-E2-A1LS-11A-32D-A161-05 a2c2973d-0af5-4065-a5b0-1dd73abdc581 a2c2973d-0af5-4065-a5b0-1dd73abdc581 TCGA-E2-A2P5-01 TCGA-E2-A2P5-01 High BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 5 TCGA-E2-A2P5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 78 Left Axillary lymph node dissection alone TCGA-E2-A2P5-F68575 TCGA-E2-A2P5 TCGA-E2-A2P5-01A Positive Positive Modified Radical Mastectomy NO -28621 219 821 0 515 597 NO Allred score = 8 Scheduled Follow-up Submission 2014-11-26 FEMALE 1.0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 260 NO Negative NO 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone Distant Metastasis NO YES 21 true Yes M0 N3 T2 Stage IIIC TCGA-E2-A2P5.85E91C9F-9F61-4A25-B4D9-1BCBC7108F5E.pdf A2P5 WITH TUMOR Allred score = 8 Allred score = 8 Allred score = 8 YES YES YES Primary Tumor 01 7th YES NO YES E2 Breast A DECEASED 2011 90d04601-4a15-44fc-bf1b-e0859310e644 90d04601-4a15-44fc-bf1b-e0859310e644 TCGA-E2-A2P5-01A-21-A24A-20 TCGA-E2-A2P5-01 TCGA-E2-A2P5-01A-11D-A19Z-05 b4da5ffb-397d-4760-8e01-a67791dd37fc TCGA-E2-A2P5-01 TCGA-E2-A2P5-01A-11D-A19Y-09 TCGA-E2-A2P5-01 90d04601-4a15-44fc-bf1b-e0859310e644 TCGA-E2-A2P5-01A-11D-A19X-01 TCGA-E2-A2P5-01 90d04601-4a15-44fc-bf1b-e0859310e644 TCGA-E2-A2P5-01A-11D-A19X-01 TCGA-E2-A2P6-01 TCGA-E2-A2P6-01 Iq BRCA CIMP c7 miRNA cluster 14 TCGA-E2-A2P6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A2P6-F68574 TCGA-E2-A2P6 Negative Positive Modified radical mastectomy Positive Lumpectomy NO -28411 0 1051 NO Allread score 5+3 = 8 Scheduled Follow-up Submission 2014-11-26 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative NO 5 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 No M0 N1 T2 Stage IIB A2P6 TUMOR FREE Allred score 2+2 = 4 Allred score = 4 Allred score = 8 YES YES NO Primary Tumor 01 7th YES NO YES E2 Breast LIVING 2011 bc94874b-f73a-44c8-bc6f-9ec50972c9b2 bc94874b-f73a-44c8-bc6f-9ec50972c9b2 TCGA-E2-A2P6-01 TCGA-E2-A2P6-01A-11D-A19Z-05 TCGA-E2-A2P6-01 TCGA-E2-A2P6-01A-11D-A19Y-09 TCGA-E2-A2P6-01 bc94874b-f73a-44c8-bc6f-9ec50972c9b2 TCGA-E2-A2P6-01A-11D-A19X-01 TCGA-E2-A2P6-01 bc94874b-f73a-44c8-bc6f-9ec50972c9b2 TCGA-E2-A2P6-01A-11D-A19X-01 TCGA-E2-A3DX-01 LumA TCGA-E2-A3DX-01 Quiet C3-BRCA/Luminal BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-E2-A3DX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Right Axillary lymph node dissection alone TCGA-E2-A3DX-F70017 TCGA-E2-A3DX TCGA-E2-A3DX-01A Positive Positive Modified Radical Mastectomy NO -15969 142 0 1325 NO 2015-2-9 FEMALE 7.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 180 NO Positive NO 36 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 25 false No M0 N3 T2 Stage IIIC TCGA-E2-A3DX.3B7CA8ED-58E2-4609-BE41-46525D3732E7.pdf A3DX TUMOR FREE Allred score = 8 Allred score = 7 YES YES YES Primary Tumor 01 7th NO YES E2 Breast A LIVING 2011 2424c058-78c6-41dd-86e9-efcd61b72add 2424c058-78c6-41dd-86e9-efcd61b72add TCGA-E2-A3DX-01A-11-A24A-20 TCGA-E2-A3DX-01 TCGA-E2-A3DX-01A-21D-A212-05 8439f41b-dd33-46a5-bf4a-f10a23d65b36 TCGA-E2-A3DX-01 TCGA-E2-A3DX-01A-21D-A20S-09 TCGA-E2-A3DX-01 2424c058-78c6-41dd-86e9-efcd61b72add TCGA-E2-A3DX-01A-21D-A20R-01 TCGA-E2-A3DX-01 2424c058-78c6-41dd-86e9-efcd61b72add TCGA-E2-A3DX-01A-21D-A20R-01 TCGA-E2-A56Z-01 TCGA-E2-A56Z-01 TCGA-E2-A56Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Sentinel lymph node biopsy plus axillary dissection TCGA-E2-A56Z-F67584 TCGA-E2-A56Z TCGA-E2-A56Z-01A Positive Positive Lumpectomy NO -25282 254 0 252 Allred 8 = 5+3 10-19% 2.2 2014-11-6 FEMALE 10-19% 2+ 200 3.2 1.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 150 NO Equivocal Negative NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No M0 N1a T2 Stage IIB TCGA-E2-A56Z.83AAF7BF-131D-4044-AD3B-670B838A23D6.pdf A56Z TUMOR FREE Allred 5 = 2+3 Allred Score Allred Score YES YES <10% YES Primary Tumor 01 7th NO YES E2 Breast A LIVING 2012 96af7552-6f51-4abe-8394-b9e966a70228 96af7552-6f51-4abe-8394-b9e966a70228 TCGA-E2-A56Z-01 TCGA-E2-A56Z-01A-12D-A29O-05 dc92e37a-e9dd-4055-acaf-bb63ec1d901b TCGA-E2-A56Z-01 TCGA-E2-A56Z-01A-12D-A29N-09 TCGA-E2-A56Z-01 96af7552-6f51-4abe-8394-b9e966a70228 TCGA-E2-A56Z-01A-12D-A29M-01 TCGA-E2-A56Z-01 96af7552-6f51-4abe-8394-b9e966a70228 TCGA-E2-A56Z-01A-12D-A29M-01 TCGA-E2-A570-01 TCGA-E2-A570-01 TCGA-E2-A570 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Lower Inner Quadrant Sentinel node biopsy alone TCGA-E2-A570-F61335 TCGA-E2-A570 TCGA-E2-A570-01A Positive Positive Simple Mastectomy NO -17456 416 0 931 Allred 7 = 5+2 2.0 2014-6-27 FEMALE 10-19% 2+ 200 2.2 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 80 NO Equivocal Negative NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 true No M0 N1mi T1c Stage IB TCGA-E2-A570.803922CD-3D37-47DC-8BDC-EF8F4779685A.pdf A570 TUMOR FREE Allred 8 = 5+3 Allred Score Allred Score YES YES NO Primary Tumor 01 7th NO YES E2 Breast A LIVING 2011 635a7c2c-7731-48c1-948d-4d7ecf05c472 635a7c2c-7731-48c1-948d-4d7ecf05c472 TCGA-E2-A570-01 TCGA-E2-A570-01A-11D-A29O-05 TCGA-E2-A570-01 TCGA-E2-A570-01A-11D-A29N-09 TCGA-E2-A570-01 635a7c2c-7731-48c1-948d-4d7ecf05c472 TCGA-E2-A570-01A-11D-A29M-01 TCGA-E2-A570-01 635a7c2c-7731-48c1-948d-4d7ecf05c472 TCGA-E2-A570-01A-11D-A29M-01 TCGA-E2-A572-01 TCGA-E2-A572-01 TCGA-E2-A572 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Left Axillary lymph node dissection alone TCGA-E2-A572-F65007 TCGA-E2-A572 TCGA-E2-A572-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Modified Radical Mastectomy YES -26399 560 0 1208 2014-9-17 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 140 NO Equivocal Negative NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 8 true Yes M0 N2 T2 Stage IIIA TCGA-E2-A572.5CED2FBF-42DB-4D17-95C0-DEAE27BBFD02.pdf A572 TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES E2 Breast A LIVING 2011 43a88718-f528-4d0b-88e6-f2ade6854c53 43a88718-f528-4d0b-88e6-f2ade6854c53 TCGA-E2-A572-01 TCGA-E2-A572-01A-13D-A31V-05 7b3b60fa-cd2e-4340-98f8-085f61b2148d TCGA-E2-A572-01 43a88718-f528-4d0b-88e6-f2ade6854c53 TCGA-E2-A572-01 43a88718-f528-4d0b-88e6-f2ade6854c53 TCGA-E2-A573-01 TCGA-E2-A573-01 TCGA-E2-A573 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A573-F61338 TCGA-E2-A573 Negative Negative Other NO -17689 0 1062 Allred 0 = 0+0 1.8 2014-6-27 FEMALE 10-19% 2+ 200 2.3 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative NO 4 Negative Peri (6-12 months since last menstrual period) NO 0 No M0 N0 T1c Stage IA A573 TUMOR FREE Allred 0 = 0+0 Allred Score Allred Score YES YES YES Primary Tumor 01 Partial Mastectomy 7th NO YES E2 Breast LIVING 2011 be17bc7b-550a-461b-9f7b-2a5845cc12b2 be17bc7b-550a-461b-9f7b-2a5845cc12b2 TCGA-E2-A573-01 TCGA-E2-A573-01A-11D-A29O-05 TCGA-E2-A573-01 TCGA-E2-A573-01A-11D-A29N-09 TCGA-E2-A573-01 be17bc7b-550a-461b-9f7b-2a5845cc12b2 TCGA-E2-A573-01A-11D-A29M-01 TCGA-E2-A573-01 be17bc7b-550a-461b-9f7b-2a5845cc12b2 TCGA-E2-A573-01A-11D-A29M-01 TCGA-E2-A574-01 TCGA-E2-A574-01 TCGA-E2-A574 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left Sentinel node biopsy alone TCGA-E2-A574-F70296 TCGA-E2-A574 TCGA-E2-A574-01A Negative Negative Lumpectomy NO -16195 429 0 1179 Allred 0 = 0+0 2.8 2015-2-9 FEMALE 10-19% 2+ 200 2.8 1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Equivocal Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 T2 Stage IIA TCGA-E2-A574.F3FAB505-03FF-4FAA-ABB6-96AD20F47871.pdf A574 TUMOR FREE Allred 0 = 0+0 Allred Score Allred Score YES YES YES Primary Tumor 01 7th NO YES E2 Breast A LIVING 2011 fec9b75b-9a91-4979-9056-ecdd852429d8 fec9b75b-9a91-4979-9056-ecdd852429d8 TCGA-E2-A574-01 TCGA-E2-A574-01A-11D-A29O-05 19a7926b-5288-4e60-b0a3-ebdb0ff58b1a TCGA-E2-A574-01 TCGA-E2-A574-01A-11D-A29N-09 TCGA-E2-A574-01 fec9b75b-9a91-4979-9056-ecdd852429d8 TCGA-E2-A574-01A-11D-A29M-01 TCGA-E2-A574-01 fec9b75b-9a91-4979-9056-ecdd852429d8 TCGA-E2-A574-01A-11D-A29M-01 TCGA-E2-A576-01 TCGA-E2-A576-01 TCGA-E2-A576 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-E2-A576-F67575 TCGA-E2-A576 TCGA-E2-A576-01A Positive Positive Lumpectomy YES -25350 343 0 1043 2014-11-6 FEMALE 2+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Fine needle aspiration biopsy 80 NO Equivocal Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No MX N0 T1c Stage IA TCGA-E2-A576.967CCAA8-5BC6-4744-BD9A-3DFEF9EF4F27.pdf A576 TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES E2 Breast A LIVING 2011 1323e58e-5e3f-459a-99ff-e7a6748d3d77 1323e58e-5e3f-459a-99ff-e7a6748d3d77 TCGA-E2-A576-01 TCGA-E2-A576-01A-11D-A31V-05 TCGA-E2-A576-01 TCGA-E2-A576-01 1323e58e-5e3f-459a-99ff-e7a6748d3d77 TCGA-E2-A576-01A-11D-A31T-01 TCGA-E2-A576-01 1323e58e-5e3f-459a-99ff-e7a6748d3d77 TCGA-E2-A576-01A-11D-A31T-01 TCGA-E2-A9RU-01 TCGA-E2-A9RU-01 TCGA-E2-A9RU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E2-A9RU-F70313 TCGA-E2-A9RU TCGA-E2-A9RU-01A Positive Negative Lumpectomy YES -32873 188 0 538 70-79% 2015-2-9 FEMALE 2+ 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 220 NO Equivocal Negative NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 12 true No MX N3a T2 Stage IIIC TCGA-E2-A9RU.E28607CD-0847-46F4-8E69-2D1DC80DE56F.pdf A9RU TUMOR FREE Allred Score 6 YES YES YES Primary Tumor 01 7th NO YES E2 Breast A LIVING 2013 12037b1a-ef64-4ea7-99c8-703132eb2d1e 12037b1a-ef64-4ea7-99c8-703132eb2d1e TCGA-E2-A9RU-01 TCGA-E2-A9RU-01A-11D-A41Q-05 5492E47A-045A-4CB8-A83D-D30F7E68CCF0 TCGA-E2-A9RU-01 TCGA-E2-A9RU-01 12037b1a-ef64-4ea7-99c8-703132eb2d1e TCGA-E2-A9RU-01A-11D-A41E-01 TCGA-E2-A9RU-01 12037b1a-ef64-4ea7-99c8-703132eb2d1e TCGA-E2-A9RU-01A-11D-A41E-01 TCGA-E9-A1N3-01 Stage IIIA 70 1 Stage IIIA 0 FEMALE Negative Negative M0 Positive N2 0 0 LumA enrollment T1 T1 LIVING TCGA-E9-A1N3-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 mutation c1uster 9 TCGA-E9-A1N3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1N3-F62627 TCGA-E9-A1N3 TCGA-E9-A1N3-01A Modified Radical Mastectomy NO -25714 65 0 1059 NO Scheduled Follow-up Submission 2014-7-22 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 230 NO NO 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 7 true No M0 N2 T1c Stage IIIA TCGA-E9-A1N3.4F50E811-0743-440B-9094-6BA0F40BD734.pdf A1N3 TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2010 aaddb80d-7710-4aab-8efc-e84da79f9c68 aaddb80d-7710-4aab-8efc-e84da79f9c68 TCGA-E9-A1N3-01A-21-A17J-20 TCGA-E9-A1N3-01A-12D-A159-09 TCGA-E9-A1N3-01 TCGA-E9-A1N3-01A-12D-A161-05 167bccdb-afaa-49f7-b3af-6d5bd49e7422 TCGA-E9-A1N3-01 TCGA-E9-A1N3-01A-12D-A159-09 TCGA-E9-A1N3-01 TCGA-E9-A1N3-01A-12D-A159-09 aaddb80d-7710-4aab-8efc-e84da79f9c68 TCGA-E9-A1N3-01A-12D-A160-01 TCGA-E9-A1N3-01 aaddb80d-7710-4aab-8efc-e84da79f9c68 TCGA-E9-A1N3-01A-12D-A160-01 TCGA-E9-A1N4-01 Stage IIIA 41 2 Stage IIIA 0 Positive FEMALE Negative Negative M0 Positive N2 0 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E9-A1N4-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation c1uster 9 TCGA-E9-A1N4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1N4-F39767 TCGA-E9-A1N4 TCGA-E9-A1N4-01A Positive Positive NO -15055 65 0 1000 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 310 NO Positive NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 7 NO 4 0 true No M0 N2 T2 Stage IIIA TCGA-E9-A1N4.64B91C7E-E6D8-4952-B49F-0F5D57332994.pdf A1N4 TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2010 55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a 55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a TCGA-E9-A1N4-01A-21-A17K-20 TCGA-E9-A1N4-01A-11D-A14K-09 TCGA-E9-A1N4-01 TCGA-E9-A1N4-01A-11D-A14N-05 e593a9f8-484a-4693-9d6c-75ddc09dea59 TCGA-E9-A1N4-01 TCGA-E9-A1N4-01A-11D-A14K-09 TCGA-E9-A1N4-01 TCGA-E9-A1N4-01A-11D-A14K-09 55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a TCGA-E9-A1N4-01A-11D-A14J-01 TCGA-E9-A1N4-01 55b3f26e-8f8f-48b8-8c3a-4e648ac7e05a TCGA-E9-A1N4-01A-11D-A14J-01 TCGA-E9-A1N4-11 41 0 FEMALE 0 0 Normal enrollment LIVING TCGA-E9-A1N4-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-E9-A1N4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1N4-F39767 TCGA-E9-A1N4 TCGA-E9-A1N4-11A Positive Positive NO -15055 65 0 1000 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 340 NO Positive NO 7 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 4 0 true No M0 N2 T2 Stage IIIA A1N4 TUMOR FREE YES YES YES Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2010 922b7051-1447-4e8d-9343-c5521ee45346 922b7051-1447-4e8d-9343-c5521ee45346 TCGA-E9-A1N4-11A-33D-A14N-05 TCGA-E9-A1N4-11 922b7051-1447-4e8d-9343-c5521ee45346 TCGA-E9-A1N4-11 922b7051-1447-4e8d-9343-c5521ee45346 TCGA-E9-A1N5-01 Stage IIB 45 5 Stage IIB 0 Positive FEMALE Negative Negative M0 Positive N1 0 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E9-A1N5-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation cluster 3 TCGA-E9-A1N5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1N5-F39765 TCGA-E9-A1N5 TCGA-E9-A1N5-01A Positive Positive NO -16736 63 0 1120 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 190 NO Positive NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 2 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1N5.224A51C8-8EEB-424C-AD88-44C4321050EA.pdf A1N5 TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2010 1adf0e70-b1fb-4862-8a01-6454b09636f4 1adf0e70-b1fb-4862-8a01-6454b09636f4 TCGA-E9-A1N5-01A-21-A17J-20 TCGA-E9-A1N5-01A-11D-A14G-09 TCGA-E9-A1N5-01 TCGA-E9-A1N5-01A-11D-A14H-05 1efeb02c-7e68-449e-9f4f-8b8f985ab01e TCGA-E9-A1N5-01 TCGA-E9-A1N5-01A-11D-A14G-09 TCGA-E9-A1N5-01 TCGA-E9-A1N5-01A-11D-A14G-09 1adf0e70-b1fb-4862-8a01-6454b09636f4 TCGA-E9-A1N5-01A-11D-A14F-01 TCGA-E9-A1N5-01 1adf0e70-b1fb-4862-8a01-6454b09636f4 TCGA-E9-A1N5-01A-11D-A14F-01 TCGA-E9-A1N5-11 45 0 FEMALE 0 0 Normal enrollment LIVING TCGA-E9-A1N5-11 C3-BRCA/Luminal mutation cluster 3 TCGA-E9-A1N5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1N5-F39765 TCGA-E9-A1N5 TCGA-E9-A1N5-11A Positive Positive NO -16736 63 0 1120 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection NO Positive NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 0 true No M0 N1 T2 Stage IIB A1N5 TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2010 8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7 8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7 TCGA-E9-A1N5-11A-41D-A14H-05 0D7A5303-6F45-4910-8BC5-F08E8FC11463 TCGA-E9-A1N5-11 8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7 TCGA-E9-A1N5-11 8e7ab480-e75d-49a4-98a6-fcdd2ccefaa7 TCGA-E9-A1N6-01 Stage IIB 52 5 Stage IIB 0 Positive FEMALE Positive Negative M0 Positive N1 0 0 LumB Positive enrollment T_Other T2 LIVING TCGA-E9-A1N6-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 cluster 4 TCGA-E9-A1N6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 52 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1N6-F63536 TCGA-E9-A1N6 TCGA-E9-A1N6-01A Positive Positive NO -19327 63 678 0 410 443 NO Scheduled Follow-up Submission 2014-8-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 220 NO Positive NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 Bone Distant Metastasis NO YES 2 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1N6.910A4342-BBC1-47AE-9316-695B0CD0375D.pdf A1N6 WITH TUMOR YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A DECEASED 2010 05b5084f-5e4f-43a3-9819-456a4f24ad82 05b5084f-5e4f-43a3-9819-456a4f24ad82 TCGA-E9-A1N6-01A-21-A17K-20 TCGA-E9-A1N6-01 TCGA-E9-A1N6-01A-11D-A145-05 4a7c1f26-54e8-40e4-a966-b01498c98782 TCGA-E9-A1N6-01 TCGA-E9-A1N6-01 05b5084f-5e4f-43a3-9819-456a4f24ad82 TCGA-E9-A1N6-01A-11D-A141-01 TCGA-E9-A1N6-01 05b5084f-5e4f-43a3-9819-456a4f24ad82 TCGA-E9-A1N6-01A-11D-A141-01 TCGA-E9-A1N6-11 52 0 FEMALE 0 0 Normal enrollment LIVING TCGA-E9-A1N6-11 C3-BRCA/Luminal TCGA-E9-A1N6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 52 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1N6-F63536 TCGA-E9-A1N6 TCGA-E9-A1N6-11A Positive Positive NO -19327 63 678 0 410 443 NO Scheduled Follow-up Submission 2014-8-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 670 NO Positive NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone Distant Metastasis NO YES 2 0 true No M0 N1 T2 Stage IIB A1N6 WITH TUMOR YES YES YES Solid Tissue Normal 11 7th YES YES NO E9 Breast A DECEASED 2010 0f263a65-a664-4e23-bd9c-91e955f3bf21 0f263a65-a664-4e23-bd9c-91e955f3bf21 TCGA-E9-A1N6-11A-32D-A145-05 F251633F-A6B6-4238-93A8-6C32EFCA1607 TCGA-E9-A1N6-11 0f263a65-a664-4e23-bd9c-91e955f3bf21 TCGA-E9-A1N6-11 0f263a65-a664-4e23-bd9c-91e955f3bf21 TCGA-E9-A1N8-01 Stage IIA 48 1 Stage IIA 0 Negative FEMALE Negative Negative M0 Negative N0 0 0 Basal enrollment T_Other T2 LIVING TCGA-E9-A1N8-01 Squamous C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E9-A1N8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1N8-F53518 TCGA-E9-A1N8 TCGA-E9-A1N8-01A Negative NO -17652 66 0 1039 NO Scheduled Follow-up Submission 2013-12-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 680 NO Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1N8.4F15F8D6-9F34-4A61-A006-E5E7A2E68207.pdf A1N8 TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2010 7d6b6a17-5f1e-4586-9316-195c0e96925c 7d6b6a17-5f1e-4586-9316-195c0e96925c TCGA-E9-A1N8-01A-21-A17K-20 TCGA-E9-A1N8-01A-11D-A142-09 TCGA-E9-A1N8-01 TCGA-E9-A1N8-01A-11D-A145-05 8ea109e3-1e03-468c-b117-43cbd5c7571d TCGA-E9-A1N8-01 TCGA-E9-A1N8-01A-11D-A142-09 TCGA-E9-A1N8-01 TCGA-E9-A1N8-01A-11D-A142-09 7d6b6a17-5f1e-4586-9316-195c0e96925c TCGA-E9-A1N8-01A-11D-A141-01 TCGA-E9-A1N8-01 7d6b6a17-5f1e-4586-9316-195c0e96925c TCGA-E9-A1N8-01A-11D-A141-01 TCGA-E9-A1N8-11 48 0 FEMALE 0 0 enrollment LIVING TCGA-E9-A1N8-11 C4-BRCA/Basal mutation cluster 5 TCGA-E9-A1N8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1N8-F53518 TCGA-E9-A1N8 TCGA-E9-A1N8-11A Negative NO -17652 66 0 1039 NO Scheduled Follow-up Submission 2013-12-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 510 NO Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T2 Stage IIA A1N8 TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2010 TCGA-E9-A1N8-11A-42D-A145-05 EFBC87A0-993F-4C1E-9D9A-32C76BCCC13A TCGA-E9-A1N9-01 Stage IIA 58 4 Stage IIA 0 Negative FEMALE Negative Negative M0 Negative N0 0 0 Basal Positive enrollment T_Other T2 LIVING TCGA-E9-A1N9-01 High C3-BRCA/Luminal cluster 1 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-E9-A1N9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1N9-F58373 TCGA-E9-A1N9 Negative Positive YES -21228 0 1101 NO Scheduled Follow-up Submission 2014-4-8 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection Positive NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 5 NO 0 0 No M0 N0 T2 Stage IIA A1N9 TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast LIVING 2011 cdada0b1-f90d-40bc-9257-6377987b7baa cdada0b1-f90d-40bc-9257-6377987b7baa TCGA-E9-A1N9-01A-21-A17K-20 TCGA-E9-A1N9-01A-11D-A14G-09 TCGA-E9-A1N9-01 TCGA-E9-A1N9-01A-11D-A14H-05 f211c550-de9f-47f6-a1c2-546f560ac335 TCGA-E9-A1N9-01 TCGA-E9-A1N9-01A-11D-A14G-09 TCGA-E9-A1N9-01 TCGA-E9-A1N9-01A-11D-A14G-09 cdada0b1-f90d-40bc-9257-6377987b7baa TCGA-E9-A1N9-01A-11D-A14F-01 TCGA-E9-A1N9-01 cdada0b1-f90d-40bc-9257-6377987b7baa TCGA-E9-A1N9-01A-11D-A14F-01 TCGA-E9-A1N9-11 58 0 FEMALE 0 0 Normal enrollment LIVING TCGA-E9-A1N9-11 C3-BRCA/Luminal mutation cluster 5 TCGA-E9-A1N9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1N9-F58373 TCGA-E9-A1N9 TCGA-E9-A1N9-11A Negative Positive YES -21228 44 0 1101 NO Scheduled Follow-up Submission 2014-4-8 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 1190 NO Positive NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T2 Stage IIA A1N9 TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 f6e8424b-338c-4f9a-bdc7-f7d8de0c5634 f6e8424b-338c-4f9a-bdc7-f7d8de0c5634 39636744-785B-4D93-8EE5-40D075AEAB71 TCGA-E9-A1N9-11 f6e8424b-338c-4f9a-bdc7-f7d8de0c5634 TCGA-E9-A1N9-11 f6e8424b-338c-4f9a-bdc7-f7d8de0c5634 TCGA-E9-A1NA-01 Stage IIA 58 5 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumB Positive enrollment T_Other T2 LIVING TCGA-E9-A1NA-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-E9-A1NA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1-F39782 TCGA-E9-A1 TCGA-E9-A1-01A Positive Positive YES -21397 42 0 1112 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 110 NO Positive NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1.595BB256-2F3D-493A-AA90-022BE0CC995F.pdf A1 TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 7edc6614-6c8b-43ec-87dd-7720961bd174 7edc6614-6c8b-43ec-87dd-7720961bd174 TCGA-E9-A1NA-01A-21-A17K-20 TCGA-E9-A1NA-01A-11D-A142-09 TCGA-E9-A1NA-01 TCGA-E9-A1NA-01A-11D-A145-05 693f43fc-0cb7-44e8-90c4-7c1bc12d7da6 TCGA-E9-A1NA-01 TCGA-E9-A1NA-01A-11D-A142-09 TCGA-E9-A1NA-01 TCGA-E9-A1NA-01A-11D-A142-09 7edc6614-6c8b-43ec-87dd-7720961bd174 TCGA-E9-A1NA-01A-11D-A141-01 TCGA-E9-A1NA-01 7edc6614-6c8b-43ec-87dd-7720961bd174 TCGA-E9-A1NA-01A-11D-A141-01 TCGA-E9-A1NA-11 58 0 FEMALE 0 0 Normal enrollment LIVING TCGA-E9-A1NA-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-E9-A1NA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1-F39782 TCGA-E9-A1 TCGA-E9-A1-11A Positive Positive YES -21397 42 0 1112 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 330 NO Positive NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T2 Stage IIA A1 TUMOR FREE YES YES YES Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 7b9569bc-f513-4b64-9a7c-7bb53b9be79b 7b9569bc-f513-4b64-9a7c-7bb53b9be79b TCGA-E9-A1NA-11A-33D-A145-05 TCGA-E9-A1NA-11 7b9569bc-f513-4b64-9a7c-7bb53b9be79b TCGA-E9-A1NA-11 7b9569bc-f513-4b64-9a7c-7bb53b9be79b TCGA-E9-A1NC-01 Stage IIB 61 1 Stage IIB 0 Negative FEMALE Negative Negative M0 Positive N1 0 0 Positive enrollment T_Other T2 LIVING TCGA-E9-A1NC-01 Squamous cluster 5 Low purity c2 miRNA cluster 13 mutation c1uster 9 TCGA-E9-A1NC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1NC-F40639 TCGA-E9-A1NC TCGA-E9-A1NC-01A Negative Positive YES -22355 38 0 1203 NO Scheduled Follow-up Submission 2013-2-26 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 200 NO Positive NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 1 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1NC.AA1B707B-4DE8-4E0D-87CA-601760F4A6CF.pdf A1NC TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 50f23d00-f6fd-4b3d-aed2-0705f7ae6a17 50f23d00-f6fd-4b3d-aed2-0705f7ae6a17 TCGA-E9-A1NC-01A-12W-A16L-09 TCGA-E9-A1NC-01 TCGA-E9-A1NC-01A-12D-A161-05 TCGA-E9-A1NC-01 TCGA-E9-A1NC-01A-12W-A16L-09 TCGA-E9-A1NC-01A-12W-A16L-09 50f23d00-f6fd-4b3d-aed2-0705f7ae6a17 TCGA-E9-A1NC-01A-12D-A160-01 50f23d00-f6fd-4b3d-aed2-0705f7ae6a17 TCGA-E9-A1NC-01A-12D-A160-01 TCGA-E9-A1ND-01 Stage IIB 75 1 Stage IIB 0 Negative FEMALE Negative Negative M0 Positive N1 0 0 Basal Negative enrollment T_Other T2 LIVING TCGA-E9-A1ND-01 Squamous C4-BRCA/Basal cluster 5 Cluster 5 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 11 cluster 5 mutation cluster 2 TCGA-E9-A1ND TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1ND-F62586 TCGA-E9-A1ND TCGA-E9-A1ND-01A Negative Negative YES -27400 37 0 1266 NO Scheduled Follow-up Submission 2014-7-21 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 420 NO Positive NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 1 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1ND.AC26EE69-27D8-4523-917A-68573F5F614E.pdf A1ND TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 526da11e-9125-4fcd-98d7-02994c9783d1 526da11e-9125-4fcd-98d7-02994c9783d1 TCGA-E9-A1ND-01A-21-A17J-20 TCGA-E9-A1ND-01A-11D-A142-09 TCGA-E9-A1ND-01 TCGA-E9-A1ND-01A-11D-A145-05 c323e6ab-8ba2-4347-a5d0-931a5d9754a1 TCGA-E9-A1ND-01 TCGA-E9-A1ND-01A-11D-A142-09 TCGA-E9-A1ND-01 TCGA-E9-A1ND-01A-11D-A142-09 526da11e-9125-4fcd-98d7-02994c9783d1 TCGA-E9-A1ND-01A-11D-A141-01 TCGA-E9-A1ND-01 526da11e-9125-4fcd-98d7-02994c9783d1 TCGA-E9-A1ND-01A-11D-A141-01 TCGA-E9-A1ND-11 75 0 FEMALE 0 0 Normal enrollment LIVING TCGA-E9-A1ND-11 C4-BRCA/Basal mutation cluster 2 TCGA-E9-A1ND TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1ND-F62586 TCGA-E9-A1ND TCGA-E9-A1ND-11A Negative Negative YES -27400 37 0 1266 NO Scheduled Follow-up Submission 2014-7-21 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 1070 NO Positive NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 0 true No M0 N1 T2 Stage IIB A1ND TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 ef84a69f-37bc-46fa-98ac-b3976212e11d ef84a69f-37bc-46fa-98ac-b3976212e11d TCGA-E9-A1ND-11A-43D-A145-05 1DFA3ABA-51BC-48FA-B854-39ED4F94E701 TCGA-E9-A1ND-11 ef84a69f-37bc-46fa-98ac-b3976212e11d TCGA-E9-A1ND-11 ef84a69f-37bc-46fa-98ac-b3976212e11d TCGA-E9-A1NE-01 Stage IIB 28 1 Stage IIB 0 Positive FEMALE Negative Negative M0 Positive N1 0 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E9-A1NE-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-E9-A1NE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 28 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1NE-F39781 TCGA-E9-A1NE TCGA-E9-A1NE-01A Positive Positive YES -10564 31 0 1088 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 280 NO Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 6 NO 1 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1NE.CF6E29A2-FAE6-45BB-B625-33877887A89E.pdf A1NE TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 92691eb7-5df9-4da9-8bd0-c4f4de528bdc 92691eb7-5df9-4da9-8bd0-c4f4de528bdc TCGA-E9-A1NE-01A-11-A17K-20 TCGA-E9-A1NE-01A-21D-A14K-09 TCGA-E9-A1NE-01 TCGA-E9-A1NE-01A-21D-A14N-05 8eb2885b-f9c7-4fcc-a9fe-a7673af9a3ec TCGA-E9-A1NE-01 TCGA-E9-A1NE-01A-21D-A14K-09 TCGA-E9-A1NE-01 TCGA-E9-A1NE-01A-21D-A14K-09 92691eb7-5df9-4da9-8bd0-c4f4de528bdc TCGA-E9-A1NE-01A-21D-A14J-01 TCGA-E9-A1NE-01 92691eb7-5df9-4da9-8bd0-c4f4de528bdc TCGA-E9-A1NE-01A-21D-A14J-01 TCGA-E9-A1NE-11 28 0 FEMALE 0 0 enrollment LIVING TCGA-E9-A1NE-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-E9-A1NE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 28 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1NE-F39781 TCGA-E9-A1NE TCGA-E9-A1NE-11A Positive Positive YES -10564 31 0 1088 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 830 NO Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 0 true No M0 N1 T2 Stage IIB A1NE TUMOR FREE YES YES YES Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 TCGA-E9-A1NE-11A-43D-A14N-05 233FE7AC-4003-4A6C-80A1-101B561B6842 TCGA-E9-A1NF-01 Stage IIA 60 5 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumB Positive enrollment T_Other T2 LIVING TCGA-E9-A1NF-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 13 TCGA-E9-A1NF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 60 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1NF-F39778 TCGA-E9-A1NF TCGA-E9-A1NF-01A Positive Positive YES -21981 31 1072 0 610 90 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 240 NO Negative NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 Lung Distant Metastasis NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1NF.740CF6E1-C742-47DC-8057-9D73AF4D6171.pdf A1NF WITH TUMOR YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A DECEASED 2011 69e0026c-c87c-4987-8e46-f94d21f6bfb6 69e0026c-c87c-4987-8e46-f94d21f6bfb6 TCGA-E9-A1NF-01A-21-A17K-20 TCGA-E9-A1NF-01A-11D-A14G-09 TCGA-E9-A1NF-01 TCGA-E9-A1NF-01A-11D-A14H-05 710e4246-7a43-4a0a-b6e2-0dddc3420c59 TCGA-E9-A1NF-01 TCGA-E9-A1NF-01A-11D-A14G-09 TCGA-E9-A1NF-01 TCGA-E9-A1NF-01A-11D-A14G-09 69e0026c-c87c-4987-8e46-f94d21f6bfb6 TCGA-E9-A1NF-01A-11D-A14F-01 TCGA-E9-A1NF-01 69e0026c-c87c-4987-8e46-f94d21f6bfb6 TCGA-E9-A1NF-01A-11D-A14F-01 TCGA-E9-A1NF-11 60 0 FEMALE 0 0 LumA enrollment LIVING TCGA-E9-A1NF-11 C3-BRCA/Luminal mutation cluster 13 TCGA-E9-A1NF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 60 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1NF-F39778 TCGA-E9-A1NF TCGA-E9-A1NF-11A Positive Positive YES -21981 31 1072 0 610 90 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 1520 NO Negative NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lung Distant Metastasis NO 0 0 true No M0 N0 T2 Stage IIA A1NF WITH TUMOR YES YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A DECEASED 2011 39f6a4d4-650f-4caf-a778-4a24af4f11ba 39f6a4d4-650f-4caf-a778-4a24af4f11ba TCGA-E9-A1NF-11A-73D-A14H-05 DF5927EA-DE81-492A-B1AD-03A0E533A338 39f6a4d4-650f-4caf-a778-4a24af4f11ba 39f6a4d4-650f-4caf-a778-4a24af4f11ba TCGA-E9-A1NG-01 Stage IIA 62 1 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E9-A1NG-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 1 TCGA-E9-A1NG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1NG-F39774 TCGA-E9-A1NG TCGA-E9-A1NG-01A Positive Positive YES -22896 30 786 0 656 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 380 NO Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1NG.73953A70-DAC0-443A-AC04-28BDA8D5F673.pdf A1NG TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A DECEASED 2011 91918c5e-3c5c-4674-9a7f-1e93d9cf9949 91918c5e-3c5c-4674-9a7f-1e93d9cf9949 TCGA-E9-A1NG-01A-11-A17K-20 TCGA-E9-A1NG-01A-21D-A14K-09 TCGA-E9-A1NG-01 TCGA-E9-A1NG-01A-21D-A14N-05 38b632fe-cdcb-4b5d-9687-86977604c842 TCGA-E9-A1NG-01 TCGA-E9-A1NG-01A-21D-A14K-09 TCGA-E9-A1NG-01 TCGA-E9-A1NG-01A-21D-A14K-09 91918c5e-3c5c-4674-9a7f-1e93d9cf9949 TCGA-E9-A1NG-01A-21D-A14J-01 TCGA-E9-A1NG-01 91918c5e-3c5c-4674-9a7f-1e93d9cf9949 TCGA-E9-A1NG-01A-21D-A14J-01 TCGA-E9-A1NG-11 62 0 FEMALE 0 0 Normal enrollment LIVING TCGA-E9-A1NG-11 C3-BRCA/Luminal mutation cluster 1 TCGA-E9-A1NG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1NG-F39774 TCGA-E9-A1NG TCGA-E9-A1NG-11A Positive Positive YES -22896 30 786 0 656 NO Scheduled Follow-up Submission 2013-2-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 740 NO Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T2 Stage IIA A1NG TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A DECEASED 2011 a4172e12-2a82-436e-8cb9-a532dc0e9ec4 a4172e12-2a82-436e-8cb9-a532dc0e9ec4 TCGA-E9-A1NG-11A-52D-A14N-05 89FE3D24-088B-4F16-82A2-534DB14FF98D TCGA-E9-A1NG-11 a4172e12-2a82-436e-8cb9-a532dc0e9ec4 TCGA-E9-A1NG-11 a4172e12-2a82-436e-8cb9-a532dc0e9ec4 TCGA-E9-A1NH-01 Stage IIB 71 2 Stage IIB 0 Positive FEMALE Negative Negative M0 Positive N1 0 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E9-A1NH-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 4 mutation cluster 4 TCGA-E9-A1NH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1NH-F35049 TCGA-E9-A1NH TCGA-E9-A1NH-01A Positive Positive Modified Radical Mastectomy YES -26221 30 0 576 NO 2012-9-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 140 NO Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 3 0 true No M0 N1 T2 Stage IIB TCGA-E9-A1NH.A6248687-C0C0-4DEF-9D92-196CBDB5CBDE.pdf A1NH TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO E9 Breast A LIVING 2011 0eb9c5a5-1e4e-4808-882e-858b4d0ed396 0eb9c5a5-1e4e-4808-882e-858b4d0ed396 TCGA-E9-A1NH-01A-21-A17K-20 TCGA-E9-A1NH-01A-11D-A14G-09 TCGA-E9-A1NH-01 TCGA-E9-A1NH-01A-11D-A14H-05 14a33bcb-ec41-48da-9c49-cfbcc3fab7de TCGA-E9-A1NH-01 TCGA-E9-A1NH-01A-11D-A14G-09 TCGA-E9-A1NH-01 TCGA-E9-A1NH-01A-11D-A14G-09 0eb9c5a5-1e4e-4808-882e-858b4d0ed396 TCGA-E9-A1NH-01A-11D-A14F-01 TCGA-E9-A1NH-01 0eb9c5a5-1e4e-4808-882e-858b4d0ed396 TCGA-E9-A1NH-01A-11D-A14F-01 TCGA-E9-A1NH-11 71 0 FEMALE 0 0 enrollment LIVING TCGA-E9-A1NH-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E9-A1NH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1NH-F35049 TCGA-E9-A1NH TCGA-E9-A1NH-11A Positive Positive Modified Radical Mastectomy YES -26221 30 0 576 NO 2012-9-14 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 730 NO Negative NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 3 0 true No M0 N1 T2 Stage IIB A1NH TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES NO E9 Breast A LIVING 2011 A6417AA5-7E20-4D27-AFCC-306B837B095F TCGA-E9-A1NI-01 Stage IIA 51 2 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumB Positive enrollment T_Other T2 LIVING TCGA-E9-A1NI-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1NI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1NI-F52056 TCGA-E9-A1NI TCGA-E9-A1NI-01A Positive Positive YES -18985 21 0 300 NO Scheduled Follow-up Submission 2013-11-27 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection 280 NO Negative YES 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1NI.3F4F5A98-F6EA-46D5-95E8-6797D419328A.pdf A1NI TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 07ac0536-240f-46be-9909-a8af1a22e2b8 07ac0536-240f-46be-9909-a8af1a22e2b8 TCGA-E9-A1NI-01A-21-A17K-20 TCGA-E9-A1NI-01A-11W-A16H-09 TCGA-E9-A1NI-01 TCGA-E9-A1NI-01A-11D-A14H-05 e1eda531-b715-4139-9c80-c91ffc100fc2 TCGA-E9-A1NI-01 TCGA-E9-A1NI-01A-11W-A16H-09 TCGA-E9-A1NI-01 TCGA-E9-A1NI-01A-11W-A16H-09 07ac0536-240f-46be-9909-a8af1a22e2b8 TCGA-E9-A1NI-01A-11D-A14F-01 TCGA-E9-A1NI-01 07ac0536-240f-46be-9909-a8af1a22e2b8 TCGA-E9-A1NI-01A-11D-A14F-01 TCGA-E9-A1QZ-01 Stage IIA 61 3 Stage IIA 0 FEMALE Negative Negative M0 Negative N0 0 0 LumA enrollment T_Other T2 LIVING TCGA-E9-A1QZ-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 mutation c1uster 9 TCGA-E9-A1QZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1QZ-F66270 TCGA-E9-A1QZ TCGA-E9-A1QZ-01A -22397 58 0 755 NO Scheduled Follow-up Submission 2014-10-7 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 590 NO NO 19 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 NO 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1QZ.864BB34A-1008-480C-A3B5-A2C616E95C49.pdf A1QZ TUMOR FREE NO YES NO Primary Tumor 01 7th NO YES NO E9 Breast A LIVING 2011 64897f59-3a93-4ac3-82d5-66e9f4dc7ac6 64897f59-3a93-4ac3-82d5-66e9f4dc7ac6 TCGA-E9-A1QZ-01A-41-A17J-20 TCGA-E9-A1QZ-01A-21D-A167-09 TCGA-E9-A1QZ-01 TCGA-E9-A1QZ-01A-21D-A16A-05 0794c219-5e82-4c62-9e40-091a0c71c6b4 TCGA-E9-A1QZ-01 TCGA-E9-A1QZ-01A-21D-A167-09 TCGA-E9-A1QZ-01 TCGA-E9-A1QZ-01A-21D-A167-09 64897f59-3a93-4ac3-82d5-66e9f4dc7ac6 TCGA-E9-A1QZ-01A-21D-A166-01 TCGA-E9-A1QZ-01 64897f59-3a93-4ac3-82d5-66e9f4dc7ac6 TCGA-E9-A1QZ-01A-21D-A166-01 TCGA-E9-A1R0-01 Stage IIA 58 2 Stage IIA 0 FEMALE Negative Negative M0 Positive N1 0 0 LumA enrollment T1 T1 LIVING TCGA-E9-A1R0-01 Kirc+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 mutation cluster 4 TCGA-E9-A1R0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1R0-F41214 TCGA-E9-A1R0 TCGA-E9-A1R0-01A -21394 44 0 860 NO Scheduled Follow-up Submission 2013-3-13 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 400 NO NO 12 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 1 true No M0 N1 T1c Stage IIA TCGA-E9-A1R0.DD0ADC20-2059-435E-9EB4-351C87D7CBEB.pdf A1R0 TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3 4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3 TCGA-E9-A1R0-01A-11-A17J-20 TCGA-E9-A1R0-01A-22D-A16D-09 TCGA-E9-A1R0-01 TCGA-E9-A1R0-01A-22D-A16G-05 79bdc020-426c-41df-8b45-be0425815405 TCGA-E9-A1R0-01 TCGA-E9-A1R0-01A-22D-A16D-09 TCGA-E9-A1R0-01 TCGA-E9-A1R0-01A-22D-A16D-09 4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3 TCGA-E9-A1R0-01A-22D-A16C-01 TCGA-E9-A1R0-01 4c6443ed-bc36-4c94-85dd-9bf7aab6a5b3 TCGA-E9-A1R0-01A-22D-A16C-01 TCGA-E9-A1R2-01 Stage IIIC 51 5 Stage IIIC 19 Positive FEMALE Negative Negative M0 Positive N3 19 0 LumA Negative enrollment T_Other T2 LIVING TCGA-E9-A1R2-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 7 mutation c1uster 9 TCGA-E9-A1R2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1R2-F57941 TCGA-E9-A1R2 Positive Negative Lumpectomy NO -18936 0 1063 NO 90-99% 74 Scheduled Follow-up Submission 2014-3-31 FEMALE 90-99% 114 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy Equivocal Negative YES 19 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 NO 17 No MX N3 T2 Stage IIIC A1R2 TUMOR FREE Two-tier Two-tier YES YES Primary Tumor 01 7th YES YES NO E9 Breast LIVING 2011 e24bfd9d-87b2-44a7-bddc-7b7f60461252 e24bfd9d-87b2-44a7-bddc-7b7f60461252 TCGA-E9-A1R2-01A-21-A17J-20 TCGA-E9-A1R2-01A-11D-A14G-09 TCGA-E9-A1R2-01 TCGA-E9-A1R2-01A-11D-A14H-05 e2a04b43-75e6-4ede-8536-d3cfe5eb9113 TCGA-E9-A1R2-01 TCGA-E9-A1R2-01A-11D-A14G-09 TCGA-E9-A1R2-01 TCGA-E9-A1R2-01A-11D-A14G-09 e24bfd9d-87b2-44a7-bddc-7b7f60461252 TCGA-E9-A1R2-01A-11D-A14F-01 TCGA-E9-A1R2-01 e24bfd9d-87b2-44a7-bddc-7b7f60461252 TCGA-E9-A1R2-01A-11D-A14F-01 TCGA-E9-A1R3-01 Stage IIIC 70 2 Stage IIIC 64 FEMALE Negative Negative M0 Positive N3 64 0 LumA enrollment T_Other T2 LIVING TCGA-E9-A1R3-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1R3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1R3-F48697 TCGA-E9-A1R3 TCGA-E9-A1R3-01A Modified Radical Mastectomy NO -25693 80 0 78 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 420 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 10 true No M0 N3 T2 Stage IIIC TCGA-E9-A1R3.BE186852-8596-4CDB-B5C4-AA5838C15B5F.pdf A1R3 TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2010 678ba111-3b01-49b7-83d9-165ef0288a34 678ba111-3b01-49b7-83d9-165ef0288a34 TCGA-E9-A1R3-01A-41-A17J-20 TCGA-E9-A1R3-01A-31D-A14K-09 TCGA-E9-A1R3-01 TCGA-E9-A1R3-01A-31D-A14N-05 fa7047e6-5a4e-4979-a1ee-ecac9434f163 TCGA-E9-A1R3-01 TCGA-E9-A1R3-01A-31D-A14K-09 TCGA-E9-A1R3-01 TCGA-E9-A1R3-01A-31D-A14K-09 678ba111-3b01-49b7-83d9-165ef0288a34 TCGA-E9-A1R3-01A-31D-A14J-01 TCGA-E9-A1R3-01 678ba111-3b01-49b7-83d9-165ef0288a34 TCGA-E9-A1R3-01A-31D-A14J-01 TCGA-E9-A1R4-01 Stage IA 66 1 Stage I 29 FEMALE Negative Negative M0 Negative N0 29 0 LumB enrollment T1 T1 LIVING TCGA-E9-A1R4-01 Squamous C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 4 mutation cluster 4 TCGA-E9-A1R4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1R4-F48699 TCGA-E9-A1R4 TCGA-E9-A1R4-01A NO -24181 45 0 186 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Lumpectomy Other method, specify: 430 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 true No M0 N0 T1c Stage IA TCGA-E9-A1R4.AA095896-8217-4BEE-97EC-BC79F5C395BA.pdf A1R4 TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 11353ea3-2ff0-4658-b528-6aa922dbb665 11353ea3-2ff0-4658-b528-6aa922dbb665 TCGA-E9-A1R4-01A-11-A17J-20 TCGA-E9-A1R4-01A-21D-A14G-09 TCGA-E9-A1R4-01 TCGA-E9-A1R4-01A-21D-A14H-05 146230f2-2e64-46d7-84da-719567028426 TCGA-E9-A1R4-01 TCGA-E9-A1R4-01A-21D-A14G-09 TCGA-E9-A1R4-01 TCGA-E9-A1R4-01A-21D-A14G-09 11353ea3-2ff0-4658-b528-6aa922dbb665 TCGA-E9-A1R4-01A-21D-A14F-01 TCGA-E9-A1R4-01 11353ea3-2ff0-4658-b528-6aa922dbb665 TCGA-E9-A1R4-01A-21D-A14F-01 TCGA-E9-A1R5-01 Stage IA 63 2 Stage I 42 FEMALE Negative Negative M0 Negative N0 42 0 LumA enrollment T1 T1 LIVING TCGA-E9-A1R5-01 Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1R5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1R5-F48700 TCGA-E9-A1R5 TCGA-E9-A1R5-01A Lumpectomy NO -23116 58 0 92 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 370 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO 0 true No M0 N0 T1c Stage IA TCGA-E9-A1R5.141B770B-22DD-4C87-AFF7-04D85FC9C74A.pdf A1R5 TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 7b06a333-ba77-41dd-bfd1-4824fe43d06f 7b06a333-ba77-41dd-bfd1-4824fe43d06f TCGA-E9-A1R5-01A-21-A17J-20 TCGA-E9-A1R5-01A-11D-A14K-09 TCGA-E9-A1R5-01 TCGA-E9-A1R5-01A-11D-A14N-05 95daa854-64b7-48d2-a82b-bacbfea25944 TCGA-E9-A1R5-01 TCGA-E9-A1R5-01A-11D-A14K-09 TCGA-E9-A1R5-01 TCGA-E9-A1R5-01A-11D-A14K-09 7b06a333-ba77-41dd-bfd1-4824fe43d06f TCGA-E9-A1R5-01A-11D-A14J-01 TCGA-E9-A1R5-01 7b06a333-ba77-41dd-bfd1-4824fe43d06f TCGA-E9-A1R5-01A-11D-A14J-01 TCGA-E9-A1R6-01 Stage IIA 63 4 Stage IIA 84 FEMALE Negative Negative M0 Negative N0 84 0 LumA enrollment T_Other T2 LIVING TCGA-E9-A1R6-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-E9-A1R6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1R6-F39520 TCGA-E9-A1R6 TCGA-E9-A1R6-01A Lumpectomy NO -23347 100 0 339 NO Scheduled Follow-up Submission 2013-1-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 730 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 2 NO 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1R6.8A865E33-082A-454F-A6DF-89E994206E65.pdf A1R6 TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2010 2b022043-a976-40a7-929e-664b9549c411 2b022043-a976-40a7-929e-664b9549c411 TCGA-E9-A1R6-01A-21-A17J-20 TCGA-E9-A1R6-01A-11D-A14G-09 TCGA-E9-A1R6-01 TCGA-E9-A1R6-01A-11D-A14H-05 e3b3d877-30e8-48f5-bc12-87618c1dbb34 TCGA-E9-A1R6-01 TCGA-E9-A1R6-01A-11D-A14G-09 TCGA-E9-A1R6-01 TCGA-E9-A1R6-01A-11D-A14G-09 2b022043-a976-40a7-929e-664b9549c411 TCGA-E9-A1R6-01A-11D-A14F-01 TCGA-E9-A1R6-01 2b022043-a976-40a7-929e-664b9549c411 TCGA-E9-A1R6-01A-11D-A14F-01 TCGA-E9-A1R7-01 Stage IIA 64 5 Stage IIA 34 FEMALE Negative Negative M0 Negative N0 34 0 LumB enrollment T_Other T2 LIVING TCGA-E9-A1R7-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-E9-A1R7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1R7-F71424 TCGA-E9-A1R7 TCGA-E9-A1R7-01A Lumpectomy NO -23397 51 0 1467 NO Scheduled Follow-up Submission 2015-3-25 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 400 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 1 NO 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1R7.FA19C3C4-E13B-464B-84CC-3AF7E83D5B9C.pdf A1R7 TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 5ac273e2-3a3f-48a6-8782-956587bab667 5ac273e2-3a3f-48a6-8782-956587bab667 TCGA-E9-A1R7-01A-21-A17J-20 TCGA-E9-A1R7-01A-11D-A14K-09 TCGA-E9-A1R7-01 TCGA-E9-A1R7-01A-11D-A14N-05 95f3d6af-2e61-4df8-b5bd-ce495b3b8b69 TCGA-E9-A1R7-01 TCGA-E9-A1R7-01A-11D-A14K-09 TCGA-E9-A1R7-01 TCGA-E9-A1R7-01A-11D-A14K-09 5ac273e2-3a3f-48a6-8782-956587bab667 TCGA-E9-A1R7-01A-11D-A14J-01 TCGA-E9-A1R7-01 5ac273e2-3a3f-48a6-8782-956587bab667 TCGA-E9-A1R7-01A-11D-A14J-01 TCGA-E9-A1R7-11 64 34 FEMALE 34 0 Normal enrollment LIVING TCGA-E9-A1R7-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-E9-A1R7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1R7-F71424 TCGA-E9-A1R7 TCGA-E9-A1R7-11A Lumpectomy NO -23397 51 0 1467 NO Scheduled Follow-up Submission 2015-3-25 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 440 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T2 Stage IIA A1R7 TUMOR FREE YES YES YES Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 1457ae2c-4b9b-448a-b455-432a7121beb4 1457ae2c-4b9b-448a-b455-432a7121beb4 TCGA-E9-A1R7-11A-42D-A14N-05 TCGA-E9-A1R7-11 1457ae2c-4b9b-448a-b455-432a7121beb4 TCGA-E9-A1R7-11 1457ae2c-4b9b-448a-b455-432a7121beb4 TCGA-E9-A1RA-01 Stage IA 48 3 Stage I 29 FEMALE Negative Negative M0 Negative N0 29 0 enrollment T1 T1 LIVING TCGA-E9-A1RA-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 miRNA cluster 4 cluster 6 mutation cluster 4 TCGA-E9-A1RA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RA-F68493 TCGA-E9-A1RA NO -17699 0 1369 NO Scheduled Follow-up Submission 2014-11-20 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Lumpectomy Other method, specify: NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 6 NO 0 No M0 N0 T1c Stage IA A1RA TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast LIVING 2011 da9bcd8c-7f5b-41f4-bff8-7129a88caf22 da9bcd8c-7f5b-41f4-bff8-7129a88caf22 TCGA-E9-A1RA-01A-21-A17J-20 TCGA-E9-A1RA-01A-11D-A14G-09 TCGA-E9-A1RA-01 TCGA-E9-A1RA-01A-11D-A14H-05 e20d43c8-401d-4975-ac2a-b355dd5bd528 TCGA-E9-A1RA-01 TCGA-E9-A1RA-01A-11D-A14G-09 TCGA-E9-A1RA-01 TCGA-E9-A1RA-01A-11D-A14G-09 da9bcd8c-7f5b-41f4-bff8-7129a88caf22 TCGA-E9-A1RA-01A-11D-A14F-01 TCGA-E9-A1RA-01 da9bcd8c-7f5b-41f4-bff8-7129a88caf22 TCGA-E9-A1RA-01A-11D-A14F-01 TCGA-E9-A1RB-01 Stage IIA 40 4 Stage IIA 21 FEMALE Negative Negative M0 Negative N0 21 0 LumB enrollment T_Other T2 LIVING TCGA-E9-A1RB-01 High C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 5 TCGA-E9-A1RB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1RB-F39530 TCGA-E9-A1RB TCGA-E9-A1RB-01A Modified Radical Mastectomy NO -14755 39 976 0 633 NO Scheduled Follow-up Submission 2013-1-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 490 NO NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1RB.3BE8EA29-3C5F-4339-9CE7-98994B545848.pdf A1RB TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A DECEASED 2011 7e2a8676-10a4-4abf-b153-2255e06bcb40 7e2a8676-10a4-4abf-b153-2255e06bcb40 TCGA-E9-A1RB-01A-21-A17J-20 TCGA-E9-A1RB-01A-11D-A17G-09 TCGA-E9-A1RB-01 TCGA-E9-A1RB-01A-11D-A161-05 d0e45995-93b2-4247-85b7-bc7071578e1f TCGA-E9-A1RB-01 TCGA-E9-A1RB-01A-11D-A17G-09 TCGA-E9-A1RB-01 TCGA-E9-A1RB-01A-11D-A17G-09 7e2a8676-10a4-4abf-b153-2255e06bcb40 TCGA-E9-A1RB-01A-11D-A160-01 TCGA-E9-A1RB-01 7e2a8676-10a4-4abf-b153-2255e06bcb40 TCGA-E9-A1RB-01A-11D-A160-01 TCGA-E9-A1RB-11 40 21 FEMALE 21 0 Normal enrollment LIVING TCGA-E9-A1RB-11 C3-BRCA/Luminal mutation cluster 5 TCGA-E9-A1RB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1RB-F39530 TCGA-E9-A1RB TCGA-E9-A1RB-11A Modified Radical Mastectomy NO -14755 39 976 0 633 NO Scheduled Follow-up Submission 2013-1-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 640 NO NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 0 false No M0 N0 T2 Stage IIA A1RB TUMOR FREE YES YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A DECEASED 2011 b8499b28-1746-4ffd-a183-a765e6d290e3 b8499b28-1746-4ffd-a183-a765e6d290e3 TCGA-E9-A1RB-11A-33D-A161-05 0EFB66E0-3439-4FAE-9B6A-C5D085876AAF TCGA-E9-A1RB-11 b8499b28-1746-4ffd-a183-a765e6d290e3 TCGA-E9-A1RB-11 b8499b28-1746-4ffd-a183-a765e6d290e3 TCGA-E9-A1RC-01 Stage IIIC 56 3 Stage IIIC 1228 FEMALE Negative Negative M0 Positive N3 1228 0 LumA enrollment T_Other T4 LIVING TCGA-E9-A1RC-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 mutation cluster 4 TCGA-E9-A1RC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RC-F48701 TCGA-E9-A1RC TCGA-E9-A1RC-01A Modified Radical Mastectomy NO -20795 1246 0 1224 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 620 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 10 0 true No M0 N3 T4b Stage IIIC TCGA-E9-A1RC.D10A419F-B161-4998-97DE-45DF70F4E212.pdf A1RC TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2007 00168e86-d23a-48ae-8c60-36d970051907 00168e86-d23a-48ae-8c60-36d970051907 TCGA-E9-A1RC-01A-21-A17J-20 TCGA-E9-A1RC-01A-11D-A159-09 TCGA-E9-A1RC-01 TCGA-E9-A1RC-01A-11D-A161-05 9243e0b1-b98d-4d50-817a-b2fed305e841 TCGA-E9-A1RC-01 TCGA-E9-A1RC-01A-11D-A159-09 TCGA-E9-A1RC-01 TCGA-E9-A1RC-01A-11D-A159-09 00168e86-d23a-48ae-8c60-36d970051907 TCGA-E9-A1RC-01A-11D-A160-01 TCGA-E9-A1RC-01 00168e86-d23a-48ae-8c60-36d970051907 TCGA-E9-A1RC-01A-11D-A160-01 TCGA-E9-A1RC-11 56 1228 FEMALE 1228 0 LumA enrollment LIVING TCGA-E9-A1RC-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E9-A1RC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RC-F48701 TCGA-E9-A1RC TCGA-E9-A1RC-11A Modified Radical Mastectomy NO -20795 1246 0 1224 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1040 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 10 0 false No M0 N3 T4b Stage IIIC A1RC TUMOR FREE YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2007 81769714-1765-4b76-8a3a-18f79e314852 81769714-1765-4b76-8a3a-18f79e314852 TCGA-E9-A1RC-11A-33D-A161-05 68A3D687-0B01-4BDD-B650-D8D204E65559 81769714-1765-4b76-8a3a-18f79e314852 81769714-1765-4b76-8a3a-18f79e314852 TCGA-E9-A1RD-01 Stage IIA 67 2 Stage IIA 20 FEMALE Negative Negative M0 Negative N0 20 0 LumA enrollment T_Other T2 LIVING TCGA-E9-A1RD-01 Iq C3-BRCA/Luminal cluster 3 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 mutation cluster 4 TCGA-E9-A1RD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1RD-F48702 TCGA-E9-A1RD Modified Radical Mastectomy NO -24719 0 34 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 0 No M0 N0 T2 Stage IIA A1RD TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO E9 Breast LIVING 2011 eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16 eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16 TCGA-E9-A1RD-01A-21-A17J-20 TCGA-E9-A1RD-01A-11D-A159-09 TCGA-E9-A1RD-01 TCGA-E9-A1RD-01A-11D-A161-05 ef7d073e-90b6-4d14-bcad-a6d9759122dc TCGA-E9-A1RD-01 TCGA-E9-A1RD-01A-11D-A159-09 TCGA-E9-A1RD-01 TCGA-E9-A1RD-01A-11D-A159-09 eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16 TCGA-E9-A1RD-01A-11D-A160-01 TCGA-E9-A1RD-01 eaacfa7a-fa77-42e6-b9ff-fb529bdd6e16 TCGA-E9-A1RD-01A-11D-A160-01 TCGA-E9-A1RD-11 67 20 FEMALE 20 0 Normal enrollment LIVING TCGA-E9-A1RD-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E9-A1RD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A1RD-F48702 TCGA-E9-A1RD TCGA-E9-A1RD-11A Modified Radical Mastectomy NO -24719 38 0 34 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 640 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T2 Stage IIA A1RD TUMOR FREE YES NO Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 000d877f-8d03-44bc-8607-27b5ba84b5fe 000d877f-8d03-44bc-8607-27b5ba84b5fe TCGA-E9-A1RD-11A-33D-A161-05 738328DA-0CBE-4801-A523-667D56E6A73E TCGA-E9-A1RD-11 000d877f-8d03-44bc-8607-27b5ba84b5fe TCGA-E9-A1RD-11 000d877f-8d03-44bc-8607-27b5ba84b5fe TCGA-E9-A1RE-01 Stage IIIA 74 4 Stage IIIA 47 FEMALE Negative Negative M0 Positive N2 47 0 LumB enrollment T_Other T2 LIVING TCGA-E9-A1RE-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 mutation cluster 4 TCGA-E9-A1RE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RE-F68732 TCGA-E9-A1RE TCGA-E9-A1RE-01A Modified Radical Mastectomy NO -27392 65 0 1419 NO Scheduled Follow-up Submission 2014-12-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 730 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 9 true No M0 N2 T2 Stage IIIA TCGA-E9-A1RE.80831A1A-95BD-4ECD-B7D9-6DDCD5313B25.pdf A1RE TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 dce9e705-2d4f-4786-ad68-fb47615c7f3f dce9e705-2d4f-4786-ad68-fb47615c7f3f TCGA-E9-A1RE-01A-21-A17J-20 TCGA-E9-A1RE-01A-11D-A159-09 TCGA-E9-A1RE-01 TCGA-E9-A1RE-01A-11D-A161-05 347208e2-3e3d-4b02-8fc0-1092a95f9bcf TCGA-E9-A1RE-01 TCGA-E9-A1RE-01A-11D-A159-09 TCGA-E9-A1RE-01 TCGA-E9-A1RE-01A-11D-A159-09 dce9e705-2d4f-4786-ad68-fb47615c7f3f TCGA-E9-A1RE-01A-11D-A160-01 TCGA-E9-A1RE-01 dce9e705-2d4f-4786-ad68-fb47615c7f3f TCGA-E9-A1RE-01A-11D-A160-01 TCGA-E9-A1RF-01 Stage IIIA 68 5 Stage IIIA 38 FEMALE Negative Negative M0 Positive N2 38 0 LumA enrollment T_Other T2 LIVING TCGA-E9-A1RF-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation c1uster 9 TCGA-E9-A1RF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RF-F48703 TCGA-E9-A1RF TCGA-E9-A1RF-01A Modified Radical Mastectomy NO -25119 56 0 200 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 330 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 5 true No M0 N2 T2 Stage IIIA TCGA-E9-A1RF.50F3690C-2082-4590-A923-656C5F226FAE.pdf A1RF TUMOR FREE YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 502939cc-3381-4bc2-9ae6-332846cf836b 502939cc-3381-4bc2-9ae6-332846cf836b TCGA-E9-A1RF-01A-21-A17J-20 TCGA-E9-A1RF-01A-11D-A159-09 TCGA-E9-A1RF-01 TCGA-E9-A1RF-01A-11D-A161-05 97534d53-162f-4e78-bf68-a227f1c2ae36 TCGA-E9-A1RF-01 TCGA-E9-A1RF-01A-11D-A159-09 TCGA-E9-A1RF-01 TCGA-E9-A1RF-01A-11D-A159-09 502939cc-3381-4bc2-9ae6-332846cf836b TCGA-E9-A1RF-01A-11D-A160-01 TCGA-E9-A1RF-01 502939cc-3381-4bc2-9ae6-332846cf836b TCGA-E9-A1RF-01A-11D-A160-01 TCGA-E9-A1RF-11 68 38 FEMALE 38 0 LumA enrollment LIVING TCGA-E9-A1RF-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-E9-A1RF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RF-F48703 TCGA-E9-A1RF TCGA-E9-A1RF-11A Modified Radical Mastectomy NO -25119 56 0 200 NO Scheduled Follow-up Submission 2013-9-19 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 1050 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 5 false No M0 N2 T2 Stage IIIA A1RF TUMOR FREE YES YES Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 da13db3f-cde6-4e25-9596-009147aa3fa9 da13db3f-cde6-4e25-9596-009147aa3fa9 TCGA-E9-A1RF-11A-32D-A161-05 97627951-60EF-4283-940A-9550114962F1 da13db3f-cde6-4e25-9596-009147aa3fa9 da13db3f-cde6-4e25-9596-009147aa3fa9 TCGA-E9-A1RG-01 Stage IIIA 62 2 Stage IIIA 35 FEMALE Negative Negative M0 Positive N2 35 0 enrollment T1 T1 LIVING TCGA-E9-A1RG-01 High C1-LUAD-enriched cluster 2 Cluster 5 BRCA nonbasal-like c8 miRNA cluster 2 cluster 5 mutation c1uster 9 TCGA-E9-A1RG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RG-F39534 TCGA-E9-A1RG TCGA-E9-A1RG-01A Lumpectomy NO -22788 53 0 647 NO Scheduled Follow-up Submission 2013-1-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 540 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 5 NO 4 true No M0 N2 T1c Stage IIIA TCGA-E9-A1RG.59D84893-8946-4C5C-A338-3E33A1F7DE00.pdf A1RG TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 dbf09347-4e3e-490e-977f-97d826143634 dbf09347-4e3e-490e-977f-97d826143634 TCGA-E9-A1RG-01A-21-A17J-20 TCGA-E9-A1RG-01A-11D-A14G-09 TCGA-E9-A1RG-01 TCGA-E9-A1RG-01A-11D-A14H-05 4c16616e-47cf-474c-b8c3-f681f390493f TCGA-E9-A1RG-01 TCGA-E9-A1RG-01A-11D-A14G-09 TCGA-E9-A1RG-01 TCGA-E9-A1RG-01A-11D-A14G-09 dbf09347-4e3e-490e-977f-97d826143634 TCGA-E9-A1RG-01A-11D-A14F-01 TCGA-E9-A1RG-01 dbf09347-4e3e-490e-977f-97d826143634 TCGA-E9-A1RG-01A-11D-A14F-01 TCGA-E9-A1RH-01 Stage IIA 63 4 Stage IIA 14 FEMALE Negative Negative M0 Negative N0 14 0 Her2 enrollment T_Other T2 LIVING TCGA-E9-A1RH-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1RH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RH-F70141 TCGA-E9-A1RH TCGA-E9-A1RH-01A Lumpectomy NO -23224 32 0 1417 NO Scheduled Follow-up Submission 2015-1-28 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 410 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 true No M0 N0 T2 Stage IIA TCGA-E9-A1RH.FA93BDAA-B56E-4217-9022-4EBE6009FCF7.pdf A1RH TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 422a4277-12f1-42ae-9f94-88d37517b9b0 422a4277-12f1-42ae-9f94-88d37517b9b0 TCGA-E9-A1RH-01A-11-A17J-20 TCGA-E9-A1RH-01A-21D-A167-09 TCGA-E9-A1RH-01 TCGA-E9-A1RH-01A-21D-A16A-05 7daa20aa-d253-4dc4-a90b-c68c6535d837 TCGA-E9-A1RH-01 TCGA-E9-A1RH-01A-21D-A167-09 TCGA-E9-A1RH-01 TCGA-E9-A1RH-01A-21D-A167-09 422a4277-12f1-42ae-9f94-88d37517b9b0 TCGA-E9-A1RH-01A-21D-A166-01 TCGA-E9-A1RH-01 422a4277-12f1-42ae-9f94-88d37517b9b0 TCGA-E9-A1RH-01A-21D-A166-01 TCGA-E9-A1RH-11 63 14 FEMALE 14 0 Normal enrollment LIVING TCGA-E9-A1RH-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E9-A1RH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RH-F70141 TCGA-E9-A1RH TCGA-E9-A1RH-11A Lumpectomy NO -23224 32 0 1417 NO Scheduled Follow-up Submission 2015-1-28 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 720 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No M0 N0 T2 Stage IIA A1RH TUMOR FREE YES YES YES Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 6574e15e-7e1f-4dca-899e-56e911f27848 6574e15e-7e1f-4dca-899e-56e911f27848 TCGA-E9-A1RH-11A-34D-A16A-05 ABDD9B9C-278F-4077-BB4F-5B890D7E58C7 TCGA-E9-A1RH-11 6574e15e-7e1f-4dca-899e-56e911f27848 TCGA-E9-A1RH-11 6574e15e-7e1f-4dca-899e-56e911f27848 TCGA-E9-A1RI-01 Stage IIIA 43 2 Stage IIIA 48 FEMALE Negative M0 Positive N2 48 0 LumA enrollment T1 T1 LIVING TCGA-E9-A1RI-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-E9-A1RI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RI-F70144 TCGA-E9-A1RI TCGA-E9-A1RI-01A Modified Radical Mastectomy NO -15942 64 0 1449 NO Scheduled Follow-up Submission 2015-1-28 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 290 NO NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 5 true No M0 N2 T1c Stage IIIA TCGA-E9-A1RI.91303D10-CC36-47CF-BF14-E1DCE0157D1C.pdf A1RI TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 1c77a00e-8cea-48ae-b9b5-193cdecf3604 1c77a00e-8cea-48ae-b9b5-193cdecf3604 TCGA-E9-A1RI-01A-21-A17J-20 TCGA-E9-A1RI-01A-11D-A167-09 TCGA-E9-A1RI-01 TCGA-E9-A1RI-01A-11D-A16A-05 fde109be-d1bb-48df-af59-0bee2ca9ed1e TCGA-E9-A1RI-01 TCGA-E9-A1RI-01A-11D-A167-09 TCGA-E9-A1RI-01 TCGA-E9-A1RI-01A-11D-A167-09 1c77a00e-8cea-48ae-b9b5-193cdecf3604 TCGA-E9-A1RI-01A-11D-A166-01 TCGA-E9-A1RI-01 1c77a00e-8cea-48ae-b9b5-193cdecf3604 TCGA-E9-A1RI-01A-11D-A166-01 TCGA-E9-A1RI-11 43 48 FEMALE 48 0 LumA enrollment LIVING TCGA-E9-A1RI-11 C3-BRCA/Luminal mutation cluster 4 TCGA-E9-A1RI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A1RI-F70144 TCGA-E9-A1RI TCGA-E9-A1RI-11A Modified Radical Mastectomy NO -15942 64 0 1449 NO Scheduled Follow-up Submission 2015-1-28 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 800 NO NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 5 false No M0 N2 T1c Stage IIIA A1RI TUMOR FREE YES YES YES Solid Tissue Normal 11 7th YES YES NO E9 Breast A LIVING 2011 7391b882-0be5-45b0-aa01-43c3381a476d 7391b882-0be5-45b0-aa01-43c3381a476d TCGA-E9-A1RI-11A-41D-A16A-05 21E8CC9D-962D-4FA5-9814-8134FFA59C51 7391b882-0be5-45b0-aa01-43c3381a476d 7391b882-0be5-45b0-aa01-43c3381a476d TCGA-E9-A226-01 Stage IIIA 45 2 Stage IIIA 16 FEMALE Negative Negative M0 Positive N2 16 0 LumB enrollment T_Other T2 LIVING TCGA-E9-A226-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 3 TCGA-E9-A226 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 45 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A226-F39536 TCGA-E9-A226 TCGA-E9-A226-01A Modified Radical Mastectomy NO -16511 48 1048 0 628 790 NO Scheduled Follow-up Submission 2015-3-2 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 510 NO NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 Bone Distant Metastasis NO NO 6 true No M0 N2 T2 Stage IIIA TCGA-E9-A226.7C8F01DC-9CD9-4D61-9032-BC9F28A687EE.pdf A226 WITH TUMOR YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A DECEASED 2011 2f11f003-9c39-46ba-990f-10d326953f1b 2f11f003-9c39-46ba-990f-10d326953f1b TCGA-E9-A226-01A-11-A17K-20 TCGA-E9-A226-01A-21D-A159-09 TCGA-E9-A226-01 TCGA-E9-A226-01A-21D-A161-05 67837600-8189-44bd-af2f-1cb30522bc65 TCGA-E9-A226-01 TCGA-E9-A226-01A-21D-A159-09 TCGA-E9-A226-01 TCGA-E9-A226-01A-21D-A159-09 2f11f003-9c39-46ba-990f-10d326953f1b TCGA-E9-A226-01A-21D-A160-01 TCGA-E9-A226-01 2f11f003-9c39-46ba-990f-10d326953f1b TCGA-E9-A226-01A-21D-A160-01 TCGA-E9-A227-01 Stage IIB 42 2 Stage IIB 24 Positive FEMALE Negative Negative M0 Positive N1 24 0 LumA Positive enrollment T_Other T2 LIVING TCGA-E9-A227-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 mutation cluster 1 TCGA-E9-A227 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-E9-A227-F58571 TCGA-E9-A227 TCGA-E9-A227-01A Negative Positive 4+ Other Positive Lumpectomy Re-excision of original lumpectomy site NO -15602 66 0 975 NO 90-99% Scheduled Follow-up Submission 2014-4-29 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 4+ YES Core needle biopsy 180 NO Negative YES 17 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 NO 1 true No M0 N1 T2 Stage IIB TCGA-E9-A227.13CA22BB-5EA5-46C9-82D3-77867122D1B4.pdf A227 TUMOR FREE Two-tier Two-tier YES 80-89% YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 2f315234-dee1-4f36-b7dc-72280c219a1c 2f315234-dee1-4f36-b7dc-72280c219a1c TCGA-E9-A227-01A-21-A17K-20 TCGA-E9-A227-01A-11D-A159-09 TCGA-E9-A227-01 TCGA-E9-A227-01A-11D-A161-05 ad8672fa-20e1-4624-ac65-10e1d4f057ed TCGA-E9-A227-01 TCGA-E9-A227-01A-11D-A159-09 TCGA-E9-A227-01 TCGA-E9-A227-01A-11D-A159-09 2f315234-dee1-4f36-b7dc-72280c219a1c TCGA-E9-A227-01A-11D-A160-01 TCGA-E9-A227-01 2f315234-dee1-4f36-b7dc-72280c219a1c TCGA-E9-A227-01A-11D-A160-01 TCGA-E9-A228-01 Stage IIB 58 5 Stage IIB 0 FEMALE Positive Negative M0 Positive N1 0 0 LumB enrollment T_Other T2 LIVING TCGA-E9-A228-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 mutation c1uster 9 TCGA-E9-A228 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A228-F65804 TCGA-E9-A228 TCGA-E9-A228-01A -21294 42 0 1285 NO Scheduled Follow-up Submission 2014-9-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 740 NO NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 2 true No M0 N1 T2 Stage IIB TCGA-E9-A228.B0E8F3C1-E996-4E70-9630-AC95AF6E4EDC.pdf A228 TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 5903d969-2fd6-4952-b475-a79e6c241efd 5903d969-2fd6-4952-b475-a79e6c241efd TCGA-E9-A228-01A-41-A17K-20 TCGA-E9-A228-01A-31D-A159-09 TCGA-E9-A228-01 TCGA-E9-A228-01A-31D-A161-05 edcb326a-16d2-4ac1-a8da-de4ffcaca34a TCGA-E9-A228-01 TCGA-E9-A228-01A-31D-A159-09 TCGA-E9-A228-01 TCGA-E9-A228-01A-31D-A159-09 5903d969-2fd6-4952-b475-a79e6c241efd TCGA-E9-A228-01A-31D-A160-01 TCGA-E9-A228-01 5903d969-2fd6-4952-b475-a79e6c241efd TCGA-E9-A228-01A-31D-A160-01 TCGA-E9-A229-01 Stage IA 37 5 Stage I 0 FEMALE Negative Negative M0 Negative N0 0 0 LumA enrollment T1 T1 LIVING TCGA-E9-A229-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation cluster 4 TCGA-E9-A229 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 37 Right Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A229-F65803 TCGA-E9-A229 TCGA-E9-A229-01A -13817 56 0 1148 NO Scheduled Follow-up Submission 2014-9-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 160 NO NO 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 NO 0 true No M0 N0 T1c Stage IA TCGA-E9-A229.15FA41AE-3A0F-4112-828B-EE8687A6F158.pdf A229 TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 b956a823-b7d5-4a9e-a9d1-c66f0faf544a b956a823-b7d5-4a9e-a9d1-c66f0faf544a TCGA-E9-A229-01A-21-A17K-20 TCGA-E9-A229-01A-31D-A17G-09 TCGA-E9-A229-01 TCGA-E9-A229-01A-31D-A161-05 9ff7a9ee-7e6e-4f4d-95f8-d2f6e1e88cc3 TCGA-E9-A229-01 TCGA-E9-A229-01A-31D-A17G-09 TCGA-E9-A229-01 TCGA-E9-A229-01A-31D-A17G-09 b956a823-b7d5-4a9e-a9d1-c66f0faf544a TCGA-E9-A229-01A-31D-A160-01 TCGA-E9-A229-01 b956a823-b7d5-4a9e-a9d1-c66f0faf544a TCGA-E9-A229-01A-31D-A160-01 TCGA-E9-A22A-01 Stage IIA 74 1 Stage IIA 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumB Negative enrollment T_Other T2 LIVING TCGA-E9-A22A-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 mutation c1uster 9 TCGA-E9-A22A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A22A-F39785 TCGA-E9-A22A TCGA-E9-A22A-01A Positive Negative YES -27288 59 0 1189 NO 10-19% Scheduled Follow-up Submission 2013-2-1 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 340 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A22A.BC3061B7-9C99-4270-84EE-B1306FA01AE2.pdf A22A TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 2513da31-4ee0-49cd-85de-d2bc8e71e2e5 2513da31-4ee0-49cd-85de-d2bc8e71e2e5 TCGA-E9-A22A-01A-21-A17K-20 TCGA-E9-A22A-01A-11D-A159-09 TCGA-E9-A22A-01 TCGA-E9-A22A-01A-11D-A161-05 31514349-7cce-4d67-8dd4-4fb5f7fea530 TCGA-E9-A22A-01 TCGA-E9-A22A-01A-11D-A159-09 TCGA-E9-A22A-01 TCGA-E9-A22A-01A-11D-A159-09 2513da31-4ee0-49cd-85de-d2bc8e71e2e5 TCGA-E9-A22A-01A-11D-A160-01 TCGA-E9-A22A-01 2513da31-4ee0-49cd-85de-d2bc8e71e2e5 TCGA-E9-A22A-01A-11D-A160-01 TCGA-E9-A22B-01 Stage IA 71 5 Stage I 0 Positive FEMALE Negative Negative M0 Negative N0 0 0 LumA Negative enrollment T1 T1 LIVING TCGA-E9-A22B-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 mutation c1uster 9 TCGA-E9-A22B TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A22B-F64425 TCGA-E9-A22B Positive Negative YES -26278 0 1167 NO 10-19% Scheduled Follow-up Submission 2014-9-2 FEMALE Mixed Histology (please specify) Infiltrating ductal and lobular carcinoma No C50.9 8522/3 C50.9 YES Tumor resection Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 0 0 No M0 N0 T1c Stage IA A22B TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast LIVING 2011 f563bc24-00d1-4637-a073-87744ed7311a f563bc24-00d1-4637-a073-87744ed7311a TCGA-E9-A22B-01A-21-A17K-20 TCGA-E9-A22B-01A-11D-A159-09 TCGA-E9-A22B-01 TCGA-E9-A22B-01A-11D-A161-05 be719b89-4746-465d-9b38-1f32c86a2914 TCGA-E9-A22B-01 TCGA-E9-A22B-01A-11D-A159-09 TCGA-E9-A22B-01 TCGA-E9-A22B-01A-11D-A159-09 f563bc24-00d1-4637-a073-87744ed7311a TCGA-E9-A22B-01A-11D-A160-01 TCGA-E9-A22B-01 f563bc24-00d1-4637-a073-87744ed7311a TCGA-E9-A22B-01A-11D-A160-01 TCGA-E9-A22D-01 Stage IIA 38 5 Stage IIA 0 Positive FEMALE Positive Negative M0 Negative N0 0 0 LumB Positive enrollment T_Other T2 LIVING TCGA-E9-A22D-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation c1uster 9 TCGA-E9-A22D TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A22D-F39787 TCGA-E9-A22D TCGA-E9-A22D-01A Positive Positive Modified Radical Mastectomy YES -14115 52 0 1248 10-19% Scheduled Follow-up Submission 2013-2-1 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 620 NO Positive NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A22D.ED60F792-A71B-4BAE-A536-5FF6D8C3DEAA.pdf A22D TUMOR FREE YES YES <10% NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 1fdac226-ed6b-41a8-9575-67117b4cf035 1fdac226-ed6b-41a8-9575-67117b4cf035 TCGA-E9-A22D-01A-21-A17K-20 TCGA-E9-A22D-01A-11D-A159-09 TCGA-E9-A22D-01 TCGA-E9-A22D-01A-11D-A161-05 4691c2b1-8da2-48b4-9510-badea3a8353f TCGA-E9-A22D-01 TCGA-E9-A22D-01A-11D-A159-09 TCGA-E9-A22D-01 TCGA-E9-A22D-01A-11D-A159-09 1fdac226-ed6b-41a8-9575-67117b4cf035 TCGA-E9-A22D-01A-11D-A160-01 TCGA-E9-A22D-01 1fdac226-ed6b-41a8-9575-67117b4cf035 TCGA-E9-A22D-01A-11D-A160-01 TCGA-E9-A22E-01 Stage IIIA 56 1 Stage IIIA 0 Positive FEMALE Negative Negative M0 Positive N2 0 0 LumB Positive enrollment T_Other T2 LIVING TCGA-E9-A22E-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 9 mutation c1uster 9 TCGA-E9-A22E TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A22E-F63565 TCGA-E9-A22E TCGA-E9-A22E-01A Positive Positive YES -20574 52 0 1269 NO 10-19% Scheduled Follow-up Submission 2014-8-13 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 620 NO Positive NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 4 0 true No M0 N2 T2 Stage IIIA TCGA-E9-A22E.7788E7FD-B5A3-4B22-83CA-EA3FB5E826FC.pdf A22E TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b TCGA-E9-A22E-01A-21-A17K-20 TCGA-E9-A22E-01A-11D-A159-09 TCGA-E9-A22E-01 TCGA-E9-A22E-01A-11D-A161-05 30d1b1ed-e4da-4758-b523-271f2bc19e6c TCGA-E9-A22E-01 TCGA-E9-A22E-01A-11D-A159-09 TCGA-E9-A22E-01 TCGA-E9-A22E-01A-11D-A159-09 e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b TCGA-E9-A22E-01A-11D-A160-01 TCGA-E9-A22E-01 e4d09b12-f1b4-4d66-bc6c-ccd32ad8185b TCGA-E9-A22E-01A-11D-A160-01 TCGA-E9-A22G-01 Stage IIIA 47 1 Stage IIA 0 Negative FEMALE Negative Negative M0 Negative N0 0 0 Basal Negative enrollment T_Other T2 LIVING TCGA-E9-A22G-01 Squamous C4-BRCA/Basal cluster 3 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 1 mutation cluster 5 TCGA-E9-A22G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A22G-F62594 TCGA-E9-A22G TCGA-E9-A22G-01A Negative Negative YES -17300 45 0 1239 NO Scheduled Follow-up Submission 2014-7-21 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 650 NO Positive NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 0 0 true No M0 N0 T2 Stage IIA TCGA-E9-A22G.E34F4BF0-A0C3-4C72-8E3A-F319D4CDDD5D.pdf A22G TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 88d93dca-ffae-4d57-9a60-346aec436543 88d93dca-ffae-4d57-9a60-346aec436543 TCGA-E9-A22G-01A-21-A17K-20 TCGA-E9-A22G-01A-11D-A159-09 TCGA-E9-A22G-01 TCGA-E9-A22G-01A-11D-A161-05 62d5983b-ccc1-4700-9cb9-e97ff4bb1277 TCGA-E9-A22G-01 TCGA-E9-A22G-01A-11D-A159-09 TCGA-E9-A22G-01 TCGA-E9-A22G-01A-11D-A159-09 88d93dca-ffae-4d57-9a60-346aec436543 TCGA-E9-A22G-01A-11D-A160-01 TCGA-E9-A22G-01 88d93dca-ffae-4d57-9a60-346aec436543 TCGA-E9-A22G-01A-11D-A160-01 TCGA-E9-A22H-01 Stage IIB 42 2 Stage IIB 0 Positive FEMALE Negative Negative M0 Positive N1 0 0 LumB Positive enrollment T_Other T2 LIVING TCGA-E9-A22H-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 mutation cluster 4 TCGA-E9-A22H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 42 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A22H-F63224 TCGA-E9-A22H TCGA-E9-A22H-01A Positive Positive Modified Radical Mastectomy YES -15504 38 0 1232 NO <10% Scheduled Follow-up Submission 2014-8-4 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection 500 NO Positive NO 8 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 NO 1 0 true No M0 N1 T2 Stage IIB TCGA-E9-A22H.672E4D81-DA47-495C-A58B-BD2B4FEA2380.pdf A22H TUMOR FREE YES YES 10-19% YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 c388d3be-37d9-4377-8c85-f6124b2ad436 c388d3be-37d9-4377-8c85-f6124b2ad436 TCGA-E9-A22H-01A-21-A17K-20 TCGA-E9-A22H-01A-11D-A159-09 TCGA-E9-A22H-01 TCGA-E9-A22H-01A-11D-A161-05 25eba4f9-cda1-4925-8504-5291fd135b5f TCGA-E9-A22H-01 TCGA-E9-A22H-01A-11D-A159-09 TCGA-E9-A22H-01 TCGA-E9-A22H-01A-11D-A159-09 c388d3be-37d9-4377-8c85-f6124b2ad436 TCGA-E9-A22H-01A-11D-A160-01 TCGA-E9-A22H-01 c388d3be-37d9-4377-8c85-f6124b2ad436 TCGA-E9-A22H-01A-11D-A160-01 TCGA-E9-A243-01 Stage IIA 52 3 Stage IIA 43 FEMALE Negative Negative M0 Negative N0 43 0 Basal enrollment T_Other T2 LIVING TCGA-E9-A243-01 High C4-BRCA/Basal cluster 5 OV-like c1 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation cluster 5 TCGA-E9-A243 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES 52 Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A243-F56656 TCGA-E9-A243 TCGA-E9-A243-01A Lumpectomy NO 305 -19035 94 0 612 305 NO Scheduled Follow-up Submission 2014-2-18 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 270 NO YES 10 Negative Peri (6-12 months since last menstrual period) Negative Negative Negative 5 3 Bone Distant Metastasis YES 0 true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A243.742A4812-9EB1-4348-996E-3F1AD7FA3E5D.pdf A243 WITH TUMOR YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 619ffb2b-a591-4f3b-aa48-b0c44f4ee36a 619ffb2b-a591-4f3b-aa48-b0c44f4ee36a TCGA-E9-A243-01A-11-A17K-20 TCGA-E9-A243-01A-21D-A167-09 TCGA-E9-A243-01 TCGA-E9-A243-01A-21D-A16A-05 a1b3b8fa-af81-479c-a27b-485bc4557e82 TCGA-E9-A243-01 TCGA-E9-A243-01A-21D-A167-09 TCGA-E9-A243-01 TCGA-E9-A243-01A-21D-A167-09 619ffb2b-a591-4f3b-aa48-b0c44f4ee36a TCGA-E9-A243-01A-21D-A166-01 TCGA-E9-A243-01 619ffb2b-a591-4f3b-aa48-b0c44f4ee36a TCGA-E9-A243-01A-21D-A166-01 TCGA-E9-A244-01 Stage IIA 54 1 Stage IIA 20 FEMALE Negative Negative M0 Negative N0 20 0 Basal enrollment T_Other T2 LIVING TCGA-E9-A244-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA c1uster 9 mutation cluster 5 TCGA-E9-A244 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A244-F31164 TCGA-E9-A244 TCGA-E9-A244-01A Lumpectomy NO -19778 58 0 21 NO Scheduled Follow-up Submission 2012-4-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 310 NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A244.4158FEAB-066B-4500-8FD2-3F197438DFB5.pdf A244 TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 147d6ebb-7359-449a-9e6a-6c8443ebaa2e 147d6ebb-7359-449a-9e6a-6c8443ebaa2e TCGA-E9-A244-01A-21-A17K-20 TCGA-E9-A244-01A-11D-A167-09 TCGA-E9-A244-01 TCGA-E9-A244-01A-11D-A16A-05 a6266eec-b341-4642-aed5-9c6cd44f14df TCGA-E9-A244-01 TCGA-E9-A244-01A-11D-A167-09 TCGA-E9-A244-01 TCGA-E9-A244-01A-11D-A167-09 147d6ebb-7359-449a-9e6a-6c8443ebaa2e TCGA-E9-A244-01A-11D-A166-01 TCGA-E9-A244-01 147d6ebb-7359-449a-9e6a-6c8443ebaa2e TCGA-E9-A244-01A-11D-A166-01 TCGA-E9-A245-01 Stage IIB 47 3 Stage IIB 25 FEMALE Negative Negative M0 Positive N1 25 0 LumA enrollment T_Other T2 LIVING TCGA-E9-A245-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 mutation c1uster 9 TCGA-E9-A245 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A245-F31169 TCGA-E9-A245 TCGA-E9-A245-01A Lumpectomy NO -17363 62 0 26 NO Scheduled Follow-up Submission 2012-4-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 490 NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 NO 3 true No M0 N1 T2 Stage IIB TCGA-E9-A245.5F2A52E5-2844-4242-8CE4-A87DF9D9C97B.pdf A245 TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO E9 Breast A DECEASED 2011 538ab6dc-6dff-49e2-ae6a-b91ee6619bce 538ab6dc-6dff-49e2-ae6a-b91ee6619bce TCGA-E9-A245-01A-11-A17K-20 TCGA-E9-A245-01A-22D-A16D-09 TCGA-E9-A245-01 TCGA-E9-A245-01A-22D-A16G-05 7a2a6276-0ac6-40a8-b678-d53877fe07fb TCGA-E9-A245-01 TCGA-E9-A245-01A-22D-A16D-09 TCGA-E9-A245-01 TCGA-E9-A245-01A-22D-A16D-09 538ab6dc-6dff-49e2-ae6a-b91ee6619bce TCGA-E9-A245-01A-22D-A16C-01 TCGA-E9-A245-01 538ab6dc-6dff-49e2-ae6a-b91ee6619bce TCGA-E9-A245-01A-22D-A16C-01 TCGA-E9-A247-01 Stage IB 59 4 Stage I 12 FEMALE Negative Negative M0 Negative N0 12 0 LumA enrollment T1 T1 LIVING TCGA-E9-A247-01 High C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 mutation c1uster 9 TCGA-E9-A247 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A247-F61874 TCGA-E9-A247 TCGA-E9-A247-01A -21562 49 0 1186 NO Scheduled Follow-up Submission 2014-7-23 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Lumpectomy Other method, specify: 370 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 NO 0 true No M0 N0 (i-) T1c Stage IA TCGA-E9-A247.61E73960-32B0-413E-AF1D-2EF4582293B3.pdf A247 TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 3c38c1fe-9f57-4523-9654-c4bc6b02e84f 3c38c1fe-9f57-4523-9654-c4bc6b02e84f TCGA-E9-A247-01A-21-A17K-20 TCGA-E9-A247-01A-11D-A167-09 TCGA-E9-A247-01 TCGA-E9-A247-01A-11D-A16A-05 572eb344-87fb-46f5-9d4b-81756d946892 TCGA-E9-A247-01 TCGA-E9-A247-01A-11D-A167-09 TCGA-E9-A247-01 TCGA-E9-A247-01A-11D-A167-09 3c38c1fe-9f57-4523-9654-c4bc6b02e84f TCGA-E9-A247-01A-11D-A166-01 TCGA-E9-A247-01 3c38c1fe-9f57-4523-9654-c4bc6b02e84f TCGA-E9-A247-01A-11D-A166-01 TCGA-E9-A248-01 Stage IIA 51 4 Stage IIA 21 FEMALE Negative Negative M0 Negative N0 21 0 Her2 enrollment T_Other T2 LIVING TCGA-E9-A248-01 Squamous C3-BRCA/Luminal cluster 1 OV-like c1 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-E9-A248 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A248-F31211 TCGA-E9-A248 TCGA-E9-A248-01A Lumpectomy NO -18684 52 0 59 NO Scheduled Follow-up Submission 2012-4-25 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 540 NO 10 Negative Peri (6-12 months since last menstrual period) 1 3 NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A248.8950E632-451D-4436-9AA2-740CB08237E8.pdf A248 TUMOR FREE YES NO Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 0a9215ea-d5d2-41ad-a00d-bd7722f41229 0a9215ea-d5d2-41ad-a00d-bd7722f41229 TCGA-E9-A248-01A-21-A17K-20 TCGA-E9-A248-01A-11D-A167-09 TCGA-E9-A248-01 TCGA-E9-A248-01A-11D-A16A-05 1b143b9f-74db-42c6-903c-b446834bd9f2 TCGA-E9-A248-01 TCGA-E9-A248-01A-11D-A167-09 TCGA-E9-A248-01 TCGA-E9-A248-01A-11D-A167-09 0a9215ea-d5d2-41ad-a00d-bd7722f41229 TCGA-E9-A248-01A-11D-A166-01 TCGA-E9-A248-01 0a9215ea-d5d2-41ad-a00d-bd7722f41229 TCGA-E9-A248-01A-11D-A166-01 TCGA-E9-A249-01 Stage IIA 45 2 Stage IIA 28 FEMALE Negative Negative M0 Negative N0 28 0 LumB enrollment T_Other T2 LIVING TCGA-E9-A249-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-E9-A249 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A249-F49108 TCGA-E9-A249 TCGA-E9-A249-01A Lumpectomy NO -16689 59 0 217 NO Scheduled Follow-up Submission 2013-9-25 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 470 NO YES 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 3 NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A249.6272ED78-501A-4055-8C87-430F46F518AA.pdf A249 TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 5285c747-0cb2-4f6a-83d8-40e45f8e4f6e 5285c747-0cb2-4f6a-83d8-40e45f8e4f6e TCGA-E9-A249-01A-21-A17K-20 TCGA-E9-A249-01A-11D-A167-09 TCGA-E9-A249-01 TCGA-E9-A249-01A-11D-A16A-05 8917880a-d278-410b-974b-440741ceb6de TCGA-E9-A249-01 TCGA-E9-A249-01A-11D-A167-09 TCGA-E9-A249-01 TCGA-E9-A249-01A-11D-A167-09 5285c747-0cb2-4f6a-83d8-40e45f8e4f6e TCGA-E9-A249-01A-11D-A166-01 TCGA-E9-A249-01 5285c747-0cb2-4f6a-83d8-40e45f8e4f6e TCGA-E9-A249-01A-11D-A166-01 TCGA-E9-A24A-01 Stage IIA 69 2 Stage IIA 10 FEMALE Negative Negative M0 Positive N1 10 0 LumA enrollment T1 T1 LIVING TCGA-E9-A24A-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-E9-A24A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A24A-F39541 TCGA-E9-A24A TCGA-E9-A24A-01A NO -25370 41 0 747 NO Scheduled Follow-up Submission 2013-1-24 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Lumpectomy Other method, specify: 390 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 1 true No M0 N1 T1c Stage IIA TCGA-E9-A24A.392524F7-B570-4047-A439-71FC15642DC8.pdf A24A TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 a2bec98a-d946-40d2-b4d9-6495d815de9a a2bec98a-d946-40d2-b4d9-6495d815de9a TCGA-E9-A24A-01A-21-A17K-20 TCGA-E9-A24A-01A-11D-A167-09 TCGA-E9-A24A-01 TCGA-E9-A24A-01A-11D-A16A-05 8d96bc5d-6af2-4f5b-82d2-2b8f20848870 TCGA-E9-A24A-01 TCGA-E9-A24A-01A-11D-A167-09 TCGA-E9-A24A-01 TCGA-E9-A24A-01A-11D-A167-09 a2bec98a-d946-40d2-b4d9-6495d815de9a TCGA-E9-A24A-01A-11D-A166-01 TCGA-E9-A24A-01 a2bec98a-d946-40d2-b4d9-6495d815de9a TCGA-E9-A24A-01A-11D-A166-01 TCGA-E9-A295-01 3 LumA TCGA-E9-A295-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 mutation cluster 4 TCGA-E9-A295 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Lower Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A295-F35355 TCGA-E9-A295 TCGA-E9-A295-01A Positive Positive Modified Radical Mastectomy YES -25957 63 0 375 80-89% 2012-9-25 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 670 NO Positive YES 7 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-E9-A295.A23D86FF-CCA9-42B2-B6AE-9E365AAC03C8.pdf A295 TUMOR FREE 7 7 YES YES 80-89% YES Primary Tumor 01 7th YES NO E9 Breast A LIVING 2011 28ad8481-78a8-4103-b501-5cfd23ae3e81 28ad8481-78a8-4103-b501-5cfd23ae3e81 TCGA-E9-A295-01A-21-A17K-20 TCGA-E9-A295-01A-11D-A16D-09 TCGA-E9-A295-01 TCGA-E9-A295-01A-11D-A16G-05 21dc7633-3a7e-407d-ae43-88edfef05091 TCGA-E9-A295-01 TCGA-E9-A295-01A-11D-A16D-09 TCGA-E9-A295-01 TCGA-E9-A295-01A-11D-A16D-09 28ad8481-78a8-4103-b501-5cfd23ae3e81 TCGA-E9-A295-01A-11D-A16C-01 TCGA-E9-A295-01 28ad8481-78a8-4103-b501-5cfd23ae3e81 TCGA-E9-A295-01A-11D-A16C-01 TCGA-E9-A2JS-01 LumB TCGA-E9-A2JS-01 High C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-E9-A2JS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO NO 72 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A2JS-F40293 TCGA-E9-A2JS TCGA-E9-A2JS-01A Lumpectomy NO -26407 79 904 0 540 524 Scheduled Follow-up Submission 2013-2-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 420 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone Distant Metastasis Liver NO YES 1 true No M0 N1 T2 Stage IIB TCGA-E9-A2JS.1DFFCBD1-962D-4E9B-BEE1-726CABE3AA95.pdf A2JS WITH TUMOR YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A DECEASED 2011 4fe55069-e1b6-4d85-a51a-03a10c6116e2 4fe55069-e1b6-4d85-a51a-03a10c6116e2 TCGA-E9-A2JS-01A-21-A24B-20 TCGA-E9-A2JS-01 TCGA-E9-A2JS-01A-11D-A17Z-05 e26e41fb-223b-484b-8463-a20e34844050 TCGA-E9-A2JS-01 TCGA-E9-A2JS-01A-11D-A17W-09 TCGA-E9-A2JS-01 4fe55069-e1b6-4d85-a51a-03a10c6116e2 TCGA-E9-A2JS-01A-11D-A17U-01 TCGA-E9-A2JS-01 4fe55069-e1b6-4d85-a51a-03a10c6116e2 TCGA-E9-A2JS-01A-11D-A17U-01 TCGA-E9-A2JT-01 LumA TCGA-E9-A2JT-01 Kirc+ C3-BRCA/Luminal Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-E9-A2JT TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A2JT-F40292 TCGA-E9-A2JT TCGA-E9-A2JT-01A Lumpectomy NO -23318 94 0 288 Scheduled Follow-up Submission 2013-2-15 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 260 NO YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A2JT.C70325C1-54EB-41BF-B77C-D92FADA8D23E.pdf A2JT TUMOR FREE YES YES YES Primary Tumor 01 7th YES YES NO E9 Breast A LIVING 2011 95b5e301-f942-43bb-8211-d992948e8136 95b5e301-f942-43bb-8211-d992948e8136 TCGA-E9-A2JT-01A-11-A24A-20 TCGA-E9-A2JT-01 TCGA-E9-A2JT-01A-22D-A18O-05 013e6c9f-a4fb-4588-9159-562bd6f2721c TCGA-E9-A2JT-01 TCGA-E9-A2JT-01A-22D-A18P-09 TCGA-E9-A2JT-01 95b5e301-f942-43bb-8211-d992948e8136 TCGA-E9-A2JT-01A-22D-A18N-01 TCGA-E9-A2JT-01 95b5e301-f942-43bb-8211-d992948e8136 TCGA-E9-A2JT-01A-22D-A18N-01 TCGA-E9-A3HO-01 LumB TCGA-E9-A3HO-01 Iq C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 TCGA-E9-A3HO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A3HO-F61875 TCGA-E9-A3HO Modified Radical Mastectomy NO -18046 0 1158 NO Scheduled Follow-up Submission 2014-7-9 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 No M0 N0 (i-) T2 Stage IIA A3HO TUMOR FREE YES YES NO Primary Tumor 01 7th YES YES NO E9 Breast LIVING 2011 d151b46a-1e20-455a-bab3-9c698cee312d d151b46a-1e20-455a-bab3-9c698cee312d TCGA-E9-A3HO-01A-21-A24A-20 TCGA-E9-A3HO-01 TCGA-E9-A3HO-01A-11D-A212-05 c6f8e3fb-8702-4064-b325-1f85c2d9815b TCGA-E9-A3HO-01 TCGA-E9-A3HO-01A-11D-A20S-09 d151b46a-1e20-455a-bab3-9c698cee312d TCGA-E9-A3HO-01A-11D-A20R-01 d151b46a-1e20-455a-bab3-9c698cee312d TCGA-E9-A3HO-01A-11D-A20R-01 TCGA-E9-A3Q9-01 LumA TCGA-E9-A3Q9-01 Iq C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 TCGA-E9-A3Q9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 78 Right Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A3Q9-F59741 TCGA-E9-A3Q9 TCGA-E9-A3Q9-01A Positive Positive YES -28715 198 0 1001 NO 40-49% 2014-5-20 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 580 NO Indeterminate NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 22 0 true No M0 N3 T3 Stage IIIC TCGA-E9-A3Q9.FE3E1376-1527-42C0-8F5F-8849D0F2743B.pdf A3Q9 TUMOR FREE 8 8 YES YES 40-49% NO Primary Tumor 01 7th YES NO E9 Breast A LIVING 2011 941748e8-5690-4e98-a5f4-d79b0e033ba1 941748e8-5690-4e98-a5f4-d79b0e033ba1 TCGA-E9-A3Q9-01A-21-A24A-20 TCGA-E9-A3Q9-01 TCGA-E9-A3Q9-01A-11D-A21R-05 acbb7029-4851-48e2-8517-9c69b0f9aaf4 TCGA-E9-A3Q9-01 TCGA-E9-A3Q9-01A-11D-A21Q-09 TCGA-E9-A3Q9-01 941748e8-5690-4e98-a5f4-d79b0e033ba1 TCGA-E9-A3Q9-01A-11D-A21P-01 TCGA-E9-A3Q9-01 941748e8-5690-4e98-a5f4-d79b0e033ba1 TCGA-E9-A3Q9-01A-11D-A21P-01 TCGA-E9-A3QA-01 TCGA-E9-A3QA-01 High Low purity c2 BRCA basal-like c6 miRNA cluster 4 TCGA-E9-A3QA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 33 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-E9-A3QA-F66100 TCGA-E9-A3QA TCGA-E9-A3QA-01A -12142 282 0 918 NO 2014-10-2 FEMALE Medullary Carcinoma No C50.9 8510/3 C50.9 YES Tumor resection 750 NO NO 14 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 (i-) T2 Stage IIA TCGA-E9-A3QA.1F02AA5F-67B1-4BAF-A3A9-CA20BCD7FBAF.pdf A3QA TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO E9 Breast A LIVING 2011 8a7e272c-39f2-42e6-b1d5-7225cf12fceb 8a7e272c-39f2-42e6-b1d5-7225cf12fceb TCGA-E9-A3QA-01A-71-A24A-20 TCGA-E9-A3QA-01 TCGA-E9-A3QA-01A-61D-A22B-05 ed7f6269-7805-4032-870a-0f105960bfbc TCGA-E9-A3QA-01 TCGA-E9-A3QA-01A-61D-A228-09 TCGA-E9-A3QA-01 8a7e272c-39f2-42e6-b1d5-7225cf12fceb TCGA-E9-A3QA-01A-61D-A227-01 TCGA-E9-A3QA-01 8a7e272c-39f2-42e6-b1d5-7225cf12fceb TCGA-E9-A3QA-01A-61D-A227-01 TCGA-E9-A3X8-01 TCGA-E9-A3X8-01 BRCA nonbasal-like c8 TCGA-E9-A3X8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A3X8-F59742 TCGA-E9-A3X8 TCGA-E9-A3X8-01A Positive Positive Modified Radical Mastectomy YES -17588 233 0 926 NO 20-29% 2014-5-20 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 260 NO Positive NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 4 0 true No M0 N1 T2 Stage IIB TCGA-E9-A3X8.00058FFD-35E6-4891-8B01-DAB3AE9EBF78.pdf A3X8 TUMOR FREE 8 8 YES YES 20-29% YES Primary Tumor 01 7th YES NO E9 Breast A LIVING 2011 b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9 b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9 TCGA-E9-A3X8-01A-21-A24A-20 TCGA-E9-A3X8-01 TCGA-E9-A3X8-01A-31D-A230-05 1ba9391b-4d20-4637-8c2a-6765cd37beb4 TCGA-E9-A3X8-01 TCGA-E9-A3X8-01A-31D-A22X-09 TCGA-E9-A3X8-01 b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9 TCGA-E9-A3X8-01A-31D-A22W-01 TCGA-E9-A3X8-01 b2d76401-5eae-4aa9-9c5c-3d6ad41f50d9 TCGA-E9-A3X8-01A-31D-A22W-01 TCGA-E9-A54X-01 TCGA-E9-A54X-01 TCGA-E9-A54X TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 85 Left|Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A54X-F66449 TCGA-E9-A54X TCGA-E9-A54X-01A Positive 3+ Positive Lumpectomy NO -31173 78 0 727 90-99% 2014-10-15 FEMALE Mucinous Carcinoma No C50.9 8480/3 C50.9 3+ YES Core needle biopsy 220 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 (i-) T1b Stage IA TCGA-E9-A54X.BCDA7E7B-396B-4809-A0B3-2BC2C22DC908.pdf A54X TUMOR FREE NO YES 90-99% NO Primary Tumor 01 7th YES NO E9 Breast A LIVING 2012 fc36b662-fabd-4caa-81f7-00fe0a3164a6 fc36b662-fabd-4caa-81f7-00fe0a3164a6 TCGA-E9-A54X-01 TCGA-E9-A54X-01A-11D-A268-05 4168faaa-8df8-48b5-a9cb-86932b2a0ffe TCGA-E9-A54X-01 TCGA-E9-A54X-01A-11D-A25Q-09 TCGA-E9-A54X-01 fc36b662-fabd-4caa-81f7-00fe0a3164a6 TCGA-E9-A54X-01A-11D-A25N-01 TCGA-E9-A54X-01 fc36b662-fabd-4caa-81f7-00fe0a3164a6 TCGA-E9-A54X-01A-11D-A25N-01 TCGA-E9-A54Y-01 TCGA-E9-A54Y-01 TCGA-E9-A54Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Axillary lymph node dissection alone TCGA-E9-A54Y-F66450 TCGA-E9-A54Y TCGA-E9-A54Y-01A Positive 3+ Positive Modified Radical Mastectomy NO -23057 76 0 725 90-99% 2014-10-15 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Fine needle aspiration biopsy 370 NO Negative NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 8 true No M0 N2 T2 Stage IIIA TCGA-E9-A54Y.3F43AE57-0EB8-4F40-980F-6E2C8C2B3A74.pdf A54Y TUMOR FREE NO YES 50-59% NO Primary Tumor 01 7th YES NO E9 Breast A LIVING 2012 c11ffcd0-8e82-4815-b30b-2d08945ce0bc c11ffcd0-8e82-4815-b30b-2d08945ce0bc TCGA-E9-A54Y-01 TCGA-E9-A54Y-01A-11D-A268-05 190643c9-d8a9-4e20-ac54-de58928ddfaf TCGA-E9-A54Y-01 TCGA-E9-A54Y-01A-11D-A25Q-09 TCGA-E9-A54Y-01 c11ffcd0-8e82-4815-b30b-2d08945ce0bc TCGA-E9-A54Y-01A-11D-A25N-01 TCGA-E9-A54Y-01 c11ffcd0-8e82-4815-b30b-2d08945ce0bc TCGA-E9-A54Y-01A-11D-A25N-01 TCGA-E9-A5FK-01 TCGA-E9-A5FK-01 TCGA-E9-A5FK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A5FK-F70209 TCGA-E9-A5FK TCGA-E9-A5FK-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -22199 77 0 812 80-89% 2015-1-30 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Cytology (e.g. Peritoneal or pleural fluid) 490 NO Negative NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 10 true No M0 N3 T2 Stage IIIC TCGA-E9-A5FK.D346F4E5-4E4A-4161-96FB-7B8ABBB17128.pdf A5FK TUMOR FREE YES YES 70-79% YES Primary Tumor 01 7th YES NO E9 Breast A LIVING 2012 6cdd2900-2b84-44d4-a9b3-bf75b12946b9 6cdd2900-2b84-44d4-a9b3-bf75b12946b9 TCGA-E9-A5FK-01 TCGA-E9-A5FK-01A-11D-A27Y-05 4dc0a26f-8214-4458-a74d-309dcd10c6a1 TCGA-E9-A5FK-01 TCGA-E9-A5FK-01A-11D-A27P-09 TCGA-E9-A5FK-01 6cdd2900-2b84-44d4-a9b3-bf75b12946b9 TCGA-E9-A5FK-01A-11D-A27O-01 TCGA-E9-A5FK-01 6cdd2900-2b84-44d4-a9b3-bf75b12946b9 TCGA-E9-A5FK-01A-11D-A27O-01 TCGA-E9-A5FL-01 TCGA-E9-A5FL-01 TCGA-E9-A5FL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A5FL-F56061 TCGA-E9-A5FL TCGA-E9-A5FL-01A Negative Negative Modified Radical Mastectomy NO -24053 73 0 24 2014-1-24 FEMALE Metaplastic Carcinoma No C50.9 8575/3 C50.9 YES Cytology (e.g. Peritoneal or pleural fluid) 590 NO Negative YES 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T3 Stage IIB TCGA-E9-A5FL.72186F5B-9F97-428C-8E06-9240E17E88DD.pdf A5FL TUMOR FREE NO YES NO Primary Tumor 01 7th YES NO E9 Breast A LIVING 2012 7810122d-fa8b-483d-9398-aa26fc7fedc5 7810122d-fa8b-483d-9398-aa26fc7fedc5 TCGA-E9-A5FL-01 TCGA-E9-A5FL-01A-11D-A27Y-05 dca0a85a-e2c5-4dcf-bc19-4b0374669de4 TCGA-E9-A5FL-01 TCGA-E9-A5FL-01A-11D-A27P-09 TCGA-E9-A5FL-01 7810122d-fa8b-483d-9398-aa26fc7fedc5 TCGA-E9-A5FL-01A-11D-A27O-01 TCGA-E9-A5FL-01 7810122d-fa8b-483d-9398-aa26fc7fedc5 TCGA-E9-A5FL-01A-11D-A27O-01 TCGA-E9-A5UO-01 TCGA-E9-A5UO-01 TCGA-E9-A5UO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A5UO-F70210 TCGA-E9-A5UO TCGA-E9-A5UO-01A Other NO -15050 98 0 785 2015-1-30 FEMALE Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Fine needle aspiration biopsy 400 NO NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 T2 Stage IIA TCGA-E9-A5UO.6C698240-6557-4F96-BF56-60792693920F.pdf A5UO TUMOR FREE NO YES NO Primary Tumor 01 Partial mastectomy 7th YES NO E9 Breast A LIVING 2012 4d601c2f-824f-461e-9270-42db0ab9138e 4d601c2f-824f-461e-9270-42db0ab9138e TCGA-E9-A5UO-01 TCGA-E9-A5UO-01A-11D-A28C-05 9efb2dc7-5c0d-459f-9819-f1ca46df5bb0 TCGA-E9-A5UO-01 TCGA-E9-A5UO-01A-11D-A28B-09 TCGA-E9-A5UO-01 4d601c2f-824f-461e-9270-42db0ab9138e TCGA-E9-A5UO-01A-11D-A28A-01 TCGA-E9-A5UO-01 4d601c2f-824f-461e-9270-42db0ab9138e TCGA-E9-A5UO-01A-11D-A28A-01 TCGA-E9-A5UP-01 TCGA-E9-A5UP-01 TCGA-E9-A5UP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-E9-A5UP-F71525 TCGA-E9-A5UP TCGA-E9-A5UP-01A NO -23371 85 0 803 2015-3-26 FEMALE Other, specify No C50.9 8503/3 C50.9 YES Tumor resection 140 NO NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T2 Stage IIA TCGA-E9-A5UP.B50AB6D5-3010-450E-9CCE-E9BFA0202736.pdf A5UP TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO E9 Breast A LIVING 2012 0a9af348-b2a7-4fad-b939-7eda53e4f5a0 0a9af348-b2a7-4fad-b939-7eda53e4f5a0 TCGA-E9-A5UP-01 TCGA-E9-A5UP-01A-11D-A28C-05 7ba6fce9-3ad3-4659-9756-a6642af820e1 TCGA-E9-A5UP-01 TCGA-E9-A5UP-01A-11D-A28B-09 TCGA-E9-A5UP-01 0a9af348-b2a7-4fad-b939-7eda53e4f5a0 TCGA-E9-A5UP-01A-11D-A28A-01 TCGA-E9-A5UP-01 0a9af348-b2a7-4fad-b939-7eda53e4f5a0 TCGA-E9-A5UP-01A-11D-A28A-01 TCGA-E9-A6HE-01 TCGA-E9-A6HE-01 TCGA-E9-A6HE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 45 Right Sentinel lymph node biopsy plus axillary dissection TCGA-E9-A6HE-F70947 TCGA-E9-A6HE Positive Positive Simple Mastectomy NO -16697 0 847 90-99% 1.7 2015-3-10 FEMALE <10% 1+ 30 1.8 1.08 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative Negative NO 12 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 12 No MX N3 T3 Stage IIIC A6HE TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO E9 Breast LIVING 2012 ce48b228-7e2a-46e9-beca-ab990b5c2b3e ce48b228-7e2a-46e9-beca-ab990b5c2b3e TCGA-E9-A6HE-01 TCGA-E9-A6HE-01A-11D-A31V-05 a828df39-aa87-48a0-936a-7fd28c031dcf TCGA-E9-A6HE-01 TCGA-E9-A6HE-01 ce48b228-7e2a-46e9-beca-ab990b5c2b3e TCGA-E9-A6HE-01A-11D-A31T-01 TCGA-E9-A6HE-01 ce48b228-7e2a-46e9-beca-ab990b5c2b3e TCGA-E9-A6HE-01A-11D-A31T-01 TCGA-EW-A1IW-01 Stage IIB 80 2 Stage IIB 252 Positive FEMALE Positive Negative M0 Positive N1 252 0 LumA Positive enrollment T_Other T2 LIVING TCGA-EW-A1IW-01 Iq C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-EW-A1IW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Right Lower Inner Quadrant|Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1IW-F21380 TCGA-EW-A1IW TCGA-EW-A1IW-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Other YES -29529 213 0 371 NO 90-99% Scheduled Follow-up Submission 2012-2-6 FEMALE + or - 90-99% 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 90 NO Positive 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 3 4 NO 2 0 true No MX N1a T2 Stage IIB TCGA-EW-A1IW.D4194F52-3E15-4105-9A1A-1326CF128BF8.pdf A1IW TUMOR FREE CISH YES 90-99% NO Primary Tumor 01 total mastectomy 7th YES NO YES EW Breast A LIVING 2010 7ddad1e7-783e-4095-87e0-48dbf5c5aa39 7ddad1e7-783e-4095-87e0-48dbf5c5aa39 TCGA-EW-A1IW-01A-11D-A13L-09 TCGA-EW-A1IW-01 TCGA-EW-A1IW-01A-11D-A13K-05 TCGA-EW-A1IW-01 TCGA-EW-A1IW-01A-11D-A13L-09 TCGA-EW-A1IW-01 TCGA-EW-A1IW-01A-11D-A13L-09 7ddad1e7-783e-4095-87e0-48dbf5c5aa39 TCGA-EW-A1IW-01A-11D-A13J-01 TCGA-EW-A1IW-01 7ddad1e7-783e-4095-87e0-48dbf5c5aa39 TCGA-EW-A1IW-01A-11D-A13J-01 TCGA-EW-A1IX-01 Stage IIA 48 4 Stage IIA 1082 Positive FEMALE Negative Negative M0 Positive N1 1082 0 LumA Positive enrollment T1 T1 LIVING TCGA-EW-A1IX-01 Kirc+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 4 TCGA-EW-A1IX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1IX-F21542 TCGA-EW-A1IX TCGA-EW-A1IX-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Other YES -17597 1030 0 1208 NO 90-99% Scheduled Follow-up Submission 2012-2-6 FEMALE <10% Other, specify No C50.9 8524/3 C50.9 3+ YES Core needle biopsy 130 NO Negative 27 Negative Peri (6-12 months since last menstrual period) 1 4 NO 1 1 true No MX N1a T1b Stage IIA TCGA-EW-A1IX.3CF4FC36-70EF-4EA3-874C-4A514FCDB717.pdf A1IX TUMOR FREE YES 90-99% NO Primary Tumor 01 total mastectomy 6th YES NO YES EW Breast A LIVING 2008 b908cd1b-b274-4b23-9cd5-b59d93a7a6c2 b908cd1b-b274-4b23-9cd5-b59d93a7a6c2 TCGA-EW-A1IX-01A-21-A17J-20 TCGA-EW-A1IX-01A-12D-A142-09 TCGA-EW-A1IX-01 TCGA-EW-A1IX-01A-12D-A145-05 9b8d5601-180a-45df-a639-787f257c2e95 TCGA-EW-A1IX-01 TCGA-EW-A1IX-01A-12D-A142-09 TCGA-EW-A1IX-01 TCGA-EW-A1IX-01A-12D-A142-09 b908cd1b-b274-4b23-9cd5-b59d93a7a6c2 TCGA-EW-A1IX-01A-12D-A141-01 TCGA-EW-A1IX-01 b908cd1b-b274-4b23-9cd5-b59d93a7a6c2 TCGA-EW-A1IX-01A-12D-A141-01 TCGA-EW-A1IY-01 Stage I 38 2 Stage I 258 Positive FEMALE Negative Negative M0 Negative N0 258 0 LumB Positive enrollment T1 T1 LIVING TCGA-EW-A1IY-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 12 cluster 7 mutation cluster 4 TCGA-EW-A1IY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Right Upper Inner Quadrant Other (specify) sentinel LN and one non sentinel LN TCGA-EW-A1IY-F29084 TCGA-EW-A1IY TCGA-EW-A1IY-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy YES -14122 590 0 258 NO 90-99% Scheduled Follow-up Submission 2012-3-5 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 50 NO Negative 6 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 7 NO 0 0 true No MX N0 T1c Stage I TCGA-EW-A1IY.7C003A4F-DC30-43D0-AC61-ACE6BA118BEE.pdf A1IY TUMOR FREE YES 90-99% NO Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2009 9b605e4f-fb75-4b02-a827-a6acfeb3c1b2 9b605e4f-fb75-4b02-a827-a6acfeb3c1b2 TCGA-EW-A1IY-01A-11D-A188-09 TCGA-EW-A1IY-01 TCGA-EW-A1IY-01A-11D-A13K-05 TCGA-EW-A1IY-01 TCGA-EW-A1IY-01A-11D-A188-09 TCGA-EW-A1IY-01 TCGA-EW-A1IY-01A-11D-A188-09 9b605e4f-fb75-4b02-a827-a6acfeb3c1b2 TCGA-EW-A1IY-01A-11D-A13J-01 TCGA-EW-A1IY-01 9b605e4f-fb75-4b02-a827-a6acfeb3c1b2 TCGA-EW-A1IY-01A-11D-A13J-01 TCGA-EW-A1IZ-01 Stage IIIA 53 1 Stage IIIA 260 Positive FEMALE Negative Negative M0 Positive N2 260 0 Positive enrollment T_Other T2 LIVING TCGA-EW-A1IZ-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-EW-A1IZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-EW-A1IZ-F21543 TCGA-EW-A1IZ TCGA-EW-A1IZ-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -19706 194 0 554 NO 90-99% Scheduled Follow-up Submission 2012-2-6 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES stereotactic biopsy Other method, specify: 130 NO Negative 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 3 NO 5 true No MX N2a T2 Stage IIIA TCGA-EW-A1IZ.F5EF4698-364C-4A5B-A8EC-1CF231BEEF31.pdf A1IZ TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2010 f5c72291-4c3f-456f-97a3-d93878744b54 f5c72291-4c3f-456f-97a3-d93878744b54 TCGA-EW-A1IZ-01A-21-A17J-20 TCGA-EW-A1IZ-01A-11D-A188-09 TCGA-EW-A1IZ-01 TCGA-EW-A1IZ-01A-11D-A13K-05 401f0a1d-c38e-463b-8195-8eba9ea21869 TCGA-EW-A1IZ-01 TCGA-EW-A1IZ-01A-11D-A188-09 TCGA-EW-A1IZ-01 TCGA-EW-A1IZ-01A-11D-A188-09 f5c72291-4c3f-456f-97a3-d93878744b54 TCGA-EW-A1IZ-01A-11D-A13J-01 TCGA-EW-A1IZ-01 f5c72291-4c3f-456f-97a3-d93878744b54 TCGA-EW-A1IZ-01A-11D-A13J-01 TCGA-EW-A1J1-01 Stage IIB 38 2 Stage IIB 282 Positive FEMALE Negative Negative M0 Positive N1 282 0 LumA Positive enrollment T_Other T2 LIVING TCGA-EW-A1J1-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-EW-A1J1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 38 Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1J1-F21181 TCGA-EW-A1J1 TCGA-EW-A1J1-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy YES -14122 214 0 575 NO 90-99% Scheduled Follow-up Submission 2012-2-3 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 170 NO Negative 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 5 NO 1 0 true No M0 N1a T2 Stage IIB TCGA-EW-A1J1.E8B860F6-F3FD-4FDF-B467-8988646C2F00.pdf A1J1 TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2010 9d64aa0c-84a6-4e48-b28b-12aaf04813b6 9d64aa0c-84a6-4e48-b28b-12aaf04813b6 TCGA-EW-A1J1-01A-21-A17J-20 TCGA-EW-A1J1-01A-11D-A188-09 TCGA-EW-A1J1-01 TCGA-EW-A1J1-01A-11D-A13K-05 e87551f0-94b3-418c-b313-7cea4e66f70d TCGA-EW-A1J1-01 TCGA-EW-A1J1-01A-11D-A188-09 TCGA-EW-A1J1-01 TCGA-EW-A1J1-01A-11D-A188-09 9d64aa0c-84a6-4e48-b28b-12aaf04813b6 TCGA-EW-A1J1-01A-11D-A13J-01 TCGA-EW-A1J1-01 9d64aa0c-84a6-4e48-b28b-12aaf04813b6 TCGA-EW-A1J1-01A-11D-A13J-01 TCGA-EW-A1J2-01 Stage IIB 50 2 Stage IIA 139 Positive FEMALE Negative Negative M0 Positive N1 139 0 LumA Positive enrollment T1 T1 LIVING TCGA-EW-A1J2-01 Iq C3-BRCA/Luminal cluster 2 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 13 cluster 6 mutation cluster 4 TCGA-EW-A1J2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1J2-F21544 TCGA-EW-A1J2 TCGA-EW-A1J2-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Other YES -18558 51 0 403 NO 90-99% Scheduled Follow-up Submission 2012-2-6 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 110 NO Negative 21 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 2 6 NO 1 1 true No MX N1mi T1c [Discrepancy] TCGA-EW-A1J2.0046FACA-9E90-4BA9-B216-258A2A7A2EC6.pdf A1J2 TUMOR FREE YES 90-99% NO Primary Tumor 01 total mastectomy 7th YES NO YES EW Breast A LIVING 2010 5a6b6013-11d0-498d-a014-3ea8e14c61d5 5a6b6013-11d0-498d-a014-3ea8e14c61d5 TCGA-EW-A1J2-01A-11-A17J-20 TCGA-EW-A1J2-01A-21D-A13L-09 TCGA-EW-A1J2-01 TCGA-EW-A1J2-01A-21D-A13K-05 ff844a9f-6c79-4252-bbb3-b5bbf5c3cf6f TCGA-EW-A1J2-01 TCGA-EW-A1J2-01A-21D-A13L-09 TCGA-EW-A1J2-01 TCGA-EW-A1J2-01A-21D-A13L-09 5a6b6013-11d0-498d-a014-3ea8e14c61d5 TCGA-EW-A1J2-01A-21D-A13J-01 TCGA-EW-A1J2-01 5a6b6013-11d0-498d-a014-3ea8e14c61d5 TCGA-EW-A1J2-01A-21D-A13J-01 TCGA-EW-A1J3-01 Stage IA 61 2 Stage I 252 Positive FEMALE Positive Negative M0 Negative N0 252 0 LumA Positive enrollment T1 T1 LIVING TCGA-EW-A1J3-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-EW-A1J3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-EW-A1J3-F21351 TCGA-EW-A1J3 TCGA-EW-A1J3-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Other YES -22332 155 0 504 NO 90-99% Scheduled Follow-up Submission 2012-2-6 FEMALE 90-99% 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 80 NO Positive 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 2 NO 0 0 true No M0 N0 T1c Stage IA TCGA-EW-A1J3.79C0D757-50BE-4375-AF69-E577629EE0CA.pdf A1J3 TUMOR FREE YES 90-99% NO Primary Tumor 01 TOTAL MASTECTOMY 7th YES NO YES EW Breast A LIVING 2010 6e757a91-de03-4c2d-9088-22235e4b745a 6e757a91-de03-4c2d-9088-22235e4b745a TCGA-EW-A1J3-01A-21-A17J-20 TCGA-EW-A1J3-01A-11D-A13L-09 TCGA-EW-A1J3-01 TCGA-EW-A1J3-01A-11D-A13K-05 01473e37-dbc5-42f9-b5e1-332a9b47c175 TCGA-EW-A1J3-01 TCGA-EW-A1J3-01A-11D-A13L-09 TCGA-EW-A1J3-01 TCGA-EW-A1J3-01A-11D-A13L-09 6e757a91-de03-4c2d-9088-22235e4b745a TCGA-EW-A1J3-01A-11D-A13J-01 TCGA-EW-A1J3-01 6e757a91-de03-4c2d-9088-22235e4b745a TCGA-EW-A1J3-01A-11D-A13J-01 TCGA-EW-A1J5-01 Stage IIB 59 5 Stage IIB 227 Positive FEMALE Negative Negative M0 Negative N0 227 0 LumA Positive enrollment T_Other T3 LIVING TCGA-EW-A1J5-01 Iq C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-EW-A1J5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Sentinel node biopsy alone TCGA-EW-A1J5-F21353 TCGA-EW-A1J5 TCGA-EW-A1J5-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Other YES -21559 123 0 477 NO 90-99% Scheduled Follow-up Submission 2012-2-6 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 180 NO Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 7 NO 0 0 true No M0 N0 (i-) T3 Stage IIB TCGA-EW-A1J5.D92CABBE-8D7E-41E5-B702-9ED07E94E5C4.pdf A1J5 TUMOR FREE YES 90-99% NO Primary Tumor 01 total mastectomy 7th YES NO YES EW Breast A LIVING 2010 b1c4af00-f395-47ac-93c7-b32a293ca060 b1c4af00-f395-47ac-93c7-b32a293ca060 TCGA-EW-A1J5-01A-21-A17J-20 TCGA-EW-A1J5-01A-11D-A13L-09 TCGA-EW-A1J5-01 TCGA-EW-A1J5-01A-11D-A13K-05 7470a7db-5af2-4e9e-92f6-d9f8ca74e15d TCGA-EW-A1J5-01 TCGA-EW-A1J5-01A-11D-A13L-09 TCGA-EW-A1J5-01 TCGA-EW-A1J5-01A-11D-A13L-09 b1c4af00-f395-47ac-93c7-b32a293ca060 TCGA-EW-A1J5-01A-11D-A13J-01 TCGA-EW-A1J5-01 b1c4af00-f395-47ac-93c7-b32a293ca060 TCGA-EW-A1J5-01A-11D-A13J-01 TCGA-EW-A1J6-01 Stage I 70 4 Stage I 595 Positive FEMALE Negative Negative M0 Negative N0 595 0 LumB Positive enrollment T1 T1 LIVING TCGA-EW-A1J6-01 High C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-EW-A1J6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-EW-A1J6-F21347 TCGA-EW-A1J6 TCGA-EW-A1J6-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy YES -25830 528 0 875 NO 90-99% Scheduled Follow-up Submission 2012-2-6 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 80 NO Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 2 NO 0 0 true No M0 N0 (i-) T1c Stage I TCGA-EW-A1J6.F282122D-C129-4A8B-9A49-78D5267C37CA.pdf A1J6 TUMOR FREE YES 90-99% NO Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2009 7051836f-e1d4-49dd-8118-4541c0bdde57 7051836f-e1d4-49dd-8118-4541c0bdde57 TCGA-EW-A1J6-01A-11D-A188-09 TCGA-EW-A1J6-01 TCGA-EW-A1J6-01A-11D-A13K-05 TCGA-EW-A1J6-01 TCGA-EW-A1J6-01A-11D-A188-09 TCGA-EW-A1J6-01 TCGA-EW-A1J6-01A-11D-A188-09 7051836f-e1d4-49dd-8118-4541c0bdde57 TCGA-EW-A1J6-01A-11D-A13J-01 TCGA-EW-A1J6-01 7051836f-e1d4-49dd-8118-4541c0bdde57 TCGA-EW-A1J6-01A-11D-A13J-01 TCGA-EW-A1OV-01 Stage IIB 56 1 Stage IIB 522 Negative FEMALE Negative Negative M0 Positive N1 522 0 Her2 Negative enrollment T_Other T2 LIVING TCGA-EW-A1OV-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 12 cluster 5 mutation cluster 4 TCGA-EW-A1OV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-EW-A1OV-F29119 TCGA-EW-A1OV Negative Negative 3 Point Scale 3 Point Scale Modified radical mastectomy Negative Lumpectomy YES -20764 0 789 NO <10% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% 1.8 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative Negative 6 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 5 NO 0 1 No MX N1mi T2 Stage IIB A1OV TUMOR FREE YES <10% NO Primary Tumor 01 6th YES NO YES EW Breast LIVING 2009 b21367b5-91a3-4546-ba89-e33c462cb75b b21367b5-91a3-4546-ba89-e33c462cb75b TCGA-EW-A1OV-01A-21-A17J-20 TCGA-EW-A1OV-01A-11D-A142-09 TCGA-EW-A1OV-01 TCGA-EW-A1OV-01A-11D-A145-05 c9e8a21c-2cd8-404b-a8dc-7958940df71a TCGA-EW-A1OV-01 TCGA-EW-A1OV-01A-11D-A142-09 TCGA-EW-A1OV-01 TCGA-EW-A1OV-01A-11D-A142-09 b21367b5-91a3-4546-ba89-e33c462cb75b TCGA-EW-A1OV-01A-11D-A141-01 TCGA-EW-A1OV-01 b21367b5-91a3-4546-ba89-e33c462cb75b TCGA-EW-A1OV-01A-11D-A141-01 TCGA-EW-A1OW-01 Stage IIA 58 1 Stage IIA 463 Negative FEMALE Negative Negative M0 Negative N0 463 0 Basal Negative enrollment T_Other T2 LIVING TCGA-EW-A1OW-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 TCGA-EW-A1OW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-EW-A1OW-F29117 TCGA-EW-A1OW TCGA-EW-A1OW-01A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy YES -21465 444 0 694 NO <10% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8090/3 C50.9 YES Core needle biopsy 100 NO Negative 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 NO 0 0 true No MX N0 T2 Stage IIA TCGA-EW-A1OW.2153CBCE-6DA9-4E0F-9F41-B9F08FD50647.pdf A1OW TUMOR FREE YES <10% YES Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2009 21cc5775-0987-4088-b19c-86bf43f09bb2 21cc5775-0987-4088-b19c-86bf43f09bb2 TCGA-EW-A1OW-01A-11-A17J-20 TCGA-EW-A1OW-01 TCGA-EW-A1OW-01A-21D-A145-05 a4d72446-5d9b-4b8d-af59-9add055da84e TCGA-EW-A1OW-01 TCGA-EW-A1OW-01 21cc5775-0987-4088-b19c-86bf43f09bb2 TCGA-EW-A1OW-01A-21D-A141-01 TCGA-EW-A1OW-01 21cc5775-0987-4088-b19c-86bf43f09bb2 TCGA-EW-A1OW-01A-21D-A141-01 TCGA-EW-A1OX-01 Stage IIA 43 3 Stage IIA 562 Positive FEMALE Negative Negative M0 Negative N0 562 0 LumB Positive enrollment T_Other T2 LIVING TCGA-EW-A1OX-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 1 mutation c1uster 9 TCGA-EW-A1OX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Right Upper Inner Quadrant Other (specify) sentinel + non sentinel TCGA-EW-A1OX-F29099 TCGA-EW-A1OX TCGA-EW-A1OX-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy YES -15837 550 0 911 NO 90-99% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% Mucinous Carcinoma No C50.9 8523/3 C50.9 3+ YES Core needle biopsy 140 NO Negative 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 3 1 NO 0 0 true No MX N0 T2 Stage IIA TCGA-EW-A1OX.4C40B309-3178-4E7E-A987-47698E5E364B.pdf A1OX TUMOR FREE YES 90-99% YES Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2009 9b5d680e-5662-442c-a8ab-5fd16551b23e 9b5d680e-5662-442c-a8ab-5fd16551b23e TCGA-EW-A1OX-01A-21-A17J-20 TCGA-EW-A1OX-01A-11D-A142-09 TCGA-EW-A1OX-01 TCGA-EW-A1OX-01A-11D-A145-05 7cf0f94c-e8fc-4237-8cbf-164c073c26b0 TCGA-EW-A1OX-01 TCGA-EW-A1OX-01A-11D-A142-09 TCGA-EW-A1OX-01 TCGA-EW-A1OX-01A-11D-A142-09 9b5d680e-5662-442c-a8ab-5fd16551b23e TCGA-EW-A1OX-01A-11D-A141-01 TCGA-EW-A1OX-01 9b5d680e-5662-442c-a8ab-5fd16551b23e TCGA-EW-A1OX-01A-11D-A141-01 TCGA-EW-A1OY-01 Stage IIA 63 5 Stage IIA 593 Positive FEMALE Negative Negative M0 Negative N0 593 0 LumB Positive enrollment T_Other T2 LIVING TCGA-EW-A1OY-01 Squamous C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 5 TCGA-EW-A1OY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Sentinel node biopsy alone TCGA-EW-A1OY-F30950 TCGA-EW-A1OY TCGA-EW-A1OY-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy YES -23266 526 0 908 NO 90-99% Scheduled Follow-up Submission 2012-3-23 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 100 NO Negative Negative 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 4 NO 0 0 true No MX N0 T2 Stage IIA TCGA-EW-A1OY.76358109-41A0-4D5C-8894-F6A63A925961.pdf A1OY TUMOR FREE YES 90-99% YES Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2009 0c3f0857-32d7-4ef6-b303-6e452ee04516 0c3f0857-32d7-4ef6-b303-6e452ee04516 TCGA-EW-A1OY-01A-21-A17J-20 TCGA-EW-A1OY-01A-11D-A142-09 TCGA-EW-A1OY-01 TCGA-EW-A1OY-01A-11D-A145-05 5355fa5f-6aba-4f01-9799-7f1a83eadc2a TCGA-EW-A1OY-01 TCGA-EW-A1OY-01A-11D-A142-09 TCGA-EW-A1OY-01 TCGA-EW-A1OY-01A-11D-A142-09 0c3f0857-32d7-4ef6-b303-6e452ee04516 TCGA-EW-A1OY-01A-11D-A141-01 TCGA-EW-A1OY-01 0c3f0857-32d7-4ef6-b303-6e452ee04516 TCGA-EW-A1OY-01A-11D-A141-01 TCGA-EW-A1OZ-01 Stage IIA 56 5 Stage IIA 941 Positive FEMALE Positive Negative M0 Negative N0 941 0 LumB Negative enrollment T_Other T2 LIVING TCGA-EW-A1OZ-01 High C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation cluster 8 TCGA-EW-A1OZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-EW-A1OZ-F29098 TCGA-EW-A1OZ TCGA-EW-A1OZ-01A Positive 3 Point Scale 3 Point Scale Negative Other YES -20664 928 0 1229 NO 90-99% 2 Scheduled Follow-up Submission 2012-3-8 FEMALE 20-29% 2+ 40 2.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 210 NO Equivocal Positive 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 4 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-EW-A1OZ.42DE8E2C-395D-4E9B-B7BC-6A0B2F9BD7CE.pdf A1OZ TUMOR FREE YES <10% NO Primary Tumor 01 total mastectomy 6th YES NO YES EW Breast A LIVING 2008 73f6a579-eab4-4fbf-bb17-41f1a6614ace 73f6a579-eab4-4fbf-bb17-41f1a6614ace TCGA-EW-A1OZ-01A-21-A17J-20 TCGA-EW-A1OZ-01A-11D-A142-09 TCGA-EW-A1OZ-01 TCGA-EW-A1OZ-01A-11D-A145-05 ec87ecc1-dbdd-478f-aea6-a982f92222e8 TCGA-EW-A1OZ-01 TCGA-EW-A1OZ-01A-11D-A142-09 TCGA-EW-A1OZ-01 TCGA-EW-A1OZ-01A-11D-A142-09 73f6a579-eab4-4fbf-bb17-41f1a6614ace TCGA-EW-A1OZ-01A-11D-A141-01 TCGA-EW-A1OZ-01 73f6a579-eab4-4fbf-bb17-41f1a6614ace TCGA-EW-A1OZ-01A-11D-A141-01 TCGA-EW-A1P0-01 Stage IIB 55 4 Stage IIB 1121 Positive FEMALE Negative Negative M0 Positive N1 1121 0 LumB Negative enrollment T_Other T2 LIVING TCGA-EW-A1P0-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 5 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA c1uster 10 cluster 7 mutation cluster 4 TCGA-EW-A1P0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES 55 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-EW-A1P0-F29105 TCGA-EW-A1P0 TCGA-EW-A1P0-01A Positive 3 Point Scale 3 Point Scale Negative Modified Radical Mastectomy NO 1105 -20107 1142 0 1251 1094 YES 90-99% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% Other, specify No C50.9 8523/3 C50.9 3+ YES Core needle biopsy 190 NO Negative 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative 1+ Positive 90-99% <10% 3+ 1+ <10% Negative 5 7 Other, specify Distant Metastasis mediastinal lymph node YES 1 true No MX N1b T2 Stage IIB TCGA-EW-A1P0.F9FB00C3-9F86-40AC-A5E8-08712CD5002B.pdf A1P0 TUMOR FREE YES <10% YES Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2008 16fcbaec-f629-4d04-ab61-3f9b782e710d 16fcbaec-f629-4d04-ab61-3f9b782e710d TCGA-EW-A1P0-01A-21-A17J-20 TCGA-EW-A1P0-01A-11D-A142-09 TCGA-EW-A1P0-01 TCGA-EW-A1P0-01A-11D-A145-05 d39ecd5c-5a18-46dc-b6e6-356c239d7ec3 TCGA-EW-A1P0-01 TCGA-EW-A1P0-01A-11D-A142-09 TCGA-EW-A1P0-01 TCGA-EW-A1P0-01A-11D-A142-09 16fcbaec-f629-4d04-ab61-3f9b782e710d TCGA-EW-A1P0-01A-11D-A141-01 TCGA-EW-A1P0-01 16fcbaec-f629-4d04-ab61-3f9b782e710d TCGA-EW-A1P0-01A-11D-A141-01 TCGA-EW-A1P1-01 Stage IIIC 68 1 Stage IIIC 919 Negative FEMALE Negative Negative M0 Positive N3 919 0 Negative enrollment T_Other T2 LIVING TCGA-EW-A1P1-01 Kirc+ C5-KIRC cluster 1 Low purity c2 KIRC-like c1 miRNA cluster 13 cluster 6 mutation c1uster 9 TCGA-EW-A1P1 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO YES 68 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1P1-F29115 TCGA-EW-A1P1 TCGA-EW-A1P1-01A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy NO 1200 -24923 850 0 1210 1014 YES <10% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% 2+ 1.8 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Equivocal Negative 32 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Equivocal 1+ Negative <10% <10% <10% Negative Lung 1 6 Lung Distant Metastasis YES 11 true No MX N3b T2 Stage IIIC TCGA-EW-A1P1.AE0C51EF-017E-4F53-968C-804110F9A7E6.pdf A1P1 TUMOR FREE YES <10% YES Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2008 8a430d45-6511-4900-954e-fd01106d0f22 8a430d45-6511-4900-954e-fd01106d0f22 TCGA-EW-A1P1-01A-21-A17J-20 TCGA-EW-A1P1-01A-31D-A14G-09 TCGA-EW-A1P1-01 TCGA-EW-A1P1-01A-31D-A14H-05 3d649ce7-95df-442d-a4bb-88e71c4f5b10 TCGA-EW-A1P1-01 TCGA-EW-A1P1-01A-31D-A14G-09 TCGA-EW-A1P1-01 TCGA-EW-A1P1-01A-31D-A14G-09 8a430d45-6511-4900-954e-fd01106d0f22 TCGA-EW-A1P1-01A-31D-A14F-01 TCGA-EW-A1P1-01 8a430d45-6511-4900-954e-fd01106d0f22 TCGA-EW-A1P1-01A-31D-A14F-01 TCGA-EW-A1P3-01 Stage IIA 48 2 Stage IIA 987 Positive FEMALE Negative Negative M0 Negative N0 987 0 LumA Positive enrollment T_Other T2 LIVING TCGA-EW-A1P3-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 mutation c1uster 9 TCGA-EW-A1P3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Lower Outer Quadrant Other (specify) SN+1 non sentinel node TCGA-EW-A1P3-F41142 TCGA-EW-A1P3 TCGA-EW-A1P3-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy YES -17637 919 0 1611 NO 90-99% Scheduled Follow-up Submission 2013-3-12 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 150 NO Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 1 4 NO 0 0 true Yes MX N0 T2 Stage IIA TCGA-EW-A1P3.042304AE-706A-4033-A97F-3765A6AEC649.pdf A1P3 TUMOR FREE YES YES 90-99% NO Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2008 43c8eaea-f686-4e28-ba9c-360fea61b3ca 43c8eaea-f686-4e28-ba9c-360fea61b3ca TCGA-EW-A1P3-01A-21-A17J-20 TCGA-EW-A1P3-01A-11D-A142-09 TCGA-EW-A1P3-01 TCGA-EW-A1P3-01A-11D-A145-05 d1b203a1-19d6-4504-a925-2cf22b888095 TCGA-EW-A1P3-01 TCGA-EW-A1P3-01A-11D-A142-09 TCGA-EW-A1P3-01 TCGA-EW-A1P3-01A-11D-A142-09 43c8eaea-f686-4e28-ba9c-360fea61b3ca TCGA-EW-A1P3-01A-11D-A141-01 TCGA-EW-A1P3-01 43c8eaea-f686-4e28-ba9c-360fea61b3ca TCGA-EW-A1P3-01A-11D-A141-01 TCGA-EW-A1P4-01 Stage IIA 43 1 Stage IIA 501 Negative FEMALE Negative Negative M0 Negative N0 501 0 Basal Negative enrollment T_Other T2 LIVING TCGA-EW-A1P4-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 4 cluster 5 mutation cluster 5 TCGA-EW-A1P4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-EW-A1P4-F29684 TCGA-EW-A1P4 TCGA-EW-A1P4-01A Negative 3 Point Scale 3 Point Scale Negative Simple Mastectomy YES -15989 525 0 907 NO <10% Scheduled Follow-up Submission 2012-3-26 FEMALE <10% Medullary Carcinoma No C50.9 8510/3 C50.9 YES Core needle biopsy 290 NO Negative 3 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 5 5 NO 0 0 true No M0 N0 (i-) T2 Stage IIA TCGA-EW-A1P4.70C8D54A-9698-4275-BD96-A6EF2E26474B.pdf A1P4 TUMOR FREE YES <10% YES Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2009 91a5b906-6a04-4f0d-8710-172311e84789 91a5b906-6a04-4f0d-8710-172311e84789 TCGA-EW-A1P4-01A-11-A17J-20 TCGA-EW-A1P4-01A-21D-A142-09 TCGA-EW-A1P4-01 TCGA-EW-A1P4-01A-21D-A145-05 b7cf8b60-fd76-4c2c-aa8e-cc0d0c89009a TCGA-EW-A1P4-01 TCGA-EW-A1P4-01A-21D-A142-09 TCGA-EW-A1P4-01 TCGA-EW-A1P4-01A-21D-A142-09 91a5b906-6a04-4f0d-8710-172311e84789 TCGA-EW-A1P4-01A-21D-A141-01 TCGA-EW-A1P4-01 91a5b906-6a04-4f0d-8710-172311e84789 TCGA-EW-A1P4-01A-21D-A141-01 TCGA-EW-A1P5-01 Stage IIB 77 3 Stage IIB 365 Positive FEMALE Negative Negative M0 Positive N1 365 0 LumA Positive enrollment T_Other T2 LIVING TCGA-EW-A1P5-01 High C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 cluster 3 mutation cluster 4 TCGA-EW-A1P5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1P5-F32249 TCGA-EW-A1P5 Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy YES -28177 0 703 NO 90-99% Scheduled Follow-up Submission 2012-5-15 FEMALE <10% 1.12 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Negative Negative 40 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 3 NO 3 0 No M0 N1a T2 Stage IIB A1P5 TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO YES EW Breast LIVING 2010 e9d4f9c8-7355-44c4-9b18-923db7bae832 e9d4f9c8-7355-44c4-9b18-923db7bae832 TCGA-EW-A1P5-01A-21-A17J-20 TCGA-EW-A1P5-01A-11D-A142-09 TCGA-EW-A1P5-01 TCGA-EW-A1P5-01A-11D-A145-05 ef44d5ee-0e6f-4ec3-8db0-b0c426708430 TCGA-EW-A1P5-01 TCGA-EW-A1P5-01A-11D-A142-09 TCGA-EW-A1P5-01 TCGA-EW-A1P5-01A-11D-A142-09 e9d4f9c8-7355-44c4-9b18-923db7bae832 TCGA-EW-A1P5-01A-11D-A141-01 TCGA-EW-A1P5-01 e9d4f9c8-7355-44c4-9b18-923db7bae832 TCGA-EW-A1P5-01A-11D-A141-01 TCGA-EW-A1P6-01 Stage IIB 64 4 Stage IIB 312 Positive FEMALE Negative Negative M0 Positive N1 312 0 LumA Positive enrollment T_Other T2 LIVING TCGA-EW-A1P6-01 Kirc+ C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 14 cluster 2 mutation c1uster 9 TCGA-EW-A1P6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1P6-F29114 TCGA-EW-A1P6 TCGA-EW-A1P6-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy YES -23485 249 0 562 NO 90-99% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 50 NO Negative 25 Close Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 2 NO 2 0 true No M0 N1a T2 Stage IIB TCGA-EW-A1P6.6FEAD496-58BA-42DC-A3F2-2F380EEB1588.pdf A1P6 TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2010 9dddaf60-64ed-4d41-a546-79e86db1101e 9dddaf60-64ed-4d41-a546-79e86db1101e TCGA-EW-A1P6-01A-11D-A142-09 TCGA-EW-A1P6-01 TCGA-EW-A1P6-01A-11D-A145-05 TCGA-EW-A1P6-01 TCGA-EW-A1P6-01A-11D-A142-09 TCGA-EW-A1P6-01 TCGA-EW-A1P6-01A-11D-A142-09 9dddaf60-64ed-4d41-a546-79e86db1101e TCGA-EW-A1P6-01A-11D-A141-01 TCGA-EW-A1P6-01 9dddaf60-64ed-4d41-a546-79e86db1101e TCGA-EW-A1P6-01A-11D-A141-01 TCGA-EW-A1P7-01 Stage IIA 59 1 Stage IIA 635 Negative FEMALE Negative Negative M0 Negative N0 635 0 Normal Negative enrollment T_Other T2 LIVING TCGA-EW-A1P7-01 Kirc+ C4-BRCA/Basal cluster 5 Low purity c2 BRCA basal-like c8 miRNA cluster 7 cluster 3 mutation c1uster 9 TCGA-EW-A1P7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO YES 59 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-EW-A1P7-F29118 TCGA-EW-A1P7 Negative 3 Point Scale 3 Point Scale Negative Lumpectomy YES 793 -21750 0 915 729 NO <10% Scheduled Follow-up Submission 2012-3-8 FEMALE 10-19% 2+ 1.8 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 3 Other, specify Distant Metastasis mediastinal lymph nodes YES 0 0 No M0 N0 (i-) T2 Stage IIA A1P7 WITH TUMOR YES <10% NO Primary Tumor 01 6th YES NO YES EW Breast LIVING 2009 e11a1fd3-d409-4e09-a8ab-5d0afb455263 e11a1fd3-d409-4e09-a8ab-5d0afb455263 TCGA-EW-A1P7-01A-21D-A142-09 TCGA-EW-A1P7-01 TCGA-EW-A1P7-01A-21D-A145-05 TCGA-EW-A1P7-01 TCGA-EW-A1P7-01A-21D-A142-09 TCGA-EW-A1P7-01 TCGA-EW-A1P7-01A-21D-A142-09 e11a1fd3-d409-4e09-a8ab-5d0afb455263 TCGA-EW-A1P7-01A-21D-A141-01 TCGA-EW-A1P7-01 e11a1fd3-d409-4e09-a8ab-5d0afb455263 TCGA-EW-A1P7-01A-21D-A141-01 TCGA-EW-A1P8-01 Stage IIIC 58 3 Stage IIIC 239 239 Negative FEMALE Negative Negative M0 Positive N3 239 1 Basal Negative enrollment T_Other T2 DECEASED TCGA-EW-A1P8-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 12 TCGA-EW-A1P8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO 58 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1P8-F29121 TCGA-EW-A1P8 TCGA-EW-A1P8-01A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy NO -21501 224 239 0 207 YES <10% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 160 NO Negative 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Negative Negative <10% <10% <10% Negative Lung|Bone|Liver|Other, specify skin 5 5 Lung Distant Metastasis YES 14 true No M0 N3b T2 Stage IIIC TCGA-EW-A1P8.6CB5A0ED-5569-4FDC-B651-758BFC6B59D8.pdf A1P8 WITH TUMOR YES <10% NO Primary Tumor 01 7th YES NO YES EW Breast A DECEASED 2010 d763ccd4-4a11-4e84-b0a6-1b42da020ce4 d763ccd4-4a11-4e84-b0a6-1b42da020ce4 TCGA-EW-A1P8-01A-21-A17J-20 TCGA-EW-A1P8-01A-11D-A142-09 TCGA-EW-A1P8-01 TCGA-EW-A1P8-01A-11D-A145-05 9729bae9-2494-4ef3-9382-a564fa2a1363 TCGA-EW-A1P8-01 TCGA-EW-A1P8-01A-11D-A142-09 TCGA-EW-A1P8-01 TCGA-EW-A1P8-01A-11D-A142-09 d763ccd4-4a11-4e84-b0a6-1b42da020ce4 TCGA-EW-A1P8-01A-11D-A141-01 TCGA-EW-A1P8-01 d763ccd4-4a11-4e84-b0a6-1b42da020ce4 TCGA-EW-A1P8-01A-11D-A141-01 TCGA-EW-A1PA-01 Stage IIB 59 1 Stage IIB 267 Positive FEMALE Negative Negative M0 Positive N1 267 0 LumA Positive enrollment T_Other T2 LIVING TCGA-EW-A1PA-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 mutation cluster 5 TCGA-EW-A1PA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-EW-A1PA-F30937 TCGA-EW-A1PA TCGA-EW-A1PA-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy NO -21837 220 0 575 NO 90-99% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 60 NO Negative 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 4 NO 1 true No M0 N1a T2 Stage IIB TCGA-EW-A1PA.A68B2364-89DA-4DC7-9AA7-A08BBCC85025.pdf A1PA TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2010 8c0b7027-f371-4a72-9152-2d00fc54e086 8c0b7027-f371-4a72-9152-2d00fc54e086 TCGA-EW-A1PA-01A-21-A17K-20 TCGA-EW-A1PA-01A-11D-A142-09 TCGA-EW-A1PA-01 TCGA-EW-A1PA-01A-11D-A145-05 281ecf6a-bcfa-485e-bec7-694899bf33ba TCGA-EW-A1PA-01 TCGA-EW-A1PA-01A-11D-A142-09 TCGA-EW-A1PA-01 TCGA-EW-A1PA-01A-11D-A142-09 8c0b7027-f371-4a72-9152-2d00fc54e086 TCGA-EW-A1PA-01A-11D-A141-01 TCGA-EW-A1PA-01 8c0b7027-f371-4a72-9152-2d00fc54e086 TCGA-EW-A1PA-01A-11D-A141-01 TCGA-EW-A1PB-01 Stage IIIA 70 3 Stage IIIA 608 Negative FEMALE Negative Negative M0 Positive N1 608 0 Basal Negative enrollment T_Other T3 LIVING TCGA-EW-A1PB-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 14 cluster 2 mutation cluster 5 TCGA-EW-A1PB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-EW-A1PB-F29107 TCGA-EW-A1PB TCGA-EW-A1PB-01A Negative 3 Point Scale 3 Point Scale Negative Simple Mastectomy NO -25770 569 0 608 <10% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 320 NO Negative 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 2 NO 2 true No MX N1a T3 Stage IIIA TCGA-EW-A1PB.B3B6DE56-F40C-40BF-B6B3-2BC10F695F16.pdf A1PB TUMOR FREE YES <10% NO Primary Tumor 01 6th NO NO YES EW Breast A LIVING 2009 50674dde-30c1-4530-a164-381d5326e29c 50674dde-30c1-4530-a164-381d5326e29c TCGA-EW-A1PB-01A-21-A17J-20 TCGA-EW-A1PB-01A-11D-A142-09 TCGA-EW-A1PB-01 TCGA-EW-A1PB-01A-11D-A145-05 0bdf178b-3488-411a-bda6-2b7ee3beb0fd TCGA-EW-A1PB-01 TCGA-EW-A1PB-01A-11D-A142-09 TCGA-EW-A1PB-01 TCGA-EW-A1PB-01A-11D-A142-09 50674dde-30c1-4530-a164-381d5326e29c TCGA-EW-A1PB-01A-11D-A141-01 TCGA-EW-A1PB-01 50674dde-30c1-4530-a164-381d5326e29c TCGA-EW-A1PB-01A-11D-A141-01 TCGA-EW-A1PC-01 LumB TCGA-EW-A1PC-01 High C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-EW-A1PC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left Sentinel node biopsy alone TCGA-EW-A1PC-F29681 TCGA-EW-A1PC TCGA-EW-A1PC-01B Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy YES -24434 146 0 187 NO 90-99% Scheduled Follow-up Submission 2012-3-26 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 150 NO Negative 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No MX N0 (i-) T3 Stage IIB TCGA-EW-A1PC.4A0524B4-2A0B-4442-91B6-0E2FEA90CBC6.pdf A1PC TUMOR FREE YES 50-59% NO Primary Tumor 01 7th YES NO YES EW Breast B LIVING 2011 3960601b-c341-45fb-8a8c-ec244ee719ac 3960601b-c341-45fb-8a8c-ec244ee719ac TCGA-EW-A1PC-01B-21-A24A-20 TCGA-EW-A1PC-01 TCGA-EW-A1PC-01B-11D-A21R-05 ea4d6b89-3adf-4eb2-a91c-88e799d79af3 TCGA-EW-A1PC-01 TCGA-EW-A1PC-01B-11D-A21Q-09 TCGA-EW-A1PC-01 3960601b-c341-45fb-8a8c-ec244ee719ac TCGA-EW-A1PC-01B-11D-A21P-01 TCGA-EW-A1PC-01 3960601b-c341-45fb-8a8c-ec244ee719ac TCGA-EW-A1PC-01B-11D-A21P-01 TCGA-EW-A1PD-01 Stage IIA 61 5 Stage IIA 174 Positive MALE Positive Negative M0 Positive N1 174 0 LumA Positive enrollment T1 T1 LIVING TCGA-EW-A1PD-01 High C3-BRCA/Luminal cluster 2 BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 14 cluster 4 mutation c1uster 9 TCGA-EW-A1PD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1PD-F29106 TCGA-EW-A1PD TCGA-EW-A1PD-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -22536 112 0 424 NO 90-99% Scheduled Follow-up Submission 2012-3-8 MALE 20-29% 2+ >6.0 2.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 120 NO Equivocal Positive 7 Negative 2 4 NO 2 true No M0 N1a T1c Stage IIA TCGA-EW-A1PD.B6D80CA9-F4DA-4DFB-80BF-08BEE17142BD.pdf A1PD TUMOR FREE YES 90-99% NO Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2010 69971d5c-5be4-4886-bf7c-753de9593a1e 69971d5c-5be4-4886-bf7c-753de9593a1e TCGA-EW-A1PD-01A-21-A17J-20 TCGA-EW-A1PD-01A-11D-A142-09 TCGA-EW-A1PD-01 TCGA-EW-A1PD-01A-11D-A145-05 1dab2beb-b0c7-4eee-bc45-71997f6077e9 TCGA-EW-A1PD-01 TCGA-EW-A1PD-01A-11D-A142-09 TCGA-EW-A1PD-01 TCGA-EW-A1PD-01A-11D-A142-09 69971d5c-5be4-4886-bf7c-753de9593a1e TCGA-EW-A1PD-01A-11D-A141-01 TCGA-EW-A1PD-01 69971d5c-5be4-4886-bf7c-753de9593a1e TCGA-EW-A1PD-01A-11D-A141-01 TCGA-EW-A1PE-01 Stage IIA 56 2 Stage IIA 139 Positive FEMALE Negative Negative M0 Positive N1 139 0 LumA Positive enrollment T1 T1 LIVING TCGA-EW-A1PE-01 Iq C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 7 cluster 3 mutation cluster 4 TCGA-EW-A1PE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-EW-A1PE-F29108 TCGA-EW-A1PE TCGA-EW-A1PE-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy NO -20694 44 0 320 NO 90-99% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8507/3 C50.9 3+ YES [Discrepancy] 150 NO Negative 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 3 NO 1 true No M0 N1a T1c Stage IIA TCGA-EW-A1PE.F59530A5-7370-4E77-9099-9F38B25A38EB.pdf A1PE TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2011 4a21d42c-b231-4ffc-8c15-4bd73bf610b4 4a21d42c-b231-4ffc-8c15-4bd73bf610b4 TCGA-EW-A1PE-01A-21-A17J-20 TCGA-EW-A1PE-01A-11D-A142-09 TCGA-EW-A1PE-01 TCGA-EW-A1PE-01A-11D-A145-05 f5581422-7c21-4ccb-8006-b976b1b49459 TCGA-EW-A1PE-01 TCGA-EW-A1PE-01A-11D-A142-09 TCGA-EW-A1PE-01 TCGA-EW-A1PE-01A-11D-A142-09 4a21d42c-b231-4ffc-8c15-4bd73bf610b4 TCGA-EW-A1PE-01A-11D-A141-01 TCGA-EW-A1PE-01 4a21d42c-b231-4ffc-8c15-4bd73bf610b4 TCGA-EW-A1PE-01A-11D-A141-01 TCGA-EW-A1PF-01 Stage IA 50 5 Stage I 139 Positive FEMALE Negative Negative M0 Negative N0 139 0 LumA Positive enrollment T1 T1 LIVING TCGA-EW-A1PF-01 Kirc+ cluster 1 BRCA CIMP c7 BRCA nonbasal-like c7 miRNA cluster 4 cluster 4 TCGA-EW-A1PF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right Upper Outer Quadrant Other (specify) sentinel + 2 non-sentinel LN TCGA-EW-A1PF-F29109 TCGA-EW-A1PF Positive 3 Point Scale 3+ 3 Point Scale Positive Other YES -18384 0 439 NO 90-99% Scheduled Follow-up Submission 2012-3-8 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Negative 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 4 NO 0 0 No M0 N0 T1c Stage IA A1PF TUMOR FREE YES 90-99% NO Primary Tumor 01 total mastectomy 7th YES NO YES EW Breast LIVING 2010 faa3383f-6f9f-43d8-b61d-4a1522a71444 faa3383f-6f9f-43d8-b61d-4a1522a71444 TCGA-EW-A1PF-01 TCGA-EW-A1PF-01A-11D-A145-05 TCGA-EW-A1PF-01 TCGA-EW-A1PF-01 faa3383f-6f9f-43d8-b61d-4a1522a71444 TCGA-EW-A1PF-01A-11D-A141-01 TCGA-EW-A1PF-01 faa3383f-6f9f-43d8-b61d-4a1522a71444 TCGA-EW-A1PF-01A-11D-A141-01 TCGA-EW-A1PG-01 Stage IIB 53 1 Stage IIB 875 Positive FEMALE Negative Negative M0 Positive N1 875 0 Normal Positive enrollment T_Other T2 LIVING TCGA-EW-A1PG-01 Quiet C3-BRCA/Luminal cluster 1 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 14 cluster 6 mutation c1uster 9 TCGA-EW-A1PG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Lower Inner Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1PG-F29103 TCGA-EW-A1PG TCGA-EW-A1PG-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy YES -19464 829 0 1051 NO 90-99% Scheduled Follow-up Submission 2012-3-8 FEMALE 10-19% 2+ <4.0 1.8 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 210 NO Equivocal Negative 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 1 6 NO 1 1 true No MX N1a T2 Stage IIB TCGA-EW-A1PG.6197798C-6F04-470E-BA91-922548E2DFAF.pdf A1PG TUMOR FREE YES 90-99% NO Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2008 1205dc3c-e766-4a25-b485-c66e301e3b6d 1205dc3c-e766-4a25-b485-c66e301e3b6d TCGA-EW-A1PG-01A-21-A17J-20 TCGA-EW-A1PG-01A-11D-A142-09 TCGA-EW-A1PG-01 TCGA-EW-A1PG-01A-11D-A145-05 6621baf4-3dc5-4905-99b2-f40d75886fa0 TCGA-EW-A1PG-01 TCGA-EW-A1PG-01A-11D-A142-09 TCGA-EW-A1PG-01 TCGA-EW-A1PG-01A-11D-A142-09 1205dc3c-e766-4a25-b485-c66e301e3b6d TCGA-EW-A1PG-01A-11D-A141-01 TCGA-EW-A1PG-01 1205dc3c-e766-4a25-b485-c66e301e3b6d TCGA-EW-A1PG-01A-11D-A141-01 TCGA-EW-A1PH-01 Stage IIA 52 1 Stage IIA 139 Negative FEMALE Negative M0 Positive N1 139 0 Basal Negative enrollment T1 T1 LIVING TCGA-EW-A1PH-01 High C4-BRCA/Basal cluster 5 BRCA basal-like c8 BRCA basal-like c8 miRNA cluster 12 cluster 5 mutation cluster 5 TCGA-EW-A1PH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A1PH-F41145 TCGA-EW-A1PH TCGA-EW-A1PH-01A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy YES -19073 77 0 607 NO <10% Scheduled Follow-up Submission 2013-3-12 FEMALE <10% Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 70 NO Negative NO 10 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 5 5 NO 1 0 true No M0 N1a T1c Stage IIA TCGA-EW-A1PH.2E77693B-FAAD-4CCC-BD4F-3D2470C25143.pdf A1PH TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2010 39413018-090f-46ca-b6df-244124f098c3 39413018-090f-46ca-b6df-244124f098c3 TCGA-EW-A1PH-01A-11D-A14K-09 TCGA-EW-A1PH-01 TCGA-EW-A1PH-01A-11D-A14N-05 TCGA-EW-A1PH-01 TCGA-EW-A1PH-01A-11D-A14K-09 TCGA-EW-A1PH-01 TCGA-EW-A1PH-01A-11D-A14K-09 39413018-090f-46ca-b6df-244124f098c3 TCGA-EW-A1PH-01A-11D-A14J-01 TCGA-EW-A1PH-01 39413018-090f-46ca-b6df-244124f098c3 TCGA-EW-A1PH-01A-11D-A14J-01 TCGA-EW-A2FR-01 Her2 TCGA-EW-A2FR-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-EW-A2FR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-EW-A2FR-F42056 TCGA-EW-A2FR TCGA-EW-A2FR-01A Negative 3 Point Scale 1+ 3 Point Scale Negative Lumpectomy NO -21628 1015 0 1673 NO <10% 2 Scheduled Follow-up Submission 2013-4-10 FEMALE 10-19% ratio > 2.2 is positive 2+ 40 >6 3.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Core needle biopsy 100 NO Equivocal Positive NO 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 19 true No MX N3a T1b Stage IIIC TCGA-EW-A2FR.792A24F5-065E-4001-97F6-3F9BA121C65D.pdf A2FR TUMOR FREE YES YES <10% YES Primary Tumor 01 6th YES NO YES EW Breast A LIVING 2008 2bd1673c-b5c0-425b-9e62-c501bf29616b 2bd1673c-b5c0-425b-9e62-c501bf29616b TCGA-EW-A2FR-01A-21-A24A-20 TCGA-EW-A2FR-01 TCGA-EW-A2FR-01A-11D-A21R-05 977e315e-d1c6-4ef2-a078-178b88ff0ee5 TCGA-EW-A2FR-01 TCGA-EW-A2FR-01A-11D-A21Q-09 TCGA-EW-A2FR-01 2bd1673c-b5c0-425b-9e62-c501bf29616b TCGA-EW-A2FR-01A-11D-A21P-01 TCGA-EW-A2FR-01 2bd1673c-b5c0-425b-9e62-c501bf29616b TCGA-EW-A2FR-01A-11D-A21P-01 TCGA-EW-A2FS-01 41 5 1173 Positive FEMALE 1173 0 LumA Negative enrollment LIVING TCGA-EW-A2FS-01 Squamous C3-BRCA/Luminal cluster 4 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-EW-A2FS TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-EW-A2FS-F42061 TCGA-EW-A2FS Positive 3 Point Scale 1+ 3 Point Scale Negative Lumpectomy YES -15302 0 1604 NO 90-99% Scheduled Follow-up Submission 2013-4-10 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy Negative NO 8 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 1 No MX N1mi T2 Stage IIB A2FS TUMOR FREE YES YES <10% YES Primary Tumor 01 6th YES NO YES EW Breast LIVING 2008 c0f29396-d239-4f0d-a95a-0838770eb24a c0f29396-d239-4f0d-a95a-0838770eb24a TCGA-EW-A2FS-01A-21-A24A-20 TCGA-EW-A2FS-01 TCGA-EW-A2FS-01A-11D-A17F-05 f5d09917-197f-4ba1-b19d-437841854522 TCGA-EW-A2FS-01 TCGA-EW-A2FS-01A-11D-A17D-09 TCGA-EW-A2FS-01 c0f29396-d239-4f0d-a95a-0838770eb24a TCGA-EW-A2FS-01A-11D-A17C-01 TCGA-EW-A2FS-01 c0f29396-d239-4f0d-a95a-0838770eb24a TCGA-EW-A2FS-01A-11D-A17C-01 TCGA-EW-A2FV-01 39 3 238 Positive FEMALE 238 0 LumA Positive enrollment LIVING TCGA-EW-A2FV-01 BRCA-LUAD+ C3-BRCA/Luminal cluster 4 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-EW-A2FV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Left Upper Inner Quadrant Axillary lymph node dissection alone TCGA-EW-A2FV-F42065 TCGA-EW-A2FV TCGA-EW-A2FV-01A Negative Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -14316 133 0 788 NO 90-99% Scheduled Follow-up Submission 2013-4-10 FEMALE <10% 1+ Other, specify No C50.9 8507/3 C50.9 3+ YES Excisional Biopsy 80 NO Negative NO 32 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) 4 NO 29 true No MX N3a T3 Stage IIIC TCGA-EW-A2FV.335BFEB5-6356-43A3-896D-50BF3830B59E.pdf A2FV TUMOR FREE YES 90-99% YES Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2011 d60bfd82-87f0-4f13-8e90-6766beb84e9a d60bfd82-87f0-4f13-8e90-6766beb84e9a TCGA-EW-A2FV-01A-21-A24A-20 TCGA-EW-A2FV-01 TCGA-EW-A2FV-01A-11D-A17F-05 65bf3e8b-5558-49a2-a59e-6066ce8f38b5 TCGA-EW-A2FV-01 TCGA-EW-A2FV-01A-11D-A17D-09 TCGA-EW-A2FV-01 d60bfd82-87f0-4f13-8e90-6766beb84e9a TCGA-EW-A2FV-01A-11D-A17C-01 TCGA-EW-A2FV-01 d60bfd82-87f0-4f13-8e90-6766beb84e9a TCGA-EW-A2FV-01A-11D-A17C-01 TCGA-EW-A2FW-01 52 3 190 Positive FEMALE 190 0 LumB Positive enrollment LIVING TCGA-EW-A2FW-01 Iq C3-BRCA/Luminal cluster 2 BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 TCGA-EW-A2FW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-EW-A2FW-F42062 TCGA-EW-A2FW TCGA-EW-A2FW-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy YES -19085 99 0 672 NO 90-99% Scheduled Follow-up Submission 2013-4-10 FEMALE <10% 1+ Other, specify No C50.9 8503/3 C50.9 3+ YES Core needle biopsy 150 NO Negative NO 6 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 2 NO 0 0 true No MX N0 (i-) T2 Stage IIA TCGA-EW-A2FW.0487E2B3-C03F-43A0-ABCB-B2BDBE0FF47E.pdf A2FW TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO YES EW Breast A LIVING 2011 743f2962-126c-4b28-92fa-250b1170b825 743f2962-126c-4b28-92fa-250b1170b825 TCGA-EW-A2FW-01A-21-A24A-20 TCGA-EW-A2FW-01 TCGA-EW-A2FW-01A-11D-A17F-05 a4c623f3-e037-4a14-9be5-665cfc6a0c65 TCGA-EW-A2FW-01 TCGA-EW-A2FW-01A-11D-A17D-09 TCGA-EW-A2FW-01 743f2962-126c-4b28-92fa-250b1170b825 TCGA-EW-A2FW-01A-11D-A17C-01 TCGA-EW-A2FW-01 743f2962-126c-4b28-92fa-250b1170b825 TCGA-EW-A2FW-01A-11D-A17C-01 TCGA-EW-A3E8-01 TCGA-EW-A3E8-01 TCGA-EW-A3E8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A3E8-F57617 TCGA-EW-A3E8 TCGA-EW-A3E8-01B Positive Negative Simple Mastectomy -21922 505 0 1035 2014-3-18 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 50 NO Negative NO 2 Negative NO 0 true No MX N0 T3 Stage IIB TCGA-EW-A3E8.E4ECB8AA-0ECC-47A5-B940-045A2C3D9A1A.pdf A3E8 TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO EW Breast B LIVING 2011 37cb523b-c33a-4980-9b06-6e91389ce70e 37cb523b-c33a-4980-9b06-6e91389ce70e TCGA-EW-A3E8-01 TCGA-EW-A3E8-01B-11D-A244-05 TCGA-EW-A3E8-01 TCGA-EW-A3E8-01B-11D-A243-09 TCGA-EW-A3E8-01 37cb523b-c33a-4980-9b06-6e91389ce70e TCGA-EW-A3E8-01B-11D-A242-01 TCGA-EW-A3E8-01 37cb523b-c33a-4980-9b06-6e91389ce70e TCGA-EW-A3E8-01B-11D-A242-01 TCGA-EW-A3U0-01 TCGA-EW-A3U0-01 High Low purity c2 BRCA basal-like c6 miRNA cluster 4 TCGA-EW-A3U0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Sentinel lymph node biopsy plus axillary dissection TCGA-EW-A3U0-F42032 TCGA-EW-A3U0 TCGA-EW-A3U0-01A Negative Negative Other NO -22520 182 0 532 NO 2013-4-9 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 280 NO Negative NO 25 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No M0 N1a T3 Stage IIIA TCGA-EW-A3U0.8652E026-9C4D-4AB6-AADE-29DA3345892E.pdf A3U0 TUMOR FREE YES YES YES Primary Tumor 01 partial left mastectomy 7th YES NO EW Breast A LIVING 2011 4763b4dd-1eef-4503-9381-4baa57cc690f 4763b4dd-1eef-4503-9381-4baa57cc690f TCGA-EW-A3U0-01A-21-A24A-20 TCGA-EW-A3U0-01 TCGA-EW-A3U0-01A-11D-A22B-05 0c52f4b2-07d9-4591-a6b7-e4700f8d476d TCGA-EW-A3U0-01 TCGA-EW-A3U0-01A-11D-A228-09 TCGA-EW-A3U0-01 4763b4dd-1eef-4503-9381-4baa57cc690f TCGA-EW-A3U0-01A-11D-A227-01 TCGA-EW-A3U0-01 4763b4dd-1eef-4503-9381-4baa57cc690f TCGA-EW-A3U0-01A-11D-A227-01 TCGA-EW-A423-01 TCGA-EW-A423-01 TCGA-EW-A423 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-EW-A423-F42558 TCGA-EW-A423 TCGA-EW-A423-01A Positive Positive Lumpectomy NO -27627 161 0 533 50-59% 2014-3-18 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 80 NO Negative YES 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No MX N0 T2 Stage IIA TCGA-EW-A423.0BB6CAC8-CE26-461F-A9FE-46E28E96A368.pdf A423 TUMOR FREE [Discrepancy] YES <10% [Discrepancy] Primary Tumor 01 7th YES NO EW Breast A LIVING 2012 994c8287-b6e2-4743-80bb-fe8d0076ae44 994c8287-b6e2-4743-80bb-fe8d0076ae44 TCGA-EW-A423-01 TCGA-EW-A423-01A-11D-A244-05 9632bb77-ebd1-4a10-86ba-86f090839a31 TCGA-EW-A423-01 TCGA-EW-A423-01A-11D-A243-09 TCGA-EW-A423-01 994c8287-b6e2-4743-80bb-fe8d0076ae44 TCGA-EW-A423-01A-11D-A242-01 TCGA-EW-A423-01 994c8287-b6e2-4743-80bb-fe8d0076ae44 TCGA-EW-A423-01A-11D-A242-01 TCGA-EW-A424-01 TCGA-EW-A424-01 TCGA-EW-A424 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Sentinel node biopsy alone TCGA-EW-A424-F57612 TCGA-EW-A424 TCGA-EW-A424-01A Positive Positive Simple Mastectomy YES -18850 141 0 715 50-59% 2014-3-18 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 140 NO Positive NO 1 Negative NO 0 1 true No MX N1 T3 Stage IIIA TCGA-EW-A424.EE644ADF-639E-450A-92E6-2A6F1BAD561F.pdf A424 TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO EW Breast A LIVING 2012 1a571942-1f4c-4f93-8ad3-ea84dad7edaa 1a571942-1f4c-4f93-8ad3-ea84dad7edaa TCGA-EW-A424-01 TCGA-EW-A424-01A-11D-A244-05 f3c98936-9cae-4e6c-8ff3-0af1a45b4a24 TCGA-EW-A424-01 TCGA-EW-A424-01 1a571942-1f4c-4f93-8ad3-ea84dad7edaa TCGA-EW-A424-01A-11D-A242-01 TCGA-EW-A424-01 1a571942-1f4c-4f93-8ad3-ea84dad7edaa TCGA-EW-A424-01A-11D-A242-01 TCGA-EW-A6S9-01 TCGA-EW-A6S9-01 TCGA-EW-A6S9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 34 Right|Right Upper Outer Quadrant TCGA-EW-A6S9-F71706 TCGA-EW-A6S9 TCGA-EW-A6S9-01A Positive Positive Lumpectomy -12755 139 0 463 50-59% 2015-3-30 FEMALE 50-59% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 190 NO Positive NO 3 NO 1 1 true No M0 N1 T1c Stage IIA TCGA-EW-A6S9.4FC32F17-7A4D-4FF6-A710-FFFBC610CB56.pdf A6S9 TUMOR FREE NO YES NO Primary Tumor 01 7th EW Breast A LIVING 2013 692abecd-9c2a-48ec-8794-7e84a5317c46 692abecd-9c2a-48ec-8794-7e84a5317c46 TCGA-EW-A6S9-01 TCGA-EW-A6S9-01A-22D-A33F-05 58744A3B-FEB8-4ADD-8B01-36397505D052 TCGA-EW-A6S9-01 TCGA-EW-A6S9-01 692abecd-9c2a-48ec-8794-7e84a5317c46 TCGA-EW-A6S9-01A-22D-A33D-01 TCGA-EW-A6S9-01 692abecd-9c2a-48ec-8794-7e84a5317c46 TCGA-EW-A6S9-01A-22D-A33D-01 TCGA-EW-A6SA-01 TCGA-EW-A6SA-01 TCGA-EW-A6SA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left|Left Lower Inner Quadrant Sentinel node biopsy alone TCGA-EW-A6SA TCGA-EW-A6SA-01A Positive Negative Simple Mastectomy YES -21623 152 0 510 50-59% 2015-2-27 MALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 80 NO Negative 4 Negative NO 1 true No MX N0 (i+) T2 Stage II TCGA-EW-A6SA.9C971870-BA92-4E0C-9861-31C56B7E7D64.pdf A6SA TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO EW Breast A LIVING 2013 2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168 2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168 TCGA-EW-A6SA-01 TCGA-EW-A6SA-01A-21D-A32T-05 3C4C4A1F-544E-4CB5-A1E8-50534496B737 TCGA-EW-A6SA-01 TCGA-EW-A6SA-01 2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168 TCGA-EW-A6SA-01A-21D-A32H-01 TCGA-EW-A6SA-01 2aac1ce6-fc3e-474c-9e0e-5a6d05ff9168 TCGA-EW-A6SA-01A-21D-A32H-01 TCGA-EW-A6SB-01 TCGA-EW-A6SB-01 TCGA-EW-A6SB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left|Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-EW-A6SB TCGA-EW-A6SB-01A Negative Negative Modified Radical Mastectomy YES -22844 244 0 760 2015-3-12 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 200 NO Negative 8 Negative NO 0 0 true No M0 N0 T2 Stage II TCGA-EW-A6SB.6EEF1F11-603E-4196-91AB-724BBEE20CE7.pdf A6SB TUMOR FREE YES YES YES Primary Tumor 01 7th EW Breast A LIVING 2012 5cb6b038-fe0b-48db-af0b-2a25beb8d79b 5cb6b038-fe0b-48db-af0b-2a25beb8d79b TCGA-EW-A6SB-01 TCGA-EW-A6SB-01A-12D-A32T-05 85666B68-022F-4583-83BB-7CD199387E0F TCGA-EW-A6SB-01 TCGA-EW-A6SB-01 5cb6b038-fe0b-48db-af0b-2a25beb8d79b TCGA-EW-A6SB-01A-12D-A32H-01 TCGA-EW-A6SB-01 5cb6b038-fe0b-48db-af0b-2a25beb8d79b TCGA-EW-A6SB-01A-12D-A32H-01 TCGA-EW-A6SC-01 TCGA-EW-A6SC-01 TCGA-EW-A6SC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 60 Left|Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-EW-A6SC-F71017 TCGA-EW-A6SC TCGA-EW-A6SC-01A Positive Positive Lumpectomy YES -21918 350 0 952 50-59% 2015-3-12 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 160 NO Negative NO 2 Negative NO 0 0 true No M0 N0 T2 Stage IIA TCGA-EW-A6SC.315A77B4-1A2E-468D-9E44-FF0B07697943.pdf A6SC TUMOR FREE YES YES 40-49% YES Primary Tumor 01 7th EW Breast A LIVING 2012 3b7ae466-954f-42aa-8e01-9908ef1c8123 3b7ae466-954f-42aa-8e01-9908ef1c8123 TCGA-EW-A6SC-01 TCGA-EW-A6SC-01A-12D-A32T-05 79418E7F-949D-489B-B953-B4942BC4C027 TCGA-EW-A6SC-01 TCGA-EW-A6SC-01 3b7ae466-954f-42aa-8e01-9908ef1c8123 TCGA-EW-A6SC-01A-12D-A32H-01 TCGA-EW-A6SC-01 3b7ae466-954f-42aa-8e01-9908ef1c8123 TCGA-EW-A6SC-01A-12D-A32H-01 TCGA-EW-A6SD-01 TCGA-EW-A6SD-01 TCGA-EW-A6SD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 32 Left|Left Upper Outer Quadrant TCGA-EW-A6SD TCGA-EW-A6SD-01A Negative Negative Lumpectomy -12006 441 0 1010 <10% 2015-3-14 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO 31 Negative NO 2 0 true No M0 N1a T2 Stage IIB TCGA-EW-A6SD.9FB40DC5-BED9-420E-B334-4D0BE8B8BCF5.pdf A6SD TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO EW Breast A LIVING 2012 54d166b6-fb32-4003-b944-8d0f23cfa125 54d166b6-fb32-4003-b944-8d0f23cfa125 TCGA-EW-A6SD-01 TCGA-EW-A6SD-01A-12D-A33F-05 9085B5BF-0B41-4E31-940F-BE8AF05ED3EC TCGA-EW-A6SD-01 TCGA-EW-A6SD-01 54d166b6-fb32-4003-b944-8d0f23cfa125 TCGA-EW-A6SD-01A-12D-A33D-01 TCGA-EW-A6SD-01 54d166b6-fb32-4003-b944-8d0f23cfa125 TCGA-EW-A6SD-01A-12D-A33D-01 TCGA-GI-A2C8-01 3 LumA TCGA-GI-A2C8-01 Squamous C3-BRCA/Luminal cluster 3 BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 mutation c1uster 9 TCGA-GI-A2C8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Sentinel node biopsy alone TCGA-GI-A2C8-F21661 TCGA-GI-A2C8 TCGA-GI-A2C8-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy NO -23103 2429 0 225 NO 90-99% Scheduled Follow-up Submission 2012-5-8 FEMALE Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 3+ YES 100 NO Negative Negative 10 Negative 3 NO 0 false No MX N0 T4b Stage IIIB TCGA-GI-A2C8.4AABCBD1-DF12-45E1-9307-21D6CB0894A9.pdf A2C8 YES <10% YES Primary Tumor 01 6th YES NO YES GI Breast A LIVING 2004 21531069-76ec-4e0f-b915-51c00b2c42f1 21531069-76ec-4e0f-b915-51c00b2c42f1 TCGA-GI-A2C8-01A-21-A17K-20 TCGA-GI-A2C8-01A-11D-A16D-09 TCGA-GI-A2C8-01 TCGA-GI-A2C8-01A-11D-A16G-05 b9f3060c-ac00-4181-acde-92e45a2ae5a8 TCGA-GI-A2C8-01 TCGA-GI-A2C8-01A-11D-A16D-09 TCGA-GI-A2C8-01 TCGA-GI-A2C8-01A-11D-A16D-09 21531069-76ec-4e0f-b915-51c00b2c42f1 TCGA-GI-A2C8-01A-11D-A16C-01 TCGA-GI-A2C8-01 21531069-76ec-4e0f-b915-51c00b2c42f1 TCGA-GI-A2C8-01A-11D-A16C-01 TCGA-GI-A2C8-11 LumA TCGA-GI-A2C8-11 C3-BRCA/Luminal mutation c1uster 9 TCGA-GI-A2C8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Sentinel node biopsy alone TCGA-GI-A2C8-F21661 TCGA-GI-A2C8 TCGA-GI-A2C8-11A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy NO -23103 2429 0 225 NO 90-99% Scheduled Follow-up Submission 2012-5-8 FEMALE Infiltrating Ductal Carcinoma Yes C50.9 8500/3 C50.9 3+ YES 100 NO Negative Negative 10 Negative NO 0 false No MX N0 T4b Stage IIIB A2C8 YES <10% YES Solid Tissue Normal 11 6th YES NO YES GI Breast A LIVING 2004 6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7 6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7 6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7 6eaf6c1c-13d6-4293-aaa5-7d9aecf61db7 TCGA-GI-A2C9-01 Basal TCGA-GI-A2C9-01 High C4-BRCA/Basal BRCA basal-like c8 BRCA basal-like c6 BRCA basal-like c8 miRNA cluster 4 TCGA-GI-A2C9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Sentinel lymph node biopsy plus axillary dissection TCGA-GI-A2C9-F21663 TCGA-GI-A2C9 TCGA-GI-A2C9-01A Negative Negative Lumpectomy YES -21534 2979 0 3342 NO Scheduled Follow-up Submission 2012-5-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 T3 Stage IIB TCGA-GI-A2C9.ADDE6090-5278-42D5-8E89-E0AB630A4C06.pdf A2C9 TUMOR FREE YES YES Primary Tumor 01 6th YES NO YES GI Breast A LIVING 2003 b5b8fdd8-c4df-4f79-aed5-23ac41f75f18 b5b8fdd8-c4df-4f79-aed5-23ac41f75f18 TCGA-GI-A2C9-01A-21-A24A-20 TCGA-GI-A2C9-01 TCGA-GI-A2C9-01A-11D-A21R-05 179ce5cd-da63-4c2e-bf72-253129faf128 TCGA-GI-A2C9-01 TCGA-GI-A2C9-01A-11D-A21Q-09 TCGA-GI-A2C9-01 b5b8fdd8-c4df-4f79-aed5-23ac41f75f18 TCGA-GI-A2C9-01A-11D-A21P-01 TCGA-GI-A2C9-01 b5b8fdd8-c4df-4f79-aed5-23ac41f75f18 TCGA-GI-A2C9-01A-11D-A21P-01 TCGA-GI-A2C9-11 Normal TCGA-GI-A2C9-11 C4-BRCA/Basal TCGA-GI-A2C9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Sentinel lymph node biopsy plus axillary dissection TCGA-GI-A2C9-F21663 TCGA-GI-A2C9 TCGA-GI-A2C9-11A Negative Negative Lumpectomy YES -21534 2979 0 3342 NO Scheduled Follow-up Submission 2012-5-8 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 T3 Stage IIB A2C9 TUMOR FREE YES YES Solid Tissue Normal 11 6th YES NO YES GI Breast A LIVING 2003 69a8b5fd-7ca6-49d7-b16a-2beba16e40b1 69a8b5fd-7ca6-49d7-b16a-2beba16e40b1 TCGA-GI-A2C9-11 69a8b5fd-7ca6-49d7-b16a-2beba16e40b1 TCGA-GI-A2C9-11 69a8b5fd-7ca6-49d7-b16a-2beba16e40b1 TCGA-GM-A2D9-01 69 1812 Positive FEMALE 1812 1 LumA Positive enrollment DECEASED TCGA-GM-A2D9-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 TCGA-GM-A2D9 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES 69 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-GM-A2D9-F47033 TCGA-GM-A2D9 TCGA-GM-A2D9-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy YES -25490 1910 1812 0 536 536 YES 90-99% 1.93 2013-8-21 FEMALE 60 2.23 1.16 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 130 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Positive 90-99% Bone Bone Distant Metastasis YES YES 0 0 false No M0 N0 (i-) T1c Stage I TCGA-GM-A2D9.C690925E-38A2-48BC-8E2B-4EA383E27FE2.pdf A2D9 WITH TUMOR YES YES 40-49% YES Primary Tumor 01 6th NO YES GM Breast A DECEASED 2006 4ffff9ea-3386-47d5-8974-722037f31849 4ffff9ea-3386-47d5-8974-722037f31849 TCGA-GM-A2D9-01A-21-A24A-20 TCGA-GM-A2D9-01 TCGA-GM-A2D9-01A-11D-A18O-05 3a04c178-dd57-499e-959e-ba106a878397 TCGA-GM-A2D9-01 TCGA-GM-A2D9-01A-11D-A18P-09 TCGA-GM-A2D9-01 4ffff9ea-3386-47d5-8974-722037f31849 TCGA-GM-A2D9-01A-11D-A18N-01 TCGA-GM-A2D9-01 4ffff9ea-3386-47d5-8974-722037f31849 TCGA-GM-A2D9-01A-11D-A18N-01 TCGA-GM-A2DA-01 46 5909 Positive FEMALE 5909 0 LumA Positive enrollment LIVING TCGA-GM-A2DA-01 Iq BRCA non-CIMP c9 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-GM-A2DA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES 46 Right Upper Inner Quadrant|Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-GM-A2DA-F47040 TCGA-GM-A2DA Positive Positive Modified Radical Mastectomy NO -16854 6593 0 5909 3014 YES 90-99% 3.70 2013-8-21 FEMALE 90-99% 2+ 60 15 4.05 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy Equivocal Positive NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone Distant Metastasis NO YES 2 0 No M0 N1b T2 Stage IIB A2DA WITH TUMOR YES YES 50-59% YES Primary Tumor 01 4th NO YES GM Breast DECEASED 1993 df5061ca-929b-4e23-89fb-6d05c1a9ffa4 df5061ca-929b-4e23-89fb-6d05c1a9ffa4 TCGA-GM-A2DA-01 TCGA-GM-A2DA-01A-11D-A18O-05 TCGA-GM-A2DA-01 TCGA-GM-A2DA-01A-11D-A18P-09 TCGA-GM-A2DA-01 df5061ca-929b-4e23-89fb-6d05c1a9ffa4 TCGA-GM-A2DA-01A-11D-A18N-01 TCGA-GM-A2DA-01 df5061ca-929b-4e23-89fb-6d05c1a9ffa4 TCGA-GM-A2DA-01A-11D-A18N-01 TCGA-GM-A2DB-01 62 1615 Negative FEMALE 1615 0 Her2 Negative enrollment LIVING TCGA-GM-A2DB-01 Squamous C3-BRCA/Luminal BRCA CIMP c7 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-GM-A2DB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-GM-A2DB-F47156 TCGA-GM-A2DB TCGA-GM-A2DB-01A Negative Negative Lumpectomy YES -22883 1644 0 2406 NO <10% 1.50 2013-8-22 FEMALE 1+ 60 1.67 1.11 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 190 NO Negative Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-GM-A2DB.5A315635-886B-459E-AF5D-079F66E859F0.pdf A2DB TUMOR FREE YES YES <10% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2006 e5aeb7a3-1454-4605-a924-d4b1ed082e87 e5aeb7a3-1454-4605-a924-d4b1ed082e87 TCGA-GM-A2DB-01A-21-A24A-20 TCGA-GM-A2DB-01 TCGA-GM-A2DB-01A-31D-A18O-05 06141302-8b54-448e-811d-c6b69434ec4a TCGA-GM-A2DB-01 TCGA-GM-A2DB-01A-31D-A19Y-09 TCGA-GM-A2DB-01 e5aeb7a3-1454-4605-a924-d4b1ed082e87 TCGA-GM-A2DB-01A-31D-A18N-01 TCGA-GM-A2DB-01 e5aeb7a3-1454-4605-a924-d4b1ed082e87 TCGA-GM-A2DB-01A-31D-A18N-01 TCGA-GM-A2DC-01 57 1628 Positive FEMALE 1628 0 LumA Positive enrollment LIVING TCGA-GM-A2DC-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-GM-A2DC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-GM-A2DC-F47061 TCGA-GM-A2DC Positive Positive Lumpectomy NO -21122 0 2535 NO 90-99% 4.43 2013-8-22 FEMALE 60 4.70 1.06 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative NO 21 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 0 No M0 N1a T1c Stage IIA A2DC TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES GM Breast LIVING 2006 beb2f2cc-8893-4db2-a527-50a7a40d6d4f beb2f2cc-8893-4db2-a527-50a7a40d6d4f TCGA-GM-A2DC-01A-21-A24A-20 TCGA-GM-A2DC-01 TCGA-GM-A2DC-01A-11D-A18O-05 efd14d4d-750d-43ac-ae08-7e75a25ec143 TCGA-GM-A2DC-01 TCGA-GM-A2DC-01A-11D-A18P-09 TCGA-GM-A2DC-01 beb2f2cc-8893-4db2-a527-50a7a40d6d4f TCGA-GM-A2DC-01A-11D-A18N-01 TCGA-GM-A2DC-01 beb2f2cc-8893-4db2-a527-50a7a40d6d4f TCGA-GM-A2DC-01A-11D-A18N-01 TCGA-GM-A2DD-01 53 1309 Negative FEMALE 1309 0 Normal Negative enrollment LIVING TCGA-GM-A2DD-01 High C3-BRCA/Luminal BRCA CIMP c7 KIRC-like c1 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-GM-A2DD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Right Sentinel node biopsy alone TCGA-GM-A2DD-F47070 TCGA-GM-A2DD Negative Negative Simple Mastectomy YES -19415 0 2282 NO <10% 1.45 2013-8-22 FEMALE <10% 2+ 60 1.62 1.11 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 Yes M0 N0 (i-) T1c Stage I A2DD TUMOR FREE YES YES <10% NO Primary Tumor 01 6th NO YES GM Breast LIVING 2007 ddc6e148-34b7-4466-b692-3bb227004e2b ddc6e148-34b7-4466-b692-3bb227004e2b TCGA-GM-A2DD-01A-21-A24A-20 TCGA-GM-A2DD-01 TCGA-GM-A2DD-01A-11D-A17Z-05 cf5d72b5-6d47-450b-90e3-8ffe9e291e75 TCGA-GM-A2DD-01 TCGA-GM-A2DD-01A-11D-A17W-09 TCGA-GM-A2DD-01 ddc6e148-34b7-4466-b692-3bb227004e2b TCGA-GM-A2DD-01A-11D-A17U-01 TCGA-GM-A2DD-01 ddc6e148-34b7-4466-b692-3bb227004e2b TCGA-GM-A2DD-01A-11D-A17U-01 TCGA-GM-A2DF-01 53 1299 Negative FEMALE 1299 0 Basal Negative enrollment LIVING TCGA-GM-A2DF-01 High C4-BRCA/Basal BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 5 TCGA-GM-A2DF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 53 Left Lower Outer Quadrant Axillary lymph node dissection alone TCGA-GM-A2DF-F47074 TCGA-GM-A2DF TCGA-GM-A2DF-01A Negative Negative Lumpectomy NO -19614 1372 0 2155 NO <10% 1.40 2013-8-22 FEMALE 1+ 60 1.57 1.12 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 100 NO Negative Negative NO 32 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 0 false No M0 N1a T1c Stage IIA TCGA-GM-A2DF.CA6B733A-6030-422C-9DE9-B9718CBB2FDC.pdf A2DF TUMOR FREE YES YES <10% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2007 83f8c292-5ae0-4c58-9f08-e58ce391f4f4 83f8c292-5ae0-4c58-9f08-e58ce391f4f4 TCGA-GM-A2DF-01A-21-A24A-20 TCGA-GM-A2DF-01 TCGA-GM-A2DF-01A-11D-A17Z-05 1af97bf7-a99d-48f9-9ed1-69612327c1f9 TCGA-GM-A2DF-01 TCGA-GM-A2DF-01A-11D-A17W-09 TCGA-GM-A2DF-01 83f8c292-5ae0-4c58-9f08-e58ce391f4f4 TCGA-GM-A2DF-01A-11D-A17U-01 TCGA-GM-A2DF-01 83f8c292-5ae0-4c58-9f08-e58ce391f4f4 TCGA-GM-A2DF-01A-11D-A17U-01 TCGA-GM-A2DH-01 58 1286 Negative FEMALE 1286 0 Her2 Negative enrollment LIVING TCGA-GM-A2DH-01 High C3-BRCA/Luminal BRCA non-CIMP c9 BRCA basal-like c6 BRCA nonbasal-like c7 miRNA c1uster 10 TCGA-GM-A2DH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-GM-A2DH-F47081 TCGA-GM-A2DH Negative Negative Simple Mastectomy YES -21344 0 2193 NO <10% 2.80 2013-8-22 FEMALE 1+ 60 2.80 1.00 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Negative Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 1 No M0 N0 (i+) T1c Stage I A2DH TUMOR FREE YES YES <10% NO Primary Tumor 01 6th NO YES GM Breast LIVING 2007 ec2ac902-f5ca-45a5-a72a-1b266360410a ec2ac902-f5ca-45a5-a72a-1b266360410a TCGA-GM-A2DH-01A-21-A24A-20 TCGA-GM-A2DH-01 TCGA-GM-A2DH-01A-11D-A17Z-05 d2a00ef2-dd0f-4bd7-91e5-21e80e8b7e9e TCGA-GM-A2DH-01 TCGA-GM-A2DH-01A-11D-A17W-09 TCGA-GM-A2DH-01 ec2ac902-f5ca-45a5-a72a-1b266360410a TCGA-GM-A2DH-01A-11D-A17U-01 TCGA-GM-A2DH-01 ec2ac902-f5ca-45a5-a72a-1b266360410a TCGA-GM-A2DH-01A-11D-A17U-01 TCGA-GM-A2DI-01 52 1883 Negative FEMALE 1883 0 LumA Negative enrollment LIVING TCGA-GM-A2DI-01 Squamous C3-BRCA/Luminal Low purity c2 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 3 TCGA-GM-A2DI TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-GM-A2DI-F47089 TCGA-GM-A2DI TCGA-GM-A2DI-01A Negative Negative Simple Mastectomy YES -19030 2144 0 2590 NO <10% 3.33 2013-8-22 FEMALE 60 3.53 1.06 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 150 NO Negative NO 9 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 1 false No M0 N0 (i+) T1c Stage I TCGA-GM-A2DI.D437E9FF-5C09-4FD6-BB0B-0881CD4C50D7.pdf A2DI TUMOR FREE YES YES <10% NO Primary Tumor 01 6th NO YES GM Breast A LIVING 2005 c50e1f9f-6059-4609-876d-938efb8a784e c50e1f9f-6059-4609-876d-938efb8a784e TCGA-GM-A2DI-01A-21-A24A-20 TCGA-GM-A2DI-01 TCGA-GM-A2DI-01A-31D-A18O-05 88140136-0e0a-44e3-84ac-ae2e2724a95f TCGA-GM-A2DI-01 TCGA-GM-A2DI-01A-31D-A18P-09 TCGA-GM-A2DI-01 c50e1f9f-6059-4609-876d-938efb8a784e TCGA-GM-A2DI-01A-31D-A18N-01 TCGA-GM-A2DI-01 c50e1f9f-6059-4609-876d-938efb8a784e TCGA-GM-A2DI-01A-31D-A18N-01 TCGA-GM-A2DK-01 58 1896 Positive FEMALE 1896 0 LumA Negative enrollment LIVING TCGA-GM-A2DK-01 COAD-READ C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-GM-A2DK TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-GM-A2DK-F47094 TCGA-GM-A2DK TCGA-GM-A2DK-01A Positive Negative Lumpectomy YES -21198 2109 0 2645 NO 90-99% 2013-8-22 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T1c Stage I TCGA-GM-A2DK.FBD7BD94-2870-431D-A519-DAF72A97845F.pdf A2DK TUMOR FREE YES YES <10% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2005 52df7d5d-7236-464f-9394-7c20f8726280 52df7d5d-7236-464f-9394-7c20f8726280 TCGA-GM-A2DK-01A-11-A24A-20 TCGA-GM-A2DK-01 TCGA-GM-A2DK-01A-21D-A17Z-05 7f74c5f0-6c1f-4b93-a192-ee7d9c492c67 TCGA-GM-A2DK-01 TCGA-GM-A2DK-01A-21D-A17W-09 TCGA-GM-A2DK-01 52df7d5d-7236-464f-9394-7c20f8726280 TCGA-GM-A2DK-01A-21D-A17U-01 TCGA-GM-A2DK-01 52df7d5d-7236-464f-9394-7c20f8726280 TCGA-GM-A2DK-01A-21D-A17U-01 TCGA-GM-A2DL-01 50 2762 Positive FEMALE 2762 0 LumA Positive enrollment LIVING TCGA-GM-A2DL-01 BRCA-LUAD+ C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-GM-A2DL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-GM-A2DL-F47098 TCGA-GM-A2DL TCGA-GM-A2DL-01A Positive Positive Lumpectomy YES -18475 2723 0 3519 NO 90-99% 2013-8-22 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 130 NO Negative NO 2 Negative Peri (6-12 months since last menstrual period) NO 0 0 false No M0 N0 (i-) T1c Stage I TCGA-GM-A2DL.8CF4E53E-924F-4DC6-8748-BC8A1F7D5662.pdf A2DL TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2003 8955404a-c756-4116-9613-dea06077a056 8955404a-c756-4116-9613-dea06077a056 TCGA-GM-A2DL-01A-21-A24A-20 TCGA-GM-A2DL-01 TCGA-GM-A2DL-01A-11D-A18O-05 eba15eee-e233-45cc-b24d-fd3d99aa7e00 TCGA-GM-A2DL-01 TCGA-GM-A2DL-01A-11D-A18P-09 TCGA-GM-A2DL-01 8955404a-c756-4116-9613-dea06077a056 TCGA-GM-A2DL-01A-11D-A18N-01 TCGA-GM-A2DL-01 8955404a-c756-4116-9613-dea06077a056 TCGA-GM-A2DL-01A-11D-A18N-01 TCGA-GM-A2DM-01 57 2331 Positive FEMALE 2331 0 LumA Positive enrollment LIVING TCGA-GM-A2DM-01 Quiet C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 TCGA-GM-A2DM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-GM-A2DM-F47104 TCGA-GM-A2DM TCGA-GM-A2DM-01A Positive Positive Lumpectomy YES -21160 2464 0 3226 NO 40-49% 2013-8-22 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-GM-A2DM.18D46E96-4E16-4736-AACF-C6BF8AEC9368.pdf A2DM TUMOR FREE YES YES 30-39% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2004 8d8fed5e-4b27-472a-93fa-2dba57098576 8d8fed5e-4b27-472a-93fa-2dba57098576 TCGA-GM-A2DM-01A-21-A24A-20 TCGA-GM-A2DM-01 TCGA-GM-A2DM-01A-11D-A17Z-05 0f5e7aba-bcea-43bb-b280-ad49450691dd TCGA-GM-A2DM-01 TCGA-GM-A2DM-01A-11D-A17W-09 TCGA-GM-A2DM-01 8d8fed5e-4b27-472a-93fa-2dba57098576 TCGA-GM-A2DM-01A-11D-A17U-01 TCGA-GM-A2DM-01 8d8fed5e-4b27-472a-93fa-2dba57098576 TCGA-GM-A2DM-01A-11D-A17U-01 TCGA-GM-A2DN-01 58 2352 Positive FEMALE 2352 0 LumA Positive enrollment LIVING TCGA-GM-A2DN-01 Iq C3-BRCA/Luminal BRCA non-CIMP c9 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 5 TCGA-GM-A2DN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 58 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-GM-A2DN-F47124 TCGA-GM-A2DN TCGA-GM-A2DN-01A Positive Positive Modified Radical Mastectomy YES -21288 2436 0 3091 NO 90-99% 2013-8-22 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 210 NO Negative NO 9 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-GM-A2DN.8829274B-EB82-4155-A458-CF9F0E60B36E.pdf A2DN TUMOR FREE YES YES 90-99% NO Primary Tumor 01 6th NO YES GM Breast A LIVING 2004 0872770d-ed18-47c4-8190-212b7250f7cf 0872770d-ed18-47c4-8190-212b7250f7cf TCGA-GM-A2DN-01A-21-A24A-20 TCGA-GM-A2DN-01 TCGA-GM-A2DN-01A-11D-A17Z-05 cbb6932d-84f3-4a8f-9518-d8135db77eb2 TCGA-GM-A2DN-01 TCGA-GM-A2DN-01A-11D-A17W-09 TCGA-GM-A2DN-01 0872770d-ed18-47c4-8190-212b7250f7cf TCGA-GM-A2DN-01A-11D-A17U-01 TCGA-GM-A2DN-01 0872770d-ed18-47c4-8190-212b7250f7cf TCGA-GM-A2DN-01A-11D-A17U-01 TCGA-GM-A2DO-01 54 1622 Positive FEMALE 1622 0 LumB Positive enrollment LIVING TCGA-GM-A2DO-01 Kirc+ C3-BRCA/Luminal Cluster 5 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 4 TCGA-GM-A2DO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-GM-A2DO-F47151 TCGA-GM-A2DO TCGA-GM-A2DO-01A Positive Positive Lumpectomy YES -19842 1932 0 2596 NO 90-99% 2013-8-22 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 110 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T1c Stage I TCGA-GM-A2DO.100E842E-0ADD-4E58-B31B-0C67DC175787.pdf A2DO TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2006 9827d98e-4e2e-44cb-b0a5-f51b74ec0675 9827d98e-4e2e-44cb-b0a5-f51b74ec0675 TCGA-GM-A2DO-01A-21-A24A-20 TCGA-GM-A2DO-01 TCGA-GM-A2DO-01A-11D-A18O-05 0db11312-24bd-4df2-9bb6-f271db3a0d30 TCGA-GM-A2DO-01 TCGA-GM-A2DO-01A-11D-A19Y-09 TCGA-GM-A2DO-01 9827d98e-4e2e-44cb-b0a5-f51b74ec0675 TCGA-GM-A2DO-01A-11D-A18N-01 TCGA-GM-A2DO-01 9827d98e-4e2e-44cb-b0a5-f51b74ec0675 TCGA-GM-A2DO-01A-11D-A18N-01 TCGA-GM-A3NW-01 TCGA-GM-A3NW-01 BRCA-LUAD+ BRCA CIMP c7 miRNA cluster 14 TCGA-GM-A3NW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Inner Quadrant Sentinel node biopsy alone TCGA-GM-A3NW-F40398 TCGA-GM-A3NW Negative Positive Simple Mastectomy YES -23041 0 3361 NO 1.57 2013-2-18 FEMALE 30-39% 1+ 60 1.80 1.15 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Equivocal Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 No M0 N0 (i-) T2 Stage IIA A3NW TUMOR FREE YES YES 20-29% NO Primary Tumor 01 6th NO YES GM Breast LIVING 2003 e996b750-d0d3-43c8-860a-17da2f607b15 e996b750-d0d3-43c8-860a-17da2f607b15 TCGA-GM-A3NW-01 TCGA-GM-A3NW-01A-21D-A22B-05 TCGA-GM-A3NW-01 TCGA-GM-A3NW-01A-21D-A228-09 TCGA-GM-A3NW-01 e996b750-d0d3-43c8-860a-17da2f607b15 TCGA-GM-A3NW-01A-21D-A227-01 TCGA-GM-A3NW-01 e996b750-d0d3-43c8-860a-17da2f607b15 TCGA-GM-A3NW-01A-21D-A227-01 TCGA-GM-A3NY-01 LumA TCGA-GM-A3NY-01 Iq C3-BRCA/Luminal BRCA CIMP c7 BRCA nonbasal-like c8 BRCA nonbasal-like c7 miRNA cluster 6 TCGA-GM-A3NY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-GM-A3NY-F40403 TCGA-GM-A3NY TCGA-GM-A3NY-01A Positive Positive Lumpectomy NO -26642 778 0 1162 NO 90-99% 2013-2-19 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 140 NO Negative NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 0 false No M0 N1a T2 Stage IIB TCGA-GM-A3NY.1659798C-9B6A-4DF9-A5B6-79AD2194DF11.pdf A3NY TUMOR FREE YES YES 20-29% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2009 85c4a097-4567-4bdf-879c-96c9a4f48052 85c4a097-4567-4bdf-879c-96c9a4f48052 TCGA-GM-A3NY-01A-21-A24A-20 TCGA-GM-A3NY-01 TCGA-GM-A3NY-01A-11D-A21R-05 b6420819-1738-4d07-9a22-c3a38f0755d4 TCGA-GM-A3NY-01 TCGA-GM-A3NY-01A-11D-A21Q-09 TCGA-GM-A3NY-01 85c4a097-4567-4bdf-879c-96c9a4f48052 TCGA-GM-A3NY-01A-11D-A21P-01 TCGA-GM-A3NY-01 85c4a097-4567-4bdf-879c-96c9a4f48052 TCGA-GM-A3NY-01A-11D-A21P-01 TCGA-GM-A3XG-01 TCGA-GM-A3XG-01 TCGA-GM-A3XG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right|Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-GM-A3XG-F46963 TCGA-GM-A3XG TCGA-GM-A3XG-01A Positive Positive Modified Radical Mastectomy YES -16948 899 0 1330 90-99% 1.67 2013-8-20 FEMALE 1+ 60 1.73 1.04 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 270 NO Negative Negative NO 26 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 3 0 false No M0 N1a T3 Stage IIIA TCGA-GM-A3XG.E76B5204-99E5-42D0-AE7E-ED5525796CCB.pdf A3XG TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2009 718c3d2a-517e-4e32-a96b-ef17848d56d8 718c3d2a-517e-4e32-a96b-ef17848d56d8 TCGA-GM-A3XG-01 TCGA-GM-A3XG-01A-31D-A244-05 fef9a497-d85c-46eb-9ebf-6a9645462a4a TCGA-GM-A3XG-01 TCGA-GM-A3XG-01A-31D-A243-09 TCGA-GM-A3XG-01 718c3d2a-517e-4e32-a96b-ef17848d56d8 TCGA-GM-A3XG-01A-31D-A242-01 TCGA-GM-A3XG-01 718c3d2a-517e-4e32-a96b-ef17848d56d8 TCGA-GM-A3XG-01A-31D-A242-01 TCGA-GM-A3XL-01 TCGA-GM-A3XL-01 BRCA basal-like c6 miRNA cluster 4 TCGA-GM-A3XL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right|Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-GM-A3XL-F41970 TCGA-GM-A3XL TCGA-GM-A3XL-01A Negative Negative Lumpectomy YES -18171 1779 0 2108 <10% 2013-4-8 FEMALE 0.99 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-GM-A3XL.E8583D11-D6F7-41AC-8CD5-53437CBD8820.pdf A3XL TUMOR FREE YES YES <10% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2007 29c98197-249e-45c9-96dc-34dfb4ac1430 29c98197-249e-45c9-96dc-34dfb4ac1430 TCGA-GM-A3XL-01A-21-A24A-20 TCGA-GM-A3XL-01 TCGA-GM-A3XL-01A-11D-A230-05 01083b39-09ef-40dd-86c0-5cb8a2a5a646 TCGA-GM-A3XL-01 TCGA-GM-A3XL-01A-11D-A22X-09 TCGA-GM-A3XL-01 29c98197-249e-45c9-96dc-34dfb4ac1430 TCGA-GM-A3XL-01A-11D-A22W-01 TCGA-GM-A3XL-01 29c98197-249e-45c9-96dc-34dfb4ac1430 TCGA-GM-A3XL-01A-11D-A22W-01 TCGA-GM-A3XN-01 TCGA-GM-A3XN-01 BRCA nonbasal-like c8 miRNA cluster 4 TCGA-GM-A3XN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-GM-A3XN-F46967 TCGA-GM-A3XN TCGA-GM-A3XN-01A Positive Positive Lumpectomy NO -16109 1627 0 2019 80-89% 1.73 2013-8-20 FEMALE 1+ 60 1.85 1.07 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Incisional Biopsy 100 NO Negative Negative NO 34 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 5 0 false No M0 N2a T1c Stage IIIA TCGA-GM-A3XN.E9A88E5B-4F50-4683-9C65-56CFCB15405E.pdf A3XN TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2007 740c53d0-b037-4475-82b3-044b2f879aac 740c53d0-b037-4475-82b3-044b2f879aac TCGA-GM-A3XN-01A-21-A24A-20 TCGA-GM-A3XN-01 TCGA-GM-A3XN-01A-12D-A230-05 dc2ec9a1-7c3d-4265-be91-132bb9456eff TCGA-GM-A3XN-01 TCGA-GM-A3XN-01A-12D-A22X-09 TCGA-GM-A3XN-01 740c53d0-b037-4475-82b3-044b2f879aac TCGA-GM-A3XN-01A-12D-A22W-01 TCGA-GM-A3XN-01 740c53d0-b037-4475-82b3-044b2f879aac TCGA-GM-A3XN-01A-12D-A22W-01 TCGA-GM-A4E0-01 TCGA-GM-A4E0-01 TCGA-GM-A4E0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Left|Left Upper Inner Quadrant|Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-GM-A4E0-F47030 TCGA-GM-A4E0 TCGA-GM-A4E0-01A Positive Positive Modified Radical Mastectomy YES -24788 1871 0 2191 90-99% 2013-8-21 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 210 NO Negative NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 10 1 false No M0 N3a T3 Stage IIIC TCGA-GM-A4E0.DB0291E6-E371-40F8-BDB3-0F85F015B3DE.pdf A4E0 TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES GM Breast A LIVING 2007 da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0 da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0 TCGA-GM-A4E0-01 TCGA-GM-A4E0-01A-12D-A268-05 016da2b9-36c0-4cde-bf58-e0a46e381af9 TCGA-GM-A4E0-01 TCGA-GM-A4E0-01A-12D-A25Q-09 TCGA-GM-A4E0-01 da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0 TCGA-GM-A4E0-01A-12D-A25N-01 TCGA-GM-A4E0-01 da8c1ab5-7b67-4ebc-b854-cc45eaec8ee0 TCGA-GM-A4E0-01A-12D-A25N-01 TCGA-GM-A5PV-01 TCGA-GM-A5PV-01 TCGA-GM-A5PV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right Sentinel lymph node biopsy plus axillary dissection TCGA-GM-A5PV TCGA-GM-A5PV-01A Positive Positive Modified Radical Mastectomy NO -23215 499 0 412 90-99% 2.70 2013-4-12 FEMALE 40 3.65 1.35 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 190 NO Negative 24 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 false No M0 N1a T2 Stage IIB TCGA-GM-A5PV.A616A83A-8D19-4085-B430-1AF80D4F9642.pdf A5PV TUMOR FREE YES YES 30-39% NO Primary Tumor 01 7th NO YES GM Breast A LIVING 2011 96c1cfef-0507-46f5-a007-d0f7369cced5 96c1cfef-0507-46f5-a007-d0f7369cced5 TCGA-GM-A5PV-01 TCGA-GM-A5PV-01A-11D-A28C-05 a099aed3-9597-47e9-afd2-58e19aba2018 TCGA-GM-A5PV-01 TCGA-GM-A5PV-01A-11D-A28B-09 TCGA-GM-A5PV-01 96c1cfef-0507-46f5-a007-d0f7369cced5 TCGA-GM-A5PV-01A-11D-A28A-01 TCGA-GM-A5PV-01 96c1cfef-0507-46f5-a007-d0f7369cced5 TCGA-GM-A5PV-01A-11D-A28A-01 TCGA-GM-A5PX-01 TCGA-GM-A5PX-01 TCGA-GM-A5PX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Left Sentinel lymph node biopsy plus axillary dissection TCGA-GM-A5PX TCGA-GM-A5PX-01A Positive Positive Simple Mastectomy YES -23753 616 0 551 90-99% 1.78 2013-4-12 FEMALE 30-39% 1+ 60 1.98 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 110 NO Negative Negative 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 2 false No M0 N1mi T2 Stage IIB TCGA-GM-A5PX.E49FAC55-434A-429B-8E61-C5E0FBD7C15C.pdf A5PX TUMOR FREE YES YES 90-99% NO Primary Tumor 01 7th NO YES GM Breast A LIVING 2011 76f171dd-1980-4504-8dc2-d8c8264458c9 76f171dd-1980-4504-8dc2-d8c8264458c9 TCGA-GM-A5PX-01 TCGA-GM-A5PX-01A-12D-A28C-05 e0413f7a-1629-4323-84d0-53d7819eea0e TCGA-GM-A5PX-01 TCGA-GM-A5PX-01A-12D-A28B-09 TCGA-GM-A5PX-01 76f171dd-1980-4504-8dc2-d8c8264458c9 TCGA-GM-A5PX-01A-12D-A28A-01 TCGA-GM-A5PX-01 76f171dd-1980-4504-8dc2-d8c8264458c9 TCGA-GM-A5PX-01A-12D-A28A-01 TCGA-HN-A2NL-01 Basal TCGA-HN-A2NL-01 Squamous C4-BRCA/Basal BRCA basal-like c8 KIRC-like c1 BRCA basal-like c8 miRNA cluster 1 TCGA-HN-A2NL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-HN-A2NL-F60149 TCGA-HN-A2NL TCGA-HN-A2NL-01A Negative Negative Simple Mastectomy YES -20483 0 79 2014-5-30 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Tumor resection 170 NO Negative YES 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 T2 Stage IIA TCGA-HN-A2NL.CC1EE9E0-BC1A-46ED-A262-7A2B9CC8BBB1.pdf A2NL TUMOR FREE YES YES Primary Tumor 01 6th NO YES HN Breast A LIVING 6593576c-a4a8-4284-8591-321f980f2e58 6593576c-a4a8-4284-8591-321f980f2e58 TCGA-HN-A2NL-01A-21-A24A-20 TCGA-HN-A2NL-01 TCGA-HN-A2NL-01A-11D-A18O-05 826ef0de-68ba-4771-a305-97f27770407a TCGA-HN-A2NL-01 TCGA-HN-A2NL-01A-11D-A18P-09 TCGA-HN-A2NL-01 6593576c-a4a8-4284-8591-321f980f2e58 TCGA-HN-A2NL-01A-11D-A18N-01 TCGA-HN-A2NL-01 6593576c-a4a8-4284-8591-321f980f2e58 TCGA-HN-A2NL-01A-11D-A18N-01 TCGA-HN-A2OB-01 TCGA-HN-A2OB-01 TCGA-HN-A2OB TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES NO 45 Right|Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-HN-A2OB-F71891 TCGA-HN-A2OB TCGA-HN-A2OB-01A Positive Positive Simple Mastectomy NO -16672 1900 0 1849 1552 1.7 2015-4-1 FEMALE 60 2.0 1.2 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 320 NO Negative Negative NO 10 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Negative 1+ Positive 3 Point Scale 3+ 2+ Positive 3 Point Scale Bone Distant Metastasis NO YES 2 false No M0 N1 T2 Stage IIB TCGA-HN-A2OB.32AE5A1A-703B-43C3-948A-719A90DDACC5.pdf A2OB WITH TUMOR YES YES YES Primary Tumor 01 6th NO YES HN Breast A DECEASED f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e TCGA-HN-A2OB-01 TCGA-HN-A2OB-01A-21D-A27Y-05 27e8a52c-a4b2-4773-afde-1e2dba0e5822 TCGA-HN-A2OB-01 TCGA-HN-A2OB-01A-21D-A27P-09 TCGA-HN-A2OB-01 f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e TCGA-HN-A2OB-01A-21D-A27O-01 TCGA-HN-A2OB-01 f6aa5164-4438-4df2-9e5d-9dd8f5cdfd5e TCGA-HN-A2OB-01A-21D-A27O-01 TCGA-JL-A3YW-01 TCGA-JL-A3YW-01 BRCA basal-like c6 TCGA-JL-A3YW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Axillary lymph node dissection alone TCGA-JL-A3YW Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy 0 360 30-39% 2012-11-8 FEMALE 30-39% 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Tumor resection Positive 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 3 0 No M0 N1 T2 Stage IIB A3YW NO YES 30-39% NO Primary Tumor 01 7th YES NO JL Breast LIVING 2011 a550da17-2d06-49ac-96dc-a2204298ddfb a550da17-2d06-49ac-96dc-a2204298ddfb TCGA-JL-A3YW-01A-21-A24B-20 TCGA-JL-A3YW-01 TCGA-JL-A3YW-01A-12D-A23D-05 c2d6cdae-b8a7-4d4b-a4ee-b4ff66bd1b38 TCGA-JL-A3YW-01 TCGA-JL-A3YW-01A-12D-A23C-09 TCGA-JL-A3YW-01 a550da17-2d06-49ac-96dc-a2204298ddfb TCGA-JL-A3YW-01A-12D-A238-01 TCGA-JL-A3YW-01 a550da17-2d06-49ac-96dc-a2204298ddfb TCGA-JL-A3YW-01A-12D-A238-01 TCGA-JL-A3YX-01 TCGA-JL-A3YX-01 KIRC-like c1 miRNA cluster 4 TCGA-JL-A3YX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Axillary lymph node dissection alone TCGA-JL-A3YX TCGA-JL-A3YX-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy 306 0 352 30-39% 2012-11-8 FEMALE 30-39% 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Tumor resection 900 NO Positive 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 T2 Stage IIA TCGA-JL-A3YX.25782EF0-8786-446E-ADBA-21F489844237.pdf A3YX NO YES 30-39% NO Primary Tumor 01 7th YES NO JL Breast A LIVING 2011 b2b92b23-3f2a-4305-8c6c-27c91c67c072 b2b92b23-3f2a-4305-8c6c-27c91c67c072 TCGA-JL-A3YX-01A-21-A24B-20 TCGA-JL-A3YX-01 TCGA-JL-A3YX-01A-11D-A230-05 28195fde-9084-494d-9b76-a65c7fe11ba9 TCGA-JL-A3YX-01 TCGA-JL-A3YX-01A-11D-A22X-09 TCGA-JL-A3YX-01 b2b92b23-3f2a-4305-8c6c-27c91c67c072 TCGA-JL-A3YX-01A-11D-A22W-01 TCGA-JL-A3YX-01 b2b92b23-3f2a-4305-8c6c-27c91c67c072 TCGA-JL-A3YX-01A-11D-A22W-01 TCGA-LD-A66U-01 TCGA-LD-A66U-01 TCGA-LD-A66U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-LD-A66U-F63067 TCGA-LD-A66U Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy NO -16101 0 646 90-99% 2014-7-30 FEMALE <10% Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy Negative NO 15 Negative NO 2 No MX N1mi T2 Stage IIB A66U TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO LD Breast LIVING 2012 d37ab528-22b6-4b9e-b838-4d90f6d8bc14 d37ab528-22b6-4b9e-b838-4d90f6d8bc14 TCGA-LD-A66U-01 TCGA-LD-A66U-01A-11D-A31V-05 c65aac48-9f36-4802-8509-a1bff8136db3 TCGA-LD-A66U-01 TCGA-LD-A66U-01 d37ab528-22b6-4b9e-b838-4d90f6d8bc14 TCGA-LD-A66U-01A-11D-A31T-01 TCGA-LD-A66U-01 d37ab528-22b6-4b9e-b838-4d90f6d8bc14 TCGA-LD-A66U-01A-11D-A31T-01 TCGA-LD-A74U-01 TCGA-LD-A74U-01 TCGA-LD-A74U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 79 Right Axillary lymph node dissection alone TCGA-LD-A74U-F69186 TCGA-LD-A74U TCGA-LD-A74U-01A Positive 3 Point Scale 3 Point Scale Negative Lumpectomy -28981 59 0 402 <10% 2014-12-30 FEMALE Other, specify No C50.9 8524/3 C50.9 3+ YES Core needle biopsy 210 NO Negative NO 12 Negative NO 11 true Yes M0 N3a T3 Stage IIIC TCGA-LD-A74U.CA6A13D4-DD80-4424-B5F3-654EE31263AE.pdf A74U WITH TUMOR YES YES <10% NO Primary Tumor 01 7th YES NO LD Breast A LIVING 2013 11782f87-4d58-4897-9a61-7a4605c05eca 11782f87-4d58-4897-9a61-7a4605c05eca TCGA-LD-A74U-01 TCGA-LD-A74U-01A-13D-A33F-05 F4F6B174-8640-46C3-9913-5F5043856ADA TCGA-LD-A74U-01 TCGA-LD-A74U-01 11782f87-4d58-4897-9a61-7a4605c05eca TCGA-LD-A74U-01A-13D-A33D-01 TCGA-LD-A74U-01 11782f87-4d58-4897-9a61-7a4605c05eca TCGA-LD-A74U-01A-13D-A33D-01 TCGA-LD-A7W5-01 TCGA-LD-A7W5-01 TCGA-LD-A7W5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-LD-A7W5-F69184 TCGA-LD-A7W5 TCGA-LD-A7W5-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy NO -19169 83 0 216 90-99% 2014-12-30 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 360 NO Negative NO 23 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 23 true No M0 N3a T2 Stage IIIC TCGA-LD-A7W5.ADBA741B-AABF-4A33-A61F-C10EE555D175.pdf A7W5 WITH TUMOR YES YES NO Primary Tumor 01 7th YES NO LD Breast A LIVING 2013 c83d9436-3f08-4197-9392-ff33fe4c632e c83d9436-3f08-4197-9392-ff33fe4c632e TCGA-LD-A7W5-01 TCGA-LD-A7W5-01A-22D-A357-05 7DEB3148-9179-4E71-98E3-81DE903CE3E5 TCGA-LD-A7W5-01 TCGA-LD-A7W5-01 c83d9436-3f08-4197-9392-ff33fe4c632e TCGA-LD-A7W5-01A-22D-A350-01 TCGA-LD-A7W5-01 c83d9436-3f08-4197-9392-ff33fe4c632e TCGA-LD-A7W5-01A-22D-A350-01 TCGA-LD-A7W6-01 TCGA-LD-A7W6-01 TCGA-LD-A7W6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right|Right Upper Inner Quadrant Axillary lymph node dissection alone TCGA-LD-A7W6-F69193 TCGA-LD-A7W6 TCGA-LD-A7W6-01A Positive 3 Point Scale 3 Point Scale Positive Modified Radical Mastectomy NO -20077 91 0 404 90-99% 2014-12-30 FEMALE Other, specify No C50.2 8524/3 C50.2 3+ YES Core needle biopsy 630 NO Negative NO 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 true No M0 N1a T2 Stage IIB TCGA-LD-A7W6.859561F6-3113-45C8-8FBE-718BF860B582.pdf A7W6 TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO LD Breast A LIVING 2013 da8e08c7-6006-4e66-ae0f-7047177ca02a da8e08c7-6006-4e66-ae0f-7047177ca02a TCGA-LD-A7W6-01 TCGA-LD-A7W6-01A-81D-A357-05 4F831753-0FF7-4B6E-987C-CCC50799E73D TCGA-LD-A7W6-01 TCGA-LD-A7W6-01 da8e08c7-6006-4e66-ae0f-7047177ca02a TCGA-LD-A7W6-01A-81D-A350-01 TCGA-LD-A7W6-01 da8e08c7-6006-4e66-ae0f-7047177ca02a TCGA-LD-A7W6-01A-81D-A350-01 TCGA-LD-A9QF-01 TCGA-LD-A9QF-01 TCGA-LD-A9QF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Left Sentinel node biopsy alone TCGA-LD-A9QF-F69216 TCGA-LD-A9QF TCGA-LD-A9QF-01A Negative Negative Simple Mastectomy YES -26869 85 0 323 2014-12-30 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 190 NO Positive NO 14 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T1c Stage IA TCGA-LD-A9QF.E8601979-AE05-4E4D-BB39-6B9C5E67D050.pdf A9QF TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO LD Breast A LIVING 2013 c2df60f6-40d5-4fe0-88f8-d168feb0d921 c2df60f6-40d5-4fe0-88f8-d168feb0d921 TCGA-LD-A9QF-01 TCGA-LD-A9QF-01A-32D-A41Q-05 1D404A66-9E4B-4AA3-9ADA-A5A789ECF185 TCGA-LD-A9QF-01 TCGA-LD-A9QF-01 c2df60f6-40d5-4fe0-88f8-d168feb0d921 TCGA-LD-A9QF-01A-32D-A41E-01 TCGA-LD-A9QF-01 c2df60f6-40d5-4fe0-88f8-d168feb0d921 TCGA-LD-A9QF-01A-32D-A41E-01 TCGA-LL-A440-01 TCGA-LL-A440-01 TCGA-LL-A440 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-LL-A440-F46387 TCGA-LL-A440 TCGA-LL-A440-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy YES -22497 32 0 759 90-99% 46 2013-8-7 FEMALE 2+ 20 79 1.7 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 200 NO Equivocal Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false Yes MX N0 (i-) T1c Stage IA TCGA-LL-A440.5577BE88-72ED-43E5-9BB1-83D56C2EA346.pdf A440 TUMOR FREE YES YES 90-99% NO Primary Tumor 01 7th YES NO LL Breast A LIVING 2012 f34965fe-e7d5-48bd-b0a0-575cbd895c5a f34965fe-e7d5-48bd-b0a0-575cbd895c5a TCGA-LL-A440-01 TCGA-LL-A440-01A-11D-A244-05 4bc983f8-0b5f-456c-88be-f1a7e901255b TCGA-LL-A440-01 TCGA-LL-A440-01A-11D-A243-09 TCGA-LL-A440-01 f34965fe-e7d5-48bd-b0a0-575cbd895c5a TCGA-LL-A440-01A-11D-A242-01 TCGA-LL-A440-01 f34965fe-e7d5-48bd-b0a0-575cbd895c5a TCGA-LL-A440-01A-11D-A242-01 TCGA-LL-A441-01 TCGA-LL-A441-01 TCGA-LL-A441 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 62 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-LL-A441-F46386 TCGA-LL-A441 TCGA-LL-A441-01A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy YES -22772 37 0 996 2013-8-7 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 300 NO Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 T1c Stage IA TCGA-LL-A441.1FFDD2E3-02D5-4C38-B6E9-1261EB57835A.pdf A441 TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO LL Breast A LIVING 2012 8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662 8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662 TCGA-LL-A441-01 TCGA-LL-A441-01A-11D-A244-05 76fc75d8-5131-4ccf-9c99-be1dac58876d TCGA-LL-A441-01 TCGA-LL-A441-01A-11D-A243-09 TCGA-LL-A441-01 8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662 TCGA-LL-A441-01A-11D-A242-01 TCGA-LL-A441-01 8fe6cbcd-5ffc-4bad-9fa2-90a6c1dcb662 TCGA-LL-A441-01A-11D-A242-01 TCGA-LL-A442-01 TCGA-LL-A442-01 TCGA-LL-A442 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 56 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-LL-A442-F46384 TCGA-LL-A442 TCGA-LL-A442-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Simple Mastectomy YES -20495 60 0 889 90-99% 35 2013-8-7 FEMALE 2+ 20 60 1.7 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 140 NO Equivocal Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false Yes MX N0 (i-) T2 Stage IIA TCGA-LL-A442.389044F0-9D90-4639-8C42-C1A6EA816442.pdf A442 TUMOR FREE YES YES 90-99% NO Primary Tumor 01 7th YES NO LL Breast A LIVING 2012 7c355987-c70f-43f1-94cc-f4d12afe0132 7c355987-c70f-43f1-94cc-f4d12afe0132 TCGA-LL-A442-01 TCGA-LL-A442-01A-11D-A244-05 068153fa-935a-429c-9719-84aebe91f185 TCGA-LL-A442-01 TCGA-LL-A442-01 7c355987-c70f-43f1-94cc-f4d12afe0132 TCGA-LL-A442-01A-11D-A242-01 TCGA-LL-A442-01 7c355987-c70f-43f1-94cc-f4d12afe0132 TCGA-LL-A442-01A-11D-A242-01 TCGA-LL-A50Y-01 TCGA-LL-A50Y-01 TCGA-LL-A50Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 84 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-LL-A50Y-F50406 TCGA-LL-A50Y TCGA-LL-A50Y-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy YES -30934 91 0 762 90-99% 2.5 2013-10-23 FEMALE 2+ 167 2.6 1.0 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 130 NO Equivocal Negative NO 8 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false Yes MX N0 T2 Stage IIA TCGA-LL-A50Y.C3BD4B5F-0FB9-4B22-B8FE-9D689660B5E9.pdf A50Y TUMOR FREE YES YES 90-99% NO Primary Tumor 01 7th YES NO LL Breast A LIVING 2012 02a65cb0-158c-478b-b72e-d6bae04429c7 02a65cb0-158c-478b-b72e-d6bae04429c7 TCGA-LL-A50Y-01 TCGA-LL-A50Y-01A-11D-A268-05 acabe392-7b49-4967-90b5-81ac53cfec8e TCGA-LL-A50Y-01 TCGA-LL-A50Y-01A-11D-A25Q-09 TCGA-LL-A50Y-01 02a65cb0-158c-478b-b72e-d6bae04429c7 TCGA-LL-A50Y-01A-11D-A25N-01 TCGA-LL-A50Y-01 02a65cb0-158c-478b-b72e-d6bae04429c7 TCGA-LL-A50Y-01A-11D-A25N-01 TCGA-LL-A5YL-01 TCGA-LL-A5YL-01 TCGA-LL-A5YL TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right|Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-LL-A5YL-F59650 TCGA-LL-A5YL TCGA-LL-A5YL-01A Positive 3 Point Scale 3 Point Scale Negative Simple Mastectomy -23395 84 0 519 90-99% 2.9 2014-5-19 FEMALE 3+ 65 2.6 0.9 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 570 NO Positive Negative NO 23 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 3 0 false No MX N1a T2 Stage IIB TCGA-LL-A5YL.17B51CA5-E325-4EA0-AFED-C6D0FD5A40EF.pdf A5YL YES YES <10% YES Primary Tumor 01 7th YES NO LL Breast A LIVING 2012 979d9841-337c-47a3-acaf-77d45e276589 979d9841-337c-47a3-acaf-77d45e276589 TCGA-LL-A5YL-01 TCGA-LL-A5YL-01A-12D-A29O-05 daaf11f9-0595-4ad7-9f96-7a3a0a82513e TCGA-LL-A5YL-01 TCGA-LL-A5YL-01A-12D-A29N-09 TCGA-LL-A5YL-01 979d9841-337c-47a3-acaf-77d45e276589 TCGA-LL-A5YL-01A-12D-A29M-01 TCGA-LL-A5YL-01 979d9841-337c-47a3-acaf-77d45e276589 TCGA-LL-A5YL-01A-12D-A29M-01 TCGA-LL-A5YM-01 TCGA-LL-A5YM-01 TCGA-LL-A5YM TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES 88 Left|Left Upper Inner Quadrant No axillary staging TCGA-LL-A5YM-F57541 TCGA-LL-A5YM TCGA-LL-A5YM-01A Negative Positive 3 Point Scale 3+ 3 Point Scale Mastectomy NOS Positive Other -32478 131 0 466 258 258 90-99% 54 2014-3-14 FEMALE 2+ 20 172 3.2 Infiltrating Ductal Carcinoma No C50.9 8541/3 C50.9 3+ YES Core needle biopsy 280 NO Equivocal Positive NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify Locoregional Recurrence Skin left chest wall YES YES false No M0 NX T4b Stage IIIB TCGA-LL-A5YM.B169A5B5-27CD-48A6-A8D7-C14D3824A20A.pdf A5YM WITH TUMOR NO NO 90-99% NO Primary Tumor 01 partial mastectomy 7th YES NO LL Breast A LIVING 2012 02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6 02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6 TCGA-LL-A5YM-01 TCGA-LL-A5YM-01A-11D-A28C-05 38350a57-ff95-4cd4-bf2c-44c934606d80 TCGA-LL-A5YM-01 TCGA-LL-A5YM-01A-11D-A28B-09 TCGA-LL-A5YM-01 02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6 TCGA-LL-A5YM-01A-11D-A28A-01 TCGA-LL-A5YM-01 02a7b2f2-7ae3-426c-9ec5-cdb5ffcaaaa6 TCGA-LL-A5YM-01A-11D-A28A-01 TCGA-LL-A5YN-01 TCGA-LL-A5YN-01 TCGA-LL-A5YN TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right|Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-LL-A5YN-F59362 TCGA-LL-A5YN TCGA-LL-A5YN-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy NO -16884 41 0 447 90-99% 54 2014-5-9 FEMALE 2+ 20 172 3.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 230 NO Equivocal Positive NO 5 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 (i-) T2 Stage IIA TCGA-LL-A5YN.4D4811FB-5BF1-4574-975B-1740602E43D8.pdf A5YN TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 844d9d2c-4467-415f-b66d-a4c35c818310 844d9d2c-4467-415f-b66d-a4c35c818310 TCGA-LL-A5YN-01 TCGA-LL-A5YN-01A-11D-A28C-05 297362a8-ec87-42d7-b56a-25a29b04b91d TCGA-LL-A5YN-01 TCGA-LL-A5YN-01A-11D-A28B-09 TCGA-LL-A5YN-01 844d9d2c-4467-415f-b66d-a4c35c818310 TCGA-LL-A5YN-01A-11D-A28A-01 TCGA-LL-A5YN-01 844d9d2c-4467-415f-b66d-a4c35c818310 TCGA-LL-A5YN-01A-11D-A28A-01 TCGA-LL-A5YO-01 TCGA-LL-A5YO-01 TCGA-LL-A5YO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-LL-A5YO-F58638 TCGA-LL-A5YO TCGA-LL-A5YO-01A Negative Negative Lumpectomy YES -18354 47 0 440 2014-4-17 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 260 NO Negative NO 1 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 0 false No MX N0 T1b Stage IA TCGA-LL-A5YO.C5C5D704-2558-4D4B-937B-33BD91132882.pdf A5YO TUMOR FREE YES YES YES Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 4b5b44ea-8589-4aea-a69f-b5d5041b1acd 4b5b44ea-8589-4aea-a69f-b5d5041b1acd TCGA-LL-A5YO-01 TCGA-LL-A5YO-01A-21D-A28C-05 62e25802-1209-470d-8fe1-6c17c1c28b71 TCGA-LL-A5YO-01 TCGA-LL-A5YO-01A-21D-A28B-09 TCGA-LL-A5YO-01 4b5b44ea-8589-4aea-a69f-b5d5041b1acd TCGA-LL-A5YO-01A-21D-A28A-01 TCGA-LL-A5YO-01 4b5b44ea-8589-4aea-a69f-b5d5041b1acd TCGA-LL-A5YO-01A-21D-A28A-01 TCGA-LL-A5YP-01 TCGA-LL-A5YP-01 TCGA-LL-A5YP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right|Right Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-LL-A5YP-F59323 TCGA-LL-A5YP TCGA-LL-A5YP-01A Positive 3 Point Scale 3 Point Scale Negative Modified Radical Mastectomy NO -18041 29 0 450 <10% 35 2014-5-8 FEMALE <10% 1+ 20 118 3.4 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 490 NO Negative Positive NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 false Yes M0 N1a T2 Stage IIB TCGA-LL-A5YP.B6B4DCFE-F044-44D6-BB90-EF71E6981E82.pdf A5YP YES YES <10% YES Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c 5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c TCGA-LL-A5YP-01 TCGA-LL-A5YP-01A-21D-A28C-05 e0457a11-2e43-40f1-a33b-f7cae98e4073 TCGA-LL-A5YP-01 TCGA-LL-A5YP-01A-21D-A28B-09 TCGA-LL-A5YP-01 5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c TCGA-LL-A5YP-01A-21D-A28A-01 TCGA-LL-A5YP-01 5cc1fd95-8c43-4d40-9e50-fe9f65ee9f1c TCGA-LL-A5YP-01A-21D-A28A-01 TCGA-LL-A6FP-01 TCGA-LL-A6FP-01 TCGA-LL-A6FP TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 90 Right Upper Outer Quadrant No axillary staging TCGA-LL-A6FP-F64050 TCGA-LL-A6FP Positive 3 Point Scale 1+ 3 Point Scale Positive Simple Mastectomy NO -32873 0 677 90-99% 3.1 2014-8-25 FEMALE 2+ 549 2.6 0.9 Infiltrating Lobular Carcinoma Yes C50.9 8520/3 C50.9 3+ YES Core needle biopsy Equivocal Negative NO Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO No MX NX T2 Stage IIA A6FP TUMOR FREE YES NO 20-29% NO Primary Tumor 01 7th YES NO LL Breast LIVING 2012 b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1 b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1 TCGA-LL-A6FP-01 TCGA-LL-A6FP-01A-11D-A31V-05 abc6d9bf-6269-4601-8200-f1e6758789fb TCGA-LL-A6FP-01 TCGA-LL-A6FP-01 b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1 TCGA-LL-A6FP-01A-11D-A31T-01 TCGA-LL-A6FP-01 b7cbb41f-b7ba-4bc7-8b6a-ce93317495b1 TCGA-LL-A6FP-01A-11D-A31T-01 TCGA-LL-A6FQ-01 TCGA-LL-A6FQ-01 TCGA-LL-A6FQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-LL-A6FQ-F58204 TCGA-LL-A6FQ TCGA-LL-A6FQ-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy YES -28375 128 0 80 90-99% 2014-4-2 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 250 NO Negative YES 18 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) 7 0 false No MX N2a T2 Stage IIIA TCGA-LL-A6FQ.5C3D9179-7434-4776-A2FF-68CEA0149C68.pdf A6FQ NO YES 80-89% NO Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 d490ceb7-e3b2-44ee-8c46-923cbd4374dd d490ceb7-e3b2-44ee-8c46-923cbd4374dd TCGA-LL-A6FQ-01 TCGA-LL-A6FQ-01A-11D-A31V-05 349f287a-7f9a-4b55-a3ad-0f8527b84b94 TCGA-LL-A6FQ-01 TCGA-LL-A6FQ-01 d490ceb7-e3b2-44ee-8c46-923cbd4374dd TCGA-LL-A6FQ-01A-11D-A31T-01 TCGA-LL-A6FQ-01 d490ceb7-e3b2-44ee-8c46-923cbd4374dd TCGA-LL-A6FQ-01A-11D-A31T-01 TCGA-LL-A6FR-01 TCGA-LL-A6FR-01 TCGA-LL-A6FR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 50 Right|Right Lower Inner Quadrant Sentinel node biopsy alone TCGA-LL-A6FR-F64045 TCGA-LL-A6FR TCGA-LL-A6FR-01A Negative 1+ 3 Point Scale Positive Lumpectomy YES -18520 30 0 489 2014-8-25 FEMALE 2+ 20 2.7 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 250 NO Equivocal Positive NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 (i-) T2 Stage IIA TCGA-LL-A6FR.B18B184D-B7F1-4C4D-8DA2-D5ECF49749F6.pdf A6FR TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 1cefed42-1e09-4bff-b323-55faeaee18e1 1cefed42-1e09-4bff-b323-55faeaee18e1 TCGA-LL-A6FR-01 TCGA-LL-A6FR-01A-12D-A31V-05 dda737e9-f03b-4125-9b62-3a8fa1e2da16 TCGA-LL-A6FR-01 TCGA-LL-A6FR-01 1cefed42-1e09-4bff-b323-55faeaee18e1 TCGA-LL-A6FR-01A-12D-A31T-01 TCGA-LL-A6FR-01 1cefed42-1e09-4bff-b323-55faeaee18e1 TCGA-LL-A6FR-01A-12D-A31T-01 TCGA-LL-A73Y-01 TCGA-LL-A73Y-01 TCGA-LL-A73Y TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right|Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-LL-A73Y-F67099 TCGA-LL-A73Y TCGA-LL-A73Y-01A Negative 3 Point Scale 3+ 3 Point Scale Negative Simple Mastectomy NO -24647 55 0 477 2014-10-30 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 60 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 T1c Stage IA TCGA-LL-A73Y.9A8F7726-D97C-44DE-B72F-6BF0FC2078F8.pdf A73Y TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 535ab8cf-47a9-4541-b3ef-223bba76a13e 535ab8cf-47a9-4541-b3ef-223bba76a13e TCGA-LL-A73Y-01 TCGA-LL-A73Y-01A-11D-A33F-05 TCGA-LL-A73Y-01 TCGA-LL-A73Y-01 535ab8cf-47a9-4541-b3ef-223bba76a13e TCGA-LL-A73Y-01A-11D-A33D-01 TCGA-LL-A73Y-01 535ab8cf-47a9-4541-b3ef-223bba76a13e TCGA-LL-A73Y-01A-11D-A33D-01 TCGA-LL-A73Z-01 TCGA-LL-A73Z-01 TCGA-LL-A73Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast NO NO 55 Left|Left Lower Inner Quadrant No axillary staging TCGA-LL-A73Z-F64983 TCGA-LL-A73Z TCGA-LL-A73Z-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Lumpectomy NO -20118 40 227 0 137 192 10-19% 2.2 2014-9-16 FEMALE 2+ 243 2.5 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Excisional Biopsy 240 NO Equivocal Negative NO Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Other, specify skin Brain Distant Metastasis NO YES false No M1 NX T1c Stage IV TCGA-LL-A73Z.D9FE314C-61F4-4E4D-BB29-4B681C2A8A10.pdf A73Z WITH TUMOR YES NO <10% YES Primary Tumor 01 7th YES NO LL Breast A DECEASED 2013 9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126 9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126 TCGA-LL-A73Z-01 TCGA-LL-A73Z-01A-11D-A32T-05 31B0CE66-3E66-4210-ABBC-82C85BB9902C TCGA-LL-A73Z-01 TCGA-LL-A73Z-01 9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126 TCGA-LL-A73Z-01A-11D-A32H-01 TCGA-LL-A73Z-01 9ec15bb0-29a1-4285-8d6b-f9e5fa1b5126 TCGA-LL-A73Z-01A-11D-A32H-01 TCGA-LL-A740-01 TCGA-LL-A740-01 TCGA-LL-A740 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-LL-A740-F65059 TCGA-LL-A740 TCGA-LL-A740-01A Negative 3 Point Scale 3 Point Scale Negative Lumpectomy YES -22416 37 0 441 2.9 2014-9-18 FEMALE 2+ 113 3.3 1.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 410 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 (i-) T1c Stage IA TCGA-LL-A740.3AD4AA3C-5F68-43D1-B578-07AB574D4DE3.pdf A740 TUMOR FREE YES YES NO Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 9014d9c4-ab6b-4318-9b07-c00266d9f5a9 9014d9c4-ab6b-4318-9b07-c00266d9f5a9 TCGA-LL-A740-01 TCGA-LL-A740-01A-21D-A32T-05 A13762BD-83CD-4DBC-94FE-1879E3A4B5A4 TCGA-LL-A740-01 TCGA-LL-A740-01 9014d9c4-ab6b-4318-9b07-c00266d9f5a9 TCGA-LL-A740-01A-21D-A32H-01 TCGA-LL-A740-01 9014d9c4-ab6b-4318-9b07-c00266d9f5a9 TCGA-LL-A740-01A-21D-A32H-01 TCGA-LL-A7SZ-01 TCGA-LL-A7SZ-01 TCGA-LL-A7SZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-LL-A7SZ-F66973 TCGA-LL-A7SZ TCGA-LL-A7SZ-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Other YES -18161 63 0 594 90-99% 2014-10-29 FEMALE 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 240 NO Negative NO 11 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 2 0 false No MX N1a T2 Stage IIB TCGA-LL-A7SZ.3FA5FACA-8A6B-4F42-A557-3B69866859E7.pdf A7SZ TUMOR FREE YES YES 90-99% YES Primary Tumor 01 SKIN SPARING RADICAL MASTECTOMY 7th YES NO LL Breast A LIVING 2013 e256282c-da2c-4272-a94b-14cf44da6178 e256282c-da2c-4272-a94b-14cf44da6178 TCGA-LL-A7SZ-01 TCGA-LL-A7SZ-01A-32D-A357-05 C972C687-4BA1-4F38-A073-4A2AB182F8B0 TCGA-LL-A7SZ-01 TCGA-LL-A7SZ-01 e256282c-da2c-4272-a94b-14cf44da6178 TCGA-LL-A7SZ-01A-32D-A350-01 TCGA-LL-A7SZ-01 e256282c-da2c-4272-a94b-14cf44da6178 TCGA-LL-A7SZ-01A-32D-A350-01 TCGA-LL-A7T0-01 TCGA-LL-A7T0-01 TCGA-LL-A7T0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Left Lower Inner Quadrant Axillary lymph node dissection alone TCGA-LL-A7T0-F64970 TCGA-LL-A7T0 TCGA-LL-A7T0-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Simple Mastectomy NO -25867 70 0 376 90-99% 2014-9-16 FEMALE 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Tumor resection 380 NO Positive NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 false No M0 N1a T2 Stage IIB TCGA-LL-A7T0.5540DD9C-FA3F-48B6-8243-414616816A76.pdf A7T0 TUMOR FREE NO YES <10% NO Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 67e967d6-be17-4fe1-a1fb-197655fad18d 67e967d6-be17-4fe1-a1fb-197655fad18d TCGA-LL-A7T0-01 TCGA-LL-A7T0-01A-31D-A357-05 TCGA-LL-A7T0-01 TCGA-LL-A7T0-01 67e967d6-be17-4fe1-a1fb-197655fad18d TCGA-LL-A7T0-01A-31D-A350-01 TCGA-LL-A7T0-01 67e967d6-be17-4fe1-a1fb-197655fad18d TCGA-LL-A7T0-01A-31D-A350-01 TCGA-LL-A8F5-01 TCGA-LL-A8F5-01 TCGA-LL-A8F5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right|Right Upper Inner Quadrant Sentinel node biopsy alone TCGA-LL-A8F5-F66965 TCGA-LL-A8F5 TCGA-LL-A8F5-01A Positive 3 Point Scale 3 Point Scale Negative Lumpectomy YES -22544 78 0 596 20-29% 2014-10-29 FEMALE <10% 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 1+ YES Core needle biopsy 230 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No MX N0 (i-) T2 Stage IIA TCGA-LL-A8F5.79A10C4B-1B5F-47BB-99EA-E694FB341696.pdf A8F5 TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 3cc7e12e-2bc8-494c-b74a-de071d711410 3cc7e12e-2bc8-494c-b74a-de071d711410 TCGA-LL-A8F5-01 TCGA-LL-A8F5-01A-11D-A36K-05 FBB89BA4-95C2-4EEE-8248-B344B94C696F TCGA-LL-A8F5-01 TCGA-LL-A8F5-01 3cc7e12e-2bc8-494c-b74a-de071d711410 TCGA-LL-A8F5-01A-11D-A36I-01 TCGA-LL-A8F5-01 3cc7e12e-2bc8-494c-b74a-de071d711410 TCGA-LL-A8F5-01A-11D-A36I-01 TCGA-LL-A9Q3-01 TCGA-LL-A9Q3-01 TCGA-LL-A9Q3 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 69 Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-LL-A9Q3-F67103 TCGA-LL-A9Q3 TCGA-LL-A9Q3-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Modified Radical Mastectomy YES -25477 80 0 532 90-99% 2014-10-30 FEMALE 3+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 610 NO Positive NO 28 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 28 0 false No MX N3a T3 Stage IIIC TCGA-LL-A9Q3.2697F2B6-725C-438F-B4D3-3E32DEF86FD6.pdf A9Q3 TUMOR FREE YES YES <10% YES Primary Tumor 01 7th YES NO LL Breast A LIVING 2013 0aad6d2a-1699-4403-8d45-f0b315ec89c7 0aad6d2a-1699-4403-8d45-f0b315ec89c7 TCGA-LL-A9Q3-01 TCGA-LL-A9Q3-01A-11D-A41Q-05 A26726B7-5B72-4AC3-9EDF-F3F13C2E471F TCGA-LL-A9Q3-01 TCGA-LL-A9Q3-01 0aad6d2a-1699-4403-8d45-f0b315ec89c7 TCGA-LL-A9Q3-01A-11D-A41E-01 TCGA-LL-A9Q3-01 0aad6d2a-1699-4403-8d45-f0b315ec89c7 TCGA-LL-A9Q3-01A-11D-A41E-01 TCGA-LQ-A4E4-01 TCGA-LQ-A4E4-01 TCGA-LQ-A4E4 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast YES YES 73 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-LQ-A4E4-F52290 TCGA-LQ-A4E4 TCGA-LQ-A4E4-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Modified Radical Mastectomy NO -26883 414 0 849 681 90-99% 1.1 2013-12-2 FEMALE 60 1.1 1.05 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 1+ YES Core needle biopsy 200 NO Negative NO 26 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Positive Negative Bone Distant Metastasis NO YES 3 0 true No MX N1a T3 Stage IIIA TCGA-LQ-A4E4.C13D16C9-BAC7-4CA4-B062-D925466F9E2B.pdf A4E4 WITH TUMOR YES YES 90-99% YES Primary Tumor 01 7th NO YES LQ Breast A LIVING 2011 5965fc49-0ee5-41d8-b673-9ade5c70db71 5965fc49-0ee5-41d8-b673-9ade5c70db71 TCGA-LQ-A4E4-01 TCGA-LQ-A4E4-01A-11D-A268-05 610e443b-3ef2-4a65-80f9-6d300736ba70 TCGA-LQ-A4E4-01 TCGA-LQ-A4E4-01A-11D-A25Q-09 TCGA-LQ-A4E4-01 5965fc49-0ee5-41d8-b673-9ade5c70db71 TCGA-LQ-A4E4-01A-11D-A25N-01 TCGA-LQ-A4E4-01 5965fc49-0ee5-41d8-b673-9ade5c70db71 TCGA-LQ-A4E4-01A-11D-A25N-01 TCGA-MS-A51U-01 TCGA-MS-A51U-01 TCGA-MS-A51U TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 44 Left Upper Outer Quadrant|Left Lower Outer Quadrant|Left TCGA-MS-A51U-F59818 TCGA-MS-A51U TCGA-MS-A51U-01A Positive Positive Modified Radical Mastectomy -16213 129 0 681 NO 90-99% 2014-6-4 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 190 NO Negative Negative NO 18 Negative NO 2 true No M0 N1 T2 Stage IIB TCGA-MS-A51U.58D54D1A-3A8D-40DD-A643-846CAF242494.pdf A51U TUMOR FREE YES YES 20-29% YES Primary Tumor 01 7th YES NO MS Breast A LIVING 2012 b41dfa6b-a221-4e03-95d7-428781787067 b41dfa6b-a221-4e03-95d7-428781787067 TCGA-MS-A51U-01 TCGA-MS-A51U-01A-31D-A268-05 8eb29e3b-4e9b-481e-9bb2-564d1ee1a5dc TCGA-MS-A51U-01 TCGA-MS-A51U-01A-31D-A25Q-09 TCGA-MS-A51U-01 b41dfa6b-a221-4e03-95d7-428781787067 TCGA-MS-A51U-01A-31D-A25N-01 TCGA-MS-A51U-01 b41dfa6b-a221-4e03-95d7-428781787067 TCGA-MS-A51U-01A-31D-A25N-01 TCGA-OK-A5Q2-01 TCGA-OK-A5Q2-01 TCGA-OK-A5Q2 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Right Axillary lymph node dissection alone TCGA-OK-A5Q2 Positive 3 Point Scale 3+ 3 Point Scale Positive Modified Radical Mastectomy YES -21555 0 64 90-99% 2013-1-22 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Negative 13 Negative NO 2 2 No MX N1a T2 Stage II A5Q2 YES 20-29% Primary Tumor 01 7th YES NO OK Breast LIVING 2012 b835c127-4f06-4870-a0a4-7f95be0260a4 b835c127-4f06-4870-a0a4-7f95be0260a4 TCGA-OK-A5Q2-01 TCGA-OK-A5Q2-01A-11D-A27Y-05 TCGA-OK-A5Q2-01 TCGA-OK-A5Q2-01A-11D-A27P-09 TCGA-OK-A5Q2-01 b835c127-4f06-4870-a0a4-7f95be0260a4 TCGA-OK-A5Q2-01A-11D-A27O-01 TCGA-OK-A5Q2-01 b835c127-4f06-4870-a0a4-7f95be0260a4 TCGA-OK-A5Q2-01A-11D-A27O-01 TCGA-OL-A5D6-01 TCGA-OL-A5D6-01 TCGA-OL-A5D6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left Lower Outer Quadrant Sentinel node biopsy alone TCGA-OL-A5D6-F55437 TCGA-OL-A5D6 TCGA-OL-A5D6-01A Negative Negative Simple Mastectomy -26052 1378 1104 0 385 2014-1-10 FEMALE 1.13 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 200 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No MX N0 T2 Stage IIA TCGA-OL-A5D6.AD80BBA3-DA8E-4DFB-BDA1-FFDC131E9740.pdf A5D6 TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES OL Breast A DECEASED 2009 5657c6b6-ba04-4dd8-8623-2a3834820f7d 5657c6b6-ba04-4dd8-8623-2a3834820f7d TCGA-OL-A5D6-01 TCGA-OL-A5D6-01A-21D-A27Y-05 TCGA-OL-A5D6-01 TCGA-OL-A5D6-01A-21D-A27P-09 TCGA-OL-A5D6-01 5657c6b6-ba04-4dd8-8623-2a3834820f7d TCGA-OL-A5D6-01A-21D-A27O-01 TCGA-OL-A5D6-01 5657c6b6-ba04-4dd8-8623-2a3834820f7d TCGA-OL-A5D6-01A-21D-A27O-01 TCGA-OL-A5D7-01 TCGA-OL-A5D7-01 TCGA-OL-A5D7 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 70 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-OL-A5D7-F55439 TCGA-OL-A5D7 TCGA-OL-A5D7-01A Negative Negative Lumpectomy -25643 1415 0 1780 2014-1-10 FEMALE 1.36 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 370 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No MX N0 T2 Stage IIA TCGA-OL-A5D7.A8980EE8-52DE-4DA5-84DD-F8E86EBF6A9B.pdf A5D7 TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES OL Breast A LIVING 2009 a9f404db-e7fa-49bf-acca-fccd676f2e7c a9f404db-e7fa-49bf-acca-fccd676f2e7c TCGA-OL-A5D7-01 TCGA-OL-A5D7-01A-11D-A27Y-05 2cdb08fa-d13c-496e-8f53-9852a8a165ef TCGA-OL-A5D7-01 TCGA-OL-A5D7-01A-11D-A27P-09 TCGA-OL-A5D7-01 a9f404db-e7fa-49bf-acca-fccd676f2e7c TCGA-OL-A5D7-01A-11D-A27O-01 TCGA-OL-A5D7-01 a9f404db-e7fa-49bf-acca-fccd676f2e7c TCGA-OL-A5D7-01A-11D-A27O-01 TCGA-OL-A5D8-01 TCGA-OL-A5D8-01 TCGA-OL-A5D8 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Left Lower Outer Quadrant Other (specify) axillary ultrasound TCGA-OL-A5D8-F55438 TCGA-OL-A5D8 TCGA-OL-A5D8-01A Positive Positive Simple Mastectomy NO -14853 1357 0 973 90-99% 2.25 2014-1-10 FEMALE 20 2 0.8 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 370 NO Negative NO 2 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO true No MX N0 T3 Stage IIB TCGA-OL-A5D8.FD496AFB-43EF-41D8-850F-E57DD53C185C.pdf A5D8 TUMOR FREE YES YES 90-99% YES Primary Tumor 01 6th NO YES OL Breast A LIVING 2009 8c435d42-a76a-4078-a593-6a41a2bb6f5e 8c435d42-a76a-4078-a593-6a41a2bb6f5e TCGA-OL-A5D8-01 TCGA-OL-A5D8-01A-11D-A27Y-05 321a0511-ed95-4937-92b2-5a77c86e1f48 TCGA-OL-A5D8-01 TCGA-OL-A5D8-01A-11D-A27P-09 TCGA-OL-A5D8-01 8c435d42-a76a-4078-a593-6a41a2bb6f5e TCGA-OL-A5D8-01A-11D-A27O-01 TCGA-OL-A5D8-01 8c435d42-a76a-4078-a593-6a41a2bb6f5e TCGA-OL-A5D8-01A-11D-A27O-01 TCGA-OL-A5DA-01 TCGA-OL-A5DA-01 TCGA-OL-A5DA TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-OL-A5DA-F55440 TCGA-OL-A5DA TCGA-OL-A5DA-01A Positive Positive Other -22411 1407 0 1783 60-69% 2014-1-10 FEMALE 1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Ultrasound-guided mammotome biopsy Other method, specify: 240 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No MX N0 T2 Stage IIA TCGA-OL-A5DA.5049C91E-F4BB-4AA7-BE64-837168189379.pdf A5DA TUMOR FREE NO YES 60-69% NO Primary Tumor 01 partial mastectomy 6th NO YES OL Breast A LIVING 2009 b881706f-5ee8-43da-a691-53c036d94494 b881706f-5ee8-43da-a691-53c036d94494 TCGA-OL-A5DA-01 TCGA-OL-A5DA-01A-11D-A27Y-05 1e062952-e6da-43a7-ad52-e2eff10461da TCGA-OL-A5DA-01 TCGA-OL-A5DA-01A-11D-A27P-09 TCGA-OL-A5DA-01 b881706f-5ee8-43da-a691-53c036d94494 TCGA-OL-A5DA-01A-11D-A27O-01 TCGA-OL-A5DA-01 b881706f-5ee8-43da-a691-53c036d94494 TCGA-OL-A5DA-01A-11D-A27O-01 TCGA-OL-A5RU-01 TCGA-OL-A5RU-01 TCGA-OL-A5RU TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-OL-A5RU-F56569 TCGA-OL-A5RU TCGA-OL-A5RU-01A Positive Positive Modified Radical Mastectomy -23108 826 0 1219 90-99% 2014-2-14 FEMALE 1.02 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 430 NO Negative NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No MX N1 T1c Stage IIA TCGA-OL-A5RU.7507AC79-4C8E-4393-92B9-BFA6BEB492D0.pdf A5RU TUMOR FREE YES YES 80-89% YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2010 02873204-1097-45ea-b143-a97f3e047537 02873204-1097-45ea-b143-a97f3e047537 TCGA-OL-A5RU-01 TCGA-OL-A5RU-01A-11D-A28C-05 63002326-8f58-4457-b841-9d0773e65587 TCGA-OL-A5RU-01 TCGA-OL-A5RU-01A-11D-A28B-09 TCGA-OL-A5RU-01 02873204-1097-45ea-b143-a97f3e047537 TCGA-OL-A5RU-01A-11D-A28A-01 TCGA-OL-A5RU-01 02873204-1097-45ea-b143-a97f3e047537 TCGA-OL-A5RU-01A-11D-A28A-01 TCGA-OL-A5RV-01 TCGA-OL-A5RV-01 TCGA-OL-A5RV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-OL-A5RV-F56564 TCGA-OL-A5RV TCGA-OL-A5RV-01A Positive Positive Modified Radical Mastectomy NO -15820 755 0 1062 90-99% 2014-2-14 FEMALE 1.00 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 370 NO Negative NO 29 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 20 true No MX N3 T2 Stage IIIC TCGA-OL-A5RV.0CA74400-1596-4C14-AF02-4F5169D61942.pdf A5RV TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2011 2dca31d2-af60-4529-afac-e8838a7ee67c 2dca31d2-af60-4529-afac-e8838a7ee67c TCGA-OL-A5RV-01 TCGA-OL-A5RV-01A-12D-A28C-05 ec9c3ed3-1246-42ab-9120-6a027f56d494 TCGA-OL-A5RV-01 TCGA-OL-A5RV-01A-12D-A28B-09 TCGA-OL-A5RV-01 2dca31d2-af60-4529-afac-e8838a7ee67c TCGA-OL-A5RV-01A-12D-A28A-01 TCGA-OL-A5RV-01 2dca31d2-af60-4529-afac-e8838a7ee67c TCGA-OL-A5RV-01A-12D-A28A-01 TCGA-OL-A5RW-01 TCGA-OL-A5RW-01 TCGA-OL-A5RW TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 40 Right Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-OL-A5RW-F56568 TCGA-OL-A5RW Negative Negative Lumpectomy -14638 0 1106 2014-2-14 FEMALE 1.91 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 1 No MX N1 T1c Stage IIA A5RW TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES OL Breast LIVING 2010 c5a7673a-c45e-4789-a2c8-32889f39c102 c5a7673a-c45e-4789-a2c8-32889f39c102 TCGA-OL-A5RW-01 TCGA-OL-A5RW-01A-11D-A28C-05 e1d1d1cd-4b4d-4cfe-86b8-7dfe9ca08c75 TCGA-OL-A5RW-01 TCGA-OL-A5RW-01A-11D-A28B-09 TCGA-OL-A5RW-01 c5a7673a-c45e-4789-a2c8-32889f39c102 TCGA-OL-A5RW-01A-11D-A28A-01 TCGA-OL-A5RW-01 c5a7673a-c45e-4789-a2c8-32889f39c102 TCGA-OL-A5RW-01A-11D-A28A-01 TCGA-OL-A5RX-01 TCGA-OL-A5RX-01 TCGA-OL-A5RX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-OL-A5RX-F56570 TCGA-OL-A5RX TCGA-OL-A5RX-01A Positive Positive Simple Mastectomy -18942 561 0 878 90-99% 2014-2-14 FEMALE 1.0 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 260 NO Negative NO 4 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO true No MX N0 T1c Stage IA TCGA-OL-A5RX.9536A134-A44C-4698-A525-DEEE7FACD144.pdf A5RX TUMOR FREE NO YES 90-99% NO Primary Tumor 01 7th NO YES OL Breast A LIVING 2011 650c0c98-4432-4e9a-9e83-4ad8a7a0d628 650c0c98-4432-4e9a-9e83-4ad8a7a0d628 TCGA-OL-A5RX-01 TCGA-OL-A5RX-01A-11D-A28C-05 7f3a5deb-3015-4ca7-aa12-f46870a5da8e TCGA-OL-A5RX-01 TCGA-OL-A5RX-01A-11D-A28B-09 TCGA-OL-A5RX-01 650c0c98-4432-4e9a-9e83-4ad8a7a0d628 TCGA-OL-A5RX-01A-11D-A28A-01 TCGA-OL-A5RX-01 650c0c98-4432-4e9a-9e83-4ad8a7a0d628 TCGA-OL-A5RX-01A-11D-A28A-01 TCGA-OL-A5RY-01 TCGA-OL-A5RY-01 TCGA-OL-A5RY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 52 Right Sentinel node biopsy alone TCGA-OL-A5RY-F56565 TCGA-OL-A5RY TCGA-OL-A5RY-01A Negative Positive Mastectomy NOS Negative Lumpectomy -19216 421 0 752 10-19% 2014-2-14 FEMALE 7.6 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Ultrasound-guided biopsy Other method, specify: 300 NO Positive NO 25 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 true No MX N1 T1c Stage IIA TCGA-OL-A5RY.C8297152-7551-49A1-8C9D-6B411391AC77.pdf A5RY TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2011 2407816a-86e7-4094-a028-e81c0cda5448 2407816a-86e7-4094-a028-e81c0cda5448 TCGA-OL-A5RY-01 TCGA-OL-A5RY-01A-21D-A28C-05 7bd9aba2-054f-48ac-ab14-ee53896d353d TCGA-OL-A5RY-01 TCGA-OL-A5RY-01A-21D-A28B-09 TCGA-OL-A5RY-01 2407816a-86e7-4094-a028-e81c0cda5448 TCGA-OL-A5RY-01A-21D-A28A-01 TCGA-OL-A5RY-01 2407816a-86e7-4094-a028-e81c0cda5448 TCGA-OL-A5RY-01A-21D-A28A-01 TCGA-OL-A5RZ-01 TCGA-OL-A5RZ-01 TCGA-OL-A5RZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 57 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-OL-A5RZ-F56571 TCGA-OL-A5RZ Positive Negative Simple Mastectomy -21038 0 679 30-39% 2.0 2014-2-14 FEMALE 21.0 10.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy Positive NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO No MX N0 T1b Stage IA A5RZ TUMOR FREE YES YES <10% NO Primary Tumor 01 7th NO YES OL Breast LIVING 2012 fc8c0c74-cd1b-4bc7-ab1d-568d302c5719 fc8c0c74-cd1b-4bc7-ab1d-568d302c5719 TCGA-OL-A5RZ-01 TCGA-OL-A5RZ-01A-11D-A28C-05 aae8eb5d-0797-424c-a2a1-6b8d08c7463e TCGA-OL-A5RZ-01 TCGA-OL-A5RZ-01A-11D-A28B-09 TCGA-OL-A5RZ-01 fc8c0c74-cd1b-4bc7-ab1d-568d302c5719 TCGA-OL-A5RZ-01A-11D-A28A-01 TCGA-OL-A5RZ-01 fc8c0c74-cd1b-4bc7-ab1d-568d302c5719 TCGA-OL-A5RZ-01A-11D-A28A-01 TCGA-OL-A5S0-01 TCGA-OL-A5S0-01 TCGA-OL-A5S0 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Right Axillary lymph node dissection alone TCGA-OL-A5S0-F56567 TCGA-OL-A5S0 TCGA-OL-A5S0-01A Positive Negative Modified Radical Mastectomy -24139 279 0 620 30-39% 2014-2-14 FEMALE 3.8 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 530 NO Positive NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 true No MX N1a T2 Stage IIB TCGA-OL-A5S0.EDF80CFD-4115-48E9-BF76-DDE957A97AEB.pdf A5S0 TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2012 f6e02767-7522-4895-bc70-c7de6b1796ab f6e02767-7522-4895-bc70-c7de6b1796ab TCGA-OL-A5S0-01 TCGA-OL-A5S0-01A-11D-A28C-05 07817555-b5eb-4502-9229-236a38430974 TCGA-OL-A5S0-01 TCGA-OL-A5S0-01A-11D-A28B-09 TCGA-OL-A5S0-01 f6e02767-7522-4895-bc70-c7de6b1796ab TCGA-OL-A5S0-01A-11D-A28A-01 TCGA-OL-A5S0-01 f6e02767-7522-4895-bc70-c7de6b1796ab TCGA-OL-A5S0-01A-11D-A28A-01 TCGA-OL-A66H-01 TCGA-OL-A66H-01 TCGA-OL-A66H TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 74 Right TCGA-OL-A66H-F58492 TCGA-OL-A66H TCGA-OL-A66H-01A Positive Positive Lumpectomy -27280 441 0 812 90-99% 1.7 2014-4-11 FEMALE 1.8 1.03 Mucinous Carcinoma No C50.9 8480/3 C50.9 YES Fine needle aspiration biopsy 80 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No MX N1mi T1c Stage IB TCGA-OL-A66H.3D84D02A-42B1-42E1-84FB-E9AE9381ABB4.pdf A66H TUMOR FREE NO YES 80-89% YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2012 428ca7a1-6f08-4426-8f2d-28939166df70 428ca7a1-6f08-4426-8f2d-28939166df70 TCGA-OL-A66H-01 TCGA-OL-A66H-01A-11D-A29O-05 TCGA-OL-A66H-01 TCGA-OL-A66H-01A-11D-A29N-09 TCGA-OL-A66H-01 428ca7a1-6f08-4426-8f2d-28939166df70 TCGA-OL-A66H-01A-11D-A29M-01 TCGA-OL-A66H-01 428ca7a1-6f08-4426-8f2d-28939166df70 TCGA-OL-A66H-01A-11D-A29M-01 TCGA-OL-A66I-01 TCGA-OL-A66I-01 TCGA-OL-A66I TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 36 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-OL-A66I-F58496 TCGA-OL-A66I TCGA-OL-A66I-01A Negative Negative Lumpectomy -13458 1715 0 714 2014-4-11 FEMALE 1.04 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 240 NO Negative YES 13 Negative NO 0 true No MX N1mi T1c Stage IIA TCGA-OL-A66I.800346FC-BC14-4A33-B10C-84224D908481.pdf A66I TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES OL Breast A LIVING 2008 d92ddf45-68b6-42da-9497-8faabcc50be0 d92ddf45-68b6-42da-9497-8faabcc50be0 TCGA-OL-A66I-01 TCGA-OL-A66I-01A-21D-A29O-05 3e69923d-a657-4a7f-b605-bd2b9222c94f TCGA-OL-A66I-01 TCGA-OL-A66I-01A-21D-A29N-09 TCGA-OL-A66I-01 d92ddf45-68b6-42da-9497-8faabcc50be0 TCGA-OL-A66I-01A-21D-A29M-01 TCGA-OL-A66I-01 d92ddf45-68b6-42da-9497-8faabcc50be0 TCGA-OL-A66I-01A-21D-A29M-01 TCGA-OL-A66J-01 TCGA-OL-A66J-01 TCGA-OL-A66J TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 80 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-OL-A66J-F58495 TCGA-OL-A66J Positive Positive Lumpectomy -29345 0 1996 90-99% 2014-4-11 FEMALE 1.50 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 No MX N0 T1c Stage I A66J TUMOR FREE NO YES 50-59% YES Primary Tumor 01 6th NO YES OL Breast LIVING 2008 fc8cb6a7-c7ed-4037-8fb9-7530cdebc705 fc8cb6a7-c7ed-4037-8fb9-7530cdebc705 TCGA-OL-A66J-01 TCGA-OL-A66J-01A-11D-A29O-05 cffbe18d-d8c9-4bb3-8916-634e6ad7ab8a TCGA-OL-A66J-01 TCGA-OL-A66J-01A-11D-A29N-09 TCGA-OL-A66J-01 fc8cb6a7-c7ed-4037-8fb9-7530cdebc705 TCGA-OL-A66J-01A-11D-A29M-01 TCGA-OL-A66J-01 fc8cb6a7-c7ed-4037-8fb9-7530cdebc705 TCGA-OL-A66J-01A-11D-A29M-01 TCGA-OL-A66K-01 TCGA-OL-A66K-01 TCGA-OL-A66K TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-OL-A66K-F58498 TCGA-OL-A66K TCGA-OL-A66K-01A Positive Positive Simple Mastectomy -26299 981 1275 0 1021 70-79% 2014-4-11 FEMALE 2+ 1.23 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 230 NO Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No MX N0 T2 Stage IIA TCGA-OL-A66K.8A19AA55-9B1F-4325-B730-068F928F1C13.pdf A66K TUMOR FREE NO YES 90-99% NO Primary Tumor 01 7th NO YES OL Breast A DECEASED 2010 7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf 7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf TCGA-OL-A66K-01 TCGA-OL-A66K-01A-11D-A29O-05 97c6fb8d-f158-4f4c-8139-6a886bf38f99 TCGA-OL-A66K-01 TCGA-OL-A66K-01A-11D-A29N-09 TCGA-OL-A66K-01 7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf TCGA-OL-A66K-01A-11D-A29M-01 TCGA-OL-A66K-01 7cd7e1cf-4390-4b0e-884c-fc0a26c7e1bf TCGA-OL-A66K-01A-11D-A29M-01 TCGA-OL-A66L-01 TCGA-OL-A66L-01 TCGA-OL-A66L TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Right Lower Inner Quadrant TCGA-OL-A66L-F58493 TCGA-OL-A66L TCGA-OL-A66L-01A Positive Positive Lumpectomy -26186 952 0 1301 90-99% 2014-4-11 FEMALE 1.10 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 170 NO Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO true No MX N0 T1c Stage IA TCGA-OL-A66L.B8C192A7-E530-4301-B4D3-FF528A230260.pdf A66L TUMOR FREE NO YES 90-99% YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2010 0df01f96-a14b-4bd9-bddb-1dab47491d2d 0df01f96-a14b-4bd9-bddb-1dab47491d2d TCGA-OL-A66L-01 TCGA-OL-A66L-01A-12D-A31V-05 TCGA-OL-A66L-01 TCGA-OL-A66L-01 0df01f96-a14b-4bd9-bddb-1dab47491d2d TCGA-OL-A66L-01A-12D-A31T-01 TCGA-OL-A66L-01 0df01f96-a14b-4bd9-bddb-1dab47491d2d TCGA-OL-A66L-01A-12D-A31T-01 TCGA-OL-A66N-01 TCGA-OL-A66N-01 TCGA-OL-A66N TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 59 Left Sentinel node biopsy alone TCGA-OL-A66N-F58500 TCGA-OL-A66N TCGA-OL-A66N-01A Positive Negative Modified Radical Mastectomy -21608 505 0 792 80-89% 2014-4-11 FEMALE 1.1 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 310 NO Negative NO 15 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 13 true No MX N3 T3 Stage IIIC TCGA-OL-A66N.CDB6A529-DE8B-48F6-A569-D07251D139C3.pdf A66N TUMOR FREE NO YES YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2011 43cde130-82ef-43ca-ba81-8ab14588069c 43cde130-82ef-43ca-ba81-8ab14588069c TCGA-OL-A66N-01 TCGA-OL-A66N-01A-12D-A31V-05 3acac7e1-22c1-4a61-847d-bda89e3a10c1 TCGA-OL-A66N-01 TCGA-OL-A66N-01 43cde130-82ef-43ca-ba81-8ab14588069c TCGA-OL-A66N-01A-12D-A31T-01 TCGA-OL-A66N-01 43cde130-82ef-43ca-ba81-8ab14588069c TCGA-OL-A66N-01A-12D-A31T-01 TCGA-OL-A66O-01 TCGA-OL-A66O-01 TCGA-OL-A66O TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 39 Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-OL-A66O-F58497 TCGA-OL-A66O TCGA-OL-A66O-01A Positive Positive Modified Radical Mastectomy -14272 170 0 528 90-99% 2014-4-11 FEMALE 1.2 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 260 NO Negative NO 17 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 3 true No MX N1a T2 Stage IIB TCGA-OL-A66O.60ACE33B-BEE2-4A49-85F0-1364D245FCA9.pdf A66O TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2012 c7f57147-b774-4209-8b7f-2666f59543d8 c7f57147-b774-4209-8b7f-2666f59543d8 TCGA-OL-A66O-01 TCGA-OL-A66O-01A-11D-A31V-05 024e8275-694b-4942-832d-3137b1c5303a TCGA-OL-A66O-01 TCGA-OL-A66O-01 c7f57147-b774-4209-8b7f-2666f59543d8 TCGA-OL-A66O-01A-11D-A31T-01 TCGA-OL-A66O-01 c7f57147-b774-4209-8b7f-2666f59543d8 TCGA-OL-A66O-01A-11D-A31T-01 TCGA-OL-A66P-01 TCGA-OL-A66P-01 TCGA-OL-A66P TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Right Sentinel node biopsy alone TCGA-OL-A66P-F58494 TCGA-OL-A66P TCGA-OL-A66P-01A Negative Negative Simple Mastectomy -27489 98 0 428 2014-4-11 FEMALE 1.13 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 140 NO Negative NO 2 Negative NO true No MX N0 T2 Stage IIA TCGA-OL-A66P.979468F0-6B4A-4759-9CA2-7BA1D1441BC2.pdf A66P TUMOR FREE YES YES NO Primary Tumor 01 7th NO YES OL Breast A LIVING 2013 bbd01868-6fc1-42e7-b375-f0ac1a54a43c bbd01868-6fc1-42e7-b375-f0ac1a54a43c TCGA-OL-A66P-01 TCGA-OL-A66P-01A-11D-A31V-05 737f4dca-ab51-4053-ad90-6654f312ca6d TCGA-OL-A66P-01 TCGA-OL-A66P-01 bbd01868-6fc1-42e7-b375-f0ac1a54a43c TCGA-OL-A66P-01A-11D-A31T-01 TCGA-OL-A66P-01 bbd01868-6fc1-42e7-b375-f0ac1a54a43c TCGA-OL-A66P-01A-11D-A31T-01 TCGA-OL-A6VO-01 TCGA-OL-A6VO-01 TCGA-OL-A6VO TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 43 Right|Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-OL-A6VO-F59365 TCGA-OL-A6VO TCGA-OL-A6VO-01A Negative Negative Lumpectomy -15780 507 0 858 2014-5-10 FEMALE 1.23 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 120 NO Negative Negative NO 7 Negative NO 0 true No MX N0 T1c Stage IA TCGA-OL-A6VO.961547D2-F235-47E9-9A6D-D286758E332E.pdf A6VO TUMOR FREE YES YES YES Primary Tumor 01 7th NO YES OL Breast A LIVING 2012 5cb12edf-25a1-40f6-831a-5fb1f56676e1 5cb12edf-25a1-40f6-831a-5fb1f56676e1 TCGA-OL-A6VO-01 TCGA-OL-A6VO-01A-12D-A33F-05 79E2C9D4-0FF5-43E0-B7CE-EF665A49853D TCGA-OL-A6VO-01 TCGA-OL-A6VO-01 5cb12edf-25a1-40f6-831a-5fb1f56676e1 TCGA-OL-A6VO-01A-12D-A33D-01 TCGA-OL-A6VO-01 5cb12edf-25a1-40f6-831a-5fb1f56676e1 TCGA-OL-A6VO-01A-12D-A33D-01 TCGA-OL-A6VQ-01 TCGA-OL-A6VQ-01 TCGA-OL-A6VQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 49 Right TCGA-OL-A6VQ-F59366 TCGA-OL-A6VQ TCGA-OL-A6VQ-01A Negative Positive Mastectomy NOS Positive Lumpectomy -18151 278 0 600 90-99% 2014-5-10 FEMALE 1.05 Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 110 NO Negative NO 1 Positive Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No MX N0 T2 Stage IIA TCGA-OL-A6VQ.17C74789-D7B0-4291-A2AC-7A72C5DC58EE.pdf A6VQ TUMOR FREE NO YES 10-19% NO Primary Tumor 01 7th NO YES OL Breast A LIVING 2012 10fbe91f-3570-4cc4-9a86-ea660a86a806 10fbe91f-3570-4cc4-9a86-ea660a86a806 TCGA-OL-A6VQ-01 TCGA-OL-A6VQ-01A-12D-A41Q-05 EF77266B-ED91-4FDA-AA99-CCCFAA90E687 TCGA-OL-A6VQ-01 TCGA-OL-A6VQ-01 10fbe91f-3570-4cc4-9a86-ea660a86a806 TCGA-OL-A6VQ-01A-12D-A41E-01 TCGA-OL-A6VQ-01 10fbe91f-3570-4cc4-9a86-ea660a86a806 TCGA-OL-A6VQ-01A-12D-A41E-01 TCGA-OL-A6VR-01 TCGA-OL-A6VR-01 TCGA-OL-A6VR TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 48 Right Sentinel lymph node biopsy plus axillary dissection TCGA-OL-A6VR-F59367 TCGA-OL-A6VR TCGA-OL-A6VR-01A Positive Positive Simple Mastectomy -17702 869 0 1220 30-39% 2014-5-10 FEMALE 1.23 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 380 NO Negative Negative NO 2 Negative NO 0 true No MX N0 T1b Stage IA TCGA-OL-A6VR.217745AA-6C5A-46C5-AC04-1C6581A96A04.pdf A6VR TUMOR FREE NO YES 90-99% NO Primary Tumor 01 7th NO YES OL Breast A LIVING 2011 19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4 19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4 TCGA-OL-A6VR-01 TCGA-OL-A6VR-01A-32D-A33F-05 TCGA-OL-A6VR-01 TCGA-OL-A6VR-01 19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4 TCGA-OL-A6VR-01A-32D-A33D-01 TCGA-OL-A6VR-01 19cbf7e8-ab1f-495c-a09e-ff3fe7c172e4 TCGA-OL-A6VR-01A-32D-A33D-01 TCGA-OL-A97C-01 TCGA-OL-A97C-01 TCGA-OL-A97C TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Left TCGA-OL-A97C-F66330 TCGA-OL-A97C TCGA-OL-A97C-01A Negative Negative Simple Mastectomy -24735 216 0 271 2014-10-31 FEMALE Other, specify No C50.9 9020/3 C50.9 YES Fine needle aspiration biopsy 410 NO Negative NO 6 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T3 Stage IIB TCGA-OL-A97C.1582865E-9294-4D78-8B16-92FB70381D15.pdf A97C TUMOR FREE YES NO Primary Tumor 01 7th NO YES OL Breast A LIVING 2013 590ae2bc-c076-4547-97dc-e2c8a0d396a6 590ae2bc-c076-4547-97dc-e2c8a0d396a6 TCGA-OL-A97C-01 TCGA-OL-A97C-01A-32D-A41Q-05 TCGA-OL-A97C-01 TCGA-OL-A97C-01 590ae2bc-c076-4547-97dc-e2c8a0d396a6 TCGA-OL-A97C-01A-32D-A41E-01 TCGA-OL-A97C-01 590ae2bc-c076-4547-97dc-e2c8a0d396a6 TCGA-OL-A97C-01A-32D-A41E-01 TCGA-PE-A5DC-01 TCGA-PE-A5DC-01 TCGA-PE-A5DC TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 72 Right Upper Inner Quadrant TCGA-PE-A5DC TCGA-PE-A5DC-01A Positive Positive -26514 2858 1430 0 2013-4-30 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES 350 NO Positive 31 Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 5 true No M0 N2a T2 Stage IIIA TCGA-PE-A5DC.8693580D-FCB3-4943-9C2F-5F3DABFB5AF0.pdf A5DC TUMOR FREE YES YES YES Primary Tumor 01 6th NO YES PE Breast A DECEASED 2005 05a8e240-5384-4a03-abeb-7ef3697c946d 05a8e240-5384-4a03-abeb-7ef3697c946d TCGA-PE-A5DC-01 TCGA-PE-A5DC-01A-12D-A27Y-05 bf2669ec-ff95-4bbd-9d78-451fd90ba389 TCGA-PE-A5DC-01 TCGA-PE-A5DC-01A-12D-A27P-09 TCGA-PE-A5DC-01 05a8e240-5384-4a03-abeb-7ef3697c946d TCGA-PE-A5DC-01A-12D-A27O-01 TCGA-PE-A5DC-01 05a8e240-5384-4a03-abeb-7ef3697c946d TCGA-PE-A5DC-01A-12D-A27O-01 TCGA-PE-A5DD-01 TCGA-PE-A5DD-01 TCGA-PE-A5DD TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right Lower Inner Quadrant TCGA-PE-A5DD-F66361 TCGA-PE-A5DD TCGA-PE-A5DD-01A Positive Negative Other -23686 2411 0 1953 2014-10-13 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Incisional Biopsy 270 NO Positive Positive YES 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T2 Stage IIA TCGA-PE-A5DD.7A2719FC-1CA2-4D58-9EF7-594926D1FF66.pdf A5DD TUMOR FREE YES YES YES Primary Tumor 01 Reexc of biopsy site for gross/micro residual disease 6th NO YES PE Breast A LIVING 2006 38adc5a4-bf82-4a06-a179-e84dd42593da 38adc5a4-bf82-4a06-a179-e84dd42593da TCGA-PE-A5DD-01 TCGA-PE-A5DD-01A-12D-A27Y-05 9e583b42-e1d2-4055-bf6d-eb6122474edf TCGA-PE-A5DD-01 TCGA-PE-A5DD-01A-12D-A27P-09 TCGA-PE-A5DD-01 38adc5a4-bf82-4a06-a179-e84dd42593da TCGA-PE-A5DD-01A-12D-A27O-01 TCGA-PE-A5DD-01 38adc5a4-bf82-4a06-a179-e84dd42593da TCGA-PE-A5DD-01A-12D-A27O-01 TCGA-PE-A5DE-01 TCGA-PE-A5DE-01 TCGA-PE-A5DE TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 41 Left TCGA-PE-A5DE-F66373 TCGA-PE-A5DE TCGA-PE-A5DE-01A Positive Positive Other -15216 2066 0 2645 2014-10-13 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 190 NO Negative NO 1 Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 true No M0 N0 T2 Stage IIA TCGA-PE-A5DE.6D2FA4DD-285F-4815-9494-76B297FA04AF.pdf A5DE TUMOR FREE YES YES YES Primary Tumor 01 Partial Mastectomy 6th NO YES PE Breast A LIVING 2007 041c71a0-06d5-44a5-8930-7f1dd2a638d1 041c71a0-06d5-44a5-8930-7f1dd2a638d1 TCGA-PE-A5DE-01 TCGA-PE-A5DE-01A-11D-A27Y-05 9a364ab7-d541-4771-bf12-11b8628cd9f1 TCGA-PE-A5DE-01 TCGA-PE-A5DE-01A-11D-A27P-09 TCGA-PE-A5DE-01 041c71a0-06d5-44a5-8930-7f1dd2a638d1 TCGA-PE-A5DE-01A-11D-A27O-01 TCGA-PE-A5DE-01 041c71a0-06d5-44a5-8930-7f1dd2a638d1 TCGA-PE-A5DE-01A-11D-A27O-01 TCGA-PL-A8LV-01 TCGA-PL-A8LV-01 TCGA-PL-A8LV TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 54 Right|Right Upper Outer Quadrant No axillary staging TCGA-PL-A8LV-F64849 TCGA-PL-A8LV TCGA-PL-A8LV-01A -19746 240 0 -7 2014-10-17 FEMALE Medullary Carcinoma No C50.9 8510/3 C50.9 YES Excisional Biopsy 840 NO YES false No M0 N0 T4 Stage IIIB TCGA-PL-A8LV.D35DBECD-5241-4562-85CC-2822BB338279.pdf A8LV WITH TUMOR NO NO Primary Tumor 01 7th YES NO PL Breast A LIVING 2013 34f3d207-0bfe-4699-b01b-d145942ba488 34f3d207-0bfe-4699-b01b-d145942ba488 TCGA-PL-A8LV-01 TCGA-PL-A8LV-01A-21D-A41Q-05 E260A9A0-230C-482C-A3E6-9A4DB6ECD90F TCGA-PL-A8LV-01 TCGA-PL-A8LV-01 34f3d207-0bfe-4699-b01b-d145942ba488 TCGA-PL-A8LV-01A-21D-A41E-01 TCGA-PL-A8LV-01 34f3d207-0bfe-4699-b01b-d145942ba488 TCGA-PL-A8LV-01A-21D-A41E-01 TCGA-PL-A8LX-01 TCGA-PL-A8LX-01 TCGA-PL-A8LX TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 35 Left|Left Upper Outer Quadrant TCGA-PL-A8LX-F64852 TCGA-PL-A8LX TCGA-PL-A8LX-01A -12840 74 0 5 2014-10-17 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 540 NO YES Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) Bone|Liver false No M1 N1a T4 Stage IV TCGA-PL-A8LX.E6DD0840-4D71-4EEC-B559-F6BFC9E7E68B.pdf A8LX WITH TUMOR NO YES NO Primary Tumor 01 7th YES NO PL Breast A LIVING 2013 19cadb60-b213-4fd3-b5ad-d2b49000b6a3 19cadb60-b213-4fd3-b5ad-d2b49000b6a3 TCGA-PL-A8LX-01 TCGA-PL-A8LX-01A-11D-A41Q-05 22B100C7-397E-4940-8A06-94FA7D3F46DC TCGA-PL-A8LX-01 TCGA-PL-A8LX-01 19cadb60-b213-4fd3-b5ad-d2b49000b6a3 TCGA-PL-A8LX-01A-11D-A41E-01 TCGA-PL-A8LX-01 19cadb60-b213-4fd3-b5ad-d2b49000b6a3 TCGA-PL-A8LX-01A-11D-A41E-01 TCGA-PL-A8LY-01 TCGA-PL-A8LY-01 TCGA-PL-A8LY TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 30 Right|Right Upper Outer Quadrant TCGA-PL-A8LY-F64851 TCGA-PL-A8LY TCGA-PL-A8LY-01A -11199 129 0 8 2014-10-17 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy 350 NO YES Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO false No M0 N0 T3 Stage IIB TCGA-PL-A8LY.8C97B391-96B4-468D-AAA3-24E196DE03CA.pdf A8LY WITH TUMOR NO NO NO Primary Tumor 01 7th YES NO PL Breast A LIVING 2013 2ca5942e-dcbf-46f1-8427-1ea7216dc559 2ca5942e-dcbf-46f1-8427-1ea7216dc559 TCGA-PL-A8LY-01 TCGA-PL-A8LY-01A-11D-A41Q-05 1133DAAA-33B9-4DA6-B84C-F1C7B576AB64 TCGA-PL-A8LY-01 TCGA-PL-A8LY-01 2ca5942e-dcbf-46f1-8427-1ea7216dc559 TCGA-PL-A8LY-01A-11D-A41E-01 TCGA-PL-A8LY-01 2ca5942e-dcbf-46f1-8427-1ea7216dc559 TCGA-PL-A8LY-01A-11D-A41E-01 TCGA-PL-A8LZ-01 TCGA-PL-A8LZ-01 TCGA-PL-A8LZ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 29 Left|Left Upper Outer Quadrant TCGA-PL-A8LZ-F64850 TCGA-PL-A8LZ -10869 0 302 2014-9-15 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Excisional Biopsy NO Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO No M0 N2 T4b Stage IIIB A8LZ TUMOR FREE YES NO Primary Tumor 01 7th YES NO PL Breast LIVING 2013 de01d9b6-e29d-495e-815a-c7d2a7c15af3 de01d9b6-e29d-495e-815a-c7d2a7c15af3 TCGA-PL-A8LZ-01 TCGA-PL-A8LZ-01A-31D-A36K-05 TCGA-PL-A8LZ-01 TCGA-PL-A8LZ-01 de01d9b6-e29d-495e-815a-c7d2a7c15af3 TCGA-PL-A8LZ-01A-31D-A36I-01 TCGA-PL-A8LZ-01 de01d9b6-e29d-495e-815a-c7d2a7c15af3 TCGA-PL-A8LZ-01A-31D-A36I-01 TCGA-S3-A6ZF-01 TCGA-S3-A6ZF-01 TCGA-S3-A6ZF TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right|Right Upper Outer Quadrant Sentinel node biopsy alone TCGA-S3-A6ZF-F67764 TCGA-S3-A6ZF TCGA-S3-A6ZF-01A Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy YES -23650 107 0 572 CAP scoring guideline 2010 90-99% 39 2014-11-11 FEMALE CAP scoring guideline 2010 50-59% 2+ 20 60 1.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 1350 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false No M0 N0 T2 Stage IIA TCGA-S3-A6ZF.7B53A0D4-E13E-4573-B0A2-BB55AE54BD62.pdf A6ZF TUMOR FREE CAP scoring guideline 2010 moderate Moderate YES YES 40-49% NO Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 4d464cde-4885-4b17-9e02-23be26be0540 4d464cde-4885-4b17-9e02-23be26be0540 TCGA-S3-A6ZF-01 TCGA-S3-A6ZF-01A-32D-A32T-05 TCGA-S3-A6ZF-01 TCGA-S3-A6ZF-01 4d464cde-4885-4b17-9e02-23be26be0540 TCGA-S3-A6ZF-01A-32D-A32H-01 TCGA-S3-A6ZF-01 4d464cde-4885-4b17-9e02-23be26be0540 TCGA-S3-A6ZF-01A-32D-A32H-01 TCGA-S3-A6ZG-01 TCGA-S3-A6ZG-01 TCGA-S3-A6ZG TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 71 Left|Left Upper Outer Quadrant Sentinel node biopsy alone TCGA-S3-A6ZG-F70438 TCGA-S3-A6ZG TCGA-S3-A6ZG-01A Positive 3 Point Scale 3 Point Scale Positive Lumpectomy YES -26141 102 0 562 CAP scoring guideline 2010 90-99% 2015-2-26 FEMALE CAP scoring guidelines 2010 <10% Mixed Histology (please specify) Invasive mixed ductal and lobular carcinoma No C50.9 8520/3 C50.9 YES Excisional Biopsy 980 NO Negative NO 3 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 0 false No M0 N1 T2 Stage IIB TCGA-S3-A6ZG.47D02B80-47DA-4135-A288-21077C5947A9.pdf A6ZG TUMOR FREE CAP scoring guideline 2010 Moderate Moderate YES YES 80-89% YES Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 0967df37-66ae-4ab3-a1fd-e196d4bc9995 0967df37-66ae-4ab3-a1fd-e196d4bc9995 TCGA-S3-A6ZG-01 TCGA-S3-A6ZG-01A-22D-A32T-05 CA211F7F-3EF6-4AC7-9C51-321C035AA4AF TCGA-S3-A6ZG-01 TCGA-S3-A6ZG-01 0967df37-66ae-4ab3-a1fd-e196d4bc9995 TCGA-S3-A6ZG-01A-22D-A32H-01 TCGA-S3-A6ZG-01 0967df37-66ae-4ab3-a1fd-e196d4bc9995 TCGA-S3-A6ZG-01A-22D-A32H-01 TCGA-S3-A6ZH-01 TCGA-S3-A6ZH-01 TCGA-S3-A6ZH TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 29 Left|Left Upper Outer Quadrant Axillary lymph node dissection alone TCGA-S3-A6ZH-F68306 TCGA-S3-A6ZH TCGA-S3-A6ZH-01A Positive 3 Point Scale 3 Point Scale Positive Simple Mastectomy NO -10832 158 0 641 90-99% 69 2014-11-14 FEMALE CAP scoring guideline 2010 CAP scoring guideline 2010 2+ 20 79 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 580 NO Equivocal Negative NO 21 Negative NO 14 0 false No MX N3a T3 Stage IIIC TCGA-S3-A6ZH.030860D0-66DF-46FF-95A3-2AE4852D5C19.pdf A6ZH TUMOR FREE CAP scoring guideline 2010 Strong Strong YES YES 80-89% YES Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 4cb51871-a26f-467e-8742-bb7c09b26ed2 4cb51871-a26f-467e-8742-bb7c09b26ed2 TCGA-S3-A6ZH-01 TCGA-S3-A6ZH-01A-22D-A32T-05 45E0455A-5D80-4D40-ACE5-F70316204288 TCGA-S3-A6ZH-01 TCGA-S3-A6ZH-01 4cb51871-a26f-467e-8742-bb7c09b26ed2 TCGA-S3-A6ZH-01A-22D-A32H-01 TCGA-S3-A6ZH-01 4cb51871-a26f-467e-8742-bb7c09b26ed2 TCGA-S3-A6ZH-01A-22D-A32H-01 TCGA-S3-AA0Z-01 TCGA-S3-AA0Z-01 TCGA-S3-AA0Z TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Left|Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-S3-AA0Z-F70168 TCGA-S3-AA0Z TCGA-S3-AA0Z-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Modified Radical Mastectomy YES -23314 204 0 629 CAP scoring guideline 2010 90-99% 33 2015-2-26 FEMALE CAP scoring guideline 2010 10-19% CAP scoring guideline 2010 1+ 20 42 1.3 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 330 NO Equivocal Negative NO 12 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 0 true No M0 N1a T2 Stage IIB TCGA-S3-AA0Z.6EC48BF8-C9AE-4B53-9DF4-850A5BAC6A6E.pdf AA0Z TUMOR FREE CAP scoring guideline 2010 moderate YES YES <10% NO Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 cfe44709-9e63-4dd4-9778-80176be7fbd9 cfe44709-9e63-4dd4-9778-80176be7fbd9 TCGA-S3-AA0Z-01 TCGA-S3-AA0Z-01A-11D-A41Q-05 A46027BA-DFAC-427A-89E3-51088763C0A0 TCGA-S3-AA0Z-01 TCGA-S3-AA0Z-01 cfe44709-9e63-4dd4-9778-80176be7fbd9 TCGA-S3-AA0Z-01A-11D-A41E-01 TCGA-S3-AA0Z-01 cfe44709-9e63-4dd4-9778-80176be7fbd9 TCGA-S3-AA0Z-01A-11D-A41E-01 TCGA-S3-AA10-01 TCGA-S3-AA10-01 TCGA-S3-AA10 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 65 Right|Right Upper Outer Quadrant Axillary lymph node dissection alone TCGA-S3-AA10-F70441 TCGA-S3-AA10 TCGA-S3-AA10-01A Negative 3 Point Scale 3 Point Scale Negative Simple Mastectomy NO -24075 168 0 586 CAP scoring guideline 2010 2015-2-26 FEMALE CAP scoring guideline 2010 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Fine needle aspiration biopsy 410 NO Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 true No M0 N0 T2 Stage IIA TCGA-S3-AA10.6A981CB0-F551-48B1-AB91-5D5585A7F282.pdf AA10 TUMOR FREE CAP scoring guideline 2010 YES YES NO Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 4c80c4a1-7e99-4f9e-b32c-898ae20206c5 4c80c4a1-7e99-4f9e-b32c-898ae20206c5 TCGA-S3-AA10-01 TCGA-S3-AA10-01A-21D-A41Q-05 F3DF6E4D-CA53-4DEA-B48D-652306B60C77 TCGA-S3-AA10-01 TCGA-S3-AA10-01 4c80c4a1-7e99-4f9e-b32c-898ae20206c5 TCGA-S3-AA10-01A-21D-A41E-01 TCGA-S3-AA10-01 4c80c4a1-7e99-4f9e-b32c-898ae20206c5 TCGA-S3-AA10-01A-21D-A41E-01 TCGA-S3-AA11-01 TCGA-S3-AA11-01 TCGA-S3-AA11 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 67 Right Sentinel node biopsy alone TCGA-S3-AA11-F67563 TCGA-S3-AA11 TCGA-S3-AA11-01A Positive 4 Point Scale 2+ 3 Point Scale Positive Lumpectomy YES -24813 148 0 421 CAP scoring guideline 2010 90-99% 40 2014-11-7 FEMALE CAP scoring guideline 2010 <10% CAP scoring guideline 2010 2+ 20 59 1.5 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 280 NO Equivocal Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 true No M0 N0 T2 Stage IIA TCGA-S3-AA11.B6605B1A-264D-46EF-BB6F-AD5EBE1B34DB.pdf AA11 TUMOR FREE CAP scoring guideline 2010 YES YES 60-69% YES Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 11785b0e-04c6-4cf5-80c6-2c4ffcb206f6 11785b0e-04c6-4cf5-80c6-2c4ffcb206f6 TCGA-S3-AA11-01 TCGA-S3-AA11-01A-31D-A41Q-05 424E9C41-A1FA-4342-AFA8-01DA15FD41E7 TCGA-S3-AA11-01 TCGA-S3-AA11-01 11785b0e-04c6-4cf5-80c6-2c4ffcb206f6 TCGA-S3-AA11-01A-31D-A41E-01 TCGA-S3-AA11-01 11785b0e-04c6-4cf5-80c6-2c4ffcb206f6 TCGA-S3-AA11-01A-31D-A41E-01 TCGA-S3-AA12-01 TCGA-S3-AA12-01 TCGA-S3-AA12 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 82 Left|Left Upper Inner Quadrant|Left Lower Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-S3-AA12-F70442 TCGA-S3-AA12 TCGA-S3-AA12-01A Positive 3 Point Scale 2+ 3 Point Scale Negative Simple Mastectomy NO -30101 156 0 574 CAP SCORING GUIDELINE 2010 90-99% 2015-2-26 FEMALE CAP SCORING GUIDELINE 2010 CAP SCORING GUIDELINE 2007 1+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 2+ YES Core needle biopsy 2190 NO Negative Negative NO 16 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Lung|Other, specify left adrenal gland NO 2 0 true Yes MX N1a T3 Stage IIIA TCGA-S3-AA12.9F96B0B1-2B88-49AE-8D3C-9FED70F1D950.pdf AA12 TUMOR FREE CAP SCORING GUIDELINE 2010 MODERATE MODERATE YES YES NO Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 a18a4d65-5383-4c29-ac03-959f8b9cb37d a18a4d65-5383-4c29-ac03-959f8b9cb37d TCGA-S3-AA12-01 TCGA-S3-AA12-01A-11D-A41Q-05 3761BFE6-9A5D-41AB-AA78-DFF11DA7B9B3 TCGA-S3-AA12-01 TCGA-S3-AA12-01 a18a4d65-5383-4c29-ac03-959f8b9cb37d TCGA-S3-AA12-01A-11D-A41E-01 TCGA-S3-AA12-01 a18a4d65-5383-4c29-ac03-959f8b9cb37d TCGA-S3-AA12-01A-11D-A41E-01 TCGA-S3-AA14-01 TCGA-S3-AA14-01 TCGA-S3-AA14 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 47 Right Sentinel node biopsy alone TCGA-S3-AA14-F70444 TCGA-S3-AA14 TCGA-S3-AA14-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Other YES -17352 127 0 529 CAP SCORING GUIDELINE 2010 70-79% 2015-2-26 FEMALE CAP SCORING GUIDELINE 2010 70-79% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 290 NO Positive NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 3 true No cM0 (i+) N0 (i+) T1 Stage I TCGA-S3-AA14.F4B87B89-A066-4BE9-88C9-60C7FB5BF373.pdf AA14 TUMOR FREE CAP SCORING GUIDELINE 2010 YES YES 70-79% YES Primary Tumor 01 EXCISION WITH NEEDLE WIRE LOCALIZATION 7th YES NO S3 Breast A LIVING 2013 eb8b259a-b2b3-4fb1-b9d3-b41480642da7 eb8b259a-b2b3-4fb1-b9d3-b41480642da7 TCGA-S3-AA14-01 TCGA-S3-AA14-01A-11D-A41Q-05 0F0662DF-E193-4F71-B2A3-FBE544DA5869 TCGA-S3-AA14-01 TCGA-S3-AA14-01 eb8b259a-b2b3-4fb1-b9d3-b41480642da7 TCGA-S3-AA14-01A-11D-A41E-01 TCGA-S3-AA14-01 eb8b259a-b2b3-4fb1-b9d3-b41480642da7 TCGA-S3-AA14-01A-11D-A41E-01 TCGA-S3-AA15-01 TCGA-S3-AA15-01 TCGA-S3-AA15 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 51 Right|Right Upper Inner Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-S3-AA15-F72098 TCGA-S3-AA15 TCGA-S3-AA15-01A Negative 3 Point Scale Negative Simple Mastectomy YES -18659 93 0 525 CAP SCORING GUIDELINE 2010 2015-4-10 FEMALE CAP SCORING GUIDELINE 2010 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 990 NO Negative NO 13 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 2 0 true No cM0 (i+) N1a T2 Stage IIB TCGA-S3-AA15.DD2B9E47-8C67-4599-B0B6-0D30DE727B55.pdf AA15 TUMOR FREE CAP SCORING GUIDELINE 2010 YES YES YES Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 181e9c9f-7dbd-4f3a-8298-12797c717e1f 181e9c9f-7dbd-4f3a-8298-12797c717e1f TCGA-S3-AA15-01 TCGA-S3-AA15-01A-11D-A41Q-05 A6D6E30B-1F8A-4B8B-B81C-5E016CBC4561 TCGA-S3-AA15-01 TCGA-S3-AA15-01 181e9c9f-7dbd-4f3a-8298-12797c717e1f TCGA-S3-AA15-01A-11D-A41E-01 TCGA-S3-AA15-01 181e9c9f-7dbd-4f3a-8298-12797c717e1f TCGA-S3-AA15-01A-11D-A41E-01 TCGA-S3-AA17-01 TCGA-S3-AA17-01 TCGA-S3-AA17 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 64 Right|Right Lower Outer Quadrant Sentinel node biopsy alone TCGA-S3-AA17-F67708 TCGA-S3-AA17 TCGA-S3-AA17-01A Positive 3 Point Scale 2+ 3 Point Scale Positive Simple Mastectomy YES -23642 92 0 424 CAP SCORING GUIDELINE 2010 90-99% 35 2014-11-11 FEMALE CAP SCORING GUIDELINE 2010 CAP SCORING GUIDELINE 2010 2+ 20 61 1.7 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 520 NO Equivocal Negative NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 1 true Yes cM0 (i+) N1mi T2 Stage IIB TCGA-S3-AA17.D7E24E6B-797F-4FC9-B0FB-794C4D379091.pdf AA17 TUMOR FREE CAP SCORING GUIDELINE 2010 MODERATE STRONG YES YES 70-79% YES Primary Tumor 01 7th YES NO S3 Breast A LIVING 2013 5e032694-2d7f-4e11-8800-0451ff71e5fe 5e032694-2d7f-4e11-8800-0451ff71e5fe TCGA-S3-AA17-01 TCGA-S3-AA17-01A-11D-A41Q-05 6D0969F0-27F9-4FF0-B943-F4F4510F917D TCGA-S3-AA17-01 TCGA-S3-AA17-01 5e032694-2d7f-4e11-8800-0451ff71e5fe TCGA-S3-AA17-01A-11D-A41E-01 TCGA-S3-AA17-01 5e032694-2d7f-4e11-8800-0451ff71e5fe TCGA-S3-AA17-01A-11D-A41E-01 TCGA-UL-AAZ6-01 TCGA-UL-AAZ6-01 TCGA-UL-AAZ6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 73 Right TCGA-UL-AAZ6-F69329 TCGA-UL-AAZ6 TCGA-UL-AAZ6-01A Positive 3 Point Scale Positive -26999 187 0 518 90-99% 2015-1-5 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES 170 NO Positive NO Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Positive 3+ Positive 90-99% 50-59% 3 Point Scale 3+ 1+ <10% Negative 3 Point Scale NO true No MX N0 T2 Stage IIA TCGA-UL-AAZ6.1AD1E3C4-0D7C-447B-B330-0245F9159FCC.pdf AAZ6 TUMOR FREE YES <10% NO Primary Tumor 01 7th YES NO UL Breast A LIVING 2013 5a6b1292-431d-4057-912f-6c8b8f12aed8 5a6b1292-431d-4057-912f-6c8b8f12aed8 TCGA-UL-AAZ6-01 TCGA-UL-AAZ6-01A-11D-A41Q-05 2102D1F5-40E4-41EA-A564-27AABF047BF9 TCGA-UL-AAZ6-01 TCGA-UL-AAZ6-01 5a6b1292-431d-4057-912f-6c8b8f12aed8 TCGA-UL-AAZ6-01A-11D-A41E-01 TCGA-UL-AAZ6-01 5a6b1292-431d-4057-912f-6c8b8f12aed8 TCGA-UL-AAZ6-01A-11D-A41E-01 TCGA-UU-A93S-01 TCGA-UU-A93S-01 TCGA-UU-A93S TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 63 Right|Right Upper Inner Quadrant|Right Upper Outer Quadrant|Right Lower Inner Quadrant|Right Lower Outer Quadrant No axillary staging TCGA-UU-A93S TCGA-UU-A93S-01A Negative Negative Modified Radical Mastectomy YES -23278 22 116 0 2014-11-11 FEMALE 90-99% 3+ Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Core needle biopsy 980 NO Positive Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone|Liver NO true No M1 N3b T4d Stage IV TCGA-UU-A93S.821ED144-DF12-4E49-ADC7-27FA5E422B83.pdf A93S WITH TUMOR NO NO NO Primary Tumor 01 7th YES NO UU Breast A DECEASED 2013 24ef9702-a1e5-4276-abb2-87088861d471 24ef9702-a1e5-4276-abb2-87088861d471 TCGA-UU-A93S-01 TCGA-UU-A93S-01A-21D-A41Q-05 49836FDA-BD22-48FC-A520-BC9CA5757C04 TCGA-UU-A93S-01 TCGA-UU-A93S-01 24ef9702-a1e5-4276-abb2-87088861d471 TCGA-UU-A93S-01A-21D-A41E-01 TCGA-UU-A93S-01 24ef9702-a1e5-4276-abb2-87088861d471 TCGA-UU-A93S-01A-21D-A41E-01 TCGA-V7-A7HQ-01 TCGA-V7-A7HQ-01 TCGA-V7-A7HQ TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 75 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-V7-A7HQ-F71970 TCGA-V7-A7HQ Negative Positive 3 Point Scale 3+ 3 Point Scale Other Positive Modified Radical Mastectomy Additional resection/ margins (taken after first margin positive) NO -27684 0 2033 60-69% 1.0 2015-3-31 FEMALE 20 1.1 1.1 Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 YES Tumor resection Negative NO 18 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 5 No M0 N2a T1c Stage IIIA A7HQ TUMOR FREE Moderate to strong YES YES 80-89% YES Primary Tumor 01 6th NO YES V7 Breast LIVING 2009 d42c079f-31a6-42cd-b02a-ea951b8d15a9 d42c079f-31a6-42cd-b02a-ea951b8d15a9 TCGA-V7-A7HQ-01 TCGA-V7-A7HQ-01A-11D-A33F-05 TCGA-V7-A7HQ-01 TCGA-V7-A7HQ-01 d42c079f-31a6-42cd-b02a-ea951b8d15a9 TCGA-V7-A7HQ-01A-11D-A33D-01 TCGA-V7-A7HQ-01 d42c079f-31a6-42cd-b02a-ea951b8d15a9 TCGA-V7-A7HQ-01A-11D-A33D-01 TCGA-W8-A86G-01 TCGA-W8-A86G-01 TCGA-W8-A86G TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 66 Left|Left Lower Inner Quadrant Sentinel node biopsy alone TCGA-W8-A86G-F65574 TCGA-W8-A86G TCGA-W8-A86G-01A Negative Positive 3 Point Scale 1+ 3 Point Scale Other Positive Lumpectomy Mastectomy YES -24125 126 0 347 90-99% 2014-9-25 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 1+ YES Core needle biopsy 210 NO Negative NO 1 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 0 false Yes MX N0 (i-) T2a Stage IIA TCGA-W8-A86G.A5433CA5-1DCC-4711-9B3B-6478AE7B5FAA.pdf A86G TUMOR FREE YES YES 70-79% NO Primary Tumor 01 7th YES NO W8 Breast A LIVING 2013 37106eb9-90ee-4468-aded-0709fa4bba47 37106eb9-90ee-4468-aded-0709fa4bba47 TCGA-W8-A86G-01 TCGA-W8-A86G-01A-21D-A36K-05 3927BD5E-5BB3-45A3-886F-639895BA69F8 TCGA-W8-A86G-01 TCGA-W8-A86G-01 37106eb9-90ee-4468-aded-0709fa4bba47 TCGA-W8-A86G-01A-21D-A36I-01 TCGA-W8-A86G-01 37106eb9-90ee-4468-aded-0709fa4bba47 TCGA-W8-A86G-01A-21D-A36I-01 TCGA-WT-AB41-01 TCGA-WT-AB41-01 TCGA-WT-AB41 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 55 Left Upper Outer Quadrant|Left Lower Inner Quadrant|Left Lower Outer Quadrant No axillary staging TCGA-WT-AB41-F66639 TCGA-WT-AB41 TCGA-WT-AB41-01A Positive 3 Point Scale 1+ 3 Point Scale Positive Modified Radical Mastectomy 1415 0 1611 90-99% 2014-10-21 FEMALE Infiltrating Ductal Carcinoma No C50.9 8500/3 C50.9 3+ YES Core needle biopsy 110 NO NO 2 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 1 false Yes MX N1mi T2 Stage IIB TCGA-WT-AB41.FDB00212-9782-4ACE-AD59-019384297A2F.pdf AB41 TUMOR FREE YES YES <10% NO Primary Tumor 01 7th NO YES WT Breast A LIVING 2010 a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa TCGA-WT-AB41-01 TCGA-WT-AB41-01A-11D-A41Q-05 3A31AEBF-2CC3-4604-8AF6-84DB45550587 TCGA-WT-AB41-01 TCGA-WT-AB41-01 a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa TCGA-WT-AB41-01A-11D-A41E-01 TCGA-WT-AB41-01 a8358182-9a5c-4272-b0e3-1cfc5b4cb2aa TCGA-WT-AB41-01A-11D-A41E-01 TCGA-WT-AB44-01 TCGA-WT-AB44-01 TCGA-WT-AB44 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 77 Left No axillary staging TCGA-WT-AB44-F66640 TCGA-WT-AB44 TCGA-WT-AB44-01A Positive 3 Point Scale 3+ 3 Point Scale Positive Lumpectomy 656 0 883 90-99% 2014-10-21 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 3+ YES Core needle biopsy 20 NO Negative NO 4 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No MX N0 (i-) T1c Stage IA TCGA-WT-AB44.B7EB0E0B-46C5-43C0-A78D-FB094290765A.pdf AB44 TUMOR FREE YES YES 90-99% YES Primary Tumor 01 7th NO YES WT Breast A LIVING 2012 77ea5b95-f8df-4fae-b271-182680c4a62a 77ea5b95-f8df-4fae-b271-182680c4a62a TCGA-WT-AB44-01 TCGA-WT-AB44-01A-11D-A41Q-05 TCGA-WT-AB44-01 TCGA-WT-AB44-01 77ea5b95-f8df-4fae-b271-182680c4a62a TCGA-WT-AB44-01A-11D-A41E-01 TCGA-WT-AB44-01 77ea5b95-f8df-4fae-b271-182680c4a62a TCGA-WT-AB44-01A-11D-A41E-01 TCGA-XX-A899-01 TCGA-XX-A899-01 TCGA-XX-A899 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-XX-A899-F67626 TCGA-XX-A899 TCGA-XX-A899-01A Positive Positive Modified Radical Mastectomy NO -17022 181 0 467 90-99% 2014-11-11 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 260 NO Negative NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 5 0 false No MX N2a T1c Stage IIIA TCGA-XX-A899.EA8A0A91-7A83-4EC9-B7A0-0C3300D1FD14.pdf A899 TUMOR FREE strong strong YES YES 70-79% YES Primary Tumor 01 7th NO YES XX Breast A LIVING 2013 8e339298-3e3c-4b31-96a9-a842e973e583 8e339298-3e3c-4b31-96a9-a842e973e583 TCGA-XX-A899-01 TCGA-XX-A899-01A-11D-A36K-05 1D814A7B-DA34-4E53-B6C5-23A22F6B5F10 TCGA-XX-A899-01 TCGA-XX-A899-01 8e339298-3e3c-4b31-96a9-a842e973e583 TCGA-XX-A899-01A-11D-A36I-01 TCGA-XX-A899-01 8e339298-3e3c-4b31-96a9-a842e973e583 TCGA-XX-A899-01A-11D-A36I-01 TCGA-XX-A899-11 TCGA-XX-A899-11 TCGA-XX-A899 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Right Lower Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-XX-A899-F67626 TCGA-XX-A899 TCGA-XX-A899-11A Positive Positive Modified Radical Mastectomy NO -17022 181 0 467 90-99% 2014-11-11 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 510 NO Negative NO 22 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 5 0 false No MX N2a T1c Stage IIIA A899 TUMOR FREE strong strong YES YES 70-79% YES Solid Tissue Normal 11 7th NO YES XX Breast A LIVING 2013 A8CECAA2-9F67-4079-8D69-3EA987F4BF69 TCGA-XX-A89A-01 TCGA-XX-A89A-01 TCGA-XX-A89A TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 68 Left Upper Outer Quadrant TCGA-XX-A89A-F67425 TCGA-XX-A89A TCGA-XX-A89A-01A Positive Positive Simple Mastectomy -25000 174 0 488 70-79% 2014-11-11 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 YES Core needle biopsy 250 NO Negative NO 11 Negative Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) NO 0 false No MX N0 T3 Stage IIB TCGA-XX-A89A.5D85E578-64B4-4238-922E-802B8ED87800.pdf A89A TUMOR FREE moderately to strongly moderately to strongly NO YES 70-79% YES Primary Tumor 01 7th NO YES XX Breast A LIVING 2013 501a70d8-3932-49c0-aa13-774756fb89e3 501a70d8-3932-49c0-aa13-774756fb89e3 TCGA-XX-A89A-01 TCGA-XX-A89A-01A-11D-A36K-05 TCGA-XX-A89A-01 TCGA-XX-A89A-01 501a70d8-3932-49c0-aa13-774756fb89e3 TCGA-XX-A89A-01A-11D-A36I-01 TCGA-XX-A89A-01 501a70d8-3932-49c0-aa13-774756fb89e3 TCGA-XX-A89A-01A-11D-A36I-01 TCGA-Z7-A8R5-01 TCGA-Z7-A8R5-01 TCGA-Z7-A8R5 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 61 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-Z7-A8R5-F58763 TCGA-Z7-A8R5 TCGA-Z7-A8R5-01A Positive 4 Point Scale 1+ 4 Point Scale Positive Other YES -22280 2928 0 3287 3287 2014-7-9 FEMALE Infiltrating Lobular Carcinoma No C50.9 8520/3 C50.9 2+ YES Core needle biopsy 450 NO Negative NO 5 Positive Post (prior bilateral ovariectomy OR >12 mo since LMP with no prior hysterectomy) Bone Locoregional Recurrence YES 3 3 true Yes MX N1a T3 Stage IIIA TCGA-Z7-A8R5.7726F7AA-88A8-4DD6-B322-6FC68893E0D2.pdf A8R5 WITH TUMOR YES YES NO Primary Tumor 01 Segmental Mastectomy 6th NO YES Z7 Breast A LIVING 2005 43c6d23b-2fcd-499e-82ef-10f15d8ede90 43c6d23b-2fcd-499e-82ef-10f15d8ede90 TCGA-Z7-A8R5-01 TCGA-Z7-A8R5-01A-42D-A41Q-05 049AE25E-31B6-4E0D-B67F-08B7034BF093 TCGA-Z7-A8R5-01 TCGA-Z7-A8R5-01 43c6d23b-2fcd-499e-82ef-10f15d8ede90 TCGA-Z7-A8R5-01A-42D-A41E-01 TCGA-Z7-A8R5-01 43c6d23b-2fcd-499e-82ef-10f15d8ede90 TCGA-Z7-A8R5-01A-42D-A41E-01 TCGA-Z7-A8R6-01 TCGA-Z7-A8R6-01 TCGA-Z7-A8R6 TCGA Breast Cancer (BRCA) breast invasive carcinoma Breast 46 Left Upper Outer Quadrant Sentinel lymph node biopsy plus axillary dissection TCGA-Z7-A8R6-F58752 TCGA-Z7-A8R6 TCGA-Z7-A8R6-01A Positive 4 Point Scale 2+ 4 Point Scale Positive Lumpectomy YES -16955 3020 0 3256 2014-7-9 FEMALE 1+ Infiltrating Lobular Carcinoma No C50.8 8022/3 C50.8 2+ YES Tumor resection 520 NO Negative NO 2 Negative Pre (<6 months since LMP AND no prior bilateral ovariectomy AND not on estrogen replacement) NO 0 0 true No M0 N0 T1c Stage I TCGA-Z7-A8R6.9A5C8EDF-9243-4F55-9036-A400CF3F4CC1.pdf A8R6 TUMOR FREE YES YES NO Primary Tumor 01 6th NO YES Z7 Breast A LIVING 2005 d8a45ca6-8f09-4949-8d55-13259b4826d2 d8a45ca6-8f09-4949-8d55-13259b4826d2 TCGA-Z7-A8R6-01 TCGA-Z7-A8R6-01A-11D-A41Q-05 DEEEA4DC-9DF5-4D60-92BF-01AEA22171DD TCGA-Z7-A8R6-01 TCGA-Z7-A8R6-01 d8a45ca6-8f09-4949-8d55-13259b4826d2 TCGA-Z7-A8R6-01A-11D-A41E-01 TCGA-Z7-A8R6-01 d8a45ca6-8f09-4949-8d55-13259b4826d2 TCGA-Z7-A8R6-01A-11D-A41E-01